TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207102_at	30	0.133333	0.00678861	0.12014	-1.52871	0.711675	0.395456	1.49 [0.18 - 12.09]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1692661	165	0.272727	0.00119357	0.0295516	-0.785135	0.0127222	-2.59808	0.07 [0.01 - 0.57]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1692661	165	0.248485	0.000655591	0.0178468	-1.14739	0.014154	-3.96175	0.02 [0.00 - 0.45]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207102_at	163	0.877301	0.103432	-	-0.561535	0.448044	-0.366452	0.69 [0.27 - 1.79]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207102_at	79	0.417722	0.165555	-	-0.401156	0.870967	0.142919	1.15 [0.21 - 6.47]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207102_at	58	0.827586	0.0343275	0.387369	0.808851	0.383948	0.15441	1.17 [0.82 - 1.65]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207102_at	34	0.882353	0.220375	-	-0.877791	0.76874	-0.0855212	0.92 [0.52 - 1.62]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207102_at	158	0.841772	0.0509135	-	-0.756112	0.541095	-0.437867	0.65 [0.16 - 2.63]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207102_at	53	0.150943	0.161624	-	0.8243	0.409037	0.188862	1.21 [0.77 - 1.89]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207102_at	53	0.113208	0.21454	-	0.880908	0.368224	0.221516	1.25 [0.77 - 2.02]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207102_at	180	0.716667	0.250666	-	-0.28088	0.670002	0.0552206	1.06 [0.82 - 1.36]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207102_at	559	0.347048	0.0540404	-	-0.395736	0.213061	-0.172243	0.84 [0.64 - 1.10]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207102_at	77	0.246753	0.0634746	-	-0.521696	0.31059	-0.28722	0.75 [0.43 - 1.31]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207102_at	70	0.885714	0.0584527	-	0.762501	0.0966221	2.6029	13.50 [0.63 - 291.06]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34084_at	50	0.52	0.0195626	0.26379	-0.810134	0.128256	-1.33087	0.26 [0.05 - 1.47]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207102_at	74	0.121622	0.00490351	0.093202	-1.05997	0.0643263	-0.524899	0.59 [0.34 - 1.03]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207102_at	67	0.731343	0.0750835	-	-15.5043	0.340756	-5.51647	0.00 [0.00 - 341.37]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207102_at	115	0.8	0.199248	-	-1.24974	0.266572	-0.651206	0.52 [0.17 - 1.64]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34084_at	158	0.829114	0.049958	0.491371	0.647035	0.5511	0.0761154	1.08 [0.84 - 1.39]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34084_at	76	0.302632	0.0298096	0.352753	1.93745	0.41933	0.182778	1.20 [0.77 - 1.87]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207102_at	204	0.803922	0.14818	-	-0.250726	0.878007	0.00792227	1.01 [0.91 - 1.12]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207102_at	87	0.712644	0.153033	-	0.557522	0.516187	-0.418253	0.66 [0.19 - 2.33]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207102_at	87	0.712644	0.153033	-	0.557522	0.516187	-0.418253	0.66 [0.19 - 2.33]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207102_at	77	0.272727	0.00769903	0.132363	-1.56196	0.105689	-4.47267	0.01 [0.00 - 2.57]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207102_at	77	0.324675	0.00956685	0.156159	-1.37179	0.120325	-3.46597	0.03 [0.00 - 2.48]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207102_at	136	0.191176	0.0266377	0.326919	-0.979946	0.131346	-0.29922	0.74 [0.50 - 1.09]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207102_at	200	0.135	0.270809	-	0.568799	0.643294	-0.0761079	0.93 [0.67 - 1.28]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9970	60	0.866667	0.236351	-	-0.845511	0.602588	0.0838971	1.09 [0.79 - 1.49]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	260	60	0.433333	0.125263	-	0.613857	0.258725	0.196245	1.22 [0.87 - 1.71]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9970	60	0.883333	0.0761965	-	0.858127	0.239186	0.167719	1.18 [0.89 - 1.56]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	260	60	0.183333	0.000451694	0.0129908	-1.39918	0.43181	0.129527	1.14 [0.82 - 1.57]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	8008	155	0.316129	8.78139e-06	0.000397154	-1.18367	0.000662681	-0.647633	0.52 [0.36 - 0.76]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207102_at	286	0.758741	0.0228373	0.294049	0.468554	0.728531	0.044014	1.04 [0.82 - 1.34]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207102_at	159	0.106918	0.296399	-	-0.458211	0.62051	0.108631	1.11 [0.73 - 1.71]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207102_at	159	0.72327	0.160352	-	-0.677382	0.29759	0.246175	1.28 [0.80 - 2.03]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207102_at	159	0.194969	0.102593	-	0.836182	0.0801791	0.329946	1.39 [0.96 - 2.01]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207102_at	54	0.203704	0.112037	-	15.4475	0.849506	-0.32094	0.73 [0.03 - 19.97]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207102_at	117	0.239316	0.185869	-	0.578284	0.753282	-0.104601	0.90 [0.47 - 1.73]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207102_at	117	0.205128	0.233936	-	0.712454	0.805404	-0.0953436	0.91 [0.43 - 1.94]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207102_at	117	0.735043	0.388089	-	-0.426585	0.793919	-0.108148	0.90 [0.40 - 2.02]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207102_at	117	0.239316	0.185869	-	0.578284	0.753282	-0.104601	0.90 [0.47 - 1.73]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207102_at	236	0.639831	0.125882	-	0.414679	0.150754	0.454355	1.58 [0.85 - 2.93]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207102_at	249	0.361446	0.0545357	-	-0.406701	0.967388	0.00858846	1.01 [0.67 - 1.52]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207102_at	62	0.887097	0.0353896	0.395169	-15.478	0.506366	-0.354543	0.70 [0.25 - 2.00]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207102_at	125	0.664	0.0119178	0.184092	0.922523	0.183787	0.466731	1.59 [0.80 - 3.17]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207102_at	125	0.664	0.0688337	-	0.519166	0.101592	0.448985	1.57 [0.92 - 2.68]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207102_at	54	0.87037	0.0638151	-	-15.5442	0.4804	-0.460181	0.63 [0.18 - 2.27]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207102_at	198	0.560606	0.00398739	0.0791223	0.730457	0.0177529	0.20102	1.22 [1.04 - 1.44]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207102_at	198	0.580808	0.00370035	0.0745459	0.7705	0.0182532	0.207634	1.23 [1.04 - 1.46]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207102_at	198	0.686869	0.011624	0.180708	0.539758	0.0195691	0.165263	1.18 [1.03 - 1.36]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207102_at	51	0.882353	0.000308077	0.00934826	2.54999	0.00359584	10.4298	33853.58 [30.23 - 37914841.89]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207102_at	62	0.870968	0.000303635	0.00923175	1.85562	0.00273072	5.862	351.43 [7.60 - 16256.85]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207102_at	177	0.20339	0.00501633	0.094886	-0.791991	0.127381	-2.16571	0.11 [0.01 - 1.86]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207102_at	177	0.20339	0.0337817	0.383312	-0.553256	0.577152	0.233206	1.26 [0.56 - 2.87]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207102_at	145	0.793103	0.0297383	0.352188	0.77353	0.431224	1.47652	4.38 [0.11 - 173.00]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207102_at	226	0.597345	0.0175328	0.243994	-0.769473	0.0952979	-0.234582	0.79 [0.60 - 1.04]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207102_at	55	0.690909	0.0439718	0.454078	0.882092	0.00825759	2.33337	10.31 [1.83 - 58.26]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207102_at	55	0.890909	0.0186107	0.254613	1.42789	0.0181933	1.7566	5.79 [1.35 - 24.89]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207102_at	49	0.734694	0.156412	-	0.812036	0.334699	2.2214	9.22 [0.10 - 841.10]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207102_at	63	0.238095	0.00226986	0.0502351	-1.03594	0.0921659	-6.94732	0.00 [0.00 - 3.12]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5174694_3p_at	28	0.25	0.10564	-	-0.929474	0.260893	-1.8362	0.16 [0.01 - 3.92]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207102_at	82	0.634146	0.175252	-	0.458467	0.893719	-0.055088	0.95 [0.42 - 2.12]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207102_at	79	0.835443	0.0737546	-	-0.673663	0.849242	0.0797321	1.08 [0.48 - 2.46]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207102_at	104	0.317308	0.143393	-	0.57405	0.614305	0.28784	1.33 [0.44 - 4.09]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207102_at	204	0.622549	0.130742	-	-0.614662	0.976856	0.00588119	1.01 [0.68 - 1.50]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207102_at	204	0.102941	0.0295203	0.350453	-0.746122	0.111185	-0.219797	0.80 [0.61 - 1.05]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207102_at	178	0.331461	0.0456466	0.4648	-0.405016	0.693197	-0.0877713	0.92 [0.59 - 1.42]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207102_at	111	0.576577	0.0132591	0.199189	-0.67391	0.192325	-0.192711	0.82 [0.62 - 1.10]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207102_at	90	0.177778	0.100613	-	-0.596927	0.699296	-0.667964	0.51 [0.02 - 15.20]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207102_at	90	0.533333	0.13228	-	0.560382	0.596144	0.962406	2.62 [0.07 - 92.00]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207102_at	138	0.818841	0.0365725	0.403714	-0.770746	0.048681	-4.54573	0.01 [0.00 - 0.97]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207102_at	129	0.534884	0.017143	0.240091	0.591136	0.144802	0.439379	1.55 [0.86 - 2.80]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23930	56	0.892857	0.0113623	0.177671	1.21155	0.226558	0.206258	1.23 [0.88 - 1.72]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27421	56	0.892857	0.0137016	0.204051	1.10763	0.387401	0.24771	1.28 [0.73 - 2.25]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23930	56	0.303571	0.0585948	-	0.800911	0.188428	0.211726	1.24 [0.90 - 1.69]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27421	56	0.803571	0.0339138	0.384297	0.855089	0.670626	0.128139	1.14 [0.63 - 2.05]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207102_at	278	0.899281	0.0837352	-	0.496541	0.551456	0.573898	1.78 [0.27 - 11.73]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207102_at	133	0.601504	0.00164445	0.0385571	0.732626	0.0378856	0.670711	1.96 [1.04 - 3.68]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6074	81	0.246914	0.146106	-	1.06109	0.655654	0.159684	1.17 [0.58 - 2.37]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9440	81	0.209877	0.222268	-	0.929322	0.995126	-0.00408007	1.00 [0.27 - 3.69]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207102_at	185	0.864865	0.243258	-	0.26936	0.582573	0.0942834	1.10 [0.79 - 1.54]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207102_at	185	0.864865	0.170279	-	0.333496	0.468503	0.123862	1.13 [0.81 - 1.58]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P255185	110	0.681818	0.00266129	0.0571744	0.708637	0.556309	0.0872076	1.09 [0.82 - 1.46]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P382000	110	0.627273	0.00157077	0.037124	0.727923	0.265388	0.214255	1.24 [0.85 - 1.81]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P255185	110	0.7	0.022083	0.287248	0.67955	0.604924	0.107824	1.11 [0.74 - 1.68]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P382000	110	0.718182	0.0290814	0.346941	0.666449	0.609158	0.133787	1.14 [0.68 - 1.91]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207102_at	80	0.8875	0.0158712	0.227117	1.12904	0.199902	0.354963	1.43 [0.83 - 2.45]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1588	281	0.768683	0.0819008	-	-0.293801	0.284095	-0.101366	0.90 [0.75 - 1.09]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207102_at	38	0.684211	0.0774297	-	-0.927018	0.761335	-0.0794478	0.92 [0.55 - 1.54]
GENE	AKR1D1	aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207102_at	140	0.271429	0.104793	-	0.618667	0.940979	0.157259	1.17 [0.02 - 75.21]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202139_at	30	0.866667	0.00229181	0.0506309	1.92091	0.514551	0.312955	1.37 [0.53 - 3.50]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214259_s_at	30	0.133333	0.253784	-	-0.628529	0.806644	-0.173747	0.84 [0.21 - 3.38]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1677043	165	0.830303	0.0201938	0.269776	0.673425	0.2948	0.248177	1.28 [0.81 - 2.04]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1677043	165	0.8	0.0028259	0.0600213	1.04721	0.0285709	0.82421	2.28 [1.09 - 4.77]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202139_at	163	0.552147	0.0846877	-	-0.345532	0.83948	-0.0275994	0.97 [0.74 - 1.27]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214259_s_at	163	0.895706	0.282434	-	0.317611	0.674287	0.0672352	1.07 [0.78 - 1.46]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202139_at	79	0.56962	0.00361332	0.0731411	0.836462	0.114872	0.248647	1.28 [0.94 - 1.75]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214259_s_at	79	0.379747	0.016477	0.233344	0.766156	0.0983886	0.311232	1.37 [0.94 - 1.97]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214259_s_at	58	0.793103	0.0104749	0.16719	0.852368	0.974093	-0.0157345	0.98 [0.38 - 2.54]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202139_at	58	0.862069	0.011926	0.184186	0.953637	0.279312	0.298303	1.35 [0.78 - 2.31]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214259_s_at	34	0.117647	0.0289763	0.346097	1.93105	0.125068	0.536146	1.71 [0.86 - 3.39]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202139_at	34	0.823529	0.00913448	0.150789	1.17317	0.0551197	1.12122	3.07 [0.98 - 9.65]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214259_s_at	158	0.386076	0.144457	-	-0.338714	0.52347	-0.205397	0.81 [0.43 - 1.53]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202139_at	158	0.126582	0.00397211	0.0788809	-0.815706	0.297888	-0.272401	0.76 [0.46 - 1.27]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202139_at	53	0.339623	0.27419	-	-0.406144	0.996534	0.00219556	1.00 [0.37 - 2.70]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214259_s_at	53	0.415094	0.00876022	0.146077	-0.942759	0.40379	-0.540965	0.58 [0.16 - 2.07]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202139_at	53	0.132075	0.240647	-	0.696234	0.918694	-0.0465798	0.95 [0.39 - 2.33]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214259_s_at	53	0.415094	0.0202417	0.270228	-0.792345	0.44142	-0.458735	0.63 [0.20 - 2.03]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202139_at	180	0.188889	0.00144092	0.0345639	-0.760804	0.0471643	-0.643264	0.53 [0.28 - 0.99]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214259_s_at	180	0.316667	0.212221	-	-0.268579	0.693511	-0.124169	0.88 [0.48 - 1.64]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202139_at	559	0.447227	0.0143599	0.211182	-0.513618	0.0826631	-0.44316	0.64 [0.39 - 1.06]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214259_s_at	559	0.815742	0.0327695	0.375702	-0.816639	0.225739	-0.353817	0.70 [0.40 - 1.24]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214259_s_at	77	0.766234	0.00951921	0.155571	0.759721	0.480047	0.276769	1.32 [0.61 - 2.84]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202139_at	77	0.896104	0.00591854	0.108006	1.0275	0.579498	-0.132734	0.88 [0.55 - 1.40]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214259_s_at	70	0.828571	0.0236994	0.301704	0.742148	0.728403	0.109109	1.12 [0.60 - 2.06]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202139_at	70	0.814286	0.100448	-	0.535993	0.666672	0.139075	1.15 [0.61 - 2.16]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32510_at	50	0.6	0.104233	-	0.577754	0.178103	0.276359	1.32 [0.88 - 1.97]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202139_at	74	0.351351	0.128552	-	0.479464	0.991152	-0.00633251	0.99 [0.32 - 3.04]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214259_s_at	74	0.891892	0.00404959	0.0801029	1.11134	0.0354925	1.17452	3.24 [1.08 - 9.67]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214259_s_at	67	0.179104	0.0231755	0.297066	-1.41737	0.0567126	-1.39753	0.25 [0.06 - 1.04]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202139_at	67	0.104478	0.00479871	0.0916286	-1.77774	0.0219524	-1.12493	0.32 [0.12 - 0.85]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214259_s_at	115	0.53913	0.00198678	0.0450493	-2.50384	0.0610049	-1.47813	0.23 [0.05 - 1.07]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202139_at	115	0.895652	0.186254	-	-15.1878	0.429266	-0.615233	0.54 [0.12 - 2.49]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32510_at	158	0.594937	0.0133876	0.200607	-0.778399	0.0542651	-0.684543	0.50 [0.25 - 1.01]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32510_at	76	0.368421	0.0985206	-	1.02632	0.407886	0.411073	1.51 [0.57 - 3.99]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202139_at	204	0.343137	0.078751	-	-0.262427	0.170396	-0.231717	0.79 [0.57 - 1.10]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214259_s_at	204	0.740196	0.013185	0.19837	-0.401935	0.157378	-0.267221	0.77 [0.53 - 1.11]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214259_s_at	87	0.83908	0.0330236	0.377623	0.865813	0.717573	0.170751	1.19 [0.47 - 2.99]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202139_at	87	0.873563	0.0110885	0.174467	1.06007	0.997794	-0.000878605	1.00 [0.54 - 1.86]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202139_at	87	0.873563	0.0110885	0.174467	1.06007	0.997794	-0.000878605	1.00 [0.54 - 1.86]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214259_s_at	87	0.83908	0.0330236	0.377623	0.865813	0.717573	0.170751	1.19 [0.47 - 2.99]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214259_s_at	77	0.74026	0.0502227	-	-15.5313	0.194603	-0.823486	0.44 [0.13 - 1.52]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202139_at	77	0.701299	0.0300591	0.35473	-15.6354	0.240176	-0.602112	0.55 [0.20 - 1.50]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202139_at	77	0.194805	0.0319691	0.3696	-1.15959	0.107189	-0.721483	0.49 [0.20 - 1.17]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214259_s_at	77	0.194805	0.024944	0.312545	-1.20953	0.109698	-0.889984	0.41 [0.14 - 1.22]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202139_at	136	0.102941	0.0406854	0.432336	-1.10624	0.210177	-0.394361	0.67 [0.36 - 1.25]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214259_s_at	136	0.735294	0.00356389	0.0723395	1.24788	0.0779715	0.785003	2.19 [0.92 - 5.25]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202139_at	200	0.19	0.034171	0.386209	-0.658071	0.539351	-0.256594	0.77 [0.34 - 1.76]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214259_s_at	200	0.89	0.000628088	0.0172091	1.16728	0.349854	0.39283	1.48 [0.65 - 3.38]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20286	60	0.7	0.133576	-	-0.681389	0.581876	-0.150259	0.86 [0.50 - 1.47]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20286	60	0.55	0.17467	-	-0.521855	0.950774	-0.0322276	0.97 [0.35 - 2.69]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18589	155	0.129032	0.000449824	0.0129447	-1.07982	0.51647	0.0856655	1.09 [0.84 - 1.41]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202139_at	286	0.272727	0.000727088	0.0194831	-0.661954	0.0187293	-0.432701	0.65 [0.45 - 0.93]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214259_s_at	286	0.29021	0.0144531	0.212181	0.586719	0.333312	0.242948	1.28 [0.78 - 2.09]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214259_s_at	159	0.603774	0.0202808	0.270595	0.850012	0.919677	0.051024	1.05 [0.39 - 2.84]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202139_at	159	0.679245	0.0156921	0.225258	0.748242	0.56111	0.234245	1.26 [0.57 - 2.78]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202139_at	159	0.383648	0.19287	-	0.445998	0.734377	0.135722	1.15 [0.52 - 2.51]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214259_s_at	159	0.591195	0.0327188	0.375318	0.666863	0.771249	0.124218	1.13 [0.49 - 2.62]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202139_at	159	0.691824	0.0678319	-	0.669867	0.667102	0.203607	1.23 [0.48 - 3.10]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214259_s_at	159	0.603774	0.107168	-	0.504718	0.88856	-0.0605915	0.94 [0.40 - 2.20]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214259_s_at	54	0.814815	0.175838	-	0.940856	0.383779	0.554261	1.74 [0.50 - 6.06]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202139_at	54	0.833333	0.117653	-	1.21375	0.409044	0.319654	1.38 [0.64 - 2.94]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214259_s_at	117	0.111111	0.0625825	-	15.1885	0.477208	0.209047	1.23 [0.69 - 2.19]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214259_s_at	117	0.615385	0.208454	-	-0.430632	0.880226	0.0354567	1.04 [0.65 - 1.64]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214259_s_at	117	0.17094	0.150925	-	1.01427	0.837897	0.0597337	1.06 [0.60 - 1.88]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214259_s_at	117	0.615385	0.208454	-	-0.430632	0.880226	0.0354567	1.04 [0.65 - 1.64]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202139_at	117	0.717949	0.152474	-	-0.586567	0.819483	-0.0432756	0.96 [0.66 - 1.39]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202139_at	117	0.564103	0.0794512	-	0.658732	0.734157	0.0775579	1.08 [0.69 - 1.69]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202139_at	117	0.717949	0.152474	-	-0.586567	0.819483	-0.0432756	0.96 [0.66 - 1.39]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202139_at	117	0.854701	0.0374469	0.409938	-15.2472	0.418537	-0.184913	0.83 [0.53 - 1.30]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202139_at	236	0.275424	0.255587	-	0.380556	0.877014	0.0439621	1.04 [0.60 - 1.82]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214259_s_at	236	0.576271	0.114969	-	0.422906	0.748194	0.124519	1.13 [0.53 - 2.42]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214259_s_at	249	0.590361	0.0927959	-	0.354345	0.845996	0.0595342	1.06 [0.58 - 1.94]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202139_at	249	0.204819	0.320224	-	0.286829	0.920687	-0.0225033	0.98 [0.63 - 1.52]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214259_s_at	62	0.854839	0.0278949	0.337321	1.07684	0.566568	0.178725	1.20 [0.65 - 2.20]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202139_at	125	0.856	0.0588327	-	-0.886412	0.87055	-0.0310322	0.97 [0.67 - 1.41]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202139_at	54	0.796296	0.0465638	0.470575	1.11456	0.352333	0.445909	1.56 [0.61 - 4.00]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214259_s_at	125	0.4	0.123477	-	0.663868	0.727372	0.142748	1.15 [0.52 - 2.57]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214259_s_at	125	0.336	0.0824766	-	0.610319	0.861124	0.0541141	1.06 [0.58 - 1.94]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214259_s_at	54	0.87037	0.0304688	0.357957	1.27497	0.484994	0.272661	1.31 [0.61 - 2.82]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202139_at	62	0.790323	0.00682789	0.120677	1.21596	0.255635	0.432141	1.54 [0.73 - 3.25]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202139_at	125	0.36	0.0880947	-	0.823169	0.734809	0.0847688	1.09 [0.67 - 1.78]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214259_s_at	198	0.787879	0.0995131	-	-0.61541	0.329796	-0.21632	0.81 [0.52 - 1.24]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214259_s_at	198	0.535354	0.0916893	-	-0.461888	0.212694	-0.291401	0.75 [0.47 - 1.18]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202139_at	198	0.611111	0.0734365	-	0.380141	0.255714	0.176459	1.19 [0.88 - 1.62]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202139_at	198	0.843434	0.0943684	-	-0.763146	0.908704	-0.0213246	0.98 [0.68 - 1.41]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214259_s_at	198	0.712121	0.174142	-	-0.331706	0.876382	-0.0285278	0.97 [0.68 - 1.39]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202139_at	198	0.843434	0.0595328	-	-0.942917	0.648795	-0.0875106	0.92 [0.63 - 1.34]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202139_at	62	0.274194	0.0701166	-	1.68718	0.516864	0.264067	1.30 [0.59 - 2.89]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214259_s_at	51	0.72549	0.0665006	-	1.53061	0.478864	0.630232	1.88 [0.33 - 10.75]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214259_s_at	62	0.467742	0.265219	-	0.670349	0.657281	0.250547	1.28 [0.42 - 3.89]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202139_at	51	0.176471	0.277317	-	15.3433	0.159134	0.82735	2.29 [0.72 - 7.24]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214259_s_at	177	0.435028	0.117255	-	0.436082	0.918102	0.033785	1.03 [0.54 - 1.97]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202139_at	177	0.847458	0.145098	-	-0.540415	0.856007	0.043847	1.04 [0.65 - 1.68]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202139_at	177	0.751412	0.201257	-	-0.444493	0.863367	0.0481862	1.05 [0.61 - 1.82]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214259_s_at	177	0.435028	0.133221	-	0.359809	0.782608	0.0787577	1.08 [0.62 - 1.89]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202139_at	145	0.724138	0.0415265	0.437992	-0.948479	0.29344	-0.342663	0.71 [0.37 - 1.35]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214259_s_at	145	0.365517	0.0221672	0.288013	-0.747091	0.158672	-0.549394	0.58 [0.27 - 1.24]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202139_at	226	0.60177	0.0129172	0.195393	-0.803106	0.0665898	-0.511319	0.60 [0.35 - 1.04]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214259_s_at	226	0.252212	0.00519259	0.0974967	-0.782742	0.0836875	-0.496125	0.61 [0.35 - 1.07]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202139_at	55	0.690909	0.03363	0.382179	0.9269	0.615799	0.175872	1.19 [0.60 - 2.37]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214259_s_at	55	0.654545	0.0376494	0.411368	0.903302	0.202622	0.604103	1.83 [0.72 - 4.63]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214259_s_at	55	0.690909	0.0830931	-	0.784426	0.223838	0.607305	1.84 [0.69 - 4.88]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214259_s_at	49	0.734694	0.0278119	0.336641	1.22654	0.167992	0.840175	2.32 [0.70 - 7.65]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202139_at	55	0.218182	0.104181	-	-0.835817	0.855453	-0.0667936	0.94 [0.46 - 1.92]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202139_at	49	0.244898	0.0841771	-	-0.976154	0.728307	-0.14917	0.86 [0.37 - 2.00]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202139_at	63	0.333333	0.168973	-	-0.472206	0.938732	-0.0129085	0.99 [0.71 - 1.37]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214259_s_at	63	0.15873	0.220664	-	-0.489821	0.456807	-0.144512	0.87 [0.59 - 1.27]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502020_3p_a_at	28	0.607143	0.176629	-	0.747062	0.843328	0.0246157	1.02 [0.80 - 1.31]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202139_at	82	0.109756	0.109685	-	-0.702066	0.351745	-0.388569	0.68 [0.30 - 1.54]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214259_s_at	82	0.109756	0.0215885	0.282738	-0.942412	0.111301	-0.806721	0.45 [0.17 - 1.20]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32510_at	84	0.166667	0.00452935	0.0875423	-0.96702	0.305549	-0.441794	0.64 [0.28 - 1.50]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202139_at	79	0.227848	0.0872092	-	-0.498416	0.235744	-0.46614	0.63 [0.29 - 1.36]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214259_s_at	79	0.316456	0.0201957	0.269794	-0.610655	0.151449	-0.659979	0.52 [0.21 - 1.27]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202139_at	104	0.576923	0.262641	-	-0.379233	0.909077	0.0467373	1.05 [0.47 - 2.34]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214259_s_at	104	0.432692	0.0871295	-	-0.549104	0.464334	-0.48623	0.61 [0.17 - 2.26]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P115356	117	0.74359	0.00264631	0.0569133	0.866489	0.427092	0.277268	1.32 [0.67 - 2.62]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214259_s_at	204	0.882353	0.287571	-	0.386116	0.723448	0.184565	1.20 [0.43 - 3.34]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202139_at	204	0.5	0.100936	-	-0.613548	0.785615	-0.157359	0.85 [0.27 - 2.66]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202139_at	204	0.220588	0.0297581	0.352345	0.909651	0.222112	0.542138	1.72 [0.72 - 4.11]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214259_s_at	204	0.127451	0.226606	-	-0.545656	0.734099	-0.235576	0.79 [0.20 - 3.08]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202139_at	178	0.573034	0.0133053	0.199699	-0.506936	0.0764296	-0.611367	0.54 [0.28 - 1.07]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214259_s_at	178	0.252809	0.216655	-	0.301723	0.995445	0.00196022	1.00 [0.51 - 1.96]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200001339	41	0.829268	0.0677973	-	0.85215	0.592677	0.238696	1.27 [0.53 - 3.04]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202139_at	111	0.522523	0.0143349	0.210913	0.640206	0.112699	0.643862	1.90 [0.86 - 4.22]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214259_s_at	111	0.18018	0.00584916	0.107018	1.13584	0.050525	0.646172	1.91 [1.00 - 3.65]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202139_at	90	0.855556	0.15026	-	0.649649	0.500182	0.242257	1.27 [0.63 - 2.58]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202139_at	90	0.577778	0.067268	-	0.588858	0.314089	0.316091	1.37 [0.74 - 2.54]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214259_s_at	90	0.722222	0.106246	-	0.537512	0.464055	0.25808	1.29 [0.65 - 2.58]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214259_s_at	90	0.733333	0.212922	-	0.482482	0.745798	0.131516	1.14 [0.51 - 2.53]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4078	50	0.12	0.0886338	-	15.255	0.525554	0.272732	1.31 [0.57 - 3.05]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202139_at	138	0.572464	0.275086	-	0.263293	0.697834	0.048083	1.05 [0.82 - 1.34]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214259_s_at	138	0.608696	0.0171156	0.239815	-0.623916	0.636949	-0.0812909	0.92 [0.66 - 1.29]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202139_at	129	0.51938	0.0785754	-	-0.43879	0.710157	-0.186949	0.83 [0.31 - 2.22]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214259_s_at	129	0.116279	0.108567	-	0.732925	0.460289	0.315122	1.37 [0.59 - 3.16]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27798	56	0.767857	0.241644	-	0.437824	0.631424	0.165757	1.18 [0.60 - 2.32]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4329	56	0.75	0.116283	-	0.568559	0.256431	0.362021	1.44 [0.77 - 2.68]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27798	56	0.375	0.21767	-	-0.435889	0.842514	0.0765838	1.08 [0.51 - 2.30]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4329	56	0.75	0.206526	-	0.495676	0.415592	0.288361	1.33 [0.67 - 2.67]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214259_s_at	278	0.546763	0.0222557	0.288815	0.433886	0.100238	0.333544	1.40 [0.94 - 2.08]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202139_at	278	0.694245	0.0502529	-	0.385017	0.260285	0.196646	1.22 [0.86 - 1.71]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214259_s_at	133	0.458647	0.012992	0.196227	0.61101	0.035792	0.314392	1.37 [1.02 - 1.84]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202139_at	133	0.849624	0.00882915	0.14695	0.759945	0.110976	0.165928	1.18 [0.96 - 1.45]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214259_s_at	185	0.805405	0.0609588	-	-0.392357	0.641732	-0.060864	0.94 [0.73 - 1.22]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202139_at	185	0.108108	0.0328004	0.375936	-0.534602	0.696261	-0.0369385	0.96 [0.80 - 1.16]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202139_at	185	0.108108	0.0806721	-	-0.479098	0.786564	-0.0279167	0.97 [0.79 - 1.19]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214259_s_at	185	0.383784	0.177423	-	-0.250147	0.873253	0.0230808	1.02 [0.77 - 1.36]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P115356	110	0.4	0.123705	-	0.367785	0.720985	0.0698554	1.07 [0.73 - 1.57]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P115356	110	0.7	0.0139695	0.206967	-0.892717	0.775257	-0.0671124	0.94 [0.59 - 1.48]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202139_at	80	0.125	0.180997	-	-0.678674	0.604011	-0.207248	0.81 [0.37 - 1.78]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214259_s_at	80	0.125	0.103103	-	-0.829896	0.416354	-0.430721	0.65 [0.23 - 1.84]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_3569	281	0.231317	0.0454844	0.463772	0.348005	0.381057	0.153645	1.17 [0.83 - 1.64]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:238805	59	0.423729	0.0170036	0.238688	1.40463	0.244441	0.77354	2.17 [0.59 - 7.97]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:322522	59	0.135593	0.130034	-	-0.859992	0.108904	-0.801277	0.45 [0.17 - 1.20]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214259_s_at	38	0.368421	0.000266493	0.00824665	2.40721	0.00224718	1.92652	6.87 [2.00 - 23.63]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202139_at	38	0.315789	3.22915e-05	0.00128364	16.2569	0.000148219	2.07046	7.93 [2.72 - 23.11]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202139_at	140	0.214286	0.101877	-	-0.516359	0.515868	-0.185068	0.83 [0.48 - 1.45]
GENE	AKR7A2	aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214259_s_at	140	0.257143	0.0853534	-	-0.514873	0.662537	-0.166326	0.85 [0.40 - 1.79]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALAD	aminolevulinate dehydratase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218489_s_at	30	0.866667	0.000434724	0.0125715	2.12976	0.0673918	2.27087	9.69 [0.85 - 110.42]
GENE	ALAD	aminolevulinate dehydratase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218487_at	30	0.5	0.109283	-	-0.642633	0.298937	-0.749841	0.47 [0.11 - 1.94]
GENE	ALAD	aminolevulinate dehydratase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1747577	165	0.830303	0.00965218	0.157209	-1.25253	0.143775	-0.271003	0.76 [0.53 - 1.10]
GENE	ALAD	aminolevulinate dehydratase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1747577	165	0.745455	0.00637929	0.114491	-1.7584	0.15414	-0.37719	0.69 [0.41 - 1.15]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218487_at	163	0.803681	0.0076578	0.131819	-0.731485	0.10442	-0.230466	0.79 [0.60 - 1.05]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218489_s_at	163	0.607362	0.000323525	0.00975143	-0.751297	0.015815	-0.736697	0.48 [0.26 - 0.87]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218487_at	79	0.518987	0.0165734	0.234327	-0.709434	0.318809	-0.187066	0.83 [0.57 - 1.20]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218489_s_at	79	0.822785	0.0986927	-	-0.760183	0.306454	-0.222204	0.80 [0.52 - 1.23]
GENE	ALAD	aminolevulinate dehydratase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218487_at	58	0.775862	0.00483329	0.0921488	-1.00883	0.115589	-0.349516	0.71 [0.46 - 1.09]
GENE	ALAD	aminolevulinate dehydratase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218489_s_at	58	0.87931	0.0584589	-	-0.819908	0.342239	-0.150216	0.86 [0.63 - 1.17]
GENE	ALAD	aminolevulinate dehydratase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218487_at	34	0.558824	0.0734262	-	-0.697847	0.3434	-0.445166	0.64 [0.26 - 1.61]
GENE	ALAD	aminolevulinate dehydratase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218489_s_at	34	0.705882	0.0391707	0.421985	-0.88952	0.446956	-0.153865	0.86 [0.58 - 1.27]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218489_s_at	158	0.196203	0.00369471	0.0744552	-0.747029	0.126355	-1.27706	0.28 [0.05 - 1.43]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218487_at	158	0.132911	0.0694381	-	-0.551259	0.45244	-0.405516	0.67 [0.23 - 1.92]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218489_s_at	53	0.113208	0.0328806	0.376543	1.88056	0.264496	0.53294	1.70 [0.67 - 4.35]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218487_at	53	0.54717	0.0550121	-	-0.728734	0.342082	-0.279159	0.76 [0.43 - 1.35]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218489_s_at	53	0.113208	0.0579848	-	1.71373	0.314764	0.506979	1.66 [0.62 - 4.46]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218487_at	53	0.54717	0.147297	-	-0.508113	0.766297	-0.0849759	0.92 [0.52 - 1.61]
GENE	ALAD	aminolevulinate dehydratase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218489_s_at	180	0.894444	0.0399334	0.427224	-0.845791	0.124204	-0.146932	0.86 [0.72 - 1.04]
GENE	ALAD	aminolevulinate dehydratase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218487_at	180	0.172222	0.00249384	0.0542364	-0.738789	0.0229336	-0.650633	0.52 [0.30 - 0.91]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218487_at	559	0.148479	0.0626158	-	-0.48313	0.241545	-0.362625	0.70 [0.38 - 1.28]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218489_s_at	559	0.77102	0.0360368	0.399862	0.493287	0.358655	0.137866	1.15 [0.86 - 1.54]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218487_at	77	0.844156	0.253851	-	0.381595	0.602185	0.162352	1.18 [0.64 - 2.17]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218489_s_at	77	0.324675	0.136801	-	-0.403024	0.487213	-0.14065	0.87 [0.58 - 1.29]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218489_s_at	70	0.371429	0.0102683	0.164707	-0.681961	0.649318	-0.351267	0.70 [0.15 - 3.20]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218487_at	70	0.842857	0.296084	-	-0.40485	0.962434	-0.014309	0.99 [0.54 - 1.79]
GENE	ALAD	aminolevulinate dehydratase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34506_at	50	0.88	0.0214789	0.281732	-1.55647	0.0645649	-2.44704	0.09 [0.01 - 1.16]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218489_s_at	74	0.77027	0.00290874	0.0614391	0.901622	0.629798	0.153932	1.17 [0.62 - 2.18]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218487_at	74	0.675676	0.0195412	0.263585	0.690013	0.300122	0.361707	1.44 [0.72 - 2.85]
GENE	ALAD	aminolevulinate dehydratase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218489_s_at	67	0.104478	0.36105	-	-0.72188	0.711979	0.510745	1.67 [0.11 - 25.08]
GENE	ALAD	aminolevulinate dehydratase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218487_at	67	0.761194	0.102374	-	-15.4344	0.419737	-0.860675	0.42 [0.05 - 3.42]
GENE	ALAD	aminolevulinate dehydratase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218489_s_at	115	0.686957	0.0212215	0.279361	1.1742	0.083508	1.54229	4.68 [0.82 - 26.81]
GENE	ALAD	aminolevulinate dehydratase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218487_at	115	0.269565	0.244036	-	0.860708	0.886028	0.0889165	1.09 [0.32 - 3.69]
GENE	ALAD	aminolevulinate dehydratase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34506_at	158	0.28481	0.039139	0.421766	-0.598852	0.0771742	-0.427296	0.65 [0.41 - 1.05]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34506_at	76	0.157895	0.206112	-	1.23416	0.845307	0.0838118	1.09 [0.47 - 2.52]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218489_s_at	204	0.122549	0.0134514	0.201309	-0.534792	0.23566	-0.180438	0.83 [0.62 - 1.12]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218487_at	204	0.867647	0.00461063	0.0887819	-0.574545	0.0424333	-0.307087	0.74 [0.55 - 0.99]
GENE	ALAD	aminolevulinate dehydratase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218489_s_at	87	0.862069	0.0229388	0.294956	0.957769	0.917229	-0.0361091	0.96 [0.49 - 1.91]
GENE	ALAD	aminolevulinate dehydratase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218489_s_at	87	0.862069	0.0229388	0.294956	0.957769	0.917229	-0.0361091	0.96 [0.49 - 1.91]
GENE	ALAD	aminolevulinate dehydratase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218487_at	87	0.517241	0.00225532	0.0499723	-1.25248	0.380978	-0.31586	0.73 [0.36 - 1.48]
GENE	ALAD	aminolevulinate dehydratase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218487_at	87	0.517241	0.00225532	0.0499723	-1.25248	0.380978	-0.31586	0.73 [0.36 - 1.48]
GENE	ALAD	aminolevulinate dehydratase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218487_at	77	0.727273	0.0376682	0.411501	-15.5927	0.151156	-0.967572	0.38 [0.10 - 1.42]
GENE	ALAD	aminolevulinate dehydratase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218489_s_at	77	0.597403	0.138986	-	-0.939911	0.843773	0.108606	1.11 [0.38 - 3.28]
GENE	ALAD	aminolevulinate dehydratase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218487_at	77	0.25974	0.0366254	0.404093	-1.1086	0.241983	-0.669387	0.51 [0.17 - 1.57]
GENE	ALAD	aminolevulinate dehydratase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218489_s_at	77	0.597403	0.143708	-	-1.1007	0.727358	-0.230069	0.79 [0.22 - 2.90]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218487_at	136	0.139706	0.0324933	0.373605	-1.08812	0.208347	-0.571448	0.56 [0.23 - 1.38]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218489_s_at	136	0.183824	0.00432606	0.084416	-1.22798	0.383914	-0.268779	0.76 [0.42 - 1.40]
GENE	ALAD	aminolevulinate dehydratase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218489_s_at	200	0.215	0.0412615	0.436217	-0.632191	0.48469	-0.179409	0.84 [0.51 - 1.38]
GENE	ALAD	aminolevulinate dehydratase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218487_at	200	0.43	0.0303935	0.357366	-0.639405	0.161673	-0.512188	0.60 [0.29 - 1.23]
GENE	ALAD	aminolevulinate dehydratase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17058	60	0.35	0.0839254	-	-0.648145	0.556272	-0.18347	0.83 [0.45 - 1.53]
GENE	ALAD	aminolevulinate dehydratase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17058	60	0.45	0.00684174	0.120866	-1.02594	0.0191302	-0.863856	0.42 [0.20 - 0.87]
GENE	ALAD	aminolevulinate dehydratase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15714	155	0.864516	1.59335e-05	0.000680653	1.23925	0.0618418	0.225973	1.25 [0.99 - 1.59]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218489_s_at	286	0.79021	0.077033	-	-0.463271	0.481118	-0.1138	0.89 [0.65 - 1.22]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218487_at	286	0.157343	0.0194331	0.262552	0.792099	0.778221	-0.0580991	0.94 [0.63 - 1.41]
GENE	ALAD	aminolevulinate dehydratase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218489_s_at	159	0.748428	0.179734	-	-0.551147	0.8363	-0.0609668	0.94 [0.53 - 1.68]
GENE	ALAD	aminolevulinate dehydratase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218489_s_at	159	0.207547	0.0514939	-	1.32766	0.413287	0.313591	1.37 [0.65 - 2.90]
GENE	ALAD	aminolevulinate dehydratase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218487_at	159	0.345912	0.0602766	-	-0.586761	0.102707	-0.451782	0.64 [0.37 - 1.10]
GENE	ALAD	aminolevulinate dehydratase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218487_at	159	0.232704	0.036272	0.401557	-0.682199	0.0817849	-0.458928	0.63 [0.38 - 1.06]
GENE	ALAD	aminolevulinate dehydratase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218489_s_at	159	0.207547	0.0666467	-	0.93276	0.690731	0.124171	1.13 [0.61 - 2.09]
GENE	ALAD	aminolevulinate dehydratase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218487_at	159	0.232704	0.0452453	0.462253	-0.750099	0.0923595	-0.543577	0.58 [0.31 - 1.09]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218487_at	54	0.555556	0.0425082	0.444512	-1.49431	0.662709	-0.19971	0.82 [0.33 - 2.01]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218489_s_at	54	0.592593	0.0150865	0.218916	1.73765	0.348739	0.6137	1.85 [0.51 - 6.67]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218487_at	117	0.888889	0.00146321	0.0350067	1.14935	0.0775289	0.52976	1.70 [0.94 - 3.06]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218487_at	117	0.888889	0.0470151	0.473392	0.953834	0.251774	0.431439	1.54 [0.74 - 3.22]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218489_s_at	117	0.470085	0.0953231	-	0.64759	0.152893	0.659846	1.93 [0.78 - 4.78]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218489_s_at	117	0.102564	0.164896	-	0.970477	0.194936	0.510028	1.67 [0.77 - 3.60]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218489_s_at	117	0.102564	0.164896	-	0.970477	0.194936	0.510028	1.67 [0.77 - 3.60]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218489_s_at	117	0.897436	0.0769906	-	0.851457	0.107665	0.703215	2.02 [0.86 - 4.76]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218487_at	117	0.888889	0.00146321	0.0350067	1.14935	0.0775289	0.52976	1.70 [0.94 - 3.06]
GENE	ALAD	aminolevulinate dehydratase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218487_at	117	0.888889	9.173e-05	0.0032457	1.50087	0.0127577	0.911714	2.49 [1.21 - 5.10]
GENE	ALAD	aminolevulinate dehydratase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218487_at	236	0.34322	0.0429729	0.447569	-0.541933	0.185236	-0.425691	0.65 [0.35 - 1.23]
GENE	ALAD	aminolevulinate dehydratase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218489_s_at	236	0.525424	0.0610885	-	0.510513	0.880061	-0.0373765	0.96 [0.59 - 1.57]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218487_at	249	0.341365	0.0103726	0.165963	-0.541282	0.075941	-0.474134	0.62 [0.37 - 1.05]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218489_s_at	249	0.216867	0.0250469	0.31343	-0.521919	0.163397	-0.262333	0.77 [0.53 - 1.11]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218487_at	62	0.193548	0.00190266	0.0434778	-1.37682	0.24642	-0.285045	0.75 [0.46 - 1.22]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218487_at	125	0.16	0.237094	-	-0.540803	0.665088	-0.175099	0.84 [0.38 - 1.85]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218489_s_at	62	0.709677	0.0747845	-	-1.0252	0.478123	-0.138452	0.87 [0.59 - 1.28]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218487_at	125	0.552	0.0778312	-	-0.533227	0.28237	-0.335223	0.72 [0.39 - 1.32]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218487_at	54	0.185185	0.0015957	0.0376104	-1.6531	0.253293	-0.340983	0.71 [0.40 - 1.28]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218489_s_at	125	0.888	0.0394239	0.423731	0.883159	0.44452	0.46366	1.59 [0.48 - 5.22]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218489_s_at	125	0.368	0.0507079	-	-0.592692	0.621353	-0.230696	0.79 [0.32 - 1.98]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218489_s_at	54	0.666667	0.132886	-	-1.02171	0.68279	-0.0959536	0.91 [0.57 - 1.44]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218487_at	198	0.742424	0.0162792	0.231321	-0.853447	0.0458479	-0.411602	0.66 [0.44 - 0.99]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218489_s_at	198	0.393939	0.00942229	0.154372	0.75278	0.0347787	0.289753	1.34 [1.02 - 1.75]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218489_s_at	198	0.393939	0.0499142	0.491108	0.583399	0.106017	0.224466	1.25 [0.95 - 1.64]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218487_at	198	0.863636	0.024381	0.307671	-0.860952	0.293563	-0.168487	0.84 [0.62 - 1.16]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218487_at	198	0.141414	0.0377616	0.412159	-0.641094	0.198346	-0.251032	0.78 [0.53 - 1.14]
GENE	ALAD	aminolevulinate dehydratase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218489_s_at	198	0.111111	0.0897724	-	0.70759	0.138811	0.151447	1.16 [0.95 - 1.42]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218487_at	51	0.529412	0.542941	-	0.54853	0.922952	-0.109891	0.90 [0.10 - 8.31]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218487_at	62	0.741935	0.0262117	0.323343	-15.5658	0.378578	-0.703126	0.50 [0.10 - 2.37]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218489_s_at	51	0.27451	0.150808	-	15.5668	0.521666	0.863557	2.37 [0.17 - 33.28]
GENE	ALAD	aminolevulinate dehydratase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218489_s_at	62	0.725806	0.315667	-	0.607257	0.841247	0.173449	1.19 [0.22 - 6.49]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218489_s_at	145	0.268966	0.00507543	0.0957641	-0.911507	0.0932928	-1.16026	0.31 [0.08 - 1.22]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218487_at	177	0.80791	0.0199638	0.267604	0.595575	0.0557582	0.841553	2.32 [0.98 - 5.49]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218489_s_at	177	0.248588	0.00753043	0.130133	-0.731316	0.0498567	-1.0847	0.34 [0.11 - 1.00]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218487_at	145	0.124138	0.037423	0.409769	1.84072	0.41509	0.507342	1.66 [0.49 - 5.63]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218487_at	177	0.813559	0.0281924	0.339751	0.643819	0.0640647	0.938832	2.56 [0.95 - 6.91]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218489_s_at	177	0.248588	0.0426203	0.445252	-0.50233	0.192946	-0.617454	0.54 [0.21 - 1.37]
GENE	ALAD	aminolevulinate dehydratase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218489_s_at	226	0.769912	0.0108721	0.171915	-1.24659	0.250599	-0.26637	0.77 [0.49 - 1.21]
GENE	ALAD	aminolevulinate dehydratase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218487_at	226	0.132743	0.175415	-	0.692909	0.304578	0.341203	1.41 [0.73 - 2.70]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218489_s_at	49	0.591837	0.0413382	0.436731	1.1841	0.166815	1.55786	4.75 [0.52 - 43.23]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218487_at	55	0.527273	0.000328259	0.00987437	1.97806	0.010196	1.86947	6.48 [1.56 - 27.00]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218487_at	55	0.454545	0.000991929	0.0253126	1.81015	0.0279629	1.44253	4.23 [1.17 - 15.32]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218487_at	49	0.510204	0.000658625	0.0179169	2.68529	0.0321454	1.86982	6.49 [1.17 - 35.88]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218489_s_at	55	0.363636	0.175281	-	0.687878	0.331131	0.835661	2.31 [0.43 - 12.44]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218489_s_at	55	0.581818	0.0043311	0.084494	1.40607	0.0358544	1.96837	7.16 [1.14 - 45.00]
GENE	ALAD	aminolevulinate dehydratase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218487_at	63	0.571429	0.0221012	0.287414	-0.820038	0.0665479	-0.554171	0.57 [0.32 - 1.04]
GENE	ALAD	aminolevulinate dehydratase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218489_s_at	63	0.746032	0.143368	-	0.517807	0.325328	0.39822	1.49 [0.67 - 3.29]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12654312_3p_at	28	0.142857	0.189061	-	1.27843	0.553262	0.324277	1.38 [0.47 - 4.04]
GENE	ALAD	aminolevulinate dehydratase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557296_3p_a_at	28	0.642857	0.0153059	0.221224	-1.6982	0.0709891	-18.0295	0.00 [0.00 - 4.68]
GENE	ALAD	aminolevulinate dehydratase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218487_at	82	0.890244	0.020251	0.270315	-15.2317	0.0592777	-0.793294	0.45 [0.20 - 1.03]
GENE	ALAD	aminolevulinate dehydratase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218489_s_at	82	0.670732	0.0337692	0.38322	0.710836	0.27652	0.685973	1.99 [0.58 - 6.83]
GENE	ALAD	aminolevulinate dehydratase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218487_at	79	0.278481	0.00318873	0.0661632	-0.823685	0.204917	-0.491806	0.61 [0.29 - 1.31]
GENE	ALAD	aminolevulinate dehydratase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218489_s_at	79	0.594937	0.147351	-	-0.388937	0.692657	0.208883	1.23 [0.44 - 3.47]
GENE	ALAD	aminolevulinate dehydratase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218489_s_at	104	0.230769	0.0577791	-	0.883273	0.321556	0.559355	1.75 [0.58 - 5.29]
GENE	ALAD	aminolevulinate dehydratase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218487_at	104	0.105769	0.00492644	0.0935451	-1.12323	0.219242	-0.59368	0.55 [0.21 - 1.42]
GENE	ALAD	aminolevulinate dehydratase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P324278	117	0.205128	0.0924849	-	0.674707	0.0691595	0.384399	1.47 [0.97 - 2.22]
GENE	ALAD	aminolevulinate dehydratase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P217114	117	0.709402	0.100832	-	-0.575459	0.383196	-0.208611	0.81 [0.51 - 1.30]
GENE	ALAD	aminolevulinate dehydratase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218489_s_at	204	0.892157	0.00819537	0.138845	1.0936	0.0724311	0.977968	2.66 [0.91 - 7.73]
GENE	ALAD	aminolevulinate dehydratase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218489_s_at	204	0.867647	2.60096e-06	0.000130997	1.31107	0.00105833	1.33068	3.78 [1.71 - 8.39]
GENE	ALAD	aminolevulinate dehydratase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218487_at	204	0.45098	0.0322447	0.37171	0.857924	0.121567	0.742452	2.10 [0.82 - 5.38]
GENE	ALAD	aminolevulinate dehydratase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218487_at	204	0.343137	0.035329	0.394726	0.676077	0.0284337	0.787158	2.20 [1.09 - 4.44]
GENE	ALAD	aminolevulinate dehydratase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218487_at	178	0.865169	0.17291	-	-0.432266	0.727497	-0.0870258	0.92 [0.56 - 1.50]
GENE	ALAD	aminolevulinate dehydratase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218489_s_at	178	0.505618	0.0244426	0.308207	0.450333	0.129357	0.556471	1.74 [0.85 - 3.58]
GENE	ALAD	aminolevulinate dehydratase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200000317	41	0.609756	0.00263102	0.0566465	-1.52423	0.224788	-0.443987	0.64 [0.31 - 1.31]
GENE	ALAD	aminolevulinate dehydratase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218489_s_at	111	0.864865	0.0860304	-	-0.8639	0.95394	-0.0157623	0.98 [0.58 - 1.68]
GENE	ALAD	aminolevulinate dehydratase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218487_at	111	0.720721	0.0582082	-	-0.605945	0.102631	-0.408915	0.66 [0.41 - 1.09]
GENE	ALAD	aminolevulinate dehydratase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218487_at	90	0.288889	0.0788146	-	0.720403	0.815383	0.130815	1.14 [0.38 - 3.42]
GENE	ALAD	aminolevulinate dehydratase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218487_at	90	0.3	0.0720053	-	0.858498	0.577038	0.349167	1.42 [0.42 - 4.84]
GENE	ALAD	aminolevulinate dehydratase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218489_s_at	90	0.277778	0.0633906	-	-0.607421	0.350996	-0.518328	0.60 [0.20 - 1.77]
GENE	ALAD	aminolevulinate dehydratase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218489_s_at	90	0.277778	0.0571231	-	-0.703342	0.865908	-0.106177	0.90 [0.26 - 3.08]
GENE	ALAD	aminolevulinate dehydratase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218489_s_at	138	0.311594	0.00613352	0.111049	0.800521	0.0810174	0.257139	1.29 [0.97 - 1.73]
GENE	ALAD	aminolevulinate dehydratase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218487_at	138	0.188406	0.0187411	0.255881	0.907726	0.091964	0.320829	1.38 [0.95 - 2.00]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218489_s_at	129	0.325581	0.011084	0.174413	-0.640877	0.19576	-0.341402	0.71 [0.42 - 1.19]
GENE	ALAD	aminolevulinate dehydratase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218487_at	129	0.782946	0.0180978	0.249591	-0.827022	0.248164	-0.234129	0.79 [0.53 - 1.18]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26247	56	0.803571	0.0363033	0.401782	-1.19869	0.407413	-0.312242	0.73 [0.35 - 1.53]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22137	56	0.482143	0.183575	-	0.477915	0.841521	0.0391563	1.04 [0.71 - 1.53]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26247	56	0.803571	0.0214639	0.281594	-1.16494	0.375572	-0.31008	0.73 [0.37 - 1.46]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22137	56	0.482143	0.173702	-	0.471112	0.833915	0.0412982	1.04 [0.71 - 1.53]
GENE	ALAD	aminolevulinate dehydratase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218487_at	278	0.809353	0.01547	0.222944	-0.698203	0.125295	-0.284558	0.75 [0.52 - 1.08]
GENE	ALAD	aminolevulinate dehydratase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218489_s_at	278	0.848921	0.00972669	0.158124	-0.777196	0.0585118	-0.411899	0.66 [0.43 - 1.01]
GENE	ALAD	aminolevulinate dehydratase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218487_at	133	0.736842	0.00421495	0.0826914	-0.907507	0.0855167	-0.342194	0.71 [0.48 - 1.05]
GENE	ALAD	aminolevulinate dehydratase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218489_s_at	133	0.766917	0.0631789	-	0.500729	0.57506	0.201396	1.22 [0.60 - 2.47]
GENE	ALAD	aminolevulinate dehydratase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13163	81	0.148148	0.0154486	0.22272	-1.20957	0.233017	-0.847305	0.43 [0.11 - 1.72]
GENE	ALAD	aminolevulinate dehydratase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218487_at	185	0.102703	0.153257	-	0.447027	0.896901	0.0330776	1.03 [0.63 - 1.70]
GENE	ALAD	aminolevulinate dehydratase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218489_s_at	185	0.491892	0.029988	0.354167	-0.3519	0.390413	-0.284234	0.75 [0.39 - 1.44]
GENE	ALAD	aminolevulinate dehydratase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218487_at	185	0.172973	0.0723438	-	0.397463	0.783296	0.0634482	1.07 [0.68 - 1.67]
GENE	ALAD	aminolevulinate dehydratase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218489_s_at	185	0.464865	0.0343905	0.387835	-0.371959	0.257252	-0.411593	0.66 [0.33 - 1.35]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P324278	110	0.318182	0.155203	-	0.48841	0.587669	0.111511	1.12 [0.75 - 1.67]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P217114	110	0.781818	0.0706097	-	0.634529	0.488829	0.190578	1.21 [0.71 - 2.08]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P324278	110	0.309091	0.05813	-	0.503893	0.155556	0.230863	1.26 [0.92 - 1.73]
GENE	ALAD	aminolevulinate dehydratase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P217114	110	0.781818	0.117688	-	0.413463	0.655232	0.0946754	1.10 [0.73 - 1.67]
GENE	ALAD	aminolevulinate dehydratase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218489_s_at	80	0.475	0.190856	-	0.587086	0.946358	0.0127398	1.01 [0.70 - 1.47]
GENE	ALAD	aminolevulinate dehydratase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218487_at	80	0.625	0.113122	-	-0.804011	0.876516	-0.0512491	0.95 [0.50 - 1.81]
GENE	ALAD	aminolevulinate dehydratase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0731	281	0.384342	0.21677	-	-0.177475	0.955467	-0.00469359	1.00 [0.84 - 1.17]
GENE	ALAD	aminolevulinate dehydratase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218489_s_at	38	0.131579	0.0909447	-	1.6353	0.260616	0.603411	1.83 [0.64 - 5.23]
GENE	ALAD	aminolevulinate dehydratase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218487_at	38	0.131579	0.211314	-	0.943187	0.660755	0.176344	1.19 [0.54 - 2.62]
GENE	ALAD	aminolevulinate dehydratase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218487_at	140	0.657143	0.000334505	0.0100361	-1.44042	0.00128376	-1.18673	0.31 [0.15 - 0.63]
GENE	ALAD	aminolevulinate dehydratase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218489_s_at	140	0.8	0.00321215	0.0665537	-1.58842	0.0689173	-1.03438	0.36 [0.12 - 1.08]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205633_s_at	30	0.366667	0.103141	-	-0.663438	0.57342	-0.212325	0.81 [0.39 - 1.69]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1728309	165	0.49697	0.0609857	-	-0.452753	0.936641	0.0208071	1.02 [0.61 - 1.71]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1728309	165	0.163636	0.0726313	-	-0.693132	0.445118	-0.306145	0.74 [0.34 - 1.62]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205633_s_at	163	0.889571	0.0840513	-	0.482	0.24372	0.14099	1.15 [0.91 - 1.46]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205633_s_at	79	0.658228	0.0111015	0.174619	0.735826	0.0501976	0.392481	1.48 [1.00 - 2.19]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205633_s_at	58	0.655172	0.00224344	0.0497573	0.890704	0.419899	0.253329	1.29 [0.70 - 2.38]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205633_s_at	34	0.852941	0.0225633	0.29159	1.17514	0.174254	0.383245	1.47 [0.84 - 2.55]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205633_s_at	158	0.164557	4.48753e-05	0.00172197	-1.04059	0.027731	-0.571509	0.56 [0.34 - 0.94]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205633_s_at	53	0.113208	0.106386	-	-0.768896	0.942408	0.0314272	1.03 [0.44 - 2.42]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205633_s_at	53	0.113208	0.0519457	-	-0.924818	0.806884	-0.113618	0.89 [0.36 - 2.22]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205633_s_at	180	0.166667	0.102036	-	0.48619	0.612256	0.16998	1.19 [0.61 - 2.29]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205633_s_at	559	0.878354	0.0569336	-	0.562756	0.477794	-0.178339	0.84 [0.51 - 1.37]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205633_s_at	77	0.883117	0.0236982	0.301693	0.803477	0.575719	0.249873	1.28 [0.54 - 3.08]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205633_s_at	70	0.714286	0.0912962	-	-0.522094	0.437077	-0.213122	0.81 [0.47 - 1.38]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37674_at	50	0.6	0.0826372	-	0.607172	0.504736	0.348752	1.42 [0.51 - 3.95]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205633_s_at	74	0.135135	0.0172777	0.241444	1.33406	0.370838	0.408143	1.50 [0.62 - 3.68]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205633_s_at	67	0.328358	0.146047	-	1.42073	0.617935	0.504951	1.66 [0.23 - 12.05]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205633_s_at	115	0.895652	0.145004	-	0.920434	0.248217	1.00533	2.73 [0.50 - 15.06]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37674_at	158	0.468354	0.000857351	0.0223921	0.985323	0.0738817	0.629337	1.88 [0.94 - 3.74]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37674_at	76	0.407895	0.117246	-	-0.805555	0.334223	-0.551073	0.58 [0.19 - 1.76]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205633_s_at	204	0.446078	0.0137856	0.204968	0.345544	0.142458	0.307512	1.36 [0.90 - 2.05]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205633_s_at	87	0.114943	0.00125628	0.0308404	-1.33487	0.0276641	-0.961662	0.38 [0.16 - 0.90]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205633_s_at	87	0.114943	0.00125628	0.0308404	-1.33487	0.0276641	-0.961662	0.38 [0.16 - 0.90]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205633_s_at	77	0.363636	0.0650395	-	1.7245	0.25782	0.747301	2.11 [0.58 - 7.70]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205633_s_at	77	0.181818	0.0698169	-	15.3659	0.172464	0.79427	2.21 [0.71 - 6.93]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205633_s_at	136	0.213235	0.0873119	-	-0.784403	0.114933	-0.627148	0.53 [0.24 - 1.16]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205633_s_at	200	0.39	0.0919494	-	0.546078	0.743269	0.153529	1.17 [0.47 - 2.92]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1821	60	0.3	0.0559677	-	-0.732656	0.583647	-0.159085	0.85 [0.48 - 1.51]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1821	60	0.116667	0.0474136	0.475865	-0.977821	0.46771	-0.276656	0.76 [0.36 - 1.60]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21384	155	0.76129	0.000136532	0.00460454	1.01934	0.00612194	0.492439	1.64 [1.15 - 2.33]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205633_s_at	286	0.101399	0.000933564	0.0240558	-0.832676	0.0229661	-0.821871	0.44 [0.22 - 0.89]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205633_s_at	159	0.880503	0.00274381	0.0586064	1.04867	0.0311062	1.12545	3.08 [1.11 - 8.57]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205633_s_at	159	0.880503	0.000330801	0.00994025	1.34055	0.116107	0.955618	2.60 [0.79 - 8.56]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205633_s_at	159	0.880503	0.00270109	0.0578664	1.0486	0.154811	0.742434	2.10 [0.76 - 5.84]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205633_s_at	54	0.888889	0.213211	-	0.97838	0.911453	-0.0489951	0.95 [0.40 - 2.26]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205633_s_at	117	0.188034	0.174346	-	-0.493443	0.900165	0.0339071	1.03 [0.61 - 1.76]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205633_s_at	117	0.119658	0.0432457	0.449355	-0.857497	0.597794	-0.165028	0.85 [0.46 - 1.57]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205633_s_at	117	0.188034	0.174346	-	-0.493443	0.900165	0.0339071	1.03 [0.61 - 1.76]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205633_s_at	117	0.128205	0.00349347	0.0711928	-1.18624	0.433267	-0.257051	0.77 [0.41 - 1.47]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205633_s_at	236	0.423729	0.0132039	0.198579	0.734141	0.0730913	0.867897	2.38 [0.92 - 6.15]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205633_s_at	249	0.297189	0.00036921	0.0109265	0.995713	0.00945868	0.928466	2.53 [1.26 - 5.10]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205633_s_at	62	0.887097	0.0643803	-	1.01603	0.553335	-0.165107	0.85 [0.49 - 1.46]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205633_s_at	125	0.272	0.146142	-	0.703186	0.612814	0.223487	1.25 [0.53 - 2.97]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205633_s_at	125	0.248	0.0202909	0.27069	0.974131	0.381061	0.299613	1.35 [0.69 - 2.64]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205633_s_at	54	0.351852	0.178706	-	-0.76731	0.434101	-0.26348	0.77 [0.40 - 1.49]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205633_s_at	198	0.111111	0.170175	-	-0.471898	0.555519	-0.141765	0.87 [0.54 - 1.39]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205633_s_at	198	0.111111	0.297121	-	-0.377608	0.587164	-0.13937	0.87 [0.53 - 1.44]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205633_s_at	198	0.893939	0.191996	-	-0.515473	0.900005	-0.0236716	0.98 [0.68 - 1.41]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205633_s_at	51	0.607843	0.329091	-	-1.04394	0.754142	-0.22191	0.80 [0.20 - 3.21]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205633_s_at	62	0.870968	0.0158666	0.22707	1.37016	0.0868852	0.935293	2.55 [0.87 - 7.43]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205633_s_at	177	0.757062	0.0476986	0.477627	0.502354	0.281358	0.355898	1.43 [0.75 - 2.73]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205633_s_at	145	0.862069	0.180351	-	-0.940109	0.448968	-0.346863	0.71 [0.29 - 1.74]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205633_s_at	177	0.107345	0.245124	-	-0.442256	0.914808	-0.0404869	0.96 [0.46 - 2.02]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205633_s_at	226	0.132743	0.00644924	0.115463	-0.848391	0.185918	-0.405513	0.67 [0.37 - 1.22]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205633_s_at	55	0.872727	0.00834039	0.140716	1.39313	0.0186066	1.17366	3.23 [1.22 - 8.59]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205633_s_at	49	0.897959	0.010536	0.16792	1.57595	0.0317636	1.4247	4.16 [1.13 - 15.26]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205633_s_at	55	0.872727	0.000154667	0.00513585	1.69427	0.0127012	1.24405	3.47 [1.30 - 9.23]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	22940	34	0.764706	0.1305	-	0.700499	0.56683	0.219987	1.25 [0.59 - 2.65]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205633_s_at	63	0.111111	0.0213653	0.280687	-1.01082	0.381757	-0.22375	0.80 [0.48 - 1.32]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502024_3p_a_at	28	0.392857	0.37588	-	-0.472922	0.930002	0.0364363	1.04 [0.46 - 2.34]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205633_s_at	82	0.512195	0.0461177	0.467775	-0.686813	0.571293	-0.226151	0.80 [0.36 - 1.75]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37674_at	84	0.785714	0.0488584	0.484731	-0.761828	0.27732	-0.465593	0.63 [0.27 - 1.45]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205633_s_at	79	0.455696	0.0134059	0.200808	-0.641692	0.286773	-0.368301	0.69 [0.35 - 1.36]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	Y00451_s_at	86	0.174419	0.158195	-	-0.655606	0.630773	-0.210802	0.81 [0.34 - 1.91]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205633_s_at	104	0.307692	0.0133821	0.200547	-0.819291	0.141974	-0.560654	0.57 [0.27 - 1.21]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P57877	117	0.239316	0.0198859	0.266865	-0.698253	0.199022	-0.209837	0.81 [0.59 - 1.12]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P191588	117	0.153846	0.000189263	0.00612573	-1.15371	0.0029011	-0.903984	0.40 [0.22 - 0.73]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205633_s_at	204	0.254902	0.140207	-	0.773111	0.896607	0.0696813	1.07 [0.37 - 3.07]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205633_s_at	204	0.117647	0.116926	-	0.901105	0.820179	0.0905735	1.09 [0.50 - 2.39]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205633_s_at	178	0.533708	0.0120014	0.18505	-0.5006	0.132038	-0.43992	0.64 [0.36 - 1.14]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006543	41	0.878049	0.11281	-	-1.48352	0.470131	-0.341415	0.71 [0.28 - 1.80]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205633_s_at	111	0.45045	0.30563	-	-0.267871	0.681395	-0.112808	0.89 [0.52 - 1.53]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205633_s_at	90	0.744444	0.0432931	0.449665	0.668193	0.135923	0.433547	1.54 [0.87 - 2.73]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205633_s_at	90	0.744444	0.0618611	-	0.701293	0.40179	0.278625	1.32 [0.69 - 2.53]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1931	50	0.4	0.0245628	0.309251	1.33454	0.282944	0.669118	1.95 [0.58 - 6.62]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205633_s_at	138	0.101449	0.0515786	-	0.976335	0.192866	0.226919	1.25 [0.89 - 1.77]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205633_s_at	129	0.875969	0.167604	-	0.473613	0.832715	-0.0921752	0.91 [0.39 - 2.15]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15467	56	0.125	0.0114541	0.178738	-1.188	0.365049	-0.450158	0.64 [0.24 - 1.69]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7738	56	0.875	0.084901	-	-1.58083	0.695713	-0.157518	0.85 [0.39 - 1.88]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7826	56	0.142857	0.113293	-	-0.767676	0.464337	-0.326065	0.72 [0.30 - 1.73]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7738	56	0.303571	0.108515	-	0.683573	0.872969	0.0686256	1.07 [0.46 - 2.48]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15467	56	0.375	0.0196843	0.26495	-0.784999	0.243233	-0.576433	0.56 [0.21 - 1.48]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7826	56	0.196429	0.11729	-	-0.631508	0.375265	-0.377073	0.69 [0.30 - 1.58]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205633_s_at	278	0.107914	0.123418	-	-0.458644	0.769859	-0.0617331	0.94 [0.62 - 1.42]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205633_s_at	133	0.225564	0.0272656	0.332142	-0.582574	0.0896748	-0.275179	0.76 [0.55 - 1.04]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4252	81	0.851852	0.00546324	0.101459	1.43161	0.306261	0.521416	1.68 [0.62 - 4.57]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11597	81	0.395062	0.0898161	-	0.963716	0.462462	0.610247	1.84 [0.36 - 9.37]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205633_s_at	185	0.832432	0.0603895	-	-0.463671	0.338334	-0.126888	0.88 [0.68 - 1.14]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205633_s_at	185	0.843243	0.0725415	-	-0.405086	0.79267	-0.0321227	0.97 [0.76 - 1.23]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P57877	110	0.745455	0.271325	-	-0.367406	0.723375	-0.0595991	0.94 [0.68 - 1.31]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P191588	110	0.890909	0.124312	-	-0.602428	0.589232	0.109021	1.12 [0.75 - 1.66]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P57877	110	0.436364	0.114031	-	0.373588	0.767207	0.0436795	1.04 [0.78 - 1.39]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P191588	110	0.863636	0.0943097	-	-0.775449	0.931474	0.0201657	1.02 [0.64 - 1.62]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205633_s_at	80	0.7625	0.0969867	-	0.759308	0.760362	0.135441	1.15 [0.48 - 2.73]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3697	281	0.711744	0.0113353	0.177355	-0.404774	0.143318	-0.200193	0.82 [0.63 - 1.07]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205633_s_at	38	0.263158	0.000925369	0.0238781	2.76506	0.0026597	1.51443	4.55 [1.69 - 12.21]
GENE	ALAS1	aminolevulinate, delta-, synthase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205633_s_at	140	0.664286	0.0247559	0.310922	-0.778708	0.0647513	-0.438968	0.64 [0.40 - 1.03]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216568_x_at	30	0.133333	0.184364	-	-0.743118	0.622891	-0.321875	0.72 [0.20 - 2.61]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1708323	165	0.10303	0.00272692	0.0583142	-0.933315	0.0142301	-2.43101	0.09 [0.01 - 0.61]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1708323	165	0.10303	0.00646124	0.11563	-1.11396	0.0301148	-3.19808	0.04 [0.00 - 0.74]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216568_x_at	163	0.877301	0.140728	-	-0.485813	0.386466	-0.630908	0.53 [0.13 - 2.22]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	238813_at	163	0.153374	0.0675438	-	0.555873	0.172321	0.68774	1.99 [0.74 - 5.34]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	244205_at	163	0.128834	0.0197318	0.265402	0.835057	0.626006	0.328329	1.39 [0.37 - 5.20]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	238813_at	79	0.126582	0.0101267	0.162997	-0.936287	0.791125	-0.110086	0.90 [0.40 - 2.02]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216568_x_at	79	0.177215	0.260307	-	-0.377378	0.882414	-0.109502	0.90 [0.21 - 3.82]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	244205_at	79	0.683544	0.00148148	0.0353684	-1.08994	0.0383384	-1.604	0.20 [0.04 - 0.92]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216568_x_at	58	0.706897	0.0654769	-	0.574117	0.802578	0.0410627	1.04 [0.76 - 1.44]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216568_x_at	34	0.676471	0.0811405	-	0.687743	0.59742	0.148224	1.16 [0.67 - 2.01]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216568_x_at	158	0.696203	0.188179	-	-0.354278	0.448017	-0.664599	0.51 [0.09 - 2.86]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216568_x_at	53	0.811321	0.213764	-	0.500639	0.92445	0.0191775	1.02 [0.69 - 1.52]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216568_x_at	53	0.811321	0.0912301	-	0.686772	0.596959	0.114753	1.12 [0.73 - 1.72]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216568_x_at	180	0.894444	0.0118404	0.183203	0.751801	0.370138	0.100463	1.11 [0.89 - 1.38]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	238813_at	180	0.65	0.0139511	0.206767	0.51899	0.49375	0.168216	1.18 [0.73 - 1.92]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	244205_at	180	0.6	0.0980084	-	-0.364358	0.397133	-0.172124	0.84 [0.57 - 1.25]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216568_x_at	559	0.710197	0.00428644	0.0838023	-0.669846	0.0928373	-0.183901	0.83 [0.67 - 1.03]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	238813_at	559	0.726297	0.00404512	0.0800326	-0.832957	0.05855	-0.319645	0.73 [0.52 - 1.01]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	244205_at	559	0.404293	0.0296525	0.351505	0.467018	0.199543	0.145172	1.16 [0.93 - 1.44]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216568_x_at	77	0.883117	0.11965	-	-0.662564	0.796614	-0.0386756	0.96 [0.72 - 1.29]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	238813_at	77	0.155844	0.000217226	0.00690641	1.74275	0.000163866	0.825247	2.28 [1.49 - 3.51]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	244205_at	77	0.402597	0.00324322	0.0670708	-0.766054	0.0587313	-0.387369	0.68 [0.45 - 1.01]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216568_x_at	70	0.614286	0.0871727	-	-0.477088	0.246857	-0.586345	0.56 [0.21 - 1.50]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	238813_at	70	0.6	0.150949	-	0.379265	0.390682	0.632255	1.88 [0.44 - 7.97]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	244205_at	70	0.214286	0.075561	-	-0.535837	0.771308	-0.343719	0.71 [0.07 - 7.20]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37285_at	50	0.7	0.141228	-	-0.574009	0.717937	-0.351521	0.70 [0.10 - 4.74]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216568_x_at	74	0.351351	0.026692	0.327373	0.730319	0.183143	0.261399	1.30 [0.88 - 1.91]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	238813_at	74	0.108108	0.305398	-	0.530501	0.856617	-0.0393464	0.96 [0.63 - 1.47]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	244205_at	74	0.162162	0.0888669	-	-0.598422	0.761868	-0.0724752	0.93 [0.58 - 1.49]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	244205_at	67	0.671642	0.1093	-	1.03672	0.775292	0.924755	2.52 [0.00 - 1442.65]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	238813_at	67	0.731343	0.0129718	0.196002	1.54042	0.0940296	2.92468	18.63 [0.61 - 571.35]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216568_x_at	67	0.208955	0.105533	-	15.4233	0.720704	0.960316	2.61 [0.01 - 505.22]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216568_x_at	115	0.869565	0.0512586	-	1.09391	0.919614	0.0367779	1.04 [0.51 - 2.12]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	244205_at	115	0.678261	0.0341868	0.386326	-1.89955	0.113697	-0.862663	0.42 [0.14 - 1.23]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	238813_at	115	0.4	0.0423162	0.443244	1.42784	0.563787	0.317353	1.37 [0.47 - 4.03]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37285_at	158	0.101266	0.047859	0.478616	-0.752688	0.719675	-0.157942	0.85 [0.36 - 2.02]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37285_at	76	0.381579	0.254705	-	-0.590594	0.50987	-0.730845	0.48 [0.05 - 4.23]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	244205_at	204	0.803922	0.15398	-	-0.250683	0.52208	-0.0469589	0.95 [0.83 - 1.10]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	238813_at	204	0.622549	0.251724	-	-0.163486	0.667069	-0.0591075	0.94 [0.72 - 1.23]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216568_x_at	204	0.622549	0.263983	-	-0.161904	0.734289	-0.0315605	0.97 [0.81 - 1.16]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216568_x_at	87	0.609195	0.0498523	0.490737	0.727761	0.253591	0.394648	1.48 [0.75 - 2.92]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216568_x_at	87	0.609195	0.0498523	0.490737	0.727761	0.253591	0.394648	1.48 [0.75 - 2.92]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	244205_at	87	0.701149	0.156571	-	0.542278	0.740187	0.488594	1.63 [0.09 - 29.27]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	238813_at	87	0.471264	0.132118	-	0.588487	0.720596	0.144274	1.16 [0.52 - 2.55]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	238813_at	87	0.471264	0.132118	-	0.588487	0.720596	0.144274	1.16 [0.52 - 2.55]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	244205_at	87	0.701149	0.156571	-	0.542278	0.740187	0.488594	1.63 [0.09 - 29.27]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	238813_at	77	0.831169	0.33387	-	-0.967738	0.783901	-0.168517	0.84 [0.25 - 2.82]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	244205_at	77	0.714286	0.00021328	0.00679717	1.92055	0.0222386	3.16359	23.66 [1.57 - 356.28]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216568_x_at	77	0.675325	0.128702	-	-1.46673	0.857055	-0.0951536	0.91 [0.32 - 2.56]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	244205_at	77	0.714286	0.0128784	0.19496	1.47092	0.176982	2.16787	8.74 [0.38 - 203.37]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	238813_at	77	0.142857	0.527835	-	-0.494382	0.96721	-0.0290177	0.97 [0.24 - 3.87]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216568_x_at	77	0.675325	0.176411	-	-0.997755	0.520563	-0.30942	0.73 [0.29 - 1.89]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216568_x_at	136	0.897059	0.00592088	0.10804	1.3464	0.0737824	0.747184	2.11 [0.93 - 4.79]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216568_x_at	200	0.645	0.0568343	-	0.556987	0.0842048	0.526373	1.69 [0.93 - 3.08]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15523	60	0.783333	0.277777	-	-0.578678	0.792731	-0.117709	0.89 [0.37 - 2.14]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15523	60	0.616667	0.182638	-	0.503888	0.345885	0.271398	1.31 [0.75 - 2.31]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	9606	155	0.283871	1.4429e-05	0.000622404	-1.14617	0.000168983	-0.260814	0.77 [0.67 - 0.88]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216568_x_at	286	0.13986	0.0522478	-	0.66326	0.309658	0.170591	1.19 [0.85 - 1.65]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216568_x_at	159	0.27044	0.00492441	0.0935148	1.37299	0.0631981	0.462629	1.59 [0.97 - 2.59]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216568_x_at	159	0.27044	0.0063267	0.113757	1.76504	0.0593787	0.560038	1.75 [0.98 - 3.13]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216568_x_at	159	0.27044	0.00173981	0.0403922	1.67834	0.0697786	0.451917	1.57 [0.96 - 2.56]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	244205_at	159	0.371069	0.117832	-	-0.49053	0.777425	-0.0842908	0.92 [0.51 - 1.65]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	244205_at	159	0.100629	0.0368897	0.405981	-0.843394	0.142816	-0.381362	0.68 [0.41 - 1.14]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	244205_at	159	0.358491	0.123677	-	-0.564933	0.538747	-0.202579	0.82 [0.43 - 1.56]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238813_at	159	0.842767	0.117767	-	-0.907639	0.880142	0.0329112	1.03 [0.67 - 1.59]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238813_at	159	0.446541	0.0523125	-	0.644376	0.604358	0.11435	1.12 [0.73 - 1.73]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238813_at	159	0.396226	0.068051	-	0.772598	0.710157	0.0967235	1.10 [0.66 - 1.83]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216568_x_at	54	0.703704	0.0499225	0.491158	1.3326	0.477255	0.413659	1.51 [0.48 - 4.73]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216568_x_at	117	0.82906	0.0241703	0.305834	0.808141	0.149707	0.330131	1.39 [0.89 - 2.18]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216568_x_at	117	0.384615	0.0271905	0.33152	0.978013	0.24938	0.311227	1.37 [0.80 - 2.32]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216568_x_at	117	0.82906	0.0241703	0.305834	0.808141	0.149707	0.330131	1.39 [0.89 - 2.18]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216568_x_at	117	0.82906	0.0289145	0.345599	0.942704	0.787848	0.0789154	1.08 [0.61 - 1.92]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216568_x_at	236	0.288136	0.0101786	0.163625	0.906243	0.0437298	0.517826	1.68 [1.01 - 2.78]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	238813_at	236	0.54661	0.0303458	0.356991	0.581012	0.144211	0.46204	1.59 [0.85 - 2.95]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	244205_at	236	0.521186	0.013863	0.205811	0.670861	0.482121	0.243027	1.28 [0.65 - 2.51]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216568_x_at	249	0.285141	0.00332191	0.0683749	0.791229	0.0159478	0.496261	1.64 [1.10 - 2.46]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	238813_at	249	0.606426	0.00932458	0.15316	0.545902	0.0754124	0.429666	1.54 [0.96 - 2.47]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	244205_at	249	0.485944	0.0209242	0.276609	0.495992	0.461416	0.196636	1.22 [0.72 - 2.05]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216568_x_at	62	0.790323	0.196423	-	-0.819475	0.917026	-0.02477	0.98 [0.61 - 1.55]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216568_x_at	125	0.896	0.0371831	0.408068	0.927633	0.0569301	0.67961	1.97 [0.98 - 3.97]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216568_x_at	125	0.896	0.0217476	0.284193	0.79669	0.117745	0.444077	1.56 [0.89 - 2.72]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216568_x_at	54	0.277778	0.0478536	0.478582	15.4914	0.812631	0.0671979	1.07 [0.61 - 1.86]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216568_x_at	198	0.39899	0.061488	-	0.511055	0.378068	0.122363	1.13 [0.86 - 1.48]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216568_x_at	198	0.409091	0.0814887	-	0.501966	0.49197	0.0988775	1.10 [0.83 - 1.46]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216568_x_at	198	0.409091	0.0576853	-	0.418317	0.819263	0.0254327	1.03 [0.82 - 1.28]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216568_x_at	51	0.45098	0.112858	-	-1.59748	0.355913	-1.21243	0.30 [0.02 - 3.90]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216568_x_at	62	0.870968	0.208516	-	0.817034	0.321092	0.73458	2.08 [0.49 - 8.90]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	244205_at	177	0.271186	0.0100283	0.161805	-0.69793	0.0337832	-2.36388	0.09 [0.01 - 0.83]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	238813_at	177	0.412429	0.11743	-	-0.420149	0.708682	-0.141349	0.87 [0.41 - 1.82]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	244205_at	177	0.271186	0.0315827	0.366627	-0.521974	0.0770358	-1.65183	0.19 [0.03 - 1.20]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216568_x_at	177	0.587571	0.00407455	0.0804952	0.767312	0.0526204	0.515623	1.67 [0.99 - 2.82]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	238813_at	177	0.519774	0.0667213	-	-0.436988	0.666507	-0.142158	0.87 [0.45 - 1.66]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	244205_at	145	0.337931	0.0172061	0.240726	-0.77528	0.202131	-1.73718	0.18 [0.01 - 2.54]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216568_x_at	177	0.451977	0.0055267	0.102381	0.680478	0.0559708	0.441893	1.56 [0.99 - 2.45]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	238813_at	145	0.4	0.0227688	0.293435	-0.746174	0.186912	-0.638105	0.53 [0.20 - 1.36]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216568_x_at	145	0.586207	0.0236333	0.301121	0.745579	0.459878	0.250085	1.28 [0.66 - 2.49]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	238813_at	226	0.659292	0.0922223	-	-0.537009	0.700126	-0.0554736	0.95 [0.71 - 1.25]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	244205_at	226	0.699115	0.0964671	-	-0.580797	0.544403	-0.0973036	0.91 [0.66 - 1.24]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216568_x_at	226	0.123894	0.0491812	0.48669	-0.669751	0.784059	0.048044	1.05 [0.74 - 1.48]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	244205_at	55	0.109091	0.0275709	0.334662	-1.23721	0.0596807	-3.14197	0.04 [0.00 - 1.14]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216568_x_at	55	0.654545	0.0394467	0.423887	0.89549	0.367885	0.270137	1.31 [0.73 - 2.36]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	238813_at	55	0.890909	0.219574	-	0.837545	0.399053	0.691402	2.00 [0.40 - 9.96]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	244205_at	49	0.714286	0.0821899	-	-1.63029	0.256064	-2.21971	0.11 [0.00 - 5.01]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	238813_at	49	0.142857	0.167121	-	-0.892797	0.630809	0.41221	1.51 [0.28 - 8.11]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216568_x_at	55	0.654545	0.0327874	0.375837	1.00498	0.159567	0.47225	1.60 [0.83 - 3.10]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216568_x_at	49	0.632653	0.0100454	0.162012	1.43625	0.0793757	0.745216	2.11 [0.92 - 4.84]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	238813_at	55	0.163636	0.00736905	0.127985	-1.24055	0.651259	-0.332762	0.72 [0.17 - 3.03]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	244205_at	55	0.109091	0.0257487	0.319427	-1.18877	0.137362	-2.33961	0.10 [0.00 - 2.11]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	203494	34	0.882353	0.192478	-	-1.25432	0.887501	0.085709	1.09 [0.33 - 3.57]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	206873	34	0.558824	0.0522493	-	0.882365	0.236495	0.510802	1.67 [0.72 - 3.88]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	238813_at	63	0.285714	0.0176591	0.245251	1.09396	0.0489101	0.673286	1.96 [1.00 - 3.83]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	244205_at	63	0.15873	4.47565e-05	0.00171791	-1.48193	0.404027	-4.75841	0.01 [0.00 - 613.00]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216568_x_at	63	0.142857	0.0169295	0.23794	-0.964902	0.343279	-0.745418	0.47 [0.10 - 2.22]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.103381.0.A1_3p_at	28	0.357143	0.00211602	0.0474356	-1.75169	0.227003	-2.85871	0.06 [0.00 - 5.92]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.247994.0.S1_3p_x_at	28	0.642857	0.0502235	-	-1.27383	0.096574	-1.22266	0.29 [0.07 - 1.25]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.114018.0.A1_3p_at	28	0.214286	0.027653	0.335337	-1.23725	0.825595	-0.544926	0.58 [0.00 - 73.85]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	216568_3p_x_at	28	0.642857	0.00435588	0.084877	-2.53472	0.106139	-1.24508	0.29 [0.06 - 1.30]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.114018.0.A1_3p_x_at	28	0.285714	0.0191692	0.260019	-1.31879	0.538617	-3.46719	0.03 [0.00 - 1967.36]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216568_x_at	82	0.719512	0.17709	-	0.466241	0.448103	0.320621	1.38 [0.60 - 3.16]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37285_at	84	0.416667	0.204485	-	-0.367593	0.523284	-0.295411	0.74 [0.30 - 1.84]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216568_x_at	79	0.405063	0.00280425	0.059649	-0.780453	0.0133037	-0.766668	0.46 [0.25 - 0.85]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216568_x_at	104	0.673077	0.0598749	-	-0.736841	0.959949	-0.0160499	0.98 [0.53 - 1.84]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P385587	117	0.128205	0.0343898	0.387829	-0.734862	0.198622	-0.233372	0.79 [0.55 - 1.13]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216568_x_at	204	0.333333	0.000368455	0.0109073	2.71343	0.0015706	1.44338	4.23 [1.73 - 10.36]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216568_x_at	204	0.421569	0.00064646	0.0176356	1.06655	0.0114368	0.763208	2.15 [1.19 - 3.88]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	244205_at	204	0.122549	0.000361864	0.0107392	-1.32602	0.0524104	-0.55095	0.58 [0.33 - 1.01]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	238813_at	204	0.897059	0.0724704	-	0.799848	0.398387	0.592726	1.81 [0.46 - 7.16]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	244205_at	204	0.156863	0.000330731	0.00993843	-1.0265	0.0713819	-0.407844	0.67 [0.43 - 1.04]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	238813_at	204	0.813725	0.00448986	0.0869378	0.812298	0.0479584	1.03883	2.83 [1.01 - 7.91]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216568_x_at	178	0.668539	0.00425728	0.0833497	0.570323	0.295768	0.236612	1.27 [0.81 - 1.97]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	244205_at	111	0.423423	0.059292	-	0.521259	0.402163	0.14333	1.15 [0.83 - 1.61]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	238813_at	111	0.351351	0.0295183	0.350436	-0.566811	0.125793	-0.253167	0.78 [0.56 - 1.07]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216568_x_at	111	0.783784	0.00229361	0.0506634	0.850715	0.704308	0.0562297	1.06 [0.79 - 1.41]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216568_x_at	90	0.633333	0.228295	-	-0.42789	0.83011	-0.117706	0.89 [0.30 - 2.61]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216568_x_at	90	0.333333	0.080562	-	0.781581	0.90741	-0.0730245	0.93 [0.27 - 3.18]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1930	50	0.42	0.0189057	0.257476	1.38658	0.0872597	1.2437	3.47 [0.83 - 14.43]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216568_x_at	138	0.123188	0.0281129	0.339103	1.07996	0.48589	0.107423	1.11 [0.82 - 1.51]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	238813_at	138	0.898551	0.0598275	-	0.611918	0.445877	0.173248	1.19 [0.76 - 1.86]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	244205_at	138	0.210145	0.0179806	0.248435	-0.610846	0.0429262	-8.15926	0.00 [0.00 - 0.77]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216568_x_at	129	0.837209	0.0604623	-	0.585745	0.945645	0.0126231	1.01 [0.70 - 1.46]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19044	56	0.892857	0.118796	-	0.833961	0.903878	-0.0280084	0.97 [0.62 - 1.53]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18841	56	0.446429	0.276925	-	-0.369335	0.918546	0.0227322	1.02 [0.66 - 1.58]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19044	56	0.892857	0.0380995	0.414533	1.11834	0.650276	-0.109153	0.90 [0.56 - 1.44]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18841	56	0.446429	0.205499	-	-0.450107	0.768485	-0.0673198	0.93 [0.60 - 1.46]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	244205_at	278	0.715827	0.0599829	-	-0.40369	0.217547	-0.806793	0.45 [0.12 - 1.61]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	238813_at	278	0.334532	0.00427301	0.083594	-0.538226	0.101372	-0.295286	0.74 [0.52 - 1.06]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216568_x_at	278	0.845324	0.0201823	0.269668	0.530698	0.601901	0.0914987	1.10 [0.78 - 1.55]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216568_x_at	133	0.556391	0.18706	-	0.310605	0.710872	0.0542837	1.06 [0.79 - 1.41]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	287	81	0.888889	0.00989378	0.160167	1.41059	0.331356	0.917461	2.50 [0.39 - 15.94]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12163	81	0.382716	0.0305868	0.358883	1.52072	0.218791	0.611868	1.84 [0.70 - 4.89]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216568_x_at	185	0.286486	0.122287	-	-0.282602	0.90707	-0.0202764	0.98 [0.70 - 1.38]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216568_x_at	185	0.259459	0.103904	-	-0.321608	0.740989	-0.0621217	0.94 [0.65 - 1.36]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P385587	110	0.109091	0.00476559	0.0911294	-0.906538	0.586859	-0.16415	0.85 [0.47 - 1.53]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P22654	110	0.109091	0.032878	0.376523	-0.832003	0.829832	0.0249249	1.03 [0.82 - 1.29]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P385587	110	0.4	0.215555	-	-0.365447	0.999803	-8.36648e-05	1.00 [0.51 - 1.95]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P22654	110	0.281818	0.177899	-	-0.32997	0.849812	-0.0187572	0.98 [0.81 - 1.19]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216568_x_at	80	0.475	0.145962	-	0.65001	0.488168	0.148354	1.16 [0.76 - 1.76]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_4008	281	0.459075	0.0319763	0.369656	0.304526	0.770617	-0.048854	0.95 [0.69 - 1.32]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216568_x_at	38	0.421053	0.0279122	0.337463	-1.0408	0.521378	-0.1509	0.86 [0.54 - 1.36]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	244205_at	38	0.473684	0.0857982	-	-0.835887	0.503191	-0.273638	0.76 [0.34 - 1.69]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	238813_at	38	0.368421	0.155396	-	0.735154	0.400089	0.258992	1.30 [0.71 - 2.37]
GENE	ALAS2	aminolevulinate, delta-, synthase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216568_x_at	140	0.35	2.02023e-05	0.00084285	1.92301	0.00301984	2.05099	7.78 [2.00 - 30.16]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217791_s_at	30	0.133333	0.0600803	-	-1.00586	0.892357	0.0845824	1.09 [0.32 - 3.70]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217791_s_at	163	0.852761	0.00213701	0.0478203	0.76131	0.16761	0.244806	1.28 [0.90 - 1.81]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222416_at	163	0.858896	2.10365e-05	0.000874075	1.03471	0.0755546	0.219845	1.25 [0.98 - 1.59]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222416_at	79	0.696203	0.0465606	0.470555	0.590255	0.172176	0.24673	1.28 [0.90 - 1.82]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217791_s_at	79	0.835443	0.0524102	-	0.683239	0.153921	0.305682	1.36 [0.89 - 2.07]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217791_s_at	58	0.810345	0.000138161	0.00465268	1.3545	0.00995518	0.681312	1.98 [1.18 - 3.32]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217791_s_at	34	0.882353	0.321315	-	0.545842	0.956856	0.0186614	1.02 [0.52 - 2.00]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217791_s_at	158	0.234177	0.0448771	0.459902	0.602788	0.700867	0.108962	1.12 [0.64 - 1.94]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217791_s_at	53	0.113208	0.0167029	0.235644	15.2922	0.57943	0.314985	1.37 [0.45 - 4.17]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217791_s_at	53	0.113208	0.0319792	0.369677	1.88733	0.130109	0.89821	2.46 [0.77 - 7.86]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217791_s_at	180	0.533333	0.126011	-	-0.322452	0.512192	-0.145157	0.86 [0.56 - 1.33]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222416_at	180	0.472222	0.137959	-	0.313348	0.783025	0.0723168	1.07 [0.64 - 1.80]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222416_at	559	0.152057	0.265471	-	-0.288941	0.953748	0.0137807	1.01 [0.64 - 1.62]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217791_s_at	559	0.232558	0.197818	-	0.321144	0.659611	0.133913	1.14 [0.63 - 2.07]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217791_s_at	77	0.285714	0.0594097	-	-0.513218	0.470279	-0.205688	0.81 [0.47 - 1.42]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222416_at	77	0.896104	0.0257668	0.319581	0.853322	0.906332	-0.0425336	0.96 [0.47 - 1.95]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222416_at	70	0.414286	0.026838	0.328591	-0.598582	0.0355904	-0.701213	0.50 [0.26 - 0.95]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217791_s_at	70	0.885714	0.0292583	0.348359	-1.08074	0.194659	-0.478743	0.62 [0.30 - 1.28]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217791_s_at	74	0.351351	0.00184497	0.0423914	-0.899605	0.127181	-0.550285	0.58 [0.28 - 1.17]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222416_at	74	0.135135	0.0501064	-	-0.747321	0.207135	-0.45791	0.63 [0.31 - 1.29]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222416_at	67	0.134328	0.229713	-	15.2454	0.75464	-0.433595	0.65 [0.04 - 9.83]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217791_s_at	67	0.238806	0.0413918	0.43709	-1.28288	0.552877	-0.797618	0.45 [0.03 - 6.28]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222416_at	115	0.226087	0.230849	-	-0.656538	0.870163	0.100911	1.11 [0.33 - 3.71]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217791_s_at	115	0.826087	0.0437671	0.452751	1.07377	0.285672	0.80185	2.23 [0.51 - 9.72]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217791_s_at	204	0.872549	0.0898543	-	0.355873	0.729342	-0.0573952	0.94 [0.68 - 1.31]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222416_at	204	0.882353	0.23605	-	0.25953	0.972016	0.00672611	1.01 [0.69 - 1.47]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222416_at	87	0.275862	0.0831495	-	-0.659543	0.225123	-0.570783	0.57 [0.22 - 1.42]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222416_at	87	0.275862	0.0831495	-	-0.659543	0.225123	-0.570783	0.57 [0.22 - 1.42]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217791_s_at	87	0.241379	0.0425801	0.444987	-0.782055	0.166334	-0.650095	0.52 [0.21 - 1.31]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217791_s_at	87	0.241379	0.0425801	0.444987	-0.782055	0.166334	-0.650095	0.52 [0.21 - 1.31]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217791_s_at	77	0.467532	0.0856525	-	1.27163	0.460931	0.395662	1.49 [0.52 - 4.25]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222416_at	77	0.896104	0.00429679	0.0839627	1.55741	0.271874	0.666323	1.95 [0.59 - 6.39]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217791_s_at	77	0.25974	0.120903	-	1.47684	0.621146	0.231453	1.26 [0.50 - 3.16]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222416_at	77	0.896104	0.000290851	0.00889492	1.99667	0.246754	0.80191	2.23 [0.57 - 8.66]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217791_s_at	136	0.117647	0.0142352	0.20984	-1.21593	0.23473	-0.514837	0.60 [0.26 - 1.40]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217791_s_at	200	0.11	0.0031874	0.066141	-1.01958	0.281388	-0.51937	0.59 [0.23 - 1.53]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21339	60	0.2	0.0484327	0.482135	1.34431	0.166473	0.52869	1.70 [0.80 - 3.59]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21339	60	0.466667	0.188743	-	0.512782	0.616651	0.185471	1.20 [0.58 - 2.49]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217791_s_at	286	0.79021	0.0491953	0.486775	-0.526901	0.228447	-0.219827	0.80 [0.56 - 1.15]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217791_s_at	159	0.396226	0.280208	-	-0.340295	0.904059	0.0520636	1.05 [0.45 - 2.46]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217791_s_at	159	0.72956	0.0275276	0.334305	0.698294	0.190414	0.567477	1.76 [0.75 - 4.12]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217791_s_at	159	0.119497	0.14646	-	-0.654355	0.734119	0.172539	1.19 [0.44 - 3.22]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222416_at	159	0.886792	0.104277	-	0.664285	0.660511	0.164188	1.18 [0.57 - 2.45]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222416_at	159	0.610063	0.00828739	0.140033	0.817222	0.219625	0.456387	1.58 [0.76 - 3.27]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222416_at	159	0.685535	0.152867	-	0.533048	0.55646	0.258177	1.29 [0.55 - 3.06]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217791_s_at	54	0.203704	0.108339	-	15.4245	0.497114	0.270327	1.31 [0.60 - 2.86]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217791_s_at	117	0.837607	0.115095	-	-0.91538	0.670781	-0.0966682	0.91 [0.58 - 1.42]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217791_s_at	117	0.675214	0.0498848	0.490932	-1.01995	0.257744	-0.307387	0.74 [0.43 - 1.25]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217791_s_at	117	0.837607	0.115095	-	-0.91538	0.670781	-0.0966682	0.91 [0.58 - 1.42]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217791_s_at	117	0.230769	0.302801	-	0.504061	0.864173	-0.0466903	0.95 [0.56 - 1.63]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217791_s_at	236	0.716102	0.0364526	0.402855	0.573001	0.577563	0.234242	1.26 [0.55 - 2.88]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222416_at	236	0.669492	0.0104741	0.167179	0.681551	0.236675	0.442542	1.56 [0.75 - 3.24]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217791_s_at	249	0.891566	0.048036	0.479704	0.584656	0.874752	0.0522097	1.05 [0.55 - 2.02]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222416_at	249	0.710843	0.131476	-	0.340021	0.24688	0.367654	1.44 [0.78 - 2.69]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217791_s_at	125	0.752	0.0531249	-	0.740376	0.283493	0.36842	1.45 [0.74 - 2.83]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217791_s_at	125	0.752	0.169783	-	0.416628	0.894681	0.0360447	1.04 [0.61 - 1.77]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217791_s_at	54	0.351852	0.241114	-	0.884311	0.881876	0.0508909	1.05 [0.54 - 2.06]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217791_s_at	62	0.241935	0.238842	-	0.859037	0.501358	0.186808	1.21 [0.70 - 2.08]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217791_s_at	198	0.550505	0.00196203	0.0445884	-0.679041	0.00622525	-0.614715	0.54 [0.35 - 0.84]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217791_s_at	198	0.80303	0.033036	0.377717	-0.888781	0.067577	-0.500946	0.61 [0.35 - 1.04]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217791_s_at	198	0.80303	0.0356899	0.397352	-0.949944	0.053697	-0.560855	0.57 [0.32 - 1.01]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217791_s_at	51	0.411765	0.0646465	-	-1.8093	0.220099	-1.44668	0.24 [0.02 - 2.38]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217791_s_at	62	0.483871	0.328722	-	0.589734	0.953397	0.0350514	1.04 [0.32 - 3.36]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217791_s_at	177	0.231638	0.162119	-	0.413829	0.581162	0.168658	1.18 [0.65 - 2.16]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222416_at	145	0.62069	0.00826236	0.13971	-1.06336	0.353156	-0.372284	0.69 [0.31 - 1.51]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217791_s_at	145	0.710345	0.0385363	0.417586	-0.962321	0.617254	-0.206821	0.81 [0.36 - 1.83]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217791_s_at	177	0.728814	0.074704	-	-0.64016	0.851452	0.0652686	1.07 [0.54 - 2.11]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222416_at	177	0.254237	0.10898	-	0.451315	0.364447	0.261491	1.30 [0.74 - 2.29]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222416_at	177	0.819209	0.0549064	-	-0.873706	0.861942	0.0572653	1.06 [0.56 - 2.02]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222416_at	226	0.579646	0.0386256	0.418207	-0.62888	0.106031	-0.496631	0.61 [0.33 - 1.11]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217791_s_at	226	0.349558	0.0342567	0.386845	-0.591833	0.168119	-0.474413	0.62 [0.32 - 1.22]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217791_s_at	55	0.836364	0.024364	0.307523	1.26468	0.165433	0.895113	2.45 [0.69 - 8.67]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222416_at	55	0.854545	0.0251198	0.314056	1.18433	0.392105	0.508573	1.66 [0.52 - 5.33]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217791_s_at	49	0.897959	0.2226	-	0.925862	0.599611	0.389408	1.48 [0.34 - 6.32]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222416_at	49	0.857143	0.00960616	0.156643	1.47844	0.374805	0.729423	2.07 [0.41 - 10.38]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222416_at	55	0.836364	0.00463314	0.0891241	1.30366	0.750273	0.165838	1.18 [0.43 - 3.28]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217791_s_at	55	0.890909	0.0138982	0.206193	1.29728	0.235035	0.66389	1.94 [0.65 - 5.81]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	26406	34	0.441176	0.00104665	0.0264781	-1.42209	0.0283945	-1.07568	0.34 [0.13 - 0.89]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217791_s_at	63	0.603175	0.110769	-	-0.574709	0.737726	0.0588274	1.06 [0.75 - 1.50]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222416_at	63	0.52381	0.0145423	0.213137	-0.849438	0.844225	-0.0447971	0.96 [0.61 - 1.49]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4335784_3p_at	28	0.535714	0.0377521	0.412092	1.17134	0.247812	0.657545	1.93 [0.63 - 5.89]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4506348_3p_a_at	28	0.892857	0.0642932	-	-15.4298	0.183557	-3.80038	0.02 [0.00 - 6.05]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217791_s_at	82	0.182927	0.0375931	0.410971	1.18912	0.348809	0.663978	1.94 [0.48 - 7.79]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217791_s_at	79	0.797468	0.030619	0.359135	0.685035	0.956408	-0.0257341	0.97 [0.39 - 2.45]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X94453_at	86	0.895349	0.000241996	0.00758542	1.58755	0.17137	0.661598	1.94 [0.75 - 5.00]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217791_s_at	104	0.653846	0.00495427	0.093961	0.886441	0.00983083	1.34438	3.84 [1.38 - 10.64]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P1361	117	0.529915	0.000881168	0.0229149	0.962438	0.013427	0.705045	2.02 [1.16 - 3.54]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217791_s_at	204	0.833333	0.00102187	0.0259518	1.18468	0.0273536	0.963205	2.62 [1.11 - 6.16]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222416_at	204	0.602941	0.000292876	0.00894843	1.34167	0.00459794	1.6028	4.97 [1.64 - 15.05]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217791_s_at	204	0.823529	1.14027e-05	0.000503159	1.18468	0.000267393	1.14937	3.16 [1.70 - 5.86]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222416_at	204	0.622549	3.60404e-09	2.82577e-07	1.58991	5.65609e-06	1.76878	5.86 [2.73 - 12.59]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217791_s_at	178	0.898876	0.030833	0.360808	0.613414	0.628164	0.178914	1.20 [0.58 - 2.47]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200011919	41	0.878049	0.0372713	0.408694	1.10402	0.301193	0.353662	1.42 [0.73 - 2.78]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217791_s_at	111	0.702703	0.054271	-	0.521863	0.219282	0.392451	1.48 [0.79 - 2.77]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222416_at	111	0.783784	0.178228	-	0.402221	0.794088	-0.0759356	0.93 [0.52 - 1.64]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217791_s_at	90	0.444444	0.155401	-	0.549654	0.541015	0.270068	1.31 [0.55 - 3.11]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217791_s_at	90	0.266667	0.204739	-	0.525293	0.948764	0.0250097	1.03 [0.48 - 2.20]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1254	50	0.16	0.0428971	0.447073	15.3522	0.281621	0.464297	1.59 [0.68 - 3.70]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217791_s_at	138	0.268116	0.0367502	0.404985	0.632906	0.295896	0.165788	1.18 [0.86 - 1.61]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222416_at	138	0.847826	0.040554	0.431446	-0.850873	0.468457	-0.166296	0.85 [0.54 - 1.33]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217791_s_at	129	0.155039	0.0164933	0.233511	-0.710625	0.644384	-0.207577	0.81 [0.34 - 1.96]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19763	56	0.892857	0.0114696	0.178919	1.22689	0.851463	0.0747555	1.08 [0.49 - 2.36]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19763	56	0.892857	0.0011795	0.0292606	1.47943	0.521196	0.302577	1.35 [0.54 - 3.41]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217791_s_at	278	0.776978	0.192271	-	0.28238	0.944992	-0.0143883	0.99 [0.66 - 1.48]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222416_at	278	0.100719	0.067217	-	0.660277	0.419951	0.177896	1.19 [0.78 - 1.84]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217791_s_at	133	0.834586	0.0185027	0.25356	0.680782	0.691607	-0.0630308	0.94 [0.69 - 1.28]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7845	81	0.283951	0.0359827	0.399471	-1.08724	0.657851	-0.153654	0.86 [0.43 - 1.69]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217791_s_at	185	0.443243	0.167308	-	0.247317	0.671311	0.064625	1.07 [0.79 - 1.44]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217791_s_at	185	0.118919	0.266647	-	0.288493	0.894079	0.0185983	1.02 [0.77 - 1.34]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P1361	110	0.854545	0.133858	-	-0.503058	0.543874	-0.130067	0.88 [0.58 - 1.34]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P1361	110	0.218182	0.0573512	-	-0.595138	0.444699	-0.211423	0.81 [0.47 - 1.39]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217791_s_at	80	0.2625	0.0272286	0.331836	1.50439	0.105109	0.718502	2.05 [0.86 - 4.89]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_5082	281	0.103203	0.0574029	-	0.455437	0.0685126	0.180886	1.20 [0.99 - 1.46]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:264161	59	0.288136	0.0179788	0.248418	-1.09742	0.0319162	-2.03687	0.13 [0.02 - 0.84]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217791_s_at	38	0.763158	0.00598449	0.108943	1.28363	0.00456681	1.93904	6.95 [1.82 - 26.55]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222416_at	38	0.684211	0.0043774	0.085209	1.32948	0.00560842	1.25579	3.51 [1.44 - 8.54]
GENE	ALDH18A1	aldehyde dehydrogenase 18 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217791_s_at	140	0.642857	1.24977e-06	6.68234e-05	1.34217	0.00078706	0.929008	2.53 [1.47 - 4.36]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212224_at	30	0.6	0.0363135	0.401856	0.864107	0.221702	0.167163	1.18 [0.90 - 1.55]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1709348	165	0.89697	0.0206767	0.274304	0.777726	0.0266309	0.193431	1.21 [1.02 - 1.44]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1709348	165	0.89697	0.0402421	0.429329	0.901049	0.0664102	0.216859	1.24 [0.99 - 1.57]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212224_at	163	0.190184	0.0712823	-	0.487161	0.0848425	0.218448	1.24 [0.97 - 1.60]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212224_at	79	0.873418	0.030991	0.362041	0.79209	0.0505029	0.227384	1.26 [1.00 - 1.58]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212224_at	58	0.5	0.120875	-	0.423401	0.848684	0.021675	1.02 [0.82 - 1.28]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212224_at	34	0.470588	0.0332219	0.379118	-0.803627	0.223429	-0.264241	0.77 [0.50 - 1.17]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212224_at	158	0.341772	0.00462365	0.0889799	-0.653036	0.0813148	-0.315056	0.73 [0.51 - 1.04]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212224_at	53	0.566038	0.1779	-	0.460914	0.640578	0.0819742	1.09 [0.77 - 1.53]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212224_at	53	0.528302	0.22115	-	0.448059	0.899001	0.0239359	1.02 [0.71 - 1.48]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212224_at	180	0.761111	0.0842867	-	0.397971	0.97684	-0.0033829	1.00 [0.79 - 1.25]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212224_at	559	0.559928	0.00596817	0.108712	0.546071	0.272928	0.117186	1.12 [0.91 - 1.39]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212224_at	77	0.87013	0.0432242	0.449215	0.739803	0.959086	0.00606809	1.01 [0.80 - 1.27]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212224_at	70	0.828571	0.0743626	-	0.59362	0.357503	0.104143	1.11 [0.89 - 1.39]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37015_at	50	0.12	0.0448777	0.459907	-0.914872	0.641059	0.157038	1.17 [0.60 - 2.26]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212224_at	74	0.864865	0.23201	-	0.442051	0.69889	0.0556904	1.06 [0.80 - 1.40]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212224_at	67	0.313433	0.179643	-	1.32591	0.531457	-0.260686	0.77 [0.34 - 1.74]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212224_at	115	0.147826	0.0169477	0.238124	-1.25665	0.646645	-0.192588	0.82 [0.36 - 1.88]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37015_at	158	0.594937	0.102076	-	-0.525249	0.498913	-0.145778	0.86 [0.57 - 1.32]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37015_at	76	0.236842	0.0653645	-	1.70538	0.566475	0.190456	1.21 [0.63 - 2.32]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212224_at	204	0.676471	0.0274552	0.333708	-0.329854	0.245888	-0.0996854	0.91 [0.76 - 1.07]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212224_at	87	0.287356	0.0672373	-	-0.70505	0.279073	-0.143375	0.87 [0.67 - 1.12]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212224_at	87	0.287356	0.0672373	-	-0.70505	0.279073	-0.143375	0.87 [0.67 - 1.12]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212224_at	77	0.168831	0.0288633	0.345187	-1.31653	0.361285	-0.417253	0.66 [0.27 - 1.61]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212224_at	77	0.519481	0.00967577	0.157499	-1.75919	0.2576	-0.459461	0.63 [0.29 - 1.40]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212224_at	136	0.514706	0.0185726	0.254242	-1.14894	0.0672214	-0.333026	0.72 [0.50 - 1.02]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212224_at	200	0.56	0.000914476	0.0236416	-1.07127	0.00417755	-0.42109	0.66 [0.49 - 0.88]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13170	60	0.816667	0.201213	-	0.550321	0.938917	0.0116138	1.01 [0.75 - 1.36]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13170	60	0.366667	0.0462575	0.468654	0.888806	0.228048	0.227125	1.25 [0.87 - 1.82]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1245	155	0.845161	0.00372888	0.0750048	0.865289	0.0372566	0.511377	1.67 [1.03 - 2.70]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212224_at	286	0.898601	0.020179	0.269636	-1.01958	0.129994	-0.124344	0.88 [0.75 - 1.04]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212224_at	159	0.559748	0.00568742	0.104701	-0.971909	0.132912	-0.256027	0.77 [0.55 - 1.08]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212224_at	159	0.559748	0.00143071	0.0343606	-1.44079	0.0609581	-0.364746	0.69 [0.47 - 1.02]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212224_at	159	0.72956	0.000637675	0.0174319	-2.08161	0.0129103	-0.40369	0.67 [0.49 - 0.92]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212224_at	54	0.259259	0.0034436	0.0703773	-1.8929	0.56598	-0.21671	0.81 [0.38 - 1.69]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212224_at	117	0.632479	0.273958	-	0.349485	0.432382	0.113419	1.12 [0.84 - 1.49]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212224_at	117	0.324786	0.316605	-	-0.385478	0.879158	0.0273114	1.03 [0.72 - 1.46]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212224_at	117	0.632479	0.273958	-	0.349485	0.432382	0.113419	1.12 [0.84 - 1.49]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212224_at	117	0.324786	0.100415	-	-0.632853	0.360129	-0.189306	0.83 [0.55 - 1.24]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212224_at	236	0.627119	0.000893576	0.0231862	-1.10514	0.00121923	-0.3501	0.70 [0.57 - 0.87]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212224_at	249	0.726908	0.0105392	0.167959	-0.677762	0.0118421	-0.238201	0.79 [0.65 - 0.95]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212224_at	62	0.612903	0.0895515	-	-0.932615	0.470422	-0.282629	0.75 [0.35 - 1.62]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212224_at	125	0.824	0.180782	-	-0.800145	0.334788	-0.156707	0.85 [0.62 - 1.18]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212224_at	125	0.304	0.110293	-	-0.501095	0.311024	-0.125586	0.88 [0.69 - 1.12]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212224_at	54	0.166667	0.0502372	-	-1.14145	0.404594	-0.411379	0.66 [0.25 - 1.74]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212224_at	198	0.393939	0.0168474	0.237109	-0.5989	0.0851289	-0.167326	0.85 [0.70 - 1.02]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212224_at	198	0.388889	0.0144612	0.212269	-0.644288	0.0691378	-0.18447	0.83 [0.68 - 1.01]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212224_at	198	0.409091	0.0386058	0.418069	-0.43223	0.391957	-0.0706692	0.93 [0.79 - 1.10]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212224_at	51	0.54902	0.112858	-	1.59748	0.531956	-0.360962	0.70 [0.22 - 2.16]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212224_at	62	0.854839	0.124275	-	-15.291	0.507412	-0.229044	0.80 [0.40 - 1.57]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212224_at	177	0.305085	0.0876253	-	0.537069	0.635427	0.0486813	1.05 [0.86 - 1.28]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212224_at	177	0.305085	0.0370321	0.406995	0.570974	0.433	0.0697535	1.07 [0.90 - 1.28]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212224_at	145	0.882759	0.206207	-	-0.890373	0.863792	0.0222774	1.02 [0.79 - 1.32]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212224_at	226	0.163717	0.132105	-	0.696479	0.859288	0.0175181	1.02 [0.84 - 1.24]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212224_at	55	0.145455	0.131656	-	1.42454	0.470862	0.117046	1.12 [0.82 - 1.55]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212224_at	55	0.254545	0.19142	-	-0.642279	0.483716	-0.122834	0.88 [0.63 - 1.25]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212224_at	49	0.836735	0.140063	-	-15.2706	0.676325	-0.0924819	0.91 [0.59 - 1.41]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	299020	34	0.705882	0.0304341	0.357684	-1.30301	0.30945	-0.307731	0.74 [0.41 - 1.33]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212224_at	63	0.349206	0.0986654	-	0.630664	0.820255	-0.0350367	0.97 [0.71 - 1.31]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.76392.0.S1_3p_at	28	0.428571	0.0500631	-	-1.08464	0.266741	-0.600439	0.55 [0.19 - 1.58]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212224_at	82	0.390244	0.179521	-	-0.454457	0.992739	-0.00139249	1.00 [0.74 - 1.35]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37015_at	84	0.547619	0.0340302	0.385164	-0.635675	0.874481	-0.0187401	0.98 [0.78 - 1.24]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212224_at	79	0.151899	0.0907614	-	-0.561952	0.542695	-0.0847772	0.92 [0.70 - 1.21]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M31994_at	86	0.127907	0.00326544	0.0674399	-1.30606	0.00429252	-0.736907	0.48 [0.29 - 0.79]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212224_at	104	0.211538	0.00907378	0.150029	-0.867517	0.0272839	-0.345144	0.71 [0.52 - 0.96]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P83098	117	0.504274	0.0157932	0.226308	-0.702043	0.24842	-0.14192	0.87 [0.68 - 1.10]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212224_at	204	0.397059	0.0547949	-	-0.694073	0.641907	-0.087523	0.92 [0.63 - 1.32]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212224_at	204	0.406863	0.00980029	0.159025	-0.693678	0.146842	-0.201502	0.82 [0.62 - 1.07]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212224_at	178	0.44382	0.0816968	-	-0.342366	0.343097	-0.114486	0.89 [0.70 - 1.13]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212224_at	111	0.117117	0.0078054	0.133763	-0.906986	0.125245	-0.151599	0.86 [0.71 - 1.04]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212224_at	90	0.833333	0.0722439	-	-1.03593	0.416467	-0.0779842	0.92 [0.77 - 1.12]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212224_at	90	0.688889	0.0872064	-	-0.765865	0.467057	-0.0802625	0.92 [0.74 - 1.15]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4398	50	0.88	0.0352362	0.394049	1.13922	0.869388	-0.0560254	0.95 [0.48 - 1.84]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212224_at	138	0.84058	0.0110519	0.174036	-1.12179	0.0853699	-0.0946526	0.91 [0.82 - 1.01]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212224_at	129	0.302326	0.024469	0.308436	-0.577329	0.903987	0.0141261	1.01 [0.81 - 1.28]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33528	56	0.142857	0.00179249	0.0413968	-1.28253	0.871913	-0.0171292	0.98 [0.80 - 1.21]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	725	56	0.196429	0.000618163	0.0169777	-1.3075	0.789604	-0.0290068	0.97 [0.78 - 1.20]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33528	56	0.142857	0.00116573	0.0289752	-1.4587	0.906838	0.0135981	1.01 [0.81 - 1.27]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	725	56	0.196429	0.00475993	0.0910441	-1.22431	0.957604	0.00626114	1.01 [0.80 - 1.27]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212224_at	278	0.758993	0.029346	0.349061	-0.530301	0.0748659	-0.119838	0.89 [0.78 - 1.01]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212224_at	133	0.593985	0.00914215	0.150885	-0.677713	0.0578341	-0.154838	0.86 [0.73 - 1.01]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5561	81	0.604938	0.25918	-	-0.651397	0.445423	-0.16667	0.85 [0.55 - 1.30]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212224_at	185	0.778378	0.000872207	0.0227185	0.677273	0.00478431	0.205992	1.23 [1.06 - 1.42]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212224_at	185	0.778378	0.00243428	0.0531805	0.585312	0.0200627	0.163235	1.18 [1.03 - 1.35]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P83098	110	0.145455	0.0647966	-	-0.655459	0.333933	-0.110317	0.90 [0.72 - 1.12]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P83098	110	0.263636	0.037245	0.408508	-0.505365	0.112336	-0.136643	0.87 [0.74 - 1.03]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212224_at	80	0.5125	0.25468	-	-0.522183	0.705005	-0.0541833	0.95 [0.72 - 1.25]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_1392	281	0.679715	0.00100954	0.0256889	0.47619	0.121724	0.158792	1.17 [0.96 - 1.43]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212224_at	38	0.894737	0.0341783	0.386264	1.29737	0.628424	0.121528	1.13 [0.69 - 1.85]
GENE	ALDH1A1	aldehyde dehydrogenase 1 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212224_at	140	0.15	1.01955e-06	5.53942e-05	-1.39758	0.00112714	-0.30764	0.74 [0.61 - 0.88]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207015_s_at	30	0.3	0.175317	-	-0.557411	0.802202	-0.184602	0.83 [0.20 - 3.52]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207016_s_at	30	0.466667	0.461172	-	-0.292099	0.861033	0.0610019	1.06 [0.54 - 2.10]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1748538	165	0.30303	0.0320856	0.370493	0.616502	0.105444	0.161177	1.17 [0.97 - 1.43]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1748538	165	0.89697	0.00197389	0.0448094	1.19326	0.00904346	0.346608	1.41 [1.09 - 1.83]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207016_s_at	163	0.509202	0.306513	-	-0.202422	0.964823	-0.0229839	0.98 [0.35 - 2.71]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207015_s_at	163	0.895706	0.0940219	-	-0.607732	0.366955	-0.558038	0.57 [0.17 - 1.92]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207015_s_at	79	0.21519	0.00617035	0.111567	-0.853377	0.033184	-1.7904	0.17 [0.03 - 0.87]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207016_s_at	79	0.101266	0.155392	-	-0.613961	0.792577	-0.192536	0.82 [0.20 - 3.46]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207015_s_at	58	0.189655	0.161232	-	0.490386	0.832291	0.0318354	1.03 [0.77 - 1.39]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207016_s_at	58	0.137931	0.0203967	0.271684	0.928828	0.285366	0.154722	1.17 [0.88 - 1.55]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207015_s_at	34	0.735294	0.0238779	0.303274	-1.16204	0.236494	-0.354903	0.70 [0.39 - 1.26]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207016_s_at	34	0.176471	0.00708939	0.124229	-1.22793	0.300447	-0.224618	0.80 [0.52 - 1.22]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207015_s_at	158	0.291139	0.050876	-	0.557449	0.382384	0.624621	1.87 [0.46 - 7.58]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207016_s_at	158	0.613924	0.00502976	0.0950857	-0.715886	0.0546078	-1.80381	0.16 [0.03 - 1.04]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207016_s_at	53	0.396226	0.139737	-	0.582912	0.81376	-0.0512128	0.95 [0.62 - 1.45]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207015_s_at	53	0.886792	0.172576	-	-0.957783	0.910219	0.0291661	1.03 [0.62 - 1.71]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207016_s_at	53	0.679245	0.197591	-	-0.496972	0.717149	-0.0735143	0.93 [0.62 - 1.38]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207015_s_at	53	0.245283	0.216055	-	0.597683	0.666797	0.11983	1.13 [0.65 - 1.95]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207015_s_at	180	0.261111	0.129264	-	-0.342492	0.313073	-0.0995452	0.91 [0.75 - 1.10]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207016_s_at	180	0.122222	0.0167081	0.235697	-0.68987	0.367623	-0.0882008	0.92 [0.76 - 1.11]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207015_s_at	559	0.34347	0.00789123	0.134888	-0.529129	0.149315	-0.201192	0.82 [0.62 - 1.07]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207016_s_at	559	0.227191	0.053843	-	-0.433067	0.604288	-0.0608584	0.94 [0.75 - 1.18]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207015_s_at	77	0.753247	0.10362	-	0.466639	0.380214	0.151977	1.16 [0.83 - 1.63]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207016_s_at	77	0.454545	0.000564783	0.0157221	-0.885739	0.0197036	-0.423112	0.66 [0.46 - 0.93]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207015_s_at	70	0.685714	0.166242	-	0.386792	0.274411	0.823956	2.28 [0.52 - 9.99]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207016_s_at	70	0.7	0.0469528	0.473004	-0.598402	0.181805	-0.426349	0.65 [0.35 - 1.22]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38315_at	50	0.82	0.0570783	-	-0.874267	0.0540891	-1.87433	0.15 [0.02 - 1.03]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207015_s_at	74	0.189189	0.181169	-	0.578563	0.770318	0.064986	1.07 [0.69 - 1.65]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207016_s_at	74	0.837838	0.174385	-	0.463266	0.481315	0.138052	1.15 [0.78 - 1.69]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207015_s_at	67	0.38806	0.0326853	0.375064	1.98319	0.957076	0.0282976	1.03 [0.37 - 2.88]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207016_s_at	67	0.746269	0.32515	-	-1.00188	0.730641	-0.091264	0.91 [0.54 - 1.53]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207015_s_at	115	0.269565	0.0177508	0.246162	15.552	0.150713	1.40917	4.09 [0.60 - 27.97]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207016_s_at	115	0.226087	0.0506785	-	-1.01151	0.339792	-0.534174	0.59 [0.20 - 1.76]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38315_at	158	0.120253	0.00555663	0.102814	-0.922479	0.0192399	-0.587698	0.56 [0.34 - 0.91]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38315_at	76	0.684211	0.0170053	0.238705	1.18583	0.0979666	1.36353	3.91 [0.78 - 19.66]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207016_s_at	204	0.20098	0.111805	-	-0.277725	0.341188	-0.0559851	0.95 [0.84 - 1.06]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207015_s_at	204	0.122549	0.164499	-	0.292447	0.591747	0.0437935	1.04 [0.89 - 1.23]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207016_s_at	87	0.873563	0.0141715	0.209153	-15.3335	0.0937573	-0.660818	0.52 [0.24 - 1.12]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207015_s_at	87	0.333333	0.195944	-	0.558071	0.847475	0.14721	1.16 [0.26 - 5.19]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207015_s_at	87	0.333333	0.195944	-	0.558071	0.847475	0.14721	1.16 [0.26 - 5.19]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207016_s_at	87	0.873563	0.0141715	0.209153	-15.3335	0.0937573	-0.660818	0.52 [0.24 - 1.12]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207015_s_at	77	0.857143	0.0286885	0.343777	1.23838	0.919997	0.157543	1.17 [0.05 - 25.33]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207016_s_at	77	0.831169	0.0014119	0.0339853	1.77878	0.0131663	0.568579	1.77 [1.13 - 2.77]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207015_s_at	77	0.857143	0.00378638	0.0759266	1.67431	0.72098	0.626843	1.87 [0.06 - 58.38]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207016_s_at	77	0.831169	0.0165143	0.233725	1.28	0.0363256	0.473523	1.61 [1.03 - 2.50]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207016_s_at	136	0.610294	0.0863201	-	-0.927005	0.20486	-0.267952	0.76 [0.51 - 1.16]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207015_s_at	136	0.323529	0.14545	-	0.796889	0.502952	0.210077	1.23 [0.67 - 2.28]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207015_s_at	200	0.435	0.0316599	0.367223	0.67917	0.240417	0.223046	1.25 [0.86 - 1.81]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207016_s_at	200	0.795	0.0104923	0.167398	-1.26046	0.559797	-0.104663	0.90 [0.63 - 1.28]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21861	60	0.466667	0.389129	-	0.326321	0.903628	0.0684198	1.07 [0.35 - 3.24]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5240	60	0.216667	0.139287	-	0.779881	0.819448	-0.0624307	0.94 [0.55 - 1.61]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21861	60	0.85	0.0310548	0.362538	0.980463	0.113422	1.28734	3.62 [0.74 - 17.84]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5240	60	0.85	0.100921	-	-1.1411	0.761992	-0.0953394	0.91 [0.49 - 1.68]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	11675	155	0.109677	9.51464e-05	0.00335206	-1.16231	0.182914	-0.150771	0.86 [0.69 - 1.07]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207015_s_at	286	0.286713	0.296001	-	0.231886	0.701542	0.0496531	1.05 [0.82 - 1.35]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207016_s_at	286	0.874126	0.0261685	0.322979	-0.844047	0.548769	-0.0726046	0.93 [0.73 - 1.18]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207015_s_at	159	0.81761	0.275842	-	0.395239	0.684729	0.0932365	1.10 [0.70 - 1.72]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207016_s_at	159	0.534591	1.54049e-06	8.10025e-05	-1.9699	0.000457463	-0.673961	0.51 [0.35 - 0.74]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207015_s_at	159	0.641509	0.239899	-	-0.483713	0.71401	-0.100398	0.90 [0.53 - 1.55]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207016_s_at	159	0.509434	4.37373e-06	0.000210673	-1.70308	0.00614389	-0.543461	0.58 [0.39 - 0.86]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207016_s_at	159	0.534591	7.9234e-05	0.002852	-1.85402	0.00511106	-0.641072	0.53 [0.34 - 0.83]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207015_s_at	159	0.100629	0.0287756	0.34448	-0.884122	0.329802	-0.228355	0.80 [0.50 - 1.26]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207016_s_at	54	0.611111	0.0802922	-	-1.67001	0.392276	-0.694848	0.50 [0.10 - 2.45]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207015_s_at	54	0.62963	0.0945118	-	-1.59911	0.988559	-0.0158901	0.98 [0.11 - 8.64]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207015_s_at	117	0.393162	0.102183	-	0.556691	0.822914	0.153688	1.17 [0.30 - 4.48]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207015_s_at	117	0.42735	0.237896	-	0.46142	0.841609	0.162209	1.18 [0.24 - 5.77]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207015_s_at	117	0.393162	0.102183	-	0.556691	0.822914	0.153688	1.17 [0.30 - 4.48]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207015_s_at	117	0.111111	0.194558	-	1.24184	0.787618	0.227698	1.26 [0.24 - 6.58]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207016_s_at	117	0.74359	0.0172207	0.240872	0.898757	0.440554	0.342962	1.41 [0.59 - 3.37]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207016_s_at	117	0.74359	0.00286053	0.0606151	0.937741	0.0429204	0.683986	1.98 [1.02 - 3.84]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207016_s_at	117	0.74359	0.00286053	0.0606151	0.937741	0.0429204	0.683986	1.98 [1.02 - 3.84]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207016_s_at	117	0.290598	0.0584157	-	-0.725117	0.817199	-0.119709	0.89 [0.32 - 2.45]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207016_s_at	236	0.101695	6.09689e-06	0.000285123	-1.31305	2.53478e-05	-0.969935	0.38 [0.24 - 0.60]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207015_s_at	236	0.741525	0.0636024	-	0.520735	0.381704	0.197339	1.22 [0.78 - 1.90]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207015_s_at	249	0.216867	0.102772	-	0.470506	0.285027	0.187305	1.21 [0.86 - 1.70]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207016_s_at	249	0.100402	5.87358e-06	0.000275605	-1.16578	0.00524307	-0.537756	0.58 [0.40 - 0.85]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207016_s_at	125	0.4	0.012655	0.192459	-0.721848	0.281268	-0.413264	0.66 [0.31 - 1.40]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207016_s_at	54	0.12963	0.0400645	0.428119	-1.39428	0.394462	-0.229447	0.79 [0.47 - 1.35]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207015_s_at	62	0.290323	0.385489	-	-0.467928	0.737337	-0.114502	0.89 [0.46 - 1.74]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207015_s_at	125	0.776	0.355289	-	-0.462649	0.977194	0.0179965	1.02 [0.30 - 3.50]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207016_s_at	62	0.274194	0.0352291	0.393998	-0.981954	0.3282	-0.218529	0.80 [0.52 - 1.25]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207015_s_at	125	0.824	0.0418641	0.440244	-0.943401	0.142053	-0.710041	0.49 [0.19 - 1.27]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207015_s_at	54	0.888889	0.229368	-	0.786851	0.813591	-0.0979025	0.91 [0.40 - 2.05]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207016_s_at	125	0.4	0.0058875	0.107565	-1.04485	0.292391	-0.529289	0.59 [0.22 - 1.58]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207015_s_at	198	0.116162	0.00782683	0.134044	2.20657	0.278149	0.129006	1.14 [0.90 - 1.44]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207016_s_at	198	0.262626	0.115345	-	0.397605	0.383123	0.0641823	1.07 [0.92 - 1.23]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207015_s_at	198	0.116162	0.011538	0.179713	2.12648	0.312361	0.125393	1.13 [0.89 - 1.45]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207016_s_at	198	0.863636	0.0194303	0.262525	-1.29269	0.753307	-0.027005	0.97 [0.82 - 1.15]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207016_s_at	198	0.863636	0.0153343	0.221522	-1.57793	0.502023	-0.0589522	0.94 [0.79 - 1.12]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207015_s_at	198	0.111111	0.0680482	-	0.758522	0.758996	0.0293718	1.03 [0.85 - 1.24]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207016_s_at	62	0.177419	0.105557	-	-0.954821	0.412091	-1.09111	0.34 [0.02 - 4.55]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207015_s_at	51	0.156863	0.0896007	-	-1.42951	0.452764	-1.60869	0.20 [0.00 - 13.34]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207015_s_at	62	0.193548	0.16294	-	-0.831541	0.379116	-1.12819	0.32 [0.03 - 4.00]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207016_s_at	51	0.27451	0.155638	-	15.5546	0.828369	0.181669	1.20 [0.23 - 6.20]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207016_s_at	177	0.491525	0.180667	-	-0.362167	0.885351	0.0239229	1.02 [0.74 - 1.42]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207015_s_at	145	0.758621	0.0545027	-	-0.980512	0.521693	-0.427976	0.65 [0.18 - 2.41]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207015_s_at	177	0.101695	0.0248625	0.311843	-0.799428	0.0765418	-1.08847	0.34 [0.10 - 1.12]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207016_s_at	177	0.785311	0.0889858	-	-0.55113	0.488036	-0.113167	0.89 [0.65 - 1.23]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207016_s_at	145	0.213793	0.0938654	-	0.862032	0.251636	0.191101	1.21 [0.87 - 1.68]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207015_s_at	177	0.19774	0.00134226	0.0325871	-0.812759	0.017763	-1.29704	0.27 [0.09 - 0.80]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207016_s_at	226	0.176991	0.0148335	0.216239	1.348	0.118907	0.109023	1.12 [0.97 - 1.28]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207015_s_at	226	0.238938	0.0173859	0.242527	0.995337	0.54629	0.0705646	1.07 [0.85 - 1.35]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207016_s_at	55	0.4	0.0607912	-	-0.823757	0.788388	-0.145922	0.86 [0.30 - 2.51]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207016_s_at	55	0.218182	0.066957	-	-0.852713	0.217477	-0.852787	0.43 [0.11 - 1.65]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207016_s_at	49	0.367347	0.220821	-	-0.694093	0.820474	-0.147679	0.86 [0.24 - 3.09]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207015_s_at	55	0.781818	0.00890533	0.147912	-15.5419	0.0474794	-2.20052	0.11 [0.01 - 0.98]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207015_s_at	55	0.527273	0.0392339	0.422422	-0.972697	0.164686	-1.30043	0.27 [0.04 - 1.71]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207015_s_at	49	0.591837	0.0214825	0.281765	-1.62071	0.0692623	-2.37268	0.09 [0.01 - 1.21]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207016_s_at	63	0.31746	0.00633204	0.113832	1.24176	0.0871359	0.128602	1.14 [0.98 - 1.32]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207015_s_at	63	0.507937	0.0433356	0.449942	-0.693908	0.493894	0.595653	1.81 [0.33 - 10.00]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g10835044_3p_a_at	28	0.392857	0.0686408	-	-1.00871	0.742288	0.531041	1.70 [0.07 - 40.30]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g3970845_3p_a_at	28	0.107143	0.0598975	-	-1.22538	0.189337	-5.60127	0.00 [0.00 - 15.85]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207016_s_at	82	0.52439	0.0288065	0.344729	0.745898	0.224192	0.212916	1.24 [0.88 - 1.74]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207015_s_at	82	0.292683	0.0304675	0.357947	-0.755375	0.403007	-0.422588	0.66 [0.24 - 1.76]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38315_at	84	0.333333	0.034667	0.389875	-0.618842	0.730968	-0.0962281	0.91 [0.52 - 1.57]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207016_s_at	79	0.189873	0.0310865	0.362784	-0.682785	0.408133	-0.147265	0.86 [0.61 - 1.22]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207015_s_at	79	0.316456	0.00172125	0.0400368	-0.830292	0.0139291	-1.51102	0.22 [0.07 - 0.74]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207015_s_at	104	0.105769	0.177579	-	-0.635377	0.764219	-0.2032	0.82 [0.22 - 3.08]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207016_s_at	104	0.346154	0.0224418	0.290496	-0.729008	0.33309	-0.19881	0.82 [0.55 - 1.23]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207015_s_at	204	0.887255	0.000164414	0.00541768	1.13967	0.00309325	0.499025	1.65 [1.18 - 2.29]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207016_s_at	204	0.259804	0.0318699	0.368839	1.22795	0.43765	0.138102	1.15 [0.81 - 1.63]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207016_s_at	204	0.539216	0.212384	-	-0.346475	0.735898	-0.0488748	0.95 [0.72 - 1.27]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207015_s_at	204	0.534314	0.000161652	0.00533808	1.4905	0.00210556	0.678306	1.97 [1.28 - 3.04]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207016_s_at	178	0.258427	0.0534685	-	-0.408824	0.341505	-0.0976852	0.91 [0.74 - 1.11]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207015_s_at	178	0.657303	0.186337	-	0.26798	0.511089	-0.189304	0.83 [0.47 - 1.46]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207016_s_at	111	0.576577	0.0581293	-	-0.519501	0.940068	-0.00945796	0.99 [0.77 - 1.27]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207015_s_at	111	0.837838	0.0328492	0.376305	0.680718	0.31961	0.174943	1.19 [0.84 - 1.68]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207016_s_at	90	0.833333	0.107588	-	0.605735	0.365471	0.285066	1.33 [0.72 - 2.47]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207016_s_at	90	0.122222	0.0862095	-	-0.768252	0.731302	-0.147403	0.86 [0.37 - 2.00]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207015_s_at	90	0.822222	0.166898	-	-0.716329	0.668435	-0.220295	0.80 [0.29 - 2.20]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207015_s_at	90	0.822222	0.202096	-	-0.760347	0.779911	-0.162198	0.85 [0.27 - 2.65]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	1719	50	0.78	0.07237	-	-1.65061	0.325451	-0.376978	0.69 [0.32 - 1.45]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207016_s_at	138	0.789855	0.0477989	0.478246	0.520845	0.538413	0.0487129	1.05 [0.90 - 1.23]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207015_s_at	138	0.449275	0.134487	-	-0.359469	0.527902	-0.267834	0.77 [0.33 - 1.76]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207015_s_at	129	0.162791	0.0453846	0.463139	0.785201	0.236876	0.205143	1.23 [0.87 - 1.72]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207016_s_at	129	0.472868	0.247803	-	-0.286352	0.766237	0.0599175	1.06 [0.72 - 1.58]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38291	56	0.714286	0.241707	-	0.451007	0.809523	0.0653822	1.07 [0.63 - 1.82]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38811	56	0.892857	0.199554	-	0.619829	0.539132	0.101021	1.11 [0.80 - 1.53]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20562	56	0.375	0.136038	-	-0.50752	0.895066	-0.0330943	0.97 [0.59 - 1.58]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38291	56	0.857143	0.0876132	-	0.836633	0.850945	0.0550858	1.06 [0.59 - 1.88]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41445	56	0.125	0.250017	-	0.681773	0.621707	0.0665946	1.07 [0.82 - 1.39]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20562	56	0.321429	0.075292	-	-0.625488	0.827353	-0.0581687	0.94 [0.56 - 1.59]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38811	56	0.25	0.199186	-	0.569451	0.521544	0.096042	1.10 [0.82 - 1.48]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41445	56	0.892857	0.199554	-	0.619829	0.576683	0.0813326	1.08 [0.82 - 1.44]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207016_s_at	278	0.5	4.42118e-05	0.00169927	0.787817	0.00157383	0.165626	1.18 [1.06 - 1.31]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207015_s_at	278	0.859712	0.297809	-	0.250244	0.570808	0.115602	1.12 [0.75 - 1.67]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207015_s_at	133	0.270677	0.000545515	0.0152639	1.12071	0.55354	0.102613	1.11 [0.79 - 1.56]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207016_s_at	133	0.894737	0.0410304	0.434664	-1.00893	0.195882	-0.0724067	0.93 [0.83 - 1.04]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1943	81	0.728395	0.0492368	0.487026	0.98199	0.897195	0.0194598	1.02 [0.76 - 1.37]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207015_s_at	185	0.378378	0.0156931	0.225269	-0.40444	0.0904316	-0.455448	0.63 [0.37 - 1.07]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207016_s_at	185	0.756757	0.000197243	0.00635014	0.735103	0.00429837	0.243783	1.28 [1.08 - 1.51]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207015_s_at	185	0.427027	0.00230013	0.0507809	-0.53686	0.108116	-0.475481	0.62 [0.35 - 1.11]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207016_s_at	185	0.756757	0.000322924	0.00973581	0.668187	0.0203205	0.186801	1.21 [1.03 - 1.41]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P73577	110	0.318182	0.13993	-	0.38508	0.918562	0.00555135	1.01 [0.90 - 1.12]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P99956	110	0.518182	0.187136	-	-0.305823	0.974882	-0.00543328	0.99 [0.71 - 1.39]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P73577	110	0.154545	0.045854	0.466112	-0.739804	0.32866	-0.0763296	0.93 [0.79 - 1.08]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P99956	110	0.472727	0.105223	-	-0.485625	0.97484	-0.00739758	0.99 [0.63 - 1.57]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207015_s_at	80	0.2	0.053368	-	-0.955386	0.549475	-0.132387	0.88 [0.57 - 1.35]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207016_s_at	80	0.8375	0.0629935	-	-15.2567	0.787754	-0.0402373	0.96 [0.72 - 1.29]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0213	281	0.145907	0.00231759	0.0510949	-0.556591	0.02592	-0.154182	0.86 [0.75 - 0.98]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207016_s_at	38	0.894737	0.013028	0.196628	1.54179	0.144678	0.446967	1.56 [0.86 - 2.85]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207015_s_at	38	0.815789	0.061799	-	0.981902	0.575457	-0.316288	0.73 [0.24 - 2.20]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207016_s_at	140	0.135714	2.9255e-05	0.00117505	-1.25694	0.303349	-0.188834	0.83 [0.58 - 1.19]
GENE	ALDH1A2	aldehyde dehydrogenase 1 family, member A2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207015_s_at	140	0.142857	0.0233624	0.298726	-0.789878	0.321463	-0.692088	0.50 [0.13 - 1.97]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203180_at	30	0.3	0.449578	-	-0.314081	0.655553	-0.116852	0.89 [0.53 - 1.49]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1807439	165	0.127273	0.0280955	0.338962	-0.665488	0.590432	-0.0473286	0.95 [0.80 - 1.13]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1807439	165	0.121212	0.0312787	0.364276	-0.892851	0.952099	-0.00743024	0.99 [0.78 - 1.26]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203180_at	163	0.815951	0.0739539	-	0.429074	0.67012	0.15016	1.16 [0.58 - 2.32]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203180_at	79	0.898734	0.168466	-	-0.798905	0.691682	-0.117635	0.89 [0.50 - 1.59]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203180_at	58	0.103448	0.0519739	-	0.983817	0.0755836	0.262321	1.30 [0.97 - 1.74]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203180_at	34	0.235294	0.0179295	0.247931	-0.993115	0.509187	-0.249102	0.78 [0.37 - 1.63]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203180_at	158	0.405063	0.00758788	0.130895	-0.611405	0.0616519	-0.524874	0.59 [0.34 - 1.03]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203180_at	53	0.528302	0.0202343	0.270157	-0.815024	0.286062	-0.156258	0.86 [0.64 - 1.14]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203180_at	53	0.528302	0.136273	-	-0.548974	0.964274	-0.00696203	0.99 [0.73 - 1.35]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203180_at	180	0.355556	0.00424586	0.0831723	-0.596336	0.184461	-0.0882753	0.92 [0.80 - 1.04]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203180_at	559	0.722719	0.00647627	0.115838	-0.746009	0.0740913	-0.220153	0.80 [0.63 - 1.02]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203180_at	77	0.12987	0.0564206	-	-0.666055	0.162202	-0.142687	0.87 [0.71 - 1.06]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203180_at	70	0.685714	0.0383475	0.416269	-0.619046	0.171374	-0.207671	0.81 [0.60 - 1.09]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36686_at	50	0.24	0.109087	-	-0.626966	0.690515	0.17467	1.19 [0.50 - 2.81]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203180_at	74	0.689189	0.00588884	0.107584	0.809598	0.0498556	0.239083	1.27 [1.00 - 1.61]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203180_at	67	0.820895	0.112821	-	1.07747	0.863816	0.0715588	1.07 [0.47 - 2.43]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203180_at	115	0.817391	0.000815572	0.0214685	1.61171	0.0896063	0.610938	1.84 [0.91 - 3.73]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36686_at	158	0.341772	0.127494	-	-0.432183	0.921816	-0.0231955	0.98 [0.61 - 1.55]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36686_at	76	0.144737	0.411732	-	0.826446	0.877079	-0.0636828	0.94 [0.42 - 2.10]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203180_at	204	0.308824	0.0010483	0.026513	0.4946	0.114092	0.107357	1.11 [0.97 - 1.27]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203180_at	87	0.172414	0.138862	-	-0.639032	0.51411	-0.118879	0.89 [0.62 - 1.27]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203180_at	87	0.172414	0.138862	-	-0.639032	0.51411	-0.118879	0.89 [0.62 - 1.27]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203180_at	77	0.12987	0.224128	-	-0.781561	0.595443	-0.149465	0.86 [0.50 - 1.50]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203180_at	77	0.194805	0.0842552	-	-1.06453	0.462454	-0.238082	0.79 [0.42 - 1.49]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203180_at	136	0.102941	0.052593	-	-1.05199	0.195496	-0.301269	0.74 [0.47 - 1.17]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203180_at	200	0.2	0.00566402	0.104364	-0.846554	0.240319	-0.217681	0.80 [0.56 - 1.16]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20009	60	0.816667	0.0205115	0.27276	0.958263	0.381301	0.0823153	1.09 [0.90 - 1.31]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20009	60	0.583333	0.0367595	0.405052	0.781529	0.1289	0.209636	1.23 [0.94 - 1.62]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21929	155	0.354839	0.0492157	0.486898	-0.545122	0.998088	0.000458093	1.00 [0.69 - 1.46]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203180_at	286	0.807692	0.00534666	0.0997591	0.605538	0.509705	0.0728871	1.08 [0.87 - 1.34]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203180_at	159	0.320755	0.0176857	0.245516	-0.735061	0.486717	-0.110961	0.89 [0.65 - 1.22]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203180_at	159	0.119497	0.0486026	0.483173	-0.878015	0.702953	-0.0772727	0.93 [0.62 - 1.38]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203180_at	159	0.100629	0.000645719	0.0176185	-1.22057	0.198461	-0.215431	0.81 [0.58 - 1.12]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203180_at	54	0.5	0.161565	-	-0.956796	0.306094	-0.512984	0.60 [0.22 - 1.60]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	222168_at	54	0.5	0.0430841	0.448298	-1.86864	0.219028	-3.74877	0.02 [0.00 - 9.29]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203180_at	117	0.57265	0.0842333	-	-0.575288	0.504357	-0.0996055	0.91 [0.68 - 1.21]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203180_at	117	0.504274	0.0217684	0.284384	-0.898366	0.218971	-0.231332	0.79 [0.55 - 1.15]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203180_at	117	0.57265	0.0842333	-	-0.575288	0.504357	-0.0996055	0.91 [0.68 - 1.21]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203180_at	117	0.34188	0.0219801	0.286314	-0.878324	0.365563	-0.171211	0.84 [0.58 - 1.22]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203180_at	236	0.122881	0.00533911	0.0996487	-0.908836	0.217087	-0.214472	0.81 [0.57 - 1.13]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203180_at	249	0.120482	0.00426606	0.0834861	-0.771738	0.426134	-0.114921	0.89 [0.67 - 1.18]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203180_at	62	0.112903	0.0236835	0.301564	-1.26762	0.187375	-0.262357	0.77 [0.52 - 1.14]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203180_at	125	0.808	0.00264898	0.0569599	1.13055	0.0924809	0.502515	1.65 [0.92 - 2.97]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203180_at	125	0.776	3.53805e-05	0.00139288	1.15068	0.00455842	0.638334	1.89 [1.22 - 2.94]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203180_at	54	0.111111	0.000279542	0.00859504	-2.08233	0.17271	-0.335912	0.71 [0.44 - 1.16]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203180_at	198	0.888889	0.0281945	0.339768	0.744133	0.328418	0.0901413	1.09 [0.91 - 1.31]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203180_at	198	0.888889	0.00831693	0.140414	0.893018	0.353587	0.0873434	1.09 [0.91 - 1.31]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203180_at	198	0.883838	0.0625705	-	0.552618	0.519689	0.0485404	1.05 [0.91 - 1.22]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203180_at	51	0.313726	0.0108044	0.171114	-2.30848	0.304078	-1.51801	0.22 [0.01 - 3.96]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203180_at	62	0.177419	0.0527256	-	-1.13418	0.330466	0.531522	1.70 [0.58 - 4.96]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203180_at	177	0.785311	0.00980803	0.15912	0.659851	0.020579	0.414367	1.51 [1.07 - 2.15]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203180_at	145	0.882759	0.0171619	0.240282	0.92397	0.0888718	0.435122	1.55 [0.94 - 2.55]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203180_at	177	0.858757	0.000597138	0.0164855	1.01286	0.0104125	0.528465	1.70 [1.13 - 2.54]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203180_at	226	0.707965	0.00867006	0.144933	0.73462	0.0181711	0.447467	1.56 [1.08 - 2.27]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203180_at	55	0.745455	0.00127896	0.0313036	1.5397	0.0174	0.510202	1.67 [1.09 - 2.54]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203180_at	49	0.591837	0.00950224	0.155361	1.56824	0.159741	0.409916	1.51 [0.85 - 2.67]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203180_at	55	0.418182	0.000750916	0.0200219	2.10706	0.0214332	0.471732	1.60 [1.07 - 2.40]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	814798	34	0.882353	0.000654463	0.0178208	1.81438	0.016178	0.911431	2.49 [1.18 - 5.23]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203180_at	63	0.666667	0.00722753	0.12609	-1.14772	0.0481913	-0.247234	0.78 [0.61 - 1.00]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502040_3p_at	28	0.178571	0.113943	-	-1.01426	0.965659	0.0164575	1.02 [0.48 - 2.15]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203180_at	82	0.182927	0.124036	-	0.798466	0.575442	0.112346	1.12 [0.76 - 1.66]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36686_at	84	0.52381	0.327069	-	0.286299	0.938931	-0.0213811	0.98 [0.57 - 1.69]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203180_at	79	0.721519	0.0853013	-	-0.509704	0.16485	-0.198633	0.82 [0.62 - 1.09]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U07919_at	86	0.325581	0.159041	-	0.694471	0.431484	0.233413	1.26 [0.71 - 2.26]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203180_at	104	0.269231	0.184248	-	0.526035	0.967908	0.00857983	1.01 [0.66 - 1.53]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P205959	117	0.897436	0.0047565	0.0909923	1.0086	0.637988	0.0595606	1.06 [0.83 - 1.36]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203180_at	204	0.352941	0.218526	-	0.503161	0.898715	0.0335109	1.03 [0.62 - 1.73]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203180_at	204	0.289216	0.0351884	0.3937	0.722737	0.323592	0.188647	1.21 [0.83 - 1.76]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203180_at	178	0.52809	0.1924	-	0.257171	0.765653	0.046168	1.05 [0.77 - 1.42]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203180_at	111	0.531532	0.0683479	-	0.477635	0.840251	0.0380611	1.04 [0.72 - 1.50]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203180_at	90	0.166667	0.0220068	0.286557	-0.823604	0.109364	-0.425093	0.65 [0.39 - 1.10]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203180_at	90	0.355556	0.00189723	0.0433758	-1.11494	0.027688	-0.756637	0.47 [0.24 - 0.92]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203180_at	138	0.108696	0.148872	-	0.659843	0.807798	-0.0236127	0.98 [0.81 - 1.18]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203180_at	129	0.829457	0.0701801	-	0.539464	0.712924	0.0484018	1.05 [0.81 - 1.36]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8299	56	0.428571	0.246577	-	-0.389792	0.735343	-0.0459945	0.96 [0.73 - 1.25]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25190	56	0.821429	0.274479	-	0.503323	0.90677	-0.0173242	0.98 [0.74 - 1.31]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8299	56	0.732143	0.171787	-	0.543729	0.890096	-0.0199718	0.98 [0.74 - 1.30]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40294	56	0.535714	0.132603	-	-0.517096	0.583454	-0.0776393	0.93 [0.70 - 1.22]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25190	56	0.107143	0.205984	-	0.75232	0.773397	-0.0397187	0.96 [0.73 - 1.26]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40294	56	0.517857	0.266373	-	-0.398024	0.710204	-0.0566217	0.94 [0.70 - 1.27]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203180_at	278	0.68705	0.0126594	0.192507	0.484395	0.182888	0.0857535	1.09 [0.96 - 1.24]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203180_at	133	0.744361	0.0441708	0.455364	-0.611616	0.394657	-0.0870295	0.92 [0.75 - 1.12]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1676	81	0.790123	0.039035	0.421047	-15.4082	0.250793	-0.31225	0.73 [0.43 - 1.25]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203180_at	185	0.832432	0.0207946	0.275403	0.520868	0.790258	0.0305613	1.03 [0.82 - 1.29]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203180_at	185	0.832432	0.0311005	0.362893	0.456998	0.875028	-0.0164501	0.98 [0.80 - 1.21]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P205959	110	0.254545	0.0320295	0.370063	-0.541573	0.916292	-0.00910864	0.99 [0.84 - 1.17]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P917280	110	0.627273	0.00365584	0.0738286	0.671107	0.00880392	0.40874	1.50 [1.11 - 2.04]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P205959	110	0.218182	0.0281537	0.339436	-0.730006	0.537761	-0.06878	0.93 [0.75 - 1.16]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P917280	110	0.618182	0.00982872	0.159373	0.754378	0.115995	0.267688	1.31 [0.94 - 1.82]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203180_at	80	0.8	0.248083	-	0.551698	0.849856	0.024676	1.02 [0.79 - 1.32]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0263	281	0.234875	0.00660781	0.117657	-0.435184	0.00994677	-0.506286	0.60 [0.41 - 0.89]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203180_at	38	0.105263	0.0226574	0.292436	15.6468	0.0571219	0.343447	1.41 [0.99 - 2.01]
GENE	ALDH1A3	aldehyde dehydrogenase 1 family, member A3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203180_at	140	0.792857	0.000863794	0.0225338	0.991553	0.282229	0.0969385	1.10 [0.92 - 1.31]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209646_x_at	30	0.266667	0.200785	-	-0.589028	0.946135	-0.0201008	0.98 [0.55 - 1.76]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209645_s_at	30	0.833333	0.277366	-	-0.662794	0.997232	0.00217078	1.00 [0.29 - 3.42]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1675398	165	0.769697	0.0295617	0.350782	-0.729822	0.167983	-0.245193	0.78 [0.55 - 1.11]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1675398	165	0.587879	0.25448	-	0.399895	0.738046	-0.0769011	0.93 [0.59 - 1.45]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209645_s_at	163	0.699386	0.127429	-	0.316169	0.477737	0.420681	1.52 [0.48 - 4.87]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209646_x_at	163	0.361963	0.0238924	0.303401	-0.450088	0.818113	-0.0620323	0.94 [0.55 - 1.59]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209645_s_at	79	0.734177	0.00705419	0.123753	0.814448	0.0729129	1.01193	2.75 [0.91 - 8.31]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209646_x_at	79	0.64557	0.0539289	-	0.561989	0.112874	0.649532	1.91 [0.86 - 4.27]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209645_s_at	58	0.344828	0.235297	-	-0.337979	0.912113	-0.0194499	0.98 [0.69 - 1.39]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209646_x_at	58	0.12069	0.0192356	0.260658	1.09142	0.26677	0.147579	1.16 [0.89 - 1.50]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209645_s_at	34	0.352941	0.00629782	0.113354	1.23157	0.101026	0.414289	1.51 [0.92 - 2.48]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209646_x_at	34	0.382353	0.14255	-	0.589383	0.629533	0.0737074	1.08 [0.80 - 1.45]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209646_x_at	158	0.259494	0.0734121	-	0.540148	0.914227	-0.0484049	0.95 [0.39 - 2.30]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209645_s_at	158	0.107595	0.143775	-	-0.513662	0.741573	-0.166686	0.85 [0.31 - 2.28]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209646_x_at	53	0.811321	0.00277347	0.0591188	1.12725	0.256938	0.26381	1.30 [0.83 - 2.05]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209645_s_at	53	0.754717	0.00253715	0.0550005	1.11682	0.321817	0.560716	1.75 [0.58 - 5.31]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209646_x_at	53	0.811321	0.0026054	0.0561986	1.19647	0.213137	0.322224	1.38 [0.83 - 2.29]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209645_s_at	53	0.754717	0.0119175	0.184088	0.910587	0.512419	0.341965	1.41 [0.51 - 3.92]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209646_x_at	180	0.772222	0.0289937	0.346236	0.511001	0.203537	0.199953	1.22 [0.90 - 1.66]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209645_s_at	180	0.866667	0.000964037	0.0247138	0.867725	0.0126726	0.65795	1.93 [1.15 - 3.24]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209646_x_at	559	0.617174	0.0276833	0.335586	0.440092	0.10832	0.185846	1.20 [0.96 - 1.51]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209645_s_at	559	0.751342	0.0162872	0.231402	-0.661358	0.967369	0.00852377	1.01 [0.67 - 1.52]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209645_s_at	77	0.12987	0.00152527	0.0362321	-1.10152	0.46632	-0.242792	0.78 [0.41 - 1.51]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209646_x_at	77	0.168831	0.0248745	0.311946	0.832009	0.113282	0.2222	1.25 [0.95 - 1.64]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209645_s_at	70	0.8	0.0433155	0.449811	-0.724618	0.540336	-0.364736	0.69 [0.22 - 2.23]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209646_x_at	70	0.414286	0.0105925	0.168595	0.700183	0.641586	0.203372	1.23 [0.52 - 2.89]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38503_at	50	0.16	0.000134422	0.00454211	-1.71108	0.10414	-1.82249	0.16 [0.02 - 1.46]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209646_x_at	74	0.337838	0.0234756	0.299728	-0.649155	0.19859	-0.225955	0.80 [0.57 - 1.13]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209645_s_at	74	0.324324	0.000912291	0.0235941	-0.956614	0.0128818	-0.94807	0.39 [0.18 - 0.82]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209646_x_at	67	0.835821	0.0281949	0.339771	1.48149	0.193956	2.63299	13.92 [0.26 - 739.44]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209645_s_at	67	0.895522	0.00509752	0.0960915	2.07099	0.0461245	1.9551	7.06 [1.03 - 48.26]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209646_x_at	115	0.486957	0.114348	-	0.900135	0.407309	0.64749	1.91 [0.41 - 8.84]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209645_s_at	115	0.104348	0.147444	-	-0.923396	0.994855	-0.00392487	1.00 [0.30 - 3.28]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38503_at	158	0.348101	0.0143151	0.2107	0.815405	0.243646	0.243044	1.28 [0.85 - 1.92]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38503_at	76	0.486842	0.164975	-	0.744008	0.935908	-0.0295058	0.97 [0.47 - 1.99]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209646_x_at	204	0.52451	0.0152855	0.221011	0.339852	0.350313	0.1138	1.12 [0.88 - 1.42]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209645_s_at	204	0.460784	0.0250005	0.313031	0.312888	0.118151	0.193723	1.21 [0.95 - 1.55]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209645_s_at	87	0.586207	0.00434132	0.084652	1.07357	0.0595774	0.862666	2.37 [0.97 - 5.81]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209646_x_at	87	0.517241	0.00115121	0.0286734	1.32173	0.0116792	1.42852	4.17 [1.37 - 12.67]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209646_x_at	87	0.517241	0.00115121	0.0286734	1.32173	0.0116792	1.42852	4.17 [1.37 - 12.67]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209645_s_at	87	0.586207	0.00434132	0.084652	1.07357	0.0595774	0.862666	2.37 [0.97 - 5.81]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209645_s_at	77	0.597403	0.0430913	0.448345	1.3026	0.26316	1.19715	3.31 [0.41 - 26.95]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209646_x_at	77	0.74026	0.126635	-	-1.45754	0.62263	-0.400932	0.67 [0.14 - 3.31]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209645_s_at	77	0.571429	0.039507	0.424302	1.17043	0.17983	1.2588	3.52 [0.56 - 22.16]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209646_x_at	77	0.220779	0.153516	-	-0.892403	0.565294	-0.545818	0.58 [0.09 - 3.72]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209645_s_at	136	0.485294	0.0217334	0.284064	-1.12827	0.59618	0.219004	1.24 [0.55 - 2.80]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209646_x_at	136	0.676471	0.0256576	0.318653	1.00085	0.568432	0.180408	1.20 [0.64 - 2.23]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209646_x_at	200	0.88	0.0139939	0.207232	0.888798	0.837914	0.0694632	1.07 [0.55 - 2.09]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209645_s_at	200	0.775	0.110205	-	0.507709	0.945058	-0.0275289	0.97 [0.44 - 2.13]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	22100	60	0.733333	0.144595	-	-0.768004	0.541388	-0.131167	0.88 [0.58 - 1.34]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	22100	60	0.883333	0.0995902	-	0.815197	0.695815	0.151957	1.16 [0.54 - 2.49]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3554	155	0.219355	8.11369e-05	0.00291245	-1.06901	0.000668975	-0.332647	0.72 [0.59 - 0.87]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209646_x_at	286	0.748252	0.136824	-	0.309094	0.612728	0.0792576	1.08 [0.80 - 1.47]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209645_s_at	286	0.898601	0.0248383	0.311633	-0.986322	0.443993	-0.184101	0.83 [0.52 - 1.33]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209646_x_at	159	0.100629	0.178866	-	-0.587789	0.745498	0.0954379	1.10 [0.62 - 1.96]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209646_x_at	159	0.515723	0.170436	-	0.518848	0.697234	0.134566	1.14 [0.58 - 2.25]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209645_s_at	159	0.515723	0.0482237	0.480856	0.634931	0.201703	0.583232	1.79 [0.73 - 4.39]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209645_s_at	159	0.823899	0.0279744	0.337972	0.74182	0.289583	0.474306	1.61 [0.67 - 3.87]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209646_x_at	159	0.63522	0.125587	-	-0.536439	0.796105	-0.07318	0.93 [0.53 - 1.62]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209645_s_at	159	0.534591	0.0320871	0.370504	0.814942	0.097162	0.91836	2.51 [0.85 - 7.41]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209645_s_at	54	0.462963	0.242981	-	-0.809152	0.415076	-0.868216	0.42 [0.05 - 3.39]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209646_x_at	54	0.166667	0.521283	-	0.675146	0.599719	-0.718988	0.49 [0.03 - 7.14]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209645_s_at	117	0.897436	0.17686	-	-0.944098	0.517534	-0.225063	0.80 [0.40 - 1.58]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209645_s_at	117	0.897436	0.0610896	-	-15.2047	0.248057	-0.549834	0.58 [0.23 - 1.47]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209646_x_at	117	0.769231	0.0568341	-	0.735779	0.593484	0.205945	1.23 [0.58 - 2.62]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209646_x_at	117	0.111111	0.0473634	0.475554	-0.810731	0.801857	-0.0929242	0.91 [0.44 - 1.88]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209646_x_at	117	0.111111	0.0473634	0.475554	-0.810731	0.801857	-0.0929242	0.91 [0.44 - 1.88]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209646_x_at	117	0.435897	0.105902	-	-0.633101	0.574319	-0.278827	0.76 [0.29 - 2.00]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209645_s_at	117	0.897436	0.17686	-	-0.944098	0.517534	-0.225063	0.80 [0.40 - 1.58]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209645_s_at	117	0.897436	0.0545087	-	-15.202	0.589978	-0.22091	0.80 [0.36 - 1.79]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209645_s_at	236	0.635593	0.0729804	-	0.479987	0.421068	0.345982	1.41 [0.61 - 3.28]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209646_x_at	236	0.101695	0.0295257	0.350496	1.8981	0.2803	0.368266	1.45 [0.74 - 2.82]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209645_s_at	249	0.891566	0.129359	-	-0.629654	0.846444	0.064848	1.07 [0.55 - 2.06]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209646_x_at	249	0.674699	0.145064	-	-0.354842	0.206839	-0.297019	0.74 [0.47 - 1.18]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209645_s_at	62	0.870968	0.13456	-	-1.43129	0.642434	-0.126873	0.88 [0.52 - 1.50]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209645_s_at	125	0.76	0.0294791	0.350124	-1.26137	0.282204	-0.630803	0.53 [0.17 - 1.68]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209646_x_at	62	0.887097	0.207475	-	-1.23184	0.585062	-0.119174	0.89 [0.58 - 1.36]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209645_s_at	125	0.784	0.0997164	-	-0.607531	0.451664	-0.325465	0.72 [0.31 - 1.69]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209645_s_at	54	0.722222	0.198133	-	-0.987925	0.748769	-0.105332	0.90 [0.47 - 1.71]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209646_x_at	125	0.608	0.0392773	0.422721	-0.985054	0.247715	-0.35616	0.70 [0.38 - 1.28]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209646_x_at	125	0.608	0.10285	-	-0.564856	0.638057	-0.111676	0.89 [0.56 - 1.42]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209646_x_at	54	0.5	0.294271	-	-0.618376	0.634058	-0.125214	0.88 [0.53 - 1.48]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209645_s_at	198	0.136364	0.138619	-	0.750924	0.816603	0.0476906	1.05 [0.70 - 1.57]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209646_x_at	198	0.530303	0.104397	-	-0.426191	0.856174	0.0233465	1.02 [0.80 - 1.32]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209646_x_at	198	0.565657	0.0311079	0.36295	-0.617287	0.870974	-0.0210972	0.98 [0.76 - 1.26]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209645_s_at	198	0.136364	0.0480725	0.479928	0.760375	0.283981	0.174978	1.19 [0.86 - 1.64]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209645_s_at	198	0.136364	0.079157	-	0.879597	0.37575	0.174055	1.19 [0.81 - 1.75]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209646_x_at	198	0.530303	0.0996163	-	-0.351536	0.533771	0.066782	1.07 [0.87 - 1.32]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209645_s_at	51	0.411765	0.0582483	-	15.9115	0.28141	1.24931	3.49 [0.36 - 33.87]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209645_s_at	62	0.16129	0.0616612	-	-1.09084	0.725995	0.227214	1.26 [0.35 - 4.47]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209646_x_at	51	0.411765	0.0558376	-	15.9264	0.170291	1.08808	2.97 [0.63 - 14.06]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209646_x_at	62	0.112903	0.169817	-	15.2364	0.312317	0.487141	1.63 [0.63 - 4.19]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209645_s_at	177	0.632768	0.0154544	0.22278	-0.752454	0.574069	-0.129999	0.88 [0.56 - 1.38]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209646_x_at	177	0.723164	0.145688	-	-0.419079	0.289105	-0.357469	0.70 [0.36 - 1.35]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209646_x_at	145	0.8	0.063793	-	-1.0668	0.165186	-0.679364	0.51 [0.19 - 1.32]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209645_s_at	177	0.587571	0.0228024	0.293736	-0.567288	0.591743	-0.107244	0.90 [0.61 - 1.33]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209646_x_at	177	0.480226	0.091346	-	-0.46064	0.226303	-0.477162	0.62 [0.29 - 1.34]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209645_s_at	145	0.710345	0.0276306	0.335152	-1.01703	0.160294	-0.396522	0.67 [0.39 - 1.17]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209646_x_at	226	0.380531	0.0191869	0.26019	-0.653842	0.126409	-0.238619	0.79 [0.58 - 1.07]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209645_s_at	226	0.79646	0.036532	0.403423	-0.950113	0.267439	-0.250947	0.78 [0.50 - 1.21]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209646_x_at	55	0.109091	0.105538	-	15.2162	0.356791	0.393523	1.48 [0.64 - 3.42]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209646_x_at	49	0.22449	0.252186	-	-0.757701	0.547856	0.300403	1.35 [0.51 - 3.60]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209645_s_at	55	0.745455	0.055648	-	0.925162	0.583682	0.209522	1.23 [0.58 - 2.61]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209645_s_at	55	0.254545	0.0557367	-	-0.849864	0.604467	-0.191925	0.83 [0.40 - 1.71]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209645_s_at	49	0.244898	0.184557	-	-0.797759	0.799292	-0.117336	0.89 [0.36 - 2.20]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209646_x_at	55	0.2	0.0373422	0.409197	-0.945365	0.516551	-0.267682	0.77 [0.34 - 1.72]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	197657	34	0.205882	0.111423	-	-0.770906	0.67143	-0.144998	0.87 [0.44 - 1.69]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209645_s_at	63	0.111111	0.0808185	-	-0.767112	0.840168	-0.0309828	0.97 [0.72 - 1.31]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209646_x_at	63	0.555556	0.00228385	0.0504875	-1.12421	0.244266	-0.415365	0.66 [0.33 - 1.33]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	209646_3p_x_at	28	0.392857	0.0942106	-	-0.93814	0.34959	-0.265531	0.77 [0.44 - 1.34]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12804426_3p_a_at	28	0.678571	0.0611072	-	0.981718	0.43768	0.1624	1.18 [0.78 - 1.77]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.169517.0.S1_3p_a_at	28	0.535714	0.321976	-	-0.552372	0.818249	-0.469435	0.63 [0.01 - 34.28]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209645_s_at	82	0.146341	0.0686709	-	-0.717035	0.473769	-0.344453	0.71 [0.28 - 1.82]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209646_x_at	82	0.170732	0.0587654	-	1.08916	0.0656452	0.712952	2.04 [0.95 - 4.36]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209645_s_at	79	0.316456	0.0705866	-	-0.496499	0.685573	-0.17622	0.84 [0.36 - 1.97]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209646_x_at	79	0.898734	0.0355002	0.395973	0.831973	0.431559	0.228079	1.26 [0.71 - 2.22]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209646_x_at	104	0.288462	0.130061	-	0.598326	0.156917	0.446034	1.56 [0.84 - 2.90]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209645_s_at	104	0.836538	0.216602	-	0.465996	0.728081	0.19508	1.22 [0.40 - 3.65]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P64233	117	0.666667	0.0104367	0.166731	0.722265	0.205756	0.262944	1.30 [0.87 - 1.95]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P135294	117	0.65812	0.127696	-	0.439828	0.861065	0.0382772	1.04 [0.68 - 1.60]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209646_x_at	204	0.642157	5.3196e-06	0.000251835	1.63465	6.82004e-05	1.22254	3.40 [1.86 - 6.20]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209646_x_at	204	0.54902	1.02184e-09	8.56394e-08	1.77519	1.91162e-07	1.16397	3.20 [2.07 - 4.96]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209645_s_at	204	0.460784	0.00563092	0.103887	1.13395	0.0308008	0.803952	2.23 [1.08 - 4.63]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209645_s_at	204	0.583333	4.0934e-07	2.38261e-05	1.37718	0.000311895	0.971748	2.64 [1.56 - 4.48]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209645_s_at	178	0.882023	0.0937106	-	0.452903	0.648571	0.122461	1.13 [0.67 - 1.91]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209646_x_at	178	0.348315	0.178835	-	-0.278059	0.984856	0.00314446	1.00 [0.73 - 1.39]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209646_x_at	111	0.189189	0.0674627	-	0.72258	0.582031	0.126214	1.13 [0.72 - 1.78]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209645_s_at	111	0.558559	0.219528	-	0.321627	0.55582	0.125848	1.13 [0.75 - 1.72]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209645_s_at	90	0.177778	0.065025	-	0.943162	0.863521	0.0767823	1.08 [0.45 - 2.59]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209645_s_at	90	0.144444	0.0385723	0.417836	1.83855	0.646851	0.23148	1.26 [0.47 - 3.39]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209646_x_at	90	0.222222	0.100423	-	0.717881	0.826118	0.125049	1.13 [0.37 - 3.46]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209646_x_at	90	0.544444	0.0462785	0.468786	0.738695	0.407901	0.520101	1.68 [0.49 - 5.77]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209646_x_at	138	0.536232	0.0125261	0.191007	-0.62264	0.263611	-0.176288	0.84 [0.62 - 1.14]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209645_s_at	138	0.23913	0.000572551	0.015906	1.22112	0.120724	0.208201	1.23 [0.95 - 1.60]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209646_x_at	129	0.891473	0.0367265	0.404816	0.7104	0.950447	-0.0176923	0.98 [0.56 - 1.72]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209645_s_at	129	0.410853	0.046902	0.472687	-0.492773	0.873946	0.0569096	1.06 [0.52 - 2.14]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11371	56	0.678571	0.117411	-	0.55587	0.525746	0.221825	1.25 [0.63 - 2.48]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39994	56	0.571429	0.0258053	0.319908	0.788368	0.491593	0.292016	1.34 [0.58 - 3.08]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11371	56	0.178571	0.107853	-	-0.639893	0.723902	0.131936	1.14 [0.55 - 2.37]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39994	56	0.571429	0.04517	0.461773	0.670768	0.452826	0.32118	1.38 [0.60 - 3.19]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209645_s_at	278	0.176259	0.0929457	-	-0.433587	0.835533	-0.0456999	0.96 [0.62 - 1.47]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209646_x_at	278	0.147482	0.0310077	0.362171	-0.550251	0.546888	0.180837	1.20 [0.67 - 2.16]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209645_s_at	133	0.390977	0.0277988	0.336534	0.546832	0.922984	0.0227247	1.02 [0.65 - 1.62]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209646_x_at	133	0.646617	7.45217e-06	0.000342194	1.02096	0.0550708	0.415266	1.51 [0.99 - 2.32]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6391	81	0.197531	0.0860956	-	1.60332	0.124149	1.35726	3.89 [0.69 - 21.92]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12311	81	0.320988	0.0300775	0.354875	1.51753	0.028458	1.68123	5.37 [1.19 - 24.17]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209646_x_at	185	0.4	0.132231	-	0.273358	0.996027	-0.00104956	1.00 [0.66 - 1.51]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209645_s_at	185	0.891892	0.194227	-	-0.425506	0.82035	-0.0499901	0.95 [0.62 - 1.46]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209646_x_at	185	0.8	0.147279	-	-0.300464	0.590342	-0.106891	0.90 [0.61 - 1.33]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209645_s_at	185	0.318919	0.273059	-	-0.188339	0.951249	0.0120987	1.01 [0.69 - 1.49]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P64233	110	0.345455	0.248592	-	0.286175	0.50302	0.154999	1.17 [0.74 - 1.84]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P135294	110	0.809091	0.0188754	0.257183	0.641078	0.173346	0.264473	1.30 [0.89 - 1.91]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P64233	110	0.118182	0.0689682	-	-0.640352	0.584167	-0.164707	0.85 [0.47 - 1.53]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P135294	110	0.4	0.282233	-	-0.313539	0.690297	-0.099043	0.91 [0.56 - 1.47]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209646_x_at	80	0.8	0.00042492	0.0123281	1.49152	0.156736	0.533431	1.70 [0.81 - 3.57]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209645_s_at	80	0.8875	0.12836	-	0.827612	0.39927	0.399472	1.49 [0.59 - 3.77]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_6068	281	0.120996	4.61205e-07	2.66111e-05	1.40219	7.04934e-05	0.485182	1.62 [1.28 - 2.06]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:197657	59	0.813559	0.156728	-	0.811239	0.50801	0.589701	1.80 [0.31 - 10.34]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209646_x_at	38	0.210526	0.11675	-	1.11358	0.638932	0.169478	1.18 [0.58 - 2.40]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209645_s_at	38	0.763158	0.00254276	0.0550992	1.35481	0.0806474	0.778776	2.18 [0.91 - 5.22]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209645_s_at	140	0.857143	9.95326e-05	0.00348788	1.21535	0.0264901	0.537899	1.71 [1.06 - 2.75]
GENE	ALDH1B1	aldehyde dehydrogenase 1 family, member B1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209646_x_at	140	0.685714	0.0404575	0.430792	0.590703	0.083964	0.626407	1.87 [0.92 - 3.81]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205208_at	30	0.3	0.238411	-	0.528933	0.536968	0.146227	1.16 [0.73 - 1.84]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215798_at	30	0.3	0.0418073	0.439866	-0.908797	0.936042	0.0502443	1.05 [0.31 - 3.59]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1802167	165	0.436364	0.000114714	0.00395195	-0.915373	0.00491047	-0.178257	0.84 [0.74 - 0.95]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1802167	165	0.551515	0.000444236	0.0128069	-1.46282	0.0289942	-0.203111	0.82 [0.68 - 0.98]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215798_at	163	0.184049	0.00788086	0.134752	-0.605687	0.0236414	-1.74795	0.17 [0.04 - 0.79]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205208_at	163	0.539877	0.0303439	0.356975	-0.434715	0.504298	-0.525216	0.59 [0.13 - 2.76]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205208_at	79	0.177215	0.00553677	0.102527	-0.895865	0.0290281	-1.8055	0.16 [0.03 - 0.83]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215798_at	79	0.696203	0.0224503	0.290572	0.676122	0.274692	1.03218	2.81 [0.44 - 17.89]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205208_at	58	0.12069	0.0529568	-	0.893148	0.307908	0.204298	1.23 [0.83 - 1.82]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215798_at	58	0.103448	0.0741151	-	0.825927	0.415184	0.191658	1.21 [0.76 - 1.92]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205208_at	34	0.441176	0.265109	-	0.434451	0.929629	0.0257813	1.03 [0.58 - 1.82]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215798_at	34	0.647059	0.00108606	0.0273104	-1.51372	0.00231966	-0.948075	0.39 [0.21 - 0.71]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205208_at	158	0.35443	0.0333426	0.380025	0.535801	0.242413	0.959441	2.61 [0.52 - 13.04]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215798_at	158	0.683544	0.212325	-	-0.33075	0.734927	-0.319659	0.73 [0.11 - 4.62]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215798_at	53	0.830189	0.0268083	0.328344	0.936001	0.935491	-0.0248349	0.98 [0.53 - 1.78]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205208_at	53	0.698113	0.0250802	0.313717	-0.976718	0.0465794	-0.767065	0.46 [0.22 - 0.99]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215798_at	53	0.490566	0.0227507	0.293273	-0.794618	0.488273	-0.201723	0.82 [0.46 - 1.45]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205208_at	53	0.113208	0.015557	0.223851	-1.14783	0.117125	-0.675579	0.51 [0.22 - 1.18]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205208_at	180	0.283333	0.00192423	0.0438821	0.800854	0.0271222	0.591834	1.81 [1.07 - 3.05]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215798_at	180	0.638889	0.024242	0.30646	0.472789	0.40137	0.139211	1.15 [0.83 - 1.59]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205208_at	559	0.157424	0.193666	-	-0.330078	0.429758	-0.0877091	0.92 [0.74 - 1.14]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215798_at	559	0.119857	0.0446194	0.458252	-0.617147	0.0985197	-0.438439	0.65 [0.38 - 1.09]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205208_at	77	0.87013	0.00361792	0.0732157	1.03531	0.971954	0.00627629	1.01 [0.71 - 1.43]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215798_at	77	0.168831	0.00938858	0.153954	-0.84381	0.464675	-0.202108	0.82 [0.48 - 1.40]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205208_at	70	0.442857	0.000172687	0.00565503	1.04111	0.0014694	0.471425	1.60 [1.20 - 2.14]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215798_at	70	0.228571	0.0414642	0.437575	0.683862	0.132452	1.03234	2.81 [0.73 - 10.77]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38316_at	50	0.36	0.186071	-	-0.480436	0.643997	-0.0669004	0.94 [0.70 - 1.24]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205208_at	74	0.77027	0.0086601	0.144806	0.830873	0.905153	0.0281154	1.03 [0.65 - 1.63]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215798_at	74	0.851351	0.131968	-	0.557703	0.996891	0.00158441	1.00 [0.45 - 2.22]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205208_at	67	0.850746	0.0846614	-	1.15768	0.181916	1.13769	3.12 [0.59 - 16.58]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215798_at	67	0.223881	0.112842	-	15.4118	0.942652	0.0978024	1.10 [0.08 - 15.84]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215798_at	115	0.486957	0.313206	-	0.555569	0.611825	-0.289007	0.75 [0.25 - 2.29]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205208_at	115	0.173913	0.00690415	0.121717	-1.3589	0.169361	-0.853325	0.43 [0.13 - 1.44]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38316_at	158	0.620253	0.0372783	0.408744	0.586728	0.82435	0.0476682	1.05 [0.69 - 1.60]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38316_at	76	0.328947	0.029032	0.346545	-1.10458	0.516508	-0.323505	0.72 [0.27 - 1.92]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215798_at	204	0.602941	0.0863599	-	-0.246367	0.349815	-0.0977554	0.91 [0.74 - 1.11]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205208_at	204	0.181373	0.269939	-	0.203283	0.633965	0.0593657	1.06 [0.83 - 1.35]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205208_at	87	0.678161	0.210523	-	-0.542135	0.838611	-0.114506	0.89 [0.30 - 2.68]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205208_at	87	0.678161	0.210523	-	-0.542135	0.838611	-0.114506	0.89 [0.30 - 2.68]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215798_at	87	0.770115	0.11443	-	0.613108	0.478074	0.520345	1.68 [0.40 - 7.09]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215798_at	87	0.770115	0.11443	-	0.613108	0.478074	0.520345	1.68 [0.40 - 7.09]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215798_at	77	0.142857	0.109822	-	-1.0569	0.75609	0.422913	1.53 [0.11 - 22.01]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205208_at	77	0.584416	0.0471417	0.474179	1.28096	0.755924	0.372355	1.45 [0.14 - 15.18]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215798_at	77	0.896104	0.00849371	0.142683	1.45199	0.348135	1.09729	3.00 [0.30 - 29.65]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205208_at	77	0.519481	0.071675	-	1.03645	0.603752	0.533384	1.70 [0.23 - 12.78]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215798_at	136	0.897059	0.0450347	0.46091	1.08622	0.456463	0.26789	1.31 [0.65 - 2.65]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205208_at	136	0.176471	0.0329998	0.377444	15.3596	0.488357	0.220587	1.25 [0.67 - 2.33]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205208_at	200	0.11	0.149172	-	-0.554272	0.390998	-0.227566	0.80 [0.47 - 1.34]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215798_at	200	0.875	0.0686027	-	0.667421	0.763226	0.120754	1.13 [0.51 - 2.48]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7749	60	0.35	0.0798247	-	-0.662507	0.822333	0.121603	1.13 [0.39 - 3.26]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7749	60	0.15	0.000917894	0.0237159	-1.38754	0.236811	-0.836703	0.43 [0.11 - 1.73]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205208_at	286	0.272727	0.000189647	0.00613655	-0.729503	0.0448061	-0.328827	0.72 [0.52 - 0.99]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215798_at	286	0.118881	0.0198569	0.266591	-0.59521	0.129937	-0.247654	0.78 [0.57 - 1.08]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205208_at	159	0.327044	0.000134259	0.00453728	-1.15792	0.017394	-0.642282	0.53 [0.31 - 0.89]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215798_at	159	0.119497	0.0470945	0.473886	-0.766213	0.776832	-0.094357	0.91 [0.47 - 1.75]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205208_at	159	0.327044	0.00127551	0.0312332	-1.15114	0.026307	-0.688858	0.50 [0.27 - 0.92]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215798_at	159	0.314465	0.0368383	0.405614	0.843439	0.23174	0.451324	1.57 [0.75 - 3.29]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215798_at	159	0.899371	0.0565363	-	0.848695	0.773819	0.120196	1.13 [0.50 - 2.56]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205208_at	159	0.352201	0.00909664	0.150316	-0.804915	0.143767	-0.416191	0.66 [0.38 - 1.15]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205208_at	54	0.703704	0.172375	-	-1.40146	0.400779	-1.27354	0.28 [0.01 - 5.46]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215798_at	54	0.481481	0.098045	-	-1.25726	0.356963	-1.41073	0.24 [0.01 - 4.91]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205208_at	117	0.786325	0.0576428	-	-0.880642	0.248541	-0.630192	0.53 [0.18 - 1.55]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205208_at	117	0.213675	0.0559394	-	1.30676	0.398621	-0.529083	0.59 [0.17 - 2.01]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205208_at	117	0.786325	0.0576428	-	-0.880642	0.248541	-0.630192	0.53 [0.18 - 1.55]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205208_at	117	0.213675	0.170924	-	0.815873	0.535001	-0.378117	0.69 [0.21 - 2.26]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215798_at	117	0.393162	0.0581379	-	-0.709875	0.386875	-0.829324	0.44 [0.07 - 2.86]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215798_at	117	0.222222	0.127085	-	0.663544	0.685232	-0.282403	0.75 [0.19 - 2.95]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215798_at	117	0.222222	0.127085	-	0.663544	0.685232	-0.282403	0.75 [0.19 - 2.95]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215798_at	117	0.760684	0.255725	-	-0.604103	0.769043	-0.271569	0.76 [0.12 - 4.67]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215798_at	236	0.868644	0.00335752	0.0689626	0.92751	0.376883	0.28575	1.33 [0.71 - 2.51]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205208_at	236	0.381356	0.0209989	0.277302	-0.613268	0.10741	-0.473561	0.62 [0.35 - 1.11]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205208_at	249	0.538153	0.00605942	0.110004	-0.603161	0.307764	-0.245385	0.78 [0.49 - 1.25]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215798_at	249	0.373494	0.0443765	0.45669	-0.425705	0.484439	-0.155122	0.86 [0.55 - 1.32]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215798_at	125	0.224	0.430301	-	-0.286219	0.992011	-0.00227069	1.00 [0.64 - 1.56]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215798_at	54	0.796296	0.206318	-	-1.24493	0.725217	-0.158702	0.85 [0.35 - 2.07]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205208_at	62	0.83871	0.209716	-	-0.916133	0.573185	-0.12821	0.88 [0.56 - 1.37]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205208_at	125	0.568	0.15529	-	0.552233	0.730088	0.132793	1.14 [0.54 - 2.43]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215798_at	62	0.806452	0.251892	-	-0.837628	0.628007	-0.180591	0.83 [0.40 - 1.73]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205208_at	125	0.12	0.17671	-	-0.556054	0.882864	-0.0460758	0.95 [0.52 - 1.76]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205208_at	54	0.12963	0.13371	-	-1.18146	0.585593	-0.151025	0.86 [0.50 - 1.48]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215798_at	125	0.664	0.209172	-	0.47612	0.506095	0.193295	1.21 [0.69 - 2.14]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205208_at	198	0.575758	0.0174637	0.243305	0.600136	0.0906719	0.285002	1.33 [0.96 - 1.85]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215798_at	198	0.141414	0.0312798	0.364285	0.785593	0.616788	0.061272	1.06 [0.84 - 1.35]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205208_at	198	0.50505	0.0315551	0.366414	0.582428	0.129058	0.27339	1.31 [0.92 - 1.87]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215798_at	198	0.141414	0.0444979	0.457471	0.99911	0.514144	0.0985454	1.10 [0.82 - 1.48]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215798_at	198	0.50505	0.0376432	0.411325	-0.566556	0.907812	0.0174714	1.02 [0.76 - 1.37]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205208_at	198	0.50505	0.0745249	-	0.377655	0.163545	0.189174	1.21 [0.93 - 1.58]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215798_at	62	0.193548	0.227795	-	-0.722838	0.991235	-0.0157002	0.98 [0.06 - 16.21]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205208_at	51	0.745098	0.177622	-	-15.506	0.822906	-0.290941	0.75 [0.06 - 9.55]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205208_at	62	0.177419	0.133456	-	-0.891208	0.984926	0.0142382	1.01 [0.23 - 4.44]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215798_at	51	0.54902	0.0981252	-	1.65494	0.24838	2.54296	12.72 [0.17 - 954.24]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205208_at	177	0.38983	0.0593626	-	0.552718	0.668172	0.103777	1.11 [0.69 - 1.78]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215798_at	177	0.779661	0.00352939	0.0717784	-1.00149	0.156661	-0.985766	0.37 [0.10 - 1.46]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215798_at	145	0.875862	0.172219	-	0.568765	0.752051	0.299386	1.35 [0.21 - 8.64]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205208_at	177	0.38983	0.0461885	0.46822	0.503439	0.69171	0.0830761	1.09 [0.72 - 1.64]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215798_at	177	0.774011	0.0116604	0.181129	-0.986146	0.261734	-0.90154	0.41 [0.08 - 1.96]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205208_at	145	0.117241	0.021463	0.281586	-0.895777	0.315663	-0.333419	0.72 [0.37 - 1.37]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215798_at	226	0.353982	0.0189655	0.258054	0.810187	0.0562311	0.547005	1.73 [0.99 - 3.03]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205208_at	226	0.278761	0.0132785	0.199403	-0.723487	0.227501	-0.144317	0.87 [0.68 - 1.09]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215798_at	55	0.690909	0.243047	-	0.590958	0.448576	1.10305	3.01 [0.17 - 52.25]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215798_at	49	0.44898	0.180961	-	0.801903	0.386759	1.40819	4.09 [0.17 - 99.20]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205208_at	55	0.109091	0.089457	-	15.2428	0.831791	0.0890657	1.09 [0.48 - 2.49]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205208_at	55	0.290909	0.0225935	0.291862	1.5461	0.109924	0.626536	1.87 [0.87 - 4.03]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205208_at	49	0.244898	0.110531	-	1.5193	0.590362	0.268084	1.31 [0.49 - 3.47]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215798_at	55	0.345455	0.160582	-	0.710965	0.672658	0.584851	1.79 [0.12 - 27.06]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215798_at	63	0.126984	0.00254367	0.0551152	-1.21854	0.309404	-1.26409	0.28 [0.02 - 3.23]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205208_at	63	0.698413	0.000211446	0.0067463	-1.75883	0.00108014	-0.500395	0.61 [0.45 - 0.82]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7110594_3p_at	28	0.178571	0.28937	-	-0.706904	0.564965	-0.574834	0.56 [0.08 - 3.99]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.272307.0.S1_3p_at	28	0.571429	0.0331852	0.378841	-1.23871	0.780715	-1.06705	0.34 [0.00 - 629.91]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215798_at	82	0.52439	0.0668432	-	0.618071	0.921609	-0.048639	0.95 [0.36 - 2.51]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205208_at	82	0.231707	0.0327684	0.375693	1.08138	0.771498	0.0728889	1.08 [0.66 - 1.76]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38316_at	84	0.107143	0.147261	-	0.842066	0.974538	-0.0134133	0.99 [0.43 - 2.25]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215798_at	79	0.177215	0.288702	-	0.384488	0.858848	0.0836721	1.09 [0.43 - 2.73]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205208_at	79	0.379747	0.148246	-	-0.38005	0.464166	-0.283545	0.75 [0.35 - 1.61]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205208_at	104	0.384615	0.0133402	0.200085	-0.791513	0.1419	-0.633231	0.53 [0.23 - 1.24]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215798_at	104	0.201923	0.0116661	0.181195	1.42122	0.353053	0.504671	1.66 [0.57 - 4.81]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P258887	117	0.196581	0.0121886	0.187185	-0.759815	0.570901	-0.0525317	0.95 [0.79 - 1.14]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215798_at	204	0.397059	0.161428	-	-0.506653	0.788319	0.177263	1.19 [0.33 - 4.35]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215798_at	204	0.539216	0.00674769	0.11958	-0.775899	0.174753	-0.604291	0.55 [0.23 - 1.31]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205208_at	204	0.730392	0.207787	-	-0.608794	0.819769	-0.0777762	0.93 [0.47 - 1.81]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205208_at	204	0.79902	0.0602019	-	-0.793094	0.570657	-0.142992	0.87 [0.53 - 1.42]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215798_at	178	0.685393	0.120795	-	-0.34705	0.473925	-0.17076	0.84 [0.53 - 1.35]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205208_at	178	0.314607	0.140491	-	0.322588	0.939672	0.0123372	1.01 [0.74 - 1.39]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215798_at	111	0.801802	0.0916132	-	0.500417	0.969452	0.0122083	1.01 [0.54 - 1.89]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205208_at	111	0.603604	0.114382	-	-0.440737	0.649329	-0.0748037	0.93 [0.67 - 1.28]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215798_at	90	0.322222	0.0711791	-	0.679609	0.522666	0.415258	1.51 [0.42 - 5.41]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215798_at	90	0.322222	0.0729192	-	0.80327	0.335385	0.726773	2.07 [0.47 - 9.07]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205208_at	90	0.877778	0.0280185	0.338333	0.899468	0.298566	0.493743	1.64 [0.65 - 4.16]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205208_at	90	0.211111	0.0253163	0.315741	1.49788	0.0763246	0.869661	2.39 [0.91 - 6.24]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205208_at	138	0.188406	0.0309726	0.361898	0.794547	0.956885	0.00700852	1.01 [0.78 - 1.30]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215798_at	138	0.811594	0.0941812	-	-0.589584	0.235813	-1.04335	0.35 [0.06 - 1.98]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205208_at	129	0.534884	0.0298587	0.353143	-0.542761	0.364023	-0.172768	0.84 [0.58 - 1.22]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215798_at	129	0.310078	0.066563	-	0.546219	0.513457	0.274523	1.32 [0.58 - 3.00]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31455	56	0.107143	0.16676	-	-0.619241	0.565245	-0.0981844	0.91 [0.65 - 1.27]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31455	56	0.535714	0.177001	-	-0.495747	0.473811	-0.121363	0.89 [0.64 - 1.23]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215798_at	278	0.107914	0.0610694	-	0.637634	0.90199	0.0450555	1.05 [0.51 - 2.14]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205208_at	278	0.845324	0.0719397	-	0.443067	0.484481	0.142168	1.15 [0.77 - 1.72]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205208_at	133	0.857143	0.00947713	0.155051	-1.13949	0.0438269	-0.625869	0.53 [0.29 - 0.98]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215798_at	133	0.511278	0.0482529	0.481035	0.469291	0.133243	1.23319	3.43 [0.69 - 17.17]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15911	81	0.160494	0.0453677	0.463031	15.3962	0.998528	0.000542809	1.00 [0.56 - 1.78]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205208_at	185	0.248649	0.0365935	0.403864	-0.385844	0.721748	-0.0730611	0.93 [0.62 - 1.39]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215798_at	185	0.594595	0.0216898	0.283665	0.405341	0.187576	0.282963	1.33 [0.87 - 2.02]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205208_at	185	0.248649	0.107922	-	-0.323942	0.93198	0.0185674	1.02 [0.67 - 1.56]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215798_at	185	0.183784	0.00751803	0.129969	0.561388	0.247697	0.22052	1.25 [0.86 - 1.81]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P258887	110	0.3	0.000420792	0.0122253	-0.849632	0.145613	-0.182177	0.83 [0.65 - 1.07]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P941870	110	0.436364	0.0138805	0.206	0.584788	0.201006	0.179066	1.20 [0.91 - 1.57]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P258887	110	0.3	0.00827225	0.139838	-0.778104	0.516084	-0.101632	0.90 [0.66 - 1.23]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P941870	110	0.263636	0.0119727	0.184721	1.00673	0.148612	0.234003	1.26 [0.92 - 1.74]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205208_at	80	0.7	0.0454199	0.463362	-1.18447	0.58258	-0.110132	0.90 [0.60 - 1.33]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215798_at	80	0.8625	0.0293625	0.349193	1.03735	0.577533	0.182431	1.20 [0.63 - 2.28]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_2661	281	0.818505	0.0520148	-	0.338925	0.628058	0.0400699	1.04 [0.89 - 1.22]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215798_at	38	0.605263	0.00344243	0.070358	-1.59202	0.221019	-0.530628	0.59 [0.25 - 1.38]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205208_at	38	0.526316	0.0893429	-	0.794853	0.778791	0.103325	1.11 [0.54 - 2.28]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215798_at	140	0.121429	0.0612198	-	-0.713302	0.481724	-0.381779	0.68 [0.24 - 1.98]
GENE	ALDH1L1	aldehyde dehydrogenase 1 family, member L1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205208_at	140	0.271429	8.57474e-09	6.40488e-07	-1.53745	0.00168438	-0.707056	0.49 [0.32 - 0.77]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201425_at	30	0.766667	0.269832	-	0.488782	0.97533	0.00671286	1.01 [0.66 - 1.54]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1793859	165	0.224242	0.160978	-	0.419471	0.798797	0.0241179	1.02 [0.85 - 1.23]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1793859	165	0.254545	0.0558337	-	0.983244	0.57668	0.0762069	1.08 [0.83 - 1.41]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201425_at	163	0.294479	0.00110893	0.0277906	0.7939	0.0349517	0.187225	1.21 [1.01 - 1.44]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201425_at	79	0.21519	0.015294	0.221099	1.09452	0.063246	0.233676	1.26 [0.99 - 1.62]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201425_at	58	0.896552	0.00270898	0.0580033	1.30949	0.0781468	0.298869	1.35 [0.97 - 1.88]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201425_at	34	0.882353	1.07459e-05	0.000476864	2.30656	0.795389	0.0678939	1.07 [0.64 - 1.79]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201425_at	158	0.525316	4.15894e-07	2.41795e-05	-1.24923	1.74539e-05	-0.633297	0.53 [0.40 - 0.71]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201425_at	53	0.566038	0.127483	-	-0.534147	0.745037	-0.0693366	0.93 [0.61 - 1.42]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201425_at	53	0.566038	0.156576	-	-0.532678	0.84689	-0.0444585	0.96 [0.61 - 1.50]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201425_at	180	0.394444	0.00791475	0.135195	-0.557944	0.0267018	-0.406438	0.67 [0.46 - 0.95]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201425_at	559	0.440072	0.00498551	0.094427	-0.559393	0.020231	-0.258615	0.77 [0.62 - 0.96]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201425_at	77	0.649351	0.00267692	0.0574463	-0.842518	0.0010571	-0.8382	0.43 [0.26 - 0.71]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201425_at	70	0.742857	0.0640658	-	0.545538	0.753728	0.0860388	1.09 [0.64 - 1.87]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32747_at	50	0.44	0.00148226	0.0353838	-1.09475	0.0519105	-0.321314	0.73 [0.52 - 1.00]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201425_at	74	0.527027	0.00174629	0.0405162	-0.921039	0.04501	-0.700667	0.50 [0.25 - 0.98]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201425_at	67	0.328358	0.0790939	-	-1.12288	0.656542	-0.351615	0.70 [0.15 - 3.31]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201425_at	115	0.565217	0.0980419	-	0.890667	0.604815	0.282993	1.33 [0.45 - 3.88]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32747_at	158	0.512658	0.147397	-	0.413871	0.66443	0.108875	1.12 [0.68 - 1.82]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32747_at	76	0.697368	0.123659	-	-1.1122	0.273669	-0.431228	0.65 [0.30 - 1.41]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201425_at	204	0.328431	0.163707	-	0.207692	0.666251	-0.045771	0.96 [0.78 - 1.18]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201425_at	87	0.402299	0.0116362	0.180849	-0.934864	0.130551	-0.379596	0.68 [0.42 - 1.12]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201425_at	87	0.402299	0.0116362	0.180849	-0.934864	0.130551	-0.379596	0.68 [0.42 - 1.12]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201425_at	77	0.103896	0.0320957	0.37057	-1.37487	0.633653	-0.155584	0.86 [0.45 - 1.62]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201425_at	77	0.103896	0.0988329	-	-1.04847	0.93526	-0.0242796	0.98 [0.54 - 1.75]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201425_at	136	0.330882	0.0988505	-	-0.723072	0.770145	-0.102731	0.90 [0.45 - 1.80]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201425_at	200	0.12	0.00634776	0.114051	-0.981526	0.248467	-0.314519	0.73 [0.43 - 1.25]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8523	60	0.2	0.0737552	-	-0.738637	0.172303	-0.146873	0.86 [0.70 - 1.07]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8523	60	0.883333	0.0180109	0.248735	1.04925	0.654768	0.125782	1.13 [0.65 - 1.97]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12476	155	0.548387	1.87535e-06	9.70478e-05	1.54276	0.00130432	0.244566	1.28 [1.10 - 1.48]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201425_at	286	0.527972	0.00201752	0.0456199	-0.616061	0.216812	-0.217651	0.80 [0.57 - 1.14]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201425_at	159	0.339623	0.0267171	0.327582	-0.68853	0.313202	-0.343742	0.71 [0.36 - 1.38]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201425_at	159	0.339623	0.00822149	0.139183	-0.951772	0.255198	-0.431265	0.65 [0.31 - 1.37]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201425_at	159	0.503145	0.0614835	-	-0.602079	0.413712	-0.274625	0.76 [0.39 - 1.47]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201425_at	54	0.648148	0.133881	-	-1.15692	0.969485	0.0126798	1.01 [0.53 - 1.94]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201425_at	117	0.299145	0.16802	-	0.516637	0.591897	0.10309	1.11 [0.76 - 1.62]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201425_at	117	0.504274	0.257242	-	0.430264	0.8057	0.0566562	1.06 [0.67 - 1.66]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201425_at	117	0.299145	0.16802	-	0.516637	0.591897	0.10309	1.11 [0.76 - 1.62]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201425_at	117	0.606838	0.0718861	-	-0.814886	0.749377	-0.0734491	0.93 [0.59 - 1.46]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201425_at	236	0.211864	0.000749964	0.0200004	-0.914801	0.0109936	-0.58236	0.56 [0.36 - 0.88]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201425_at	249	0.188755	0.00104182	0.0263757	-0.756472	0.0367337	-0.404861	0.67 [0.46 - 0.98]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201425_at	62	0.290323	0.00153269	0.036378	-1.47543	0.00878062	-0.750511	0.47 [0.27 - 0.83]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201425_at	125	0.56	0.00117058	0.0290757	-1.3958	0.00876862	-0.524671	0.59 [0.40 - 0.88]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201425_at	125	0.56	0.0015324	0.0363722	-0.958116	0.0301187	-0.353856	0.70 [0.51 - 0.97]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201425_at	54	0.296296	0.000855848	0.022359	-1.88491	0.00586045	-1.0415	0.35 [0.17 - 0.74]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201425_at	198	0.414141	0.0257133	0.319126	-0.562478	0.537652	-0.0962312	0.91 [0.67 - 1.23]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201425_at	198	0.414141	0.0123334	0.188829	-0.660754	0.506832	-0.10733	0.90 [0.65 - 1.23]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201425_at	198	0.414141	0.0115296	0.179615	-0.528297	0.323646	-0.124234	0.88 [0.69 - 1.13]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201425_at	51	0.254902	0.0033886	0.0694745	-2.53869	0.166996	-1.20552	0.30 [0.05 - 1.66]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201425_at	62	0.16129	0.0703494	-	-1.05966	0.680068	-0.230952	0.79 [0.26 - 2.38]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201425_at	177	0.830508	0.0194519	0.262732	-1.15551	0.177962	-0.533912	0.59 [0.27 - 1.27]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201425_at	177	0.836158	0.0687283	-	-0.67309	0.473422	-0.25601	0.77 [0.38 - 1.56]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201425_at	145	0.482759	0.00251498	0.0546097	-1.0596	0.0140111	-1.07221	0.34 [0.15 - 0.81]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201425_at	226	0.70354	0.000250729	0.00782227	-1.57665	5.44123e-05	-1.16455	0.31 [0.18 - 0.55]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201425_at	55	0.854545	0.101624	-	0.829378	0.986903	0.008731	1.01 [0.36 - 2.86]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201425_at	55	0.854545	0.0524571	-	0.978833	0.14654	0.844885	2.33 [0.74 - 7.28]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201425_at	49	0.55102	0.0297132	0.351988	1.35251	0.129952	1.12233	3.07 [0.72 - 13.13]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201425_at	63	0.365079	0.0196413	0.26454	0.913393	0.0832355	0.242434	1.27 [0.97 - 1.68]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502032_3p_at	28	0.5	0.090657	-	-0.970366	0.616648	-0.0499593	0.95 [0.78 - 1.16]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201425_at	82	0.121951	3.82588e-05	0.00149365	-1.53863	0.00136514	-0.979977	0.38 [0.21 - 0.68]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32747_at	84	0.416667	0.00259078	0.0559425	-0.868844	0.0148915	-0.476783	0.62 [0.42 - 0.91]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201425_at	79	0.64557	0.225293	-	0.318725	0.783501	-0.0734349	0.93 [0.55 - 1.57]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X05409_at	86	0.732558	0.0895873	-	0.703747	0.340091	0.350482	1.42 [0.69 - 2.92]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201425_at	104	0.798077	0.00734097	0.12761	-2.22806	0.32903	-0.254212	0.78 [0.47 - 1.29]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P36753	117	0.128205	0.000722519	0.0193794	-1.1086	0.10739	-0.237047	0.79 [0.59 - 1.05]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P36745	117	0.188034	0.00317888	0.0659987	-0.906582	0.031994	-0.297458	0.74 [0.57 - 0.97]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201425_at	204	0.245098	0.00244952	0.0534513	-1.063	0.0317992	-0.747204	0.47 [0.24 - 0.94]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201425_at	204	0.215686	2.89255e-05	0.00116319	-1.10713	0.01382	-0.649393	0.52 [0.31 - 0.88]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201425_at	178	0.550562	0.0273741	0.333039	0.434554	0.765162	0.0734368	1.08 [0.66 - 1.74]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200014708	41	0.878049	0.0961527	-	-1.54639	0.528588	-0.164353	0.85 [0.51 - 1.41]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201425_at	111	0.117117	0.0858402	-	-0.589323	0.60833	-0.116193	0.89 [0.57 - 1.39]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201425_at	90	0.866667	0.0741941	-	0.697186	0.505407	0.142843	1.15 [0.76 - 1.76]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201425_at	90	0.866667	0.145793	-	0.655676	0.881043	0.0365468	1.04 [0.64 - 1.67]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201425_at	138	0.797101	0.058244	-	-0.638514	0.605892	-0.0539714	0.95 [0.77 - 1.16]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201425_at	129	0.325581	0.057581	-	-0.473162	0.337086	-0.240756	0.79 [0.48 - 1.29]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43598	56	0.107143	0.0189762	0.258158	-1.23029	0.96135	-0.0111209	0.99 [0.63 - 1.55]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33552	56	0.196429	0.038649	0.41837	-0.839225	0.889716	0.0315142	1.03 [0.66 - 1.61]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43598	56	0.107143	0.002084	0.0468476	-1.60152	0.811268	-0.0558254	0.95 [0.60 - 1.50]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33552	56	0.178571	0.0565688	-	-0.871897	0.875982	-0.0352895	0.97 [0.62 - 1.50]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201425_at	278	0.201439	0.0322352	0.371637	0.584952	0.251098	0.127392	1.14 [0.91 - 1.41]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201425_at	133	0.533835	0.00563468	0.103942	-0.672163	0.0269083	-0.179357	0.84 [0.71 - 0.98]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3439	81	0.197531	0.0347501	0.390487	1.95094	0.388326	0.245462	1.28 [0.73 - 2.23]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201425_at	185	0.621622	0.165194	-	0.229284	0.478966	0.070157	1.07 [0.88 - 1.30]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201425_at	185	0.286486	0.163176	-	0.275417	0.487425	0.0749308	1.08 [0.87 - 1.33]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P36745	110	0.890909	0.149986	-	0.558329	0.658533	0.0678084	1.07 [0.79 - 1.45]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P36753	110	0.309091	0.251772	-	-0.354985	0.584474	0.0799744	1.08 [0.81 - 1.44]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P36745	110	0.572727	0.20616	-	0.294847	0.706777	0.0451462	1.05 [0.83 - 1.32]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P36753	110	0.618182	0.312797	-	0.238175	0.844286	0.0222529	1.02 [0.82 - 1.28]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201425_at	80	0.6125	0.062037	-	-0.99732	0.163765	-0.43571	0.65 [0.35 - 1.19]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_2962	281	0.227758	0.00125269	0.0307671	-0.501875	0.165712	-0.107155	0.90 [0.77 - 1.05]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:770886	59	0.677966	0.105432	-	-1.15523	0.627639	-0.438007	0.65 [0.11 - 3.79]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201425_at	38	0.631579	0.0447341	0.458987	-1.1942	0.566493	-0.131855	0.88 [0.56 - 1.38]
GENE	ALDH2	aldehyde dehydrogenase 2 family (mitochondrial)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201425_at	140	0.692857	0.000209536	0.00669327	-1.71945	0.00648099	-0.346849	0.71 [0.55 - 0.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205623_at	30	0.3	0.114364	-	-0.689957	0.924555	0.0253317	1.03 [0.61 - 1.73]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1702503	165	0.666667	0.0587181	-	0.464972	0.680163	0.0356936	1.04 [0.87 - 1.23]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1702503	165	0.830303	0.108908	-	-1.11314	0.830846	-0.0288231	0.97 [0.75 - 1.27]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205623_at	163	0.337423	0.214697	-	0.268346	0.735508	-0.217776	0.80 [0.23 - 2.85]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205623_at	79	0.101266	0.0232779	0.297976	-0.959929	0.214772	-1.44274	0.24 [0.02 - 2.31]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205623_at	58	0.672414	0.0445988	0.458119	0.587311	0.428881	0.1608	1.17 [0.79 - 1.75]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205623_at	34	0.617647	0.0806396	-	-0.703341	0.450779	-0.159374	0.85 [0.56 - 1.29]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205623_at	158	0.727848	0.0117829	0.182541	0.605389	0.144081	0.793559	2.21 [0.76 - 6.41]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205623_at	53	0.603774	0.0892712	-	-0.670291	0.274423	-0.295059	0.74 [0.44 - 1.26]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205623_at	53	0.433962	0.0179357	0.247992	-0.809299	0.0823402	-0.454369	0.63 [0.38 - 1.06]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205623_at	180	0.116667	0.0958429	-	-0.496823	0.718142	0.0425053	1.04 [0.83 - 1.31]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205623_at	559	0.209302	0.0963591	-	-0.364692	0.129495	-0.203655	0.82 [0.63 - 1.06]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205623_at	77	0.285714	0.0493348	0.487619	0.583595	0.181187	0.19439	1.21 [0.91 - 1.62]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205623_at	70	0.5	0.144852	-	0.382062	0.935421	0.0316726	1.03 [0.48 - 2.22]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40031_at	50	0.74	0.123512	-	-0.623532	0.26022	-1.25948	0.28 [0.03 - 2.54]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205623_at	74	0.810811	0.0273306	0.332679	0.753319	0.838619	0.042598	1.04 [0.69 - 1.57]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205623_at	67	0.104478	0.206668	-	-0.976151	0.747964	-0.631122	0.53 [0.01 - 24.99]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205623_at	115	0.313043	0.0035262	0.0717265	-1.48896	0.0897692	-0.944014	0.39 [0.13 - 1.16]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40031_at	158	0.898734	0.0654337	-	0.669428	0.612965	0.135849	1.15 [0.68 - 1.94]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40031_at	76	0.105263	0.0688391	-	-1.1544	0.88425	0.0904764	1.09 [0.32 - 3.70]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205623_at	204	0.568627	0.00910557	0.150428	0.372344	0.0851294	0.156832	1.17 [0.98 - 1.40]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205623_at	87	0.356322	0.0480265	0.479646	0.884073	0.3221	0.780342	2.18 [0.47 - 10.23]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205623_at	87	0.356322	0.0480265	0.479646	0.884073	0.3221	0.780342	2.18 [0.47 - 10.23]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205623_at	77	0.792208	0.00743741	0.128897	1.54111	0.127743	2.02563	7.58 [0.56 - 102.76]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205623_at	77	0.896104	8.51908e-06	0.000386379	2.1423	0.00256142	3.28715	26.77 [3.16 - 226.64]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205623_at	136	0.838235	0.132897	-	0.726162	0.876526	0.0375746	1.04 [0.65 - 1.67]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205623_at	200	0.385	0.0768309	-	0.572093	0.616595	0.0939832	1.10 [0.76 - 1.59]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6625	60	0.866667	0.142647	-	-1.03567	0.691311	0.423629	1.53 [0.19 - 12.36]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6625	60	0.566667	0.0169565	0.238212	-0.964961	0.415435	-0.72673	0.48 [0.08 - 2.78]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18315	155	0.419355	3.46692e-09	2.72401e-07	-1.73237	9.20412e-05	-0.296558	0.74 [0.64 - 0.86]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205623_at	286	0.192308	0.00103757	0.0262856	-0.695061	0.084943	-0.25721	0.77 [0.58 - 1.04]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205623_at	159	0.792453	0.00117628	0.029194	1.03148	0.0133007	0.644764	1.91 [1.14 - 3.17]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205623_at	159	0.805031	0.0350439	0.392643	0.713455	0.320528	0.257697	1.29 [0.78 - 2.15]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205623_at	159	0.805031	0.0161186	0.229671	0.933042	0.100758	0.503747	1.65 [0.91 - 3.02]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205623_at	54	0.444444	0.239118	-	-0.815015	0.619248	-0.574176	0.56 [0.06 - 5.42]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205623_at	117	0.162393	0.0283879	0.341341	1.45799	0.621131	0.356296	1.43 [0.35 - 5.87]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205623_at	117	0.333333	0.034626	0.389573	1.09159	0.0592794	1.39121	4.02 [0.95 - 17.06]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205623_at	117	0.162393	0.0283879	0.341341	1.45799	0.621131	0.356296	1.43 [0.35 - 5.87]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205623_at	117	0.162393	0.0488784	0.484852	1.76587	0.369835	0.739569	2.10 [0.42 - 10.55]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205623_at	236	0.868644	0.0208356	0.275785	-1.51561	0.172014	-0.363027	0.70 [0.41 - 1.17]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205623_at	249	0.835341	0.015181	0.219912	-0.872056	0.211064	-0.257412	0.77 [0.52 - 1.16]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205623_at	62	0.193548	0.213494	-	1.20772	0.903855	-0.0367527	0.96 [0.53 - 1.75]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205623_at	125	0.528	0.160948	-	0.555255	0.516433	0.348839	1.42 [0.49 - 4.07]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205623_at	125	0.728	0.0486698	0.483583	-0.708847	0.523087	-0.26153	0.77 [0.34 - 1.72]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205623_at	54	0.462963	0.296502	-	0.695312	0.92225	-0.036179	0.96 [0.47 - 1.99]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205623_at	198	0.121212	0.00389274	0.0776227	-0.888194	0.111626	-0.171214	0.84 [0.68 - 1.04]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205623_at	198	0.10101	0.0261093	0.32248	-0.65923	0.223725	-0.105393	0.90 [0.76 - 1.07]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205623_at	198	0.121212	0.00420453	0.082529	-0.871994	0.141655	-0.153158	0.86 [0.70 - 1.05]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205623_at	51	0.823529	0.285015	-	-15.3321	0.92503	-0.0797992	0.92 [0.18 - 4.87]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205623_at	62	0.548387	0.0953588	-	0.982633	0.257407	0.450095	1.57 [0.72 - 3.42]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205623_at	177	0.853107	0.0186852	0.255338	-1.30475	0.0605587	-0.68596	0.50 [0.25 - 1.03]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205623_at	177	0.146893	0.0282232	0.340002	-0.648153	0.0692666	-0.556155	0.57 [0.31 - 1.04]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205623_at	145	0.868966	0.027107	0.330828	-1.92833	0.200159	-0.551619	0.58 [0.25 - 1.34]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205623_at	226	0.699115	0.0426197	0.445248	-0.731033	0.16929	-0.122917	0.88 [0.74 - 1.05]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205623_at	55	0.127273	0.000332078	0.00997332	-1.62094	0.138278	-0.662547	0.52 [0.21 - 1.24]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205623_at	55	0.127273	0.00409288	0.0807831	-1.52458	0.0129894	-1.37242	0.25 [0.09 - 0.75]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205623_at	49	0.102041	0.0233983	0.299044	-1.40209	0.106242	-0.978896	0.38 [0.11 - 1.23]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205623_at	63	0.301587	0.000342866	0.0102519	-1.15777	0.32448	-0.770126	0.46 [0.10 - 2.14]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502034_3p_at	28	0.428571	0.159375	-	0.77886	0.403137	-0.411795	0.66 [0.25 - 1.74]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205623_at	82	0.195122	0.0381963	0.415211	-0.741347	0.370572	0.197527	1.22 [0.79 - 1.88]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205623_at	79	0.835443	0.000683467	0.0184884	1.08982	0.0071659	0.403457	1.50 [1.12 - 2.01]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M74542_at	86	0.825581	0.0332599	0.379403	0.985717	0.506319	0.149103	1.16 [0.75 - 1.80]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205623_at	104	0.894231	0.184352	-	0.629943	0.495021	0.136113	1.15 [0.78 - 1.69]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P207213	117	0.384615	0.00647189	0.115778	-0.762433	0.365332	-0.132796	0.88 [0.66 - 1.17]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205623_at	204	0.455882	0.0037506	0.0753533	-1.10083	0.0150469	-0.419495	0.66 [0.47 - 0.92]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205623_at	204	0.151961	1.03728e-05	0.000461851	-1.22164	0.000574834	-0.452973	0.64 [0.49 - 0.82]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205623_at	178	0.101124	0.0316294	0.366988	-0.610811	0.860078	0.0173957	1.02 [0.84 - 1.23]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300017726	41	0.536585	0.0727154	-	0.752093	0.296589	0.528487	1.70 [0.63 - 4.58]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200000146	41	0.390244	0.00577976	0.106026	1.31522	0.0536665	0.250189	1.28 [1.00 - 1.66]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205623_at	111	0.369369	0.0375646	0.41077	-0.541888	0.0935039	-0.0989723	0.91 [0.81 - 1.02]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205623_at	90	0.144444	0.108703	-	-0.629127	0.846924	-0.0159278	0.98 [0.84 - 1.16]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205623_at	90	0.144444	0.0133163	0.199821	-0.990027	0.665618	-0.0414905	0.96 [0.79 - 1.16]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205623_at	138	0.34058	0.117556	-	-0.389968	0.335051	-0.0357101	0.96 [0.90 - 1.04]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205623_at	129	0.116279	0.0296383	0.351392	-0.748505	0.934992	-0.00449337	1.00 [0.89 - 1.11]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28051	56	0.142857	0.0370214	0.406919	-0.936882	0.305614	-0.089346	0.91 [0.77 - 1.09]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3223	56	0.25	0.00414104	0.0815377	-1.059	0.581637	-0.0492378	0.95 [0.80 - 1.13]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28051	56	0.125	0.120724	-	-0.752003	0.973273	-0.00298874	1.00 [0.84 - 1.19]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3223	56	0.803571	0.0348289	0.391066	0.910731	0.716951	0.0326343	1.03 [0.87 - 1.23]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205623_at	278	0.388489	0.00845333	0.142166	-0.498066	0.255733	-0.241941	0.79 [0.52 - 1.19]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205623_at	133	0.203008	0.00162599	0.0381993	1.12827	0.47962	-0.159545	0.85 [0.55 - 1.33]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16447	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17360	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205623_at	185	0.162162	0.150214	-	-0.340365	0.440697	-0.17315	0.84 [0.54 - 1.31]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205623_at	185	0.475676	0.0504998	-	-0.321363	0.179734	-0.280547	0.76 [0.50 - 1.14]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P207213	110	0.436364	0.00387637	0.0773625	-0.662159	0.033567	-0.16348	0.85 [0.73 - 0.99]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P207213	110	0.463636	0.102776	-	-0.483423	0.372835	-0.0887072	0.92 [0.75 - 1.11]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205623_at	80	0.175	0.0729711	-	1.64838	0.619886	0.0751319	1.08 [0.80 - 1.45]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0630	281	0.893238	0.0130982	0.197407	-0.606721	0.210181	-0.134877	0.87 [0.71 - 1.08]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205623_at	38	0.394737	0.0702273	-	-0.848536	0.173711	-0.855535	0.43 [0.12 - 1.46]
GENE	ALDH3A1	aldehyde dehydrogenase 3 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205623_at	140	0.785714	0.00970463	0.157853	-1.26935	0.028728	-1.83738	0.16 [0.03 - 0.83]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202053_s_at	30	0.433333	0.152235	-	0.598158	0.977157	0.0156894	1.02 [0.35 - 2.97]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202054_s_at	30	0.733333	0.0338997	0.384193	-1.03114	0.369444	-0.381455	0.68 [0.30 - 1.57]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210544_s_at	30	0.133333	0.0701209	-	-1.06432	0.895924	-0.0733571	0.93 [0.31 - 2.79]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1794825	165	0.375758	0.0370966	0.407454	-0.497306	0.144427	-0.224394	0.80 [0.59 - 1.08]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1794825	165	0.472727	0.0304293	0.357647	-0.785745	0.191055	-0.293592	0.75 [0.48 - 1.16]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202054_s_at	163	0.895706	0.134256	-	0.440913	0.559796	0.109269	1.12 [0.77 - 1.61]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210544_s_at	163	0.196319	0.119854	-	-0.367229	0.699766	-0.192542	0.82 [0.31 - 2.19]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202053_s_at	163	0.840491	0.0450479	0.460994	-0.630148	0.661943	-0.0724751	0.93 [0.67 - 1.29]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210544_s_at	79	0.658228	0.0280394	0.338503	0.638855	0.0858795	0.61571	1.85 [0.92 - 3.74]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202054_s_at	79	0.35443	0.00418801	0.0822715	0.955096	0.0334195	0.38338	1.47 [1.03 - 2.09]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202053_s_at	79	0.455696	0.00162093	0.0381011	0.946542	0.015371	0.404506	1.50 [1.08 - 2.08]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202053_s_at	58	0.568965	0.154051	-	0.397183	0.699061	0.103926	1.11 [0.66 - 1.88]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202054_s_at	58	0.775862	0.0601757	-	0.630387	0.382851	0.127346	1.14 [0.85 - 1.51]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210544_s_at	58	0.103448	0.0770237	-	0.814042	0.447395	0.155204	1.17 [0.78 - 1.74]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210544_s_at	34	0.823529	2.84592e-06	0.000142251	2.319	0.0136253	1.05367	2.87 [1.24 - 6.62]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202053_s_at	34	0.441176	0.323976	-	-0.375159	0.876816	0.0745166	1.08 [0.42 - 2.76]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202054_s_at	34	0.882353	0.0966631	-	0.896907	0.785016	0.0666899	1.07 [0.66 - 1.73]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210544_s_at	158	0.189873	0.0423229	0.443288	0.706808	0.740485	0.172689	1.19 [0.43 - 3.30]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202053_s_at	158	0.113924	0.136761	-	0.624114	0.29054	0.287027	1.33 [0.78 - 2.27]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202054_s_at	158	0.860759	0.15792	-	0.431338	0.614549	0.164812	1.18 [0.62 - 2.24]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202054_s_at	53	0.358491	0.0480132	0.479564	0.831935	0.429039	0.230523	1.26 [0.71 - 2.23]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202053_s_at	53	0.45283	0.0533825	-	0.686375	0.901218	-0.0450161	0.96 [0.47 - 1.95]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210544_s_at	53	0.45283	0.0976741	-	0.634071	0.422767	0.252743	1.29 [0.69 - 2.39]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202054_s_at	53	0.264151	0.0940175	-	0.738987	0.667024	0.110228	1.12 [0.68 - 1.84]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202053_s_at	53	0.45283	0.014412	0.211741	0.945292	0.354499	0.385573	1.47 [0.65 - 3.33]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210544_s_at	53	0.283019	0.0755784	-	0.784389	0.552236	0.167082	1.18 [0.68 - 2.05]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202053_s_at	180	0.666667	0.264582	-	-0.255529	0.584092	-0.18129	0.83 [0.44 - 1.60]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202054_s_at	180	0.3	0.215923	-	0.298013	0.753419	-0.0695506	0.93 [0.60 - 1.44]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210544_s_at	180	0.866667	0.0871539	-	-0.593482	0.538284	-0.154835	0.86 [0.52 - 1.40]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210544_s_at	559	0.354204	0.0662099	-	-0.376819	0.249265	-0.343926	0.71 [0.39 - 1.27]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202054_s_at	559	0.415027	0.0265328	0.326041	-0.441015	0.1228	-0.351927	0.70 [0.45 - 1.10]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202053_s_at	559	0.751342	7.29667e-05	0.00265153	0.781289	0.041081	0.702602	2.02 [1.03 - 3.96]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210544_s_at	77	0.753247	0.226172	-	0.349159	0.382899	0.297563	1.35 [0.69 - 2.63]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202053_s_at	77	0.896104	0.142851	-	0.563215	0.315204	0.360868	1.43 [0.71 - 2.90]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202054_s_at	77	0.103896	0.0719386	-	-0.710607	0.758741	0.116611	1.12 [0.53 - 2.36]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210544_s_at	70	0.814286	0.0740741	-	0.588383	0.287974	0.519745	1.68 [0.64 - 4.39]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202054_s_at	70	0.557143	0.0725217	-	0.471753	0.24537	0.334302	1.40 [0.79 - 2.46]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202053_s_at	70	0.128571	0.265733	-	0.448103	0.563026	0.184779	1.20 [0.64 - 2.25]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40409_at	50	0.82	0.0128749	0.194922	0.959099	0.109991	0.732812	2.08 [0.85 - 5.11]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202053_s_at	74	0.108108	3.539e-06	0.000173632	-1.75634	0.0785854	-0.918877	0.40 [0.14 - 1.11]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202054_s_at	74	0.635135	0.388474	-	-0.26028	0.82042	-0.110681	0.90 [0.34 - 2.33]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210544_s_at	74	0.108108	0.00271536	0.0581139	-1.15724	0.0117324	-0.705823	0.49 [0.29 - 0.85]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210544_s_at	67	0.686567	0.125343	-	0.988829	0.408527	0.671489	1.96 [0.40 - 9.62]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202054_s_at	67	0.462687	0.1415	-	1.12364	0.22859	1.03353	2.81 [0.52 - 15.12]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202053_s_at	67	0.850746	0.092811	-	1.13038	0.467389	0.66857	1.95 [0.32 - 11.84]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210544_s_at	115	0.686957	0.107665	-	0.834158	0.759743	0.133126	1.14 [0.49 - 2.68]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202054_s_at	115	0.304348	0.270588	-	-0.586089	0.464828	-0.34195	0.71 [0.28 - 1.78]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202053_s_at	115	0.86087	0.0626755	-	1.04826	0.772617	-0.159979	0.85 [0.29 - 2.52]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40409_at	158	0.272152	0.000635215	0.0173748	-0.943679	0.00760795	-0.843754	0.43 [0.23 - 0.80]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40409_at	76	0.815789	0.185887	-	-1.28042	0.467397	-0.293362	0.75 [0.34 - 1.65]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202054_s_at	204	0.328431	0.0111732	0.17546	-0.376636	0.339286	-0.113646	0.89 [0.71 - 1.13]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202053_s_at	204	0.794118	0.155844	-	-0.246776	0.89765	-0.0166512	0.98 [0.76 - 1.27]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210544_s_at	204	0.137255	0.000256289	0.0079724	-0.743487	0.136567	-0.155036	0.86 [0.70 - 1.05]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202054_s_at	87	0.16092	0.0263836	0.32479	-0.937289	0.592789	-0.13364	0.87 [0.54 - 1.43]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210544_s_at	87	0.885057	0.0363155	0.40187	0.944246	0.958512	0.0128136	1.01 [0.63 - 1.64]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202053_s_at	87	0.114943	0.0162677	0.231203	-1.06195	0.0731388	-0.508454	0.60 [0.34 - 1.05]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202054_s_at	87	0.16092	0.0263836	0.32479	-0.937289	0.592789	-0.13364	0.87 [0.54 - 1.43]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202053_s_at	87	0.114943	0.0162677	0.231203	-1.06195	0.0731388	-0.508454	0.60 [0.34 - 1.05]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210544_s_at	87	0.885057	0.0363155	0.40187	0.944246	0.958512	0.0128136	1.01 [0.63 - 1.64]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202054_s_at	77	0.207792	0.000480427	0.0136947	-1.73432	0.203667	-0.452982	0.64 [0.32 - 1.28]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202053_s_at	77	0.155844	0.000209493	0.00669207	-1.82611	0.123326	-0.710299	0.49 [0.20 - 1.21]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210544_s_at	77	0.857143	0.131751	-	0.999745	0.738334	-0.137441	0.87 [0.39 - 1.95]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202054_s_at	77	0.207792	0.000193489	0.00624474	-2.05759	0.189771	-0.530163	0.59 [0.27 - 1.30]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210544_s_at	77	0.25974	0.207995	-	-0.703909	0.638941	-0.169018	0.84 [0.42 - 1.71]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202053_s_at	77	0.155844	0.000135403	0.00457114	-2.07122	0.073873	-0.952193	0.39 [0.14 - 1.10]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202054_s_at	136	0.779412	0.0945887	-	0.776107	0.955778	0.022471	1.02 [0.46 - 2.26]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210544_s_at	136	0.411765	0.244083	-	-0.519779	0.985952	0.00720578	1.01 [0.45 - 2.25]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202053_s_at	136	0.867647	0.105817	-	0.789238	0.434768	0.30497	1.36 [0.63 - 2.92]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202053_s_at	200	0.865	0.149857	-	0.529201	0.864594	0.0497932	1.05 [0.59 - 1.86]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202054_s_at	200	0.125	0.0125409	0.191175	-0.867083	0.406247	-0.208881	0.81 [0.50 - 1.33]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210544_s_at	200	0.19	0.00136716	0.0330887	-0.957368	0.0516213	-0.520399	0.59 [0.35 - 1.00]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15167	60	0.35	0.132972	-	0.648923	0.474165	0.12179	1.13 [0.81 - 1.58]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15167	60	0.7	0.0984777	-	0.624129	0.695936	0.0861075	1.09 [0.71 - 1.68]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3239	155	0.6	2.57596e-07	1.5501e-05	1.45855	0.00103141	0.275683	1.32 [1.12 - 1.55]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202053_s_at	286	0.115385	0.0339192	0.384338	-0.55418	0.124073	-0.304488	0.74 [0.50 - 1.09]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202054_s_at	286	0.573427	0.0254904	0.317229	-0.448617	0.321774	-0.161152	0.85 [0.62 - 1.17]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210544_s_at	286	0.486014	0.000920132	0.0237645	-0.644415	0.00646797	-0.369184	0.69 [0.53 - 0.90]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202053_s_at	159	0.893082	0.117929	-	0.641529	0.924475	0.0362367	1.04 [0.49 - 2.19]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202054_s_at	159	0.220126	0.00621284	0.112164	-0.867151	0.803841	-0.071926	0.93 [0.53 - 1.64]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202053_s_at	159	0.893082	0.0219589	0.286121	1.00953	0.352871	0.409313	1.51 [0.63 - 3.57]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210544_s_at	159	0.899371	0.071608	-	0.734399	0.819443	0.0783722	1.08 [0.55 - 2.12]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202054_s_at	159	0.238994	0.00104591	0.0264625	-1.00764	0.294386	-0.280714	0.76 [0.45 - 1.28]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202054_s_at	159	0.238994	0.00064602	0.0176254	-1.19647	0.513533	-0.21143	0.81 [0.43 - 1.53]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202053_s_at	159	0.893082	0.00196493	0.0446425	1.11681	0.302824	0.386803	1.47 [0.71 - 3.07]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210544_s_at	159	0.761006	0.123176	-	-0.669832	0.669058	-0.142034	0.87 [0.45 - 1.66]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210544_s_at	159	0.761006	0.194796	-	-0.68492	0.839278	-0.0814839	0.92 [0.42 - 2.03]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210544_s_at	54	0.462963	0.125143	-	1.16781	0.431405	0.377807	1.46 [0.57 - 3.74]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202053_s_at	54	0.555556	0.0202481	0.270287	1.67014	0.175386	0.650553	1.92 [0.75 - 4.91]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202054_s_at	54	0.611111	0.17441	-	0.935481	0.520065	0.300139	1.35 [0.54 - 3.37]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210544_s_at	117	0.863248	0.145962	-	0.569107	0.525809	0.185474	1.20 [0.68 - 2.14]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210544_s_at	117	0.581197	0.116412	-	0.587246	0.238422	0.385427	1.47 [0.77 - 2.79]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202053_s_at	117	0.299145	0.0336928	0.382649	0.861272	0.10076	0.36844	1.45 [0.93 - 2.24]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210544_s_at	117	0.846154	0.166638	-	0.626929	0.891819	0.046049	1.05 [0.54 - 2.03]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202053_s_at	117	0.299145	0.0430652	0.448174	1.04509	0.127091	0.397613	1.49 [0.89 - 2.48]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210544_s_at	117	0.863248	0.145962	-	0.569107	0.525809	0.185474	1.20 [0.68 - 2.14]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202053_s_at	117	0.299145	0.0336928	0.382649	0.861272	0.10076	0.36844	1.45 [0.93 - 2.24]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202053_s_at	117	0.299145	0.0170211	0.238864	1.35924	0.218341	0.294449	1.34 [0.84 - 2.15]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202054_s_at	117	0.504274	0.0235198	0.30012	0.887875	0.0765913	0.384466	1.47 [0.96 - 2.25]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202054_s_at	117	0.82906	0.0851406	-	0.624652	0.198619	0.240509	1.27 [0.88 - 1.84]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202054_s_at	117	0.82906	0.0851406	-	0.624652	0.198619	0.240509	1.27 [0.88 - 1.84]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202054_s_at	117	0.555556	0.0409205	0.433923	0.802442	0.268958	0.237351	1.27 [0.83 - 1.93]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202054_s_at	236	0.512712	0.0671398	-	-0.503592	0.399863	-0.24275	0.78 [0.45 - 1.38]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210544_s_at	236	0.254237	0.142117	-	-0.419374	0.914367	-0.0351609	0.97 [0.51 - 1.83]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202053_s_at	236	0.783898	0.322011	-	-0.358829	0.530102	-0.215763	0.81 [0.41 - 1.58]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210544_s_at	249	0.148594	0.127147	-	-0.420568	0.792233	-0.0677648	0.93 [0.56 - 1.55]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202053_s_at	249	0.819277	0.110455	-	-0.508493	0.285228	-0.292612	0.75 [0.44 - 1.28]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202054_s_at	249	0.654619	0.0947076	-	-0.392105	0.452772	-0.166592	0.85 [0.55 - 1.31]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202054_s_at	125	0.128	0.000665095	0.0180661	-1.08556	0.0878096	-0.441928	0.64 [0.39 - 1.07]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202054_s_at	54	0.111111	0.0591533	-	-1.19915	0.619381	-0.163801	0.85 [0.44 - 1.62]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210544_s_at	125	0.584	0.119738	-	-0.624005	0.563308	-0.299102	0.74 [0.27 - 2.04]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210544_s_at	125	0.584	0.0245145	0.308831	-0.680707	0.123772	-0.633742	0.53 [0.24 - 1.19]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202053_s_at	62	0.112903	0.000158871	0.00525771	-1.89693	0.363856	-0.233722	0.79 [0.48 - 1.31]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202053_s_at	125	0.104	0.103477	-	-0.783852	0.540602	-0.255182	0.77 [0.34 - 1.75]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210544_s_at	54	0.148148	0.0348979	0.391572	-1.22607	0.465754	-0.196272	0.82 [0.48 - 1.39]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202054_s_at	62	0.112903	0.00451807	0.0873698	-1.39954	0.369077	-0.232114	0.79 [0.48 - 1.32]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202053_s_at	125	0.856	0.0283982	0.341425	-1.23078	0.285977	-0.34476	0.71 [0.38 - 1.33]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202053_s_at	54	0.185185	0.319034	-	-0.661229	0.882026	-0.0492226	0.95 [0.50 - 1.82]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210544_s_at	62	0.193548	0.00894582	0.148422	-1.21353	0.415144	-0.173937	0.84 [0.55 - 1.28]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202054_s_at	125	0.128	0.0694669	-	-0.813503	0.526229	-0.21509	0.81 [0.41 - 1.57]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210544_s_at	198	0.338384	0.189638	-	0.379648	0.657817	0.0802759	1.08 [0.76 - 1.55]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210544_s_at	198	0.338384	0.153867	-	0.43688	0.768215	0.0545734	1.06 [0.73 - 1.52]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202053_s_at	198	0.565657	0.390847	-	-0.223909	0.868363	0.0262812	1.03 [0.75 - 1.40]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202054_s_at	198	0.313131	0.0652624	-	0.448754	0.701764	0.0476369	1.05 [0.82 - 1.34]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202053_s_at	198	0.439394	0.431946	-	0.214694	0.771301	0.0468627	1.05 [0.76 - 1.44]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210544_s_at	198	0.868687	0.290019	-	0.298959	0.671641	0.0618172	1.06 [0.80 - 1.42]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202054_s_at	198	0.868687	0.116349	-	-0.79246	0.852632	-0.028975	0.97 [0.72 - 1.32]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202054_s_at	198	0.868687	0.129738	-	-0.768015	0.675947	-0.0675778	0.93 [0.68 - 1.28]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202053_s_at	198	0.424242	0.0729508	-	0.388989	0.763484	0.0380383	1.04 [0.81 - 1.33]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202054_s_at	62	0.854839	0.180163	-	0.870022	0.92352	0.0473427	1.05 [0.40 - 2.76]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210544_s_at	51	0.803922	0.24613	-	1.01536	0.235227	2.37682	10.77 [0.21 - 545.37]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210544_s_at	62	0.725806	0.0829116	-	0.964278	0.913613	0.153109	1.17 [0.07 - 18.53]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202053_s_at	51	0.176471	0.178824	-	-1.16116	0.836719	-0.184546	0.83 [0.14 - 4.81]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202053_s_at	62	0.387097	0.110973	-	1.1677	0.427761	0.45786	1.58 [0.51 - 4.90]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202054_s_at	51	0.882353	0.0208854	0.276249	1.84683	0.674295	-0.320591	0.73 [0.16 - 3.24]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202053_s_at	177	0.327684	0.0979062	-	0.438577	0.560025	0.164801	1.18 [0.68 - 2.05]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202054_s_at	145	0.772414	0.276867	-	-0.518523	0.560131	-0.214545	0.81 [0.39 - 1.66]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202053_s_at	145	0.565517	0.215203	-	-0.435364	0.652261	-0.188618	0.83 [0.36 - 1.88]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210544_s_at	177	0.248588	0.18917	-	0.475437	0.622678	0.165213	1.18 [0.61 - 2.28]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202054_s_at	177	0.728814	0.254806	-	0.332669	0.964838	-0.013033	0.99 [0.55 - 1.76]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210544_s_at	177	0.887006	0.219082	-	0.416489	0.377479	0.256713	1.29 [0.73 - 2.29]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202053_s_at	177	0.276836	0.106775	-	0.538581	0.88661	-0.0473428	0.95 [0.50 - 1.83]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202054_s_at	177	0.728814	0.150673	-	0.361513	0.717183	0.0930131	1.10 [0.66 - 1.82]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210544_s_at	145	0.234483	0.0543409	-	0.981024	0.789134	0.115854	1.12 [0.48 - 2.62]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202053_s_at	226	0.115044	0.0420377	0.441398	-0.681964	0.181489	-0.373721	0.69 [0.40 - 1.19]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210544_s_at	226	0.460177	0.0530963	-	-0.547822	0.997009	0.00103528	1.00 [0.58 - 1.72]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202054_s_at	226	0.172566	0.00563649	0.103968	-0.831394	0.122499	-0.342141	0.71 [0.46 - 1.10]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202053_s_at	55	0.836364	0.0111574	0.175275	1.29248	0.135736	0.453833	1.57 [0.87 - 2.86]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202053_s_at	49	0.897959	0.0287941	0.344629	1.3788	0.137085	0.495821	1.64 [0.85 - 3.16]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210544_s_at	55	0.690909	0.0166217	0.234819	1.03409	0.103006	0.48615	1.63 [0.91 - 2.92]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210544_s_at	55	0.8	0.00880208	0.146607	1.29586	0.369704	0.313804	1.37 [0.69 - 2.72]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202054_s_at	55	0.890909	0.0284628	0.34195	1.16473	0.141374	0.385055	1.47 [0.88 - 2.46]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210544_s_at	49	0.102041	0.123748	-	-0.987499	0.574362	0.233893	1.26 [0.56 - 2.86]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202053_s_at	55	0.890909	0.0258384	0.320188	1.1962	0.0905324	0.492508	1.64 [0.93 - 2.89]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202054_s_at	55	0.854545	0.0308497	0.360939	1.14632	0.300349	0.298406	1.35 [0.77 - 2.37]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202054_s_at	49	0.877551	0.0826819	-	1.1054	0.330345	0.31399	1.37 [0.73 - 2.58]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	813624	34	0.147059	0.09339	-	1.56074	0.798622	0.138717	1.15 [0.40 - 3.33]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	856519	34	0.294118	0.0093064	0.152934	1.72812	0.0441894	1.55872	4.75 [1.04 - 21.69]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210544_s_at	63	0.349206	0.00364852	0.0737103	-0.954899	0.125516	-0.333062	0.72 [0.47 - 1.10]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202054_s_at	63	0.730159	0.0288074	0.344736	-1.02119	0.269229	-0.23308	0.79 [0.52 - 1.20]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202053_s_at	63	0.714286	0.0130251	0.196595	-1.14565	0.219134	-0.316592	0.73 [0.44 - 1.21]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12803234_3p_a_at	28	0.642857	0.116773	-	-1.00635	0.530157	-1.51538	0.22 [0.00 - 24.93]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557302_3p_a_at	28	0.642857	0.26969	-	0.640775	0.67959	-0.0684302	0.93 [0.67 - 1.29]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g1082035_3p_a_at	28	0.285714	0.00978832	0.158879	2.26392	0.278027	0.272751	1.31 [0.80 - 2.15]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202054_s_at	82	0.512195	0.0375535	0.410692	-0.707309	0.52441	-0.14103	0.87 [0.56 - 1.34]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210544_s_at	82	0.426829	0.0472178	0.474652	-0.661493	0.183839	-0.354965	0.70 [0.42 - 1.18]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202053_s_at	82	0.353659	0.0695546	-	-0.616284	0.373872	-0.212731	0.81 [0.51 - 1.29]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40409_at	84	0.892857	0.137009	-	-0.864349	0.354483	-0.189139	0.83 [0.55 - 1.24]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202054_s_at	79	0.873418	0.160283	-	0.535402	0.874874	-0.0287714	0.97 [0.68 - 1.39]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210544_s_at	79	0.101266	0.0126182	0.192044	-0.948793	0.594913	-0.104644	0.90 [0.61 - 1.32]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202053_s_at	79	0.126582	0.0214809	0.28175	-0.794967	0.696155	-0.0726849	0.93 [0.65 - 1.34]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202053_s_at	104	0.490385	0.00746185	0.129222	-0.893354	0.040998	-0.495287	0.61 [0.38 - 0.98]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202054_s_at	104	0.596154	0.00150243	0.0357824	-1.24908	0.0105947	-0.554146	0.57 [0.38 - 0.88]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210544_s_at	104	0.567308	0.000464841	0.0133138	-1.30748	0.00462446	-0.765603	0.47 [0.27 - 0.79]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P129896	117	0.820513	0.0223697	0.289845	-1.13112	0.2107	-0.168349	0.85 [0.65 - 1.10]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210544_s_at	204	0.362745	3.4623e-08	2.37961e-06	-1.44842	1.33879e-06	-1.27077	0.28 [0.17 - 0.47]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202054_s_at	204	0.406863	0.000214503	0.00683106	-1.36902	0.00425511	-1.0475	0.35 [0.17 - 0.72]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202054_s_at	204	0.539216	2.14319e-06	0.000109697	-1.47249	0.000135886	-1.01577	0.36 [0.21 - 0.61]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202053_s_at	204	0.161765	0.000846104	0.0221443	-1.19349	0.012906	-0.798099	0.45 [0.24 - 0.84]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202053_s_at	204	0.161765	3.85903e-05	0.0015052	-1.14605	0.00129731	-0.760275	0.47 [0.29 - 0.74]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210544_s_at	204	0.343137	5.25281e-05	0.001981	-1.44112	0.000879967	-1.19144	0.30 [0.15 - 0.61]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202054_s_at	178	0.241573	0.025538	0.317635	-0.481577	0.212794	-0.186165	0.83 [0.62 - 1.11]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210544_s_at	178	0.174157	0.00163908	0.0384533	-0.722876	0.164902	-0.207599	0.81 [0.61 - 1.09]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202053_s_at	178	0.123596	0.000735806	0.0196806	-0.83955	0.368739	-0.133389	0.88 [0.65 - 1.17]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300018520	41	0.170732	0.253998	-	-0.537321	0.493446	-0.187247	0.83 [0.49 - 1.42]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202054_s_at	111	0.117117	0.000434748	0.0125722	-1.13681	0.0760275	-0.385891	0.68 [0.44 - 1.04]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202053_s_at	111	0.117117	0.00878644	0.146409	-0.856372	0.112028	-0.403112	0.67 [0.41 - 1.10]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210544_s_at	111	0.540541	0.00289717	0.0612417	-0.811051	0.0824432	-0.463607	0.63 [0.37 - 1.06]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202054_s_at	90	0.244444	0.284899	-	-0.381951	0.873209	0.0388612	1.04 [0.65 - 1.68]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202054_s_at	90	0.411111	0.0989112	-	-0.608728	0.894841	0.0364667	1.04 [0.60 - 1.78]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210544_s_at	90	0.455556	0.0681362	-	-0.588719	0.892199	0.0497583	1.05 [0.51 - 2.16]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210544_s_at	90	0.455556	0.0540005	-	-0.713955	0.70088	0.156375	1.17 [0.53 - 2.60]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202053_s_at	90	0.811111	0.0937252	-	0.612092	0.196129	0.328486	1.39 [0.84 - 2.29]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202053_s_at	90	0.888889	0.0344333	0.388151	0.937386	0.212572	0.357558	1.43 [0.81 - 2.51]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4397	50	0.46	0.136613	-	-0.71958	0.542679	-0.211177	0.81 [0.41 - 1.60]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202054_s_at	138	0.876812	0.203795	-	0.401257	0.762319	0.0333316	1.03 [0.83 - 1.28]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202053_s_at	138	0.246377	0.0137036	0.204072	-0.638291	0.641529	0.0526674	1.05 [0.84 - 1.32]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210544_s_at	138	0.876812	0.21321	-	0.393203	0.44968	0.0684299	1.07 [0.90 - 1.28]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202053_s_at	129	0.736434	0.12919	-	0.399818	0.391253	0.173269	1.19 [0.80 - 1.77]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202054_s_at	129	0.658915	0.0185619	0.254137	0.578812	0.633424	0.099093	1.10 [0.73 - 1.66]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210544_s_at	129	0.224806	0.130319	-	0.461707	0.640119	0.106087	1.11 [0.71 - 1.73]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41351	56	0.839286	0.187421	-	-0.777784	0.482112	-0.155558	0.86 [0.55 - 1.32]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38502	56	0.214286	0.000203938	0.0065374	-1.47764	0.300855	-0.262391	0.77 [0.47 - 1.26]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41351	56	0.214286	0.338904	-	0.506469	0.860712	0.0404174	1.04 [0.66 - 1.64]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38502	56	0.214286	0.0152909	0.221067	-1.06657	0.831495	-0.0543413	0.95 [0.57 - 1.56]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210544_s_at	278	0.809353	0.0935247	-	-0.490452	0.641902	-0.066501	0.94 [0.71 - 1.24]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202054_s_at	278	0.104317	0.031272	0.364225	0.720016	0.914273	0.0133666	1.01 [0.79 - 1.29]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202053_s_at	278	0.140288	0.15534	-	0.430776	0.871702	0.0238989	1.02 [0.77 - 1.37]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210544_s_at	133	0.105263	0.0590742	-	-0.614492	0.87371	0.0179971	1.02 [0.82 - 1.27]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202053_s_at	133	0.87218	0.0543934	-	0.585257	0.495774	0.110003	1.12 [0.81 - 1.53]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202054_s_at	133	0.789474	0.18219	-	0.362786	0.477971	0.114212	1.12 [0.82 - 1.54]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1621	81	0.111111	0.12739	-	-0.959533	0.180724	-0.379218	0.68 [0.39 - 1.19]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2883	81	0.160494	8.88675e-07	4.88012e-05	-2.22548	0.00183576	-0.749081	0.47 [0.30 - 0.76]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202053_s_at	185	0.205405	0.00752	0.129995	0.649913	0.33189	0.178503	1.20 [0.83 - 1.71]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210544_s_at	185	0.113514	0.0249922	0.31296	0.567865	0.272313	0.27334	1.31 [0.81 - 2.14]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202054_s_at	185	0.102703	0.0882066	-	0.509245	0.617702	0.0748314	1.08 [0.80 - 1.45]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210544_s_at	185	0.151351	0.125463	-	0.375318	0.433329	0.213837	1.24 [0.73 - 2.11]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202053_s_at	185	0.167568	0.00871964	0.145562	0.611919	0.479848	0.119303	1.13 [0.81 - 1.57]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202054_s_at	185	0.221622	0.127709	-	0.344854	0.427718	0.1294	1.14 [0.83 - 1.57]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P129896	110	0.272727	0.175932	-	-0.335846	0.696469	-0.06378	0.94 [0.68 - 1.29]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P129896	110	0.272727	0.201293	-	-0.396641	0.98255	-0.0045885	1.00 [0.66 - 1.50]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202053_s_at	80	0.8125	0.134138	-	-1.08571	0.50512	-0.218311	0.80 [0.42 - 1.53]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202054_s_at	80	0.4125	0.00373339	0.0750771	-1.34686	0.0187768	-0.648977	0.52 [0.30 - 0.90]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210544_s_at	80	0.4875	0.0782693	-	0.797229	0.365992	0.352508	1.42 [0.66 - 3.06]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_5925	281	0.58363	0.0316029	0.366783	-0.308289	0.613569	-0.0607556	0.94 [0.74 - 1.19]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202053_s_at	38	0.131579	0.213263	-	0.941029	0.806719	0.0987314	1.10 [0.50 - 2.43]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210544_s_at	38	0.578947	0.182198	-	-0.681491	0.614543	0.181022	1.20 [0.59 - 2.42]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202054_s_at	38	0.868421	0.0871816	-	-15.2563	0.625628	-0.191376	0.83 [0.38 - 1.78]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202054_s_at	140	0.664286	0.00107891	0.0271599	-1.19727	0.0107535	-0.511659	0.60 [0.40 - 0.89]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210544_s_at	140	0.842857	0.00259089	0.0559444	-2.41813	0.0132045	-0.737939	0.48 [0.27 - 0.86]
GENE	ALDH3A2	aldehyde dehydrogenase 3 family, member A2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202053_s_at	140	0.764286	0.00132463	0.0322308	-1.53077	0.017243	-0.529232	0.59 [0.38 - 0.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205640_at	30	0.4	0.0248031	0.31133	0.978024	0.0755897	1.3021	3.68 [0.87 - 15.46]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211004_s_at	30	0.366667	0.193792	-	0.567629	0.928455	-0.0546935	0.95 [0.29 - 3.12]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1728662	165	0.454545	0.0271558	0.331232	-0.530759	0.18881	-0.183049	0.83 [0.63 - 1.09]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1728662	165	0.4	0.167725	-	-0.483238	0.737234	-0.068573	0.93 [0.63 - 1.39]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211004_s_at	163	0.815951	0.0426042	0.445146	-0.560279	0.2376	-0.347049	0.71 [0.40 - 1.26]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205640_at	163	0.355828	0.00520875	0.0977347	-0.551662	0.0983687	-0.336583	0.71 [0.48 - 1.06]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211004_s_at	79	0.64557	0.145415	-	0.43455	0.569089	0.169673	1.18 [0.66 - 2.12]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205640_at	79	0.683544	0.0802804	-	0.528082	0.301177	0.20716	1.23 [0.83 - 1.82]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1565731_at	79	0.253165	0.100613	-	-0.510534	0.284844	-0.880208	0.41 [0.08 - 2.08]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205640_at	58	0.465517	0.0126083	0.191934	0.69814	0.0213397	0.497612	1.64 [1.08 - 2.51]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211004_s_at	58	0.327586	0.00765999	0.131848	0.79398	0.0438308	0.516602	1.68 [1.01 - 2.77]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205640_at	34	0.117647	0.0318625	0.368782	-1.1924	0.158376	-0.364486	0.69 [0.42 - 1.15]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211004_s_at	34	0.176471	0.345973	-	0.505231	0.908087	-0.0387484	0.96 [0.50 - 1.86]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205640_at	158	0.449367	0.0335709	0.381737	0.507812	0.0917345	0.750555	2.12 [0.89 - 5.07]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211004_s_at	158	0.310127	0.000644206	0.0175834	1.03175	0.00401377	1.79742	6.03 [1.77 - 20.53]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211004_s_at	53	0.679245	0.0775976	-	0.641928	0.596098	0.358697	1.43 [0.38 - 5.39]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205640_at	53	0.54717	0.201389	-	0.43696	0.412435	0.21533	1.24 [0.74 - 2.08]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211004_s_at	53	0.660377	0.151188	-	0.496973	0.73458	0.211683	1.24 [0.36 - 4.20]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205640_at	53	0.245283	0.124719	-	0.737295	0.292647	0.289574	1.34 [0.78 - 2.29]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205640_at	180	0.861111	0.0228203	0.293897	0.605932	0.975878	0.00449537	1.00 [0.75 - 1.34]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211004_s_at	180	0.544444	0.0228764	0.294398	0.477517	0.19738	0.349156	1.42 [0.83 - 2.41]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211004_s_at	559	0.135957	0.0288337	0.344948	-0.522592	0.242658	-0.231371	0.79 [0.54 - 1.17]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1565731_at	559	0.187835	0.0225671	0.291624	-0.502807	0.050297	-0.303791	0.74 [0.54 - 1.00]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205640_at	559	0.101968	0.00898817	0.148955	-0.682689	0.0675877	-0.26542	0.77 [0.58 - 1.02]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205640_at	77	0.311688	0.0234505	0.299506	-0.599352	0.324138	-0.159519	0.85 [0.62 - 1.17]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211004_s_at	77	0.61039	0.401776	-	-0.220828	0.781593	-0.111204	0.89 [0.41 - 1.96]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211004_s_at	70	0.871429	0.0139345	0.206587	0.877387	0.54015	0.514423	1.67 [0.32 - 8.67]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1565731_at	70	0.171429	0.0654401	-	-0.605701	0.3072	-1.51136	0.22 [0.01 - 4.01]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205640_at	70	0.814286	0.0091459	0.150932	-1.07739	0.124336	-0.672909	0.51 [0.22 - 1.20]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40685_at	50	0.52	0.238794	-	0.414815	0.273763	0.566907	1.76 [0.64 - 4.87]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205640_at	74	0.689189	0.00132067	0.0321507	0.969827	0.0124539	0.498189	1.65 [1.11 - 2.43]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211004_s_at	74	0.689189	0.0249919	0.312957	0.654841	0.288369	0.602594	1.83 [0.60 - 5.56]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211004_s_at	67	0.41791	0.215454	-	0.961386	0.820173	0.257796	1.29 [0.14 - 11.95]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205640_at	67	0.58209	0.225528	-	0.80008	0.694302	0.262113	1.30 [0.35 - 4.80]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1565731_at	67	0.208955	0.109242	-	-1.13729	0.852977	-0.300535	0.74 [0.03 - 17.78]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1565731_at	115	0.895652	0.0206026	0.273612	1.28426	0.0638301	1.92192	6.83 [0.90 - 52.17]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211004_s_at	115	0.617391	0.132604	-	0.789548	0.286294	1.09463	2.99 [0.40 - 22.35]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205640_at	115	0.208696	0.0251774	0.314551	-1.14535	0.220135	-0.569874	0.57 [0.23 - 1.41]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40685_at	158	0.886076	0.0179463	0.248097	0.854005	0.205539	0.266339	1.31 [0.86 - 1.97]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40685_at	76	0.802632	0.0981359	-	-1.56349	0.281354	-0.322205	0.72 [0.40 - 1.30]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211004_s_at	204	0.112745	0.0494081	0.488061	0.449279	0.490083	0.111086	1.12 [0.82 - 1.53]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205640_at	204	0.264706	0.122503	-	0.238976	0.926137	0.00814507	1.01 [0.85 - 1.20]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1565731_at	204	0.808824	0.0151029	0.219089	0.438511	0.702582	0.0379458	1.04 [0.85 - 1.26]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211004_s_at	87	0.885057	0.0891734	-	-1.5684	0.315588	-0.780635	0.46 [0.10 - 2.10]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1565731_at	87	0.114943	0.21373	-	1.19438	0.354515	0.838748	2.31 [0.39 - 13.66]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205640_at	87	0.218391	0.019308	0.261353	-0.900586	0.556232	-0.265715	0.77 [0.32 - 1.86]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211004_s_at	87	0.885057	0.0891734	-	-1.5684	0.315588	-0.780635	0.46 [0.10 - 2.10]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1565731_at	87	0.114943	0.21373	-	1.19438	0.354515	0.838748	2.31 [0.39 - 13.66]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205640_at	87	0.218391	0.019308	0.261353	-0.900586	0.556232	-0.265715	0.77 [0.32 - 1.86]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211004_s_at	77	0.363636	0.0910147	-	1.22218	0.480032	0.580882	1.79 [0.36 - 8.96]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1565731_at	77	0.376623	0.0143386	0.210953	2.13034	0.126658	1.8733	6.51 [0.59 - 72.03]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205640_at	77	0.155844	0.0986497	-	15.3082	0.446076	0.335674	1.40 [0.59 - 3.32]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1565731_at	77	0.376623	0.0500549	-	1.81145	0.432046	1.20541	3.34 [0.17 - 67.52]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211004_s_at	77	0.12987	0.199252	-	15.2452	0.99982	0.000222546	1.00 [0.15 - 6.89]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205640_at	77	0.155844	0.148607	-	15.3068	0.939272	-0.043724	0.96 [0.31 - 2.95]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211004_s_at	136	0.882353	0.196163	-	0.710682	0.959496	-0.0312258	0.97 [0.29 - 3.23]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205640_at	136	0.764706	0.231764	-	0.554143	0.880901	0.0427578	1.04 [0.60 - 1.83]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205640_at	200	0.13	0.170129	-	0.797935	0.557833	0.117649	1.12 [0.76 - 1.67]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211004_s_at	200	0.495	0.0651722	-	0.563684	0.491865	0.273413	1.31 [0.60 - 2.87]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10702	60	0.216667	0.292398	-	0.55718	0.88633	0.0255647	1.03 [0.72 - 1.46]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10702	60	0.5	0.0126686	0.192611	0.970049	0.1357	0.364984	1.44 [0.89 - 2.33]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16832	155	0.193548	2.85168e-05	0.00114846	-1.13591	0.0029643	-0.41215	0.66 [0.50 - 0.87]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205640_at	286	0.262238	0.0221521	0.287876	0.560353	0.57779	0.0742894	1.08 [0.83 - 1.40]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211004_s_at	286	0.79021	2.15185e-05	0.000892054	-1.43601	2.90605e-05	-1.08333	0.34 [0.20 - 0.56]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205640_at	159	0.836478	0.193715	-	0.487898	0.995848	0.00122694	1.00 [0.63 - 1.59]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211004_s_at	159	0.880503	0.0183409	0.251978	0.866297	0.197105	0.755081	2.13 [0.68 - 6.70]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205640_at	159	0.157233	0.0735806	-	-0.727876	0.362231	-0.24019	0.79 [0.47 - 1.32]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211004_s_at	159	0.861635	0.251485	-	0.449324	0.444949	0.426505	1.53 [0.51 - 4.58]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211004_s_at	159	0.880503	0.265342	-	0.541231	0.732734	0.229967	1.26 [0.34 - 4.71]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205640_at	159	0.515723	0.0524118	-	-0.633008	0.282452	-0.241439	0.79 [0.51 - 1.22]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205640_at	54	0.277778	0.0480118	0.479556	-1.30805	0.773768	0.245784	1.28 [0.24 - 6.83]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211004_s_at	54	0.703704	0.268796	-	-1.11514	0.968659	0.0455583	1.05 [0.11 - 10.16]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205640_at	117	0.82906	0.0969053	-	-0.856254	0.606227	-0.18769	0.83 [0.41 - 1.69]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205640_at	117	0.811966	0.0724263	-	-1.23887	0.436104	-0.354866	0.70 [0.29 - 1.71]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205640_at	117	0.82906	0.0969053	-	-0.856254	0.606227	-0.18769	0.83 [0.41 - 1.69]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205640_at	117	0.811966	0.0348947	0.391549	-1.86371	0.507164	-0.30698	0.74 [0.30 - 1.82]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211004_s_at	117	0.880342	0.208397	-	0.610796	0.904649	-0.0685005	0.93 [0.30 - 2.86]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211004_s_at	117	0.393162	0.341896	-	-0.303088	0.668773	-0.215698	0.81 [0.30 - 2.17]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211004_s_at	117	0.393162	0.341896	-	-0.303088	0.668773	-0.215698	0.81 [0.30 - 2.17]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211004_s_at	117	0.316239	0.138606	-	0.724188	0.652352	0.251326	1.29 [0.43 - 3.84]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211004_s_at	236	0.483051	0.13522	-	0.407891	0.863025	0.0904929	1.09 [0.39 - 3.06]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205640_at	236	0.605932	0.214874	-	0.333004	0.726711	-0.0693081	0.93 [0.63 - 1.38]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205640_at	249	0.590361	0.109986	-	0.337526	0.46279	0.116168	1.12 [0.82 - 1.53]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211004_s_at	249	0.429719	0.164581	-	-0.292593	0.369023	-0.382398	0.68 [0.30 - 1.57]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211004_s_at	125	0.216	0.101085	-	-0.499924	0.677333	-0.209797	0.81 [0.30 - 2.18]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211004_s_at	54	0.148148	0.345376	-	-0.735933	0.604232	-0.165166	0.85 [0.45 - 1.58]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205640_at	62	0.725806	0.0223275	0.289463	-1.41905	0.817156	-0.0427692	0.96 [0.67 - 1.38]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205640_at	125	0.816	0.108447	-	0.647728	0.83023	-0.108747	0.90 [0.33 - 2.42]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211004_s_at	62	0.774194	0.126326	-	-0.962383	0.631691	-0.125647	0.88 [0.53 - 1.47]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205640_at	125	0.104	0.0579045	-	-0.769044	0.616341	-0.201646	0.82 [0.37 - 1.80]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205640_at	54	0.222222	0.0728649	-	15.408	0.971865	-0.00788376	0.99 [0.64 - 1.54]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211004_s_at	125	0.192	0.0891915	-	-0.67836	0.457593	-0.480874	0.62 [0.17 - 2.20]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205640_at	198	0.343434	0.143682	-	-0.377299	0.721398	-0.0370271	0.96 [0.79 - 1.18]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211004_s_at	198	0.262626	0.143041	-	-0.337764	0.6535	-0.112127	0.89 [0.55 - 1.46]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205640_at	198	0.343434	0.106899	-	-0.435287	0.514199	-0.0706044	0.93 [0.75 - 1.15]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211004_s_at	198	0.712121	0.0477336	0.477843	-0.615668	0.80101	-0.0763553	0.93 [0.51 - 1.68]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211004_s_at	198	0.333333	0.0915344	-	-0.461972	0.840071	-0.0631651	0.94 [0.51 - 1.73]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205640_at	198	0.686869	0.079107	-	0.379703	0.431301	0.0668929	1.07 [0.91 - 1.26]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211004_s_at	62	0.354839	0.12508	-	1.12814	0.585097	0.496577	1.64 [0.28 - 9.77]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205640_at	51	0.352941	0.0909695	-	15.7513	0.686308	0.418078	1.52 [0.20 - 11.55]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205640_at	62	0.5	0.234737	-	0.712883	0.959742	0.0382931	1.04 [0.23 - 4.60]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211004_s_at	51	0.627451	0.259704	-	0.988359	0.847441	0.27454	1.32 [0.08 - 21.58]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211004_s_at	145	0.496552	0.132206	-	-0.505084	0.681247	0.278444	1.32 [0.35 - 4.99]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1565731_at	177	0.864407	0.0062686	0.112945	0.84697	0.768354	0.291147	1.34 [0.19 - 9.29]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205640_at	177	0.107345	0.0150244	0.21826	1.57584	0.123876	0.508357	1.66 [0.87 - 3.18]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1565731_at	177	0.220339	0.00615693	0.111378	-0.680906	0.475446	-0.62178	0.54 [0.10 - 2.96]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205640_at	145	0.234483	0.040226	0.429219	1.04233	0.206266	0.598468	1.82 [0.72 - 4.60]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211004_s_at	177	0.124294	0.120802	-	0.8923	0.694905	0.213672	1.24 [0.43 - 3.60]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1565731_at	145	0.882759	0.0910484	-	0.699932	0.714342	0.451306	1.57 [0.14 - 17.60]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205640_at	177	0.107345	0.0220413	0.28687	1.97437	0.0512854	0.745833	2.11 [1.00 - 4.46]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211004_s_at	177	0.502825	0.0901686	-	-0.398552	0.912222	-0.0511703	0.95 [0.38 - 2.36]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205640_at	226	0.10177	0.0558589	-	-0.694856	0.873493	0.0170641	1.02 [0.82 - 1.25]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1565731_at	226	0.190265	0.012359	0.189119	1.38096	0.0773632	0.306456	1.36 [0.97 - 1.91]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211004_s_at	226	0.123894	0.0601966	-	1.27055	0.321283	0.256917	1.29 [0.78 - 2.15]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205640_at	55	0.109091	0.00228403	0.0504908	-1.61395	0.582329	-0.39106	0.68 [0.17 - 2.73]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1565731_at	55	0.836364	0.182102	-	0.679371	0.920773	-0.157832	0.85 [0.04 - 19.15]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205640_at	49	0.102041	0.00613293	0.111041	-1.6745	0.306099	-0.953794	0.39 [0.06 - 2.39]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1565731_at	55	0.4	0.178088	-	0.675403	0.90479	0.213635	1.24 [0.04 - 41.03]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1565731_at	49	0.122449	0.154778	-	-0.922034	0.374163	-1.87101	0.15 [0.00 - 9.54]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211004_s_at	55	0.2	0.00994437	0.160784	-1.12477	0.20138	-1.20677	0.30 [0.05 - 1.91]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211004_s_at	55	0.363636	0.0112487	0.176344	-1.1481	0.196005	-1.37155	0.25 [0.03 - 2.03]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205640_at	55	0.127273	0.000674748	0.0182882	-1.5289	0.191637	-0.913582	0.40 [0.10 - 1.58]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211004_s_at	49	0.367347	0.0715129	-	-1.01506	0.176212	-1.58904	0.20 [0.02 - 2.04]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	307069	34	0.735294	0.131791	-	-0.913766	0.499781	-0.300606	0.74 [0.31 - 1.77]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211004_s_at	63	0.111111	4.34979e-06	0.000209621	-1.82953	0.124325	-0.568524	0.57 [0.27 - 1.17]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1565731_at	63	0.349206	0.00130054	0.0317426	-1.04689	0.336135	-1.34066	0.26 [0.02 - 4.02]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205640_at	63	0.777778	0.397024	-	-0.356712	0.736782	0.064371	1.07 [0.73 - 1.55]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12803456_3p_a_at	28	0.214286	0.0111153	0.174782	15.6654	0.256338	0.275419	1.32 [0.82 - 2.12]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.407070.1.S1_3p_at	28	0.714286	0.211802	-	-0.936575	0.565082	-4.20847	0.01 [0.00 - 25063.92]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502042_3p_at	28	0.607143	0.119362	-	0.851211	0.762401	-0.122006	0.89 [0.40 - 1.95]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	211004_3p_s_at	28	0.821429	0.320022	-	-0.762708	0.6215	-0.27176	0.76 [0.26 - 2.24]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502042_3p_x_at	28	0.428571	0.0622423	-	-1.0032	0.852324	0.225116	1.25 [0.12 - 13.40]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211004_s_at	82	0.158537	0.113626	-	-0.629144	0.429152	-0.354982	0.70 [0.29 - 1.69]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205640_at	82	0.109756	0.00131993	0.0321357	-1.29432	0.31135	-0.230968	0.79 [0.51 - 1.24]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40685_at	84	0.857143	0.283848	-	0.412631	0.472575	0.127413	1.14 [0.80 - 1.61]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211004_s_at	79	0.341772	0.0771219	-	-0.472714	0.878302	0.0642517	1.07 [0.47 - 2.43]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205640_at	79	0.886076	0.0580269	-	0.678501	0.56716	0.0979826	1.10 [0.79 - 1.54]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U10868_at	86	0.895349	0.00351124	0.0714827	1.2909	0.0575441	0.576138	1.78 [0.98 - 3.22]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205640_at	104	0.134615	0.233628	-	-0.498922	0.467369	-0.159214	0.85 [0.56 - 1.31]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211004_s_at	104	0.817308	0.0219397	0.285946	-1.28361	0.1253	-0.743488	0.48 [0.18 - 1.23]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P218688	117	0.136752	4.25578e-05	0.0016425	-1.28579	0.0023261	-0.548362	0.58 [0.41 - 0.82]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211004_s_at	204	0.357843	0.000378655	0.0111664	-1.26353	0.0539137	-0.906858	0.40 [0.16 - 1.02]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211004_s_at	204	0.367647	0.000408921	0.0119288	-0.934869	0.0547404	-0.667605	0.51 [0.26 - 1.01]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205640_at	204	0.583333	0.121783	-	-0.607662	0.553613	-0.17787	0.84 [0.46 - 1.51]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205640_at	204	0.583333	0.0101471	0.163244	-0.76307	0.124851	-0.34445	0.71 [0.46 - 1.10]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1565731_at	204	0.563725	0.000670512	0.0181908	-1.52003	0.0112539	-0.669265	0.51 [0.31 - 0.86]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1565731_at	204	0.593137	3.03065e-05	0.0012128	-1.40848	0.000664652	-0.659897	0.52 [0.35 - 0.76]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211004_s_at	178	0.494382	0.206497	-	-0.24959	0.673293	-0.123667	0.88 [0.50 - 1.57]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205640_at	178	0.123596	0.106773	-	0.586106	0.771642	0.0342129	1.03 [0.82 - 1.30]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211004_s_at	111	0.441441	0.338179	-	0.258311	0.916342	0.0250909	1.03 [0.64 - 1.64]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205640_at	111	0.504505	0.0725312	-	0.475302	0.286574	0.0922481	1.10 [0.93 - 1.30]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1565731_at	111	0.882883	0.0601788	-	-0.942901	0.957259	-0.01159	0.99 [0.65 - 1.51]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211004_s_at	90	0.588889	0.0486506	0.483466	0.635128	0.0847832	0.826119	2.28 [0.89 - 5.84]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211004_s_at	90	0.2	0.036436	0.402735	1.41532	0.0836726	0.934945	2.55 [0.88 - 7.35]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205640_at	90	0.711111	0.0303586	0.357091	0.706167	0.0372214	0.665731	1.95 [1.04 - 3.64]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205640_at	90	0.788889	0.0313081	0.364504	0.820035	0.0341538	0.747626	2.11 [1.06 - 4.22]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4395	50	0.12	0.000801273	0.0211505	-1.64232	0.0360807	-1.75366	0.17 [0.03 - 0.89]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1565731_at	138	0.898551	0.0181267	0.249875	0.768607	0.173771	1.99686	7.37 [0.41 - 130.88]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211004_s_at	138	0.637681	0.127307	-	0.369529	0.657131	0.0594379	1.06 [0.82 - 1.38]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205640_at	138	0.108696	0.0108439	0.171582	-0.791562	0.824102	0.0188792	1.02 [0.86 - 1.20]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205640_at	129	0.868217	0.0201043	0.268932	0.730797	0.238568	0.171124	1.19 [0.89 - 1.58]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211004_s_at	129	0.193798	0.0153324	0.221503	0.889792	0.0113991	0.842296	2.32 [1.21 - 4.46]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3882	56	0.107143	0.0731248	-	-0.802961	0.99887	0.000451655	1.00 [0.54 - 1.87]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11470	56	0.232143	0.102281	-	0.684112	0.43578	0.1655	1.18 [0.78 - 1.79]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5655	56	0.285714	0.0189035	0.257455	1.0175	0.42163	0.428041	1.53 [0.54 - 4.36]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11470	56	0.107143	0.232338	-	-0.581213	0.758291	0.0670897	1.07 [0.70 - 1.64]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3882	56	0.107143	0.0673376	-	-0.812278	0.624036	0.1517	1.16 [0.63 - 2.13]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5655	56	0.285714	0.0245529	0.309165	1.05232	0.439942	0.435472	1.55 [0.51 - 4.67]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1565731_at	278	0.395683	0.249894	-	0.226998	0.93416	0.0409154	1.04 [0.39 - 2.75]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211004_s_at	278	0.233813	0.00691724	0.121895	-0.566462	0.0175914	-0.543484	0.58 [0.37 - 0.91]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205640_at	278	0.100719	0.00549497	0.10192	-0.762864	0.0797524	-0.233292	0.79 [0.61 - 1.03]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205640_at	133	0.609023	0.00832387	0.140503	0.616328	0.51429	0.0595764	1.06 [0.89 - 1.27]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211004_s_at	133	0.466165	0.00115014	0.0286511	0.79415	0.0705728	0.266012	1.30 [0.98 - 1.74]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7121	81	0.851852	0.0778264	-	0.993765	0.723339	0.113391	1.12 [0.60 - 2.10]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205640_at	185	0.691892	0.00341734	0.0699466	-0.584349	0.0896541	-0.344274	0.71 [0.48 - 1.05]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211004_s_at	185	0.313514	0.00625503	0.112755	-0.464408	0.360855	-0.191973	0.83 [0.55 - 1.25]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205640_at	185	0.691892	0.0133333	0.200008	-0.443866	0.118313	-0.288202	0.75 [0.52 - 1.08]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211004_s_at	185	0.313514	0.00577244	0.105921	-0.502012	0.379584	-0.203046	0.82 [0.52 - 1.28]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P225263	110	0.127273	0.123219	-	-0.609131	0.409353	-0.161906	0.85 [0.58 - 1.25]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P218688	110	0.872727	0.0414453	0.437449	-0.841888	0.590408	-0.076593	0.93 [0.70 - 1.22]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P225263	110	0.190909	0.00368033	0.0742235	-0.766102	0.0197886	-0.3588	0.70 [0.52 - 0.94]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P218688	110	0.790909	0.211521	-	-0.542954	0.898263	-0.0254341	0.97 [0.66 - 1.44]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205640_at	80	0.175	0.00551793	0.102253	-1.23726	0.0792508	-0.376716	0.69 [0.45 - 1.04]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211004_s_at	80	0.2875	0.0440101	0.454326	1.38713	0.120627	0.742386	2.10 [0.82 - 5.36]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_5600	281	0.747331	0.155785	-	0.223659	0.606069	0.0365256	1.04 [0.90 - 1.19]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205640_at	38	0.815789	0.124381	-	-1.44736	0.937514	0.0266726	1.03 [0.53 - 2.00]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1565731_at	38	0.184211	0.0114248	0.178397	-1.23192	0.433204	-0.509385	0.60 [0.17 - 2.15]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211004_s_at	38	0.605263	0.184944	-	-0.663092	0.781265	-0.274469	0.76 [0.11 - 5.27]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211004_s_at	140	0.785714	0.106912	-	-0.649206	0.607556	-0.316764	0.73 [0.22 - 2.44]
GENE	ALDH3B1	aldehyde dehydrogenase 3 family, member B1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205640_at	140	0.114286	0.132099	-	-0.577726	0.908938	-0.0605809	0.94 [0.33 - 2.66]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204941_s_at	30	0.866667	0.0726666	-	1.00255	0.205619	0.504575	1.66 [0.76 - 3.62]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204942_s_at	30	0.6	0.163773	-	-0.5769	0.375693	-0.16207	0.85 [0.59 - 1.22]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1763666	165	0.890909	0.000123204	0.00420777	1.10799	0.027131	0.200652	1.22 [1.02 - 1.46]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1763666	165	0.854545	0.000251213	0.00783535	1.27959	0.00992648	0.343486	1.41 [1.09 - 1.83]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204941_s_at	163	0.190184	0.0070035	0.123066	-0.621204	0.0168793	-1.90105	0.15 [0.03 - 0.71]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204942_s_at	163	0.104294	0.142209	-	-0.434044	0.594366	-0.356896	0.70 [0.19 - 2.60]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204941_s_at	79	0.177215	0.0001725	0.00564969	-1.18726	0.00988376	-2.01671	0.13 [0.03 - 0.62]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204942_s_at	79	0.240506	0.0968214	-	0.668155	0.409437	0.779461	2.18 [0.34 - 13.90]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204942_s_at	58	0.137931	0.0731017	-	-0.690868	0.576785	-0.0992827	0.91 [0.64 - 1.28]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204941_s_at	58	0.689655	0.115252	-	0.482326	0.731298	0.0540742	1.06 [0.78 - 1.44]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204942_s_at	34	0.823529	0.0262732	0.323861	-1.3009	0.987427	-0.00555678	0.99 [0.50 - 1.98]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204941_s_at	34	0.676471	0.00322882	0.0668313	-1.38488	0.0592587	-0.756818	0.47 [0.21 - 1.03]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204942_s_at	158	0.898734	0.178949	-	0.504289	0.972156	0.0241522	1.02 [0.26 - 3.98]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204941_s_at	158	0.170886	0.0114315	0.178475	-0.675453	0.0741252	-1.58293	0.21 [0.04 - 1.17]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204941_s_at	53	0.735849	0.192546	-	0.514412	0.858081	0.0457696	1.05 [0.63 - 1.73]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204942_s_at	53	0.849057	0.0862544	-	0.772995	0.635891	0.133558	1.14 [0.66 - 1.99]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204941_s_at	53	0.433962	0.363956	-	-0.312149	0.589601	-0.135685	0.87 [0.53 - 1.43]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204942_s_at	53	0.698113	0.327361	-	-0.394733	0.989587	-0.00327573	1.00 [0.61 - 1.63]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204941_s_at	180	0.405556	0.110771	-	0.342406	0.29554	0.131636	1.14 [0.89 - 1.46]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204942_s_at	180	0.583333	8.87158e-05	0.00315142	0.816513	0.0464614	0.256301	1.29 [1.00 - 1.66]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204941_s_at	559	0.711986	0.00716352	0.125229	-0.661795	0.0943486	-0.150856	0.86 [0.72 - 1.03]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204942_s_at	559	0.422182	0.147143	-	-0.289736	0.374984	-0.145106	0.86 [0.63 - 1.19]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204942_s_at	77	0.896104	0.116193	-	-0.721804	0.47268	-0.19872	0.82 [0.48 - 1.41]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204941_s_at	77	0.519481	0.0409058	0.433824	-0.527615	0.733489	-0.0594758	0.94 [0.67 - 1.33]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204941_s_at	70	0.114286	0.069598	-	-0.685854	0.798919	0.214613	1.24 [0.24 - 6.46]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204942_s_at	70	0.5	0.401984	-	0.220444	0.88417	-0.187375	0.83 [0.07 - 10.31]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204941_s_at	74	0.891892	0.0676061	-	0.740601	0.965894	0.0115449	1.01 [0.60 - 1.72]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204942_s_at	74	0.108108	0.105898	-	-0.70351	0.572059	-0.195659	0.82 [0.42 - 1.62]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204941_s_at	67	0.373134	0.207168	-	1.26794	0.540411	1.46096	4.31 [0.04 - 463.31]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204942_s_at	67	0.597015	0.200575	-	0.840461	0.851483	-0.470594	0.62 [0.00 - 86.13]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204941_s_at	115	0.269565	0.0177508	0.246162	15.552	0.287988	0.216839	1.24 [0.83 - 1.85]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204942_s_at	115	0.382609	0.0470764	0.473773	1.39795	0.57295	0.125201	1.13 [0.73 - 1.75]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204942_s_at	204	0.598039	0.0820064	-	0.255758	0.594337	0.0279057	1.03 [0.93 - 1.14]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204941_s_at	204	0.166667	0.262597	-	0.209658	0.959799	0.00176762	1.00 [0.94 - 1.07]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204941_s_at	87	0.850575	0.0673319	-	0.828569	0.241249	0.30106	1.35 [0.82 - 2.24]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204941_s_at	87	0.850575	0.0673319	-	0.828569	0.241249	0.30106	1.35 [0.82 - 2.24]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204942_s_at	87	0.632184	0.0416545	0.438847	0.753368	0.29111	0.122775	1.13 [0.90 - 1.42]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204942_s_at	87	0.632184	0.0416545	0.438847	0.753368	0.29111	0.122775	1.13 [0.90 - 1.42]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204942_s_at	77	0.168831	0.147996	-	15.3064	0.902088	-0.0202126	0.98 [0.71 - 1.35]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204942_s_at	77	0.415584	0.121891	-	-0.855957	0.476128	-0.101562	0.90 [0.68 - 1.19]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204941_s_at	77	0.376623	0.139223	-	-0.921991	0.455001	-0.186271	0.83 [0.51 - 1.35]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204941_s_at	77	0.376623	0.057125	-	-1.03816	0.411815	-0.177387	0.84 [0.55 - 1.28]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204941_s_at	136	0.661765	0.156835	-	-0.772579	0.773986	-0.0499715	0.95 [0.68 - 1.34]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204942_s_at	136	0.257353	0.266751	-	0.683224	0.879396	0.0356053	1.04 [0.65 - 1.64]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204941_s_at	200	0.78	0.0383413	0.416225	-0.946361	0.262064	-0.113108	0.89 [0.73 - 1.09]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204942_s_at	200	0.83	0.025616	0.318299	-1.25258	0.260259	-0.137902	0.87 [0.69 - 1.11]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12479	60	0.2	0.00884502	0.14715	2.19836	0.0740515	0.235184	1.27 [0.98 - 1.64]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12479	60	0.866667	0.0146455	0.214238	1.07527	0.217279	0.168325	1.18 [0.91 - 1.55]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	17884	155	0.180645	0.00365194	0.0737655	-0.845328	0.300743	-0.0983596	0.91 [0.75 - 1.09]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204941_s_at	286	0.129371	0.00693184	0.122093	-0.64776	0.0458626	-0.214088	0.81 [0.65 - 1.00]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204942_s_at	286	0.206294	0.0398469	0.426633	-0.44904	0.316984	-0.0969686	0.91 [0.75 - 1.10]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204942_s_at	159	0.874214	0.000181065	0.00589373	1.39239	0.0186898	0.390195	1.48 [1.07 - 2.05]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204941_s_at	159	0.792453	0.0023912	0.0524132	0.957974	0.0155485	0.245149	1.28 [1.05 - 1.56]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204941_s_at	159	0.761006	0.00119611	0.0296041	0.998354	0.0376904	0.205591	1.23 [1.01 - 1.49]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204942_s_at	159	0.874214	0.000244389	0.00765045	1.22497	0.0496115	0.281553	1.33 [1.00 - 1.76]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204941_s_at	159	0.792453	0.000347464	0.0103703	1.25552	0.0182673	0.282589	1.33 [1.05 - 1.68]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204942_s_at	159	0.874214	0.00402652	0.0797397	1.01018	0.0640269	0.264843	1.30 [0.98 - 1.72]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204941_s_at	54	0.777778	0.0830356	-	-15.5272	0.398007	-0.634101	0.53 [0.12 - 2.31]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204942_s_at	54	0.796296	0.120733	-	-15.4283	0.554402	-0.117973	0.89 [0.60 - 1.31]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204941_s_at	117	0.102564	0.144932	-	-0.638811	0.247114	-0.360788	0.70 [0.38 - 1.28]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204941_s_at	117	0.102564	0.0246304	0.309836	-0.99399	0.48614	-0.22944	0.79 [0.42 - 1.52]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204942_s_at	117	0.547009	0.236233	-	0.373619	0.942212	-0.00635771	0.99 [0.84 - 1.18]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204941_s_at	117	0.102564	0.0330765	0.378022	-1.01957	0.505962	-0.228294	0.80 [0.41 - 1.56]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204942_s_at	117	0.589744	0.0901266	-	0.632709	0.676368	0.0432076	1.04 [0.85 - 1.28]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204941_s_at	117	0.102564	0.144932	-	-0.638811	0.247114	-0.360788	0.70 [0.38 - 1.28]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204942_s_at	117	0.811966	0.262406	-	0.490033	0.921219	0.0107031	1.01 [0.82 - 1.25]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204942_s_at	117	0.547009	0.236233	-	0.373619	0.942212	-0.00635771	0.99 [0.84 - 1.18]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204941_s_at	236	0.597458	0.0151316	0.219392	0.644321	0.103121	0.152465	1.16 [0.97 - 1.40]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204942_s_at	236	0.317797	0.0352169	0.393909	0.675379	0.559075	0.0845075	1.09 [0.82 - 1.44]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204942_s_at	249	0.803213	0.0325946	0.374375	0.52096	0.515834	0.0737615	1.08 [0.86 - 1.34]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204941_s_at	249	0.646586	0.0126345	0.192228	0.527777	0.237638	0.0867833	1.09 [0.94 - 1.26]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204941_s_at	125	0.872	0.100167	-	0.712085	0.502808	0.124908	1.13 [0.79 - 1.63]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204942_s_at	62	0.435484	0.0631059	-	-0.900065	0.225284	-0.226994	0.80 [0.55 - 1.15]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204941_s_at	125	0.136	0.174914	-	0.79297	0.967983	0.00603295	1.01 [0.75 - 1.35]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204942_s_at	125	0.12	0.252818	-	-0.560793	0.96987	-0.00532533	0.99 [0.75 - 1.31]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204942_s_at	125	0.232	0.397909	-	0.328434	0.831701	0.0231523	1.02 [0.83 - 1.27]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204941_s_at	54	0.87037	0.196005	-	-15.2364	0.613247	-0.269555	0.76 [0.27 - 2.17]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204942_s_at	54	0.685185	0.0327746	0.37574	-1.95538	0.271591	-0.250831	0.78 [0.50 - 1.22]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204941_s_at	62	0.209677	0.248049	-	-0.606919	0.612966	-0.20785	0.81 [0.36 - 1.82]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204942_s_at	198	0.833333	0.000293817	0.00897328	0.971766	0.00643258	0.201315	1.22 [1.06 - 1.41]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204941_s_at	198	0.808081	8.21639e-05	0.002945	1.04361	0.00335026	0.193217	1.21 [1.07 - 1.38]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204942_s_at	198	0.833333	5.22967e-05	0.00197324	1.0962	0.00243466	0.233709	1.26 [1.09 - 1.47]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204941_s_at	198	0.808081	0.000105548	0.00367283	1.00037	0.00447691	0.176751	1.19 [1.06 - 1.35]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204941_s_at	198	0.808081	0.00774555	0.132976	0.619529	0.0423878	0.0989172	1.10 [1.00 - 1.21]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204942_s_at	198	0.833333	0.0192348	0.26065	0.577427	0.0854458	0.103673	1.11 [0.99 - 1.25]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204941_s_at	62	0.741935	0.078367	-	0.992441	0.285031	2.05125	7.78 [0.18 - 334.25]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204941_s_at	51	0.764706	0.0425868	0.445031	1.65779	0.0973979	4.42958	83.90 [0.45 - 15791.84]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204942_s_at	51	0.45098	0.0985962	-	-1.65275	0.405573	-1.42079	0.24 [0.01 - 6.87]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204942_s_at	62	0.467742	0.0432416	0.449329	-1.26358	0.671194	-0.42475	0.65 [0.09 - 4.65]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204942_s_at	177	0.548023	0.00219098	0.0488052	-0.758043	0.0209508	-0.949915	0.39 [0.17 - 0.87]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204942_s_at	145	0.241379	0.0454921	0.463821	1.0176	0.682291	0.18265	1.20 [0.50 - 2.88]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204941_s_at	177	0.169492	0.00098552	0.0251752	-0.980038	0.117304	-1.24514	0.29 [0.06 - 1.37]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204941_s_at	177	0.118644	0.0219938	0.286438	-0.716539	0.247565	-0.775176	0.46 [0.12 - 1.71]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204941_s_at	145	0.131034	0.0568693	-	-0.783937	0.886156	-0.135687	0.87 [0.14 - 5.59]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204942_s_at	177	0.525424	0.013001	0.196327	-0.695726	0.0965156	-0.757132	0.47 [0.19 - 1.15]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204942_s_at	226	0.243363	0.00448091	0.0868006	-0.801901	0.248327	-0.162646	0.85 [0.64 - 1.12]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204941_s_at	226	0.123894	0.0524914	-	1.30637	0.324456	0.0934329	1.10 [0.91 - 1.32]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204942_s_at	55	0.872727	0.0706237	-	-15.2677	0.576627	-0.515611	0.60 [0.10 - 3.65]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204942_s_at	49	0.714286	0.104946	-	0.924323	0.531293	-0.761289	0.47 [0.04 - 5.06]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204941_s_at	55	0.890909	0.0831715	-	0.943704	0.256201	0.689154	1.99 [0.61 - 6.55]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204941_s_at	49	0.142857	0.140555	-	15.2725	0.806054	0.246517	1.28 [0.18 - 9.16]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204941_s_at	55	0.145455	0.0280543	0.338624	15.4385	0.606999	0.376469	1.46 [0.35 - 6.12]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204942_s_at	55	0.436364	0.0844842	-	-0.768955	0.679458	-0.340902	0.71 [0.14 - 3.58]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204942_s_at	63	0.206349	0.000179405	0.00584655	-1.28554	0.352288	-3.70032	0.02 [0.00 - 60.15]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204941_s_at	63	0.222222	0.00151592	0.0360481	-1.07735	0.151462	-12.4104	0.00 [0.00 - 94.41]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.87539.0.S1_3p_s_at	28	0.107143	0.0598975	-	-1.22538	0.599727	-0.761424	0.47 [0.03 - 8.02]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4580414_3p_a_at	28	0.571429	0.0546801	-	1.05858	0.695672	0.0698014	1.07 [0.76 - 1.52]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204942_s_at	82	0.548781	0.0091302	0.150736	0.886707	0.04972	0.433518	1.54 [1.00 - 2.38]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204941_s_at	79	0.620253	0.0702923	-	0.473923	0.296812	0.127974	1.14 [0.89 - 1.45]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204942_s_at	79	0.278481	0.0028593	0.0605941	0.950665	0.0293005	0.433324	1.54 [1.04 - 2.28]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204942_s_at	104	0.894231	0.11036	-	0.759122	0.735417	0.111613	1.12 [0.59 - 2.14]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P24311	117	0.529915	0.168207	-	0.392474	0.765325	0.0754574	1.08 [0.66 - 1.77]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204941_s_at	204	0.862745	1.03884e-05	0.000462478	1.50017	0.000337826	0.691444	2.00 [1.37 - 2.91]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204942_s_at	204	0.843137	0.000333956	0.0100219	1.27491	0.000286727	0.658838	1.93 [1.35 - 2.76]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204942_s_at	204	0.833333	9.63573e-08	6.20181e-06	1.39447	7.48576e-07	0.674268	1.96 [1.50 - 2.56]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204941_s_at	204	0.862745	0.00010565	0.00367595	1.1212	0.0110308	0.384094	1.47 [1.09 - 1.97]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204942_s_at	178	0.865169	0.00883138	0.146978	0.687554	0.0779478	0.228992	1.26 [0.97 - 1.62]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204942_s_at	111	0.891892	0.148753	-	0.543587	0.256073	0.152215	1.16 [0.90 - 1.51]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204941_s_at	111	0.882883	0.00352745	0.0717468	0.953252	0.634713	0.0556592	1.06 [0.84 - 1.33]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204941_s_at	90	0.411111	0.163685	-	0.481547	0.850591	0.075146	1.08 [0.49 - 2.36]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204942_s_at	90	0.866667	0.0659253	-	0.719052	0.979823	-0.00523553	0.99 [0.66 - 1.49]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204942_s_at	90	0.677778	0.214271	-	-0.533091	0.668505	-0.104211	0.90 [0.56 - 1.45]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204941_s_at	90	0.411111	0.0958611	-	0.678978	0.713787	0.161716	1.18 [0.50 - 2.79]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1937	50	0.12	0.0886338	-	15.255	0.314002	0.412114	1.51 [0.68 - 3.37]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204941_s_at	138	0.231884	0.286173	-	0.317909	0.821917	-0.0333276	0.97 [0.72 - 1.29]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204942_s_at	138	0.898551	0.0933828	-	0.592069	0.939001	-0.00493516	1.00 [0.88 - 1.13]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204941_s_at	129	0.736434	0.0276224	0.335085	0.556826	0.12558	0.124807	1.13 [0.97 - 1.33]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204942_s_at	129	0.589147	0.0285045	0.342287	0.535345	0.290591	0.170072	1.19 [0.86 - 1.62]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18208	56	0.142857	0.100595	-	0.889553	0.833307	0.051021	1.05 [0.65 - 1.69]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27351	56	0.178571	0.0013179	0.0320946	2.61867	0.177277	0.470453	1.60 [0.81 - 3.17]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18208	56	0.160714	0.0393164	0.42299	1.22821	0.382912	0.218185	1.24 [0.76 - 2.03]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27351	56	0.178571	0.00589709	0.107701	1.57733	0.516372	0.208648	1.23 [0.66 - 2.31]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204942_s_at	278	0.546763	0.0331604	0.378655	-0.413351	0.122108	-0.120459	0.89 [0.76 - 1.03]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204941_s_at	278	0.104317	0.00720218	0.125749	-0.689224	0.0607788	-0.26044	0.77 [0.59 - 1.01]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204942_s_at	133	0.218045	0.0360034	0.399621	0.674004	0.30953	0.0725402	1.08 [0.93 - 1.24]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204941_s_at	133	0.488722	0.00771498	0.132574	0.638164	0.266124	0.136793	1.15 [0.90 - 1.46]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204942_s_at	185	0.47027	0.00312346	0.0650711	-0.521636	0.143806	-0.202881	0.82 [0.62 - 1.07]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204941_s_at	185	0.118919	0.0110936	0.174526	0.643768	0.936459	0.023005	1.02 [0.58 - 1.80]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204941_s_at	185	0.681081	0.0589454	-	-0.387394	0.580944	-0.187287	0.83 [0.43 - 1.61]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204942_s_at	185	0.491892	0.0146991	0.214809	-0.398531	0.195554	-0.163166	0.85 [0.66 - 1.09]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P24311	110	0.345455	0.0649899	-	-0.433614	0.595891	-0.0610926	0.94 [0.75 - 1.18]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P24311	110	0.345455	0.0298695	0.353228	-0.635727	0.393212	-0.125871	0.88 [0.66 - 1.18]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204941_s_at	80	0.875	0.0826889	-	-15.2385	0.713304	-0.04596	0.96 [0.75 - 1.22]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204942_s_at	80	0.1625	0.0145266	0.212968	-1.14094	0.252492	-0.259219	0.77 [0.49 - 1.20]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_5371	281	0.359431	0.00532314	0.0994149	-0.397956	0.171602	-0.0891437	0.91 [0.80 - 1.04]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204942_s_at	38	0.236842	0.00612706	0.110958	2.33114	0.156812	0.171357	1.19 [0.94 - 1.50]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204941_s_at	38	0.289474	0.155003	-	0.866252	0.379735	0.217085	1.24 [0.77 - 2.02]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204942_s_at	140	0.785714	0.00342465	0.0700666	-1.58253	0.0684388	-2.23829	0.11 [0.01 - 1.18]
GENE	ALDH3B2	aldehyde dehydrogenase 3 family, member B2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204941_s_at	140	0.285714	0.0502254	-	0.781991	0.219796	1.65282	5.22 [0.37 - 73.18]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211552_s_at	30	0.633333	0.171364	-	-0.574604	0.759867	-0.185368	0.83 [0.25 - 2.73]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203722_at	30	0.866667	0.344851	-	-0.579961	0.953977	0.0156081	1.02 [0.60 - 1.73]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1656368	165	0.678788	0.000996074	0.0254013	-0.954037	0.0651643	-0.199735	0.82 [0.66 - 1.01]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1656368	165	0.606061	0.000308209	0.00935172	-1.71713	0.00527749	-0.427472	0.65 [0.48 - 0.88]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203722_at	163	0.453988	0.0388932	0.420065	-0.405247	0.519137	-0.196611	0.82 [0.45 - 1.49]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211552_s_at	163	0.895706	0.054791	-	-0.787826	0.0811337	-0.83501	0.43 [0.17 - 1.11]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211552_s_at	79	0.113924	0.11998	-	-0.628084	0.632417	-0.247243	0.78 [0.28 - 2.15]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203722_at	79	0.696203	0.00854102	0.143288	0.778546	0.164921	0.474499	1.61 [0.82 - 3.14]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203722_at	58	0.396552	0.0103269	0.165413	0.741306	0.0389977	0.40103	1.49 [1.02 - 2.19]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211552_s_at	58	0.844828	0.0841993	-	-0.674071	0.784138	-0.0394869	0.96 [0.72 - 1.28]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203722_at	34	0.882353	0.147155	-	-1.07625	0.46292	-0.177199	0.84 [0.52 - 1.34]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211552_s_at	34	0.117647	0.00598851	0.109	-1.45104	0.443854	-0.222578	0.80 [0.45 - 1.42]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211552_s_at	158	0.734177	0.0158162	0.226547	0.585998	0.343157	0.588728	1.80 [0.53 - 6.09]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203722_at	158	0.120253	0.0683861	-	0.821057	0.690817	0.25678	1.29 [0.36 - 4.58]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211552_s_at	53	0.811321	0.209753	-	0.503698	0.983853	-0.00745701	0.99 [0.48 - 2.04]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203722_at	53	0.320755	0.0273264	0.332645	-0.797957	0.232668	-0.414581	0.66 [0.33 - 1.31]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211552_s_at	53	0.584906	0.180799	-	0.484575	0.690444	-0.156728	0.85 [0.40 - 1.85]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203722_at	53	0.320755	0.0749473	-	-0.624427	0.55769	-0.187633	0.83 [0.44 - 1.55]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211552_s_at	180	0.377778	0.125223	-	-0.325034	0.516135	-0.112053	0.89 [0.64 - 1.25]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203722_at	180	0.372222	0.0194031	0.262265	-0.486536	0.0772939	-0.180955	0.83 [0.68 - 1.02]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211552_s_at	559	0.384615	0.0968682	-	0.357529	0.712446	0.0666984	1.07 [0.75 - 1.52]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203722_at	559	0.699463	0.16338	-	-0.309841	0.575244	0.080846	1.08 [0.82 - 1.44]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203722_at	77	0.12987	0.000509377	0.0143968	-1.23954	0.034443	-0.317331	0.73 [0.54 - 0.98]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211552_s_at	77	0.402597	0.00331911	0.0683288	-0.77799	0.11157	-0.434377	0.65 [0.38 - 1.11]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203722_at	70	0.542857	0.0435495	0.451337	0.529037	0.0613383	0.507441	1.66 [0.98 - 2.83]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211552_s_at	70	0.142857	0.00703591	0.123505	1.31039	0.0429079	1.15551	3.18 [1.04 - 9.72]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37331_g_at	50	0.26	0.0193633	0.261883	1.187	0.454512	0.0931575	1.10 [0.86 - 1.40]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37332_r_at	50	0.26	1.31421e-07	8.28485e-06	-1.99041	0.0583839	-0.430553	0.65 [0.42 - 1.02]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37330_at	50	0.82	0.14386	-	-0.763085	0.265986	-0.260203	0.77 [0.49 - 1.22]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211552_s_at	74	0.337838	0.0305402	0.358517	-0.622143	0.210866	-0.368009	0.69 [0.39 - 1.23]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203722_at	74	0.297297	0.0329015	0.376701	-0.639534	0.481678	-0.117634	0.89 [0.64 - 1.23]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211552_s_at	67	0.761194	0.0718421	-	-15.5098	0.43439	-0.988078	0.37 [0.03 - 4.43]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203722_at	67	0.462687	0.0379258	0.413314	-1.51774	0.107586	-1.87812	0.15 [0.02 - 1.51]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203722_at	115	0.756522	0.0747766	-	0.928595	0.380718	0.31649	1.37 [0.68 - 2.78]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211552_s_at	115	0.730435	0.43115	-	0.435643	0.813738	0.11026	1.12 [0.45 - 2.79]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37332_r_at	158	0.892405	0.0991095	-	-0.951873	0.808297	-0.066459	0.94 [0.55 - 1.60]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37330_at	158	0.689873	0.0619717	-	0.533189	0.351735	0.263348	1.30 [0.75 - 2.27]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37331_g_at	158	0.588608	0.0703864	-	0.50875	0.412039	0.267685	1.31 [0.69 - 2.48]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37332_r_at	76	0.736842	0.205268	-	-0.928706	0.77837	-0.143549	0.87 [0.32 - 2.35]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37330_at	76	0.25	0.169577	-	1.00436	0.56671	0.332906	1.40 [0.45 - 4.36]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37331_g_at	76	0.171053	0.181969	-	1.29865	0.55635	0.277572	1.32 [0.52 - 3.33]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211552_s_at	204	0.593137	0.00882217	0.146861	-0.377693	0.230985	-0.106489	0.90 [0.76 - 1.07]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203722_at	204	0.367647	0.128852	-	-0.22059	0.792807	-0.023924	0.98 [0.82 - 1.17]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203722_at	87	0.206897	0.23401	-	0.712631	0.800051	0.0673195	1.07 [0.64 - 1.80]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211552_s_at	87	0.114943	0.147026	-	1.36813	0.590495	0.322186	1.38 [0.43 - 4.46]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203722_at	87	0.206897	0.23401	-	0.712631	0.800051	0.0673195	1.07 [0.64 - 1.80]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211552_s_at	87	0.114943	0.147026	-	1.36813	0.590495	0.322186	1.38 [0.43 - 4.46]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211552_s_at	77	0.766234	0.0736355	-	-15.4513	0.185181	-1.33391	0.26 [0.04 - 1.90]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203722_at	77	0.324675	0.0084877	0.142606	-1.63042	0.170751	-0.843518	0.43 [0.13 - 1.44]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211552_s_at	77	0.766234	0.0405973	0.43174	-15.4553	0.238371	-0.970526	0.38 [0.08 - 1.90]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203722_at	77	0.623377	0.0631745	-	-1.32928	0.21269	-0.63919	0.53 [0.19 - 1.44]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203722_at	136	0.191176	0.260242	-	0.816616	0.814054	0.0584767	1.06 [0.65 - 1.73]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211552_s_at	136	0.867647	0.0480547	0.479819	0.988588	0.598462	0.146848	1.16 [0.67 - 2.00]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211552_s_at	200	0.485	0.00190464	0.043515	-0.944044	0.101027	-0.500311	0.61 [0.33 - 1.10]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203722_at	200	0.115	0.0558923	-	-0.696611	0.486054	-0.145867	0.86 [0.57 - 1.30]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5804	60	0.833333	0.0101237	0.162961	1.03933	0.172664	0.402163	1.50 [0.84 - 2.66]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5804	60	0.816667	0.0108833	0.172048	1.03217	0.280338	0.267192	1.31 [0.80 - 2.12]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	17314	155	0.109677	0.0352492	0.394144	-0.738519	0.352703	-0.278976	0.76 [0.42 - 1.36]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211552_s_at	286	0.111888	0.0259809	0.321395	-0.582069	0.404188	-0.125465	0.88 [0.66 - 1.18]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203722_at	286	0.258741	0.023977	0.304143	0.563701	0.554474	0.0688289	1.07 [0.85 - 1.35]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211552_s_at	159	0.477987	0.025629	0.31841	-0.714233	0.334688	-0.33663	0.71 [0.36 - 1.42]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203722_at	159	0.874214	0.0667969	-	0.710921	0.503452	0.134099	1.14 [0.77 - 1.69]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211552_s_at	159	0.880503	0.0341022	0.385698	0.890976	0.691705	-0.171268	0.84 [0.36 - 1.96]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203722_at	159	0.383648	0.0905908	-	-0.528689	0.386986	-0.168879	0.84 [0.58 - 1.24]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211552_s_at	159	0.383648	0.0589132	-	-0.588963	0.445	-0.27062	0.76 [0.38 - 1.53]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203722_at	159	0.855346	0.0821964	-	0.738156	0.84214	0.0465686	1.05 [0.66 - 1.66]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211552_s_at	54	0.87037	0.0397694	0.426102	1.53416	0.209494	1.13776	3.12 [0.53 - 18.44]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203722_at	54	0.759259	0.00843003	0.141867	1.67086	0.0122454	1.31669	3.73 [1.33 - 10.45]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203722_at	117	0.367521	0.0541664	-	0.870254	0.272732	0.272158	1.31 [0.81 - 2.14]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203722_at	117	0.880342	0.0456201	0.464632	0.773535	0.209851	0.25105	1.29 [0.87 - 1.90]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211552_s_at	117	0.752137	0.0810102	-	0.582226	0.823157	0.0724206	1.08 [0.57 - 2.03]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211552_s_at	117	0.752137	0.0208016	0.275468	0.868849	0.366515	0.324414	1.38 [0.68 - 2.80]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211552_s_at	117	0.752137	0.0810102	-	0.582226	0.823157	0.0724206	1.08 [0.57 - 2.03]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211552_s_at	117	0.752137	0.00386341	0.0771562	1.10918	0.216544	0.439943	1.55 [0.77 - 3.12]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203722_at	117	0.880342	0.0456201	0.464632	0.773535	0.209851	0.25105	1.29 [0.87 - 1.90]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203722_at	117	0.435897	0.05277	-	0.790304	0.227945	0.287134	1.33 [0.84 - 2.13]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203722_at	236	0.597458	0.0039797	0.0790009	0.761981	0.073131	0.326506	1.39 [0.97 - 1.98]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211552_s_at	236	0.75	0.328015	-	-0.328657	0.778742	0.082155	1.09 [0.61 - 1.93]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203722_at	249	0.554217	0.00399203	0.0791956	0.606295	0.0875813	0.237314	1.27 [0.97 - 1.66]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211552_s_at	249	0.176707	0.116098	-	-0.396865	0.54735	-0.130867	0.88 [0.57 - 1.34]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203722_at	62	0.854839	0.00761198	0.131214	1.26981	0.840521	-0.0503159	0.95 [0.58 - 1.55]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203722_at	125	0.136	0.101169	-	-0.741448	0.554995	-0.22783	0.80 [0.37 - 1.70]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211552_s_at	62	0.870968	0.107862	-	0.845315	0.761022	-0.0631926	0.94 [0.62 - 1.41]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203722_at	125	0.136	0.07566	-	-0.623321	0.849309	0.0541251	1.06 [0.60 - 1.84]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203722_at	54	0.259259	0.0183704	0.252267	-1.39308	0.91828	-0.0314175	0.97 [0.53 - 1.77]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211552_s_at	125	0.232	0.0820483	-	1.20563	0.767049	0.108815	1.11 [0.54 - 2.29]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211552_s_at	125	0.376	0.109869	-	-0.488609	0.865175	-0.0489074	0.95 [0.54 - 1.67]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211552_s_at	54	0.481481	0.223281	-	0.801428	0.768018	-0.0746885	0.93 [0.56 - 1.52]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203722_at	198	0.752525	0.00011716	0.00402593	1.00919	0.00180017	0.353977	1.42 [1.14 - 1.78]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211552_s_at	198	0.833333	0.0127505	0.19353	0.697355	0.0501765	0.274202	1.32 [1.00 - 1.73]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211552_s_at	198	0.818182	0.00488798	0.0929695	0.785223	0.0761726	0.254586	1.29 [0.97 - 1.71]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203722_at	198	0.409091	0.00482038	0.0919547	0.640445	0.00248121	0.256852	1.29 [1.09 - 1.53]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203722_at	198	0.782828	0.000133916	0.00452711	0.98088	0.00130375	0.348008	1.42 [1.15 - 1.75]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211552_s_at	198	0.585859	0.0317117	0.367622	0.452069	0.0542274	0.219184	1.25 [1.00 - 1.56]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203722_at	51	0.294118	0.126374	-	15.6341	0.537428	1.89014	6.62 [0.02 - 2690.08]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203722_at	62	0.887097	0.0393357	0.423124	1.28898	0.208516	1.67311	5.33 [0.39 - 72.28]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211552_s_at	51	0.54902	0.09718	-	1.66066	0.498453	0.976081	2.65 [0.16 - 44.80]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211552_s_at	62	0.564516	0.0154766	0.223012	1.47873	0.379465	0.843059	2.32 [0.35 - 15.23]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211552_s_at	177	0.463277	0.00874864	0.14593	-0.720139	0.333685	-0.379724	0.68 [0.32 - 1.48]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203722_at	177	0.214689	0.0337423	0.383019	-0.604599	0.950003	-0.0163847	0.98 [0.59 - 1.64]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211552_s_at	177	0.19774	0.0332193	0.379098	-0.547311	0.517954	-0.212793	0.81 [0.42 - 1.54]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203722_at	177	0.20339	0.0545094	-	-0.494685	0.915992	-0.0238759	0.98 [0.63 - 1.52]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211552_s_at	145	0.455172	0.00197741	0.0448748	-1.06811	0.0741835	-0.984066	0.37 [0.13 - 1.10]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203722_at	145	0.213793	0.000447507	0.0128876	-1.12882	0.0385167	-0.787814	0.45 [0.22 - 0.96]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211552_s_at	226	0.628319	0.00482175	0.0919754	-0.996491	0.439707	-0.121032	0.89 [0.65 - 1.20]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203722_at	226	0.216814	0.0121036	0.186217	-0.740876	0.126956	-0.139303	0.87 [0.73 - 1.04]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211552_s_at	55	0.527273	0.011604	0.180477	-1.22866	0.276728	-0.808543	0.45 [0.10 - 1.91]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211552_s_at	55	0.527273	0.0666624	-	-0.92919	0.781299	-0.188042	0.83 [0.22 - 3.13]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203722_at	55	0.2	0.153225	-	1.02054	0.869396	-0.0527605	0.95 [0.51 - 1.78]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211552_s_at	49	0.489796	0.0159602	0.228037	-1.47671	0.0779227	-2.03306	0.13 [0.01 - 1.26]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203722_at	55	0.236364	0.0228882	0.294505	1.95476	0.446753	0.236151	1.27 [0.69 - 2.33]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203722_at	49	0.632653	0.0864039	-	-1.24678	0.315028	-0.47036	0.62 [0.25 - 1.56]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211552_s_at	63	0.190476	0.0804923	-	1.01303	0.790406	-0.138092	0.87 [0.31 - 2.41]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203722_at	63	0.111111	0.0183644	0.252209	-1.02579	0.570879	0.125503	1.13 [0.73 - 1.75]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g1353249_3p_a_at	28	0.107143	0.126995	-	15.2751	0.751036	0.151761	1.16 [0.46 - 2.97]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203722_at	82	0.243902	0.162143	-	0.620451	0.923997	0.0382479	1.04 [0.47 - 2.28]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211552_s_at	82	0.841463	0.0253529	0.316054	0.842841	0.625651	0.20935	1.23 [0.53 - 2.86]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37330_at	84	0.845238	0.0215922	0.282772	-1.28233	0.13423	-0.514221	0.60 [0.31 - 1.17]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37331_g_at	84	0.154762	0.000668186	0.0181373	-1.15208	0.00144975	-1.13112	0.32 [0.16 - 0.65]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203722_at	79	0.227848	0.0452772	0.462455	-0.598953	0.380861	-0.281853	0.75 [0.40 - 1.42]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211552_s_at	79	0.873418	0.268097	-	-0.444596	0.85967	-0.0565779	0.94 [0.50 - 1.77]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U24266_at	86	0.244186	0.0470964	0.473897	-0.817688	0.20251	-0.901822	0.41 [0.10 - 1.62]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211552_s_at	104	0.884615	0.177982	-	-0.944491	0.91878	-0.0485864	0.95 [0.37 - 2.42]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203722_at	104	0.240385	0.0203266	0.271025	-0.754025	0.314073	-0.682557	0.51 [0.13 - 1.91]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P170337	117	0.102564	0.00976172	0.158553	-0.963998	0.280328	-0.25971	0.77 [0.48 - 1.24]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P263036	117	0.102564	0.000311906	0.00944848	-1.25561	0.339545	-0.206136	0.81 [0.53 - 1.24]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203722_at	204	0.661765	0.00150607	0.035854	-1.72153	0.0238379	-0.449751	0.64 [0.43 - 0.94]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203722_at	204	0.465686	0.00260425	0.0561785	-0.827354	0.0108188	-0.392199	0.68 [0.50 - 0.91]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211552_s_at	204	0.661765	0.118097	-	0.564608	0.316626	0.415138	1.51 [0.67 - 3.41]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211552_s_at	204	0.558824	0.00549206	0.101878	0.757656	0.151263	0.449365	1.57 [0.85 - 2.90]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203722_at	178	0.52809	0.0143896	0.2115	-0.492888	0.242677	-0.255016	0.77 [0.51 - 1.19]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211552_s_at	178	0.735955	0.0196654	0.26477	-0.564294	0.442914	-0.146833	0.86 [0.59 - 1.26]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211552_s_at	111	0.117117	0.14	-	0.749116	0.785189	0.0643126	1.07 [0.67 - 1.69]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203722_at	111	0.18018	0.206719	-	0.476793	0.98381	0.0023435	1.00 [0.80 - 1.26]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203722_at	90	0.644444	0.13086	-	-0.550948	0.747339	-0.136649	0.87 [0.38 - 2.00]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203722_at	90	0.622222	0.0833168	-	-0.735565	0.587909	-0.273774	0.76 [0.28 - 2.05]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211552_s_at	90	0.411111	0.0560156	-	-0.611868	0.20284	-0.821384	0.44 [0.12 - 1.56]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211552_s_at	90	0.111111	0.0369955	0.406734	-0.925103	0.162013	-1.04211	0.35 [0.08 - 1.52]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1978	50	0.22	0.0622377	-	1.70744	0.478225	0.355603	1.43 [0.53 - 3.81]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203722_at	138	0.427536	0.00500807	0.0947631	0.714084	0.96865	-0.00560921	0.99 [0.75 - 1.32]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211552_s_at	138	0.166667	0.0147915	0.215793	-0.65966	0.728226	-0.158135	0.85 [0.35 - 2.08]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211552_s_at	129	0.162791	0.01436	0.211182	-0.733017	0.109975	-0.444994	0.64 [0.37 - 1.11]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203722_at	129	0.24031	0.0134425	0.201211	-0.648343	0.368015	-0.13232	0.88 [0.66 - 1.17]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25513	56	0.517857	0.153814	-	0.512092	0.85059	0.0497657	1.05 [0.63 - 1.76]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23496	56	0.142857	0.216343	-	-0.564451	0.713543	-0.0844748	0.92 [0.59 - 1.44]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39047	56	0.125	0.0528066	-	-0.886691	0.791443	-0.0555815	0.95 [0.63 - 1.43]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25175	56	0.303571	0.248973	-	-0.426761	0.610869	-0.144918	0.87 [0.50 - 1.51]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8876	56	0.785714	0.181371	-	-0.593103	0.765407	-0.0639483	0.94 [0.62 - 1.43]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31124	56	0.642857	0.16591	-	0.47139	0.699204	0.105137	1.11 [0.65 - 1.89]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23496	56	0.214286	0.299396	-	0.469315	0.915428	-0.0249802	0.98 [0.62 - 1.55]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39047	56	0.125	0.181889	-	-0.610856	0.950855	-0.0137248	0.99 [0.64 - 1.53]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25513	56	0.107143	0.132731	-	-0.728456	0.886731	-0.0364632	0.96 [0.58 - 1.59]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8876	56	0.785714	0.246128	-	-0.560272	0.940094	-0.0166671	0.98 [0.64 - 1.52]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31124	56	0.875	0.0508138	-	0.86637	0.515554	0.18867	1.21 [0.68 - 2.13]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25175	56	0.785714	0.195152	-	-0.575723	0.521395	-0.176409	0.84 [0.49 - 1.44]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211552_s_at	278	0.215827	0.221971	-	0.306759	0.703469	0.099451	1.10 [0.66 - 1.84]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203722_at	278	0.794964	0.0064803	0.115894	0.567771	0.0246726	0.280804	1.32 [1.04 - 1.69]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203722_at	133	0.609023	0.000406359	0.0118647	0.834065	0.039328	0.355299	1.43 [1.02 - 2.00]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211552_s_at	133	0.526316	0.00622416	0.112323	0.647925	0.0435195	0.98347	2.67 [1.03 - 6.95]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2695	81	0.62963	0.0602164	-	-1.33109	0.217484	-0.344667	0.71 [0.41 - 1.23]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6955	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211552_s_at	185	0.735135	0.162784	-	-0.257861	0.420774	-0.209236	0.81 [0.49 - 1.35]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203722_at	185	0.886486	0.0140586	0.207933	-0.632919	0.102142	-0.347426	0.71 [0.47 - 1.07]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211552_s_at	185	0.535135	0.320757	-	0.17531	0.835615	-0.0572442	0.94 [0.55 - 1.62]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203722_at	185	0.897297	0.057365	-	-0.555896	0.2601	-0.260562	0.77 [0.49 - 1.21]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P263036	110	0.254545	0.00471646	0.0903874	0.817988	0.186553	0.234671	1.26 [0.89 - 1.79]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P192970	110	0.509091	0.0321777	0.371198	0.645922	0.0949594	0.390213	1.48 [0.93 - 2.34]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P170337	110	0.209091	0.0183724	0.252287	0.748792	0.306726	0.224562	1.25 [0.81 - 1.93]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P263036	110	0.209091	0.033109	0.378268	0.977596	0.574931	0.13097	1.14 [0.72 - 1.80]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P170337	110	0.209091	0.0844382	-	0.745167	0.877307	0.0446904	1.05 [0.59 - 1.84]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P192970	110	0.890909	0.00402751	0.0797553	0.906243	0.0937341	0.329926	1.39 [0.95 - 2.05]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211552_s_at	80	0.1375	0.189218	-	1.26133	0.634553	0.126468	1.13 [0.67 - 1.91]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203722_at	80	0.5	0.122388	-	-0.734555	0.165844	-0.290461	0.75 [0.50 - 1.13]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_2049	281	0.718861	0.228647	-	-0.189945	0.817606	-0.0292035	0.97 [0.76 - 1.24]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:44289	59	0.355932	0.0549413	-	-0.916046	0.759945	0.204691	1.23 [0.33 - 4.56]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211552_s_at	38	0.815789	0.00165729	0.0388056	1.69601	0.00965144	1.34291	3.83 [1.39 - 10.59]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203722_at	38	0.868421	3.29497e-06	0.000162655	2.43381	0.0132416	1.12553	3.08 [1.26 - 7.51]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203722_at	140	0.135714	3.22367e-06	0.000159433	-1.38657	0.00137056	-0.980155	0.38 [0.21 - 0.68]
GENE	ALDH4A1	aldehyde dehydrogenase 4 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211552_s_at	140	0.185714	0.000441931	0.0127499	-1.05806	0.00506702	-1.48896	0.23 [0.08 - 0.64]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203609_s_at	30	0.366667	0.171958	-	0.583769	0.814644	0.130826	1.14 [0.38 - 3.40]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217405_x_at	30	0.233333	0.146699	-	0.781776	0.525111	0.45234	1.57 [0.39 - 6.34]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203608_at	30	0.533333	0.0111342	0.175003	-1.06395	0.314273	-0.202292	0.82 [0.55 - 1.21]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1715859	165	0.89697	0.00904781	0.149704	0.839301	0.413975	0.113186	1.12 [0.85 - 1.47]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1715859	165	0.89697	0.00682293	0.120609	1.1048	0.45239	0.150604	1.16 [0.78 - 1.72]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217405_x_at	163	0.515337	0.117711	-	-0.310682	0.84618	-0.108812	0.90 [0.30 - 2.69]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203608_at	163	0.515337	0.0808514	-	0.344877	0.168911	0.145797	1.16 [0.94 - 1.42]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203609_s_at	163	0.889571	0.0381102	0.414608	0.574069	0.821829	0.120536	1.13 [0.40 - 3.22]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203609_s_at	79	0.810127	0.0305166	0.358333	-0.985961	0.0686019	-0.966847	0.38 [0.13 - 1.08]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203608_at	79	0.658228	0.072813	-	-0.594608	0.352948	-0.138448	0.87 [0.65 - 1.17]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217405_x_at	79	0.164557	0.229479	-	-0.442773	0.931627	-0.0713577	0.93 [0.18 - 4.75]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203608_at	58	0.137931	0.00996557	0.161042	-1.00335	0.171659	-0.172167	0.84 [0.66 - 1.08]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203609_s_at	58	0.844828	0.0446335	0.458342	0.758458	0.475464	0.155408	1.17 [0.76 - 1.79]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217405_x_at	58	0.275862	0.156881	-	0.45114	0.8594	-0.0399627	0.96 [0.62 - 1.50]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203608_at	34	0.235294	0.0998484	-	-0.728653	0.661558	-0.0877924	0.92 [0.62 - 1.36]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203609_s_at	34	0.617647	0.130415	-	-0.643787	0.693523	-0.141512	0.87 [0.43 - 1.75]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217405_x_at	34	0.352941	0.00372406	0.0749273	-1.15412	0.448057	-0.255057	0.77 [0.40 - 1.50]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203609_s_at	158	0.85443	0.000325968	0.0098149	-2.1474	0.0552326	-0.482676	0.62 [0.38 - 1.01]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217405_x_at	158	0.867089	0.021905	0.28563	-1.01854	0.443551	-0.529281	0.59 [0.15 - 2.28]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203608_at	158	0.841772	0.00623283	0.112444	-1.19593	0.113241	-0.168712	0.84 [0.69 - 1.04]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203609_s_at	53	0.641509	0.160187	-	0.485428	0.921076	0.0192382	1.02 [0.70 - 1.49]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203608_at	53	0.584906	0.0840197	-	0.62268	0.54548	0.168976	1.18 [0.68 - 2.05]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217405_x_at	53	0.622642	0.0461037	0.467687	0.673846	0.158953	0.475198	1.61 [0.83 - 3.12]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203609_s_at	53	0.641509	0.0512384	-	0.707303	0.598172	0.106784	1.11 [0.75 - 1.66]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203608_at	53	0.584906	0.18641	-	0.451126	0.930501	0.0232946	1.02 [0.61 - 1.73]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217405_x_at	53	0.358491	0.0233044	0.298211	0.947487	0.0822149	0.688975	1.99 [0.92 - 4.33]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203609_s_at	180	0.805556	0.194959	-	0.326903	0.381326	0.108382	1.11 [0.87 - 1.42]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217405_x_at	180	0.344444	0.234852	-	-0.258487	0.849213	-0.0408422	0.96 [0.63 - 1.46]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203608_at	180	0.594444	0.178271	-	0.282401	0.308169	0.170245	1.19 [0.85 - 1.64]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203609_s_at	559	0.60644	0.0597441	-	-0.386563	0.215212	-0.14349	0.87 [0.69 - 1.09]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203608_at	559	0.284436	0.240785	-	0.270614	0.730524	0.0310584	1.03 [0.86 - 1.23]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217405_x_at	559	0.733453	0.068616	-	-0.451591	0.482838	-0.0996793	0.91 [0.69 - 1.20]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203608_at	77	0.61039	0.000480023	0.0136849	-0.957104	0.0318887	-0.381286	0.68 [0.48 - 0.97]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203609_s_at	77	0.792208	3.11115e-05	0.00124159	-1.55311	0.00753291	-0.305637	0.74 [0.59 - 0.92]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217405_x_at	77	0.168831	0.0574087	-	-0.595583	0.839767	-0.0748715	0.93 [0.45 - 1.92]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203609_s_at	70	0.885714	0.102988	-	0.614363	0.568799	0.312325	1.37 [0.47 - 4.00]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203608_at	70	0.2	0.314474	-	0.334986	0.45268	0.0923418	1.10 [0.86 - 1.40]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217405_x_at	70	0.185714	0.195733	-	0.44679	0.904031	0.141852	1.15 [0.11 - 11.56]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41790_at	50	0.62	0.0120315	0.185394	-0.986332	0.0159673	-0.415899	0.66 [0.47 - 0.93]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203609_s_at	74	0.216216	4.03084e-05	0.00156485	-1.27771	0.000387988	-0.563437	0.57 [0.42 - 0.78]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217405_x_at	74	0.310811	0.0965853	-	-0.488731	0.416897	-0.449106	0.64 [0.22 - 1.89]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203608_at	74	0.837838	0.000167527	0.00550718	-2.26835	0.0010146	-0.730161	0.48 [0.31 - 0.74]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203609_s_at	67	0.567164	0.114698	-	-1.2002	0.7576	-0.56496	0.57 [0.02 - 20.55]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203608_at	67	0.850746	0.00535031	0.0998125	1.6959	0.399223	0.730657	2.08 [0.38 - 11.35]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217405_x_at	67	0.835821	0.147681	-	-15.3848	0.859518	-0.365531	0.69 [0.01 - 39.74]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203609_s_at	115	0.756522	0.0126151	0.19201	1.25385	0.759432	0.173211	1.19 [0.39 - 3.60]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203608_at	115	0.669565	0.414611	-	0.439296	0.912749	0.0493931	1.05 [0.43 - 2.54]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217405_x_at	115	0.756522	0.0909607	-	0.88362	0.480498	0.802162	2.23 [0.24 - 20.71]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41790_at	158	0.898734	0.0307212	0.359935	-1.89391	0.868323	0.023738	1.02 [0.77 - 1.36]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41790_at	76	0.578947	0.137914	-	0.763831	0.891062	0.0446745	1.05 [0.55 - 1.98]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203608_at	204	0.862745	0.0726543	-	-0.363154	0.361442	-0.0878692	0.92 [0.76 - 1.11]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217405_x_at	204	0.877451	0.251435	-	-0.247007	0.880099	-0.0121513	0.99 [0.84 - 1.16]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203609_s_at	204	0.607843	0.0187343	0.255815	-0.33916	0.0380218	-0.135681	0.87 [0.77 - 0.99]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217405_x_at	87	0.850575	0.000354745	0.0105571	1.31468	0.0543134	1.86352	6.45 [0.97 - 43.02]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203608_at	87	0.241379	0.0141405	0.208818	1.6189	0.118256	0.276288	1.32 [0.93 - 1.86]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203609_s_at	87	0.896552	0.289251	-	0.568725	0.780998	0.201417	1.22 [0.30 - 5.06]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203608_at	87	0.241379	0.0141405	0.208818	1.6189	0.118256	0.276288	1.32 [0.93 - 1.86]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217405_x_at	87	0.850575	0.000354745	0.0105571	1.31468	0.0543134	1.86352	6.45 [0.97 - 43.02]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203609_s_at	87	0.896552	0.289251	-	0.568725	0.780998	0.201417	1.22 [0.30 - 5.06]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203608_at	77	0.12987	0.137064	-	15.2537	0.495602	0.186079	1.20 [0.71 - 2.06]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217405_x_at	77	0.506494	0.157077	-	0.941524	0.82244	0.359754	1.43 [0.06 - 33.18]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203609_s_at	77	0.896104	0.193607	-	0.990692	0.533235	0.813161	2.26 [0.17 - 29.11]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217405_x_at	77	0.493506	0.0380702	0.414328	1.27729	0.272328	1.52925	4.61 [0.30 - 70.79]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203608_at	77	0.818182	0.0366728	0.404432	1.26699	0.531109	0.197082	1.22 [0.66 - 2.26]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203609_s_at	77	0.714286	0.106168	-	0.872303	0.177782	1.49561	4.46 [0.51 - 39.29]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217405_x_at	136	0.323529	0.031708	0.367593	-0.940419	0.158016	-0.419168	0.66 [0.37 - 1.18]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203608_at	136	0.110294	0.00220149	0.0489964	-1.38804	0.0611489	-0.449955	0.64 [0.40 - 1.02]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203609_s_at	136	0.566176	0.218932	-	0.560329	0.949315	-0.0164037	0.98 [0.59 - 1.63]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203609_s_at	200	0.895	0.00345002	0.0704825	1.00832	0.0252609	0.476932	1.61 [1.06 - 2.45]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217405_x_at	200	0.13	0.0498786	0.490895	-0.753085	0.366342	-0.351562	0.70 [0.33 - 1.51]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203608_at	200	0.785	0.0351913	0.393721	0.663298	0.759336	-0.0649927	0.94 [0.62 - 1.42]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12468	60	0.25	0.0193135	0.261405	-0.906488	0.172814	-0.182215	0.83 [0.64 - 1.08]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12468	60	0.216667	0.0105039	0.167536	-1.01865	0.214676	-0.2545	0.78 [0.52 - 1.16]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	20036	155	0.858065	1.36198e-05	0.000590806	1.23248	0.876448	-0.0266909	0.97 [0.70 - 1.36]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203609_s_at	286	0.206294	0.00530097	0.09909	-0.594148	0.233681	-0.206779	0.81 [0.58 - 1.14]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217405_x_at	286	0.395105	9.42994e-05	0.00332574	-0.742227	0.0112856	-0.450043	0.64 [0.45 - 0.90]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203608_at	286	0.101399	0.229234	-	-0.342394	0.808144	0.0295966	1.03 [0.81 - 1.31]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217405_x_at	159	0.138365	0.0767324	-	-0.658823	0.672543	0.213325	1.24 [0.46 - 3.33]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203609_s_at	159	0.679245	0.126857	-	-0.570551	0.704324	-0.114325	0.89 [0.49 - 1.61]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203609_s_at	159	0.132075	0.08766	-	1.57179	0.932878	0.0290202	1.03 [0.52 - 2.02]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203608_at	159	0.710692	0.13656	-	0.482548	0.641019	-0.0923221	0.91 [0.62 - 1.34]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217405_x_at	159	0.138365	0.0587256	-	-0.701581	0.589014	0.269463	1.31 [0.49 - 3.48]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217405_x_at	159	0.138365	0.0209018	0.276401	-0.927151	0.991533	-0.00617168	0.99 [0.32 - 3.11]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203608_at	159	0.113208	0.00842426	0.141793	-0.961537	0.110575	-0.285716	0.75 [0.53 - 1.07]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203609_s_at	159	0.132075	0.0842246	-	1.18291	0.803635	0.0721437	1.07 [0.61 - 1.90]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203608_at	159	0.113208	0.0148421	0.21633	-1.01417	0.127499	-0.311122	0.73 [0.49 - 1.09]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203608_at	54	0.722222	0.092832	-	-15.4948	0.948565	0.0193112	1.02 [0.57 - 1.83]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203609_s_at	54	0.444444	0.0324267	0.373098	-1.95097	0.140654	-1.96024	0.14 [0.01 - 1.91]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203608_at	117	0.307692	0.130706	-	-0.493492	0.657717	-0.0662652	0.94 [0.70 - 1.25]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203608_at	117	0.282051	0.0159857	0.2283	-0.918839	0.781761	-0.0505083	0.95 [0.67 - 1.36]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203609_s_at	117	0.529915	0.34052	-	-0.366733	0.568165	-0.455506	0.63 [0.13 - 3.03]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203609_s_at	117	0.700855	0.269342	-	0.365712	0.800378	-0.163087	0.85 [0.24 - 3.01]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203609_s_at	117	0.700855	0.269342	-	0.365712	0.800378	-0.163087	0.85 [0.24 - 3.01]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203609_s_at	117	0.384615	0.0755924	-	-0.690363	0.336447	-0.844303	0.43 [0.08 - 2.40]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217405_x_at	117	0.162393	0.147997	-	0.745955	0.150183	0.931127	2.54 [0.71 - 9.02]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217405_x_at	117	0.324786	0.0503951	-	0.931049	0.096676	1.1456	3.14 [0.81 - 12.15]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203608_at	117	0.307692	0.130706	-	-0.493492	0.657717	-0.0662652	0.94 [0.70 - 1.25]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217405_x_at	117	0.623932	0.236553	-	0.463632	0.176309	1.26451	3.54 [0.57 - 22.14]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203608_at	117	0.264957	0.0638807	-	-0.702094	0.702094	-0.0672126	0.93 [0.66 - 1.32]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217405_x_at	117	0.162393	0.147997	-	0.745955	0.150183	0.931127	2.54 [0.71 - 9.02]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217405_x_at	236	0.139831	0.258022	-	0.523691	0.498452	0.254779	1.29 [0.62 - 2.70]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203608_at	236	0.139831	0.0133424	0.200109	-0.770935	0.845959	-0.0353631	0.97 [0.68 - 1.38]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203609_s_at	236	0.754237	0.0677716	-	0.513475	0.106771	0.221859	1.25 [0.95 - 1.63]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203608_at	249	0.610442	0.160795	-	0.298401	0.848464	0.027883	1.03 [0.77 - 1.37]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203609_s_at	249	0.891566	0.0644493	-	0.532224	0.544726	0.0734961	1.08 [0.85 - 1.37]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217405_x_at	249	0.714859	0.253412	-	0.25699	0.758784	0.0878689	1.09 [0.62 - 1.91]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203608_at	62	0.83871	0.0390239	0.420971	1.06318	0.105184	0.358495	1.43 [0.93 - 2.21]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203608_at	125	0.896	0.0413277	0.436661	0.908974	0.673518	0.0853169	1.09 [0.73 - 1.62]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217405_x_at	54	0.388889	0.21951	-	0.923303	0.779581	-0.0789121	0.92 [0.53 - 1.61]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203609_s_at	62	0.854839	0.112166	-	0.888792	0.808471	0.0482804	1.05 [0.71 - 1.55]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203608_at	125	0.104	0.0716116	-	-0.772893	0.388572	-0.139439	0.87 [0.63 - 1.19]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203608_at	54	0.518519	0.0768528	-	1.04754	0.165807	0.387195	1.47 [0.85 - 2.55]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217405_x_at	62	0.258065	0.111349	-	1.49869	0.774234	-0.0666526	0.94 [0.59 - 1.48]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203609_s_at	125	0.584	0.130004	-	-0.657417	0.606598	-0.127734	0.88 [0.54 - 1.43]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203609_s_at	125	0.272	0.363408	-	-0.272208	0.886561	-0.0269151	0.97 [0.67 - 1.41]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203609_s_at	54	0.296296	0.112079	-	1.51895	0.929545	0.0219172	1.02 [0.63 - 1.66]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217405_x_at	125	0.176	0.0774827	-	1.61831	0.491865	0.557582	1.75 [0.36 - 8.56]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217405_x_at	125	0.872	0.0451055	0.461362	-0.955491	0.819682	-0.14293	0.87 [0.25 - 2.96]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203608_at	198	0.843434	0.171618	-	0.429802	0.952701	0.00737714	1.01 [0.79 - 1.29]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217405_x_at	198	0.580808	0.0558422	-	0.39991	0.916492	0.0127497	1.01 [0.80 - 1.29]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203609_s_at	198	0.570707	0.0191191	0.259537	0.590519	0.0794921	0.203642	1.23 [0.98 - 1.54]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203609_s_at	198	0.116162	0.0191841	0.260163	1.53375	0.100323	0.198193	1.22 [0.96 - 1.54]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203608_at	198	0.207071	0.310596	-	-0.252239	0.635784	-0.0454493	0.96 [0.79 - 1.15]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217405_x_at	198	0.626263	0.0975882	-	0.420198	0.881459	0.0211735	1.02 [0.77 - 1.35]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217405_x_at	198	0.626263	0.051042	-	0.516522	0.72796	0.0536331	1.06 [0.78 - 1.43]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203608_at	198	0.843434	0.222439	-	0.379407	0.984664	-0.00224557	1.00 [0.79 - 1.25]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203609_s_at	198	0.116162	0.0210624	0.27789	0.946139	0.0717167	0.175858	1.19 [0.98 - 1.44]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203608_at	51	0.352941	0.223586	-	-1.06099	0.872729	-0.0808992	0.92 [0.34 - 2.48]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203608_at	62	0.370968	0.0185774	0.254289	-1.34102	0.218117	-0.435425	0.65 [0.32 - 1.29]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203609_s_at	51	0.27451	0.0959227	-	-1.40246	0.545652	1.09723	3.00 [0.09 - 105.22]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203609_s_at	62	0.290323	0.335955	-	-0.556928	0.594783	0.646353	1.91 [0.18 - 20.66]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217405_x_at	51	0.27451	0.155638	-	15.5546	0.573861	1.37524	3.96 [0.03 - 477.37]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217405_x_at	62	0.370968	0.11836	-	1.14615	0.571578	0.901874	2.46 [0.11 - 56.06]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203608_at	145	0.158621	0.0484615	0.482311	1.33555	0.352444	0.214959	1.24 [0.79 - 1.95]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217405_x_at	177	0.423729	0.279698	-	-0.290875	0.766146	-0.261998	0.77 [0.14 - 4.33]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217405_x_at	177	0.768362	0.168305	-	-0.432325	0.740097	-0.253734	0.78 [0.17 - 3.47]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203609_s_at	177	0.412429	0.0134977	0.201817	-0.6632	0.199339	-0.828409	0.44 [0.12 - 1.55]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203608_at	177	0.146893	0.0661525	-	0.922968	0.617691	0.0927273	1.10 [0.76 - 1.58]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203609_s_at	177	0.847458	0.00643358	0.115246	-1.30854	0.061156	-1.0494	0.35 [0.12 - 1.05]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217405_x_at	145	0.765517	0.0983152	-	-0.77841	0.359934	-0.970275	0.38 [0.05 - 3.03]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203608_at	177	0.146893	0.050794	-	0.811742	0.951686	0.00944808	1.01 [0.74 - 1.37]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203609_s_at	145	0.448276	0.046974	0.473136	-0.660522	0.219751	-0.943709	0.39 [0.09 - 1.76]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217405_x_at	226	0.49115	0.159183	-	0.402844	0.781917	0.0385137	1.04 [0.79 - 1.37]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203609_s_at	226	0.783186	0.143334	-	-0.587898	0.838288	-0.0230777	0.98 [0.78 - 1.22]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203608_at	226	0.765487	0.0556745	-	-0.7621	0.934465	-0.0136475	0.99 [0.71 - 1.37]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217405_x_at	55	0.127273	0.274338	-	-0.602597	0.756296	-0.421583	0.66 [0.05 - 9.40]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217405_x_at	55	0.672727	0.244797	-	0.560786	0.757218	-0.464753	0.63 [0.03 - 11.96]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203609_s_at	55	0.472727	0.0294655	0.350016	1.02316	0.0303492	1.65202	5.22 [1.17 - 23.27]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217405_x_at	49	0.836735	0.0979671	-	-15.3387	0.397017	-1.4882	0.23 [0.01 - 7.07]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203608_at	55	0.854545	0.00691082	0.121808	1.26311	0.054121	0.702076	2.02 [0.99 - 4.12]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203609_s_at	55	0.490909	0.000190658	0.00616505	2.27143	0.00149027	2.32091	10.18 [2.43 - 42.65]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203609_s_at	49	0.55102	0.00886553	0.147409	1.59179	0.0462465	2.00126	7.40 [1.03 - 52.95]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203608_at	55	0.472727	0.00203327	0.0459115	1.74278	0.0171457	0.845387	2.33 [1.16 - 4.67]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203608_at	49	0.489796	0.0121001	0.186177	1.53468	0.0595716	0.875979	2.40 [0.97 - 5.97]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217405_x_at	63	0.190476	0.000439159	0.0126814	-1.23108	0.0415286	-25.8172	0.00 [0.00 - 0.37]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203609_s_at	63	0.111111	0.037104	0.407507	-0.908344	0.133422	-0.422633	0.66 [0.38 - 1.14]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203608_at	63	0.634921	0.013136	0.197826	-0.965076	0.0501683	-0.241329	0.79 [0.62 - 1.00]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.272529.1.S1_3p_x_at	28	0.714286	0.0499211	0.49115	-1.42805	0.521238	-2.8736	0.06 [0.00 - 367.62]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4507228_3p_a_at	28	0.821429	0.107985	-	-1.52874	0.270304	-10.8139	0.00 [0.00 - 4506.64]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.5299.0.S2_3p_at	28	0.357143	0.00115982	0.0288525	-1.62727	0.0728524	-0.940748	0.39 [0.14 - 1.09]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.272529.1.S1_3p_a_at	28	0.535714	0.0649152	-	-1.04746	0.197749	-2.46151	0.09 [0.00 - 3.61]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217405_x_at	82	0.597561	0.315648	-	0.342486	0.573984	0.290935	1.34 [0.49 - 3.69]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203608_at	82	0.865854	0.044274	0.45603	-1.79143	0.0516616	-0.42756	0.65 [0.42 - 1.00]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203609_s_at	82	0.707317	0.0832845	-	-0.718143	0.57699	-0.243283	0.78 [0.33 - 1.84]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217405_x_at	79	0.468354	0.292492	-	0.275657	0.8096	0.114964	1.12 [0.44 - 2.86]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203608_at	79	0.556962	0.245455	-	0.301258	0.422819	0.140678	1.15 [0.82 - 1.62]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203609_s_at	79	0.670886	0.0595667	-	0.501929	0.153188	0.536713	1.71 [0.82 - 3.57]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203609_s_at	104	0.201923	0.0357841	0.398035	-0.764309	0.276089	-0.446628	0.64 [0.29 - 1.43]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217405_x_at	104	0.625	0.0135979	0.202917	-0.893393	0.0956807	-1.00853	0.36 [0.11 - 1.19]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203608_at	104	0.788462	0.0226826	0.292662	-1.28455	0.0447465	-0.414857	0.66 [0.44 - 0.99]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P3761	117	0.273504	0.093449	-	0.588133	0.227984	0.21554	1.24 [0.87 - 1.76]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P923353	117	0.205128	0.233408	-	0.482327	0.841261	0.0319142	1.03 [0.76 - 1.41]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P115007	117	0.897436	0.100969	-	-1.12464	0.962542	0.0087573	1.01 [0.70 - 1.45]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203609_s_at	204	0.348039	0.00174211	0.0404362	-0.829865	0.0466728	-0.594462	0.55 [0.31 - 0.99]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203608_at	204	0.764706	0.00564803	0.104134	-2.28505	0.123058	-0.448508	0.64 [0.36 - 1.13]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203608_at	204	0.191176	4.00476e-05	0.00155582	-1.11693	0.00762412	-0.568848	0.57 [0.37 - 0.86]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217405_x_at	204	0.862745	0.0781831	-	-1.61152	0.851668	-0.0499836	0.95 [0.56 - 1.61]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217405_x_at	204	0.867647	0.017989	0.248519	-1.54641	0.0957273	-0.296979	0.74 [0.52 - 1.05]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203609_s_at	204	0.833333	0.12674	-	-1.06668	0.497691	-0.277761	0.76 [0.34 - 1.69]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217405_x_at	178	0.842697	0.0291919	0.347828	-0.744225	0.402424	-0.259117	0.77 [0.42 - 1.42]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203608_at	178	0.455056	0.0164128	0.232688	-0.471007	0.235615	-0.195481	0.82 [0.60 - 1.14]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203609_s_at	178	0.735955	0.0768459	-	-0.411747	0.363956	-0.232077	0.79 [0.48 - 1.31]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300013604	41	0.463415	0.0197541	0.265614	1.02772	0.355152	0.273717	1.31 [0.74 - 2.35]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203608_at	111	0.72973	0.218825	-	-0.384658	0.614205	-0.0680592	0.93 [0.72 - 1.22]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217405_x_at	111	0.108108	0.0337602	0.383152	1.18886	0.194206	0.219565	1.25 [0.89 - 1.74]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203609_s_at	111	0.855856	0.0240058	0.304395	0.71877	0.541341	-0.0871954	0.92 [0.69 - 1.21]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217405_x_at	90	0.877778	0.150038	-	0.632647	0.384439	0.75097	2.12 [0.39 - 11.51]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217405_x_at	90	0.211111	0.0319029	0.369092	1.44487	0.0958124	1.50871	4.52 [0.77 - 26.69]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203608_at	90	0.877778	0.30928	-	-0.604229	0.902781	-0.0275352	0.97 [0.63 - 1.51]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203608_at	90	0.288889	0.135287	-	-0.556703	0.499366	-0.182546	0.83 [0.49 - 1.42]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203609_s_at	90	0.666667	0.102739	-	0.531313	0.297492	0.776119	2.17 [0.50 - 9.36]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203609_s_at	90	0.211111	0.182559	-	-0.529092	0.515571	0.55484	1.74 [0.33 - 9.28]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2558	50	0.22	0.0622377	-	1.70744	0.187251	0.620884	1.86 [0.74 - 4.68]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203608_at	138	0.804348	0.0166677	0.235286	-0.873596	0.349113	-0.0938604	0.91 [0.75 - 1.11]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217405_x_at	138	0.282609	0.00488651	0.0929475	-0.678832	0.165808	-7.23268	0.00 [0.00 - 20.02]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203609_s_at	138	0.181159	0.0109913	0.173323	-0.682599	0.849651	-0.398102	0.67 [0.01 - 41.19]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203609_s_at	129	0.589147	0.144042	-	-0.370932	0.703162	-0.0728745	0.93 [0.64 - 1.35]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217405_x_at	129	0.837209	0.0110869	0.174447	0.714735	0.519469	0.215064	1.24 [0.64 - 2.39]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203608_at	129	0.333333	0.168964	-	-0.346908	0.867195	-0.0247108	0.98 [0.73 - 1.30]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35383	56	0.125	0.148903	-	0.76816	0.805414	0.0794457	1.08 [0.58 - 2.04]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43913	56	0.214286	0.0960903	-	-0.71154	0.880947	-0.134906	0.87 [0.15 - 5.11]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19648	56	0.125	0.101478	-	-0.78562	0.966315	0.00945935	1.01 [0.65 - 1.57]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35383	56	0.642857	0.213816	-	-0.462668	0.86912	-0.0544718	0.95 [0.50 - 1.81]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19648	56	0.125	0.0458426	0.46604	-0.95353	0.662966	-0.103307	0.90 [0.57 - 1.44]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43913	56	0.214286	0.320695	-	-0.425266	0.897623	0.107976	1.11 [0.22 - 5.77]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217405_x_at	278	0.100719	0.00328575	0.0677766	-0.803128	0.0240185	-1.25292	0.29 [0.10 - 0.85]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203609_s_at	278	0.672662	0.0305349	0.358476	-0.450982	0.1072	-0.358561	0.70 [0.45 - 1.08]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203608_at	278	0.607914	0.00115226	0.0286953	-0.665807	0.0432169	-0.232553	0.79 [0.63 - 0.99]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203608_at	133	0.180451	0.0157699	0.226067	-0.666256	0.0442624	-0.218633	0.80 [0.65 - 0.99]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203609_s_at	133	0.496241	0.17437	-	0.322928	0.362969	0.187165	1.21 [0.81 - 1.80]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217405_x_at	133	0.639098	0.00184928	0.0424728	0.732784	0.038966	3.25291	25.87 [1.18 - 567.42]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12307	81	0.666667	4.16966e-05	0.00161283	2.06846	0.0582054	0.65904	1.93 [0.98 - 3.82]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203609_s_at	185	0.502703	0.0540595	-	-0.312246	0.103657	-0.433281	0.65 [0.38 - 1.09]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217405_x_at	185	0.151351	0.125423	-	-0.340565	0.621615	-0.209758	0.81 [0.35 - 1.86]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203608_at	185	0.816216	0.025273	0.315371	-0.467904	0.156694	-0.136147	0.87 [0.72 - 1.05]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203609_s_at	185	0.324324	0.0351225	0.393218	-0.383478	0.0779503	-0.523015	0.59 [0.33 - 1.06]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203608_at	185	0.837838	0.0104451	0.166832	-0.647812	0.0954029	-0.176346	0.84 [0.68 - 1.03]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217405_x_at	185	0.8	0.179681	-	-0.275671	0.680129	-0.160048	0.85 [0.40 - 1.82]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P923353	110	0.727273	0.0631368	-	-0.681516	0.577223	-0.0967825	0.91 [0.65 - 1.28]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P115007	110	0.545455	0.152591	-	-0.333759	0.353012	-0.113347	0.89 [0.70 - 1.13]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P3761	110	0.3	0.0314434	0.365551	-0.636634	0.275138	-0.226961	0.80 [0.53 - 1.20]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P115007	110	0.563636	0.114587	-	-0.481093	0.467964	-0.110037	0.90 [0.67 - 1.21]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P923353	110	0.763636	0.0818379	-	-0.498739	0.467416	-0.0993178	0.91 [0.69 - 1.18]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P3761	110	0.3	0.108733	-	-0.389831	0.330588	-0.156151	0.86 [0.62 - 1.17]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203609_s_at	80	0.575	0.294016	-	0.461258	0.806378	0.0688373	1.07 [0.62 - 1.86]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217405_x_at	80	0.1125	0.053134	-	-1.04106	0.0948243	-0.381928	0.68 [0.44 - 1.07]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203608_at	80	0.5125	0.0110722	0.174274	-1.32442	0.327029	-0.243884	0.78 [0.48 - 1.28]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_1277	281	0.27758	0.165394	-	0.225343	0.886292	0.0159401	1.02 [0.82 - 1.26]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217405_x_at	38	0.842105	0.0152979	0.221141	-15.4773	0.770497	-0.187384	0.83 [0.24 - 2.92]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203609_s_at	38	0.894737	0.00702433	0.123349	1.68194	0.499011	0.372445	1.45 [0.49 - 4.27]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203608_at	38	0.868421	0.053097	-	1.07357	0.471235	0.168576	1.18 [0.75 - 1.87]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217405_x_at	140	0.514286	0.00102033	0.0259189	-1.00628	0.00690862	-2.87008	0.06 [0.01 - 0.45]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203608_at	140	0.278571	2.0785e-05	0.000864678	-1.17139	0.000824559	-0.494139	0.61 [0.46 - 0.82]
GENE	ALDH5A1	aldehyde dehydrogenase 5 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203609_s_at	140	0.442857	0.000117906	0.00404845	-1.1025	0.033631	-1.25314	0.29 [0.09 - 0.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221588_x_at	30	0.866667	0.0766672	-	-1.23482	0.674487	-0.161426	0.85 [0.40 - 1.81]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204290_s_at	30	0.733333	0.0726768	-	-0.87351	0.721218	-0.129227	0.88 [0.43 - 1.79]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1785284	165	0.848485	0.203779	-	0.389997	0.996261	0.000810229	1.00 [0.71 - 1.40]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1785284	165	0.890909	0.096411	-	0.73596	0.464461	0.185512	1.20 [0.73 - 1.98]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204290_s_at	163	0.736196	0.000148336	0.00495142	0.777987	0.541231	0.128611	1.14 [0.75 - 1.72]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221588_x_at	163	0.687117	0.0174172	0.242841	0.482062	0.265981	0.228912	1.26 [0.84 - 1.88]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204290_s_at	79	0.696203	0.0242323	0.306375	0.667291	0.199315	0.320101	1.38 [0.84 - 2.25]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221588_x_at	79	0.316456	0.0692359	-	0.618679	0.276264	0.251984	1.29 [0.82 - 2.03]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204290_s_at	58	0.724138	0.18464	-	0.407934	0.824731	0.0754382	1.08 [0.55 - 2.10]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221588_x_at	58	0.258621	0.197502	-	-0.393617	0.829916	0.0901065	1.09 [0.48 - 2.49]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204290_s_at	34	0.411765	0.270639	-	-0.441161	0.783311	-0.0957048	0.91 [0.46 - 1.80]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221588_x_at	34	0.823529	0.0201669	0.269522	-1.62867	0.103885	-0.704367	0.49 [0.21 - 1.16]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221588_x_at	158	0.329114	0.00517804	0.0972821	0.75596	0.0195959	0.911611	2.49 [1.16 - 5.35]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204290_s_at	158	0.5	0.00134025	0.0325466	0.748274	0.0243928	0.948935	2.58 [1.13 - 5.90]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221588_x_at	53	0.113208	0.0997904	-	1.13938	0.249904	0.661781	1.94 [0.63 - 5.98]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204290_s_at	53	0.264151	0.0740494	-	0.851047	0.250324	0.592768	1.81 [0.66 - 4.97]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221588_x_at	53	0.113208	0.0621879	-	1.69042	0.206916	0.801914	2.23 [0.64 - 7.75]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204290_s_at	53	0.264151	0.15277	-	0.598728	0.698034	0.177126	1.19 [0.49 - 2.92]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221588_x_at	180	0.85	0.134833	-	-0.44669	0.718353	-0.117026	0.89 [0.47 - 1.68]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204290_s_at	180	0.138889	0.112217	-	0.581001	0.747765	0.0858917	1.09 [0.65 - 1.84]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204290_s_at	559	0.107335	0.10096	-	0.632419	0.962969	0.00836283	1.01 [0.71 - 1.44]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221588_x_at	559	0.116279	0.208438	-	-0.341828	0.620508	-0.11846	0.89 [0.56 - 1.42]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204290_s_at	77	0.688312	0.000915947	0.0236735	-1.00162	0.003595	-0.570262	0.57 [0.39 - 0.83]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221588_x_at	77	0.662338	0.00142519	0.0342507	-0.915003	0.0145289	-0.63182	0.53 [0.32 - 0.88]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204290_s_at	70	0.871429	0.0023275	0.0512729	1.11892	0.109063	0.334167	1.40 [0.93 - 2.10]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221588_x_at	70	0.814286	0.0128722	0.194892	0.805292	0.0830592	0.398278	1.49 [0.95 - 2.34]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32676_at	50	0.76	0.0311133	0.362992	-1.01099	0.319368	-0.126922	0.88 [0.69 - 1.13]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221588_x_at	74	0.756757	0.0284236	0.341632	-0.804929	0.13238	-0.504073	0.60 [0.31 - 1.16]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204290_s_at	74	0.837838	0.00268466	0.057581	-1.47087	0.0140065	-0.652302	0.52 [0.31 - 0.88]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204290_s_at	67	0.895522	0.00066026	0.0179546	2.17012	0.599146	0.359376	1.43 [0.38 - 5.47]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221588_x_at	67	0.895522	0.00233394	0.0513886	1.92315	0.919053	0.0683671	1.07 [0.29 - 4.00]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221588_x_at	115	0.765217	0.211256	-	0.68418	0.997132	-0.00200717	1.00 [0.33 - 2.98]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204290_s_at	115	0.817391	0.0503581	-	1.0449	0.735664	0.184163	1.20 [0.41 - 3.50]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32676_at	158	0.677215	0.0206711	0.274252	-0.797581	0.0771195	-0.345486	0.71 [0.48 - 1.04]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32676_at	76	0.644737	0.140044	-	0.746862	0.566806	0.225537	1.25 [0.58 - 2.71]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221588_x_at	204	0.372549	0.00137794	0.0333053	-0.468293	0.0394312	-0.265095	0.77 [0.60 - 0.99]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204290_s_at	204	0.352941	0.00433853	0.0846089	-0.42235	0.0973399	-0.203159	0.82 [0.64 - 1.04]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204290_s_at	87	0.114943	0.0289763	0.346097	-1.04915	0.083632	-0.540819	0.58 [0.32 - 1.07]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204290_s_at	87	0.114943	0.0289763	0.346097	-1.04915	0.083632	-0.540819	0.58 [0.32 - 1.07]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221588_x_at	87	0.528736	0.0776424	-	-0.684088	0.158935	-0.4607	0.63 [0.33 - 1.20]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221588_x_at	87	0.528736	0.0776424	-	-0.684088	0.158935	-0.4607	0.63 [0.33 - 1.20]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221588_x_at	77	0.857143	0.176952	-	-15.2693	0.525959	-0.2994	0.74 [0.29 - 1.87]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204290_s_at	77	0.766234	0.0679408	-	-15.4682	0.295521	-0.453803	0.64 [0.27 - 1.49]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221588_x_at	77	0.857143	0.119477	-	-15.2754	0.959428	0.0208638	1.02 [0.46 - 2.28]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204290_s_at	77	0.805195	0.0624893	-	-15.3833	0.565814	-0.213781	0.81 [0.39 - 1.68]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204290_s_at	136	0.102941	0.031273	0.364232	-1.06393	0.169338	-0.760548	0.47 [0.16 - 1.38]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221588_x_at	136	0.5	0.00471696	0.0903949	-1.39056	0.100924	-1.09962	0.33 [0.09 - 1.24]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221588_x_at	200	0.795	0.0500028	-	0.620696	0.933235	0.0310428	1.03 [0.50 - 2.13]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204290_s_at	200	0.725	0.0608059	-	0.568953	0.999612	0.000154622	1.00 [0.54 - 1.86]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	10793	155	0.219355	0.00568321	0.10464	-0.77933	0.739152	-0.0456619	0.96 [0.73 - 1.25]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221588_x_at	286	0.625874	0.00566626	0.104397	-0.588067	0.101142	-0.417409	0.66 [0.40 - 1.09]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204290_s_at	286	0.587413	0.00555006	0.102719	-0.569072	0.193377	-0.248211	0.78 [0.54 - 1.13]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221588_x_at	159	0.157233	0.0394814	0.424126	-0.736126	0.307628	-0.475352	0.62 [0.25 - 1.55]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221588_x_at	159	0.157233	0.00843706	0.141958	-1.01386	0.0527485	-1.04146	0.35 [0.12 - 1.01]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204290_s_at	159	0.308176	0.152171	-	-0.458283	0.702343	-0.119137	0.89 [0.48 - 1.64]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204290_s_at	159	0.308176	0.0576297	-	-0.598908	0.382345	-0.267713	0.77 [0.42 - 1.40]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221588_x_at	159	0.157233	0.0457796	0.465642	-0.714455	0.191019	-0.612157	0.54 [0.22 - 1.36]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204290_s_at	159	0.308176	0.0277309	0.335977	-0.797041	0.281918	-0.380701	0.68 [0.34 - 1.37]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204289_at	54	0.759259	0.148361	-	-15.3764	0.507541	-0.850727	0.43 [0.03 - 5.29]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221589_s_at	54	0.166667	0.156154	-	15.361	0.682512	0.160889	1.17 [0.54 - 2.54]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204290_s_at	54	0.851852	0.063274	-	1.27025	0.462554	0.316364	1.37 [0.59 - 3.19]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221588_x_at	54	0.777778	0.0503275	-	1.2933	0.644545	0.278631	1.32 [0.40 - 4.32]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204290_s_at	117	0.606838	0.0504378	-	0.612348	0.160759	0.250801	1.29 [0.91 - 1.82]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204290_s_at	117	0.615385	0.0416886	0.439074	0.785415	0.502995	0.151581	1.16 [0.75 - 1.81]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221588_x_at	117	0.581197	0.00895578	0.148547	0.990622	0.0215151	0.596977	1.82 [1.09 - 3.02]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221588_x_at	117	0.136752	0.00353076	0.0718007	15.3162	0.122753	0.320558	1.38 [0.92 - 2.07]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221588_x_at	117	0.136752	0.00353076	0.0718007	15.3162	0.122753	0.320558	1.38 [0.92 - 2.07]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221588_x_at	117	0.264957	0.0444578	0.457213	1.16801	0.326289	0.251237	1.29 [0.78 - 2.12]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204290_s_at	117	0.606838	0.0504378	-	0.612348	0.160759	0.250801	1.29 [0.91 - 1.82]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204290_s_at	117	0.606838	0.00192145	0.0438301	1.15953	0.0456271	0.423639	1.53 [1.01 - 2.31]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204290_s_at	236	0.538136	0.0981443	-	-0.460008	0.126898	-0.458961	0.63 [0.35 - 1.14]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221588_x_at	236	0.567797	0.0296211	0.351256	-0.63573	0.119859	-0.635211	0.53 [0.24 - 1.18]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204290_s_at	249	0.24498	0.255366	-	-0.268924	0.489976	-0.173641	0.84 [0.51 - 1.38]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221588_x_at	249	0.562249	0.0467236	0.471575	-0.439019	0.146659	-0.474029	0.62 [0.33 - 1.18]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204290_s_at	62	0.370968	0.156682	-	-0.68327	0.675585	-0.104634	0.90 [0.55 - 1.47]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204290_s_at	125	0.576	0.0358518	0.398525	-0.858968	0.61493	-0.195157	0.82 [0.38 - 1.76]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221588_x_at	62	0.177419	0.0430012	0.447755	-1.07765	0.436676	-0.191628	0.83 [0.51 - 1.34]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204290_s_at	125	0.592	0.0212967	0.280055	-0.700525	0.370984	-0.263261	0.77 [0.43 - 1.37]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204290_s_at	54	0.203704	0.0681434	-	-1.0883	0.337693	-0.291798	0.75 [0.41 - 1.36]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221588_x_at	125	0.136	0.0372927	0.408846	15.2359	0.842632	0.0660387	1.07 [0.56 - 2.05]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221588_x_at	125	0.696	0.0482845	0.481229	-0.653031	0.540988	-0.1564	0.86 [0.52 - 1.41]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221588_x_at	54	0.166667	0.00463091	0.0890902	-1.70505	0.236531	-0.357739	0.70 [0.39 - 1.26]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204290_s_at	198	0.333333	0.193487	-	-0.354763	0.988223	0.002762	1.00 [0.69 - 1.45]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221588_x_at	198	0.782828	0.125925	-	-0.545915	0.854049	-0.0344448	0.97 [0.67 - 1.39]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221588_x_at	198	0.358586	0.0656883	-	-0.491072	0.842489	-0.0393604	0.96 [0.65 - 1.42]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204290_s_at	198	0.227273	0.255472	-	-0.274605	0.86641	0.0245736	1.02 [0.77 - 1.36]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204290_s_at	198	0.181818	0.264724	-	-0.347387	0.967247	-0.00728684	0.99 [0.70 - 1.41]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221588_x_at	198	0.848485	0.0270208	0.330113	-0.845713	0.877142	-0.0235633	0.98 [0.72 - 1.32]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204290_s_at	51	0.45098	0.24334	-	1.22632	0.897283	-0.210851	0.81 [0.03 - 19.89]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204290_s_at	62	0.274194	0.118519	-	1.48959	0.63787	0.483454	1.62 [0.22 - 12.14]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221588_x_at	51	0.196078	0.187473	-	-1.1436	0.66029	-0.472141	0.62 [0.08 - 5.12]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221588_x_at	62	0.209677	0.00983458	0.159445	-1.40755	0.935325	-0.0536284	0.95 [0.26 - 3.46]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204290_s_at	177	0.152542	0.00282412	0.0599906	2.39805	0.512112	0.202696	1.22 [0.67 - 2.25]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221588_x_at	177	0.338983	0.0377081	0.411782	0.547853	0.437989	0.213481	1.24 [0.72 - 2.12]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221588_x_at	145	0.17931	0.0450408	0.460948	1.3544	0.516501	0.247332	1.28 [0.61 - 2.70]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204290_s_at	177	0.152542	0.00804407	0.136882	1.27602	0.496617	0.180215	1.20 [0.71 - 2.01]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221588_x_at	177	0.350282	0.0223511	0.289677	0.711087	0.434926	0.250827	1.29 [0.68 - 2.41]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204290_s_at	145	0.137931	0.0105802	0.168447	15.2746	0.515601	0.238553	1.27 [0.62 - 2.61]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221588_x_at	226	0.610619	0.0127463	0.193483	-0.831252	0.188058	-0.334917	0.72 [0.43 - 1.18]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204290_s_at	226	0.756637	0.00106441	0.0268538	-1.72944	0.113999	-0.250795	0.78 [0.57 - 1.06]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221588_x_at	55	0.4	0.304761	-	0.499264	0.602511	0.28464	1.33 [0.46 - 3.88]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221588_x_at	49	0.469388	0.0670035	-	1.15862	0.620136	0.32697	1.39 [0.38 - 5.05]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204290_s_at	55	0.636364	0.0810935	-	0.830528	0.284593	0.512036	1.67 [0.65 - 4.26]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204290_s_at	55	0.363636	0.16645	-	0.701603	0.369665	0.406774	1.50 [0.62 - 3.65]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204290_s_at	49	0.571429	0.0284649	0.341967	1.2615	0.517451	0.369267	1.45 [0.47 - 4.43]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221588_x_at	55	0.745455	0.220584	-	-0.749709	0.843988	0.104498	1.11 [0.39 - 3.14]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221588_x_at	63	0.698413	0.00256865	0.0555543	-1.35704	0.198739	-0.227692	0.80 [0.56 - 1.13]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204290_s_at	63	0.603175	0.00300521	0.0630785	-1.13714	0.0941555	-0.249582	0.78 [0.58 - 1.04]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11095440_3p_a_at	28	0.142857	0.0384153	0.416742	-1.21205	0.6059	-0.810319	0.44 [0.02 - 9.66]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.293970.1.A1_3p_a_at	28	0.821429	0.345102	-	-0.714435	0.843515	-0.206185	0.81 [0.11 - 6.30]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204290_s_at	82	0.304878	0.000472383	0.0134984	-1.12616	0.0410972	-0.704386	0.49 [0.25 - 0.97]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221588_x_at	82	0.353659	0.0183508	0.252075	-0.777603	0.0678033	-0.609576	0.54 [0.28 - 1.05]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204290_s_at	79	0.506329	0.0367396	0.404909	-0.539074	0.429353	-0.194719	0.82 [0.51 - 1.33]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221588_x_at	79	0.177215	0.014981	0.217802	-0.789463	0.470021	-0.180369	0.83 [0.51 - 1.36]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221588_x_at	104	0.721154	0.00131189	0.0319728	-1.71675	0.00876634	-0.826511	0.44 [0.24 - 0.81]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204290_s_at	104	0.5	0.0125609	0.1914	-0.835638	0.0567412	-0.529311	0.59 [0.34 - 1.02]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P128967	117	0.222222	0.0270304	0.330192	-0.674927	0.295202	-0.20817	0.81 [0.55 - 1.20]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221588_x_at	204	0.279412	0.0302347	0.356116	-0.781494	0.153797	-0.55832	0.57 [0.27 - 1.23]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221588_x_at	204	0.284314	0.000376833	0.0111202	-0.940617	0.0563451	-0.555767	0.57 [0.32 - 1.02]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204290_s_at	204	0.47549	0.0221319	0.287693	-0.861246	0.0908484	-0.724422	0.48 [0.21 - 1.12]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204290_s_at	204	0.480392	0.0027419	0.0585734	-0.830324	0.144647	-0.453879	0.64 [0.35 - 1.17]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204290_s_at	178	0.533708	0.0636119	-	-0.372487	0.224996	-0.256704	0.77 [0.51 - 1.17]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221588_x_at	178	0.398876	0.152256	-	-0.285519	0.470076	-0.138298	0.87 [0.60 - 1.27]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200009618	41	0.439024	0.35223	-	0.395556	0.701364	0.124607	1.13 [0.60 - 2.14]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221588_x_at	111	0.252252	0.220536	-	0.39593	0.922747	-0.0368732	0.96 [0.46 - 2.03]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204290_s_at	111	0.891892	0.107281	-	0.607361	0.9749	-0.0112149	0.99 [0.49 - 1.99]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204290_s_at	90	0.111111	0.00424854	0.083214	-1.15079	0.885652	0.0651467	1.07 [0.44 - 2.59]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204290_s_at	90	0.111111	0.00343488	0.0702343	-1.27624	0.833294	0.108357	1.11 [0.41 - 3.06]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221588_x_at	90	0.111111	0.0954603	-	-0.728667	0.749782	0.136273	1.15 [0.50 - 2.65]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221588_x_at	90	0.111111	0.0952684	-	-0.801006	0.744178	0.159727	1.17 [0.45 - 3.06]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	592	50	0.16	0.210714	-	1.20679	0.98124	0.0488891	1.05 [0.02 - 61.81]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204290_s_at	138	0.231884	0.0859537	-	0.543081	0.919102	0.0100117	1.01 [0.83 - 1.23]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221588_x_at	138	0.347826	0.39746	-	0.221753	0.994424	-0.000779277	1.00 [0.80 - 1.24]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221588_x_at	129	0.868217	0.000391204	0.0114837	1.07744	0.120299	0.671643	1.96 [0.84 - 4.57]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204290_s_at	129	0.837209	0.0119643	0.184625	0.753314	0.605584	0.111527	1.12 [0.73 - 1.71]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18785	56	0.410714	0.230782	-	0.443928	0.99612	-0.00137738	1.00 [0.57 - 1.74]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35345	56	0.178571	0.109455	-	1.11478	0.986246	0.00454471	1.00 [0.60 - 1.68]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3756	56	0.375	0.0633056	-	0.695361	0.963968	-0.0118997	0.99 [0.59 - 1.66]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32108	56	0.357143	0.0981185	-	0.640631	0.880004	0.0375845	1.04 [0.64 - 1.69]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11292	56	0.178571	0.203234	-	0.75631	0.863645	0.0462472	1.05 [0.62 - 1.78]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32438	56	0.803571	0.206816	-	-0.610288	0.997643	0.000809872	1.00 [0.58 - 1.71]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28464	56	0.339286	0.0825298	-	0.687696	0.960282	-0.0111847	0.99 [0.64 - 1.54]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3756	56	0.285714	0.0996796	-	0.735432	0.961326	-0.0134594	0.99 [0.57 - 1.70]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32108	56	0.160714	0.110874	-	1.11077	0.825545	0.058526	1.06 [0.63 - 1.78]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18785	56	0.410714	0.131005	-	0.538809	0.943202	-0.0190967	0.98 [0.58 - 1.66]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35345	56	0.178571	0.158201	-	0.832366	0.994035	0.00185269	1.00 [0.62 - 1.63]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28464	56	0.857143	0.0713933	-	-1.05661	0.840909	-0.0474281	0.95 [0.60 - 1.52]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11292	56	0.267857	0.159953	-	0.590139	0.876276	0.0396761	1.04 [0.63 - 1.71]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32438	56	0.892857	0.173994	-	-0.956018	0.924853	-0.0243265	0.98 [0.59 - 1.62]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221588_x_at	278	0.820144	0.118906	-	-0.433028	0.625548	-0.0700315	0.93 [0.70 - 1.24]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204290_s_at	278	0.76259	0.0873386	-	-0.417262	0.459228	-0.104138	0.90 [0.68 - 1.19]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204290_s_at	133	0.157895	7.27895e-05	0.00264583	-1.04546	0.0490884	-0.216036	0.81 [0.65 - 1.00]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221588_x_at	133	0.390977	0.00794412	0.135579	-0.628263	0.180526	-0.200985	0.82 [0.61 - 1.10]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12247	81	0.518519	0.00580447	0.10638	1.48918	0.0249326	0.428369	1.53 [1.06 - 2.23]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204290_s_at	185	0.881081	0.00163638	0.0384009	0.751189	0.030231	0.391895	1.48 [1.04 - 2.11]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221588_x_at	185	0.410811	0.0219167	0.285737	0.416623	0.159858	0.276137	1.32 [0.90 - 1.94]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204290_s_at	185	0.881081	0.00771251	0.132541	0.690574	0.123578	0.304001	1.36 [0.92 - 2.00]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221588_x_at	185	0.421622	0.00850108	0.142777	0.437123	0.0737368	0.323034	1.38 [0.97 - 1.97]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P128967	110	0.109091	0.130916	-	0.683311	0.974964	0.00605895	1.01 [0.69 - 1.47]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P128967	110	0.109091	0.257765	-	0.799559	0.669897	0.115086	1.12 [0.66 - 1.90]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221588_x_at	80	0.8125	0.0153281	0.221458	-15.4102	0.336657	-0.408673	0.66 [0.29 - 1.53]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204290_s_at	80	0.8625	0.131839	-	-1.42538	0.950639	0.0223513	1.02 [0.50 - 2.08]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_2680	281	0.441281	0.000812502	0.0214003	-0.464509	0.00219561	-0.560987	0.57 [0.40 - 0.82]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221588_x_at	38	0.789474	0.012951	0.19577	1.34812	0.199145	0.781511	2.18 [0.66 - 7.20]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204290_s_at	38	0.894737	0.0356461	0.397034	1.29432	0.242107	0.590368	1.80 [0.67 - 4.85]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204290_s_at	140	0.342857	8.92132e-05	0.00316701	-1.08833	0.00121637	-0.659159	0.52 [0.35 - 0.77]
GENE	ALDH6A1	aldehyde dehydrogenase 6 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221588_x_at	140	0.357143	4.6308e-05	0.00177085	-1.13483	0.00375699	-0.501573	0.61 [0.43 - 0.85]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208951_at	30	0.833333	0.0230613	0.29605	1.14844	0.361213	0.20847	1.23 [0.79 - 1.93]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213591_at	30	0.2	0.10732	-	0.872293	0.790335	0.167811	1.18 [0.34 - 4.08]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208950_s_at	30	0.866667	0.0782407	-	0.973958	0.732176	0.0823044	1.09 [0.68 - 1.74]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1687508	165	0.218182	6.63753e-05	0.00243827	-0.99025	0.00177834	-0.24645	0.78 [0.67 - 0.91]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1687508	165	0.218182	1.95281e-05	0.000817507	-1.40418	7.47705e-05	-0.43456	0.65 [0.52 - 0.80]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213591_at	163	0.736196	0.000582032	0.01613	0.710566	0.0163494	1.03822	2.82 [1.21 - 6.59]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208950_s_at	163	0.736196	0.000794166	0.020992	0.705839	0.0194201	0.640303	1.90 [1.11 - 3.25]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208951_at	163	0.785276	0.00604912	0.109858	0.612072	0.0129602	0.83531	2.31 [1.19 - 4.46]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208951_at	79	0.898734	0.0195249	0.263429	0.936515	0.656032	0.137407	1.15 [0.63 - 2.10]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208950_s_at	79	0.873418	0.0367518	0.404997	0.79792	0.392836	0.245844	1.28 [0.73 - 2.25]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213591_at	79	0.139241	0.0697609	-	1.03532	0.871514	0.107526	1.11 [0.30 - 4.10]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208950_s_at	58	0.568965	0.00860232	0.14407	0.792542	0.0603875	0.2662	1.30 [0.99 - 1.72]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208951_at	58	0.862069	0.105958	-	0.648847	0.532748	0.154136	1.17 [0.72 - 1.89]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213591_at	58	0.862069	0.0446092	0.458186	0.785167	0.386564	0.134338	1.14 [0.84 - 1.55]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208950_s_at	34	0.147059	0.0309051	0.361371	-1.06065	0.101469	-0.422088	0.66 [0.40 - 1.09]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208951_at	34	0.794118	0.00866709	0.144895	-1.52989	0.0305794	-0.537261	0.58 [0.36 - 0.95]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213591_at	34	0.705882	0.0587491	-	-0.823387	0.408456	-0.17272	0.84 [0.56 - 1.27]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208951_at	158	0.658228	0.0175953	0.244616	-0.612667	0.0389687	-0.663629	0.51 [0.27 - 0.97]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213591_at	158	0.443038	0.228713	-	-0.277644	0.974237	0.0159089	1.02 [0.39 - 2.67]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208950_s_at	158	0.227848	0.0040085	0.0794556	-0.700856	0.0308982	-0.630556	0.53 [0.30 - 0.94]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208951_at	53	0.735849	0.0612652	-	-0.822528	0.851775	-0.0432407	0.96 [0.61 - 1.51]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208950_s_at	53	0.339623	0.046709	0.471483	-0.72138	0.314725	-0.19712	0.82 [0.56 - 1.21]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213591_at	53	0.150943	0.262446	-	-0.50167	0.875614	-0.0347734	0.97 [0.62 - 1.49]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208951_at	53	0.735849	0.194876	-	-0.584498	0.98918	-0.00350542	1.00 [0.60 - 1.65]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208950_s_at	53	0.339623	0.00491979	0.0934457	-0.951025	0.227982	-0.216937	0.80 [0.57 - 1.15]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213591_at	53	0.150943	0.0961172	-	-0.749482	0.740492	-0.0793037	0.92 [0.58 - 1.48]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208951_at	180	0.888889	0.0250391	0.313363	0.59622	0.480907	0.187961	1.21 [0.72 - 2.04]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213591_at	180	0.105556	0.115398	-	-0.483468	0.946841	0.00569733	1.01 [0.85 - 1.19]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208950_s_at	180	0.177778	0.128277	-	-0.403107	0.29741	-0.276472	0.76 [0.45 - 1.28]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208951_at	559	0.418605	0.0197893	0.265949	-0.463066	0.805048	-0.0398712	0.96 [0.70 - 1.32]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208950_s_at	559	0.837209	0.0804915	-	0.412984	0.753614	-0.0397928	0.96 [0.75 - 1.23]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213591_at	559	0.248658	0.0220652	0.287087	-0.491382	0.705596	-0.0484968	0.95 [0.74 - 1.23]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208950_s_at	77	0.623377	0.000101907	0.00356106	0.996248	0.175774	0.413661	1.51 [0.83 - 2.75]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208951_at	77	0.714286	0.077078	-	0.480338	0.391866	0.248702	1.28 [0.73 - 2.27]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213591_at	77	0.675325	0.0362937	0.401713	0.559112	0.771129	-0.0615162	0.94 [0.62 - 1.42]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208950_s_at	70	0.685714	0.00645774	0.115581	0.751741	0.00540606	0.634488	1.89 [1.21 - 2.95]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213591_at	70	0.4	0.000931043	0.0240012	0.924851	0.0029498	0.569837	1.77 [1.21 - 2.57]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208951_at	70	0.885714	0.000574685	0.0159565	1.30412	0.0114938	0.552511	1.74 [1.13 - 2.67]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36132_at	50	0.28	0.0482574	0.481063	0.928798	0.380366	0.255306	1.29 [0.73 - 2.28]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208951_at	74	0.337838	0.05572	-	0.626422	0.739348	0.11529	1.12 [0.57 - 2.21]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213591_at	74	0.121622	0.00937654	0.153805	-0.99159	0.506362	-0.219679	0.80 [0.42 - 1.53]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208950_s_at	74	0.472973	0.0429352	0.447323	0.611823	0.344172	0.340895	1.41 [0.69 - 2.85]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208951_at	67	0.850746	0.00341579	0.0699212	1.74186	0.168964	1.15131	3.16 [0.61 - 16.31]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208950_s_at	67	0.80597	0.019538	0.263555	1.44957	0.282774	0.878315	2.41 [0.48 - 11.95]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213591_at	67	0.641791	0.000392879	0.0115259	2.7879	0.0950285	1.59138	4.91 [0.76 - 31.81]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208950_s_at	115	0.217391	0.0399028	0.427015	-1.05948	0.745057	-0.291613	0.75 [0.13 - 4.33]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213591_at	115	0.208696	0.00237003	0.0520351	-1.49219	0.0351448	-1.58054	0.21 [0.05 - 0.90]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208951_at	115	0.895652	0.128125	-	0.950654	0.917453	0.0802421	1.08 [0.24 - 4.94]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36132_at	158	0.310127	0.153538	-	0.502148	0.935642	0.0241458	1.02 [0.57 - 1.84]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36132_at	76	0.644737	0.262682	-	0.57659	0.993476	0.00645359	1.01 [0.21 - 4.73]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213591_at	204	0.196078	0.0261138	0.322518	-0.3965	0.110216	-0.2478	0.78 [0.58 - 1.06]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208951_at	204	0.490196	9.85337e-05	0.00345702	0.546111	0.173938	0.199504	1.22 [0.92 - 1.63]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208950_s_at	204	0.387255	0.000894146	0.0231986	0.475086	0.193624	0.216239	1.24 [0.90 - 1.72]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208950_s_at	87	0.850575	0.040138	0.42862	0.869206	0.849446	0.0796356	1.08 [0.48 - 2.46]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208951_at	87	0.862069	0.027475	0.333872	0.930446	0.836232	0.088518	1.09 [0.47 - 2.53]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208950_s_at	87	0.850575	0.040138	0.42862	0.869206	0.849446	0.0796356	1.08 [0.48 - 2.46]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213591_at	87	0.885057	0.121699	-	0.754068	0.201014	0.432201	1.54 [0.79 - 2.99]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208951_at	87	0.862069	0.027475	0.333872	0.930446	0.836232	0.088518	1.09 [0.47 - 2.53]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213591_at	87	0.885057	0.121699	-	0.754068	0.201014	0.432201	1.54 [0.79 - 2.99]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213591_at	77	0.649351	0.0830473	-	1.06755	0.769513	0.195443	1.22 [0.33 - 4.49]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208951_at	77	0.103896	0.00838132	0.141242	-1.64886	0.247131	-0.596625	0.55 [0.20 - 1.51]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213591_at	77	0.558442	0.0446106	0.458195	1.1441	0.965871	0.0253471	1.03 [0.32 - 3.28]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208950_s_at	77	0.194805	0.0291411	0.34742	-1.32561	0.185466	-0.807466	0.45 [0.13 - 1.47]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208951_at	77	0.103896	0.0508925	-	-1.21715	0.33716	-0.434393	0.65 [0.27 - 1.57]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208950_s_at	77	0.220779	0.0723723	-	-0.989709	0.231217	-0.631826	0.53 [0.19 - 1.50]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213591_at	136	0.139706	0.000343642	0.0102719	-1.5745	0.0659875	-0.441315	0.64 [0.40 - 1.03]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208950_s_at	136	0.742647	0.0272752	0.332222	-1.9443	0.336993	-0.381724	0.68 [0.31 - 1.49]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208951_at	136	0.823529	0.0890147	-	-1.57936	0.145731	-0.803214	0.45 [0.15 - 1.32]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208951_at	200	0.145	0.262728	-	-0.413296	0.920895	-0.0311016	0.97 [0.52 - 1.79]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213591_at	200	0.895	0.0573806	-	-1.70716	0.693201	-0.119077	0.89 [0.49 - 1.60]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208950_s_at	200	0.86	0.106742	-	0.570606	0.858871	0.0704353	1.07 [0.49 - 2.33]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15106	60	0.833333	0.000996444	0.0254092	1.26675	0.0188846	0.588499	1.80 [1.10 - 2.94]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15106	60	0.833333	0.0164497	0.233065	0.976272	0.152407	0.309282	1.36 [0.89 - 2.08]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1874	155	0.167742	0.00626993	0.112964	2.25531	0.0927016	0.277633	1.32 [0.96 - 1.82]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208951_at	286	0.293706	0.00688936	0.121515	-0.532538	0.00688399	-0.64772	0.52 [0.33 - 0.84]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213591_at	286	0.356643	0.146163	-	-0.286211	0.381993	-0.121525	0.89 [0.67 - 1.16]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208950_s_at	286	0.625874	0.000755771	0.0201313	-0.73387	0.0877832	-0.346584	0.71 [0.47 - 1.05]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213591_at	159	0.138365	0.0042096	0.082608	-0.974929	0.056803	-0.314824	0.73 [0.53 - 1.01]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208951_at	159	0.654088	0.00533282	0.0995566	0.85728	0.0358054	0.8948	2.45 [1.06 - 5.64]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208951_at	159	0.654088	0.00126483	0.0310152	1.1549	0.0485769	0.980495	2.67 [1.01 - 7.06]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208950_s_at	159	0.685535	0.000291244	0.00890531	1.09568	0.0205844	0.875145	2.40 [1.14 - 5.03]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213591_at	159	0.207547	0.0155854	0.224148	-0.782872	0.0450651	-0.32707	0.72 [0.52 - 0.99]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213591_at	159	0.125786	0.000685468	0.0185343	-1.27532	0.0105689	-0.468551	0.63 [0.44 - 0.90]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208950_s_at	159	0.874214	0.0016084	0.0378578	1.09844	0.0188406	0.916423	2.50 [1.16 - 5.37]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208951_at	159	0.654088	0.00097825	0.0250193	1.00847	0.0631601	0.790821	2.21 [0.96 - 5.08]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208950_s_at	159	0.855346	0.001927	0.0439339	1.17699	0.0146324	1.07198	2.92 [1.24 - 6.91]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213591_at	54	0.111111	0.00157838	0.0372727	-1.99686	0.0445231	-3.10206	0.04 [0.00 - 0.93]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208950_s_at	54	0.296296	0.0548924	-	15.5642	0.248368	0.637995	1.89 [0.64 - 5.59]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208951_at	54	0.314815	0.0435431	0.451295	15.6154	0.294237	0.566634	1.76 [0.61 - 5.08]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208950_s_at	117	0.111111	0.276102	-	0.643859	0.422526	0.177248	1.19 [0.77 - 1.84]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208950_s_at	117	0.632479	0.234971	-	-0.520477	0.921278	-0.0262389	0.97 [0.58 - 1.64]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208951_at	117	0.786325	0.0780681	-	0.698694	0.675989	0.109575	1.12 [0.67 - 1.87]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208951_at	117	0.786325	0.0492316	0.486994	0.661427	0.408491	0.182592	1.20 [0.78 - 1.85]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208951_at	117	0.786325	0.0492316	0.486994	0.661427	0.408491	0.182592	1.20 [0.78 - 1.85]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208951_at	117	0.854701	0.131084	-	-1.41797	0.767421	-0.0792791	0.92 [0.55 - 1.56]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213591_at	117	0.880342	0.0467995	0.472048	0.739747	0.490295	0.20532	1.23 [0.69 - 2.20]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213591_at	117	0.683761	0.106475	-	0.604955	0.577173	0.21324	1.24 [0.58 - 2.62]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208950_s_at	117	0.111111	0.276102	-	0.643859	0.422526	0.177248	1.19 [0.77 - 1.84]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213591_at	117	0.683761	0.0760343	-	0.687721	0.873101	-0.0756807	0.93 [0.37 - 2.35]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208950_s_at	117	0.820513	0.294624	-	0.453139	0.767592	0.0761853	1.08 [0.65 - 1.79]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213591_at	117	0.880342	0.0467995	0.472048	0.739747	0.490295	0.20532	1.23 [0.69 - 2.20]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213591_at	236	0.728814	0.00909618	0.15031	0.704682	0.131595	0.323668	1.38 [0.91 - 2.11]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208950_s_at	236	0.868644	0.0161329	0.229818	0.792979	0.233814	0.402855	1.50 [0.77 - 2.90]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208951_at	236	0.733051	0.0168783	0.237422	0.652486	0.367999	0.40891	1.51 [0.62 - 3.67]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208950_s_at	249	0.899598	0.000960944	0.0246471	0.931773	0.0454223	0.557199	1.75 [1.01 - 3.01]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208951_at	249	0.746988	0.00374836	0.0753174	0.641268	0.172572	0.511447	1.67 [0.80 - 3.48]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213591_at	249	0.730924	0.0518545	-	0.435778	0.142687	0.25045	1.28 [0.92 - 1.80]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208950_s_at	62	0.887097	0.135312	-	0.840357	0.564466	0.315024	1.37 [0.47 - 4.00]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208950_s_at	125	0.68	0.014067	0.208024	0.905428	0.114078	0.426875	1.53 [0.90 - 2.60]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213591_at	54	0.777778	0.127096	-	-1.48455	0.725719	-0.146094	0.86 [0.38 - 1.95]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208951_at	62	0.370968	0.060764	-	-0.894866	0.838108	-0.0572614	0.94 [0.55 - 1.64]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208950_s_at	125	0.232	0.140236	-	0.6383	0.348677	0.201329	1.22 [0.80 - 1.86]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208950_s_at	54	0.259259	0.36062	-	0.695825	0.616347	0.339876	1.40 [0.37 - 5.31]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213591_at	62	0.145161	0.233859	-	1.1635	0.81855	-0.0779109	0.93 [0.48 - 1.80]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208951_at	125	0.488	0.0466517	0.471125	0.816793	0.198895	0.481295	1.62 [0.78 - 3.37]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208951_at	125	0.8	0.307835	-	-0.381276	0.750076	0.0961001	1.10 [0.61 - 1.99]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208951_at	54	0.148148	0.178109	-	15.2301	0.875073	-0.0541347	0.95 [0.48 - 1.86]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213591_at	125	0.744	0.00863086	0.144434	0.962794	0.374587	0.546333	1.73 [0.52 - 5.77]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213591_at	125	0.728	0.218647	-	0.366944	0.730541	-0.173353	0.84 [0.31 - 2.26]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208950_s_at	198	0.671717	0.148606	-	0.39004	0.749417	-0.0596106	0.94 [0.65 - 1.36]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213591_at	198	0.873737	0.186942	-	-0.462142	0.817722	-0.021392	0.98 [0.82 - 1.17]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208951_at	198	0.308081	0.211307	-	0.369169	0.634194	-0.0935966	0.91 [0.62 - 1.34]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208951_at	198	0.313131	0.254037	-	0.350373	0.444545	-0.157995	0.85 [0.57 - 1.28]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208950_s_at	198	0.79798	0.0120938	0.186104	0.584931	0.376681	0.134628	1.14 [0.85 - 1.54]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213591_at	198	0.873737	0.0137438	0.204512	-1.59685	0.132114	-0.157689	0.85 [0.70 - 1.05]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213591_at	198	0.89899	0.00733908	0.127584	-15.1966	0.0796355	-0.188599	0.83 [0.67 - 1.02]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208950_s_at	198	0.671717	0.0975252	-	0.428469	0.82316	0.0400158	1.04 [0.73 - 1.48]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208951_at	198	0.808081	0.0192326	0.260629	0.560656	0.6605	0.0757206	1.08 [0.77 - 1.51]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208950_s_at	51	0.607843	0.0546247	-	-15.9397	0.297945	-0.674736	0.51 [0.14 - 1.81]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208950_s_at	62	0.66129	0.00584849	0.107009	-15.8288	0.0305743	-0.947092	0.39 [0.16 - 0.92]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208951_at	51	0.411765	0.0044778	0.086753	-16.797	0.0987891	-1.78407	0.17 [0.02 - 1.40]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208951_at	62	0.725806	0.0211533	0.278731	-15.6064	0.0677447	-1.09378	0.33 [0.10 - 1.08]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213591_at	51	0.215686	0.00886824	0.147444	-2.05009	0.111072	-3.24446	0.04 [0.00 - 2.11]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213591_at	62	0.241935	0.00694995	0.12234	-1.44755	0.0309849	-2.60252	0.07 [0.01 - 0.79]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208951_at	177	0.740113	0.031401	0.365223	0.597755	0.0976877	0.440034	1.55 [0.92 - 2.61]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213591_at	177	0.480226	0.0815486	-	0.413473	0.558728	0.246929	1.28 [0.56 - 2.93]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208950_s_at	177	0.666667	0.037458	0.410017	0.563281	0.114936	0.410471	1.51 [0.90 - 2.51]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208951_at	177	0.463277	0.00719254	0.125619	0.66074	0.0409793	0.473852	1.61 [1.02 - 2.53]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213591_at	145	0.882759	0.0912729	-	0.697859	0.696576	0.238353	1.27 [0.38 - 4.21]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208950_s_at	177	0.666667	0.00297848	0.0626256	0.68838	0.0358832	0.479264	1.61 [1.03 - 2.53]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208951_at	145	0.731034	0.177941	-	0.463003	0.897187	0.039347	1.04 [0.57 - 1.89]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208950_s_at	145	0.227586	0.171045	-	-0.49279	0.958657	0.0150779	1.02 [0.57 - 1.80]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213591_at	177	0.480226	0.0898803	-	0.466612	0.433236	0.376611	1.46 [0.57 - 3.74]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213591_at	226	0.526549	0.0566809	-	-0.563752	0.577162	-0.100942	0.90 [0.63 - 1.29]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208951_at	226	0.362832	0.0044173	0.0858237	-0.788336	0.0638125	-0.333118	0.72 [0.50 - 1.02]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208950_s_at	226	0.504425	0.0279641	0.337888	-0.6373	0.119543	-0.330557	0.72 [0.47 - 1.09]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213591_at	55	0.145455	0.000730388	0.0195579	-1.72304	0.174254	-1.75827	0.17 [0.01 - 2.18]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208951_at	55	0.872727	0.0283153	0.340751	1.09583	0.148159	0.550686	1.73 [0.82 - 3.66]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213591_at	49	0.102041	0.00384288	0.0768291	-1.72971	0.228413	-1.96259	0.14 [0.01 - 3.43]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208950_s_at	55	0.181818	0.0590695	-	1.71975	0.211934	0.41621	1.52 [0.79 - 2.91]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208951_at	55	0.872727	0.006131	0.111013	1.44384	0.0831356	0.728996	2.07 [0.91 - 4.73]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208951_at	49	0.897959	0.0251663	0.314456	1.43303	0.0834182	0.876322	2.40 [0.89 - 6.48]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208950_s_at	55	0.890909	0.0186107	0.254613	1.42789	0.0930529	0.656346	1.93 [0.90 - 4.15]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208950_s_at	49	0.469388	0.0626568	-	1.17714	0.0864309	0.748671	2.11 [0.90 - 4.98]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213591_at	55	0.127273	2.66574e-05	0.00108112	-1.86999	0.0811831	-2.10217	0.12 [0.01 - 1.30]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213591_at	63	0.222222	0.0184064	0.252619	-0.822044	0.42905	-0.352828	0.70 [0.29 - 1.68]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208951_at	63	0.269841	0.0672534	-	0.758015	0.212103	0.208044	1.23 [0.89 - 1.71]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208950_s_at	63	0.825397	0.0418277	0.440002	0.780686	0.294678	0.187059	1.21 [0.85 - 1.71]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12803386_3p_a_at	28	0.642857	0.0650495	-	-1.31829	0.423541	-0.490207	0.61 [0.18 - 2.03]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.74294.1.S1_3p_at	28	0.535714	0.121641	-	-0.870115	0.4151	-0.557028	0.57 [0.15 - 2.19]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213591_at	82	0.134146	0.135629	-	1.04032	0.447819	0.433846	1.54 [0.50 - 4.73]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208950_s_at	82	0.487805	0.0406024	0.431774	-0.707154	0.379271	-0.555514	0.57 [0.17 - 1.98]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208951_at	82	0.682927	0.0439263	0.453783	-0.832114	0.25445	-0.508255	0.60 [0.25 - 1.44]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213591_at	79	0.367089	0.022283	0.289062	-0.598022	0.311278	-0.44529	0.64 [0.27 - 1.52]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208950_s_at	79	0.443038	0.0737203	-	0.4714	0.490505	0.318218	1.37 [0.56 - 3.40]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208951_at	79	0.683544	0.103514	-	0.433893	0.987849	0.00485552	1.00 [0.54 - 1.88]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	S74728_at	86	0.127907	0.145762	-	-0.787601	0.710826	-0.208899	0.81 [0.27 - 2.45]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208951_at	104	0.673077	0.0514689	-	-0.79771	0.215342	-0.495455	0.61 [0.28 - 1.33]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213591_at	104	0.326923	0.240635	-	0.443555	0.876607	0.111165	1.12 [0.27 - 4.55]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208950_s_at	104	0.884615	0.0706101	-	-1.64216	0.518613	-0.40077	0.67 [0.20 - 2.26]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P70231	117	0.452991	0.215654	-	0.359361	0.889369	-0.0284604	0.97 [0.65 - 1.45]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P269006	117	0.760684	0.102981	-	-0.620789	0.163689	-0.205269	0.81 [0.61 - 1.09]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208950_s_at	204	0.230392	0.00118068	0.0292851	-1.14016	0.0558292	-0.782094	0.46 [0.21 - 1.02]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208950_s_at	204	0.102941	0.0240295	0.304603	-0.804457	0.103181	-0.523534	0.59 [0.32 - 1.11]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213591_at	204	0.843137	0.0105289	0.167835	-15.3219	0.062388	-0.859703	0.42 [0.17 - 1.05]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213591_at	204	0.161765	0.000334304	0.0100309	-1.03089	0.00252756	-1.03042	0.36 [0.18 - 0.70]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208951_at	204	0.210784	0.0154829	0.223078	-0.888995	0.0631688	-0.821833	0.44 [0.18 - 1.05]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208951_at	204	0.656863	0.0665664	-	-0.576126	0.246402	-0.384341	0.68 [0.36 - 1.30]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213591_at	178	0.696629	0.0365362	0.403454	-0.478408	0.181552	-0.400473	0.67 [0.37 - 1.21]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208950_s_at	178	0.882023	0.0472792	0.475033	-0.716806	0.180167	-0.455528	0.63 [0.33 - 1.23]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208951_at	178	0.775281	0.0752771	-	-0.441348	0.271242	-0.185193	0.83 [0.60 - 1.16]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213591_at	111	0.513514	0.123001	-	-0.407071	0.501471	-0.104216	0.90 [0.66 - 1.22]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208951_at	111	0.657658	0.164582	-	0.371637	0.611604	0.107232	1.11 [0.74 - 1.68]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208950_s_at	111	0.378378	0.0831252	-	0.494791	0.564788	0.0971782	1.10 [0.79 - 1.53]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213591_at	90	0.588889	0.313242	-	0.32937	0.677527	0.490235	1.63 [0.16 - 16.46]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213591_at	90	0.588889	0.128353	-	0.559458	0.47102	0.944159	2.57 [0.20 - 33.50]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208950_s_at	90	0.122222	0.132956	-	-0.620369	0.822739	0.0787285	1.08 [0.54 - 2.15]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208950_s_at	90	0.266667	0.259784	-	-0.437757	0.89643	0.0532754	1.05 [0.47 - 2.35]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208951_at	90	0.444444	0.0853625	-	0.581313	0.371434	0.280435	1.32 [0.72 - 2.45]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208951_at	90	0.444444	0.163268	-	0.538584	0.245452	0.417881	1.52 [0.75 - 3.07]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1582	50	0.12	0.0886338	-	15.255	0.375264	0.662266	1.94 [0.45 - 8.38]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208950_s_at	138	0.514493	0.0556444	-	0.460377	0.613351	0.0398498	1.04 [0.89 - 1.21]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213591_at	138	0.202899	0.00837299	0.141135	-0.67913	0.159621	-0.41665	0.66 [0.37 - 1.18]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208951_at	138	0.521739	0.0846635	-	0.414737	0.679039	0.0332111	1.03 [0.88 - 1.21]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208951_at	129	0.209302	0.00863774	0.144521	0.918704	0.0735405	0.433318	1.54 [0.96 - 2.48]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213591_at	129	0.465116	0.0879138	-	-0.427804	0.258546	-0.16035	0.85 [0.64 - 1.13]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208950_s_at	129	0.713178	0.0121142	0.186338	0.65205	0.0593649	0.273596	1.31 [0.99 - 1.75]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4139	56	0.892857	0.0598783	-	-1.30266	0.6522	-0.0556275	0.95 [0.74 - 1.20]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25256	56	0.785714	0.0261577	0.322888	-1.13766	0.474825	-0.104078	0.90 [0.68 - 1.20]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4139	56	0.892857	0.0374553	0.409997	-1.8501	0.639678	-0.0604795	0.94 [0.73 - 1.21]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25256	56	0.785714	0.0242603	0.30662	-1.05687	0.479012	-0.0989916	0.91 [0.69 - 1.19]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213591_at	278	0.503597	0.159704	-	0.266103	0.739832	0.0633394	1.07 [0.73 - 1.55]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208951_at	278	0.514389	0.0684417	-	0.349656	0.581669	0.102139	1.11 [0.77 - 1.59]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208950_s_at	278	0.44964	0.13846	-	0.289688	0.488512	0.127558	1.14 [0.79 - 1.63]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208950_s_at	133	0.105263	0.0262929	0.324027	-0.696854	0.180838	-0.209626	0.81 [0.60 - 1.10]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208951_at	133	0.263158	0.0768723	-	-0.442991	0.362162	-0.134691	0.87 [0.65 - 1.17]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213591_at	133	0.609023	3.66168e-05	0.00143628	0.953289	0.0018397	0.616184	1.85 [1.26 - 2.73]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7088	81	0.37037	0.00552655	0.102378	-1.38144	0.0480869	-1.14255	0.32 [0.10 - 0.99]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14100	81	0.395062	0.0142335	0.209822	-1.2651	0.010345	-0.816758	0.44 [0.24 - 0.82]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4054	81	0.197531	0.19251	-	-0.765433	0.480608	-0.364133	0.69 [0.25 - 1.91]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208951_at	185	0.859459	0.15861	-	-0.333732	0.988945	0.00180107	1.00 [0.78 - 1.29]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213591_at	185	0.237838	0.0484269	0.4821	0.444509	0.904658	0.0512021	1.05 [0.46 - 2.43]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208950_s_at	185	0.221622	0.130166	-	-0.297474	0.612747	-0.0629992	0.94 [0.74 - 1.20]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208951_at	185	0.859459	0.17501	-	-0.354417	0.979541	0.0036361	1.00 [0.76 - 1.33]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208950_s_at	185	0.178378	0.122958	-	-0.345426	0.776933	-0.0381764	0.96 [0.74 - 1.25]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213591_at	185	0.778378	0.0672818	-	-0.370057	0.766219	-0.118016	0.89 [0.41 - 1.93]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P70231	110	0.7	0.00145227	0.0347894	0.749684	0.414116	0.176234	1.19 [0.78 - 1.82]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P70231	110	0.154545	0.000180091	0.00586605	-1.31891	0.56628	-0.159135	0.85 [0.50 - 1.47]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208951_at	80	0.2625	0.103058	-	0.982868	0.520438	0.259932	1.30 [0.59 - 2.87]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213591_at	80	0.8875	0.07315	-	0.967406	0.442425	0.182697	1.20 [0.75 - 1.91]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208950_s_at	80	0.5875	0.0773946	-	-0.884526	0.580928	-0.198629	0.82 [0.41 - 1.66]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_5790	281	0.508897	0.00349748	0.0712583	-0.410804	0.0121371	-0.353349	0.70 [0.53 - 0.93]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:278976	59	0.338983	0.00116889	0.0290407	-1.49304	0.0118613	-1.40626	0.25 [0.08 - 0.73]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213591_at	38	0.236842	0.00441487	0.0857863	2.40439	0.0552549	0.520682	1.68 [0.99 - 2.87]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208951_at	38	0.289474	0.00243052	0.0531136	2.0662	0.0128416	1.18406	3.27 [1.29 - 8.30]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208950_s_at	38	0.289474	0.00243052	0.0531136	2.0662	0.0306408	1.04725	2.85 [1.10 - 7.37]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213591_at	140	0.442857	1.60577e-05	0.000685435	-1.25598	0.000458654	-3.00521	0.05 [0.01 - 0.27]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208950_s_at	140	0.264286	0.0274344	0.333537	-0.64786	0.708159	-0.121683	0.89 [0.47 - 1.67]
GENE	ALDH7A1	aldehyde dehydrogenase 7 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208951_at	140	0.342857	0.144801	-	-0.42544	0.604491	-0.167211	0.85 [0.45 - 1.59]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201612_at	30	0.833333	0.0100918	0.162574	-1.71822	0.117311	-0.563421	0.57 [0.28 - 1.15]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1761804	165	0.769697	0.00526489	0.0985606	-1.06325	0.680895	-0.0540446	0.95 [0.73 - 1.23]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1761804	165	0.466667	0.0112657	0.176543	-0.913264	0.377518	-0.164512	0.85 [0.59 - 1.22]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201612_at	163	0.337423	0.24605	-	0.24727	0.899575	0.0235544	1.02 [0.71 - 1.48]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201612_at	79	0.898734	0.0358965	0.398848	0.842775	0.34949	0.263404	1.30 [0.75 - 2.26]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201612_at	58	0.758621	0.0929978	-	0.546391	0.102202	0.610355	1.84 [0.89 - 3.83]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201612_at	34	0.5	0.000811193	0.0213713	1.2774	0.00762829	1.53242	4.63 [1.50 - 14.27]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201612_at	158	0.132911	0.13272	-	0.587692	0.32754	0.370066	1.45 [0.69 - 3.04]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201612_at	53	0.867925	0.122378	-	-1.0765	0.829774	0.0897911	1.09 [0.48 - 2.48]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201612_at	53	0.849057	0.11836	-	-1.09074	0.904408	0.0538443	1.06 [0.44 - 2.54]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201612_at	180	0.127778	0.0495794	0.489095	0.715258	0.111315	0.701718	2.02 [0.85 - 4.78]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201612_at	559	0.44186	0.123922	-	0.311301	0.530382	0.218319	1.24 [0.63 - 2.46]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201612_at	77	0.298701	0.0808277	-	0.514553	0.273704	0.412964	1.51 [0.72 - 3.17]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201612_at	70	0.271429	0.0485472	0.482835	0.630469	0.218026	0.444149	1.56 [0.77 - 3.16]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33899_at	50	0.58	0.10783	-	-0.591538	0.328633	-0.259359	0.77 [0.46 - 1.30]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201612_at	74	0.297297	0.0526722	-	-0.572191	0.175089	-0.632515	0.53 [0.21 - 1.33]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201612_at	67	0.522388	0.256813	-	0.78647	0.73559	0.471259	1.60 [0.10 - 24.69]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201612_at	115	0.895652	0.186254	-	-15.1878	0.34915	-0.612643	0.54 [0.15 - 1.95]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33899_at	158	0.537975	0.00876203	0.1461	-0.790835	0.0376629	-0.763665	0.47 [0.23 - 0.96]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33899_at	76	0.657895	0.0356393	0.396984	1.06032	0.192096	0.830071	2.29 [0.66 - 7.98]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201612_at	204	0.696078	0.184586	-	-0.20016	0.339365	-0.185831	0.83 [0.57 - 1.22]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201612_at	87	0.114943	0.00459012	0.0884695	-1.17275	0.0340705	-0.997277	0.37 [0.15 - 0.93]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201612_at	87	0.114943	0.00459012	0.0884695	-1.17275	0.0340705	-0.997277	0.37 [0.15 - 0.93]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201612_at	77	0.103896	0.00176301	0.0408354	-1.6846	0.222798	-0.943624	0.39 [0.09 - 1.77]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201612_at	77	0.103896	0.0195444	0.263616	-1.47849	0.176192	-1.20559	0.30 [0.05 - 1.72]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201612_at	136	0.330882	0.0798604	-	-0.767206	0.626411	-0.307532	0.74 [0.21 - 2.54]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201612_at	200	0.105	0.00596967	0.108733	-0.951167	0.46851	-0.334686	0.72 [0.29 - 1.77]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10148	60	0.883333	0.137481	-	0.715763	0.34323	0.634453	1.89 [0.51 - 7.00]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10148	60	0.866667	0.000664403	0.0180502	1.39805	0.0601643	1.22452	3.40 [0.95 - 12.20]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	11183	155	0.819355	5.86903e-05	0.00218616	1.10456	0.000306453	0.248313	1.28 [1.12 - 1.47]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201612_at	286	0.353147	0.167049	-	-0.272844	0.982534	0.00562308	1.01 [0.61 - 1.66]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201612_at	159	0.899371	0.0724723	-	0.730907	0.514767	0.296426	1.35 [0.55 - 3.28]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201612_at	159	0.188679	0.237238	-	-0.486308	0.717022	-0.194954	0.82 [0.29 - 2.36]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201612_at	159	0.735849	0.174593	-	0.446409	0.941139	0.0335507	1.03 [0.42 - 2.52]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201612_at	54	0.296296	0.18726	-	-0.862164	0.827016	-0.14952	0.86 [0.23 - 3.29]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201612_at	117	0.811966	0.121407	-	-0.796017	0.769248	0.0784194	1.08 [0.64 - 1.83]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201612_at	117	0.811966	0.0924326	-	-1.16807	0.898307	-0.0400602	0.96 [0.52 - 1.78]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201612_at	117	0.811966	0.121407	-	-0.796017	0.769248	0.0784194	1.08 [0.64 - 1.83]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201612_at	117	0.487179	0.0731389	-	0.738318	0.755555	0.107181	1.11 [0.57 - 2.19]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201612_at	236	0.122881	0.0101439	0.163206	-0.817009	0.125544	-0.674445	0.51 [0.21 - 1.21]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201612_at	249	0.208835	0.142317	-	-0.360401	0.55159	-0.207838	0.81 [0.41 - 1.61]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201612_at	62	0.177419	0.0332603	0.379407	-1.06061	0.312238	-0.375262	0.69 [0.33 - 1.42]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201612_at	125	0.688	0.0114486	0.178674	0.932941	0.383822	0.350024	1.42 [0.65 - 3.12]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201612_at	125	0.312	0.197182	-	-0.413338	0.621933	-0.153771	0.86 [0.47 - 1.58]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201612_at	54	0.203704	0.0112231	0.176044	-1.47483	0.100979	-0.786888	0.46 [0.18 - 1.17]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201612_at	198	0.535354	0.0790974	-	-0.463913	0.239449	-0.277301	0.76 [0.48 - 1.20]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201612_at	198	0.19697	0.0442283	0.455735	-0.588262	0.239684	-0.282948	0.75 [0.47 - 1.21]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201612_at	198	0.176768	0.0391903	0.42212	-0.519159	0.0977643	-0.330335	0.72 [0.49 - 1.06]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201612_at	51	0.431373	0.297319	-	1.10809	0.605832	0.518749	1.68 [0.23 - 12.05]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201612_at	62	0.145161	0.129607	-	15.2851	0.500569	0.447264	1.56 [0.43 - 5.75]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201612_at	145	0.834483	0.0425282	0.444644	-1.3673	0.899788	-0.0681907	0.93 [0.32 - 2.70]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201612_at	177	0.847458	0.00214649	0.0479937	-2.44525	0.431454	-0.35858	0.70 [0.29 - 1.71]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201612_at	177	0.858757	0.0605579	-	-0.78128	0.718601	-0.143207	0.87 [0.40 - 1.89]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201612_at	226	0.628319	0.00342989	0.0701525	-0.993523	0.0144131	-0.918368	0.40 [0.19 - 0.83]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201612_at	49	0.408163	0.0525529	-	-1.1297	0.738935	0.233837	1.26 [0.32 - 5.00]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201612_at	55	0.181818	0.0590695	-	1.71975	0.810442	0.118714	1.13 [0.43 - 2.97]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201612_at	55	0.2	0.00797312	0.135958	15.558	0.357546	0.525419	1.69 [0.55 - 5.18]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201612_at	63	0.857143	0.00330622	0.0681155	-2.40818	0.0940274	-0.501531	0.61 [0.34 - 1.09]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502046_3p_at	28	0.25	0.0528834	-	1.4147	0.959079	0.00985197	1.01 [0.69 - 1.47]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201612_at	82	0.280488	4.56978e-05	0.00175006	-1.32741	0.0193858	-1.1896	0.30 [0.11 - 0.83]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33899_at	84	0.107143	0.00756376	0.130575	-1.01618	0.125826	-0.591228	0.55 [0.26 - 1.18]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201612_at	79	0.177215	0.0122473	0.187853	1.04104	0.469802	0.276729	1.32 [0.62 - 2.79]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U34252_at	86	0.197674	0.000273132	0.00842421	-1.40394	0.00344717	-1.70233	0.18 [0.06 - 0.57]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201612_at	104	0.182692	0.00266842	0.0572985	-1.01981	0.0193827	-1.52413	0.22 [0.06 - 0.78]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P385280	117	0.17094	0.0680191	-	-0.597929	0.437532	-0.215172	0.81 [0.47 - 1.39]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201612_at	204	0.269608	0.0125299	0.191051	-0.890044	0.0322473	-1.93792	0.14 [0.02 - 0.85]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201612_at	204	0.117647	0.00192814	0.0439553	-0.977591	0.0909795	-1.16466	0.31 [0.08 - 1.20]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201612_at	178	0.146067	0.000776754	0.0206026	-0.791282	0.0127045	-0.939444	0.39 [0.19 - 0.82]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200000635	41	0.731707	0.122111	-	0.665628	0.513809	0.267749	1.31 [0.59 - 2.92]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201612_at	111	0.54955	0.0180191	0.248815	-0.644	0.0760806	-0.756972	0.47 [0.20 - 1.08]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201612_at	90	0.155556	0.0833047	-	-0.680794	0.728169	-0.11714	0.89 [0.46 - 1.72]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201612_at	90	0.155556	0.0544481	-	-0.816837	0.277631	-0.402562	0.67 [0.32 - 1.38]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201612_at	138	0.507246	0.248083	-	0.282584	0.932699	0.0189462	1.02 [0.66 - 1.58]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201612_at	129	0.341085	0.0377466	0.412054	0.57898	0.874986	0.0535491	1.06 [0.54 - 2.06]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40243	56	0.196429	0.140277	-	-0.642073	0.656712	-0.163294	0.85 [0.41 - 1.75]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21896	56	0.553571	0.0708257	-	0.664375	0.866687	0.0671033	1.07 [0.49 - 2.34]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40243	56	0.196429	0.22524	-	-0.494949	0.924524	0.0317624	1.03 [0.54 - 1.99]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21896	56	0.553571	0.17279	-	0.47672	0.930868	-0.0326697	0.97 [0.46 - 2.02]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201612_at	278	0.18705	1.38589e-05	0.000600161	-0.90421	0.00290338	-0.644164	0.53 [0.34 - 0.80]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201612_at	133	0.631579	0.000491001	0.013952	-0.938015	0.0117554	-0.352632	0.70 [0.53 - 0.92]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3261	81	0.617284	0.0625378	-	-1.14349	0.500168	-0.423204	0.65 [0.19 - 2.24]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201612_at	185	0.178378	0.0413745	0.436975	0.437761	0.308115	0.147424	1.16 [0.87 - 1.54]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201612_at	185	0.843243	0.0170486	0.239141	0.530103	0.315318	0.161612	1.18 [0.86 - 1.61]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P385280	110	0.536364	0.0615873	-	0.558517	0.651761	0.111397	1.12 [0.69 - 1.81]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P385280	110	0.772727	0.134924	-	-0.438069	0.724759	-0.068548	0.93 [0.64 - 1.37]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201612_at	80	0.8375	0.014433	0.211966	1.1635	0.154232	0.664886	1.94 [0.78 - 4.85]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_4190	281	0.19573	0.267705	-	0.193109	0.698257	0.0427579	1.04 [0.84 - 1.30]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201612_at	38	0.815789	0.0116991	0.181576	1.36263	0.0352889	1.55918	4.75 [1.11 - 20.31]
GENE	ALDH9A1	aldehyde dehydrogenase 9 family, member A1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201612_at	140	0.35	0.000663119	0.0180206	-0.960679	0.0030318	-0.632392	0.53 [0.35 - 0.81]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	200966_x_at	30	0.633333	0.0220865	0.28728	0.925248	0.254197	0.569115	1.77 [0.66 - 4.70]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214687_x_at	30	0.566667	0.00864771	0.144648	1.07136	0.377581	0.475653	1.61 [0.56 - 4.63]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1723927	165	0.315152	0.12027	-	-0.380788	0.969181	0.00579246	1.01 [0.75 - 1.35]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1723927	165	0.406061	0.212026	-	-0.438189	0.511823	-0.142019	0.87 [0.57 - 1.33]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214687_x_at	163	0.644172	0.0901778	-	-0.365539	0.889914	0.0300432	1.03 [0.67 - 1.58]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	200966_x_at	163	0.705521	0.215086	-	-0.284019	0.930969	-0.0174068	0.98 [0.66 - 1.46]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	238996_x_at	163	0.546012	0.179747	-	0.264891	0.897615	0.0219518	1.02 [0.73 - 1.43]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	238996_x_at	79	0.278481	0.0233976	0.299038	0.821653	0.0977859	0.434868	1.54 [0.92 - 2.58]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214687_x_at	79	0.721519	0.00953768	0.155799	0.785449	0.228074	0.42184	1.52 [0.77 - 3.03]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	200966_x_at	79	0.759494	0.0223556	0.289718	0.711425	0.29598	0.353123	1.42 [0.73 - 2.76]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200966_x_at	58	0.344828	0.0439154	0.453713	-0.597903	0.272862	-0.264006	0.77 [0.48 - 1.23]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214687_x_at	58	0.413793	0.0498045	0.49045	-0.583009	0.452205	-0.180306	0.84 [0.52 - 1.34]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200966_x_at	34	0.117647	0.049437	0.488236	1.77039	0.601486	0.118489	1.13 [0.72 - 1.76]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214687_x_at	34	0.117647	0.114428	-	1.4766	0.225526	0.234789	1.26 [0.87 - 1.85]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	200966_x_at	158	0.373418	0.00594158	0.108334	-0.635921	0.227964	-0.278368	0.76 [0.48 - 1.19]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214687_x_at	158	0.28481	0.00851378	0.14294	-0.631517	0.354712	-0.23149	0.79 [0.49 - 1.30]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214687_x_at	53	0.113208	0.0674976	-	-0.874145	0.82109	-0.15681	0.85 [0.22 - 3.33]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	200966_x_at	53	0.169811	0.257675	-	0.595382	0.745648	-0.19661	0.82 [0.25 - 2.69]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214687_x_at	53	0.113208	0.216711	-	-0.591554	0.830016	-0.134228	0.87 [0.26 - 2.98]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	200966_x_at	53	0.377358	0.204523	-	-0.461641	0.671959	-0.289008	0.75 [0.20 - 2.85]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	200966_x_at	180	0.761111	0.0298609	0.353161	-0.620802	0.947992	-0.0242065	0.98 [0.47 - 2.02]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214687_x_at	180	0.861111	0.141753	-	-0.537691	0.937531	-0.030598	0.97 [0.45 - 2.08]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	238996_x_at	180	0.788889	0.0641359	-	-0.547947	0.43728	-0.160306	0.85 [0.57 - 1.28]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	238996_x_at	559	0.88551	0.0586402	-	0.527829	0.682273	0.0405733	1.04 [0.86 - 1.26]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214687_x_at	559	0.747764	3.27301e-05	0.00129922	0.864386	0.080878	0.469921	1.60 [0.94 - 2.71]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	200966_x_at	559	0.744186	2.73946e-05	0.00110788	0.892267	0.18952	0.345134	1.41 [0.84 - 2.36]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	200966_x_at	77	0.402597	0.00227322	0.0502957	-0.78937	0.246638	-0.335496	0.71 [0.41 - 1.26]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214687_x_at	77	0.324675	0.00547965	0.101698	-0.755433	0.283929	-0.327699	0.72 [0.40 - 1.31]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	238996_x_at	77	0.155844	0.00730478	0.127126	-0.869822	0.286131	-0.206126	0.81 [0.56 - 1.19]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	238996_x_at	70	0.857143	0.130881	-	0.553052	0.694358	0.102505	1.11 [0.66 - 1.85]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214687_x_at	70	0.885714	0.0111041	0.174649	0.972257	0.553909	0.181818	1.20 [0.66 - 2.19]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	200966_x_at	70	0.814286	0.0643986	-	0.601535	0.504889	0.19679	1.22 [0.68 - 2.17]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32336_at	50	0.88	0.00184773	0.0424435	1.37998	0.048227	0.80887	2.25 [1.01 - 5.01]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	200966_x_at	74	0.216216	0.0106498	0.169277	1.07524	0.165005	0.793029	2.21 [0.72 - 6.77]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214687_x_at	74	0.756757	0.0136397	0.203374	0.761351	0.0832055	0.964731	2.62 [0.88 - 7.82]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	238996_x_at	74	0.175676	0.00494957	0.0938909	-0.915699	0.51117	-0.176879	0.84 [0.49 - 1.42]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214687_x_at	67	0.791045	0.00026337	0.00816289	2.17876	0.0640311	2.60279	13.50 [0.86 - 212.18]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	238996_x_at	67	0.850746	0.00703825	0.123537	1.64305	0.0509781	1.7669	5.85 [0.99 - 34.51]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	200966_x_at	67	0.791045	0.00026337	0.00816289	2.17876	0.0486636	2.60095	13.48 [1.02 - 178.88]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214687_x_at	115	0.286957	0.217408	-	0.911435	0.362255	0.644903	1.91 [0.48 - 7.63]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	200966_x_at	115	0.104348	0.186254	-	15.1878	0.327478	0.707676	2.03 [0.49 - 8.37]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	238996_x_at	115	0.8	0.0963485	-	0.902292	0.426797	0.490092	1.63 [0.49 - 5.47]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32336_at	158	0.613924	0.00622949	0.112397	0.759365	0.177598	0.431806	1.54 [0.82 - 2.89]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32336_at	76	0.881579	0.160759	-	0.803593	0.911146	0.0565558	1.06 [0.39 - 2.86]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214687_x_at	204	0.102941	0.204795	-	0.287811	0.407287	0.151083	1.16 [0.81 - 1.66]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	238996_x_at	204	0.897059	0.0324522	0.373292	0.492489	0.199624	0.161314	1.18 [0.92 - 1.50]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	200966_x_at	204	0.102941	0.307249	-	0.233178	0.453391	0.128216	1.14 [0.81 - 1.59]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214687_x_at	87	0.793103	0.0333624	0.380174	0.81711	0.551501	0.226909	1.25 [0.59 - 2.65]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	200966_x_at	87	0.816092	0.030506	0.358249	0.850866	0.552555	0.222445	1.25 [0.60 - 2.60]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214687_x_at	87	0.793103	0.0333624	0.380174	0.81711	0.551501	0.226909	1.25 [0.59 - 2.65]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	200966_x_at	87	0.816092	0.030506	0.358249	0.850866	0.552555	0.222445	1.25 [0.60 - 2.60]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	238996_x_at	87	0.885057	0.04634	0.469172	0.889893	0.477509	0.199675	1.22 [0.70 - 2.12]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	238996_x_at	87	0.885057	0.04634	0.469172	0.889893	0.477509	0.199675	1.22 [0.70 - 2.12]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214687_x_at	77	0.896104	8.6001e-08	5.57694e-06	2.39365	0.131408	1.05478	2.87 [0.73 - 11.30]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	238996_x_at	77	0.896104	0.00030083	0.00915803	2.00355	0.170566	0.745176	2.11 [0.73 - 6.12]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	200966_x_at	77	0.896104	8.6001e-08	5.57694e-06	2.39365	0.120096	1.0468	2.85 [0.76 - 10.66]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214687_x_at	77	0.896104	0.000383245	0.0112826	1.96831	0.360265	0.695346	2.00 [0.45 - 8.89]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	238996_x_at	77	0.896104	1.2788e-05	0.000558113	2.11207	0.0937072	0.819791	2.27 [0.87 - 5.92]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	200966_x_at	77	0.896104	0.000383245	0.0112826	1.96831	0.291007	0.776843	2.17 [0.51 - 9.20]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214687_x_at	136	0.610294	0.0183281	0.251852	1.04813	0.720229	-0.140345	0.87 [0.40 - 1.87]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	200966_x_at	136	0.610294	0.0494642	0.4884	0.872758	0.311685	-0.281521	0.75 [0.44 - 1.30]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	200966_x_at	200	0.37	0.0641548	-	0.599734	0.840835	0.0905361	1.09 [0.45 - 2.65]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214687_x_at	200	0.405	0.0393956	0.423536	0.651368	0.899557	0.0587948	1.06 [0.43 - 2.64]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15624	60	0.483333	0.0912744	-	0.65609	0.376198	0.171454	1.19 [0.81 - 1.74]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15624	60	0.283333	0.0271148	0.330893	1.13657	0.162288	0.333797	1.40 [0.87 - 2.23]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16380	155	0.787097	3.44492e-05	0.00136007	1.1158	0.000645681	0.126643	1.14 [1.06 - 1.22]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	200966_x_at	286	0.153846	0.209157	-	-0.309909	0.991075	0.00272724	1.00 [0.62 - 1.62]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214687_x_at	286	0.877622	0.190395	-	0.346144	0.722808	0.0903972	1.09 [0.66 - 1.80]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200966_x_at	159	0.503145	0.00205565	0.0463251	1.02107	0.00904994	1.10313	3.01 [1.32 - 6.90]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214687_x_at	159	0.54717	0.00928275	0.15264	0.827512	0.0683	0.803249	2.23 [0.94 - 5.30]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200966_x_at	159	0.899371	0.00173664	0.0403317	1.2747	0.00390702	1.52033	4.57 [1.63 - 12.85]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214687_x_at	159	0.534591	0.00181486	0.0418215	1.01242	0.00913965	1.15077	3.16 [1.33 - 7.51]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214687_x_at	159	0.54717	0.0010797	0.0271765	1.27273	0.00285113	1.6292	5.10 [1.75 - 14.87]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200966_x_at	159	0.899371	0.00649474	0.116094	1.03211	0.047564	0.82993	2.29 [1.01 - 5.21]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238996_x_at	159	0.836478	0.00733536	0.127535	0.921263	0.0546481	0.485408	1.62 [0.99 - 2.67]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238996_x_at	159	0.779874	0.00669211	0.118817	0.874344	0.0209502	0.585683	1.80 [1.09 - 2.95]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238996_x_at	159	0.779874	0.00190086	0.043444	1.11658	0.0145024	0.760566	2.14 [1.16 - 3.94]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214687_x_at	54	0.12963	0.175363	-	15.346	0.432434	0.496017	1.64 [0.48 - 5.67]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	200966_x_at	54	0.148148	0.175363	-	15.346	0.397892	0.495776	1.64 [0.52 - 5.18]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200966_x_at	117	0.555556	0.00401614	0.0795761	0.902863	0.0654108	0.675864	1.97 [0.96 - 4.03]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200966_x_at	117	0.555556	0.00354883	0.0720948	1.09762	0.0365082	0.927441	2.53 [1.06 - 6.03]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200966_x_at	117	0.555556	0.00401614	0.0795761	0.902863	0.0654108	0.675864	1.97 [0.96 - 4.03]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200966_x_at	117	0.871795	0.102777	-	0.800364	0.354854	0.417181	1.52 [0.63 - 3.67]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214687_x_at	117	0.538462	0.00609189	0.110462	1.03866	0.0249196	1.11644	3.05 [1.15 - 8.10]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214687_x_at	117	0.564103	0.0050755	0.095765	0.873181	0.0459473	0.816964	2.26 [1.01 - 5.05]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214687_x_at	117	0.564103	0.0050755	0.095765	0.873181	0.0459473	0.816964	2.26 [1.01 - 5.05]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214687_x_at	117	0.888889	0.0326843	0.375056	1.03336	0.351744	0.467235	1.60 [0.60 - 4.27]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214687_x_at	236	0.877119	0.00539125	0.100411	0.882066	0.0243529	0.793683	2.21 [1.11 - 4.41]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	200966_x_at	236	0.762712	0.00175766	0.0407334	0.846264	0.0411202	0.731568	2.08 [1.03 - 4.19]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	238996_x_at	236	0.783898	0.00474289	0.0907869	0.793848	0.0211873	0.559305	1.75 [1.09 - 2.82]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	200966_x_at	249	0.7751	0.00460562	0.0887056	0.637153	0.0381244	0.578334	1.78 [1.03 - 3.08]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214687_x_at	249	0.883534	0.0153405	0.221587	0.675713	0.0332372	0.584068	1.79 [1.05 - 3.07]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	238996_x_at	249	0.100402	0.0310513	0.36251	1.05325	0.0226608	0.445651	1.56 [1.06 - 2.29]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214687_x_at	125	0.744	0.000326883	0.00983865	1.00922	0.0675742	0.551521	1.74 [0.96 - 3.14]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214687_x_at	54	0.888889	0.034214	0.386528	1.24515	0.52379	0.245645	1.28 [0.60 - 2.72]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200966_x_at	62	0.758065	0.188348	-	0.654889	0.79461	0.0821788	1.09 [0.58 - 2.02]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200966_x_at	125	0.888	0.0287035	0.343898	0.926541	0.0319411	0.620404	1.86 [1.06 - 3.28]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214687_x_at	62	0.306452	0.0742614	-	-0.85354	0.891696	-0.0401745	0.96 [0.54 - 1.71]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200966_x_at	125	0.176	0.0415473	0.438131	1.15477	0.148468	0.32667	1.39 [0.89 - 2.16]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200966_x_at	54	0.888889	0.034214	0.386528	1.24515	0.248871	0.487764	1.63 [0.71 - 3.73]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214687_x_at	125	0.744	0.00125511	0.0308167	1.16223	0.0241836	0.877791	2.41 [1.12 - 5.16]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200966_x_at	198	0.868687	0.0802242	-	0.557755	0.686324	0.101383	1.11 [0.68 - 1.81]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214687_x_at	198	0.606061	0.0622408	-	0.394511	0.446998	0.165496	1.18 [0.77 - 1.81]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200966_x_at	198	0.89899	0.0934727	-	0.601459	0.864832	0.0454272	1.05 [0.62 - 1.77]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214687_x_at	198	0.888889	0.104553	-	0.55552	0.992184	-0.00259781	1.00 [0.59 - 1.68]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214687_x_at	198	0.343434	0.141469	-	-0.397861	0.789474	-0.0751153	0.93 [0.53 - 1.61]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200966_x_at	198	0.611111	0.0133712	0.200426	0.520368	0.227879	0.248744	1.28 [0.86 - 1.92]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214687_x_at	62	0.322581	0.0523741	-	1.78183	0.117702	1.03949	2.83 [0.77 - 10.40]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	200966_x_at	51	0.294118	0.0954196	-	-1.40532	0.33848	-0.851641	0.43 [0.07 - 2.44]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	200966_x_at	62	0.774194	0.087274	-	0.964716	0.181357	0.844377	2.33 [0.67 - 8.03]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214687_x_at	51	0.784314	0.235924	-	-15.4008	0.873465	-0.147689	0.86 [0.14 - 5.31]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	200966_x_at	177	0.887006	0.02366	0.301356	0.704273	0.115277	0.672842	1.96 [0.85 - 4.53]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214687_x_at	145	0.889655	0.00128519	0.0314303	1.23515	0.0888648	1.00105	2.72 [0.86 - 8.62]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	200966_x_at	145	0.889655	0.0195657	0.263819	0.957598	0.14234	0.885523	2.42 [0.74 - 7.91]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214687_x_at	177	0.350282	0.0307806	0.360399	0.661598	0.212301	0.58379	1.79 [0.72 - 4.49]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	238996_x_at	177	0.858757	0.0157765	0.226135	0.713939	0.0902328	0.47933	1.61 [0.93 - 2.81]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	238996_x_at	177	0.418079	0.149516	-	0.408833	0.28727	0.345126	1.41 [0.75 - 2.67]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	238996_x_at	145	0.855172	0.0218182	0.284839	0.900937	0.177285	0.531198	1.70 [0.79 - 3.68]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	200966_x_at	177	0.322034	0.11633	-	0.484065	0.319479	0.481911	1.62 [0.63 - 4.18]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214687_x_at	177	0.887006	0.00456051	0.0880182	0.850898	0.0694289	0.748314	2.11 [0.94 - 4.74]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	200966_x_at	226	0.106195	0.130237	-	-0.552456	0.934842	-0.0359876	0.96 [0.41 - 2.29]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	238996_x_at	226	0.756637	0.194254	-	-0.49776	0.957122	0.0148236	1.01 [0.59 - 1.74]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214687_x_at	226	0.871681	0.344979	-	0.36331	0.883966	-0.0675985	0.93 [0.38 - 2.32]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	200966_x_at	55	0.890909	0.0361411	0.400615	1.18085	0.790944	0.178608	1.20 [0.32 - 4.48]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	200966_x_at	49	0.857143	0.0125658	0.191455	1.43532	0.614919	0.420415	1.52 [0.30 - 7.83]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	238996_x_at	55	0.418182	0.107463	-	-0.709059	0.63875	-0.216551	0.81 [0.33 - 1.99]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214687_x_at	55	0.872727	0.204706	-	0.698661	0.822688	-0.149793	0.86 [0.23 - 3.19]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214687_x_at	55	0.381818	0.19751	-	0.69058	0.831094	0.159739	1.17 [0.27 - 5.09]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	200966_x_at	55	0.872727	0.204706	-	0.698661	0.975817	-0.0179087	0.98 [0.31 - 3.13]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	238996_x_at	55	0.418182	0.184705	-	-0.663053	0.869736	-0.0804062	0.92 [0.35 - 2.41]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214687_x_at	49	0.857143	0.0125658	0.191455	1.43532	0.529738	0.596894	1.82 [0.28 - 11.69]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	238996_x_at	49	0.857143	0.0238353	0.3029	1.30045	0.578953	0.34532	1.41 [0.42 - 4.78]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	878578	34	0.823529	0.000422853	0.0122767	1.75279	0.0146334	0.638464	1.89 [1.13 - 3.16]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	238996_x_at	63	0.380952	0.0101074	0.162764	0.980337	0.14873	0.288959	1.34 [0.90 - 1.98]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214687_x_at	63	0.380952	0.00534744	0.0997706	1.08847	0.0525475	0.562653	1.76 [0.99 - 3.10]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	200966_x_at	63	0.396825	0.00615955	0.111415	1.03632	0.0502012	0.574255	1.78 [1.00 - 3.16]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.273415.1.S1_3p_x_at	28	0.464286	0.0851669	-	1.00587	0.842589	-0.0360852	0.96 [0.68 - 1.38]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.201569.0.A1_3p_x_at	28	0.821429	0.125818	-	-1.46181	0.250029	-24.6278	0.00 [0.00 - 33814085.35]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214687_x_at	82	0.841463	0.0395452	0.424564	0.774439	0.232587	0.991018	2.69 [0.53 - 13.71]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	200966_x_at	82	0.463415	0.0401434	0.428657	0.718098	0.18603	1.06922	2.91 [0.60 - 14.21]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32336_at	84	0.785714	0.0017146	0.0399092	0.942436	0.0411488	0.703924	2.02 [1.03 - 3.97]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214687_x_at	79	0.493671	0.153798	-	-0.373339	0.932391	-0.0572761	0.94 [0.25 - 3.55]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	200966_x_at	79	0.696203	0.18412	-	-0.3882	0.991285	-0.00724078	0.99 [0.27 - 3.64]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X12447_at	86	0.372093	0.00734758	0.127698	1.30098	0.0154164	1.41796	4.13 [1.31 - 13.00]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	200966_x_at	104	0.855769	0.109614	-	0.626844	0.522216	0.505434	1.66 [0.35 - 7.80]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214687_x_at	104	0.865385	0.0104346	0.166706	0.947497	0.419272	0.644483	1.91 [0.40 - 9.10]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P88963	117	0.461538	0.0264529	0.325371	0.665685	0.126102	0.443448	1.56 [0.88 - 2.75]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P921584	117	0.213675	0.00121676	0.0300299	-0.96388	0.0412232	-0.568624	0.57 [0.33 - 0.98]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214687_x_at	204	0.70098	1.68128e-07	1.04225e-05	1.82471	2.96722e-05	2.99932	20.07 [4.91 - 82.03]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	238996_x_at	204	0.480392	4.07567e-05	0.00158037	1.90446	0.00135134	1.19513	3.30 [1.59 - 6.86]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214687_x_at	204	0.764706	2.43636e-10	2.19186e-08	1.5665	9.09353e-09	2.92266	18.59 [6.86 - 50.37]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	238996_x_at	204	0.480392	5.89545e-06	0.000276539	1.3741	7.36585e-06	1.22369	3.40 [1.99 - 5.80]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	200966_x_at	204	0.735294	3.13099e-07	1.8581e-05	1.72445	3.16941e-05	2.86088	17.48 [4.54 - 67.26]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	200966_x_at	204	0.745098	6.14701e-11	5.89407e-09	1.61721	1.05039e-08	2.78317	16.17 [6.23 - 41.95]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214687_x_at	178	0.758427	0.00219397	0.0488596	0.640069	0.0057217	1.34382	3.83 [1.48 - 9.94]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	200966_x_at	178	0.724719	0.00392129	0.0780761	0.591715	0.00834854	1.2592	3.52 [1.38 - 8.98]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300012670	41	0.317073	0.0394	0.423566	1.08375	0.0980347	0.486914	1.63 [0.91 - 2.90]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200016990	41	0.268293	0.0904796	-	0.905237	0.412949	0.328668	1.39 [0.63 - 3.05]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214687_x_at	111	0.711712	2.07807e-05	0.000864517	1.11645	0.00506272	0.894733	2.45 [1.31 - 4.57]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	200966_x_at	111	0.756757	0.000518423	0.0146148	0.949985	0.00619568	0.817457	2.26 [1.26 - 4.07]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	238996_x_at	111	0.225225	0.00820059	0.138912	1.02303	0.0139281	0.627154	1.87 [1.14 - 3.09]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214687_x_at	90	0.233333	0.0668161	-	0.853909	0.646859	0.144745	1.16 [0.62 - 2.15]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214687_x_at	90	0.233333	0.127121	-	0.800434	0.879349	-0.0531005	0.95 [0.48 - 1.88]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	200966_x_at	90	0.233333	0.0601382	-	0.874554	0.634485	0.145004	1.16 [0.64 - 2.10]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	200966_x_at	90	0.233333	0.12268	-	0.809464	0.940794	-0.0253201	0.97 [0.50 - 1.90]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214687_x_at	138	0.268116	0.0185296	0.253823	0.731627	0.161892	0.274341	1.32 [0.90 - 1.93]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	200966_x_at	138	0.23913	0.0332915	0.379642	0.686272	0.137533	0.300224	1.35 [0.91 - 2.01]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	238996_x_at	138	0.666667	0.0173977	0.242645	0.574519	0.102597	0.267997	1.31 [0.95 - 1.80]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	200966_x_at	129	0.612403	0.0323406	0.372442	0.52201	0.193341	0.594462	1.81 [0.74 - 4.44]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214687_x_at	129	0.596899	0.0360184	0.399729	0.511192	0.226205	0.572459	1.77 [0.70 - 4.48]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30296	56	0.464286	0.132217	-	-0.519577	0.466812	-0.153904	0.86 [0.57 - 1.30]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6438	56	0.875	0.0953881	-	0.798494	0.390571	0.24789	1.28 [0.73 - 2.26]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29707	56	0.642857	0.182723	-	0.474872	0.772227	0.084853	1.09 [0.61 - 1.93]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30296	56	0.428571	0.0355721	0.396496	-0.765312	0.37132	-0.193859	0.82 [0.54 - 1.26]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18980	56	0.714286	0.0978074	-	0.595969	0.725357	0.123403	1.13 [0.57 - 2.25]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29707	56	0.392857	0.113836	-	0.605722	0.484726	0.205674	1.23 [0.69 - 2.19]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6438	56	0.875	0.141692	-	0.704384	0.611172	0.142936	1.15 [0.66 - 2.00]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18980	56	0.714286	0.0485178	0.482655	0.709377	0.472898	0.248765	1.28 [0.65 - 2.53]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214687_x_at	278	0.323741	0.0389014	0.420123	-0.399588	0.177459	-0.227388	0.80 [0.57 - 1.11]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	238996_x_at	278	0.464029	0.0160093	0.228545	-0.452486	0.13554	-0.190603	0.83 [0.64 - 1.06]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	200966_x_at	278	0.115108	0.0669411	-	-0.46747	0.204705	-0.212612	0.81 [0.58 - 1.12]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	200966_x_at	133	0.639098	0.0676802	-	-0.464937	0.49893	-0.117553	0.89 [0.63 - 1.25]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214687_x_at	133	0.639098	0.03333	0.379931	-0.546807	0.455582	-0.143669	0.87 [0.59 - 1.26]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5740	81	0.345679	0.0349117	0.391674	1.48767	0.164309	0.757891	2.13 [0.73 - 6.21]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200966_x_at	185	0.237838	0.0421959	0.442448	-0.403808	0.658175	-0.0445271	0.96 [0.79 - 1.17]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214687_x_at	185	0.227027	0.196049	-	-0.247495	0.955177	0.00583265	1.01 [0.82 - 1.23]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200966_x_at	185	0.237838	0.115786	-	-0.296316	0.892045	0.0128965	1.01 [0.84 - 1.22]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214687_x_at	185	0.221622	0.0659568	-	-0.371133	0.585873	-0.0594417	0.94 [0.76 - 1.17]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P921584	110	0.672727	0.103915	-	0.385367	0.751473	-0.0641857	0.94 [0.63 - 1.40]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P88963	110	0.181818	0.017654	0.245201	-0.647154	0.747303	-0.080686	0.92 [0.56 - 1.51]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P921584	110	0.509091	0.35827	-	-0.271862	0.407518	-0.207848	0.81 [0.50 - 1.33]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P88963	110	0.145455	0.0059943	0.109082	-0.930075	0.851849	0.0585295	1.06 [0.57 - 1.96]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	200966_x_at	80	0.1625	0.054341	-	1.74784	0.316636	0.405824	1.50 [0.68 - 3.32]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214687_x_at	80	0.2	0.0459166	0.466507	1.79667	0.247857	0.454367	1.58 [0.73 - 3.40]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3962	281	0.409253	0.0123089	0.188552	0.361979	0.149928	0.0974967	1.10 [0.97 - 1.26]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	200966_x_at	38	0.842105	0.00545396	0.101324	1.44018	0.0148045	2.02409	7.57 [1.49 - 38.55]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	238996_x_at	38	0.447368	0.000583214	0.0161579	2.01148	0.00540488	1.87664	6.53 [1.74 - 24.50]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214687_x_at	38	0.789474	0.0103713	0.165947	1.27735	0.0134955	2.17267	8.78 [1.57 - 49.23]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214687_x_at	140	0.871429	0.04817	0.480527	0.719969	0.166217	0.393095	1.48 [0.85 - 2.58]
GENE	ALDOA	aldolase A, fructose-bisphosphate	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	200966_x_at	140	0.892857	0.0570475	-	0.726987	0.345146	0.253726	1.29 [0.76 - 2.18]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214423_x_at	30	0.333333	0.213638	-	0.556071	0.901843	-0.0759104	0.93 [0.28 - 3.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214424_s_at	30	0.133333	0.208949	-	0.903223	0.943477	0.0740565	1.08 [0.14 - 8.34]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216600_x_at	30	0.5	0.337291	-	-0.392258	0.791507	0.139219	1.15 [0.41 - 3.23]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204705_x_at	30	0.266667	0.00484424	0.0923133	-1.37688	0.596853	-0.345833	0.71 [0.20 - 2.55]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217238_s_at	30	0.6	0.0990604	-	0.667757	0.917481	0.0792105	1.08 [0.24 - 4.84]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1771970	165	0.642424	0.0788066	-	-0.48685	0.486721	-0.536938	0.58 [0.13 - 2.65]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1771970	165	0.727273	0.0580628	-	-0.974281	0.379905	-1.03816	0.35 [0.03 - 3.59]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214424_s_at	163	0.245399	0.0100956	0.16262	-0.549274	0.0439813	-1.48004	0.23 [0.05 - 0.96]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216600_x_at	163	0.644172	0.0463612	0.469305	-0.428723	0.743805	-0.152173	0.86 [0.34 - 2.14]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217238_s_at	163	0.564417	0.0411292	0.435328	0.4019	0.602703	0.29619	1.34 [0.44 - 4.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204705_x_at	163	0.202454	0.102842	-	-0.385553	0.140378	-1.08592	0.34 [0.08 - 1.43]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214423_x_at	163	0.435583	0.205486	-	0.253511	0.890358	0.0713248	1.07 [0.39 - 2.96]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	241280_at	163	0.699386	0.0642119	-	-0.418902	0.0908097	-1.42673	0.24 [0.05 - 1.25]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214423_x_at	79	0.443038	0.100142	-	0.489975	0.699782	0.325377	1.38 [0.26 - 7.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	241280_at	79	0.265823	0.022653	0.292397	0.85865	0.315109	0.923725	2.52 [0.42 - 15.27]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204705_x_at	79	0.78481	0.148159	-	-0.584366	0.962838	-0.0440432	0.96 [0.15 - 6.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217238_s_at	79	0.341772	9.18678e-05	0.00325	-1.10255	0.00300879	-2.77267	0.06 [0.01 - 0.39]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216600_x_at	79	0.898734	0.00617579	0.111644	1.03083	0.0380505	1.548	4.70 [1.09 - 20.30]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214424_s_at	79	0.329114	0.0898783	-	-0.505912	0.528467	-0.597113	0.55 [0.09 - 3.52]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217238_s_at	58	0.172414	0.0825276	-	0.665512	0.560399	0.0775239	1.08 [0.83 - 1.40]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214423_x_at	58	0.172414	0.214147	-	0.462598	0.722545	0.0539098	1.06 [0.78 - 1.42]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214424_s_at	58	0.810345	0.000234743	0.00738772	1.28428	0.0360988	0.492429	1.64 [1.03 - 2.59]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216600_x_at	58	0.87931	0.0734599	-	0.747062	0.223413	0.321223	1.38 [0.82 - 2.31]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204705_x_at	58	0.206897	0.210899	-	0.439877	0.775257	0.0659254	1.07 [0.68 - 1.68]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204705_x_at	34	0.735294	0.000678742	0.01838	-1.88909	0.0258701	-0.749679	0.47 [0.24 - 0.91]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217238_s_at	34	0.794118	0.0556321	-	0.901017	0.924831	-0.023052	0.98 [0.61 - 1.58]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214423_x_at	34	0.147059	0.119057	-	0.924191	0.848217	0.0807372	1.08 [0.47 - 2.48]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214424_s_at	34	0.352941	0.0121164	0.186363	-0.947564	0.0040176	-1.04857	0.35 [0.17 - 0.72]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216600_x_at	34	0.852941	0.108562	-	-0.98185	0.976274	0.00909328	1.01 [0.55 - 1.84]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217238_s_at	158	0.107595	0.116605	-	0.710469	0.960444	-0.0268844	0.97 [0.34 - 2.82]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214423_x_at	158	0.189873	0.204882	-	0.411807	0.869331	-0.172418	0.84 [0.11 - 6.57]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214424_s_at	158	0.424051	0.0885826	-	0.404332	0.69828	0.369346	1.45 [0.22 - 9.36]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216600_x_at	158	0.170886	0.0377689	0.41221	-0.557859	0.635275	-0.41284	0.66 [0.12 - 3.64]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204705_x_at	158	0.803797	0.0378405	0.412715	0.549223	0.686342	0.189401	1.21 [0.48 - 3.03]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216600_x_at	53	0.45283	0.135225	-	0.560283	0.368872	0.273266	1.31 [0.72 - 2.39]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204705_x_at	53	0.566038	0.269398	-	-0.41727	0.662477	-0.150772	0.86 [0.44 - 1.69]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214424_s_at	53	0.188679	0.00026553	0.00822083	-1.36259	0.00473894	-0.703131	0.50 [0.30 - 0.81]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217238_s_at	53	0.811321	0.085915	-	-1.00407	0.512592	-0.14051	0.87 [0.57 - 1.32]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216600_x_at	53	0.660377	0.296842	-	0.366444	0.516541	0.166439	1.18 [0.71 - 1.95]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214423_x_at	53	0.113208	0.463825	-	-0.39204	0.797968	0.0927123	1.10 [0.54 - 2.23]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214424_s_at	53	0.150943	0.000551841	0.0154146	-1.36728	0.0703809	-0.472603	0.62 [0.37 - 1.04]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217238_s_at	53	0.207547	0.0382302	0.415449	1.05573	0.678705	-0.0807868	0.92 [0.63 - 1.35]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204705_x_at	53	0.490566	0.193524	-	-0.446876	0.525256	-0.208414	0.81 [0.43 - 1.54]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214423_x_at	53	0.113208	0.190384	-	-0.629167	0.881157	-0.0468135	0.95 [0.52 - 1.76]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204705_x_at	180	0.111111	0.0268664	0.328828	0.9058	0.0910466	0.430943	1.54 [0.93 - 2.54]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214423_x_at	180	0.894444	0.0163161	0.231699	0.692526	0.139021	0.460287	1.58 [0.86 - 2.92]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214424_s_at	180	0.766667	0.0562295	-	0.443865	0.748587	0.0518031	1.05 [0.77 - 1.45]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216600_x_at	180	0.144444	0.0861662	-	-0.46983	0.545619	0.190371	1.21 [0.65 - 2.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217238_s_at	180	0.311111	0.0838544	-	0.404069	0.794256	0.0230303	1.02 [0.86 - 1.22]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	241280_at	180	0.361111	0.199714	-	0.283107	0.723934	0.0754969	1.08 [0.71 - 1.64]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214423_x_at	559	0.595707	0.0240659	0.304922	-0.46862	0.0782522	-0.526325	0.59 [0.33 - 1.06]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	241280_at	559	0.511628	0.132097	-	-0.302776	0.504452	-0.134238	0.87 [0.59 - 1.30]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204705_x_at	559	0.125224	0.216104	-	0.393603	0.640271	-0.0726288	0.93 [0.69 - 1.26]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217238_s_at	559	0.100179	0.00013005	0.00441228	-0.882353	0.0957918	-0.186291	0.83 [0.67 - 1.03]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216600_x_at	559	0.26297	0.0100952	0.162616	-0.564255	0.0532715	-0.621198	0.54 [0.29 - 1.01]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214424_s_at	559	0.325581	0.00545453	0.101333	-0.554546	0.21368	-0.1691	0.84 [0.65 - 1.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204705_x_at	77	0.220779	0.35212	-	-0.284994	0.899701	0.0480087	1.05 [0.50 - 2.21]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217238_s_at	77	0.12987	0.00220123	0.0489916	-1.03205	0.518153	-0.113865	0.89 [0.63 - 1.26]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214423_x_at	77	0.116883	0.0194693	0.262898	-0.876699	0.447845	-0.257016	0.77 [0.40 - 1.50]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214424_s_at	77	0.857143	0.258159	-	0.393454	0.951735	0.0151806	1.02 [0.62 - 1.66]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216600_x_at	77	0.831169	0.0472149	0.474633	-0.742112	0.267986	-0.325387	0.72 [0.41 - 1.28]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	241280_at	77	0.194805	0.0233444	0.298566	-0.701017	0.0976936	-0.621045	0.54 [0.26 - 1.12]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204705_x_at	70	0.728571	0.115036	-	0.458979	0.828994	-0.198938	0.82 [0.13 - 4.98]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217238_s_at	70	0.414286	0.0336682	0.382465	-0.562423	0.344565	-0.949401	0.39 [0.05 - 2.77]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216600_x_at	70	0.757143	0.0840649	-	-0.556016	0.241811	-1.24405	0.29 [0.04 - 2.31]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214424_s_at	70	0.114286	7.47042e-08	4.88922e-06	-1.94884	0.256351	-1.55289	0.21 [0.01 - 3.09]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214423_x_at	70	0.114286	0.0182435	0.251024	-0.905997	0.550369	-0.656045	0.52 [0.06 - 4.47]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	241280_at	70	0.828571	0.19408	-	0.421759	0.818518	0.191925	1.21 [0.24 - 6.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33455_at	50	0.18	0.0175205	0.243871	-0.953811	0.29879	-0.645413	0.52 [0.16 - 1.77]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214424_s_at	74	0.554054	0.011344	0.177457	0.722462	0.166152	0.324463	1.38 [0.87 - 2.19]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216600_x_at	74	0.121622	0.018786	0.256317	-0.897843	0.183385	-0.675091	0.51 [0.19 - 1.38]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204705_x_at	74	0.202703	0.0016741	0.0391301	-1.00364	0.698282	-0.199116	0.82 [0.30 - 2.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217238_s_at	74	0.783784	0.0491999	0.486803	0.630627	0.256361	0.211104	1.24 [0.86 - 1.78]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214423_x_at	74	0.148649	0.0103569	0.165774	-0.901947	0.191058	-0.572118	0.56 [0.24 - 1.33]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	241280_at	74	0.878378	0.0133516	0.200211	0.940814	0.265076	0.534694	1.71 [0.67 - 4.37]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214423_x_at	67	0.895522	0.0610572	-	1.44287	0.191905	2.81885	16.76 [0.24 - 1155.91]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204705_x_at	67	0.895522	1.26005e-05	0.000550713	2.6638	0.0471007	5.5257	251.06 [1.07 - 58731.58]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	241280_at	67	0.328358	0.0664054	-	1.76779	0.175745	3.54615	34.68 [0.20 - 5881.27]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217238_s_at	67	0.895522	0.000143919	0.00482209	2.38789	0.0270785	8.2368	3777.43 [2.54 - 5612818.74]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216600_x_at	67	0.865672	0.0257182	0.319168	1.50031	0.0522087	4.21938	67.99 [0.96 - 4813.43]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214424_s_at	67	0.268657	0.0382589	0.415649	15.7612	0.0810385	3.7921	44.35 [0.63 - 3140.63]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204705_x_at	115	0.678261	0.124134	-	-1.11376	0.450493	-0.368043	0.69 [0.27 - 1.80]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217238_s_at	115	0.817391	0.258031	-	0.658572	0.774341	0.145183	1.16 [0.43 - 3.12]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216600_x_at	115	0.26087	0.0315606	0.366457	-1.09314	0.667076	-0.407264	0.67 [0.10 - 4.26]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	241280_at	115	0.756522	0.0775379	-	0.920138	0.368902	1.31725	3.73 [0.21 - 66.06]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214424_s_at	115	0.808696	0.228472	-	-1.17632	0.892717	0.0843242	1.09 [0.32 - 3.71]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214423_x_at	115	0.104348	0.000315991	0.00955519	-1.78937	0.00953418	-1.74445	0.17 [0.05 - 0.65]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33455_at	158	0.531646	0.0486861	0.483682	0.563088	0.147043	0.287639	1.33 [0.90 - 1.97]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33455_at	76	0.421053	0.0639721	-	1.1352	0.406247	0.268265	1.31 [0.69 - 2.46]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216600_x_at	204	0.632353	0.0263526	0.324529	0.326359	0.0904106	0.210401	1.23 [0.97 - 1.57]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214424_s_at	204	0.813725	0.0294552	0.349934	-0.390929	0.28426	-0.0741123	0.93 [0.81 - 1.06]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214423_x_at	204	0.681373	0.0854253	-	0.258336	0.510164	0.0874523	1.09 [0.84 - 1.42]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204705_x_at	204	0.186275	0.0226619	0.292477	-0.409406	0.419041	-0.105915	0.90 [0.70 - 1.16]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	241280_at	204	0.622549	0.175852	-	-0.192959	0.466328	-0.0653042	0.94 [0.79 - 1.12]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217238_s_at	204	0.862745	0.051939	-	0.400296	0.422687	0.0631827	1.07 [0.91 - 1.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204705_x_at	87	0.367816	0.0966393	-	0.71103	0.893013	0.111281	1.12 [0.22 - 5.66]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217238_s_at	87	0.793103	0.030157	0.355502	-1.46232	0.16163	-1.60592	0.20 [0.02 - 1.90]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214423_x_at	87	0.689655	0.000419559	0.0121946	1.26828	0.052618	1.99245	7.33 [0.98 - 55.01]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216600_x_at	87	0.678161	0.362878	-	0.35041	0.552012	0.545975	1.73 [0.29 - 10.44]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204705_x_at	87	0.367816	0.0966393	-	0.71103	0.893013	0.111281	1.12 [0.22 - 5.66]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217238_s_at	87	0.793103	0.030157	0.355502	-1.46232	0.16163	-1.60592	0.20 [0.02 - 1.90]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214424_s_at	87	0.252874	0.19774	-	0.626083	0.534265	0.692597	2.00 [0.23 - 17.76]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216600_x_at	87	0.678161	0.362878	-	0.35041	0.552012	0.545975	1.73 [0.29 - 10.44]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214423_x_at	87	0.689655	0.000419559	0.0121946	1.26828	0.052618	1.99245	7.33 [0.98 - 55.01]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	241280_at	87	0.885057	0.0378569	0.41283	-15.2319	0.480845	-0.797422	0.45 [0.05 - 4.14]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	241280_at	87	0.885057	0.0378569	0.41283	-15.2319	0.480845	-0.797422	0.45 [0.05 - 4.14]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214424_s_at	87	0.252874	0.19774	-	0.626083	0.534265	0.692597	2.00 [0.23 - 17.76]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214424_s_at	77	0.623377	0.234285	-	-0.908761	0.740648	0.571342	1.77 [0.06 - 52.17]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216600_x_at	77	0.311688	0.165544	-	1.02191	0.826068	0.341396	1.41 [0.07 - 29.56]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214423_x_at	77	0.805195	0.105682	-	-15.3764	0.828831	-0.34166	0.71 [0.03 - 15.73]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214424_s_at	77	0.233766	0.159467	-	1.35777	0.272788	1.61963	5.05 [0.28 - 91.31]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204705_x_at	77	0.116883	0.224045	-	15.2222	0.929536	0.15069	1.16 [0.04 - 32.81]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217238_s_at	77	0.376623	0.0278075	0.336605	-1.40109	0.206931	-2.20874	0.11 [0.00 - 3.39]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214423_x_at	77	0.636364	0.142728	-	0.795101	0.587136	0.746029	2.11 [0.14 - 31.15]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	241280_at	77	0.103896	0.112815	-	-1.00206	0.571973	-0.862215	0.42 [0.02 - 8.40]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216600_x_at	77	0.545455	0.109867	-	-1.19226	0.572728	-1.02908	0.36 [0.01 - 12.77]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204705_x_at	77	0.714286	0.125537	-	0.828584	0.282746	1.59336	4.92 [0.27 - 90.08]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	241280_at	77	0.220779	0.0244975	0.308683	-1.32541	0.141512	-2.72972	0.07 [0.00 - 2.48]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217238_s_at	77	0.74026	0.0267771	0.328084	-15.5232	0.237548	-1.796	0.17 [0.01 - 3.27]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214424_s_at	136	0.191176	0.079348	-	1.61987	0.437541	0.254299	1.29 [0.68 - 2.45]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216600_x_at	136	0.772059	0.0951452	-	0.76979	0.957298	0.0160193	1.02 [0.57 - 1.83]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217238_s_at	136	0.852941	0.0114188	0.178328	1.19355	0.664336	0.0890553	1.09 [0.73 - 1.63]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204705_x_at	136	0.816176	0.101394	-	-1.52878	0.232185	-0.563029	0.57 [0.23 - 1.43]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214423_x_at	136	0.875	0.178231	-	0.746353	0.425127	-0.286199	0.75 [0.37 - 1.52]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214424_s_at	200	0.58	0.0125263	0.19101	0.732734	0.292866	0.224597	1.25 [0.82 - 1.90]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216600_x_at	200	0.15	0.0859049	-	-0.63239	0.676587	-0.146188	0.86 [0.43 - 1.72]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204705_x_at	200	0.885	0.0484116	0.482006	0.720496	0.48926	0.205013	1.23 [0.69 - 2.19]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217238_s_at	200	0.665	0.0147212	0.215045	0.707151	0.186597	0.202652	1.22 [0.91 - 1.65]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214423_x_at	200	0.545	0.0249915	0.312954	-0.690859	0.158821	-0.554859	0.57 [0.27 - 1.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5932	60	0.5	0.0933839	-	0.650824	0.730634	-0.101071	0.90 [0.51 - 1.61]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5932	60	0.133333	0.000125567	0.00427854	-1.56507	0.500458	-0.299843	0.74 [0.31 - 1.77]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	19693	155	0.309677	0.00321665	0.0666287	-0.800815	0.0576974	-0.519961	0.59 [0.35 - 1.02]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214424_s_at	286	0.895105	0.171776	-	-0.497366	0.825859	0.0317429	1.03 [0.78 - 1.37]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216600_x_at	286	0.143357	0.0115559	0.179919	-0.60702	0.010884	-0.553117	0.58 [0.38 - 0.88]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204705_x_at	286	0.104895	0.0289315	0.345736	-0.585082	0.653292	-0.108315	0.90 [0.56 - 1.44]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217238_s_at	286	0.104895	0.232799	-	0.43588	0.51645	0.0746612	1.08 [0.86 - 1.35]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214423_x_at	286	0.5	0.0232921	0.298102	-0.440658	0.082208	-0.353569	0.70 [0.47 - 1.05]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216600_x_at	159	0.893082	0.0255026	0.317333	0.857022	0.451727	0.47147	1.60 [0.47 - 5.47]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217238_s_at	159	0.496855	0.314918	-	0.37673	0.775972	0.056344	1.06 [0.72 - 1.56]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214423_x_at	159	0.710692	0.0177058	0.245715	0.855655	0.169509	0.919996	2.51 [0.68 - 9.32]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204705_x_at	159	0.691824	0.271507	-	-0.399187	0.863108	0.0735862	1.08 [0.47 - 2.48]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214424_s_at	159	0.647799	0.00274996	0.0587129	0.91985	0.0653193	0.518684	1.68 [0.97 - 2.92]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214424_s_at	159	0.647799	0.0415011	0.437822	0.740782	0.245309	0.372628	1.45 [0.77 - 2.72]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204705_x_at	159	0.477987	0.167131	-	-0.43619	0.871625	-0.0704856	0.93 [0.40 - 2.19]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217238_s_at	159	0.427673	0.145607	-	0.486489	0.49954	0.113856	1.12 [0.81 - 1.56]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216600_x_at	159	0.893082	0.036294	0.401715	0.806649	0.530611	0.387159	1.47 [0.44 - 4.94]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214423_x_at	159	0.735849	0.0862958	-	0.553421	0.368617	0.507901	1.66 [0.55 - 5.03]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216600_x_at	159	0.893082	0.00685388	0.121032	1.11541	0.584916	0.402391	1.50 [0.35 - 6.34]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204705_x_at	159	0.477987	0.233101	-	-0.442205	0.778688	-0.144827	0.87 [0.32 - 2.38]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217238_s_at	159	0.100629	0.26603	-	0.785702	0.960312	0.00839188	1.01 [0.72 - 1.40]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214424_s_at	159	0.647799	0.0321474	0.370966	0.665446	0.187384	0.358343	1.43 [0.84 - 2.44]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214423_x_at	159	0.710692	0.0116538	0.181053	0.782261	0.286747	0.609922	1.84 [0.60 - 5.65]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241280_at	159	0.666667	0.0390944	0.421458	-0.794644	0.864484	-0.0881449	0.92 [0.33 - 2.52]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241280_at	159	0.226415	0.0935191	-	0.78159	0.531837	0.328164	1.39 [0.50 - 3.88]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241280_at	159	0.226415	0.081517	-	1.01774	0.54131	0.372714	1.45 [0.44 - 4.80]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214424_s_at	54	0.518519	0.150751	-	-1.10083	0.58846	-0.844969	0.43 [0.02 - 9.17]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204705_x_at	54	0.314815	0.224508	-	0.963278	0.961089	0.0427492	1.04 [0.19 - 5.81]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216600_x_at	54	0.888889	0.00684306	0.120884	1.93304	0.355863	1.74468	5.72 [0.14 - 232.39]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214423_x_at	54	0.648148	0.130513	-	-1.46851	0.579684	-0.988558	0.37 [0.01 - 12.30]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217238_s_at	54	0.851852	0.176097	-	1.05717	0.91651	-0.149357	0.86 [0.05 - 14.06]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204704_s_at	54	0.277778	0.129031	-	-0.978902	0.259338	-3.00529	0.05 [0.00 - 9.18]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217238_s_at	117	0.888889	0.0326274	0.374624	-1.8775	0.316565	-1.02985	0.36 [0.05 - 2.68]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217238_s_at	117	0.888889	0.0278806	0.337205	-15.2601	0.233167	-1.49624	0.22 [0.02 - 2.62]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214423_x_at	117	0.675214	0.128993	-	-0.73268	0.94478	-0.0611026	0.94 [0.17 - 5.30]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204705_x_at	117	0.888889	0.150591	-	-1.00195	0.362905	-0.584925	0.56 [0.16 - 1.96]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204705_x_at	117	0.119658	0.142381	-	1.38145	0.422037	-0.624562	0.54 [0.12 - 2.46]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214423_x_at	117	0.17094	0.172164	-	0.706196	0.494754	0.481129	1.62 [0.41 - 6.44]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204705_x_at	117	0.119658	0.139344	-	1.39233	0.485437	-0.561684	0.57 [0.12 - 2.76]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217238_s_at	117	0.888889	0.0353235	0.394686	-15.26	0.365178	-1.13144	0.32 [0.03 - 3.73]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217238_s_at	117	0.888889	0.0326274	0.374624	-1.8775	0.316565	-1.02985	0.36 [0.05 - 2.68]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204705_x_at	117	0.888889	0.150591	-	-1.00195	0.362905	-0.584925	0.56 [0.16 - 1.96]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214423_x_at	117	0.675214	0.0665051	-	-0.959692	0.283282	-1.02291	0.36 [0.06 - 2.33]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214423_x_at	117	0.17094	0.172164	-	0.706196	0.494754	0.481129	1.62 [0.41 - 6.44]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214424_s_at	117	0.598291	0.278754	-	0.3435	0.683849	-0.254964	0.77 [0.23 - 2.64]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214424_s_at	117	0.837607	0.38498	-	0.39736	0.761556	-0.228094	0.80 [0.18 - 3.47]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216600_x_at	117	0.675214	0.0189438	0.257845	0.860833	0.345949	0.526847	1.69 [0.57 - 5.07]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216600_x_at	117	0.675214	0.0255366	0.317622	0.697388	0.708259	0.193089	1.21 [0.44 - 3.33]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214424_s_at	117	0.74359	0.249572	-	-0.610876	0.597526	-0.465714	0.63 [0.11 - 3.54]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214424_s_at	117	0.598291	0.278754	-	0.3435	0.683849	-0.254964	0.77 [0.23 - 2.64]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216600_x_at	117	0.675214	0.0255366	0.317622	0.697388	0.708259	0.193089	1.21 [0.44 - 3.33]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216600_x_at	117	0.675214	0.0219924	0.286426	0.872552	0.497211	0.44957	1.57 [0.43 - 5.74]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216600_x_at	236	0.415254	0.0737672	-	0.509626	0.351217	0.555316	1.74 [0.54 - 5.60]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217238_s_at	236	0.101695	0.0240804	0.305048	-0.804499	0.558454	-0.0972655	0.91 [0.66 - 1.26]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204705_x_at	236	0.334746	0.0231854	0.297154	0.747331	0.308786	0.467994	1.60 [0.65 - 3.93]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214423_x_at	236	0.305085	0.0259166	0.320851	-0.596994	0.372249	-0.466313	0.63 [0.23 - 1.75]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214424_s_at	236	0.177966	0.116512	-	0.667513	0.705245	0.0789279	1.08 [0.72 - 1.63]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	241280_at	236	0.855932	0.0380038	0.413862	0.66646	0.686619	0.20441	1.23 [0.45 - 3.31]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204705_x_at	249	0.401606	0.28909	-	0.234617	0.699807	0.13351	1.14 [0.58 - 2.25]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217238_s_at	249	0.100402	0.139671	-	-0.473038	0.70026	-0.0485179	0.95 [0.74 - 1.22]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214423_x_at	249	0.46988	0.0153659	0.221854	-0.514357	0.264816	-0.447678	0.64 [0.29 - 1.40]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214424_s_at	249	0.795181	0.0848829	-	-0.51217	0.900275	0.0199903	1.02 [0.75 - 1.39]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216600_x_at	249	0.710843	0.169992	-	-0.346996	0.747917	-0.14677	0.86 [0.35 - 2.11]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	241280_at	249	0.140562	0.134547	-	-0.401417	0.891857	-0.0519585	0.95 [0.45 - 2.01]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214424_s_at	125	0.264	0.140658	-	-0.433961	0.736568	-0.245883	0.78 [0.19 - 3.28]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204705_x_at	125	0.36	0.0685128	-	-0.683408	0.334342	-0.781594	0.46 [0.09 - 2.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216600_x_at	125	0.784	0.130085	-	-0.565966	0.760494	-0.0964659	0.91 [0.49 - 1.69]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214424_s_at	54	0.148148	0.225999	-	15.2203	0.81196	-0.102625	0.90 [0.39 - 2.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217238_s_at	62	0.790323	0.168646	-	0.684351	0.688623	-0.186928	0.83 [0.33 - 2.07]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216600_x_at	54	0.333333	0.107188	-	1.53358	0.861961	-0.0508989	0.95 [0.54 - 1.69]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214423_x_at	62	0.709677	0.298733	-	-0.564454	0.647148	-0.104671	0.90 [0.58 - 1.41]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204705_x_at	125	0.256	0.179423	-	-0.405222	0.45434	-0.457598	0.63 [0.19 - 2.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217238_s_at	125	0.288	0.0398512	0.426662	1.19075	0.45302	0.385115	1.47 [0.54 - 4.02]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214424_s_at	62	0.145161	0.128322	-	15.218	0.743149	-0.116517	0.89 [0.44 - 1.79]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214423_x_at	125	0.72	0.0375375	0.410578	-1.19867	0.354131	-1.17095	0.31 [0.03 - 3.69]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217238_s_at	125	0.288	0.147548	-	0.562034	0.794313	-0.103375	0.90 [0.41 - 1.96]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214423_x_at	125	0.864	0.231966	-	0.465789	0.550062	-0.580882	0.56 [0.08 - 3.76]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217238_s_at	54	0.888889	0.139021	-	-15.2936	0.742893	-0.187408	0.83 [0.27 - 2.54]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216600_x_at	62	0.306452	0.124723	-	1.09882	0.758122	-0.0742272	0.93 [0.58 - 1.49]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204705_x_at	54	0.259259	0.0621836	-	15.4424	0.672142	-0.0969993	0.91 [0.58 - 1.42]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214424_s_at	125	0.624	0.122271	-	-0.702662	0.494512	-0.648153	0.52 [0.08 - 3.36]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214423_x_at	54	0.259259	0.119105	-	1.49094	0.7487	-0.0884796	0.92 [0.53 - 1.57]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204705_x_at	62	0.403226	0.034274	0.386973	1.46051	0.639221	-0.0886706	0.92 [0.63 - 1.33]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216600_x_at	125	0.464	0.255027	-	0.463347	0.606946	0.208094	1.23 [0.56 - 2.72]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217238_s_at	198	0.429293	0.101498	-	-0.413807	0.348696	-0.0842557	0.92 [0.77 - 1.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214424_s_at	198	0.252525	0.026837	0.328583	0.601964	0.272589	0.114576	1.12 [0.91 - 1.38]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217238_s_at	198	0.429293	0.0602369	-	-0.499205	0.398677	-0.0801953	0.92 [0.77 - 1.11]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214423_x_at	198	0.378788	0.0343524	0.387553	0.596447	0.210386	0.225016	1.25 [0.88 - 1.78]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204705_x_at	198	0.863636	0.0496079	0.489266	-1.10763	0.393344	-0.180575	0.83 [0.55 - 1.26]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216600_x_at	198	0.494949	0.000418145	0.0121593	-0.762481	0.0609874	-0.223774	0.80 [0.63 - 1.01]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214423_x_at	198	0.69697	0.0515135	-	0.523372	0.408982	0.149796	1.16 [0.81 - 1.66]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204705_x_at	198	0.863636	0.0283839	0.341309	-1.22085	0.373025	-0.177077	0.84 [0.57 - 1.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214424_s_at	198	0.267677	0.0122773	0.188193	0.876302	0.0528383	0.264441	1.30 [1.00 - 1.70]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204705_x_at	198	0.873737	0.0703589	-	-0.698805	0.997997	0.000371866	1.00 [0.75 - 1.34]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217238_s_at	198	0.131313	0.00662344	0.117872	-0.694431	0.425305	-0.060264	0.94 [0.81 - 1.09]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214424_s_at	198	0.267677	0.0120925	0.18609	0.925604	0.0565834	0.272153	1.31 [0.99 - 1.74]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216600_x_at	198	0.611111	0.00055819	0.0155656	-1.03515	0.0973999	-0.237955	0.79 [0.59 - 1.04]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214423_x_at	198	0.19697	0.0923458	-	0.500958	0.60685	0.0668352	1.07 [0.83 - 1.38]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216600_x_at	198	0.444444	0.000824097	0.0216577	-0.89664	0.114133	-0.236087	0.79 [0.59 - 1.06]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216600_x_at	62	0.854839	0.00393099	0.0782299	1.61453	0.154839	2.17595	8.81 [0.44 - 176.58]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204705_x_at	62	0.66129	0.0107491	0.170458	-15.7205	0.189096	-0.54705	0.58 [0.26 - 1.31]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217238_s_at	51	0.529412	0.120967	-	1.5687	0.880441	-0.145877	0.86 [0.13 - 5.78]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204705_x_at	51	0.411765	0.0470445	0.473575	15.9903	0.682332	0.167987	1.18 [0.53 - 2.64]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214423_x_at	51	0.313726	0.108715	-	15.6896	0.932597	-0.211321	0.81 [0.01 - 108.40]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217238_s_at	62	0.741935	0.0434262	0.450534	-15.4767	0.297385	-1.01564	0.36 [0.05 - 2.45]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214423_x_at	62	0.112903	0.0754362	-	-1.12762	0.748918	-0.495277	0.61 [0.03 - 12.65]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214424_s_at	51	0.313726	0.108715	-	15.6896	0.206815	3.93956	51.40 [0.11 - 23300.95]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214424_s_at	62	0.887097	0.0288475	0.345059	1.35376	0.0961608	3.28207	26.63 [0.56 - 1272.25]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216600_x_at	51	0.745098	0.0550642	-	1.58242	0.508455	1.55745	4.75 [0.05 - 480.04]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214423_x_at	177	0.175141	0.0016775	0.0391956	-0.906588	0.493157	-0.805205	0.45 [0.04 - 4.47]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214424_s_at	177	0.785311	0.00208184	0.0468078	-1.16062	0.0645056	-1.82254	0.16 [0.02 - 1.12]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216600_x_at	145	0.206897	0.0549117	-	1.10155	0.533008	0.642649	1.90 [0.25 - 14.34]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214423_x_at	177	0.175141	0.00986807	0.159854	-0.689404	0.324005	-1.01802	0.36 [0.05 - 2.73]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214424_s_at	145	0.282759	0.154646	-	-0.490725	0.662307	-0.578696	0.56 [0.04 - 7.53]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204705_x_at	177	0.813559	0.0149759	0.217747	-1.09255	0.279234	-0.129854	0.88 [0.69 - 1.11]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	241280_at	177	0.231638	0.00114761	0.0285985	-0.879426	0.010923	-1.68875	0.18 [0.05 - 0.68]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217238_s_at	177	0.819209	0.0227294	0.293082	-1.02858	0.262827	-0.101362	0.90 [0.76 - 1.08]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	241280_at	177	0.231638	0.00033891	0.0101499	-0.847985	0.00391483	-1.66051	0.19 [0.06 - 0.59]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214423_x_at	145	0.317241	0.181568	-	0.530108	0.62029	0.686925	1.99 [0.13 - 30.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216600_x_at	177	0.220339	0.0768406	-	-0.533225	0.252277	-1.03819	0.35 [0.06 - 2.09]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204705_x_at	177	0.847458	0.0281293	0.339237	-0.852251	0.153644	-0.149897	0.86 [0.70 - 1.06]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217238_s_at	177	0.841808	0.0217966	0.284641	-0.887676	0.121399	-0.12327	0.88 [0.76 - 1.03]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	241280_at	145	0.186207	0.0101819	0.163666	-0.880206	0.181374	-1.0248	0.36 [0.08 - 1.61]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204705_x_at	145	0.248276	0.208876	-	-0.44161	0.98414	-0.00273204	1.00 [0.76 - 1.31]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214424_s_at	177	0.785311	0.0173832	0.2425	-0.99095	0.0876211	-1.94777	0.14 [0.02 - 1.33]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216600_x_at	177	0.864407	0.0552091	-	-0.797733	0.170592	-1.07542	0.34 [0.07 - 1.59]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217238_s_at	145	0.165517	0.123599	-	-0.584025	0.878402	-0.0163851	0.98 [0.80 - 1.21]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216600_x_at	226	0.880531	0.172018	-	0.500019	0.751008	0.12167	1.13 [0.53 - 2.39]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214424_s_at	226	0.659292	0.0110653	0.174194	-0.904465	0.0980368	-0.224269	0.80 [0.61 - 1.04]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214423_x_at	226	0.402655	0.0079047	0.135064	-0.743849	0.033853	-0.836159	0.43 [0.20 - 0.94]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	241280_at	226	0.318584	0.0683891	-	-0.514634	0.832431	-0.0601843	0.94 [0.54 - 1.64]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204705_x_at	226	0.300885	0.0369269	0.406246	-0.590016	0.351338	-0.0546169	0.95 [0.84 - 1.06]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217238_s_at	226	0.225664	0.0177284	0.24594	-0.696555	0.184391	-0.0688816	0.93 [0.84 - 1.03]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216600_x_at	49	0.469388	0.0467547	0.471768	1.2476	0.180254	1.90614	6.73 [0.41 - 109.32]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214423_x_at	55	0.836364	0.00717412	0.125371	1.25029	0.0402056	0.919752	2.51 [1.04 - 6.04]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214424_s_at	55	0.145455	0.22598	-	-0.690648	0.0990772	0.467827	1.60 [0.92 - 2.78]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	241280_at	55	0.709091	0.00373934	0.0751728	-2.38134	0.0120651	-4.23894	0.01 [0.00 - 0.39]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214424_s_at	49	0.408163	0.238406	-	-0.677751	0.449461	-1.39392	0.25 [0.01 - 9.19]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214423_x_at	55	0.836364	0.0576728	-	1.07333	0.089563	0.731734	2.08 [0.89 - 4.84]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204705_x_at	55	0.8	0.0029544	0.0622167	1.31514	0.0476254	0.32924	1.39 [1.00 - 1.93]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217238_s_at	55	0.763636	0.00470872	0.0902703	1.22454	0.0285728	0.317459	1.37 [1.03 - 1.83]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214423_x_at	49	0.469388	0.0513681	-	1.22338	0.87465	-0.269843	0.76 [0.03 - 21.82]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216600_x_at	55	0.836364	0.0943665	-	0.844083	0.0195121	1.00984	2.75 [1.18 - 6.41]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204705_x_at	55	0.690909	0.0520943	-	0.912586	0.185474	0.236883	1.27 [0.89 - 1.80]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	241280_at	55	0.163636	0.00853951	0.143269	-1.20295	0.00748263	-5.09537	0.01 [0.00 - 0.26]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217238_s_at	55	0.763636	0.129308	-	0.774617	0.18166	0.209573	1.23 [0.91 - 1.68]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204705_x_at	49	0.693878	0.0021242	0.0475857	1.64403	0.285655	0.283356	1.33 [0.79 - 2.23]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	241280_at	49	0.469388	0.00350932	0.0714514	-1.95068	0.00534649	-6.1283	0.00 [0.00 - 0.16]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217238_s_at	49	0.714286	0.0076564	0.131801	1.44036	0.281354	0.247623	1.28 [0.82 - 2.01]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216600_x_at	55	0.509091	0.0301503	0.355449	1.08926	0.034007	0.846917	2.33 [1.07 - 5.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214424_s_at	55	0.890909	0.052471	-	1.04409	0.0363004	0.606922	1.83 [1.04 - 3.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214424_s_at	63	0.222222	0.00268654	0.0576136	-1.03686	0.0164771	-14.4653	0.00 [0.00 - 0.07]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214423_x_at	63	0.111111	0.000178408	0.00581819	-1.5053	0.08617	2.30022	9.98 [0.72 - 138.05]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	241280_at	63	0.238095	0.0301245	0.355246	-0.755448	0.408205	-4.05364	0.02 [0.00 - 257.98]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204705_x_at	63	0.142857	7.38261e-05	0.00267914	-1.47471	0.0114949	-33.7309	0.00 [0.00 - 0.00]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217238_s_at	63	0.15873	4.12952e-07	2.40209e-05	-1.86198	0.0118145	-19.5215	0.00 [0.00 - 0.01]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216600_x_at	63	0.190476	0.000385978	0.0113518	-1.24549	0.472072	2.27468	9.72 [0.02 - 4791.09]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.315235.0.A1_3p_at	28	0.285714	0.0707113	-	-0.990967	0.626028	0.807884	2.24 [0.09 - 57.81]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557306_3p_a_at	28	0.75	0.0171766	0.240429	-2.10666	0.259441	-1.5783	0.21 [0.01 - 3.21]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.234234.2.A2_3p_a_at	28	0.785714	0.0416632	0.438905	-1.86914	0.268994	-4.26306	0.01 [0.00 - 27.00]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.234234.2.A1_3p_a_at	28	0.214286	0.120745	-	-0.931287	0.153133	1.3684	3.93 [0.60 - 25.68]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.234234.4.A1_3p_a_at	28	0.142857	0.115926	-	-1.04689	0.389364	-0.895655	0.41 [0.05 - 3.14]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.234234.2.A1_3p_x_at	28	0.464286	0.0641907	-	-1.04352	0.808103	0.3074	1.36 [0.11 - 16.25]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214424_s_at	82	0.280488	0.193853	-	0.540143	0.813614	0.0349972	1.04 [0.77 - 1.39]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216600_x_at	82	0.182927	0.0419829	0.441034	1.37205	0.65755	0.246192	1.28 [0.43 - 3.80]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217238_s_at	82	0.768293	0.056675	-	-0.897612	0.689666	-0.129662	0.88 [0.46 - 1.66]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214423_x_at	82	0.841463	0.124761	-	0.648565	0.449394	0.306934	1.36 [0.61 - 3.01]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216600_x_at	79	0.898734	0.0152943	0.221102	0.902212	0.167079	0.906318	2.48 [0.68 - 8.95]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204705_x_at	79	0.151899	0.00276743	0.0590146	-0.961758	0.036426	-0.390722	0.68 [0.47 - 0.98]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217238_s_at	79	0.227848	0.0160133	0.228585	-0.704785	0.127713	-0.369035	0.69 [0.43 - 1.11]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214423_x_at	79	0.151899	6.14328e-05	0.00227658	-1.32057	0.0210677	-0.982452	0.37 [0.16 - 0.86]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214424_s_at	79	0.518987	0.0822224	-	0.449821	0.469928	0.110868	1.12 [0.83 - 1.51]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214423_x_at	104	0.153846	0.0875837	-	1.17477	0.657832	0.281842	1.33 [0.38 - 4.61]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214424_s_at	104	0.894231	0.129246	-	-1.09486	0.876456	-0.025899	0.97 [0.70 - 1.35]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216600_x_at	104	0.451923	0.065711	-	-0.59762	0.182704	-0.935024	0.39 [0.10 - 1.55]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217238_s_at	104	0.673077	0.116889	-	-0.569022	0.420879	-0.288112	0.75 [0.37 - 1.51]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204705_x_at	204	0.102941	0.0102478	0.16446	-1.06178	0.328022	0.147449	1.16 [0.86 - 1.56]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	241280_at	204	0.455882	0.0909921	-	-0.620223	0.312735	-0.384198	0.68 [0.32 - 1.44]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217238_s_at	204	0.808824	0.182235	-	0.546097	0.368068	0.118822	1.13 [0.87 - 1.46]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204705_x_at	204	0.848039	0.00854223	0.143304	0.797164	0.124154	0.17168	1.19 [0.95 - 1.48]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	241280_at	204	0.852941	0.113367	-	0.52988	0.747672	0.108677	1.11 [0.57 - 2.16]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217238_s_at	204	0.803922	0.00165097	0.0386833	0.883853	0.211469	0.123963	1.13 [0.93 - 1.37]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216600_x_at	204	0.318627	0.0291294	0.347327	-0.777877	0.315195	-0.233825	0.79 [0.50 - 1.25]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216600_x_at	204	0.470588	0.0962916	-	-0.454031	0.451108	-0.132907	0.88 [0.62 - 1.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214424_s_at	204	0.397059	0.00746582	0.129275	1.2317	0.273179	0.320976	1.38 [0.78 - 2.45]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214424_s_at	204	0.284314	0.144876	-	0.487859	0.539379	0.126833	1.14 [0.76 - 1.70]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214423_x_at	204	0.328431	0.142914	-	-0.534672	0.48563	-0.361785	0.70 [0.25 - 1.93]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214423_x_at	204	0.617647	0.0251005	0.313891	-0.682925	0.0900624	-0.632843	0.53 [0.26 - 1.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216600_x_at	178	0.696629	0.0621115	-	0.379792	0.289914	0.41493	1.51 [0.70 - 3.27]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217238_s_at	178	0.511236	0.304271	-	-0.203026	0.865115	-0.0292819	0.97 [0.69 - 1.36]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214423_x_at	178	0.713483	0.0281941	0.339765	-0.52337	0.146359	-0.343716	0.71 [0.45 - 1.13]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214424_s_at	178	0.865169	0.0296247	0.351285	0.59109	0.775351	0.0284357	1.03 [0.85 - 1.25]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216600_x_at	111	0.684685	0.037677	0.411563	-0.6317	0.193737	-0.581337	0.56 [0.23 - 1.34]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	241280_at	111	0.306306	0.051832	-	0.602777	0.282063	0.344718	1.41 [0.75 - 2.65]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214424_s_at	111	0.162162	0.0181643	0.250245	-0.758102	0.158355	-0.247931	0.78 [0.55 - 1.10]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214423_x_at	111	0.891892	0.136889	-	0.560313	0.492603	0.32556	1.38 [0.55 - 3.51]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204705_x_at	111	0.891892	0.00588984	0.107598	0.943676	0.229941	0.250327	1.28 [0.85 - 1.93]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217238_s_at	111	0.882883	0.0540946	-	-1.08949	0.992944	0.00108368	1.00 [0.79 - 1.27]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204705_x_at	90	0.344444	0.284818	-	0.441408	0.887827	0.0874989	1.09 [0.32 - 3.68]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214424_s_at	90	0.233333	0.038887	0.420023	-0.692945	0.392172	-0.825044	0.44 [0.07 - 2.90]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214424_s_at	90	0.255556	0.057261	-	-0.71308	0.661494	-0.487272	0.61 [0.07 - 5.44]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216600_x_at	90	0.844444	0.0127124	0.193103	-2.11146	0.361276	-0.638715	0.53 [0.13 - 2.08]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216600_x_at	90	0.844444	0.0378959	0.413104	-1.84198	0.943909	0.0602802	1.06 [0.20 - 5.69]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204705_x_at	90	0.888889	0.231304	-	-0.846113	0.733003	0.186444	1.20 [0.41 - 3.52]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217238_s_at	90	0.577778	0.0646639	-	-0.650076	0.929865	0.0762557	1.08 [0.20 - 5.90]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217238_s_at	90	0.611111	0.0704759	-	-0.766947	0.818724	0.226681	1.25 [0.18 - 8.72]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214423_x_at	90	0.4	0.0406194	0.431889	-0.656617	0.3905	-0.645187	0.52 [0.12 - 2.29]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214423_x_at	90	0.4	0.0281586	0.339476	-0.806239	0.621641	-0.431797	0.65 [0.12 - 3.61]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3452	50	0.78	0.0666715	-	-1.6846	0.30403	-1.12701	0.32 [0.04 - 2.78]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204705_x_at	138	0.362319	0.040876	0.433623	-0.491574	0.247495	0.351297	1.42 [0.78 - 2.58]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217238_s_at	138	0.115942	0.0382079	0.415293	-0.629792	0.0938699	0.780639	2.18 [0.88 - 5.44]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216600_x_at	138	0.101449	0.00106564	0.0268799	-0.976171	0.780862	1.49072	4.44 [0.00 - 161684.08]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	241280_at	138	0.717391	0.0476077	0.477066	-0.58492	0.0798393	-7.26629	0.00 [0.00 - 2.37]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214424_s_at	138	0.666667	0.0459888	0.466963	-0.550951	0.0355259	-7.70241	0.00 [0.00 - 0.59]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214423_x_at	138	0.115942	0.00287968	0.0609429	-0.869639	0.936939	0.180668	1.20 [0.01 - 105.26]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214423_x_at	129	0.821705	0.0828145	-	0.529824	0.268596	0.468548	1.60 [0.70 - 3.66]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214424_s_at	129	0.744186	0.225473	-	-0.373589	0.91353	0.0222052	1.02 [0.68 - 1.53]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216600_x_at	129	0.44186	0.160772	-	0.360948	0.823636	-0.0978966	0.91 [0.38 - 2.14]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204705_x_at	129	0.806202	0.0906429	-	-0.629232	0.282157	-0.374761	0.69 [0.35 - 1.36]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217238_s_at	129	0.302326	0.102996	-	-0.41166	0.621469	-0.0689408	0.93 [0.71 - 1.23]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17806	56	0.375	0.00675942	0.11974	-0.973399	0.204612	-0.902718	0.41 [0.10 - 1.64]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19539	56	0.714286	0.1956	-	0.449833	0.546745	0.166557	1.18 [0.69 - 2.03]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17806	56	0.375	0.00563402	0.103932	-0.94476	0.373719	-0.588163	0.56 [0.15 - 2.03]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19539	56	0.714286	0.14013	-	0.535725	0.590389	0.15704	1.17 [0.66 - 2.07]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214424_s_at	278	0.165468	0.0171206	0.239867	-0.529824	0.117583	-0.875373	0.42 [0.14 - 1.25]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214423_x_at	278	0.755396	0.0498732	0.490862	-0.484234	0.33092	-0.477983	0.62 [0.24 - 1.63]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204705_x_at	278	0.769784	0.0271762	0.331402	-0.548153	0.219083	-0.488259	0.61 [0.28 - 1.34]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	241280_at	278	0.471223	0.0299013	0.353481	0.415805	0.406333	0.431334	1.54 [0.56 - 4.26]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217238_s_at	278	0.208633	0.113502	-	0.396962	0.739394	0.124422	1.13 [0.54 - 2.36]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216600_x_at	278	0.100719	0.250021	-	0.418438	0.760491	0.13777	1.15 [0.47 - 2.78]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217238_s_at	133	0.631579	0.000122293	0.00418046	0.891683	0.0147614	1.08736	2.97 [1.24 - 7.11]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214423_x_at	133	0.661654	0.00259783	0.0560661	0.715181	0.0459061	4.60831	100.31 [1.09 - 9255.11]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204705_x_at	133	0.736842	0.00280952	0.0597397	0.762521	0.025448	7.93357	2789.37 [2.65 - 2935629.30]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214424_s_at	133	0.819549	0.00529826	0.0990503	0.76776	0.0192963	2.1803	8.85 [1.42 - 54.97]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216600_x_at	133	0.75188	0.000688005	0.0185924	0.837533	0.00177183	7.68784	2181.66 [17.59 - 270510.99]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4697	81	0.222222	0.166782	-	1.33417	0.977088	0.00254192	1.00 [0.84 - 1.19]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214423_x_at	185	0.162162	0.0517243	-	0.426449	0.877282	-0.0354173	0.97 [0.62 - 1.51]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214424_s_at	185	0.643243	0.00790269	0.135038	-0.50818	0.216439	-0.493957	0.61 [0.28 - 1.34]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204705_x_at	185	0.124324	0.101771	-	0.412034	0.876233	0.0332182	1.03 [0.68 - 1.57]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217238_s_at	185	0.389189	0.000226166	0.00715275	-0.597892	0.231498	-0.374446	0.69 [0.37 - 1.27]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214423_x_at	185	0.162162	0.0868764	-	0.408942	0.908095	0.0289206	1.03 [0.63 - 1.68]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216600_x_at	185	0.827027	0.114827	-	-0.359737	0.773086	-0.0755937	0.93 [0.55 - 1.55]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204705_x_at	185	0.124324	0.092136	-	0.475756	0.637079	0.109309	1.12 [0.71 - 1.76]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217238_s_at	185	0.367568	0.000154767	0.00513876	-0.663687	0.315111	-0.3408	0.71 [0.37 - 1.38]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214424_s_at	185	0.643243	0.0285485	0.342644	-0.376306	0.381391	-0.301622	0.74 [0.38 - 1.45]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216600_x_at	185	0.243243	0.0272089	0.331672	-0.420836	0.712716	-0.107436	0.90 [0.51 - 1.59]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P32143	110	0.736364	0.212455	-	-0.332233	0.390884	-0.245036	0.78 [0.45 - 1.37]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P415974	110	0.463636	0.000161611	0.00533688	0.885998	0.13341	0.147659	1.16 [0.96 - 1.41]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P32143	110	0.890909	0.0965949	-	0.671922	0.8329	-0.078033	0.92 [0.45 - 1.91]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P415974	110	0.763636	0.018866	0.257092	0.754292	0.0545068	0.249025	1.28 [1.00 - 1.65]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214423_x_at	80	0.425	0.278755	-	-0.470326	0.77529	-0.124292	0.88 [0.38 - 2.07]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214424_s_at	80	0.8875	0.0239836	0.304201	1.1235	0.162917	0.446052	1.56 [0.83 - 2.92]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216600_x_at	80	0.175	0.167727	-	1.3152	0.661496	0.126673	1.14 [0.64 - 2.00]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204705_x_at	80	0.6	0.0371249	0.407655	0.933134	0.860292	0.0581707	1.06 [0.55 - 2.03]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217238_s_at	80	0.2375	0.0545456	-	-0.868254	0.733103	-0.0551768	0.95 [0.69 - 1.30]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3055	281	0.341637	0.119567	-	0.239652	0.745461	-0.0359647	0.96 [0.78 - 1.20]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:121997	59	0.457627	0.0964492	-	-0.824716	0.443485	-0.356806	0.70 [0.28 - 1.74]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:293281	59	0.152542	0.335053	-	0.95574	0.92195	0.0368376	1.04 [0.50 - 2.17]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216600_x_at	38	0.184211	0.044159	0.455288	-1.05775	0.5235	-0.388247	0.68 [0.21 - 2.24]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	241280_at	38	0.815789	0.000723991	0.0194128	1.61503	0.800712	0.0839254	1.09 [0.57 - 2.09]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214424_s_at	38	0.868421	0.0110654	0.174195	1.36306	0.115748	1.17429	3.24 [0.75 - 13.98]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214423_x_at	38	0.105263	0.0929906	-	15.2661	0.733828	0.283305	1.33 [0.26 - 6.80]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204705_x_at	38	0.368421	0.040983	0.434345	-0.969092	0.183803	-0.361754	0.70 [0.41 - 1.19]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217238_s_at	38	0.236842	0.00350058	0.0713088	-1.43404	0.141395	-0.476822	0.62 [0.33 - 1.17]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216600_x_at	140	0.45	0.0404843	0.430974	0.641183	0.0677787	1.37558	3.96 [0.90 - 17.32]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217238_s_at	140	0.378571	0.115876	-	0.496084	0.673158	0.437984	1.55 [0.20 - 11.86]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214423_x_at	140	0.221429	0.0475614	0.476779	0.905857	0.369492	0.865974	2.38 [0.36 - 15.76]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204705_x_at	140	0.528571	0.0418579	0.440203	-0.598988	0.0746702	-1.46698	0.23 [0.05 - 1.16]
GENE	ALDOB	aldolase B, fructose-bisphosphate	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214424_s_at	140	0.814286	0.115763	-	0.519634	0.621015	-0.740053	0.48 [0.03 - 8.97]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202022_at	30	0.733333	0.231096	-	0.547808	0.201313	0.587638	1.80 [0.73 - 4.43]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1755974	165	0.339394	0.00782034	0.133959	0.747945	0.0695616	0.249915	1.28 [0.98 - 1.68]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1755974	165	0.315152	0.0297567	0.352334	1.0148	0.303629	0.209238	1.23 [0.83 - 1.84]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202022_at	163	0.871166	0.000121748	0.00416408	0.937348	0.000892252	1.08466	2.96 [1.56 - 5.61]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202022_at	79	0.886076	6.00154e-06	0.000281064	1.69589	0.0423358	0.614864	1.85 [1.02 - 3.35]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202022_at	58	0.603448	0.00844806	0.142099	0.73658	0.262663	0.270819	1.31 [0.82 - 2.11]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202022_at	34	0.735294	0.199231	-	-0.636191	0.832302	-0.0604974	0.94 [0.54 - 1.65]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202022_at	158	0.177215	0.151393	-	-0.393322	0.893901	0.024836	1.03 [0.71 - 1.48]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202022_at	53	0.849057	0.159077	-	0.627435	0.967058	-0.0110359	0.99 [0.59 - 1.67]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202022_at	53	0.849057	0.0719787	-	0.804991	0.661207	0.117144	1.12 [0.67 - 1.90]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202022_at	180	0.111111	0.0133813	0.200538	-0.707137	0.829871	-0.0549273	0.95 [0.57 - 1.56]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202022_at	559	0.363148	0.00148996	0.0355361	-0.626415	0.00735388	-0.425075	0.65 [0.48 - 0.89]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202022_at	77	0.753247	0.00211228	0.0473671	-1.01548	0.00826371	-0.301442	0.74 [0.59 - 0.93]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202022_at	70	0.871429	0.0108581	0.171749	0.923787	0.143181	0.200719	1.22 [0.93 - 1.60]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40107_at	50	0.34	0.000646964	0.0176473	-1.23338	0.000516005	-0.368695	0.69 [0.56 - 0.85]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202022_at	74	0.121622	0.00880988	0.146706	-1.02843	0.0252557	-0.397629	0.67 [0.47 - 0.95]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202022_at	67	0.492537	0.103566	-	1.2291	0.553686	0.335212	1.40 [0.46 - 4.24]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202022_at	115	0.217391	0.0390943	0.421457	-1.06347	0.205215	-1.03557	0.36 [0.07 - 1.76]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40107_at	158	0.14557	0.0290684	0.346837	1.4474	0.237562	0.463802	1.59 [0.74 - 3.43]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40107_at	76	0.131579	0.071975	-	-1.01287	0.2684	-0.966329	0.38 [0.07 - 2.11]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202022_at	204	0.436274	0.0028598	0.0606026	0.430514	0.004792	0.240773	1.27 [1.08 - 1.50]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202022_at	87	0.873563	0.00446342	0.0865325	1.13301	0.0464875	0.346191	1.41 [1.01 - 1.99]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202022_at	87	0.873563	0.00446342	0.0865325	1.13301	0.0464875	0.346191	1.41 [1.01 - 1.99]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202022_at	77	0.285714	0.117467	-	-0.847677	0.515908	-0.315839	0.73 [0.28 - 1.89]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202022_at	77	0.142857	0.111612	-	-1.05077	0.676495	-0.2235	0.80 [0.28 - 2.29]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202022_at	136	0.838235	0.0316063	0.36681	1.02167	0.620698	0.19985	1.22 [0.55 - 2.69]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202022_at	200	0.63	0.0371707	0.407981	0.606937	0.440636	0.216155	1.24 [0.72 - 2.15]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19578	60	0.366667	0.143634	-	0.627775	0.644006	0.143782	1.15 [0.63 - 2.12]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19578	60	0.3	0.248435	-	-0.451575	0.895181	0.0416501	1.04 [0.56 - 1.94]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5972	155	0.883871	0.0100908	0.162562	0.851094	0.342035	0.219284	1.25 [0.79 - 1.96]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202022_at	286	0.776224	0.0541327	-	0.412027	0.664617	0.0884978	1.09 [0.73 - 1.63]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202022_at	159	0.748428	0.104787	-	-0.703865	0.441825	-0.268109	0.76 [0.39 - 1.51]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202022_at	159	0.748428	0.261038	-	-0.545858	0.563125	0.246849	1.28 [0.55 - 2.96]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202022_at	159	0.188679	0.115582	-	0.807387	0.513481	0.237951	1.27 [0.62 - 2.59]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202022_at	54	0.666667	0.195246	-	-1.28489	0.896606	-0.0528099	0.95 [0.43 - 2.10]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202022_at	117	0.811966	0.0990669	-	-0.844717	0.53112	-0.125038	0.88 [0.60 - 1.31]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202022_at	117	0.111111	0.0546199	-	15.1988	0.875734	-0.0360797	0.96 [0.61 - 1.52]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202022_at	117	0.811966	0.0990669	-	-0.844717	0.53112	-0.125038	0.88 [0.60 - 1.31]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202022_at	117	0.128205	0.0396355	0.425185	15.2419	0.667324	-0.104593	0.90 [0.56 - 1.45]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202022_at	236	0.677966	0.0224212	0.29031	0.612522	0.030953	0.643053	1.90 [1.06 - 3.41]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202022_at	249	0.638554	0.023583	0.300677	0.480303	0.0215005	0.600973	1.82 [1.09 - 3.04]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202022_at	62	0.806452	0.221126	-	0.612734	0.987469	-0.00304867	1.00 [0.68 - 1.46]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202022_at	125	0.576	0.0156303	0.224616	0.92429	0.602747	0.150456	1.16 [0.66 - 2.05]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202022_at	125	0.576	0.032989	0.377363	0.608776	0.898747	0.0290523	1.03 [0.66 - 1.61]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202022_at	54	0.796296	0.158792	-	0.814192	0.965484	-0.0102228	0.99 [0.62 - 1.57]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202022_at	198	0.151515	0.0574692	-	-0.589834	0.553474	0.104116	1.11 [0.79 - 1.57]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202022_at	198	0.136364	0.0386772	0.418566	-0.665446	0.589924	0.0994175	1.10 [0.77 - 1.59]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202022_at	198	0.287879	0.189837	-	0.325485	0.77361	0.0405415	1.04 [0.79 - 1.37]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202022_at	51	0.490196	0.14756	-	-1.48054	0.90522	-0.126259	0.88 [0.11 - 7.04]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202022_at	62	0.16129	0.281803	-	-0.704362	0.649795	0.244487	1.28 [0.44 - 3.67]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202022_at	145	0.193103	0.0198261	0.266298	1.5422	0.0225021	0.883687	2.42 [1.13 - 5.17]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202022_at	177	0.898305	0.0437102	0.452382	0.72182	0.0764066	0.559746	1.75 [0.94 - 3.25]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202022_at	177	0.39548	0.0206802	0.274337	0.600588	0.0286976	0.59858	1.82 [1.06 - 3.11]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202022_at	226	0.323009	0.0281175	0.339141	0.759334	0.293146	0.255258	1.29 [0.80 - 2.08]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202022_at	49	0.714286	0.0126482	0.192382	1.34609	0.232228	0.701148	2.02 [0.64 - 6.37]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202022_at	55	0.690909	0.0241994	0.306088	0.979051	0.961621	0.0188639	1.02 [0.47 - 2.20]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202022_at	55	0.618182	0.000430699	0.0124717	1.69613	0.00569002	1.06566	2.90 [1.36 - 6.18]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202022_at	63	0.253968	0.104489	-	0.677437	0.865815	-0.0193433	0.98 [0.78 - 1.23]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4885062_3p_at	28	0.107143	0.000339674	0.0101697	-2.37204	0.509286	-0.609821	0.54 [0.09 - 3.32]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202022_at	82	0.865854	0.023115	0.296528	0.935167	0.21094	0.620905	1.86 [0.70 - 4.92]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40107_at	84	0.190476	0.0111013	0.174617	1.24525	0.586387	0.269145	1.31 [0.50 - 3.45]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202022_at	79	0.417722	0.147743	-	-0.374736	0.551088	-0.25785	0.77 [0.33 - 1.80]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X05196_at	86	0.744186	0.0533715	-	0.7808	0.7481	0.0858723	1.09 [0.65 - 1.84]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202022_at	104	0.442308	0.0162164	0.230676	0.842062	0.213344	0.660506	1.94 [0.68 - 5.48]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P78108	117	0.119658	0.11247	-	-0.605227	0.447311	-0.140359	0.87 [0.61 - 1.25]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202022_at	204	0.843137	0.0218645	0.285261	0.886122	0.820702	0.0815492	1.08 [0.54 - 2.20]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202022_at	204	0.828431	2.08858e-06	0.00010713	1.25558	0.020071	0.628758	1.88 [1.10 - 3.19]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202022_at	178	0.769663	0.0321882	0.371278	0.469823	0.405309	0.257505	1.29 [0.71 - 2.37]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200014052	41	0.756098	0.0636859	-	-1.09609	0.117383	-0.449258	0.64 [0.36 - 1.12]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202022_at	111	0.18018	0.180421	-	-0.420748	0.300148	-0.222101	0.80 [0.53 - 1.22]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202022_at	90	0.488889	0.244033	-	0.384758	0.495097	0.176322	1.19 [0.72 - 1.98]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202022_at	90	0.488889	0.209203	-	0.476289	0.869145	0.0503667	1.05 [0.58 - 1.91]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202022_at	138	0.181159	0.324166	-	0.336226	0.872049	0.0135826	1.01 [0.86 - 1.20]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202022_at	129	0.899225	0.0250316	0.313299	0.75553	0.368956	0.250672	1.28 [0.74 - 2.22]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30319	56	0.410714	0.157881	-	-0.497714	0.77339	-0.0821524	0.92 [0.53 - 1.61]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2544	56	0.625	0.309039	-	-0.398322	0.669317	-0.115498	0.89 [0.52 - 1.51]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31767	56	0.107143	0.0858927	-	-0.844711	0.568898	-0.168275	0.85 [0.47 - 1.51]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30319	56	0.410714	0.167041	-	-0.466988	0.876747	-0.0430784	0.96 [0.56 - 1.65]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31767	56	0.107143	0.142213	-	-0.717637	0.539809	-0.188273	0.83 [0.45 - 1.51]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2544	56	0.625	0.377844	-	-0.329692	0.826748	-0.0569942	0.94 [0.57 - 1.57]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202022_at	278	0.866906	0.0268001	0.328275	0.529768	0.347426	0.145677	1.16 [0.85 - 1.57]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202022_at	133	0.676692	0.0223345	0.289527	0.550088	0.0371035	0.258408	1.29 [1.02 - 1.65]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16702	81	0.432099	0.214787	-	0.710314	0.925677	0.0237142	1.02 [0.62 - 1.69]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202022_at	185	0.756757	0.36736	-	-0.172967	0.704526	0.0781147	1.08 [0.72 - 1.62]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202022_at	185	0.681081	0.219634	-	0.226372	0.465375	0.163462	1.18 [0.76 - 1.83]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P78108	110	0.190909	0.0353629	0.394974	1.18727	0.106242	0.236317	1.27 [0.95 - 1.69]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P78108	110	0.172727	0.0436384	0.451915	0.703075	0.151488	0.153092	1.17 [0.95 - 1.44]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202022_at	80	0.8	0.0104895	0.167364	1.12086	0.34429	0.345759	1.41 [0.69 - 2.89]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1066	281	0.266904	0.138694	-	0.239383	0.785495	0.030439	1.03 [0.83 - 1.28]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202022_at	38	0.631579	0.0306804	0.359615	1.01356	0.302056	0.340792	1.41 [0.74 - 2.69]
GENE	ALDOC	aldolase C, fructose-bisphosphate	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202022_at	140	0.807143	0.00671398	0.119117	-1.4804	0.024383	-0.643457	0.53 [0.30 - 0.92]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1718093	165	0.878788	0.0386384	0.418296	-1.02309	0.274766	-0.330589	0.72 [0.40 - 1.30]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1718093	165	0.375758	0.215686	-	0.48144	0.968115	0.017367	1.02 [0.43 - 2.38]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	223355_at	163	0.723926	0.0672058	-	0.385635	0.485092	0.249251	1.28 [0.64 - 2.58]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	223355_at	79	0.392405	0.0274628	0.333771	0.681084	0.189193	0.55564	1.74 [0.76 - 4.00]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	223355_at	180	0.355556	0.00553441	0.102492	0.665318	0.150314	0.25246	1.29 [0.91 - 1.82]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	223355_at	559	0.858676	0.196692	-	-0.409907	0.764262	-0.0399545	0.96 [0.74 - 1.25]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	223355_at	77	0.766234	6.11145e-05	0.00226612	1.1391	0.0557256	0.432022	1.54 [0.99 - 2.40]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	223355_at	70	0.757143	0.146204	-	-0.482205	0.749851	-0.173985	0.84 [0.29 - 2.45]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	223355_at	74	0.148649	0.0326534	0.374821	-0.781933	0.918046	-0.0244766	0.98 [0.61 - 1.56]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	223355_at	67	0.895522	0.066345	-	1.41913	0.369518	1.41645	4.12 [0.19 - 90.94]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	223355_at	115	0.66087	0.0427973	0.446416	1.0505	0.444684	0.77906	2.18 [0.30 - 16.07]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	223355_at	204	0.470588	0.419989	-	-0.11598	0.60988	0.0722703	1.07 [0.81 - 1.42]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	223355_at	87	0.218391	0.0435608	0.45141	-0.802052	0.684303	-0.175471	0.84 [0.36 - 1.95]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	223355_at	87	0.218391	0.0435608	0.45141	-0.802052	0.684303	-0.175471	0.84 [0.36 - 1.95]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	223355_at	77	0.246753	0.0626055	-	15.4848	0.310761	0.691996	2.00 [0.52 - 7.61]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	223355_at	77	0.246753	0.032316	0.372254	15.4922	0.470133	0.443762	1.56 [0.47 - 5.20]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223355_at	159	0.465409	0.00876594	0.14615	1.08413	0.161672	0.422833	1.53 [0.84 - 2.76]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223355_at	159	0.465409	0.0193838	0.26208	0.786768	0.225147	0.305189	1.36 [0.83 - 2.22]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223355_at	159	0.861635	0.000119214	0.00408787	1.24812	0.0119613	0.700193	2.01 [1.17 - 3.48]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	223355_at	236	0.677966	0.00397902	0.0789901	0.764942	0.574712	0.133629	1.14 [0.72 - 1.82]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	223355_at	249	0.670683	0.0262872	0.323979	0.476741	0.525422	0.119732	1.13 [0.78 - 1.63]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	223355_at	177	0.694915	0.00883455	0.147018	-0.761214	0.480597	-0.276893	0.76 [0.35 - 1.64]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	223355_at	177	0.711864	0.00233064	0.0513292	-1.16697	0.146843	-0.65914	0.52 [0.21 - 1.26]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	223355_at	145	0.689655	0.00381727	0.0764205	-1.4145	0.0311705	-1.20799	0.30 [0.10 - 0.90]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	223355_at	226	0.287611	0.0162458	0.230978	-0.678705	0.0851335	-0.366585	0.69 [0.46 - 1.05]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	223355_at	55	0.509091	0.11276	-	-0.7278	0.489915	-0.316719	0.73 [0.30 - 1.79]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	223355_at	55	0.145455	0.233581	-	1.1228	0.904109	0.0603694	1.06 [0.40 - 2.84]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	223355_at	49	0.285714	0.104281	-	-0.927514	0.456582	-0.46531	0.63 [0.18 - 2.14]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	223355_at	63	0.619048	0.00253724	0.0550021	0.990703	0.00808347	0.512447	1.67 [1.14 - 2.44]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13325167_3p_at	28	0.607143	0.144225	-	-0.881767	0.37405	-4.56961	0.01 [0.00 - 246.19]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P169131	117	0.102564	6.03938e-06	0.000282676	-1.4884	0.00343251	-0.875823	0.42 [0.23 - 0.75]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P565556	117	0.589744	0.00782385	0.134005	-0.819988	0.0194978	-0.533053	0.59 [0.38 - 0.92]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P65395	117	0.128205	3.574e-06	0.000175201	-1.4451	0.00620663	-0.792516	0.45 [0.26 - 0.80]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P586523	117	0.521368	0.197859	-	-0.373085	0.516088	-0.165025	0.85 [0.52 - 1.40]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P66306	117	0.128205	6.34499e-06	0.000295658	-1.40024	0.0168164	-0.81937	0.44 [0.23 - 0.86]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	223355_at	204	0.818627	0.00802615	0.136649	-15.3408	0.372399	-0.412403	0.66 [0.27 - 1.64]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	223355_at	204	0.862745	0.0290023	0.346306	-1.22086	0.373707	-0.293812	0.75 [0.39 - 1.42]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200004717	41	0.585366	0.0325246	0.373843	0.881526	0.141546	0.423531	1.53 [0.87 - 2.69]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	223355_at	111	0.297297	0.208177	-	-0.342651	0.677658	0.103185	1.11 [0.68 - 1.80]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	223355_at	138	0.818841	0.0243634	0.307518	0.622542	0.817316	0.06546	1.07 [0.61 - 1.86]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32041	56	0.571429	0.311769	-	-0.372245	0.931875	0.045289	1.05 [0.37 - 2.96]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32041	56	0.339286	0.364214	-	0.331326	0.931218	-0.0438826	0.96 [0.35 - 2.59]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	223355_at	278	0.546763	1.85006e-05	0.000778696	-0.841983	0.0239692	-0.544106	0.58 [0.36 - 0.93]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P169131	110	0.2	0.189554	-	-0.454888	0.75309	0.0836413	1.09 [0.65 - 1.83]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P586523	110	0.336364	0.100035	-	-0.395897	0.999068	0.000257238	1.00 [0.65 - 1.54]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P565556	110	0.836364	0.00585056	0.107038	0.884081	0.174263	0.301148	1.35 [0.88 - 2.09]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P66306	110	0.318182	0.0437532	0.452661	-0.488827	0.636162	-0.133906	0.87 [0.50 - 1.52]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P586523	110	0.163636	0.152289	-	-0.527666	0.793111	0.0673892	1.07 [0.65 - 1.77]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P169131	110	0.345455	0.358352	-	0.230811	0.718065	0.0752472	1.08 [0.72 - 1.62]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P66306	110	0.118182	0.10109	-	-0.669281	0.624397	-0.179402	0.84 [0.41 - 1.71]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P565556	110	0.836364	0.0320823	0.370468	0.615223	0.355417	0.171603	1.19 [0.83 - 1.71]
GENE	ALG1	asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	223355_at	38	0.842105	0.00200434	0.0453754	1.58927	0.00632849	1.41651	4.12 [1.49 - 11.40]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1730304	165	0.109091	0.154358	-	0.651553	0.88014	-0.0551621	0.95 [0.46 - 1.94]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1730304	165	0.745455	0.0453934	0.463194	0.71537	0.199974	0.664487	1.94 [0.70 - 5.37]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1552304_at	79	0.101266	0.0664107	-	1.24557	0.311634	0.741082	2.10 [0.50 - 8.82]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1552306_at	79	0.493671	0.024752	0.310888	0.65825	0.0552678	0.69596	2.01 [0.98 - 4.09]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1552304_at	559	0.220036	0.00432653	0.0844232	0.91997	0.0192425	0.412642	1.51 [1.07 - 2.13]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1552306_at	559	0.889088	0.0448597	0.459791	0.54434	0.317306	0.215328	1.24 [0.81 - 1.89]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1552304_at	70	0.328571	0.0481399	0.480342	0.603307	0.820256	0.147601	1.16 [0.32 - 4.14]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1552306_at	70	0.371429	0.269931	-	-0.296547	0.959031	-0.0226171	0.98 [0.41 - 2.32]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1552304_at	67	0.328358	0.155287	-	1.39867	0.72584	-0.659129	0.52 [0.01 - 20.59]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1552306_at	67	0.58209	0.105528	-	1.09087	0.594838	0.563528	1.76 [0.22 - 14.02]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1552304_at	115	0.26087	0.0923657	-	1.57796	0.376616	0.628427	1.87 [0.47 - 7.55]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1552306_at	115	0.843478	0.121498	-	0.888704	0.149252	1.0039	2.73 [0.70 - 10.68]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1552304_at	204	0.828431	0.0429973	0.447729	0.383631	0.512027	0.0579424	1.06 [0.89 - 1.26]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1552306_at	204	0.308824	0.0274664	0.3338	0.334055	0.149091	0.194235	1.21 [0.93 - 1.58]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1552304_at	87	0.114943	0.0474973	0.476384	15.2124	0.668341	0.203437	1.23 [0.48 - 3.11]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1552304_at	87	0.114943	0.0474973	0.476384	15.2124	0.668341	0.203437	1.23 [0.48 - 3.11]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1552306_at	87	0.781609	0.365205	-	0.377715	0.766156	0.0857899	1.09 [0.62 - 1.92]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1552306_at	87	0.781609	0.365205	-	0.377715	0.766156	0.0857899	1.09 [0.62 - 1.92]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552304_at	77	0.753247	0.0271859	0.331482	-15.5222	0.303184	-0.888734	0.41 [0.08 - 2.23]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552306_at	77	0.714286	0.0898218	-	-1.59233	0.487767	-0.318809	0.73 [0.30 - 1.79]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552304_at	77	0.753247	0.0556892	-	-15.5101	0.278126	-1.12047	0.33 [0.04 - 2.47]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552306_at	77	0.649351	0.0870116	-	-1.62081	0.675973	-0.216963	0.80 [0.29 - 2.23]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7012	60	0.333333	0.115685	-	0.677996	0.26093	0.222416	1.25 [0.85 - 1.84]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7012	60	0.45	0.121922	-	-0.587945	0.593141	0.175267	1.19 [0.63 - 2.27]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1552304_at	177	0.898305	0.0061942	0.111902	0.917417	0.131588	0.743478	2.10 [0.80 - 5.53]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1552304_at	177	0.423729	0.137437	-	-0.403857	0.917766	0.0623458	1.06 [0.33 - 3.48]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1552306_at	177	0.19774	0.00770519	0.132445	0.965603	0.535729	0.146983	1.16 [0.73 - 1.84]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1552306_at	177	0.19774	0.0217297	0.28403	0.961287	0.628858	-0.144622	0.87 [0.48 - 1.56]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1552304_at	145	0.834483	0.0833647	-	0.684047	0.861984	0.126366	1.13 [0.27 - 4.72]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1552306_at	145	0.386207	0.17992	-	0.480668	0.893465	0.0469331	1.05 [0.53 - 2.08]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1552304_at	226	0.504425	0.000294942	0.00900297	-1.08922	0.150924	-0.200853	0.82 [0.62 - 1.08]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1552306_at	226	0.10177	0.0274299	0.3335	-0.831351	0.263497	-0.302896	0.74 [0.43 - 1.26]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1552304_at	55	0.745455	0.00126593	0.0310378	1.49193	0.0212155	2.56088	12.95 [1.47 - 114.35]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1552306_at	55	0.872727	5.58051e-05	0.00209046	2.22813	0.0094939	0.989653	2.69 [1.27 - 5.68]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1552304_at	49	0.897959	0.000235327	0.00740367	2.04644	0.0104166	3.24271	25.60 [2.14 - 306.06]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1552306_at	49	0.897959	2.76268e-05	0.00111629	2.27688	0.0202364	0.852043	2.34 [1.14 - 4.81]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1552304_at	55	0.727273	3.21546e-05	0.00127877	1.73159	0.00174931	3.106	22.33 [3.19 - 156.19]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1552306_at	55	0.854545	1.60042e-07	9.95479e-06	2.17447	0.00331825	0.864737	2.37 [1.33 - 4.23]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1552304_at	63	0.142857	1.81774e-05	0.000766438	-1.58686	0.701782	-0.773053	0.46 [0.01 - 24.14]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1552306_at	63	0.190476	0.000230513	0.007272	-1.26778	0.263759	-0.835627	0.43 [0.10 - 1.88]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.102971.1.S2_3p_s_at	28	0.535714	0.131953	-	-0.893374	0.727413	-0.342689	0.71 [0.10 - 4.88]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.102971.1.S1_3p_at	28	0.178571	0.143103	-	-0.959833	0.68913	-0.307108	0.74 [0.16 - 3.31]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P204333	117	0.888889	0.000785441	0.0207971	1.1401	0.0546486	0.425277	1.53 [0.99 - 2.36]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1552304_at	204	0.705882	2.77063e-06	0.000138802	1.60553	6.06108e-05	1.63698	5.14 [2.31 - 11.44]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1552306_at	204	0.642157	0.00179045	0.041358	1.1084	0.014412	1.17885	3.25 [1.26 - 8.36]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1552304_at	204	0.813725	1.72942e-09	1.41038e-07	1.52553	1.05816e-06	1.48549	4.42 [2.43 - 8.02]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1552306_at	204	0.843137	0.0056347	0.103942	0.836937	0.00701069	0.981988	2.67 [1.31 - 5.45]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1552304_at	111	0.792793	0.132767	-	-0.570527	0.90987	0.0145149	1.01 [0.79 - 1.30]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1552306_at	111	0.306306	0.0602211	-	-0.495328	0.489831	-0.106381	0.90 [0.66 - 1.22]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1552304_at	138	0.5	0.0975296	-	-0.402263	0.460787	-0.368537	0.69 [0.26 - 1.84]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1552306_at	138	0.108696	0.0600884	-	0.941892	0.620715	0.0763626	1.08 [0.80 - 1.46]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9529	56	0.339286	0.292974	-	0.413051	0.895327	0.0248114	1.03 [0.71 - 1.48]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9529	56	0.339286	0.153762	-	0.607236	0.539176	0.117985	1.13 [0.77 - 1.64]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1552304_at	278	0.215827	0.232668	-	-0.268329	0.895727	0.0224644	1.02 [0.73 - 1.43]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1552306_at	278	0.892086	0.119819	-	-0.564746	0.929489	-0.012093	0.99 [0.76 - 1.29]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P204333	110	0.790909	0.16116	-	0.372983	0.405346	0.127012	1.14 [0.84 - 1.53]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P204333	110	0.754545	0.0315565	0.366426	0.665474	0.12724	0.305387	1.36 [0.92 - 2.01]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1552304_at	38	0.421053	0.0263006	0.324092	-1.05941	0.604516	-0.123675	0.88 [0.55 - 1.41]
GENE	ALG10	asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1552306_at	38	0.368421	0.101517	-	0.812087	0.691274	0.161211	1.17 [0.53 - 2.60]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218444_at	30	0.333333	0.197549	-	0.556462	0.67609	0.393637	1.48 [0.23 - 9.40]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1743995	165	0.606061	0.025244	0.315122	-0.571596	0.55994	-0.22765	0.80 [0.37 - 1.71]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1743995	165	0.624242	0.0244965	0.308675	-0.930898	0.538712	-0.352114	0.70 [0.23 - 2.16]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218444_at	163	0.558282	0.0451459	0.461619	0.393628	0.340621	0.416631	1.52 [0.64 - 3.57]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218444_at	79	0.481013	0.315433	-	-0.292056	0.883124	0.0944968	1.10 [0.31 - 3.87]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218444_at	58	0.413793	0.0449772	0.460543	0.564183	0.415506	0.11883	1.13 [0.85 - 1.50]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218444_at	34	0.147059	0.320315	-	-0.538775	0.446674	-0.242686	0.78 [0.42 - 1.47]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218444_at	158	0.424051	0.00908901	0.15022	0.643183	0.112865	0.986072	2.68 [0.79 - 9.07]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218444_at	53	0.396226	0.304094	-	0.395763	0.591546	0.147335	1.16 [0.68 - 1.98]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218444_at	53	0.773585	0.189046	-	-0.626688	0.603434	-0.128394	0.88 [0.54 - 1.43]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218444_at	180	0.605556	0.0808268	-	0.367819	0.606701	0.103002	1.11 [0.75 - 1.64]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218444_at	559	0.810376	0.00738157	0.128152	-0.951684	0.164732	-0.181898	0.83 [0.64 - 1.08]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218444_at	77	0.272727	0.159732	-	-0.410071	0.87821	0.0250439	1.03 [0.74 - 1.41]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218444_at	70	0.871429	0.102498	-	0.619772	0.67544	0.304732	1.36 [0.33 - 5.65]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218444_at	74	0.162162	0.0063484	0.11406	1.35473	0.131516	0.34571	1.41 [0.90 - 2.21]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218444_at	67	0.597015	0.171013	-	0.893654	0.85949	-0.260175	0.77 [0.04 - 13.74]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218444_at	115	0.86087	0.0903902	-	0.960231	0.880425	-0.113107	0.89 [0.20 - 3.90]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218444_at	204	0.70098	0.00848396	0.142558	-0.403023	0.112417	-0.206308	0.81 [0.63 - 1.05]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218444_at	87	0.793103	0.014209	0.209558	0.933917	0.170299	0.709729	2.03 [0.74 - 5.61]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218444_at	87	0.793103	0.014209	0.209558	0.933917	0.170299	0.709729	2.03 [0.74 - 5.61]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218444_at	77	0.623377	0.00601772	0.109414	1.51163	0.0611218	1.20819	3.35 [0.95 - 11.86]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218444_at	77	0.623377	0.0909632	-	1.0458	0.450095	0.559743	1.75 [0.41 - 7.48]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218444_at	136	0.882353	0.227726	-	0.671765	0.56967	0.190336	1.21 [0.63 - 2.33]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218444_at	200	0.135	0.0925969	-	-0.59224	0.361063	-0.365177	0.69 [0.32 - 1.52]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3252	60	0.783333	0.0287494	0.344268	-1.27585	0.939242	-0.0225052	0.98 [0.55 - 1.74]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3252	60	0.783333	0.0146356	0.214133	0.937488	0.29261	0.391424	1.48 [0.71 - 3.07]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218444_at	286	0.13986	0.286242	-	0.325641	0.914215	0.0142162	1.01 [0.78 - 1.31]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218444_at	159	0.842767	0.0976312	-	0.596462	0.294181	0.29112	1.34 [0.78 - 2.30]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218444_at	159	0.72327	0.180992	-	-0.523088	0.729073	0.0907998	1.10 [0.66 - 1.83]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218444_at	159	0.893082	0.297243	-	0.507074	0.696056	0.121094	1.13 [0.61 - 2.07]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218444_at	54	0.314815	0.130674	-	-1.02577	0.648151	-0.302245	0.74 [0.20 - 2.71]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218444_at	117	0.837607	0.0854243	-	0.645422	0.818232	0.0825959	1.09 [0.54 - 2.20]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218444_at	117	0.470085	0.0438668	0.453398	0.8297	0.381978	0.389273	1.48 [0.62 - 3.53]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218444_at	117	0.837607	0.0854243	-	0.645422	0.818232	0.0825959	1.09 [0.54 - 2.20]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218444_at	117	0.470085	0.141354	-	0.572146	0.780702	0.121487	1.13 [0.48 - 2.66]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218444_at	236	0.661017	0.114509	-	0.428069	0.571626	0.157308	1.17 [0.68 - 2.02]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218444_at	249	0.722892	0.356059	-	0.21368	0.893898	0.0276763	1.03 [0.68 - 1.54]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218444_at	125	0.144	0.0117033	0.181624	-1.01498	0.746618	-0.17063	0.84 [0.30 - 2.37]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218444_at	125	0.144	0.0135009	0.201853	-0.801997	0.545688	-0.249001	0.78 [0.35 - 1.75]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218444_at	54	0.148148	0.0280661	0.338721	-1.49504	0.367558	-0.245887	0.78 [0.46 - 1.34]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218444_at	62	0.145161	0.0623886	-	-1.05805	0.404689	-0.185608	0.83 [0.54 - 1.29]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218444_at	198	0.792929	0.1477	-	0.349155	0.551617	0.0956411	1.10 [0.80 - 1.51]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218444_at	198	0.363636	0.0865305	-	0.483655	0.615629	0.094997	1.10 [0.76 - 1.59]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218444_at	198	0.363636	0.0733247	-	0.534865	0.625278	0.09821	1.10 [0.74 - 1.64]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218444_at	51	0.27451	0.0683678	-	-1.51656	0.526239	-1.04265	0.35 [0.01 - 8.86]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218444_at	62	0.290323	0.0629306	-	-1.02933	0.407998	-0.880953	0.41 [0.05 - 3.34]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218444_at	177	0.502825	0.000484251	0.0137879	-0.834494	0.023064	-1.48839	0.23 [0.06 - 0.81]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218444_at	145	0.441379	0.068655	-	-0.602861	0.664198	-0.41572	0.66 [0.10 - 4.31]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218444_at	177	0.502825	9.20241e-05	0.00325488	-1.11154	0.00116386	-2.44286	0.09 [0.02 - 0.38]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218444_at	226	0.659292	0.0469337	0.472885	-0.667089	0.825399	0.0357941	1.04 [0.75 - 1.42]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218444_at	55	0.654545	0.00289073	0.0611318	-2.39298	0.00356261	-2.44075	0.09 [0.02 - 0.45]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218444_at	49	0.142857	0.00776616	0.133247	-1.54638	0.0416637	-1.72842	0.18 [0.03 - 0.94]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218444_at	55	0.236364	0.00635797	0.114194	-1.16933	0.0394319	-1.54306	0.21 [0.05 - 0.93]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	42047	34	0.852941	0.0547384	-	0.958298	0.513664	0.509463	1.66 [0.36 - 7.68]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218444_at	63	0.349206	0.170244	-	-0.471203	0.984253	-0.0136137	0.99 [0.26 - 3.81]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	218444_3p_at	28	0.25	0.313087	-	-0.61526	0.672585	-1.07596	0.34 [0.00 - 50.11]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13129113_3p_x_at	28	0.821429	0.107985	-	-1.52874	0.406118	-4.04741	0.02 [0.00 - 245.13]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13129113_3p_at	28	0.107143	0.217563	-	-0.925143	0.837447	0.641266	1.90 [0.00 - 869.22]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13129113_3p_s_at	28	0.464286	0.00897176	0.148748	1.57726	0.4363	0.224298	1.25 [0.71 - 2.20]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218444_at	82	0.158537	0.0370404	0.407054	1.40311	0.475321	0.216785	1.24 [0.68 - 2.25]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218444_at	79	0.139241	0.0994109	-	-0.573628	0.908586	-0.0359969	0.96 [0.52 - 1.78]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218444_at	104	0.769231	0.0547791	-	-0.97635	0.483535	-0.236279	0.79 [0.41 - 1.53]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P60718	117	0.316239	0.073445	-	-0.514942	0.317118	-0.303738	0.74 [0.41 - 1.34]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218444_at	204	0.823529	0.022723	0.293025	-1.97903	0.304363	-0.375356	0.69 [0.34 - 1.41]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218444_at	204	0.186275	0.0330798	0.378047	-0.637357	0.177224	-0.379089	0.68 [0.39 - 1.19]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218444_at	178	0.224719	0.00430988	0.0841656	-0.605606	0.435029	-0.197227	0.82 [0.50 - 1.35]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218444_at	111	0.837838	0.186134	-	0.416808	0.965299	0.00726594	1.01 [0.73 - 1.40]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218444_at	90	0.888889	0.0304461	0.357779	0.959138	0.739334	0.204848	1.23 [0.37 - 4.10]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218444_at	90	0.822222	0.0294862	0.350181	0.762479	0.613142	0.272556	1.31 [0.46 - 3.78]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218444_at	138	0.652174	0.227716	-	-0.31258	0.59585	-0.0913123	0.91 [0.65 - 1.28]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218444_at	129	0.209302	0.0342716	0.386955	-0.605608	0.173717	-0.238027	0.79 [0.56 - 1.11]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30928	56	0.5	0.0146752	0.214555	-0.840437	0.924019	-0.0505566	0.95 [0.34 - 2.69]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30928	56	0.5	0.00700943	0.123147	-1.00492	0.639812	-0.259142	0.77 [0.26 - 2.28]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218444_at	278	0.622302	0.0812096	-	-0.34425	0.741793	-0.0986941	0.91 [0.50 - 1.63]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218444_at	133	0.451128	0.0269563	0.329576	0.534607	0.944924	-0.0174161	0.98 [0.60 - 1.61]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218444_at	185	0.162162	0.0192272	0.260577	-0.522803	0.510486	-0.168822	0.84 [0.51 - 1.40]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218444_at	185	0.162162	0.0567156	-	-0.413955	0.134506	-0.359831	0.70 [0.44 - 1.12]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P60718	110	0.236364	0.0252141	0.314865	-0.689891	0.399869	-0.355176	0.70 [0.31 - 1.60]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P60718	110	0.736364	0.0438581	0.453341	0.514998	0.895319	-0.0406569	0.96 [0.52 - 1.76]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218444_at	80	0.85	0.0959673	-	0.800189	0.581087	-0.105504	0.90 [0.62 - 1.31]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218444_at	38	0.868421	0.103278	-	1.0464	0.507715	0.293504	1.34 [0.56 - 3.20]
GENE	ALG12	asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218444_at	140	0.5	0.0160303	0.22876	-0.724447	0.418133	-0.504952	0.60 [0.18 - 2.05]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216821_at	30	0.6	0.0346908	0.39005	-0.885343	0.710621	-0.27833	0.76 [0.17 - 3.29]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1722688	165	0.648485	0.0797658	-	-0.469025	0.752216	-0.183422	0.83 [0.27 - 2.60]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1722688	165	0.648485	0.0925326	-	-0.705217	0.634777	-0.414575	0.66 [0.12 - 3.65]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216821_at	163	0.306748	0.262633	-	-0.233939	0.826347	-0.123469	0.88 [0.29 - 2.66]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225621_at	163	0.865031	0.0221697	0.288035	0.601647	0.223877	0.169078	1.18 [0.90 - 1.56]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	228166_at	163	0.110429	0.0821299	-	0.62972	0.862073	0.174467	1.19 [0.17 - 8.52]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225621_at	79	0.341772	0.0565876	-	-0.561662	0.666733	-0.107564	0.90 [0.55 - 1.47]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216821_at	79	0.227848	0.0764266	-	0.677277	0.737486	-0.215163	0.81 [0.23 - 2.84]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	228166_at	79	0.544304	0.290958	-	-0.311996	0.71074	-0.311127	0.73 [0.14 - 3.79]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216821_at	58	0.775862	0.0267339	0.327723	0.779654	0.723616	0.0626699	1.06 [0.75 - 1.51]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216821_at	34	0.147059	0.038624	0.418196	-1.02301	0.153759	-0.503307	0.60 [0.30 - 1.21]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216821_at	158	0.405063	0.0816525	-	0.42837	0.486633	0.33451	1.40 [0.54 - 3.59]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216821_at	53	0.830189	0.0023233	0.0511976	1.1628	0.253062	0.355068	1.43 [0.78 - 2.62]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216821_at	53	0.849057	0.00805791	0.137062	1.03663	0.291779	0.298582	1.35 [0.77 - 2.35]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216821_at	180	0.355556	0.293469	-	0.234082	0.90808	0.0163424	1.02 [0.77 - 1.34]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	228166_at	180	0.888889	0.0101905	0.163769	0.699154	0.784293	0.0646937	1.07 [0.67 - 1.70]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225621_at	180	0.144444	0.00353181	0.0718179	1.16604	0.0230762	0.758692	2.14 [1.11 - 4.11]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225621_at	559	0.830054	0.00407382	0.0804839	-1.07379	0.00768737	-0.796035	0.45 [0.25 - 0.81]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216821_at	559	0.701252	0.0724935	-	0.362205	0.78514	-0.0461332	0.95 [0.69 - 1.33]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	228166_at	559	0.148479	0.0178052	0.246701	-0.529481	0.0755083	-0.268828	0.76 [0.57 - 1.03]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216821_at	77	0.402597	0.122959	-	0.410212	0.862877	0.0678082	1.07 [0.50 - 2.31]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	228166_at	77	0.103896	0.0329543	0.3771	-0.818486	0.15086	-0.427668	0.65 [0.36 - 1.17]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225621_at	77	0.350649	0.000827701	0.0217375	0.953694	0.00857642	0.631675	1.88 [1.17 - 3.01]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225621_at	70	0.757143	0.0874261	-	-0.564568	0.561458	-0.184111	0.83 [0.45 - 1.55]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216821_at	70	0.728571	0.0652798	-	0.51919	0.359939	0.731987	2.08 [0.43 - 9.97]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	228166_at	70	0.642857	0.0832365	-	-0.491071	0.162513	-1.23935	0.29 [0.05 - 1.65]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216821_at	74	0.216216	0.00182178	0.0419528	-0.979715	0.0970464	-0.480917	0.62 [0.35 - 1.09]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225621_at	74	0.108108	0.0270692	0.330515	-0.885449	0.89456	-0.054392	0.95 [0.42 - 2.12]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	228166_at	74	0.743243	6.15663e-05	0.00228097	1.23518	0.00844541	1.04822	2.85 [1.31 - 6.22]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225621_at	67	0.791045	0.00569798	0.104853	1.74958	0.0727348	2.1126	8.27 [0.82 - 83.10]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	228166_at	67	0.432836	0.100954	-	1.25389	0.768539	0.80721	2.24 [0.01 - 484.62]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216821_at	67	0.820895	0.186546	-	1.07835	0.601792	0.906187	2.47 [0.08 - 74.43]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216821_at	115	0.721739	0.0535511	-	0.989843	0.243523	0.816395	2.26 [0.57 - 8.92]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	228166_at	115	0.513043	0.114463	-	-0.902468	0.660481	-0.303399	0.74 [0.19 - 2.86]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225621_at	115	0.104348	0.0197573	0.265645	-1.29983	0.850725	0.172917	1.19 [0.20 - 7.20]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216821_at	204	0.107843	0.117032	-	0.351443	0.340512	0.0991674	1.10 [0.90 - 1.35]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225621_at	204	0.612745	0.0158298	0.226688	0.352213	0.31804	0.258011	1.29 [0.78 - 2.15]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	228166_at	204	0.872549	0.21987	-	0.262051	0.858339	0.0153337	1.02 [0.86 - 1.20]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216821_at	87	0.333333	0.00745259	0.129099	1.34444	0.266855	0.58287	1.79 [0.64 - 5.01]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216821_at	87	0.333333	0.00745259	0.129099	1.34444	0.266855	0.58287	1.79 [0.64 - 5.01]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	228166_at	87	0.195402	0.156512	-	0.841198	0.597751	0.41452	1.51 [0.32 - 7.06]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	228166_at	87	0.195402	0.156512	-	0.841198	0.597751	0.41452	1.51 [0.32 - 7.06]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225621_at	87	0.850575	0.0137235	0.20429	1.03932	0.886496	0.0780533	1.08 [0.37 - 3.16]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225621_at	87	0.850575	0.0137235	0.20429	1.03932	0.886496	0.0780533	1.08 [0.37 - 3.16]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216821_at	77	0.74026	0.193841	-	0.727344	0.484315	0.777955	2.18 [0.25 - 19.26]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225621_at	77	0.220779	0.164031	-	-0.870932	0.526515	-0.438086	0.65 [0.17 - 2.50]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	228166_at	77	0.792208	0.225944	-	0.713183	0.758915	0.417273	1.52 [0.11 - 21.80]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216821_at	77	0.324675	0.238586	-	-0.729331	0.755211	0.401284	1.49 [0.12 - 18.62]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225621_at	77	0.220779	0.116448	-	-0.868168	0.325445	-0.5958	0.55 [0.17 - 1.81]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	228166_at	77	0.87013	0.232107	-	-15.2145	0.429313	-1.277	0.28 [0.01 - 6.62]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216821_at	136	0.661765	0.0175867	0.24453	-1.59777	0.531858	-0.192344	0.83 [0.45 - 1.51]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216821_at	200	0.205	0.142613	-	-0.491353	0.996459	0.00142404	1.00 [0.53 - 1.88]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21002	60	0.75	0.00926996	0.15248	-1.48559	0.270748	-0.35514	0.70 [0.37 - 1.32]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21002	60	0.683333	0.0252294	0.314997	-1.06729	0.147866	-0.567916	0.57 [0.26 - 1.22]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216821_at	286	0.881119	0.0128805	0.194984	-1.00249	0.694806	-0.0652177	0.94 [0.68 - 1.30]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216821_at	159	0.207547	0.214455	-	-0.436224	0.75684	0.115756	1.12 [0.54 - 2.34]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216821_at	159	0.553459	0.0712666	-	-0.600183	0.961177	0.0175115	1.02 [0.50 - 2.06]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216821_at	159	0.207547	0.046141	0.467922	-0.76076	0.633897	-0.1885	0.83 [0.38 - 1.80]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225621_at	159	0.465409	0.182046	-	-0.421163	0.792551	0.117213	1.12 [0.47 - 2.69]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225621_at	159	0.490566	0.0621617	-	-0.600545	0.850477	-0.0829922	0.92 [0.39 - 2.18]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225621_at	159	0.465409	0.124473	-	-0.57162	0.878667	0.0796894	1.08 [0.39 - 3.01]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228166_at	159	0.773585	0.177383	-	0.461493	0.882071	0.0786219	1.08 [0.38 - 3.06]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228166_at	159	0.773585	0.00186723	0.0428114	0.967301	0.0162515	1.49358	4.45 [1.32 - 15.05]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228166_at	159	0.584906	0.00746118	0.129213	1.00294	0.00765479	2.17197	8.78 [1.78 - 43.30]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216821_at	117	0.581197	0.0755691	-	0.558746	0.570506	0.322525	1.38 [0.45 - 4.21]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216821_at	117	0.897436	0.00705204	0.123724	1.20201	0.193983	0.877448	2.40 [0.64 - 9.04]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216821_at	117	0.581197	0.0755691	-	0.558746	0.570506	0.322525	1.38 [0.45 - 4.21]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216821_at	117	0.529915	0.0383187	0.416068	0.795945	0.31991	0.642312	1.90 [0.54 - 6.74]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216821_at	236	0.216102	0.165703	-	-0.416781	0.332699	-0.24851	0.78 [0.47 - 1.29]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	228166_at	236	0.872881	0.0950712	-	0.556578	0.908025	0.0493775	1.05 [0.45 - 2.43]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225621_at	236	0.707627	0.143829	-	-0.488215	0.533717	-0.235722	0.79 [0.38 - 1.66]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216821_at	249	0.875502	0.162961	-	-0.543014	0.351705	-0.189179	0.83 [0.56 - 1.23]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	228166_at	249	0.200803	0.0227145	0.292948	0.717832	0.276474	0.401091	1.49 [0.73 - 3.08]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225621_at	249	0.144578	0.0588132	-	0.727373	0.972626	-0.0102178	0.99 [0.55 - 1.77]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216821_at	125	0.12	0.0260647	0.322103	-0.943709	0.54576	-0.213826	0.81 [0.40 - 1.62]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216821_at	125	0.152	0.0290204	0.346451	-0.697947	0.941684	-0.0203982	0.98 [0.57 - 1.69]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216821_at	54	0.5	0.244687	-	0.771328	0.918557	-0.0280164	0.97 [0.57 - 1.66]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216821_at	62	0.483871	0.227093	-	0.638005	0.800555	-0.0566754	0.94 [0.61 - 1.47]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216821_at	198	0.469697	0.065206	-	-0.387002	0.607994	-0.0698328	0.93 [0.71 - 1.22]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216821_at	198	0.60101	0.287795	-	0.271674	0.71642	0.0656796	1.07 [0.75 - 1.52]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216821_at	198	0.868687	0.149736	-	-0.73153	0.96718	-0.00757096	0.99 [0.69 - 1.42]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216821_at	51	0.117647	0.0369309	0.406274	-1.69653	0.193707	-2.31708	0.10 [0.00 - 3.25]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216821_at	62	0.725806	0.0307117	0.359861	-15.5374	0.436024	-0.888075	0.41 [0.04 - 3.84]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216821_at	145	0.875862	0.201972	-	-0.898558	0.576223	-0.340721	0.71 [0.22 - 2.35]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225621_at	177	0.887006	0.197084	-	-0.664911	0.613948	-0.228032	0.80 [0.33 - 1.93]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	228166_at	177	0.305085	0.149769	-	-0.345695	0.407537	-0.670584	0.51 [0.10 - 2.50]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	228166_at	177	0.305085	0.223925	-	-0.336734	0.594939	-0.493508	0.61 [0.10 - 3.76]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216821_at	177	0.107345	0.229693	-	-0.464763	0.593324	-0.251161	0.78 [0.31 - 1.96]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225621_at	177	0.836158	0.162818	-	-0.494056	0.912023	-0.0435959	0.96 [0.44 - 2.07]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	228166_at	145	0.586207	0.110553	-	-0.586253	0.334339	-1.11102	0.33 [0.03 - 3.14]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216821_at	177	0.887006	0.23959	-	-0.539035	0.706788	-0.1543	0.86 [0.38 - 1.91]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225621_at	145	0.737931	0.0376762	0.411558	-0.966931	0.361179	-0.520195	0.59 [0.19 - 1.82]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	228166_at	226	0.681416	0.0063574	0.114186	-1.06372	0.0797788	-0.325521	0.72 [0.50 - 1.04]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225621_at	226	0.486726	0.0588276	-	-0.540145	0.522603	-0.234902	0.79 [0.38 - 1.62]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216821_at	226	0.761062	0.128735	-	-0.578215	0.847959	0.0531547	1.05 [0.61 - 1.82]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	228166_at	55	0.418182	0.0450854	0.461234	-0.886635	0.437995	-1.45755	0.23 [0.01 - 9.26]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225621_at	55	0.690909	0.000444272	0.0128077	1.47804	0.048007	1.10104	3.01 [1.01 - 8.96]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216821_at	55	0.127273	0.0215387	0.282281	-1.13478	0.838847	-0.202651	0.82 [0.12 - 5.76]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225621_at	55	0.690909	0.0203295	0.271053	1.09711	0.66762	0.275889	1.32 [0.37 - 4.64]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	228166_at	55	0.4	0.0509073	-	-0.94167	0.461232	-1.53931	0.21 [0.00 - 12.88]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225621_at	49	0.653061	0.0231375	0.296728	1.29825	0.32551	0.703264	2.02 [0.50 - 8.21]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	228166_at	49	0.22449	0.0242926	0.306901	-1.24948	0.161031	-3.34789	0.04 [0.00 - 3.80]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216821_at	55	0.890909	0.0361411	0.400615	1.18085	0.630036	0.529637	1.70 [0.20 - 14.66]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216821_at	49	0.530612	0.0914283	-	0.993987	0.488419	0.94685	2.58 [0.18 - 37.54]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	228166_at	63	0.269841	1.89876e-06	9.81596e-05	-1.5304	0.335379	-4.30862	0.01 [0.00 - 86.29]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225621_at	63	0.650794	0.106988	-	0.541409	0.812975	0.0639792	1.07 [0.63 - 1.81]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216821_at	63	0.396825	0.00207772	0.046732	-1.01263	0.399959	1.07596	2.93 [0.24 - 35.93]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.40919.1.S1_3p_at	28	0.785714	0.00880968	0.146703	1.47119	0.332204	0.151268	1.16 [0.86 - 1.58]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.307126.0.S1_3p_at	28	0.821429	0.0502379	-	-1.81683	0.201537	-5.25263	0.01 [0.00 - 16.58]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.40919.0.A1_3p_at	28	0.821429	0.107985	-	-1.52874	0.287266	-5.95328	0.00 [0.00 - 150.19]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216821_at	82	0.792683	0.163362	-	0.518863	0.514729	0.401329	1.49 [0.45 - 5.00]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216821_at	79	0.544304	0.00786812	0.134585	-0.707682	0.0554951	-0.864757	0.42 [0.17 - 1.02]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216821_at	104	0.298077	0.0533071	-	-0.621141	0.460851	-0.421349	0.66 [0.21 - 2.01]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P146728	117	0.102564	0.226361	-	0.70666	0.678281	0.146933	1.16 [0.58 - 2.32]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225621_at	204	0.867647	0.000766906	0.0203817	1.02828	0.0037116	1.52675	4.60 [1.64 - 12.91]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	228166_at	204	0.151961	0.0814307	-	0.877333	0.655148	0.100409	1.11 [0.71 - 1.72]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216821_at	204	0.406863	0.180466	-	-0.484702	0.564152	-0.300317	0.74 [0.27 - 2.06]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216821_at	204	0.186275	0.0650396	-	-0.566033	0.0823511	-0.631773	0.53 [0.26 - 1.08]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225621_at	204	0.215686	0.00977275	0.158688	2.17487	0.0207016	1.59458	4.93 [1.28 - 19.02]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	228166_at	204	0.720588	0.0752027	-	0.652125	0.627233	0.143701	1.15 [0.65 - 2.06]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216821_at	178	0.893258	0.000359993	0.0106914	0.942314	0.120611	0.445641	1.56 [0.89 - 2.74]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200004499	41	0.317073	0.017251	0.241176	-0.968008	0.272349	-0.486977	0.61 [0.26 - 1.47]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216821_at	111	0.216216	0.268529	-	-0.33136	0.94247	-0.0154295	0.98 [0.65 - 1.50]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	228166_at	111	0.531532	0.111427	-	0.41695	0.401314	0.161643	1.18 [0.81 - 1.71]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225621_at	111	0.135135	0.0249905	0.312945	-0.714755	0.0664288	-0.62812	0.53 [0.27 - 1.04]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216821_at	90	0.166667	0.19087	-	0.78044	0.467772	0.334435	1.40 [0.57 - 3.45]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216821_at	90	0.166667	0.0464941	0.470139	1.14013	0.627094	0.198878	1.22 [0.55 - 2.72]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216821_at	138	0.826087	0.188613	-	0.393782	0.576466	0.304094	1.36 [0.47 - 3.94]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	228166_at	138	0.463768	0.0516957	-	-0.469456	0.474213	-1.24036	0.29 [0.01 - 8.64]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225621_at	138	0.869565	0.114549	-	-0.662993	0.628463	-0.11429	0.89 [0.56 - 1.42]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216821_at	129	0.108527	0.0368284	0.405544	1.03484	0.371337	0.227245	1.26 [0.76 - 2.07]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29939	56	0.125	0.000332994	0.00999705	-1.67755	0.659793	-0.163981	0.85 [0.41 - 1.76]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29939	56	0.125	0.0879097	-	-1.02954	0.859335	0.0702714	1.07 [0.49 - 2.33]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225621_at	278	0.223022	0.00353707	0.0719035	-0.602791	0.0191868	-0.424343	0.65 [0.46 - 0.93]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	228166_at	278	0.183453	0.0729039	-	-0.419941	0.531165	-0.298664	0.74 [0.29 - 1.89]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216821_at	278	0.654676	0.336584	-	-0.190895	0.794948	-0.0923064	0.91 [0.45 - 1.83]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216821_at	133	0.894737	0.000807861	0.0212971	1.03879	0.00109186	2.12693	8.39 [2.34 - 30.07]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17459	81	0.888889	0.251251	-	0.729949	0.648141	0.242937	1.27 [0.45 - 3.62]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216821_at	185	0.654054	1.78465e-05	0.000753866	-0.769304	0.000151701	-0.866412	0.42 [0.27 - 0.66]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216821_at	185	0.481081	1.84124e-05	0.000775352	-0.771279	0.000417772	-0.88447	0.41 [0.25 - 0.67]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P146728	110	0.454545	0.259879	-	0.348566	0.722634	0.1025	1.11 [0.63 - 1.95]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P146728	110	0.109091	0.369187	-	0.348404	0.830593	0.0468405	1.05 [0.68 - 1.61]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216821_at	80	0.725	0.217205	-	-0.676949	0.575524	0.190305	1.21 [0.62 - 2.35]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:150443	59	0.474576	0.000771134	0.0204766	1.87738	0.0152586	1.16788	3.22 [1.25 - 8.26]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	228166_at	38	0.105263	0.0791426	-	15.2839	0.523103	0.379254	1.46 [0.46 - 4.68]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225621_at	38	0.315789	0.274936	-	0.566739	0.63145	0.27614	1.32 [0.43 - 4.07]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216821_at	38	0.473684	0.0857982	-	-0.835887	0.384503	-0.308536	0.73 [0.37 - 1.47]
GENE	ALG2	asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216821_at	140	0.892857	0.0475616	0.476781	-1.76472	0.232907	-1.00441	0.37 [0.07 - 1.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207396_s_at	30	0.333333	0.106412	-	0.709108	0.59008	0.47825	1.61 [0.28 - 9.19]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1711886	165	0.775758	0.0183162	0.251736	0.611831	0.305824	0.23018	1.26 [0.81 - 1.96]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1711886	165	0.89697	0.000693267	0.0187128	1.29813	0.046306	0.711414	2.04 [1.01 - 4.10]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207396_s_at	163	0.190184	0.0364258	0.402662	-0.484264	0.788063	-0.0904295	0.91 [0.47 - 1.77]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207396_s_at	79	0.721519	0.0104991	0.167479	0.767314	0.346059	0.270745	1.31 [0.75 - 2.30]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207396_s_at	58	0.862069	0.129681	-	0.583238	0.869136	-0.0378646	0.96 [0.61 - 1.51]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207396_s_at	34	0.764706	0.251708	-	-0.51782	0.884662	-0.0515812	0.95 [0.47 - 1.91]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207396_s_at	158	0.436709	0.0257806	0.319698	0.538703	0.0284309	0.858095	2.36 [1.09 - 5.08]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207396_s_at	53	0.886792	3.3942e-06	0.000167128	2.10446	0.00721461	2.11099	8.26 [1.77 - 38.51]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207396_s_at	53	0.886792	0.0278459	0.33692	1.06328	0.0346051	1.6338	5.12 [1.13 - 23.32]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207396_s_at	180	0.361111	0.186568	-	0.293708	0.507519	0.204769	1.23 [0.67 - 2.25]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207396_s_at	559	0.776386	0.000961931	0.0246684	0.689666	0.0217895	0.529162	1.70 [1.08 - 2.67]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207396_s_at	77	0.87013	0.0156691	0.22502	0.833197	0.494214	0.160157	1.17 [0.74 - 1.86]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207396_s_at	70	0.428571	0.00063409	0.0173487	-0.904452	0.0172587	-1.35216	0.26 [0.08 - 0.79]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38161_at	50	0.76	0.000533457	0.0149757	1.34894	0.0037927	1.87966	6.55 [1.83 - 23.39]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207396_s_at	74	0.878378	0.0145938	0.213687	0.886524	0.639055	0.182818	1.20 [0.56 - 2.58]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207396_s_at	67	0.358209	0.00617974	0.111699	16.0785	0.0375252	3.58289	35.98 [1.23 - 1052.65]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207396_s_at	115	0.269565	0.0784596	-	1.63398	0.167096	1.17773	3.25 [0.61 - 17.26]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38161_at	158	0.575949	0.0125776	0.191589	0.701871	0.0418061	0.877106	2.40 [1.03 - 5.59]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38161_at	76	0.776316	0.197656	-	0.6932	0.693738	0.507385	1.66 [0.13 - 20.75]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207396_s_at	204	0.892157	2.84623e-05	0.00114649	0.953596	0.0119784	0.405605	1.50 [1.09 - 2.06]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207396_s_at	87	0.896552	0.0178672	0.247315	1.11532	0.0734289	0.751693	2.12 [0.93 - 4.83]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207396_s_at	87	0.896552	0.0178672	0.247315	1.11532	0.0734289	0.751693	2.12 [0.93 - 4.83]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207396_s_at	77	0.480519	0.00858626	0.143865	1.77942	0.132947	1.11496	3.05 [0.71 - 13.06]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207396_s_at	77	0.480519	0.0500499	-	1.42671	0.213605	1.05799	2.88 [0.54 - 15.26]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207396_s_at	136	0.367647	0.0643447	-	0.995953	0.342203	0.595621	1.81 [0.53 - 6.20]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207396_s_at	200	0.86	2.27361e-08	1.60347e-06	1.56006	0.00011601	1.72642	5.62 [2.34 - 13.52]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17722	60	0.333333	0.00329827	0.0679839	1.46794	0.0314047	0.650632	1.92 [1.06 - 3.47]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17722	60	0.733333	0.000514561	0.0145218	1.27749	0.00184699	1.056	2.87 [1.48 - 5.59]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207396_s_at	286	0.101399	0.22509	-	-0.345917	0.844572	-0.0476037	0.95 [0.59 - 1.53]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207396_s_at	159	0.301887	0.000358035	0.0106413	1.86402	0.00958746	1.01155	2.75 [1.28 - 5.91]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207396_s_at	159	0.36478	0.00029421	0.00898366	2.19186	0.00553012	1.26028	3.53 [1.45 - 8.59]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207396_s_at	159	0.421384	0.000263203	0.00815842	1.40497	0.0297402	0.855948	2.35 [1.09 - 5.09]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207396_s_at	54	0.462963	0.0440763	0.454754	1.87516	0.0760829	1.35545	3.88 [0.87 - 17.34]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207396_s_at	117	0.470085	0.0380219	0.413989	-0.659891	0.275018	-0.353777	0.70 [0.37 - 1.33]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207396_s_at	117	0.461538	0.0271873	0.331494	-0.845871	0.470732	-0.276556	0.76 [0.36 - 1.61]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207396_s_at	117	0.470085	0.0380219	0.413989	-0.659891	0.275018	-0.353777	0.70 [0.37 - 1.33]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207396_s_at	117	0.461538	0.00450069	0.0871037	-1.14918	0.388232	-0.346529	0.71 [0.32 - 1.55]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207396_s_at	236	0.444915	0.00149019	0.0355406	0.913314	0.00159665	1.11398	3.05 [1.53 - 6.08]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207396_s_at	249	0.313253	0.000167461	0.00550531	0.99913	0.000611465	1.03162	2.81 [1.56 - 5.06]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207396_s_at	62	0.83871	0.000264021	0.00818038	1.75336	0.707345	0.092142	1.10 [0.68 - 1.77]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207396_s_at	125	0.84	0.00572679	0.105267	1.06148	0.123322	0.585282	1.80 [0.85 - 3.78]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207396_s_at	125	0.248	0.0351512	0.393428	0.966852	0.414234	0.241882	1.27 [0.71 - 2.28]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207396_s_at	54	0.833333	0.00301028	0.0631643	1.74043	0.709043	0.112294	1.12 [0.62 - 2.02]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207396_s_at	198	0.641414	7.55539e-06	0.000346495	1.11095	0.00026299	0.748505	2.11 [1.41 - 3.16]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207396_s_at	198	0.641414	2.85948e-05	0.00115127	1.08573	0.00087406	0.71944	2.05 [1.34 - 3.14]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207396_s_at	198	0.242424	5.88965e-05	0.00219298	1.31767	0.00613629	0.468359	1.60 [1.14 - 2.23]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207396_s_at	51	0.45098	0.103666	-	-1.63268	0.302771	-0.963467	0.38 [0.06 - 2.38]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207396_s_at	62	0.887097	0.0634327	-	1.17562	0.458156	0.472931	1.60 [0.46 - 5.60]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207396_s_at	145	0.655172	0.0315559	0.366421	-0.880349	0.220154	-0.734845	0.48 [0.15 - 1.55]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207396_s_at	177	0.531073	0.0238654	0.303164	-0.638503	0.254822	-0.514625	0.60 [0.25 - 1.45]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207396_s_at	177	0.536723	0.0358547	0.398546	-0.507829	0.417521	-0.324766	0.72 [0.33 - 1.58]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207396_s_at	226	0.615044	0.0569278	-	-0.605249	0.204521	-0.401758	0.67 [0.36 - 1.24]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207396_s_at	55	0.109091	0.158372	-	-0.770792	0.54554	-0.387887	0.68 [0.19 - 2.39]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207396_s_at	55	0.581818	0.16616	-	-0.698431	0.565546	-0.4463	0.64 [0.14 - 2.93]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207396_s_at	49	0.102041	0.127819	-	-1.15165	0.388017	-0.642195	0.53 [0.12 - 2.26]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	730269	34	0.823529	0.155404	-	-1.01783	0.882317	0.143895	1.15 [0.17 - 7.76]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207396_s_at	63	0.126984	0.270871	-	0.655216	0.570972	0.0836965	1.09 [0.81 - 1.45]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5031952_3p_a_at	28	0.571429	0.151538	-	0.769408	0.965095	0.0119504	1.01 [0.59 - 1.73]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207396_s_at	82	0.231707	0.102035	-	0.772955	0.638561	0.252308	1.29 [0.45 - 3.69]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38161_at	84	0.809524	0.0333732	0.380255	0.666757	0.0868639	0.955325	2.60 [0.87 - 7.76]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207396_s_at	79	0.43038	0.0364224	0.402637	0.555201	0.196154	0.627682	1.87 [0.72 - 4.85]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	Y09022_at	86	0.872093	0.00950369	0.155379	1.23736	0.769564	0.100219	1.11 [0.57 - 2.16]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207396_s_at	104	0.711538	0.0264865	0.325652	0.718926	0.173645	0.720341	2.06 [0.73 - 5.80]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P414269	117	0.641026	1.15972e-05	0.000510914	1.19995	0.000734229	0.942661	2.57 [1.49 - 4.44]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P7005	117	0.837607	0.0148782	0.216713	0.770244	0.0846213	0.611752	1.84 [0.92 - 3.70]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207396_s_at	204	0.715686	5.92906e-08	3.93887e-06	1.84069	1.89768e-05	2.26999	9.68 [3.42 - 27.39]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207396_s_at	204	0.681373	9.7089e-13	1.10437e-10	1.81838	1.32344e-08	2.20945	9.11 [4.25 - 19.52]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207396_s_at	178	0.837079	0.0117856	0.182573	0.610641	0.438098	0.260872	1.30 [0.67 - 2.51]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200013885	41	0.780488	0.0988997	-	0.735264	0.580011	0.164824	1.18 [0.66 - 2.11]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300011935	41	0.463415	0.0202692	0.270486	1.01227	0.228556	0.379993	1.46 [0.79 - 2.71]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207396_s_at	111	0.747748	0.0074529	0.129103	-0.941712	0.451134	-0.145013	0.87 [0.59 - 1.26]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207396_s_at	90	0.3	0.0558073	-	0.780953	0.792206	-0.0812703	0.92 [0.50 - 1.69]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207396_s_at	90	0.3	0.0732187	-	0.855072	0.739411	0.112456	1.12 [0.58 - 2.17]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3327	50	0.14	0.145154	-	-0.805428	0.994259	-0.0020118	1.00 [0.58 - 1.73]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207396_s_at	138	0.217391	0.0981467	-	0.536232	0.660534	0.0550357	1.06 [0.83 - 1.35]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207396_s_at	129	0.883721	0.0263057	0.324134	-0.997463	0.782148	-0.0700978	0.93 [0.57 - 1.53]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4124	56	0.892857	0.0876015	-	-1.18728	0.928534	0.0211162	1.02 [0.64 - 1.62]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41735	56	0.196429	0.0939162	-	0.870039	0.724152	-0.0894172	0.91 [0.56 - 1.50]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9390	56	0.839286	0.0659244	-	-1.06545	0.745314	-0.101601	0.90 [0.49 - 1.67]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41735	56	0.892857	0.0876015	-	-1.18728	0.707269	-0.0920251	0.91 [0.56 - 1.47]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4124	56	0.125	0.0799027	-	1.22124	0.926922	0.0222156	1.02 [0.64 - 1.64]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9390	56	0.839286	0.0697944	-	-1.05858	0.699965	-0.119353	0.89 [0.48 - 1.63]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207396_s_at	278	0.104317	0.111922	-	0.715411	0.273949	0.223245	1.25 [0.84 - 1.86]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207396_s_at	133	0.383459	0.0162553	0.231075	0.648369	0.214598	0.205945	1.23 [0.89 - 1.70]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2594	81	0.802469	3.56667e-05	0.00140294	1.95068	0.0115804	0.997457	2.71 [1.25 - 5.88]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207396_s_at	185	0.248649	0.17079	-	0.264111	0.937363	-0.0149362	0.99 [0.68 - 1.43]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207396_s_at	185	0.897297	0.0346373	0.389656	-0.756321	0.36875	-0.187287	0.83 [0.55 - 1.25]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P414269	110	0.845455	0.0302759	0.35644	0.618598	0.112195	0.325837	1.39 [0.93 - 2.07]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P7005	110	0.881818	0.00255624	0.0553363	0.939195	0.0580392	0.461464	1.59 [0.98 - 2.56]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P414269	110	0.845455	0.0655191	-	0.659204	0.188014	0.365556	1.44 [0.84 - 2.48]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P7005	110	0.872727	0.00869265	0.14522	0.944921	0.240493	0.371801	1.45 [0.78 - 2.70]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207396_s_at	80	0.475	0.0922269	-	-0.742316	0.974092	0.0126702	1.01 [0.47 - 2.18]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_3043	281	0.192171	0.00190176	0.0434609	0.592294	0.0035228	0.328264	1.39 [1.11 - 1.73]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207396_s_at	38	0.342105	0.000982709	0.025115	1.93156	0.00133364	1.98693	7.29 [2.17 - 24.55]
GENE	ALG3	asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207396_s_at	140	0.25	0.185164	-	-0.404675	0.863294	0.101239	1.11 [0.35 - 3.50]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218203_at	30	0.366667	0.0387769	0.419259	-0.863947	0.705234	-0.193234	0.82 [0.30 - 2.24]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1664449	165	0.339394	0.0265171	0.325909	-0.534082	0.716332	-0.056288	0.95 [0.70 - 1.28]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1664449	165	0.339394	0.00397403	0.0789112	-0.986991	0.375645	-0.205257	0.81 [0.52 - 1.28]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218203_at	163	0.834356	0.141762	-	0.373182	0.25354	0.237301	1.27 [0.84 - 1.91]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222556_at	163	0.754601	0.0492516	0.487116	-0.505315	0.66028	0.186569	1.21 [0.52 - 2.77]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222556_at	79	0.708861	0.0568509	-	0.583929	0.318186	0.557397	1.75 [0.58 - 5.22]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218203_at	79	0.797468	0.00081085	0.0213636	1.02917	0.104708	0.673528	1.96 [0.87 - 4.42]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218203_at	58	0.724138	0.122034	-	0.46814	0.758364	0.113877	1.12 [0.54 - 2.32]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218203_at	34	0.147059	0.0057803	0.106034	-1.46093	0.99552	-0.00318217	1.00 [0.33 - 3.03]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218203_at	158	0.892405	0.0634795	-	0.577902	0.751279	0.0821322	1.09 [0.65 - 1.80]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218203_at	53	0.698113	0.0865169	-	-0.764909	0.868537	-0.10355	0.90 [0.26 - 3.07]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218203_at	53	0.660377	0.0867692	-	-0.680634	0.769266	-0.17488	0.84 [0.26 - 2.70]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218203_at	180	0.144444	0.224578	-	0.389215	0.529597	0.359659	1.43 [0.47 - 4.40]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222556_at	180	0.838889	0.036489	0.403116	0.536415	0.620132	0.148373	1.16 [0.65 - 2.09]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222556_at	559	0.418605	0.0597879	-	-0.375504	0.518469	-0.114776	0.89 [0.63 - 1.26]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218203_at	559	0.364937	0.0870411	-	-0.343328	0.565454	-0.141456	0.87 [0.54 - 1.41]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218203_at	77	0.181818	0.00957073	0.156206	0.968	0.170354	0.482208	1.62 [0.81 - 3.23]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222556_at	77	0.857143	0.212948	-	0.434246	0.530829	0.211043	1.23 [0.64 - 2.39]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222556_at	70	0.871429	0.0189659	0.258059	-1.06144	0.316011	-0.482128	0.62 [0.24 - 1.58]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218203_at	70	0.314286	0.110093	-	-0.452958	0.671569	-0.134134	0.87 [0.47 - 1.63]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218203_at	74	0.108108	0.0494132	0.488093	-0.795572	0.562383	-0.368874	0.69 [0.20 - 2.41]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222556_at	74	0.162162	0.0375454	0.410634	-0.767657	0.98727	-0.00705539	0.99 [0.42 - 2.36]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222556_at	67	0.104478	0.0591242	-	-1.26627	0.785161	-0.283352	0.75 [0.10 - 5.78]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218203_at	67	0.462687	0.146903	-	1.11354	0.295253	1.92248	6.84 [0.19 - 250.27]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222556_at	115	0.747826	0.00228466	0.0505022	1.50243	0.0810337	1.23729	3.45 [0.86 - 13.84]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218203_at	115	0.104348	0.0197573	0.265645	-1.29983	0.122338	-1.3548	0.26 [0.05 - 1.44]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218203_at	204	0.25	0.234717	-	-0.191366	0.876631	0.0336033	1.03 [0.68 - 1.58]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222556_at	204	0.313726	0.119136	-	0.233418	0.42359	0.107169	1.11 [0.86 - 1.45]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222556_at	87	0.83908	0.327454	-	-0.590317	0.91276	-0.0339102	0.97 [0.53 - 1.77]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222556_at	87	0.83908	0.327454	-	-0.590317	0.91276	-0.0339102	0.97 [0.53 - 1.77]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218203_at	87	0.827586	0.0111777	0.175513	0.989694	0.669802	-0.195728	0.82 [0.33 - 2.02]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218203_at	87	0.827586	0.0111777	0.175513	0.989694	0.669802	-0.195728	0.82 [0.33 - 2.02]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218203_at	77	0.181818	0.0051438	0.0967763	-1.60062	0.0263914	-1.51947	0.22 [0.06 - 0.84]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222556_at	77	0.584416	0.00752372	0.130044	-2.26705	0.0829711	-1.60894	0.20 [0.03 - 1.23]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218203_at	77	0.350649	0.00391746	0.0780153	-1.57117	0.022828	-1.3357	0.26 [0.08 - 0.83]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222556_at	77	0.103896	0.015039	0.218415	-1.53222	0.122744	-1.66293	0.19 [0.02 - 1.57]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218203_at	136	0.375	0.016348	0.232025	-1.05011	0.514772	-0.415664	0.66 [0.19 - 2.30]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218203_at	200	0.805	0.132843	-	-0.697899	0.43896	-0.419993	0.66 [0.23 - 1.90]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14546	60	0.866667	0.215988	-	0.5609	0.711187	-0.115211	0.89 [0.48 - 1.64]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14546	60	0.466667	0.0900272	-	0.658128	0.707095	0.164938	1.18 [0.50 - 2.79]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	7421	155	0.806452	0.00030461	0.00925736	0.998399	0.00376563	0.266524	1.31 [1.09 - 1.56]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218203_at	286	0.884615	0.0460675	0.467459	0.523017	0.32762	0.300862	1.35 [0.74 - 2.47]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218203_at	159	0.754717	0.0327723	0.375723	0.684379	0.23887	0.695186	2.00 [0.63 - 6.37]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218203_at	159	0.238994	0.0497038	0.489844	0.906782	0.555965	0.349167	1.42 [0.44 - 4.53]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218203_at	159	0.754717	0.0217858	0.284543	0.84067	0.4459	0.531701	1.70 [0.43 - 6.68]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222556_at	159	0.433962	0.00404547	0.0800381	1.04108	0.0202061	1.01742	2.77 [1.17 - 6.53]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222556_at	159	0.742138	0.157517	-	0.464799	0.413912	0.353943	1.42 [0.61 - 3.33]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222556_at	159	0.742138	0.0066359	0.118044	0.970454	0.0126578	1.29404	3.65 [1.32 - 10.09]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218203_at	54	0.462963	0.0262603	0.323753	2.01143	0.134117	0.872596	2.39 [0.76 - 7.50]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218203_at	117	0.145299	0.138163	-	-0.579456	0.705438	-0.112459	0.89 [0.50 - 1.60]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218203_at	117	0.880342	0.0555592	-	-15.2112	0.613964	-0.182248	0.83 [0.41 - 1.69]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218203_at	117	0.145299	0.138163	-	-0.579456	0.705438	-0.112459	0.89 [0.50 - 1.60]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218203_at	117	0.641026	0.127918	-	0.57075	0.627738	0.179295	1.20 [0.58 - 2.47]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218203_at	236	0.127119	0.0728341	-	-0.596117	0.75442	-0.158282	0.85 [0.32 - 2.30]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222556_at	236	0.686441	0.172056	-	0.377777	0.891291	0.0670292	1.07 [0.41 - 2.80]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218203_at	249	0.425703	0.21002	-	0.272421	0.393663	0.342502	1.41 [0.64 - 3.09]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222556_at	249	0.614458	0.192271	-	0.280237	0.726371	0.136155	1.15 [0.53 - 2.46]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218203_at	125	0.432	0.238039	-	0.496083	0.903868	0.0366522	1.04 [0.57 - 1.88]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218203_at	125	0.624	0.310744	-	-0.306866	0.748368	-0.0751972	0.93 [0.59 - 1.47]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218203_at	54	0.388889	0.11766	-	-0.911049	0.406423	-0.316724	0.73 [0.34 - 1.54]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218203_at	62	0.112903	0.0503751	-	-0.990425	0.357218	-0.28929	0.75 [0.40 - 1.39]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218203_at	198	0.868687	0.0218299	0.284945	-0.935444	0.436919	-0.1625	0.85 [0.56 - 1.28]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218203_at	198	0.515152	0.0415751	0.438317	-0.530292	0.257473	-0.299253	0.74 [0.44 - 1.24]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218203_at	198	0.50505	0.0365315	0.40342	-0.570011	0.249532	-0.31885	0.73 [0.42 - 1.25]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218203_at	51	0.823529	0.139498	-	1.26811	0.674332	0.313555	1.37 [0.32 - 5.91]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218203_at	62	0.790323	0.0513466	-	1.09338	0.21618	0.597564	1.82 [0.71 - 4.69]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218203_at	177	0.20339	0.0612915	-	0.628192	0.311825	0.330182	1.39 [0.73 - 2.64]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222556_at	145	0.131034	0.0748431	-	-0.705573	0.646242	-0.241249	0.79 [0.28 - 2.20]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218203_at	145	0.896552	0.107897	-	-1.48991	0.535874	-0.292631	0.75 [0.30 - 1.88]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218203_at	177	0.20339	0.0167363	0.235984	1.0721	0.249551	0.430721	1.54 [0.74 - 3.20]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222556_at	177	0.836158	0.00330183	0.0680429	0.846998	0.212598	0.458885	1.58 [0.77 - 3.26]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222556_at	177	0.841808	0.0238556	0.303078	0.759504	0.160124	0.591575	1.81 [0.79 - 4.12]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222556_at	226	0.384956	0.143249	-	0.449763	0.462082	-0.13459	0.87 [0.61 - 1.25]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218203_at	226	0.265487	0.141001	-	-0.436182	0.331536	-0.391384	0.68 [0.31 - 1.49]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218203_at	55	0.872727	0.120806	-	0.810249	0.986959	-0.00987719	0.99 [0.30 - 3.24]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222556_at	55	0.636364	0.000209081	0.00668064	1.77472	0.0101634	1.18567	3.27 [1.33 - 8.08]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218203_at	49	0.163265	0.000492644	0.0139919	-2.11124	0.401441	-0.595995	0.55 [0.14 - 2.22]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222556_at	49	0.836735	0.0166444	0.23505	1.37773	0.0832951	0.936608	2.55 [0.88 - 7.36]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222556_at	55	0.472727	0.0373951	0.409572	0.980172	0.130858	0.607402	1.84 [0.83 - 4.04]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218203_at	55	0.309091	0.0540788	-	-0.843831	0.157445	-0.735739	0.48 [0.17 - 1.33]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	288850	34	0.117647	0.000877523	0.022835	-1.78577	0.414636	-0.421725	0.66 [0.24 - 1.81]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218203_at	63	0.571429	4.57096e-06	0.000219322	1.52092	0.00332847	0.620753	1.86 [1.23 - 2.82]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222556_at	63	0.174603	5.51564e-06	0.000260274	-1.60625	0.039809	-34.9284	0.00 [0.00 - 0.20]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9665250_3p_s_at	28	0.642857	0.203018	-	0.705383	0.92439	-0.0168724	0.98 [0.69 - 1.39]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.227933.0.S1_3p_at	28	0.25	0.0541134	-	-1.10326	0.329076	-2.17156	0.11 [0.00 - 8.93]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218203_at	82	0.353659	0.0127283	0.193281	-0.824691	0.0492123	-0.777384	0.46 [0.21 - 1.00]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218203_at	79	0.835443	0.120075	-	0.521207	0.522628	0.32601	1.39 [0.51 - 3.76]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218203_at	104	0.105769	0.0843521	-	-0.722345	0.516772	-0.372055	0.69 [0.22 - 2.12]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P151436	117	0.299145	0.0339876	0.384847	-0.614536	0.552631	-0.181921	0.83 [0.46 - 1.52]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218203_at	204	0.102941	0.053464	-	15.1882	0.188635	0.91553	2.50 [0.64 - 9.78]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222556_at	204	0.122549	0.108568	-	-0.718042	0.0852335	-0.732069	0.48 [0.21 - 1.11]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218203_at	204	0.70098	0.00303632	0.0636045	0.791674	0.0266028	1.12732	3.09 [1.14 - 8.36]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222556_at	204	0.52451	0.0441744	0.455387	0.550836	0.836398	-0.0769827	0.93 [0.45 - 1.92]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218203_at	178	0.44382	0.0817469	-	-0.342532	0.208764	-0.470684	0.62 [0.30 - 1.30]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200015411	41	0.829268	0.160242	-	0.697582	0.49482	0.242183	1.27 [0.64 - 2.55]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218203_at	111	0.126126	0.0234493	0.299496	-0.753188	0.959668	-0.0236838	0.98 [0.39 - 2.45]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222556_at	111	0.432432	0.0279721	0.337953	0.598127	0.53484	0.122333	1.13 [0.77 - 1.66]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218203_at	90	0.244444	0.141115	-	-0.567899	0.68726	-0.120352	0.89 [0.49 - 1.59]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218203_at	90	0.877778	0.280038	-	-0.639583	0.712319	-0.0970138	0.91 [0.54 - 1.52]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4071	50	0.22	0.262096	-	0.823936	0.519021	0.21493	1.24 [0.65 - 2.38]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218203_at	138	0.833333	0.147815	-	-0.539255	0.651851	-0.0780909	0.92 [0.66 - 1.30]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222556_at	138	0.521739	0.0844029	-	-0.42229	0.820326	-0.135685	0.87 [0.27 - 2.82]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218203_at	129	0.379845	0.0786551	-	-0.438448	0.854179	-0.102059	0.90 [0.30 - 2.68]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32681	56	0.553571	0.000744043	0.0198668	-1.26965	0.0252528	-0.791055	0.45 [0.23 - 0.91]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20317	56	0.535714	0.00112134	0.0280504	-1.27083	0.0996807	-0.42866	0.65 [0.39 - 1.09]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32681	56	0.553571	0.000210726	0.00672634	-1.40672	0.0375605	-0.677146	0.51 [0.27 - 0.96]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20317	56	0.535714	0.00134335	0.0326091	-1.18758	0.132859	-0.376155	0.69 [0.42 - 1.12]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218203_at	278	0.848921	0.105821	-	0.407413	0.340152	0.20504	1.23 [0.81 - 1.87]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222556_at	278	0.866906	0.0102465	0.164445	0.615129	0.385008	0.280632	1.32 [0.70 - 2.49]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218203_at	133	0.285714	0.00599281	0.109061	-0.660782	0.108993	-0.222138	0.80 [0.61 - 1.05]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3267	81	0.839506	0.208099	-	0.6837	0.953971	0.0287945	1.03 [0.39 - 2.74]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218203_at	185	0.227027	0.126023	-	0.335108	0.284691	0.0964441	1.10 [0.92 - 1.31]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218203_at	185	0.302703	0.104044	-	0.292337	0.292052	0.0861362	1.09 [0.93 - 1.28]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P151436	110	0.827273	0.211018	-	0.447799	0.718895	0.0910148	1.10 [0.67 - 1.80]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P151436	110	0.827273	0.0256994	0.319008	0.647716	0.740616	0.0684783	1.07 [0.71 - 1.61]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218203_at	80	0.65	0.0286614	0.343558	0.930993	0.120214	0.666699	1.95 [0.84 - 4.52]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218203_at	38	0.894737	0.206017	-	0.813528	0.706208	0.236623	1.27 [0.37 - 4.34]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222556_at	38	0.868421	0.00953761	0.155798	1.46769	0.471157	0.252018	1.29 [0.65 - 2.55]
GENE	ALG5	asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218203_at	140	0.7	0.110191	-	-0.560966	0.275148	-0.472756	0.62 [0.27 - 1.46]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219649_at	30	0.366667	0.0261386	0.322727	0.990741	0.348083	0.500117	1.65 [0.58 - 4.69]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1771411	165	0.636364	0.0628407	-	0.45344	0.447806	0.156034	1.17 [0.78 - 1.75]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1771411	165	0.660606	0.0260094	0.321636	0.768234	0.160551	0.43884	1.55 [0.84 - 2.86]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219649_at	163	0.171779	0.0381384	0.414806	-0.486238	0.882206	0.0265036	1.03 [0.72 - 1.46]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219649_at	79	0.898734	0.0103375	0.16554	1.02506	0.112142	0.322946	1.38 [0.93 - 2.06]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219649_at	58	0.12069	0.130916	-	0.608983	0.595659	0.145476	1.16 [0.68 - 1.98]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219649_at	34	0.441176	0.0342009	0.38643	0.858156	0.0745753	0.787552	2.20 [0.92 - 5.22]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219649_at	158	0.753165	0.143052	-	0.375789	0.518872	0.220414	1.25 [0.64 - 2.44]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219649_at	53	0.509434	0.183125	-	-0.491941	0.304503	-0.773957	0.46 [0.11 - 2.02]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219649_at	53	0.509434	0.439786	-	-0.266536	0.469089	-0.506645	0.60 [0.15 - 2.38]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219649_at	180	0.233333	0.187572	-	-0.319293	0.705281	-0.17718	0.84 [0.33 - 2.10]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219649_at	559	0.892665	0.0346547	0.389784	0.543793	0.374329	0.346254	1.41 [0.66 - 3.03]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219649_at	77	0.532468	0.000159003	0.00526153	0.987081	0.00402628	0.887258	2.43 [1.33 - 4.45]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219649_at	70	0.314286	0.0636561	-	0.548136	0.402891	0.164066	1.18 [0.80 - 1.73]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219649_at	74	0.837838	0.0685113	-	0.640582	0.330059	0.418365	1.52 [0.65 - 3.53]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219649_at	67	0.268657	0.0358734	0.398681	-1.31628	0.280694	-0.640731	0.53 [0.16 - 1.69]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219649_at	115	0.365217	0.0159223	0.227645	2.09383	0.381354	0.767708	2.15 [0.39 - 12.02]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219649_at	204	0.269608	0.00104394	0.0264206	0.512956	0.0690438	0.331076	1.39 [0.97 - 1.99]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219649_at	87	0.885057	0.104321	-	0.732399	0.623277	0.203508	1.23 [0.54 - 2.76]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219649_at	87	0.885057	0.104321	-	0.732399	0.623277	0.203508	1.23 [0.54 - 2.76]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219649_at	77	0.103896	2.17098e-06	0.000111001	-2.40375	0.000673944	-2.46659	0.08 [0.02 - 0.35]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219649_at	77	0.12987	6.08019e-06	0.000284413	-2.12913	0.00299153	-2.07017	0.13 [0.03 - 0.49]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219649_at	136	0.220588	0.0259808	0.321394	-0.973362	0.503532	-0.318686	0.73 [0.29 - 1.85]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219649_at	200	0.81	0.124328	-	-0.712936	0.38162	-0.45418	0.63 [0.23 - 1.76]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18634	60	0.183333	0.124774	-	-0.630801	0.425661	-0.278389	0.76 [0.38 - 1.50]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18634	60	0.65	0.0807829	-	-0.746583	0.387257	-0.214469	0.81 [0.50 - 1.31]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5252	155	0.187097	0.000302277	0.00919608	-1.00958	0.00128174	-0.264417	0.77 [0.65 - 0.90]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219649_at	286	0.772727	0.0744486	-	0.381888	0.760235	-0.120482	0.89 [0.41 - 1.92]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219649_at	159	0.754717	0.0288063	0.344727	0.699909	0.135785	0.865806	2.38 [0.76 - 7.41]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219649_at	159	0.836478	0.158708	-	0.528251	0.243266	0.682796	1.98 [0.63 - 6.23]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219649_at	159	0.106918	0.183729	-	1.2667	0.555844	0.411032	1.51 [0.38 - 5.92]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219649_at	54	0.240741	0.163097	-	15.3532	0.99506	0.00292561	1.00 [0.40 - 2.53]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219649_at	117	0.735043	0.335988	-	-0.36229	0.794303	0.054083	1.06 [0.70 - 1.59]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219649_at	117	0.863248	0.330107	-	-0.698674	0.902595	-0.0315067	0.97 [0.59 - 1.60]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219649_at	117	0.735043	0.335988	-	-0.36229	0.794303	0.054083	1.06 [0.70 - 1.59]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219649_at	117	0.717949	0.283225	-	-0.489035	0.920019	0.0247576	1.03 [0.63 - 1.66]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219649_at	236	0.114407	0.0140563	0.207908	-0.811708	0.931826	0.0443686	1.05 [0.38 - 2.89]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219649_at	249	0.550201	0.266639	-	0.236394	0.757769	0.123165	1.13 [0.52 - 2.47]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219649_at	125	0.304	0.0517333	-	1.13245	0.309142	0.440597	1.55 [0.66 - 3.63]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219649_at	125	0.736	0.2135	-	0.367324	0.592196	0.177427	1.19 [0.62 - 2.29]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219649_at	54	0.37037	0.0563452	-	-1.16997	0.169686	-0.417202	0.66 [0.36 - 1.20]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219649_at	62	0.516129	0.0689628	-	-0.903458	0.351543	-0.227986	0.80 [0.49 - 1.29]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219649_at	198	0.873737	0.0338833	0.38407	-0.816917	0.994696	-0.00138354	1.00 [0.66 - 1.50]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219649_at	198	0.292929	0.107602	-	0.498541	0.513126	0.167639	1.18 [0.72 - 1.95]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219649_at	198	0.292929	0.0175234	0.2439	0.840089	0.108097	0.428521	1.53 [0.91 - 2.59]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219649_at	51	0.176471	0.192801	-	-1.12851	0.427288	-0.456377	0.63 [0.21 - 1.96]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219649_at	62	0.419355	0.251225	-	-0.660223	0.669183	-0.154413	0.86 [0.42 - 1.74]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219649_at	177	0.638418	0.0877899	-	-0.512124	0.749607	-0.143157	0.87 [0.36 - 2.09]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219649_at	177	0.242938	0.117121	-	0.463044	0.730055	0.134005	1.14 [0.53 - 2.45]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219649_at	145	0.675862	0.00474554	0.0908269	-1.27534	0.0628844	-0.999931	0.37 [0.13 - 1.06]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219649_at	226	0.59292	0.00506425	0.0955982	-0.900166	0.00551144	-1.20408	0.30 [0.13 - 0.70]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219649_at	55	0.890909	0.0926034	-	0.911169	0.57314	0.394746	1.48 [0.38 - 5.86]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219649_at	55	0.727273	0.075265	-	-1.21811	0.636699	-0.393919	0.67 [0.13 - 3.46]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219649_at	49	0.877551	0.0927458	-	1.07129	0.942034	-0.0710265	0.93 [0.14 - 6.32]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219649_at	63	0.761905	0.184565	-	0.479366	0.617021	0.072861	1.08 [0.81 - 1.43]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7019324_3p_at	28	0.142857	0.0104779	0.167224	-1.48125	0.614106	-0.434814	0.65 [0.12 - 3.51]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219649_at	82	0.329268	0.00457494	0.0882383	-0.928655	0.455017	-0.448366	0.64 [0.20 - 2.07]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219649_at	79	0.35443	0.0826815	-	0.469692	0.656926	0.206411	1.23 [0.49 - 3.06]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219649_at	104	0.596154	0.0215438	0.282328	-0.810764	0.317245	-0.571794	0.56 [0.18 - 1.73]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P35168	117	0.461538	0.0783112	-	0.522616	0.991425	0.00279608	1.00 [0.60 - 1.67]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219649_at	204	0.220588	0.0821281	-	1.01423	0.65135	0.311681	1.37 [0.35 - 5.28]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219649_at	204	0.362745	0.00529592	0.099016	0.91093	0.0109054	1.29825	3.66 [1.35 - 9.95]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219649_at	178	0.38764	0.00337983	0.0693302	-0.579258	0.47766	-0.25012	0.78 [0.39 - 1.55]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300003286	41	0.146341	0.0756619	-	1.63238	0.852915	0.0893416	1.09 [0.43 - 2.81]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219649_at	111	0.135135	0.105445	-	0.74202	0.599713	0.214938	1.24 [0.56 - 2.77]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219649_at	90	0.733333	0.030019	0.354412	0.797912	0.667812	0.178229	1.20 [0.53 - 2.70]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219649_at	90	0.711111	0.0306904	0.359694	0.697381	0.771617	0.105491	1.11 [0.55 - 2.27]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219649_at	138	0.797101	0.0120455	0.185553	0.656543	0.0787887	0.34913	1.42 [0.96 - 2.09]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219649_at	129	0.310078	0.210809	-	-0.318953	0.74904	0.141688	1.15 [0.48 - 2.75]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39419	56	0.339286	0.0358514	0.398522	0.932141	0.258309	0.334407	1.40 [0.78 - 2.49]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39419	56	0.339286	0.0236289	0.301083	0.941769	0.44852	0.215396	1.24 [0.71 - 2.17]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219649_at	278	0.665468	0.214222	-	-0.254302	0.77746	0.0527468	1.05 [0.73 - 1.52]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219649_at	133	0.691729	0.00318825	0.0661551	-0.856853	0.022083	-0.249738	0.78 [0.63 - 0.96]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12867	81	0.839506	0.0266629	0.32713	1.16607	0.415466	0.521437	1.68 [0.48 - 5.91]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219649_at	185	0.102703	0.164423	-	0.401291	0.716595	-0.0546475	0.95 [0.70 - 1.27]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219649_at	185	0.102703	0.11742	-	0.510359	0.744972	-0.0531156	0.95 [0.69 - 1.31]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P35168	110	0.581818	0.356509	-	0.273357	0.644087	0.110555	1.12 [0.70 - 1.79]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P35168	110	0.118182	0.281682	-	-0.365586	0.814599	0.0461827	1.05 [0.71 - 1.54]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219649_at	80	0.275	0.110577	-	-0.71054	0.545522	-0.332547	0.72 [0.24 - 2.11]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219649_at	38	0.473684	0.0962109	-	0.788304	0.254431	0.477884	1.61 [0.71 - 3.67]
GENE	ALG6	asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219649_at	140	0.8	5.28937e-05	0.00199326	1.18004	0.00737352	0.780786	2.18 [1.23 - 3.86]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203545_at	30	0.6	0.16225	-	-0.58444	0.841653	0.117009	1.12 [0.36 - 3.54]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1685413	165	0.842424	0.0446668	0.458556	0.63456	0.296634	0.229647	1.26 [0.82 - 1.94]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1685413	165	0.842424	0.000798916	0.0210979	1.21466	0.0544843	0.622543	1.86 [0.99 - 3.52]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203545_at	163	0.895706	0.000282728	0.00867972	0.971659	0.321357	0.136549	1.15 [0.88 - 1.50]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203545_at	79	0.898734	0.0283662	0.341165	0.876696	0.210337	0.240273	1.27 [0.87 - 1.85]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203545_at	58	0.844828	0.000646733	0.017642	1.22952	0.086407	0.581698	1.79 [0.92 - 3.48]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203545_at	34	0.382353	0.0503753	-	0.812277	0.425149	0.271009	1.31 [0.67 - 2.55]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203545_at	158	0.898734	0.048035	0.479698	0.662908	0.285358	0.363884	1.44 [0.74 - 2.81]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203545_at	53	0.150943	0.15232	-	-0.600308	0.453837	-0.546484	0.58 [0.14 - 2.42]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203545_at	53	0.150943	0.0439077	0.453663	-0.853289	0.243107	-0.933364	0.39 [0.08 - 1.88]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203545_at	180	0.627778	0.0130817	0.197224	0.521457	0.198273	0.617643	1.85 [0.72 - 4.75]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203545_at	559	0.155635	0.128842	-	-0.370933	0.727488	-0.114624	0.89 [0.47 - 1.70]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203545_at	77	0.597403	0.0033483	0.0688107	0.737504	0.798966	-0.0833863	0.92 [0.48 - 1.75]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203545_at	70	0.114286	0.0168339	0.236972	-0.900847	0.165866	-0.583508	0.56 [0.24 - 1.27]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32051_at	50	0.88	0.0344721	0.388438	1.03125	0.440384	0.242696	1.27 [0.69 - 2.36]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203545_at	74	0.716216	0.0922359	-	-0.571854	0.977533	-0.015804	0.98 [0.33 - 2.96]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203545_at	67	0.835821	0.0943683	-	1.12648	0.179649	1.73272	5.66 [0.45 - 71.07]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203545_at	115	0.608696	0.153329	-	-0.898298	0.605311	-0.320421	0.73 [0.22 - 2.45]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32051_at	158	0.101266	0.0551686	-	-0.695686	0.309557	-0.304204	0.74 [0.41 - 1.33]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32051_at	76	0.565789	0.00295092	0.0621574	-2.43643	0.0841139	-0.8157	0.44 [0.18 - 1.12]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203545_at	204	0.617647	0.13211	-	0.21691	0.960473	-0.00672722	0.99 [0.76 - 1.30]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203545_at	87	0.172414	0.0291233	0.347277	-0.886251	0.465555	0.192779	1.21 [0.72 - 2.04]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203545_at	87	0.172414	0.0291233	0.347277	-0.886251	0.465555	0.192779	1.21 [0.72 - 2.04]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203545_at	77	0.207792	0.114299	-	-0.980024	0.867939	-0.0759559	0.93 [0.38 - 2.27]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203545_at	77	0.883117	0.122693	-	0.978867	0.51165	0.212825	1.24 [0.66 - 2.34]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203545_at	136	0.897059	0.000125209	0.00426783	1.69507	0.00523622	1.01092	2.75 [1.35 - 5.59]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203545_at	200	0.21	0.0666264	-	-0.597082	0.424486	-0.348505	0.71 [0.30 - 1.66]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11627	60	0.75	0.335802	-	0.404845	0.946223	0.0205646	1.02 [0.56 - 1.86]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11627	60	0.3	0.0453378	0.462841	-0.750556	0.530091	-0.200683	0.82 [0.44 - 1.53]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203545_at	286	0.13986	0.0376291	0.411225	-0.51018	0.226765	0.228582	1.26 [0.87 - 1.82]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203545_at	159	0.257862	0.0311797	0.363508	0.989536	0.016312	0.560517	1.75 [1.11 - 2.77]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203545_at	159	0.188679	0.0243688	0.307565	1.96148	0.0469634	0.514578	1.67 [1.01 - 2.78]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203545_at	159	0.352201	0.0282379	0.340122	0.842363	0.129792	0.367777	1.44 [0.90 - 2.32]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203545_at	54	0.296296	0.0106763	0.169592	-1.68989	0.23512	-0.570949	0.56 [0.22 - 1.45]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203545_at	117	0.435897	0.0045574	0.0879706	0.974234	0.322497	0.146445	1.16 [0.87 - 1.55]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203545_at	117	0.444444	0.0267022	0.327458	0.899235	0.578533	0.105306	1.11 [0.77 - 1.61]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203545_at	117	0.435897	0.0045574	0.0879706	0.974234	0.322497	0.146445	1.16 [0.87 - 1.55]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203545_at	117	0.863248	0.00153977	0.036517	1.27924	0.170514	0.248816	1.28 [0.90 - 1.83]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203545_at	236	0.860169	0.000481065	0.0137103	1.03886	0.243715	0.355055	1.43 [0.79 - 2.59]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203545_at	249	0.859438	0.0602165	-	0.515968	0.8301	0.0533078	1.05 [0.65 - 1.72]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203545_at	62	0.854839	0.0194459	0.262674	1.18433	0.5498	0.110406	1.12 [0.78 - 1.60]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203545_at	125	0.376	0.0878584	-	-0.651295	0.436059	-0.230817	0.79 [0.44 - 1.42]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203545_at	125	0.376	0.16534	-	-0.428909	0.301348	-0.234078	0.79 [0.51 - 1.23]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203545_at	54	0.444444	0.239749	-	0.772455	0.848017	0.0440137	1.04 [0.67 - 1.64]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203545_at	198	0.742424	0.0265476	0.326164	0.586149	0.592853	0.0946982	1.10 [0.78 - 1.56]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203545_at	198	0.742424	0.00375388	0.075406	0.781735	0.475442	0.125803	1.13 [0.80 - 1.60]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203545_at	198	0.742424	0.0354798	0.395826	0.472806	0.416108	0.116319	1.12 [0.85 - 1.49]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203545_at	51	0.607843	0.0621829	-	-15.8886	0.259158	-1.03753	0.35 [0.06 - 2.15]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203545_at	62	0.306452	0.424682	-	-0.463482	0.687443	0.21121	1.24 [0.44 - 3.46]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203545_at	177	0.892655	0.270816	-	0.473296	0.76228	0.133115	1.14 [0.48 - 2.71]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203545_at	177	0.892655	0.0245629	0.309251	0.750037	0.151356	0.551789	1.74 [0.82 - 3.69]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203545_at	145	0.365517	0.00446145	0.0865022	-0.924434	0.134484	-0.804135	0.45 [0.16 - 1.28]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203545_at	226	0.10177	0.00230872	0.0509355	-1.00206	0.0185826	-0.878009	0.42 [0.20 - 0.86]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203545_at	55	0.890909	0.0948083	-	0.906331	0.893269	0.0717302	1.07 [0.38 - 3.06]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203545_at	55	0.890909	0.0281456	0.33937	1.23146	0.420744	0.481752	1.62 [0.50 - 5.23]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203545_at	49	0.897959	0.0528893	-	1.2233	0.990428	-0.00868238	0.99 [0.24 - 4.10]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	595109	34	0.882353	0.0392408	0.422469	-15.3309	0.660123	-0.206411	0.81 [0.32 - 2.04]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203545_at	63	0.333333	0.000496463	0.0140845	1.54567	0.00775161	0.854184	2.35 [1.25 - 4.41]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13129069_3p_at	28	0.285714	0.0222605	0.288858	1.62808	0.125352	0.299523	1.35 [0.92 - 1.98]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203545_at	82	0.231707	0.0127595	0.19363	-0.848772	0.889661	-0.0758714	0.93 [0.32 - 2.71]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32051_at	84	0.72619	0.0196235	0.264371	0.707275	0.181426	0.52493	1.69 [0.78 - 3.65]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203545_at	79	0.835443	0.150365	-	0.480047	0.822683	0.0817035	1.09 [0.53 - 2.22]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203545_at	104	0.884615	0.15113	-	-0.867103	0.764537	-0.116785	0.89 [0.41 - 1.91]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P13554	117	0.880342	5.87879e-05	0.00218939	1.29919	0.000110684	1.01399	2.76 [1.65 - 4.61]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203545_at	204	0.509804	0.000386892	0.0113749	0.998948	0.00516037	1.09358	2.98 [1.39 - 6.42]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203545_at	204	0.617647	0.000117869	0.00404733	1.41418	0.00631201	1.41143	4.10 [1.49 - 11.29]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203545_at	178	0.882023	0.0344273	0.388107	0.585103	0.425579	0.223999	1.25 [0.72 - 2.17]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300007316	41	0.146341	0.368911	-	0.654277	0.969427	0.0133601	1.01 [0.51 - 2.01]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203545_at	111	0.747748	0.0919773	-	0.485908	0.194552	0.467914	1.60 [0.79 - 3.24]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203545_at	90	0.877778	0.00801152	0.136458	1.01419	0.136604	0.559027	1.75 [0.84 - 3.65]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203545_at	90	0.877778	0.00312074	0.0650254	1.2106	0.157858	0.607925	1.84 [0.79 - 4.27]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203545_at	138	0.413043	0.0580721	-	0.479739	0.577961	0.103274	1.11 [0.77 - 1.60]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203545_at	129	0.767442	0.000424234	0.012311	0.939336	0.00496486	1.18957	3.29 [1.43 - 7.53]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36447	56	0.589286	0.155032	-	-0.493833	0.999634	-0.000148727	1.00 [0.53 - 1.89]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4633	56	0.607143	0.0177058	0.245715	-0.850508	0.965292	-0.0162604	0.98 [0.47 - 2.05]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36447	56	0.589286	0.0351265	0.393247	-0.779438	0.517623	-0.220126	0.80 [0.41 - 1.56]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4633	56	0.607143	0.00595297	0.108496	-1.08426	0.470813	-0.275665	0.76 [0.36 - 1.61]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203545_at	278	0.435252	0.00438282	0.0852927	-0.544731	0.0312404	-0.39542	0.67 [0.47 - 0.97]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203545_at	133	0.736842	0.163938	-	-0.387946	0.807064	0.0279941	1.03 [0.82 - 1.29]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12841	81	0.333333	0.22793	-	0.763125	0.729165	-0.196049	0.82 [0.27 - 2.49]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203545_at	185	0.372973	0.031457	0.365657	-0.364857	0.6571	-0.0587693	0.94 [0.73 - 1.22]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203545_at	185	0.421622	0.0154314	0.222539	-0.431311	0.379803	-0.126471	0.88 [0.66 - 1.17]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P13554	110	0.118182	0.0151563	0.219652	1.17924	0.116309	0.25916	1.30 [0.94 - 1.79]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P13554	110	0.127273	0.0910005	-	0.984365	0.132549	0.325093	1.38 [0.91 - 2.11]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203545_at	80	0.8125	0.117801	-	-1.11113	0.754729	-0.112718	0.89 [0.44 - 1.81]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_0721	281	0.402135	0.147434	-	-0.205038	0.932893	-0.00910221	0.99 [0.80 - 1.22]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203545_at	38	0.868421	0.000277446	0.00853924	1.77289	0.071933	1.04415	2.84 [0.91 - 8.86]
GENE	ALG8	asparagine-linked glycosylation 8, alpha-1,3-glucosyltransferase homolog (S. cerevisiae)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203545_at	140	0.2	0.00121184	0.0299285	-0.933296	0.00604343	-1.17437	0.31 [0.13 - 0.71]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207206_s_at	30	0.566667	0.050004	-	-0.798699	0.241474	-0.427396	0.65 [0.32 - 1.33]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1713731	165	0.69697	0.00111598	0.0279383	0.781515	0.117626	0.173047	1.19 [0.96 - 1.48]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1713731	165	0.775758	0.00359617	0.0728633	1.00679	0.0495996	0.300783	1.35 [1.00 - 1.82]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207206_s_at	163	0.190184	0.0412195	0.435935	-0.472709	0.262747	-0.688663	0.50 [0.15 - 1.68]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207206_s_at	79	0.43038	0.213603	-	0.37334	0.950173	-0.0158898	0.98 [0.60 - 1.62]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207206_s_at	58	0.672414	0.0723972	-	-0.531827	0.430287	-0.102847	0.90 [0.70 - 1.17]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207206_s_at	34	0.852941	0.334074	-	-0.526131	0.554016	-0.122338	0.88 [0.59 - 1.33]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207206_s_at	158	0.537975	0.048724	0.483913	0.459064	0.303219	1.03972	2.83 [0.39 - 20.47]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207206_s_at	53	0.339623	0.0653512	-	0.704669	0.211524	0.269876	1.31 [0.86 - 2.00]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207206_s_at	53	0.698113	0.0696898	-	0.666318	0.324465	0.231782	1.26 [0.80 - 2.00]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207206_s_at	180	0.622222	0.0132073	0.198616	-0.567807	0.402935	-0.0721181	0.93 [0.79 - 1.10]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207206_s_at	559	0.862254	0.0910965	-	-0.582655	0.372255	-0.101165	0.90 [0.72 - 1.13]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207206_s_at	77	0.441558	0.0188392	0.256832	-0.593343	0.129358	-0.213262	0.81 [0.61 - 1.06]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207206_s_at	70	0.285714	0.0434286	0.450549	-0.566079	0.105112	-2.09892	0.12 [0.01 - 1.55]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35124_at	50	0.74	0.114614	-	-0.638455	0.125855	-1.71591	0.18 [0.02 - 1.62]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207206_s_at	74	0.162162	0.140834	-	0.683959	0.970807	0.00670282	1.01 [0.70 - 1.44]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207206_s_at	67	0.462687	0.154239	-	-0.973837	0.476465	-1.89322	0.15 [0.00 - 27.62]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207206_s_at	115	0.443478	0.212614	-	0.724128	0.949025	0.044399	1.05 [0.27 - 4.08]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35124_at	158	0.151899	0.0270129	0.330047	-0.743736	0.471724	-0.240133	0.79 [0.41 - 1.51]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35124_at	76	0.789474	0.126078	-	-1.45332	0.92598	0.0635624	1.07 [0.28 - 4.07]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207206_s_at	204	0.27451	0.120893	-	-0.248509	0.344272	-0.074204	0.93 [0.80 - 1.08]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207206_s_at	87	0.862069	0.00173638	0.0403266	1.23964	0.00938744	2.72173	15.21 [1.95 - 118.56]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207206_s_at	87	0.862069	0.00173638	0.0403266	1.23964	0.00938744	2.72173	15.21 [1.95 - 118.56]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207206_s_at	77	0.168831	0.144513	-	-0.85344	0.918125	0.174163	1.19 [0.04 - 32.95]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207206_s_at	77	0.233766	0.0283539	0.341065	-1.29711	0.46792	-1.51835	0.22 [0.00 - 13.22]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207206_s_at	136	0.102941	0.0823416	-	-0.94981	0.898972	-0.0297357	0.97 [0.61 - 1.54]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207206_s_at	200	0.895	0.109549	-	0.64928	0.991171	0.00189343	1.00 [0.72 - 1.40]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15184	60	0.116667	0.00990712	0.16033	-1.25141	0.553521	-0.350397	0.70 [0.22 - 2.25]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15184	60	0.15	6.92014e-08	4.55166e-06	-2.13894	6.75989e-05	-3.25819	0.04 [0.01 - 0.19]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15546	155	0.116129	0.00787513	0.134677	-0.864032	0.0536497	-0.443307	0.64 [0.41 - 1.01]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207206_s_at	286	0.881119	0.0270549	0.330396	0.564955	0.345682	0.11508	1.12 [0.88 - 1.43]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207206_s_at	159	0.27673	0.00536492	0.100026	1.36056	0.0359964	0.45152	1.57 [1.03 - 2.40]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207206_s_at	159	0.283019	0.0247013	0.31045	1.2804	0.22052	0.302824	1.35 [0.83 - 2.20]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207206_s_at	159	0.283019	0.195892	-	0.505898	0.941561	0.0146796	1.01 [0.69 - 1.50]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207206_s_at	54	0.537037	0.110924	-	-1.53886	0.311515	-1.55157	0.21 [0.01 - 4.28]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207206_s_at	117	0.478632	0.0343099	0.387238	-0.680241	0.664214	-0.334891	0.72 [0.16 - 3.25]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207206_s_at	117	0.581197	0.0122658	0.188063	-1.09959	0.380536	-0.902329	0.41 [0.05 - 3.05]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207206_s_at	117	0.478632	0.0343099	0.387238	-0.680241	0.664214	-0.334891	0.72 [0.16 - 3.25]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207206_s_at	117	0.837607	0.0240498	0.304781	0.933657	0.804683	0.209279	1.23 [0.23 - 6.48]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207206_s_at	236	0.292373	0.0384313	0.416854	0.708286	0.615691	0.0911687	1.10 [0.77 - 1.56]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207206_s_at	249	0.46988	0.126743	-	-0.324106	0.62875	-0.0689283	0.93 [0.71 - 1.23]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207206_s_at	62	0.435484	0.0328906	0.376619	-1.05593	0.562754	-0.0994682	0.91 [0.65 - 1.27]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207206_s_at	125	0.36	0.0385044	0.417363	-0.778032	0.243403	-0.733822	0.48 [0.14 - 1.65]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207206_s_at	125	0.408	0.0984001	-	-0.482143	0.48038	-0.339426	0.71 [0.28 - 1.83]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207206_s_at	54	0.277778	0.0951271	-	-1.04858	0.605431	-0.107568	0.90 [0.60 - 1.35]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207206_s_at	198	0.787879	0.0723047	-	0.499285	0.317061	0.0875231	1.09 [0.92 - 1.30]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207206_s_at	198	0.858586	0.0516509	-	0.624804	0.395751	0.0779226	1.08 [0.90 - 1.29]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207206_s_at	198	0.106061	0.114147	-	0.657014	0.935978	-0.00559865	0.99 [0.87 - 1.14]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207206_s_at	51	0.803922	0.229911	-	1.04791	0.710841	0.704947	2.02 [0.05 - 84.09]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207206_s_at	62	0.112903	0.0397358	0.425872	-1.29341	0.803956	0.31339	1.37 [0.12 - 16.25]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207206_s_at	145	0.841379	0.181751	-	-0.785609	0.446665	-0.949828	0.39 [0.03 - 4.47]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207206_s_at	177	0.632768	0.0317693	0.368065	-0.671479	0.0421633	-2.14841	0.12 [0.01 - 0.93]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207206_s_at	177	0.225989	0.00443988	0.0861709	-0.691353	0.0246454	-2.05867	0.13 [0.02 - 0.77]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207206_s_at	226	0.632743	0.0149251	0.21721	0.685924	0.9048	0.0141647	1.01 [0.80 - 1.28]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207206_s_at	55	0.236364	0.0195518	0.263687	-1.02391	0.225676	0.993005	2.70 [0.54 - 13.46]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207206_s_at	55	0.381818	0.0432129	0.449141	-0.979293	0.505307	0.571319	1.77 [0.33 - 9.51]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207206_s_at	49	0.22449	0.0881381	-	-0.966716	0.502208	-1.37336	0.25 [0.00 - 13.99]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	121454	34	0.529412	0.0319855	0.369726	0.939694	0.214574	0.384329	1.47 [0.80 - 2.69]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207206_s_at	63	0.142857	0.0011887	0.029451	-1.24081	0.0162747	-27.3202	0.00 [0.00 - 0.01]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502050_3p_a_at	28	0.75	0.193772	-	-0.958898	0.381087	-2.04664	0.13 [0.00 - 12.59]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207206_s_at	82	0.890244	2.68006e-05	0.00108632	1.66661	0.60456	0.315819	1.37 [0.41 - 4.53]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	35124_at	84	0.892857	0.0444071	0.456887	-1.35042	0.201927	-0.712443	0.49 [0.16 - 1.46]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207206_s_at	79	0.582278	0.0197223	0.265311	0.600199	0.71813	0.285779	1.33 [0.28 - 6.28]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207206_s_at	104	0.875	0.0409683	0.434246	0.804268	0.00451412	1.46316	4.32 [1.57 - 11.86]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P152909	117	0.435897	0.0687843	-	-0.517167	0.559786	-0.119314	0.89 [0.59 - 1.33]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207206_s_at	204	0.897059	0.00396063	0.0786992	1.17689	0.476671	0.27713	1.32 [0.62 - 2.83]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207206_s_at	204	0.122549	0.0774019	-	1.00655	0.283192	0.31435	1.37 [0.77 - 2.43]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207206_s_at	178	0.320225	0.040466	0.43085	0.46761	0.663499	0.117093	1.12 [0.66 - 1.91]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200000311	41	0.390244	0.0418857	0.440388	0.936743	0.0967057	0.205062	1.23 [0.96 - 1.56]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207206_s_at	111	0.117117	0.00176532	0.0408796	-1.01906	0.192345	-0.185926	0.83 [0.63 - 1.10]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207206_s_at	90	0.333333	0.378817	-	0.313717	0.967845	0.011882	1.01 [0.57 - 1.80]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207206_s_at	90	0.2	0.255541	-	-0.468279	0.556892	-0.219936	0.80 [0.39 - 1.67]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4046	50	0.88	0.30631	-	0.644113	0.983863	-0.00605083	0.99 [0.55 - 1.79]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207206_s_at	138	0.746377	0.0989285	-	-0.519434	0.203757	-0.143094	0.87 [0.70 - 1.08]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207206_s_at	129	0.100775	0.0124742	0.190422	-0.846793	0.554105	-0.0738319	0.93 [0.73 - 1.19]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7084	56	0.625	0.126593	-	-0.595029	0.705632	-0.0468774	0.95 [0.75 - 1.22]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26404	56	0.107143	0.00976267	0.158565	-1.21389	0.431154	-0.207805	0.81 [0.48 - 1.36]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7084	56	0.625	0.0471839	0.474441	-0.754668	0.355016	-0.11316	0.89 [0.70 - 1.14]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26404	56	0.25	0.0474505	0.476094	-0.715313	0.748167	-0.0843925	0.92 [0.55 - 1.54]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207206_s_at	278	0.136691	0.0853326	-	-0.423653	0.725406	0.0763818	1.08 [0.70 - 1.65]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207206_s_at	133	0.684211	0.00341332	0.0698807	0.702712	0.40309	0.290946	1.34 [0.68 - 2.65]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16783	81	0.197531	0.0610212	-	-0.956442	0.975609	0.0148638	1.01 [0.39 - 2.63]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11400	81	0.530864	0.0217075	0.283827	1.24085	0.224253	0.363976	1.44 [0.80 - 2.59]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207206_s_at	185	0.6	0.13963	-	0.247432	0.354558	0.249346	1.28 [0.76 - 2.18]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207206_s_at	185	0.702703	0.0615482	-	0.355321	0.321573	0.292052	1.34 [0.75 - 2.39]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P152906	110	0.127273	0.353088	-	-0.317836	0.707438	0.0328613	1.03 [0.87 - 1.23]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P152909	110	0.636364	0.0798834	-	-0.423837	0.998816	0.000315509	1.00 [0.66 - 1.52]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P152906	110	0.2	0.0285783	0.342885	-0.793597	0.969805	-0.00431142	1.00 [0.80 - 1.24]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P152909	110	0.636364	0.0540678	-	-0.625016	0.937442	0.0225112	1.02 [0.58 - 1.79]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207206_s_at	80	0.8875	0.227047	-	0.66267	0.694312	0.0683653	1.07 [0.76 - 1.51]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5915	281	0.209964	0.322238	-	-0.165172	0.292388	-0.169474	0.84 [0.62 - 1.16]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:81434	59	0.59322	0.0328908	0.37662	-1.26868	0.408564	-0.552076	0.58 [0.16 - 2.13]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207206_s_at	38	0.894737	0.111528	-	1.0328	0.514278	0.35416	1.42 [0.49 - 4.13]
GENE	ALOX12	arachidonate 12-lipoxygenase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207206_s_at	140	0.878571	0.0047462	0.0908369	-15.2541	0.0283276	-2.77955	0.06 [0.01 - 0.74]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207381_at	30	0.766667	0.126189	-	0.667939	0.921393	-0.0183237	0.98 [0.68 - 1.41]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1692332	165	0.606061	0.105216	-	0.394183	0.753306	0.0823255	1.09 [0.65 - 1.81]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1692332	165	0.539394	0.0551303	-	0.677632	0.274694	0.370941	1.45 [0.74 - 2.82]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207381_at	163	0.877301	0.0323983	0.372881	0.551363	0.351322	0.525892	1.69 [0.56 - 5.11]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207381_at	79	0.696203	0.000344176	0.0102857	-1.45136	0.000434275	-2.63405	0.07 [0.02 - 0.31]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207381_at	58	0.189655	0.110012	-	0.578543	0.328433	0.168486	1.18 [0.84 - 1.66]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207381_at	34	0.764706	0.0383963	0.416609	0.861596	0.131465	0.519438	1.68 [0.86 - 3.30]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207381_at	158	0.550633	0.014079	0.208154	0.566025	0.14434	1.085	2.96 [0.69 - 12.70]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207381_at	53	0.773585	0.0917383	-	0.632685	0.914019	0.0308059	1.03 [0.59 - 1.80]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207381_at	53	0.773585	0.0996021	-	0.650978	0.898674	-0.0387376	0.96 [0.53 - 1.75]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207381_at	180	0.383333	0.0198005	0.266055	-0.489541	0.660571	-0.0671189	0.94 [0.69 - 1.26]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207381_at	559	0.184258	0.0515516	-	-0.452475	0.724414	-0.076829	0.93 [0.60 - 1.42]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207381_at	77	0.337662	0.027706	0.335772	-0.578481	0.101644	-0.505427	0.60 [0.33 - 1.10]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207381_at	70	0.328571	0.0592169	-	-0.528874	0.818739	0.159726	1.17 [0.30 - 4.60]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33029_at	50	0.64	0.155874	-	-0.511751	0.501461	-0.891393	0.41 [0.03 - 5.52]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207381_at	74	0.121622	0.0215372	0.282267	1.51331	0.279878	0.234037	1.26 [0.83 - 1.93]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207381_at	67	0.686567	0.169373	-	-1.35313	0.733694	-0.791614	0.45 [0.00 - 43.33]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207381_at	115	0.852174	0.106174	-	-15.2744	0.640907	0.190619	1.21 [0.54 - 2.70]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33029_at	158	0.240506	0.00888296	0.147629	-0.77423	0.442541	-0.178039	0.84 [0.53 - 1.32]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33029_at	76	0.868421	0.28462	-	-1.06118	0.900286	0.0648322	1.07 [0.39 - 2.94]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207381_at	204	0.529412	0.160108	-	-0.192897	0.764958	-0.0274967	0.97 [0.81 - 1.17]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207381_at	87	0.643678	0.276886	-	-0.452071	0.771669	-0.210474	0.81 [0.20 - 3.36]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207381_at	87	0.643678	0.276886	-	-0.452071	0.771669	-0.210474	0.81 [0.20 - 3.36]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207381_at	77	0.298701	0.142327	-	1.42354	0.505726	1.12955	3.09 [0.11 - 86.16]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207381_at	77	0.272727	0.0747699	-	1.65928	0.30611	1.47509	4.37 [0.26 - 73.71]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207381_at	136	0.573529	0.0285746	0.342855	-1.16071	0.407671	-0.300991	0.74 [0.36 - 1.51]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207381_at	200	0.115	0.126804	-	-0.58735	0.837243	0.0405116	1.04 [0.71 - 1.53]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10141	60	0.133333	0.226063	-	0.863544	0.874493	0.0585738	1.06 [0.51 - 2.19]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10141	60	0.883333	0.0081225	0.137901	1.16555	0.0332072	0.819851	2.27 [1.07 - 4.83]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	2405	155	0.825806	2.47963e-05	0.00101317	1.15914	0.00625917	0.484996	1.62 [1.15 - 2.30]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207381_at	286	0.136364	0.0566369	-	0.652086	0.825538	0.0413079	1.04 [0.72 - 1.50]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207381_at	159	0.754717	0.0411107	0.435204	-0.94156	0.318926	-0.365439	0.69 [0.34 - 1.42]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207381_at	159	0.157233	0.164664	-	0.978961	0.804751	-0.105689	0.90 [0.39 - 2.08]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207381_at	159	0.515723	0.132341	-	0.48114	0.597106	0.185545	1.20 [0.61 - 2.40]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207381_at	54	0.537037	0.0629673	-	1.238	0.810839	-0.178752	0.84 [0.19 - 3.61]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207381_at	117	0.74359	0.098546	-	0.542241	0.91692	0.0779526	1.08 [0.25 - 4.68]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207381_at	117	0.752137	0.299559	-	0.41734	0.957402	0.0474704	1.05 [0.18 - 5.99]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207381_at	117	0.74359	0.098546	-	0.542241	0.91692	0.0779526	1.08 [0.25 - 4.68]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207381_at	117	0.487179	0.229503	-	-0.477801	0.840757	-0.196358	0.82 [0.12 - 5.58]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207381_at	236	0.881356	0.014473	0.212395	0.778448	0.322248	0.233521	1.26 [0.80 - 2.01]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207381_at	249	0.875502	0.183229	-	0.384298	0.717889	0.075243	1.08 [0.72 - 1.62]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207381_at	62	0.354839	0.234822	-	0.742503	0.670949	-0.195831	0.82 [0.33 - 2.03]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207381_at	125	0.12	0.261213	-	1.0911	0.6802	-0.34547	0.71 [0.14 - 3.66]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207381_at	125	0.352	0.0405078	0.431133	-0.622465	0.349796	-0.604468	0.55 [0.15 - 1.94]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207381_at	54	0.37037	0.263326	-	0.845129	0.800603	-0.140171	0.87 [0.29 - 2.58]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207381_at	198	0.611111	0.133561	-	0.380942	0.226882	0.166145	1.18 [0.90 - 1.55]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207381_at	198	0.646465	0.165455	-	0.374896	0.237227	0.165161	1.18 [0.90 - 1.55]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207381_at	198	0.257576	0.0726733	-	-0.402675	0.567278	0.0675272	1.07 [0.85 - 1.35]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207381_at	51	0.392157	0.0546247	-	15.9397	0.366634	1.95163	7.04 [0.10 - 487.21]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207381_at	62	0.370968	0.0198619	0.266638	2.05458	0.122758	2.18588	8.90 [0.55 - 142.87]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207381_at	177	0.101695	0.0214072	0.281073	-0.774762	0.198137	-0.933688	0.39 [0.09 - 1.63]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207381_at	145	0.17931	0.118397	-	1.08331	0.803807	0.235169	1.27 [0.20 - 8.09]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207381_at	177	0.101695	0.030999	0.362103	-0.814616	0.336771	-0.796728	0.45 [0.09 - 2.29]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207381_at	226	0.10177	0.0850004	-	-0.655826	0.50426	-0.153983	0.86 [0.55 - 1.35]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207381_at	55	0.163636	0.00942806	0.154444	-1.19018	0.0920194	-2.16741	0.11 [0.01 - 1.42]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207381_at	49	0.122449	0.000650578	0.0177309	-1.89139	0.112024	-2.63296	0.07 [0.00 - 1.85]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207381_at	55	0.145455	0.00376816	0.0756349	-1.32678	0.0992596	-1.9937	0.14 [0.01 - 1.46]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207381_at	63	0.15873	1.43598e-05	0.000619708	-1.55479	0.179976	-12.5591	0.00 [0.00 - 330.14]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502052_3p_at	28	0.107143	0.0168481	0.237117	-1.55541	0.422888	0.246165	1.28 [0.70 - 2.34]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207381_at	82	0.158537	0.0461278	0.467838	1.34921	0.2066	0.452634	1.57 [0.78 - 3.17]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33029_at	84	0.785714	0.154187	-	-0.574152	0.451356	-0.282325	0.75 [0.36 - 1.57]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207381_at	79	0.113924	0.216316	-	-0.496019	0.976702	-0.00943902	0.99 [0.53 - 1.87]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207381_at	104	0.548077	0.0012918	0.0315649	-1.12989	0.0254478	-0.619379	0.54 [0.31 - 0.93]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P83634	117	0.102564	7.01768e-05	0.00256158	-1.32785	0.00997582	-0.719972	0.49 [0.28 - 0.84]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207381_at	204	0.730392	0.0266138	0.326719	0.796217	0.20237	0.305813	1.36 [0.85 - 2.17]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207381_at	204	0.843137	0.00336844	0.0691426	0.867184	0.00974208	0.443569	1.56 [1.11 - 2.18]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207381_at	178	0.539326	0.0300585	0.354725	-0.437712	0.843942	-0.0327256	0.97 [0.70 - 1.34]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207381_at	111	0.522523	0.0263475	0.324486	-0.593109	0.57731	-0.114768	0.89 [0.60 - 1.33]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207381_at	90	0.633333	0.311836	-	0.331178	0.408363	0.308713	1.36 [0.65 - 2.83]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207381_at	90	0.111111	0.176006	-	-0.654429	0.349132	0.381052	1.46 [0.66 - 3.25]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207381_at	138	0.173913	0.0482642	0.481104	-0.546287	0.650944	-0.0795637	0.92 [0.65 - 1.30]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207381_at	129	0.100775	0.28907	-	0.489766	0.916124	0.0148983	1.02 [0.77 - 1.34]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8820	56	0.178571	0.335541	-	0.430982	0.807855	0.0732218	1.08 [0.60 - 1.94]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8820	56	0.857143	0.15526	-	0.702637	0.431636	0.242021	1.27 [0.70 - 2.33]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207381_at	278	0.568345	0.112062	-	-0.3074	0.320129	-0.427628	0.65 [0.28 - 1.52]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207381_at	133	0.857143	0.00260889	0.0562597	0.858591	0.0107906	3.66336	38.99 [2.33 - 651.83]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9972	81	0.148148	0.000610302	0.0167941	-1.66786	0.00913779	-3.5251	0.03 [0.00 - 0.42]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18251	81	0.246914	0.354561	-	0.599182	0.60301	-0.335221	0.72 [0.20 - 2.53]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207381_at	185	0.545946	0.0792195	-	0.310999	0.576186	0.197201	1.22 [0.61 - 2.43]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207381_at	185	0.437838	0.0518653	-	0.320595	0.684633	0.132143	1.14 [0.60 - 2.16]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P83634	110	0.281818	0.38082	-	-0.21771	0.577503	-0.195942	0.82 [0.41 - 1.64]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P83634	110	0.654545	0.289091	-	-0.359734	0.720293	-0.168939	0.84 [0.33 - 2.13]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207381_at	80	0.475	0.00378747	0.075944	1.47604	0.612227	0.0922479	1.10 [0.77 - 1.57]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207381_at	38	0.894737	0.128328	-	-15.2003	0.442268	-0.180514	0.83 [0.53 - 1.32]
GENE	ALOX12B	arachidonate 12-lipoxygenase, 12R type	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207381_at	140	0.228571	0.0462918	0.468869	-0.613236	0.166783	-1.5277	0.22 [0.02 - 1.89]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207328_at	30	0.233333	0.0368969	0.406032	-0.930552	0.64349	-0.338796	0.71 [0.17 - 2.99]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1676042	165	0.654545	0.000452083	0.0130004	0.834178	0.280941	0.667731	1.95 [0.58 - 6.56]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1676042	165	0.660606	0.0487674	0.484177	0.687257	0.419516	0.723225	2.06 [0.36 - 11.93]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207328_at	163	0.650307	0.0548134	-	-0.418535	0.337685	-0.471514	0.62 [0.24 - 1.64]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207328_at	79	0.607595	0.0548212	-	-0.605528	0.417302	-0.729503	0.48 [0.08 - 2.81]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207328_at	58	0.603448	0.0433922	0.450312	0.57257	0.407402	0.14018	1.15 [0.83 - 1.60]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207328_at	34	0.529412	0.0694497	-	-0.720735	0.132815	-0.395371	0.67 [0.40 - 1.13]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207328_at	158	0.753165	0.0178786	0.247428	-0.728848	0.159958	-0.858392	0.42 [0.13 - 1.40]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207328_at	53	0.188679	0.00660539	0.117624	-1.0621	0.638166	-0.135619	0.87 [0.50 - 1.54]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207328_at	53	0.132075	0.0142593	0.2101	-1.07489	0.459614	-0.203697	0.82 [0.48 - 1.40]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207328_at	180	0.855556	0.142418	-	-0.471274	0.82295	-0.0158363	0.98 [0.86 - 1.13]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207328_at	559	0.121646	0.0171597	0.24026	-0.598961	0.749553	-0.0468668	0.95 [0.72 - 1.27]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207328_at	77	0.194805	0.139738	-	0.507765	0.657168	0.0853461	1.09 [0.75 - 1.59]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207328_at	70	0.128571	0.370592	-	0.361812	0.811142	0.294587	1.34 [0.12 - 15.04]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34636_at	50	0.12	0.00249698	0.0542918	-1.34327	0.154157	-2.00615	0.13 [0.01 - 2.12]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207328_at	74	0.337838	0.0443575	0.456568	0.661367	0.207382	0.252349	1.29 [0.87 - 1.91]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207328_at	67	0.358209	0.0162872	0.231402	15.8441	0.0641623	3.47603	32.33 [0.81 - 1282.61]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207328_at	115	0.13913	0.119022	-	15.2566	0.532529	0.253717	1.29 [0.58 - 2.86]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34636_at	158	0.759494	0.000113849	0.00392576	1.0701	0.00885037	0.484334	1.62 [1.13 - 2.33]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34636_at	76	0.118421	0.0644753	-	-1.17621	0.839158	-0.0824667	0.92 [0.42 - 2.04]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207328_at	204	0.857843	0.000232984	0.00733965	0.752721	0.332693	0.0679296	1.07 [0.93 - 1.23]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207328_at	87	0.206897	0.00666025	0.118379	2.2567	0.0506504	1.545	4.69 [1.00 - 22.07]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207328_at	87	0.206897	0.00666025	0.118379	2.2567	0.0506504	1.545	4.69 [1.00 - 22.07]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207328_at	77	0.103896	0.275261	-	-0.838394	0.969374	0.0421781	1.04 [0.12 - 8.98]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207328_at	77	0.428571	0.281232	-	0.637974	0.868339	0.155526	1.17 [0.19 - 7.35]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207328_at	136	0.169118	0.033023	0.377619	15.3351	0.465915	0.184055	1.20 [0.73 - 1.97]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207328_at	200	0.49	0.0148145	0.216037	0.763265	0.0916504	0.260104	1.30 [0.96 - 1.75]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17392	60	0.533333	0.0622382	-	0.702889	0.904193	-0.0864482	0.92 [0.22 - 3.75]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17392	60	0.683333	2.0996e-08	1.48789e-06	2.00169	0.000381571	2.49149	12.08 [3.06 - 47.76]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14880	155	0.148387	0.000851897	0.022272	-0.973384	0.00146912	-0.276486	0.76 [0.64 - 0.90]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207328_at	286	0.272727	0.112131	-	-0.329809	0.774924	-0.0424472	0.96 [0.72 - 1.28]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207328_at	159	0.427673	0.0318995	0.369066	0.742921	0.199495	0.237539	1.27 [0.88 - 1.82]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207328_at	159	0.515723	0.00686661	0.121205	0.883755	0.19087	0.238979	1.27 [0.89 - 1.82]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207328_at	159	0.534591	0.00816054	0.138394	1.01757	0.114469	0.333123	1.40 [0.92 - 2.11]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207328_at	54	0.12963	0.293067	-	15.2164	0.95882	-0.0921042	0.91 [0.03 - 30.09]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207328_at	117	0.504274	0.050487	-	0.622373	0.404283	0.508029	1.66 [0.50 - 5.48]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207328_at	117	0.504274	0.0148529	0.216445	0.950467	0.315304	0.696705	2.01 [0.52 - 7.82]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207328_at	117	0.461538	0.00348982	0.0711332	1.27707	0.100261	1.09252	2.98 [0.81 - 10.97]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207328_at	117	0.504274	0.050487	-	0.622373	0.404283	0.508029	1.66 [0.50 - 5.48]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207328_at	236	0.300847	0.0148858	0.216794	-0.651862	0.203042	-0.284004	0.75 [0.49 - 1.17]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207328_at	249	0.293173	0.00191086	0.0436316	-0.659021	0.0398976	-0.366892	0.69 [0.49 - 0.98]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207328_at	125	0.304	0.0269647	0.329646	-0.816334	0.516126	-0.512318	0.60 [0.13 - 2.81]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207328_at	125	0.304	0.024645	0.309962	-0.637619	0.587714	-0.334123	0.72 [0.21 - 2.40]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207328_at	62	0.451613	0.249744	-	0.60484	0.687237	-0.0963871	0.91 [0.57 - 1.45]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207328_at	54	0.481481	0.0723108	-	1.31164	0.810157	-0.069535	0.93 [0.53 - 1.65]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207328_at	198	0.878788	0.0237629	0.302263	0.724217	0.262903	0.11757	1.12 [0.92 - 1.38]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207328_at	198	0.878788	0.0257143	0.319135	0.707181	0.282915	0.108723	1.11 [0.91 - 1.36]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207328_at	198	0.323232	0.200952	-	-0.278598	0.915453	0.00899277	1.01 [0.85 - 1.19]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207328_at	51	0.529412	0.116007	-	1.5866	0.489527	1.71585	5.56 [0.04 - 722.27]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207328_at	62	0.112903	0.131685	-	-0.968267	0.785212	-0.457391	0.63 [0.02 - 16.98]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207328_at	177	0.327684	0.0635926	-	-0.506104	0.0930308	-1.15176	0.32 [0.08 - 1.21]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207328_at	177	0.757062	0.0304577	0.35787	-0.722101	0.0536894	-1.15439	0.32 [0.10 - 1.02]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207328_at	145	0.896552	0.0428129	0.446519	0.879711	0.576165	0.422981	1.53 [0.35 - 6.73]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207328_at	226	0.207965	0.160058	-	-0.439805	0.949586	0.00697456	1.01 [0.81 - 1.25]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207328_at	55	0.581818	0.000232368	0.00732279	-2.25841	0.0117618	-2.77472	0.06 [0.01 - 0.54]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207328_at	55	0.618182	0.00280471	0.059657	-1.95176	0.0722442	-2.01824	0.13 [0.01 - 1.20]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207328_at	49	0.55102	0.000289757	0.00886599	-16.3303	0.00458042	-5.14652	0.01 [0.00 - 0.20]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207328_at	63	0.52381	0.0264377	0.325243	-0.762599	0.509657	-1.21898	0.30 [0.01 - 11.07]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	207328_3p_at	28	0.892857	0.0593188	-	1.1806	0.254847	1.26819	3.55 [0.40 - 31.54]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502054_3p_x_at	28	0.571429	0.123424	-	-0.924564	0.306864	-0.410223	0.66 [0.30 - 1.46]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P931250	117	0.581197	0.0391383	0.421762	-0.629415	0.442245	-0.149444	0.86 [0.59 - 1.26]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207328_at	204	0.132353	0.0149798	0.217789	15.2993	0.922835	0.0131281	1.01 [0.78 - 1.32]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207328_at	204	0.132353	0.0367593	0.40505	1.1738	0.747206	-0.0328586	0.97 [0.79 - 1.18]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207328_at	111	0.891892	0.0216946	0.283709	-1.50823	0.52036	-0.0824121	0.92 [0.72 - 1.18]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207328_at	90	0.811111	0.0188285	0.256729	-2.02664	0.504713	-0.322032	0.72 [0.28 - 1.87]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207328_at	90	0.833333	0.0568629	-	-1.09167	0.921305	0.0304944	1.03 [0.56 - 1.89]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207328_at	138	0.304348	0.000759659	0.0202188	-0.801176	0.564776	-0.132191	0.88 [0.56 - 1.37]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207328_at	129	0.27907	0.0503241	-	0.582794	0.971162	0.00463333	1.00 [0.78 - 1.29]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20390	56	0.892857	0.0253604	0.316119	0.997134	0.483456	0.199829	1.22 [0.70 - 2.14]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20390	56	0.892857	0.00329109	0.0678651	1.30927	0.419198	0.247347	1.28 [0.70 - 2.33]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207328_at	278	0.309353	0.0182597	0.251182	-0.468999	0.219643	0.197176	1.22 [0.89 - 1.67]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207328_at	133	0.87218	7.94625e-05	0.00285927	1.11115	0.107337	0.81168	2.25 [0.84 - 6.05]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	418	81	0.888889	0.0054394	0.101112	1.51999	0.505606	0.41532	1.51 [0.45 - 5.15]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207328_at	185	0.237838	0.102936	-	-0.309927	0.864033	-0.0438069	0.96 [0.58 - 1.58]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207328_at	185	0.854054	0.0966181	-	0.39676	0.69261	0.105529	1.11 [0.66 - 1.88]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P931250	110	0.490909	0.185559	-	-0.400582	0.620802	0.153296	1.17 [0.64 - 2.14]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P55373	110	0.609091	0.139039	-	0.342407	0.380068	0.150307	1.16 [0.83 - 1.63]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P931250	110	0.490909	0.0471059	0.473956	-0.457513	0.657786	0.107632	1.11 [0.69 - 1.79]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P55373	110	0.818182	0.16363	-	0.481231	0.628112	-0.119985	0.89 [0.55 - 1.44]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207328_at	80	0.55	0.126911	-	0.687972	0.882568	-0.0321449	0.97 [0.63 - 1.48]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_5361	281	0.80427	0.0504511	-	-0.361797	0.20876	-0.0837913	0.92 [0.81 - 1.05]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207328_at	38	0.552632	0.0123736	0.189285	-1.20515	0.109999	-0.574655	0.56 [0.28 - 1.14]
GENE	ALOX15	arachidonate 15-lipoxygenase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207328_at	140	0.478571	0.118098	-	-0.454672	0.292887	-1.73887	0.18 [0.01 - 4.49]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206714_at	30	0.133333	0.0801115	-	1.22609	0.179763	0.857218	2.36 [0.67 - 8.25]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1751975	165	0.715151	0.0838985	-	-0.513442	0.238452	-0.413929	0.66 [0.33 - 1.32]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1751975	165	0.430303	0.299089	-	0.384494	0.946923	-0.0277212	0.97 [0.43 - 2.20]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206714_at	163	0.846626	0.0235287	0.300198	0.55928	0.342113	0.469465	1.60 [0.61 - 4.21]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206714_at	79	0.898734	0.000287453	0.00880503	1.34434	0.00744064	0.964743	2.62 [1.29 - 5.32]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1555416_a_at	79	0.329114	0.181696	-	0.443095	0.762271	0.242546	1.27 [0.26 - 6.14]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206714_at	58	0.293103	0.150325	-	0.441937	0.656599	0.0682972	1.07 [0.79 - 1.45]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206714_at	34	0.676471	0.0786612	-	-0.729461	0.393426	-0.290447	0.75 [0.38 - 1.46]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206714_at	158	0.727848	0.0387367	0.418979	-0.589651	0.43577	-0.331144	0.72 [0.31 - 1.65]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206714_at	53	0.132075	0.050015	-	-0.874134	0.632944	-0.111414	0.89 [0.57 - 1.41]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206714_at	53	0.132075	0.0477762	0.478106	-0.879616	0.98693	0.00378701	1.00 [0.64 - 1.58]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206714_at	180	0.477778	0.0540095	-	0.402504	0.182176	0.214693	1.24 [0.90 - 1.70]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1555416_a_at	559	0.509839	0.0319924	0.369779	-0.44355	0.652999	-0.054958	0.95 [0.74 - 1.20]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206714_at	559	0.32737	0.193104	-	0.296798	0.75586	0.0454243	1.05 [0.79 - 1.39]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206714_at	77	0.636364	0.00952734	0.155671	0.669774	0.463821	0.196567	1.22 [0.72 - 2.06]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206714_at	70	0.885714	0.0117164	0.181776	0.942709	0.493531	0.303295	1.35 [0.57 - 3.23]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1555416_a_at	70	0.214286	0.0965173	-	-0.513393	0.236336	-1.57833	0.21 [0.02 - 2.81]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37430_at	50	0.18	0.0841527	-	-0.733679	0.295979	-0.739899	0.48 [0.12 - 1.91]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206714_at	74	0.891892	0.0929485	-	0.725803	0.861601	0.0632383	1.07 [0.52 - 2.17]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206714_at	67	0.373134	0.0260859	0.322282	15.7307	0.437527	0.422897	1.53 [0.52 - 4.44]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1555416_a_at	67	0.283582	0.0563266	-	15.5596	0.467208	0.581619	1.79 [0.37 - 8.58]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206714_at	115	0.565217	0.311247	-	0.541072	0.73347	0.0930386	1.10 [0.64 - 1.87]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1555416_a_at	115	0.73913	0.138057	-	0.783958	0.4024	0.375492	1.46 [0.60 - 3.51]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37430_at	158	0.563291	0.0168717	0.237356	-0.725886	0.366551	-0.0865863	0.92 [0.76 - 1.11]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37430_at	76	0.105263	0.119959	-	-0.968704	0.464909	-0.147	0.86 [0.58 - 1.28]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1555416_a_at	204	0.122549	0.0480151	0.479576	-0.42409	0.416487	-0.0374238	0.96 [0.88 - 1.05]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206714_at	204	0.485294	0.00426212	0.083425	-0.40278	0.0716279	-0.104624	0.90 [0.80 - 1.01]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206714_at	87	0.344828	0.255692	-	-0.437822	0.668991	-0.059682	0.94 [0.72 - 1.24]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1555416_a_at	87	0.287356	0.193593	-	0.592399	0.608339	-0.121733	0.89 [0.56 - 1.41]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206714_at	87	0.344828	0.255692	-	-0.437822	0.668991	-0.059682	0.94 [0.72 - 1.24]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1555416_a_at	87	0.287356	0.193593	-	0.592399	0.608339	-0.121733	0.89 [0.56 - 1.41]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555416_a_at	77	0.103896	0.0321623	0.37108	-1.36966	0.584091	0.15242	1.16 [0.67 - 2.01]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206714_at	77	0.142857	0.188947	-	-0.878302	0.573074	0.121405	1.13 [0.74 - 1.72]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206714_at	77	0.896104	0.0715835	-	1.12776	0.463577	0.134114	1.14 [0.80 - 1.64]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555416_a_at	77	0.805195	0.0316887	0.367444	1.16012	0.526026	0.152481	1.16 [0.73 - 1.87]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206714_at	136	0.617647	0.111629	-	0.706829	0.841318	0.0405532	1.04 [0.70 - 1.55]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206714_at	200	0.89	0.0172883	0.24155	-2.04132	0.0293289	-0.292631	0.75 [0.57 - 0.97]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15628	60	0.816667	0.0216881	0.28365	0.945578	0.111151	0.136278	1.15 [0.97 - 1.36]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15628	60	0.883333	0.000606594	0.0167073	1.53441	0.00120154	0.311782	1.37 [1.13 - 1.65]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21095	155	0.180645	6.02294e-05	0.00223697	-1.10289	0.00597249	-0.167526	0.85 [0.75 - 0.95]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206714_at	286	0.185315	0.102413	-	-0.377463	0.436689	-0.0810519	0.92 [0.75 - 1.13]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206714_at	159	0.509434	0.0142011	0.209473	-0.80649	0.996381	-0.000827635	1.00 [0.70 - 1.43]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206714_at	159	0.509434	0.0271366	0.331074	-0.717716	0.613169	-0.0921991	0.91 [0.64 - 1.30]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206714_at	159	0.509434	0.0601914	-	-0.719203	0.787436	0.0561873	1.06 [0.70 - 1.59]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206714_at	54	0.37037	0.0258957	0.320674	-1.63322	0.477515	-0.267458	0.77 [0.37 - 1.60]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206714_at	117	0.367521	0.111803	-	-0.498583	0.302436	-0.140421	0.87 [0.67 - 1.13]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206714_at	117	0.307692	0.0119688	0.184677	-0.953796	0.394872	-0.148293	0.86 [0.61 - 1.21]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206714_at	117	0.367521	0.111803	-	-0.498583	0.302436	-0.140421	0.87 [0.67 - 1.13]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206714_at	117	0.25641	0.0481357	0.480316	-0.739533	0.353343	-0.151215	0.86 [0.62 - 1.18]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206714_at	236	0.487288	0.114937	-	0.435378	0.613083	0.0899987	1.09 [0.77 - 1.55]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206714_at	249	0.542169	0.156615	-	-0.303879	0.895713	-0.0189255	0.98 [0.74 - 1.30]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206714_at	62	0.66129	0.2491	-	-0.61064	0.669036	-0.0662235	0.94 [0.69 - 1.27]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206714_at	125	0.256	0.0483188	0.481438	-0.746433	0.81354	-0.044158	0.96 [0.66 - 1.38]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206714_at	125	0.256	0.158977	-	-0.426355	0.891183	-0.0184798	0.98 [0.75 - 1.28]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206714_at	54	0.518519	0.337579	-	-0.569878	0.845752	-0.0370569	0.96 [0.66 - 1.40]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206714_at	198	0.722222	0.163117	-	-0.464959	0.853408	0.0160146	1.02 [0.86 - 1.20]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206714_at	198	0.308081	0.054646	-	0.474635	0.532881	0.0406612	1.04 [0.92 - 1.18]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206714_at	198	0.111111	0.116624	-	0.899079	0.674598	0.0338976	1.03 [0.88 - 1.21]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206714_at	51	0.176471	0.191049	-	-1.13246	0.784983	0.423628	1.53 [0.07 - 32.04]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206714_at	62	0.532258	0.336498	-	-0.580535	0.93024	-0.0881025	0.92 [0.13 - 6.58]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206714_at	177	0.683616	0.0379528	0.413504	-0.689183	0.463315	-0.302995	0.74 [0.33 - 1.66]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1555416_a_at	177	0.333333	0.0681159	-	-0.492044	0.946783	-0.0662955	0.94 [0.13 - 6.56]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206714_at	177	0.683616	0.0186693	0.255183	-0.671496	0.199621	-0.465781	0.63 [0.31 - 1.28]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1555416_a_at	177	0.169492	0.0357734	0.397957	-0.587978	0.485101	-0.623128	0.54 [0.09 - 3.08]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206714_at	145	0.193103	0.0219119	0.285693	1.5184	0.844273	-0.0936341	0.91 [0.36 - 2.32]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1555416_a_at	145	0.855172	0.0864511	-	-1.17855	0.585452	-0.672318	0.51 [0.05 - 5.72]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206714_at	226	0.181416	0.0630605	-	0.935111	0.309267	0.181613	1.20 [0.84 - 1.70]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1555416_a_at	226	0.588496	0.0683515	-	-0.556509	0.244305	-0.185291	0.83 [0.61 - 1.14]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206714_at	55	0.127273	0.000983607	0.0251342	-1.48919	0.403497	-0.630383	0.53 [0.12 - 2.34]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1555416_a_at	55	0.8	0.287894	-	0.513466	0.409664	0.558333	1.75 [0.46 - 6.59]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206714_at	55	0.345455	3.86324e-05	0.00150666	-1.93409	0.00174657	-2.9326	0.05 [0.01 - 0.33]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206714_at	49	0.102041	0.00191403	0.043691	-1.73909	0.0325964	-2.46858	0.08 [0.01 - 0.82]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1555416_a_at	55	0.509091	0.025812	0.319965	-1.09934	0.117297	-2.50261	0.08 [0.00 - 1.88]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1555416_a_at	49	0.530612	0.0602685	-	-1.18362	0.207567	-2.81883	0.06 [0.00 - 4.78]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	2408159	34	0.617647	0.180511	-	0.58513	0.48752	0.671901	1.96 [0.29 - 13.05]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206714_at	63	0.539683	0.0192369	0.26067	-0.812965	0.228093	-1.95881	0.14 [0.01 - 3.41]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1555416_a_at	63	0.126984	6.83216e-06	0.000316227	-1.73784	0.0338211	-20.4479	0.00 [0.00 - 0.21]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.111256.4.S1_3p_s_at	28	0.857143	0.186921	-	1.04216	0.316682	0.492825	1.64 [0.62 - 4.30]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557308_3p_at	28	0.25	0.208123	-	-0.732082	0.491042	-0.918642	0.40 [0.03 - 5.45]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206714_at	82	0.304878	0.000168816	0.00554418	-1.22559	0.0109838	-0.617435	0.54 [0.34 - 0.87]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206714_at	79	0.810127	0.118273	-	-0.538377	0.442945	-0.10492	0.90 [0.69 - 1.18]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206714_at	104	0.105769	0.00533261	0.0995536	-1.12354	0.0748457	-0.366127	0.69 [0.46 - 1.04]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P60627	117	0.102564	0.00012799	0.00435091	-1.32758	0.0389576	-0.226111	0.80 [0.64 - 0.99]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206714_at	204	0.411765	8.10908e-05	0.00291099	-1.05352	0.000357949	-0.518487	0.60 [0.45 - 0.79]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1555416_a_at	204	0.593137	0.00397535	0.0789321	-1.31642	0.0548959	-0.305295	0.74 [0.54 - 1.01]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1555416_a_at	204	0.808824	0.000807588	0.0212911	-2.04196	0.0281071	-0.263859	0.77 [0.61 - 0.97]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206714_at	204	0.784314	0.00232115	0.051159	-15.4402	0.0036317	-0.560728	0.57 [0.39 - 0.83]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206714_at	178	0.685393	0.0107278	0.170205	-0.57958	0.0683622	-0.198762	0.82 [0.66 - 1.02]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1555416_a_at	111	0.117117	0.111289	-	-0.59879	0.118382	-0.21897	0.80 [0.61 - 1.06]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206714_at	111	0.162162	0.0493187	0.487521	-0.628491	0.279582	-0.168496	0.84 [0.62 - 1.15]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206714_at	90	0.833333	0.117827	-	0.589247	0.978956	-0.00559948	0.99 [0.66 - 1.51]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206714_at	90	0.844444	0.129865	-	0.646539	0.806814	0.0576844	1.06 [0.67 - 1.68]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1555416_a_at	138	0.115942	0.00572625	0.105259	-0.83075	0.272744	-0.124956	0.88 [0.71 - 1.10]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206714_at	138	0.862319	0.010123	0.162952	-1.24481	0.384079	-0.0559157	0.95 [0.83 - 1.07]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206714_at	129	0.79845	0.0760039	-	-0.627429	0.4505	-0.180494	0.83 [0.52 - 1.33]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13039	56	0.357143	0.0609146	-	-0.639319	0.188713	-0.163833	0.85 [0.66 - 1.08]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13039	56	0.357143	0.0714585	-	-0.650541	0.165841	-0.183547	0.83 [0.64 - 1.08]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206714_at	278	0.895683	0.189576	-	-0.45147	0.254864	-0.244148	0.78 [0.51 - 1.19]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1555416_a_at	278	0.780576	0.0404331	0.430627	-0.514435	0.09371	-0.697027	0.50 [0.22 - 1.13]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206714_at	133	0.62406	0.0117715	0.182411	0.594439	0.233874	-0.343384	0.71 [0.40 - 1.25]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18135	81	0.851852	0.0198107	0.266152	1.22964	0.409253	0.328616	1.39 [0.64 - 3.03]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206714_at	185	0.335135	0.0795113	-	-0.292412	0.535499	-0.126873	0.88 [0.59 - 1.32]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206714_at	185	0.275676	0.0258461	0.320253	-0.41269	0.476556	-0.162404	0.85 [0.54 - 1.33]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P60627	110	0.109091	0.00129	0.0315283	-1.03392	0.963067	0.00497134	1.00 [0.81 - 1.24]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P60627	110	0.109091	0.0887533	-	-0.653547	0.834889	0.0282877	1.03 [0.79 - 1.34]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206714_at	80	0.6625	0.000455149	0.0130758	1.49617	0.0199263	0.761175	2.14 [1.13 - 4.06]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_2857	281	0.483986	1.02921e-07	6.59536e-06	-0.742835	1.8237e-05	-0.176313	0.84 [0.77 - 0.91]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1555416_a_at	38	0.315789	0.165961	-	0.846351	0.723576	-0.0995624	0.91 [0.52 - 1.57]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206714_at	38	0.552632	0.0460995	0.46766	0.954126	0.591904	0.158023	1.17 [0.66 - 2.09]
GENE	ALOX15B	arachidonate 15-lipoxygenase, type B	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206714_at	140	0.207143	3.525e-05	0.00138829	-1.18968	0.0154191	-1.56136	0.21 [0.06 - 0.74]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214366_s_at	30	0.633333	0.161355	-	0.575584	0.809832	0.0577242	1.06 [0.66 - 1.70]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204445_s_at	30	0.633333	0.161355	-	0.575584	0.545407	0.205903	1.23 [0.63 - 2.39]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204446_s_at	30	0.333333	0.0492807	0.487292	-0.809468	0.472158	-0.161036	0.85 [0.55 - 1.32]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213952_s_at	30	0.6	0.252766	-	0.463801	0.760461	0.20255	1.22 [0.33 - 4.50]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1651466	165	0.224242	0.00170021	0.0396328	-0.811503	0.0663338	-0.193911	0.82 [0.67 - 1.01]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1651466	165	0.218182	2.4074e-05	0.000986647	-1.39789	0.000450353	-0.498452	0.61 [0.46 - 0.80]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204446_s_at	163	0.466258	0.0301215	0.355223	0.433771	0.228354	0.089198	1.09 [0.95 - 1.26]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213952_s_at	163	0.822086	0.120036	-	0.372426	0.687296	0.230027	1.26 [0.41 - 3.86]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214366_s_at	163	0.171779	0.18151	-	0.381811	0.810989	0.0349554	1.04 [0.78 - 1.38]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204445_s_at	163	0.104294	0.164655	-	0.50683	0.897052	0.0340413	1.03 [0.62 - 1.73]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213952_s_at	79	0.405063	0.00788138	0.134759	0.849957	0.0265563	1.5366	4.65 [1.20 - 18.07]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204446_s_at	79	0.253165	0.0403702	0.430199	0.777236	0.106621	0.139656	1.15 [0.97 - 1.36]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204445_s_at	79	0.341772	0.0571518	-	0.62845	0.244689	0.218255	1.24 [0.86 - 1.80]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214366_s_at	79	0.531646	0.0396726	0.425439	0.5982	0.124789	0.209267	1.23 [0.94 - 1.61]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213952_s_at	58	0.810345	5.49354e-05	0.00206149	1.53057	0.344651	0.205358	1.23 [0.80 - 1.88]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214366_s_at	58	0.224138	0.00634324	0.113988	-0.890528	0.901262	0.0224585	1.02 [0.72 - 1.46]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204445_s_at	58	0.551724	0.0361456	0.400647	0.591905	0.151259	0.195976	1.22 [0.93 - 1.59]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204446_s_at	58	0.241379	0.157823	-	-0.439392	0.953316	0.00662183	1.01 [0.81 - 1.26]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204446_s_at	34	0.264706	0.0435231	0.451165	-0.832379	0.356591	-0.200754	0.82 [0.53 - 1.25]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213952_s_at	34	0.852941	0.189417	-	-0.790134	0.234133	-0.37374	0.69 [0.37 - 1.27]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214366_s_at	34	0.705882	0.420982	-	0.347945	0.889291	0.0240452	1.02 [0.73 - 1.44]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204445_s_at	34	0.352941	0.200808	-	0.527087	0.82427	0.0550028	1.06 [0.65 - 1.72]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213952_s_at	158	0.411392	0.153886	-	-0.327641	0.863473	-0.168561	0.84 [0.12 - 5.77]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214366_s_at	158	0.443038	0.0217829	0.284516	-0.527254	0.683323	-0.0622289	0.94 [0.70 - 1.27]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204445_s_at	158	0.436709	0.06379	-	-0.427004	0.929229	0.0158037	1.02 [0.72 - 1.44]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204446_s_at	158	0.367089	0.0158487	0.226883	-0.554016	0.23135	-0.118117	0.89 [0.73 - 1.08]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214366_s_at	53	0.811321	0.147849	-	-0.753191	0.864185	-0.0320558	0.97 [0.67 - 1.40]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204446_s_at	53	0.320755	0.0890207	-	-0.625771	0.509147	-0.134411	0.87 [0.59 - 1.30]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204445_s_at	53	0.113208	0.107457	-	1.11785	0.317627	0.223174	1.25 [0.81 - 1.94]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213952_s_at	53	0.396226	0.136763	-	0.570697	0.865802	-0.0571841	0.94 [0.49 - 1.83]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204446_s_at	53	0.320755	0.281588	-	-0.384952	0.937205	-0.0151552	0.98 [0.68 - 1.44]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214366_s_at	53	0.811321	0.0973433	-	-0.971148	0.473953	-0.133258	0.88 [0.61 - 1.26]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204445_s_at	53	0.113208	0.0591796	-	1.70713	0.592227	0.11515	1.12 [0.74 - 1.71]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213952_s_at	53	0.886792	0.148786	-	-1.0101	0.757454	-0.0988927	0.91 [0.48 - 1.70]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213952_s_at	180	0.872222	0.136684	-	0.430777	0.545268	0.148997	1.16 [0.72 - 1.88]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214366_s_at	180	0.611111	0.00203601	0.0459622	-0.701206	0.0196597	-0.206379	0.81 [0.68 - 0.97]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204445_s_at	180	0.122222	0.00361803	0.0732174	-0.832051	0.0286071	-0.265884	0.77 [0.60 - 0.97]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204446_s_at	180	0.544444	0.0447431	0.459045	-0.422981	0.1799	-0.142355	0.87 [0.70 - 1.07]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213952_s_at	559	0.624329	0.137275	-	-0.310804	0.482395	-0.131708	0.88 [0.61 - 1.27]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204446_s_at	559	0.880143	0.00931224	0.153006	-1.0486	0.0397345	-0.210005	0.81 [0.66 - 0.99]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204445_s_at	559	0.277281	0.00583405	0.106802	-0.560986	0.0216585	-0.283963	0.75 [0.59 - 0.96]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214366_s_at	559	0.152057	0.0427687	0.446229	-0.477023	0.111704	-0.188924	0.83 [0.66 - 1.04]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204446_s_at	77	0.376623	0.301667	-	0.278877	0.541292	0.0994938	1.10 [0.80 - 1.52]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213952_s_at	77	0.857143	0.0461349	0.467883	-0.787152	0.453747	-0.212819	0.81 [0.46 - 1.41]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214366_s_at	77	0.519481	0.118463	-	0.396034	0.988757	0.00172624	1.00 [0.79 - 1.27]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204445_s_at	77	0.103896	0.000750389	0.02001	-1.27802	0.00718347	-0.482311	0.62 [0.43 - 0.88]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213952_s_at	70	0.285714	0.377657	-	-0.249811	0.946884	0.05208	1.05 [0.23 - 4.88]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204446_s_at	70	0.857143	0.0631426	-	-0.84472	0.271558	-0.1457	0.86 [0.67 - 1.12]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204445_s_at	70	0.114286	0.152451	-	-0.574469	0.502947	-0.417282	0.66 [0.19 - 2.23]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214366_s_at	70	0.271429	0.0638524	-	-0.534894	0.203054	-0.439084	0.64 [0.33 - 1.27]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33153_at	50	0.76	0.0663382	-	-0.773557	0.249318	-1.2767	0.28 [0.03 - 2.45]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	307_at	50	0.26	0.0111029	0.174635	1.41978	0.957077	0.0198093	1.02 [0.50 - 2.10]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214366_s_at	74	0.432432	0.00298133	0.0626739	0.916764	0.0164402	0.53059	1.70 [1.10 - 2.62]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204445_s_at	74	0.567568	0.0146864	0.214675	0.714793	0.261342	0.231443	1.26 [0.84 - 1.89]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204446_s_at	74	0.364865	0.0121713	0.186988	0.801824	0.0500602	0.39562	1.49 [1.00 - 2.21]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213952_s_at	74	0.797297	0.103575	-	0.527238	0.834563	0.121931	1.13 [0.36 - 3.55]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213952_s_at	67	0.104478	0.180921	-	-1.05062	0.613557	-1.57049	0.21 [0.00 - 92.28]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204446_s_at	67	0.746269	0.353785	-	-0.949541	0.887245	-0.0608109	0.94 [0.41 - 2.18]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204445_s_at	67	0.656716	0.0992984	-	1.07196	0.878333	0.134909	1.14 [0.20 - 6.44]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214366_s_at	67	0.686567	0.206999	-	-1.25799	0.67568	-0.255726	0.77 [0.23 - 2.57]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213952_s_at	115	0.478261	0.0635081	-	-1.05167	0.418968	-0.597774	0.55 [0.13 - 2.34]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204446_s_at	115	0.173913	0.00688752	0.12149	-1.35941	0.0178381	-1.1083	0.33 [0.13 - 0.83]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204445_s_at	115	0.530435	0.044581	0.458005	-1.23128	0.173395	-1.16459	0.31 [0.06 - 1.67]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214366_s_at	115	0.217391	0.00586196	0.107201	-1.36885	0.0666166	-0.73014	0.48 [0.22 - 1.05]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	307_at	158	0.791139	0.151049	-	-0.580646	0.58395	0.129744	1.14 [0.72 - 1.81]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33153_at	158	0.139241	0.0976347	-	-0.608028	0.871094	-0.0434383	0.96 [0.57 - 1.62]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	307_at	76	0.355263	0.00350747	0.0714213	-1.46785	0.135697	-0.45739	0.63 [0.35 - 1.15]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33153_at	76	0.144737	0.343672	-	-0.604073	0.901394	-0.0703216	0.93 [0.31 - 2.84]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204446_s_at	204	0.102941	0.257915	-	-0.254809	0.87131	-0.0157884	0.98 [0.81 - 1.19]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204445_s_at	204	0.897059	0.345272	-	-0.214228	0.813559	-0.021414	0.98 [0.82 - 1.17]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214366_s_at	204	0.196078	0.0511294	-	-0.344194	0.237753	-0.107141	0.90 [0.75 - 1.07]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213952_s_at	204	0.235294	0.080427	-	0.290511	0.5123	0.059413	1.06 [0.89 - 1.27]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214366_s_at	87	0.436782	0.00106076	0.0267768	-1.23799	0.0135535	-0.688301	0.50 [0.29 - 0.87]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204446_s_at	87	0.436782	0.00277203	0.059094	-1.12756	0.0379141	-0.349294	0.71 [0.51 - 0.98]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213952_s_at	87	0.229885	0.0432118	0.449134	-0.800103	0.169023	-1.4489	0.23 [0.03 - 1.85]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204445_s_at	87	0.770115	0.1171	-	-0.825136	0.206983	-0.629359	0.53 [0.20 - 1.42]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204446_s_at	87	0.436782	0.00277203	0.059094	-1.12756	0.0379141	-0.349294	0.71 [0.51 - 0.98]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214366_s_at	87	0.436782	0.00106076	0.0267768	-1.23799	0.0135535	-0.688301	0.50 [0.29 - 0.87]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204445_s_at	87	0.770115	0.1171	-	-0.825136	0.206983	-0.629359	0.53 [0.20 - 1.42]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213952_s_at	87	0.229885	0.0432118	0.449134	-0.800103	0.169023	-1.4489	0.23 [0.03 - 1.85]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214366_s_at	77	0.376623	0.205121	-	0.964523	0.869286	-0.0868858	0.92 [0.33 - 2.58]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204445_s_at	77	0.571429	0.00420501	0.0825365	1.68447	0.42024	0.476251	1.61 [0.51 - 5.13]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213952_s_at	77	0.623377	0.0537487	-	-1.7875	0.395294	-1.41097	0.24 [0.01 - 6.31]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214366_s_at	77	0.376623	0.0677909	-	1.30946	0.877243	-0.0703445	0.93 [0.38 - 2.28]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204446_s_at	77	0.896104	0.218639	-	0.938625	0.960971	-0.0189775	0.98 [0.46 - 2.10]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213952_s_at	77	0.87013	0.14113	-	-15.2483	0.675654	-0.582027	0.56 [0.04 - 8.54]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204445_s_at	77	0.571429	0.0488608	0.484745	1.27406	0.720045	0.261126	1.30 [0.31 - 5.41]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204446_s_at	77	0.558442	0.140935	-	0.817064	0.762023	0.101066	1.11 [0.58 - 2.13]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204445_s_at	136	0.161765	0.223708	-	1.18286	0.954284	-0.019743	0.98 [0.50 - 1.93]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204446_s_at	136	0.147059	0.276356	-	-0.610594	0.752226	0.103362	1.11 [0.58 - 2.11]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213952_s_at	136	0.507353	0.0570314	-	0.881837	0.761787	0.0898729	1.09 [0.61 - 1.96]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214366_s_at	136	0.610294	0.11448	-	-0.795948	0.705882	-0.101955	0.90 [0.53 - 1.53]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214366_s_at	200	0.165	0.0284602	0.341928	-0.703328	0.405762	-0.17296	0.84 [0.56 - 1.26]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204445_s_at	200	0.22	0.00636461	0.114286	-0.811745	0.0996813	-0.372003	0.69 [0.44 - 1.07]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204446_s_at	200	0.845	0.050538	-	0.646796	0.521342	0.158308	1.17 [0.72 - 1.90]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213952_s_at	200	0.515	0.0142807	0.21033	0.73294	0.103238	0.577224	1.78 [0.89 - 3.57]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11596	60	0.2	0.0402473	0.429364	1.38928	0.313544	0.148361	1.16 [0.87 - 1.55]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11596	60	0.883333	0.0421713	0.442284	0.977858	0.246986	0.308401	1.36 [0.81 - 2.29]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18912	155	0.296774	3.4575e-08	2.37651e-06	-1.43945	7.53248e-05	-0.361485	0.70 [0.58 - 0.83]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214366_s_at	286	0.839161	0.00443839	0.0861481	-1.00266	0.429702	-0.0880281	0.92 [0.74 - 1.14]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204445_s_at	286	0.853147	0.0023244	0.0512174	-1.13022	0.0813481	-0.204721	0.81 [0.65 - 1.03]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204446_s_at	286	0.727273	0.008797	0.146543	-0.650856	0.223263	-0.195453	0.82 [0.60 - 1.13]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213952_s_at	286	0.867133	0.0241149	0.30535	-0.806607	0.22344	-0.292249	0.75 [0.47 - 1.20]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214366_s_at	159	0.18239	0.0131911	0.198437	-0.832042	0.0203026	-0.504623	0.60 [0.39 - 0.92]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204445_s_at	159	0.484277	0.0323248	0.372321	-0.686106	0.248607	-0.297788	0.74 [0.45 - 1.23]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204446_s_at	159	0.805031	0.0270355	0.330234	-1.24557	0.194249	-0.355672	0.70 [0.41 - 1.20]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214366_s_at	159	0.36478	0.0227394	0.293172	-0.827146	0.00677388	-0.666516	0.51 [0.32 - 0.83]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204445_s_at	159	0.672956	0.0199182	0.267172	-1.18341	0.33136	-0.296782	0.74 [0.41 - 1.35]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213952_s_at	159	0.578616	0.0783199	-	0.55271	0.481064	0.336995	1.40 [0.55 - 3.58]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204446_s_at	159	0.163522	0.0337255	0.382893	-0.7361	0.216775	-0.3438	0.71 [0.41 - 1.22]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214366_s_at	159	0.603774	0.031656	0.367193	-0.765935	0.00373667	-0.618856	0.54 [0.35 - 0.82]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204445_s_at	159	0.672956	0.218202	-	-0.445958	0.52273	-0.172835	0.84 [0.50 - 1.43]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204446_s_at	159	0.805031	0.0157239	0.225589	-2.06913	0.0875168	-0.549019	0.58 [0.31 - 1.08]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213952_s_at	159	0.597484	0.0264388	0.325253	0.692137	0.468133	0.339284	1.40 [0.56 - 3.51]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213952_s_at	159	0.786164	0.120518	-	-0.914579	0.960356	-0.0264674	0.97 [0.34 - 2.77]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213952_s_at	54	0.203704	0.137851	-	15.3798	0.640661	-0.729993	0.48 [0.02 - 10.33]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204445_s_at	54	0.888889	0.0110204	0.173666	1.66219	0.280943	1.10201	3.01 [0.41 - 22.32]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214366_s_at	54	0.796296	0.194361	-	0.917043	0.816514	0.220247	1.25 [0.19 - 8.01]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204446_s_at	54	0.851852	0.146419	-	-15.4001	0.476047	-0.249571	0.78 [0.39 - 1.55]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204446_s_at	117	0.888889	0.0324724	0.373446	0.825813	0.341126	0.169183	1.18 [0.84 - 1.68]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204446_s_at	117	0.529915	0.14815	-	-0.590568	0.813504	0.0503007	1.05 [0.69 - 1.60]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213952_s_at	117	0.102564	5.83963e-05	0.00217643	-1.42316	0.239173	-1.10094	0.33 [0.05 - 2.08]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214366_s_at	117	0.111111	0.0435459	0.451313	-0.818917	0.915658	0.0440508	1.05 [0.46 - 2.36]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214366_s_at	117	0.82906	0.0724146	-	0.736324	0.55917	0.275359	1.32 [0.52 - 3.32]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204445_s_at	117	0.444444	0.0285788	0.342889	0.740385	0.879369	0.0873576	1.09 [0.35 - 3.37]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213952_s_at	117	0.102564	2.42226e-06	0.000122726	-1.88262	0.220429	-1.47565	0.23 [0.02 - 2.42]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204445_s_at	117	0.418803	0.0313032	0.364466	0.908393	0.639113	0.313783	1.37 [0.37 - 5.08]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213952_s_at	117	0.102564	5.83963e-05	0.00217643	-1.42316	0.239173	-1.10094	0.33 [0.05 - 2.08]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214366_s_at	117	0.111111	0.0435459	0.451313	-0.818917	0.915658	0.0440508	1.05 [0.46 - 2.36]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214366_s_at	117	0.102564	0.0467228	0.471569	-0.959333	0.266861	-0.653448	0.52 [0.16 - 1.65]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204445_s_at	117	0.444444	0.0285788	0.342889	0.740385	0.879369	0.0873576	1.09 [0.35 - 3.37]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204445_s_at	117	0.777778	0.0550039	-	-1.31624	0.770521	-0.233145	0.79 [0.17 - 3.79]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204446_s_at	117	0.888889	0.0482693	0.481135	0.882944	0.29098	0.224965	1.25 [0.82 - 1.90]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204446_s_at	117	0.888889	0.0324724	0.373446	0.825813	0.341126	0.169183	1.18 [0.84 - 1.68]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213952_s_at	117	0.102564	0.000195944	0.00631369	-1.49496	0.270841	-1.24934	0.29 [0.03 - 2.65]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204446_s_at	236	0.127119	3.11626e-05	0.00124342	-1.21567	0.0103771	-0.609858	0.54 [0.34 - 0.87]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213952_s_at	236	0.584746	0.0646307	-	0.493606	0.541638	0.28606	1.33 [0.53 - 3.34]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214366_s_at	236	0.110169	1.41769e-05	0.00061258	-1.29172	0.000176352	-0.687228	0.50 [0.35 - 0.72]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204445_s_at	236	0.101695	0.120854	-	-0.585914	0.373677	-0.1852	0.83 [0.55 - 1.25]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213952_s_at	249	0.13253	0.0192838	0.261121	-0.622055	0.750058	-0.112238	0.89 [0.45 - 1.78]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214366_s_at	249	0.108434	8.94739e-06	0.000403955	-1.14525	0.0019321	-0.491705	0.61 [0.45 - 0.83]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204445_s_at	249	0.232932	0.306435	-	0.281095	0.701891	-0.0653058	0.94 [0.67 - 1.31]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204446_s_at	249	0.285141	0.00527979	0.0987794	-0.605043	0.0900274	-0.31798	0.73 [0.50 - 1.05]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204445_s_at	54	0.407407	0.206027	-	-0.734976	0.721258	-0.119965	0.89 [0.46 - 1.71]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213952_s_at	62	0.241935	0.116095	-	1.48644	0.77898	-0.0749038	0.93 [0.55 - 1.57]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204446_s_at	125	0.352	0.0251195	0.314054	-0.83726	0.178114	-0.292478	0.75 [0.49 - 1.14]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204446_s_at	125	0.568	0.15492	-	-0.443731	0.746762	-0.0536258	0.95 [0.68 - 1.31]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204446_s_at	54	0.111111	0.00947641	0.155042	-1.46216	0.279683	-0.186782	0.83 [0.59 - 1.16]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214366_s_at	62	0.112903	0.0150968	0.219025	-1.33503	0.244129	-0.328048	0.72 [0.41 - 1.25]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213952_s_at	125	0.2	0.206337	-	0.754865	0.964764	0.044315	1.05 [0.15 - 7.47]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213952_s_at	125	0.256	0.0603936	-	-0.572926	0.526504	-0.485287	0.62 [0.14 - 2.76]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213952_s_at	54	0.333333	0.0935152	-	1.58314	0.763955	-0.0976458	0.91 [0.48 - 1.72]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204445_s_at	62	0.870968	0.174075	-	-1.02532	0.543403	-0.170069	0.84 [0.49 - 1.46]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214366_s_at	125	0.48	0.0155733	0.224022	-0.944869	0.106872	-0.81757	0.44 [0.16 - 1.19]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204445_s_at	125	0.832	0.195345	-	-0.77688	0.812066	0.0859044	1.09 [0.54 - 2.21]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214366_s_at	125	0.48	0.037967	0.413604	-0.602456	0.184104	-0.505114	0.60 [0.29 - 1.27]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214366_s_at	54	0.203704	0.0439618	0.454013	-1.16994	0.432891	-0.259481	0.77 [0.40 - 1.48]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204446_s_at	62	0.677419	0.0414293	0.437342	-1.15788	0.135002	-0.221263	0.80 [0.60 - 1.07]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204445_s_at	125	0.368	0.274075	-	-0.341794	0.710606	-0.10402	0.90 [0.52 - 1.56]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204445_s_at	198	0.136364	0.0551792	-	-0.538312	0.668209	-0.0431538	0.96 [0.79 - 1.17]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213952_s_at	198	0.181818	0.160601	-	0.55842	0.213504	0.181905	1.20 [0.90 - 1.60]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213952_s_at	198	0.671717	0.290336	-	0.291075	0.291136	0.162771	1.18 [0.87 - 1.59]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214366_s_at	198	0.328283	0.228954	-	0.348699	0.771757	0.0383563	1.04 [0.80 - 1.35]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214366_s_at	198	0.328283	0.24256	-	0.352029	0.851658	0.0258787	1.03 [0.78 - 1.35]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204445_s_at	198	0.782828	0.0553292	-	0.515931	0.971321	-0.00454134	1.00 [0.78 - 1.28]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204446_s_at	198	0.530303	0.122648	-	-0.327113	0.950781	-0.00734914	0.99 [0.79 - 1.25]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204445_s_at	198	0.121212	0.133028	-	-0.54143	0.646695	-0.0577867	0.94 [0.74 - 1.21]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213952_s_at	198	0.828283	0.107519	-	0.407675	0.617871	0.0538485	1.06 [0.85 - 1.30]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204446_s_at	198	0.772727	0.157884	-	0.390143	0.860781	0.0260416	1.03 [0.77 - 1.37]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204446_s_at	198	0.782828	0.160837	-	0.412017	0.982045	-0.00347092	1.00 [0.74 - 1.35]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214366_s_at	198	0.106061	0.332648	-	-0.299829	0.75397	-0.032084	0.97 [0.79 - 1.18]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204446_s_at	51	0.823529	0.178824	-	1.16116	0.984422	0.00729947	1.01 [0.48 - 2.10]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204446_s_at	62	0.677419	0.123405	-	0.863657	0.854773	0.0439152	1.04 [0.65 - 1.67]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213952_s_at	51	0.882353	0.0132073	0.198616	1.95667	0.677029	0.825097	2.28 [0.05 - 110.80]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213952_s_at	62	0.887097	0.219039	-	0.925658	0.997402	-0.00461044	1.00 [0.06 - 15.96]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214366_s_at	51	0.666667	0.205647	-	1.09924	0.485385	1.49886	4.48 [0.07 - 301.78]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204445_s_at	51	0.588235	0.057636	-	1.84988	0.358355	2.22884	9.29 [0.08 - 1080.26]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214366_s_at	62	0.725806	0.145296	-	-1.404	0.782509	-0.480288	0.62 [0.02 - 18.72]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204445_s_at	62	0.112903	0.142259	-	-0.943663	0.841806	-0.304898	0.74 [0.04 - 14.72]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214366_s_at	177	0.361582	0.0697826	-	0.542893	0.721517	0.0786472	1.08 [0.70 - 1.67]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204445_s_at	145	0.296552	0.0110775	0.174337	1.16127	0.164372	0.661701	1.94 [0.76 - 4.93]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213952_s_at	177	0.898305	0.0298571	0.35313	-1.89653	0.0921925	-1.5869	0.20 [0.03 - 1.30]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214366_s_at	177	0.225989	0.0437231	0.452465	0.651282	0.891795	0.0264556	1.03 [0.70 - 1.50]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214366_s_at	145	0.655172	0.0246086	0.309647	0.732949	0.272617	0.282499	1.33 [0.80 - 2.20]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204446_s_at	177	0.423729	0.0515089	-	0.560924	0.165919	0.189925	1.21 [0.92 - 1.58]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213952_s_at	177	0.864407	0.0180962	0.249575	-1.30197	0.0240479	-1.8895	0.15 [0.03 - 0.78]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204445_s_at	177	0.112994	0.0759048	-	1.02049	0.651406	0.177524	1.19 [0.55 - 2.58]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204446_s_at	177	0.412429	0.0489138	0.485067	0.491258	0.332489	0.114926	1.12 [0.89 - 1.42]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213952_s_at	145	0.427586	0.00142375	0.0342218	-1.0781	0.0617989	-2.17745	0.11 [0.01 - 1.11]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204446_s_at	145	0.262069	0.00722599	0.126069	1.48078	0.0423384	0.352246	1.42 [1.01 - 2.00]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204445_s_at	177	0.107345	0.129611	-	0.694953	0.763649	-0.104066	0.90 [0.46 - 1.78]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204445_s_at	226	0.362832	0.00454148	0.0877275	1.00259	0.0366181	0.30777	1.36 [1.02 - 1.82]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214366_s_at	226	0.752212	0.15916	-	0.423727	0.480559	0.0926845	1.10 [0.85 - 1.42]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213952_s_at	226	0.380531	0.000186817	0.00605664	-1.04016	0.125425	-0.284714	0.75 [0.52 - 1.08]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204446_s_at	226	0.327434	0.0173085	0.241753	0.850812	0.356115	0.131194	1.14 [0.86 - 1.51]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214366_s_at	55	0.109091	0.0990462	-	-0.894087	0.880865	-0.0505427	0.95 [0.49 - 1.84]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204445_s_at	49	0.122449	0.00757163	0.13068	-1.52672	0.539324	-0.449465	0.64 [0.15 - 2.68]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214366_s_at	55	0.109091	0.00093917	0.0241771	-1.74318	0.614138	-0.198474	0.82 [0.38 - 1.77]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213952_s_at	55	0.890909	0.0137929	0.205048	1.29552	0.278596	1.75442	5.78 [0.24 - 138.12]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214366_s_at	49	0.102041	0.0293782	0.349319	-1.36829	0.484282	-0.319907	0.73 [0.30 - 1.78]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204446_s_at	55	0.454545	0.0258191	0.320025	1.09828	0.346559	0.207312	1.23 [0.80 - 1.89]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213952_s_at	55	0.818182	0.124245	-	0.817738	0.559473	1.00454	2.73 [0.09 - 79.69]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213952_s_at	49	0.836735	0.10698	-	0.954265	0.826877	0.469248	1.60 [0.02 - 107.18]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204445_s_at	55	0.163636	0.0228286	0.293971	-1.06524	0.843012	-0.107108	0.90 [0.31 - 2.59]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204446_s_at	55	0.454545	0.118129	-	0.830018	0.753601	0.0772059	1.08 [0.67 - 1.75]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204446_s_at	49	0.489796	0.138628	-	0.952098	0.502221	0.198466	1.22 [0.68 - 2.18]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204445_s_at	55	0.127273	0.0110419	0.173919	-1.2638	0.218986	-0.787179	0.46 [0.13 - 1.60]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214366_s_at	63	0.190476	0.000827458	0.0217322	-1.17893	0.137715	2.2781	9.76 [0.48 - 197.59]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213952_s_at	63	0.222222	2.74839e-05	0.00111111	-1.41719	0.00963933	-38.9208	0.00 [0.00 - 0.00]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204446_s_at	63	0.857143	0.0738628	-	-1.22515	0.189198	-0.169424	0.84 [0.66 - 1.09]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204445_s_at	63	0.142857	0.00365031	0.0737393	-1.13359	0.697555	-0.631318	0.53 [0.02 - 12.84]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.89499.1.A1_3p_at	28	0.535714	0.0299684	0.354012	-1.22041	0.331752	-3.81598	0.02 [0.00 - 48.91]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502056_3p_a_at	28	0.75	0.148173	-	0.813599	0.816377	0.0968674	1.10 [0.49 - 2.50]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.89499.2.S1_3p_a_at	28	0.285714	0.0707113	-	-0.990967	0.0673927	6.08146	437.67 [0.65 - 296067.40]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.89499.0.A1_3p_a_at	28	0.75	0.132812	-	-1.11021	0.199428	-15.71	0.00 [0.00 - 3969.04]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204445_s_at	82	0.414634	0.0454657	0.463653	-0.669334	0.446543	-0.396988	0.67 [0.24 - 1.87]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204446_s_at	82	0.487805	0.010562	0.16823	-0.886573	0.104031	-0.343886	0.71 [0.47 - 1.07]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213952_s_at	82	0.109756	0.115259	-	1.46458	0.709734	0.223765	1.25 [0.38 - 4.06]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214366_s_at	82	0.658537	0.0105209	0.167739	-1.0939	0.409753	-0.257908	0.77 [0.42 - 1.43]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	307_at	84	0.107143	0.0500796	-	1.12183	0.195926	0.2941	1.34 [0.86 - 2.10]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204445_s_at	79	0.151899	0.0136862	0.203883	-0.82121	0.718971	-0.131974	0.88 [0.43 - 1.80]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204446_s_at	79	0.518987	0.126666	-	0.396679	0.721665	0.0648211	1.07 [0.75 - 1.52]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213952_s_at	79	0.78481	0.0397081	0.425682	-0.708237	0.413443	-0.382376	0.68 [0.27 - 1.71]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214366_s_at	79	0.721519	0.157265	-	0.385467	0.963732	-0.0111875	0.99 [0.61 - 1.60]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	J03600_at	86	0.813953	0.304041	-	0.48151	0.541539	0.19425	1.21 [0.65 - 2.27]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213952_s_at	104	0.701923	0.0729573	-	-0.702368	0.701784	-0.276653	0.76 [0.18 - 3.13]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214366_s_at	104	0.865385	0.199705	-	0.511621	0.641987	-0.153607	0.86 [0.45 - 1.64]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204445_s_at	104	0.182692	0.00443586	0.0861092	-0.992273	0.681356	-0.223705	0.80 [0.27 - 2.33]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204446_s_at	104	0.115385	0.152635	-	-0.635779	0.665679	-0.0966537	0.91 [0.59 - 1.41]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P104464	117	0.735043	0.0416732	0.438971	-0.768747	0.146576	-0.261714	0.77 [0.54 - 1.10]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213952_s_at	204	0.446078	0.113218	-	0.443471	0.761329	0.0984745	1.10 [0.58 - 2.08]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204446_s_at	204	0.29902	0.0384133	0.416728	1.06171	0.0475369	0.81901	2.27 [1.01 - 5.10]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204446_s_at	204	0.151961	0.0239852	0.304215	1.25712	0.120282	0.459947	1.58 [0.89 - 2.83]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204445_s_at	204	0.558824	0.00935949	0.153593	0.969814	0.0804487	0.672339	1.96 [0.92 - 4.16]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204445_s_at	204	0.245098	0.00195782	0.0445098	1.35084	0.0262688	0.627301	1.87 [1.08 - 3.26]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214366_s_at	204	0.686275	0.0143229	0.210784	0.867605	0.152333	0.488358	1.63 [0.83 - 3.18]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214366_s_at	204	0.367647	0.0114593	0.178799	0.806173	0.0999303	0.416754	1.52 [0.92 - 2.49]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213952_s_at	204	0.416667	0.00110379	0.0276829	1.4699	0.0645212	0.912015	2.49 [0.95 - 6.55]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204446_s_at	178	0.882023	0.0649819	-	0.498833	0.259721	0.161871	1.18 [0.89 - 1.56]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213952_s_at	178	0.837079	0.00355873	0.0722558	0.680411	0.0459567	0.923662	2.52 [1.02 - 6.24]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214366_s_at	178	0.275281	0.111783	-	0.369875	0.391634	0.135807	1.15 [0.84 - 1.56]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204445_s_at	178	0.595506	0.0147057	0.21488	0.483393	0.0708758	0.49949	1.65 [0.96 - 2.83]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204446_s_at	111	0.135135	0.0174754	0.243421	-0.814544	0.452061	-0.104253	0.90 [0.69 - 1.18]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204445_s_at	111	0.351351	0.0429483	0.447408	-0.533193	0.630554	-0.0762291	0.93 [0.68 - 1.26]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214366_s_at	111	0.792793	0.0260059	0.321607	0.634348	0.400796	0.115662	1.12 [0.86 - 1.47]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213952_s_at	111	0.72973	0.18103	-	-0.420273	0.856643	-0.0339793	0.97 [0.67 - 1.40]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204446_s_at	90	0.666667	0.120514	-	0.505449	0.493184	0.0970562	1.10 [0.83 - 1.45]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204446_s_at	90	0.822222	0.0851171	-	0.701609	0.829026	0.0350079	1.04 [0.75 - 1.42]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213952_s_at	90	0.255556	0.115723	-	-0.523246	0.699612	0.288327	1.33 [0.31 - 5.77]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213952_s_at	90	0.722222	0.18335	-	-0.643193	0.390917	0.697672	2.01 [0.41 - 9.89]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214366_s_at	90	0.833333	0.0852258	-	0.646866	0.301414	0.29753	1.35 [0.77 - 2.37]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214366_s_at	90	0.833333	0.0425957	0.44509	0.820591	0.320231	0.321273	1.38 [0.73 - 2.60]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204445_s_at	90	0.822222	0.00401466	0.0795527	1.00124	0.394038	0.412356	1.51 [0.59 - 3.90]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204445_s_at	90	0.822222	0.00147365	0.0352134	1.18324	0.198665	0.657925	1.93 [0.71 - 5.27]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1238	50	0.16	0.191954	-	1.26074	0.448735	0.728224	2.07 [0.31 - 13.63]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204446_s_at	138	0.565217	0.0682661	-	0.441222	0.730989	0.0259456	1.03 [0.89 - 1.19]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204445_s_at	138	0.666667	0.133759	-	0.370683	0.37314	0.119143	1.13 [0.87 - 1.46]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214366_s_at	138	0.355072	0.0243763	0.30763	0.602417	0.277472	0.0975415	1.10 [0.92 - 1.31]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213952_s_at	138	0.181159	0.0151047	0.219108	-0.644682	0.192649	-10.1531	0.00 [0.00 - 167.67]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213952_s_at	129	0.162791	0.030376	0.357228	0.905346	0.129152	0.554953	1.74 [0.85 - 3.57]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214366_s_at	129	0.821705	0.0987463	-	-0.61408	0.672276	0.0875892	1.09 [0.73 - 1.64]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204445_s_at	129	0.697674	0.115089	-	0.405512	0.413385	0.203287	1.23 [0.75 - 1.99]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204446_s_at	129	0.728682	0.140826	-	-0.441516	0.929411	0.0152243	1.02 [0.72 - 1.42]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27471	56	0.482143	0.177149	-	-0.47261	0.936023	0.0107084	1.01 [0.78 - 1.31]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6911	56	0.839286	0.156124	-	-0.737409	0.968434	0.00565675	1.01 [0.76 - 1.33]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27471	56	0.446429	0.193913	-	-0.459206	0.908883	-0.0160766	0.98 [0.75 - 1.30]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6911	56	0.839286	0.153021	-	-0.843408	0.817359	-0.0347046	0.97 [0.72 - 1.30]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214366_s_at	278	0.338129	0.20081	-	0.25907	0.762084	0.0347775	1.04 [0.83 - 1.30]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213952_s_at	278	0.241007	0.229721	-	-0.260241	0.553764	-0.346268	0.71 [0.22 - 2.23]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204446_s_at	278	0.751799	0.04074	0.432705	-0.490686	0.840215	0.0136314	1.01 [0.89 - 1.16]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204445_s_at	278	0.309353	0.134056	-	0.322753	0.856345	0.0307488	1.03 [0.74 - 1.44]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213952_s_at	133	0.827068	0.00233387	0.0513873	0.836085	0.0172691	5.09832	163.75 [2.46 - 10886.60]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214366_s_at	133	0.428571	0.00327105	0.0675329	0.722508	0.072683	0.345408	1.41 [0.97 - 2.06]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204445_s_at	133	0.827068	0.000195383	0.00629797	1.02694	0.000245865	1.14449	3.14 [1.70 - 5.79]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204446_s_at	133	0.383459	0.0435174	0.451128	-0.483783	0.258271	-0.0778083	0.93 [0.81 - 1.06]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6770	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15159	81	0.185185	0.0842191	-	15.3141	0.651032	0.179119	1.20 [0.55 - 2.60]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213952_s_at	185	0.621622	0.0537086	-	-0.333593	0.952366	0.0148326	1.01 [0.62 - 1.65]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214366_s_at	185	0.172973	0.00329013	0.0678491	-0.634589	0.0222701	-0.572918	0.56 [0.35 - 0.92]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204446_s_at	185	0.118919	0.060054	-	-0.446047	0.662614	-0.0436869	0.96 [0.79 - 1.16]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213952_s_at	185	0.605405	0.0721675	-	-0.334907	0.972558	-0.00930548	0.99 [0.58 - 1.68]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204445_s_at	185	0.145946	0.0157627	0.225992	-0.509712	0.203986	-0.351694	0.70 [0.41 - 1.21]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204446_s_at	185	0.118919	0.0262706	0.323839	-0.543142	0.488938	-0.0758672	0.93 [0.75 - 1.15]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214366_s_at	185	0.172973	0.0132132	0.198682	-0.519946	0.0472889	-0.447078	0.64 [0.41 - 0.99]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204445_s_at	185	0.145946	0.00688038	0.121393	-0.595834	0.139488	-0.453271	0.64 [0.35 - 1.16]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P104464	110	0.481818	0.0703103	-	-0.417162	0.185313	-0.144099	0.87 [0.70 - 1.07]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P104464	110	0.7	0.104945	-	-0.598914	0.457887	-0.09441	0.91 [0.71 - 1.17]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214366_s_at	80	0.325	0.0790043	-	-0.77351	0.269719	-0.188468	0.83 [0.59 - 1.16]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204445_s_at	80	0.4	0.144076	-	0.731923	0.765738	0.0769723	1.08 [0.65 - 1.79]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204446_s_at	80	0.5875	0.0468428	0.472319	-0.964103	0.237679	-0.205252	0.81 [0.58 - 1.15]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213952_s_at	80	0.3125	0.0606395	-	-0.815651	0.65044	-0.143097	0.87 [0.47 - 1.61]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1994	281	0.177936	0.00771529	0.132578	-0.463036	0.04893	-0.169173	0.84 [0.71 - 1.00]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:138085	59	0.898305	0.0450964	0.461303	1.24756	0.997688	-0.00282829	1.00 [0.15 - 6.75]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204445_s_at	38	0.105263	0.0428434	0.44672	-1.28829	0.198531	-0.681834	0.51 [0.18 - 1.43]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214366_s_at	38	0.789474	0.0913088	-	-1.57405	0.556723	-0.140414	0.87 [0.54 - 1.39]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213952_s_at	38	0.526316	0.000398024	0.0116554	-1.81533	0.0137504	-1.42269	0.24 [0.08 - 0.75]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204446_s_at	38	0.578947	0.00969792	0.157771	-1.49299	0.378667	-0.170465	0.84 [0.58 - 1.23]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204446_s_at	140	0.107143	0.0586738	-	-0.75717	0.726234	0.0395055	1.04 [0.83 - 1.30]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213952_s_at	140	0.735714	0.101693	-	0.484	0.767675	0.201305	1.22 [0.32 - 4.65]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214366_s_at	140	0.835714	0.133843	-	0.509409	0.564707	0.196092	1.22 [0.62 - 2.37]
GENE	ALOX5	arachidonate 5-lipoxygenase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204445_s_at	140	0.2	2.05865e-05	0.000857248	-1.22516	0.0164014	-1.74062	0.18 [0.04 - 0.73]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207140_at	30	0.566667	0.00383319	0.0766746	1.23992	0.276774	0.908591	2.48 [0.48 - 12.76]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211618_s_at	30	0.766667	0.215136	-	0.554974	0.622975	0.556849	1.75 [0.19 - 16.07]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1752669	165	0.127273	0.00806514	0.137156	-0.783071	0.422267	-0.686921	0.50 [0.09 - 2.69]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1752669	165	0.563636	0.06093	-	-0.721596	0.169344	-1.87958	0.15 [0.01 - 2.23]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211618_s_at	163	0.539877	0.120704	-	0.305163	0.91641	0.0639065	1.07 [0.32 - 3.52]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207140_at	163	0.668712	0.0419905	0.441084	-0.439335	0.183979	-0.748285	0.47 [0.16 - 1.43]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207140_at	79	0.189873	0.00232734	0.0512701	-0.975094	0.016996	-1.87487	0.15 [0.03 - 0.72]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211618_s_at	79	0.177215	0.0904153	-	-0.596569	0.515697	-0.546303	0.58 [0.11 - 3.01]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211618_s_at	58	0.155172	0.0189241	0.257655	0.930123	0.209949	0.192801	1.21 [0.90 - 1.64]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207140_at	58	0.155172	0.0314629	0.365702	0.861337	0.426913	0.131014	1.14 [0.83 - 1.57]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211618_s_at	34	0.470588	0.296283	-	0.400968	0.896916	0.0495807	1.05 [0.50 - 2.22]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207140_at	34	0.852941	0.208203	-	-0.755049	0.600265	-0.302808	0.74 [0.24 - 2.29]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211618_s_at	158	0.481013	0.0617732	-	-0.433698	0.554681	-0.487289	0.61 [0.12 - 3.09]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207140_at	158	0.265823	0.00064551	0.0176136	1.14884	0.00759388	2.09137	8.10 [1.74 - 37.59]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211618_s_at	53	0.150943	0.0617045	-	1.28032	0.165773	0.580685	1.79 [0.79 - 4.06]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211618_s_at	53	0.150943	0.0307843	0.360428	1.44801	0.27983	0.428397	1.53 [0.71 - 3.34]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207140_at	53	0.584906	0.00269576	0.0577738	1.06747	0.306883	0.495982	1.64 [0.63 - 4.25]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207140_at	53	0.509434	0.00528813	0.0989018	0.955628	0.412721	0.374833	1.45 [0.59 - 3.57]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207140_at	180	0.127778	0.105909	-	0.561482	0.524213	0.276261	1.32 [0.56 - 3.08]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211618_s_at	180	0.366667	0.00163215	0.038319	0.748169	0.00532819	0.508329	1.66 [1.16 - 2.38]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207140_at	559	0.554562	0.00652961	0.116577	-0.568611	0.0108139	-0.664295	0.51 [0.31 - 0.86]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211618_s_at	559	0.13059	0.000352428	0.0104977	-0.826345	0.0419294	-0.286369	0.75 [0.57 - 0.99]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211618_s_at	77	0.168831	0.0327271	0.375381	0.888228	0.99206	-0.00227926	1.00 [0.64 - 1.56]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207140_at	77	0.753247	0.325074	-	0.280135	0.53175	0.303399	1.35 [0.52 - 3.51]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207140_at	70	0.585714	0.166038	-	0.366325	0.489292	0.449755	1.57 [0.44 - 5.61]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211618_s_at	70	0.742857	0.0224572	0.290634	0.655255	0.0635579	1.64253	5.17 [0.91 - 29.31]
GENE	ALPI	alkaline phosphatase, intestinal	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33523_at	50	0.54	0.0442737	0.456028	-0.701633	0.148198	-1.01153	0.36 [0.09 - 1.43]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207140_at	74	0.364865	0.0226953	0.292777	0.716113	0.0835968	0.84961	2.34 [0.89 - 6.12]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211618_s_at	74	0.459459	0.156329	-	0.415955	0.518061	0.210014	1.23 [0.65 - 2.33]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211618_s_at	67	0.537313	0.239384	-	-0.837267	0.976404	0.0593332	1.06 [0.02 - 54.12]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207140_at	67	0.597015	0.0743852	-	-1.68606	0.813835	-0.483998	0.62 [0.01 - 34.62]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207140_at	115	0.634783	0.0696394	-	-1.29177	0.199017	-0.511397	0.60 [0.27 - 1.31]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211618_s_at	115	0.156522	0.166028	-	-0.804822	0.654705	-0.216486	0.81 [0.31 - 2.08]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33523_at	158	0.120253	0.0424287	0.443988	1.79919	0.32385	-0.189418	0.83 [0.57 - 1.21]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33523_at	76	0.736842	0.0631706	-	-1.70855	0.130191	-0.849728	0.43 [0.14 - 1.29]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211618_s_at	204	0.735294	0.0182371	0.25096	0.381132	0.108531	0.124132	1.13 [0.97 - 1.32]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207140_at	204	0.107843	0.0692808	-	-0.417206	0.431242	-0.171587	0.84 [0.55 - 1.29]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207140_at	87	0.482759	0.00143745	0.0344948	1.36125	0.0341548	1.95901	7.09 [1.16 - 43.45]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211618_s_at	87	0.149425	0.224373	-	-0.553105	0.903832	0.0891697	1.09 [0.26 - 4.64]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211618_s_at	87	0.149425	0.224373	-	-0.553105	0.903832	0.0891697	1.09 [0.26 - 4.64]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207140_at	87	0.482759	0.00143745	0.0344948	1.36125	0.0341548	1.95901	7.09 [1.16 - 43.45]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211618_s_at	77	0.883117	0.174359	-	-15.2146	0.937844	-0.113414	0.89 [0.05 - 15.44]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207140_at	77	0.857143	0.0751184	-	1.16553	0.278818	1.60921	5.00 [0.27 - 91.98]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207140_at	77	0.454545	0.0683436	-	1.13842	0.22168	1.57958	4.85 [0.39 - 61.13]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211618_s_at	77	0.792208	0.0677624	-	1.12753	0.925537	0.154702	1.17 [0.05 - 29.93]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211618_s_at	136	0.213235	0.0960982	-	1.55028	0.711532	0.129932	1.14 [0.57 - 2.27]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207140_at	136	0.860294	0.199541	-	-1.24135	0.487266	-0.41238	0.66 [0.21 - 2.12]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211618_s_at	200	0.44	0.0780772	-	0.547965	0.604991	0.123705	1.13 [0.71 - 1.81]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207140_at	200	0.88	0.0143454	0.211026	0.849728	0.157861	0.379515	1.46 [0.86 - 2.47]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9625	60	0.2	0.143433	-	-0.639317	0.596783	-0.472268	0.62 [0.11 - 3.59]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9625	60	0.416667	0.00591229	0.107918	1.19924	0.0101702	2.06422	7.88 [1.63 - 38.03]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	22200	155	0.735484	0.0119105	0.184008	0.737859	0.473076	0.151885	1.16 [0.77 - 1.76]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211618_s_at	286	0.884615	0.00947283	0.154998	-1.127	0.0360378	-0.476656	0.62 [0.40 - 0.97]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207140_at	286	0.541958	0.00204703	0.0461659	-0.617982	0.0795641	-0.541039	0.58 [0.32 - 1.07]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211618_s_at	159	0.672956	0.0108087	0.171165	0.785754	0.18422	0.507938	1.66 [0.79 - 3.52]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207140_at	159	0.465409	0.0223944	0.290068	0.76934	0.272487	0.798296	2.22 [0.53 - 9.25]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207140_at	159	0.899371	0.00222149	0.0493596	1.10303	0.0523516	1.4074	4.09 [0.99 - 16.93]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207140_at	159	0.566038	0.00826174	0.139702	0.992323	0.0923522	1.43593	4.20 [0.79 - 22.38]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211618_s_at	159	0.685535	0.241912	-	0.375607	0.767173	0.122006	1.13 [0.50 - 2.53]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211618_s_at	159	0.232704	0.182198	-	0.703837	0.640703	0.218652	1.24 [0.50 - 3.12]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207140_at	54	0.759259	0.108339	-	-15.4245	0.46586	-1.16614	0.31 [0.01 - 7.16]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211618_s_at	54	0.814815	0.0717097	-	1.24865	0.87737	-0.193062	0.82 [0.07 - 9.58]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211618_s_at	117	0.393162	0.104681	-	-0.626173	0.874196	-0.101666	0.90 [0.26 - 3.18]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211618_s_at	117	0.42735	0.0489392	0.485222	-0.626112	0.533795	-0.365231	0.69 [0.22 - 2.19]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207140_at	117	0.401709	0.0601732	-	0.648406	0.970639	-0.0342799	0.97 [0.16 - 6.00]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207140_at	117	0.102564	0.0876172	-	-0.821953	0.593741	-0.622236	0.54 [0.05 - 5.28]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207140_at	117	0.683761	0.0710827	-	0.698247	0.908444	0.129805	1.14 [0.12 - 10.40]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207140_at	117	0.401709	0.0601732	-	0.648406	0.970639	-0.0342799	0.97 [0.16 - 6.00]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211618_s_at	117	0.42735	0.0489392	0.485222	-0.626112	0.533795	-0.365231	0.69 [0.22 - 2.19]
GENE	ALPI	alkaline phosphatase, intestinal	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211618_s_at	117	0.581197	0.0420834	0.441701	-0.861837	0.545978	-0.432985	0.65 [0.16 - 2.64]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211618_s_at	236	0.309322	0.0309748	0.361915	-0.576005	0.39849	-0.354808	0.70 [0.31 - 1.60]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207140_at	236	0.381356	0.0564962	-	-0.509003	0.970316	-0.0279339	0.97 [0.22 - 4.23]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207140_at	249	0.365462	0.000705083	0.0189827	-0.704344	0.101888	-0.995531	0.37 [0.11 - 1.22]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211618_s_at	249	0.144578	0.120965	-	-0.41591	0.408818	-0.257211	0.77 [0.42 - 1.42]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211618_s_at	125	0.832	0.0155541	0.223821	-2.10161	0.600594	-0.428688	0.65 [0.13 - 3.24]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207140_at	125	0.464	0.232692	-	0.484503	0.53888	0.447323	1.56 [0.38 - 6.51]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211618_s_at	125	0.832	0.0717722	-	-0.740066	0.573286	-0.35537	0.70 [0.20 - 2.41]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207140_at	125	0.744	0.0582713	-	-0.683236	0.542336	-0.341154	0.71 [0.24 - 2.13]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211618_s_at	54	0.148148	0.122469	-	15.3009	0.769116	-0.16983	0.84 [0.27 - 2.62]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207140_at	62	0.387097	0.101663	-	1.00092	0.774377	-0.0792155	0.92 [0.54 - 1.59]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207140_at	54	0.518519	0.156388	-	0.927612	0.825015	-0.0745252	0.93 [0.48 - 1.80]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211618_s_at	62	0.387097	0.0792655	-	1.06737	0.789021	-0.127855	0.88 [0.34 - 2.24]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207140_at	198	0.217172	0.0657511	-	-0.529209	0.815428	-0.0929785	0.91 [0.42 - 1.99]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211618_s_at	198	0.353535	0.170602	-	-0.294103	0.995599	0.000735676	1.00 [0.77 - 1.30]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207140_at	198	0.217172	0.0706102	-	-0.503301	0.92129	-0.0378375	0.96 [0.45 - 2.04]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207140_at	198	0.353535	0.0155517	0.223797	-0.506239	0.454479	-0.236339	0.79 [0.43 - 1.47]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211618_s_at	198	0.353535	0.00292507	0.0617176	-0.739719	0.0715298	-0.302935	0.74 [0.53 - 1.03]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211618_s_at	198	0.353535	0.00214827	0.0480263	-0.800434	0.0669161	-0.335091	0.72 [0.50 - 1.02]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211618_s_at	51	0.117647	4.81847e-05	0.00183461	-2.7788	0.016688	-13.415	0.00 [0.00 - 0.09]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211618_s_at	62	0.145161	0.0366814	0.404494	-1.20767	0.173024	-3.33672	0.04 [0.00 - 4.32]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207140_at	51	0.666667	0.0996955	-	-15.7191	0.639131	-0.638667	0.53 [0.04 - 7.62]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207140_at	62	0.709677	0.0624927	-	-1.72688	0.405409	-0.735913	0.48 [0.08 - 2.71]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207140_at	177	0.372881	0.00245169	0.0534898	-0.812737	0.0863247	-0.990038	0.37 [0.12 - 1.15]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211618_s_at	177	0.112994	0.0981897	-	-0.559704	0.284363	-0.473323	0.62 [0.26 - 1.48]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211618_s_at	145	0.841379	0.119366	-	0.592199	0.906874	0.0751133	1.08 [0.31 - 3.79]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207140_at	177	0.372881	0.0111864	0.175615	-0.598187	0.107605	-0.815844	0.44 [0.16 - 1.19]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207140_at	145	0.4	0.115667	-	-0.519146	0.971218	-0.0267783	0.97 [0.23 - 4.17]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211618_s_at	177	0.101695	0.0148522	0.216437	-0.867587	0.224901	-0.618497	0.54 [0.20 - 1.46]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211618_s_at	226	0.730088	0.0433277	0.449891	-0.762742	0.921385	-0.0137686	0.99 [0.75 - 1.30]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207140_at	226	0.402655	0.156573	-	0.445787	0.445879	0.157252	1.17 [0.78 - 1.75]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211618_s_at	55	0.127273	0.0706237	-	15.2677	0.0876039	0.519324	1.68 [0.93 - 3.05]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211618_s_at	49	0.795918	0.105027	-	0.961352	0.256505	1.06357	2.90 [0.46 - 18.19]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207140_at	55	0.8	0.0760324	-	-1.59507	0.285686	0.29959	1.35 [0.78 - 2.34]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207140_at	55	0.163636	0.137988	-	-0.749847	0.175503	0.38598	1.47 [0.84 - 2.57]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207140_at	49	0.795918	0.172217	-	-1.3282	0.931091	0.081334	1.08 [0.17 - 6.85]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211618_s_at	55	0.254545	0.125211	-	0.928333	0.0161163	0.715145	2.04 [1.14 - 3.66]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	626967	34	0.205882	0.41698	-	0.501821	0.591451	0.303855	1.36 [0.45 - 4.11]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207140_at	63	0.190476	0.00114534	0.0285512	-1.15255	0.0561565	-21.9225	0.00 [0.00 - 1.78]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211618_s_at	63	0.174603	3.51514e-05	0.00138481	-1.4849	0.0450392	-22.1857	0.00 [0.00 - 0.61]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g178443_3p_s_at	28	0.285714	0.0191692	0.260019	-1.31879	0.217374	-13.6335	0.00 [0.00 - 3069.30]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13787191_3p_at	28	0.107143	0.12219	-	-1.16158	0.764643	0.356345	1.43 [0.14 - 14.72]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13787191_3p_x_at	28	0.535714	0.163673	-	-0.785136	0.728499	-0.973623	0.38 [0.00 - 92.19]
GENE	ALPI	alkaline phosphatase, intestinal	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211618_s_at	82	0.597561	0.0286101	0.343142	-0.804599	0.655638	-0.0931098	0.91 [0.61 - 1.37]
GENE	ALPI	alkaline phosphatase, intestinal	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211618_s_at	79	0.455696	0.0567762	-	-0.495004	0.410485	-0.223012	0.80 [0.47 - 1.36]
GENE	ALPI	alkaline phosphatase, intestinal	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211618_s_at	104	0.480769	0.0295499	0.350689	0.739553	0.718035	0.127237	1.14 [0.57 - 2.27]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P337658	117	0.264957	1.11286e-05	0.000492203	-1.22482	0.00419487	-0.670605	0.51 [0.32 - 0.81]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211618_s_at	204	0.882353	0.00581634	0.106549	1.13424	0.606114	0.126352	1.13 [0.70 - 1.83]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211618_s_at	204	0.877451	0.000349706	0.0104278	1.11683	0.161503	0.261049	1.30 [0.90 - 1.87]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207140_at	204	0.789216	0.145214	-	-0.860847	0.397815	-0.576165	0.56 [0.15 - 2.14]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207140_at	204	0.382353	0.0853864	-	-0.464507	0.219502	-0.62437	0.54 [0.20 - 1.45]
GENE	ALPI	alkaline phosphatase, intestinal	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211618_s_at	178	0.61236	0.192827	-	-0.267949	0.280608	-0.168043	0.85 [0.62 - 1.15]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211618_s_at	111	0.765766	0.428464	-	-0.249175	0.788875	0.0550322	1.06 [0.71 - 1.58]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207140_at	111	0.846847	0.0746598	-	-0.754412	0.723484	0.128273	1.14 [0.56 - 2.31]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207140_at	90	0.177778	0.0693959	-	-0.738941	0.797232	0.149901	1.16 [0.37 - 3.65]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211618_s_at	90	0.111111	0.121373	-	1.07473	0.528179	0.449725	1.57 [0.39 - 6.34]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211618_s_at	90	0.122222	0.237603	-	0.841116	0.861283	0.144062	1.15 [0.23 - 5.81]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207140_at	90	0.177778	0.160895	-	-0.529599	0.897035	0.0665892	1.07 [0.39 - 2.93]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211618_s_at	138	0.246377	0.00542567	0.100913	-0.685258	0.0440264	-13.9245	0.00 [0.00 - 0.69]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207140_at	138	0.398551	0.0118024	0.182766	-0.599556	0.163015	-8.19532	0.00 [0.00 - 27.64]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211618_s_at	129	0.193798	0.0269	0.329107	0.857752	0.379199	0.272921	1.31 [0.72 - 2.41]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207140_at	129	0.852713	0.0472638	0.474937	0.627469	0.773173	-0.145703	0.86 [0.32 - 2.33]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30871	56	0.107143	0.0152391	0.220523	-1.07387	0.132763	-0.901457	0.41 [0.13 - 1.32]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33490	56	0.517857	0.138281	-	0.524896	0.502974	0.258355	1.29 [0.61 - 2.76]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41859	56	0.375	0.0685217	-	-0.619862	0.370874	-0.477852	0.62 [0.22 - 1.77]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30871	56	0.5	0.0346224	0.389546	-0.805425	0.0605319	-1.21694	0.30 [0.08 - 1.06]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34627	56	0.625	0.103822	-	-0.607546	0.359034	-0.39456	0.67 [0.29 - 1.57]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41859	56	0.375	0.0831723	-	-0.617387	0.216203	-0.711241	0.49 [0.16 - 1.52]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33490	56	0.446429	0.160052	-	0.487826	0.293329	0.445294	1.56 [0.68 - 3.58]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34627	56	0.75	0.0849771	-	-1.00432	0.266876	-0.523208	0.59 [0.24 - 1.49]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207140_at	278	0.208633	0.00376775	0.0756284	-0.620371	0.0476602	-0.837539	0.43 [0.19 - 0.99]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211618_s_at	278	0.201439	0.0954135	-	0.446528	0.827485	-0.0701645	0.93 [0.50 - 1.75]
GENE	ALPI	alkaline phosphatase, intestinal	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207140_at	133	0.646617	0.000863993	0.0225382	0.782118	0.0163859	2.05558	7.81 [1.46 - 41.85]
GENE	ALPI	alkaline phosphatase, intestinal	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211618_s_at	133	0.87218	0.00526754	0.0985994	0.847513	0.0375525	2.17776	8.83 [1.13 - 68.73]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17239	81	0.851852	9.02101e-05	0.00319821	2.00683	0.000386299	1.91924	6.82 [2.36 - 19.67]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4167	81	0.864198	0.0864559	-	0.965389	0.452882	-0.208363	0.81 [0.47 - 1.40]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211618_s_at	185	0.275676	0.0011441	0.0285254	-0.605553	0.036309	-1.08914	0.34 [0.12 - 0.93]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207140_at	185	0.378378	0.00242526	0.0530201	-0.532925	0.0226681	-0.679571	0.51 [0.28 - 0.91]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211618_s_at	185	0.275676	0.000689555	0.0186279	-0.589345	0.0217202	-1.09057	0.34 [0.13 - 0.85]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207140_at	185	0.178378	0.0031108	0.0648586	-0.587266	0.031074	-0.573186	0.56 [0.33 - 0.95]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P337658	110	0.872727	0.0397149	0.425729	0.834967	0.253274	0.348488	1.42 [0.78 - 2.58]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P337658	110	0.481818	0.0605165	-	0.435092	0.430177	0.173395	1.19 [0.77 - 1.83]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211618_s_at	80	0.325	0.00767626	0.132063	-1.1345	0.0684899	-0.56653	0.57 [0.31 - 1.04]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207140_at	80	0.1875	0.0265191	0.325926	1.95731	0.34075	0.391639	1.48 [0.66 - 3.31]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_2329	281	0.651246	0.237268	-	0.172383	0.886929	0.00871037	1.01 [0.89 - 1.14]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211618_s_at	38	0.289474	0.0194429	0.262646	-1.09207	0.0783749	-0.594418	0.55 [0.28 - 1.07]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207140_at	38	0.815789	0.0885357	-	0.996934	0.263055	0.297638	1.35 [0.80 - 2.27]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211618_s_at	140	0.178571	0.0679703	-	-0.585084	0.271964	-1.49634	0.22 [0.02 - 3.23]
GENE	ALPI	alkaline phosphatase, intestinal	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207140_at	140	0.435714	0.00521397	0.0978116	-0.798095	0.0432393	-1.61906	0.20 [0.04 - 0.95]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215783_s_at	30	0.8	0.30311	-	-0.561287	0.835756	0.125664	1.13 [0.35 - 3.72]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1701603	165	0.333333	0.0060805	0.110302	-0.6535	0.228059	-0.198143	0.82 [0.59 - 1.13]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1701603	165	0.115152	0.0174935	0.243602	-0.978075	0.256216	-0.276646	0.76 [0.47 - 1.22]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215783_s_at	163	0.846626	0.0239631	0.304022	-0.736355	0.363628	-0.345188	0.71 [0.34 - 1.49]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215783_s_at	79	0.860759	0.183425	-	0.489505	0.62159	-0.213501	0.81 [0.35 - 1.89]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1557924_s_at	79	0.873418	0.0891051	-	-0.864214	0.355843	-0.745348	0.47 [0.10 - 2.31]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215783_s_at	58	0.275862	0.0198957	0.266959	0.729627	0.314167	0.169215	1.18 [0.85 - 1.65]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215783_s_at	34	0.676471	0.255206	-	-0.505412	0.457164	0.290683	1.34 [0.62 - 2.88]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215783_s_at	158	0.835443	0.0118149	0.18291	-1.02733	0.147971	-0.528537	0.59 [0.29 - 1.21]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215783_s_at	53	0.132075	0.391299	-	-0.42124	0.520402	-0.216345	0.81 [0.42 - 1.56]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215783_s_at	53	0.584906	0.27799	-	0.371411	0.73917	-0.0983403	0.91 [0.51 - 1.62]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215783_s_at	180	0.172222	0.0961294	-	0.511836	0.221873	0.146443	1.16 [0.92 - 1.46]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1557924_s_at	559	0.125224	0.100025	-	0.597487	0.982707	-0.00345753	1.00 [0.73 - 1.36]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215783_s_at	559	0.815742	0.0443507	0.456524	-0.60942	0.619553	-0.0756149	0.93 [0.69 - 1.25]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215783_s_at	77	0.246753	0.0117821	0.182533	-0.741513	0.0564637	-0.478501	0.62 [0.38 - 1.01]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1557924_s_at	70	0.171429	0.00423097	0.0829408	-0.924254	0.580461	-0.71291	0.49 [0.04 - 6.14]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215783_s_at	70	0.185714	0.00434488	0.084707	-0.936403	0.942614	-0.049479	0.95 [0.25 - 3.66]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36623_at	50	0.56	0.014381	0.211408	-0.886462	0.744449	-0.149179	0.86 [0.35 - 2.11]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215783_s_at	74	0.581081	4.94375e-05	0.00187699	-1.26198	0.023256	-0.785226	0.46 [0.23 - 0.90]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215783_s_at	67	0.731343	0.0677666	-	-15.5272	0.212462	-0.409613	0.66 [0.35 - 1.26]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1557924_s_at	67	0.791045	0.109058	-	-15.4093	0.283031	-0.460564	0.63 [0.27 - 1.46]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1557924_s_at	115	0.504348	0.0205317	0.27295	1.39294	0.270991	0.649515	1.91 [0.60 - 6.09]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215783_s_at	115	0.695652	0.164909	-	-1.01748	0.311304	-1.04454	0.35 [0.05 - 2.66]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36623_at	158	0.563291	0.0271365	0.331072	0.62438	0.376653	0.144592	1.16 [0.84 - 1.59]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36623_at	76	0.131579	0.0694758	-	-1.02166	0.518602	-0.195979	0.82 [0.45 - 1.49]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215783_s_at	204	0.598039	0.0227795	0.293532	0.331276	0.256655	0.128467	1.14 [0.91 - 1.42]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1557924_s_at	204	0.181373	0.0933314	-	-0.311689	0.787651	-0.0182643	0.98 [0.86 - 1.12]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1557924_s_at	87	0.425287	0.0456422	0.464772	0.84727	0.323448	1.32374	3.76 [0.27 - 52.01]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215783_s_at	87	0.126437	0.134598	-	-0.677168	0.947262	-0.0372584	0.96 [0.32 - 2.91]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1557924_s_at	87	0.425287	0.0456422	0.464772	0.84727	0.323448	1.32374	3.76 [0.27 - 52.01]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215783_s_at	87	0.126437	0.134598	-	-0.677168	0.947262	-0.0372584	0.96 [0.32 - 2.91]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1557924_s_at	77	0.883117	0.16088	-	0.893675	0.728712	0.607884	1.84 [0.06 - 57.00]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215783_s_at	77	0.116883	0.161841	-	15.2268	0.782482	0.184676	1.20 [0.32 - 4.46]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1557924_s_at	77	0.428571	0.211244	-	-0.787033	0.425975	-1.688	0.18 [0.00 - 11.80]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215783_s_at	77	0.116883	0.224045	-	15.2222	0.963039	0.036833	1.04 [0.22 - 4.93]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215783_s_at	136	0.860294	0.169411	-	-1.31593	0.372611	-0.257258	0.77 [0.44 - 1.36]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215783_s_at	200	0.285	0.07021	-	-0.541319	0.840231	0.0661837	1.07 [0.56 - 2.03]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12859	60	0.766667	0.0048352	0.0921775	-1.8276	0.0654268	-0.999351	0.37 [0.13 - 1.07]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12859	60	0.8	0.0369803	0.406626	-1.41043	0.401142	-0.410267	0.66 [0.25 - 1.73]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	17533	155	0.645161	0.0306203	0.359145	0.592419	0.394345	0.193443	1.21 [0.78 - 1.89]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215783_s_at	286	0.576923	0.000389836	0.0114492	-0.740182	0.0790095	-0.311235	0.73 [0.52 - 1.04]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215783_s_at	159	0.421384	0.0981135	-	-0.518139	0.262326	-0.357974	0.70 [0.37 - 1.31]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215783_s_at	159	0.767296	0.0668706	-	-0.85008	0.17372	-0.420965	0.66 [0.36 - 1.20]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215783_s_at	159	0.572327	0.246125	-	-0.449499	0.960398	-0.019827	0.98 [0.45 - 2.14]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215783_s_at	54	0.851852	0.204229	-	-15.3255	0.611597	-0.494599	0.61 [0.09 - 4.11]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215783_s_at	117	0.880342	0.0619922	-	-1.26976	0.21908	-0.473027	0.62 [0.29 - 1.32]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215783_s_at	117	0.871795	0.0307341	0.360036	-15.2679	0.382869	-0.401641	0.67 [0.27 - 1.65]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215783_s_at	117	0.880342	0.0619922	-	-1.26976	0.21908	-0.473027	0.62 [0.29 - 1.32]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215783_s_at	117	0.871795	0.0244106	0.307929	-15.2684	0.138749	-0.722393	0.49 [0.19 - 1.26]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215783_s_at	236	0.101695	0.0267745	0.328062	-0.761077	0.247357	-0.388868	0.68 [0.35 - 1.31]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215783_s_at	249	0.100402	0.00062314	0.0170939	-0.915926	0.0627641	-0.529281	0.59 [0.34 - 1.03]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215783_s_at	62	0.177419	0.0329548	0.377104	-1.11221	0.430205	-0.152289	0.86 [0.59 - 1.25]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215783_s_at	125	0.288	0.0335863	0.381852	-0.788035	0.131291	-0.566595	0.57 [0.27 - 1.18]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215783_s_at	125	0.344	0.113836	-	-0.454404	0.30671	-0.28306	0.75 [0.44 - 1.30]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215783_s_at	54	0.222222	0.0178775	0.247417	-1.36818	0.482837	-0.16335	0.85 [0.54 - 1.34]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215783_s_at	198	0.50505	0.00827933	0.139929	0.71668	0.255492	0.160092	1.17 [0.89 - 1.55]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215783_s_at	198	0.525253	0.00341226	0.0698632	0.622983	0.130805	0.174423	1.19 [0.95 - 1.49]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215783_s_at	198	0.525253	0.0030303	0.0635029	0.769229	0.151517	0.19444	1.21 [0.93 - 1.58]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215783_s_at	51	0.705882	0.122315	-	1.31474	0.984703	-0.0429239	0.96 [0.01 - 77.10]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215783_s_at	62	0.580645	0.253454	-	0.657198	0.938177	0.113941	1.12 [0.06 - 19.95]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1557924_s_at	177	0.231638	0.128852	-	-0.449813	0.218107	-1.32904	0.26 [0.03 - 2.19]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215783_s_at	177	0.853107	0.161145	-	0.417304	0.992802	0.00530703	1.01 [0.32 - 3.18]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1557924_s_at	177	0.898305	0.0840853	-	-0.861851	0.121154	-1.4577	0.23 [0.04 - 1.47]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215783_s_at	145	0.882759	0.021475	0.281696	0.896831	0.268654	0.890507	2.44 [0.50 - 11.80]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1557924_s_at	145	0.310345	0.0326505	0.374799	-0.703137	0.583136	-0.698763	0.50 [0.04 - 6.03]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215783_s_at	177	0.853107	0.0888271	-	0.554965	0.536505	0.41299	1.51 [0.41 - 5.60]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1557924_s_at	226	0.743363	0.0725029	-	0.524543	0.520619	0.0930077	1.10 [0.83 - 1.46]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215783_s_at	226	0.818584	0.0166255	0.234858	0.713642	0.0988736	0.453088	1.57 [0.92 - 2.69]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215783_s_at	55	0.327273	0.0190445	0.258818	-1.10054	0.0818922	-1.53475	0.22 [0.04 - 1.21]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215783_s_at	49	0.265306	0.00041103	0.0119816	-1.84907	0.0539478	-2.94645	0.05 [0.00 - 1.05]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1557924_s_at	55	0.763636	0.202053	-	0.621202	0.344489	-1.36844	0.25 [0.01 - 4.34]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1557924_s_at	49	0.795918	0.0949087	-	0.945354	0.383281	-1.19761	0.30 [0.02 - 4.46]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215783_s_at	55	0.327273	0.00039139	0.0114884	-1.49786	0.0464877	-1.70069	0.18 [0.03 - 0.97]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1557924_s_at	55	0.763636	0.00962704	0.1569	1.11222	0.975323	0.0360775	1.04 [0.11 - 10.20]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1557924_s_at	63	0.126984	2.12837e-07	1.29804e-05	-1.99426	0.504372	-1.70781	0.18 [0.00 - 27.27]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215783_s_at	63	0.31746	0.0145122	0.212814	-0.819441	0.846026	0.137449	1.15 [0.29 - 4.59]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.250769.1.S1_3p_a_at	28	0.357143	0.217816	-	-0.692907	0.679853	-0.721908	0.49 [0.02 - 14.98]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.435999.1.S1_3p_s_at	28	0.25	0.0468457	0.472336	-1.13531	0.449542	-2.87185	0.06 [0.00 - 96.73]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215783_s_at	82	0.109756	0.0333329	0.379952	-0.922355	0.486852	-0.101193	0.90 [0.68 - 1.20]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215783_s_at	79	0.594937	0.10141	-	0.422123	0.345739	0.11042	1.12 [0.89 - 1.40]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M24439_at	86	0.244186	0.0258859	0.320591	-0.893208	0.0210666	-0.879584	0.41 [0.20 - 0.88]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215783_s_at	104	0.307692	0.033314	0.37981	-0.693301	0.162204	-0.185496	0.83 [0.64 - 1.08]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P97046	117	0.222222	0.00598199	0.108908	-0.820897	0.124829	-0.163671	0.85 [0.69 - 1.05]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215783_s_at	204	0.357843	0.000123869	0.00422771	-1.37695	0.0023169	-0.632788	0.53 [0.35 - 0.80]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215783_s_at	204	0.357843	9.24496e-07	5.06133e-05	-1.28424	6.39488e-06	-0.699224	0.50 [0.37 - 0.67]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1557924_s_at	204	0.627451	0.00990069	0.160252	-1.19222	0.0331807	-0.434094	0.65 [0.43 - 0.97]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1557924_s_at	204	0.220588	0.0406759	0.432272	-0.601919	0.18595	-0.197297	0.82 [0.61 - 1.10]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215783_s_at	178	0.679775	0.0015921	0.0375404	-0.743269	0.0367405	-0.165921	0.85 [0.72 - 0.99]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300011148	41	0.560976	0.312824	-	-0.428683	0.825969	-0.100124	0.90 [0.37 - 2.21]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215783_s_at	111	0.234234	0.0427143	0.445871	-0.580274	0.684071	0.0652607	1.07 [0.78 - 1.46]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1557924_s_at	111	0.567568	0.00705014	0.123698	0.703724	0.146428	0.179936	1.20 [0.94 - 1.53]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215783_s_at	90	0.344444	0.00462286	0.0889678	-0.894578	0.240089	-0.253137	0.78 [0.51 - 1.18]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215783_s_at	90	0.111111	0.000915427	0.0236622	-1.34627	0.248921	-0.293198	0.75 [0.45 - 1.23]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1557924_s_at	138	0.76087	0.0798679	-	0.455725	0.360951	0.0860005	1.09 [0.91 - 1.31]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215783_s_at	138	0.101449	0.0404633	0.430832	1.14723	0.22852	0.0795217	1.08 [0.95 - 1.23]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215783_s_at	129	0.100775	0.00019189	0.00619976	-1.18521	0.126845	-0.316502	0.73 [0.49 - 1.09]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42318	56	0.589286	0.0452607	0.462351	-0.786512	0.199701	-0.280931	0.76 [0.49 - 1.16]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7097	56	0.553571	0.0199288	0.267272	-0.89279	0.174523	-0.672029	0.51 [0.19 - 1.35]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21934	56	0.732143	0.0612328	-	-0.845921	0.164667	-0.520187	0.59 [0.29 - 1.24]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42318	56	0.589286	0.0636248	-	-0.735336	0.147288	-0.332153	0.72 [0.46 - 1.12]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7097	56	0.553571	0.0123238	0.188721	-0.998948	0.0974945	-0.873741	0.42 [0.15 - 1.17]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20895	56	0.607143	0.0134258	0.201027	-0.996882	0.218061	-0.197757	0.82 [0.60 - 1.12]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21934	56	0.732143	0.0538363	-	-0.920099	0.11138	-0.648868	0.52 [0.24 - 1.16]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20895	56	0.607143	0.0205622	0.273235	-0.93979	0.151916	-0.244299	0.78 [0.56 - 1.09]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1557924_s_at	278	0.841727	0.0815554	-	-0.494376	0.0914514	-0.28489	0.75 [0.54 - 1.05]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215783_s_at	278	0.794964	0.0790932	-	-0.43988	0.366244	-0.0706211	0.93 [0.80 - 1.09]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215783_s_at	133	0.105263	0.125474	-	0.650275	0.486871	0.0468524	1.05 [0.92 - 1.20]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14157	81	0.111111	0.139072	-	15.2217	0.665142	0.14979	1.16 [0.59 - 2.29]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215783_s_at	185	0.859459	0.146128	-	-0.379387	0.433629	-0.0950281	0.91 [0.72 - 1.15]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215783_s_at	185	0.859459	0.158423	-	-0.328021	0.442842	-0.0836806	0.92 [0.74 - 1.14]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P353619	110	0.772727	0.066569	-	-0.706238	0.322773	-0.221351	0.80 [0.52 - 1.24]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P97046	110	0.709091	0.0894189	-	-0.599735	0.520128	-0.130137	0.88 [0.59 - 1.31]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P353619	110	0.181818	0.190975	-	0.442004	0.583012	0.0941696	1.10 [0.79 - 1.54]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P97046	110	0.2	0.0496091	0.489274	0.652858	0.41803	0.127224	1.14 [0.83 - 1.55]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215783_s_at	80	0.825	0.0356446	0.397023	-15.3107	0.955927	0.0105902	1.01 [0.69 - 1.47]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_0648	281	0.718861	0.0123427	0.188935	0.376241	0.792963	0.0198281	1.02 [0.88 - 1.18]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:238794	59	0.237288	0.0254841	0.317174	15.4361	0.550177	0.265678	1.30 [0.55 - 3.12]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215783_s_at	38	0.236842	0.165919	-	0.862331	0.428365	0.28489	1.33 [0.66 - 2.69]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1557924_s_at	38	0.184211	0.112178	-	-0.934645	0.606406	-0.206881	0.81 [0.37 - 1.79]
GENE	ALPL	alkaline phosphatase, liver/bone/kidney	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215783_s_at	140	0.778571	0.0858968	-	0.555548	0.469207	0.0999318	1.11 [0.84 - 1.45]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALPP	alkaline phosphatase, placental	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211619_s_at	30	0.866667	7.74568e-05	0.00279537	2.12315	0.0292783	1.25333	3.50 [1.13 - 10.81]
GENE	ALPP	alkaline phosphatase, placental	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204664_at	30	0.466667	0.00262791	0.0565921	1.31178	0.00704356	1.20269	3.33 [1.39 - 7.98]
GENE	ALPP	alkaline phosphatase, placental	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1693789	165	0.745455	0.0337215	0.382863	0.531728	0.181866	0.392815	1.48 [0.83 - 2.64]
GENE	ALPP	alkaline phosphatase, placental	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1693789	165	0.836364	0.0238735	0.303235	0.838556	0.54489	0.254548	1.29 [0.57 - 2.94]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204664_at	163	0.546012	0.0793375	-	-0.350156	0.915601	-0.0774013	0.93 [0.22 - 3.87]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211619_s_at	163	0.846626	0.160439	-	0.361492	0.782561	0.177373	1.19 [0.34 - 4.21]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204664_at	79	0.113924	0.0146365	0.214142	-0.927135	0.258246	-0.995999	0.37 [0.07 - 2.08]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211619_s_at	79	0.126582	0.049028	0.485761	1.1245	0.960755	0.0370071	1.04 [0.24 - 4.53]
GENE	ALPP	alkaline phosphatase, placental	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211619_s_at	58	0.810345	0.0547076	-	0.676645	0.0783319	0.219241	1.25 [0.98 - 1.59]
GENE	ALPP	alkaline phosphatase, placental	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204664_at	58	0.327586	0.0108172	0.171265	0.764045	0.0759206	0.320826	1.38 [0.97 - 1.96]
GENE	ALPP	alkaline phosphatase, placental	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204664_at	34	0.852941	0.0266919	0.327372	-1.5319	0.0349497	-1.09105	0.34 [0.12 - 0.93]
GENE	ALPP	alkaline phosphatase, placental	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211619_s_at	34	0.117647	0.054345	-	1.32791	0.179161	0.237586	1.27 [0.90 - 1.79]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211619_s_at	158	0.78481	0.0958283	-	0.417405	0.189283	0.950536	2.59 [0.63 - 10.70]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204664_at	158	0.183544	0.00462568	0.0890107	1.07321	0.089912	1.56653	4.79 [0.78 - 29.28]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204664_at	53	0.603774	0.00971345	0.157962	0.919103	0.629002	0.188978	1.21 [0.56 - 2.60]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211619_s_at	53	0.716981	0.123292	-	-0.691136	0.939576	0.01631	1.02 [0.67 - 1.55]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204664_at	53	0.603774	0.033463	0.380928	0.716609	0.759603	0.123476	1.13 [0.51 - 2.50]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211619_s_at	53	0.320755	0.0339262	0.38439	0.876692	0.532839	0.126316	1.13 [0.76 - 1.69]
GENE	ALPP	alkaline phosphatase, placental	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211619_s_at	180	0.755556	0.0667937	-	-0.478582	0.681598	-0.0299598	0.97 [0.84 - 1.12]
GENE	ALPP	alkaline phosphatase, placental	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204664_at	180	0.211111	0.012023	0.185297	0.717658	0.119878	0.359429	1.43 [0.91 - 2.25]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204664_at	559	0.744186	0.000644661	0.017594	-1.08419	0.00111034	-0.717395	0.49 [0.32 - 0.75]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211619_s_at	559	0.161002	0.172501	-	-0.373481	0.762428	-0.0324789	0.97 [0.78 - 1.19]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204664_at	77	0.363636	0.00130674	0.0318685	-0.869766	0.027952	-0.891513	0.41 [0.19 - 0.91]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211619_s_at	77	0.116883	0.088675	-	-0.648591	0.279139	0.190213	1.21 [0.86 - 1.71]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211619_s_at	70	0.114286	0.140227	-	-0.559399	0.876587	0.105065	1.11 [0.29 - 4.18]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204664_at	70	0.728571	0.0720648	-	0.512725	0.279927	0.600005	1.82 [0.61 - 5.41]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204664_at	74	0.432432	0.32958	-	0.287101	0.977446	-0.0133176	0.99 [0.39 - 2.48]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211619_s_at	74	0.121622	0.120292	-	-0.596845	0.857931	0.0315752	1.03 [0.73 - 1.46]
GENE	ALPP	alkaline phosphatase, placental	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211619_s_at	67	0.880597	0.00918328	0.151399	2.09314	0.223983	2.72926	15.32 [0.19 - 1246.86]
GENE	ALPP	alkaline phosphatase, placental	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204664_at	67	0.283582	0.16163	-	-0.920366	0.821983	-0.538789	0.58 [0.01 - 63.74]
GENE	ALPP	alkaline phosphatase, placental	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211619_s_at	115	0.373913	0.0948308	-	-0.872368	0.23655	-0.50227	0.61 [0.26 - 1.39]
GENE	ALPP	alkaline phosphatase, placental	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204664_at	115	0.521739	0.129469	-	-0.871746	0.418444	-0.290403	0.75 [0.37 - 1.51]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211619_s_at	204	0.656863	0.00357947	0.0725925	0.434026	0.221357	0.0986778	1.10 [0.94 - 1.29]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204664_at	204	0.539216	0.00411227	0.0810872	-0.409671	0.728237	-0.0604405	0.94 [0.67 - 1.32]
GENE	ALPP	alkaline phosphatase, placental	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204664_at	87	0.528736	0.0701689	-	0.687693	0.691453	0.270221	1.31 [0.34 - 4.98]
GENE	ALPP	alkaline phosphatase, placental	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211619_s_at	87	0.436782	0.0121242	0.186452	-0.939916	0.261071	-0.70928	0.49 [0.14 - 1.70]
GENE	ALPP	alkaline phosphatase, placental	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211619_s_at	87	0.436782	0.0121242	0.186452	-0.939916	0.261071	-0.70928	0.49 [0.14 - 1.70]
GENE	ALPP	alkaline phosphatase, placental	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204664_at	87	0.528736	0.0701689	-	0.687693	0.691453	0.270221	1.31 [0.34 - 4.98]
GENE	ALPP	alkaline phosphatase, placental	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211619_s_at	77	0.727273	0.329799	-	-0.733329	0.542792	-0.731081	0.48 [0.05 - 5.07]
GENE	ALPP	alkaline phosphatase, placental	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204664_at	77	0.103896	0.0142817	0.210341	-1.5396	0.301077	-1.23714	0.29 [0.03 - 3.03]
GENE	ALPP	alkaline phosphatase, placental	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204664_at	77	0.103896	0.0728383	-	-1.12297	0.855608	0.133662	1.14 [0.27 - 4.82]
GENE	ALPP	alkaline phosphatase, placental	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211619_s_at	77	0.467532	0.151278	-	-0.954995	0.232467	-1.70806	0.18 [0.01 - 2.99]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204664_at	136	0.463235	0.0637027	-	0.88731	0.673855	0.159708	1.17 [0.56 - 2.47]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211619_s_at	136	0.882353	0.0719137	-	-15.2667	0.284139	-0.292689	0.75 [0.44 - 1.27]
GENE	ALPP	alkaline phosphatase, placental	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204664_at	200	0.8	0.220683	-	0.40925	0.426152	0.215305	1.24 [0.73 - 2.11]
GENE	ALPP	alkaline phosphatase, placental	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211619_s_at	200	0.415	0.000905307	0.023442	1.16655	0.0116912	0.394774	1.48 [1.09 - 2.02]
GENE	ALPP	alkaline phosphatase, placental	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7744	60	0.25	0.0130704	0.197098	-0.951202	0.171117	-1.35808	0.26 [0.04 - 1.80]
GENE	ALPP	alkaline phosphatase, placental	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7744	60	0.483333	0.000648242	0.0176769	1.34651	0.0049708	1.99641	7.36 [1.83 - 29.65]
GENE	ALPP	alkaline phosphatase, placental	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	19582	155	0.16129	2.97332e-05	0.00119224	-1.15452	0.038825	-0.210189	0.81 [0.66 - 0.99]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204664_at	286	0.538462	0.0379055	0.413172	-0.40846	0.914053	0.0241318	1.02 [0.66 - 1.59]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211619_s_at	286	0.115385	7.81568e-05	0.00281769	-0.935052	0.0427736	-0.23116	0.79 [0.63 - 0.99]
GENE	ALPP	alkaline phosphatase, placental	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211619_s_at	159	0.207547	0.271542	-	-0.453038	0.821066	-0.0521587	0.95 [0.60 - 1.49]
GENE	ALPP	alkaline phosphatase, placental	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204664_at	159	0.377358	0.129824	-	0.530329	0.605544	0.293687	1.34 [0.44 - 4.09]
GENE	ALPP	alkaline phosphatase, placental	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204664_at	159	0.100629	0.247286	-	0.816582	0.96446	-0.0255316	0.97 [0.32 - 3.00]
GENE	ALPP	alkaline phosphatase, placental	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211619_s_at	159	0.899371	0.0441838	0.455448	0.815518	0.902519	0.0240177	1.02 [0.70 - 1.50]
GENE	ALPP	alkaline phosphatase, placental	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204664_at	159	0.377358	0.190935	-	0.537029	0.799575	0.170036	1.19 [0.32 - 4.40]
GENE	ALPP	alkaline phosphatase, placental	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211619_s_at	159	0.572327	0.0728337	-	-0.609563	0.59456	-0.103204	0.90 [0.62 - 1.32]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211619_s_at	54	0.296296	0.0368209	0.40549	-1.408	0.977675	-0.059783	0.94 [0.01 - 62.02]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204664_at	54	0.851852	0.356316	-	0.737175	0.783391	-0.444075	0.64 [0.03 - 15.21]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204664_at	117	0.803419	0.165548	-	-0.652702	0.405324	-0.637527	0.53 [0.12 - 2.37]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204664_at	117	0.863248	0.124571	-	-1.43334	0.762409	-0.275816	0.76 [0.13 - 4.54]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211619_s_at	117	0.803419	0.137017	-	-0.880849	0.575626	-0.452692	0.64 [0.13 - 3.10]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211619_s_at	117	0.752137	0.113087	-	-0.688811	0.437065	-0.529201	0.59 [0.16 - 2.24]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211619_s_at	117	0.803419	0.181479	-	-0.796379	0.70288	-0.323444	0.72 [0.14 - 3.81]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211619_s_at	117	0.752137	0.113087	-	-0.688811	0.437065	-0.529201	0.59 [0.16 - 2.24]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204664_at	117	0.803419	0.165548	-	-0.652702	0.405324	-0.637527	0.53 [0.12 - 2.37]
GENE	ALPP	alkaline phosphatase, placental	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204664_at	117	0.863248	0.113128	-	-1.47608	0.456353	-0.719056	0.49 [0.07 - 3.23]
GENE	ALPP	alkaline phosphatase, placental	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204664_at	236	0.131356	0.122231	-	0.781887	0.321686	0.380143	1.46 [0.69 - 3.10]
GENE	ALPP	alkaline phosphatase, placental	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211619_s_at	236	0.889831	0.170421	-	-0.793498	0.768216	-0.0531539	0.95 [0.67 - 1.35]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211619_s_at	249	0.188755	0.0904153	-	-0.420456	0.896503	-0.0184525	0.98 [0.74 - 1.30]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204664_at	249	0.84739	0.0440416	0.454529	-0.729411	0.809644	-0.0726664	0.93 [0.51 - 1.68]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204664_at	125	0.248	0.0508314	-	-0.739679	0.288465	-1.10837	0.33 [0.04 - 2.56]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211619_s_at	62	0.145161	0.16703	-	15.1775	0.8395	-0.118367	0.89 [0.28 - 2.79]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204664_at	125	0.208	0.021643	0.283237	-0.687654	0.306539	-0.822138	0.44 [0.09 - 2.13]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204664_at	54	0.481481	0.192788	-	0.851703	0.743262	-0.0901296	0.91 [0.53 - 1.57]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211619_s_at	125	0.288	0.250644	-	0.564778	0.685844	0.330965	1.39 [0.28 - 6.92]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211619_s_at	125	0.68	0.0843987	-	-0.573004	0.460742	-0.462747	0.63 [0.18 - 2.15]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211619_s_at	54	0.314815	0.15814	-	1.37174	0.803352	-0.178371	0.84 [0.21 - 3.41]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204664_at	62	0.725806	0.068643	-	-1.12128	0.619707	-0.113319	0.89 [0.57 - 1.40]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211619_s_at	198	0.777778	0.0617825	-	-0.694637	0.675489	-0.0403574	0.96 [0.80 - 1.16]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211619_s_at	198	0.777778	0.0750493	-	-0.704935	0.734172	-0.0349917	0.97 [0.79 - 1.18]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204664_at	198	0.106061	0.00874805	0.145923	-0.748609	0.0132594	-0.55329	0.58 [0.37 - 0.89]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204664_at	198	0.373737	0.108966	-	-0.406523	0.174828	-0.322293	0.72 [0.45 - 1.15]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211619_s_at	198	0.10101	0.147423	-	0.608286	0.645973	0.0370716	1.04 [0.89 - 1.22]
GENE	ALPP	alkaline phosphatase, placental	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204664_at	198	0.621212	0.124492	-	-0.443346	0.190349	-0.333017	0.72 [0.44 - 1.18]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204664_at	51	0.764706	0.0354497	0.395606	1.70766	0.310331	1.63756	5.14 [0.22 - 121.66]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204664_at	62	0.758065	0.104544	-	0.919687	0.635222	0.532711	1.70 [0.19 - 15.39]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211619_s_at	51	0.411765	0.00573906	0.105443	-16.7107	0.123216	-3.86254	0.02 [0.00 - 2.85]
GENE	ALPP	alkaline phosphatase, placental	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211619_s_at	62	0.209677	0.0382178	0.415362	-1.15268	0.136548	-2.36415	0.09 [0.00 - 2.11]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211619_s_at	145	0.793103	0.396635	-	-0.378638	0.989312	-0.00565591	0.99 [0.43 - 2.27]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204664_at	177	0.881356	0.1398	-	-0.672426	0.55739	-0.285052	0.75 [0.29 - 1.95]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204664_at	145	0.124138	0.014292	0.210452	15.2541	0.363994	0.659062	1.93 [0.47 - 8.02]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211619_s_at	177	0.135593	0.042168	0.442263	-0.708706	0.0801166	-0.676407	0.51 [0.24 - 1.08]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204664_at	177	0.322034	0.0899327	-	-0.469377	0.376522	-0.485952	0.62 [0.21 - 1.81]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211619_s_at	177	0.813559	0.0354032	0.395267	-0.77041	0.096508	-0.550503	0.58 [0.30 - 1.10]
GENE	ALPP	alkaline phosphatase, placental	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211619_s_at	226	0.393805	0.0354152	0.395355	0.686019	0.468556	0.0690544	1.07 [0.89 - 1.29]
GENE	ALPP	alkaline phosphatase, placental	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204664_at	226	0.411504	0.149544	-	0.441723	0.711401	-0.146956	0.86 [0.40 - 1.88]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211619_s_at	49	0.77551	0.000182988	0.00594828	1.94107	0.39403	0.450209	1.57 [0.56 - 4.42]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204664_at	55	0.418182	0.111516	-	-0.703599	0.489495	-0.662932	0.52 [0.08 - 3.38]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204664_at	49	0.408163	0.132789	-	-0.856847	0.621024	-0.599056	0.55 [0.05 - 5.91]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204664_at	55	0.472727	0.00922143	0.151876	-1.27211	0.0646587	-2.09938	0.12 [0.01 - 1.14]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211619_s_at	55	0.727273	0.0016715	0.0390799	1.32498	0.664118	0.216443	1.24 [0.47 - 3.30]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211619_s_at	55	0.763636	0.00251085	0.0545368	1.42382	0.812599	0.130276	1.14 [0.39 - 3.34]
GENE	ALPP	alkaline phosphatase, placental	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204664_at	63	0.142857	0.00126201	0.0309577	-1.23539	0.0463906	-17.7666	0.00 [0.00 - 0.75]
GENE	ALPP	alkaline phosphatase, placental	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211619_s_at	63	0.126984	0.000140607	0.00472477	-1.46082	0.299111	-1.37591	0.25 [0.02 - 3.39]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g178471_3p_s_at	28	0.357143	0.0856212	-	-0.923344	0.194247	-16.7554	0.00 [0.00 - 5131.25]
GENE	ALPP	alkaline phosphatase, placental	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13787194_3p_at	28	0.892857	0.0391283	0.421692	1.29458	0.0767155	0.302213	1.35 [0.97 - 1.89]
GENE	ALPP	alkaline phosphatase, placental	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204664_at	82	0.439024	0.0922613	-	0.593265	0.970996	0.0188292	1.02 [0.37 - 2.81]
GENE	ALPP	alkaline phosphatase, placental	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211619_s_at	82	0.219512	0.0945291	-	-0.62602	0.972782	-0.00712698	0.99 [0.66 - 1.50]
GENE	ALPP	alkaline phosphatase, placental	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204664_at	79	0.594937	0.182916	-	-0.360324	0.969446	0.020852	1.02 [0.35 - 2.97]
GENE	ALPP	alkaline phosphatase, placental	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211619_s_at	79	0.101266	0.0401219	0.42851	-0.777818	0.383816	-0.244633	0.78 [0.45 - 1.36]
GENE	ALPP	alkaline phosphatase, placental	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211619_s_at	104	0.567308	0.0125977	0.191814	0.813196	0.0453158	0.503223	1.65 [1.01 - 2.71]
GENE	ALPP	alkaline phosphatase, placental	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204664_at	104	0.894231	0.00174959	0.0405792	1.1961	0.0817968	1.24819	3.48 [0.85 - 14.21]
GENE	ALPP	alkaline phosphatase, placental	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P79587	117	0.521368	0.0723167	-	-0.526015	0.391243	-0.218819	0.80 [0.49 - 1.33]
GENE	ALPP	alkaline phosphatase, placental	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211619_s_at	204	0.205882	0.0128995	0.195195	-0.911498	0.254978	-0.303007	0.74 [0.44 - 1.24]
GENE	ALPP	alkaline phosphatase, placental	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211619_s_at	204	0.205882	0.00520116	0.097623	-0.78707	0.174348	-0.278788	0.76 [0.51 - 1.13]
GENE	ALPP	alkaline phosphatase, placental	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204664_at	204	0.303922	0.0639817	-	-0.671936	0.111721	0.416369	1.52 [0.91 - 2.53]
GENE	ALPP	alkaline phosphatase, placental	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204664_at	204	0.264706	0.1137	-	-0.454107	0.331376	0.227005	1.25 [0.79 - 1.98]
GENE	ALPP	alkaline phosphatase, placental	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204664_at	178	0.140449	0.015388	0.222085	-0.622848	0.452596	-0.272782	0.76 [0.37 - 1.55]
GENE	ALPP	alkaline phosphatase, placental	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211619_s_at	178	0.134831	0.113074	-	-0.429858	0.403853	-0.151998	0.86 [0.60 - 1.23]
GENE	ALPP	alkaline phosphatase, placental	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211619_s_at	111	0.189189	0.0550214	-	-0.570208	0.786736	-0.0498352	0.95 [0.66 - 1.37]
GENE	ALPP	alkaline phosphatase, placental	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204664_at	111	0.675676	0.024271	0.306713	-0.68031	0.979443	-0.00737502	0.99 [0.57 - 1.74]
GENE	ALPP	alkaline phosphatase, placental	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204664_at	90	0.244444	0.0857709	-	0.897104	0.496385	0.449297	1.57 [0.43 - 5.72]
GENE	ALPP	alkaline phosphatase, placental	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204664_at	90	0.244444	0.0319502	0.369455	0.99164	0.610338	0.298746	1.35 [0.43 - 4.25]
GENE	ALPP	alkaline phosphatase, placental	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211619_s_at	90	0.388889	0.271979	-	0.374587	0.52438	0.37444	1.45 [0.46 - 4.61]
GENE	ALPP	alkaline phosphatase, placental	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211619_s_at	90	0.411111	0.135224	-	0.591858	0.16117	0.786892	2.20 [0.73 - 6.60]
GENE	ALPP	alkaline phosphatase, placental	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211619_s_at	138	0.326087	0.0716615	-	-0.436451	0.411654	0.481659	1.62 [0.51 - 5.11]
GENE	ALPP	alkaline phosphatase, placental	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204664_at	138	0.15942	0.00517359	0.0972164	-0.752279	0.303123	-5.41997	0.00 [0.00 - 133.78]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211619_s_at	129	0.155039	0.324306	-	0.369804	0.588034	0.0933425	1.10 [0.78 - 1.54]
GENE	ALPP	alkaline phosphatase, placental	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204664_at	129	0.682171	0.0117934	0.182663	0.637144	0.532419	0.103478	1.11 [0.80 - 1.53]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9867	56	0.214286	0.0623104	-	-0.686768	0.437425	-0.364926	0.69 [0.28 - 1.74]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9867	56	0.214286	0.014469	0.212352	-0.886932	0.475985	-0.324333	0.72 [0.30 - 1.76]
GENE	ALPP	alkaline phosphatase, placental	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204664_at	278	0.579137	0.000885612	0.0230121	-0.667991	0.00675692	-0.236255	0.79 [0.67 - 0.94]
GENE	ALPP	alkaline phosphatase, placental	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211619_s_at	278	0.848921	0.00805239	0.13699	-0.820584	0.0255958	-0.268076	0.76 [0.60 - 0.97]
GENE	ALPP	alkaline phosphatase, placental	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211619_s_at	133	0.526316	0.0209537	0.276882	0.541489	0.931564	-0.00748033	0.99 [0.84 - 1.18]
GENE	ALPP	alkaline phosphatase, placental	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204664_at	133	0.511278	0.00353734	0.0719078	0.688303	0.991104	-0.000862095	1.00 [0.86 - 1.16]
GENE	ALPP	alkaline phosphatase, placental	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204664_at	185	0.389189	0.149721	-	0.239605	0.901968	-0.0135926	0.99 [0.79 - 1.22]
GENE	ALPP	alkaline phosphatase, placental	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204664_at	185	0.389189	0.258139	-	0.204373	0.941669	-0.00871523	0.99 [0.78 - 1.25]
GENE	ALPP	alkaline phosphatase, placental	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211619_s_at	185	0.535135	0.0186281	0.254782	-0.384346	0.337734	-0.194653	0.82 [0.55 - 1.23]
GENE	ALPP	alkaline phosphatase, placental	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211619_s_at	185	0.535135	0.00802187	0.136593	-0.473392	0.416363	-0.175369	0.84 [0.55 - 1.28]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P79587	110	0.572727	0.0109865	0.173266	-0.613704	0.135183	-0.147157	0.86 [0.71 - 1.05]
GENE	ALPP	alkaline phosphatase, placental	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P79587	110	0.545455	0.019407	0.262302	-0.74067	0.233128	-0.161722	0.85 [0.65 - 1.11]
GENE	ALPP	alkaline phosphatase, placental	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211619_s_at	80	0.2375	0.0379303	0.413346	1.85395	0.872589	-0.0186687	0.98 [0.78 - 1.23]
GENE	ALPP	alkaline phosphatase, placental	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204664_at	80	0.8875	0.109027	-	-1.51327	0.363508	-0.141954	0.87 [0.64 - 1.18]
GENE	ALPP	alkaline phosphatase, placental	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_5148	281	0.441281	0.0615617	-	-0.264259	0.230849	-0.121299	0.89 [0.73 - 1.08]
GENE	ALPP	alkaline phosphatase, placental	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211619_s_at	38	0.868421	0.0181614	0.250217	-15.4968	0.297833	-0.461428	0.63 [0.26 - 1.50]
GENE	ALPP	alkaline phosphatase, placental	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204664_at	38	0.157895	0.00834085	0.140722	-1.33598	0.107013	-1.10858	0.33 [0.09 - 1.27]
GENE	ALPP	alkaline phosphatase, placental	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204664_at	140	0.235714	0.178406	-	-0.434198	0.61208	-0.321817	0.72 [0.21 - 2.51]
GENE	ALPP	alkaline phosphatase, placental	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211619_s_at	140	0.428571	0.2183	-	-0.355237	0.589023	-0.406182	0.67 [0.15 - 2.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210431_at	30	0.5	0.0473173	0.475269	0.838903	0.385135	0.752697	2.12 [0.39 - 11.60]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216377_x_at	30	0.6	0.225269	-	-0.50064	0.485522	-0.720388	0.49 [0.06 - 3.68]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1801851	165	0.236364	0.00769351	0.132291	-0.680461	0.0954994	-1.79283	0.17 [0.02 - 1.37]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1801851	165	0.745455	0.0735176	-	0.643523	0.558164	-0.612676	0.54 [0.07 - 4.21]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216377_x_at	163	0.815951	0.0244268	0.30807	-0.638212	0.877958	-0.115044	0.89 [0.21 - 3.87]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210431_at	163	0.128834	0.00710068	0.124381	-0.680583	0.258677	-0.772839	0.46 [0.12 - 1.77]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216377_x_at	79	0.392405	0.000650422	0.0177273	-0.970707	0.0412344	-1.90504	0.15 [0.02 - 0.93]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210431_at	79	0.265823	0.020043	0.268353	-0.698511	0.134266	-1.53779	0.21 [0.03 - 1.61]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210431_at	58	0.293103	0.11088	-	0.48976	0.497503	0.124103	1.13 [0.79 - 1.62]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216377_x_at	58	0.172414	0.150142	-	-0.511043	0.677936	-0.1198	0.89 [0.50 - 1.56]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210431_at	34	0.852941	0.00102989	0.0261225	1.65028	0.0636297	0.670789	1.96 [0.96 - 3.97]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216377_x_at	34	0.852941	0.218734	-	-0.740742	0.842791	0.130591	1.14 [0.31 - 4.14]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210431_at	158	0.462025	0.00376132	0.0755253	0.692636	0.153856	0.985043	2.68 [0.69 - 10.37]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216377_x_at	158	0.753165	0.139457	-	-0.426852	0.578043	-0.621358	0.54 [0.06 - 4.80]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216377_x_at	53	0.301887	0.0590525	-	0.839044	0.359223	0.5131	1.67 [0.56 - 5.00]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210431_at	53	0.603774	0.0846522	-	-0.623411	0.480714	-0.275076	0.76 [0.35 - 1.63]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216377_x_at	53	0.660377	0.0959854	-	0.569373	0.451443	0.398767	1.49 [0.53 - 4.21]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210431_at	53	0.603774	0.0879438	-	-0.668209	0.421394	-0.337815	0.71 [0.31 - 1.63]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210431_at	180	0.161111	0.140307	-	0.488845	0.986892	-0.00178601	1.00 [0.81 - 1.24]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216377_x_at	180	0.516667	0.13336	-	0.313784	0.749269	0.0969855	1.10 [0.61 - 2.00]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216377_x_at	559	0.384615	0.0525396	-	-0.386722	0.229446	-0.242701	0.78 [0.53 - 1.17]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210431_at	559	0.794275	0.14757	-	-0.361652	0.852118	-0.0227148	0.98 [0.77 - 1.24]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210431_at	77	0.779221	0.00837961	0.14122	0.766613	0.347008	0.219964	1.25 [0.79 - 1.97]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216377_x_at	77	0.285714	0.0558828	-	-0.528242	0.319667	-0.319514	0.73 [0.39 - 1.36]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216377_x_at	70	0.642857	0.190997	-	-0.369055	0.856405	-0.139673	0.87 [0.19 - 3.95]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210431_at	70	0.885714	0.0433283	0.449895	0.759683	0.712032	0.353708	1.42 [0.22 - 9.32]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	678_at	50	0.12	0.00039356	0.0115431	-1.59022	0.0675952	-1.64335	0.19 [0.03 - 1.13]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210431_at	74	0.797297	0.0908842	-	-0.653954	0.333493	-0.278516	0.76 [0.43 - 1.33]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216377_x_at	74	0.567568	0.0342472	0.386774	0.609937	0.477384	0.289096	1.34 [0.60 - 2.96]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216377_x_at	67	0.268657	0.0714986	-	15.5344	0.218138	2.27134	9.69 [0.26 - 360.08]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210431_at	67	0.537313	0.00319634	0.0662902	2.46364	0.0401428	6.98394	1079.16 [1.37 - 850737.76]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216377_x_at	115	0.721739	0.0634258	-	0.96132	0.580864	0.74902	2.11 [0.15 - 30.20]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210431_at	115	0.573913	0.268731	-	-0.642791	0.520186	-0.218149	0.80 [0.41 - 1.56]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	678_at	158	0.367089	0.0264293	0.325173	-0.652725	0.875096	-0.0587849	0.94 [0.45 - 1.96]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	678_at	76	0.105263	0.0190019	0.258407	-1.29745	0.642282	-0.487682	0.61 [0.08 - 4.81]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210431_at	204	0.348039	0.213484	-	0.185747	0.642711	-0.0390163	0.96 [0.82 - 1.13]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216377_x_at	204	0.563725	0.317408	-	-0.14043	0.829811	-0.0337185	0.97 [0.71 - 1.31]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216377_x_at	87	0.321839	0.00538102	0.100261	1.54611	0.702854	0.26124	1.30 [0.34 - 4.97]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216377_x_at	87	0.321839	0.00538102	0.100261	1.54611	0.702854	0.26124	1.30 [0.34 - 4.97]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210431_at	87	0.83908	0.0135658	0.202565	0.996112	0.349282	0.82861	2.29 [0.40 - 12.98]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210431_at	87	0.83908	0.0135658	0.202565	0.996112	0.349282	0.82861	2.29 [0.40 - 12.98]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210431_at	77	0.857143	0.0247702	0.311046	1.26835	0.125635	1.90045	6.69 [0.59 - 76.14]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216377_x_at	77	0.818182	0.00382921	0.076611	1.64208	0.222372	2.06192	7.86 [0.29 - 215.69]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210431_at	77	0.285714	0.157331	-	1.38008	0.751326	0.410715	1.51 [0.12 - 19.13]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216377_x_at	77	0.662338	0.00286256	0.0606499	1.61426	0.0733597	2.65619	14.24 [0.78 - 260.78]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216377_x_at	136	0.183824	0.00554536	0.102651	-1.19857	0.424449	-0.453335	0.64 [0.21 - 1.93]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210431_at	136	0.463235	0.187847	-	-0.593547	0.521688	-0.204751	0.81 [0.44 - 1.52]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210431_at	200	0.11	0.0208025	0.275477	-0.877208	0.40017	-0.270575	0.76 [0.41 - 1.43]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216377_x_at	200	0.515	0.0181175	0.249784	-0.71286	0.412717	-0.336742	0.71 [0.32 - 1.60]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6943	60	0.4	0.0478976	0.478853	-0.734404	0.452362	-0.404202	0.67 [0.23 - 1.92]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6943	60	0.733333	0.000677344	0.0183479	1.2917	0.000721548	1.36947	3.93 [1.78 - 8.70]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18417	155	0.806452	0.010422	0.166556	0.753317	0.102562	0.295834	1.34 [0.94 - 1.92]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210431_at	286	0.15035	0.378662	-	0.2586	0.972907	0.00771564	1.01 [0.65 - 1.57]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216377_x_at	286	0.43007	0.00212759	0.0476478	-0.588417	0.0313318	-0.563433	0.57 [0.34 - 0.95]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210431_at	159	0.622642	0.106664	-	0.505599	0.492394	0.211473	1.24 [0.68 - 2.26]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216377_x_at	159	0.654088	0.0626731	-	-0.691171	0.848925	-0.0934931	0.91 [0.35 - 2.38]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210431_at	159	0.899371	0.180875	-	0.706283	0.314457	0.376968	1.46 [0.70 - 3.04]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216377_x_at	159	0.603774	0.0464293	0.469732	-0.691902	0.478467	-0.331021	0.72 [0.29 - 1.79]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216377_x_at	159	0.654088	0.0729496	-	-0.800618	0.844545	-0.112757	0.89 [0.29 - 2.76]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210431_at	159	0.899371	0.0158726	0.227131	0.966695	0.113145	0.49406	1.64 [0.89 - 3.02]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210431_at	54	0.796296	0.100633	-	-15.4424	0.456187	-1.09292	0.34 [0.02 - 5.94]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216377_x_at	54	0.37037	0.104405	-	-1.10701	0.389849	-1.26038	0.28 [0.02 - 5.02]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210431_at	117	0.512821	0.0675754	-	0.577028	0.882894	0.0836802	1.09 [0.36 - 3.31]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210431_at	117	0.538462	0.00582273	0.106641	1.06439	0.548151	0.355506	1.43 [0.45 - 4.55]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210431_at	117	0.512821	0.0675754	-	0.577028	0.882894	0.0836802	1.09 [0.36 - 3.31]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210431_at	117	0.538462	0.000611225	0.0168157	1.40452	0.132898	0.753435	2.12 [0.80 - 5.68]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216377_x_at	117	0.350427	0.0911191	-	-0.632648	0.937009	0.0730717	1.08 [0.18 - 6.59]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216377_x_at	117	0.102564	0.0261294	0.322649	-0.861209	0.631294	-0.393426	0.67 [0.14 - 3.36]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216377_x_at	117	0.102564	0.0261294	0.322649	-0.861209	0.631294	-0.393426	0.67 [0.14 - 3.36]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216377_x_at	117	0.752137	0.00525669	0.0984402	1.05612	0.291742	0.935687	2.55 [0.45 - 14.51]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216377_x_at	236	0.809322	0.177956	-	0.413903	0.99547	0.00300105	1.00 [0.36 - 2.83]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210431_at	236	0.635593	0.0167035	0.23565	0.636487	0.257289	0.344772	1.41 [0.78 - 2.56]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210431_at	249	0.269076	0.0134818	0.201643	0.670024	0.129751	0.354398	1.43 [0.90 - 2.25]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216377_x_at	249	0.694779	0.291464	-	0.23416	0.567932	-0.232861	0.79 [0.36 - 1.76]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216377_x_at	125	0.296	0.249344	-	-0.338153	0.931339	-0.073796	0.93 [0.17 - 4.98]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216377_x_at	54	0.37037	0.333537	-	0.74022	0.654584	-0.0949726	0.91 [0.60 - 1.38]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210431_at	62	0.774194	0.207949	-	-0.786983	0.770172	-0.106328	0.90 [0.44 - 1.83]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210431_at	125	0.48	0.0544906	-	-0.742311	0.769995	-0.322466	0.72 [0.08 - 6.29]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216377_x_at	62	0.387097	0.166477	-	0.858942	0.714964	-0.0633347	0.94 [0.67 - 1.32]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210431_at	125	0.52	0.0888856	-	-0.502789	0.315196	-0.817082	0.44 [0.09 - 2.18]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210431_at	54	0.851852	0.444291	-	-0.780366	0.826241	-0.0969834	0.91 [0.38 - 2.16]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216377_x_at	125	0.144	0.0223721	0.289867	-0.925468	0.678292	-0.457432	0.63 [0.07 - 5.50]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210431_at	198	0.116162	0.0511324	-	1.10096	0.788508	0.0325791	1.03 [0.81 - 1.31]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216377_x_at	198	0.39899	0.0410275	0.434644	-0.427088	0.434341	-0.14726	0.86 [0.60 - 1.25]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210431_at	198	0.116162	0.064352	-	1.05071	0.919548	-0.0129095	0.99 [0.77 - 1.27]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216377_x_at	198	0.838384	0.0670019	-	-0.780225	0.362315	-0.207688	0.81 [0.52 - 1.27]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216377_x_at	198	0.883838	0.0233571	0.298679	-1.49221	0.164198	-0.328633	0.72 [0.45 - 1.14]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210431_at	198	0.106061	0.0453944	0.4632	0.892498	0.745963	0.0327151	1.03 [0.85 - 1.26]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216377_x_at	62	0.129032	0.19332	-	-0.842519	0.99204	-0.0123472	0.99 [0.09 - 11.17]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210431_at	51	0.784314	0.217208	-	-15.4333	0.669623	-0.673739	0.51 [0.02 - 11.26]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210431_at	62	0.129032	0.147487	-	15.2597	0.603793	0.507521	1.66 [0.24 - 11.29]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216377_x_at	51	0.764706	0.208253	-	-15.4466	0.906744	-0.231459	0.79 [0.02 - 38.13]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210431_at	177	0.553672	0.0508982	-	-0.471811	0.150785	-0.565878	0.57 [0.26 - 1.23]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216377_x_at	177	0.418079	0.00336336	0.0690589	-0.791219	0.00418967	-1.89308	0.15 [0.04 - 0.55]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210431_at	145	0.131034	0.0435782	0.451524	1.79578	0.310331	0.347529	1.42 [0.72 - 2.77]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210431_at	177	0.231638	0.110444	-	-0.472093	0.273499	-0.489172	0.61 [0.26 - 1.47]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216377_x_at	177	0.180791	0.00220301	0.049024	-0.789594	0.00606694	-1.55995	0.21 [0.07 - 0.64]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216377_x_at	145	0.151724	0.143739	-	-0.578214	0.650662	-0.28277	0.75 [0.22 - 2.56]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210431_at	226	0.566372	0.240907	-	0.330523	0.653299	0.0592613	1.06 [0.82 - 1.37]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216377_x_at	226	0.110619	0.379458	-	-0.381537	0.852081	0.049861	1.05 [0.62 - 1.78]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210431_at	49	0.489796	0.0365735	0.403721	1.30416	0.621041	0.329887	1.39 [0.38 - 5.14]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216377_x_at	55	0.127273	0.00263164	0.0566574	-1.37624	0.24269	-1.24116	0.29 [0.04 - 2.32]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216377_x_at	55	0.163636	0.0946967	-	-0.838695	0.306212	-1.0899	0.34 [0.04 - 2.71]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216377_x_at	49	0.183673	0.0126828	0.192771	-1.41318	0.43754	-0.973842	0.38 [0.03 - 4.41]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210431_at	55	0.472727	0.0698514	-	0.919239	0.724114	-0.247618	0.78 [0.20 - 3.09]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210431_at	55	0.490909	0.24938	-	0.520391	0.940306	-0.0468799	0.95 [0.28 - 3.25]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210431_at	63	0.142857	4.59202e-05	0.00175764	-1.5685	0.613908	0.340967	1.41 [0.37 - 5.29]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216377_x_at	63	0.539683	0.00156054	0.0369241	-1.10444	0.140361	-4.23867	0.01 [0.00 - 4.04]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.284255.2.S1_3p_at	28	0.535714	0.0482083	0.480762	-1.16227	0.310101	-1.22163	0.29 [0.03 - 3.12]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	216377_3p_x_at	28	0.428571	0.269514	-	0.613929	0.428643	-1.31403	0.27 [0.01 - 6.96]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.284255.2.S1_3p_s_at	28	0.785714	0.0558496	-	-1.77687	0.188258	-5.35613	0.00 [0.00 - 13.77]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g178418_3p_at	28	0.5	0.0144926	0.212605	-1.44523	0.445421	-0.586144	0.56 [0.12 - 2.51]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216377_x_at	82	0.121951	0.0307469	0.360136	1.89606	0.36089	0.78829	2.20 [0.41 - 11.93]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210431_at	82	0.804878	0.136592	-	-0.77445	0.867429	-0.0349955	0.97 [0.64 - 1.46]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	678_at	84	0.202381	0.0630341	-	-0.596607	0.14807	-0.817155	0.44 [0.15 - 1.34]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216377_x_at	79	0.278481	0.0599221	-	0.587842	0.975329	0.0207311	1.02 [0.27 - 3.80]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210431_at	79	0.772152	0.180997	-	0.389363	0.49273	0.211186	1.24 [0.68 - 2.26]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210431_at	104	0.875	0.00320126	0.0663722	1.12625	0.205617	0.638036	1.89 [0.70 - 5.08]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216377_x_at	104	0.201923	0.0931337	-	-0.609428	0.481801	-0.587136	0.56 [0.11 - 2.85]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P131580	117	0.239316	0.000440943	0.0127255	-0.99662	0.331502	-0.179925	0.84 [0.58 - 1.20]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P68183	117	0.401709	0.140524	-	-0.419557	0.672255	-0.0731742	0.93 [0.66 - 1.30]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216377_x_at	204	0.112745	0.0659242	-	-0.82236	0.689876	-0.238474	0.79 [0.24 - 2.54]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216377_x_at	204	0.303922	0.175299	-	0.440116	0.530089	0.289577	1.34 [0.54 - 3.30]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210431_at	204	0.828431	0.0130581	0.196962	0.928328	0.0740166	0.290663	1.34 [0.97 - 1.84]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210431_at	204	0.29902	0.0120195	0.185256	0.888395	0.00990963	0.31127	1.37 [1.08 - 1.73]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216377_x_at	178	0.814607	0.0558665	-	-0.563597	0.773919	-0.108268	0.90 [0.43 - 1.88]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210431_at	178	0.882023	0.0361731	0.400845	-0.760366	0.809074	-0.0488897	0.95 [0.64 - 1.42]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210431_at	111	0.756757	0.112306	-	-0.545374	0.434427	-0.126905	0.88 [0.64 - 1.21]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216377_x_at	111	0.522523	0.165712	-	-0.372046	0.67119	-0.189048	0.83 [0.35 - 1.98]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216377_x_at	90	0.844444	0.0597826	-	-1.2799	0.68801	0.279098	1.32 [0.34 - 5.16]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216377_x_at	90	0.2	0.116839	-	0.924032	0.48197	0.55038	1.73 [0.37 - 8.04]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210431_at	90	0.455556	0.0329606	0.377148	0.710843	0.0615621	1.27624	3.58 [0.94 - 13.66]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210431_at	90	0.455556	0.0198134	0.266177	0.910587	0.0658897	1.37834	3.97 [0.91 - 17.24]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216377_x_at	138	0.268116	0.0334294	0.380677	-0.535238	0.0630494	-2.30089	0.10 [0.01 - 1.13]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210431_at	138	0.326087	0.0292553	0.348335	-0.524098	0.25532	-0.443445	0.64 [0.30 - 1.38]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210431_at	129	0.883721	0.273118	-	-0.505493	0.82427	-0.0759354	0.93 [0.47 - 1.81]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216377_x_at	129	0.891473	0.0632283	-	-0.924736	0.258374	-0.441766	0.64 [0.30 - 1.38]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6080	56	0.392857	0.0959867	-	-0.587855	0.269296	-0.361782	0.70 [0.37 - 1.32]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6080	56	0.125	0.112484	-	-0.717301	0.254377	-0.34929	0.71 [0.39 - 1.29]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216377_x_at	278	0.348921	0.00673399	0.119392	-0.514194	0.123606	-0.332196	0.72 [0.47 - 1.09]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210431_at	278	0.507194	0.00587417	0.107375	-0.523199	0.0615226	-0.234259	0.79 [0.62 - 1.01]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210431_at	133	0.112782	0.00076162	0.0202629	2.05633	0.804043	0.0295506	1.03 [0.82 - 1.30]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216377_x_at	133	0.225564	0.00283745	0.0602196	1.02135	0.933612	0.0106438	1.01 [0.79 - 1.30]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	10488	81	0.333333	0.110263	-	-0.808482	0.69882	-0.0912932	0.91 [0.57 - 1.45]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216377_x_at	185	0.897297	0.105301	-	-0.467022	0.226848	-0.311983	0.73 [0.44 - 1.21]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210431_at	185	0.518919	0.0069353	0.12214	-0.442497	0.42924	-0.108207	0.90 [0.69 - 1.17]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216377_x_at	185	0.502703	0.0917728	-	-0.298185	0.28346	-0.304053	0.74 [0.42 - 1.29]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210431_at	185	0.518919	0.0278648	0.337075	-0.392313	0.613259	-0.0731262	0.93 [0.70 - 1.23]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P131580	110	0.590909	0.0116268	0.180741	-0.810656	0.100817	-0.258575	0.77 [0.57 - 1.05]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P68183	110	0.427273	0.00286063	0.0606169	-0.683727	0.0496174	-0.236194	0.79 [0.62 - 1.00]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P131580	110	0.345455	0.00124341	0.0305771	-0.757759	0.0534694	-0.213884	0.81 [0.65 - 1.00]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P68183	110	0.372727	0.0047572	0.0910029	-0.826118	0.169666	-0.231325	0.79 [0.57 - 1.10]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210431_at	80	0.3125	0.207008	-	0.687012	0.844069	-0.0322466	0.97 [0.70 - 1.34]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216377_x_at	80	0.2875	0.00256363	0.0554661	15.6039	0.290588	0.490302	1.63 [0.66 - 4.05]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_1989	281	0.462633	0.0584342	-	0.268099	0.951451	0.00544124	1.01 [0.84 - 1.20]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210431_at	38	0.447368	0.0823748	-	-0.796556	0.596498	-0.324375	0.72 [0.22 - 2.40]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216377_x_at	38	0.868421	0.017823	0.246877	1.36979	0.0471795	1.75443	5.78 [1.02 - 32.69]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216377_x_at	140	0.314286	0.122533	-	-0.460013	0.383581	-0.802031	0.45 [0.07 - 2.72]
GENE	ALPPL2	alkaline phosphatase, placental-like 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210431_at	140	0.314286	0.00136094	0.0329635	-0.895021	0.0270356	-2.09757	0.12 [0.02 - 0.79]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217113_at	30	0.466667	0.133963	-	-0.60099	0.394814	-0.613815	0.54 [0.13 - 2.23]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209425_at	30	0.266667	0.00942778	0.15444	-1.12273	0.548057	-0.210545	0.81 [0.41 - 1.61]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209426_s_at	30	0.766667	0.135973	-	0.678742	0.487908	0.168833	1.18 [0.73 - 1.91]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217111_at	30	0.7	0.227517	-	0.505133	0.490422	0.579743	1.79 [0.34 - 9.28]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209424_s_at	30	0.766667	0.235518	-	0.532423	0.553111	0.132508	1.14 [0.74 - 1.77]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1759670	165	0.442424	0.0177086	0.245743	0.594918	0.392841	0.122501	1.13 [0.85 - 1.50]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1759670	165	0.363636	0.0325621	0.374128	0.885929	0.769286	-0.0676947	0.93 [0.59 - 1.47]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209426_s_at	163	0.871166	0.000380565	0.0112148	0.884595	0.014512	0.982924	2.67 [1.22 - 5.88]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217111_at	163	0.349693	0.186655	-	-0.267215	0.98243	-0.0146095	0.99 [0.27 - 3.62]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209424_s_at	163	0.730061	0.135139	-	0.320744	0.458412	0.241541	1.27 [0.67 - 2.41]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217113_at	163	0.515337	0.266505	-	0.218739	0.827429	0.155835	1.17 [0.29 - 4.74]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209425_at	163	0.447853	0.00452216	0.0874323	0.576248	0.0414647	0.622407	1.86 [1.02 - 3.39]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217111_at	79	0.303797	0.0869425	-	0.566733	0.773469	0.205666	1.23 [0.30 - 4.98]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209426_s_at	79	0.797468	0.00286324	0.0606616	0.948551	0.000677226	1.16178	3.20 [1.64 - 6.24]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209425_at	79	0.886076	0.000622564	0.0170804	1.22881	0.107013	0.483815	1.62 [0.90 - 2.92]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217113_at	79	0.886076	0.141398	-	-0.852515	0.71855	-0.428111	0.65 [0.06 - 6.69]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209424_s_at	79	0.898734	0.0001463	0.00489187	1.39426	0.0104943	0.916328	2.50 [1.24 - 5.04]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209424_s_at	58	0.810345	0.0709464	-	0.624337	0.395035	0.163906	1.18 [0.81 - 1.72]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217113_at	58	0.362069	0.0734639	-	0.521186	0.144685	0.197912	1.22 [0.93 - 1.59]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209425_at	58	0.655172	0.0142661	0.210173	0.706705	0.302511	0.254704	1.29 [0.79 - 2.09]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209426_s_at	58	0.862069	0.0100733	0.16235	1.00982	0.410268	0.262644	1.30 [0.70 - 2.43]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217111_at	58	0.87931	0.0841216	-	0.725922	0.961069	0.00602889	1.01 [0.79 - 1.28]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217111_at	34	0.676471	0.435704	-	0.310943	0.975677	-0.00645967	0.99 [0.66 - 1.51]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209424_s_at	34	0.382353	0.0315494	0.366371	-0.831812	0.28676	-0.344613	0.71 [0.38 - 1.34]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217113_at	34	0.735294	0.0250755	0.313676	0.921401	0.191966	0.370288	1.45 [0.83 - 2.53]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209425_at	34	0.441176	0.0775312	-	0.690785	0.371861	0.34992	1.42 [0.66 - 3.06]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209426_s_at	34	0.529412	0.00592483	0.108096	1.07103	0.147737	0.70092	2.02 [0.78 - 5.21]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217113_at	158	0.120253	0.180804	-	0.610162	0.648687	0.447305	1.56 [0.23 - 10.72]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209425_at	158	0.189873	0.192913	-	-0.355116	0.763548	-0.191948	0.83 [0.24 - 2.88]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209426_s_at	158	0.78481	0.365187	-	0.240614	0.5088	0.392905	1.48 [0.46 - 4.75]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217111_at	158	0.297468	0.121855	-	0.425062	0.831326	0.1342	1.14 [0.33 - 3.93]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209424_s_at	158	0.35443	0.0218549	0.285173	-0.527341	0.575355	-0.294683	0.74 [0.27 - 2.09]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209425_at	53	0.113208	0.078603	-	-0.843332	0.380738	-0.323765	0.72 [0.35 - 1.49]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217111_at	53	0.45283	0.00236185	0.0518888	1.21709	0.0311341	0.400703	1.49 [1.04 - 2.15]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209424_s_at	53	0.150943	0.0667483	-	-0.824437	0.514141	-0.300763	0.74 [0.30 - 1.83]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209426_s_at	53	0.471698	0.0730214	-	-0.60982	0.355871	-0.584195	0.56 [0.16 - 1.93]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217111_at	53	0.45283	0.00562913	0.103862	0.99348	0.0264259	0.379498	1.46 [1.05 - 2.04]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217113_at	53	0.377358	0.0132307	0.198875	1.02982	0.261774	0.295349	1.34 [0.80 - 2.25]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209425_at	53	0.830189	0.0366273	0.404107	0.886259	0.403049	-0.304508	0.74 [0.36 - 1.51]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209424_s_at	53	0.320755	0.138119	-	-0.520679	0.444374	-0.329461	0.72 [0.31 - 1.67]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209426_s_at	53	0.245283	0.0954313	-	0.868609	0.91707	-0.0686162	0.93 [0.26 - 3.40]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217113_at	53	0.377358	0.00472876	0.0905733	1.09732	0.115149	0.381791	1.46 [0.91 - 2.36]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217113_at	180	0.472222	0.0177862	0.246512	-0.493201	0.313696	-0.109812	0.90 [0.72 - 1.11]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209425_at	180	0.85	0.000155018	0.00514602	0.92363	0.0305864	0.665053	1.94 [1.06 - 3.55]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209426_s_at	180	0.455556	0.0918231	-	0.362488	0.332974	0.357753	1.43 [0.69 - 2.95]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217111_at	180	0.2	0.169802	-	0.378288	0.919485	-0.00779626	0.99 [0.85 - 1.15]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209424_s_at	180	0.711111	0.0470793	0.473791	0.437536	0.284892	0.215114	1.24 [0.84 - 1.84]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217111_at	559	0.347048	0.130916	-	-0.319635	0.885984	-0.0296517	0.97 [0.65 - 1.46]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209426_s_at	559	0.286225	0.0199794	0.267751	0.597652	0.240197	0.25643	1.29 [0.84 - 1.98]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209425_at	559	0.110912	0.153948	-	-0.386812	0.616204	-0.105964	0.90 [0.59 - 1.36]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209424_s_at	559	0.78712	0.0714039	-	0.399439	0.4491	0.123668	1.13 [0.82 - 1.56]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217113_at	559	0.427549	0.061793	-	-0.372631	0.197029	-0.169474	0.84 [0.65 - 1.09]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217111_at	77	0.116883	0.0791192	-	0.882061	0.224754	0.172487	1.19 [0.90 - 1.57]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209424_s_at	77	0.831169	0.0133293	0.199964	0.787584	0.0648078	0.607024	1.83 [0.96 - 3.49]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217113_at	77	0.883117	0.0520363	-	-0.88389	0.716665	-0.0659214	0.94 [0.66 - 1.34]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209425_at	77	0.896104	0.154877	-	0.542718	0.774408	-0.101719	0.90 [0.45 - 1.81]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209426_s_at	77	0.896104	3.01469e-05	0.00120708	1.53139	0.838892	-0.0919623	0.91 [0.38 - 2.21]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217111_at	70	0.185714	0.264248	-	-0.360817	0.520916	0.505789	1.66 [0.35 - 7.77]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209426_s_at	70	0.371429	0.0180382	0.249004	-0.62867	0.031944	-0.73885	0.48 [0.24 - 0.94]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209425_at	70	0.114286	0.0417193	0.439279	-0.787593	0.148761	-0.462742	0.63 [0.34 - 1.18]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217113_at	70	0.128571	0.0777799	-	0.801167	0.561029	0.245489	1.28 [0.56 - 2.92]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209424_s_at	70	0.842857	0.00690955	0.12179	-1.11771	0.104358	-0.605684	0.55 [0.26 - 1.13]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41706_at	50	0.88	0.112496	-	-0.942906	0.352721	-1.31429	0.27 [0.02 - 4.30]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209425_at	74	0.459459	0.0849964	-	0.510425	0.661243	0.207938	1.23 [0.49 - 3.12]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209426_s_at	74	0.216216	0.101229	-	-0.535026	0.595458	-0.361242	0.70 [0.18 - 2.64]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217111_at	74	0.378378	0.00770989	0.132506	-0.778009	0.0609827	-0.272946	0.76 [0.57 - 1.01]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209424_s_at	74	0.135135	0.0828964	-	0.879536	0.830685	0.0824903	1.09 [0.51 - 2.31]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217113_at	74	0.878378	0.044433	0.457054	0.766015	0.38128	-0.188416	0.83 [0.54 - 1.26]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217111_at	67	0.895522	0.0293577	0.349155	1.43759	0.0760245	4.13707	62.62 [0.65 - 6046.89]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209426_s_at	67	0.238806	0.0563311	-	15.5701	0.733795	-0.301956	0.74 [0.13 - 4.21]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209425_at	67	0.179104	0.113451	-	15.405	0.514768	0.547586	1.73 [0.33 - 8.98]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209424_s_at	67	0.820895	0.0984245	-	-15.4441	0.708362	-0.30117	0.74 [0.15 - 3.59]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217113_at	67	0.223881	0.113669	-	15.3986	0.274675	2.29601	9.93 [0.16 - 611.37]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217111_at	115	0.217391	0.0270066	0.329994	-1.12886	0.299981	-0.854587	0.43 [0.08 - 2.14]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209426_s_at	115	0.886957	0.000680888	0.0184292	1.68759	0.45707	0.53652	1.71 [0.42 - 7.03]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209425_at	115	0.356522	0.244303	-	0.743098	0.834972	0.149722	1.16 [0.28 - 4.75]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209424_s_at	115	0.791304	0.0262345	0.323535	1.13429	0.203499	1.1618	3.20 [0.53 - 19.15]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217113_at	115	0.469565	0.0484237	0.48208	-1.11248	0.256886	-0.603458	0.55 [0.19 - 1.55]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41706_at	158	0.234177	0.011528	0.179597	1.24079	0.344212	0.286731	1.33 [0.74 - 2.41]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41706_at	76	0.473684	0.0844075	-	0.971068	0.331816	0.546311	1.73 [0.57 - 5.21]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209426_s_at	204	0.269608	0.352211	-	0.149627	0.933436	0.0146578	1.01 [0.72 - 1.43]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209425_at	204	0.127451	0.044153	0.455249	-0.421219	0.138481	-0.213466	0.81 [0.61 - 1.07]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209424_s_at	204	0.191176	0.169329	-	0.242549	0.995068	0.000987319	1.00 [0.73 - 1.37]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217113_at	204	0.102941	0.0364119	0.402562	-0.477524	0.0419884	-0.167929	0.85 [0.72 - 0.99]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217111_at	204	0.294118	0.1988	-	0.197625	0.974706	-0.00322552	1.00 [0.82 - 1.22]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209424_s_at	87	0.103448	0.102062	-	-0.788311	0.396467	-0.283405	0.75 [0.39 - 1.45]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217113_at	87	0.310345	0.0521504	-	1.00675	0.355766	0.655922	1.93 [0.48 - 7.75]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209426_s_at	87	0.252874	0.0651445	-	-0.716005	0.666048	-0.133005	0.88 [0.48 - 1.60]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217111_at	87	0.804598	0.0140533	0.207875	-2.0971	0.0769303	-1.6576	0.19 [0.03 - 1.20]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209425_at	87	0.45977	0.13587	-	-0.562407	0.270933	-0.342268	0.71 [0.39 - 1.31]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209426_s_at	87	0.252874	0.0651445	-	-0.716005	0.666048	-0.133005	0.88 [0.48 - 1.60]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217113_at	87	0.310345	0.0521504	-	1.00675	0.355766	0.655922	1.93 [0.48 - 7.75]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209424_s_at	87	0.103448	0.102062	-	-0.788311	0.396467	-0.283405	0.75 [0.39 - 1.45]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209425_at	87	0.45977	0.13587	-	-0.562407	0.270933	-0.342268	0.71 [0.39 - 1.31]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217111_at	87	0.804598	0.0140533	0.207875	-2.0971	0.0769303	-1.6576	0.19 [0.03 - 1.20]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209426_s_at	77	0.376623	0.0410057	0.434497	-1.1105	0.739099	-0.215015	0.81 [0.23 - 2.86]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209424_s_at	77	0.818182	0.0649162	-	1.13104	0.393881	0.576596	1.78 [0.47 - 6.70]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217113_at	77	0.233766	0.17173	-	-0.856158	0.564252	-0.922978	0.40 [0.02 - 9.16]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209425_at	77	0.207792	0.00658783	0.117381	-1.40362	0.564961	-0.27648	0.76 [0.30 - 1.94]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217111_at	77	0.103896	0.02453	0.308966	-1.42948	0.314616	-1.89324	0.15 [0.00 - 6.03]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209424_s_at	77	0.103896	0.052733	-	-1.2035	0.96779	-0.0253565	0.97 [0.28 - 3.34]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217113_at	77	0.779221	0.40273	-	0.498452	0.958626	-0.0722013	0.93 [0.06 - 14.23]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209426_s_at	77	0.883117	0.0597868	-	1.22296	0.684925	0.300935	1.35 [0.32 - 5.78]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217111_at	77	0.103896	0.0739241	-	-1.12107	0.48514	-1.14044	0.32 [0.01 - 7.86]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209425_at	77	0.792208	0.020753	0.275016	1.35727	0.552994	0.331945	1.39 [0.47 - 4.17]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209426_s_at	136	0.382353	0.00353838	0.0719248	1.79241	0.0302867	1.25827	3.52 [1.13 - 10.99]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217111_at	136	0.867647	1.47693e-06	7.79243e-05	1.96663	0.517654	0.133636	1.14 [0.76 - 1.71]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209424_s_at	136	0.102941	0.00863616	0.144501	-1.27491	0.443835	-0.393874	0.67 [0.25 - 1.85]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217113_at	136	0.595588	0.0746096	-	-0.962322	0.108301	-0.569928	0.57 [0.28 - 1.13]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209425_at	136	0.507353	0.0327638	0.375658	1.0041	0.355452	0.50962	1.66 [0.56 - 4.91]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209425_at	200	0.235	0.00170432	0.0397118	-0.919904	0.0381339	-0.696994	0.50 [0.26 - 0.96]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209426_s_at	200	0.88	0.0210475	0.277752	-1.98886	0.202374	-0.639797	0.53 [0.20 - 1.41]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217111_at	200	0.89	5.33995e-05	0.00201019	1.32531	0.0379005	0.35225	1.42 [1.02 - 1.98]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209424_s_at	200	0.125	0.00888825	0.147696	-0.913939	0.0709911	-0.641884	0.53 [0.26 - 1.06]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217113_at	200	0.895	0.00803458	0.136759	0.917132	0.312566	0.211482	1.24 [0.82 - 1.86]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9143	60	0.883333	0.0249398	0.312509	1.08388	0.481353	0.214318	1.24 [0.68 - 2.25]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9143	60	0.866667	0.0347633	0.390584	0.968832	0.195897	0.483535	1.62 [0.78 - 3.37]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	4922	155	0.683871	0.015372	0.221918	0.667087	0.16817	0.216827	1.24 [0.91 - 1.69]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209425_at	286	0.727273	0.00780698	0.133784	-0.648686	0.0880086	-0.376479	0.69 [0.45 - 1.06]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209426_s_at	286	0.160839	0.109797	-	-0.387408	0.252199	-0.309751	0.73 [0.43 - 1.25]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217111_at	286	0.129371	0.148929	-	-0.37113	0.920775	0.00900348	1.01 [0.84 - 1.20]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209424_s_at	286	0.821678	0.0472477	0.474837	-0.57924	0.806768	-0.0487272	0.95 [0.64 - 1.41]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217113_at	286	0.101399	0.00174521	0.0404956	-0.810108	0.0272936	-0.37786	0.69 [0.49 - 0.96]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209426_s_at	159	0.591195	0.10368	-	-0.554514	0.533327	-0.363205	0.70 [0.22 - 2.18]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209425_at	159	0.685535	0.0271038	0.330801	-0.890461	0.494477	-0.201961	0.82 [0.46 - 1.46]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217111_at	159	0.899371	0.0358938	0.398829	0.848161	0.379176	0.139188	1.15 [0.84 - 1.57]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217113_at	159	0.339623	0.0981154	-	-0.605503	0.671645	-0.10476	0.90 [0.55 - 1.46]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209425_at	159	0.314465	0.00514466	0.0967891	-0.998448	0.357534	-0.287207	0.75 [0.41 - 1.38]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209424_s_at	159	0.301887	0.244056	-	0.437745	0.683031	0.159949	1.17 [0.54 - 2.53]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209426_s_at	159	0.886792	0.213373	-	0.511991	0.926986	0.0524151	1.05 [0.34 - 3.23]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209426_s_at	159	0.886792	0.126759	-	0.686783	0.907984	-0.0777328	0.93 [0.25 - 3.46]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217113_at	159	0.100629	0.0965774	-	1.52945	0.904814	0.0253661	1.03 [0.68 - 1.55]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217111_at	159	0.899371	0.184036	-	0.581306	0.65841	0.0696476	1.07 [0.79 - 1.46]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209424_s_at	159	0.207547	0.183233	-	-0.466825	0.900579	-0.0482156	0.95 [0.45 - 2.03]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209425_at	159	0.201258	0.000518884	0.0146259	-1.08131	0.114588	-0.376721	0.69 [0.43 - 1.10]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217111_at	159	0.899371	0.080025	-	0.836516	0.583423	0.101126	1.11 [0.77 - 1.59]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209424_s_at	159	0.327044	0.152028	-	0.645621	0.46612	0.338869	1.40 [0.56 - 3.49]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217113_at	159	0.345912	0.0258552	0.320331	-0.69083	0.569505	-0.119931	0.89 [0.59 - 1.34]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209424_s_at	54	0.277778	0.034251	0.386802	15.8424	0.75965	0.211235	1.24 [0.32 - 4.78]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217111_at	54	0.888889	0.129604	-	1.17267	0.473643	1.2919	3.64 [0.11 - 124.66]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209425_at	54	0.277778	0.053358	-	15.58	0.973845	-0.0193705	0.98 [0.31 - 3.12]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217113_at	54	0.777778	0.0845916	-	-15.4747	0.518701	-1.02169	0.36 [0.02 - 8.01]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209426_s_at	54	0.333333	0.0187435	0.255905	15.916	0.432239	0.447113	1.56 [0.51 - 4.77]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217111_at	117	0.247863	0.0319124	0.369165	0.918697	0.373781	0.652458	1.92 [0.46 - 8.09]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217111_at	117	0.777778	0.164709	-	0.585007	0.769695	0.290149	1.34 [0.19 - 9.32]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209424_s_at	117	0.589744	0.0604535	-	0.588495	0.592045	0.209233	1.23 [0.57 - 2.65]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217113_at	117	0.846154	0.0327122	0.375268	-1.4263	0.429747	-0.681522	0.51 [0.09 - 2.75]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217113_at	117	0.358974	0.107306	-	0.689102	0.95257	-0.0577617	0.94 [0.14 - 6.33]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209424_s_at	117	0.564103	0.0698084	-	0.704634	0.897766	0.0612136	1.06 [0.42 - 2.70]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209425_at	117	0.82906	0.00743572	0.128874	1.03914	0.234826	0.343481	1.41 [0.80 - 2.48]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209425_at	117	0.82906	0.0161346	0.229835	0.832168	0.613498	0.126809	1.14 [0.69 - 1.86]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217113_at	117	0.846154	0.179088	-	-0.953967	0.842414	-0.205382	0.81 [0.11 - 6.17]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217113_at	117	0.846154	0.0327122	0.375268	-1.4263	0.429747	-0.681522	0.51 [0.09 - 2.75]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209425_at	117	0.82906	0.0161346	0.229835	0.832168	0.613498	0.126809	1.14 [0.69 - 1.86]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209425_at	117	0.82906	0.0165313	0.233898	0.980277	0.593164	0.169166	1.18 [0.64 - 2.20]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209426_s_at	117	0.709402	0.270128	-	-0.417014	0.84593	0.0549804	1.06 [0.61 - 1.84]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209426_s_at	117	0.470085	0.205455	-	0.486239	0.687779	0.13544	1.15 [0.59 - 2.22]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217111_at	117	0.504274	0.0291966	0.347865	0.836997	0.298359	0.875128	2.40 [0.46 - 12.48]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217111_at	117	0.247863	0.0319124	0.369165	0.918697	0.373781	0.652458	1.92 [0.46 - 8.09]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209424_s_at	117	0.589744	0.0604535	-	0.588495	0.592045	0.209233	1.23 [0.57 - 2.65]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209426_s_at	117	0.299145	0.208704	-	-0.497027	0.624911	-0.177462	0.84 [0.41 - 1.71]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209424_s_at	117	0.564103	0.0109978	0.173399	0.966354	0.315192	0.454531	1.58 [0.65 - 3.82]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209426_s_at	117	0.709402	0.270128	-	-0.417014	0.84593	0.0549804	1.06 [0.61 - 1.84]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209426_s_at	236	0.830508	0.0182609	0.251194	0.716701	0.234613	0.608432	1.84 [0.67 - 5.01]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217111_at	236	0.877119	0.163075	-	-0.709273	0.857083	-0.0254898	0.97 [0.74 - 1.29]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209424_s_at	236	0.898305	0.0604349	-	0.671667	0.260327	0.382923	1.47 [0.75 - 2.86]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217113_at	236	0.292373	0.021178	0.27896	-0.620344	0.372615	-0.228733	0.80 [0.48 - 1.32]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209425_at	236	0.889831	0.022762	0.293375	0.776709	0.224572	0.483042	1.62 [0.74 - 3.53]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209424_s_at	249	0.248996	0.0311613	0.363365	0.61717	0.242847	0.300006	1.35 [0.82 - 2.23]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217113_at	249	0.293173	0.00197852	0.0448956	-0.658686	0.0277777	-0.441384	0.64 [0.43 - 0.95]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209425_at	249	0.86747	0.00738136	0.128149	0.69437	0.131173	0.463363	1.59 [0.87 - 2.90]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209426_s_at	249	0.827309	0.011761	0.182289	0.62104	0.0820081	0.653087	1.92 [0.92 - 4.01]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217111_at	249	0.883534	0.131935	-	-0.585232	0.923676	-0.0107486	0.99 [0.79 - 1.23]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209424_s_at	62	0.258065	0.100465	-	-0.773754	0.528229	-0.237589	0.79 [0.38 - 1.65]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217111_at	125	0.128	0.0415769	0.438329	15.2279	0.689513	0.402813	1.50 [0.21 - 10.79]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209424_s_at	125	0.792	0.0974323	-	0.653585	0.836613	0.0904715	1.09 [0.46 - 2.59]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217113_at	62	0.822581	0.0475824	0.47691	-1.8118	0.689511	-0.127091	0.88 [0.47 - 1.64]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217111_at	125	0.808	0.0285828	0.342922	-0.906489	0.603423	-0.396374	0.67 [0.15 - 3.00]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209426_s_at	54	0.314815	0.0686047	-	-1.03964	0.530635	-0.165825	0.85 [0.50 - 1.42]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217111_at	54	0.185185	0.129478	-	15.2963	0.861149	-0.105857	0.90 [0.27 - 2.95]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209425_at	62	0.33871	0.108301	-	-0.753258	0.412301	-0.26119	0.77 [0.41 - 1.44]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209424_s_at	125	0.184	0.0829675	-	-0.603724	0.977599	-0.00967249	0.99 [0.50 - 1.95]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217113_at	125	0.208	0.00332757	0.0684685	-1.07004	0.647081	-0.59087	0.55 [0.04 - 6.95]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209424_s_at	54	0.296296	0.0816556	-	-0.999434	0.51523	-0.298914	0.74 [0.30 - 1.82]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209426_s_at	62	0.145161	0.27024	-	1.08247	0.593058	-0.116938	0.89 [0.58 - 1.37]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209425_at	125	0.88	0.0012112	0.0299153	1.27895	0.29328	0.540267	1.72 [0.63 - 4.70]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217113_at	125	0.224	0.0168302	0.236936	-0.70515	0.24821	-1.16815	0.31 [0.04 - 2.26]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209425_at	125	0.784	0.0341089	0.385748	0.637307	0.750348	0.12881	1.14 [0.51 - 2.52]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217113_at	54	0.740741	0.0846513	-	-1.63656	0.685393	-0.157045	0.85 [0.40 - 1.83]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209425_at	54	0.111111	0.0126551	0.192459	-1.41275	0.249923	-0.451414	0.64 [0.30 - 1.37]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217111_at	62	0.822581	0.130299	-	-1.10465	0.659984	-0.220378	0.80 [0.30 - 2.14]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209426_s_at	125	0.744	0.0164795	0.23337	0.883253	0.6924	0.171484	1.19 [0.51 - 2.78]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209426_s_at	125	0.896	0.0661805	-	0.701418	0.793386	0.0885409	1.09 [0.56 - 2.12]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209424_s_at	198	0.858586	0.0305964	0.358958	0.672569	0.189773	0.289114	1.34 [0.87 - 2.06]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217113_at	198	0.717172	0.33831	-	-0.284065	0.86442	0.0206203	1.02 [0.81 - 1.29]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209426_s_at	198	0.777778	0.384127	-	-0.229413	0.713515	0.0775455	1.08 [0.71 - 1.63]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217113_at	198	0.712121	0.296434	-	-0.321686	0.977535	0.00360118	1.00 [0.78 - 1.29]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209425_at	198	0.207071	0.111544	-	0.594721	0.657076	0.0830053	1.09 [0.75 - 1.57]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217111_at	198	0.40404	0.0026503	0.0569828	0.683816	0.0281216	0.159483	1.17 [1.02 - 1.35]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209425_at	198	0.207071	0.235562	-	0.449589	0.993642	-0.00155937	1.00 [0.68 - 1.47]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209424_s_at	198	0.848485	0.00329673	0.0679585	0.732184	0.0925635	0.303753	1.35 [0.95 - 1.93]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209426_s_at	198	0.893939	0.294933	-	0.377651	0.732114	0.0871491	1.09 [0.66 - 1.80]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217113_at	198	0.242424	0.13312	-	0.401942	0.479177	0.0678339	1.07 [0.89 - 1.29]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209426_s_at	198	0.89899	0.190281	-	0.495842	0.706941	0.100357	1.11 [0.66 - 1.87]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217111_at	198	0.5	0.00451873	0.0873798	0.736413	0.11267	0.139045	1.15 [0.97 - 1.36]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217111_at	198	0.5	0.00718725	0.125548	0.734633	0.106117	0.148521	1.16 [0.97 - 1.39]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209424_s_at	198	0.893939	0.0135363	0.202242	0.777383	0.280201	0.225631	1.25 [0.83 - 1.89]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209425_at	198	0.207071	0.0685883	-	0.541886	0.310886	0.158948	1.17 [0.86 - 1.59]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217111_at	51	0.45098	0.103127	-	-1.63441	0.41089	-1.93085	0.15 [0.00 - 14.46]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209424_s_at	51	0.568627	0.082505	-	1.72119	0.919231	0.0654418	1.07 [0.30 - 3.78]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217111_at	62	0.306452	0.146539	-	-0.817271	0.670034	-0.599895	0.55 [0.03 - 8.67]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209424_s_at	62	0.112903	0.0340155	0.385054	-1.32127	0.372721	-0.433779	0.65 [0.25 - 1.68]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217113_at	51	0.27451	0.164482	-	15.5337	0.883806	-0.293335	0.75 [0.01 - 38.12]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209425_at	51	0.54902	0.228579	-	-1.26168	0.814678	0.126022	1.13 [0.40 - 3.25]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217113_at	62	0.532258	0.105644	-	-1.03266	0.373867	-1.24484	0.29 [0.02 - 4.48]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209425_at	62	0.193548	0.00563917	0.104006	-1.48655	0.110562	-0.545626	0.58 [0.30 - 1.13]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209426_s_at	51	0.823529	0.16732	-	1.1895	0.564597	0.301494	1.35 [0.48 - 3.77]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209426_s_at	62	0.145161	0.107358	-	-1.02928	0.323902	-0.293653	0.75 [0.42 - 1.34]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209426_s_at	145	0.310345	0.0159646	0.228083	-0.785276	0.340521	-0.17876	0.84 [0.58 - 1.21]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209424_s_at	177	0.124294	0.00552086	0.102296	-0.884663	0.0470171	-0.296538	0.74 [0.55 - 1.00]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209425_at	177	0.519774	0.0797372	-	-0.419788	0.272775	-0.116138	0.89 [0.72 - 1.10]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217113_at	177	0.384181	0.00781888	0.13394	-0.71137	0.0101364	-1.77385	0.17 [0.04 - 0.66]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217111_at	177	0.59887	0.00223534	0.0496107	-0.940697	0.0105047	-1.03474	0.36 [0.16 - 0.78]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217113_at	177	0.107345	0.00087398	0.0227574	-0.964429	0.00971316	-1.5468	0.21 [0.07 - 0.69]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209424_s_at	177	0.124294	0.00390839	0.0778713	-0.819667	0.177885	-0.170632	0.84 [0.66 - 1.08]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209425_at	145	0.206897	0.0235167	0.300092	-0.791662	0.528208	-0.0954644	0.91 [0.68 - 1.22]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217113_at	145	0.372414	0.0182312	0.250902	-0.771251	0.0193773	-2.02485	0.13 [0.02 - 0.72]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209424_s_at	145	0.137931	0.0107977	0.171035	-0.954332	0.469442	-0.131615	0.88 [0.61 - 1.25]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209426_s_at	177	0.19774	0.00562841	0.103851	-0.794507	0.0390341	-0.313428	0.73 [0.54 - 0.98]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217111_at	177	0.59887	0.0058498	0.107027	-0.702029	0.0630797	-0.664608	0.51 [0.26 - 1.04]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209425_at	177	0.186441	0.0244572	0.308334	-0.661675	0.0845865	-0.213006	0.81 [0.63 - 1.03]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209426_s_at	177	0.19774	0.00750882	0.129846	-0.683062	0.162274	-0.180451	0.83 [0.65 - 1.08]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217111_at	145	0.565517	0.0954565	-	-0.581812	0.769506	-0.155893	0.86 [0.30 - 2.43]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209425_at	226	0.106195	0.0107651	0.170648	-0.913647	0.307076	-0.135381	0.87 [0.67 - 1.13]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217113_at	226	0.10177	0.026295	0.324044	-0.837305	0.17586	-0.163077	0.85 [0.67 - 1.08]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209424_s_at	226	0.10177	4.48122e-05	0.00171982	-1.3133	0.0751026	-0.287166	0.75 [0.55 - 1.03]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217111_at	226	0.539823	0.21336	-	-0.359198	0.893303	-0.0200354	0.98 [0.73 - 1.31]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209426_s_at	226	0.132743	0.000753554	0.0200813	-1.07773	0.23737	-0.186118	0.83 [0.61 - 1.13]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209425_at	55	0.381818	0.112165	-	-0.757234	0.77472	-0.0751337	0.93 [0.55 - 1.55]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217113_at	55	0.181818	0.0242667	0.306676	-1.01863	0.232275	-1.50309	0.22 [0.02 - 2.62]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209424_s_at	55	0.418182	0.0234586	0.299578	-0.996282	0.0662772	-0.550054	0.58 [0.32 - 1.04]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209425_at	49	0.346939	0.162242	-	-0.787813	0.527403	-0.209181	0.81 [0.42 - 1.55]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209424_s_at	55	0.418182	0.243605	-	-0.560215	0.706288	-0.113603	0.89 [0.49 - 1.61]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217111_at	55	0.254545	0.0278556	0.337	-0.956071	0.296095	-1.07512	0.34 [0.05 - 2.56]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217113_at	55	0.727273	0.0591535	-	-1.28126	0.233448	-1.67605	0.19 [0.01 - 2.95]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209424_s_at	49	0.326531	0.246002	-	-0.668474	0.409057	-0.302735	0.74 [0.36 - 1.52]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217113_at	49	0.489796	0.196798	-	0.771628	0.774541	0.447709	1.56 [0.07 - 33.49]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217111_at	55	0.8	0.1389	-	0.743148	0.95377	0.054666	1.06 [0.17 - 6.71]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209426_s_at	55	0.436364	0.0128616	0.194773	-1.11157	0.0359105	-0.646089	0.52 [0.29 - 0.96]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217111_at	49	0.795918	0.109432	-	0.949067	0.925225	-0.120562	0.89 [0.07 - 10.99]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209426_s_at	55	0.363636	0.241466	-	-0.555649	0.706962	-0.117992	0.89 [0.48 - 1.64]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209425_at	55	0.381818	0.00613653	0.111091	-1.18818	0.0334619	-0.55405	0.57 [0.34 - 0.96]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209426_s_at	49	0.408163	0.128917	-	-0.863118	0.499103	-0.263801	0.77 [0.36 - 1.65]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	788180	34	0.323529	0.263665	-	-0.499571	0.972994	-0.0161891	0.98 [0.39 - 2.51]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209424_s_at	63	0.809524	0.136249	-	-0.773345	0.338127	-0.264955	0.77 [0.45 - 1.32]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217113_at	63	0.111111	6.77584e-05	0.00248323	-1.57337	0.0230129	-36.526	0.00 [0.00 - 0.01]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217111_at	63	0.269841	0.0490283	0.485763	-0.67858	0.23464	-0.627307	0.53 [0.19 - 1.50]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209426_s_at	63	0.142857	0.118257	-	0.913618	0.796285	-0.0364127	0.96 [0.73 - 1.27]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209425_at	63	0.857143	0.142159	-	-0.865542	0.975803	0.00504307	1.01 [0.73 - 1.39]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.128749.0.S3_3p_at	28	0.357143	0.0485423	0.482805	1.23312	0.57085	0.13751	1.15 [0.71 - 1.85]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.128749.1.S1_3p_at	28	0.678571	0.135669	-	-0.963211	0.326755	-0.570291	0.57 [0.18 - 1.77]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4204096_3p_a_at	28	0.714286	0.0201431	0.269298	1.22214	0.0354516	0.829459	2.29 [1.06 - 4.97]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.128749.0.S3_3p_x_at	28	0.214286	0.0453302	0.462793	1.82822	0.88039	0.0428868	1.04 [0.60 - 1.82]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.128749.1.S1_3p_x_at	28	0.285714	0.0473916	0.475729	-1.11911	0.347177	-1.01325	0.36 [0.04 - 3.00]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.128749.0.S1_3p_a_at	28	0.642857	0.116773	-	-1.00635	0.490276	-1.71579	0.18 [0.00 - 23.55]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.128749.1.A1_3p_at	28	0.892857	0.0259833	0.321415	1.3664	0.0459981	4.56226	95.80 [1.08 - 8463.90]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209426_s_at	82	0.731707	0.0874152	-	-0.801055	0.287025	-0.4188	0.66 [0.30 - 1.42]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217111_at	82	0.451219	0.132421	-	-0.509248	0.998142	0.00100611	1.00 [0.43 - 2.34]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209424_s_at	82	0.317073	0.146738	-	-0.494983	0.484786	-0.31927	0.73 [0.30 - 1.78]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217113_at	82	0.792683	0.000112641	0.0038891	1.28192	0.110516	0.572129	1.77 [0.88 - 3.58]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209425_at	82	0.134146	0.00223122	0.049536	-1.17754	0.0855152	-0.655631	0.52 [0.25 - 1.10]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209426_s_at	79	0.151899	0.0251045	0.313925	-0.747382	0.617133	-0.125526	0.88 [0.54 - 1.44]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217111_at	79	0.126582	0.0771294	-	0.808052	0.762028	-0.164752	0.85 [0.29 - 2.46]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209424_s_at	79	0.278481	0.020273	0.270522	-0.648555	0.331942	-0.259877	0.77 [0.46 - 1.30]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217113_at	79	0.822785	0.0171264	0.239925	-0.987532	0.324701	-0.24821	0.78 [0.48 - 1.28]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209425_at	79	0.101266	0.00693275	0.122106	-1.10902	0.445664	-0.19244	0.82 [0.50 - 1.35]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217113_at	104	0.701923	0.215209	-	-0.470647	0.957793	-0.0216503	0.98 [0.44 - 2.18]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209425_at	104	0.653846	0.00725188	0.126416	-1.07283	0.0777151	-0.578587	0.56 [0.29 - 1.07]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209426_s_at	104	0.798077	0.00760129	0.131073	-1.72004	0.290108	-0.384185	0.68 [0.33 - 1.39]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217111_at	104	0.288462	0.010655	0.16934	-0.860221	0.0605173	-1.22611	0.29 [0.08 - 1.06]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209424_s_at	104	0.894231	0.0126649	0.192569	-15.2633	0.266595	-0.525485	0.59 [0.23 - 1.49]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P106297	117	0.897436	0.165905	-	0.559309	0.566007	0.0856319	1.09 [0.81 - 1.46]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217111_at	204	0.220588	0.00204556	0.0461387	-0.84504	0.0281891	-0.63852	0.53 [0.30 - 0.93]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209426_s_at	204	0.426471	0.0278633	0.337063	0.917006	0.508118	0.22638	1.25 [0.64 - 2.45]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209426_s_at	204	0.294118	0.0601501	-	0.647312	0.422295	0.201568	1.22 [0.75 - 2.00]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209425_at	204	0.848039	0.0425404	0.444725	-1.80775	0.531931	-0.248876	0.78 [0.36 - 1.70]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209425_at	204	0.848039	0.00645493	0.115542	-1.73753	0.445916	-0.220285	0.80 [0.46 - 1.41]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209424_s_at	204	0.553922	0.00119481	0.0295772	1.25736	0.108445	0.500002	1.65 [0.90 - 3.04]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217113_at	204	0.666667	0.215059	-	0.453197	0.842053	0.0434414	1.04 [0.68 - 1.60]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209424_s_at	204	0.553922	0.000150567	0.00501653	1.04674	0.00690475	0.605779	1.83 [1.18 - 2.84]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217113_at	204	0.553922	0.399458	-	0.22889	0.988579	-0.00232627	1.00 [0.73 - 1.37]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217111_at	204	0.808824	0.0796224	-	-1.20872	0.228554	-0.458356	0.63 [0.30 - 1.33]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209426_s_at	178	0.870786	0.167342	-	0.374306	0.588149	0.0877159	1.09 [0.79 - 1.50]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217111_at	178	0.629214	0.0800675	-	0.347319	0.568669	-0.148955	0.86 [0.52 - 1.44]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209424_s_at	178	0.106742	0.17952	-	-0.410454	0.824324	-0.047181	0.95 [0.63 - 1.45]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217113_at	178	0.219101	0.0172928	0.241595	0.613103	0.585157	0.111707	1.12 [0.75 - 1.67]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209425_at	178	0.106742	0.0390149	0.420908	-0.588513	0.333253	-0.204749	0.81 [0.54 - 1.23]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300015585	41	0.804878	0.0640336	-	-1.28329	0.204849	-0.36192	0.70 [0.40 - 1.22]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209426_s_at	111	0.504505	0.0765834	-	0.4647	0.944352	-0.0170109	0.98 [0.61 - 1.59]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209425_at	111	0.234234	0.00275917	0.0588719	1.22063	0.856285	-0.0449891	0.96 [0.59 - 1.56]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209424_s_at	111	0.495495	0.00156692	0.0370487	0.842149	0.0846481	0.390275	1.48 [0.95 - 2.30]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217113_at	111	0.324324	0.093084	-	-0.452941	0.425252	-0.129306	0.88 [0.64 - 1.21]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217111_at	111	0.747748	0.0642815	-	-0.614815	0.430079	-0.12147	0.89 [0.65 - 1.20]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209426_s_at	90	0.877778	0.015138	0.21946	0.936979	0.0318894	0.535441	1.71 [1.05 - 2.79]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209426_s_at	90	0.877778	0.0104908	0.16738	1.06309	0.0187406	0.608308	1.84 [1.11 - 3.05]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217111_at	90	0.566667	0.167336	-	-0.479453	0.686733	0.235413	1.27 [0.40 - 3.97]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217111_at	90	0.566667	0.310577	-	-0.394592	0.468456	0.460405	1.58 [0.46 - 5.50]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209424_s_at	90	0.833333	0.0169988	0.23864	0.858673	0.0614672	0.500076	1.65 [0.98 - 2.78]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209424_s_at	90	0.833333	0.0303966	0.35739	0.874846	0.0405369	0.571455	1.77 [1.02 - 3.06]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217113_at	90	0.3	0.388015	-	-0.28988	0.797092	0.155267	1.17 [0.36 - 3.81]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217113_at	90	0.466667	0.280557	-	0.410837	0.291896	0.597638	1.82 [0.60 - 5.52]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209425_at	90	0.877778	0.000426944	0.0123784	1.26852	0.0497462	0.695044	2.00 [1.00 - 4.01]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209425_at	90	0.877778	0.00186103	0.0426947	1.27114	0.096173	0.666829	1.95 [0.89 - 4.27]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209426_s_at	138	0.144928	0.0671757	-	0.763826	0.81181	0.0235037	1.02 [0.84 - 1.24]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209425_at	138	0.108696	0.00724479	0.126321	1.71276	0.680298	-0.0405096	0.96 [0.79 - 1.16]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209424_s_at	138	0.231884	0.0743155	-	0.559588	0.672943	0.0429914	1.04 [0.86 - 1.27]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217113_at	138	0.166667	0.0694399	-	-0.502749	0.294213	-3.16256	0.04 [0.00 - 15.60]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217111_at	138	0.166667	0.272226	-	-0.319324	0.460539	0.679795	1.97 [0.32 - 12.00]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217113_at	129	0.744186	0.0306451	0.359339	-0.6827	0.348999	-0.188972	0.83 [0.56 - 1.23]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209425_at	129	0.387597	0.0920979	-	-0.41455	0.899223	-0.0386402	0.96 [0.53 - 1.75]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209426_s_at	129	0.224806	0.0284457	0.34181	-0.571906	0.681285	0.137348	1.15 [0.60 - 2.21]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217111_at	129	0.829457	0.255598	-	0.333494	0.913641	-0.0131573	0.99 [0.78 - 1.25]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209424_s_at	129	0.813953	0.193068	-	-0.463803	0.708514	-0.0847142	0.92 [0.59 - 1.43]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38986	56	0.857143	0.065194	-	-1.06958	0.419553	-0.158074	0.85 [0.58 - 1.25]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13821	56	0.428571	0.151738	-	0.506439	0.924198	-0.0200018	0.98 [0.65 - 1.48]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38986	56	0.857143	0.0849926	-	-1.00789	0.677854	-0.0845159	0.92 [0.62 - 1.37]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13821	56	0.107143	0.139249	-	1.39216	0.833036	0.0474479	1.05 [0.67 - 1.63]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209424_s_at	278	0.888489	0.0290591	0.346762	-0.74722	0.449164	-0.138033	0.87 [0.61 - 1.25]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217113_at	278	0.248201	0.000893017	0.023174	-0.677663	0.0581513	-0.725845	0.48 [0.23 - 1.03]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217111_at	278	0.302158	0.0876597	-	0.38744	0.801481	-0.106315	0.90 [0.39 - 2.06]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209426_s_at	278	0.859712	0.0838966	-	-0.524624	0.266441	-0.19001	0.83 [0.59 - 1.16]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209425_at	278	0.83813	0.0530072	-	-0.581867	0.959997	-0.00706557	0.99 [0.75 - 1.31]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209424_s_at	133	0.157895	0.0959847	-	-0.497371	0.857478	-0.0482446	0.95 [0.56 - 1.61]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217113_at	133	0.766917	0.0209649	0.276986	0.606935	0.0308333	6.20559	495.51 [1.77 - 138500.61]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209425_at	133	0.609023	0.0320027	0.369858	0.50228	0.650366	0.105563	1.11 [0.70 - 1.75]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209426_s_at	133	0.345865	0.00320284	0.0663985	-0.701539	0.195053	-0.385986	0.68 [0.38 - 1.22]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217111_at	133	0.639098	0.000802878	0.0211862	0.782336	0.12921	0.765684	2.15 [0.80 - 5.78]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209425_at	185	0.832432	0.0246633	0.310121	0.491585	0.0815494	0.632754	1.88 [0.92 - 3.84]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217111_at	185	0.616216	0.000200481	0.00644082	-0.64427	0.00114029	-1.30388	0.27 [0.12 - 0.60]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209424_s_at	185	0.897297	0.180294	-	-0.421233	0.302719	-0.467609	0.63 [0.26 - 1.52]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217113_at	185	0.318919	0.177675	-	0.25977	0.667783	0.133713	1.14 [0.62 - 2.11]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209426_s_at	185	0.313514	0.344006	-	0.166536	0.961512	0.0107798	1.01 [0.65 - 1.57]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217111_at	185	0.816216	0.00150305	0.0357946	-0.797974	0.00293497	-1.30627	0.27 [0.11 - 0.64]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209425_at	185	0.832432	0.0165374	0.23396	0.487766	0.112756	0.537191	1.71 [0.88 - 3.32]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209426_s_at	185	0.313514	0.110476	-	0.312939	0.690789	0.0969435	1.10 [0.68 - 1.78]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209424_s_at	185	0.124324	0.188691	-	-0.316294	0.286825	-0.433866	0.65 [0.29 - 1.44]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217113_at	185	0.621622	0.216105	-	0.210929	0.749589	0.0915981	1.10 [0.62 - 1.92]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P106297	110	0.454545	0.0363241	0.401932	-0.482009	0.464089	-0.121075	0.89 [0.64 - 1.23]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P106297	110	0.436364	0.210702	-	-0.374333	0.897436	0.0278108	1.03 [0.67 - 1.57]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217113_at	80	0.45	0.183591	-	-0.583133	0.584365	-0.112826	0.89 [0.60 - 1.34]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209425_at	80	0.325	0.0293691	0.349245	-0.937677	0.524494	-0.174987	0.84 [0.49 - 1.44]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209426_s_at	80	0.425	0.0873022	-	-0.746328	0.572696	-0.208144	0.81 [0.39 - 1.67]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217111_at	80	0.25	0.0798407	-	1.23512	0.263646	0.179926	1.20 [0.87 - 1.64]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209424_s_at	80	0.425	0.354476	-	-0.402887	0.997661	0.00103961	1.00 [0.50 - 2.01]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_1228	281	0.896797	0.00518799	0.0974288	0.585308	0.496112	0.0696371	1.07 [0.88 - 1.31]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209425_at	38	0.342105	0.00196062	0.044562	1.85221	0.0415283	0.496536	1.64 [1.02 - 2.65]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209424_s_at	38	0.473684	0.00107505	0.0270785	1.67479	0.0167794	0.596918	1.82 [1.11 - 2.96]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217113_at	38	0.631579	0.023529	0.300201	-1.19388	0.206191	-0.337893	0.71 [0.42 - 1.20]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217111_at	38	0.342105	0.0769746	-	-0.847524	0.880485	-0.0497258	0.95 [0.50 - 1.82]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209426_s_at	38	0.526316	0.000828944	0.0217651	1.663	0.044647	0.551575	1.74 [1.01 - 2.97]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209426_s_at	140	0.857143	0.00941047	0.154226	0.845061	0.0145375	0.598942	1.82 [1.13 - 2.94]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217111_at	140	0.685714	0.154018	-	0.419854	0.260086	1.09396	2.99 [0.44 - 20.04]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209424_s_at	140	0.892857	0.0139574	0.206837	0.884923	0.00502423	0.797462	2.22 [1.27 - 3.88]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217113_at	140	0.714286	0.00993232	0.160637	-0.964215	0.138111	-1.23207	0.29 [0.06 - 1.49]
GENE	AMACR	alpha-methylacyl-CoA racemase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209425_at	140	0.871429	0.0397904	0.426246	0.717595	0.086513	0.424748	1.53 [0.94 - 2.49]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201196_s_at	30	0.5	0.298666	-	0.416453	0.835029	0.0888372	1.09 [0.47 - 2.52]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201197_at	30	0.133333	0.262283	-	-0.630047	0.538169	-0.248505	0.78 [0.35 - 1.72]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1788462	165	0.769697	0.0185234	0.253762	0.620036	0.289059	0.176406	1.19 [0.86 - 1.65]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1788462	165	0.70303	0.0106983	0.169854	0.876375	0.0758243	0.418974	1.52 [0.96 - 2.41]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201197_at	163	0.687117	0.0215177	0.282088	0.467889	0.384456	0.142216	1.15 [0.84 - 1.59]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201196_s_at	163	0.650307	0.0535064	-	0.388091	0.3074	0.159028	1.17 [0.86 - 1.59]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201196_s_at	79	0.886076	0.069929	-	0.72775	0.507136	0.176092	1.19 [0.71 - 2.01]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201197_at	79	0.835443	0.00311047	0.0648531	0.998349	0.379537	0.336152	1.40 [0.66 - 2.96]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201196_s_at	58	0.896552	0.130937	-	-0.700848	0.596355	-0.127847	0.88 [0.55 - 1.41]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201197_at	58	0.310345	0.333822	-	-0.285735	0.762652	-0.0575425	0.94 [0.65 - 1.37]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201196_s_at	34	0.176471	0.164793	-	0.872362	0.389227	0.396525	1.49 [0.60 - 3.67]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201197_at	34	0.705882	0.00288295	0.0609988	1.21288	0.0209341	0.908215	2.48 [1.15 - 5.36]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201196_s_at	158	0.196203	0.0821872	-	-0.452609	0.856394	-0.036171	0.96 [0.65 - 1.43]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201197_at	158	0.120253	0.041949	0.440809	-0.613177	0.743702	-0.0713227	0.93 [0.61 - 1.43]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201197_at	53	0.396226	0.401244	-	0.324895	0.85403	0.0919324	1.10 [0.41 - 2.92]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201196_s_at	53	0.415094	0.221375	-	0.437542	0.587879	0.291877	1.34 [0.47 - 3.85]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201197_at	53	0.113208	0.41604	-	0.487611	0.670058	0.208048	1.23 [0.47 - 3.21]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201196_s_at	53	0.415094	0.217975	-	0.475506	0.823881	0.124735	1.13 [0.38 - 3.40]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201196_s_at	180	0.366667	0.00164499	0.0385676	-0.669877	0.525272	-0.20207	0.82 [0.44 - 1.52]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201197_at	180	0.538889	0.00852844	0.143127	-0.555866	0.0207188	-0.79718	0.45 [0.23 - 0.89]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201196_s_at	559	0.254025	0.0357764	0.397979	0.511654	0.714763	0.103893	1.11 [0.64 - 1.94]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201197_at	559	0.119857	0.0828285	-	-0.457947	0.690974	-0.110865	0.90 [0.52 - 1.55]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201196_s_at	77	0.25974	0.183991	-	0.406617	0.827719	0.073455	1.08 [0.56 - 2.09]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201197_at	77	0.350649	0.0710025	-	0.504319	0.610177	0.157307	1.17 [0.64 - 2.14]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201197_at	70	0.542857	0.0228374	0.294049	-0.626516	0.590809	-0.102432	0.90 [0.62 - 1.31]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201196_s_at	70	0.871429	0.0188957	0.257379	-1.16378	0.400758	-0.17938	0.84 [0.55 - 1.27]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	263_g_at	50	0.88	0.00134958	0.0327348	1.43169	0.0355566	0.578207	1.78 [1.04 - 3.06]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36684_at	50	0.88	9.75089e-05	0.00342532	1.68293	0.012314	0.890116	2.44 [1.21 - 4.89]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	262_at	50	0.88	0.00134958	0.0327348	1.43169	0.0640811	0.63889	1.89 [0.96 - 3.73]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201196_s_at	74	0.783784	0.00092037	0.0237696	1.02169	0.032214	0.772293	2.16 [1.07 - 4.39]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201197_at	74	0.851351	0.0173573	0.242241	0.826884	0.135705	0.736274	2.09 [0.79 - 5.49]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201196_s_at	67	0.41791	0.154427	-	1.09151	0.954813	0.0539117	1.06 [0.16 - 6.81]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201197_at	67	0.402985	0.150551	-	1.10159	0.516905	-1.06298	0.35 [0.01 - 8.60]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201197_at	115	0.104348	0.00780511	0.133759	-1.45113	0.37851	-0.543911	0.58 [0.17 - 1.95]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201196_s_at	115	0.130435	0.277343	-	-0.696441	0.802926	0.118593	1.13 [0.44 - 2.86]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36684_at	158	0.575949	0.281649	-	0.3127	0.756982	0.0887824	1.09 [0.62 - 1.92]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	262_at	158	0.151899	0.282646	-	0.472994	0.656464	0.113707	1.12 [0.68 - 1.85]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	263_g_at	158	0.234177	0.0581415	-	0.721242	0.461199	0.2077	1.23 [0.71 - 2.14]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36684_at	76	0.578947	0.02723	0.331847	1.14792	0.184762	0.461511	1.59 [0.80 - 3.14]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	262_at	76	0.802632	0.0967637	-	0.884058	0.76034	0.105206	1.11 [0.57 - 2.18]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	263_g_at	76	0.302632	0.192236	-	-0.664616	0.772304	0.0974636	1.10 [0.57 - 2.13]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201197_at	204	0.279412	0.000280303	0.00861527	0.559558	0.00303082	0.288555	1.33 [1.10 - 1.61]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201196_s_at	204	0.553922	0.00412728	0.0813224	0.40049	0.0342652	0.205863	1.23 [1.02 - 1.49]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201196_s_at	87	0.655172	0.0300994	0.355048	0.806032	0.149618	0.35713	1.43 [0.88 - 2.32]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201197_at	87	0.528736	0.0263318	0.324354	0.851389	0.161724	0.470595	1.60 [0.83 - 3.09]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201196_s_at	87	0.655172	0.0300994	0.355048	0.806032	0.149618	0.35713	1.43 [0.88 - 2.32]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201197_at	87	0.528736	0.0263318	0.324354	0.851389	0.161724	0.470595	1.60 [0.83 - 3.09]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201197_at	77	0.753247	0.0247065	0.310495	1.32622	0.393561	0.471582	1.60 [0.54 - 4.73]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201196_s_at	77	0.857143	0.00677195	0.119912	1.59963	0.200151	0.511871	1.67 [0.76 - 3.65]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201197_at	77	0.753247	0.0205063	0.272711	1.21715	0.566253	0.288648	1.33 [0.50 - 3.58]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201196_s_at	77	0.753247	0.0224085	0.290196	1.20269	0.268607	0.404789	1.50 [0.73 - 3.07]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201197_at	136	0.882353	0.0125393	0.191156	1.233	0.368691	0.574613	1.78 [0.51 - 6.22]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201196_s_at	136	0.779412	0.204501	-	0.622897	0.601832	0.293896	1.34 [0.44 - 4.05]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201196_s_at	200	0.89	0.0141065	0.208451	0.857027	0.183365	0.352031	1.42 [0.85 - 2.39]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201197_at	200	0.88	0.00434734	0.084745	0.953156	0.211383	0.358283	1.43 [0.82 - 2.51]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3559	60	0.816667	0.00285243	0.0604763	1.24803	0.138603	0.361223	1.44 [0.89 - 2.31]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3559	60	0.683333	0.00218766	0.0487447	1.11973	0.4745	0.199961	1.22 [0.71 - 2.11]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1632	155	0.812903	0.00019581	0.00630995	1.02879	0.00512025	0.32048	1.38 [1.10 - 1.72]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201196_s_at	286	0.643357	0.057576	-	0.3744	0.390059	0.144665	1.16 [0.83 - 1.61]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201197_at	286	0.681818	0.0214496	0.281462	0.454438	0.658166	0.0840335	1.09 [0.75 - 1.58]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201196_s_at	159	0.767296	0.000302065	0.00919052	1.10427	0.0109553	0.782112	2.19 [1.20 - 3.99]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201197_at	159	0.849057	0.0247437	0.310817	0.79903	0.32581	0.33186	1.39 [0.72 - 2.70]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201196_s_at	159	0.597484	0.000358892	0.0106632	1.33334	0.0128227	0.881632	2.41 [1.21 - 4.84]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201197_at	159	0.704403	0.0287173	0.344009	0.687201	0.0599898	0.608227	1.84 [0.97 - 3.46]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201196_s_at	159	0.767296	0.00140073	0.033762	0.992597	0.0712501	0.56656	1.76 [0.95 - 3.26]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201197_at	159	0.704403	0.0342861	0.387062	0.771307	0.10472	0.624891	1.87 [0.88 - 3.97]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201196_s_at	54	0.351852	0.139809	-	1.49092	0.214148	0.565814	1.76 [0.72 - 4.30]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201197_at	54	0.148148	0.217977	-	-0.975215	0.530633	0.344735	1.41 [0.48 - 4.15]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201196_s_at	117	0.846154	0.013209	0.198635	-1.62301	0.178874	-0.190168	0.83 [0.63 - 1.09]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201196_s_at	117	0.581197	0.00124176	0.0305431	-1.57669	0.0173583	-0.419426	0.66 [0.47 - 0.93]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201196_s_at	117	0.401709	0.011014	0.17359	-0.988492	0.127159	-0.276652	0.76 [0.53 - 1.08]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201196_s_at	117	0.846154	0.013209	0.198635	-1.62301	0.178874	-0.190168	0.83 [0.63 - 1.09]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201197_at	117	0.435897	0.0334069	0.380508	-0.671445	0.0710171	-0.385807	0.68 [0.45 - 1.03]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201197_at	117	0.435897	0.000945339	0.0243105	-1.29425	0.00724139	-0.723321	0.49 [0.29 - 0.82]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201197_at	117	0.435897	0.0334069	0.380508	-0.671445	0.0710171	-0.385807	0.68 [0.45 - 1.03]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201197_at	117	0.435897	0.0187827	0.256285	-0.921177	0.116605	-0.438605	0.64 [0.37 - 1.12]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201197_at	236	0.737288	0.00137141	0.0331741	0.856893	0.00726038	0.692913	2.00 [1.21 - 3.32]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201196_s_at	236	0.84322	0.00986761	0.159848	0.780982	0.00595963	0.623192	1.86 [1.20 - 2.91]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201196_s_at	249	0.891566	0.0159236	0.227659	0.691341	0.0439322	0.386921	1.47 [1.01 - 2.15]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201197_at	249	0.730924	0.00300421	0.0630616	0.651151	0.0261577	0.463004	1.59 [1.06 - 2.39]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201197_at	125	0.608	0.011714	0.181748	0.716099	0.183473	0.203926	1.23 [0.91 - 1.66]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201197_at	54	0.833333	0.0153532	0.221721	1.42519	0.803245	-0.173661	0.84 [0.21 - 3.30]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201196_s_at	62	0.112903	0.115656	-	-0.879941	0.712994	-0.0784516	0.92 [0.61 - 1.40]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201196_s_at	125	0.12	0.203675	-	1.21785	0.686219	0.0911772	1.10 [0.70 - 1.70]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201197_at	62	0.870968	0.00149436	0.0356231	1.58589	0.90275	0.0671503	1.07 [0.36 - 3.14]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201196_s_at	125	0.72	0.167101	-	0.407127	0.299514	0.175169	1.19 [0.86 - 1.66]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201196_s_at	54	0.111111	0.0514346	-	-1.26774	0.462305	-0.192947	0.82 [0.49 - 1.38]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201197_at	125	0.304	0.0134633	0.20144	1.63107	0.194836	0.254658	1.29 [0.88 - 1.90]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201196_s_at	198	0.126263	0.0479302	0.479054	1.11393	0.337718	0.151788	1.16 [0.85 - 1.59]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201197_at	198	0.808081	0.0836363	-	0.428944	0.978653	0.00358627	1.00 [0.77 - 1.31]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201196_s_at	198	0.126263	0.0308027	0.360572	1.43121	0.198034	0.211193	1.24 [0.90 - 1.70]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201197_at	198	0.50505	0.265354	-	-0.286109	0.988622	-0.00234949	1.00 [0.72 - 1.38]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201197_at	198	0.873737	0.156165	-	0.490452	0.571333	0.0937905	1.10 [0.79 - 1.52]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201196_s_at	198	0.111111	0.0401456	0.428672	0.91305	0.733255	0.044753	1.05 [0.81 - 1.35]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201197_at	62	0.887097	0.226009	-	-15.186	0.763544	-0.106242	0.90 [0.45 - 1.80]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201196_s_at	51	0.54902	0.103666	-	1.63268	0.819065	0.163646	1.18 [0.29 - 4.79]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201196_s_at	62	0.354839	0.00427915	0.0836892	15.8741	0.438352	0.366349	1.44 [0.57 - 3.64]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201197_at	51	0.705882	0.130834	-	-15.6193	0.275458	-0.723187	0.49 [0.13 - 1.78]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201196_s_at	177	0.875706	0.00348207	0.0710066	-15.2395	0.82929	-0.0678543	0.93 [0.50 - 1.73]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201197_at	177	0.288136	0.037943	0.413435	0.593166	0.240784	0.419018	1.52 [0.75 - 3.06]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201196_s_at	177	0.146893	0.00669094	0.118801	1.30189	0.347767	0.260526	1.30 [0.75 - 2.24]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201197_at	145	0.855172	0.0388374	0.419678	-1.8302	0.352443	-0.457524	0.63 [0.24 - 1.66]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201196_s_at	145	0.675862	0.0035294	0.0717787	-1.425	0.724544	-0.129295	0.88 [0.43 - 1.80]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201197_at	177	0.875706	0.0120812	0.185961	-2.11628	0.818223	-0.0940226	0.91 [0.41 - 2.03]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201197_at	226	0.212389	0.0121544	0.186796	-0.734003	0.042806	-0.7342	0.48 [0.24 - 0.98]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201196_s_at	226	0.707965	0.0386107	0.418104	-0.77865	0.365159	-0.279705	0.76 [0.41 - 1.38]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201197_at	55	0.818182	0.139273	-	0.790096	0.687335	0.222681	1.25 [0.42 - 3.70]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201196_s_at	55	0.745455	0.164944	-	0.644409	0.407831	0.409429	1.51 [0.57 - 3.97]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201197_at	49	0.673469	0.173946	-	0.767362	0.526692	0.468802	1.60 [0.37 - 6.82]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201196_s_at	55	0.690909	0.243084	-	0.590983	0.647017	0.233175	1.26 [0.47 - 3.43]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201196_s_at	49	0.693878	0.118661	-	0.875921	0.988463	0.00926036	1.01 [0.29 - 3.54]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201197_at	55	0.654545	0.301036	-	0.462205	0.537212	0.311255	1.37 [0.51 - 3.67]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	149013	34	0.764706	0.0285813	0.342909	0.99767	0.378173	0.478292	1.61 [0.56 - 4.67]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201197_at	63	0.84127	0.167729	-	0.576329	0.412166	-0.136925	0.87 [0.63 - 1.21]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201196_s_at	63	0.15873	0.387443	-	-0.364707	0.92128	-0.0150811	0.99 [0.73 - 1.33]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g178517_3p_a_at	28	0.178571	0.0259283	0.32095	15.5367	0.765504	0.0773835	1.08 [0.65 - 1.80]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5209326_3p_at	28	0.678571	0.107462	-	0.850132	0.341373	0.572015	1.77 [0.55 - 5.76]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201197_at	82	0.170732	0.00384305	0.0768318	-1.04738	0.265654	-0.394151	0.67 [0.34 - 1.35]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201196_s_at	82	0.146341	2.06346e-05	0.000859048	-1.50315	0.139894	-0.791746	0.45 [0.16 - 1.30]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36684_at	84	0.880952	0.109478	-	-0.923668	0.17897	-0.479519	0.62 [0.31 - 1.25]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	262_at	84	0.416667	0.165669	-	-0.398487	0.406909	-0.292174	0.75 [0.37 - 1.49]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	263_g_at	84	0.702381	0.133662	-	0.456899	0.669806	-0.138631	0.87 [0.46 - 1.65]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201197_at	79	0.78481	0.101219	-	0.488177	0.740358	0.171551	1.19 [0.43 - 3.27]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201196_s_at	79	0.873418	0.017544	0.244106	0.815872	0.225821	0.57406	1.78 [0.70 - 4.50]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M21154_at	86	0.686047	0.0573756	-	0.764102	0.417771	0.40826	1.50 [0.56 - 4.04]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201196_s_at	104	0.336538	0.0360769	0.400151	-0.680744	0.833155	-0.110942	0.89 [0.32 - 2.51]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201197_at	104	0.105769	0.0025144	0.0545994	-1.15979	0.694602	-0.243157	0.78 [0.23 - 2.64]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P214121	117	0.666667	0.20343	-	-0.411707	0.924987	-0.0213088	0.98 [0.63 - 1.53]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P371962	117	0.111111	0.0237108	0.301805	-0.815288	0.944415	0.0195439	1.02 [0.59 - 1.77]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201197_at	204	0.269608	0.0301447	0.355405	-0.779332	0.371857	-0.513464	0.60 [0.19 - 1.85]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201197_at	204	0.269608	0.000777259	0.0206139	-0.892846	0.0085708	-1.09943	0.33 [0.15 - 0.76]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201196_s_at	204	0.661765	0.00444233	0.0862086	1.00602	0.295772	0.694433	2.00 [0.54 - 7.36]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201196_s_at	204	0.142157	0.0520238	-	-0.626029	0.615036	-0.255486	0.77 [0.29 - 2.10]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201197_at	178	0.247191	0.150534	-	-0.319159	0.827192	0.0688717	1.07 [0.58 - 1.99]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201196_s_at	178	0.662921	0.0847488	-	0.34735	0.959523	0.0158957	1.02 [0.55 - 1.88]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300019055	41	0.634146	0.0527595	-	0.791085	0.411004	0.269438	1.31 [0.69 - 2.49]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300013469	41	0.487805	0.0392423	0.422479	-0.886911	0.528994	-0.138125	0.87 [0.57 - 1.34]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201197_at	111	0.171171	0.0135421	0.202305	1.10115	0.467327	0.213842	1.24 [0.70 - 2.20]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201196_s_at	111	0.288288	0.0949979	-	0.508053	0.926533	-0.0262428	0.97 [0.56 - 1.70]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201197_at	90	0.122222	0.26495	-	-0.542213	0.69698	-0.122471	0.88 [0.48 - 1.64]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201197_at	90	0.122222	0.29233	-	-0.465105	0.729427	-0.0934828	0.91 [0.54 - 1.55]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201196_s_at	90	0.2	0.177469	-	-0.512938	0.591949	-0.161481	0.85 [0.47 - 1.54]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201196_s_at	90	0.744444	0.189145	-	0.508585	0.846376	-0.0658758	0.94 [0.48 - 1.82]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3120	50	0.14	0.230709	-	1.16293	0.63436	0.19043	1.21 [0.55 - 2.65]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201197_at	138	0.108696	0.0910906	-	0.792568	0.165392	0.32718	1.39 [0.87 - 2.20]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201196_s_at	138	0.101449	0.121307	-	0.730877	0.626753	0.0716027	1.07 [0.80 - 1.43]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201196_s_at	129	0.449612	0.080645	-	-0.428935	0.625984	-0.166755	0.85 [0.43 - 1.66]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201197_at	129	0.542636	0.192204	-	-0.328065	0.496559	-0.301399	0.74 [0.31 - 1.76]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5341	56	0.785714	0.0465017	0.470186	-1.02443	0.71326	-0.0964126	0.91 [0.54 - 1.52]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33674	56	0.107143	0.0556306	-	-0.920359	0.300859	-0.318949	0.73 [0.40 - 1.33]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5341	56	0.785714	0.0366453	0.404235	-1.20482	0.791672	-0.071104	0.93 [0.55 - 1.58]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33674	56	0.107143	0.0113238	0.177222	-1.18932	0.0760827	-0.541682	0.58 [0.32 - 1.06]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201197_at	278	0.140288	0.113705	-	0.478337	0.894321	-0.0305464	0.97 [0.62 - 1.52]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201196_s_at	278	0.866906	0.080192	-	-0.537781	0.474768	-0.139935	0.87 [0.59 - 1.28]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201196_s_at	133	0.556391	0.00308406	0.0644092	-0.741721	0.00699913	-0.349215	0.71 [0.55 - 0.91]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201197_at	133	0.428571	3.81503e-06	0.000185964	-1.06361	0.0059955	-0.564467	0.57 [0.38 - 0.85]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13457	81	0.851852	0.00982153	0.159285	1.35032	0.114095	0.584484	1.79 [0.87 - 3.70]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201196_s_at	185	0.843243	0.00999735	0.161428	0.549007	0.173956	0.192521	1.21 [0.92 - 1.60]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201197_at	185	0.827027	0.119216	-	0.331561	0.334271	0.132926	1.14 [0.87 - 1.50]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201196_s_at	185	0.843243	0.0461031	0.467683	0.46922	0.273432	0.169359	1.18 [0.87 - 1.60]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201197_at	185	0.735135	0.197097	-	0.227417	0.355443	0.116444	1.12 [0.88 - 1.44]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P214121	110	0.863636	0.116317	-	0.492893	0.282329	0.236215	1.27 [0.82 - 1.95]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P371962	110	0.872727	0.0470206	0.473426	0.632124	0.901234	0.0282573	1.03 [0.66 - 1.61]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P214121	110	0.318182	0.00160559	0.0378031	1.18595	0.000653863	0.862738	2.37 [1.44 - 3.89]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P371962	110	0.890909	3.37389e-05	0.00133497	1.45338	0.0323583	0.605268	1.83 [1.05 - 3.19]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201196_s_at	80	0.3125	0.035527	0.396169	1.43752	0.289615	0.358279	1.43 [0.74 - 2.78]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201197_at	80	0.3875	0.0149473	0.217445	1.27926	0.0733435	0.682414	1.98 [0.94 - 4.18]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_2139	281	0.896797	0.0164228	0.232791	0.519136	0.0928741	0.436614	1.55 [0.93 - 2.58]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:304820	59	0.779661	0.183617	-	-1.28543	0.835002	-0.218345	0.80 [0.10 - 6.27]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201197_at	38	0.789474	0.185121	-	-0.953832	0.838359	-0.103228	0.90 [0.33 - 2.43]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201196_s_at	38	0.631579	0.0544244	-	0.936279	0.494845	0.296296	1.34 [0.57 - 3.15]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201197_at	140	0.892857	0.0651634	-	0.741192	0.0876397	0.587472	1.80 [0.92 - 3.53]
GENE	AMD1	adenosylmethionine decarboxylase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201196_s_at	140	0.892857	4.18328e-05	0.00161753	1.32927	0.0278532	0.784746	2.19 [1.09 - 4.41]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219082_at	30	0.133333	0.0132698	0.199308	2.1318	0.0519281	1.4753	4.37 [0.99 - 19.35]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1698834	165	0.787879	0.0609196	-	0.501096	0.933882	-0.0280588	0.97 [0.50 - 1.89]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1698834	165	0.806061	0.113823	-	0.612592	0.971395	-0.0189498	0.98 [0.35 - 2.76]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219082_at	163	0.496933	0.0405828	0.431642	-0.404518	0.420823	-0.464001	0.63 [0.20 - 1.95]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219082_at	79	0.531646	0.0414238	0.437304	-0.609889	0.0914095	-1.16134	0.31 [0.08 - 1.21]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219082_at	58	0.431034	0.036556	0.403596	-0.582639	0.891588	-0.0257534	0.97 [0.67 - 1.41]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219082_at	34	0.117647	0.100402	-	1.15036	0.520621	0.124993	1.13 [0.77 - 1.66]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219082_at	158	0.873418	0.0613556	-	0.563802	0.260229	0.512916	1.67 [0.68 - 4.08]
GENE	AMDHD2	amidohydrolase domain containing 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219082_at	53	0.113208	0.262294	-	0.799525	0.808678	0.0619222	1.06 [0.64 - 1.76]
GENE	AMDHD2	amidohydrolase domain containing 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219082_at	53	0.603774	0.329712	-	-0.349201	0.805367	-0.0594479	0.94 [0.59 - 1.51]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219082_at	180	0.844444	0.0373843	0.409495	0.572183	0.120471	-0.22431	0.80 [0.60 - 1.06]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219082_at	559	0.457961	0.189617	-	0.267478	0.720397	0.0572909	1.06 [0.77 - 1.45]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219082_at	77	0.896104	0.0689864	-	0.728419	0.65744	0.0583037	1.06 [0.82 - 1.37]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219082_at	70	0.885714	0.28898	-	-0.493879	0.694266	-0.217648	0.80 [0.27 - 2.38]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219082_at	74	0.27027	0.0423168	0.443248	0.717115	0.0837807	0.285359	1.33 [0.96 - 1.84]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219082_at	67	0.850746	0.0258201	0.320033	1.46747	0.327184	1.76155	5.82 [0.17 - 197.42]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219082_at	115	0.530435	0.0103231	0.165367	-1.73503	0.191778	-0.867443	0.42 [0.11 - 1.55]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219082_at	204	0.754902	0.270523	-	-0.178161	0.962484	0.00571912	1.01 [0.79 - 1.28]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219082_at	87	0.321839	0.0166106	0.234706	-0.885458	0.78032	-0.101012	0.90 [0.44 - 1.84]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219082_at	87	0.321839	0.0166106	0.234706	-0.885458	0.78032	-0.101012	0.90 [0.44 - 1.84]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219082_at	77	0.142857	0.112897	-	15.2878	0.713478	-0.258184	0.77 [0.19 - 3.06]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219082_at	77	0.545455	0.0753883	-	-1.31053	0.489204	-0.553298	0.58 [0.12 - 2.76]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219082_at	136	0.5	0.297029	-	0.473151	0.91596	-0.0264636	0.97 [0.60 - 1.59]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219082_at	200	0.22	0.0750105	-	-0.556574	0.619589	-0.131725	0.88 [0.52 - 1.47]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219082_at	286	0.405594	0.016788	0.236508	-0.458963	0.170055	-0.160504	0.85 [0.68 - 1.07]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219082_at	159	0.106918	0.0579797	-	1.70615	0.219288	0.294715	1.34 [0.84 - 2.15]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219082_at	159	0.748428	0.0158131	0.226515	0.761315	0.0706912	0.468394	1.60 [0.96 - 2.65]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219082_at	159	0.754717	0.0107418	0.170371	0.920513	0.0927484	0.527278	1.69 [0.92 - 3.13]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	222009_at	54	0.648148	0.41557	-	0.541328	0.813147	-0.324809	0.72 [0.05 - 10.68]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219082_at	54	0.722222	0.153422	-	0.971244	0.742199	0.258184	1.29 [0.28 - 6.03]
GENE	AMDHD2	amidohydrolase domain containing 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219082_at	117	0.213675	0.150977	-	-0.509792	0.92022	0.0368058	1.04 [0.50 - 2.13]
GENE	AMDHD2	amidohydrolase domain containing 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219082_at	117	0.34188	0.212789	-	-0.489474	0.775508	-0.127807	0.88 [0.37 - 2.12]
GENE	AMDHD2	amidohydrolase domain containing 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219082_at	117	0.213675	0.150977	-	-0.509792	0.92022	0.0368058	1.04 [0.50 - 2.13]
GENE	AMDHD2	amidohydrolase domain containing 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219082_at	117	0.213675	0.277566	-	-0.451758	0.762817	0.128913	1.14 [0.49 - 2.63]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219082_at	236	0.877119	0.000103348	0.00360537	1.14477	0.112403	0.280186	1.32 [0.94 - 1.87]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219082_at	249	0.895582	0.0004859	0.013828	0.935133	0.0654006	0.255457	1.29 [0.98 - 1.69]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219082_at	125	0.888	0.0120233	0.1853	1.06073	0.229757	0.362317	1.44 [0.80 - 2.60]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219082_at	125	0.12	0.25442	-	-0.501457	0.881427	0.0353832	1.04 [0.65 - 1.65]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219082_at	54	0.888889	0.109209	-	1.02949	0.97189	0.0179413	1.02 [0.38 - 2.76]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219082_at	62	0.112903	0.0918466	-	-0.937939	0.668723	-0.180352	0.83 [0.37 - 1.91]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219082_at	198	0.111111	0.0500638	-	0.827179	0.182794	0.120907	1.13 [0.94 - 1.35]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219082_at	198	0.222222	0.0476014	0.477027	0.735573	0.251623	0.126986	1.14 [0.91 - 1.41]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219082_at	198	0.227273	0.0412068	0.435849	0.805789	0.285059	0.125714	1.13 [0.90 - 1.43]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219082_at	51	0.803922	0.22777	-	1.05337	0.284525	2.43907	11.46 [0.13 - 998.27]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219082_at	62	0.741935	0.0172412	0.241078	1.28991	0.0748903	1.80001	6.05 [0.83 - 43.85]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219082_at	145	0.489655	0.234743	-	-0.397556	0.502613	-0.437225	0.65 [0.18 - 2.32]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219082_at	177	0.175141	0.0127952	0.19403	-0.740329	0.062311	-0.915363	0.40 [0.15 - 1.05]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219082_at	177	0.350282	0.0926352	-	-0.402274	0.168347	-0.603162	0.55 [0.23 - 1.29]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219082_at	226	0.659292	0.00281609	0.0598526	0.822558	0.154728	0.208213	1.23 [0.92 - 1.64]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219082_at	49	0.897959	0.160708	-	1.04547	0.992906	-0.00942733	0.99 [0.12 - 7.92]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219082_at	55	0.236364	0.171278	-	0.834118	0.949196	-0.0528908	0.95 [0.19 - 4.83]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219082_at	55	0.690909	0.0122163	0.1875	1.11619	0.136914	1.3463	3.84 [0.65 - 22.66]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	173909	34	0.5	0.322834	-	-0.442874	0.685534	-0.26712	0.77 [0.21 - 2.79]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219082_at	63	0.492063	0.0111406	0.175078	0.868514	0.103097	0.228556	1.26 [0.95 - 1.65]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7705595_3p_at	28	0.714286	0.28108	-	-0.697027	0.935169	-0.210121	0.81 [0.01 - 128.10]
GENE	AMDHD2	amidohydrolase domain containing 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219082_at	82	0.634146	0.233784	-	-0.44436	0.882171	-0.0564885	0.95 [0.45 - 1.99]
GENE	AMDHD2	amidohydrolase domain containing 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219082_at	79	0.670886	0.284366	-	0.2865	0.826484	0.116016	1.12 [0.40 - 3.17]
GENE	AMDHD2	amidohydrolase domain containing 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219082_at	104	0.125	0.0933069	-	1.15869	0.156494	0.623979	1.87 [0.79 - 4.42]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P49351	117	0.205128	0.158468	-	-0.45274	0.434858	-0.226672	0.80 [0.45 - 1.41]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219082_at	204	0.715686	0.0287826	0.344536	0.787098	0.0698109	0.684154	1.98 [0.95 - 4.15]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219082_at	204	0.696078	0.0113997	0.178106	0.684826	0.0384012	0.556631	1.74 [1.03 - 2.96]
GENE	AMDHD2	amidohydrolase domain containing 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219082_at	178	0.657303	0.300765	-	0.214124	0.991911	-0.00347211	1.00 [0.51 - 1.95]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219082_at	111	0.684685	0.298341	-	0.282922	0.951133	-0.0118211	0.99 [0.68 - 1.44]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219082_at	90	0.777778	0.175859	-	0.538951	0.602779	0.333186	1.40 [0.40 - 4.89]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219082_at	90	0.733333	0.0439425	0.453888	0.668441	0.486513	0.389153	1.48 [0.49 - 4.42]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219082_at	138	0.753623	0.0221499	0.287856	0.586656	0.178832	0.245286	1.28 [0.89 - 1.83]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219082_at	129	0.108527	0.00382681	0.0765728	-0.981437	0.279413	-0.194965	0.82 [0.58 - 1.17]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18852	56	0.892857	0.0209402	0.276758	1.11723	0.394099	0.323833	1.38 [0.66 - 2.91]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18852	56	0.892857	0.02349	0.299856	1.08848	0.446417	0.27537	1.32 [0.65 - 2.68]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219082_at	278	0.892086	0.0951954	-	-0.505339	0.794792	0.0524881	1.05 [0.71 - 1.57]
GENE	AMDHD2	amidohydrolase domain containing 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219082_at	133	0.255639	0.0465542	0.470515	0.574033	0.916854	0.0218918	1.02 [0.68 - 1.54]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219082_at	185	0.394595	0.00268862	0.0576498	-0.502656	0.0380564	-0.414221	0.66 [0.45 - 0.98]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219082_at	185	0.394595	0.00129243	0.0315776	-0.57559	0.0388638	-0.457723	0.63 [0.41 - 0.98]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P49351	110	0.763636	0.0820454	-	0.554069	0.993858	0.00160385	1.00 [0.67 - 1.51]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P49351	110	0.754545	0.0597256	-	0.463363	0.637227	0.0802783	1.08 [0.78 - 1.51]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219082_at	80	0.1125	0.0331438	0.37853	-1.15313	0.995498	-0.000960051	1.00 [0.72 - 1.39]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_2416	281	0.879004	0.016416	0.232721	0.473568	0.075189	0.123653	1.13 [0.99 - 1.30]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219082_at	38	0.736842	0.034748	0.390472	1.00982	0.199178	0.541098	1.72 [0.75 - 3.92]
GENE	AMDHD2	amidohydrolase domain containing 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219082_at	140	0.6	0.0963198	-	0.477407	0.537301	0.297334	1.35 [0.52 - 3.46]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206121_at	30	0.4	0.00677603	0.119968	-1.11115	0.283986	-0.70893	0.49 [0.13 - 1.80]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1759312	165	0.812121	0.0378466	0.412757	0.595384	0.311595	0.351434	1.42 [0.72 - 2.81]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1759312	165	0.157576	0.0799372	-	1.20565	0.921378	0.0575479	1.06 [0.34 - 3.32]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206121_at	163	0.736196	0.0867534	-	-0.403703	0.219494	-0.740861	0.48 [0.15 - 1.56]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206121_at	79	0.265823	0.0832566	-	0.631996	0.866293	0.0912317	1.10 [0.38 - 3.17]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206121_at	58	0.827586	0.144055	-	0.518699	0.619387	0.105087	1.11 [0.73 - 1.68]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206121_at	34	0.323529	0.000271791	0.00838841	-1.52322	0.0506595	-0.939507	0.39 [0.15 - 1.00]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206121_at	158	0.810127	0.082649	-	0.470574	0.247732	0.731937	2.08 [0.60 - 7.19]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206121_at	53	0.886792	0.113243	-	0.771907	0.546861	0.115291	1.12 [0.77 - 1.63]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206121_at	53	0.886792	0.21877	-	0.593813	0.61089	0.0917987	1.10 [0.77 - 1.56]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206121_at	180	0.816667	0.0112421	0.176267	0.605017	0.438385	0.164055	1.18 [0.78 - 1.78]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206121_at	559	0.563506	0.0107593	0.170579	-0.555788	0.10191	-0.166354	0.85 [0.69 - 1.03]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206121_at	77	0.805195	0.0822459	-	-0.593441	0.175792	-0.286689	0.75 [0.50 - 1.14]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206121_at	70	0.157143	0.124189	-	-0.537821	0.63015	-0.434757	0.65 [0.11 - 3.80]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40743_at	50	0.64	0.0327003	0.375177	-0.798703	0.092934	-1.46965	0.23 [0.04 - 1.28]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206121_at	74	0.824324	0.0367458	0.404954	-1.04428	0.84274	-0.0686877	0.93 [0.47 - 1.84]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206121_at	67	0.880597	0.23882	-	-15.2349	0.96899	-0.0841921	0.92 [0.01 - 64.11]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206121_at	115	0.782609	0.0342905	0.387095	1.08913	0.162279	1.10865	3.03 [0.64 - 14.35]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40743_at	158	0.14557	0.0163339	0.231881	1.57125	0.184823	0.242914	1.27 [0.89 - 1.83]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40743_at	76	0.657895	0.100636	-	-1.18001	0.365744	-0.296768	0.74 [0.39 - 1.41]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206121_at	204	0.406863	0.0010407	0.026352	-0.47116	0.147741	-0.107822	0.90 [0.78 - 1.04]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206121_at	87	0.758621	0.00521244	0.0977891	-1.80677	0.0462535	-1.12317	0.33 [0.11 - 0.98]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206121_at	87	0.758621	0.00521244	0.0977891	-1.80677	0.0462535	-1.12317	0.33 [0.11 - 0.98]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206121_at	77	0.61039	0.00598183	0.108905	-15.9678	0.122005	-1.71176	0.18 [0.02 - 1.58]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206121_at	77	0.61039	0.0123961	0.18954	-2.16574	0.181698	-1.22712	0.29 [0.05 - 1.77]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206121_at	136	0.147059	0.0123457	0.188969	-1.11876	0.462641	-0.169345	0.84 [0.54 - 1.33]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206121_at	200	0.535	0.0730385	-	-0.542503	0.305723	-0.297072	0.74 [0.42 - 1.31]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11577	60	0.883333	1.0575e-05	0.000469991	1.79331	0.00133421	0.459691	1.58 [1.20 - 2.10]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11577	60	0.883333	0.000149761	0.00499303	1.69697	0.139011	0.236823	1.27 [0.93 - 1.73]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5864	155	0.819355	4.92128e-05	0.0018694	1.11587	0.00139966	0.175891	1.19 [1.07 - 1.33]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206121_at	286	0.482517	0.0167346	0.235966	-0.463376	0.0743043	-0.347053	0.71 [0.48 - 1.03]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206121_at	159	0.113208	0.104993	-	-0.663287	0.62538	-0.223893	0.80 [0.33 - 1.96]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206121_at	159	0.81761	0.233993	-	-0.561795	0.783087	-0.127119	0.88 [0.36 - 2.18]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206121_at	159	0.113208	0.17396	-	-0.657405	0.951844	-0.0327656	0.97 [0.33 - 2.80]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206121_at	54	0.555556	0.146941	-	-1.41723	0.801298	-0.276058	0.76 [0.09 - 6.51]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206121_at	117	0.709402	0.0103041	0.165139	-1.16236	0.353353	-0.436031	0.65 [0.26 - 1.62]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206121_at	117	0.854701	0.195581	-	-0.921324	0.586173	0.233904	1.26 [0.54 - 2.93]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206121_at	117	0.709402	0.0103041	0.165139	-1.16236	0.353353	-0.436031	0.65 [0.26 - 1.62]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206121_at	117	0.683761	0.030902	0.361347	-1.10887	0.643243	-0.239356	0.79 [0.29 - 2.17]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206121_at	236	0.79661	0.0500374	-	-0.82455	0.376337	-0.322198	0.72 [0.35 - 1.48]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206121_at	249	0.658635	0.0334722	0.380998	-0.510632	0.108974	-0.461425	0.63 [0.36 - 1.11]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206121_at	62	0.354839	0.076571	-	-0.834332	0.871031	-0.0381763	0.96 [0.61 - 1.53]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206121_at	125	0.552	0.102117	-	-0.650918	0.842839	-0.109907	0.90 [0.30 - 2.66]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206121_at	125	0.504	0.01463	0.214074	-0.752129	0.318132	-0.433795	0.65 [0.28 - 1.52]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206121_at	54	0.111111	0.0450984	0.461316	-1.57299	0.885752	0.0410815	1.04 [0.59 - 1.82]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206121_at	198	0.823232	0.027197	0.331574	-1.09177	0.283248	-0.131507	0.88 [0.69 - 1.11]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206121_at	198	0.111111	0.123869	-	-0.458651	0.523785	-0.0637448	0.94 [0.77 - 1.14]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206121_at	198	0.823232	0.0627186	-	-0.781356	0.288665	-0.123244	0.88 [0.70 - 1.11]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206121_at	51	0.352941	0.0346762	0.389943	-2.00758	0.275492	-2.4109	0.09 [0.00 - 6.84]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206121_at	62	0.66129	0.0358858	0.398771	-1.89543	0.162166	-1.50931	0.22 [0.03 - 1.83]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206121_at	177	0.163842	0.00119597	0.0296012	-0.861502	0.0283186	-0.958766	0.38 [0.16 - 0.90]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206121_at	145	0.793103	0.0276977	0.335704	-1.24837	0.247615	-0.662228	0.52 [0.17 - 1.58]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206121_at	177	0.80226	0.00650423	0.116226	-1.31874	0.0637827	-0.930217	0.39 [0.15 - 1.05]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206121_at	226	0.424779	0.00670415	0.118983	-0.759612	0.163569	-0.211366	0.81 [0.60 - 1.09]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206121_at	55	0.381818	0.0994174	-	-0.734735	0.905715	-0.0904927	0.91 [0.20 - 4.08]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206121_at	49	0.877551	0.0404001	0.430402	1.29283	0.417401	0.704848	2.02 [0.37 - 11.12]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206121_at	55	0.672727	0.0235616	0.300489	0.976924	0.248434	0.708562	2.03 [0.61 - 6.77]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206121_at	63	0.15873	0.010723	0.170148	-0.964806	0.898115	0.487294	1.63 [0.00 - 2825.63]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557310_3p_at	28	0.857143	0.0016137	0.0379607	1.95207	0.020152	1.4151	4.12 [1.25 - 13.58]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206121_at	82	0.719512	0.0418732	0.440305	0.692822	0.389127	0.568775	1.77 [0.48 - 6.44]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206121_at	79	0.392405	0.0672194	-	-0.478289	0.243791	-0.75391	0.47 [0.13 - 1.67]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206121_at	104	0.413462	0.0409413	0.434063	0.742009	0.609784	0.362827	1.44 [0.36 - 5.79]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206121_at	204	0.745098	0.00264371	0.056868	-2.42308	0.144556	-0.260922	0.77 [0.54 - 1.09]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206121_at	204	0.745098	0.012758	0.193614	-0.971052	0.27327	-0.147986	0.86 [0.66 - 1.12]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206121_at	178	0.870786	0.0535926	-	-0.661976	0.17292	-0.490629	0.61 [0.30 - 1.24]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206121_at	111	0.585586	0.0642325	-	-0.514975	0.096325	-0.267434	0.77 [0.56 - 1.05]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206121_at	90	0.122222	0.0292021	0.34791	1.91074	0.901649	-0.0613303	0.94 [0.36 - 2.49]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206121_at	90	0.122222	0.0893113	-	1.5671	0.529499	-0.367581	0.69 [0.22 - 2.18]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4404	50	0.22	0.310036	-	-0.537713	0.705061	-0.580231	0.56 [0.03 - 11.30]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206121_at	138	0.137681	0.00546041	0.101418	-0.776335	0.0800383	-0.509641	0.60 [0.34 - 1.06]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206121_at	129	0.341085	0.251781	-	-0.289096	0.785708	-0.0991715	0.91 [0.44 - 1.85]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6411	56	0.553571	0.393258	-	-0.300211	0.946196	0.00905267	1.01 [0.78 - 1.31]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6411	56	0.821429	0.128383	-	-1.06565	0.288518	-0.170423	0.84 [0.62 - 1.16]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206121_at	278	0.643885	0.0813983	-	-0.358891	0.163203	-0.398627	0.67 [0.38 - 1.18]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206121_at	133	0.789474	0.00102809	0.0260842	0.839369	0.77005	0.0763461	1.08 [0.65 - 1.80]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4943	81	0.716049	0.151347	-	0.757657	0.988623	0.00855617	1.01 [0.31 - 3.27]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18069	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206121_at	185	0.735135	0.148067	-	0.282403	0.366655	0.213075	1.24 [0.78 - 1.97]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206121_at	185	0.335135	0.0991136	-	0.28437	0.439185	0.166878	1.18 [0.77 - 1.80]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P51787	110	0.127273	0.104719	-	0.6347	0.607004	0.0508341	1.05 [0.87 - 1.28]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P51787	110	0.663636	0.188548	-	0.39027	0.726557	0.048709	1.05 [0.80 - 1.38]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206121_at	80	0.1875	0.110961	-	-0.766635	0.858487	-0.0416918	0.96 [0.61 - 1.52]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0509	281	0.615658	0.0284527	0.341867	-0.31888	0.355454	-0.102695	0.90 [0.73 - 1.12]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206121_at	38	0.184211	0.000524813	0.0147684	-1.66341	0.359745	-0.489876	0.61 [0.21 - 1.75]
GENE	AMPD1	adenosine monophosphate deaminase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206121_at	140	0.185714	0.0755482	-	-0.625602	0.164701	-0.542485	0.58 [0.27 - 1.25]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212360_at	30	0.166667	0.0860928	-	-0.849427	0.855073	-0.128024	0.88 [0.22 - 3.48]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1786899	165	0.133333	0.118947	-	-0.478149	0.299444	-2.13426	0.12 [0.00 - 6.67]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1786899	165	0.121212	0.149039	-	-0.643953	0.335808	-2.93888	0.05 [0.00 - 21.03]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212360_at	163	0.220859	0.0492603	0.487168	0.506136	0.155153	0.248779	1.28 [0.91 - 1.81]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212360_at	79	0.632911	0.0160646	0.229114	0.697201	0.0386615	0.522892	1.69 [1.03 - 2.77]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212360_at	58	0.87931	0.0299353	0.35375	0.868665	0.385121	0.281495	1.33 [0.70 - 2.50]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212360_at	34	0.205882	0.108448	-	0.950657	0.49087	0.276841	1.32 [0.60 - 2.90]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212360_at	158	0.341772	0.101326	-	-0.380646	0.717321	-0.197884	0.82 [0.28 - 2.40]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212360_at	53	0.301887	0.330169	-	-0.348999	0.62048	0.302162	1.35 [0.41 - 4.47]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212360_at	53	0.433962	0.26222	-	0.422643	0.837559	0.133442	1.14 [0.32 - 4.09]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212360_at	180	0.838889	0.0974496	-	0.443906	0.817675	0.0708769	1.07 [0.59 - 1.96]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212360_at	559	0.304114	0.0645462	-	-0.372632	0.51013	-0.160348	0.85 [0.53 - 1.37]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212360_at	77	0.25974	0.0246064	0.309629	-0.643686	0.100546	-0.543573	0.58 [0.30 - 1.11]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212360_at	70	0.114286	0.00761125	0.131204	-1.03247	0.0594407	-0.929484	0.39 [0.15 - 1.04]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38417_at	50	0.82	0.0247506	0.310876	0.900439	0.152069	0.34478	1.41 [0.88 - 2.26]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212360_at	74	0.675676	0.144736	-	-0.470803	0.993457	0.00535178	1.01 [0.28 - 3.61]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212360_at	67	0.477612	0.083345	-	-1.30153	0.95266	-0.0682214	0.93 [0.10 - 8.88]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212360_at	115	0.782609	0.040264	0.429478	-15.4258	0.841087	-0.142035	0.87 [0.22 - 3.48]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38417_at	158	0.727848	0.0351067	0.393103	0.60648	0.402737	0.54083	1.72 [0.48 - 6.10]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38417_at	76	0.815789	0.227377	-	-1.18017	0.775243	-0.249136	0.78 [0.14 - 4.31]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212360_at	204	0.627451	0.0326351	0.374682	0.311998	0.650789	0.10649	1.11 [0.70 - 1.76]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212360_at	87	0.195402	0.00307377	0.064236	-1.11637	0.108107	-0.803128	0.45 [0.17 - 1.19]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212360_at	87	0.195402	0.00307377	0.064236	-1.11637	0.108107	-0.803128	0.45 [0.17 - 1.19]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212360_at	77	0.688312	0.120282	-	-1.4953	0.901597	-0.108948	0.90 [0.16 - 5.04]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212360_at	77	0.688312	0.04857	0.482974	-1.8008	0.510539	-0.489528	0.61 [0.14 - 2.63]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212360_at	136	0.154412	0.165672	-	1.32527	0.88818	0.077603	1.08 [0.37 - 3.19]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212360_at	200	0.735	0.274273	-	0.33778	0.682888	-0.216788	0.81 [0.28 - 2.28]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18497	60	0.6	0.118006	-	-0.647133	0.380768	-0.274896	0.76 [0.41 - 1.40]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18497	60	0.883333	0.0464062	0.469588	0.96353	0.882749	0.0687088	1.07 [0.43 - 2.67]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	22475	155	0.832258	3.23834e-05	0.00128691	1.17036	0.0983467	0.293882	1.34 [0.95 - 1.90]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212360_at	286	0.377622	0.0148886	0.216823	0.513601	0.0679771	0.469651	1.60 [0.97 - 2.65]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212360_at	159	0.886792	0.141171	-	0.60416	0.820482	0.0962677	1.10 [0.48 - 2.53]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212360_at	159	0.238994	0.160825	-	-0.541314	0.83756	0.100735	1.11 [0.42 - 2.90]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212360_at	159	0.597484	0.283124	-	0.338284	0.630825	0.199463	1.22 [0.54 - 2.75]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212360_at	54	0.240741	0.316077	-	-0.71695	0.979771	0.0233177	1.02 [0.17 - 6.21]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212360_at	117	0.555556	0.0898523	-	0.540358	0.774026	-0.100511	0.90 [0.46 - 1.80]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212360_at	117	0.529915	0.100957	-	0.636194	0.795007	-0.107115	0.90 [0.40 - 2.02]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212360_at	117	0.555556	0.0898523	-	0.540358	0.774026	-0.100511	0.90 [0.46 - 1.80]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212360_at	117	0.529915	0.0274546	0.333703	0.907492	0.332243	0.415702	1.52 [0.65 - 3.51]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212360_at	236	0.872881	0.0329278	0.3769	0.705426	0.593716	0.256001	1.29 [0.50 - 3.31]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212360_at	249	0.871486	0.00537581	0.100185	0.739074	0.284791	0.411094	1.51 [0.71 - 3.20]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212360_at	62	0.725806	0.0355046	0.396005	-1.30469	0.512623	-0.143112	0.87 [0.56 - 1.33]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212360_at	125	0.456	0.0410955	0.435102	0.874156	0.309158	0.515746	1.67 [0.62 - 4.53]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212360_at	125	0.848	0.246302	-	0.408978	0.705928	0.152086	1.16 [0.53 - 2.57]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212360_at	54	0.222222	0.0753292	-	-1.01693	0.556532	-0.154667	0.86 [0.51 - 1.43]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212360_at	198	0.171717	0.169189	-	0.546514	0.547068	0.148179	1.16 [0.72 - 1.88]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212360_at	198	0.171717	0.283936	-	0.430611	0.699312	0.100133	1.11 [0.66 - 1.84]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212360_at	198	0.171717	0.119426	-	0.496724	0.458298	0.150176	1.16 [0.78 - 1.73]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212360_at	51	0.823529	0.292593	-	-15.3231	0.844945	-0.189241	0.83 [0.12 - 5.51]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212360_at	62	0.693548	0.082799	-	-1.62814	0.593357	-0.348628	0.71 [0.20 - 2.54]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212360_at	177	0.474576	0.106557	-	0.451676	0.496992	0.339939	1.40 [0.53 - 3.75]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212360_at	177	0.531073	0.0951029	-	0.393815	0.717258	0.156189	1.17 [0.50 - 2.72]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212360_at	145	0.165517	0.106181	-	1.1185	0.761633	0.182403	1.20 [0.37 - 3.90]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212360_at	226	0.615044	0.0469229	0.472818	0.561152	0.469502	0.230206	1.26 [0.67 - 2.35]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212360_at	55	0.854545	0.17033	-	-1.3119	0.769163	-0.176467	0.84 [0.26 - 2.72]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212360_at	55	0.418182	0.0356344	0.396949	1.08839	0.258037	0.756459	2.13 [0.57 - 7.90]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212360_at	49	0.44898	0.12849	-	0.974901	0.654369	0.410984	1.51 [0.25 - 9.12]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	28410	34	0.647059	0.0404312	0.430614	0.881758	0.143035	0.712634	2.04 [0.79 - 5.29]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212360_at	63	0.730159	0.0324604	0.373354	0.737457	0.340716	0.217393	1.24 [0.79 - 1.94]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.82927.0.S2_3p_at	28	0.857143	0.0198729	0.266742	1.40256	0.286007	0.403994	1.50 [0.71 - 3.15]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212360_at	82	0.195122	0.018207	0.250665	-0.839383	0.139667	-0.835887	0.43 [0.14 - 1.31]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38417_at	84	0.404762	0.032077	0.370427	0.662179	0.664971	0.2488	1.28 [0.42 - 3.95]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212360_at	79	0.759494	0.126147	-	0.437405	0.808404	0.095078	1.10 [0.51 - 2.37]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M91029_cds2_at	86	0.44186	0.258246	-	-0.464925	0.680733	0.255135	1.29 [0.38 - 4.35]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212360_at	104	0.615385	0.0427969	0.446414	0.652402	0.466413	0.388057	1.47 [0.52 - 4.19]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P201596	117	0.196581	0.0210751	0.278008	-0.715606	0.409297	-0.246571	0.78 [0.44 - 1.40]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212360_at	204	0.259804	0.00160674	0.0378255	2.5041	0.0383846	1.34404	3.83 [1.07 - 13.68]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212360_at	204	0.602941	0.00139387	0.0336248	0.854396	0.00634	1.34071	3.82 [1.46 - 10.01]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212360_at	178	0.747191	0.258377	-	0.248208	0.993854	-0.00284822	1.00 [0.48 - 2.06]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212360_at	111	0.738739	0.220973	-	0.345684	0.294209	0.419498	1.52 [0.69 - 3.33]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212360_at	90	0.222222	0.00405002	0.0801097	-0.934977	0.230889	-0.655	0.52 [0.18 - 1.52]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212360_at	90	0.222222	0.00203287	0.045904	-1.10865	0.0668156	-1.11875	0.33 [0.10 - 1.08]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212360_at	138	0.876812	0.0172464	0.24113	0.725507	0.115003	0.435333	1.55 [0.90 - 2.66]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212360_at	129	0.852713	0.0274702	0.333832	0.655334	0.205181	0.615042	1.85 [0.71 - 4.79]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5139	56	0.803571	0.0618166	-	0.79324	0.599597	0.217621	1.24 [0.55 - 2.80]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16278	56	0.767857	0.179993	-	-0.645216	0.467178	0.262667	1.30 [0.64 - 2.64]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8422	56	0.785714	0.216431	-	-0.597509	0.654008	0.154694	1.17 [0.59 - 2.30]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16278	56	0.767857	0.0667291	-	-1.07457	0.912227	0.0426395	1.04 [0.49 - 2.23]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5139	56	0.892857	0.0549499	-	0.914053	0.318576	0.387537	1.47 [0.69 - 3.16]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8422	56	0.785714	0.0776469	-	-1.03844	0.884804	-0.0538255	0.95 [0.46 - 1.96]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212360_at	278	0.169065	0.0783352	-	0.475972	0.569636	0.130014	1.14 [0.73 - 1.78]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212360_at	133	0.203008	0.0564035	-	0.700279	0.361962	0.223465	1.25 [0.77 - 2.02]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9139	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13245	81	0.851852	1.10776e-05	0.000490162	2.10357	0.000104212	2.51218	12.33 [3.47 - 43.86]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4344	81	0.62963	0.00237961	0.0522063	1.62299	0.000541802	2.0373	7.67 [2.42 - 24.33]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212360_at	185	0.783784	0.00971533	0.157985	-0.5039	0.0309222	-0.357624	0.70 [0.51 - 0.97]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212360_at	185	0.794595	0.00343263	0.0701975	-0.66604	0.00830933	-0.487242	0.61 [0.43 - 0.88]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P201596	110	0.163636	0.0304764	0.358017	0.88869	0.325539	0.242696	1.27 [0.79 - 2.07]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P201596	110	0.472727	0.219347	-	-0.363304	0.375988	-0.29691	0.74 [0.39 - 1.43]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212360_at	80	0.1125	0.0403511	0.43007	-1.10935	0.383486	-0.562153	0.57 [0.16 - 2.02]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_4118	281	0.608541	0.0580578	-	-0.275646	0.968041	-0.00416036	1.00 [0.81 - 1.22]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212360_at	38	0.710526	0.00384582	0.076876	1.36509	0.10824	1.04373	2.84 [0.79 - 10.15]
GENE	AMPD2	adenosine monophosphate deaminase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212360_at	140	0.664286	1.17534e-07	7.46528e-06	1.45077	0.000995725	0.916339	2.50 [1.45 - 4.31]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209491_s_at	30	0.3	0.381597	-	0.401288	0.816666	0.244722	1.28 [0.16 - 10.11]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207992_s_at	30	0.366667	0.0317937	0.368253	-0.886203	0.106659	-0.97918	0.38 [0.11 - 1.23]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1660854	165	0.569697	0.03352	0.381356	-0.534358	0.3286	-0.94187	0.39 [0.06 - 2.58]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1660854	165	0.115152	0.00543258	0.101013	-1.08292	0.0774874	-2.59892	0.07 [0.00 - 1.33]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207992_s_at	163	0.521472	0.0396699	0.42542	-0.407005	0.206098	-0.240186	0.79 [0.54 - 1.14]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209491_s_at	163	0.245399	0.0273815	0.3331	-0.476322	0.355831	-0.669079	0.51 [0.12 - 2.12]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207992_s_at	79	0.35443	0.151306	-	0.453617	0.670031	0.0728986	1.08 [0.77 - 1.50]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209491_s_at	79	0.582278	0.196833	-	-0.389269	0.867006	-0.10589	0.90 [0.26 - 3.11]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207992_s_at	58	0.482759	0.120262	-	0.434125	0.90872	0.0274156	1.03 [0.64 - 1.64]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209491_s_at	58	0.87931	0.0156673	0.225001	1.01959	0.875	0.0310515	1.03 [0.70 - 1.52]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207992_s_at	34	0.882353	0.0955994	-	-1.54504	0.761611	-0.138922	0.87 [0.35 - 2.14]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209491_s_at	34	0.323529	0.0020379	0.0459971	-1.18965	0.0931571	-0.48622	0.61 [0.35 - 1.08]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209491_s_at	158	0.139241	0.139952	-	0.619165	0.261449	0.676857	1.97 [0.60 - 6.41]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207992_s_at	158	0.196203	0.0765316	-	0.594355	0.51107	0.142616	1.15 [0.75 - 1.76]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209491_s_at	53	0.169811	0.11758	-	0.813145	0.578426	0.250155	1.28 [0.53 - 3.10]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207992_s_at	53	0.188679	0.0741093	-	-0.732355	0.205088	-0.572181	0.56 [0.23 - 1.37]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209491_s_at	53	0.113208	0.0814041	-	1.59817	0.497674	0.328936	1.39 [0.54 - 3.60]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207992_s_at	53	0.754717	0.0424823	0.444342	-0.95167	0.210079	-0.515114	0.60 [0.27 - 1.34]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209491_s_at	180	0.894444	0.0608495	-	0.540848	0.287259	0.313568	1.37 [0.77 - 2.44]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207992_s_at	180	0.5	0.0664687	-	-0.384814	0.849233	-0.050728	0.95 [0.56 - 1.60]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207992_s_at	559	0.864043	0.101801	-	-0.59471	0.794682	0.0418641	1.04 [0.76 - 1.43]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209491_s_at	559	0.611807	0.356561	-	-0.191082	0.791162	-0.03162	0.97 [0.77 - 1.22]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207992_s_at	77	0.103896	2.66343e-07	1.59895e-05	-1.96513	0.0607857	-0.527677	0.59 [0.34 - 1.02]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209491_s_at	77	0.103896	0.0668697	-	-0.733963	0.388433	-0.191443	0.83 [0.53 - 1.28]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207992_s_at	70	0.471429	0.0898638	-	-0.443633	0.386189	-0.169346	0.84 [0.58 - 1.24]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209491_s_at	70	0.542857	0.192002	-	0.343288	0.41153	0.359192	1.43 [0.61 - 3.38]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38463_s_at	50	0.26	0.111995	-	-0.620058	0.990535	-0.00550338	0.99 [0.40 - 2.47]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209491_s_at	74	0.72973	0.00189331	0.0433022	0.903123	0.320452	0.367837	1.44 [0.70 - 2.98]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207992_s_at	74	0.405405	0.00060138	0.0165851	1.07951	0.0214889	0.879795	2.41 [1.14 - 5.10]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207992_s_at	67	0.552239	0.127811	-	1.03412	0.583837	0.401099	1.49 [0.36 - 6.27]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209491_s_at	67	0.850746	0.00180493	0.0416331	1.84775	0.185373	2.12254	8.35 [0.36 - 193.20]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207992_s_at	115	0.104348	0.124331	-	-0.967675	0.182092	-1.08897	0.34 [0.07 - 1.67]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209491_s_at	115	0.852174	0.0133371	0.20005	1.28573	0.623091	0.374479	1.45 [0.33 - 6.47]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38463_s_at	158	0.898734	0.00608984	0.110433	1.0247	0.679709	-0.137347	0.87 [0.45 - 1.67]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38463_s_at	76	0.855263	0.0701992	-	-15.3301	0.701389	-0.189664	0.83 [0.31 - 2.18]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209491_s_at	204	0.151961	0.0967447	-	0.321967	0.687078	0.0340361	1.03 [0.88 - 1.22]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207992_s_at	204	0.598039	0.0102757	0.164797	0.370019	0.108577	0.283531	1.33 [0.94 - 1.88]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209491_s_at	87	0.83908	0.00606046	0.110018	1.06278	0.517724	0.387889	1.47 [0.46 - 4.77]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207992_s_at	87	0.551724	0.325659	-	-0.386005	0.616327	-0.196073	0.82 [0.38 - 1.77]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207992_s_at	87	0.551724	0.325659	-	-0.386005	0.616327	-0.196073	0.82 [0.38 - 1.77]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209491_s_at	87	0.83908	0.00606046	0.110018	1.06278	0.517724	0.387889	1.47 [0.46 - 4.77]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207992_s_at	77	0.480519	0.0591679	-	1.17474	0.476324	0.382843	1.47 [0.51 - 4.21]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209491_s_at	77	0.831169	0.195131	-	0.86832	0.545466	0.996835	2.71 [0.11 - 68.62]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207992_s_at	77	0.584416	0.227939	-	0.76025	0.795442	0.152346	1.16 [0.37 - 3.68]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209491_s_at	77	0.831169	0.111507	-	0.926591	0.424181	1.14432	3.14 [0.19 - 51.98]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207992_s_at	136	0.625	0.0176826	0.245484	1.04825	0.331734	0.547495	1.73 [0.57 - 5.22]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209491_s_at	136	0.382353	0.111266	-	0.80642	0.94637	-0.0216618	0.98 [0.52 - 1.84]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209491_s_at	200	0.895	0.00266399	0.0572213	1.03093	0.284304	0.333306	1.40 [0.76 - 2.57]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207992_s_at	200	0.165	0.150238	-	-0.512639	0.996785	-0.00184324	1.00 [0.41 - 2.45]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4388	60	0.533333	0.129134	-	0.571777	0.410019	0.165948	1.18 [0.80 - 1.75]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4388	60	0.2	0.254202	-	0.604248	0.780028	0.076625	1.08 [0.63 - 1.85]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	994	155	0.122581	2.7678e-05	0.00111814	-1.24118	0.00128699	-0.216991	0.80 [0.71 - 0.92]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209491_s_at	286	0.590909	0.0233919	0.298988	-0.463687	0.0792369	-0.325592	0.72 [0.50 - 1.04]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207992_s_at	286	0.188811	0.0337012	0.382711	-0.47456	0.189321	-0.432899	0.65 [0.34 - 1.24]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209491_s_at	159	0.666667	0.0155988	0.224287	-0.968681	0.989585	0.00413208	1.00 [0.54 - 1.87]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209491_s_at	159	0.660377	0.0130288	0.196636	-1.25384	0.763426	-0.106388	0.90 [0.45 - 1.80]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207992_s_at	159	0.874214	0.116606	-	-1.08452	0.587737	-0.276679	0.76 [0.28 - 2.06]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207992_s_at	159	0.849057	0.13771	-	-0.864129	0.936766	-0.0394537	0.96 [0.36 - 2.55]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209491_s_at	159	0.660377	0.152184	-	-0.517271	0.556573	0.195942	1.22 [0.63 - 2.34]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207992_s_at	159	0.836478	0.0531558	-	-1.74004	0.576059	-0.335297	0.72 [0.22 - 2.32]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207992_s_at	54	0.796296	0.133368	-	1.04947	0.546658	0.317523	1.37 [0.49 - 3.86]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209491_s_at	54	0.796296	0.211676	-	-15.2875	0.764859	-0.372352	0.69 [0.06 - 7.91]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207992_s_at	117	0.102564	0.0593438	-	1.6986	0.688133	-0.114254	0.89 [0.51 - 1.56]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207992_s_at	117	0.82906	0.0503572	-	0.806869	0.524917	0.219876	1.25 [0.63 - 2.45]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209491_s_at	117	0.418803	0.172237	-	0.545976	0.943587	0.055384	1.06 [0.23 - 4.90]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209491_s_at	117	0.846154	0.385897	-	0.342545	0.940684	0.0491952	1.05 [0.29 - 3.84]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209491_s_at	117	0.846154	0.385897	-	0.342545	0.940684	0.0491952	1.05 [0.29 - 3.84]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209491_s_at	117	0.57265	0.341783	-	-0.38854	0.993417	-0.00674346	0.99 [0.20 - 4.93]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207992_s_at	117	0.102564	0.0593438	-	1.6986	0.688133	-0.114254	0.89 [0.51 - 1.56]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207992_s_at	117	0.102564	0.166099	-	1.31413	0.951009	0.0209157	1.02 [0.52 - 1.99]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207992_s_at	236	0.355932	0.00355421	0.0721823	-0.767524	0.212092	-0.625953	0.53 [0.20 - 1.43]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209491_s_at	236	0.504237	0.0175697	0.244361	-0.661874	0.0519222	-0.554162	0.57 [0.33 - 1.00]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207992_s_at	249	0.855422	0.0261034	0.32243	0.569031	0.668233	0.170105	1.19 [0.54 - 2.58]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209491_s_at	249	0.172691	0.00413761	0.0814841	-0.683234	0.0011686	-0.718078	0.49 [0.32 - 0.75]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207992_s_at	62	0.306452	0.0381637	0.414983	1.8613	0.807978	-0.0649079	0.94 [0.56 - 1.58]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207992_s_at	125	0.608	0.133718	-	-0.618699	0.628662	-0.263094	0.77 [0.26 - 2.23]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209491_s_at	62	0.193548	0.212687	-	1.21081	0.71238	-0.0958653	0.91 [0.55 - 1.51]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207992_s_at	125	0.144	0.19675	-	-0.499039	0.769778	-0.120956	0.89 [0.39 - 1.99]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207992_s_at	54	0.888889	0.13434	-	0.963706	0.998343	-0.000673256	1.00 [0.53 - 1.89]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209491_s_at	125	0.376	0.264491	-	0.489138	0.9252	0.0480722	1.05 [0.38 - 2.86]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209491_s_at	125	0.104	0.276042	-	-0.47835	0.859233	-0.0708206	0.93 [0.43 - 2.04]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209491_s_at	54	0.462963	0.446377	-	0.469024	0.765152	-0.0945298	0.91 [0.49 - 1.69]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207992_s_at	198	0.833333	0.0238614	0.303129	0.669956	0.689946	0.0987271	1.10 [0.68 - 1.79]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209491_s_at	198	0.156566	0.0168808	0.237447	1.16999	0.0866657	0.218444	1.24 [0.97 - 1.60]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209491_s_at	198	0.111111	0.0289534	0.345913	1.44471	0.0980928	0.224127	1.25 [0.96 - 1.63]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207992_s_at	198	0.858586	0.0806455	-	0.461303	0.807454	0.0468544	1.05 [0.72 - 1.53]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207992_s_at	198	0.772727	0.00848467	0.142567	0.687531	0.518104	0.152537	1.16 [0.73 - 1.85]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209491_s_at	198	0.358586	0.00437387	0.0851545	0.678089	0.0919648	0.173351	1.19 [0.97 - 1.45]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207992_s_at	51	0.803922	0.24613	-	1.01536	0.730638	-0.352255	0.70 [0.09 - 5.22]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207992_s_at	62	0.274194	0.144278	-	1.40641	0.829723	0.135234	1.14 [0.33 - 3.93]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209491_s_at	51	0.764706	0.2141	-	-15.4374	0.986904	-0.0309346	0.97 [0.02 - 38.97]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209491_s_at	62	0.306452	0.197169	-	0.964437	0.608888	0.585519	1.80 [0.19 - 16.92]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209491_s_at	177	0.627119	0.000567474	0.0157859	-1.18835	0.00379151	-2.48854	0.08 [0.02 - 0.45]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207992_s_at	145	0.206897	0.00903843	0.149586	1.69254	0.330519	0.556044	1.74 [0.57 - 5.34]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207992_s_at	177	0.101695	0.0488949	0.484952	-0.742225	0.616469	-0.245542	0.78 [0.30 - 2.04]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209491_s_at	177	0.350282	0.00330846	0.0681526	-0.678691	0.00513815	-1.98963	0.14 [0.03 - 0.55]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209491_s_at	145	0.6	0.00647264	0.115788	-1.09321	0.0500626	-1.95198	0.14 [0.02 - 1.00]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207992_s_at	177	0.101695	0.0343254	0.387353	-0.710876	0.531479	-0.267752	0.77 [0.33 - 1.77]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209491_s_at	226	0.876106	0.0355101	0.396046	-1.85036	0.204388	-0.18103	0.83 [0.63 - 1.10]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207992_s_at	226	0.429204	0.108648	-	0.490466	0.925866	-0.0326314	0.97 [0.49 - 1.92]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209491_s_at	55	0.872727	0.0583237	-	-15.2672	0.288941	-1.47217	0.23 [0.02 - 3.49]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209491_s_at	55	0.709091	0.0105485	0.168069	-2.16924	0.208454	-1.88488	0.15 [0.01 - 2.86]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209491_s_at	49	0.816327	0.0407723	0.432923	-15.5063	0.242974	-2.08311	0.12 [0.00 - 4.11]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207992_s_at	55	0.145455	0.20246	-	-0.72264	0.767036	-0.220565	0.80 [0.19 - 3.45]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207992_s_at	55	0.145455	0.0324041	0.372926	-1.06708	0.549067	0.379591	1.46 [0.42 - 5.06]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207992_s_at	49	0.163265	0.0288198	0.344836	-1.26383	0.546203	-0.598936	0.55 [0.08 - 3.84]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	120146	34	0.735294	0.192719	-	-0.711948	0.824499	-0.0916325	0.91 [0.41 - 2.05]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209491_s_at	63	0.555556	0.00265024	0.0569818	-1.08184	0.00373867	-23.3242	0.00 [0.00 - 0.00]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207992_s_at	63	0.873016	0.00834336	0.140754	-2.21545	0.0741019	-0.261334	0.77 [0.58 - 1.03]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502078_3p_a_at	28	0.357143	0.0280153	0.338306	-1.13189	0.126129	-0.327649	0.72 [0.47 - 1.10]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.83918.1.S1_3p_a_at	28	0.678571	0.157541	-	-0.918754	0.850505	-0.904542	0.40 [0.00 - 4924.74]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207992_s_at	82	0.731707	0.0222312	0.288593	-1.15283	0.0735865	-0.806031	0.45 [0.18 - 1.08]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209491_s_at	82	0.853659	0.245548	-	0.491889	0.809971	-0.112112	0.89 [0.36 - 2.23]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207992_s_at	79	0.253165	0.130914	-	-0.424899	0.704465	-0.134529	0.87 [0.44 - 1.75]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209491_s_at	79	0.329114	0.0360295	0.399809	-0.55681	0.561657	-0.212649	0.81 [0.39 - 1.66]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209491_s_at	104	0.490385	0.30807	-	0.340529	0.519567	0.322718	1.38 [0.52 - 3.69]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207992_s_at	104	0.173077	0.0225244	0.29124	-0.805618	0.16259	-0.60812	0.54 [0.23 - 1.28]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P304154	117	0.111111	0.0627373	-	1.26111	0.756705	-0.0688661	0.93 [0.60 - 1.44]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P116286	117	0.299145	0.108141	-	-0.46738	0.473088	-0.158762	0.85 [0.55 - 1.32]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207992_s_at	204	0.862745	7.19566e-06	0.000331478	1.2593	0.00418446	1.03088	2.80 [1.38 - 5.68]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209491_s_at	204	0.705882	0.285189	-	-0.483916	0.727374	-0.0974858	0.91 [0.52 - 1.57]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209491_s_at	204	0.245098	0.0548425	-	0.720994	0.274469	0.267482	1.31 [0.81 - 2.11]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207992_s_at	204	0.872549	8.85473e-05	0.00314614	1.38371	0.0170135	1.14487	3.14 [1.23 - 8.05]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207992_s_at	178	0.292135	0.162928	-	0.316643	0.891716	-0.0315353	0.97 [0.62 - 1.53]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209491_s_at	178	0.831461	0.0147394	0.215239	0.583684	0.151891	0.512423	1.67 [0.83 - 3.36]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209491_s_at	111	0.657658	0.00814933	0.138249	0.687543	0.667784	0.0742758	1.08 [0.77 - 1.51]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207992_s_at	111	0.486486	0.0273594	0.332917	0.590662	0.161608	0.533109	1.70 [0.81 - 3.60]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207992_s_at	90	0.177778	0.0264834	0.325627	-0.799055	0.164723	-0.647166	0.52 [0.21 - 1.30]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207992_s_at	90	0.177778	0.00937687	0.153809	-1.00271	0.143775	-0.791322	0.45 [0.16 - 1.31]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209491_s_at	90	0.588889	0.072374	-	-0.633537	0.836368	0.111151	1.12 [0.39 - 3.21]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209491_s_at	90	0.677778	0.251542	-	-0.493431	0.557431	0.338372	1.40 [0.45 - 4.34]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2281	50	0.12	0.204883	-	-0.777073	0.736158	-0.230208	0.79 [0.21 - 3.03]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209491_s_at	138	0.413043	0.233817	-	-0.286118	0.546053	0.900507	2.46 [0.13 - 45.80]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207992_s_at	138	0.804348	0.0176843	0.245501	0.64363	0.199658	0.199478	1.22 [0.90 - 1.66]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209491_s_at	129	0.736434	0.0217124	0.283872	0.609642	0.780219	0.0826622	1.09 [0.61 - 1.94]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207992_s_at	129	0.767442	0.062837	-	-0.62976	0.286218	-0.388222	0.68 [0.33 - 1.38]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44830	56	0.678571	0.0594607	-	-0.701853	0.503506	-0.150506	0.86 [0.55 - 1.34]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9766	56	0.625	0.144345	-	-0.531919	0.634736	-0.117856	0.89 [0.55 - 1.45]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44830	56	0.678571	0.13266	-	-0.585823	0.756101	-0.0705586	0.93 [0.60 - 1.45]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9766	56	0.553571	0.249867	-	-0.419162	0.893414	-0.0338409	0.97 [0.59 - 1.59]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209491_s_at	278	0.532374	0.0747163	-	-0.339781	0.703183	-0.155244	0.86 [0.39 - 1.90]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207992_s_at	278	0.776978	0.0413029	0.436494	-0.521958	0.130867	-0.201249	0.82 [0.63 - 1.06]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207992_s_at	133	0.616541	4.846e-05	0.00184393	-1.13227	0.00130342	-0.850495	0.43 [0.25 - 0.72]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209491_s_at	133	0.631579	0.0011865	0.0294055	0.762115	0.0109283	1.91416	6.78 [1.55 - 29.62]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9403	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207992_s_at	185	0.837838	0.0579043	-	-0.414821	0.421326	-0.212519	0.81 [0.48 - 1.36]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209491_s_at	185	0.713513	0.00447454	0.0867029	-0.599803	0.095495	-0.434968	0.65 [0.39 - 1.08]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207992_s_at	185	0.243243	0.133542	-	-0.297622	0.643831	-0.131532	0.88 [0.50 - 1.53]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209491_s_at	185	0.713513	0.00574477	0.105525	-0.523333	0.0533168	-0.457535	0.63 [0.40 - 1.01]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P116286	110	0.8	0.0420614	0.441556	-1.02345	0.337074	-0.224648	0.80 [0.50 - 1.26]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P304154	110	0.863636	0.0263418	0.324438	-1.48116	0.280219	-0.223541	0.80 [0.53 - 1.20]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P116286	110	0.818182	0.000784396	0.0207737	-1.42662	0.0545036	-0.339178	0.71 [0.50 - 1.01]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P304154	110	0.863636	0.000765107	0.0203413	-1.74739	0.0344618	-0.336632	0.71 [0.52 - 0.98]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209491_s_at	80	0.325	0.00641713	0.115017	1.79164	0.040287	0.665156	1.94 [1.03 - 3.67]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207992_s_at	80	0.825	0.197547	-	0.612636	0.898953	0.0541461	1.06 [0.46 - 2.43]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3958	281	0.786477	0.0164824	0.233399	0.378654	0.282407	0.0804578	1.08 [0.94 - 1.26]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209491_s_at	38	0.236842	3.44308e-07	2.0294e-05	-2.43545	0.00165724	-1.90959	0.15 [0.05 - 0.49]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207992_s_at	38	0.605263	0.00904938	0.149723	-1.50317	0.208367	-0.345373	0.71 [0.41 - 1.21]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207992_s_at	140	0.207143	0.0258956	0.320673	-0.684083	0.351797	-0.34563	0.71 [0.34 - 1.47]
GENE	AMPD3	adenosine monophosphate deaminase 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209491_s_at	140	0.878571	0.152608	-	-0.830066	0.349012	-0.86247	0.42 [0.07 - 2.57]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AMT	aminomethyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204294_at	30	0.233333	0.0583191	-	1.01843	0.400349	-0.436924	0.65 [0.23 - 1.79]
GENE	AMT	aminomethyltransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1665331	165	0.272727	0.0275837	0.334767	-0.558177	0.172565	-0.167357	0.85 [0.67 - 1.08]
GENE	AMT	aminomethyltransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1665331	165	0.272727	0.00198444	0.0450057	-1.04886	0.0271187	-0.38194	0.68 [0.49 - 0.96]
GENE	AMT	aminomethyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204294_at	163	0.815951	0.0408504	0.43345	0.482395	0.32665	0.361268	1.44 [0.70 - 2.95]
GENE	AMT	aminomethyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204294_at	79	0.886076	0.176835	-	-0.785922	0.595095	-0.171033	0.84 [0.45 - 1.58]
GENE	AMT	aminomethyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204294_at	58	0.482759	0.0400029	0.427698	-0.58429	0.785382	-0.075386	0.93 [0.54 - 1.60]
GENE	AMT	aminomethyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204294_at	34	0.676471	0.180634	-	-0.594335	0.450388	-0.430283	0.65 [0.21 - 1.99]
GENE	AMT	aminomethyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204294_at	158	0.417722	0.179345	-	0.321245	0.847402	-0.125473	0.88 [0.25 - 3.17]
GENE	AMT	aminomethyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204294_at	53	0.377358	0.117613	-	0.568714	0.592011	0.191267	1.21 [0.60 - 2.44]
GENE	AMT	aminomethyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204294_at	53	0.490566	0.0714787	-	0.6615	0.463712	0.291252	1.34 [0.61 - 2.92]
GENE	AMT	aminomethyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204294_at	180	0.683333	0.0126466	0.192364	0.52985	0.199741	0.328311	1.39 [0.84 - 2.29]
GENE	AMT	aminomethyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204294_at	559	0.661896	0.0313712	0.364993	-0.492977	0.654151	-0.1024	0.90 [0.58 - 1.41]
GENE	AMT	aminomethyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204294_at	77	0.376623	0.0802418	-	-0.458546	0.923752	-0.0270321	0.97 [0.56 - 1.69]
GENE	AMT	aminomethyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204294_at	70	0.671429	0.155768	-	0.38881	0.614914	0.13852	1.15 [0.67 - 1.97]
GENE	AMT	aminomethyltransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41120_at	50	0.2	0.170992	-	-0.552115	0.576505	-0.181148	0.83 [0.44 - 1.58]
GENE	AMT	aminomethyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204294_at	74	0.878378	0.145096	-	0.559035	0.956508	-0.0304886	0.97 [0.32 - 2.90]
GENE	AMT	aminomethyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204294_at	67	0.283582	0.00488384	0.0929075	-1.7602	0.115955	-1.89897	0.15 [0.01 - 1.60]
GENE	AMT	aminomethyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204294_at	115	0.243478	0.0885912	-	-0.885815	0.252325	-0.611655	0.54 [0.19 - 1.55]
GENE	AMT	aminomethyltransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41120_at	158	0.886076	0.217927	-	0.474218	0.99265	-0.00337698	1.00 [0.49 - 2.04]
GENE	AMT	aminomethyltransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41120_at	76	0.368421	0.0340821	0.385549	1.47576	0.347586	0.708878	2.03 [0.46 - 8.92]
GENE	AMT	aminomethyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204294_at	204	0.514706	0.00753733	0.130225	-0.376623	0.0717293	-0.295912	0.74 [0.54 - 1.03]
GENE	AMT	aminomethyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204294_at	87	0.114943	0.00046456	0.0133069	-1.49767	0.461059	-0.275662	0.76 [0.36 - 1.58]
GENE	AMT	aminomethyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204294_at	87	0.114943	0.00046456	0.0133069	-1.49767	0.461059	-0.275662	0.76 [0.36 - 1.58]
GENE	AMT	aminomethyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204294_at	77	0.662338	0.0869102	-	-1.62163	0.990507	-0.0072863	0.99 [0.30 - 3.30]
GENE	AMT	aminomethyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204294_at	77	0.38961	0.220849	-	0.785743	0.5217	0.316663	1.37 [0.52 - 3.62]
GENE	AMT	aminomethyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204294_at	136	0.404412	0.0341352	0.385944	-0.974881	0.0725964	-0.779714	0.46 [0.20 - 1.07]
GENE	AMT	aminomethyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204294_at	200	0.14	0.0247375	0.310763	-0.827929	0.924243	0.0301427	1.03 [0.55 - 1.92]
GENE	AMT	aminomethyltransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19740	60	0.266667	0.0324497	0.373273	-0.812197	0.105465	-0.375953	0.69 [0.44 - 1.08]
GENE	AMT	aminomethyltransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19740	60	0.15	5.09347e-05	0.00192748	-1.59411	0.00301456	-1.0649	0.34 [0.17 - 0.70]
GENE	AMT	aminomethyltransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21126	155	0.567742	0.0105617	0.168226	0.717013	0.151122	0.192077	1.21 [0.93 - 1.58]
GENE	AMT	aminomethyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204294_at	286	0.604895	0.0776003	-	-0.357962	0.457155	-0.184291	0.83 [0.51 - 1.35]
GENE	AMT	aminomethyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204294_at	159	0.861635	0.0223418	0.289593	-1.97624	0.252469	-0.557338	0.57 [0.22 - 1.49]
GENE	AMT	aminomethyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204294_at	159	0.735849	0.0331689	0.378719	-1.2217	0.0779343	-1.04571	0.35 [0.11 - 1.12]
GENE	AMT	aminomethyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204294_at	159	0.144654	0.0654261	-	-0.684362	0.381679	-0.434727	0.65 [0.24 - 1.71]
GENE	AMT	aminomethyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204294_at	54	0.888889	0.154565	-	-15.3631	0.451718	-0.301574	0.74 [0.34 - 1.62]
GENE	AMT	aminomethyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204294_at	117	0.188034	0.0245593	0.30922	1.26851	0.223592	0.288314	1.33 [0.84 - 2.12]
GENE	AMT	aminomethyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204294_at	117	0.188034	0.0745271	-	1.23055	0.165925	0.387112	1.47 [0.85 - 2.55]
GENE	AMT	aminomethyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204294_at	117	0.188034	0.0245593	0.30922	1.26851	0.223592	0.288314	1.33 [0.84 - 2.12]
GENE	AMT	aminomethyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204294_at	117	0.188034	0.0267842	0.328142	1.94011	0.0463804	0.570489	1.77 [1.01 - 3.10]
GENE	AMT	aminomethyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204294_at	236	0.148305	0.0104907	0.167378	-0.774424	0.0870124	-0.721696	0.49 [0.21 - 1.11]
GENE	AMT	aminomethyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204294_at	249	0.11245	0.00662689	0.11792	-0.733763	0.102395	-0.552586	0.58 [0.30 - 1.12]
GENE	AMT	aminomethyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204294_at	62	0.370968	0.27471	-	-0.531142	0.631296	-0.0684646	0.93 [0.71 - 1.24]
GENE	AMT	aminomethyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204294_at	125	0.232	0.0892124	-	0.909509	0.649925	0.203093	1.23 [0.51 - 2.95]
GENE	AMT	aminomethyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204294_at	125	0.648	0.192415	-	0.391016	0.592906	0.181087	1.20 [0.62 - 2.33]
GENE	AMT	aminomethyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204294_at	54	0.333333	0.0678713	-	-1.03092	0.58051	-0.0956197	0.91 [0.65 - 1.28]
GENE	AMT	aminomethyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204294_at	198	0.792929	0.346402	-	-0.325016	0.921161	-0.0129148	0.99 [0.76 - 1.27]
GENE	AMT	aminomethyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204294_at	198	0.50505	0.298493	-	-0.278786	0.789516	-0.0369422	0.96 [0.73 - 1.26]
GENE	AMT	aminomethyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204294_at	198	0.848485	0.127392	-	-0.530054	0.929573	-0.00968777	0.99 [0.80 - 1.23]
GENE	AMT	aminomethyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204294_at	51	0.45098	0.00796701	0.135878	-16.6038	0.172113	-1.17647	0.31 [0.06 - 1.67]
GENE	AMT	aminomethyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204294_at	62	0.177419	0.00738976	0.128261	-1.445	0.00602861	-1.43946	0.24 [0.08 - 0.66]
GENE	AMT	aminomethyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204294_at	177	0.706215	0.131039	-	-0.48916	0.900218	-0.0367247	0.96 [0.54 - 1.71]
GENE	AMT	aminomethyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204294_at	177	0.858757	0.0382531	0.415609	0.593005	0.453376	0.189345	1.21 [0.74 - 1.98]
GENE	AMT	aminomethyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204294_at	145	0.172414	0.149191	-	0.844661	0.968189	0.0150482	1.02 [0.48 - 2.13]
GENE	AMT	aminomethyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204294_at	226	0.429204	0.018618	0.254684	-0.662071	0.463838	-0.174681	0.84 [0.53 - 1.34]
GENE	AMT	aminomethyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204294_at	55	0.672727	0.0414952	0.437782	-1.20433	0.205487	-0.583749	0.56 [0.23 - 1.38]
GENE	AMT	aminomethyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204294_at	55	0.818182	0.122298	-	-1.41752	0.239967	-0.590689	0.55 [0.21 - 1.48]
GENE	AMT	aminomethyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204294_at	49	0.571429	0.0863995	-	-1.09181	0.256704	-0.699658	0.50 [0.15 - 1.66]
GENE	AMT	aminomethyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204294_at	63	0.412698	0.0237083	0.301782	-0.754733	0.213695	-0.203527	0.82 [0.59 - 1.12]
GENE	AMT	aminomethyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502082_3p_at	28	0.107143	0.0877346	-	-1.28653	0.608849	0.454985	1.58 [0.28 - 9.00]
GENE	AMT	aminomethyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204294_at	82	0.658537	0.213883	-	-0.477329	0.867946	-0.0884615	0.92 [0.32 - 2.60]
GENE	AMT	aminomethyltransferase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	41120_at	84	0.190476	0.193512	-	-0.434236	0.561401	-0.192127	0.83 [0.43 - 1.58]
GENE	AMT	aminomethyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204294_at	79	0.164557	0.0608883	-	0.741381	0.464157	0.256689	1.29 [0.65 - 2.57]
GENE	AMT	aminomethyltransferase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D14686_at	86	0.232558	0.106132	-	-0.689474	0.0956179	-1.14562	0.32 [0.08 - 1.22]
GENE	AMT	aminomethyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204294_at	104	0.278846	0.00833765	0.140681	-0.852854	0.0244503	-1.39653	0.25 [0.07 - 0.84]
GENE	AMT	aminomethyltransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P257164	117	0.615385	0.00264224	0.0568422	-0.990912	0.0439789	-0.355996	0.70 [0.50 - 0.99]
GENE	AMT	aminomethyltransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P174503	117	0.410256	0.00656058	0.117005	-0.763673	0.0745001	-0.307088	0.74 [0.52 - 1.03]
GENE	AMT	aminomethyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204294_at	204	0.632353	0.000234052	0.00736885	-2.21472	0.00084645	-1.35172	0.26 [0.12 - 0.57]
GENE	AMT	aminomethyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204294_at	204	0.323529	0.00150525	0.0358378	-0.840113	0.000212229	-1.18562	0.31 [0.16 - 0.57]
GENE	AMT	aminomethyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204294_at	178	0.11236	0.129403	-	-0.423762	0.485152	-0.210551	0.81 [0.45 - 1.46]
GENE	AMT	aminomethyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204294_at	111	0.891892	0.0481212	0.480227	-1.11177	0.722487	-0.0965888	0.91 [0.53 - 1.55]
GENE	AMT	aminomethyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204294_at	90	0.877778	0.356814	-	-0.548459	0.989901	0.00721401	1.01 [0.33 - 3.08]
GENE	AMT	aminomethyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204294_at	90	0.244444	0.266445	-	-0.443534	0.967393	-0.0268465	0.97 [0.27 - 3.53]
GENE	AMT	aminomethyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204294_at	138	0.891304	0.0281375	0.339304	-1.11516	0.218267	-0.147868	0.86 [0.68 - 1.09]
GENE	AMT	aminomethyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204294_at	129	0.488372	0.110947	-	-0.392173	0.382348	-0.380574	0.68 [0.29 - 1.61]
GENE	AMT	aminomethyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2417	56	0.25	0.00468981	0.089984	-1.11358	0.0501965	-0.481007	0.62 [0.38 - 1.00]
GENE	AMT	aminomethyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21812	56	0.25	0.0127105	0.193082	-0.994348	0.157524	-0.346566	0.71 [0.44 - 1.14]
GENE	AMT	aminomethyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25744	56	0.178571	0.0207834	0.275299	-0.970047	0.156018	-0.543124	0.58 [0.27 - 1.23]
GENE	AMT	aminomethyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21531	56	0.232143	0.00983648	0.159468	-1.0252	0.143889	-0.334028	0.72 [0.46 - 1.12]
GENE	AMT	aminomethyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21812	56	0.267857	0.00617121	0.111579	-1.0836	0.0609517	-0.489862	0.61 [0.37 - 1.02]
GENE	AMT	aminomethyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2417	56	0.160714	0.00727686	0.126751	-1.10842	0.10785	-0.374835	0.69 [0.44 - 1.09]
GENE	AMT	aminomethyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21531	56	0.25	0.00468981	0.089984	-1.11358	0.0663682	-0.445443	0.64 [0.40 - 1.03]
GENE	AMT	aminomethyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25744	56	0.160714	0.0549204	-	-0.831813	0.265096	-0.393339	0.67 [0.34 - 1.35]
GENE	AMT	aminomethyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204294_at	278	0.730216	0.0401606	0.428774	-0.474904	0.312285	-0.138588	0.87 [0.67 - 1.14]
GENE	AMT	aminomethyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204294_at	133	0.413534	0.0106765	0.169595	0.633185	0.500036	0.053239	1.05 [0.90 - 1.23]
GENE	AMT	aminomethyltransferase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17794	81	0.283951	0.00469697	0.0900925	-1.38565	0.0555602	-0.858037	0.42 [0.18 - 1.02]
GENE	AMT	aminomethyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204294_at	185	0.113514	0.120734	-	-0.389803	0.747663	-0.0519089	0.95 [0.69 - 1.30]
GENE	AMT	aminomethyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204294_at	185	0.113514	0.0280894	0.338911	-0.554825	0.364837	-0.163633	0.85 [0.60 - 1.21]
GENE	AMT	aminomethyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P174503	110	0.109091	0.099536	-	0.683266	0.709124	0.0467331	1.05 [0.82 - 1.34]
GENE	AMT	aminomethyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P257164	110	0.236364	0.198493	-	0.35834	0.738888	0.0407814	1.04 [0.82 - 1.32]
GENE	AMT	aminomethyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P174503	110	0.318182	0.193031	-	-0.393445	0.452682	-0.11698	0.89 [0.66 - 1.21]
GENE	AMT	aminomethyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P257164	110	0.509091	0.192323	-	-0.391658	0.567347	-0.0874271	0.92 [0.68 - 1.24]
GENE	AMT	aminomethyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204294_at	80	0.55	0.108238	-	-0.732715	0.703895	-0.142806	0.87 [0.42 - 1.81]
GENE	AMT	aminomethyltransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0651	281	0.103203	0.0344133	0.388003	-0.455253	0.153586	-0.0996424	0.91 [0.79 - 1.04]
GENE	AMT	aminomethyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204294_at	38	0.552632	0.0995936	-	0.811516	0.390157	0.516011	1.68 [0.52 - 5.44]
GENE	AMT	aminomethyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204294_at	140	0.192857	0.000367999	0.0108957	-1.0506	0.00446343	-0.913361	0.40 [0.21 - 0.75]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AMY2A	amylase, alpha 2A (pancreatic)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1751102	165	0.357576	0.00727967	0.126789	-0.646607	0.0215553	-1.68954	0.18 [0.04 - 0.78]
GENE	AMY2A	amylase, alpha 2A (pancreatic)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1801303	165	0.333333	0.00633461	0.113868	-0.660597	0.0639357	-0.19412	0.82 [0.67 - 1.01]
GENE	AMY2A	amylase, alpha 2A (pancreatic)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1751102	165	0.236364	0.0105367	0.167929	-0.890637	0.0605536	-2.05939	0.13 [0.01 - 1.10]
GENE	AMY2A	amylase, alpha 2A (pancreatic)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1801303	165	0.151515	2.05642e-05	0.000856412	-1.4341	0.000217824	-0.601105	0.55 [0.40 - 0.75]
GENE	AMY2A	amylase, alpha 2A (pancreatic)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1412238	34	0.823529	0.204331	-	-0.916266	0.734551	-0.143943	0.87 [0.38 - 1.99]
GENE	AMY2A	amylase, alpha 2A (pancreatic)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300007898	41	0.707317	0.189601	-	-0.652255	0.490787	-0.123749	0.88 [0.62 - 1.26]
GENE	AMY2A	amylase, alpha 2A (pancreatic)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15238	56	0.660714	0.0314547	0.365639	-0.90571	0.183959	-0.169986	0.84 [0.66 - 1.08]
GENE	AMY2A	amylase, alpha 2A (pancreatic)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15238	56	0.660714	0.0326904	0.375102	-0.906605	0.158767	-0.190606	0.83 [0.63 - 1.08]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1694882	165	0.557576	0.195954	-	-0.321928	0.307972	-0.245648	0.78 [0.49 - 1.25]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1694882	165	0.557576	0.00434989	0.0847845	-1.15515	0.0135416	-1.16569	0.31 [0.12 - 0.79]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36680_at	50	0.82	0.000755462	0.0201243	1.2577	0.316851	0.2153	1.24 [0.81 - 1.89]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36680_at	158	0.177215	0.1661	-	-0.456651	0.478692	-0.116975	0.89 [0.64 - 1.23]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36680_at	76	0.473684	0.262362	-	-0.583835	0.841264	-0.0615592	0.94 [0.51 - 1.72]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9445	60	0.35	0.00271144	0.0580458	-1.10762	0.0176785	-0.411785	0.66 [0.47 - 0.93]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9445	60	0.383333	0.0209642	0.27698	-0.851932	0.146041	-0.318093	0.73 [0.47 - 1.12]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36680_at	84	0.857143	0.021698	0.283741	-1.28073	0.0582167	-0.224611	0.80 [0.63 - 1.01]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7379	56	0.392857	0.0846885	-	-0.598557	0.316542	-0.14581	0.86 [0.65 - 1.15]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7379	56	0.428571	0.102873	-	-0.601107	0.280974	-0.165835	0.85 [0.63 - 1.15]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15743	81	0.111111	0.117322	-	-0.981785	0.825091	-0.0457346	0.96 [0.64 - 1.43]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	373	81	0.395062	0.260989	-	-0.581894	0.877231	-0.0453421	0.96 [0.54 - 1.70]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9094	81	0.469136	0.00621473	0.11219	-1.48956	0.581834	-0.101997	0.90 [0.63 - 1.30]
GENE	AMY2B	amylase, alpha 2B (pancreatic)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_2094	281	0.576512	0.00538152	0.100269	-0.397642	0.0451453	-0.268291	0.76 [0.59 - 0.99]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202888_s_at	30	0.533333	0.132143	-	-0.622236	0.984072	0.00380466	1.00 [0.69 - 1.46]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1763837	165	0.521212	0.0507579	-	-0.485843	0.532171	-0.0965608	0.91 [0.67 - 1.23]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1763837	165	0.321212	0.0060883	0.110412	1.3603	0.840472	0.0366011	1.04 [0.73 - 1.48]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202888_s_at	163	0.785276	0.0707877	-	0.414515	0.308555	0.130774	1.14 [0.89 - 1.47]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	234576_at	163	0.429448	0.000111437	0.00385252	0.805295	0.302106	0.626791	1.87 [0.57 - 6.16]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	234458_at	163	0.883436	0.0509314	-	-0.70498	0.304387	-0.774644	0.46 [0.11 - 2.02]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	234458_at	79	0.78481	0.0467742	0.47189	-0.794858	0.172641	-1.12935	0.32 [0.06 - 1.64]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202888_s_at	79	0.443038	0.0827523	-	0.518481	0.293911	0.123959	1.13 [0.90 - 1.43]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	234576_at	79	0.886076	0.00160113	0.0377162	1.13379	0.842961	0.154865	1.17 [0.25 - 5.40]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202888_s_at	58	0.206897	0.182811	-	0.452512	0.496887	0.1009	1.11 [0.83 - 1.48]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202888_s_at	34	0.882353	0.107569	-	0.88732	0.215696	0.236504	1.27 [0.87 - 1.84]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202888_s_at	158	0.848101	0.110691	-	-0.58801	0.425715	-0.335136	0.72 [0.31 - 1.63]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202888_s_at	53	0.867925	0.0658276	-	-1.25803	0.571274	0.110001	1.12 [0.76 - 1.63]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202888_s_at	53	0.396226	0.0714846	-	0.706616	0.562734	0.118705	1.13 [0.75 - 1.68]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202888_s_at	180	0.15	0.02292	0.294789	0.824144	0.360427	0.118444	1.13 [0.87 - 1.45]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	234576_at	180	0.722222	0.04788	0.478745	-0.515307	0.421365	-0.0977182	0.91 [0.71 - 1.15]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	234458_at	180	0.655556	0.0279193	0.337521	0.462492	0.310802	0.0849809	1.09 [0.92 - 1.28]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202888_s_at	559	0.143113	0.000321776	0.00970593	-0.855597	0.0155277	-0.28097	0.76 [0.60 - 0.95]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	234458_at	559	0.29517	0.175082	-	0.321076	0.955222	0.00705779	1.01 [0.79 - 1.29]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	234576_at	559	0.166369	0.0469112	0.472744	-0.477319	0.106121	-0.291995	0.75 [0.52 - 1.06]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202888_s_at	77	0.493506	0.0939589	-	-0.431791	0.721571	-0.0495589	0.95 [0.72 - 1.25]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	234576_at	77	0.779221	0.00148513	0.0354406	0.904055	0.0532317	0.439401	1.55 [0.99 - 2.42]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	234458_at	77	0.532468	0.119429	-	0.402992	0.962791	-0.0067874	0.99 [0.75 - 1.32]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	234458_at	70	0.7	0.151343	-	0.407161	0.420251	0.458409	1.58 [0.52 - 4.82]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202888_s_at	70	0.2	0.0418396	0.440081	-0.627207	0.580759	-0.179438	0.84 [0.44 - 1.58]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	234576_at	70	0.757143	0.00635638	0.114171	0.815891	0.352741	0.595849	1.81 [0.52 - 6.38]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39385_at	50	0.22	0.0393865	0.423473	1.0584	0.213898	1.05835	2.88 [0.54 - 15.29]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202888_s_at	74	0.621622	0.000761154	0.0202524	0.97079	0.0666575	0.302782	1.35 [0.98 - 1.87]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	234458_at	74	0.351351	0.00295489	0.062225	1.0224	0.093851	0.279828	1.32 [0.95 - 1.84]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	234576_at	74	0.810811	0.000250897	0.00782681	1.15047	0.00612213	0.755946	2.13 [1.24 - 3.66]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	234576_at	67	0.432836	0.011107	0.174684	-1.80716	0.211795	-2.26311	0.10 [0.00 - 3.63]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	234458_at	67	0.134328	0.0697835	-	-1.20978	0.151555	-5.06233	0.01 [0.00 - 6.40]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202888_s_at	67	0.373134	0.00151912	0.0361112	-2.59464	0.0497973	-0.775935	0.46 [0.21 - 1.00]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202888_s_at	115	0.678261	0.0341868	0.386326	-1.89955	0.112022	-0.704859	0.49 [0.21 - 1.18]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	234458_at	115	0.304348	0.00203742	0.0459883	-1.55739	4.2012e-05	-1.39086	0.25 [0.13 - 0.48]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	234576_at	115	0.608696	0.00138175	0.0333818	1.82183	0.0398348	1.26505	3.54 [1.06 - 11.84]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39385_at	158	0.310127	0.352009	-	0.302379	0.789025	-0.0513161	0.95 [0.65 - 1.38]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39385_at	76	0.75	0.0885101	-	-1.59088	0.454223	-0.21812	0.80 [0.45 - 1.42]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202888_s_at	204	0.79902	0.0349276	0.391791	0.371596	0.482387	0.0454038	1.05 [0.92 - 1.19]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	234576_at	204	0.147059	0.0830102	-	-0.340782	0.725058	-0.0243099	0.98 [0.85 - 1.12]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	234458_at	204	0.754902	0.0116016	0.180449	-0.420752	0.129093	-0.105887	0.90 [0.78 - 1.03]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202888_s_at	87	0.62069	0.0164627	0.233198	-1.05764	0.1357	-0.19988	0.82 [0.63 - 1.06]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202888_s_at	87	0.62069	0.0164627	0.233198	-1.05764	0.1357	-0.19988	0.82 [0.63 - 1.06]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	234458_at	87	0.655172	0.0834351	-	0.643828	0.727182	0.26795	1.31 [0.29 - 5.89]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	234576_at	87	0.183908	0.106139	-	1.12566	0.760434	0.262342	1.30 [0.24 - 7.02]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	234576_at	87	0.183908	0.106139	-	1.12566	0.760434	0.262342	1.30 [0.24 - 7.02]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	234458_at	87	0.655172	0.0834351	-	0.643828	0.727182	0.26795	1.31 [0.29 - 5.89]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202888_s_at	77	0.415584	0.104866	-	-0.895273	0.345458	-0.184332	0.83 [0.57 - 1.22]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	234458_at	77	0.597403	0.0839885	-	0.949706	0.778276	0.444367	1.56 [0.07 - 34.39]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	234576_at	77	0.896104	0.0532034	-	1.2031	0.584484	0.76883	2.16 [0.14 - 33.94]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202888_s_at	77	0.415584	0.0481188	0.480213	-1.27592	0.140523	-0.403698	0.67 [0.39 - 1.14]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	234458_at	77	0.324675	0.249156	-	-0.71404	0.760021	-0.56164	0.57 [0.02 - 20.95]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	234576_at	77	0.38961	0.0305801	0.35883	-1.38058	0.30216	-1.67279	0.19 [0.01 - 4.50]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202888_s_at	136	0.889706	0.115269	-	-15.2124	0.381314	-0.158986	0.85 [0.60 - 1.22]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202888_s_at	200	0.4	0.0556963	-	-0.55887	0.950343	-0.00832846	0.99 [0.76 - 1.29]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	284	60	0.2	0.0369346	0.406301	-0.853785	0.928963	-0.00893886	0.99 [0.81 - 1.21]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	284	60	0.35	0.200075	-	0.552629	0.637146	0.0577406	1.06 [0.83 - 1.35]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	19490	155	0.193548	3.52196e-05	0.00138722	-1.12536	0.000399374	-0.508847	0.60 [0.45 - 0.80]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202888_s_at	286	0.115385	0.0255654	0.317868	-0.586264	0.540978	-0.0682178	0.93 [0.75 - 1.16]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202888_s_at	159	0.603774	0.0370907	0.407412	-0.743926	0.102395	-0.281034	0.76 [0.54 - 1.06]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202888_s_at	159	0.603774	0.0817052	-	-0.738744	0.194029	-0.265784	0.77 [0.51 - 1.14]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202888_s_at	159	0.899371	0.175129	-	0.592036	0.921113	0.0163331	1.02 [0.74 - 1.40]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234458_at	159	0.433962	0.0402525	0.4294	0.694191	0.19432	0.221502	1.25 [0.89 - 1.74]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234458_at	159	0.433962	0.0554786	-	0.649316	0.24393	0.199001	1.22 [0.87 - 1.71]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234458_at	159	0.433962	0.0992053	-	0.650709	0.409552	0.164291	1.18 [0.80 - 1.74]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234576_at	159	0.377358	0.0344735	0.388448	0.780939	0.329499	0.241501	1.27 [0.78 - 2.07]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234576_at	159	0.125786	0.0382665	0.415702	1.83161	0.215543	0.302849	1.35 [0.84 - 2.19]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234576_at	159	0.377358	0.0442958	0.45617	0.892463	0.176568	0.383112	1.47 [0.84 - 2.56]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202888_s_at	54	0.518519	0.0470771	0.473778	1.47033	0.202617	0.210355	1.23 [0.89 - 1.71]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202888_s_at	117	0.145299	0.142316	-	-0.577354	0.945109	-0.00745757	0.99 [0.80 - 1.23]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202888_s_at	117	0.136752	0.180553	-	-0.606933	0.777447	-0.0372259	0.96 [0.74 - 1.25]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202888_s_at	117	0.145299	0.142316	-	-0.577354	0.945109	-0.00745757	0.99 [0.80 - 1.23]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202888_s_at	117	0.846154	0.247961	-	0.530539	0.694288	0.0489433	1.05 [0.82 - 1.34]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202888_s_at	236	0.148305	0.00078968	0.0208918	-0.976531	0.450109	-0.115553	0.89 [0.66 - 1.20]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	234458_at	236	0.652542	0.0553605	-	0.5162	0.205815	0.201609	1.22 [0.90 - 1.67]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	234576_at	236	0.898305	0.0333534	0.380106	0.759133	0.165584	0.405874	1.50 [0.85 - 2.66]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202888_s_at	249	0.136546	0.00151734	0.0360762	-0.802621	0.262682	-0.13635	0.87 [0.69 - 1.11]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	234576_at	249	0.37751	0.0343611	0.387618	0.483793	0.176	0.31533	1.37 [0.87 - 2.16]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	234458_at	249	0.228916	0.0965897	-	0.465496	0.911605	0.0139598	1.01 [0.79 - 1.30]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202888_s_at	62	0.370968	0.0230451	0.295905	-1.05062	0.411167	-0.21355	0.81 [0.49 - 1.34]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202888_s_at	125	0.112	0.0509137	-	-0.942304	0.769109	0.0444638	1.05 [0.78 - 1.41]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202888_s_at	125	0.112	0.0613461	-	-0.759265	0.924871	-0.0117212	0.99 [0.77 - 1.26]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202888_s_at	54	0.166667	0.0642721	-	-1.08656	0.391441	-0.274449	0.76 [0.41 - 1.42]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202888_s_at	198	0.151515	0.00837957	0.14122	1.43566	0.115797	0.128875	1.14 [0.97 - 1.34]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202888_s_at	198	0.151515	0.019714	0.265233	1.29227	0.260376	0.0958276	1.10 [0.93 - 1.30]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202888_s_at	198	0.10101	0.0189762	0.258158	1.13858	0.0801982	0.116998	1.12 [0.99 - 1.28]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202888_s_at	51	0.666667	0.110414	-	-15.6802	0.356862	-0.927213	0.40 [0.06 - 2.84]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202888_s_at	62	0.129032	0.19585	-	-0.83839	0.828147	0.048807	1.05 [0.68 - 1.63]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202888_s_at	145	0.227586	0.0230344	0.29581	1.28308	0.987109	-0.00223212	1.00 [0.76 - 1.31]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	234576_at	177	0.146893	0.0182172	0.250765	-0.736334	0.11276	-1.28669	0.28 [0.06 - 1.35]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	234458_at	177	0.881356	0.0193966	0.262203	-1.53192	0.0486758	-1.0196	0.36 [0.13 - 0.99]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	234576_at	177	0.491525	0.0100717	0.162331	-0.609941	0.0253842	-1.60985	0.20 [0.05 - 0.82]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202888_s_at	177	0.887006	0.0470809	0.473801	-1.33095	0.739844	-0.0401379	0.96 [0.76 - 1.22]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	234458_at	177	0.881356	0.00287072	0.0607896	-1.85913	0.0501879	-0.869097	0.42 [0.18 - 1.00]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	234576_at	145	0.813793	0.0113437	0.177453	-2.13804	0.0523429	-1.95916	0.14 [0.02 - 1.02]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202888_s_at	177	0.497175	0.0432241	0.449214	0.477119	0.666679	-0.045043	0.96 [0.78 - 1.17]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	234458_at	145	0.813793	0.0143104	0.21065	-1.60746	0.112937	-1.01207	0.36 [0.10 - 1.27]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	234576_at	226	0.460177	0.0121289	0.186506	-0.734616	0.0800898	-0.31927	0.73 [0.51 - 1.04]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	234458_at	226	0.212389	0.126688	-	-0.476876	0.557938	-0.0762629	0.93 [0.72 - 1.20]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202888_s_at	226	0.880531	0.249004	-	-0.592718	0.475344	-0.0694474	0.93 [0.77 - 1.13]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	234576_at	55	0.345455	0.0393884	0.423486	-0.894552	0.520515	-1.04016	0.35 [0.01 - 8.44]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	234458_at	55	0.254545	0.224989	-	-0.561884	0.616621	-0.697896	0.50 [0.03 - 7.65]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	234576_at	55	0.236364	0.203599	-	0.932596	0.967235	-0.0678435	0.93 [0.04 - 23.79]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202888_s_at	55	0.872727	5.25899e-05	0.00198307	1.80392	0.00362238	0.434924	1.54 [1.15 - 2.07]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	234458_at	55	0.672727	0.0937629	-	0.770205	0.683391	-0.659779	0.52 [0.02 - 12.32]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	234576_at	49	0.183673	0.116428	-	15.3025	0.670757	0.819985	2.27 [0.05 - 99.54]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	234458_at	49	0.591837	0.0259877	0.321453	1.27925	0.911046	0.197908	1.22 [0.04 - 39.25]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202888_s_at	55	0.890909	0.0244648	0.3084	1.36879	0.0263503	0.359852	1.43 [1.04 - 1.97]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202888_s_at	49	0.122449	0.152981	-	15.2554	0.777642	0.0830692	1.09 [0.61 - 1.93]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	113398	34	0.382353	0.0320712	0.370383	-0.939332	0.60443	-0.0794552	0.92 [0.68 - 1.25]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	234576_at	63	0.301587	0.000121754	0.00416426	-1.24413	0.00384492	-44.6328	0.00 [0.00 - 0.00]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	234458_at	63	0.174603	0.000561216	0.0156375	-1.25424	0.0653232	-12.4157	0.00 [0.00 - 2.20]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202888_s_at	63	0.492063	0.0253171	0.315748	-0.766163	0.351433	0.275754	1.32 [0.74 - 2.35]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502094_3p_s_at	28	0.321429	0.0492972	0.487391	-1.05679	0.210686	0.439842	1.55 [0.78 - 3.09]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.287790.0.A1_3p_at	28	0.285714	0.133237	-	-0.870607	0.405842	-3.34217	0.04 [0.00 - 93.55]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.287790.0.S1_3p_at	28	0.142857	0.0685508	-	-1.19105	0.200017	-4.186	0.02 [0.00 - 9.17]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202888_s_at	82	0.280488	0.0781975	-	-0.614695	0.974625	0.00586174	1.01 [0.70 - 1.44]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	39385_at	84	0.77381	0.0114359	0.178527	-1.13616	0.24738	-0.206313	0.81 [0.57 - 1.15]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202888_s_at	79	0.56962	0.00626932	0.112955	-0.728217	0.220733	-0.260698	0.77 [0.51 - 1.17]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M22324_at	86	0.697674	0.107145	-	-0.960353	0.785089	0.104536	1.11 [0.52 - 2.35]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202888_s_at	104	0.105769	0.189741	-	-0.622026	0.390345	0.166617	1.18 [0.81 - 1.73]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P88626	117	0.897436	0.243412	-	0.472889	0.981367	-0.00249027	1.00 [0.81 - 1.23]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	234576_at	204	0.107843	0.0287418	0.344207	-0.749184	0.389592	-0.123021	0.88 [0.67 - 1.17]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	234458_at	204	0.151961	0.15874	-	-0.472186	0.454688	-0.112175	0.89 [0.67 - 1.20]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202888_s_at	204	0.897059	0.169346	-	-1.30477	0.908197	-0.0220293	0.98 [0.67 - 1.42]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202888_s_at	204	0.872549	0.0307553	0.360202	-1.43181	0.409198	-0.119506	0.89 [0.67 - 1.18]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	234576_at	204	0.102941	0.0576704	-	-0.842254	0.734295	-0.0647423	0.94 [0.64 - 1.36]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	234458_at	204	0.5	0.108197	-	0.600186	0.46905	0.147719	1.16 [0.78 - 1.73]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202888_s_at	178	0.252809	0.17393	-	0.326689	0.994683	0.000739414	1.00 [0.81 - 1.24]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202888_s_at	111	0.108108	0.107135	-	-0.580684	0.532637	-0.0822294	0.92 [0.71 - 1.19]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	234458_at	111	0.81982	0.0874672	-	-0.676949	0.781854	-0.0502597	0.95 [0.67 - 1.36]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	234576_at	111	0.864865	0.00828765	0.140037	0.815269	0.146621	0.239258	1.27 [0.92 - 1.75]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202888_s_at	90	0.711111	0.0245788	0.309389	-0.96517	0.389093	-0.288025	0.75 [0.39 - 1.44]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202888_s_at	90	0.711111	0.0335586	0.381645	-1.09216	0.128687	-0.692406	0.50 [0.20 - 1.22]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202888_s_at	138	0.326087	0.00430219	0.0840465	0.819899	0.0627412	0.121938	1.13 [0.99 - 1.28]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	234458_at	138	0.362319	0.0188284	0.256728	-0.559905	0.0678295	-7.33931	0.00 [0.00 - 1.71]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	234576_at	138	0.202899	5.67213e-05	0.00212092	-1.00461	0.056883	-17.4953	0.00 [0.00 - 1.67]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202888_s_at	129	0.875969	0.00235497	0.0517655	0.915515	0.00914914	0.520333	1.68 [1.14 - 2.49]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16007	56	0.892857	0.0857954	-	1.0255	0.530115	0.159633	1.17 [0.71 - 1.93]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12021	56	0.25	0.0118577	0.183402	1.11322	0.115911	0.269301	1.31 [0.94 - 1.83]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16007	56	0.892857	0.0268843	0.328977	1.32909	0.660531	0.121039	1.13 [0.66 - 1.94]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12021	56	0.267857	0.00335627	0.0689422	1.37984	0.0782672	0.327356	1.39 [0.96 - 2.00]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	234576_at	278	0.122302	0.0773191	-	0.554441	0.999079	0.000569614	1.00 [0.38 - 2.63]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	234458_at	278	0.895683	0.0312171	0.363798	-0.70334	0.387662	-0.442061	0.64 [0.24 - 1.75]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202888_s_at	278	0.733813	0.00120068	0.0296984	0.6256	0.0542485	0.106578	1.11 [1.00 - 1.24]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202888_s_at	133	0.323308	0.00099609	0.0254016	0.970786	0.0210322	0.148913	1.16 [1.02 - 1.32]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	8048	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13298	81	0.469136	0.0543219	-	1.02108	0.383874	0.118194	1.13 [0.86 - 1.47]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202888_s_at	185	0.854054	0.0182893	0.251473	0.513574	0.598038	0.0547048	1.06 [0.86 - 1.29]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202888_s_at	185	0.854054	0.0443992	0.456837	0.474608	0.852346	0.0215366	1.02 [0.81 - 1.28]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P88626	110	0.3	0.135102	-	-0.363818	0.907564	0.00925575	1.01 [0.86 - 1.18]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P88626	110	0.663636	0.140192	-	0.447079	0.739431	0.0310892	1.03 [0.86 - 1.24]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202888_s_at	80	0.7875	0.166006	-	-0.991669	0.937243	-0.013033	0.99 [0.71 - 1.37]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_5091	281	0.743772	0.00128704	0.0314681	-0.54038	0.0038486	-0.149501	0.86 [0.78 - 0.95]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	234458_at	38	0.473684	0.133144	-	-0.709237	0.358035	-0.19906	0.82 [0.54 - 1.25]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	234576_at	38	0.736842	0.0770933	-	0.861807	0.443455	0.384706	1.47 [0.55 - 3.93]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202888_s_at	38	0.657895	0.0669266	-	0.863581	0.133492	0.289953	1.34 [0.92 - 1.95]
GENE	ANPEP	alanyl (membrane) aminopeptidase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202888_s_at	140	0.821429	0.0123887	0.189456	0.795735	0.271444	0.171705	1.19 [0.87 - 1.61]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207064_s_at	30	0.733333	0.0771058	-	0.813089	0.627736	0.295932	1.34 [0.41 - 4.45]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1741431	165	0.248485	0.160408	-	-0.366205	0.66844	0.197637	1.22 [0.49 - 3.01]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1741431	165	0.145455	0.0493145	0.487496	-0.783549	0.943505	-0.0531569	0.95 [0.22 - 4.13]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207064_s_at	163	0.496933	0.0316478	0.36713	-0.424465	0.603481	-0.298803	0.74 [0.24 - 2.29]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207064_s_at	79	0.43038	0.102377	-	0.493811	0.0477601	1.34032	3.82 [1.01 - 14.40]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207064_s_at	58	0.258621	0.123333	-	0.499693	0.716635	0.101395	1.11 [0.64 - 1.91]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207064_s_at	34	0.117647	0.101017	-	-0.885592	0.338752	-0.434713	0.65 [0.27 - 1.58]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207064_s_at	158	0.810127	0.228737	-	0.319729	0.579505	0.42244	1.53 [0.34 - 6.80]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207064_s_at	53	0.754717	0.121016	-	-0.685524	0.678973	0.107559	1.11 [0.67 - 1.85]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207064_s_at	53	0.169811	0.120549	-	0.913867	0.503071	0.197156	1.22 [0.68 - 2.17]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207064_s_at	180	0.694444	0.000439407	0.0126875	0.73218	0.00643683	0.773445	2.17 [1.24 - 3.78]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207064_s_at	559	0.109123	0.0915254	-	0.757841	0.866289	-0.0428435	0.96 [0.58 - 1.58]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207064_s_at	77	0.103896	0.0488711	0.484808	-0.755283	0.945225	0.0245468	1.02 [0.51 - 2.06]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207064_s_at	70	0.114286	0.0603075	-	-0.716807	0.438184	-0.814895	0.44 [0.06 - 3.47]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35593_at	50	0.84	0.0806754	-	-0.843879	0.234412	-1.68997	0.18 [0.01 - 2.99]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207064_s_at	74	0.810811	0.101932	-	-0.70221	0.216114	-0.483414	0.62 [0.29 - 1.33]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207064_s_at	67	0.880597	0.0884466	-	1.1512	0.439455	2.42879	11.35 [0.02 - 5357.68]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207064_s_at	115	0.504348	0.0777903	-	1.00358	0.214491	0.966709	2.63 [0.57 - 12.10]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35593_at	158	0.898734	9.44694e-05	0.00333103	1.22153	0.0994295	0.557528	1.75 [0.90 - 3.39]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35593_at	76	0.355263	0.0366872	0.404535	-1.05416	0.912752	-0.0690958	0.93 [0.27 - 3.21]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207064_s_at	204	0.892157	0.0369403	0.406341	0.480827	0.155186	0.130938	1.14 [0.95 - 1.37]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207064_s_at	87	0.896552	3.08623e-08	2.13629e-06	2.03492	0.000360995	2.20724	9.09 [2.70 - 30.57]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207064_s_at	87	0.896552	3.08623e-08	2.13629e-06	2.03492	0.000360995	2.20724	9.09 [2.70 - 30.57]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207064_s_at	77	0.558442	0.0413215	0.436619	1.16091	0.280412	0.919627	2.51 [0.47 - 13.32]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207064_s_at	77	0.376623	0.053866	-	1.78673	0.447548	0.747259	2.11 [0.31 - 14.52]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207064_s_at	136	0.360294	0.0221899	0.288219	-1.04524	0.0946662	-0.360403	0.70 [0.46 - 1.06]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207064_s_at	200	0.13	0.0316736	0.367329	1.88289	0.182905	0.533706	1.71 [0.78 - 3.74]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21635	60	0.566667	0.0675598	-	-0.74658	0.270412	-0.302945	0.74 [0.43 - 1.27]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21635	60	0.816667	0.0834314	-	-1.19877	0.230011	-0.541946	0.58 [0.24 - 1.41]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15160	155	0.819355	2.18161e-05	0.000903133	1.15281	0.000749865	0.376286	1.46 [1.17 - 1.81]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207064_s_at	286	0.895105	0.157121	-	0.391097	0.617056	-0.12492	0.88 [0.54 - 1.44]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207064_s_at	159	0.685535	0.0527248	-	0.606877	0.298651	0.51283	1.67 [0.63 - 4.39]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207064_s_at	159	0.157233	0.144776	-	1.02346	0.333326	0.558451	1.75 [0.56 - 5.42]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207064_s_at	159	0.157233	0.0431873	0.448974	1.35974	0.311083	0.492032	1.64 [0.63 - 4.24]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207064_s_at	54	0.703704	0.0667773	-	-15.5227	0.276186	-1.63216	0.20 [0.01 - 3.69]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207064_s_at	117	0.205128	0.203132	-	-0.447707	0.842162	0.14444	1.16 [0.28 - 4.79]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207064_s_at	117	0.581197	0.218516	-	0.462635	0.476889	0.575324	1.78 [0.36 - 8.68]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207064_s_at	117	0.205128	0.203132	-	-0.447707	0.842162	0.14444	1.16 [0.28 - 4.79]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207064_s_at	117	0.606838	0.0265536	0.326215	0.853211	0.114979	1.23365	3.43 [0.74 - 15.92]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207064_s_at	236	0.864407	0.00123416	0.0303874	0.995441	0.326709	0.460627	1.59 [0.63 - 3.98]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207064_s_at	249	0.855422	0.0244143	0.307961	0.600072	0.323578	0.362145	1.44 [0.70 - 2.95]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207064_s_at	62	0.741935	0.116503	-	-0.97592	0.640209	-0.115297	0.89 [0.55 - 1.45]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207064_s_at	125	0.648	0.249761	-	-0.480269	0.918662	0.100306	1.11 [0.16 - 7.58]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207064_s_at	125	0.536	0.507368	-	0.195513	0.976878	0.0216852	1.02 [0.24 - 4.43]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207064_s_at	54	0.555556	0.276175	-	0.67085	0.753902	-0.0931833	0.91 [0.51 - 1.63]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207064_s_at	198	0.833333	0.12472	-	0.465681	0.993624	-0.000893312	1.00 [0.80 - 1.24]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207064_s_at	198	0.540404	0.109849	-	0.426753	0.964832	-0.00519748	0.99 [0.79 - 1.25]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207064_s_at	198	0.828283	0.0407164	0.432546	0.505802	0.755072	0.0299053	1.03 [0.85 - 1.24]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207064_s_at	51	0.568627	0.0749224	-	1.75732	0.0430493	3.17211	23.86 [1.10 - 515.47]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207064_s_at	62	0.887097	0.131201	-	0.969767	0.249373	1.42132	4.14 [0.37 - 46.52]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207064_s_at	177	0.254237	0.0279114	0.337456	0.666189	0.572427	0.450041	1.57 [0.33 - 7.48]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207064_s_at	145	0.434483	0.103498	-	-0.546885	0.873296	-0.188861	0.83 [0.08 - 8.43]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207064_s_at	177	0.19209	0.0483407	0.481573	0.834747	0.661915	0.399596	1.49 [0.25 - 8.94]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207064_s_at	226	0.40708	0.0346616	0.389835	-0.591591	0.176982	-0.443392	0.64 [0.34 - 1.22]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207064_s_at	55	0.145455	0.025148	0.314299	-1.08242	0.0895703	-3.26201	0.04 [0.00 - 1.66]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207064_s_at	49	0.653061	0.0529369	-	-1.77848	0.317339	-2.27229	0.10 [0.00 - 8.86]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207064_s_at	55	0.345455	0.0347941	0.39081	-0.914946	0.61435	-0.867925	0.42 [0.01 - 12.28]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	28921	34	0.882353	0.00334788	0.0688037	1.58538	0.0278007	2.01312	7.49 [1.25 - 45.00]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207064_s_at	63	0.126984	2.82073e-05	0.00113729	-1.58602	0.350064	-3.44652	0.03 [0.00 - 43.92]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6806881_3p_a_at	28	0.25	0.189996	-	-0.726647	0.614875	-0.455208	0.63 [0.11 - 3.74]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207064_s_at	82	0.365854	0.0986754	-	0.627968	0.332343	0.572555	1.77 [0.56 - 5.64]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	35593_at	84	0.595238	0.0789303	-	0.506224	0.309603	-0.333026	0.72 [0.38 - 1.36]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207064_s_at	79	0.367089	0.0159039	0.227456	-0.628783	0.407149	-0.405863	0.67 [0.26 - 1.74]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D88213_at	86	0.627907	0.101068	-	0.680456	0.407514	0.522907	1.69 [0.49 - 5.81]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207064_s_at	104	0.192308	0.108259	-	0.830315	0.656652	0.279727	1.32 [0.39 - 4.54]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P4133	117	0.34188	0.0022508	0.0498905	-0.849681	0.0247416	-0.395719	0.67 [0.48 - 0.95]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207064_s_at	204	0.186275	0.00648854	0.116008	-0.991628	0.0568249	-0.620916	0.54 [0.28 - 1.02]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207064_s_at	204	0.186275	0.00377663	0.0757705	-0.826404	0.176224	-0.353824	0.70 [0.42 - 1.17]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207064_s_at	178	0.617977	0.146761	-	-0.30866	0.796148	-0.103612	0.90 [0.41 - 1.98]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200013380	41	0.878049	0.00162807	0.0382398	1.5667	0.00364834	0.885252	2.42 [1.33 - 4.40]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207064_s_at	111	0.18018	0.183921	-	0.530304	0.855886	0.058042	1.06 [0.57 - 1.98]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207064_s_at	90	0.222222	0.129817	-	0.663154	0.501029	0.589442	1.80 [0.32 - 10.04]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207064_s_at	90	0.422222	0.116933	-	0.620079	0.753305	0.316343	1.37 [0.19 - 9.87]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4651	50	0.82	0.149575	-	-1.36784	0.611231	-0.206618	0.81 [0.37 - 1.80]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207064_s_at	138	0.101449	0.00888599	0.147668	-0.815971	0.0797077	-10.004	0.00 [0.00 - 3.27]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207064_s_at	129	0.844961	0.00402706	0.0797482	0.87033	0.0586975	0.726963	2.07 [0.97 - 4.40]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37443	56	0.196429	0.0574448	-	0.977889	0.309219	0.62843	1.87 [0.56 - 6.29]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37443	56	0.196429	0.082828	-	1.01037	0.360579	0.6023	1.83 [0.50 - 6.64]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207064_s_at	278	0.374101	0.0489783	0.485459	0.394678	0.735366	-0.127493	0.88 [0.42 - 1.84]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207064_s_at	133	0.81203	0.000724788	0.0194309	0.895554	0.0195402	3.49024	32.79 [1.75 - 613.92]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3724	81	0.419753	0.197101	-	-0.669841	0.59741	-0.303683	0.74 [0.24 - 2.28]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207064_s_at	185	0.724324	0.0434955	0.450985	0.38427	0.117405	0.476807	1.61 [0.89 - 2.93]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207064_s_at	185	0.243243	0.0445111	0.457556	0.384294	0.148349	0.409238	1.51 [0.86 - 2.62]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P4133	110	0.245455	0.136473	-	-0.392239	0.892183	0.0446883	1.05 [0.55 - 2.00]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P4133	110	0.727273	0.0585672	-	0.581624	0.771282	0.131096	1.14 [0.47 - 2.76]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207064_s_at	80	0.825	0.123213	-	-1.45026	0.952918	0.026771	1.03 [0.42 - 2.50]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3055	281	0.893238	0.0724335	-	-0.46272	0.960906	-0.00331288	1.00 [0.87 - 1.14]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:28921	59	0.79661	0.0037661	0.0756019	1.33923	0.221683	1.29821	3.66 [0.46 - 29.38]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207064_s_at	38	0.789474	0.106755	-	0.831041	0.320074	0.450589	1.57 [0.65 - 3.81]
GENE	AOC2	amine oxidase, copper containing 2 (retina-specific)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207064_s_at	140	0.364286	1.45589e-05	0.000627459	-1.20926	0.000550206	-1.75805	0.17 [0.06 - 0.47]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204894_s_at	30	0.866667	0.162617	-	0.770378	0.833605	0.0380352	1.04 [0.73 - 1.48]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1782086	165	0.630303	0.00333005	0.0685095	0.70121	0.753429	-0.0412263	0.96 [0.74 - 1.24]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1782086	165	0.630303	0.000816934	0.0214988	1.16084	0.513365	0.103814	1.11 [0.81 - 1.51]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204894_s_at	163	0.840491	0.143133	-	-0.432488	0.504694	-0.395034	0.67 [0.21 - 2.15]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204894_s_at	79	0.696203	0.430957	-	0.243591	0.529702	0.356473	1.43 [0.47 - 4.34]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204894_s_at	58	0.706897	0.178837	-	0.402578	0.465761	0.123648	1.13 [0.81 - 1.58]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204894_s_at	34	0.882353	0.123548	-	-1.08163	0.94224	0.0208882	1.02 [0.58 - 1.80]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204894_s_at	158	0.151899	0.0537452	-	0.86692	0.777965	0.129735	1.14 [0.46 - 2.81]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204894_s_at	53	0.113208	0.0855904	-	-0.827158	0.843832	-0.0673602	0.93 [0.48 - 1.83]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204894_s_at	53	0.113208	0.0128856	0.19504	-1.07952	0.389101	-0.266974	0.77 [0.42 - 1.41]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204894_s_at	180	0.883333	0.21483	-	-0.458826	0.813976	-0.0414611	0.96 [0.68 - 1.36]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204894_s_at	559	0.887299	0.112971	-	-0.655763	0.242892	-0.152819	0.86 [0.66 - 1.11]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204894_s_at	77	0.532468	0.154775	-	0.359221	0.958953	0.0100348	1.01 [0.69 - 1.48]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204894_s_at	70	0.428571	0.00364942	0.0737249	-0.769974	0.247809	-0.476147	0.62 [0.28 - 1.39]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33756_at	50	0.14	0.0321978	0.371351	-0.955018	0.749322	-0.192537	0.82 [0.25 - 2.69]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204894_s_at	74	0.445946	0.122162	-	-0.443938	0.570606	-0.127868	0.88 [0.57 - 1.37]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204894_s_at	67	0.477612	0.155911	-	-0.990712	0.91842	-0.0837142	0.92 [0.19 - 4.56]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204894_s_at	115	0.869565	0.133281	-	-15.2391	0.341598	-0.249566	0.78 [0.47 - 1.30]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33756_at	158	0.525316	0.00238285	0.0522641	0.874488	0.027587	0.61475	1.85 [1.07 - 3.20]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33756_at	76	0.75	0.215161	-	-0.9109	0.886651	-0.0570778	0.94 [0.43 - 2.07]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204894_s_at	204	0.132353	0.111246	-	-0.335614	0.550413	-0.0592942	0.94 [0.78 - 1.14]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204894_s_at	87	0.206897	0.00971172	0.15794	-0.989542	0.130212	-0.310988	0.73 [0.49 - 1.10]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204894_s_at	87	0.206897	0.00971172	0.15794	-0.989542	0.130212	-0.310988	0.73 [0.49 - 1.10]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204894_s_at	77	0.311688	0.0547474	-	1.76298	0.662019	0.160781	1.17 [0.57 - 2.41]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204894_s_at	77	0.714286	0.0378123	0.412516	-15.589	0.785711	-0.115888	0.89 [0.39 - 2.05]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204894_s_at	136	0.5	0.0126865	0.192812	-1.26259	0.140362	-0.414795	0.66 [0.38 - 1.15]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204894_s_at	200	0.835	0.152964	-	-0.731217	0.912966	0.0241295	1.02 [0.66 - 1.58]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19382	60	0.666667	0.141671	-	-0.664886	0.97067	0.00802406	1.01 [0.66 - 1.55]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19382	60	0.483333	0.0570203	-	-0.726146	0.820377	-0.0532034	0.95 [0.60 - 1.50]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15	155	0.225806	0.310616	-	0.35577	0.769792	0.0534064	1.05 [0.74 - 1.51]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204894_s_at	286	0.199301	0.0791902	-	0.483686	0.998537	0.000282798	1.00 [0.74 - 1.35]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204894_s_at	159	0.515723	0.0102836	0.164892	-0.859482	0.145092	-0.374872	0.69 [0.42 - 1.14]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204894_s_at	159	0.622642	0.00857526	0.143725	-0.998013	0.150911	-0.366834	0.69 [0.42 - 1.14]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204894_s_at	159	0.515723	0.00477398	0.0912561	-1.15966	0.128356	-0.4626	0.63 [0.35 - 1.14]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204894_s_at	54	0.166667	0.0652778	-	-1.26594	0.301212	-0.443037	0.64 [0.28 - 1.49]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204894_s_at	117	0.299145	0.0737415	-	0.730773	0.814943	0.0447784	1.05 [0.72 - 1.52]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204894_s_at	117	0.393162	0.030306	0.356677	1.03384	0.295165	0.225407	1.25 [0.82 - 1.91]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204894_s_at	117	0.299145	0.0737415	-	0.730773	0.814943	0.0447784	1.05 [0.72 - 1.52]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204894_s_at	117	0.307692	0.019915	0.267142	1.32422	0.206936	0.258668	1.30 [0.87 - 1.94]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204894_s_at	236	0.851695	0.00282942	0.0600817	-2.39626	0.0958595	-0.361318	0.70 [0.46 - 1.07]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204894_s_at	249	0.7751	0.00499271	0.0945343	-0.847284	0.157751	-0.238036	0.79 [0.57 - 1.10]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204894_s_at	62	0.274194	0.00075713	0.0201619	-1.54183	0.0825154	-0.32642	0.72 [0.50 - 1.04]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204894_s_at	125	0.512	0.151807	-	-0.560691	0.632265	-0.108362	0.90 [0.58 - 1.40]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204894_s_at	125	0.272	0.035151	0.393427	0.759355	0.779704	0.0457267	1.05 [0.76 - 1.44]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204894_s_at	54	0.259259	0.00222097	0.0493502	-1.71399	0.10771	-0.369341	0.69 [0.44 - 1.08]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204894_s_at	198	0.151515	0.148466	-	0.665067	0.505409	0.0936027	1.10 [0.83 - 1.45]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204894_s_at	198	0.141414	0.167711	-	0.482794	0.637664	0.0511573	1.05 [0.85 - 1.30]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204894_s_at	198	0.151515	0.122921	-	0.662974	0.539804	0.0814099	1.08 [0.84 - 1.41]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204894_s_at	51	0.313726	0.127777	-	15.6271	0.970958	-0.0289629	0.97 [0.20 - 4.62]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204894_s_at	62	0.887097	0.00431785	0.084289	1.58733	0.29638	0.340397	1.41 [0.74 - 2.66]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204894_s_at	145	0.268966	0.00738665	0.12822	1.48168	0.022935	0.568795	1.77 [1.08 - 2.88]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204894_s_at	177	0.451977	0.000666725	0.0181036	1.01067	0.000530694	0.552156	1.74 [1.27 - 2.37]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204894_s_at	177	0.451977	0.0014912	0.0355607	0.790365	0.00501521	0.417346	1.52 [1.13 - 2.03]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204894_s_at	226	0.323009	0.00153013	0.0363277	1.29277	0.00769792	0.320784	1.38 [1.09 - 1.74]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204894_s_at	49	0.734694	0.00277143	0.0590835	1.59718	0.0422233	0.636393	1.89 [1.02 - 3.49]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204894_s_at	55	0.527273	0.013822	0.205365	1.14147	0.132315	0.37697	1.46 [0.89 - 2.38]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204894_s_at	55	0.545455	0.0632909	-	0.930418	0.301249	0.296456	1.35 [0.77 - 2.36]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	484535	34	0.235294	0.00456461	0.0880807	2.35912	0.0219109	1.2405	3.46 [1.20 - 9.99]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204894_s_at	63	0.142857	0.000659101	0.0179279	-1.36621	0.666222	0.111068	1.12 [0.67 - 1.85]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6806883_3p_a_at	28	0.785714	0.135945	-	0.997087	0.294903	0.646981	1.91 [0.57 - 6.41]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204894_s_at	82	0.5	0.0135711	0.202624	-0.855974	0.24251	-0.293618	0.75 [0.46 - 1.22]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204894_s_at	79	0.164557	0.000124403	0.00424371	-1.27878	0.988702	0.00363314	1.00 [0.61 - 1.66]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U39447_at	86	0.232558	0.0549603	-	-0.790253	0.125397	-0.313991	0.73 [0.49 - 1.09]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204894_s_at	104	0.567308	0.0384678	0.417108	-0.746889	0.200948	-0.292832	0.75 [0.48 - 1.17]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P426305	117	0.700855	0.00961356	0.156734	-0.964706	0.358256	-0.137332	0.87 [0.65 - 1.17]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204894_s_at	204	0.348039	4.825e-08	3.24783e-06	-2.00887	0.000369207	-0.693137	0.50 [0.34 - 0.73]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204894_s_at	204	0.397059	3.97048e-10	3.48872e-08	-1.7262	3.57707e-07	-0.775309	0.46 [0.34 - 0.62]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204894_s_at	178	0.404494	0.0686302	-	-0.359367	0.506757	-0.103954	0.90 [0.66 - 1.23]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204894_s_at	111	0.135135	0.355373	-	-0.353297	0.495863	-0.108438	0.90 [0.66 - 1.23]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204894_s_at	90	0.377778	0.296498	-	0.362478	0.916822	0.0172791	1.02 [0.74 - 1.41]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204894_s_at	90	0.6	0.285688	-	-0.425577	0.754746	-0.060421	0.94 [0.64 - 1.38]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2673	50	0.42	0.177656	-	0.701761	0.903156	-0.0474573	0.95 [0.44 - 2.05]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204894_s_at	138	0.804348	0.00940433	0.15415	-0.996003	0.135543	-0.110193	0.90 [0.77 - 1.04]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204894_s_at	129	0.868217	0.00891663	0.148054	-1.4238	0.330423	-0.18755	0.83 [0.57 - 1.21]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37537	56	0.892857	0.150582	-	-1.01211	0.596836	-0.238777	0.79 [0.33 - 1.91]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24003	56	0.482143	0.117942	-	-0.560688	0.406034	-0.134249	0.87 [0.64 - 1.20]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37954	56	0.517857	0.0751738	-	-0.625788	0.672706	-0.0514163	0.95 [0.75 - 1.21]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37537	56	0.107143	0.118146	-	1.09153	0.938155	0.0355665	1.04 [0.42 - 2.54]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37954	56	0.517857	0.0644608	-	-0.669714	0.437994	-0.0963311	0.91 [0.71 - 1.16]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24003	56	0.5	0.0941437	-	-0.590079	0.669797	-0.0673172	0.93 [0.69 - 1.27]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204894_s_at	278	0.766187	0.00031239	0.00946113	0.700814	0.0159067	0.208365	1.23 [1.04 - 1.46]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204894_s_at	133	0.210526	0.0156542	0.224864	0.805526	0.533256	-0.0605341	0.94 [0.78 - 1.14]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18054	81	0.197531	0.137414	-	1.41807	0.969948	-0.0101612	0.99 [0.58 - 1.68]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204894_s_at	185	0.67027	0.00399124	0.0791831	0.504745	0.0367845	0.205288	1.23 [1.01 - 1.49]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204894_s_at	185	0.664865	0.00281208	0.0597838	0.556446	0.0246716	0.228027	1.26 [1.03 - 1.53]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P426305	110	0.709091	0.0301454	0.355411	0.519164	0.24401	0.0853766	1.09 [0.94 - 1.26]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P426305	110	0.727273	0.0217211	0.283952	0.709268	0.352882	0.0886244	1.09 [0.91 - 1.32]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204894_s_at	80	0.2375	0.0874264	-	1.58795	0.941319	0.012358	1.01 [0.73 - 1.41]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0119	281	0.729537	0.145054	-	-0.229964	0.915838	0.00716192	1.01 [0.88 - 1.15]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204894_s_at	38	0.842105	0.033643	0.382276	-15.3676	0.406082	-0.225725	0.80 [0.47 - 1.36]
GENE	AOC3	amine oxidase, copper containing 3 (vascular adhesion protein 1)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204894_s_at	140	0.457143	5.82294e-05	0.00217091	-1.20571	0.000218274	-0.294003	0.75 [0.64 - 0.87]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AOX1	aldehyde oxidase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205083_at	30	0.4	0.321524	-	-0.413931	0.744103	-0.103707	0.90 [0.48 - 1.68]
GENE	AOX1	aldehyde oxidase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205082_s_at	30	0.133333	0.0130197	0.196535	-1.37651	0.503434	-0.492829	0.61 [0.14 - 2.59]
GENE	AOX1	aldehyde oxidase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1767113	165	0.757576	0.0288655	0.345205	0.579168	0.94751	-0.0117263	0.99 [0.70 - 1.40]
GENE	AOX1	aldehyde oxidase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1767113	165	0.787879	0.0590038	-	0.70782	0.959222	0.0120073	1.01 [0.64 - 1.60]
GENE	AOX1	aldehyde oxidase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205082_s_at	163	0.190184	0.0716216	-	-0.432702	0.790704	-0.176423	0.84 [0.23 - 3.08]
GENE	AOX1	aldehyde oxidase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205083_at	163	0.736196	0.0852357	-	0.36917	0.816359	0.0687183	1.07 [0.60 - 1.91]
GENE	AOX1	aldehyde oxidase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205083_at	79	0.873418	0.0297011	0.351892	0.796936	0.173167	0.443826	1.56 [0.82 - 2.95]
GENE	AOX1	aldehyde oxidase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205082_s_at	79	0.278481	0.00504451	0.095305	1.09657	0.0596592	1.3885	4.01 [0.95 - 17.01]
GENE	AOX1	aldehyde oxidase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205082_s_at	58	0.310345	0.0648026	-	0.557266	0.619095	0.0842324	1.09 [0.78 - 1.52]
GENE	AOX1	aldehyde oxidase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205083_at	58	0.431034	0.0577931	-	0.543771	0.331444	0.153895	1.17 [0.85 - 1.59]
GENE	AOX1	aldehyde oxidase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205082_s_at	34	0.235294	0.151214	-	-0.599613	0.796708	-0.0858807	0.92 [0.48 - 1.76]
GENE	AOX1	aldehyde oxidase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205083_at	34	0.117647	0.0951302	-	1.21129	0.794058	-0.0696817	0.93 [0.55 - 1.57]
GENE	AOX1	aldehyde oxidase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205083_at	158	0.753165	0.00111493	0.0279163	-1.06036	0.0951576	-0.708675	0.49 [0.21 - 1.13]
GENE	AOX1	aldehyde oxidase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205082_s_at	158	0.689873	0.0858314	-	-0.446685	0.372184	-0.635722	0.53 [0.13 - 2.14]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205083_at	53	0.188679	0.00285631	0.0605429	-1.11782	0.180255	-0.222654	0.80 [0.58 - 1.11]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205082_s_at	53	0.150943	0.100839	-	-0.741369	0.942659	-0.0225909	0.98 [0.53 - 1.81]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205083_at	53	0.169811	0.0014739	0.0352185	-1.25154	0.410871	-0.153494	0.86 [0.59 - 1.24]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205082_s_at	53	0.150943	0.00190478	0.0435175	-1.20682	0.263889	-0.349928	0.70 [0.38 - 1.30]
GENE	AOX1	aldehyde oxidase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205083_at	180	0.161111	0.0154599	0.222838	-0.605128	0.562075	-0.0898559	0.91 [0.67 - 1.24]
GENE	AOX1	aldehyde oxidase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205082_s_at	180	0.272222	0.0596316	-	0.48246	0.187751	0.143236	1.15 [0.93 - 1.43]
GENE	AOX1	aldehyde oxidase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205083_at	559	0.767442	0.0540411	-	-0.471757	0.299439	-0.186962	0.83 [0.58 - 1.18]
GENE	AOX1	aldehyde oxidase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205082_s_at	559	0.100179	0.0200029	0.267974	-0.661696	0.330436	-0.168847	0.84 [0.60 - 1.19]
GENE	AOX1	aldehyde oxidase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205082_s_at	77	0.87013	0.142028	-	-0.625853	0.88788	-0.0255138	0.97 [0.68 - 1.39]
GENE	AOX1	aldehyde oxidase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205083_at	77	0.25974	0.0516649	-	0.5925	0.21752	0.229279	1.26 [0.87 - 1.81]
GENE	AOX1	aldehyde oxidase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205083_at	70	0.6	0.0525178	-	0.524645	0.487649	0.171834	1.19 [0.73 - 1.93]
GENE	AOX1	aldehyde oxidase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205082_s_at	70	0.7	0.134838	-	0.426683	0.324682	0.859161	2.36 [0.43 - 13.05]
GENE	AOX1	aldehyde oxidase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37599_at	50	0.26	0.0936214	-	-0.635882	0.567825	-0.364479	0.69 [0.20 - 2.43]
GENE	AOX1	aldehyde oxidase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205083_at	74	0.72973	0.136123	-	0.466154	0.737821	0.117354	1.12 [0.57 - 2.24]
GENE	AOX1	aldehyde oxidase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205082_s_at	74	0.121622	0.127485	-	0.778608	0.974934	-0.0070004	0.99 [0.64 - 1.54]
GENE	AOX1	aldehyde oxidase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205083_at	67	0.716418	0.0569257	-	-15.593	0.514456	-0.220254	0.80 [0.41 - 1.56]
GENE	AOX1	aldehyde oxidase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205082_s_at	67	0.80597	0.134514	-	-15.3732	0.674262	-0.126914	0.88 [0.49 - 1.59]
GENE	AOX1	aldehyde oxidase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205083_at	115	0.608696	0.0422919	0.443083	-1.42801	0.138965	-0.878655	0.42 [0.13 - 1.33]
GENE	AOX1	aldehyde oxidase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205082_s_at	115	0.208696	0.0457541	0.465481	15.4059	0.337196	0.611456	1.84 [0.53 - 6.43]
GENE	AOX1	aldehyde oxidase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37599_at	158	0.240506	0.0103422	0.165597	-0.732064	0.060327	-0.30038	0.74 [0.54 - 1.01]
GENE	AOX1	aldehyde oxidase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37599_at	76	0.828947	0.214407	-	-1.21399	0.463765	-0.191452	0.83 [0.49 - 1.38]
GENE	AOX1	aldehyde oxidase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205083_at	204	0.313726	0.00221428	0.0492287	-0.462013	0.0153628	-0.237735	0.79 [0.65 - 0.96]
GENE	AOX1	aldehyde oxidase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205082_s_at	204	0.191176	6.46012e-06	0.000300533	-0.818402	0.00101106	-0.278637	0.76 [0.64 - 0.89]
GENE	AOX1	aldehyde oxidase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205082_s_at	87	0.367816	0.154272	-	0.612801	0.835738	-0.0669371	0.94 [0.50 - 1.76]
GENE	AOX1	aldehyde oxidase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205083_at	87	0.137931	0.290459	-	0.757897	0.959191	-0.00859538	0.99 [0.71 - 1.38]
GENE	AOX1	aldehyde oxidase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205083_at	87	0.137931	0.290459	-	0.757897	0.959191	-0.00859538	0.99 [0.71 - 1.38]
GENE	AOX1	aldehyde oxidase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205082_s_at	87	0.367816	0.154272	-	0.612801	0.835738	-0.0669371	0.94 [0.50 - 1.76]
GENE	AOX1	aldehyde oxidase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205083_at	77	0.168831	0.153966	-	-0.833076	0.899888	0.0355317	1.04 [0.60 - 1.80]
GENE	AOX1	aldehyde oxidase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205082_s_at	77	0.324675	0.0474868	0.476319	-1.0555	0.646385	0.267935	1.31 [0.42 - 4.11]
GENE	AOX1	aldehyde oxidase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205083_at	77	0.168831	0.248954	-	-0.776204	0.450156	0.208569	1.23 [0.72 - 2.12]
GENE	AOX1	aldehyde oxidase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205082_s_at	77	0.324675	0.0400902	0.428294	-1.24535	0.405939	0.491919	1.64 [0.51 - 5.22]
GENE	AOX1	aldehyde oxidase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205082_s_at	136	0.161765	0.19093	-	1.25896	0.990716	-0.00280641	1.00 [0.62 - 1.60]
GENE	AOX1	aldehyde oxidase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205083_at	136	0.102941	0.0246881	0.310336	-1.11672	0.069421	-0.642883	0.53 [0.26 - 1.05]
GENE	AOX1	aldehyde oxidase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205083_at	200	0.22	0.00294126	0.0619932	-0.89935	0.234748	-0.293265	0.75 [0.46 - 1.21]
GENE	AOX1	aldehyde oxidase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205082_s_at	200	0.855	0.0456922	0.465089	0.679164	0.267104	0.201024	1.22 [0.86 - 1.74]
GENE	AOX1	aldehyde oxidase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1834	155	0.141935	0.000861482	0.022483	-0.983402	0.00985349	-0.201577	0.82 [0.70 - 0.95]
GENE	AOX1	aldehyde oxidase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205083_at	286	0.713287	0.00450397	0.0871539	-0.679311	0.119401	-0.220192	0.80 [0.61 - 1.06]
GENE	AOX1	aldehyde oxidase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205082_s_at	286	0.881119	0.060633	-	-0.677054	0.502918	-0.0772621	0.93 [0.74 - 1.16]
GENE	AOX1	aldehyde oxidase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205083_at	159	0.490566	0.00210305	0.0471976	-1.01795	0.0268914	-0.456036	0.63 [0.42 - 0.95]
GENE	AOX1	aldehyde oxidase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205083_at	159	0.459119	0.000618644	0.016989	-1.37503	0.0632683	-0.456577	0.63 [0.39 - 1.03]
GENE	AOX1	aldehyde oxidase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205082_s_at	159	0.421384	0.282382	-	-0.33842	0.768128	-0.064622	0.94 [0.61 - 1.44]
GENE	AOX1	aldehyde oxidase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205082_s_at	159	0.169811	0.108203	-	-0.578521	0.415802	-0.177742	0.84 [0.55 - 1.28]
GENE	AOX1	aldehyde oxidase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205083_at	159	0.459119	0.0202055	0.269886	-0.741681	0.384258	-0.193811	0.82 [0.53 - 1.27]
GENE	AOX1	aldehyde oxidase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205082_s_at	159	0.842767	0.370321	-	0.407899	0.839215	-0.0521809	0.95 [0.57 - 1.57]
GENE	AOX1	aldehyde oxidase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205082_s_at	54	0.444444	0.0258097	0.319945	-2.0158	0.107521	-2.05275	0.13 [0.01 - 1.56]
GENE	AOX1	aldehyde oxidase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205083_at	54	0.240741	0.106887	-	-1.08733	0.346332	-0.539467	0.58 [0.19 - 1.79]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205082_s_at	117	0.589744	0.100664	-	0.517546	0.427498	0.157651	1.17 [0.79 - 1.73]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205082_s_at	117	0.290598	0.0411373	0.435383	-0.787255	0.706861	0.109976	1.12 [0.63 - 1.98]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205083_at	117	0.538462	0.0862669	-	0.653214	0.37338	0.135342	1.14 [0.85 - 1.54]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205083_at	117	0.307692	0.0748548	-	0.692292	0.432386	0.107217	1.11 [0.85 - 1.45]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205083_at	117	0.307692	0.0748548	-	0.692292	0.432386	0.107217	1.11 [0.85 - 1.45]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205083_at	117	0.538462	0.329589	-	0.381283	0.765998	0.0587075	1.06 [0.72 - 1.56]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205082_s_at	117	0.589744	0.100664	-	0.517546	0.427498	0.157651	1.17 [0.79 - 1.73]
GENE	AOX1	aldehyde oxidase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205082_s_at	117	0.623932	0.0883666	-	0.634395	0.305024	0.216759	1.24 [0.82 - 1.88]
GENE	AOX1	aldehyde oxidase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205082_s_at	236	0.144068	0.10916	-	-0.517865	0.577668	-0.106225	0.90 [0.62 - 1.31]
GENE	AOX1	aldehyde oxidase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205083_at	236	0.127119	0.000120424	0.00412428	-1.10982	0.00112339	-0.81422	0.44 [0.27 - 0.72]
GENE	AOX1	aldehyde oxidase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205082_s_at	249	0.891566	0.0998997	-	-0.682582	0.672234	0.059722	1.06 [0.80 - 1.40]
GENE	AOX1	aldehyde oxidase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205083_at	249	0.116466	9.6638e-07	5.27247e-05	-1.18506	0.000658427	-0.696158	0.50 [0.33 - 0.74]
GENE	AOX1	aldehyde oxidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205082_s_at	62	0.403226	0.0417376	0.439401	-0.984114	0.44275	-0.141452	0.87 [0.60 - 1.25]
GENE	AOX1	aldehyde oxidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205082_s_at	125	0.856	0.197777	-	-0.914199	0.627997	0.339932	1.40 [0.36 - 5.56]
GENE	AOX1	aldehyde oxidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205083_at	62	0.177419	0.00881181	0.14673	-1.37213	0.204177	-0.258965	0.77 [0.52 - 1.15]
GENE	AOX1	aldehyde oxidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205082_s_at	125	0.232	0.0975201	-	-0.562138	0.759079	-0.173153	0.84 [0.28 - 2.54]
GENE	AOX1	aldehyde oxidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205082_s_at	54	0.37037	0.0465228	0.470319	-1.18383	0.534541	-0.137911	0.87 [0.56 - 1.35]
GENE	AOX1	aldehyde oxidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205083_at	125	0.56	0.0964296	-	0.633672	0.376891	0.235906	1.27 [0.75 - 2.14]
GENE	AOX1	aldehyde oxidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205083_at	125	0.784	0.0275355	0.33437	0.671858	0.508363	0.140537	1.15 [0.76 - 1.75]
GENE	AOX1	aldehyde oxidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205083_at	54	0.148148	0.000791335	0.0209288	-2.03207	0.351679	-0.226426	0.80 [0.50 - 1.28]
GENE	AOX1	aldehyde oxidase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205082_s_at	198	0.893939	0.0820539	-	0.625913	0.926554	-0.0111754	0.99 [0.78 - 1.25]
GENE	AOX1	aldehyde oxidase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205083_at	198	0.530303	0.00762929	0.131443	0.688044	0.133911	0.211398	1.24 [0.94 - 1.63]
GENE	AOX1	aldehyde oxidase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205083_at	198	0.530303	0.00296418	0.0623828	0.803185	0.0840066	0.260147	1.30 [0.97 - 1.74]
GENE	AOX1	aldehyde oxidase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205082_s_at	198	0.116162	0.0127988	0.19407	-0.692708	0.472546	-0.0691586	0.93 [0.77 - 1.13]
GENE	AOX1	aldehyde oxidase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205082_s_at	198	0.893939	0.0849337	-	0.589902	0.924817	0.0111379	1.01 [0.80 - 1.27]
GENE	AOX1	aldehyde oxidase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205083_at	198	0.520202	0.115373	-	0.330766	0.222303	0.135376	1.14 [0.92 - 1.42]
GENE	AOX1	aldehyde oxidase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205082_s_at	51	0.215686	0.0293334	0.348961	-1.7564	0.831204	-0.395143	0.67 [0.02 - 25.49]
GENE	AOX1	aldehyde oxidase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205082_s_at	62	0.129032	0.132891	-	-0.966047	0.510116	-0.824257	0.44 [0.04 - 5.10]
GENE	AOX1	aldehyde oxidase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205083_at	51	0.235294	0.0394053	0.423602	-1.67765	0.276511	-2.43004	0.09 [0.00 - 7.01]
GENE	AOX1	aldehyde oxidase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205083_at	62	0.258065	0.0206801	0.274337	-1.25453	0.277364	-1.28902	0.28 [0.03 - 2.82]
GENE	AOX1	aldehyde oxidase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205083_at	145	0.77931	0.0157607	0.225971	0.838764	0.0941719	0.54495	1.72 [0.91 - 3.26]
GENE	AOX1	aldehyde oxidase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205082_s_at	177	0.836158	0.0461014	0.467672	-0.826329	0.591444	-0.247127	0.78 [0.32 - 1.93]
GENE	AOX1	aldehyde oxidase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205083_at	177	0.418079	0.0584275	-	0.548854	0.850752	0.0505748	1.05 [0.62 - 1.78]
GENE	AOX1	aldehyde oxidase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205082_s_at	145	0.351724	0.339463	-	0.354334	0.519474	0.403139	1.50 [0.44 - 5.10]
GENE	AOX1	aldehyde oxidase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205082_s_at	177	0.836158	0.0221988	0.288299	-1.27121	0.268232	-0.652993	0.52 [0.16 - 1.65]
GENE	AOX1	aldehyde oxidase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205083_at	177	0.112994	0.109662	-	0.727142	0.488334	0.150893	1.16 [0.76 - 1.78]
GENE	AOX1	aldehyde oxidase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205082_s_at	226	0.393805	0.0726712	-	0.559179	0.327904	0.231465	1.26 [0.79 - 2.00]
GENE	AOX1	aldehyde oxidase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205083_at	226	0.884956	0.0140319	0.207644	0.851988	0.350062	0.169826	1.19 [0.83 - 1.69]
GENE	AOX1	aldehyde oxidase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205082_s_at	55	0.818182	0.0927123	-	0.799744	0.253594	0.757576	2.13 [0.58 - 7.83]
GENE	AOX1	aldehyde oxidase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205082_s_at	55	0.709091	0.204942	-	0.572053	0.618767	0.341776	1.41 [0.37 - 5.41]
GENE	AOX1	aldehyde oxidase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205082_s_at	49	0.163265	0.0722276	-	-1.05856	0.921241	-0.0980729	0.91 [0.13 - 6.34]
GENE	AOX1	aldehyde oxidase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205083_at	55	0.872727	0.0531874	-	0.964496	0.122109	0.582393	1.79 [0.86 - 3.75]
GENE	AOX1	aldehyde oxidase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205083_at	55	0.890909	0.0312018	0.36368	1.2136	0.0788865	0.701696	2.02 [0.92 - 4.41]
GENE	AOX1	aldehyde oxidase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205083_at	49	0.734694	0.177203	-	0.771386	0.39338	0.428553	1.54 [0.57 - 4.11]
GENE	AOX1	aldehyde oxidase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205082_s_at	63	0.222222	0.00972174	0.158063	-0.894703	0.989497	-0.0262941	0.97 [0.02 - 48.84]
GENE	AOX1	aldehyde oxidase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205083_at	63	0.222222	0.000131442	0.00445368	-1.2863	0.399911	-9.08136	0.00 [0.00 - 173460.99]
GENE	AOX1	aldehyde oxidase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13516378_3p_a_at	28	0.714286	0.0499211	0.49115	-1.42805	0.331474	-3.21345	0.04 [0.00 - 26.36]
GENE	AOX1	aldehyde oxidase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6598319_3p_at	28	0.285714	0.295406	-	0.672995	0.822026	-0.0893963	0.91 [0.42 - 1.99]
GENE	AOX1	aldehyde oxidase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205082_s_at	82	0.792683	0.0189672	0.258071	0.833587	0.523412	0.133979	1.14 [0.76 - 1.73]
GENE	AOX1	aldehyde oxidase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205083_at	82	0.256098	0.0834746	-	-0.609812	0.577805	-0.164835	0.85 [0.47 - 1.52]
GENE	AOX1	aldehyde oxidase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205082_s_at	79	0.227848	0.00340175	0.0696907	-0.82599	0.0378822	-0.420966	0.66 [0.44 - 0.98]
GENE	AOX1	aldehyde oxidase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205083_at	79	0.582278	0.137884	-	-0.394283	0.20727	-0.38185	0.68 [0.38 - 1.24]
GENE	AOX1	aldehyde oxidase 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	L11005_at	86	0.127907	0.0402753	0.429555	-1.00484	0.299744	-0.332271	0.72 [0.38 - 1.34]
GENE	AOX1	aldehyde oxidase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205083_at	104	0.807692	0.00447475	0.0867061	-2.31841	0.00721981	-0.952357	0.39 [0.19 - 0.77]
GENE	AOX1	aldehyde oxidase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205082_s_at	104	0.625	0.0756028	-	-0.639587	0.4119	-0.227861	0.80 [0.46 - 1.37]
GENE	AOX1	aldehyde oxidase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P154037	117	0.794872	0.033727	0.382904	-0.965179	0.332053	-0.12833	0.88 [0.68 - 1.14]
GENE	AOX1	aldehyde oxidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205083_at	204	0.480392	0.0123312	0.188805	-0.960179	0.204054	-0.292041	0.75 [0.48 - 1.17]
GENE	AOX1	aldehyde oxidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205083_at	204	0.191176	0.00940802	0.154195	-0.743906	0.0997873	-0.283016	0.75 [0.54 - 1.06]
GENE	AOX1	aldehyde oxidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205082_s_at	204	0.573529	0.0476237	0.477165	-0.83156	0.794388	-0.0871134	0.92 [0.48 - 1.76]
GENE	AOX1	aldehyde oxidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205082_s_at	204	0.897059	0.0764824	-	-1.2028	0.403108	-0.203154	0.82 [0.51 - 1.31]
GENE	AOX1	aldehyde oxidase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205082_s_at	178	0.455056	0.135789	-	-0.294153	0.780635	-0.0384221	0.96 [0.73 - 1.26]
GENE	AOX1	aldehyde oxidase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205083_at	178	0.539326	0.320249	-	-0.200191	0.742263	-0.0612026	0.94 [0.65 - 1.35]
GENE	AOX1	aldehyde oxidase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205083_at	111	0.891892	0.0707624	-	0.643442	0.814635	0.0444322	1.05 [0.72 - 1.52]
GENE	AOX1	aldehyde oxidase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205082_s_at	111	0.801802	0.0512716	-	0.577174	0.965176	0.00796411	1.01 [0.70 - 1.44]
GENE	AOX1	aldehyde oxidase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205082_s_at	90	0.133333	0.0139039	0.206255	2.09408	0.832554	0.136901	1.15 [0.32 - 4.08]
GENE	AOX1	aldehyde oxidase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205082_s_at	90	0.133333	0.0140996	0.208376	15.3162	0.850363	-0.143456	0.87 [0.20 - 3.85]
GENE	AOX1	aldehyde oxidase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205083_at	90	0.111111	0.0657532	-	-0.756684	0.519679	-0.225997	0.80 [0.40 - 1.59]
GENE	AOX1	aldehyde oxidase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205083_at	90	0.877778	0.125658	-	-1.43315	0.320066	-0.444615	0.64 [0.27 - 1.54]
GENE	AOX1	aldehyde oxidase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205083_at	138	0.369565	0.00240518	0.0526626	-0.71917	0.331836	-0.129515	0.88 [0.68 - 1.14]
GENE	AOX1	aldehyde oxidase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205082_s_at	138	0.514493	0.0390281	0.420999	-0.504771	0.114155	-0.460954	0.63 [0.36 - 1.12]
GENE	AOX1	aldehyde oxidase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205083_at	129	0.860465	0.130602	-	-0.637297	0.613218	-0.111615	0.89 [0.58 - 1.38]
GENE	AOX1	aldehyde oxidase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205082_s_at	129	0.255814	0.00241921	0.0529125	-0.776298	0.0340069	-0.51796	0.60 [0.37 - 0.96]
GENE	AOX1	aldehyde oxidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15610	56	0.875	0.190301	-	0.633079	0.990085	-0.00251209	1.00 [0.67 - 1.48]
GENE	AOX1	aldehyde oxidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15610	56	0.607143	0.233221	-	0.413771	0.660224	0.0843447	1.09 [0.75 - 1.58]
GENE	AOX1	aldehyde oxidase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205083_at	278	0.226619	0.0199091	0.267085	0.577852	0.981254	0.00184648	1.00 [0.86 - 1.17]
GENE	AOX1	aldehyde oxidase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205082_s_at	278	0.589928	0.34481	-	-0.186837	0.714173	-0.0498845	0.95 [0.73 - 1.24]
GENE	AOX1	aldehyde oxidase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205082_s_at	133	0.601504	0.0235112	0.300043	0.536981	0.168908	0.558264	1.75 [0.79 - 3.87]
GENE	AOX1	aldehyde oxidase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205083_at	133	0.37594	0.150844	-	-0.343047	0.566324	-0.10807	0.90 [0.62 - 1.30]
GENE	AOX1	aldehyde oxidase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4863	81	0.728395	0.0976778	-	-1.18934	0.400068	-0.177168	0.84 [0.55 - 1.27]
GENE	AOX1	aldehyde oxidase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205082_s_at	185	0.12973	0.182593	-	0.360289	0.531604	0.142249	1.15 [0.74 - 1.80]
GENE	AOX1	aldehyde oxidase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205083_at	185	0.372973	0.00119609	0.0296038	0.55271	0.31879	0.0859133	1.09 [0.92 - 1.29]
GENE	AOX1	aldehyde oxidase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205082_s_at	185	0.102703	0.229307	-	0.318725	0.876544	0.0324367	1.03 [0.69 - 1.56]
GENE	AOX1	aldehyde oxidase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205083_at	185	0.318919	0.000851042	0.0222532	0.655206	0.14884	0.133398	1.14 [0.95 - 1.37]
GENE	AOX1	aldehyde oxidase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P154037	110	0.336364	0.0623464	-	0.598372	0.825472	0.0359052	1.04 [0.75 - 1.43]
GENE	AOX1	aldehyde oxidase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P154037	110	0.318182	0.0661693	-	0.470005	0.428337	0.101999	1.11 [0.86 - 1.43]
GENE	AOX1	aldehyde oxidase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205083_at	80	0.1125	0.271974	-	-0.604921	0.367353	-0.139322	0.87 [0.64 - 1.18]
GENE	AOX1	aldehyde oxidase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205082_s_at	80	0.475	0.171951	-	-0.604286	0.471329	-0.137275	0.87 [0.60 - 1.27]
GENE	AOX1	aldehyde oxidase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3066	281	0.213523	0.00147271	0.0351949	-0.508316	0.00222367	-0.225999	0.80 [0.69 - 0.92]
GENE	AOX1	aldehyde oxidase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:471487	59	0.745763	0.286283	-	-0.779468	0.638892	0.377616	1.46 [0.30 - 7.06]
GENE	AOX1	aldehyde oxidase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:114043	59	0.423729	0.195129	-	0.677318	0.712402	0.221642	1.25 [0.38 - 4.06]
GENE	AOX1	aldehyde oxidase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205082_s_at	38	0.815789	0.123004	-	-1.4565	0.39499	-0.20555	0.81 [0.51 - 1.31]
GENE	AOX1	aldehyde oxidase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205083_at	38	0.815789	0.123004	-	-1.4565	0.218319	-0.402652	0.67 [0.35 - 1.27]
GENE	AOX1	aldehyde oxidase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205082_s_at	140	0.65	0.00570929	0.105015	-0.983611	0.128898	-0.356922	0.70 [0.44 - 1.11]
GENE	AOX1	aldehyde oxidase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205083_at	140	0.121429	0.00673543	0.119412	-0.933913	0.167071	-0.179368	0.84 [0.65 - 1.08]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203219_s_at	30	0.833333	0.132935	-	0.771237	0.53924	0.268431	1.31 [0.56 - 3.08]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213892_s_at	30	0.833333	0.0050684	0.0956597	1.49754	0.806862	0.126577	1.13 [0.41 - 3.13]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1726410	165	0.654545	0.0224112	0.29022	-0.62809	0.965355	0.00661221	1.01 [0.75 - 1.36]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1726410	165	0.533333	0.0400624	0.428105	-0.765198	0.70868	-0.0869132	0.92 [0.58 - 1.45]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213892_s_at	163	0.779141	0.00487214	0.092732	0.614235	0.221725	0.223899	1.25 [0.87 - 1.79]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203219_s_at	163	0.656442	0.0430956	0.448374	0.406198	0.504247	0.117076	1.12 [0.80 - 1.59]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213892_s_at	79	0.35443	0.0404736	0.430901	0.65952	0.35562	0.249368	1.28 [0.76 - 2.18]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203219_s_at	79	0.544304	0.0237963	0.302557	0.657868	0.426103	0.19372	1.21 [0.75 - 1.96]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203219_s_at	58	0.310345	0.0228469	0.294135	-0.698708	0.178362	-0.212684	0.81 [0.59 - 1.10]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213892_s_at	58	0.896552	0.00223748	0.0496495	-1.68563	0.0103337	-0.723756	0.48 [0.28 - 0.84]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203219_s_at	34	0.117647	0.194924	-	0.92413	0.791649	-0.092883	0.91 [0.46 - 1.82]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213892_s_at	34	0.117647	0.123236	-	1.44736	0.740818	0.111509	1.12 [0.58 - 2.16]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203219_s_at	158	0.78481	0.151834	-	-0.423305	0.816628	-0.0551449	0.95 [0.59 - 1.51]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213892_s_at	158	0.822785	0.164729	-	-0.451181	0.668983	-0.0930129	0.91 [0.59 - 1.40]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213892_s_at	53	0.169811	0.00443297	0.0860648	-1.14231	0.573675	-0.375258	0.69 [0.19 - 2.54]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203219_s_at	53	0.773585	0.00824993	0.13955	0.927865	0.503995	0.438433	1.55 [0.43 - 5.61]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213892_s_at	53	0.169811	0.0186496	0.254991	-0.937382	0.521735	-0.415924	0.66 [0.18 - 2.35]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203219_s_at	53	0.698113	0.00438364	0.0853053	1.01245	0.571204	0.386582	1.47 [0.39 - 5.61]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203219_s_at	180	0.127778	0.0979461	-	-0.480212	0.626223	-0.146909	0.86 [0.48 - 1.56]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213892_s_at	180	0.161111	0.25167	-	-0.308092	0.525403	-0.207491	0.81 [0.43 - 1.54]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213892_s_at	559	0.797853	0.0482106	0.480775	0.468172	0.353983	0.195463	1.22 [0.80 - 1.84]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203219_s_at	559	0.867621	0.0152925	0.221084	0.653284	0.216826	0.18444	1.20 [0.90 - 1.61]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203219_s_at	77	0.324675	0.0206735	0.274275	0.65847	0.413473	0.22666	1.25 [0.73 - 2.16]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213892_s_at	77	0.896104	0.0379661	0.413598	0.788364	0.360615	0.332573	1.39 [0.68 - 2.85]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213892_s_at	70	0.842857	0.0688709	-	-0.7353	0.171921	-0.53056	0.59 [0.27 - 1.26]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203219_s_at	70	0.742857	0.0111795	0.175534	-0.847702	0.231925	-0.47385	0.62 [0.29 - 1.35]
GENE	APRT	adenine phosphoribosyltransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34310_at	50	0.78	0.0275354	0.334369	-1.25271	0.0433872	-1.12954	0.32 [0.11 - 0.97]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203219_s_at	74	0.648649	0.168432	-	0.40676	0.684218	-0.117612	0.89 [0.50 - 1.57]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213892_s_at	74	0.162162	0.127106	-	0.6577	0.357919	0.443462	1.56 [0.61 - 4.01]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213892_s_at	67	0.134328	0.071636	-	-1.2137	0.62936	0.4656	1.59 [0.24 - 10.55]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203219_s_at	67	0.865672	0.107371	-	1.0917	0.123399	1.76334	5.83 [0.62 - 54.96]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213892_s_at	115	0.104348	0.155558	-	-0.898426	0.226176	-0.994	0.37 [0.07 - 1.85]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203219_s_at	115	0.721739	0.0748101	-	-1.65414	0.472407	-0.370721	0.69 [0.25 - 1.90]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34310_at	158	0.797468	0.0641199	-	-0.789548	0.522819	-0.208883	0.81 [0.43 - 1.54]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34310_at	76	0.526316	0.0074862	0.129546	-1.58312	0.0428041	-0.664726	0.51 [0.27 - 0.98]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203219_s_at	204	0.323529	0.0115823	0.180226	0.373982	0.0255821	0.341341	1.41 [1.04 - 1.90]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213892_s_at	204	0.441176	0.00210597	0.0472512	0.437338	0.0218715	0.387944	1.47 [1.06 - 2.05]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213892_s_at	87	0.850575	0.170026	-	-0.970449	0.802064	-0.0775988	0.93 [0.50 - 1.70]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203219_s_at	87	0.597701	0.0673223	-	0.680922	0.907833	0.0328895	1.03 [0.59 - 1.80]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203219_s_at	87	0.597701	0.0673223	-	0.680922	0.907833	0.0328895	1.03 [0.59 - 1.80]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213892_s_at	87	0.850575	0.170026	-	-0.970449	0.802064	-0.0775988	0.93 [0.50 - 1.70]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203219_s_at	77	0.675325	0.00970869	0.157903	1.36962	0.0890579	0.755553	2.13 [0.89 - 5.09]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213892_s_at	77	0.558442	0.0130337	0.196691	1.73823	0.0504093	1.03341	2.81 [1.00 - 7.91]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203219_s_at	77	0.675325	0.00642409	0.115114	1.67964	0.0893226	0.871608	2.39 [0.87 - 6.53]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213892_s_at	77	0.558442	0.0336136	0.382056	1.20524	0.0617525	0.840132	2.32 [0.96 - 5.59]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213892_s_at	136	0.816176	0.0833726	-	0.823416	0.658661	-0.236556	0.79 [0.28 - 2.25]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203219_s_at	136	0.382353	0.114082	-	0.803981	0.980563	0.0101726	1.01 [0.45 - 2.29]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203219_s_at	200	0.575	0.106376	-	0.472819	0.36315	0.318591	1.38 [0.69 - 2.73]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213892_s_at	200	0.875	0.0320751	0.370413	0.749891	0.13874	0.541133	1.72 [0.84 - 3.52]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	22058	60	0.7	0.0370436	0.407077	0.778719	0.128812	0.75007	2.12 [0.80 - 5.57]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	22058	60	0.783333	1.70915e-07	1.05833e-05	1.94848	0.00196986	1.49682	4.47 [1.73 - 11.53]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15256	155	0.812903	0.000153183	0.00509271	1.04459	0.00142157	0.239931	1.27 [1.10 - 1.47]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203219_s_at	286	0.13986	0.0560426	-	-0.460927	0.798013	0.061513	1.06 [0.66 - 1.70]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213892_s_at	286	0.702797	0.0040507	0.0801204	0.566102	0.208028	0.294791	1.34 [0.85 - 2.12]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203219_s_at	159	0.81761	2.24041e-06	0.000114252	1.41786	4.39423e-05	1.12074	3.07 [1.79 - 5.25]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213892_s_at	159	0.811321	1.26135e-06	6.73932e-05	1.43834	0.00986828	0.704657	2.02 [1.18 - 3.46]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203219_s_at	159	0.81761	2.09807e-07	1.28084e-05	1.72117	0.000101463	1.22675	3.41 [1.84 - 6.33]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213892_s_at	159	0.811321	6.40779e-06	0.000298318	1.36284	0.00107323	0.855183	2.35 [1.41 - 3.93]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213892_s_at	159	0.811321	5.78183e-07	3.28055e-05	1.67379	0.00278273	0.907255	2.48 [1.37 - 4.49]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203219_s_at	159	0.811321	1.24749e-07	7.89192e-06	1.53718	0.000331773	1.00987	2.75 [1.58 - 4.77]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203219_s_at	54	0.592593	0.00407171	0.0804508	1.96966	0.0340604	1.00732	2.74 [1.08 - 6.95]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213892_s_at	54	0.574074	0.00279588	0.059505	2.03445	0.0453076	1.05513	2.87 [1.02 - 8.07]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203219_s_at	117	0.589744	0.0341105	0.38576	-0.716797	0.171053	-0.317724	0.73 [0.46 - 1.15]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203219_s_at	117	0.589744	0.00274397	0.0586093	-1.36879	0.0662587	-0.502248	0.61 [0.35 - 1.03]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203219_s_at	117	0.589744	0.0341105	0.38576	-0.716797	0.171053	-0.317724	0.73 [0.46 - 1.15]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203219_s_at	117	0.846154	0.0157865	0.226239	-15.3284	0.358761	-0.269365	0.76 [0.43 - 1.36]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213892_s_at	117	0.666667	0.0041768	0.0820965	-1.58091	0.0686608	-0.688121	0.50 [0.24 - 1.05]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213892_s_at	117	0.700855	0.0706793	-	-0.700857	0.326995	-0.287771	0.75 [0.42 - 1.33]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213892_s_at	117	0.700855	0.0706793	-	-0.700857	0.326995	-0.287771	0.75 [0.42 - 1.33]
GENE	APRT	adenine phosphoribosyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213892_s_at	117	0.777778	0.0109918	0.173329	-2.1525	0.30497	-0.379661	0.68 [0.33 - 1.41]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213892_s_at	236	0.84322	3.8174e-05	0.00149069	1.14562	0.000259205	1.14729	3.15 [1.70 - 5.83]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203219_s_at	236	0.885593	0.00206353	0.0464704	0.969323	0.00187336	1.05845	2.88 [1.48 - 5.62]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203219_s_at	249	0.771084	1.49671e-05	0.000643308	0.937308	0.000139343	1.04909	2.86 [1.66 - 4.90]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213892_s_at	249	0.819277	4.96607e-06	0.000236541	1.03256	1.41011e-05	1.06329	2.90 [1.79 - 4.68]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213892_s_at	125	0.304	0.0018304	0.042116	1.37513	0.0968938	0.39551	1.49 [0.93 - 2.37]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213892_s_at	54	0.851852	0.0056966	0.104833	1.58534	0.143021	0.619296	1.86 [0.81 - 4.25]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203219_s_at	62	0.887097	0.000164667	0.00542498	1.8189	0.224032	0.351875	1.42 [0.81 - 2.51]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203219_s_at	125	0.824	0.0116918	0.181492	0.969112	0.091059	0.614767	1.85 [0.91 - 3.77]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213892_s_at	62	0.854839	0.000771356	0.0204816	1.57794	0.19791	0.430752	1.54 [0.80 - 2.96]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203219_s_at	125	0.824	0.0223043	0.289254	0.707033	0.139309	0.427118	1.53 [0.87 - 2.70]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203219_s_at	54	0.888889	0.00603967	0.109724	1.68596	0.151003	0.520301	1.68 [0.83 - 3.42]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213892_s_at	125	0.304	0.00337702	0.069284	1.87309	0.0327313	0.645009	1.91 [1.05 - 3.45]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203219_s_at	198	0.535354	0.00175472	0.0406773	0.807395	0.175416	0.254653	1.29 [0.89 - 1.86]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213892_s_at	198	0.742424	0.000230294	0.00726602	0.798365	0.0233283	0.36814	1.45 [1.05 - 1.99]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203219_s_at	198	0.540404	0.00593528	0.108245	0.737996	0.306206	0.199403	1.22 [0.83 - 1.79]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213892_s_at	198	0.681818	0.00425791	0.0833595	0.72434	0.110372	0.31317	1.37 [0.93 - 2.01]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213892_s_at	198	0.681818	0.010119	0.162904	0.679719	0.164617	0.281185	1.32 [0.89 - 1.97]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203219_s_at	198	0.742424	0.000608823	0.0167595	0.751819	0.0587843	0.291014	1.34 [0.99 - 1.81]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213892_s_at	62	0.822581	0.127725	-	-15.2843	0.808832	0.144273	1.16 [0.36 - 3.72]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203219_s_at	51	0.176471	0.141445	-	-1.26	0.552179	-0.412032	0.66 [0.17 - 2.58]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203219_s_at	62	0.16129	0.0657917	-	-1.07673	0.944406	-0.0333071	0.97 [0.38 - 2.47]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213892_s_at	51	0.803922	0.266335	-	-15.3565	0.964857	-0.0381643	0.96 [0.18 - 5.26]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203219_s_at	177	0.875706	0.0471392	0.474164	-0.891169	0.720912	-0.124235	0.88 [0.45 - 1.75]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213892_s_at	177	0.898305	0.06544	-	-1.24597	0.415055	-0.262791	0.77 [0.41 - 1.45]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203219_s_at	145	0.324138	0.00073756	0.0197202	-1.08204	0.0091002	-1.31807	0.27 [0.10 - 0.72]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203219_s_at	177	0.875706	0.0200348	0.268275	-1.5245	0.266365	-0.443334	0.64 [0.29 - 1.40]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213892_s_at	177	0.898305	0.186402	-	-0.604079	0.962529	-0.0133902	0.99 [0.56 - 1.73]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213892_s_at	145	0.124138	0.00316804	0.0658175	-1.05155	0.0216943	-0.926061	0.40 [0.18 - 0.87]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203219_s_at	226	0.429204	0.00232266	0.051186	-0.860471	0.0374654	-0.595288	0.55 [0.31 - 0.97]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213892_s_at	226	0.327434	0.000204859	0.00656308	-1.01368	0.00333289	-0.8649	0.42 [0.24 - 0.75]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213892_s_at	55	0.709091	0.120446	-	0.698538	0.547334	0.246259	1.28 [0.57 - 2.85]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213892_s_at	55	0.709091	0.0104697	0.167127	1.1639	0.139452	0.698648	2.01 [0.80 - 5.08]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213892_s_at	49	0.693878	0.00836079	0.140978	1.44146	0.248859	0.636115	1.89 [0.64 - 5.57]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203219_s_at	55	0.6	0.00221792	0.0492949	1.49784	0.0798241	0.789234	2.20 [0.91 - 5.32]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203219_s_at	55	0.581818	0.00284193	0.0602963	1.32271	0.28073	0.43387	1.54 [0.70 - 3.39]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203219_s_at	49	0.632653	0.006434	0.115252	1.55365	0.209865	0.636838	1.89 [0.70 - 5.12]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	897774	34	0.205882	0.0287965	0.344648	-1.0089	0.162156	-0.690694	0.50 [0.19 - 1.32]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213892_s_at	63	0.650794	0.0845692	-	0.586334	0.839689	0.0515042	1.05 [0.64 - 1.73]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203219_s_at	63	0.730159	0.00127521	0.031227	1.08293	0.297796	0.177165	1.19 [0.86 - 1.67]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.28914.1.S1_3p_a_at	28	0.321429	0.163881	-	0.884407	0.583058	0.359429	1.43 [0.40 - 5.17]
GENE	APRT	adenine phosphoribosyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213892_s_at	82	0.634146	0.255466	-	-0.422459	0.640231	-0.222391	0.80 [0.32 - 2.03]
GENE	APRT	adenine phosphoribosyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203219_s_at	82	0.207317	0.0190648	0.259014	-0.815344	0.0723301	-0.635834	0.53 [0.26 - 1.06]
GENE	APRT	adenine phosphoribosyltransferase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34310_at	84	0.72619	0.10449	-	-0.55695	0.345756	-0.42297	0.66 [0.27 - 1.58]
GENE	APRT	adenine phosphoribosyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213892_s_at	79	0.303797	0.00327862	0.0676584	-0.792037	0.497849	-0.268529	0.76 [0.35 - 1.66]
GENE	APRT	adenine phosphoribosyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203219_s_at	79	0.531646	0.0609518	-	-0.489597	0.608038	-0.153091	0.86 [0.48 - 1.54]
GENE	APRT	adenine phosphoribosyltransferase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	Y00486_rna1_at	86	0.581395	0.336283	-	-0.41413	0.791948	0.162235	1.18 [0.35 - 3.93]
GENE	APRT	adenine phosphoribosyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203219_s_at	104	0.336538	0.00418433	0.082214	1.14199	0.0662601	0.565777	1.76 [0.96 - 3.22]
GENE	APRT	adenine phosphoribosyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213892_s_at	104	0.375	0.0227877	0.293605	0.822828	0.420204	0.319173	1.38 [0.63 - 2.99]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P117955	117	0.837607	0.129756	-	0.513791	0.915424	0.0372553	1.04 [0.52 - 2.06]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213892_s_at	204	0.710784	0.114704	-	0.437093	0.372283	0.336883	1.40 [0.67 - 2.94]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203219_s_at	204	0.45098	0.0366803	0.404486	0.837948	0.505326	0.306579	1.36 [0.55 - 3.35]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203219_s_at	204	0.45098	0.0124871	0.190568	0.728448	0.0718553	0.620718	1.86 [0.95 - 3.66]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213892_s_at	204	0.215686	0.233192	-	0.629999	0.974886	0.0158493	1.02 [0.38 - 2.73]
GENE	APRT	adenine phosphoribosyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213892_s_at	178	0.162921	0.00354875	0.0720934	-0.709007	0.357917	-0.328641	0.72 [0.36 - 1.45]
GENE	APRT	adenine phosphoribosyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203219_s_at	178	0.123596	0.0554987	-	-0.534528	0.428899	-0.194032	0.82 [0.51 - 1.33]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203219_s_at	111	0.477477	0.132014	-	0.400153	0.571184	0.129358	1.14 [0.73 - 1.78]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213892_s_at	111	0.855856	0.165361	-	-0.589558	0.597555	0.15074	1.16 [0.66 - 2.03]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213892_s_at	90	0.888889	0.0251781	0.314557	0.909766	0.608767	0.151876	1.16 [0.65 - 2.08]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213892_s_at	90	0.322222	0.287231	-	-0.398787	0.5617	-0.205502	0.81 [0.41 - 1.63]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203219_s_at	90	0.766667	0.0615046	-	0.629366	0.499423	0.217596	1.24 [0.66 - 2.34]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203219_s_at	90	0.433333	0.286036	-	0.414127	0.927168	-0.034303	0.97 [0.46 - 2.02]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1335	50	0.72	0.135482	-	0.725025	0.519617	0.292876	1.34 [0.55 - 3.27]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203219_s_at	138	0.217391	0.033836	0.383718	0.742394	0.273752	0.162895	1.18 [0.88 - 1.58]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213892_s_at	138	0.891304	0.0951059	-	0.566175	0.586604	0.1085	1.11 [0.75 - 1.65]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203219_s_at	129	0.643411	0.175936	-	0.338367	0.595044	-0.193059	0.82 [0.40 - 1.68]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213892_s_at	129	0.651163	0.0609212	-	0.461118	0.808781	0.0757482	1.08 [0.58 - 1.99]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43979	56	0.303571	0.135088	-	0.623449	0.223448	0.392197	1.48 [0.79 - 2.78]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43979	56	0.303571	0.183258	-	0.563691	0.386258	0.285865	1.33 [0.70 - 2.54]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213892_s_at	278	0.143885	0.00233859	0.0514719	-0.732447	0.152637	-0.272669	0.76 [0.52 - 1.11]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203219_s_at	278	0.201439	0.0181319	0.249926	-0.510184	0.151802	-0.255264	0.77 [0.55 - 1.10]
GENE	APRT	adenine phosphoribosyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203219_s_at	133	0.120301	0.0269204	0.329278	-0.722764	0.75342	-0.0364406	0.96 [0.77 - 1.21]
GENE	APRT	adenine phosphoribosyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213892_s_at	133	0.571429	0.0305061	0.35825	0.509863	0.719316	0.0584101	1.06 [0.77 - 1.46]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2757	81	0.790123	0.0418747	0.440315	1.0286	0.28118	0.458038	1.58 [0.69 - 3.64]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203219_s_at	185	0.264865	0.00339658	0.0696057	-0.557948	0.170135	-0.206668	0.81 [0.61 - 1.09]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213892_s_at	185	0.805405	0.0215377	0.282272	-0.475589	0.369569	-0.104217	0.90 [0.72 - 1.13]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203219_s_at	185	0.264865	0.0322539	0.37178	-0.394848	0.407119	-0.113406	0.89 [0.68 - 1.17]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213892_s_at	185	0.805405	0.0152798	0.220951	-0.56326	0.236577	-0.149098	0.86 [0.67 - 1.10]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P117955	110	0.118182	0.0324819	0.373518	-0.679409	0.897853	-0.0289545	0.97 [0.62 - 1.51]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P117955	110	0.136364	0.0312718	0.364223	-0.79338	0.86542	-0.048877	0.95 [0.54 - 1.68]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203219_s_at	80	0.7	0.195838	-	0.564409	0.55848	0.221274	1.25 [0.59 - 2.62]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213892_s_at	80	0.2375	0.137703	-	1.05868	0.904325	0.0439571	1.04 [0.51 - 2.14]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_5188	281	0.227758	0.00515133	0.0968877	-0.446727	0.0958708	-0.223641	0.80 [0.61 - 1.04]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213892_s_at	38	0.342105	0.028739	0.344184	1.1847	0.0803953	0.961282	2.62 [0.89 - 7.68]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203219_s_at	38	0.894737	0.0415348	0.438047	1.14407	0.114831	0.820222	2.27 [0.82 - 6.29]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213892_s_at	140	0.378571	4.58336e-05	0.00175469	-1.15339	0.0054402	-0.938451	0.39 [0.20 - 0.76]
GENE	APRT	adenine phosphoribosyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203219_s_at	140	0.285714	2.50648e-05	0.00102301	-1.15764	0.00389158	-1.17955	0.31 [0.14 - 0.68]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AQP8	aquaporin 8	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206784_at	30	0.166667	0.0106625	0.169429	-1.35261	0.749647	0.213158	1.24 [0.33 - 4.58]
GENE	AQP8	aquaporin 8	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1713462	165	0.884848	0.176588	-	-0.619601	0.301637	-0.692231	0.50 [0.13 - 1.86]
GENE	AQP8	aquaporin 8	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1713462	165	0.339394	0.222136	-	0.493534	0.724127	-0.333877	0.72 [0.11 - 4.57]
GENE	AQP8	aquaporin 8	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206784_at	163	0.110429	0.0479232	0.479011	-0.532199	0.553138	-0.381738	0.68 [0.19 - 2.41]
GENE	AQP8	aquaporin 8	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206784_at	79	0.240506	0.000129355	0.00439161	-1.12144	0.00214699	-3.64554	0.03 [0.00 - 0.27]
GENE	AQP8	aquaporin 8	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206784_at	58	0.275862	0.0114929	0.179189	0.813842	0.311904	0.19316	1.21 [0.83 - 1.76]
GENE	AQP8	aquaporin 8	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206784_at	34	0.264706	0.164969	-	-0.562217	0.716202	-0.0902152	0.91 [0.56 - 1.49]
GENE	AQP8	aquaporin 8	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206784_at	158	0.765823	0.0287673	0.344412	0.549387	0.279488	1.10546	3.02 [0.41 - 22.40]
GENE	AQP8	aquaporin 8	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206784_at	53	0.867925	0.0911266	-	0.747446	0.880724	0.0423142	1.04 [0.60 - 1.81]
GENE	AQP8	aquaporin 8	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206784_at	53	0.867925	0.0299502	0.353868	0.963978	0.505237	0.199782	1.22 [0.68 - 2.20]
GENE	AQP8	aquaporin 8	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206784_at	180	0.661111	0.104301	-	-0.370157	0.745957	-0.0482222	0.95 [0.71 - 1.28]
GENE	AQP8	aquaporin 8	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206784_at	559	0.592129	0.14428	-	0.291161	0.959614	-0.00594455	0.99 [0.79 - 1.25]
GENE	AQP8	aquaporin 8	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206784_at	77	0.844156	0.0141559	0.208984	0.831819	0.310073	-0.206945	0.81 [0.55 - 1.21]
GENE	AQP8	aquaporin 8	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206784_at	70	0.285714	0.0445733	0.457956	-0.576976	0.385559	-0.867933	0.42 [0.06 - 2.98]
GENE	AQP8	aquaporin 8	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33651_at	50	0.14	0.129097	-	-0.681857	0.208286	-1.92323	0.15 [0.01 - 2.92]
GENE	AQP8	aquaporin 8	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206784_at	74	0.351351	0.0275174	0.334221	0.697632	0.485903	0.140388	1.15 [0.78 - 1.71]
GENE	AQP8	aquaporin 8	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206784_at	67	0.134328	0.020683	0.274364	-1.50783	0.271896	-2.54579	0.08 [0.00 - 7.36]
GENE	AQP8	aquaporin 8	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206784_at	115	0.895652	0.162835	-	0.876506	0.353661	0.882668	2.42 [0.37 - 15.61]
GENE	AQP8	aquaporin 8	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33651_at	158	0.867089	0.108687	-	0.544322	0.475062	0.168854	1.18 [0.74 - 1.88]
GENE	AQP8	aquaporin 8	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33651_at	76	0.513158	0.00597799	0.108851	1.60333	0.033132	1.98514	7.28 [1.17 - 45.22]
GENE	AQP8	aquaporin 8	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206784_at	204	0.838235	0.116386	-	0.304519	0.641423	0.0468324	1.05 [0.86 - 1.28]
GENE	AQP8	aquaporin 8	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206784_at	87	0.62069	0.00559064	0.103306	1.01734	0.0913484	1.83857	6.29 [0.74 - 53.14]
GENE	AQP8	aquaporin 8	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206784_at	87	0.62069	0.00559064	0.103306	1.01734	0.0913484	1.83857	6.29 [0.74 - 53.14]
GENE	AQP8	aquaporin 8	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206784_at	77	0.428571	0.214278	-	-0.78198	0.921391	-0.155608	0.86 [0.04 - 18.82]
GENE	AQP8	aquaporin 8	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206784_at	77	0.74026	0.0805764	-	0.937779	0.447239	0.904957	2.47 [0.24 - 25.50]
GENE	AQP8	aquaporin 8	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206784_at	136	0.845588	0.0137997	0.205121	1.16654	0.571656	0.15682	1.17 [0.68 - 2.01]
GENE	AQP8	aquaporin 8	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206784_at	200	0.86	0.0623243	-	0.635829	0.260227	0.243002	1.28 [0.84 - 1.95]
GENE	AQP8	aquaporin 8	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1582	60	0.733333	0.310089	-	0.414075	0.901078	-0.0254685	0.97 [0.65 - 1.46]
GENE	AQP8	aquaporin 8	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1582	60	0.833333	0.0257959	0.319828	-1.94918	0.277391	-0.411524	0.66 [0.32 - 1.39]
GENE	AQP8	aquaporin 8	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12428	155	0.154839	4.92478e-06	0.000234748	-1.28066	0.179918	-0.38249	0.68 [0.39 - 1.19]
GENE	AQP8	aquaporin 8	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206784_at	286	0.681818	0.0189642	0.258042	-0.530376	0.754208	-0.0436245	0.96 [0.73 - 1.26]
GENE	AQP8	aquaporin 8	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206784_at	159	0.880503	0.232284	-	0.492665	0.5742	0.135831	1.15 [0.71 - 1.84]
GENE	AQP8	aquaporin 8	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206784_at	159	0.672956	0.127592	-	-0.685163	0.74539	-0.0889475	0.91 [0.53 - 1.57]
GENE	AQP8	aquaporin 8	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206784_at	159	0.761006	0.0621957	-	-0.864584	0.66116	-0.10205	0.90 [0.57 - 1.43]
GENE	AQP8	aquaporin 8	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206784_at	54	0.759259	0.348915	-	-0.958489	0.5271	-0.603904	0.55 [0.08 - 3.55]
GENE	AQP8	aquaporin 8	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206784_at	117	0.692308	0.0756173	-	0.571602	0.38972	0.365418	1.44 [0.63 - 3.31]
GENE	AQP8	aquaporin 8	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206784_at	117	0.418803	0.140891	-	0.588225	0.258897	0.501291	1.65 [0.69 - 3.94]
GENE	AQP8	aquaporin 8	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206784_at	117	0.692308	0.0756173	-	0.571602	0.38972	0.365418	1.44 [0.63 - 3.31]
GENE	AQP8	aquaporin 8	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206784_at	117	0.504274	0.0531268	-	0.77645	0.114754	0.73839	2.09 [0.84 - 5.24]
GENE	AQP8	aquaporin 8	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206784_at	236	0.817797	0.101405	-	0.50203	0.730217	-0.0827402	0.92 [0.58 - 1.47]
GENE	AQP8	aquaporin 8	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206784_at	249	0.248996	0.208527	-	-0.292004	0.938291	0.0143737	1.01 [0.71 - 1.46]
GENE	AQP8	aquaporin 8	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206784_at	62	0.112903	0.0265143	0.325886	-1.38845	0.760321	-0.0681899	0.93 [0.60 - 1.45]
GENE	AQP8	aquaporin 8	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206784_at	125	0.88	0.199303	-	-0.931948	0.898906	0.0917099	1.10 [0.27 - 4.51]
GENE	AQP8	aquaporin 8	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206784_at	125	0.84	0.0265943	0.326556	-1.01332	0.463184	-0.406256	0.67 [0.23 - 1.97]
GENE	AQP8	aquaporin 8	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206784_at	54	0.37037	0.102241	-	1.56046	0.86489	-0.0463044	0.95 [0.56 - 1.63]
GENE	AQP8	aquaporin 8	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206784_at	198	0.10101	0.129779	-	-0.541597	0.493187	-0.0876092	0.92 [0.71 - 1.18]
GENE	AQP8	aquaporin 8	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206784_at	198	0.10101	0.0653565	-	-0.660958	0.388928	-0.116008	0.89 [0.68 - 1.16]
GENE	AQP8	aquaporin 8	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206784_at	198	0.151515	0.0721369	-	-0.481037	0.425964	-0.0837858	0.92 [0.75 - 1.13]
GENE	AQP8	aquaporin 8	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206784_at	51	0.686275	0.116345	-	-15.6624	0.445644	-0.517231	0.60 [0.16 - 2.25]
GENE	AQP8	aquaporin 8	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206784_at	62	0.725806	0.113856	-	-1.50588	0.445078	-0.182176	0.83 [0.52 - 1.33]
GENE	AQP8	aquaporin 8	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206784_at	177	0.700565	0.176447	-	0.382616	0.668576	-0.0860291	0.92 [0.62 - 1.36]
GENE	AQP8	aquaporin 8	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206784_at	177	0.774011	0.0529196	-	0.506887	0.691918	0.0588638	1.06 [0.79 - 1.42]
GENE	AQP8	aquaporin 8	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206784_at	145	0.703448	0.06287	-	0.627681	0.393326	0.158268	1.17 [0.81 - 1.68]
GENE	AQP8	aquaporin 8	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206784_at	226	0.89823	0.0814841	-	0.664061	0.462701	0.0499485	1.05 [0.92 - 1.20]
GENE	AQP8	aquaporin 8	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206784_at	55	0.109091	0.00118517	0.029378	-1.54306	0.363479	-0.18367	0.83 [0.56 - 1.24]
GENE	AQP8	aquaporin 8	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206784_at	55	0.472727	0.00411777	0.0811733	-1.50179	0.0329254	-0.65828	0.52 [0.28 - 0.95]
GENE	AQP8	aquaporin 8	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206784_at	49	0.102041	0.0189366	0.257776	-1.4637	0.464898	-0.221543	0.80 [0.44 - 1.45]
GENE	AQP8	aquaporin 8	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206784_at	63	0.253968	0.00375372	0.0754035	-0.971761	0.187325	-11.7329	0.00 [0.00 - 301.30]
GENE	AQP8	aquaporin 8	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502188_3p_at	28	0.714286	0.112537	-	-1.15356	0.263871	-2.46571	0.08 [0.00 - 6.42]
GENE	AQP8	aquaporin 8	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206784_at	82	0.865854	0.0452895	0.462534	0.841204	0.272384	0.593579	1.81 [0.63 - 5.23]
GENE	AQP8	aquaporin 8	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33651_at	84	0.380952	0.0725257	-	-0.524638	0.482199	-0.325191	0.72 [0.29 - 1.79]
GENE	AQP8	aquaporin 8	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206784_at	79	0.101266	0.136444	-	0.684399	0.586906	0.279167	1.32 [0.48 - 3.62]
GENE	AQP8	aquaporin 8	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206784_at	104	0.769231	0.15773	-	-0.612471	0.430909	-0.522694	0.59 [0.16 - 2.18]
GENE	AQP8	aquaporin 8	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P26522	117	0.675214	0.0140529	0.207871	0.698113	0.359048	0.360385	1.43 [0.66 - 3.10]
GENE	AQP8	aquaporin 8	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206784_at	204	0.196078	0.0936168	-	0.711005	0.633396	0.0972536	1.10 [0.74 - 1.64]
GENE	AQP8	aquaporin 8	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206784_at	204	0.171569	0.125047	-	1.07128	0.582401	0.150756	1.16 [0.68 - 1.99]
GENE	AQP8	aquaporin 8	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206784_at	178	0.898876	0.284478	-	0.328741	0.860377	0.0620911	1.06 [0.53 - 2.13]
GENE	AQP8	aquaporin 8	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206784_at	111	0.693694	0.0422207	0.442612	0.539841	0.976693	-0.00452356	1.00 [0.73 - 1.35]
GENE	AQP8	aquaporin 8	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206784_at	90	0.822222	0.0733811	-	-1.03157	0.349744	-0.590453	0.55 [0.16 - 1.91]
GENE	AQP8	aquaporin 8	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206784_at	90	0.755556	0.129252	-	-0.797043	0.57883	-0.400779	0.67 [0.16 - 2.76]
GENE	AQP8	aquaporin 8	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206784_at	138	0.26087	0.00630584	0.113466	-0.672548	0.381207	-5.62598	0.00 [0.00 - 1060.52]
GENE	AQP8	aquaporin 8	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206784_at	129	0.821705	0.0249753	0.312815	0.648509	0.20459	0.293776	1.34 [0.85 - 2.11]
GENE	AQP8	aquaporin 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42711	56	0.875	0.13051	-	-1.07334	0.857477	0.119101	1.13 [0.31 - 4.13]
GENE	AQP8	aquaporin 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13269	56	0.839286	0.152428	-	-0.840754	0.832323	-0.102275	0.90 [0.35 - 2.33]
GENE	AQP8	aquaporin 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42711	56	0.875	0.251642	-	-0.820254	0.789517	0.185282	1.20 [0.31 - 4.69]
GENE	AQP8	aquaporin 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13269	56	0.839286	0.117635	-	-1.08954	0.586551	-0.279997	0.76 [0.28 - 2.07]
GENE	AQP8	aquaporin 8	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206784_at	278	0.23741	0.00353716	0.071905	-0.600598	0.302171	-0.583292	0.56 [0.18 - 1.69]
GENE	AQP8	aquaporin 8	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206784_at	133	0.691729	0.00602698	0.109545	0.672223	0.0120967	6.86009	953.45 [4.49 - 202488.02]
GENE	AQP8	aquaporin 8	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	8098	81	0.135802	0.040267	0.429499	-1.14423	0.00504584	-1.68811	0.18 [0.06 - 0.60]
GENE	AQP8	aquaporin 8	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13463	81	0.135802	0.0160949	0.229427	-1.34816	0.271364	-0.675065	0.51 [0.15 - 1.70]
GENE	AQP8	aquaporin 8	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206784_at	185	0.194595	0.0516643	-	0.407131	0.747419	0.0638838	1.07 [0.72 - 1.57]
GENE	AQP8	aquaporin 8	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206784_at	185	0.102703	0.0280086	0.338251	0.684371	0.524417	0.136434	1.15 [0.75 - 1.74]
GENE	AQP8	aquaporin 8	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P26522	110	0.745455	0.0668055	-	-0.507455	0.985406	-0.00569174	0.99 [0.54 - 1.83]
GENE	AQP8	aquaporin 8	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P26522	110	0.172727	0.0780217	-	-0.629868	0.610169	-0.229643	0.79 [0.33 - 1.92]
GENE	AQP8	aquaporin 8	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206784_at	80	0.475	0.0629658	-	1.00498	0.0900061	0.430826	1.54 [0.93 - 2.53]
GENE	AQP8	aquaporin 8	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0063	281	0.697509	0.085194	-	0.256083	0.765115	-0.0949763	0.91 [0.49 - 1.70]
GENE	AQP8	aquaporin 8	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206784_at	38	0.184211	0.136482	-	1.4162	0.791785	0.104016	1.11 [0.51 - 2.40]
GENE	AQP8	aquaporin 8	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206784_at	140	0.757143	0.240603	-	0.371305	0.864506	0.121523	1.13 [0.28 - 4.56]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AQP9	aquaporin 9	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205568_at	30	0.333333	0.376468	-	0.396083	0.829188	0.0498883	1.05 [0.67 - 1.65]
GENE	AQP9	aquaporin 9	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1715068	165	0.684848	9.10518e-07	4.99069e-05	1.17255	0.00285584	0.41869	1.52 [1.15 - 2.00]
GENE	AQP9	aquaporin 9	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1715068	165	0.684848	5.07788e-05	0.00192223	1.36433	0.0123259	0.450593	1.57 [1.10 - 2.23]
GENE	AQP9	aquaporin 9	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205568_at	163	0.263804	0.03397	0.384716	-0.445065	0.207114	-0.1463	0.86 [0.69 - 1.08]
GENE	AQP9	aquaporin 9	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205568_at	79	0.189873	0.0654059	-	0.785709	0.924842	0.00889343	1.01 [0.84 - 1.21]
GENE	AQP9	aquaporin 9	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205568_at	58	0.672414	0.0293687	0.349243	0.644545	0.097749	0.242019	1.27 [0.96 - 1.70]
GENE	AQP9	aquaporin 9	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205568_at	34	0.264706	0.208299	-	-0.51602	0.519701	-0.0821557	0.92 [0.72 - 1.18]
GENE	AQP9	aquaporin 9	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205568_at	158	0.879747	0.154939	-	-0.598331	0.517671	-0.204642	0.81 [0.44 - 1.51]
GENE	AQP9	aquaporin 9	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205568_at	53	0.226415	0.0457059	0.465176	1.15217	0.0977444	0.257446	1.29 [0.95 - 1.75]
GENE	AQP9	aquaporin 9	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205568_at	53	0.867925	0.0595685	-	0.801632	0.303276	0.151202	1.16 [0.87 - 1.55]
GENE	AQP9	aquaporin 9	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205568_at	180	0.894444	0.0578419	-	0.604563	0.12696	0.145077	1.16 [0.96 - 1.39]
GENE	AQP9	aquaporin 9	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205568_at	559	0.849732	0.201029	-	0.318845	0.520446	0.110476	1.12 [0.80 - 1.56]
GENE	AQP9	aquaporin 9	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205568_at	77	0.12987	0.131003	-	-0.549076	0.806148	0.0213086	1.02 [0.86 - 1.21]
GENE	AQP9	aquaporin 9	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205568_at	70	0.757143	0.0947741	-	-0.551588	0.595075	-0.119515	0.89 [0.57 - 1.38]
GENE	AQP9	aquaporin 9	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34435_at	50	0.32	0.0234228	0.299261	-0.824134	0.48962	-0.43712	0.65 [0.19 - 2.23]
GENE	AQP9	aquaporin 9	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205568_at	74	0.608108	0.00266585	0.0572537	0.869216	0.00598368	0.297135	1.35 [1.09 - 1.66]
GENE	AQP9	aquaporin 9	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205568_at	67	0.223881	0.130044	-	15.3767	0.262573	0.547695	1.73 [0.66 - 4.51]
GENE	AQP9	aquaporin 9	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205568_at	115	0.721739	0.220612	-	-0.90238	0.816955	-0.0726361	0.93 [0.50 - 1.72]
GENE	AQP9	aquaporin 9	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34435_at	158	0.335443	0.0687737	-	0.635046	0.23413	0.246876	1.28 [0.85 - 1.92]
GENE	AQP9	aquaporin 9	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34435_at	76	0.447368	0.0133011	0.199654	-1.34538	0.249021	-0.400211	0.67 [0.34 - 1.32]
GENE	AQP9	aquaporin 9	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205568_at	204	0.740196	0.000107582	0.00373506	0.629035	0.00351786	0.162826	1.18 [1.05 - 1.31]
GENE	AQP9	aquaporin 9	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205568_at	87	0.747126	0.00203974	0.0460311	1.12716	0.904943	0.0284667	1.03 [0.64 - 1.64]
GENE	AQP9	aquaporin 9	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205568_at	87	0.747126	0.00203974	0.0460311	1.12716	0.904943	0.0284667	1.03 [0.64 - 1.64]
GENE	AQP9	aquaporin 9	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205568_at	77	0.675325	0.0386131	0.41812	1.09747	0.283826	0.811908	2.25 [0.51 - 9.94]
GENE	AQP9	aquaporin 9	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205568_at	77	0.675325	0.141873	-	0.899899	0.984006	-0.0175329	0.98 [0.18 - 5.46]
GENE	AQP9	aquaporin 9	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205568_at	136	0.220588	0.00186555	0.0427799	-1.29906	0.351489	-0.279278	0.76 [0.42 - 1.36]
GENE	AQP9	aquaporin 9	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205568_at	200	0.48	0.000487964	0.0138782	1.1444	0.0183157	0.28686	1.33 [1.05 - 1.69]
GENE	AQP9	aquaporin 9	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2063	60	0.733333	4.85625e-05	0.0018474	1.52035	0.00237674	0.553821	1.74 [1.22 - 2.49]
GENE	AQP9	aquaporin 9	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2063	60	0.716667	0.000711256	0.0191233	1.20755	0.00169882	0.462642	1.59 [1.19 - 2.12]
GENE	AQP9	aquaporin 9	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21661	155	0.793548	0.0373201	0.40904	-1.03798	0.402113	-0.15379	0.86 [0.60 - 1.23]
GENE	AQP9	aquaporin 9	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205568_at	286	0.283217	0.00611242	0.110752	0.666646	0.767527	0.0258029	1.03 [0.86 - 1.22]
GENE	AQP9	aquaporin 9	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205568_at	159	0.874214	0.0015271	0.036268	1.1073	0.00493075	0.414817	1.51 [1.13 - 2.02]
GENE	AQP9	aquaporin 9	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205568_at	159	0.679245	2.18787e-05	0.000905462	1.27451	3.15403e-05	0.569314	1.77 [1.35 - 2.31]
GENE	AQP9	aquaporin 9	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205568_at	159	0.874214	1.1071e-05	0.0004899	1.56561	6.2019e-05	0.638064	1.89 [1.39 - 2.59]
GENE	AQP9	aquaporin 9	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205568_at	54	0.666667	0.190662	-	-1.29654	0.409919	-0.486246	0.61 [0.19 - 1.95]
GENE	AQP9	aquaporin 9	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205568_at	117	0.82906	0.0793965	-	-1.01094	0.211833	-0.325718	0.72 [0.43 - 1.20]
GENE	AQP9	aquaporin 9	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205568_at	117	0.786325	0.0742788	-	-1.23465	0.204427	-0.427556	0.65 [0.34 - 1.26]
GENE	AQP9	aquaporin 9	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205568_at	117	0.82906	0.0793965	-	-1.01094	0.211833	-0.325718	0.72 [0.43 - 1.20]
GENE	AQP9	aquaporin 9	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205568_at	117	0.803419	0.025444	0.316833	-1.95164	0.0735835	-0.636945	0.53 [0.26 - 1.06]
GENE	AQP9	aquaporin 9	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205568_at	236	0.826271	0.000361399	0.0107273	1.00353	0.00893436	0.326616	1.39 [1.09 - 1.77]
GENE	AQP9	aquaporin 9	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205568_at	249	0.738956	0.000103335	0.00360495	0.828662	0.00331805	0.287962	1.33 [1.10 - 1.62]
GENE	AQP9	aquaporin 9	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205568_at	62	0.435484	0.14899	-	0.807635	0.770513	-0.0478876	0.95 [0.69 - 1.32]
GENE	AQP9	aquaporin 9	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205568_at	125	0.528	0.104827	-	-0.634489	0.582082	-0.272291	0.76 [0.29 - 2.01]
GENE	AQP9	aquaporin 9	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205568_at	125	0.128	0.156135	-	-0.582258	0.616731	-0.185993	0.83 [0.40 - 1.72]
GENE	AQP9	aquaporin 9	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205568_at	54	0.462963	0.296444	-	0.695007	0.832637	-0.0420342	0.96 [0.65 - 1.42]
GENE	AQP9	aquaporin 9	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205568_at	198	0.80303	0.0004694	0.0134254	0.971249	0.0101399	0.229459	1.26 [1.06 - 1.50]
GENE	AQP9	aquaporin 9	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205568_at	198	0.252525	0.000677697	0.018356	0.982758	0.00698317	0.179764	1.20 [1.05 - 1.36]
GENE	AQP9	aquaporin 9	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205568_at	198	0.782828	0.00321651	0.0666264	0.783495	0.0156143	0.199989	1.22 [1.04 - 1.44]
GENE	AQP9	aquaporin 9	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205568_at	51	0.54902	0.103666	-	1.63268	0.388637	1.5995	4.95 [0.13 - 187.92]
GENE	AQP9	aquaporin 9	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205568_at	62	0.854839	0.185197	-	0.858026	0.105056	1.60433	4.97 [0.71 - 34.62]
GENE	AQP9	aquaporin 9	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205568_at	145	0.303448	0.00133209	0.0323818	1.55512	0.0305355	0.504051	1.66 [1.05 - 2.61]
GENE	AQP9	aquaporin 9	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205568_at	177	0.231638	0.0476656	0.477423	0.743308	0.401005	0.164583	1.18 [0.80 - 1.73]
GENE	AQP9	aquaporin 9	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205568_at	177	0.531073	0.0414999	0.437814	0.484049	0.583334	0.0935854	1.10 [0.79 - 1.53]
GENE	AQP9	aquaporin 9	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205568_at	226	0.59292	0.00330302	0.0680626	0.825637	0.160881	0.110445	1.12 [0.96 - 1.30]
GENE	AQP9	aquaporin 9	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205568_at	49	0.142857	0.00414038	0.0815273	-1.5985	0.371421	-0.449692	0.64 [0.24 - 1.71]
GENE	AQP9	aquaporin 9	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205568_at	55	0.872727	0.330177	-	0.538488	0.704764	0.104426	1.11 [0.65 - 1.91]
GENE	AQP9	aquaporin 9	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205568_at	55	0.563636	0.0966125	-	0.789857	0.795933	-0.0820241	0.92 [0.49 - 1.72]
GENE	AQP9	aquaporin 9	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1046484	34	0.588235	0.0101893	0.163755	-1.25367	0.0363522	-0.725833	0.48 [0.25 - 0.95]
GENE	AQP9	aquaporin 9	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1046484_1	34	0.588235	0.0101893	0.163755	-1.25367	0.0363522	-0.725833	0.48 [0.25 - 0.95]
GENE	AQP9	aquaporin 9	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205568_at	63	0.15873	6.36673e-06	0.000296579	-1.62445	0.116157	-20.3883	0.00 [0.00 - 155.50]
GENE	AQP9	aquaporin 9	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11038652_3p_at	28	0.142857	0.300172	-	1.03062	0.384881	0.54768	1.73 [0.50 - 5.95]
GENE	AQP9	aquaporin 9	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205568_at	82	0.207317	0.0336066	0.382004	-0.812961	0.394001	-0.235902	0.79 [0.46 - 1.36]
GENE	AQP9	aquaporin 9	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205568_at	79	0.721519	0.0978699	-	0.458761	0.993461	0.00186586	1.00 [0.64 - 1.57]
GENE	AQP9	aquaporin 9	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205568_at	104	0.826923	0.00132453	0.0322289	1.109	0.0024534	0.954747	2.60 [1.40 - 4.82]
GENE	AQP9	aquaporin 9	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P106362	117	0.811966	0.0408003	0.433113	-0.932444	0.666353	-0.0475938	0.95 [0.77 - 1.18]
GENE	AQP9	aquaporin 9	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205568_at	204	0.848039	0.00183001	0.0421085	1.14491	0.0593059	0.435964	1.55 [0.98 - 2.43]
GENE	AQP9	aquaporin 9	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205568_at	204	0.823529	0.00254238	0.0550925	0.872627	0.0462311	0.348864	1.42 [1.01 - 2.00]
GENE	AQP9	aquaporin 9	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205568_at	178	0.191011	0.0710991	-	0.514115	0.304842	0.139969	1.15 [0.88 - 1.50]
GENE	AQP9	aquaporin 9	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200011316	41	0.390244	0.0203042	0.270815	-0.949796	0.104072	-0.231182	0.79 [0.60 - 1.05]
GENE	AQP9	aquaporin 9	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205568_at	111	0.855856	0.020446	0.272146	0.734818	0.193924	0.14837	1.16 [0.93 - 1.45]
GENE	AQP9	aquaporin 9	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205568_at	90	0.111111	0.0536436	-	-0.78841	0.704447	-0.145729	0.86 [0.41 - 1.84]
GENE	AQP9	aquaporin 9	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205568_at	90	0.111111	0.142191	-	-0.707921	0.773489	-0.12663	0.88 [0.37 - 2.09]
GENE	AQP9	aquaporin 9	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205568_at	138	0.898551	0.00686576	0.121194	0.867545	0.0306346	0.232867	1.26 [1.02 - 1.56]
GENE	AQP9	aquaporin 9	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205568_at	129	0.844961	0.0512517	-	-0.812828	0.645071	-0.0512461	0.95 [0.76 - 1.18]
GENE	AQP9	aquaporin 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2061	56	0.875	0.0517933	-	-1.33134	0.159973	-0.149703	0.86 [0.70 - 1.06]
GENE	AQP9	aquaporin 9	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2061	56	0.875	0.0239045	0.303507	-1.51305	0.20114	-0.127776	0.88 [0.72 - 1.07]
GENE	AQP9	aquaporin 9	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205568_at	278	0.68705	0.117312	-	-0.330366	0.491562	-0.053114	0.95 [0.82 - 1.10]
GENE	AQP9	aquaporin 9	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205568_at	133	0.330827	0.0180833	0.249448	0.658042	0.372691	0.0898515	1.09 [0.90 - 1.33]
GENE	AQP9	aquaporin 9	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11790	81	0.691358	0.00442371	0.0859223	-15.8024	0.0512355	-0.610009	0.54 [0.29 - 1.00]
GENE	AQP9	aquaporin 9	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205568_at	185	0.540541	0.0158774	0.22718	0.393452	0.231907	0.139724	1.15 [0.91 - 1.45]
GENE	AQP9	aquaporin 9	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205568_at	185	0.540541	0.0363273	0.401955	0.372085	0.293319	0.137816	1.15 [0.89 - 1.48]
GENE	AQP9	aquaporin 9	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106362	110	0.118182	0.0583176	-	0.788293	0.256993	0.075505	1.08 [0.95 - 1.23]
GENE	AQP9	aquaporin 9	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106362	110	0.745455	0.0808928	-	0.538166	0.253602	0.0967559	1.10 [0.93 - 1.30]
GENE	AQP9	aquaporin 9	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205568_at	80	0.875	0.113827	-	-15.2151	0.47078	-0.104729	0.90 [0.68 - 1.20]
GENE	AQP9	aquaporin 9	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_2277	281	0.793594	0.0542018	-	0.319388	0.976018	0.00273917	1.00 [0.84 - 1.20]
GENE	AQP9	aquaporin 9	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205568_at	38	0.710526	0.206301	-	0.629549	0.724981	0.0693578	1.07 [0.73 - 1.58]
GENE	AQP9	aquaporin 9	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205568_at	140	0.621429	0.0518292	-	-0.609775	0.0575244	-0.72623	0.48 [0.23 - 1.02]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ARG1	arginase, liver	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206177_s_at	30	0.5	0.252452	-	0.463704	0.597277	-0.0943919	0.91 [0.64 - 1.29]
GENE	ARG1	arginase, liver	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1812281	165	0.575758	0.0266958	0.327405	0.531117	0.0349699	1.1821	3.26 [1.09 - 9.78]
GENE	ARG1	arginase, liver	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1812281	165	0.327273	0.0834208	-	0.765912	0.466906	0.6483	1.91 [0.33 - 10.97]
GENE	ARG1	arginase, liver	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206177_s_at	163	0.319018	0.00164358	0.0385404	-0.625499	0.234815	-0.0830582	0.92 [0.80 - 1.06]
GENE	ARG1	arginase, liver	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	231665_at	163	0.895706	0.0391902	0.42212	-0.843862	0.151255	-0.937794	0.39 [0.11 - 1.41]
GENE	ARG1	arginase, liver	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	231662_at	163	0.263804	0.0490371	0.485816	-0.416859	0.391162	-0.51592	0.60 [0.18 - 1.94]
GENE	ARG1	arginase, liver	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	231663_s_at	163	0.527607	0.287682	-	-0.210218	0.893031	0.0877029	1.09 [0.30 - 3.92]
GENE	ARG1	arginase, liver	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206177_s_at	79	0.886076	0.108098	-	0.619638	0.675349	0.0343338	1.03 [0.88 - 1.22]
GENE	ARG1	arginase, liver	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	231665_at	79	0.873418	0.0199239	0.267225	0.844166	0.265702	0.734719	2.08 [0.57 - 7.60]
GENE	ARG1	arginase, liver	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	231662_at	79	0.873418	0.0197479	0.265555	0.860893	0.279892	0.651762	1.92 [0.59 - 6.26]
GENE	ARG1	arginase, liver	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	231663_s_at	79	0.556962	0.0126177	0.192039	0.721893	0.0580924	1.16815	3.22 [0.96 - 10.77]
GENE	ARG1	arginase, liver	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206177_s_at	58	0.775862	0.0273306	0.33268	-0.749646	0.129	-0.28063	0.76 [0.53 - 1.09]
GENE	ARG1	arginase, liver	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206177_s_at	34	0.470588	0.0304413	0.357741	-0.817048	0.352535	-0.144232	0.87 [0.64 - 1.17]
GENE	ARG1	arginase, liver	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206177_s_at	158	0.221519	0.0217381	0.284107	0.762237	0.281425	0.940264	2.56 [0.46 - 14.17]
GENE	ARG1	arginase, liver	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206177_s_at	53	0.754717	0.0291163	0.347221	0.814263	0.265116	0.452964	1.57 [0.71 - 3.49]
GENE	ARG1	arginase, liver	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206177_s_at	53	0.754717	0.0950787	-	0.610128	0.328559	0.354193	1.43 [0.70 - 2.90]
GENE	ARG1	arginase, liver	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206177_s_at	180	0.594444	0.087746	-	-0.372953	0.802765	-0.0288358	0.97 [0.77 - 1.22]
GENE	ARG1	arginase, liver	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	231665_at	180	0.361111	0.0573976	-	-0.396651	0.61114	-0.0409825	0.96 [0.82 - 1.12]
GENE	ARG1	arginase, liver	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	231662_at	180	0.311111	0.0530376	-	0.454703	0.912005	0.0106152	1.01 [0.84 - 1.22]
GENE	ARG1	arginase, liver	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	231663_s_at	180	0.894444	0.0497777	0.490289	0.583028	0.737016	0.0343829	1.03 [0.85 - 1.26]
GENE	ARG1	arginase, liver	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206177_s_at	559	0.162791	0.0418478	0.440135	-0.479785	0.581282	-0.0931686	0.91 [0.65 - 1.27]
GENE	ARG1	arginase, liver	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	231663_s_at	559	0.719141	0.019488	0.263077	-0.544574	0.226601	-0.14999	0.86 [0.67 - 1.10]
GENE	ARG1	arginase, liver	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	231665_at	559	0.406082	0.022499	0.291011	0.52944	0.0745272	0.189942	1.21 [0.98 - 1.49]
GENE	ARG1	arginase, liver	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	231662_at	559	0.270125	0.00361038	0.0730936	-0.591882	0.0536659	-0.22929	0.80 [0.63 - 1.00]
GENE	ARG1	arginase, liver	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206177_s_at	77	0.350649	0.12453	-	0.419913	0.657773	0.0937077	1.10 [0.73 - 1.66]
GENE	ARG1	arginase, liver	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	231665_at	77	0.519481	0.113775	-	-0.40403	0.441186	-0.0914039	0.91 [0.72 - 1.15]
GENE	ARG1	arginase, liver	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	231662_at	77	0.194805	0.274369	-	-0.340348	0.775714	0.0469292	1.05 [0.76 - 1.45]
GENE	ARG1	arginase, liver	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	231663_s_at	77	0.649351	0.0614813	-	-0.508884	0.480283	-0.107754	0.90 [0.67 - 1.21]
GENE	ARG1	arginase, liver	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206177_s_at	70	0.357143	0.041556	0.438189	0.579746	0.627776	0.358281	1.43 [0.34 - 6.09]
GENE	ARG1	arginase, liver	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	231663_s_at	70	0.2	0.18154	-	0.467412	0.561325	0.533755	1.71 [0.28 - 10.33]
GENE	ARG1	arginase, liver	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	231665_at	70	0.557143	0.0735562	-	-0.47682	0.434734	-1.47776	0.23 [0.01 - 9.30]
GENE	ARG1	arginase, liver	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	231662_at	70	0.257143	0.0591463	-	0.591019	0.293654	0.746173	2.11 [0.52 - 8.49]
GENE	ARG1	arginase, liver	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	1962_at	50	0.56	0.00719035	0.12559	-0.9533	0.192742	-0.924794	0.40 [0.10 - 1.59]
GENE	ARG1	arginase, liver	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206177_s_at	74	0.567568	0.0014635	0.0350125	0.9036	0.028734	0.738518	2.09 [1.08 - 4.06]
GENE	ARG1	arginase, liver	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	231662_at	74	0.297297	0.162047	-	0.46427	0.386566	0.153723	1.17 [0.82 - 1.65]
GENE	ARG1	arginase, liver	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	231663_s_at	74	0.405405	0.147866	-	0.441783	0.361473	0.186174	1.20 [0.81 - 1.80]
GENE	ARG1	arginase, liver	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	231665_at	74	0.513514	7.72037e-07	4.28569e-05	1.43381	0.0043423	0.407961	1.50 [1.14 - 1.99]
GENE	ARG1	arginase, liver	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	231663_s_at	67	0.626866	0.166846	-	0.952134	0.408758	1.88278	6.57 [0.08 - 572.45]
GENE	ARG1	arginase, liver	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206177_s_at	67	0.358209	0.122746	-	1.49534	0.221279	0.803562	2.23 [0.62 - 8.09]
GENE	ARG1	arginase, liver	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	231665_at	67	0.656716	0.0814121	-	-1.65905	0.136305	-7.87344	0.00 [0.00 - 12.01]
GENE	ARG1	arginase, liver	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	231662_at	67	0.835821	0.0603853	-	1.25806	0.631103	1.81385	6.13 [0.00 - 10073.98]
GENE	ARG1	arginase, liver	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206177_s_at	115	0.878261	0.309933	-	0.652368	0.760489	0.134233	1.14 [0.48 - 2.71]
GENE	ARG1	arginase, liver	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	231663_s_at	115	0.495652	0.0228876	0.294498	-1.37127	0.254432	-0.468744	0.63 [0.28 - 1.40]
GENE	ARG1	arginase, liver	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	231665_at	115	0.782609	0.00597817	0.108854	1.36689	0.369485	0.544374	1.72 [0.52 - 5.66]
GENE	ARG1	arginase, liver	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	231662_at	115	0.26087	0.0240273	0.304584	-1.14229	0.166008	-0.603979	0.55 [0.23 - 1.28]
GENE	ARG1	arginase, liver	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	1962_at	158	0.879747	0.123592	-	0.540459	0.886148	0.0204933	1.02 [0.77 - 1.35]
GENE	ARG1	arginase, liver	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	1962_at	76	0.789474	0.037714	0.411824	-15.4104	0.857469	-0.0544637	0.95 [0.52 - 1.72]
GENE	ARG1	arginase, liver	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	231663_s_at	204	0.627451	0.0699377	-	0.263386	0.585549	0.0392179	1.04 [0.90 - 1.20]
GENE	ARG1	arginase, liver	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206177_s_at	204	0.245098	0.193469	-	0.219242	0.89476	-0.0100256	0.99 [0.85 - 1.15]
GENE	ARG1	arginase, liver	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	231665_at	204	0.220588	0.173012	-	0.234393	0.734744	0.0221758	1.02 [0.90 - 1.16]
GENE	ARG1	arginase, liver	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	231662_at	204	0.372549	0.102727	-	0.240443	0.705598	0.0270443	1.03 [0.89 - 1.18]
GENE	ARG1	arginase, liver	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206177_s_at	87	0.793103	0.0137987	0.20511	0.938378	0.229358	1.31647	3.73 [0.44 - 31.92]
GENE	ARG1	arginase, liver	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	231663_s_at	87	0.367816	0.340031	-	-0.362841	0.865694	-0.175902	0.84 [0.11 - 6.44]
GENE	ARG1	arginase, liver	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	231665_at	87	0.149425	0.148642	-	1.01669	0.880705	-0.204815	0.81 [0.06 - 11.82]
GENE	ARG1	arginase, liver	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	231665_at	87	0.149425	0.148642	-	1.01669	0.880705	-0.204815	0.81 [0.06 - 11.82]
GENE	ARG1	arginase, liver	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	231662_at	87	0.126437	0.232117	-	-0.584198	0.83496	0.222865	1.25 [0.15 - 10.17]
GENE	ARG1	arginase, liver	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	231662_at	87	0.126437	0.232117	-	-0.584198	0.83496	0.222865	1.25 [0.15 - 10.17]
GENE	ARG1	arginase, liver	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	231663_s_at	87	0.367816	0.340031	-	-0.362841	0.865694	-0.175902	0.84 [0.11 - 6.44]
GENE	ARG1	arginase, liver	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206177_s_at	87	0.793103	0.0137987	0.20511	0.938378	0.229358	1.31647	3.73 [0.44 - 31.92]
GENE	ARG1	arginase, liver	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	231663_s_at	77	0.805195	0.000261575	0.00811469	1.78823	0.0365269	3.20841	24.74 [1.22 - 500.59]
GENE	ARG1	arginase, liver	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	231665_at	77	0.116883	0.0159992	0.22844	-1.34992	0.594833	-1.24547	0.29 [0.00 - 28.34]
GENE	ARG1	arginase, liver	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	231662_at	77	0.545455	0.0207022	0.274542	-1.60365	0.209773	-2.13025	0.12 [0.00 - 3.32]
GENE	ARG1	arginase, liver	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206177_s_at	77	0.298701	0.00278027	0.059236	-1.81002	0.0369307	-4.96082	0.01 [0.00 - 0.74]
GENE	ARG1	arginase, liver	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	231663_s_at	77	0.805195	0.0605631	-	1.14865	0.677106	0.723005	2.06 [0.07 - 61.93]
GENE	ARG1	arginase, liver	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	231665_at	77	0.116883	0.00148575	0.035453	-1.81164	0.343523	-2.66519	0.07 [0.00 - 17.28]
GENE	ARG1	arginase, liver	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	231662_at	77	0.545455	0.0193999	0.262234	-2.07568	0.132108	-3.00573	0.05 [0.00 - 2.48]
GENE	ARG1	arginase, liver	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206177_s_at	77	0.298701	0.034651	0.389757	-1.11838	0.268364	-2.10666	0.12 [0.00 - 5.07]
GENE	ARG1	arginase, liver	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206177_s_at	136	0.102941	0.00659033	0.117416	-1.25792	0.050952	-0.432629	0.65 [0.42 - 1.00]
GENE	ARG1	arginase, liver	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206177_s_at	200	0.48	0.0603601	-	-0.554969	0.227763	-0.217067	0.80 [0.57 - 1.15]
GENE	ARG1	arginase, liver	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3838	60	0.85	0.165288	-	0.63527	0.0723409	0.708796	2.03 [0.94 - 4.40]
GENE	ARG1	arginase, liver	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3838	60	0.2	0.0180908	0.249522	-0.927632	0.815241	0.130845	1.14 [0.38 - 3.42]
GENE	ARG1	arginase, liver	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	2306	155	0.116129	0.000234399	0.00737832	-1.12652	0.00268317	-0.107964	0.90 [0.84 - 0.96]
GENE	ARG1	arginase, liver	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206177_s_at	286	0.482517	0.0400805	0.428228	-0.397526	0.643544	-0.0764205	0.93 [0.67 - 1.28]
GENE	ARG1	arginase, liver	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206177_s_at	159	0.754717	0.10168	-	-0.709908	0.970562	0.012214	1.01 [0.53 - 1.94]
GENE	ARG1	arginase, liver	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206177_s_at	159	0.27044	0.0576644	-	0.818144	0.874752	0.0547623	1.06 [0.53 - 2.09]
GENE	ARG1	arginase, liver	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206177_s_at	159	0.27044	0.101465	-	0.855979	0.348626	0.391618	1.48 [0.65 - 3.36]
GENE	ARG1	arginase, liver	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231663_s_at	159	0.301887	0.0885369	-	0.661428	0.575575	0.119157	1.13 [0.74 - 1.71]
GENE	ARG1	arginase, liver	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231663_s_at	159	0.886792	0.0679982	-	0.706992	0.846583	0.0417613	1.04 [0.68 - 1.59]
GENE	ARG1	arginase, liver	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231663_s_at	159	0.358491	0.112685	-	0.675854	0.551238	0.148978	1.16 [0.71 - 1.89]
GENE	ARG1	arginase, liver	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231665_at	159	0.245283	0.108289	-	-0.537077	0.617006	-0.0794916	0.92 [0.68 - 1.26]
GENE	ARG1	arginase, liver	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231665_at	159	0.163522	0.015196	0.22007	-0.836798	0.22436	-0.195766	0.82 [0.60 - 1.13]
GENE	ARG1	arginase, liver	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231665_at	159	0.163522	0.0521781	-	-0.787919	0.785674	-0.0506334	0.95 [0.66 - 1.37]
GENE	ARG1	arginase, liver	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231662_at	159	0.798742	0.0675938	-	-0.930086	0.918698	-0.0182793	0.98 [0.69 - 1.39]
GENE	ARG1	arginase, liver	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231662_at	159	0.72327	0.0419268	0.440661	-0.873387	0.466815	-0.131789	0.88 [0.61 - 1.25]
GENE	ARG1	arginase, liver	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231662_at	159	0.710692	0.0516787	-	-1.00545	0.7449	-0.0685951	0.93 [0.62 - 1.41]
GENE	ARG1	arginase, liver	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206177_s_at	54	0.666667	0.0399101	0.427065	-15.6355	0.226871	-1.61261	0.20 [0.01 - 2.73]
GENE	ARG1	arginase, liver	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206177_s_at	117	0.74359	0.0806744	-	-0.715251	0.223906	-0.954729	0.38 [0.08 - 1.79]
GENE	ARG1	arginase, liver	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206177_s_at	117	0.239316	0.0540539	-	1.31696	0.871574	-0.140482	0.87 [0.16 - 4.77]
GENE	ARG1	arginase, liver	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206177_s_at	117	0.74359	0.0806744	-	-0.715251	0.223906	-0.954729	0.38 [0.08 - 1.79]
GENE	ARG1	arginase, liver	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206177_s_at	117	0.74359	0.0614403	-	-0.973024	0.332419	-0.888175	0.41 [0.07 - 2.48]
GENE	ARG1	arginase, liver	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206177_s_at	236	0.639831	0.0365998	0.403909	-0.637151	0.158599	-0.410952	0.66 [0.37 - 1.17]
GENE	ARG1	arginase, liver	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	231662_at	236	0.322034	0.0359405	0.399166	0.693702	0.527718	0.100306	1.11 [0.81 - 1.51]
GENE	ARG1	arginase, liver	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	231663_s_at	236	0.830508	0.188012	-	-0.562486	0.620202	-0.0939483	0.91 [0.63 - 1.32]
GENE	ARG1	arginase, liver	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	231665_at	236	0.809322	0.106722	-	-0.685097	0.432802	-0.115131	0.89 [0.67 - 1.19]
GENE	ARG1	arginase, liver	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206177_s_at	249	0.538153	0.019557	0.263736	-0.507528	0.0390967	-0.479123	0.62 [0.39 - 0.98]
GENE	ARG1	arginase, liver	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	231665_at	249	0.899598	0.176435	-	0.41488	0.967545	0.00475588	1.00 [0.80 - 1.26]
GENE	ARG1	arginase, liver	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	231662_at	249	0.449799	0.0128283	0.194401	0.551652	0.195825	0.161197	1.17 [0.92 - 1.50]
GENE	ARG1	arginase, liver	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	231663_s_at	249	0.819277	0.0538107	-	-0.636743	0.683686	-0.0595261	0.94 [0.71 - 1.25]
GENE	ARG1	arginase, liver	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206177_s_at	62	0.887097	0.191135	-	0.81675	0.684102	-0.153917	0.86 [0.41 - 1.80]
GENE	ARG1	arginase, liver	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206177_s_at	125	0.768	0.0934396	-	0.651956	0.886366	0.12954	1.14 [0.19 - 6.73]
GENE	ARG1	arginase, liver	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206177_s_at	125	0.184	0.0613268	-	-0.643968	0.596613	-0.38568	0.68 [0.16 - 2.84]
GENE	ARG1	arginase, liver	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206177_s_at	54	0.444444	0.127929	-	1.13348	0.813663	-0.107768	0.90 [0.37 - 2.20]
GENE	ARG1	arginase, liver	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206177_s_at	198	0.181818	0.016815	0.236781	1.17297	0.0599577	0.218523	1.24 [0.99 - 1.56]
GENE	ARG1	arginase, liver	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206177_s_at	198	0.106061	0.0776453	-	0.791672	0.27899	0.0919539	1.10 [0.93 - 1.29]
GENE	ARG1	arginase, liver	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206177_s_at	198	0.262626	0.0064756	0.115829	0.991162	0.0251274	0.252248	1.29 [1.03 - 1.60]
GENE	ARG1	arginase, liver	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206177_s_at	51	0.490196	0.0219093	0.285669	16.2561	0.205965	4.41754	82.89 [0.09 - 77926.86]
GENE	ARG1	arginase, liver	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206177_s_at	62	0.16129	0.372414	-	0.901281	0.694064	0.701226	2.02 [0.06 - 66.38]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	231663_s_at	177	0.762712	0.219168	-	-0.445474	0.768361	-0.25216	0.78 [0.15 - 4.16]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	231665_at	177	0.276836	0.114443	-	-0.391904	0.473559	-0.899448	0.41 [0.03 - 4.76]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	231662_at	177	0.129944	0.023582	0.300669	-0.663899	0.109524	-1.3552	0.26 [0.05 - 1.36]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	231665_at	177	0.887006	0.238904	-	-0.688157	0.709314	-0.529524	0.59 [0.04 - 9.53]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	231662_at	177	0.242938	0.0477966	0.478231	-0.557592	0.199263	-1.24876	0.29 [0.04 - 1.93]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	231663_s_at	177	0.762712	0.264645	-	-0.340651	0.861744	-0.128938	0.88 [0.21 - 3.75]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	231665_at	145	0.22069	0.376206	-	0.393657	0.570186	0.96409	2.62 [0.09 - 73.13]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	231662_at	145	0.268966	0.0702116	-	-0.612332	0.138671	-1.74994	0.17 [0.02 - 1.76]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206177_s_at	177	0.723164	0.132651	-	-0.502745	0.288203	-0.797646	0.45 [0.10 - 1.96]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	231663_s_at	145	0.137931	0.118712	-	-0.61799	0.5739	-0.57062	0.57 [0.08 - 4.13]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206177_s_at	177	0.723164	0.0644712	-	-0.544013	0.454686	-0.479777	0.62 [0.18 - 2.18]
GENE	ARG1	arginase, liver	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206177_s_at	145	0.882759	0.0824601	-	-1.58885	0.736094	-0.314218	0.73 [0.12 - 4.54]
GENE	ARG1	arginase, liver	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	231665_at	226	0.154867	0.0281441	0.339357	1.23191	0.359107	0.0907053	1.09 [0.90 - 1.33]
GENE	ARG1	arginase, liver	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	231662_at	226	0.110619	0.114186	-	0.913658	0.888234	0.0173467	1.02 [0.80 - 1.30]
GENE	ARG1	arginase, liver	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	231663_s_at	226	0.628319	0.119793	-	-0.497163	0.391958	-0.149493	0.86 [0.61 - 1.21]
GENE	ARG1	arginase, liver	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206177_s_at	226	0.300885	0.0094698	0.15496	-0.739231	0.180091	-0.269123	0.76 [0.52 - 1.13]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	231663_s_at	55	0.890909	0.0361411	0.400615	1.18085	0.949765	-0.106248	0.90 [0.03 - 24.51]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206177_s_at	55	0.672727	0.0308781	0.36116	-1.27005	0.448283	-0.715685	0.49 [0.08 - 3.11]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	231665_at	55	0.290909	0.171265	-	-0.650759	0.759877	-0.655163	0.52 [0.01 - 34.68]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	231662_at	55	0.854545	0.0308497	0.360939	1.14632	0.872614	-0.310584	0.73 [0.02 - 32.66]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	231663_s_at	49	0.265306	0.109322	-	-0.908004	0.772775	-0.572943	0.56 [0.01 - 27.55]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	231665_at	49	0.244898	0.0510778	-	-1.07882	0.350194	-2.39569	0.09 [0.00 - 13.88]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	231662_at	49	0.204082	0.0217848	0.284534	-1.26497	0.251625	-2.50113	0.08 [0.00 - 5.90]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206177_s_at	55	0.672727	0.0249291	0.312417	-1.49658	0.532483	-0.614248	0.54 [0.08 - 3.72]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206177_s_at	49	0.653061	0.0189924	0.258315	-2.06851	0.0721894	-2.95503	0.05 [0.00 - 1.31]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	231665_at	55	0.290909	0.0525588	-	-0.846929	0.577116	-1.14408	0.32 [0.01 - 17.77]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	231662_at	55	0.836364	0.019514	0.263325	1.0913	0.689892	-0.702482	0.50 [0.02 - 15.62]
GENE	ARG1	arginase, liver	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	231663_s_at	55	0.890909	0.0722329	-	0.970901	0.724953	-0.570617	0.57 [0.02 - 13.57]
GENE	ARG1	arginase, liver	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	198045	34	0.205882	0.213298	-	0.764826	0.643694	0.344457	1.41 [0.33 - 6.07]
GENE	ARG1	arginase, liver	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	813635	34	0.5	0.146422	-	-0.635765	0.873499	-0.0953556	0.91 [0.28 - 2.94]
GENE	ARG1	arginase, liver	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206177_s_at	63	0.126984	0.000111531	0.0038554	-1.52898	0.402808	-1.79286	0.17 [0.00 - 11.11]
GENE	ARG1	arginase, liver	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	231663_s_at	63	0.174603	0.00168176	0.0392778	-1.13662	0.647193	-2.60397	0.07 [0.00 - 5155.41]
GENE	ARG1	arginase, liver	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	231665_at	63	0.603175	0.0210999	0.278237	-0.866734	0.0998556	-6.31527	0.00 [0.00 - 3.34]
GENE	ARG1	arginase, liver	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	231662_at	63	0.174603	0.00273999	0.0585404	-1.08826	0.157692	-6.06716	0.00 [0.00 - 10.48]
GENE	ARG1	arginase, liver	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g10947138_3p_s_at	28	0.785714	0.21617	-	-0.917544	0.848979	0.11293	1.12 [0.35 - 3.58]
GENE	ARG1	arginase, liver	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.289057.1.A1_3p_at	28	0.785714	0.152402	-	-1.06466	0.396757	-0.787777	0.45 [0.07 - 2.81]
GENE	ARG1	arginase, liver	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.332405.1.A1_3p_at	28	0.607143	0.133082	-	-0.904022	0.454701	-2.37619	0.09 [0.00 - 47.16]
GENE	ARG1	arginase, liver	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206177_s_at	82	0.329268	0.174473	-	0.540209	0.861013	0.0665687	1.07 [0.51 - 2.25]
GENE	ARG1	arginase, liver	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206177_s_at	79	0.810127	0.123955	-	-0.530058	0.281278	-0.374055	0.69 [0.35 - 1.36]
GENE	ARG1	arginase, liver	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206177_s_at	104	0.615385	0.279694	-	0.353395	0.78559	-0.185754	0.83 [0.22 - 3.17]
GENE	ARG1	arginase, liver	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206177_s_at	204	0.343137	0.159526	-	-0.384961	0.985601	0.00292893	1.00 [0.73 - 1.38]
GENE	ARG1	arginase, liver	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	231663_s_at	204	0.843137	0.00199616	0.0452236	1.13809	0.0768409	0.454885	1.58 [0.95 - 2.61]
GENE	ARG1	arginase, liver	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	231665_at	204	0.857843	0.208989	-	-0.890281	0.979077	0.00502078	1.01 [0.69 - 1.46]
GENE	ARG1	arginase, liver	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	231662_at	204	0.764706	0.127374	-	-0.798329	0.247665	-0.191097	0.83 [0.60 - 1.14]
GENE	ARG1	arginase, liver	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	231663_s_at	204	0.897059	0.000220809	0.00700531	1.15093	0.0197267	0.459054	1.58 [1.08 - 2.33]
GENE	ARG1	arginase, liver	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	231665_at	204	0.573529	0.266646	-	-0.311847	0.977016	0.00412586	1.00 [0.76 - 1.33]
GENE	ARG1	arginase, liver	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	231662_at	204	0.818627	0.0344985	0.388632	-0.95624	0.0773308	-0.21821	0.80 [0.63 - 1.02]
GENE	ARG1	arginase, liver	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206177_s_at	204	0.191176	0.106761	-	-0.632604	0.822487	-0.0481466	0.95 [0.63 - 1.45]
GENE	ARG1	arginase, liver	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206177_s_at	178	0.646067	0.0268472	0.328667	-0.48685	0.22646	-0.402042	0.67 [0.35 - 1.28]
GENE	ARG1	arginase, liver	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300018968	41	0.682927	0.137907	-	0.627354	0.908851	-0.0320696	0.97 [0.56 - 1.68]
GENE	ARG1	arginase, liver	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206177_s_at	111	0.333333	0.0426766	0.445622	0.590294	0.154677	0.323932	1.38 [0.88 - 2.16]
GENE	ARG1	arginase, liver	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	231663_s_at	111	0.297297	0.243498	-	-0.322606	0.676703	-0.0769532	0.93 [0.64 - 1.33]
GENE	ARG1	arginase, liver	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	231665_at	111	0.792793	0.0703351	-	-0.676285	0.829249	0.0256344	1.03 [0.81 - 1.30]
GENE	ARG1	arginase, liver	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	231662_at	111	0.342342	0.0147864	0.215739	-0.640005	0.511857	-0.0953717	0.91 [0.68 - 1.21]
GENE	ARG1	arginase, liver	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206177_s_at	90	0.688889	0.101981	-	-0.640923	0.861749	-0.143242	0.87 [0.17 - 4.34]
GENE	ARG1	arginase, liver	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206177_s_at	90	0.655556	0.0698282	-	-0.810149	0.759088	-0.28918	0.75 [0.12 - 4.75]
GENE	ARG1	arginase, liver	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1237	50	0.8	0.00746199	0.129224	1.24493	0.046836	1.58287	4.87 [1.02 - 23.19]
GENE	ARG1	arginase, liver	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3429	50	0.72	0.234945	-	-0.733374	0.742688	-0.132393	0.88 [0.40 - 1.93]
GENE	ARG1	arginase, liver	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	231663_s_at	138	0.152174	0.00896224	0.148628	-0.734053	0.1514	-8.30679	0.00 [0.00 - 20.95]
GENE	ARG1	arginase, liver	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	231665_at	138	0.427536	0.0194556	0.262768	-0.560179	0.0448032	-5.0988	0.01 [0.00 - 0.89]
GENE	ARG1	arginase, liver	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	231662_at	138	0.108696	0.000161916	0.00534568	-1.09046	0.0243663	-7.02396	0.00 [0.00 - 0.40]
GENE	ARG1	arginase, liver	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206177_s_at	138	0.536232	0.0176659	0.245318	-0.591713	0.560194	0.0886132	1.09 [0.81 - 1.47]
GENE	ARG1	arginase, liver	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206177_s_at	129	0.899225	0.00830647	0.140279	0.902995	0.753609	-0.0770552	0.93 [0.57 - 1.50]
GENE	ARG1	arginase, liver	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27850	56	0.535714	0.0838009	-	0.596153	0.244504	0.130283	1.14 [0.91 - 1.42]
GENE	ARG1	arginase, liver	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	27850	56	0.732143	0.021267	0.279781	0.853789	0.109385	0.190458	1.21 [0.96 - 1.53]
GENE	ARG1	arginase, liver	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	231663_s_at	278	0.866906	0.0377159	0.411837	0.53709	0.325063	0.557024	1.75 [0.58 - 5.29]
GENE	ARG1	arginase, liver	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	231665_at	278	0.276978	0.244433	-	0.249581	0.798495	0.214481	1.24 [0.24 - 6.43]
GENE	ARG1	arginase, liver	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	231662_at	278	0.604317	0.0295284	0.350517	0.408224	0.279911	0.699137	2.01 [0.57 - 7.15]
GENE	ARG1	arginase, liver	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206177_s_at	278	0.507194	0.0131328	0.197791	-0.469796	0.139077	-0.821791	0.44 [0.15 - 1.31]
GENE	ARG1	arginase, liver	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206177_s_at	133	0.759399	0.000416939	0.0121292	0.870137	0.0103519	0.843157	2.32 [1.22 - 4.43]
GENE	ARG1	arginase, liver	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15376	81	0.592593	0.00702578	0.123368	1.4154	0.203823	0.319613	1.38 [0.84 - 2.25]
GENE	ARG1	arginase, liver	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15674	81	0.209877	0.0246904	0.310356	-1.14155	0.401474	-0.428539	0.65 [0.24 - 1.77]
GENE	ARG1	arginase, liver	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206177_s_at	185	0.362162	0.33519	-	0.164285	0.637261	-0.155427	0.86 [0.45 - 1.63]
GENE	ARG1	arginase, liver	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206177_s_at	185	0.832432	0.381842	-	0.201658	0.775467	-0.103558	0.90 [0.44 - 1.84]
GENE	ARG1	arginase, liver	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P111321	110	0.781818	0.178267	-	-0.397207	0.894154	-0.0212003	0.98 [0.72 - 1.34]
GENE	ARG1	arginase, liver	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P111321	110	0.227273	0.0653252	-	0.744457	0.433187	0.148691	1.16 [0.80 - 1.68]
GENE	ARG1	arginase, liver	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206177_s_at	80	0.2375	0.0731016	-	-0.786303	0.489013	-0.152542	0.86 [0.56 - 1.32]
GENE	ARG1	arginase, liver	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_4300	281	0.562278	0.038665	0.418481	0.292023	0.682787	0.0465036	1.05 [0.84 - 1.31]
GENE	ARG1	arginase, liver	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206177_s_at	38	0.157895	0.0393401	0.423153	15.3616	0.562869	0.100188	1.11 [0.79 - 1.55]
GENE	ARG1	arginase, liver	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	231663_s_at	38	0.184211	0.0735071	-	-1.03405	0.861157	-0.112692	0.89 [0.25 - 3.16]
GENE	ARG1	arginase, liver	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	231665_at	38	0.894737	0.00618046	0.111709	1.48601	0.200405	0.809405	2.25 [0.65 - 7.76]
GENE	ARG1	arginase, liver	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	231662_at	38	0.842105	0.0643157	-	0.960475	0.671935	0.126907	1.14 [0.63 - 2.04]
GENE	ARG1	arginase, liver	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206177_s_at	140	0.407143	0.291077	-	-0.306546	0.310906	-1.32619	0.27 [0.02 - 3.45]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ARG2	arginase, type II	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203946_s_at	30	0.5	0.0870839	-	0.688816	0.193707	0.270366	1.31 [0.87 - 1.97]
GENE	ARG2	arginase, type II	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203945_at	30	0.133333	0.0802609	-	-0.973961	0.618321	0.338085	1.40 [0.37 - 5.30]
GENE	ARG2	arginase, type II	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1800898	165	0.109091	0.0263623	0.32461	-0.749699	0.227441	-0.291595	0.75 [0.47 - 1.20]
GENE	ARG2	arginase, type II	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1800898	165	0.860606	0.129369	-	0.63774	0.813382	-0.0793405	0.92 [0.48 - 1.78]
GENE	ARG2	arginase, type II	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203945_at	163	0.858896	0.0417202	0.439285	-0.666276	0.478034	-0.254496	0.78 [0.38 - 1.57]
GENE	ARG2	arginase, type II	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203946_s_at	163	0.214724	0.00123929	0.0304927	0.901672	0.0797443	0.282686	1.33 [0.97 - 1.82]
GENE	ARG2	arginase, type II	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203945_at	79	0.822785	0.0156074	0.224377	-1.19476	0.1127	-0.602852	0.55 [0.26 - 1.15]
GENE	ARG2	arginase, type II	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203946_s_at	79	0.620253	0.00340545	0.0697513	-0.953367	0.0510325	-0.423773	0.65 [0.43 - 1.00]
GENE	ARG2	arginase, type II	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203945_at	58	0.137931	0.0345689	0.389152	0.95973	0.633891	0.12774	1.14 [0.67 - 1.92]
GENE	ARG2	arginase, type II	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203946_s_at	58	0.844828	0.343173	-	-0.357229	0.564587	-0.0802767	0.92 [0.70 - 1.21]
GENE	ARG2	arginase, type II	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203945_at	34	0.235294	0.0246074	0.309637	-0.971183	0.0984114	-0.633015	0.53 [0.25 - 1.12]
GENE	ARG2	arginase, type II	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203946_s_at	34	0.117647	0.00609823	0.110552	-1.44613	0.349119	-0.2817	0.75 [0.42 - 1.36]
GENE	ARG2	arginase, type II	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203946_s_at	158	0.518987	0.0019545	0.044448	-0.741617	0.010209	-1.0675	0.34 [0.15 - 0.78]
GENE	ARG2	arginase, type II	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203945_at	158	0.759494	0.0471803	0.474419	0.510176	0.993165	0.0063762	1.01 [0.23 - 4.33]
GENE	ARG2	arginase, type II	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203946_s_at	53	0.358491	0.126135	-	0.588233	0.854231	0.0410843	1.04 [0.67 - 1.62]
GENE	ARG2	arginase, type II	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203945_at	53	0.830189	0.234796	-	-0.629951	0.596202	-0.291766	0.75 [0.25 - 2.20]
GENE	ARG2	arginase, type II	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203946_s_at	53	0.754717	0.0466371	0.471034	0.76607	0.993836	-0.0018448	1.00 [0.63 - 1.59]
GENE	ARG2	arginase, type II	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203945_at	53	0.830189	0.129296	-	-0.788312	0.569001	-0.284434	0.75 [0.28 - 2.00]
GENE	ARG2	arginase, type II	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203946_s_at	180	0.344444	0.108432	-	0.367113	0.580774	0.0469415	1.05 [0.89 - 1.24]
GENE	ARG2	arginase, type II	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203945_at	180	0.466667	0.17444	-	-0.284223	0.769576	0.0988386	1.10 [0.57 - 2.14]
GENE	ARG2	arginase, type II	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203945_at	559	0.899821	0.153769	-	-0.59222	0.524423	-0.107143	0.90 [0.65 - 1.25]
GENE	ARG2	arginase, type II	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203946_s_at	559	0.232558	0.290228	-	-0.243849	0.607188	-0.0520733	0.95 [0.78 - 1.16]
GENE	ARG2	arginase, type II	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203945_at	77	0.753247	0.258751	-	-0.352332	0.999072	-0.000505189	1.00 [0.43 - 2.34]
GENE	ARG2	arginase, type II	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203946_s_at	77	0.896104	0.0571905	-	0.760177	0.310793	0.194071	1.21 [0.83 - 1.77]
GENE	ARG2	arginase, type II	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203946_s_at	70	0.228571	0.206326	-	-0.379065	0.974174	0.00607488	1.01 [0.70 - 1.45]
GENE	ARG2	arginase, type II	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203945_at	70	0.657143	0.0318552	0.368726	-0.627748	0.41441	-0.543352	0.58 [0.16 - 2.14]
GENE	ARG2	arginase, type II	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32722_at	50	0.74	0.035922	0.399033	-0.876946	0.192837	-1.26455	0.28 [0.04 - 1.89]
GENE	ARG2	arginase, type II	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203946_s_at	74	0.324324	0.0073339	0.127515	0.903078	0.189928	0.416293	1.52 [0.81 - 2.83]
GENE	ARG2	arginase, type II	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203945_at	74	0.648649	0.00381446	0.0763755	0.822608	0.0690101	0.857665	2.36 [0.94 - 5.94]
GENE	ARG2	arginase, type II	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203946_s_at	67	0.41791	0.272348	-	0.860848	0.918552	-0.0357377	0.96 [0.49 - 1.91]
GENE	ARG2	arginase, type II	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203945_at	67	0.537313	0.134465	-	-1.13821	0.394577	-1.07154	0.34 [0.03 - 4.04]
GENE	ARG2	arginase, type II	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203946_s_at	115	0.33913	0.109536	-	1.15774	0.538871	0.342729	1.41 [0.47 - 4.20]
GENE	ARG2	arginase, type II	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203945_at	115	0.582609	0.0745155	-	0.958298	0.29906	0.91221	2.49 [0.45 - 13.93]
GENE	ARG2	arginase, type II	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32722_at	158	0.28481	0.0172197	0.240862	-0.718518	0.355633	-0.172539	0.84 [0.58 - 1.21]
GENE	ARG2	arginase, type II	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32722_at	76	0.394737	0.0476443	0.477292	1.20941	0.282423	0.363684	1.44 [0.74 - 2.79]
GENE	ARG2	arginase, type II	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203946_s_at	204	0.656863	0.00533291	0.0995579	0.411923	0.304194	0.124782	1.13 [0.89 - 1.44]
GENE	ARG2	arginase, type II	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203945_at	204	0.696078	0.0260479	0.321961	-0.346835	0.359205	-0.187471	0.83 [0.56 - 1.24]
GENE	ARG2	arginase, type II	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203946_s_at	87	0.873563	0.0241971	0.306068	-15.2734	0.458308	-0.160399	0.85 [0.56 - 1.30]
GENE	ARG2	arginase, type II	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203946_s_at	87	0.873563	0.0241971	0.306068	-15.2734	0.458308	-0.160399	0.85 [0.56 - 1.30]
GENE	ARG2	arginase, type II	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203945_at	87	0.114943	0.0348102	0.390929	-0.939608	0.783497	-0.14403	0.87 [0.31 - 2.42]
GENE	ARG2	arginase, type II	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203945_at	87	0.114943	0.0348102	0.390929	-0.939608	0.783497	-0.14403	0.87 [0.31 - 2.42]
GENE	ARG2	arginase, type II	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203945_at	77	0.701299	0.148356	-	-1.40631	0.559316	-0.607632	0.54 [0.07 - 4.19]
GENE	ARG2	arginase, type II	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203946_s_at	77	0.220779	0.186878	-	1.28389	0.622282	0.151414	1.16 [0.64 - 2.13]
GENE	ARG2	arginase, type II	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203945_at	77	0.337662	0.141828	-	1.07666	0.923825	-0.0890326	0.91 [0.15 - 5.67]
GENE	ARG2	arginase, type II	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203946_s_at	77	0.415584	0.170503	-	-0.860592	0.589515	0.183297	1.20 [0.62 - 2.34]
GENE	ARG2	arginase, type II	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203945_at	136	0.727941	0.0790681	-	0.791104	0.820435	0.114762	1.12 [0.42 - 3.02]
GENE	ARG2	arginase, type II	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203946_s_at	136	0.367647	0.164829	-	0.718372	0.623016	0.129349	1.14 [0.68 - 1.91]
GENE	ARG2	arginase, type II	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203946_s_at	200	0.335	0.0319672	0.369585	0.750271	0.53789	0.12779	1.14 [0.76 - 1.71]
GENE	ARG2	arginase, type II	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203945_at	200	0.49	0.0154076	0.22229	0.74516	0.0857053	0.624117	1.87 [0.92 - 3.80]
GENE	ARG2	arginase, type II	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11294	60	0.4	0.100382	-	-0.617154	0.648694	-0.0655698	0.94 [0.71 - 1.24]
GENE	ARG2	arginase, type II	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11294	60	0.866667	0.205686	-	-0.900733	0.68048	-0.0964176	0.91 [0.57 - 1.44]
GENE	ARG2	arginase, type II	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5505	155	0.264516	5.76201e-07	3.27015e-05	-1.31834	5.59367e-05	-0.552166	0.58 [0.44 - 0.75]
GENE	ARG2	arginase, type II	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203946_s_at	286	0.122378	0.0274625	0.333769	-0.550433	0.0256058	-0.277191	0.76 [0.59 - 0.97]
GENE	ARG2	arginase, type II	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203945_at	286	0.898601	0.0202648	0.270444	0.605713	0.41926	0.27836	1.32 [0.67 - 2.60]
GENE	ARG2	arginase, type II	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203946_s_at	159	0.867925	0.0132531	0.199123	0.877591	0.518924	0.134733	1.14 [0.76 - 1.72]
GENE	ARG2	arginase, type II	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203946_s_at	159	0.867925	0.0509048	-	0.824315	0.826332	0.0545687	1.06 [0.65 - 1.72]
GENE	ARG2	arginase, type II	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203945_at	159	0.232704	0.0292658	0.348419	1.0937	0.064016	0.845409	2.33 [0.95 - 5.70]
GENE	ARG2	arginase, type II	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203945_at	159	0.842767	0.0334098	0.38053	0.736749	0.0639458	0.863709	2.37 [0.95 - 5.92]
GENE	ARG2	arginase, type II	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203946_s_at	159	0.679245	0.0772163	-	0.558222	0.892925	0.0286025	1.03 [0.68 - 1.56]
GENE	ARG2	arginase, type II	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203945_at	159	0.427673	0.0326695	0.374943	0.89672	0.0374571	1.06767	2.91 [1.06 - 7.95]
GENE	ARG2	arginase, type II	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203945_at	54	0.314815	0.0989293	-	1.58602	0.893568	-0.126825	0.88 [0.14 - 5.65]
GENE	ARG2	arginase, type II	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203946_s_at	54	0.833333	0.0828007	-	1.19654	0.287322	0.425273	1.53 [0.70 - 3.35]
GENE	ARG2	arginase, type II	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203945_at	117	0.273504	0.0509937	-	0.840671	0.670165	0.206554	1.23 [0.48 - 3.18]
GENE	ARG2	arginase, type II	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203945_at	117	0.324786	0.0246203	0.309748	1.15721	0.756673	0.183641	1.20 [0.38 - 3.84]
GENE	ARG2	arginase, type II	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203946_s_at	117	0.777778	0.0705501	-	-1.05684	0.769359	-0.0905979	0.91 [0.50 - 1.67]
GENE	ARG2	arginase, type II	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203946_s_at	117	0.82906	0.0310991	0.362882	-1.23141	0.460766	-0.198264	0.82 [0.48 - 1.39]
GENE	ARG2	arginase, type II	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203946_s_at	117	0.82906	0.0310991	0.362882	-1.23141	0.460766	-0.198264	0.82 [0.48 - 1.39]
GENE	ARG2	arginase, type II	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203946_s_at	117	0.726496	0.00396413	0.0787547	-2.35445	0.109823	-0.772198	0.46 [0.18 - 1.19]
GENE	ARG2	arginase, type II	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203945_at	117	0.273504	0.0509937	-	0.840671	0.670165	0.206554	1.23 [0.48 - 3.18]
GENE	ARG2	arginase, type II	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203945_at	117	0.282051	0.0640884	-	0.962101	0.617246	0.280687	1.32 [0.44 - 3.98]
GENE	ARG2	arginase, type II	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203945_at	236	0.478814	0.110625	-	0.435917	0.306511	0.524817	1.69 [0.62 - 4.62]
GENE	ARG2	arginase, type II	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203946_s_at	236	0.478814	0.00549007	0.101849	0.779331	0.0683847	0.339688	1.40 [0.97 - 2.02]
GENE	ARG2	arginase, type II	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203945_at	249	0.164659	0.0188859	0.257285	-0.570195	0.573734	-0.222973	0.80 [0.37 - 1.74]
GENE	ARG2	arginase, type II	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203946_s_at	249	0.654619	0.00940005	0.154097	0.550766	0.0672211	0.254035	1.29 [0.98 - 1.69]
GENE	ARG2	arginase, type II	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203945_at	62	0.451613	0.161421	-	0.730774	0.843264	-0.0535662	0.95 [0.56 - 1.61]
GENE	ARG2	arginase, type II	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203945_at	125	0.816	0.102423	-	-0.989654	0.957488	-0.0276494	0.97 [0.35 - 2.69]
GENE	ARG2	arginase, type II	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203946_s_at	62	0.306452	0.0700971	-	-0.886256	0.415151	-0.37647	0.69 [0.28 - 1.70]
GENE	ARG2	arginase, type II	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203945_at	125	0.784	0.0114772	0.179007	-1.07134	0.309527	-0.407034	0.67 [0.30 - 1.46]
GENE	ARG2	arginase, type II	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203945_at	54	0.407407	0.105632	-	1.19164	0.896561	-0.0428141	0.96 [0.50 - 1.83]
GENE	ARG2	arginase, type II	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203946_s_at	125	0.224	0.137286	-	0.88351	0.869469	-0.0582543	0.94 [0.47 - 1.89]
GENE	ARG2	arginase, type II	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203946_s_at	125	0.224	0.0721469	-	0.832492	0.761529	-0.0810119	0.92 [0.55 - 1.56]
GENE	ARG2	arginase, type II	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203946_s_at	54	0.259259	0.0996466	-	-1.00684	0.554168	-0.330569	0.72 [0.24 - 2.15]
GENE	ARG2	arginase, type II	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203945_at	198	0.621212	0.0122989	0.188438	0.65848	0.749166	-0.0852388	0.92 [0.54 - 1.55]
GENE	ARG2	arginase, type II	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203946_s_at	198	0.388889	0.0281285	0.33923	-0.556976	0.423201	-0.0922707	0.91 [0.73 - 1.14]
GENE	ARG2	arginase, type II	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203946_s_at	198	0.459596	0.11018	-	-0.428551	0.803941	-0.0305605	0.97 [0.76 - 1.23]
GENE	ARG2	arginase, type II	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203945_at	198	0.616162	0.0579905	-	0.399094	0.749317	-0.0655983	0.94 [0.63 - 1.40]
GENE	ARG2	arginase, type II	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203945_at	198	0.651515	0.0157275	0.225627	0.608258	0.805396	-0.0618919	0.94 [0.57 - 1.54]
GENE	ARG2	arginase, type II	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203946_s_at	198	0.388889	0.119686	-	-0.326376	0.584889	-0.0522275	0.95 [0.79 - 1.14]
GENE	ARG2	arginase, type II	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203945_at	51	0.823529	0.00492224	0.0934824	2.14472	0.047646	2.18233	8.87 [1.02 - 76.87]
GENE	ARG2	arginase, type II	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203945_at	62	0.887097	0.00136597	0.0330648	1.74586	0.189244	0.970401	2.64 [0.62 - 11.24]
GENE	ARG2	arginase, type II	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203946_s_at	51	0.823529	0.191049	-	1.13246	0.949878	0.0349549	1.04 [0.35 - 3.08]
GENE	ARG2	arginase, type II	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203946_s_at	62	0.193548	0.0731856	-	15.3861	0.400177	0.261668	1.30 [0.71 - 2.39]
GENE	ARG2	arginase, type II	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203946_s_at	145	0.703448	0.0311673	0.363412	0.729801	0.452873	0.154986	1.17 [0.78 - 1.75]
GENE	ARG2	arginase, type II	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203945_at	177	0.706215	0.010927	0.172564	0.622259	0.453317	0.427999	1.53 [0.50 - 4.70]
GENE	ARG2	arginase, type II	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203946_s_at	177	0.661017	0.0235604	0.300478	0.615075	0.403954	0.141768	1.15 [0.83 - 1.61]
GENE	ARG2	arginase, type II	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203945_at	145	0.448276	0.0434144	0.450457	-0.677552	0.728008	-0.291329	0.75 [0.14 - 3.86]
GENE	ARG2	arginase, type II	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203945_at	177	0.706215	0.0103367	0.165531	0.71105	0.541283	0.399401	1.49 [0.41 - 5.37]
GENE	ARG2	arginase, type II	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203946_s_at	177	0.655367	0.00714648	0.124999	0.631221	0.16111	0.201142	1.22 [0.92 - 1.62]
GENE	ARG2	arginase, type II	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203946_s_at	226	0.336283	0.0920294	-	-0.47614	0.637307	-0.0915984	0.91 [0.62 - 1.34]
GENE	ARG2	arginase, type II	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203945_at	226	0.884956	0.16265	-	0.53442	0.78493	0.082413	1.09 [0.60 - 1.96]
GENE	ARG2	arginase, type II	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203946_s_at	49	0.204082	0.0652513	-	15.4047	0.53159	0.230361	1.26 [0.61 - 2.59]
GENE	ARG2	arginase, type II	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203945_at	55	0.872727	0.00370468	0.0746157	1.63437	0.0404648	2.07278	7.95 [1.09 - 57.72]
GENE	ARG2	arginase, type II	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203945_at	55	0.890909	0.0369854	0.406663	1.11557	0.302507	0.993573	2.70 [0.41 - 17.86]
GENE	ARG2	arginase, type II	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203945_at	49	0.897959	0.092459	-	1.24159	0.252319	1.67276	5.33 [0.30 - 93.39]
GENE	ARG2	arginase, type II	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203946_s_at	55	0.327273	0.0366188	0.404045	1.23282	0.391662	0.224885	1.25 [0.75 - 2.09]
GENE	ARG2	arginase, type II	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203946_s_at	55	0.345455	0.0104589	0.166997	1.66886	0.0849997	0.511441	1.67 [0.93 - 2.98]
GENE	ARG2	arginase, type II	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	50480	34	0.852941	0.0245294	0.30896	1.1331	0.200857	0.767439	2.15 [0.66 - 6.98]
GENE	ARG2	arginase, type II	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203945_at	63	0.126984	0.13884	-	-0.654478	0.38165	-0.712383	0.49 [0.10 - 2.42]
GENE	ARG2	arginase, type II	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203946_s_at	63	0.365079	0.00137798	0.0333061	1.27306	0.204061	0.253747	1.29 [0.87 - 1.91]
GENE	ARG2	arginase, type II	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g10947110_3p_at	28	0.321429	0.0254766	0.317111	-1.27402	0.458655	-0.477911	0.62 [0.18 - 2.19]
GENE	ARG2	arginase, type II	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g1763757_3p_a_at	28	0.75	0.11355	-	-1.02476	0.32041	-1.76566	0.17 [0.01 - 5.57]
GENE	ARG2	arginase, type II	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203945_at	82	0.292683	0.00335889	0.0689852	1.43977	0.0277436	1.81805	6.16 [1.22 - 31.10]
GENE	ARG2	arginase, type II	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203946_s_at	82	0.329268	0.0777707	-	0.729779	0.685414	0.158075	1.17 [0.55 - 2.52]
GENE	ARG2	arginase, type II	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203945_at	79	0.772152	0.216681	-	-0.412984	0.957361	-0.0177188	0.98 [0.51 - 1.88]
GENE	ARG2	arginase, type II	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203946_s_at	79	0.303797	0.0228504	0.294166	0.671773	0.385735	0.130644	1.14 [0.85 - 1.53]
GENE	ARG2	arginase, type II	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203946_s_at	104	0.153846	0.18869	-	0.700705	0.749913	0.149778	1.16 [0.46 - 2.92]
GENE	ARG2	arginase, type II	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203945_at	104	0.240385	0.00102852	0.0260933	-1.06255	0.0115245	-1.7871	0.17 [0.04 - 0.67]
GENE	ARG2	arginase, type II	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P128728	117	0.307692	0.146095	-	0.493087	0.754369	0.0416731	1.04 [0.80 - 1.35]
GENE	ARG2	arginase, type II	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203946_s_at	204	0.294118	0.132761	-	-0.554495	0.907842	-0.0282434	0.97 [0.60 - 1.57]
GENE	ARG2	arginase, type II	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203946_s_at	204	0.529412	0.13771	-	-0.411729	0.906326	0.0211208	1.02 [0.72 - 1.45]
GENE	ARG2	arginase, type II	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203945_at	204	0.284314	0.00218176	0.0486372	-1.07218	0.134697	-0.678514	0.51 [0.21 - 1.23]
GENE	ARG2	arginase, type II	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203945_at	204	0.284314	0.000313962	0.00950222	-0.953411	0.056465	-0.648142	0.52 [0.27 - 1.02]
GENE	ARG2	arginase, type II	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203945_at	178	0.730337	0.00089637	0.0232472	0.681594	0.150405	0.655291	1.93 [0.79 - 4.70]
GENE	ARG2	arginase, type II	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203946_s_at	178	0.601124	0.0344576	0.38833	-0.438132	0.288594	-0.209095	0.81 [0.55 - 1.19]
GENE	ARG2	arginase, type II	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200008089	41	0.853659	0.00240584	0.0526743	1.43633	0.0138016	0.956047	2.60 [1.22 - 5.57]
GENE	ARG2	arginase, type II	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203946_s_at	111	0.45045	0.00989696	0.160206	0.687072	0.364953	0.164468	1.18 [0.83 - 1.68]
GENE	ARG2	arginase, type II	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203945_at	111	0.891892	0.0129944	0.196253	0.91981	0.0892102	0.565501	1.76 [0.92 - 3.38]
GENE	ARG2	arginase, type II	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203945_at	90	0.111111	0.0660524	-	-0.752828	0.810369	-0.159969	0.85 [0.23 - 3.15]
GENE	ARG2	arginase, type II	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203945_at	90	0.2	0.175028	-	0.805194	0.558899	0.42613	1.53 [0.37 - 6.39]
GENE	ARG2	arginase, type II	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203946_s_at	90	0.677778	0.228462	-	0.397727	0.790588	0.0468683	1.05 [0.74 - 1.48]
GENE	ARG2	arginase, type II	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203946_s_at	90	0.522222	0.139182	-	0.551596	0.422957	0.150734	1.16 [0.80 - 1.68]
GENE	ARG2	arginase, type II	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4045	50	0.22	0.228558	-	0.880657	0.637996	0.17036	1.19 [0.58 - 2.41]
GENE	ARG2	arginase, type II	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203946_s_at	138	0.130435	0.406827	-	-0.273393	0.925875	-0.00793631	0.99 [0.84 - 1.17]
GENE	ARG2	arginase, type II	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203945_at	138	0.130435	0.0539319	-	0.870635	0.941281	0.0130823	1.01 [0.72 - 1.44]
GENE	ARG2	arginase, type II	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203946_s_at	129	0.348837	0.146051	-	0.388738	0.977483	-0.00547718	0.99 [0.68 - 1.45]
GENE	ARG2	arginase, type II	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203945_at	129	0.79845	0.046536	0.470401	-0.734187	0.910676	-0.0508156	0.95 [0.39 - 2.31]
GENE	ARG2	arginase, type II	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28372	56	0.464286	0.0735337	-	0.660653	0.898322	0.0217964	1.02 [0.73 - 1.43]
GENE	ARG2	arginase, type II	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28372	56	0.625	0.0330802	0.37805	0.73023	0.970216	0.00601443	1.01 [0.73 - 1.38]
GENE	ARG2	arginase, type II	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203945_at	278	0.327338	0.0967993	-	0.344978	0.890791	0.0342086	1.03 [0.64 - 1.69]
GENE	ARG2	arginase, type II	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203946_s_at	278	0.899281	0.13047	-	-0.584881	0.455791	-0.0749949	0.93 [0.76 - 1.13]
GENE	ARG2	arginase, type II	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203945_at	133	0.661654	0.0202246	0.270066	0.551478	0.46279	-0.546431	0.58 [0.13 - 2.49]
GENE	ARG2	arginase, type II	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203946_s_at	133	0.661654	0.034329	0.38738	-0.543419	0.125932	-0.228433	0.80 [0.59 - 1.07]
GENE	ARG2	arginase, type II	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7933	81	0.802469	0.151163	-	-1.37603	0.233206	-0.848586	0.43 [0.11 - 1.73]
GENE	ARG2	arginase, type II	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13776	81	0.876543	0.183185	-	0.842262	0.707443	0.100067	1.11 [0.66 - 1.86]
GENE	ARG2	arginase, type II	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203945_at	185	0.778378	0.226941	-	0.256376	0.658594	0.0941016	1.10 [0.72 - 1.67]
GENE	ARG2	arginase, type II	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203946_s_at	185	0.275676	0.0381394	0.414813	0.376134	0.231619	0.123154	1.13 [0.92 - 1.38]
GENE	ARG2	arginase, type II	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203945_at	185	0.167568	0.131664	-	0.325559	0.917952	0.0205402	1.02 [0.69 - 1.51]
GENE	ARG2	arginase, type II	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203946_s_at	185	0.897297	0.013172	0.198225	0.644528	0.117629	0.161858	1.18 [0.96 - 1.44]
GENE	ARG2	arginase, type II	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P128728	110	0.490909	0.163295	-	0.42336	0.232544	0.198904	1.22 [0.88 - 1.69]
GENE	ARG2	arginase, type II	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P128728	110	0.118182	0.117445	-	0.658837	0.543767	0.0738569	1.08 [0.85 - 1.37]
GENE	ARG2	arginase, type II	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203946_s_at	80	0.1125	0.163303	-	1.33178	0.982207	-0.00386749	1.00 [0.71 - 1.40]
GENE	ARG2	arginase, type II	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203945_at	80	0.2875	0.0635688	-	-0.843913	0.666692	-0.216767	0.81 [0.30 - 2.16]
GENE	ARG2	arginase, type II	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0720	281	0.106762	0.000121233	0.0041486	-0.780331	7.06525e-05	-0.390165	0.68 [0.56 - 0.82]
GENE	ARG2	arginase, type II	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203946_s_at	38	0.894737	0.007247	0.126351	1.58828	0.0762019	0.511177	1.67 [0.95 - 2.93]
GENE	ARG2	arginase, type II	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203945_at	38	0.789474	0.0434701	0.45082	-1.81837	0.578836	0.29404	1.34 [0.48 - 3.79]
GENE	ARG2	arginase, type II	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203945_at	140	0.642857	0.149912	-	-0.440991	0.362778	-0.456332	0.63 [0.24 - 1.69]
GENE	ARG2	arginase, type II	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203946_s_at	140	0.814286	0.00123315	0.0303665	0.978433	0.0322248	0.472007	1.60 [1.04 - 2.47]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ARSA	arylsulfatase A	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204443_at	30	0.7	0.00175174	0.0406204	1.38697	0.0503058	1.89512	6.65 [1.00 - 44.38]
GENE	ARSA	arylsulfatase A	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1656477	165	0.866667	0.0111435	0.175112	-1.23422	0.267261	-0.17819	0.84 [0.61 - 1.15]
GENE	ARSA	arylsulfatase A	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1656477	165	0.624242	0.0307861	0.360442	-0.895113	0.152269	-0.344862	0.71 [0.44 - 1.14]
GENE	ARSA	arylsulfatase A	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204443_at	163	0.128834	0.106588	-	0.556778	0.742249	0.0940312	1.10 [0.63 - 1.92]
GENE	ARSA	arylsulfatase A	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	236541_at	163	0.754601	0.000160731	0.00531149	0.78439	0.0153267	1.72543	5.61 [1.39 - 22.65]
GENE	ARSA	arylsulfatase A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	236541_at	79	0.101266	0.0556762	-	-0.766709	0.711518	-0.293158	0.75 [0.16 - 3.53]
GENE	ARSA	arylsulfatase A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204443_at	79	0.278481	0.0076062	0.131137	1.00563	0.228602	0.357349	1.43 [0.80 - 2.56]
GENE	ARSA	arylsulfatase A	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204443_at	58	0.896552	0.214743	-	-0.538444	0.830692	0.0493121	1.05 [0.67 - 1.65]
GENE	ARSA	arylsulfatase A	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204443_at	34	0.823529	0.114434	-	-0.835266	0.914199	-0.0232809	0.98 [0.64 - 1.49]
GENE	ARSA	arylsulfatase A	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204443_at	158	0.322785	0.027808	0.336609	0.61098	0.467262	0.401482	1.49 [0.51 - 4.41]
GENE	ARSA	arylsulfatase A	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204443_at	53	0.113208	0.00302176	0.0633585	-1.28748	0.819045	-0.070552	0.93 [0.51 - 1.71]
GENE	ARSA	arylsulfatase A	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204443_at	53	0.113208	0.0108371	0.171501	-1.12356	0.946564	-0.0216091	0.98 [0.52 - 1.84]
GENE	ARSA	arylsulfatase A	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204443_at	180	0.672222	2.18053e-05	0.000902733	0.868041	0.0658644	0.372473	1.45 [0.98 - 2.16]
GENE	ARSA	arylsulfatase A	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	236541_at	180	0.883333	0.0266768	0.327245	0.686657	0.448165	0.133019	1.14 [0.81 - 1.61]
GENE	ARSA	arylsulfatase A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	236541_at	559	0.431127	0.0896693	-	0.370927	0.590981	0.0691391	1.07 [0.83 - 1.38]
GENE	ARSA	arylsulfatase A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204443_at	559	0.107335	0.0444049	0.456873	-0.543424	0.175278	-0.148096	0.86 [0.70 - 1.07]
GENE	ARSA	arylsulfatase A	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204443_at	77	0.116883	0.0707608	-	-0.65529	0.308507	-0.188128	0.83 [0.58 - 1.19]
GENE	ARSA	arylsulfatase A	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	236541_at	77	0.168831	0.111683	-	0.624805	0.861441	0.0293549	1.03 [0.74 - 1.43]
GENE	ARSA	arylsulfatase A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204443_at	70	0.142857	0.107856	-	-0.581705	0.287685	-0.619353	0.54 [0.17 - 1.69]
GENE	ARSA	arylsulfatase A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	236541_at	70	0.685714	0.124639	-	0.42759	0.411669	0.46962	1.60 [0.52 - 4.91]
GENE	ARSA	arylsulfatase A	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37963_at	50	0.82	0.0383773	0.416476	0.830728	0.358934	0.428802	1.54 [0.61 - 3.84]
GENE	ARSA	arylsulfatase A	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204443_at	74	0.72973	0.0176463	0.245124	0.752138	0.0733483	0.501676	1.65 [0.95 - 2.86]
GENE	ARSA	arylsulfatase A	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	236541_at	74	0.783784	3.81528e-06	0.000185976	1.40388	0.0715914	0.800814	2.23 [0.93 - 5.32]
GENE	ARSA	arylsulfatase A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	236541_at	67	0.373134	0.0145749	0.213485	-1.57658	0.0836636	-4.05197	0.02 [0.00 - 1.71]
GENE	ARSA	arylsulfatase A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204443_at	67	0.164179	0.00745296	0.129104	-1.62579	0.324967	-0.817899	0.44 [0.09 - 2.25]
GENE	ARSA	arylsulfatase A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204443_at	115	0.113043	0.029058	0.346753	-1.21134	0.0545143	-1.01219	0.36 [0.13 - 1.02]
GENE	ARSA	arylsulfatase A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	236541_at	115	0.365217	0.0198771	0.266782	-1.22261	0.298005	-0.758457	0.47 [0.11 - 1.95]
GENE	ARSA	arylsulfatase A	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37963_at	158	0.651899	0.118204	-	0.441752	0.467494	-0.27463	0.76 [0.36 - 1.59]
GENE	ARSA	arylsulfatase A	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37963_at	76	0.565789	0.102695	-	-0.922363	0.92875	0.0611051	1.06 [0.28 - 4.06]
GENE	ARSA	arylsulfatase A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	236541_at	204	0.686275	0.0156152	0.224459	-0.364461	0.0746942	-0.139569	0.87 [0.75 - 1.01]
GENE	ARSA	arylsulfatase A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204443_at	204	0.289216	0.116081	-	0.246863	0.735967	0.0278687	1.03 [0.87 - 1.21]
GENE	ARSA	arylsulfatase A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204443_at	87	0.471264	0.16736	-	-0.521904	0.339437	-0.299052	0.74 [0.40 - 1.37]
GENE	ARSA	arylsulfatase A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204443_at	87	0.471264	0.16736	-	-0.521904	0.339437	-0.299052	0.74 [0.40 - 1.37]
GENE	ARSA	arylsulfatase A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	236541_at	87	0.206897	0.137492	-	0.879248	0.619132	0.411733	1.51 [0.30 - 7.65]
GENE	ARSA	arylsulfatase A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	236541_at	87	0.206897	0.137492	-	0.879248	0.619132	0.411733	1.51 [0.30 - 7.65]
GENE	ARSA	arylsulfatase A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204443_at	77	0.779221	0.0824077	-	-15.428	0.534765	-0.32028	0.73 [0.26 - 2.00]
GENE	ARSA	arylsulfatase A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	236541_at	77	0.792208	0.0933252	-	0.924172	0.459305	0.946224	2.58 [0.21 - 31.58]
GENE	ARSA	arylsulfatase A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204443_at	77	0.350649	0.0931811	-	1.215	0.981843	0.0101298	1.01 [0.42 - 2.42]
GENE	ARSA	arylsulfatase A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	236541_at	77	0.857143	0.12974	-	1.00555	0.569638	0.838153	2.31 [0.13 - 41.57]
GENE	ARSA	arylsulfatase A	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204443_at	136	0.485294	0.0879491	-	-0.818166	0.0455649	-0.515694	0.60 [0.36 - 0.99]
GENE	ARSA	arylsulfatase A	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204443_at	200	0.13	0.0250446	0.313411	-0.783527	0.236449	-0.343531	0.71 [0.40 - 1.25]
GENE	ARSA	arylsulfatase A	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	798	60	0.733333	0.128934	-	-0.739292	0.494551	-0.120514	0.89 [0.63 - 1.25]
GENE	ARSA	arylsulfatase A	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	798	60	0.65	0.191734	-	-0.561209	0.773333	0.0785209	1.08 [0.63 - 1.85]
GENE	ARSA	arylsulfatase A	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	2801	155	0.870968	0.00703493	0.123492	0.861898	0.264481	0.349322	1.42 [0.77 - 2.62]
GENE	ARSA	arylsulfatase A	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204443_at	286	0.699301	0.00162251	0.0381319	-0.762916	0.298899	-0.205275	0.81 [0.55 - 1.20]
GENE	ARSA	arylsulfatase A	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204443_at	159	0.113208	0.103383	-	-0.66524	0.649195	-0.179707	0.84 [0.39 - 1.81]
GENE	ARSA	arylsulfatase A	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204443_at	159	0.861635	0.0206452	0.274011	0.928783	0.916028	-0.0491723	0.95 [0.38 - 2.37]
GENE	ARSA	arylsulfatase A	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204443_at	159	0.113208	0.0173379	0.242047	-0.909873	0.673332	-0.167024	0.85 [0.39 - 1.84]
GENE	ARSA	arylsulfatase A	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	236541_at	159	0.408805	0.00481081	0.0918107	-0.875213	0.280005	-0.221664	0.80 [0.54 - 1.20]
GENE	ARSA	arylsulfatase A	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	236541_at	159	0.389937	0.00121946	0.0300854	-1.00272	0.176234	-0.277841	0.76 [0.51 - 1.13]
GENE	ARSA	arylsulfatase A	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	236541_at	159	0.389937	0.016755	0.236174	-0.866956	0.516486	-0.1578	0.85 [0.53 - 1.38]
GENE	ARSA	arylsulfatase A	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204443_at	54	0.740741	0.363982	-	0.600501	0.874861	0.0649026	1.07 [0.48 - 2.39]
GENE	ARSA	arylsulfatase A	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204443_at	117	0.384615	0.00250927	0.0545089	-0.935541	0.17149	-0.413916	0.66 [0.37 - 1.20]
GENE	ARSA	arylsulfatase A	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204443_at	117	0.376068	0.0099658	0.161045	-0.950153	0.423913	-0.27855	0.76 [0.38 - 1.50]
GENE	ARSA	arylsulfatase A	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204443_at	117	0.384615	0.00250927	0.0545089	-0.935541	0.17149	-0.413916	0.66 [0.37 - 1.20]
GENE	ARSA	arylsulfatase A	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204443_at	117	0.358974	0.000880551	0.0229014	-1.26546	0.0826383	-0.655673	0.52 [0.25 - 1.09]
GENE	ARSA	arylsulfatase A	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204443_at	236	0.20339	0.0341517	0.386066	-0.620165	0.292876	-0.351756	0.70 [0.37 - 1.35]
GENE	ARSA	arylsulfatase A	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	236541_at	236	0.309322	0.0340606	0.385389	-0.576885	0.206429	-0.228448	0.80 [0.56 - 1.13]
GENE	ARSA	arylsulfatase A	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204443_at	249	0.212851	0.0594342	-	-0.44664	0.323584	-0.256276	0.77 [0.47 - 1.29]
GENE	ARSA	arylsulfatase A	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	236541_at	249	0.710843	0.0232948	0.298126	-0.59037	0.275672	-0.152715	0.86 [0.65 - 1.13]
GENE	ARSA	arylsulfatase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204443_at	62	0.790323	0.134978	-	-1.07527	0.597055	-0.0809888	0.92 [0.68 - 1.25]
GENE	ARSA	arylsulfatase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204443_at	125	0.128	0.0286341	0.343337	-0.924485	0.435264	-0.506766	0.60 [0.17 - 2.15]
GENE	ARSA	arylsulfatase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204443_at	125	0.792	0.108999	-	-0.645299	0.471653	-0.353845	0.70 [0.27 - 1.84]
GENE	ARSA	arylsulfatase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204443_at	54	0.111111	0.185554	-	-1.02308	0.469107	-0.136021	0.87 [0.60 - 1.26]
GENE	ARSA	arylsulfatase A	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204443_at	198	0.116162	0.0373158	0.40901	1.16739	0.11594	0.185589	1.20 [0.96 - 1.52]
GENE	ARSA	arylsulfatase A	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204443_at	198	0.116162	0.027995	0.338141	1.45205	0.129055	0.19014	1.21 [0.95 - 1.55]
GENE	ARSA	arylsulfatase A	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204443_at	198	0.116162	0.138703	-	0.545233	0.475557	0.065044	1.07 [0.89 - 1.28]
GENE	ARSA	arylsulfatase A	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204443_at	51	0.607843	0.046248	0.468595	1.92169	0.378169	1.63423	5.13 [0.14 - 194.19]
GENE	ARSA	arylsulfatase A	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204443_at	62	0.564516	0.0426206	0.445254	1.17707	0.431008	0.892152	2.44 [0.26 - 22.48]
GENE	ARSA	arylsulfatase A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204443_at	177	0.683616	0.0210298	0.277588	-0.760806	0.145904	-0.732809	0.48 [0.18 - 1.29]
GENE	ARSA	arylsulfatase A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	236541_at	177	0.864407	0.0390464	0.421126	-0.923663	0.414042	-0.517951	0.60 [0.17 - 2.06]
GENE	ARSA	arylsulfatase A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	236541_at	177	0.864407	0.0417721	0.439631	-1.14636	0.508125	-0.482752	0.62 [0.15 - 2.58]
GENE	ARSA	arylsulfatase A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204443_at	177	0.683616	0.0389815	0.420677	-0.564575	0.190647	-0.575654	0.56 [0.24 - 1.33]
GENE	ARSA	arylsulfatase A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	236541_at	145	0.841379	0.30734	-	-0.535524	0.538135	-0.560191	0.57 [0.10 - 3.40]
GENE	ARSA	arylsulfatase A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204443_at	145	0.372414	0.041454	0.437507	0.796683	0.899547	0.0794564	1.08 [0.32 - 3.72]
GENE	ARSA	arylsulfatase A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	236541_at	226	0.880531	0.02251	0.291111	0.791272	0.348751	0.120702	1.13 [0.88 - 1.45]
GENE	ARSA	arylsulfatase A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204443_at	226	0.300885	0.101773	-	0.557272	0.337565	0.10797	1.11 [0.89 - 1.39]
GENE	ARSA	arylsulfatase A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	236541_at	55	0.709091	0.27436	-	-0.60209	0.993082	0.0124797	1.01 [0.06 - 17.01]
GENE	ARSA	arylsulfatase A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204443_at	55	0.654545	0.0305716	0.358764	0.938407	0.438451	0.463616	1.59 [0.49 - 5.14]
GENE	ARSA	arylsulfatase A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	236541_at	49	0.285714	0.0874437	-	1.60827	0.687275	0.750705	2.12 [0.05 - 81.93]
GENE	ARSA	arylsulfatase A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204443_at	55	0.309091	0.0545247	-	-0.881507	0.550221	-0.376688	0.69 [0.20 - 2.36]
GENE	ARSA	arylsulfatase A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	236541_at	55	0.272727	0.300528	-	0.649971	0.625912	0.766421	2.15 [0.10 - 46.89]
GENE	ARSA	arylsulfatase A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204443_at	49	0.816327	0.0352796	0.394366	1.22803	0.708781	-0.269745	0.76 [0.19 - 3.14]
GENE	ARSA	arylsulfatase A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	236541_at	63	0.253968	0.000664708	0.0180572	-1.17027	0.0637753	-3.64806	0.03 [0.00 - 1.23]
GENE	ARSA	arylsulfatase A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204443_at	63	0.126984	0.0815974	-	-0.768376	0.91952	-0.0546279	0.95 [0.33 - 2.73]
GENE	ARSA	arylsulfatase A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.157802.0.A1_3p_at	28	0.285714	0.00188323	0.0431127	-1.82692	0.523005	-0.805809	0.45 [0.04 - 5.30]
GENE	ARSA	arylsulfatase A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7262293_3p_at	28	0.607143	0.232575	-	-0.705658	0.10794	2.31297	10.10 [0.60 - 169.54]
GENE	ARSA	arylsulfatase A	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204443_at	82	0.158537	0.364853	-	0.479083	0.664791	0.227128	1.25 [0.45 - 3.51]
GENE	ARSA	arylsulfatase A	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37963_at	84	0.892857	0.0360734	0.400126	-1.40365	0.499538	-0.219164	0.80 [0.43 - 1.52]
GENE	ARSA	arylsulfatase A	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204443_at	79	0.632911	0.277293	-	-0.297716	0.634124	-0.141804	0.87 [0.48 - 1.56]
GENE	ARSA	arylsulfatase A	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X52151_at	86	0.255814	0.145637	-	0.780471	0.649215	0.243084	1.28 [0.45 - 3.63]
GENE	ARSA	arylsulfatase A	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204443_at	104	0.884615	0.0993443	-	0.690812	0.732124	0.164415	1.18 [0.46 - 3.02]
GENE	ARSA	arylsulfatase A	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P255436	117	0.316239	0.000378408	0.0111601	-0.980635	0.00137052	-0.719538	0.49 [0.31 - 0.76]
GENE	ARSA	arylsulfatase A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204443_at	204	0.431373	0.00101308	0.0257644	1.47505	0.00479914	1.11315	3.04 [1.40 - 6.60]
GENE	ARSA	arylsulfatase A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	236541_at	204	0.441176	0.109202	-	-0.582359	0.434637	-0.202854	0.82 [0.49 - 1.36]
GENE	ARSA	arylsulfatase A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204443_at	204	0.431373	0.000563149	0.0156833	1.0507	0.00216411	0.86422	2.37 [1.37 - 4.12]
GENE	ARSA	arylsulfatase A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	236541_at	204	0.544118	0.000626376	0.0171692	-1.01901	0.002616	-0.533724	0.59 [0.41 - 0.83]
GENE	ARSA	arylsulfatase A	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204443_at	178	0.101124	0.0511946	-	0.710002	0.461073	0.190571	1.21 [0.73 - 2.01]
GENE	ARSA	arylsulfatase A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	236541_at	111	0.153153	0.131818	-	-0.502787	0.277702	-0.211679	0.81 [0.55 - 1.19]
GENE	ARSA	arylsulfatase A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204443_at	111	0.873874	0.424331	-	0.304313	0.543177	-0.134878	0.87 [0.57 - 1.35]
GENE	ARSA	arylsulfatase A	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204443_at	90	0.877778	0.0366562	0.404313	0.810267	0.318878	0.620436	1.86 [0.55 - 6.30]
GENE	ARSA	arylsulfatase A	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204443_at	90	0.655556	0.105976	-	-0.726705	0.703181	0.266628	1.31 [0.33 - 5.15]
GENE	ARSA	arylsulfatase A	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3704	50	0.8	0.239102	-	-0.858157	0.262954	-0.385256	0.68 [0.35 - 1.34]
GENE	ARSA	arylsulfatase A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204443_at	138	0.115942	0.156055	-	0.648473	0.983649	0.00332169	1.00 [0.73 - 1.38]
GENE	ARSA	arylsulfatase A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	236541_at	138	0.869565	0.020891	0.2763	-1.03483	0.0852156	-1.74928	0.17 [0.02 - 1.27]
GENE	ARSA	arylsulfatase A	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204443_at	129	0.883721	0.0376928	0.411675	0.653944	0.201286	0.462048	1.59 [0.78 - 3.22]
GENE	ARSA	arylsulfatase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23267	56	0.767857	0.106238	-	0.600904	0.808822	0.0750991	1.08 [0.59 - 1.98]
GENE	ARSA	arylsulfatase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22673	56	0.428571	0.0287646	0.344391	-0.744209	0.688118	0.0967641	1.10 [0.69 - 1.77]
GENE	ARSA	arylsulfatase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23267	56	0.535714	0.122479	-	-0.597907	0.717129	-0.12203	0.89 [0.46 - 1.71]
GENE	ARSA	arylsulfatase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22673	56	0.428571	0.0310206	0.362271	-0.776311	0.974673	0.00775981	1.01 [0.62 - 1.63]
GENE	ARSA	arylsulfatase A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	236541_at	278	0.76259	0.0465191	0.470295	-0.458574	0.192693	-0.519255	0.59 [0.27 - 1.30]
GENE	ARSA	arylsulfatase A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204443_at	278	0.169065	0.00159412	0.0375797	-0.722652	0.0796897	-0.358441	0.70 [0.47 - 1.04]
GENE	ARSA	arylsulfatase A	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204443_at	133	0.81203	0.00137537	0.0332538	0.842154	0.0264763	0.852287	2.35 [1.10 - 4.98]
GENE	ARSA	arylsulfatase A	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1652	81	0.740741	0.00554193	0.102601	1.38731	0.741929	0.157406	1.17 [0.46 - 2.99]
GENE	ARSA	arylsulfatase A	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204443_at	185	0.664865	0.0167042	0.235657	-0.423633	0.358779	-0.224746	0.80 [0.49 - 1.29]
GENE	ARSA	arylsulfatase A	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204443_at	185	0.805405	0.00408984	0.0807353	-0.719321	0.185369	-0.35427	0.70 [0.42 - 1.19]
GENE	ARSA	arylsulfatase A	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P255436	110	0.127273	0.0392712	0.422679	-0.758119	0.952273	-0.0154886	0.98 [0.59 - 1.64]
GENE	ARSA	arylsulfatase A	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P255436	110	0.127273	0.00903435	0.149535	-0.780294	0.936157	-0.0162235	0.98 [0.66 - 1.46]
GENE	ARSA	arylsulfatase A	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204443_at	80	0.1875	0.00977451	0.15871	-1.17564	0.155415	-0.291865	0.75 [0.50 - 1.12]
GENE	ARSA	arylsulfatase A	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_1868	281	0.188612	0.000820872	0.0215862	-0.564747	0.0595762	-0.123466	0.88 [0.78 - 1.00]
GENE	ARSA	arylsulfatase A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	236541_at	38	0.315789	0.00908391	0.150156	-1.19383	0.5036	-0.258996	0.77 [0.36 - 1.65]
GENE	ARSA	arylsulfatase A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204443_at	38	0.131579	0.0278242	0.336742	15.4106	0.403024	0.378573	1.46 [0.60 - 3.55]
GENE	ARSA	arylsulfatase A	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204443_at	140	0.15	0.00191943	0.0437922	-0.975631	0.067965	-0.843529	0.43 [0.17 - 1.06]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ARSB	arylsulfatase B	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206129_s_at	30	0.333333	0.0617855	-	-0.776067	0.538611	-0.298678	0.74 [0.29 - 1.92]
GENE	ARSB	arylsulfatase B	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1712587	165	0.751515	0.207169	-	0.338453	0.902793	-0.0984794	0.91 [0.19 - 4.40]
GENE	ARSB	arylsulfatase B	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1712587	165	0.757576	0.0318586	0.368752	0.765063	0.595029	0.617145	1.85 [0.19 - 18.04]
GENE	ARSB	arylsulfatase B	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206129_s_at	163	0.177914	0.123117	-	0.418607	0.897654	0.047131	1.05 [0.51 - 2.15]
GENE	ARSB	arylsulfatase B	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554032_at	79	0.835443	0.0264184	0.325081	0.749072	0.0732683	1.70545	5.50 [0.85 - 35.58]
GENE	ARSB	arylsulfatase B	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206129_s_at	79	0.329114	0.0287976	0.344657	0.718212	0.11018	0.444007	1.56 [0.90 - 2.69]
GENE	ARSB	arylsulfatase B	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554030_at	79	0.518987	0.0267839	0.32814	0.644651	0.136145	0.659645	1.93 [0.81 - 4.61]
GENE	ARSB	arylsulfatase B	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206129_s_at	58	0.482759	0.040493	0.431033	0.568855	0.731647	0.0868239	1.09 [0.66 - 1.79]
GENE	ARSB	arylsulfatase B	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206129_s_at	34	0.176471	0.0287305	0.344116	-1.03541	0.591139	-0.208551	0.81 [0.38 - 1.74]
GENE	ARSB	arylsulfatase B	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206129_s_at	158	0.721519	0.18605	-	-0.356563	0.74751	-0.190393	0.83 [0.26 - 2.63]
GENE	ARSB	arylsulfatase B	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206129_s_at	53	0.509434	0.0634805	-	-0.682178	0.900943	-0.0591251	0.94 [0.37 - 2.39]
GENE	ARSB	arylsulfatase B	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206129_s_at	53	0.509434	0.0412636	0.436231	-0.700861	0.716225	-0.153681	0.86 [0.37 - 1.96]
GENE	ARSB	arylsulfatase B	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206129_s_at	180	0.177778	0.0563985	-	0.583818	0.366717	0.236487	1.27 [0.76 - 2.12]
GENE	ARSB	arylsulfatase B	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206129_s_at	559	0.515206	0.00209971	0.0471364	-0.635199	0.350402	-0.174642	0.84 [0.58 - 1.21]
GENE	ARSB	arylsulfatase B	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554030_at	559	0.300537	0.15379	-	-0.308179	0.941576	-0.0145245	0.99 [0.67 - 1.45]
GENE	ARSB	arylsulfatase B	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554032_at	559	0.373882	0.0626697	-	-0.377257	0.436789	-0.136456	0.87 [0.62 - 1.23]
GENE	ARSB	arylsulfatase B	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206129_s_at	77	0.675325	0.155867	-	-0.39765	0.934164	-0.0263088	0.97 [0.52 - 1.82]
GENE	ARSB	arylsulfatase B	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206129_s_at	70	0.757143	0.00103105	0.0261471	-1.22149	0.0391141	-1.16779	0.31 [0.10 - 0.94]
GENE	ARSB	arylsulfatase B	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554032_at	70	0.285714	0.0252349	0.315044	-0.630569	0.454251	-1.37257	0.25 [0.01 - 9.23]
GENE	ARSB	arylsulfatase B	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554030_at	70	0.885714	0.0423168	0.443248	-1.02031	0.194224	-1.08656	0.34 [0.07 - 1.74]
GENE	ARSB	arylsulfatase B	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37795_at	50	0.2	0.0870302	-	0.887546	0.625408	-0.28186	0.75 [0.24 - 2.34]
GENE	ARSB	arylsulfatase B	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206129_s_at	74	0.22973	0.23662	-	-0.384823	0.565454	0.249851	1.28 [0.55 - 3.01]
GENE	ARSB	arylsulfatase B	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554030_at	67	0.791045	0.159976	-	-15.3469	0.531921	-1.06186	0.35 [0.01 - 9.66]
GENE	ARSB	arylsulfatase B	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554032_at	67	0.597015	0.215676	-	-0.960671	0.996976	0.0140885	1.01 [0.00 - 1480.00]
GENE	ARSB	arylsulfatase B	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206129_s_at	67	0.656716	0.141362	-	-1.44015	0.596023	-0.589691	0.55 [0.06 - 4.91]
GENE	ARSB	arylsulfatase B	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554030_at	115	0.469565	0.0107454	0.170414	1.72753	0.134218	1.24088	3.46 [0.68 - 17.55]
GENE	ARSB	arylsulfatase B	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554032_at	115	0.408696	0.0637002	-	-0.990723	0.519262	-0.174413	0.84 [0.49 - 1.43]
GENE	ARSB	arylsulfatase B	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206129_s_at	115	0.8	6.19441e-05	0.00229338	1.87477	0.0505687	2.60356	13.51 [0.99 - 183.76]
GENE	ARSB	arylsulfatase B	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37795_at	158	0.113924	0.0375464	0.410641	1.83426	0.243797	0.221685	1.25 [0.86 - 1.81]
GENE	ARSB	arylsulfatase B	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37795_at	76	0.868421	0.0873219	-	-15.2996	0.636385	-0.152906	0.86 [0.46 - 1.62]
GENE	ARSB	arylsulfatase B	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206129_s_at	204	0.465686	0.200142	-	0.179657	0.472015	0.0823521	1.09 [0.87 - 1.36]
GENE	ARSB	arylsulfatase B	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554030_at	204	0.833333	0.0500754	-	-0.363714	0.784327	0.0253223	1.03 [0.86 - 1.23]
GENE	ARSB	arylsulfatase B	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554032_at	204	0.176471	0.0704831	-	0.329905	0.749582	0.0254033	1.03 [0.88 - 1.20]
GENE	ARSB	arylsulfatase B	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554030_at	87	0.206897	0.0215096	0.282013	-0.904471	0.794078	-0.201786	0.82 [0.18 - 3.72]
GENE	ARSB	arylsulfatase B	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554032_at	87	0.275862	0.0652641	-	0.959307	0.875771	0.212811	1.24 [0.09 - 17.83]
GENE	ARSB	arylsulfatase B	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554032_at	87	0.275862	0.0652641	-	0.959307	0.875771	0.212811	1.24 [0.09 - 17.83]
GENE	ARSB	arylsulfatase B	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206129_s_at	87	0.528736	0.209267	-	-0.483588	0.679126	-0.230595	0.79 [0.27 - 2.37]
GENE	ARSB	arylsulfatase B	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554030_at	87	0.206897	0.0215096	0.282013	-0.904471	0.794078	-0.201786	0.82 [0.18 - 3.72]
GENE	ARSB	arylsulfatase B	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206129_s_at	87	0.528736	0.209267	-	-0.483588	0.679126	-0.230595	0.79 [0.27 - 2.37]
GENE	ARSB	arylsulfatase B	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206129_s_at	77	0.519481	0.000511053	0.0144373	2.7112	0.00753428	2.40349	11.06 [1.90 - 64.48]
GENE	ARSB	arylsulfatase B	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554030_at	77	0.480519	0.0400324	0.4279	1.26714	0.192047	1.65456	5.23 [0.44 - 62.83]
GENE	ARSB	arylsulfatase B	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554032_at	77	0.883117	0.161353	-	0.892545	0.551466	1.23325	3.43 [0.06 - 198.72]
GENE	ARSB	arylsulfatase B	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554030_at	77	0.142857	0.167612	-	15.2828	0.355615	1.36102	3.90 [0.22 - 70.02]
GENE	ARSB	arylsulfatase B	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554032_at	77	0.623377	0.0632373	-	-1.73295	0.20414	-3.19244	0.04 [0.00 - 5.67]
GENE	ARSB	arylsulfatase B	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206129_s_at	77	0.519481	0.000500302	0.0141775	16.4127	0.00462656	3.12544	22.77 [2.62 - 198.06]
GENE	ARSB	arylsulfatase B	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206129_s_at	136	0.889706	0.00255523	0.0553186	1.47895	0.686272	0.152029	1.16 [0.56 - 2.43]
GENE	ARSB	arylsulfatase B	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206129_s_at	200	0.115	0.015484	0.223089	-0.881819	0.0548079	-0.700463	0.50 [0.24 - 1.01]
GENE	ARSB	arylsulfatase B	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14645	60	0.65	0.0422657	0.44291	0.752948	0.137551	0.258178	1.29 [0.92 - 1.82]
GENE	ARSB	arylsulfatase B	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14645	60	0.6	3.9104e-06	0.000190205	1.72048	0.00964935	0.934991	2.55 [1.25 - 5.17]
GENE	ARSB	arylsulfatase B	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	4218	155	0.509677	0.0111265	0.174912	0.72636	0.0395434	0.510075	1.67 [1.02 - 2.71]
GENE	ARSB	arylsulfatase B	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206129_s_at	286	0.5	0.0582269	-	-0.368277	0.579401	-0.123816	0.88 [0.57 - 1.37]
GENE	ARSB	arylsulfatase B	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206129_s_at	159	0.408805	0.146883	-	0.49565	0.969832	0.015956	1.02 [0.44 - 2.32]
GENE	ARSB	arylsulfatase B	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206129_s_at	159	0.415094	0.0227542	0.293305	0.80908	0.214076	0.528057	1.70 [0.74 - 3.90]
GENE	ARSB	arylsulfatase B	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206129_s_at	159	0.72956	0.0893142	-	0.630233	0.34463	0.481547	1.62 [0.60 - 4.39]
GENE	ARSB	arylsulfatase B	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206129_s_at	54	0.777778	0.127282	-	-15.3937	0.727772	-0.383113	0.68 [0.08 - 5.89]
GENE	ARSB	arylsulfatase B	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206129_s_at	117	0.111111	0.061229	-	-0.728142	0.879921	-0.0913595	0.91 [0.28 - 2.99]
GENE	ARSB	arylsulfatase B	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206129_s_at	117	0.324786	0.0152774	0.220925	-0.924445	0.253517	-0.912978	0.40 [0.08 - 1.92]
GENE	ARSB	arylsulfatase B	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206129_s_at	117	0.111111	0.061229	-	-0.728142	0.879921	-0.0913595	0.91 [0.28 - 2.99]
GENE	ARSB	arylsulfatase B	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206129_s_at	117	0.111111	0.0261769	0.32305	-0.937803	0.685324	-0.293702	0.75 [0.18 - 3.09]
GENE	ARSB	arylsulfatase B	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206129_s_at	236	0.483051	0.0534578	-	-0.527243	0.402398	-0.444192	0.64 [0.23 - 1.81]
GENE	ARSB	arylsulfatase B	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206129_s_at	249	0.497992	0.182911	-	-0.283143	0.587992	-0.223243	0.80 [0.36 - 1.79]
GENE	ARSB	arylsulfatase B	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206129_s_at	62	0.354839	0.0294027	0.349515	1.49833	0.595956	-0.123123	0.88 [0.56 - 1.39]
GENE	ARSB	arylsulfatase B	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206129_s_at	125	0.616	0.0908146	-	0.640363	0.818257	0.114653	1.12 [0.42 - 2.98]
GENE	ARSB	arylsulfatase B	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206129_s_at	125	0.296	0.105334	-	-0.520932	0.780635	-0.115195	0.89 [0.40 - 2.00]
GENE	ARSB	arylsulfatase B	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206129_s_at	54	0.37037	0.0370439	0.407079	1.89294	0.686472	-0.111847	0.89 [0.52 - 1.54]
GENE	ARSB	arylsulfatase B	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206129_s_at	198	0.732323	0.0608944	-	-0.669945	0.488322	-0.133546	0.87 [0.60 - 1.28]
GENE	ARSB	arylsulfatase B	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206129_s_at	198	0.732323	0.0456445	0.464787	-0.53232	0.463188	-0.108119	0.90 [0.67 - 1.20]
GENE	ARSB	arylsulfatase B	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206129_s_at	198	0.732323	0.0161064	0.229545	-0.843315	0.549949	-0.10913	0.90 [0.63 - 1.28]
GENE	ARSB	arylsulfatase B	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206129_s_at	51	0.764706	0.00168125	0.0392679	2.65901	0.228392	1.73237	5.65 [0.34 - 94.76]
GENE	ARSB	arylsulfatase B	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206129_s_at	62	0.693548	0.0231957	0.297246	1.24949	0.414007	0.787716	2.20 [0.33 - 14.55]
GENE	ARSB	arylsulfatase B	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554030_at	177	0.40678	0.0047113	0.0903093	-0.751946	0.033016	-1.59034	0.20 [0.05 - 0.88]
GENE	ARSB	arylsulfatase B	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554032_at	177	0.112994	0.171637	-	-0.444173	0.716949	-0.397515	0.67 [0.08 - 5.76]
GENE	ARSB	arylsulfatase B	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554032_at	177	0.779661	0.0517698	-	0.579308	0.39513	1.03861	2.83 [0.26 - 30.95]
GENE	ARSB	arylsulfatase B	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206129_s_at	177	0.141243	0.266153	-	0.414293	0.849032	0.0731017	1.08 [0.51 - 2.28]
GENE	ARSB	arylsulfatase B	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554030_at	177	0.40678	0.00468617	0.0899289	-0.653138	0.0491376	-1.26627	0.28 [0.08 - 1.00]
GENE	ARSB	arylsulfatase B	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554032_at	145	0.165517	0.205246	-	0.747482	0.788685	0.400102	1.49 [0.08 - 27.83]
GENE	ARSB	arylsulfatase B	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206129_s_at	145	0.137931	0.0831641	-	1.19119	0.41416	0.456337	1.58 [0.53 - 4.72]
GENE	ARSB	arylsulfatase B	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554030_at	145	0.358621	0.0849471	-	-0.568776	0.368455	-0.810143	0.44 [0.08 - 2.60]
GENE	ARSB	arylsulfatase B	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206129_s_at	177	0.502825	0.0592093	-	0.515145	0.349051	0.413361	1.51 [0.64 - 3.59]
GENE	ARSB	arylsulfatase B	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554032_at	226	0.473451	0.00278847	0.0593774	-0.860092	0.112339	-0.290836	0.75 [0.52 - 1.07]
GENE	ARSB	arylsulfatase B	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206129_s_at	226	0.411504	0.0217881	0.284564	0.724627	0.0787751	0.358161	1.43 [0.96 - 2.13]
GENE	ARSB	arylsulfatase B	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554030_at	226	0.646018	0.0398302	0.426518	0.575577	0.988495	-0.00249183	1.00 [0.71 - 1.40]
GENE	ARSB	arylsulfatase B	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554032_at	55	0.763636	0.133339	-	0.695375	0.394627	1.50255	4.49 [0.14 - 142.90]
GENE	ARSB	arylsulfatase B	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206129_s_at	55	0.4	0.106044	-	-0.745469	0.507463	-0.543284	0.58 [0.12 - 2.90]
GENE	ARSB	arylsulfatase B	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206129_s_at	55	0.836364	0.00862514	0.144361	1.17597	0.485487	0.472428	1.60 [0.43 - 6.05]
GENE	ARSB	arylsulfatase B	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554030_at	55	0.381818	0.027112	0.330869	1.1699	0.0434664	2.58489	13.26 [1.08 - 163.04]
GENE	ARSB	arylsulfatase B	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206129_s_at	49	0.469388	0.229187	-	-0.691206	0.693699	-0.387625	0.68 [0.10 - 4.67]
GENE	ARSB	arylsulfatase B	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554030_at	55	0.890909	0.0361411	0.400615	1.18085	0.0434356	2.69721	14.84 [1.08 - 203.36]
GENE	ARSB	arylsulfatase B	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554032_at	55	0.727273	0.0238603	0.303119	1.10456	0.179706	2.69273	14.77 [0.29 - 754.83]
GENE	ARSB	arylsulfatase B	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554030_at	49	0.897959	0.0540125	-	1.22554	0.0583031	3.02206	20.53 [0.90 - 468.90]
GENE	ARSB	arylsulfatase B	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554032_at	49	0.77551	0.0496432	0.48948	1.11053	0.489753	1.75791	5.80 [0.04 - 850.91]
GENE	ARSB	arylsulfatase B	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	502055	34	0.382353	0.20658	-	0.606467	0.741145	0.33446	1.40 [0.19 - 10.16]
GENE	ARSB	arylsulfatase B	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554030_at	63	0.47619	0.111909	-	-0.53521	0.5849	1.31714	3.73 [0.03 - 421.25]
GENE	ARSB	arylsulfatase B	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554032_at	63	0.555556	0.0173266	0.241934	-0.843424	0.206592	-12.4908	0.00 [0.00 - 985.64]
GENE	ARSB	arylsulfatase B	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206129_s_at	63	0.15873	2.35444e-08	1.65697e-06	-2.05176	0.48612	-5.41868	0.00 [0.00 - 18582.63]
GENE	ARSB	arylsulfatase B	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.1256.2.A1_3p_at	28	0.25	0.0541134	-	-1.10326	0.0955206	-11.4777	0.00 [0.00 - 7.52]
GENE	ARSB	arylsulfatase B	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.1256.2.A2_3p_at	28	0.857143	0.106895	-	-1.55708	0.559054	-1.67205	0.19 [0.00 - 51.28]
GENE	ARSB	arylsulfatase B	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557332_3p_a_at	28	0.857143	0.115418	-	0.908888	0.489537	1.25641	3.51 [0.10 - 123.96]
GENE	ARSB	arylsulfatase B	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206129_s_at	82	0.707317	0.203207	-	0.45249	0.85378	0.114184	1.12 [0.33 - 3.78]
GENE	ARSB	arylsulfatase B	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206129_s_at	79	0.101266	0.0254691	0.317047	-0.835661	0.634604	-0.313397	0.73 [0.20 - 2.66]
GENE	ARSB	arylsulfatase B	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206129_s_at	104	0.269231	0.016205	0.230559	1.19705	0.317229	0.931298	2.54 [0.41 - 15.74]
GENE	ARSB	arylsulfatase B	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P205213	117	0.888889	0.119404	-	0.628106	0.614478	0.132521	1.14 [0.68 - 1.91]
GENE	ARSB	arylsulfatase B	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554030_at	204	0.470588	0.306129	-	-0.278415	0.762257	-0.112711	0.89 [0.43 - 1.85]
GENE	ARSB	arylsulfatase B	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554032_at	204	0.838235	0.0191004	0.259357	0.712831	0.185385	0.221832	1.25 [0.90 - 1.73]
GENE	ARSB	arylsulfatase B	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206129_s_at	204	0.779412	0.000355595	0.0105789	1.23711	0.0434681	1.10255	3.01 [1.03 - 8.78]
GENE	ARSB	arylsulfatase B	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206129_s_at	204	0.779412	0.000264303	0.00818794	0.981551	0.0546653	0.781112	2.18 [0.98 - 4.84]
GENE	ARSB	arylsulfatase B	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554030_at	204	0.171569	0.0722095	-	1.2367	0.276639	0.54953	1.73 [0.64 - 4.66]
GENE	ARSB	arylsulfatase B	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554032_at	204	0.779412	0.238248	-	0.46663	0.880947	0.0331421	1.03 [0.67 - 1.59]
GENE	ARSB	arylsulfatase B	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206129_s_at	178	0.134831	0.0231158	0.296536	0.814553	0.244926	0.620882	1.86 [0.65 - 5.30]
GENE	ARSB	arylsulfatase B	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554030_at	111	0.891892	0.104355	-	-0.821174	0.881674	-0.028661	0.97 [0.67 - 1.42]
GENE	ARSB	arylsulfatase B	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554032_at	111	0.756757	0.0219809	0.286321	0.62398	0.225631	0.222082	1.25 [0.87 - 1.79]
GENE	ARSB	arylsulfatase B	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206129_s_at	111	0.243243	0.0381004	0.41454	-0.576041	0.229551	-0.222483	0.80 [0.56 - 1.15]
GENE	ARSB	arylsulfatase B	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206129_s_at	90	0.877778	0.0169376	0.238022	0.920023	0.929281	0.0501884	1.05 [0.35 - 3.19]
GENE	ARSB	arylsulfatase B	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206129_s_at	90	0.888889	0.0153474	0.22166	1.06529	0.566919	0.367955	1.44 [0.41 - 5.09]
GENE	ARSB	arylsulfatase B	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554030_at	138	0.173913	0.062314	-	-0.516928	0.787773	-0.276182	0.76 [0.10 - 5.67]
GENE	ARSB	arylsulfatase B	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554032_at	138	0.362319	0.0659186	-	-0.441166	0.136767	-7.01664	0.00 [0.00 - 9.26]
GENE	ARSB	arylsulfatase B	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206129_s_at	138	0.746377	0.0185427	0.25395	0.595434	0.684796	0.139765	1.15 [0.59 - 2.26]
GENE	ARSB	arylsulfatase B	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206129_s_at	129	0.674419	0.233445	-	-0.329504	0.662658	-0.201644	0.82 [0.33 - 2.02]
GENE	ARSB	arylsulfatase B	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8936	56	0.125	0.132078	-	-0.645411	0.892766	0.0673932	1.07 [0.40 - 2.85]
GENE	ARSB	arylsulfatase B	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36418	56	0.892857	0.148074	-	0.774644	0.814262	0.0879075	1.09 [0.52 - 2.27]
GENE	ARSB	arylsulfatase B	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8936	56	0.125	0.0150277	0.218295	-1.05851	0.668287	-0.237888	0.79 [0.27 - 2.34]
GENE	ARSB	arylsulfatase B	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36418	56	0.535714	0.197357	-	0.434936	0.583822	0.185793	1.20 [0.62 - 2.34]
GENE	ARSB	arylsulfatase B	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554030_at	278	0.820144	0.157509	-	0.315899	0.367519	0.423496	1.53 [0.61 - 3.84]
GENE	ARSB	arylsulfatase B	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554032_at	278	0.284173	0.206961	-	0.274215	0.68394	-0.281426	0.75 [0.19 - 2.93]
GENE	ARSB	arylsulfatase B	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206129_s_at	278	0.125899	0.038358	0.416342	0.740695	0.137673	0.433646	1.54 [0.87 - 2.74]
GENE	ARSB	arylsulfatase B	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206129_s_at	133	0.684211	0.00349018	0.071139	0.713785	0.0267983	4.25009	70.11 [1.63 - 3016.46]
GENE	ARSB	arylsulfatase B	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2507	81	0.259259	0.0897008	-	-0.870745	0.656368	0.357123	1.43 [0.30 - 6.89]
GENE	ARSB	arylsulfatase B	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	197	81	0.160494	0.00128751	0.0314776	-1.70384	0.652713	-0.298696	0.74 [0.20 - 2.72]
GENE	ARSB	arylsulfatase B	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206129_s_at	185	0.52973	0.0318947	0.369029	0.387764	0.1895	0.32084	1.38 [0.85 - 2.23]
GENE	ARSB	arylsulfatase B	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206129_s_at	185	0.52973	0.0127121	0.193099	0.413731	0.1784	0.295074	1.34 [0.87 - 2.06]
GENE	ARSB	arylsulfatase B	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P205213	110	0.827273	0.00509226	0.0960137	1.00121	0.811524	0.0618179	1.06 [0.64 - 1.77]
GENE	ARSB	arylsulfatase B	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P205213	110	0.845455	0.00513446	0.0966383	0.827103	0.562808	0.116853	1.12 [0.76 - 1.67]
GENE	ARSB	arylsulfatase B	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206129_s_at	80	0.3625	0.23718	-	0.654921	0.759168	-0.0830493	0.92 [0.54 - 1.57]
GENE	ARSB	arylsulfatase B	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_0724	281	0.669039	0.197628	-	-0.198006	0.87635	0.0115884	1.01 [0.87 - 1.17]
GENE	ARSB	arylsulfatase B	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554030_at	38	0.578947	0.00764758	0.131684	1.24175	0.123545	1.21241	3.36 [0.72 - 15.73]
GENE	ARSB	arylsulfatase B	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554032_at	38	0.5	0.0523718	-	-0.92874	0.717792	-0.137481	0.87 [0.41 - 1.84]
GENE	ARSB	arylsulfatase B	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206129_s_at	38	0.5	0.00441269	0.0857528	1.50278	0.0240779	0.925388	2.52 [1.13 - 5.64]
GENE	ARSB	arylsulfatase B	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206129_s_at	140	0.628571	0.0242878	0.306859	0.641523	0.251278	0.576845	1.78 [0.66 - 4.77]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210979_at	30	0.833333	0.298042	-	-0.636274	0.522019	-0.557868	0.57 [0.10 - 3.16]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210980_s_at	30	0.466667	0.00264727	0.0569301	-1.24306	0.0619448	-0.575141	0.56 [0.31 - 1.03]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213702_x_at	30	0.433333	0.0103927	0.166203	-1.05757	0.0757243	-0.652849	0.52 [0.25 - 1.07]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1684054	165	0.187879	0.0606692	-	0.692422	0.738545	-0.0939544	0.91 [0.52 - 1.58]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1684054	165	0.557576	0.042519	0.444584	-0.778384	0.449281	-0.320809	0.73 [0.32 - 1.67]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210980_s_at	163	0.785276	0.0533967	-	-0.520236	0.527923	-0.0821817	0.92 [0.71 - 1.19]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210979_at	163	0.257669	0.0376714	0.411523	0.504393	0.295229	0.741009	2.10 [0.52 - 8.40]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213702_x_at	163	0.638037	0.0551667	-	-0.410233	0.465148	-0.104053	0.90 [0.68 - 1.19]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1555419_a_at	79	0.556962	0.0416433	0.438772	0.588608	0.675799	0.0759891	1.08 [0.76 - 1.54]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210979_at	79	0.886076	0.0678787	-	0.698198	0.962896	0.0464319	1.05 [0.15 - 7.41]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213702_x_at	79	0.43038	0.0200192	0.268128	0.714079	0.210737	0.341821	1.41 [0.82 - 2.40]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210980_s_at	79	0.443038	0.01892	0.257614	0.707063	0.165761	0.342089	1.41 [0.87 - 2.28]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210980_s_at	58	0.103448	0.0545268	-	0.901238	0.640975	0.111307	1.12 [0.70 - 1.78]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210979_at	58	0.896552	0.0379141	0.413232	0.91631	0.148764	0.254064	1.29 [0.91 - 1.82]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213702_x_at	58	0.137931	0.0727529	-	0.742658	0.126269	0.477824	1.61 [0.87 - 2.98]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213702_x_at	34	0.852941	0.000911587	0.0235787	1.64591	0.19793	0.6037	1.83 [0.73 - 4.58]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210979_at	34	0.5	0.508746	-	-0.253185	0.933363	0.0205287	1.02 [0.63 - 1.65]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210980_s_at	34	0.823529	0.00935351	0.153519	1.20124	0.223254	0.426075	1.53 [0.77 - 3.04]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213702_x_at	158	0.398734	0.00415108	0.0816947	-0.654522	0.0116549	-0.558885	0.57 [0.37 - 0.88]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210980_s_at	158	0.329114	0.000613791	0.0168756	-0.784847	0.0182406	-0.469725	0.63 [0.42 - 0.92]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210979_at	158	0.639241	0.123824	-	0.358905	0.507426	0.430756	1.54 [0.43 - 5.50]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210980_s_at	53	0.377358	0.0850169	-	0.697677	0.938017	0.0261081	1.03 [0.53 - 1.98]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213702_x_at	53	0.113208	0.210992	-	-0.607229	0.507957	-0.363465	0.70 [0.24 - 2.04]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210980_s_at	53	0.377358	0.129929	-	0.563829	0.984359	0.00615114	1.01 [0.54 - 1.86]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210979_at	53	0.396226	0.235405	-	-0.431513	0.973123	-0.0070272	0.99 [0.66 - 1.49]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210979_at	53	0.622642	0.138546	-	0.507281	0.786906	0.051839	1.05 [0.72 - 1.53]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213702_x_at	53	0.45283	0.314636	-	-0.345466	0.501926	-0.345069	0.71 [0.26 - 1.94]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210980_s_at	180	0.827778	0.00437378	0.0851532	0.698924	0.483346	0.170157	1.19 [0.74 - 1.91]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210979_at	180	0.894444	0.106651	-	0.452828	0.628947	0.0431865	1.04 [0.88 - 1.24]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213702_x_at	180	0.616667	0.0145979	0.213731	0.507441	0.150097	0.563031	1.76 [0.82 - 3.78]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1555419_a_at	559	0.107335	0.0172026	0.240691	-0.581685	0.0718341	-0.352724	0.70 [0.48 - 1.03]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210979_at	559	0.382826	0.147888	-	0.298783	0.755756	0.0349003	1.04 [0.83 - 1.29]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213702_x_at	559	0.127013	0.00627291	0.113006	-0.702795	0.093922	-0.523083	0.59 [0.32 - 1.09]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210980_s_at	559	0.236136	0.00234243	0.0515408	-0.655439	0.0609074	-0.438091	0.65 [0.41 - 1.02]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213702_x_at	77	0.103896	0.000101131	0.00353716	-1.44342	0.88759	0.0787324	1.08 [0.36 - 3.22]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210980_s_at	77	0.584416	0.0135324	0.202199	0.641424	0.659118	0.142004	1.15 [0.61 - 2.17]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210979_at	77	0.324675	0.00473045	0.0905989	0.825892	0.114672	0.240309	1.27 [0.94 - 1.71]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213702_x_at	70	0.114286	0.0269615	0.32962	-0.830844	0.184803	-0.623981	0.54 [0.21 - 1.35]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210980_s_at	70	0.114286	0.0304812	0.358054	-0.812215	0.122232	-0.55398	0.57 [0.28 - 1.16]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1555419_a_at	70	0.128571	0.0803439	-	-0.631164	0.664062	-0.0844214	0.92 [0.63 - 1.35]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210979_at	70	0.128571	0.216226	-	-0.452774	0.844479	-0.228891	0.80 [0.08 - 7.83]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	461_at	50	0.14	1.81591e-05	0.000765744	-1.86448	0.0811365	-1.05416	0.35 [0.11 - 1.14]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36938_at	50	0.44	0.038798	0.419405	-0.717395	0.541374	-0.17451	0.84 [0.48 - 1.47]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210979_at	74	0.297297	0.10432	-	0.537381	0.646455	0.0799642	1.08 [0.77 - 1.52]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210980_s_at	74	0.108108	0.00024565	0.00768469	-1.34877	0.341053	-0.463693	0.63 [0.24 - 1.63]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213702_x_at	74	0.581081	0.013361	0.200313	0.711261	0.667044	0.321225	1.38 [0.32 - 5.96]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210979_at	67	0.268657	0.0984118	-	15.4509	0.850304	0.564872	1.76 [0.00 - 620.90]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1555419_a_at	67	0.80597	0.207503	-	0.867274	0.983205	0.0179382	1.02 [0.19 - 5.41]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213702_x_at	67	0.895522	0.322589	-	-15.1685	0.926889	-0.142572	0.87 [0.04 - 18.23]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210980_s_at	67	0.835821	0.173033	-	-15.3054	0.599782	-0.61722	0.54 [0.05 - 5.41]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213702_x_at	115	0.104348	0.0141766	0.209208	-1.35102	0.232321	-0.727887	0.48 [0.15 - 1.59]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1555419_a_at	115	0.113043	0.0279975	0.338161	-1.2325	0.726768	0.197788	1.22 [0.40 - 3.70]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210980_s_at	115	0.130435	0.0061974	0.111947	-1.41024	0.207042	-0.725247	0.48 [0.16 - 1.49]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210979_at	115	0.356522	0.0805592	-	1.24957	0.421116	0.46416	1.59 [0.51 - 4.93]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36938_at	158	0.227848	0.0016487	0.0386394	-0.894065	0.00295086	-0.946293	0.39 [0.21 - 0.72]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	461_at	158	0.291139	0.00606713	0.110113	-0.761342	0.0585738	-0.411775	0.66 [0.43 - 1.02]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36938_at	76	0.526316	0.0171028	0.239687	1.31993	0.300794	0.446731	1.56 [0.67 - 3.64]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	461_at	76	0.657895	0.0690062	-	0.91652	0.149538	0.484063	1.62 [0.84 - 3.13]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213702_x_at	204	0.740196	0.000268558	0.00830195	-0.58082	0.00104191	-0.552015	0.58 [0.41 - 0.80]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210980_s_at	204	0.769608	0.00159972	0.0376887	-0.52025	0.0026184	-0.365225	0.69 [0.55 - 0.88]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210979_at	204	0.142157	0.0187849	0.256306	-0.479527	0.563357	0.0472396	1.05 [0.89 - 1.23]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1555419_a_at	204	0.52451	0.00252514	0.0547889	-0.430417	0.0196764	-0.234688	0.79 [0.65 - 0.96]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210979_at	87	0.195402	0.0376006	0.411024	1.40834	0.129466	1.34697	3.85 [0.67 - 21.94]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213702_x_at	87	0.344828	5.10921e-07	2.92575e-05	-1.80147	0.000613317	-1.07982	0.34 [0.18 - 0.63]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210980_s_at	87	0.344828	1.04122e-05	0.000463437	-1.58128	0.000205238	-1.08704	0.34 [0.19 - 0.60]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213702_x_at	87	0.344828	5.10921e-07	2.92575e-05	-1.80147	0.000613317	-1.07982	0.34 [0.18 - 0.63]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1555419_a_at	87	0.241379	2.93762e-05	0.00117941	-1.45471	0.00114307	-0.630822	0.53 [0.36 - 0.78]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1555419_a_at	87	0.241379	2.93762e-05	0.00117941	-1.45471	0.00114307	-0.630822	0.53 [0.36 - 0.78]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210979_at	87	0.195402	0.0376006	0.411024	1.40834	0.129466	1.34697	3.85 [0.67 - 21.94]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210980_s_at	87	0.344828	1.04122e-05	0.000463437	-1.58128	0.000205238	-1.08704	0.34 [0.19 - 0.60]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210980_s_at	77	0.194805	0.000158512	0.00524732	-2.06736	0.0224613	-1.18938	0.30 [0.11 - 0.85]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213702_x_at	77	0.194805	0.00447211	0.0866657	-1.45578	0.18964	-0.640234	0.53 [0.20 - 1.37]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210979_at	77	0.623377	0.243428	-	-0.892368	0.556564	-1.14084	0.32 [0.01 - 14.33]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210980_s_at	77	0.246753	0.00413454	0.081436	-1.46427	0.103702	-0.72351	0.49 [0.20 - 1.16]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555419_a_at	77	0.311688	0.00565457	0.104228	-1.44999	0.100927	-0.412739	0.66 [0.40 - 1.08]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210979_at	77	0.753247	0.194742	-	0.72362	0.743902	0.539736	1.72 [0.07 - 43.72]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213702_x_at	77	0.194805	0.000158512	0.00524732	-2.06736	0.0350294	-1.19307	0.30 [0.10 - 0.92]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555419_a_at	77	0.311688	0.00320597	0.0664507	-1.78905	0.0306748	-0.659493	0.52 [0.28 - 0.94]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210980_s_at	136	0.595588	0.0490085	0.485643	-1.05262	0.517034	-0.210689	0.81 [0.43 - 1.53]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210979_at	136	0.889706	0.087724	-	0.930365	0.528556	0.142371	1.15 [0.74 - 1.80]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213702_x_at	136	0.661765	0.0637641	-	-1.10464	0.993358	-0.0043919	1.00 [0.35 - 2.80]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210980_s_at	200	0.21	5.61317e-05	0.00210132	-1.15536	0.00167632	-0.955677	0.38 [0.21 - 0.70]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210979_at	200	0.78	0.00188879	0.0432172	0.918788	0.102061	0.28152	1.33 [0.95 - 1.86]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213702_x_at	200	0.24	0.00105269	0.0266062	-0.946641	0.0039566	-1.15127	0.32 [0.14 - 0.69]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16339	60	0.116667	0.000951043	0.0244337	-1.45622	0.530818	-0.120529	0.89 [0.61 - 1.29]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16339	60	0.883333	0.23607	-	0.578687	0.934638	0.0268281	1.03 [0.54 - 1.95]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210980_s_at	286	0.758741	0.122396	-	0.320617	0.987446	-0.00240531	1.00 [0.74 - 1.35]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210979_at	286	0.363636	0.148635	-	0.303629	0.742541	0.0346678	1.04 [0.84 - 1.27]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213702_x_at	286	0.223776	0.0537688	-	-0.41756	0.521448	-0.156424	0.86 [0.53 - 1.38]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210980_s_at	159	0.389937	0.0145079	0.212768	-0.759001	0.117789	-0.448789	0.64 [0.36 - 1.12]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210979_at	159	0.232704	0.0242173	0.306245	-0.731546	0.326153	-0.166447	0.85 [0.61 - 1.18]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210979_at	159	0.232704	0.0681349	-	-0.607848	0.737961	-0.0578225	0.94 [0.67 - 1.32]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210979_at	159	0.257862	0.0181214	0.249823	-0.865034	0.36827	-0.179565	0.84 [0.57 - 1.24]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213702_x_at	159	0.138365	0.0170368	0.239022	-0.846429	0.0348845	-0.928032	0.40 [0.17 - 0.94]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210980_s_at	159	0.779874	0.0128788	0.194965	-1.38129	0.0772563	-0.495205	0.61 [0.35 - 1.06]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210980_s_at	159	0.779874	0.00283163	0.0601196	-15.4354	0.0251703	-0.725584	0.48 [0.26 - 0.91]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213702_x_at	159	0.144654	0.00303	0.0634978	-1.01	0.0427902	-0.891368	0.41 [0.17 - 0.97]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213702_x_at	159	0.138365	0.00251875	0.0546762	-1.14937	0.012088	-1.26866	0.28 [0.10 - 0.76]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210979_at	54	0.796296	0.143764	-	-15.3842	0.579856	-1.08927	0.34 [0.01 - 15.92]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213902_at	54	0.111111	0.0550969	-	-1.32055	0.569849	-0.281972	0.75 [0.29 - 1.99]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210980_s_at	54	0.555556	0.246347	-	0.804522	0.773753	-0.107899	0.90 [0.43 - 1.87]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213702_x_at	54	0.833333	0.128608	-	-15.3937	0.537895	-0.281551	0.75 [0.31 - 1.85]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210979_at	117	0.888889	0.183092	-	0.658716	0.638842	0.645751	1.91 [0.13 - 28.29]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210979_at	117	0.709402	0.242035	-	0.38044	0.969717	0.0436477	1.04 [0.11 - 9.95]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210979_at	117	0.350427	0.158934	-	-0.527802	0.610539	-0.735624	0.48 [0.03 - 8.13]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213702_x_at	117	0.717949	0.0208467	0.275889	0.744708	0.345575	0.211227	1.24 [0.80 - 1.92]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213702_x_at	117	0.735043	0.00514172	0.0967457	1.02874	0.0978647	0.434735	1.54 [0.92 - 2.58]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213702_x_at	117	0.376068	0.220161	-	-0.477509	0.713784	0.10167	1.11 [0.64 - 1.91]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210979_at	117	0.709402	0.242035	-	0.38044	0.969717	0.0436477	1.04 [0.11 - 9.95]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213702_x_at	117	0.717949	0.0208467	0.275889	0.744708	0.345575	0.211227	1.24 [0.80 - 1.92]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210980_s_at	117	0.811966	0.0208817	0.276214	0.905703	0.188834	0.306167	1.36 [0.86 - 2.14]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210980_s_at	117	0.735043	0.0291574	0.347551	0.714197	0.525238	0.130139	1.14 [0.76 - 1.70]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210980_s_at	117	0.735043	0.0291574	0.347551	0.714197	0.525238	0.130139	1.14 [0.76 - 1.70]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210980_s_at	117	0.897436	0.0837921	-	-15.1749	0.924408	0.0248177	1.03 [0.61 - 1.71]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210980_s_at	236	0.20339	0.00296289	0.0623609	-0.823004	0.0248635	-0.529858	0.59 [0.37 - 0.94]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210979_at	236	0.741525	0.0690772	-	0.509788	0.210183	0.20022	1.22 [0.89 - 1.67]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213702_x_at	236	0.309322	0.00824688	0.13951	-0.7038	0.0546953	-0.734347	0.48 [0.23 - 1.01]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213702_x_at	249	0.208835	0.00720189	0.125745	-0.618462	0.0303263	-0.656816	0.52 [0.29 - 0.94]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210980_s_at	249	0.293173	0.00532197	0.0993978	-0.597284	0.0114066	-0.468298	0.63 [0.44 - 0.90]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210979_at	249	0.369478	0.0042315	0.082949	0.680269	0.0678516	0.232734	1.26 [0.98 - 1.62]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210979_at	125	0.672	0.141611	-	0.554616	0.830098	-0.256752	0.77 [0.07 - 8.07]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210980_s_at	125	0.408	0.0497346	0.490029	-0.564648	0.276405	-0.190706	0.83 [0.59 - 1.16]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210979_at	125	0.672	0.169539	-	0.3989	0.537293	-0.568267	0.57 [0.09 - 3.45]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210980_s_at	54	0.240741	0.181917	-	-0.826387	0.209212	-0.513832	0.60 [0.27 - 1.33]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213702_x_at	125	0.608	0.0218765	0.285371	-1.01365	0.238525	-0.364898	0.69 [0.38 - 1.27]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213702_x_at	125	0.616	0.0123336	0.188832	-0.812334	0.174593	-0.31819	0.73 [0.46 - 1.15]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210979_at	62	0.435484	0.0522095	-	-0.960043	0.553611	-0.160968	0.85 [0.50 - 1.45]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210979_at	54	0.148148	0.0245437	0.309085	-1.52461	0.580518	-0.182641	0.83 [0.44 - 1.59]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213702_x_at	54	0.814815	0.0414919	0.43776	-15.527	0.233941	-0.5227	0.59 [0.25 - 1.40]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210980_s_at	62	0.854839	0.0985911	-	-1.547	0.214106	-0.406082	0.67 [0.35 - 1.26]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213702_x_at	62	0.854839	0.0180819	0.249435	-15.4932	0.17106	-0.480577	0.62 [0.31 - 1.23]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210980_s_at	125	0.232	0.0113713	0.177775	-0.966253	0.427019	-0.184626	0.83 [0.53 - 1.31]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213702_x_at	198	0.686869	0.109382	-	-0.461785	0.330455	-0.19202	0.83 [0.56 - 1.21]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210979_at	198	0.308081	0.0628794	-	-0.497369	0.298525	-0.102732	0.90 [0.74 - 1.10]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213702_x_at	198	0.686869	0.174848	-	-0.407857	0.681883	-0.083557	0.92 [0.62 - 1.37]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210980_s_at	198	0.732323	0.0741527	-	-0.449574	0.550855	-0.071165	0.93 [0.74 - 1.18]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210979_at	198	0.883838	0.0519392	-	0.549932	0.876173	-0.0124518	0.99 [0.84 - 1.16]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210979_at	198	0.308081	0.139016	-	-0.386026	0.502728	-0.0629821	0.94 [0.78 - 1.13]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213702_x_at	198	0.818182	0.0533399	-	-0.591904	0.605868	-0.0804704	0.92 [0.68 - 1.25]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210980_s_at	198	0.732323	0.056302	-	-0.605732	0.337748	-0.142088	0.87 [0.65 - 1.16]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210980_s_at	198	0.732323	0.0870299	-	-0.569231	0.684172	-0.0624614	0.94 [0.70 - 1.27]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210980_s_at	62	0.532258	0.0498368	0.490644	-1.23548	0.411402	-0.562736	0.57 [0.15 - 2.18]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210979_at	51	0.745098	0.064261	-	1.53451	0.878218	0.424858	1.53 [0.01 - 350.51]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213702_x_at	51	0.333333	0.0114044	0.178161	-2.30325	0.0577486	-2.17171	0.11 [0.01 - 1.07]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213702_x_at	62	0.5	0.0250205	0.313204	-1.38976	0.309843	-0.807445	0.45 [0.09 - 2.12]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210979_at	62	0.241935	0.00270014	0.0578498	-1.59122	0.257516	-2.0839	0.12 [0.00 - 4.59]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210980_s_at	51	0.45098	0.0765649	-	-1.75308	0.126972	-1.50006	0.22 [0.03 - 1.53]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213702_x_at	145	0.855172	0.323347	-	-0.587763	0.95086	0.034213	1.03 [0.35 - 3.07]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210979_at	177	0.841808	0.0177939	0.246589	-1.3122	0.169174	-1.21689	0.30 [0.05 - 1.68]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210980_s_at	177	0.892655	0.116218	-	-0.788424	0.381845	-0.26788	0.76 [0.42 - 1.39]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1555419_a_at	177	0.892655	0.0208935	0.276323	-1.50965	0.203106	-0.246012	0.78 [0.54 - 1.14]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1555419_a_at	177	0.892655	0.0764258	-	-1.20343	0.34702	-0.210535	0.81 [0.52 - 1.26]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210979_at	177	0.841808	0.0151445	0.219528	-1.07409	0.146516	-1.11703	0.33 [0.07 - 1.48]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210980_s_at	145	0.834483	0.260097	-	-0.668642	0.644516	0.221476	1.25 [0.49 - 3.20]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1555419_a_at	145	0.793103	0.0772698	-	-1.02108	0.864746	0.0496775	1.05 [0.59 - 1.86]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210979_at	145	0.172414	0.201945	-	-0.488397	0.60742	-0.583	0.56 [0.06 - 5.16]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213702_x_at	177	0.875706	0.0122171	0.18751	-2.11398	0.21121	-0.49928	0.61 [0.28 - 1.33]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210980_s_at	177	0.836158	0.0767556	-	-0.890577	0.407263	-0.291059	0.75 [0.38 - 1.49]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213702_x_at	177	0.892655	0.0144556	0.212208	-1.58375	0.179166	-0.469458	0.63 [0.32 - 1.24]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213702_x_at	226	0.526549	0.265343	-	0.315448	0.695309	-0.198374	0.82 [0.30 - 2.21]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210980_s_at	226	0.110619	0.0601329	-	-0.686713	0.422059	-0.301504	0.74 [0.35 - 1.54]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1555419_a_at	226	0.876106	0.0966484	-	0.605664	0.94182	0.0183181	1.02 [0.62 - 1.67]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210979_at	226	0.752212	0.03008	0.354895	-0.914642	0.0895914	-0.185372	0.83 [0.67 - 1.03]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213702_x_at	55	0.727273	0.182749	-	-0.779663	0.852666	-0.0959287	0.91 [0.33 - 2.50]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213702_x_at	49	0.857143	0.0902172	-	0.998825	0.60657	0.319403	1.38 [0.41 - 4.64]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1555419_a_at	55	0.509091	0.00306469	0.064083	1.4197	0.187282	0.433536	1.54 [0.81 - 2.94]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210980_s_at	55	0.381818	0.307741	-	-0.408901	0.950123	0.0287229	1.03 [0.42 - 2.53]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210979_at	55	0.181818	3.337e-06	0.000164551	-1.94904	0.000470513	-5.80802	0.00 [0.00 - 0.08]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210980_s_at	49	0.653061	0.0548073	-	1.07782	0.418759	0.442973	1.56 [0.53 - 4.56]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210979_at	55	0.563636	0.00106207	0.0268045	-2.08028	0.0144329	-3.7162	0.02 [0.00 - 0.48]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210979_at	49	0.122449	0.00231765	0.0510959	-1.7278	0.0167093	-4.58696	0.01 [0.00 - 0.44]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1555419_a_at	55	0.109091	0.295969	-	-0.642985	0.687111	-0.124136	0.88 [0.48 - 1.62]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213702_x_at	55	0.490909	0.00622908	0.112392	1.32326	0.118904	0.835841	2.31 [0.81 - 6.60]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1555419_a_at	49	0.122449	0.0871473	-	-1.0897	0.796807	-0.10021	0.90 [0.42 - 1.94]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210980_s_at	55	0.490909	0.00622908	0.112392	1.32326	0.0713596	0.846803	2.33 [0.93 - 5.85]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210980_s_at	63	0.396825	0.00575054	0.105608	-0.918868	0.0460125	-0.460019	0.63 [0.40 - 0.99]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1555419_a_at	63	0.825397	0.119579	-	0.621206	0.862481	0.0213289	1.02 [0.80 - 1.30]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210979_at	63	0.603175	0.0320516	0.370233	-0.78529	0.400925	-2.8172	0.06 [0.00 - 42.80]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213702_x_at	63	0.333333	0.0626904	-	-0.628053	0.240916	-0.41547	0.66 [0.33 - 1.32]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.75811.3.S1_3p_a_at	28	0.714286	0.279314	-	0.615221	0.327308	-0.135701	0.87 [0.67 - 1.15]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.75811.3.S1_3p_s_at	28	0.214286	0.191994	-	-0.787112	0.929306	0.117561	1.12 [0.08 - 15.10]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g3860239_3p_x_at	28	0.428571	0.0505547	-	-1.0453	0.296233	-0.233965	0.79 [0.51 - 1.23]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210980_s_at	82	0.378049	0.000704734	0.0189747	-1.10704	0.00128	-0.968694	0.38 [0.21 - 0.68]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213702_x_at	82	0.365854	0.00276684	0.0590043	-0.981935	0.00258362	-1.0074	0.37 [0.19 - 0.70]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36938_at	84	0.130952	0.0103583	0.16579	-0.927942	0.063375	-0.60276	0.55 [0.29 - 1.03]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	461_at	84	0.892857	0.0954071	-	-0.960381	0.244302	-0.317734	0.73 [0.43 - 1.24]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210980_s_at	79	0.316456	0.109177	-	-0.434521	0.6557	-0.28461	0.75 [0.22 - 2.63]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213702_x_at	79	0.78481	0.0500628	-	0.582596	0.969914	-0.0228331	0.98 [0.30 - 3.20]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U70063_at	86	0.465116	0.0677721	-	-0.754886	0.29665	-0.39376	0.67 [0.32 - 1.41]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210980_s_at	104	0.576923	0.029907	0.353526	-0.761635	0.149071	-0.568525	0.57 [0.26 - 1.23]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213702_x_at	104	0.509615	0.0214861	0.281798	-0.75883	0.198666	-0.475169	0.62 [0.30 - 1.28]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P216325	117	0.709402	0.238235	-	-0.401546	0.959107	-0.00852166	0.99 [0.72 - 1.37]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1555419_a_at	204	0.465686	0.0190731	0.259094	0.933666	0.286808	0.497683	1.64 [0.66 - 4.11]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1555419_a_at	204	0.397059	0.11499	-	0.45799	0.622748	0.163865	1.18 [0.61 - 2.26]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213702_x_at	204	0.230392	0.118861	-	-0.597199	0.500821	-0.655505	0.52 [0.08 - 3.50]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213702_x_at	204	0.279412	0.0400498	0.428019	-0.571303	0.0529663	-1.29454	0.27 [0.07 - 1.02]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210980_s_at	204	0.372549	0.104274	-	0.68778	0.941718	0.0481114	1.05 [0.29 - 3.81]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210980_s_at	204	0.818627	0.0372182	0.408318	-0.943184	0.149626	-0.64712	0.52 [0.22 - 1.26]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210979_at	204	0.808824	0.0266156	0.326734	0.835074	0.20838	0.250166	1.28 [0.87 - 1.90]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210979_at	204	0.681373	0.00335612	0.0689397	0.77952	0.122616	0.22783	1.26 [0.94 - 1.68]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210980_s_at	178	0.325843	0.142433	-	-0.299018	0.509784	-0.281843	0.75 [0.33 - 1.74]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213702_x_at	178	0.134831	0.026721	0.327615	-0.582602	0.250422	-0.449609	0.64 [0.30 - 1.37]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300019646	41	0.414634	0.0297967	0.352651	-0.889005	0.210902	-0.182345	0.83 [0.63 - 1.11]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213702_x_at	111	0.783784	0.0978803	-	-0.592554	0.185903	-0.354013	0.70 [0.42 - 1.19]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1555419_a_at	111	0.126126	0.0418494	0.440146	-0.727844	0.447032	-0.161161	0.85 [0.56 - 1.29]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210980_s_at	111	0.117117	0.0110865	0.174443	-0.861387	0.356209	-0.212254	0.81 [0.52 - 1.27]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210979_at	111	0.531532	0.138276	-	0.394121	0.807562	0.037027	1.04 [0.77 - 1.40]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210980_s_at	90	0.544444	0.271808	-	-0.364168	0.869125	-0.0307039	0.97 [0.67 - 1.40]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210980_s_at	90	0.544444	0.170435	-	-0.530401	0.746029	-0.0684936	0.93 [0.62 - 1.41]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210979_at	90	0.322222	0.0298099	0.352756	0.851667	0.29787	0.770852	2.16 [0.51 - 9.23]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213702_x_at	90	0.577778	0.326177	-	-0.329829	0.999551	0.000108157	1.00 [0.69 - 1.46]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213702_x_at	90	0.277778	0.160937	-	-0.530901	0.802097	-0.0542657	0.95 [0.62 - 1.45]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210979_at	90	0.666667	0.10234	-	0.604371	0.20255	1.06833	2.91 [0.56 - 15.05]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3253	50	0.78	0.260349	-	-0.826974	0.849939	-0.0573899	0.94 [0.52 - 1.71]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213702_x_at	138	0.217391	0.147381	-	-0.396864	0.837367	-0.0300596	0.97 [0.73 - 1.29]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1555419_a_at	138	0.862319	0.373857	-	0.282632	0.853288	0.0160586	1.02 [0.86 - 1.20]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210980_s_at	138	0.173913	0.151636	-	-0.419022	0.655154	-0.0625457	0.94 [0.71 - 1.24]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210979_at	138	0.615942	0.0255625	0.317843	-0.586585	0.175316	-2.15563	0.12 [0.01 - 2.62]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210980_s_at	129	0.108527	0.139557	-	0.745118	0.628622	0.122631	1.13 [0.69 - 1.86]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210979_at	129	0.224806	0.303086	-	-0.317866	0.913054	-0.0172275	0.98 [0.72 - 1.34]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213702_x_at	129	0.108527	0.0799238	-	0.993245	0.593493	0.211061	1.23 [0.57 - 2.68]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18834	56	0.196429	0.056261	-	1.0995	0.955765	-0.0122933	0.99 [0.64 - 1.53]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31098	56	0.142857	0.0474603	0.476155	-0.969743	0.369506	-0.217699	0.80 [0.50 - 1.29]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18834	56	0.892857	0.0447384	0.459015	-1.79555	0.656234	-0.102616	0.90 [0.57 - 1.42]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40259	56	0.857143	0.0968574	-	-0.976118	0.643332	-0.103186	0.90 [0.58 - 1.40]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31098	56	0.142857	0.159393	-	-0.688812	0.594722	-0.121881	0.89 [0.57 - 1.39]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40259	56	0.857143	0.0614466	-	-1.27983	0.437264	-0.185032	0.83 [0.52 - 1.33]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210980_s_at	278	0.892086	0.0703766	-	0.481541	0.588315	0.0896639	1.09 [0.79 - 1.51]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210979_at	278	0.784173	0.197466	-	-0.309132	0.687076	0.21703	1.24 [0.43 - 3.57]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1555419_a_at	278	0.848921	0.224974	-	0.290855	0.988531	-0.00205602	1.00 [0.75 - 1.32]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213702_x_at	278	0.899281	0.120444	-	0.442722	0.548708	0.107287	1.11 [0.78 - 1.58]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213702_x_at	133	0.62406	0.241205	-	-0.300601	0.628494	-0.0665485	0.94 [0.71 - 1.23]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210979_at	133	0.473684	0.00296729	0.0624356	0.717749	0.0219002	0.686013	1.99 [1.10 - 3.57]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210980_s_at	133	0.819549	0.0564628	-	-0.669704	0.593168	-0.0700097	0.93 [0.72 - 1.21]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5907	81	0.123457	0.0863046	-	-0.967191	0.899719	-0.0502706	0.95 [0.44 - 2.08]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6932	81	0.296296	0.0296279	0.35131	-1.07594	0.515736	-0.300079	0.74 [0.30 - 1.83]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213702_x_at	185	0.875676	0.000903499	0.0234026	0.751581	0.0126998	0.287714	1.33 [1.06 - 1.67]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210979_at	185	0.416216	0.296438	-	-0.171218	0.812296	-0.0769196	0.93 [0.49 - 1.75]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210980_s_at	185	0.783784	0.00110893	0.0277905	0.643136	0.048904	0.239113	1.27 [1.00 - 1.61]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210979_at	185	0.124324	0.130837	-	0.439917	0.617182	0.173263	1.19 [0.60 - 2.35]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213702_x_at	185	0.594595	0.00489297	0.0930443	0.462954	0.0200189	0.24171	1.27 [1.04 - 1.56]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210980_s_at	185	0.783784	0.0044595	0.0864723	0.539312	0.0588973	0.209567	1.23 [0.99 - 1.53]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P216325	110	0.618182	0.288902	-	-0.264028	0.553488	-0.0780441	0.92 [0.71 - 1.20]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P928637	110	0.127273	0.0851927	-	0.670579	0.533208	0.0981625	1.10 [0.81 - 1.50]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P216325	110	0.263636	0.162907	-	0.490373	0.772805	0.051482	1.05 [0.74 - 1.49]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P928637	110	0.136364	0.109466	-	0.817959	0.364576	0.197549	1.22 [0.79 - 1.87]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210980_s_at	80	0.6	0.085184	-	0.744436	0.7254	-0.0940704	0.91 [0.54 - 1.54]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210979_at	80	0.575	0.0432968	0.449689	-0.998191	0.154413	-0.233816	0.79 [0.57 - 1.09]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213702_x_at	80	0.6	0.227655	-	0.527363	0.535295	-0.241539	0.79 [0.37 - 1.69]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1944	281	0.259786	0.00233706	0.0514445	-0.459728	0.101399	-0.558086	0.57 [0.29 - 1.12]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213702_x_at	38	0.736842	0.00770951	0.132502	1.28219	0.165382	1.1022	3.01 [0.63 - 14.29]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1555419_a_at	38	0.815789	0.0285709	0.342826	1.13593	0.14465	0.515791	1.67 [0.84 - 3.35]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210980_s_at	38	0.868421	0.0340768	0.38551	1.16238	0.149411	0.91608	2.50 [0.72 - 8.68]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210979_at	38	0.631579	0.0686985	-	-0.905031	0.566182	-0.204717	0.81 [0.40 - 1.64]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210980_s_at	140	0.707143	0.000363571	0.0107828	-1.66596	0.0138005	-0.454146	0.63 [0.44 - 0.91]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213702_x_at	140	0.592857	5.78864e-05	0.00215956	-1.50345	0.00531079	-0.57492	0.56 [0.38 - 0.84]
GENE	ASAH1	N-acylsphingosine amidohydrolase (acid ceramidase) 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210979_at	140	0.492857	0.0106383	0.16914	-0.74755	0.141226	-1.8252	0.16 [0.01 - 1.83]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ASL	argininosuccinate lyase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204608_at	30	0.8	0.132556	-	0.70142	0.918778	-0.0508551	0.95 [0.36 - 2.53]
GENE	ASL	argininosuccinate lyase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1685142	165	0.824242	0.0335157	0.381323	0.599263	0.2981	0.386991	1.47 [0.71 - 3.05]
GENE	ASL	argininosuccinate lyase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1685142	165	0.878788	0.00720434	0.125778	1.05011	0.0931895	0.859371	2.36 [0.87 - 6.44]
GENE	ASL	argininosuccinate lyase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204608_at	163	0.251534	0.00331054	0.068187	-0.619267	0.0977089	-0.318111	0.73 [0.50 - 1.06]
GENE	ASL	argininosuccinate lyase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204608_at	79	0.101266	0.0407402	0.432706	1.37186	0.19031	0.27921	1.32 [0.87 - 2.01]
GENE	ASL	argininosuccinate lyase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204608_at	58	0.827586	0.0630767	-	0.664581	0.396759	0.215914	1.24 [0.75 - 2.04]
GENE	ASL	argininosuccinate lyase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204608_at	34	0.617647	0.205763	-	-0.503891	0.782689	-0.0915538	0.91 [0.48 - 1.75]
GENE	ASL	argininosuccinate lyase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204608_at	158	0.778481	0.0821476	-	-0.559046	0.599405	-0.144194	0.87 [0.51 - 1.48]
GENE	ASL	argininosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204608_at	53	0.792453	0.00441466	0.0857831	-1.83452	0.179304	-0.704242	0.49 [0.18 - 1.38]
GENE	ASL	argininosuccinate lyase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204608_at	53	0.792453	0.00300268	0.0630356	-1.62997	0.1437	-0.720764	0.49 [0.19 - 1.28]
GENE	ASL	argininosuccinate lyase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204608_at	180	0.883333	0.0735526	-	0.501626	0.666769	0.110202	1.12 [0.68 - 1.84]
GENE	ASL	argininosuccinate lyase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204608_at	559	0.200358	0.0402132	0.429133	-0.441488	0.830804	0.040148	1.04 [0.72 - 1.50]
GENE	ASL	argininosuccinate lyase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204608_at	77	0.428571	0.001076	0.0270985	0.872946	0.126536	0.419314	1.52 [0.89 - 2.60]
GENE	ASL	argininosuccinate lyase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204608_at	70	0.114286	0.0630428	-	0.848629	0.323828	0.25756	1.29 [0.78 - 2.16]
GENE	ASL	argininosuccinate lyase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36528_at	50	0.36	0.0847356	-	0.670516	0.479521	-0.836439	0.43 [0.04 - 4.40]
GENE	ASL	argininosuccinate lyase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204608_at	74	0.378378	5.77761e-06	0.000271504	1.50495	5.25392e-05	1.37325	3.95 [2.03 - 7.68]
GENE	ASL	argininosuccinate lyase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204608_at	67	0.865672	0.218996	-	-15.2542	0.819827	-0.234204	0.79 [0.11 - 5.94]
GENE	ASL	argininosuccinate lyase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204608_at	115	0.469565	0.0534499	-	-1.08525	0.221521	-0.879869	0.41 [0.10 - 1.70]
GENE	ASL	argininosuccinate lyase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36528_at	158	0.240506	0.000654259	0.0178161	-0.993961	0.147446	-0.267546	0.77 [0.53 - 1.10]
GENE	ASL	argininosuccinate lyase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36528_at	76	0.276316	0.0834434	-	1.61259	0.686496	0.17042	1.19 [0.52 - 2.71]
GENE	ASL	argininosuccinate lyase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204608_at	204	0.867647	0.127967	-	-0.312135	0.868235	-0.0239699	0.98 [0.74 - 1.30]
GENE	ASL	argininosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204608_at	87	0.103448	0.000231593	0.00730157	-1.49405	0.245401	-0.450703	0.64 [0.30 - 1.36]
GENE	ASL	argininosuccinate lyase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204608_at	87	0.103448	0.000231593	0.00730157	-1.49405	0.245401	-0.450703	0.64 [0.30 - 1.36]
GENE	ASL	argininosuccinate lyase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204608_at	77	0.38961	0.203128	-	0.96816	0.516804	0.420701	1.52 [0.43 - 5.43]
GENE	ASL	argininosuccinate lyase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204608_at	77	0.844156	0.122618	-	0.897739	0.311004	0.581175	1.79 [0.58 - 5.50]
GENE	ASL	argininosuccinate lyase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204608_at	136	0.102941	0.00681413	0.120489	-1.3264	0.0305064	-1.07227	0.34 [0.13 - 0.90]
GENE	ASL	argininosuccinate lyase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204608_at	200	0.5	0.0151724	0.219822	0.729688	0.111449	0.794731	2.21 [0.83 - 5.89]
GENE	ASL	argininosuccinate lyase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16586	60	0.783333	0.0105249	0.167788	1.01504	0.105177	0.573005	1.77 [0.89 - 3.55]
GENE	ASL	argininosuccinate lyase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16586	60	0.866667	0.206179	-	0.621393	0.229106	0.355463	1.43 [0.80 - 2.55]
GENE	ASL	argininosuccinate lyase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	20145	155	0.141935	0.172497	-	-0.463569	0.466269	-0.164484	0.85 [0.54 - 1.32]
GENE	ASL	argininosuccinate lyase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204608_at	286	0.86014	0.0154815	0.223063	0.573338	0.810409	0.0684504	1.07 [0.61 - 1.87]
GENE	ASL	argininosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204608_at	159	0.433962	0.000192458	0.00621573	1.42976	0.000335696	1.31815	3.74 [1.82 - 7.68]
GENE	ASL	argininosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204608_at	159	0.874214	0.000322067	0.00971352	1.21027	0.000157192	1.41093	4.10 [1.97 - 8.52]
GENE	ASL	argininosuccinate lyase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204608_at	159	0.836478	1.03704e-05	0.000461751	1.52394	7.8344e-05	1.62438	5.08 [2.27 - 11.36]
GENE	ASL	argininosuccinate lyase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204608_at	54	0.444444	0.0379463	0.413458	1.90607	0.271232	0.596058	1.81 [0.63 - 5.25]
GENE	ASL	argininosuccinate lyase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204608_at	117	0.435897	0.0345849	0.38927	0.715183	0.111812	0.482652	1.62 [0.89 - 2.94]
GENE	ASL	argininosuccinate lyase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204608_at	117	0.512821	0.0947376	-	0.662367	0.351645	0.346756	1.41 [0.68 - 2.93]
GENE	ASL	argininosuccinate lyase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204608_at	117	0.435897	0.0345849	0.38927	0.715183	0.111812	0.482652	1.62 [0.89 - 2.94]
GENE	ASL	argininosuccinate lyase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204608_at	117	0.82906	0.00573938	0.105447	1.10447	0.055427	0.683376	1.98 [0.98 - 3.99]
GENE	ASL	argininosuccinate lyase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204608_at	236	0.682203	0.0724028	-	0.485892	0.523608	0.270325	1.31 [0.57 - 3.01]
GENE	ASL	argininosuccinate lyase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204608_at	249	0.638554	0.0465129	0.470257	0.421693	0.26836	0.362145	1.44 [0.76 - 2.73]
GENE	ASL	argininosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204608_at	62	0.33871	0.121885	-	-0.725785	0.578989	-0.215361	0.81 [0.38 - 1.73]
GENE	ASL	argininosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204608_at	125	0.376	0.194024	-	-0.506008	0.639845	0.176227	1.19 [0.57 - 2.50]
GENE	ASL	argininosuccinate lyase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204608_at	125	0.376	0.0864803	-	-0.526497	0.848117	-0.055877	0.95 [0.53 - 1.68]
GENE	ASL	argininosuccinate lyase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204608_at	54	0.851852	0.122886	-	1.00569	0.420741	-0.389442	0.68 [0.26 - 1.75]
GENE	ASL	argininosuccinate lyase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204608_at	198	0.151515	0.100675	-	0.753489	0.301382	0.254939	1.29 [0.80 - 2.09]
GENE	ASL	argininosuccinate lyase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204608_at	198	0.171717	0.00941336	0.154262	0.898285	0.249647	0.222531	1.25 [0.86 - 1.82]
GENE	ASL	argininosuccinate lyase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204608_at	198	0.151515	0.108823	-	0.679765	0.268789	0.267176	1.31 [0.81 - 2.10]
GENE	ASL	argininosuccinate lyase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204608_at	51	0.117647	0.0440145	0.454354	-1.64706	0.474845	-0.550828	0.58 [0.13 - 2.61]
GENE	ASL	argininosuccinate lyase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204608_at	62	0.225806	0.254339	-	-0.685118	0.669909	-0.220529	0.80 [0.29 - 2.21]
GENE	ASL	argininosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204608_at	177	0.378531	0.00184819	0.0424523	-0.823925	0.023262	-0.519051	0.60 [0.38 - 0.93]
GENE	ASL	argininosuccinate lyase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204608_at	177	0.418079	0.03071	0.359847	-0.502046	0.291744	-0.223198	0.80 [0.53 - 1.21]
GENE	ASL	argininosuccinate lyase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204608_at	145	0.4	0.00509897	0.0961131	-0.924677	0.0342165	-0.603586	0.55 [0.31 - 0.96]
GENE	ASL	argininosuccinate lyase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204608_at	226	0.252212	0.000647337	0.0176559	-0.939693	0.00510558	-0.534328	0.59 [0.40 - 0.85]
GENE	ASL	argininosuccinate lyase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204608_at	55	0.636364	0.0245694	0.309307	-1.31449	0.263973	-0.382095	0.68 [0.35 - 1.33]
GENE	ASL	argininosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204608_at	55	0.618182	0.249721	-	-0.607674	0.772797	0.115405	1.12 [0.51 - 2.46]
GENE	ASL	argininosuccinate lyase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204608_at	49	0.632653	0.0215717	0.282584	-2.03418	0.380042	-0.406121	0.67 [0.27 - 1.65]
GENE	ASL	argininosuccinate lyase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204608_at	63	0.349206	0.00246418	0.0537112	1.22496	0.0330056	0.374279	1.45 [1.03 - 2.05]
GENE	ASL	argininosuccinate lyase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502256_3p_at	28	0.785714	0.0813526	-	-1.63146	0.342931	-4.20695	0.01 [0.00 - 88.89]
GENE	ASL	argininosuccinate lyase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204608_at	82	0.121951	0.116218	-	-0.69321	0.867915	-0.0599395	0.94 [0.46 - 1.91]
GENE	ASL	argininosuccinate lyase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204608_at	79	0.126582	0.0456524	0.464837	0.909676	0.542431	0.191047	1.21 [0.65 - 2.24]
GENE	ASL	argininosuccinate lyase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M14218_at	86	0.127907	0.103341	-	1.51616	0.599955	0.211981	1.24 [0.56 - 2.73]
GENE	ASL	argininosuccinate lyase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204608_at	104	0.365385	0.162849	-	0.505371	0.708058	0.175582	1.19 [0.48 - 2.99]
GENE	ASL	argininosuccinate lyase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P26223	117	0.683761	0.0146613	0.214407	0.695132	0.880801	-0.0362026	0.96 [0.60 - 1.55]
GENE	ASL	argininosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204608_at	204	0.588235	0.110335	-	0.576844	0.700733	0.154442	1.17 [0.53 - 2.57]
GENE	ASL	argininosuccinate lyase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204608_at	204	0.588235	0.0975621	-	0.447449	0.324947	0.29655	1.35 [0.75 - 2.43]
GENE	ASL	argininosuccinate lyase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204608_at	178	0.640449	0.253082	-	0.230016	0.455457	0.244179	1.28 [0.67 - 2.42]
GENE	ASL	argininosuccinate lyase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200005419	41	0.146341	0.0459878	0.466957	1.79666	0.747881	0.118608	1.13 [0.55 - 2.32]
GENE	ASL	argininosuccinate lyase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204608_at	111	0.693694	0.0258406	0.320207	0.595333	0.162659	0.346873	1.41 [0.87 - 2.30]
GENE	ASL	argininosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204608_at	90	0.888889	0.00980613	0.159097	1.03809	0.0915996	0.478116	1.61 [0.93 - 2.81]
GENE	ASL	argininosuccinate lyase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204608_at	90	0.888889	0.039695	0.425592	0.975997	0.303184	0.338109	1.40 [0.74 - 2.67]
GENE	ASL	argininosuccinate lyase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3706	50	0.84	0.0428971	0.447073	-15.3522	0.600797	-0.186064	0.83 [0.41 - 1.67]
GENE	ASL	argininosuccinate lyase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204608_at	138	0.478261	0.0735106	-	0.436078	0.560523	0.0603863	1.06 [0.87 - 1.30]
GENE	ASL	argininosuccinate lyase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204608_at	129	0.341085	0.00337815	0.0693025	0.81847	0.0454333	0.608609	1.84 [1.01 - 3.34]
GENE	ASL	argininosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22941	56	0.875	0.33859	-	0.464689	0.49885	0.177725	1.19 [0.71 - 2.00]
GENE	ASL	argininosuccinate lyase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22941	56	0.214286	0.235621	-	0.625122	0.452741	0.204076	1.23 [0.72 - 2.09]
GENE	ASL	argininosuccinate lyase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204608_at	278	0.104317	0.078684	-	-0.501033	0.854478	0.0254409	1.03 [0.78 - 1.35]
GENE	ASL	argininosuccinate lyase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204608_at	133	0.428571	0.0181107	0.249718	0.575181	0.0877287	0.214834	1.24 [0.97 - 1.59]
GENE	ASL	argininosuccinate lyase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15242	81	0.419753	0.0494711	0.488442	-1.03171	0.579117	-0.288571	0.75 [0.27 - 2.08]
GENE	ASL	argininosuccinate lyase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13384	81	0.753086	0.121336	-	0.814646	0.522078	0.2181	1.24 [0.64 - 2.43]
GENE	ASL	argininosuccinate lyase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204608_at	185	0.140541	0.0798693	-	-0.41817	0.404377	-0.12247	0.88 [0.66 - 1.18]
GENE	ASL	argininosuccinate lyase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204608_at	185	0.140541	0.18039	-	-0.30464	0.463679	-0.0969604	0.91 [0.70 - 1.18]
GENE	ASL	argininosuccinate lyase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P26223	110	0.163636	0.0686817	-	0.63602	0.2795	0.177531	1.19 [0.87 - 1.65]
GENE	ASL	argininosuccinate lyase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P26223	110	0.336364	0.053763	-	0.678312	0.291869	0.214224	1.24 [0.83 - 1.85]
GENE	ASL	argininosuccinate lyase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204608_at	80	0.45	0.0232377	0.297619	1.03825	0.0709888	0.528225	1.70 [0.96 - 3.01]
GENE	ASL	argininosuccinate lyase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0261	281	0.786477	0.114657	-	0.257462	0.279255	0.123777	1.13 [0.90 - 1.42]
GENE	ASL	argininosuccinate lyase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204608_at	38	0.868421	0.0068035	0.120344	1.52131	0.0310063	1.05261	2.87 [1.10 - 7.46]
GENE	ASL	argininosuccinate lyase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204608_at	140	0.164286	0.0119405	0.184352	-0.82145	0.244707	-0.666314	0.51 [0.17 - 1.58]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210551_s_at	30	0.3	0.163372	-	0.642625	0.474245	0.610154	1.84 [0.35 - 9.79]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206779_s_at	30	0.233333	0.091544	-	0.909085	0.354726	0.779516	2.18 [0.42 - 11.36]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1690595	165	0.527273	0.175111	-	-0.331136	0.29154	-0.861915	0.42 [0.09 - 2.10]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1690595	165	0.781818	0.0794305	-	0.642422	0.762538	0.25235	1.29 [0.25 - 6.61]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206779_s_at	163	0.521472	0.257801	-	-0.223831	0.904194	-0.082121	0.92 [0.24 - 3.51]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210551_s_at	163	0.208589	0.100124	-	0.433554	0.80962	0.158776	1.17 [0.32 - 4.27]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	228447_at	163	0.595092	0.133476	-	-0.309788	0.930461	-0.0786004	0.92 [0.16 - 5.40]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206779_s_at	79	0.265823	0.388912	-	-0.273416	0.771222	-0.209581	0.81 [0.20 - 3.33]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	228447_at	79	0.848101	0.0163742	0.232293	-1.33267	0.162276	-1.26111	0.28 [0.05 - 1.66]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210551_s_at	79	0.632911	0.00132207	0.032179	-1.06565	0.00888746	-1.96862	0.14 [0.03 - 0.61]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210551_s_at	58	0.724138	0.118697	-	0.485041	0.52095	0.104438	1.11 [0.81 - 1.53]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206779_s_at	58	0.827586	0.0217978	0.284652	0.83187	0.551623	0.0885378	1.09 [0.82 - 1.46]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210551_s_at	34	0.205882	0.0745132	-	-0.785497	0.342213	-0.195391	0.82 [0.55 - 1.23]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206779_s_at	34	0.147059	0.192747	-	0.735585	0.809333	-0.0559382	0.95 [0.60 - 1.49]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210551_s_at	158	0.677215	0.00146137	0.0349701	0.731971	0.442625	0.164668	1.18 [0.77 - 1.80]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206779_s_at	158	0.177215	0.00382458	0.0765371	1.16592	0.487913	0.136109	1.15 [0.78 - 1.68]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206779_s_at	53	0.339623	0.0415344	0.438045	-0.705527	0.468662	-0.0840152	0.92 [0.73 - 1.15]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210551_s_at	53	0.886792	0.14362	-	-1.02172	0.75021	-0.0352632	0.97 [0.78 - 1.20]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210551_s_at	53	0.886792	0.0730031	-	-1.63828	0.913112	-0.0127088	0.99 [0.79 - 1.24]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206779_s_at	53	0.339623	0.0562309	-	-0.700497	0.417284	-0.101348	0.90 [0.71 - 1.15]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206779_s_at	180	0.894444	0.167134	-	0.463533	0.987044	0.00145066	1.00 [0.84 - 1.19]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210551_s_at	180	0.783333	0.0387708	0.419216	0.483064	0.43011	0.0689677	1.07 [0.90 - 1.27]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	228447_at	180	0.677778	0.0961761	-	0.355429	0.469462	0.162123	1.18 [0.76 - 1.82]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	228447_at	559	0.139535	0.121638	-	-0.433836	0.83172	-0.0411639	0.96 [0.66 - 1.40]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210551_s_at	559	0.515206	0.00171018	0.0398243	-0.638205	0.035186	-0.290664	0.75 [0.57 - 0.98]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206779_s_at	559	0.731664	0.173979	-	-0.332479	0.48803	-0.0884647	0.92 [0.71 - 1.18]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210551_s_at	77	0.857143	0.236697	-	-0.50426	0.73854	-0.0484786	0.95 [0.72 - 1.27]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206779_s_at	77	0.805195	0.27788	-	-0.376071	0.911293	-0.018214	0.98 [0.71 - 1.35]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	228447_at	77	0.454545	0.208277	-	-0.321281	0.658828	-0.115752	0.89 [0.53 - 1.49]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206779_s_at	70	0.285714	0.0101962	0.163838	-0.733396	0.0481112	-1.63178	0.20 [0.04 - 0.99]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	228447_at	70	0.185714	0.163025	-	-0.454071	0.878761	-0.218584	0.80 [0.05 - 13.33]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210551_s_at	70	0.114286	0.238126	-	-0.475484	0.937459	0.0836782	1.09 [0.13 - 8.79]
GENE	ASMT	acetylserotonin O-methyltransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35447_s_at	50	0.76	0.0634287	-	-0.782103	0.166545	-1.45404	0.23 [0.03 - 1.83]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210551_s_at	74	0.256757	0.0203833	0.271559	0.878156	0.815165	0.0388801	1.04 [0.75 - 1.44]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206779_s_at	74	0.121622	0.00560559	0.103522	1.7934	0.151705	0.288443	1.33 [0.90 - 1.98]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	228447_at	74	0.378378	0.157043	-	0.427872	0.373238	0.289367	1.34 [0.71 - 2.53]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210551_s_at	67	0.895522	6.63425e-05	0.0024372	2.46442	0.443829	2.64293	14.05 [0.02 - 12182.94]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	228447_at	67	0.223881	0.149802	-	15.3678	0.454992	1.35831	3.89 [0.11 - 137.24]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206779_s_at	67	0.19403	0.0957254	-	15.45	0.50951	1.53137	4.62 [0.05 - 437.83]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210551_s_at	115	0.113043	0.18518	-	-0.834738	0.467081	-0.697387	0.50 [0.08 - 3.26]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206779_s_at	115	0.208696	0.179425	-	1.30015	0.491489	0.468632	1.60 [0.42 - 6.07]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	228447_at	115	0.895652	0.186254	-	-15.1878	0.907826	-0.0713918	0.93 [0.28 - 3.12]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35447_s_at	158	0.582278	0.00302258	0.0633725	-0.907986	0.0417654	-0.374074	0.69 [0.48 - 0.99]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35447_s_at	76	0.276316	0.0393122	0.422961	1.86261	0.185839	0.452551	1.57 [0.80 - 3.07]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210551_s_at	204	0.171569	0.000931284	0.0240064	-0.6171	0.315153	-0.0765684	0.93 [0.80 - 1.08]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	228447_at	204	0.112745	0.0395329	0.42448	0.476594	0.249267	0.0997602	1.10 [0.93 - 1.31]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206779_s_at	204	0.186275	0.00222604	0.0494421	-0.559087	0.0167793	-0.178484	0.84 [0.72 - 0.97]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206779_s_at	87	0.655172	0.151796	-	0.537371	0.996995	-0.00387376	1.00 [0.13 - 7.48]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	228447_at	87	0.16092	0.0432393	0.449314	1.80511	0.862491	0.165841	1.18 [0.18 - 7.71]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	228447_at	87	0.16092	0.0432393	0.449314	1.80511	0.862491	0.165841	1.18 [0.18 - 7.71]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210551_s_at	87	0.689655	0.0588161	-	-0.904467	0.44318	-0.758291	0.47 [0.07 - 3.25]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210551_s_at	87	0.689655	0.0588161	-	-0.904467	0.44318	-0.758291	0.47 [0.07 - 3.25]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206779_s_at	87	0.655172	0.151796	-	0.537371	0.996995	-0.00387376	1.00 [0.13 - 7.48]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	228447_at	77	0.883117	0.00067191	0.018223	1.72237	0.0621986	2.52803	12.53 [0.88 - 178.57]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206779_s_at	77	0.155844	0.0177635	0.246288	-1.41156	0.813348	-0.402218	0.67 [0.02 - 18.85]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	228447_at	77	0.883117	0.0318121	0.368394	1.37357	0.500474	1.09326	2.98 [0.12 - 71.78]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210551_s_at	77	0.857143	0.125811	-	-15.2672	0.36595	-1.43043	0.24 [0.01 - 5.32]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206779_s_at	77	0.857143	0.0555243	-	1.09663	0.890869	0.191146	1.21 [0.08 - 18.57]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210551_s_at	77	0.441558	0.0161349	0.229838	-1.69313	0.104175	-3.17618	0.04 [0.00 - 1.92]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206779_s_at	136	0.772059	0.0880991	-	0.762097	0.602808	0.130595	1.14 [0.70 - 1.86]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210551_s_at	136	0.352941	0.382498	-	0.433573	0.739224	0.0709449	1.07 [0.71 - 1.63]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210551_s_at	200	0.895	0.072378	-	0.689433	0.498084	0.115639	1.12 [0.80 - 1.57]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206779_s_at	200	0.145	0.058898	-	1.07637	0.333847	0.15708	1.17 [0.85 - 1.61]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20350	60	0.466667	0.0924721	-	0.648065	0.429902	0.189509	1.21 [0.75 - 1.93]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20350	60	0.216667	0.185245	-	-0.552423	0.418265	-0.298633	0.74 [0.36 - 1.53]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16623	155	0.76129	0.0210786	0.278041	-0.909718	0.584493	-0.0964135	0.91 [0.64 - 1.28]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210551_s_at	286	0.807692	0.0360266	0.399788	-0.592989	0.550972	-0.066088	0.94 [0.75 - 1.16]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206779_s_at	286	0.136364	0.264912	-	-0.296344	0.826292	-0.0231802	0.98 [0.79 - 1.20]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206779_s_at	159	0.496855	0.24753	-	-0.367915	0.700835	-0.0743329	0.93 [0.64 - 1.36]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210551_s_at	159	0.899371	0.0842232	-	0.704123	0.262152	0.194436	1.21 [0.86 - 1.71]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206779_s_at	159	0.496855	0.22777	-	-0.383743	0.56243	-0.111538	0.89 [0.61 - 1.30]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210551_s_at	159	0.81761	0.329994	-	0.419815	0.853388	0.0377796	1.04 [0.70 - 1.55]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206779_s_at	159	0.496855	0.13477	-	-0.565265	0.510565	-0.15019	0.86 [0.55 - 1.35]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210551_s_at	159	0.157233	0.194326	-	-0.486646	0.68108	-0.0722324	0.93 [0.66 - 1.31]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228447_at	159	0.811321	0.266361	-	0.403216	0.960208	0.0131803	1.01 [0.60 - 1.70]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228447_at	159	0.471698	0.195612	-	0.419716	0.907239	-0.0305678	0.97 [0.58 - 1.62]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	228447_at	159	0.811321	0.076065	-	0.69796	0.506599	0.220597	1.25 [0.65 - 2.39]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206779_s_at	54	0.148148	0.0166273	0.234876	-1.54157	0.0376286	-5.08336	0.01 [0.00 - 0.75]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210551_s_at	54	0.740741	0.0781045	-	-15.4935	0.251618	-2.50961	0.08 [0.00 - 5.94]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210551_s_at	117	0.649573	0.0803099	-	0.547337	0.50086	0.605955	1.83 [0.31 - 10.70]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210551_s_at	117	0.102564	0.0602487	-	15.2059	0.335256	1.04134	2.83 [0.34 - 23.56]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206779_s_at	117	0.760684	0.0353765	0.395073	0.829235	0.615521	0.600099	1.82 [0.18 - 18.96]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206779_s_at	117	0.111111	0.0332962	0.379677	-0.869264	0.826672	0.212888	1.24 [0.18 - 8.32]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206779_s_at	117	0.111111	0.0114142	0.178275	-1.11911	0.66999	-0.507621	0.60 [0.06 - 6.22]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206779_s_at	117	0.111111	0.0332962	0.379677	-0.869264	0.826672	0.212888	1.24 [0.18 - 8.32]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210551_s_at	117	0.102564	0.189626	-	1.25262	0.720382	0.38817	1.47 [0.18 - 12.35]
GENE	ASMT	acetylserotonin O-methyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210551_s_at	117	0.649573	0.0803099	-	0.547337	0.50086	0.605955	1.83 [0.31 - 10.70]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210551_s_at	236	0.131356	0.047892	0.478819	-0.638567	0.160051	-0.24941	0.78 [0.55 - 1.10]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206779_s_at	236	0.733051	0.21331	-	-0.404049	0.867916	-0.0343866	0.97 [0.64 - 1.45]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	228447_at	236	0.868644	0.027323	0.332616	-1.45677	0.664402	-0.116023	0.89 [0.53 - 1.50]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206779_s_at	249	0.11245	0.0122756	0.188174	-0.697556	0.400697	-0.142672	0.87 [0.62 - 1.21]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210551_s_at	249	0.626506	0.0135321	0.202195	-0.575438	0.0664783	-0.25295	0.78 [0.59 - 1.02]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	228447_at	249	0.759036	0.00848053	0.142514	-0.770818	0.186894	-0.265968	0.77 [0.52 - 1.14]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210551_s_at	125	0.36	0.0997567	-	-0.484797	0.655119	-0.465241	0.63 [0.08 - 4.84]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206779_s_at	125	0.864	0.034128	0.38589	-1.07502	0.457705	-0.306762	0.74 [0.33 - 1.65]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206779_s_at	125	0.824	0.108156	-	-0.965288	0.884734	0.076802	1.08 [0.38 - 3.05]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206779_s_at	54	0.203704	0.138322	-	15.3327	0.810366	-0.110878	0.90 [0.36 - 2.21]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210551_s_at	125	0.632	0.1042	-	0.605832	0.577505	0.740905	2.10 [0.15 - 28.44]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210551_s_at	54	0.277778	0.245242	-	1.15839	0.82588	-0.0879715	0.92 [0.42 - 2.01]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210551_s_at	62	0.467742	0.0564613	-	1.15603	0.885296	-0.0471736	0.95 [0.50 - 1.81]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206779_s_at	62	0.225806	0.167248	-	1.32896	0.666846	-0.164668	0.85 [0.40 - 1.80]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210551_s_at	198	0.333333	0.0465737	0.470637	0.637874	0.425554	0.0787204	1.08 [0.89 - 1.31]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206779_s_at	198	0.333333	0.0295997	0.351085	0.652485	0.536248	0.0591725	1.06 [0.88 - 1.28]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210551_s_at	198	0.323232	0.034315	0.387276	0.514171	0.890771	0.0108056	1.01 [0.87 - 1.18]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206779_s_at	198	0.333333	0.102803	-	0.382209	0.906639	0.00940876	1.01 [0.86 - 1.18]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206779_s_at	198	0.333333	0.0316806	0.367382	0.686702	0.536121	0.0619185	1.06 [0.87 - 1.29]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210551_s_at	198	0.328283	0.0489179	0.485093	0.592605	0.648538	0.0427199	1.04 [0.87 - 1.25]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210551_s_at	62	0.887097	0.0104058	0.166361	1.56457	0.248557	2.18717	8.91 [0.22 - 365.91]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206779_s_at	62	0.580645	0.186795	-	0.756428	0.838409	0.282302	1.33 [0.09 - 20.00]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210551_s_at	51	0.411765	0.296172	-	1.11046	0.33805	3.03976	20.90 [0.04 - 10495.92]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206779_s_at	51	0.117647	0.0310139	0.362219	-1.74498	0.51267	-1.40225	0.25 [0.00 - 16.38]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	228447_at	145	0.462069	0.095261	-	0.581868	0.472021	0.9869	2.68 [0.18 - 39.51]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206779_s_at	177	0.870057	0.0194693	0.262898	-1.53066	0.115931	-1.32962	0.26 [0.05 - 1.39]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210551_s_at	177	0.638418	0.00208686	0.0469002	-0.830087	0.27825	-0.80624	0.45 [0.10 - 1.92]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210551_s_at	145	0.62069	0.0105624	0.168235	-0.988135	0.322478	-1.0393	0.35 [0.05 - 2.77]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206779_s_at	177	0.870057	0.00862711	0.144386	-1.42603	0.205969	-0.942935	0.39 [0.09 - 1.68]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210551_s_at	177	0.638418	0.0103009	0.1651	-0.795195	0.200232	-1.09278	0.34 [0.06 - 1.78]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	228447_at	177	0.158192	0.0558228	-	-0.53676	0.0517455	-1.8057	0.16 [0.03 - 1.01]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	228447_at	177	0.158192	0.00602195	0.109474	-0.812854	0.0612109	-1.98527	0.14 [0.02 - 1.10]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206779_s_at	145	0.344828	0.168897	-	-0.458092	0.7817	-0.303948	0.74 [0.09 - 6.33]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210551_s_at	226	0.89823	0.0150651	0.21869	0.914301	0.382521	0.133899	1.14 [0.85 - 1.54]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206779_s_at	226	0.119469	0.0831954	-	1.18143	0.569155	0.073131	1.08 [0.84 - 1.38]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	228447_at	226	0.123894	0.000231841	0.00730838	-1.13269	0.00457867	-0.423124	0.65 [0.49 - 0.88]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210551_s_at	55	0.890909	0.00271524	0.0581118	1.48643	0.30574	1.78932	5.99 [0.19 - 183.74]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	228447_at	55	0.345455	0.00775679	0.133124	-1.26026	0.0144769	-3.66239	0.03 [0.00 - 0.48]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210551_s_at	49	0.897959	0.000126786	0.00431497	2.08155	0.30039	2.3016	9.99 [0.13 - 778.73]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	228447_at	49	0.632653	0.00959531	0.156509	-2.25522	0.0602831	-3.39316	0.03 [0.00 - 1.16]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206779_s_at	55	0.854545	0.180539	-	0.755305	0.970665	0.0441414	1.05 [0.10 - 10.99]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206779_s_at	55	0.2	0.0398087	0.426371	-0.932692	0.469576	-0.880132	0.41 [0.04 - 4.51]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206779_s_at	49	0.163265	0.148304	-	-0.859953	0.521965	-0.981162	0.37 [0.02 - 7.55]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	228447_at	55	0.2	0.00678161	0.120044	-1.20205	0.111827	-1.89587	0.15 [0.01 - 1.55]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210551_s_at	55	0.890909	0.000122771	0.0041948	1.70745	0.44093	1.31857	3.74 [0.13 - 106.93]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206779_s_at	63	0.412698	0.0260076	0.321621	-0.740942	0.351707	-2.06178	0.13 [0.00 - 9.75]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	228447_at	63	0.222222	0.000193854	0.00625501	-1.25961	0.917393	0.153665	1.17 [0.06 - 21.27]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210551_s_at	63	0.190476	0.000823774	0.0216505	-1.17927	0.0430191	-18.638	0.00 [0.00 - 0.56]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4757791_3p_a_at	28	0.821429	0.0502379	-	-1.81683	0.319521	-2.87804	0.06 [0.00 - 16.26]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.123127.0.A1_3p_at	28	0.142857	0.062747	-	-1.24058	0.315254	-0.569436	0.57 [0.19 - 1.72]
GENE	ASMT	acetylserotonin O-methyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210551_s_at	82	0.378049	0.0991421	-	0.609122	0.551292	0.115934	1.12 [0.77 - 1.64]
GENE	ASMT	acetylserotonin O-methyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210551_s_at	79	0.164557	0.263135	-	-0.362952	0.384172	-0.176848	0.84 [0.56 - 1.25]
GENE	ASMT	acetylserotonin O-methyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206779_s_at	79	0.886076	0.0146167	0.213931	0.91239	0.937737	-0.0265445	0.97 [0.50 - 1.90]
GENE	ASMT	acetylserotonin O-methyltransferase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U11090_at	86	0.139535	0.0543431	-	-0.958316	0.276028	-1.23306	0.29 [0.03 - 2.68]
GENE	ASMT	acetylserotonin O-methyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206779_s_at	104	0.317308	0.0613981	-	-0.604018	0.383669	-0.239051	0.79 [0.46 - 1.35]
GENE	ASMT	acetylserotonin O-methyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210551_s_at	104	0.855769	0.0169118	0.237761	0.855216	0.313974	0.292272	1.34 [0.76 - 2.37]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210551_s_at	204	0.156863	0.00421169	0.0826406	-1.06001	0.3887	-0.178549	0.84 [0.56 - 1.26]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	228447_at	204	0.156863	0.0782306	-	1.61194	0.401787	0.297606	1.35 [0.67 - 2.70]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210551_s_at	204	0.166667	0.00835603	0.140917	-0.782109	0.680745	0.0612581	1.06 [0.79 - 1.42]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	228447_at	204	0.264706	0.0430865	0.448314	0.756804	0.142093	0.392301	1.48 [0.88 - 2.50]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206779_s_at	204	0.142157	0.221949	-	0.866768	0.884536	-0.0299334	0.97 [0.65 - 1.45]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206779_s_at	204	0.75	0.0715485	-	-0.677421	0.386538	-0.131405	0.88 [0.65 - 1.18]
GENE	ASMT	acetylserotonin O-methyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206779_s_at	178	0.814607	0.0092869	0.152691	-0.757194	0.370812	-0.173602	0.84 [0.57 - 1.23]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210551_s_at	111	0.891892	0.0120269	0.185341	0.890189	0.0235699	0.310343	1.36 [1.04 - 1.78]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206779_s_at	111	0.756757	0.215443	-	0.349583	0.93036	-0.0134913	0.99 [0.73 - 1.34]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	228447_at	111	0.18018	0.264022	-	-0.361206	0.979569	-0.00418428	1.00 [0.72 - 1.37]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206779_s_at	90	0.888889	0.10512	-	0.778365	0.385208	0.884974	2.42 [0.33 - 17.86]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206779_s_at	90	0.888889	0.1079	-	0.702826	0.529323	0.589283	1.80 [0.29 - 11.31]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210551_s_at	90	0.877778	0.0403001	0.429724	-1.81798	0.896461	0.090055	1.09 [0.28 - 4.25]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210551_s_at	90	0.877778	0.0967587	-	-1.53549	0.425758	0.57011	1.77 [0.43 - 7.19]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210551_s_at	138	0.115942	0.0134736	0.201553	-0.727108	0.148513	-7.42224	0.00 [0.00 - 14.11]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206779_s_at	138	0.23913	0.00890476	0.147904	-0.645197	0.0593911	-3.5039	0.03 [0.00 - 1.15]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	228447_at	138	0.275362	0.0259327	0.320987	-0.552839	0.833768	0.133623	1.14 [0.33 - 3.98]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206779_s_at	129	0.131783	0.177038	-	-0.427021	0.674164	0.071622	1.07 [0.77 - 1.50]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210551_s_at	129	0.27907	0.00698985	0.122881	0.866729	0.0881694	0.236	1.27 [0.97 - 1.66]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12109	56	0.803571	0.086787	-	-0.809744	0.872481	-0.0566745	0.94 [0.47 - 1.89]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15869	56	0.375	0.202892	-	0.498096	0.650997	0.179447	1.20 [0.55 - 2.60]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12109	56	0.75	0.171843	-	-0.579624	0.875177	0.0576731	1.06 [0.52 - 2.18]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15869	56	0.375	0.0913435	-	0.644177	0.839318	0.0766236	1.08 [0.51 - 2.26]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206779_s_at	278	0.133094	0.0142098	0.209567	0.870352	0.452913	0.388833	1.48 [0.53 - 4.07]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210551_s_at	278	0.766187	0.292527	-	-0.234129	0.730189	-0.166243	0.85 [0.33 - 2.18]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	228447_at	278	0.52518	0.00815705	0.138349	-0.505121	0.158171	-0.580969	0.56 [0.25 - 1.25]
GENE	ASMT	acetylserotonin O-methyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210551_s_at	133	0.781955	0.00183165	0.0421396	0.794151	0.0206999	2.97841	19.66 [1.58 - 245.14]
GENE	ASMT	acetylserotonin O-methyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206779_s_at	133	0.62406	0.000411341	0.0119894	0.821909	0.0112341	0.857771	2.36 [1.21 - 4.58]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17577	81	0.728395	0.188546	-	0.682908	0.996683	-0.00240548	1.00 [0.32 - 3.10]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210551_s_at	185	0.108108	0.0115164	0.179462	-0.667107	0.097786	-0.738124	0.48 [0.20 - 1.15]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206779_s_at	185	0.351351	0.0177954	0.246604	0.455489	0.317787	0.415903	1.52 [0.67 - 3.43]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210551_s_at	185	0.108108	0.00474255	0.0907817	-0.685436	0.0570565	-0.77956	0.46 [0.21 - 1.02]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206779_s_at	185	0.454054	0.0810058	-	0.284419	0.708779	0.146987	1.16 [0.54 - 2.51]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P255535	110	0.309091	0.0786327	-	0.448235	0.436836	0.11847	1.13 [0.84 - 1.52]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P255535	110	0.872727	0.0843228	-	0.664022	0.515175	0.123349	1.13 [0.78 - 1.64]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210551_s_at	80	0.8375	0.0384867	0.41724	0.985635	0.552915	0.0917087	1.10 [0.81 - 1.48]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206779_s_at	80	0.2	0.120592	-	1.46086	0.655954	0.0745254	1.08 [0.78 - 1.50]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_4101	281	0.640569	2.19602e-05	0.000908493	-0.649962	0.00172019	-0.426149	0.65 [0.50 - 0.85]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210551_s_at	38	0.631579	0.0123477	0.188992	-1.30607	0.0535695	-0.690917	0.50 [0.25 - 1.01]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206779_s_at	38	0.578947	0.192788	-	-0.627146	0.815482	0.108654	1.11 [0.45 - 2.78]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	228447_at	38	0.605263	0.0483838	0.481836	0.934866	0.0877589	1.4453	4.24 [0.81 - 22.30]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210551_s_at	140	0.121429	0.0728977	-	-0.68351	0.765968	-0.399265	0.67 [0.05 - 9.30]
GENE	ASMT	acetylserotonin O-methyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206779_s_at	140	0.814286	0.258579	-	-0.488731	0.957561	-0.0661066	0.94 [0.08 - 10.68]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205047_s_at	30	0.366667	0.0101101	0.162796	-1.10524	0.182666	-0.401383	0.67 [0.37 - 1.21]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1796417	165	0.133333	0.0463309	0.469115	0.912126	0.176635	0.198996	1.22 [0.91 - 1.63]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1796417	165	0.890909	0.020918	0.276551	0.951333	0.617217	0.110461	1.12 [0.72 - 1.72]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205047_s_at	163	0.478528	0.000204359	0.00654915	0.749	0.0452602	0.263445	1.30 [1.01 - 1.68]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	241082_at	163	0.116564	0.0245557	0.309188	-0.606487	0.0952112	-1.45539	0.23 [0.04 - 1.29]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205047_s_at	79	0.101266	0.0167611	0.236235	-0.951824	0.1643	-0.271221	0.76 [0.52 - 1.12]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	241082_at	79	0.265823	0.104152	-	0.594034	0.577424	0.621575	1.86 [0.21 - 16.58]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205047_s_at	58	0.362069	0.0593962	-	-0.529779	0.131554	-0.300523	0.74 [0.50 - 1.09]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205047_s_at	34	0.470588	0.113866	-	0.601698	0.80494	0.0594493	1.06 [0.66 - 1.70]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205047_s_at	158	0.85443	0.182023	-	-0.495763	0.551398	-0.104509	0.90 [0.64 - 1.27]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205047_s_at	53	0.792453	0.100958	-	-0.849443	0.704658	-0.115132	0.89 [0.49 - 1.62]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205047_s_at	53	0.867925	0.193294	-	-0.920832	0.771167	-0.0956494	0.91 [0.48 - 1.73]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205047_s_at	180	0.85	0.232844	-	-0.415617	0.824175	0.0513844	1.05 [0.67 - 1.66]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	241082_at	180	0.127778	0.0702358	-	0.660528	0.424517	0.0799881	1.08 [0.89 - 1.32]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205047_s_at	559	0.456172	0.00696218	0.122506	0.562978	0.0333777	0.350548	1.42 [1.03 - 1.96]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	241082_at	559	0.27907	0.189085	-	-0.296686	0.999205	0.000151573	1.00 [0.74 - 1.35]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205047_s_at	77	0.350649	0.180029	-	0.364543	0.468831	0.152995	1.17 [0.77 - 1.76]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	241082_at	77	0.883117	7.35955e-06	0.000338329	1.66519	0.0925598	0.380189	1.46 [0.94 - 2.28]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	241082_at	70	0.785714	0.0909525	-	0.553821	0.605901	0.752399	2.12 [0.12 - 36.99]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205047_s_at	70	0.885714	0.193208	-	0.559492	0.980197	0.00597507	1.01 [0.63 - 1.61]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36671_at	50	0.82	8.27638e-06	0.00037638	1.80621	0.0094423	0.654173	1.92 [1.17 - 3.15]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205047_s_at	74	0.77027	0.00083717	0.0219471	0.993508	0.0175527	0.790913	2.21 [1.15 - 4.24]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	241082_at	74	0.648649	0.00446861	0.086612	0.8175	0.0879864	0.313093	1.37 [0.95 - 1.96]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205047_s_at	67	0.761194	9.20804e-05	0.00325663	2.28582	0.041911	1.63787	5.14 [1.06 - 24.92]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	241082_at	67	0.119403	0.0345242	0.388823	-1.39903	0.647478	-1.64951	0.19 [0.00 - 226.06]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	241082_at	115	0.33913	0.026786	0.328157	1.96624	0.19256	0.500839	1.65 [0.78 - 3.50]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205047_s_at	115	0.895652	0.162044	-	0.885796	0.697451	0.194284	1.21 [0.46 - 3.23]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36671_at	158	0.867089	0.130711	-	0.555016	0.49622	0.229036	1.26 [0.65 - 2.43]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36671_at	76	0.144737	0.165894	-	-0.78933	0.738192	-0.189704	0.83 [0.27 - 2.52]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	241082_at	204	0.813725	0.012681	0.192751	0.44792	0.0836391	0.152691	1.16 [0.98 - 1.38]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205047_s_at	204	0.431373	0.000124287	0.00424024	0.540981	0.00241404	0.333339	1.40 [1.13 - 1.73]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205047_s_at	87	0.344828	0.058803	-	0.846819	0.0999863	0.417276	1.52 [0.92 - 2.50]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	241082_at	87	0.494253	0.107335	-	0.625785	0.877094	-0.199607	0.82 [0.07 - 10.28]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	241082_at	87	0.494253	0.107335	-	0.625785	0.877094	-0.199607	0.82 [0.07 - 10.28]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205047_s_at	87	0.344828	0.058803	-	0.846819	0.0999863	0.417276	1.52 [0.92 - 2.50]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205047_s_at	77	0.532468	0.00463211	0.0891084	2.38199	0.112643	0.649414	1.91 [0.86 - 4.27]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	241082_at	77	0.103896	0.0393307	0.423089	-1.27749	0.428267	1.40721	4.08 [0.13 - 132.82]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205047_s_at	77	0.480519	0.0115635	0.180008	1.72226	0.148914	0.521563	1.68 [0.83 - 3.42]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	241082_at	77	0.103896	0.00894256	0.148381	-1.62942	0.788556	-0.606696	0.55 [0.01 - 45.94]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205047_s_at	136	0.786765	0.262251	-	-0.694226	0.777656	-0.110873	0.90 [0.41 - 1.93]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205047_s_at	200	0.76	0.0211274	0.278492	0.716607	0.153883	0.375606	1.46 [0.87 - 2.44]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19713	60	0.816667	0.112728	-	0.680752	0.791883	0.0595582	1.06 [0.68 - 1.65]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19713	60	0.883333	0.157909	-	0.683221	0.974194	0.00954458	1.01 [0.57 - 1.80]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	4056	155	0.122581	0.00289303	0.0611711	-0.961275	0.192864	-0.249151	0.78 [0.54 - 1.13]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205047_s_at	286	0.339161	0.00561281	0.103626	0.615473	0.0246708	0.354666	1.43 [1.05 - 1.94]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205047_s_at	159	0.830189	3.41334e-05	0.00134892	1.29137	0.000597665	0.787478	2.20 [1.40 - 3.45]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205047_s_at	159	0.830189	0.000169513	0.00556416	1.34037	0.00198856	0.830302	2.29 [1.36 - 3.88]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205047_s_at	159	0.830189	0.00333039	0.0685151	0.976119	0.0239038	0.554649	1.74 [1.08 - 2.82]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241082_at	159	0.716981	0.0467303	0.471616	-0.854495	0.724602	-0.0727269	0.93 [0.62 - 1.39]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241082_at	159	0.748428	0.0930124	-	-0.727883	0.978631	0.00549513	1.01 [0.67 - 1.50]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	241082_at	159	0.786164	0.0441477	0.455215	-1.36628	0.973895	-0.00787704	0.99 [0.62 - 1.59]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205047_s_at	54	0.87037	0.00969199	0.157698	1.69111	0.367213	0.419759	1.52 [0.61 - 3.79]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205047_s_at	117	0.65812	0.10352	-	-0.586796	0.868588	-0.0300705	0.97 [0.68 - 1.39]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205047_s_at	117	0.632479	0.0995167	-	-0.704955	0.520391	-0.136117	0.87 [0.58 - 1.32]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205047_s_at	117	0.65812	0.10352	-	-0.586796	0.868588	-0.0300705	0.97 [0.68 - 1.39]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205047_s_at	117	0.444444	0.220996	-	-0.480525	0.896099	0.0304431	1.03 [0.65 - 1.63]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205047_s_at	236	0.741525	0.00179929	0.0415261	0.844751	0.186042	0.309503	1.36 [0.86 - 2.16]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	241082_at	236	0.559322	0.110271	-	-0.449073	0.8021	-0.0519733	0.95 [0.63 - 1.43]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205047_s_at	249	0.120482	0.058037	-	0.781947	0.321559	0.189125	1.21 [0.83 - 1.76]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	241082_at	249	0.554217	0.0111816	0.175559	-0.564949	0.228165	-0.197622	0.82 [0.60 - 1.13]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205047_s_at	62	0.112903	0.355074	-	-0.685743	0.93943	0.0156298	1.02 [0.68 - 1.52]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205047_s_at	125	0.448	0.0656385	-	0.754455	0.754297	0.0689663	1.07 [0.70 - 1.65]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205047_s_at	125	0.888	0.022065	0.287086	-1.53153	0.774444	-0.0487196	0.95 [0.68 - 1.33]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205047_s_at	54	0.111111	0.071898	-	-1.35051	0.942732	-0.0179122	0.98 [0.60 - 1.60]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205047_s_at	198	0.747475	0.212284	-	-0.413297	0.955599	0.00716088	1.01 [0.78 - 1.30]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205047_s_at	198	0.424242	0.181762	-	0.367554	0.822742	0.0299548	1.03 [0.79 - 1.34]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205047_s_at	198	0.10101	0.0302313	0.356088	-0.621595	0.492728	-0.0717278	0.93 [0.76 - 1.14]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205047_s_at	51	0.470588	0.137942	-	-1.51147	0.372382	-0.487	0.61 [0.21 - 1.79]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205047_s_at	62	0.741935	0.175252	-	-1.31844	0.991887	0.00347334	1.00 [0.51 - 1.96]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205047_s_at	177	0.898305	0.00719877	0.125703	0.996811	0.0376111	0.432747	1.54 [1.03 - 2.32]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	241082_at	177	0.892655	0.00947825	0.155065	-1.66304	0.328975	-1.32152	0.27 [0.02 - 3.79]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205047_s_at	177	0.706215	0.000726686	0.019474	0.795299	0.00409352	0.52171	1.68 [1.18 - 2.41]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	241082_at	145	0.889655	0.147082	-	-1.01231	0.416233	-1.5415	0.21 [0.01 - 8.80]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205047_s_at	145	0.344828	0.0296073	0.351146	0.864157	0.920244	-0.0246595	0.98 [0.60 - 1.58]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	241082_at	177	0.892655	0.0447332	0.458981	-1.34385	0.593205	-0.832556	0.43 [0.02 - 9.23]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	241082_at	226	0.880531	0.127457	-	0.554623	0.543866	0.0842975	1.09 [0.83 - 1.43]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205047_s_at	226	0.278761	0.0663662	-	0.646761	0.825306	0.0391507	1.04 [0.73 - 1.47]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205047_s_at	55	0.272727	0.395211	-	0.471069	0.953624	0.0178269	1.02 [0.56 - 1.86]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	241082_at	49	0.326531	0.0273266	0.332647	1.97641	0.438621	2.17202	8.78 [0.04 - 2139.88]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205047_s_at	55	0.309091	0.00439909	0.0855434	2.34145	0.0472894	0.660192	1.94 [1.01 - 3.72]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	241082_at	55	0.254545	0.0186862	0.255347	2.00595	0.2385	2.72726	15.29 [0.16 - 1425.26]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205047_s_at	49	0.265306	0.152376	-	1.38353	0.447114	0.313169	1.37 [0.61 - 3.07]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	241082_at	55	0.327273	0.120732	-	0.846298	0.577099	1.18953	3.29 [0.05 - 215.00]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	241082_at	63	0.142857	0.00047295	0.0135122	-1.30855	0.0772853	-7.31558	0.00 [0.00 - 2.23]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205047_s_at	63	0.730159	0.0186057	0.254564	0.809595	0.440117	0.10439	1.11 [0.85 - 1.45]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.202216.0.A1_3p_at	28	0.535714	0.0129433	0.195684	-1.547	0.421619	-0.496273	0.61 [0.18 - 2.04]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502258_3p_a_at	28	0.25	0.00699006	0.122884	-1.37414	0.399937	-0.425889	0.65 [0.24 - 1.76]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205047_s_at	82	0.365854	0.044299	0.456191	-0.673464	0.650973	-0.105928	0.90 [0.57 - 1.42]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36671_at	84	0.654762	0.00149994	0.0357331	0.896485	0.180653	0.291761	1.34 [0.87 - 2.05]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205047_s_at	79	0.316456	0.194941	-	0.372117	0.906805	-0.0235291	0.98 [0.66 - 1.45]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M27396_s_at	86	0.813953	0.0223149	0.289349	0.9906	0.159507	0.499518	1.65 [0.82 - 3.31]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205047_s_at	104	0.115385	0.0375446	0.410629	-0.862265	0.869654	0.0468954	1.05 [0.60 - 1.83]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P232747	117	0.17094	0.0112993	0.176935	-0.820092	0.184372	-0.208786	0.81 [0.60 - 1.10]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P145694	117	0.820513	0.000363823	0.0107892	1.06034	0.0793909	0.310941	1.36 [0.96 - 1.93]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	241082_at	204	0.259804	0.0197848	0.265906	-0.83747	0.394272	-0.225416	0.80 [0.48 - 1.34]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	241082_at	204	0.745098	0.0119082	0.183981	0.695404	0.812816	0.0437046	1.04 [0.73 - 1.50]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205047_s_at	204	0.122549	0.139795	-	-0.663384	0.893831	-0.0556598	0.95 [0.42 - 2.14]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205047_s_at	204	0.75	0.0134301	0.201075	0.684406	0.67782	0.127053	1.14 [0.62 - 2.07]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205047_s_at	178	0.179775	0.00118775	0.0294313	-0.754429	0.599892	-0.101211	0.90 [0.62 - 1.32]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	241082_at	111	0.882883	0.0294172	0.34963	0.773913	0.450227	0.167634	1.18 [0.77 - 1.83]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205047_s_at	111	0.684685	0.0406061	0.4318	-0.63623	0.940507	0.0141883	1.01 [0.70 - 1.47]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205047_s_at	90	0.855556	0.158166	-	0.58382	0.732118	0.0706007	1.07 [0.72 - 1.61]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205047_s_at	90	0.855556	0.0278424	0.336891	0.924287	0.246744	0.261274	1.30 [0.83 - 2.02]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	241082_at	138	0.702899	0.0200741	0.268647	-0.684301	0.0494011	-4.74258	0.01 [0.00 - 0.99]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205047_s_at	138	0.101449	0.0563371	-	-0.644469	0.590551	-0.0527115	0.95 [0.78 - 1.15]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205047_s_at	129	0.891473	0.185787	-	0.453016	0.62121	0.0906017	1.09 [0.76 - 1.57]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13621	56	0.321429	0.0652672	-	-0.678573	0.268503	-0.232177	0.79 [0.53 - 1.20]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	45040	56	0.178571	0.029321	0.348861	-0.87237	0.27711	-0.263836	0.77 [0.48 - 1.24]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	981	56	0.589286	0.121348	-	-0.549508	0.188164	-0.253346	0.78 [0.53 - 1.13]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42243	56	0.732143	0.0693798	-	-0.756293	0.203784	-0.289678	0.75 [0.48 - 1.17]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1224	56	0.160714	0.0891672	-	-0.686795	0.331646	-0.239646	0.79 [0.49 - 1.28]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42896	56	0.464286	0.0641425	-	-0.66452	0.276878	-0.225699	0.80 [0.53 - 1.20]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16646	56	0.160714	0.0184816	0.253354	-0.93344	0.209701	-0.296373	0.74 [0.47 - 1.18]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	981	56	0.321429	0.0652672	-	-0.678573	0.258531	-0.235782	0.79 [0.52 - 1.19]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42243	56	0.267857	0.0873789	-	-0.649997	0.332446	-0.234791	0.79 [0.49 - 1.27]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13621	56	0.392857	0.104626	-	-0.562138	0.195333	-0.250171	0.78 [0.53 - 1.14]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	45040	56	0.178571	0.0332103	0.379031	-0.850536	0.176606	-0.308886	0.73 [0.47 - 1.15]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16646	56	0.160714	0.0199323	0.267305	-0.927034	0.311982	-0.253827	0.78 [0.47 - 1.27]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1224	56	0.732143	0.0472207	0.474669	-0.822308	0.23049	-0.277764	0.76 [0.48 - 1.19]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42896	56	0.589286	0.0825304	-	-0.604977	0.206851	-0.240591	0.79 [0.54 - 1.14]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	241082_at	278	0.586331	0.0247294	0.310693	0.429184	0.603276	0.37353	1.45 [0.36 - 5.94]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205047_s_at	278	0.233813	0.0162347	0.230864	0.63135	0.923456	0.0122978	1.01 [0.79 - 1.30]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205047_s_at	133	0.293233	0.0214116	0.281113	-0.571005	0.363234	-0.106101	0.90 [0.72 - 1.13]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3933	81	0.802469	0.00343663	0.0702631	1.6527	0.676237	0.0780733	1.08 [0.75 - 1.56]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205047_s_at	185	0.135135	0.191802	-	0.344379	0.879401	0.0137577	1.01 [0.85 - 1.21]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205047_s_at	185	0.551351	0.227971	-	-0.215588	0.801227	-0.0248219	0.98 [0.80 - 1.18]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P145694	110	0.854545	0.0410914	0.435074	0.623824	0.126165	0.242826	1.27 [0.93 - 1.74]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P232747	110	0.427273	0.102355	-	-0.376931	0.596012	-0.0870221	0.92 [0.66 - 1.26]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P145694	110	0.136364	0.0555984	-	1.09334	0.224514	0.237398	1.27 [0.86 - 1.86]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P232747	110	0.427273	0.160451	-	-0.417369	0.977983	0.00568338	1.01 [0.67 - 1.51]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205047_s_at	80	0.8	0.0722034	-	0.820202	0.393217	0.237674	1.27 [0.73 - 2.19]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0822	281	0.857651	0.0103425	0.165601	0.485868	0.366055	0.0880568	1.09 [0.90 - 1.32]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205047_s_at	38	0.894737	0.00019371	0.00625096	2.05705	0.0890092	0.429745	1.54 [0.94 - 2.52]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	241082_at	38	0.105263	0.033071	0.377981	-1.32226	0.499097	-0.220859	0.80 [0.42 - 1.52]
GENE	ASNS	asparagine synthetase (glutamine-hydrolyzing)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205047_s_at	140	0.8	0.000748721	0.0199724	0.998255	0.125243	0.31133	1.37 [0.92 - 2.03]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ASPA	aspartoacylase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206030_at	30	0.566667	0.162131	-	0.571896	0.42094	0.296996	1.35 [0.65 - 2.77]
GENE	ASPA	aspartoacylase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1692824	165	0.545455	0.0026627	0.057199	-0.760127	0.18926	-0.328333	0.72 [0.44 - 1.18]
GENE	ASPA	aspartoacylase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1692824	165	0.545455	0.00235549	0.0517748	-1.22391	0.0721431	-0.741109	0.48 [0.21 - 1.07]
GENE	ASPA	aspartoacylase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206030_at	163	0.423313	0.239028	-	-0.232868	0.946614	-0.0473614	0.95 [0.24 - 3.82]
GENE	ASPA	aspartoacylase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206030_at	79	0.341772	0.0962781	-	-0.491302	0.93027	-0.0602711	0.94 [0.24 - 3.63]
GENE	ASPA	aspartoacylase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206030_at	58	0.534483	0.123979	-	-0.422363	0.627988	-0.093076	0.91 [0.63 - 1.33]
GENE	ASPA	aspartoacylase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206030_at	34	0.117647	0.259742	-	-0.605886	0.856114	-0.0456914	0.96 [0.58 - 1.57]
GENE	ASPA	aspartoacylase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206030_at	158	0.202532	0.0216131	0.282963	-0.58648	0.476156	-0.575734	0.56 [0.12 - 2.74]
GENE	ASPA	aspartoacylase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206030_at	53	0.339623	0.441697	-	0.30642	0.92479	0.0206456	1.02 [0.66 - 1.57]
GENE	ASPA	aspartoacylase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206030_at	53	0.339623	0.153083	-	0.550072	0.650847	0.0952303	1.10 [0.73 - 1.66]
GENE	ASPA	aspartoacylase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206030_at	180	0.361111	0.146553	-	-0.316211	0.804958	-0.0227244	0.98 [0.82 - 1.17]
GENE	ASPA	aspartoacylase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206030_at	559	0.472272	0.00194282	0.0442299	-0.62347	0.107298	-0.168124	0.85 [0.69 - 1.04]
GENE	ASPA	aspartoacylase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206030_at	77	0.623377	0.00467985	0.0898331	-0.784104	0.103933	-0.189706	0.83 [0.66 - 1.04]
GENE	ASPA	aspartoacylase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206030_at	70	0.142857	0.0437201	0.452446	0.846895	0.386009	0.0767894	1.08 [0.91 - 1.28]
GENE	ASPA	aspartoacylase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39654_at	50	0.38	0.0886123	-	-0.606937	0.991159	0.00395479	1.00 [0.50 - 2.02]
GENE	ASPA	aspartoacylase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206030_at	74	0.567568	0.142677	-	0.42482	0.990454	-0.00194882	1.00 [0.73 - 1.37]
GENE	ASPA	aspartoacylase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206030_at	67	0.119403	0.054499	-	-1.28939	0.732923	-0.116271	0.89 [0.46 - 1.74]
GENE	ASPA	aspartoacylase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206030_at	115	0.165217	0.0841638	-	15.3107	0.784645	-0.125409	0.88 [0.36 - 2.17]
GENE	ASPA	aspartoacylase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39654_at	158	0.183544	0.350369	-	0.44061	0.946907	-0.0119748	0.99 [0.69 - 1.41]
GENE	ASPA	aspartoacylase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39654_at	76	0.263158	0.190962	-	0.958261	0.990714	-0.00342613	1.00 [0.56 - 1.77]
GENE	ASPA	aspartoacylase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206030_at	204	0.617647	0.0222538	0.288797	-0.32379	0.116334	-0.097734	0.91 [0.80 - 1.02]
GENE	ASPA	aspartoacylase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206030_at	87	0.367816	0.00243027	0.0531092	-1.1163	0.0249495	-0.697126	0.50 [0.27 - 0.92]
GENE	ASPA	aspartoacylase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206030_at	87	0.367816	0.00243027	0.0531092	-1.1163	0.0249495	-0.697126	0.50 [0.27 - 0.92]
GENE	ASPA	aspartoacylase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206030_at	77	0.597403	0.0457482	0.465443	-1.83681	0.158409	-0.942369	0.39 [0.11 - 1.44]
GENE	ASPA	aspartoacylase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206030_at	77	0.597403	0.0526136	-	-1.37845	0.311664	-0.532805	0.59 [0.21 - 1.65]
GENE	ASPA	aspartoacylase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206030_at	136	0.448529	0.00732582	0.127407	1.52901	0.152799	0.358163	1.43 [0.88 - 2.34]
GENE	ASPA	aspartoacylase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206030_at	200	0.615	0.00417133	0.0820111	-1.02054	0.644529	-0.0784945	0.92 [0.66 - 1.29]
GENE	ASPA	aspartoacylase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1887	60	0.116667	0.0671362	-	1.6687	0.763838	-0.0447203	0.96 [0.71 - 1.28]
GENE	ASPA	aspartoacylase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1887	60	0.8	0.0646444	-	-1.08515	0.704653	-0.0706734	0.93 [0.65 - 1.34]
GENE	ASPA	aspartoacylase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15319	155	0.277419	1.04171e-05	0.000463633	-1.16935	0.0112682	-0.501492	0.61 [0.41 - 0.89]
GENE	ASPA	aspartoacylase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206030_at	286	0.870629	0.0351074	0.393108	-0.756011	0.524972	-0.0661515	0.94 [0.76 - 1.15]
GENE	ASPA	aspartoacylase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206030_at	159	0.880503	0.0285195	0.342409	0.807305	0.527359	0.149775	1.16 [0.73 - 1.85]
GENE	ASPA	aspartoacylase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206030_at	159	0.603774	0.142274	-	-0.50139	0.795902	-0.0571208	0.94 [0.61 - 1.46]
GENE	ASPA	aspartoacylase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206030_at	159	0.54717	0.164647	-	-0.53666	0.661637	0.120768	1.13 [0.66 - 1.94]
GENE	ASPA	aspartoacylase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206030_at	54	0.259259	0.0729977	-	-1.14227	0.797626	-0.280356	0.76 [0.09 - 6.44]
GENE	ASPA	aspartoacylase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206030_at	117	0.247863	0.226129	-	-0.417738	0.792063	-0.169789	0.84 [0.24 - 2.98]
GENE	ASPA	aspartoacylase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206030_at	117	0.871795	0.163114	-	0.681569	0.65521	0.306709	1.36 [0.35 - 5.22]
GENE	ASPA	aspartoacylase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206030_at	117	0.247863	0.226129	-	-0.417738	0.792063	-0.169789	0.84 [0.24 - 2.98]
GENE	ASPA	aspartoacylase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206030_at	117	0.897436	0.128972	-	0.733379	0.427902	0.514872	1.67 [0.47 - 5.98]
GENE	ASPA	aspartoacylase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206030_at	236	0.233051	0.0126642	0.192561	-0.693581	0.0923265	-0.279256	0.76 [0.55 - 1.05]
GENE	ASPA	aspartoacylase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206030_at	249	0.261044	0.0244146	0.307963	-0.505034	0.354684	-0.127024	0.88 [0.67 - 1.15]
GENE	ASPA	aspartoacylase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206030_at	62	0.870968	0.0157441	0.225798	-15.572	0.408662	-0.157746	0.85 [0.59 - 1.24]
GENE	ASPA	aspartoacylase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206030_at	125	0.704	0.0557295	-	-0.997027	0.190393	-0.757636	0.47 [0.15 - 1.46]
GENE	ASPA	aspartoacylase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206030_at	125	0.48	0.0929618	-	-0.502836	0.153013	-0.634378	0.53 [0.22 - 1.27]
GENE	ASPA	aspartoacylase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206030_at	54	0.851852	0.0350815	0.392918	-15.6309	0.46529	-0.168594	0.84 [0.54 - 1.33]
GENE	ASPA	aspartoacylase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206030_at	198	0.222222	0.104939	-	0.610768	0.761066	0.0273643	1.03 [0.86 - 1.23]
GENE	ASPA	aspartoacylase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206030_at	198	0.186869	0.0739801	-	0.547977	0.435858	0.0548785	1.06 [0.92 - 1.21]
GENE	ASPA	aspartoacylase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206030_at	198	0.681818	0.168908	-	-0.398648	0.987562	-0.00132646	1.00 [0.85 - 1.18]
GENE	ASPA	aspartoacylase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206030_at	51	0.156863	0.0701226	-	-1.51735	0.330301	-1.33407	0.26 [0.02 - 3.86]
GENE	ASPA	aspartoacylase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206030_at	62	0.741935	0.0197296	0.265381	-15.6215	0.163503	-0.943532	0.39 [0.10 - 1.47]
GENE	ASPA	aspartoacylase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206030_at	177	0.457627	0.0715639	-	-0.422952	0.779368	-0.0929796	0.91 [0.48 - 1.75]
GENE	ASPA	aspartoacylase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206030_at	145	0.103448	0.00148005	0.0353402	-1.15941	0.897521	-0.0713783	0.93 [0.31 - 2.76]
GENE	ASPA	aspartoacylase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206030_at	177	0.214689	0.015916	0.22758	-0.683735	0.753859	-0.121562	0.89 [0.41 - 1.89]
GENE	ASPA	aspartoacylase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206030_at	226	0.738938	0.103635	-	0.475564	0.511204	0.0649628	1.07 [0.88 - 1.30]
GENE	ASPA	aspartoacylase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206030_at	55	0.327273	0.00587735	0.10742	2.26072	0.0405295	0.875146	2.40 [1.04 - 5.54]
GENE	ASPA	aspartoacylase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206030_at	49	0.591837	0.00440601	0.0856499	1.6991	0.0686636	0.965923	2.63 [0.93 - 7.43]
GENE	ASPA	aspartoacylase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206030_at	55	0.490909	5.50226e-05	0.0020644	2.13273	0.0104017	0.964327	2.62 [1.25 - 5.48]
GENE	ASPA	aspartoacylase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206030_at	63	0.349206	0.00129577	0.0316456	-1.07371	0.127153	-0.102421	0.90 [0.79 - 1.03]
GENE	ASPA	aspartoacylase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557334_3p_at	28	0.642857	0.262255	-	-0.665098	0.664528	-0.314163	0.73 [0.18 - 3.02]
GENE	ASPA	aspartoacylase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206030_at	82	0.280488	0.251148	-	-0.40488	0.572931	0.218726	1.24 [0.58 - 2.66]
GENE	ASPA	aspartoacylase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206030_at	79	0.101266	0.045938	0.466642	1.125	0.66122	0.172129	1.19 [0.55 - 2.57]
GENE	ASPA	aspartoacylase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206030_at	104	0.365385	0.0416393	0.438746	-0.648159	0.233857	-0.605	0.55 [0.20 - 1.48]
GENE	ASPA	aspartoacylase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206030_at	204	0.529412	8.5687e-05	0.00305625	-1.83978	0.00348675	-0.496225	0.61 [0.44 - 0.85]
GENE	ASPA	aspartoacylase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206030_at	204	0.27451	8.43194e-08	5.47499e-06	-1.35997	1.3006e-06	-0.62374	0.54 [0.42 - 0.69]
GENE	ASPA	aspartoacylase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206030_at	178	0.47191	0.272302	-	0.217847	0.7896	0.0711351	1.07 [0.64 - 1.81]
GENE	ASPA	aspartoacylase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206030_at	111	0.252252	0.10402	-	-0.475525	0.485585	-0.100321	0.90 [0.68 - 1.20]
GENE	ASPA	aspartoacylase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206030_at	90	0.733333	0.197932	-	-0.532898	0.862397	0.107601	1.11 [0.33 - 3.76]
GENE	ASPA	aspartoacylase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206030_at	90	0.733333	0.20099	-	-0.619238	0.837234	-0.149466	0.86 [0.21 - 3.58]
GENE	ASPA	aspartoacylase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1235	50	0.2	0.101164	-	-0.856624	0.632878	-0.19201	0.83 [0.38 - 1.81]
GENE	ASPA	aspartoacylase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206030_at	138	0.297101	0.000485477	0.0138177	-0.827183	0.695962	-0.171751	0.84 [0.36 - 1.99]
GENE	ASPA	aspartoacylase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206030_at	129	0.581395	0.00749364	0.129645	-0.714066	0.425836	-0.134439	0.87 [0.63 - 1.22]
GENE	ASPA	aspartoacylase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34557	56	0.803571	0.103984	-	0.656981	0.928768	0.02084	1.02 [0.65 - 1.61]
GENE	ASPA	aspartoacylase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44978	56	0.5	0.0590231	-	-0.680233	0.976049	0.00631738	1.01 [0.67 - 1.52]
GENE	ASPA	aspartoacylase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34557	56	0.803571	0.128923	-	0.621477	0.984396	0.00428812	1.00 [0.65 - 1.54]
GENE	ASPA	aspartoacylase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44978	56	0.785714	0.0691216	-	0.70929	0.753922	0.0666606	1.07 [0.70 - 1.62]
GENE	ASPA	aspartoacylase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206030_at	278	0.805755	0.00241519	0.052841	0.621756	0.238124	0.157158	1.17 [0.90 - 1.52]
GENE	ASPA	aspartoacylase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206030_at	133	0.75188	0.0250191	0.313191	0.579584	0.378013	1.37824	3.97 [0.19 - 84.99]
GENE	ASPA	aspartoacylase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206030_at	185	0.654054	0.0343908	0.387837	0.388305	0.334859	0.238368	1.27 [0.78 - 2.06]
GENE	ASPA	aspartoacylase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206030_at	185	0.118919	0.123553	-	0.365556	0.563341	0.133272	1.14 [0.73 - 1.80]
GENE	ASPA	aspartoacylase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P164436	110	0.4	0.162687	-	0.423662	0.679767	0.0612783	1.06 [0.79 - 1.42]
GENE	ASPA	aspartoacylase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P373475	110	0.309091	0.0170627	0.239283	0.640034	0.54773	0.0633915	1.07 [0.87 - 1.31]
GENE	ASPA	aspartoacylase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P164436	110	0.109091	0.028834	0.344951	-0.707419	0.849075	0.0233323	1.02 [0.80 - 1.30]
GENE	ASPA	aspartoacylase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P373475	110	0.409091	0.13651	-	0.467721	0.680023	0.0592062	1.06 [0.80 - 1.41]
GENE	ASPA	aspartoacylase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206030_at	80	0.1125	0.124152	-	-0.776837	0.380837	-0.12957	0.88 [0.66 - 1.17]
GENE	ASPA	aspartoacylase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_2136	281	0.145907	0.0221408	0.287773	-0.435238	0.229413	-0.0908535	0.91 [0.79 - 1.06]
GENE	ASPA	aspartoacylase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206030_at	38	0.342105	0.174902	-	0.705019	0.599895	0.100523	1.11 [0.76 - 1.61]
GENE	ASPA	aspartoacylase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206030_at	140	0.142857	0.000288876	0.00884268	-1.10049	0.0116898	-0.276675	0.76 [0.61 - 0.94]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ASRGL1	asparaginase like 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218857_s_at	30	0.533333	0.0104877	0.167342	1.10229	0.213275	0.401227	1.49 [0.79 - 2.81]
GENE	ASRGL1	asparaginase like 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1810199	165	0.854545	0.0832496	-	0.530024	0.487798	0.118377	1.13 [0.81 - 1.57]
GENE	ASRGL1	asparaginase like 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1810199	165	0.466667	0.109422	-	0.58681	0.332051	0.218696	1.24 [0.80 - 1.94]
GENE	ASRGL1	asparaginase like 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218857_s_at	163	0.110429	0.0130952	0.197374	-0.684106	0.364669	-0.132548	0.88 [0.66 - 1.17]
GENE	ASRGL1	asparaginase like 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222764_at	163	0.822086	0.0436823	0.452201	-0.573477	0.67433	-0.0700954	0.93 [0.67 - 1.29]
GENE	ASRGL1	asparaginase like 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218857_s_at	79	0.367089	0.0711044	-	0.571737	0.540858	0.0936578	1.10 [0.81 - 1.48]
GENE	ASRGL1	asparaginase like 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222764_at	79	0.493671	0.143168	-	0.428106	0.496625	0.101586	1.11 [0.83 - 1.48]
GENE	ASRGL1	asparaginase like 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218857_s_at	58	0.87931	0.041098	0.435119	0.82645	0.123107	0.267286	1.31 [0.93 - 1.84]
GENE	ASRGL1	asparaginase like 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218857_s_at	34	0.882353	4.62501e-07	2.66804e-05	2.6782	0.811056	0.0628994	1.06 [0.64 - 1.78]
GENE	ASRGL1	asparaginase like 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218857_s_at	158	0.620253	0.00135811	0.0329067	-0.865975	0.040183	-0.620711	0.54 [0.30 - 0.97]
GENE	ASRGL1	asparaginase like 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218857_s_at	53	0.54717	0.0923418	-	0.612085	0.460834	0.205505	1.23 [0.71 - 2.12]
GENE	ASRGL1	asparaginase like 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218857_s_at	53	0.54717	0.197544	-	0.440058	0.665098	0.110313	1.12 [0.68 - 1.84]
GENE	ASRGL1	asparaginase like 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218857_s_at	180	0.15	0.046391	0.469492	-0.567894	0.622037	-0.0701865	0.93 [0.71 - 1.23]
GENE	ASRGL1	asparaginase like 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222764_at	180	0.327778	0.0656889	-	-0.394735	0.307465	-0.125411	0.88 [0.69 - 1.12]
GENE	ASRGL1	asparaginase like 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218857_s_at	559	0.826476	0.000260731	0.008092	0.804094	0.705423	0.056994	1.06 [0.79 - 1.42]
GENE	ASRGL1	asparaginase like 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222764_at	559	0.148479	0.281316	-	-0.264375	0.963765	-0.00432084	1.00 [0.83 - 1.20]
GENE	ASRGL1	asparaginase like 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218857_s_at	77	0.896104	0.0194617	0.262826	-1.32464	0.224066	-0.299688	0.74 [0.46 - 1.20]
GENE	ASRGL1	asparaginase like 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222764_at	77	0.324675	0.158031	-	-0.372877	0.905714	0.036171	1.04 [0.57 - 1.89]
GENE	ASRGL1	asparaginase like 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218857_s_at	70	0.4	0.0379942	0.413794	0.576505	0.230703	0.316359	1.37 [0.82 - 2.30]
GENE	ASRGL1	asparaginase like 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222764_at	70	0.528571	0.0644602	-	0.484126	0.46023	0.151199	1.16 [0.78 - 1.74]
GENE	ASRGL1	asparaginase like 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218857_s_at	74	0.608108	0.00242337	0.0529865	0.856792	0.698014	0.145412	1.16 [0.55 - 2.41]
GENE	ASRGL1	asparaginase like 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222764_at	74	0.864865	0.00481075	0.0918099	1.02603	0.308494	0.366188	1.44 [0.71 - 2.92]
GENE	ASRGL1	asparaginase like 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218857_s_at	67	0.850746	0.241849	-	-15.2303	0.906825	0.123103	1.13 [0.14 - 8.89]
GENE	ASRGL1	asparaginase like 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222764_at	67	0.552239	0.0923722	-	1.13727	0.506181	0.747559	2.11 [0.23 - 19.14]
GENE	ASRGL1	asparaginase like 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218857_s_at	115	0.104348	0.148335	-	-0.91341	0.926597	0.0469439	1.05 [0.39 - 2.85]
GENE	ASRGL1	asparaginase like 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222764_at	115	0.6	0.140194	-	-0.926158	0.885915	-0.0624403	0.94 [0.40 - 2.20]
GENE	ASRGL1	asparaginase like 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222764_at	204	0.112745	0.101104	-	-0.35901	0.451652	-0.0461635	0.95 [0.85 - 1.08]
GENE	ASRGL1	asparaginase like 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218857_s_at	204	0.730392	0.180261	-	0.207074	0.675242	-0.0275237	0.97 [0.86 - 1.11]
GENE	ASRGL1	asparaginase like 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218857_s_at	87	0.252874	0.0938746	-	-0.655708	0.709798	-0.0568848	0.94 [0.70 - 1.27]
GENE	ASRGL1	asparaginase like 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222764_at	87	0.724138	0.292218	-	-0.48129	0.692036	-0.0543123	0.95 [0.72 - 1.24]
GENE	ASRGL1	asparaginase like 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222764_at	87	0.724138	0.292218	-	-0.48129	0.692036	-0.0543123	0.95 [0.72 - 1.24]
GENE	ASRGL1	asparaginase like 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218857_s_at	87	0.252874	0.0938746	-	-0.655708	0.709798	-0.0568848	0.94 [0.70 - 1.27]
GENE	ASRGL1	asparaginase like 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218857_s_at	77	0.103896	0.0339994	0.384934	-1.35833	0.980943	0.0068371	1.01 [0.57 - 1.76]
GENE	ASRGL1	asparaginase like 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222764_at	77	0.103896	0.285562	-	-0.821911	0.66063	0.102387	1.11 [0.70 - 1.75]
GENE	ASRGL1	asparaginase like 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222764_at	77	0.272727	0.124916	-	-0.830168	0.858032	-0.0411814	0.96 [0.61 - 1.51]
GENE	ASRGL1	asparaginase like 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218857_s_at	77	0.103896	0.135026	-	-0.948552	0.706047	-0.102878	0.90 [0.53 - 1.54]
GENE	ASRGL1	asparaginase like 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218857_s_at	136	0.352941	0.121969	-	0.841641	0.723912	0.0751265	1.08 [0.71 - 1.64]
GENE	ASRGL1	asparaginase like 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218857_s_at	200	0.76	4.90767e-05	0.0018648	1.15095	0.157108	0.247338	1.28 [0.91 - 1.80]
GENE	ASRGL1	asparaginase like 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16592	60	0.233333	0.00138265	0.0333999	2.5366	0.153553	0.126453	1.13 [0.95 - 1.35]
GENE	ASRGL1	asparaginase like 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16592	60	0.383333	0.0411118	0.435211	0.86755	0.334444	0.121899	1.13 [0.88 - 1.45]
GENE	ASRGL1	asparaginase like 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218857_s_at	286	0.227273	0.136605	-	-0.319654	0.754182	-0.0321451	0.97 [0.79 - 1.18]
GENE	ASRGL1	asparaginase like 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218857_s_at	159	0.779874	0.0500364	-	0.650733	0.292341	0.183939	1.20 [0.85 - 1.69]
GENE	ASRGL1	asparaginase like 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218857_s_at	159	0.773585	0.0013287	0.0323132	0.997675	0.0817435	0.305319	1.36 [0.96 - 1.91]
GENE	ASRGL1	asparaginase like 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218857_s_at	159	0.792453	0.00183502	0.0422033	1.11737	0.122317	0.319264	1.38 [0.92 - 2.06]
GENE	ASRGL1	asparaginase like 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222764_at	159	0.427673	0.0259232	0.320907	-0.698674	0.960967	-0.00655542	0.99 [0.76 - 1.29]
GENE	ASRGL1	asparaginase like 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222764_at	159	0.867925	0.00843473	0.141928	0.930721	0.0811453	0.248298	1.28 [0.97 - 1.69]
GENE	ASRGL1	asparaginase like 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222764_at	159	0.867925	0.00874014	0.145822	1.04262	0.251602	0.191387	1.21 [0.87 - 1.68]
GENE	ASRGL1	asparaginase like 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218857_s_at	54	0.333333	0.0216745	0.283525	-1.52676	0.773607	-0.0868743	0.92 [0.51 - 1.66]
GENE	ASRGL1	asparaginase like 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218857_s_at	117	0.803419	0.101728	-	-0.838611	0.35135	-0.155954	0.86 [0.62 - 1.19]
GENE	ASRGL1	asparaginase like 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218857_s_at	117	0.641026	0.125278	-	-0.699285	0.242038	-0.247292	0.78 [0.52 - 1.18]
GENE	ASRGL1	asparaginase like 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218857_s_at	117	0.803419	0.101728	-	-0.838611	0.35135	-0.155954	0.86 [0.62 - 1.19]
GENE	ASRGL1	asparaginase like 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218857_s_at	117	0.42735	0.0330216	0.377608	-0.804187	0.43866	-0.155494	0.86 [0.58 - 1.27]
GENE	ASRGL1	asparaginase like 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218857_s_at	236	0.487288	0.0438042	0.452992	0.557818	0.224383	0.174672	1.19 [0.90 - 1.58]
GENE	ASRGL1	asparaginase like 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222764_at	236	0.5	0.0549582	-	0.52668	0.363487	0.110598	1.12 [0.88 - 1.42]
GENE	ASRGL1	asparaginase like 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218857_s_at	249	0.738956	0.145256	-	0.333395	0.90905	0.0129916	1.01 [0.81 - 1.27]
GENE	ASRGL1	asparaginase like 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222764_at	249	0.176707	0.0179029	0.247668	-0.576604	0.736353	-0.0323284	0.97 [0.80 - 1.17]
GENE	ASRGL1	asparaginase like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218857_s_at	125	0.592	0.166152	-	0.519523	0.653868	0.115456	1.12 [0.68 - 1.86]
GENE	ASRGL1	asparaginase like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218857_s_at	125	0.504	0.0530015	-	0.559049	0.259812	0.210947	1.23 [0.86 - 1.78]
GENE	ASRGL1	asparaginase like 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218857_s_at	54	0.851852	0.0800902	-	-15.4193	0.36004	-0.192042	0.83 [0.55 - 1.25]
GENE	ASRGL1	asparaginase like 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218857_s_at	62	0.693548	0.0593064	-	-1.07512	0.258765	-0.19778	0.82 [0.58 - 1.16]
GENE	ASRGL1	asparaginase like 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218857_s_at	198	0.848485	0.00975813	0.158509	-0.982796	0.268586	-0.0868559	0.92 [0.79 - 1.07]
GENE	ASRGL1	asparaginase like 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218857_s_at	198	0.823232	0.0577803	-	-0.794857	0.54392	-0.0586004	0.94 [0.78 - 1.14]
GENE	ASRGL1	asparaginase like 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218857_s_at	198	0.813131	0.0861276	-	-0.726094	0.68785	-0.0395269	0.96 [0.79 - 1.17]
GENE	ASRGL1	asparaginase like 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218857_s_at	51	0.117647	0.0369309	0.406274	-1.69653	0.144724	-1.75162	0.17 [0.02 - 1.83]
GENE	ASRGL1	asparaginase like 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218857_s_at	62	0.758065	0.0367002	0.404628	-15.5087	0.107092	-1.09533	0.33 [0.09 - 1.27]
GENE	ASRGL1	asparaginase like 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222764_at	177	0.180791	0.0476921	0.477587	-0.606119	0.305992	-0.229987	0.79 [0.51 - 1.23]
GENE	ASRGL1	asparaginase like 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218857_s_at	177	0.112994	0.0500576	-	-0.67381	0.207768	-0.301671	0.74 [0.46 - 1.18]
GENE	ASRGL1	asparaginase like 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222764_at	177	0.367232	0.0162953	0.231486	-0.564623	0.0999411	-0.326253	0.72 [0.49 - 1.06]
GENE	ASRGL1	asparaginase like 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218857_s_at	177	0.706215	0.0377402	0.412009	-0.595286	0.0781972	-0.370865	0.69 [0.46 - 1.04]
GENE	ASRGL1	asparaginase like 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222764_at	145	0.103448	0.00718652	0.125538	-1.03254	0.0817087	-0.496301	0.61 [0.35 - 1.06]
GENE	ASRGL1	asparaginase like 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218857_s_at	145	0.103448	0.0120032	0.185069	-1.02047	0.0781298	-0.536726	0.58 [0.32 - 1.06]
GENE	ASRGL1	asparaginase like 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222764_at	226	0.212389	0.00119512	0.0295837	-0.924724	4.79761e-05	-0.390517	0.68 [0.56 - 0.82]
GENE	ASRGL1	asparaginase like 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218857_s_at	226	0.442478	3.13212e-05	0.00124908	-1.18575	0.000130755	-0.72187	0.49 [0.34 - 0.70]
GENE	ASRGL1	asparaginase like 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222764_at	55	0.6	0.0210335	0.277622	-1.21532	0.108193	-0.633447	0.53 [0.25 - 1.15]
GENE	ASRGL1	asparaginase like 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218857_s_at	55	0.709091	0.0791011	-	-1.05139	0.371174	-0.312261	0.73 [0.37 - 1.45]
GENE	ASRGL1	asparaginase like 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222764_at	55	0.163636	0.00701571	0.123232	-1.43762	0.0244238	-1.03748	0.35 [0.14 - 0.87]
GENE	ASRGL1	asparaginase like 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222764_at	49	0.816327	0.0441172	0.455018	-15.4841	0.0816339	-0.907309	0.40 [0.15 - 1.12]
GENE	ASRGL1	asparaginase like 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218857_s_at	55	0.181818	0.0701662	-	-0.967881	0.210697	-0.488609	0.61 [0.29 - 1.32]
GENE	ASRGL1	asparaginase like 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218857_s_at	49	0.877551	0.114434	-	-15.3148	0.292644	-0.495225	0.61 [0.24 - 1.53]
GENE	ASRGL1	asparaginase like 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	785955	34	0.147059	0.0772788	-	1.62753	0.177986	1.1203	3.07 [0.60 - 15.65]
GENE	ASRGL1	asparaginase like 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222764_at	63	0.507937	0.000431113	0.012482	-1.22235	0.0119089	-0.434627	0.65 [0.46 - 0.91]
GENE	ASRGL1	asparaginase like 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218857_s_at	63	0.222222	1.51134e-09	1.24126e-07	-2.10032	7.90678e-05	-0.610536	0.54 [0.40 - 0.74]
GENE	ASRGL1	asparaginase like 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.7331.0.A2_3p_at	28	0.321429	0.0691516	-	-1.03791	0.544075	-1.2035	0.30 [0.01 - 14.65]
GENE	ASRGL1	asparaginase like 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13376633_3p_a_at	28	0.178571	0.0229761	0.29529	-1.37487	0.225822	-4.17676	0.02 [0.00 - 13.23]
GENE	ASRGL1	asparaginase like 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218857_s_at	82	0.792683	0.0335322	0.381448	0.799227	0.225065	0.386292	1.47 [0.79 - 2.75]
GENE	ASRGL1	asparaginase like 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218857_s_at	79	0.35443	0.0171463	0.240125	-0.638918	0.0317357	-0.559537	0.57 [0.34 - 0.95]
GENE	ASRGL1	asparaginase like 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218857_s_at	104	0.163462	0.0756814	-	1.02596	0.774814	0.0816798	1.09 [0.62 - 1.90]
GENE	ASRGL1	asparaginase like 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P379864	117	0.871795	0.114472	-	0.574744	0.809514	0.0268537	1.03 [0.83 - 1.28]
GENE	ASRGL1	asparaginase like 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P203391	117	0.495726	0.131333	-	-0.432717	0.718897	-0.0537572	0.95 [0.71 - 1.27]
GENE	ASRGL1	asparaginase like 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P203392	117	0.512821	0.311597	-	0.289684	0.833279	0.0301972	1.03 [0.78 - 1.37]
GENE	ASRGL1	asparaginase like 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P1936	117	0.529915	0.3553	-	0.264217	0.837052	0.0283059	1.03 [0.79 - 1.35]
GENE	ASRGL1	asparaginase like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218857_s_at	204	0.112745	1.23334e-09	1.0237e-07	-1.64754	2.73459e-06	-1.1072	0.33 [0.21 - 0.52]
GENE	ASRGL1	asparaginase like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222764_at	204	0.245098	4.28679e-05	0.00165316	-1.38839	0.0358831	-0.776541	0.46 [0.22 - 0.95]
GENE	ASRGL1	asparaginase like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222764_at	204	0.25	3.93439e-06	0.000191271	-1.19198	0.000359027	-0.994835	0.37 [0.21 - 0.64]
GENE	ASRGL1	asparaginase like 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218857_s_at	204	0.142157	5.7922e-07	3.28599e-05	-1.67757	0.0029261	-0.920962	0.40 [0.22 - 0.73]
GENE	ASRGL1	asparaginase like 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218857_s_at	178	0.168539	0.0796149	-	-0.420887	0.777586	-0.0435308	0.96 [0.71 - 1.30]
GENE	ASRGL1	asparaginase like 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300011005	41	0.439024	0.228366	-	-0.498204	0.825092	-0.0447424	0.96 [0.64 - 1.42]
GENE	ASRGL1	asparaginase like 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218857_s_at	111	0.666667	0.0799064	-	-0.520197	0.129405	-0.215503	0.81 [0.61 - 1.07]
GENE	ASRGL1	asparaginase like 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222764_at	111	0.513514	0.105663	-	-0.426342	0.322787	-0.107745	0.90 [0.73 - 1.11]
GENE	ASRGL1	asparaginase like 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218857_s_at	90	0.644444	0.219687	-	0.454547	0.952881	-0.0189825	0.98 [0.52 - 1.84]
GENE	ASRGL1	asparaginase like 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218857_s_at	90	0.644444	0.281379	-	0.352292	0.875855	0.0422672	1.04 [0.61 - 1.77]
GENE	ASRGL1	asparaginase like 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222764_at	138	0.572464	0.023139	0.296741	0.546717	0.335694	0.0710622	1.07 [0.93 - 1.24]
GENE	ASRGL1	asparaginase like 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218857_s_at	138	0.528986	0.0443293	0.456386	0.487949	0.468114	0.0537033	1.06 [0.91 - 1.22]
GENE	ASRGL1	asparaginase like 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218857_s_at	129	0.573643	0.0325935	0.374367	-0.557728	0.503553	-0.103264	0.90 [0.67 - 1.22]
GENE	ASRGL1	asparaginase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21912	56	0.571429	0.0632516	-	0.645224	0.347556	0.163793	1.18 [0.84 - 1.66]
GENE	ASRGL1	asparaginase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23451	56	0.160714	0.158589	-	-0.577605	0.711424	-0.0535546	0.95 [0.71 - 1.26]
GENE	ASRGL1	asparaginase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21847	56	0.785714	0.183187	-	0.519049	0.553618	0.0987241	1.10 [0.80 - 1.53]
GENE	ASRGL1	asparaginase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21912	56	0.571429	0.153376	-	0.506114	0.4884	0.127355	1.14 [0.79 - 1.63]
GENE	ASRGL1	asparaginase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28595	56	0.5	0.0588675	-	0.63823	0.801304	0.0598894	1.06 [0.67 - 1.69]
GENE	ASRGL1	asparaginase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21847	56	0.5	0.306766	-	0.366046	0.762494	0.0531781	1.05 [0.75 - 1.49]
GENE	ASRGL1	asparaginase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23451	56	0.553571	0.267754	-	-0.385475	0.807849	-0.0330788	0.97 [0.74 - 1.26]
GENE	ASRGL1	asparaginase like 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28595	56	0.196429	0.0408035	0.433134	-0.824993	0.944832	0.0179949	1.02 [0.61 - 1.70]
GENE	ASRGL1	asparaginase like 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222764_at	278	0.776978	0.000277202	0.00853274	-1.09593	0.000894716	-0.229349	0.80 [0.69 - 0.91]
GENE	ASRGL1	asparaginase like 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218857_s_at	278	0.827338	0.000124045	0.004233	-1.46961	0.000640243	-0.248942	0.78 [0.68 - 0.90]
GENE	ASRGL1	asparaginase like 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218857_s_at	133	0.443609	0.00178947	0.0413394	-0.733355	0.131444	-0.0984429	0.91 [0.80 - 1.03]
GENE	ASRGL1	asparaginase like 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1693	81	0.395062	0.0339413	0.384502	-1.079	0.176286	-0.223662	0.80 [0.58 - 1.11]
GENE	ASRGL1	asparaginase like 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218857_s_at	185	0.897297	0.0929223	-	-0.442978	0.216192	-0.112315	0.89 [0.75 - 1.07]
GENE	ASRGL1	asparaginase like 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218857_s_at	185	0.897297	0.0671692	-	-0.550597	0.187686	-0.131273	0.88 [0.72 - 1.07]
GENE	ASRGL1	asparaginase like 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P203392	110	0.118182	0.00230644	0.0508944	-1.05704	0.0168954	-0.285081	0.75 [0.60 - 0.95]
GENE	ASRGL1	asparaginase like 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P203391	110	0.127273	0.0211081	0.278313	-0.76444	0.0847292	-0.185896	0.83 [0.67 - 1.03]
GENE	ASRGL1	asparaginase like 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P1936	110	0.109091	0.00264534	0.0568965	-1.04031	0.0220092	-0.276094	0.76 [0.60 - 0.96]
GENE	ASRGL1	asparaginase like 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P379864	110	0.409091	0.0276662	0.335446	-0.509824	0.049498	-0.173691	0.84 [0.71 - 1.00]
GENE	ASRGL1	asparaginase like 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P203391	110	0.127273	0.00159146	0.0375278	-1.09852	0.0316201	-0.298565	0.74 [0.57 - 0.97]
GENE	ASRGL1	asparaginase like 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P203392	110	0.118182	0.00631892	0.113649	-0.857031	0.0337889	-0.198654	0.82 [0.68 - 0.98]
GENE	ASRGL1	asparaginase like 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P379864	110	0.109091	0.00272591	0.0582967	-1.0835	0.0200427	-0.260927	0.77 [0.62 - 0.96]
GENE	ASRGL1	asparaginase like 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P1936	110	0.109091	0.0190188	0.25857	-0.769873	0.0520129	-0.184011	0.83 [0.69 - 1.00]
GENE	ASRGL1	asparaginase like 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218857_s_at	80	0.6375	0.00918978	0.151481	-1.48802	0.0738703	-0.294063	0.75 [0.54 - 1.03]
GENE	ASRGL1	asparaginase like 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3923	281	0.882562	0.0256938	0.31896	0.446764	0.10411	0.0853393	1.09 [0.98 - 1.21]
GENE	ASRGL1	asparaginase like 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:740172	59	0.305085	8.52885e-06	0.000386781	-1.96179	0.00563185	-1.51402	0.22 [0.08 - 0.64]
GENE	ASRGL1	asparaginase like 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222764_at	38	0.736842	0.000352503	0.0104996	1.68895	0.00703019	0.65184	1.92 [1.19 - 3.08]
GENE	ASRGL1	asparaginase like 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218857_s_at	38	0.789474	0.00172696	0.0401463	1.50026	0.0186671	0.802884	2.23 [1.14 - 4.36]
GENE	ASRGL1	asparaginase like 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218857_s_at	140	0.142857	0.0168557	0.237193	-0.802086	0.164839	-0.851573	0.43 [0.13 - 1.42]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ASS1	argininosuccinate synthase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207076_s_at	30	0.166667	0.15655	-	-0.725138	0.493972	-0.12303	0.88 [0.62 - 1.26]
GENE	ASS1	argininosuccinate synthase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1708778	165	0.575758	0.187763	-	-0.326846	0.932827	0.00803965	1.01 [0.84 - 1.22]
GENE	ASS1	argininosuccinate synthase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1708778	165	0.569697	0.00636158	0.114244	-1.10987	0.0710905	-0.245762	0.78 [0.60 - 1.02]
GENE	ASS1	argininosuccinate synthase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207076_s_at	163	0.865031	0.0703378	-	0.490397	0.707088	0.177839	1.19 [0.47 - 3.02]
GENE	ASS1	argininosuccinate synthase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207076_s_at	79	0.835443	0.000443902	0.0127986	1.13775	0.447688	0.12223	1.13 [0.82 - 1.55]
GENE	ASS1	argininosuccinate synthase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207076_s_at	58	0.275862	0.0369406	0.406344	-0.639698	0.781616	-0.0453605	0.96 [0.69 - 1.32]
GENE	ASS1	argininosuccinate synthase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207076_s_at	34	0.764706	0.0480718	0.479924	-1.0655	0.733923	-0.100656	0.90 [0.51 - 1.62]
GENE	ASS1	argininosuccinate synthase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207076_s_at	158	0.151899	0.002228	0.0494777	-0.826483	0.844938	-0.0837421	0.92 [0.40 - 2.13]
GENE	ASS1	argininosuccinate synthase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207076_s_at	53	0.358491	0.246919	-	0.434396	0.875615	0.0453182	1.05 [0.59 - 1.85]
GENE	ASS1	argininosuccinate synthase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207076_s_at	53	0.358491	0.0682932	-	0.769964	0.40041	0.27639	1.32 [0.69 - 2.51]
GENE	ASS1	argininosuccinate synthase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207076_s_at	180	0.888889	0.117665	-	0.466193	0.402979	0.206545	1.23 [0.76 - 1.99]
GENE	ASS1	argininosuccinate synthase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207076_s_at	559	0.892665	0.126897	-	-0.556612	0.723194	0.024398	1.02 [0.90 - 1.17]
GENE	ASS1	argininosuccinate synthase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207076_s_at	77	0.623377	0.22357	-	0.310872	0.399676	0.149647	1.16 [0.82 - 1.65]
GENE	ASS1	argininosuccinate synthase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207076_s_at	70	0.285714	0.254078	-	-0.328483	0.623355	-0.0659773	0.94 [0.72 - 1.22]
GENE	ASS1	argininosuccinate synthase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40541_at	50	0.18	0.0525964	-	-0.904505	0.162663	0.390695	1.48 [0.85 - 2.56]
GENE	ASS1	argininosuccinate synthase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207076_s_at	74	0.418919	0.000996771	0.0254162	1.0347	0.118004	0.334538	1.40 [0.92 - 2.13]
GENE	ASS1	argininosuccinate synthase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207076_s_at	67	0.283582	0.154055	-	1.40058	0.764083	0.154657	1.17 [0.43 - 3.20]
GENE	ASS1	argininosuccinate synthase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207076_s_at	115	0.817391	0.00946785	0.154936	1.30741	0.145901	0.457355	1.58 [0.85 - 2.93]
GENE	ASS1	argininosuccinate synthase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40541_at	158	0.702532	0.0024162	0.052859	0.844293	0.0322594	0.460667	1.59 [1.04 - 2.42]
GENE	ASS1	argininosuccinate synthase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40541_at	76	0.105263	0.186308	-	-0.830414	0.88011	-0.055384	0.95 [0.46 - 1.94]
GENE	ASS1	argininosuccinate synthase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207076_s_at	204	0.759804	4.13114e-05	0.00159954	0.683336	0.00317538	0.196233	1.22 [1.07 - 1.39]
GENE	ASS1	argininosuccinate synthase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207076_s_at	87	0.103448	0.0218091	0.284755	-1.10493	0.693754	-0.0632999	0.94 [0.68 - 1.29]
GENE	ASS1	argininosuccinate synthase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207076_s_at	87	0.103448	0.0218091	0.284755	-1.10493	0.693754	-0.0632999	0.94 [0.68 - 1.29]
GENE	ASS1	argininosuccinate synthase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207076_s_at	77	0.519481	0.0716501	-	-1.12565	0.309005	-0.203835	0.82 [0.55 - 1.21]
GENE	ASS1	argininosuccinate synthase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207076_s_at	77	0.220779	0.18957	-	-0.823433	0.716491	-0.0784986	0.92 [0.61 - 1.41]
GENE	ASS1	argininosuccinate synthase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207076_s_at	136	0.375	0.00329804	0.0679802	-1.29225	0.0585111	-0.469495	0.63 [0.38 - 1.02]
GENE	ASS1	argininosuccinate synthase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207076_s_at	200	0.105	0.121139	-	-0.669116	0.953099	-0.0105801	0.99 [0.70 - 1.41]
GENE	ASS1	argininosuccinate synthase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2798	60	0.7	0.0780972	-	0.660509	0.15311	0.203226	1.23 [0.93 - 1.62]
GENE	ASS1	argininosuccinate synthase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2798	60	0.25	0.0374109	0.409683	1.20128	0.0721169	0.272295	1.31 [0.98 - 1.77]
GENE	ASS1	argininosuccinate synthase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207076_s_at	286	0.202797	0.0642741	-	-0.40452	0.737048	-0.0367513	0.96 [0.78 - 1.19]
GENE	ASS1	argininosuccinate synthase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207076_s_at	159	0.238994	0.0203158	0.270924	-0.740694	0.823068	0.0446754	1.05 [0.71 - 1.55]
GENE	ASS1	argininosuccinate synthase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207076_s_at	159	0.163522	0.0199354	0.267335	-0.903754	0.453823	0.176333	1.19 [0.75 - 1.89]
GENE	ASS1	argininosuccinate synthase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207076_s_at	159	0.201258	0.00642481	0.115124	-0.876264	0.754553	0.0630439	1.07 [0.72 - 1.58]
GENE	ASS1	argininosuccinate synthase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207076_s_at	54	0.111111	0.108268	-	-1.23293	0.614007	-0.136859	0.87 [0.51 - 1.48]
GENE	ASS1	argininosuccinate synthase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207076_s_at	117	0.529915	0.106218	-	-0.522272	0.974123	-0.00373598	1.00 [0.79 - 1.25]
GENE	ASS1	argininosuccinate synthase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207076_s_at	117	0.529915	0.0723133	-	-0.711667	0.714531	-0.0503135	0.95 [0.73 - 1.25]
GENE	ASS1	argininosuccinate synthase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207076_s_at	117	0.529915	0.106218	-	-0.522272	0.974123	-0.00373598	1.00 [0.79 - 1.25]
GENE	ASS1	argininosuccinate synthase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207076_s_at	117	0.376068	0.0111599	0.175304	-0.977873	0.0838226	-0.24537	0.78 [0.59 - 1.03]
GENE	ASS1	argininosuccinate synthase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207076_s_at	236	0.826271	0.0775367	-	0.553985	0.45988	0.14265	1.15 [0.79 - 1.68]
GENE	ASS1	argininosuccinate synthase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207076_s_at	249	0.192771	0.0357863	0.398051	-0.504048	0.832793	0.0325142	1.03 [0.76 - 1.40]
GENE	ASS1	argininosuccinate synthase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207076_s_at	62	0.548387	0.0285229	0.342436	-1.10262	0.397815	-0.124347	0.88 [0.66 - 1.18]
GENE	ASS1	argininosuccinate synthase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207076_s_at	125	0.648	0.209413	-	-0.543239	0.731417	-0.0647508	0.94 [0.65 - 1.36]
GENE	ASS1	argininosuccinate synthase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207076_s_at	125	0.528	0.253278	-	0.333429	0.979188	0.00371242	1.00 [0.76 - 1.33]
GENE	ASS1	argininosuccinate synthase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207076_s_at	54	0.444444	0.0532195	-	-1.1331	0.766749	-0.0535586	0.95 [0.67 - 1.35]
GENE	ASS1	argininosuccinate synthase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207076_s_at	198	0.525253	0.0465083	0.470228	0.505917	0.798655	0.0233718	1.02 [0.86 - 1.23]
GENE	ASS1	argininosuccinate synthase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207076_s_at	198	0.525253	0.0282393	0.340134	0.584813	0.688911	0.0384406	1.04 [0.86 - 1.25]
GENE	ASS1	argininosuccinate synthase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207076_s_at	198	0.111111	0.0533064	-	-0.557029	0.434651	-0.059344	0.94 [0.81 - 1.09]
GENE	ASS1	argininosuccinate synthase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207076_s_at	51	0.117647	0.031553	0.366399	-1.73776	0.381212	-0.502445	0.61 [0.20 - 1.86]
GENE	ASS1	argininosuccinate synthase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207076_s_at	62	0.419355	0.144438	-	0.939744	0.283568	0.414512	1.51 [0.71 - 3.23]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207076_s_at	177	0.502825	0.169948	-	0.325425	0.900544	0.0216177	1.02 [0.73 - 1.43]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207076_s_at	145	0.324138	0.0674814	-	0.751922	0.345941	0.218748	1.24 [0.79 - 1.96]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207076_s_at	177	0.502825	0.0873502	-	0.470856	0.936955	0.0157455	1.02 [0.69 - 1.50]
GENE	ASS1	argininosuccinate synthase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207076_s_at	226	0.128319	0.0574505	-	-0.661393	0.567143	-0.114403	0.89 [0.60 - 1.32]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207076_s_at	55	0.818182	0.108928	-	-1.46286	0.431673	-0.25464	0.78 [0.41 - 1.46]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207076_s_at	49	0.897959	0.141562	-	-15.2846	0.43613	-0.25693	0.77 [0.41 - 1.48]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207076_s_at	55	0.527273	0.0506657	-	0.888571	0.685367	0.124629	1.13 [0.62 - 2.07]
GENE	ASS1	argininosuccinate synthase 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	243034	34	0.882353	0.124722	-	-1.44759	0.177055	-0.810018	0.44 [0.14 - 1.44]
GENE	ASS1	argininosuccinate synthase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207076_s_at	63	0.666667	2.6319e-05	0.00106881	1.36189	0.00125408	0.38278	1.47 [1.16 - 1.85]
GENE	ASS1	argininosuccinate synthase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557336_3p_a_at	28	0.892857	0.0886947	-	-15.3296	0.418641	-0.173766	0.84 [0.55 - 1.28]
GENE	ASS1	argininosuccinate synthase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207076_s_at	82	0.829268	0.0269494	0.329519	-1.47156	0.379245	-0.174643	0.84 [0.57 - 1.24]
GENE	ASS1	argininosuccinate synthase 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40541_at	84	0.297619	0.128395	-	-0.452825	0.248028	-0.23736	0.79 [0.53 - 1.18]
GENE	ASS1	argininosuccinate synthase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207076_s_at	79	0.670886	0.00284322	0.0603185	0.796793	0.09852	0.293369	1.34 [0.95 - 1.90]
GENE	ASS1	argininosuccinate synthase 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X01630_at	86	0.488372	0.0553544	-	-0.809558	0.338939	-0.304784	0.74 [0.39 - 1.38]
GENE	ASS1	argininosuccinate synthase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207076_s_at	104	0.625	0.282947	-	0.352794	0.834196	0.0414567	1.04 [0.71 - 1.54]
GENE	ASS1	argininosuccinate synthase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P31921	117	0.153846	0.0677172	-	-0.63987	0.129243	-0.2144	0.81 [0.61 - 1.06]
GENE	ASS1	argininosuccinate synthase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207076_s_at	204	0.166667	0.159019	-	0.99056	0.95284	0.0192654	1.02 [0.54 - 1.93]
GENE	ASS1	argininosuccinate synthase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207076_s_at	204	0.779412	0.00390059	0.0777475	0.801957	0.325212	0.245566	1.28 [0.78 - 2.09]
GENE	ASS1	argininosuccinate synthase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207076_s_at	178	0.151685	0.00406235	0.0803035	-0.703665	0.78042	-0.0363604	0.96 [0.75 - 1.25]
GENE	ASS1	argininosuccinate synthase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200007506	41	0.780488	6.69169e-05	0.00245589	1.73576	0.00775744	0.659675	1.93 [1.19 - 3.14]
GENE	ASS1	argininosuccinate synthase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300015847	41	0.560976	0.000976842	0.0249891	1.38526	0.00600436	0.579821	1.79 [1.18 - 2.70]
GENE	ASS1	argininosuccinate synthase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207076_s_at	111	0.495495	0.0150222	0.218237	-0.643836	0.0975676	-0.294778	0.74 [0.53 - 1.06]
GENE	ASS1	argininosuccinate synthase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207076_s_at	90	0.155556	0.269387	-	0.576038	0.887414	0.0257596	1.03 [0.72 - 1.47]
GENE	ASS1	argininosuccinate synthase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207076_s_at	90	0.8	0.255734	-	0.468472	0.79911	0.0531505	1.05 [0.70 - 1.59]
GENE	ASS1	argininosuccinate synthase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207076_s_at	138	0.833333	0.00117424	0.0291516	0.868079	0.239732	0.122704	1.13 [0.92 - 1.39]
GENE	ASS1	argininosuccinate synthase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207076_s_at	129	0.100775	0.0637773	-	-0.707527	0.225653	-0.218181	0.80 [0.56 - 1.14]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33726	56	0.196429	0.000560638	0.0156238	-1.37551	0.2962	-0.238799	0.79 [0.50 - 1.23]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37195	56	0.160714	0.00035407	0.0105398	-1.44221	0.446755	-0.172384	0.84 [0.54 - 1.31]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42716	56	0.267857	0.00224174	0.0497265	-1.19366	0.862629	-0.0380167	0.96 [0.63 - 1.48]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33726	56	0.178571	0.000778401	0.0206395	-1.37601	0.502907	-0.156566	0.86 [0.54 - 1.35]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41466	56	0.178571	0.00195979	0.0445467	-1.27181	0.293867	-0.227328	0.80 [0.52 - 1.22]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42716	56	0.714286	0.0128386	0.194515	0.897678	0.704379	0.0846896	1.09 [0.70 - 1.69]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37195	56	0.196429	0.000560638	0.0156238	-1.37551	0.233031	-0.265375	0.77 [0.50 - 1.19]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41466	56	0.232143	0.00487501	0.0927751	-1.0871	0.57059	-0.122385	0.88 [0.58 - 1.35]
GENE	ASS1	argininosuccinate synthase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207076_s_at	278	0.428058	0.0170163	0.238816	-0.449088	0.473735	-0.0713333	0.93 [0.77 - 1.13]
GENE	ASS1	argininosuccinate synthase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207076_s_at	133	0.616541	0.186546	-	-0.330065	0.997639	-0.000274211	1.00 [0.83 - 1.20]
GENE	ASS1	argininosuccinate synthase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13128	81	0.679012	0.0581486	-	-1.34598	0.399422	-0.200413	0.82 [0.51 - 1.30]
GENE	ASS1	argininosuccinate synthase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13582	81	0.814815	0.0404485	0.430731	-15.4118	0.422648	-0.184642	0.83 [0.53 - 1.31]
GENE	ASS1	argininosuccinate synthase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207076_s_at	185	0.291892	0.00570154	0.104904	-0.522545	0.0537807	-0.18564	0.83 [0.69 - 1.00]
GENE	ASS1	argininosuccinate synthase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207076_s_at	185	0.616216	0.00793903	0.135513	-0.449986	0.0659984	-0.163901	0.85 [0.71 - 1.01]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P31921	110	0.872727	1.8415e-06	9.54384e-05	1.40327	0.6714	-0.0514006	0.95 [0.75 - 1.20]
GENE	ASS1	argininosuccinate synthase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P31921	110	0.845455	0.0279844	0.338054	0.749945	0.295493	-0.143515	0.87 [0.66 - 1.13]
GENE	ASS1	argininosuccinate synthase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207076_s_at	80	0.7375	0.136528	-	-0.812492	0.35332	-0.181412	0.83 [0.57 - 1.22]
GENE	ASS1	argininosuccinate synthase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_1884	281	0.896797	0.000177194	0.00578365	0.789157	0.0255666	0.156338	1.17 [1.02 - 1.34]
GENE	ASS1	argininosuccinate synthase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:30730	59	0.20339	0.0255725	0.317928	-1.20951	0.958681	-0.0347853	0.97 [0.26 - 3.60]
GENE	ASS1	argininosuccinate synthase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207076_s_at	38	0.763158	0.109251	-	-1.14086	0.648374	-0.12217	0.88 [0.52 - 1.50]
GENE	ASS1	argininosuccinate synthase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207076_s_at	140	0.421429	2.82248e-05	0.00113792	-1.22842	0.000873457	-0.357806	0.70 [0.57 - 0.86]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208758_at	30	0.733333	0.0355188	0.396109	-1.1082	0.287232	-0.474893	0.62 [0.26 - 1.49]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1673991	165	0.878788	0.0834089	-	0.545778	0.43334	0.161731	1.18 [0.78 - 1.76]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1673991	165	0.890909	0.103113	-	0.722456	0.536209	0.202369	1.22 [0.64 - 2.32]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208758_at	163	0.889571	0.0346241	0.389559	0.602531	0.387241	0.107579	1.11 [0.87 - 1.42]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208758_at	79	0.43038	0.0725029	-	0.53987	0.524037	0.120613	1.13 [0.78 - 1.64]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208758_at	58	0.87931	0.0145696	0.213429	1.00223	0.994917	0.00140385	1.00 [0.65 - 1.54]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208758_at	34	0.647059	0.203388	-	0.500281	0.958312	0.0162128	1.02 [0.55 - 1.87]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208758_at	158	0.873418	0.0319431	0.369401	-0.891513	0.492264	-0.176424	0.84 [0.51 - 1.39]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208758_at	53	0.528302	0.0367197	0.404767	0.714233	0.302021	0.585387	1.80 [0.59 - 5.46]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208758_at	53	0.320755	0.114509	-	0.671158	0.446217	0.46097	1.59 [0.48 - 5.19]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208758_at	180	0.544444	0.0186102	0.254608	0.490719	0.140011	0.473182	1.61 [0.86 - 3.01]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208758_at	559	0.883721	3.20302e-09	2.52753e-07	1.28724	5.05044e-05	1.24043	3.46 [1.90 - 6.30]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208758_at	77	0.207792	0.0387697	0.419208	-0.624526	0.50654	-0.354609	0.70 [0.25 - 2.00]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208758_at	70	0.114286	0.26091	-	0.520525	0.927014	0.0344158	1.04 [0.50 - 2.16]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38811_at	50	0.64	0.0327409	0.375485	0.754123	0.598588	0.252434	1.29 [0.50 - 3.29]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208758_at	74	0.216216	0.0146944	0.214759	-0.762869	0.0575035	-0.858097	0.42 [0.17 - 1.03]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208758_at	67	0.895522	0.019439	0.262608	1.73351	0.0682096	2.34397	10.42 [0.84 - 129.44]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208758_at	115	0.791304	0.0263153	0.324215	1.13352	0.510943	0.628581	1.87 [0.29 - 12.22]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38811_at	158	0.563291	0.00118662	0.0294079	-1.03266	0.0251708	-0.927244	0.40 [0.18 - 0.89]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38811_at	76	0.171053	0.232925	-	1.16832	0.805747	0.166876	1.18 [0.31 - 4.47]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208758_at	204	0.730392	0.120486	-	0.244924	0.953599	-0.013806	0.99 [0.62 - 1.57]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208758_at	87	0.333333	0.028933	0.345748	1.03611	0.284924	0.627432	1.87 [0.59 - 5.91]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208758_at	87	0.333333	0.028933	0.345748	1.03611	0.284924	0.627432	1.87 [0.59 - 5.91]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208758_at	77	0.584416	0.0108691	0.17188	1.77426	0.0482037	1.45043	4.26 [1.01 - 17.98]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208758_at	77	0.272727	0.0214708	0.281658	15.5593	0.10247	0.988171	2.69 [0.82 - 8.80]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208758_at	136	0.272059	0.0598822	-	-0.827774	0.385225	-0.548782	0.58 [0.17 - 1.99]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208758_at	200	0.105	0.037549	0.41066	-0.79259	0.152585	-0.849429	0.43 [0.13 - 1.37]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12529	60	0.15	0.0390114	0.420884	1.83426	0.655815	0.27436	1.32 [0.39 - 4.40]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12529	60	0.516667	0.11115	-	0.608975	0.510191	0.50671	1.66 [0.37 - 7.50]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3011	155	0.832258	1.04709e-05	0.000465803	1.21728	0.0139762	0.317082	1.37 [1.07 - 1.77]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208758_at	286	0.258741	0.000962845	0.0246881	-0.653911	0.00482083	-0.918835	0.40 [0.21 - 0.76]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208758_at	159	0.522013	0.000205874	0.00659138	1.2363	0.0073498	1.04757	2.85 [1.33 - 6.13]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208758_at	159	0.779874	1.28279e-05	0.000559688	1.48491	0.0132285	1.12659	3.09 [1.27 - 7.52]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208758_at	159	0.767296	0.000125112	0.00426494	1.15759	0.0729567	0.741455	2.10 [0.93 - 4.72]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208758_at	54	0.388889	0.117924	-	1.51149	0.657513	0.262814	1.30 [0.41 - 4.16]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208758_at	117	0.247863	0.00508323	0.0958797	-0.885546	0.0184898	-0.636222	0.53 [0.31 - 0.90]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208758_at	117	0.247863	0.00316802	0.0658173	-1.06951	0.0106461	-0.760365	0.47 [0.26 - 0.84]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208758_at	117	0.247863	0.00508323	0.0958797	-0.885546	0.0184898	-0.636222	0.53 [0.31 - 0.90]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208758_at	117	0.230769	0.000691963	0.018683	-1.26283	0.00280883	-1.12362	0.33 [0.16 - 0.68]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208758_at	236	0.860169	1.08531e-05	0.000481165	1.23424	0.0125114	1.106	3.02 [1.27 - 7.20]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208758_at	249	0.638554	0.000232988	0.00733975	0.765207	0.00124907	1.1809	3.26 [1.59 - 6.67]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208758_at	62	0.193548	0.0896005	-	-0.825457	0.639487	0.245952	1.28 [0.46 - 3.58]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208758_at	125	0.408	0.0518005	-	0.872441	0.301211	0.382749	1.47 [0.71 - 3.03]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208758_at	125	0.104	0.0879872	-	-0.694909	0.680338	0.118098	1.13 [0.64 - 1.97]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208758_at	54	0.5	0.207269	-	0.755692	0.775794	0.176982	1.19 [0.35 - 4.03]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208758_at	198	0.247475	0.0646064	-	-0.492203	0.561595	-0.168357	0.85 [0.48 - 1.49]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208758_at	198	0.247475	0.0382791	0.41579	-0.57031	0.499174	-0.204594	0.81 [0.45 - 1.48]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208758_at	198	0.808081	0.0636896	-	-0.569018	0.45221	-0.175415	0.84 [0.53 - 1.33]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208758_at	51	0.137255	0.00143025	0.0343514	-2.34089	0.340242	-0.697478	0.50 [0.12 - 2.09]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208758_at	62	0.177419	0.117557	-	-0.925504	0.323066	-0.431996	0.65 [0.28 - 1.53]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208758_at	177	0.887006	0.0596037	-	-1.27079	0.538516	-0.261275	0.77 [0.33 - 1.77]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208758_at	177	0.327684	0.0602736	-	0.496794	0.833615	-0.0778291	0.93 [0.45 - 1.91]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208758_at	145	0.165517	0.0385041	0.417361	-0.753365	0.248296	-0.628722	0.53 [0.18 - 1.55]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208758_at	226	0.10177	0.000426191	0.0123597	-1.11391	0.0258767	-0.833411	0.43 [0.21 - 0.90]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208758_at	55	0.872727	0.0383768	0.416473	1.03569	0.930151	-0.0366311	0.96 [0.42 - 2.19]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208758_at	55	0.854545	0.00421419	0.0826796	1.38167	0.135634	0.790032	2.20 [0.78 - 6.22]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208758_at	49	0.877551	0.0424369	0.444042	1.18768	0.472302	0.466686	1.59 [0.45 - 5.69]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208758_at	63	0.380952	0.000431768	0.0124982	1.39196	0.0795343	0.413616	1.51 [0.95 - 2.40]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g2317691_3p_at	28	0.857143	0.102442	-	-15.2901	0.228612	-0.261463	0.77 [0.50 - 1.18]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208758_at	82	0.573171	0.0233515	0.298629	0.762136	0.336531	0.501089	1.65 [0.59 - 4.59]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38811_at	84	0.72619	0.000190965	0.00617369	1.09336	0.0128364	1.0563	2.88 [1.25 - 6.61]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208758_at	79	0.898734	0.0212758	0.279863	0.867854	0.104961	0.842349	2.32 [0.84 - 6.43]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D82348_at	86	0.151163	0.018485	0.253387	15.3498	0.14174	0.787042	2.20 [0.77 - 6.28]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208758_at	104	0.875	0.06992	-	0.715132	0.648461	0.198904	1.22 [0.52 - 2.87]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P68087	117	0.897436	0.0101606	0.163407	0.963466	0.202432	0.392896	1.48 [0.81 - 2.71]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208758_at	204	0.411765	0.000163135	0.00538084	1.96467	0.0074345	1.47233	4.36 [1.48 - 12.81]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208758_at	204	0.681373	0.000193324	0.00624011	0.976926	5.95487e-05	1.6387	5.15 [2.31 - 11.46]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208758_at	178	0.168539	0.310046	-	0.283022	0.770338	-0.0846074	0.92 [0.52 - 1.62]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010422	41	0.804878	0.00433413	0.0845408	1.24176	0.0674832	0.686652	1.99 [0.95 - 4.15]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208758_at	111	0.342342	0.0078796	0.134736	0.799369	0.103854	0.486506	1.63 [0.91 - 2.92]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208758_at	90	0.377778	0.0026761	0.0574321	1.18701	0.0555203	0.614721	1.85 [0.99 - 3.47]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208758_at	90	0.688889	0.0202723	0.270515	0.844229	0.106477	0.593405	1.81 [0.88 - 3.72]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208758_at	138	0.318841	0.0643586	-	0.512049	0.209597	0.228999	1.26 [0.88 - 1.80]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208758_at	129	0.868217	3.89916e-05	0.00151916	1.25364	0.0653791	0.808295	2.24 [0.95 - 5.30]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9603	56	0.892857	0.102109	-	0.787217	0.708844	0.128383	1.14 [0.58 - 2.23]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9603	56	0.160714	0.17576	-	0.659809	0.795361	0.087828	1.09 [0.56 - 2.12]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208758_at	278	0.100719	0.0226341	0.292227	-0.624143	0.51523	-0.144992	0.87 [0.56 - 1.34]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208758_at	133	0.736842	0.124579	-	0.3888	0.777011	-0.046243	0.95 [0.69 - 1.31]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3888	81	0.654321	0.0133341	0.200018	1.27594	0.078312	1.05117	2.86 [0.89 - 9.22]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5652	81	0.790123	0.102254	-	0.884768	0.225731	0.746227	2.11 [0.63 - 7.05]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208758_at	185	0.756757	0.0166465	0.235071	-0.508931	0.375017	-0.100423	0.90 [0.72 - 1.13]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208758_at	185	0.837838	0.0116305	0.180783	-0.563951	0.402383	-0.0859513	0.92 [0.75 - 1.12]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P68087	110	0.881818	0.0352766	0.394344	0.682955	0.49068	0.191547	1.21 [0.70 - 2.09]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P68087	110	0.8	0.0299642	0.353979	0.689519	0.378718	0.297517	1.35 [0.69 - 2.61]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208758_at	80	0.675	0.045959	0.466775	-1.17802	0.565345	-0.25646	0.77 [0.32 - 1.85]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_4150	281	0.565836	0.0399763	0.427517	0.287636	0.633355	0.0534381	1.05 [0.85 - 1.31]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208758_at	38	0.131579	0.0181614	0.250217	15.4968	0.196927	0.787414	2.20 [0.66 - 7.27]
GENE	ATIC	5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208758_at	140	0.564286	0.00658398	0.117328	-0.86119	0.101853	-0.549844	0.58 [0.30 - 1.12]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214256_at	30	0.466667	0.0446459	0.458422	0.876327	0.417744	0.451583	1.57 [0.53 - 4.68]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214255_at	30	0.3	0.154695	-	-0.608284	0.51726	-0.420253	0.66 [0.18 - 2.34]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1813434	165	0.654545	0.0838591	-	0.419163	0.866541	-0.043271	0.96 [0.58 - 1.59]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1813434	165	0.660606	0.077706	-	0.615639	0.950186	-0.0268394	0.97 [0.42 - 2.26]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214255_at	163	0.895706	0.0657786	-	0.541921	0.248997	0.25214	1.29 [0.84 - 1.98]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214256_at	163	0.785276	0.128495	-	0.343226	0.823231	-0.151575	0.86 [0.23 - 3.25]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214256_at	79	0.139241	0.0355812	0.396563	-0.800197	0.586278	-0.535788	0.59 [0.08 - 4.03]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214255_at	79	0.810127	0.120838	-	0.529569	0.969804	0.00856302	1.01 [0.65 - 1.57]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1568743_at	79	0.56962	0.122927	-	0.448631	0.357577	0.959639	2.61 [0.34 - 20.17]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214255_at	58	0.189655	0.275521	-	-0.374025	0.85336	-0.0232481	0.98 [0.76 - 1.25]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214256_at	58	0.396552	0.0890201	-	-0.474241	0.379911	-0.177351	0.84 [0.56 - 1.24]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214255_at	34	0.176471	0.00533257	0.099553	-1.35988	0.365936	-0.195173	0.82 [0.54 - 1.26]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214256_at	34	0.676471	0.0199945	0.267894	-1.06444	0.0701208	-0.673892	0.51 [0.25 - 1.06]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214256_at	158	0.107595	0.0708159	-	0.813854	0.352329	0.747367	2.11 [0.44 - 10.20]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214255_at	158	0.310127	0.00443682	0.0861238	-0.658985	0.137195	-1.11605	0.33 [0.08 - 1.43]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214256_at	53	0.886792	0.0167127	0.235744	1.04179	0.154178	0.457515	1.58 [0.84 - 2.96]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214255_at	53	0.113208	0.0016494	0.038653	-1.37266	0.0750403	-0.434955	0.65 [0.40 - 1.04]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214256_at	53	0.886792	0.00127152	0.0311518	1.3973	0.0300391	0.794903	2.21 [1.08 - 4.54]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214255_at	53	0.113208	0.0103193	0.165322	-1.12861	0.127956	-0.348586	0.71 [0.45 - 1.11]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214256_at	180	0.188889	0.0341519	0.386067	0.645119	0.54394	0.113191	1.12 [0.78 - 1.61]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214255_at	180	0.244444	0.000485211	0.0138112	-0.760692	0.0880035	-0.222796	0.80 [0.62 - 1.03]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214256_at	559	0.100179	0.0949564	-	0.690073	0.232826	0.169201	1.18 [0.90 - 1.56]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1568743_at	559	0.520572	0.0287327	0.344133	0.462255	0.523195	0.0985171	1.10 [0.82 - 1.49]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214255_at	559	0.613596	0.113239	-	0.318763	0.219815	0.198586	1.22 [0.89 - 1.67]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214255_at	77	0.792208	0.0176724	0.245383	-0.845837	0.434419	-0.138256	0.87 [0.62 - 1.23]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214256_at	77	0.766234	0.130966	-	0.439926	0.537267	0.148077	1.16 [0.72 - 1.86]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214255_at	70	0.728571	0.061234	-	0.533903	0.372687	0.302824	1.35 [0.70 - 2.63]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1568743_at	70	0.114286	0.275413	-	-0.41932	0.944899	-0.0540115	0.95 [0.20 - 4.38]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214256_at	70	0.114286	0.0024132	0.0528055	-1.16618	0.691759	-0.504184	0.60 [0.05 - 7.30]
GENE	ATP10A	ATPase, class V, type 10A	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39961_at	50	0.5	0.0614617	-	-0.646506	0.140289	-1.14977	0.32 [0.07 - 1.46]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214256_at	74	0.148649	0.0229022	0.294629	-0.837619	0.475745	-0.245357	0.78 [0.40 - 1.54]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214255_at	74	0.256757	0.000443446	0.0127874	-1.09137	0.00245045	-0.546446	0.58 [0.41 - 0.82]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214256_at	67	0.402985	0.148826	-	1.11747	0.487389	1.36809	3.93 [0.08 - 186.66]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214255_at	67	0.179104	0.00362272	0.0732932	-1.7563	0.217257	-0.564823	0.57 [0.23 - 1.39]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1568743_at	67	0.283582	0.0738386	-	15.5074	0.885024	0.244602	1.28 [0.05 - 35.16]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214255_at	115	0.104348	0.0105929	0.168599	-1.40954	0.206059	-0.793068	0.45 [0.13 - 1.55]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1568743_at	115	0.252174	0.103657	-	1.53413	0.35394	0.355848	1.43 [0.67 - 3.03]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214256_at	115	0.686957	0.101271	-	0.85255	0.977439	0.0232271	1.02 [0.20 - 5.12]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39961_at	158	0.696203	0.0445595	0.457867	0.58266	0.398501	0.15463	1.17 [0.82 - 1.67]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39961_at	76	0.578947	0.2593	-	0.577298	0.712247	0.14983	1.16 [0.52 - 2.58]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1568743_at	204	0.112745	0.00244152	0.0533092	-0.668977	0.0879925	-0.162657	0.85 [0.71 - 1.02]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214256_at	204	0.710784	0.0849493	-	0.269555	0.65286	0.0363903	1.04 [0.88 - 1.22]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214255_at	204	0.151961	0.0988036	-	0.323492	0.715252	0.0388249	1.04 [0.84 - 1.28]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1568743_at	87	0.747126	0.207956	-	0.505176	0.901109	0.081866	1.09 [0.30 - 3.95]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214255_at	87	0.252874	0.00159299	0.0375577	-1.1502	0.157831	-0.388491	0.68 [0.40 - 1.16]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214256_at	87	0.597701	0.0221978	0.28829	0.849163	0.049112	1.62476	5.08 [1.01 - 25.62]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1568743_at	87	0.747126	0.207956	-	0.505176	0.901109	0.081866	1.09 [0.30 - 3.95]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214255_at	87	0.252874	0.00159299	0.0375577	-1.1502	0.157831	-0.388491	0.68 [0.40 - 1.16]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214256_at	87	0.597701	0.0221978	0.28829	0.849163	0.049112	1.62476	5.08 [1.01 - 25.62]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1568743_at	77	0.207792	0.0820991	-	15.4331	0.666008	0.629607	1.88 [0.11 - 32.74]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214256_at	77	0.103896	0.268753	-	-0.849174	0.402603	-1.49529	0.22 [0.01 - 7.44]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214255_at	77	0.831169	0.0180267	0.24889	1.41133	0.850912	-0.100372	0.90 [0.32 - 2.58]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214256_at	77	0.857143	0.0489908	0.485535	1.12411	0.461671	1.04492	2.84 [0.18 - 45.93]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1568743_at	77	0.896104	0.00578139	0.10605	1.51234	0.0286902	3.56444	35.32 [1.45 - 860.81]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214255_at	77	0.831169	0.00123808	0.0304677	1.61929	0.359096	0.422041	1.53 [0.62 - 3.76]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214255_at	136	0.507353	0.0349864	0.392222	-1.04712	0.176322	-0.374256	0.69 [0.40 - 1.18]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214256_at	136	0.529412	0.128367	-	0.687962	0.664114	0.115203	1.12 [0.67 - 1.89]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214256_at	200	0.12	0.0664374	-	-0.672749	0.983528	0.0047731	1.00 [0.64 - 1.58]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214255_at	200	0.855	0.00069966	0.0188589	1.06719	0.141885	0.567202	1.76 [0.83 - 3.76]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19428	60	0.116667	0.346559	-	0.684331	0.911873	0.0143587	1.01 [0.79 - 1.31]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19428	60	0.883333	0.0586436	-	0.919398	0.851954	0.0565399	1.06 [0.58 - 1.92]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214256_at	286	0.77972	0.0237513	0.302161	-0.604561	0.747869	-0.0627939	0.94 [0.64 - 1.38]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214255_at	286	0.496504	0.0104994	0.167483	0.499092	0.0973351	0.232241	1.26 [0.96 - 1.66]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214256_at	159	0.716981	0.178956	-	0.435251	0.774926	0.108357	1.11 [0.53 - 2.34]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214256_at	159	0.874214	0.319979	-	-0.713614	0.976326	0.013002	1.01 [0.43 - 2.39]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214255_at	159	0.886792	0.117014	-	0.641925	0.54618	0.136214	1.15 [0.74 - 1.78]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214255_at	159	0.188679	0.109003	-	0.821079	0.394889	0.195747	1.22 [0.77 - 1.91]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214256_at	159	0.207547	0.188051	-	0.619493	0.462784	0.285537	1.33 [0.62 - 2.85]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214255_at	159	0.433962	0.143476	-	0.579223	0.343846	0.267274	1.31 [0.75 - 2.27]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214255_at	54	0.240741	0.0137195	0.204247	-1.5792	0.878501	-0.0971176	0.91 [0.26 - 3.15]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214256_at	54	0.203704	0.319152	-	-0.713786	0.56706	-0.726926	0.48 [0.04 - 5.83]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214255_at	117	0.794872	0.0573687	-	0.647335	0.669647	0.130943	1.14 [0.62 - 2.08]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214255_at	117	0.384615	0.101923	-	0.742059	0.907923	0.0458592	1.05 [0.48 - 2.28]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214256_at	117	0.282051	0.0878627	-	0.819144	0.593667	0.390579	1.48 [0.35 - 6.21]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214256_at	117	0.529915	0.0826373	-	0.545596	0.428162	0.476811	1.61 [0.50 - 5.24]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214256_at	117	0.529915	0.0826373	-	0.545596	0.428162	0.476811	1.61 [0.50 - 5.24]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214256_at	117	0.34188	0.117473	-	0.716523	0.815118	0.184946	1.20 [0.26 - 5.67]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214255_at	117	0.794872	0.0573687	-	0.647335	0.669647	0.130943	1.14 [0.62 - 2.08]
GENE	ATP10A	ATPase, class V, type 10A	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214255_at	117	0.811966	0.0242399	0.306442	0.885688	0.610824	0.188092	1.21 [0.58 - 2.49]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214255_at	236	0.110169	0.000302727	0.0092079	-1.12226	0.00157278	-0.653145	0.52 [0.35 - 0.78]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214256_at	236	0.258475	0.0356618	0.397148	-0.583103	0.25273	-0.446993	0.64 [0.30 - 1.38]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214255_at	249	0.11245	0.00940939	0.154212	-0.719771	0.0840581	-0.308683	0.73 [0.52 - 1.04]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214256_at	249	0.305221	0.00100871	0.0256713	-0.692749	0.0468696	-0.575758	0.56 [0.32 - 0.99]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214255_at	62	0.112903	0.0053771	0.100204	-1.52771	0.371376	-0.224924	0.80 [0.49 - 1.31]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214255_at	125	0.84	0.283925	-	0.491498	0.825856	0.132025	1.14 [0.35 - 3.70]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214256_at	62	0.758065	0.0286249	0.343262	-1.53737	0.579778	-0.120007	0.89 [0.58 - 1.36]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214255_at	125	0.24	0.103987	-	0.620281	0.753131	0.142004	1.15 [0.48 - 2.79]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214255_at	54	0.111111	0.0143845	0.211446	-1.59291	0.449471	-0.229333	0.80 [0.44 - 1.44]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214256_at	125	0.584	0.220934	-	0.460309	0.80449	-0.272117	0.76 [0.09 - 6.57]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214256_at	125	0.152	0.0188604	0.257038	-0.79203	0.528771	-0.534038	0.59 [0.11 - 3.09]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214256_at	54	0.722222	0.118121	-	-1.18106	0.643528	-0.121331	0.89 [0.53 - 1.48]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214255_at	198	0.111111	0.123454	-	0.885427	0.485471	0.119799	1.13 [0.81 - 1.58]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214256_at	198	0.131313	0.203156	-	-0.437558	0.854086	0.0224495	1.02 [0.81 - 1.30]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214256_at	198	0.131313	0.123375	-	-0.531715	0.994028	0.000941743	1.00 [0.78 - 1.28]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214255_at	198	0.141414	0.120999	-	0.539148	0.288756	0.141392	1.15 [0.89 - 1.50]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214255_at	198	0.111111	0.173467	-	0.690996	0.424224	0.130036	1.14 [0.83 - 1.57]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214256_at	198	0.131313	0.0294208	0.349659	-0.608976	0.397263	-0.0840975	0.92 [0.76 - 1.12]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214255_at	51	0.372549	0.278408	-	-0.953345	0.700053	-0.689041	0.50 [0.02 - 16.72]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214255_at	62	0.483871	0.0935837	-	1.06733	0.936995	-0.0867931	0.92 [0.11 - 7.89]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214256_at	51	0.843137	0.00174642	0.0405186	2.31741	0.0948595	4.13329	62.38 [0.49 - 7970.22]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214256_at	62	0.145161	0.00602392	0.109502	-1.47352	0.870137	-0.227082	0.80 [0.05 - 12.13]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214256_at	177	0.124294	0.0146745	0.214547	-0.780464	0.160201	-1.39557	0.25 [0.04 - 1.74]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1568743_at	145	0.875862	0.136681	-	-1.03813	0.824111	-0.216594	0.81 [0.12 - 5.44]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214255_at	177	0.587571	9.65969e-05	0.00339707	1.04783	0.00492194	0.9899	2.69 [1.35 - 5.36]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214256_at	177	0.20904	0.0240759	0.305009	-0.570818	0.151669	-1.22864	0.29 [0.05 - 1.57]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214256_at	145	0.372414	0.00454348	0.0877581	-0.927032	0.0149194	-3.19704	0.04 [0.00 - 0.54]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1568743_at	177	0.19774	0.105612	-	-0.511943	0.541926	-0.484098	0.62 [0.13 - 2.92]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214255_at	177	0.531073	0.000568926	0.0158202	0.81556	0.034471	0.676561	1.97 [1.05 - 3.68]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1568743_at	177	0.19774	0.0592331	-	-0.52074	0.317049	-0.700245	0.50 [0.13 - 1.96]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214255_at	145	0.662069	0.00120206	0.0297268	1.042	0.00784093	1.08622	2.96 [1.33 - 6.60]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1568743_at	226	0.278761	0.131585	-	0.548523	0.772626	0.0856944	1.09 [0.61 - 1.95]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214256_at	226	0.637168	0.0287426	0.344213	-0.731461	0.27138	-0.177325	0.84 [0.61 - 1.15]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214255_at	226	0.641593	0.00312026	0.0650174	0.821093	0.0238336	0.457046	1.58 [1.06 - 2.35]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1568743_at	49	0.897959	0.031018	0.362251	1.34328	0.681886	0.713842	2.04 [0.07 - 62.01]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214256_at	55	0.236364	3.28457e-05	0.00130332	-1.75147	0.00586054	-5.17907	0.01 [0.00 - 0.22]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214256_at	55	0.236364	0.00426098	0.0834073	-1.3821	0.0204182	-4.38172	0.01 [0.00 - 0.51]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214255_at	55	0.781818	0.00331914	0.0683291	1.27013	0.142521	1.08389	2.96 [0.69 - 12.59]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214256_at	49	0.183673	0.000913976	0.0236307	-1.77492	0.0452668	-4.56739	0.01 [0.00 - 0.91]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214255_at	55	0.781818	0.0131957	0.198488	1.17063	0.0569543	1.46585	4.33 [0.96 - 19.59]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1568743_at	55	0.872727	0.00710346	0.124419	1.31377	0.421641	1.09564	2.99 [0.21 - 43.29]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214255_at	49	0.795918	0.0233049	0.298216	1.24966	0.331417	0.892647	2.44 [0.40 - 14.79]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1568743_at	55	0.872727	0.0072965	0.127015	1.51233	0.126551	2.18153	8.86 [0.54 - 145.49]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	271737	34	0.764706	0.339102	-	0.459761	0.892836	-0.102175	0.90 [0.20 - 3.99]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214256_at	63	0.634921	0.000334423	0.010034	-1.4817	0.00934656	-23.2196	0.00 [0.00 - 0.00]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1568743_at	63	0.253968	0.00589333	0.107648	-0.93877	0.0102904	-19.8966	0.00 [0.00 - 0.01]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214255_at	63	0.587302	0.062505	-	0.622186	0.134119	0.22663	1.25 [0.93 - 1.69]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.44697.0.S1_3p_at	28	0.142857	0.0454981	0.463859	15.4285	0.115777	0.474284	1.61 [0.89 - 2.90]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.407513.1.S1_3p_s_at	28	0.107143	0.219776	-	15.1822	0.797138	-0.277386	0.76 [0.09 - 6.28]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.44697.0.S2_3p_at	28	0.678571	0.190772	-	-0.835497	0.970704	-0.190445	0.83 [0.00 - 21447.23]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	1568743_3p_at	28	0.142857	0.0252499	0.315173	-1.35434	0.362625	-6.97243	0.00 [0.00 - 3099.25]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.407513.1.S1_3p_at	28	0.107143	0.000167686	0.00551176	-2.44717	0.587659	0.109357	1.12 [0.75 - 1.66]
GENE	ATP10A	ATPase, class V, type 10A	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214255_at	82	0.658537	0.345071	-	-0.35017	0.735853	-0.130272	0.88 [0.41 - 1.87]
GENE	ATP10A	ATPase, class V, type 10A	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214256_at	82	0.219512	0.0463015	0.46893	-0.731688	0.923305	-0.0311555	0.97 [0.51 - 1.83]
GENE	ATP10A	ATPase, class V, type 10A	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214255_at	79	0.265823	0.139179	-	0.474737	0.760382	-0.0730603	0.93 [0.58 - 1.49]
GENE	ATP10A	ATPase, class V, type 10A	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214256_at	79	0.265823	0.0203836	0.271561	0.739378	0.36184	0.341775	1.41 [0.68 - 2.93]
GENE	ATP10A	ATPase, class V, type 10A	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214256_at	104	0.125	0.00256629	0.055513	-1.14391	0.0461483	-0.911624	0.40 [0.16 - 0.98]
GENE	ATP10A	ATPase, class V, type 10A	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214255_at	104	0.144231	0.0761009	-	1.21435	0.308603	0.409595	1.51 [0.68 - 3.31]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P65659	117	0.111111	0.0130294	0.196643	-0.889355	0.0420674	-0.28223	0.75 [0.57 - 0.99]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P215765	117	0.435897	0.00233652	0.0514349	-0.861044	0.0363531	-0.284171	0.75 [0.58 - 0.98]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214255_at	204	0.235294	0.0508738	-	-0.72492	0.540466	-0.244002	0.78 [0.36 - 1.71]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214255_at	204	0.137255	0.00180827	0.0416966	-0.935321	0.00807043	-0.796791	0.45 [0.25 - 0.81]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1568743_at	204	0.132353	0.0905875	-	1.5588	0.695774	0.155835	1.17 [0.54 - 2.55]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1568743_at	204	0.122549	0.02889	0.345402	1.44554	0.789108	0.0780149	1.08 [0.61 - 1.91]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214256_at	204	0.220588	0.102609	-	-0.622407	0.600154	-0.124901	0.88 [0.55 - 1.41]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214256_at	204	0.142157	0.0393129	0.422966	-0.664115	0.255456	-0.201361	0.82 [0.58 - 1.16]
GENE	ATP10A	ATPase, class V, type 10A	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214255_at	178	0.882023	0.0085065	0.142847	0.690438	0.20827	0.267101	1.31 [0.86 - 1.98]
GENE	ATP10A	ATPase, class V, type 10A	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214256_at	178	0.140449	0.029725	0.352082	0.781684	0.256975	0.308592	1.36 [0.80 - 2.32]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1568743_at	111	0.162162	0.00678885	0.120143	-0.861212	0.131312	-0.323477	0.72 [0.48 - 1.10]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214256_at	111	0.306306	0.0158999	0.227413	-0.634259	0.227681	-0.201911	0.82 [0.59 - 1.13]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214255_at	111	0.81982	0.0999209	-	0.517078	0.57691	0.0935256	1.10 [0.79 - 1.53]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214255_at	90	0.144444	0.121359	-	-0.607925	0.782561	0.150802	1.16 [0.40 - 3.39]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214255_at	90	0.344444	0.156598	-	-0.523589	0.781479	0.170174	1.19 [0.36 - 3.95]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214256_at	90	0.211111	0.17304	-	0.600606	0.773949	0.226865	1.25 [0.27 - 5.90]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214256_at	90	0.233333	0.140721	-	0.776656	0.430303	0.730825	2.08 [0.34 - 12.77]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	575	50	0.88	0.0886338	-	-15.255	0.7147	-0.133441	0.88 [0.43 - 1.79]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214255_at	138	0.173913	0.00576165	0.105767	-0.756814	0.438672	0.10127	1.11 [0.86 - 1.43]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1568743_at	138	0.456522	0.100826	-	-0.395078	0.85374	0.38823	1.47 [0.02 - 91.46]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214256_at	138	0.108696	0.0225464	0.291438	-0.711898	0.312908	-3.69157	0.02 [0.00 - 32.41]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214256_at	129	0.27907	0.111522	-	0.467069	0.368879	0.272916	1.31 [0.72 - 2.38]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214255_at	129	0.116279	0.0954163	-	0.836253	0.322931	0.172447	1.19 [0.84 - 1.67]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10354	56	0.392857	0.169647	-	-0.468849	0.911087	-0.0190059	0.98 [0.70 - 1.37]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35061	56	0.625	0.166564	-	-0.552903	0.983598	-0.00841137	0.99 [0.44 - 2.21]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2603	56	0.803571	0.1265	-	0.613981	0.843061	-0.058785	0.94 [0.53 - 1.69]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10354	56	0.392857	0.229599	-	-0.423228	0.982736	-0.00363689	1.00 [0.72 - 1.39]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2603	56	0.75	0.0599197	-	0.71232	0.90626	0.0354746	1.04 [0.57 - 1.87]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35061	56	0.357143	0.109172	-	-0.546394	0.815182	-0.0966789	0.91 [0.40 - 2.04]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214256_at	278	0.122302	0.0215866	0.28272	-0.589508	0.294178	-0.453518	0.64 [0.27 - 1.48]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214255_at	278	0.830935	0.0971571	-	-0.467226	0.731699	-0.0380762	0.96 [0.77 - 1.20]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1568743_at	278	0.597122	0.00537627	0.100192	-0.5592	0.277383	-0.415994	0.66 [0.31 - 1.40]
GENE	ATP10A	ATPase, class V, type 10A	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214255_at	133	0.578947	0.1028	-	-0.401218	0.575364	-0.088998	0.91 [0.67 - 1.25]
GENE	ATP10A	ATPase, class V, type 10A	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214256_at	133	0.81203	0.00208129	0.0467977	0.830119	0.0177281	2.00038	7.39 [1.41 - 38.62]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1895	81	0.641975	0.0817071	-	0.88218	0.139914	0.977144	2.66 [0.73 - 9.72]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214256_at	185	0.135135	0.0407313	0.432646	0.476473	0.848406	0.0393805	1.04 [0.69 - 1.56]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214255_at	185	0.297297	0.0179808	0.248437	0.438216	0.410528	0.140191	1.15 [0.82 - 1.61]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214256_at	185	0.135135	0.157252	-	0.348513	0.845422	0.0447088	1.05 [0.67 - 1.64]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214255_at	185	0.243243	0.0181323	0.249931	0.523419	0.264785	0.19944	1.22 [0.86 - 1.73]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P215765	110	0.890909	0.0209027	0.276409	0.742243	0.677814	-0.0380307	0.96 [0.80 - 1.15]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P65659	110	0.109091	0.00823297	0.139331	-0.967022	0.716355	-0.0738169	0.93 [0.62 - 1.38]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P390395	110	0.790909	0.00671078	0.119073	0.742357	0.112612	0.227857	1.26 [0.95 - 1.66]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P215765	110	0.890909	0.176105	-	0.606718	0.634154	-0.0516679	0.95 [0.77 - 1.17]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P390395	110	0.790909	4.59414e-05	0.00175837	1.40103	0.0233271	0.446538	1.56 [1.06 - 2.30]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P65659	110	0.172727	0.06851	-	-0.517564	0.847657	-0.0310731	0.97 [0.71 - 1.33]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214256_at	80	0.8625	0.0103073	0.165177	1.14756	0.70937	0.108627	1.11 [0.63 - 1.97]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214255_at	80	0.125	0.166659	-	-0.872924	0.533885	-0.150453	0.86 [0.54 - 1.38]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1568743_at	38	0.447368	0.0163361	0.231904	-1.10981	0.81301	-0.0520142	0.95 [0.62 - 1.46]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214256_at	38	0.868421	0.0059185	0.108006	1.40908	0.0823493	1.53069	4.62 [0.82 - 25.99]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214255_at	38	0.894737	0.000129625	0.00439963	2.09942	0.0689438	0.680574	1.98 [0.95 - 4.11]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214255_at	140	0.871429	0.0516076	-	0.707193	0.389917	0.247455	1.28 [0.73 - 2.25]
GENE	ATP10A	ATPase, class V, type 10A	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214256_at	140	0.857143	0.0125708	0.191512	-1.62334	0.244501	-0.949206	0.39 [0.08 - 1.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	220948_s_at	30	0.466667	0.11465	-	0.640545	0.830356	-0.0637614	0.94 [0.52 - 1.68]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1775566	165	0.187879	0.0708525	-	0.638823	0.0606359	0.325846	1.39 [0.99 - 1.95]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1775566	165	0.884848	0.000352817	0.0105077	1.31161	0.0298724	0.595304	1.81 [1.06 - 3.10]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	220948_s_at	163	0.895706	0.152435	-	0.437256	0.863181	0.0343419	1.03 [0.70 - 1.53]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	244606_at	163	0.398773	0.0183285	0.251857	-0.464959	0.0788114	-1.03713	0.35 [0.11 - 1.13]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	244606_at	79	0.202532	0.0308395	0.360859	-0.714327	0.622465	-0.442487	0.64 [0.11 - 3.74]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	220948_s_at	79	0.594937	0.00658578	0.117353	0.779273	0.0334541	0.658141	1.93 [1.05 - 3.54]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	220948_s_at	58	0.137931	0.0717111	-	-0.716253	0.569852	-0.125317	0.88 [0.57 - 1.36]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	220948_s_at	34	0.176471	0.292564	-	0.636917	0.853338	0.0565613	1.06 [0.58 - 1.93]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	220948_s_at	158	0.816456	0.141426	-	0.404592	0.474128	0.17519	1.19 [0.74 - 1.92]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	220948_s_at	53	0.528302	0.0340782	0.38552	0.77614	0.868827	0.0796315	1.08 [0.42 - 2.79]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	220948_s_at	53	0.886792	0.038858	0.419821	-1.83385	0.789691	-0.123606	0.88 [0.36 - 2.19]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	220948_s_at	180	0.272222	0.0763434	-	-0.390355	0.698422	-0.151617	0.86 [0.40 - 1.85]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	244606_at	180	0.833333	0.00944103	0.154604	0.640415	0.349928	0.153727	1.17 [0.84 - 1.61]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	244606_at	559	0.423971	0.0707941	-	-0.359893	0.362163	-0.122064	0.89 [0.68 - 1.15]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	220948_s_at	559	0.783542	0.0376286	0.411222	0.488379	0.827862	0.0444814	1.05 [0.70 - 1.56]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	220948_s_at	77	0.818182	0.207444	-	0.391197	0.375948	0.228996	1.26 [0.76 - 2.09]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	244606_at	77	0.87013	0.00210771	0.0472832	1.07646	0.161046	0.317582	1.37 [0.88 - 2.14]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	244606_at	70	0.114286	0.199297	-	0.588558	0.379206	0.848936	2.34 [0.35 - 15.50]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	220948_s_at	70	0.142857	0.117119	-	-0.540291	0.525745	-0.14942	0.86 [0.54 - 1.37]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	220948_s_at	74	0.418919	0.00173239	0.0402503	0.992694	0.0075236	0.883359	2.42 [1.27 - 4.62]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	244606_at	74	0.756757	0.00362468	0.0733251	0.877929	0.0717871	0.428777	1.54 [0.96 - 2.45]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	220948_s_at	67	0.38806	0.000889322	0.0230932	-2.66873	0.0558382	-1.64422	0.19 [0.04 - 1.04]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	244606_at	67	0.746269	0.00583495	0.106815	1.68516	0.333348	3.00498	20.19 [0.05 - 8895.22]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	220948_s_at	115	0.521739	0.0635081	-	1.05167	0.262704	0.952183	2.59 [0.49 - 13.71]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	244606_at	115	0.113043	0.166695	-	15.2047	0.597877	0.271328	1.31 [0.48 - 3.60]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	220948_s_at	204	0.485294	0.0434486	0.450679	0.286434	0.290986	0.175756	1.19 [0.86 - 1.65]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	244606_at	204	0.303922	0.158043	-	-0.216618	0.590706	-0.0507811	0.95 [0.79 - 1.14]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	244606_at	87	0.172414	0.0604404	-	1.28968	0.537839	0.644691	1.91 [0.25 - 14.82]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	244606_at	87	0.172414	0.0604404	-	1.28968	0.537839	0.644691	1.91 [0.25 - 14.82]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	220948_s_at	87	0.83908	0.0579774	-	0.811489	0.363738	-0.361747	0.70 [0.32 - 1.52]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	220948_s_at	87	0.83908	0.0579774	-	0.811489	0.363738	-0.361747	0.70 [0.32 - 1.52]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	244606_at	77	0.181818	0.0329728	0.37724	-1.15236	0.826126	0.372163	1.45 [0.05 - 40.15]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	220948_s_at	77	0.272727	0.0539168	-	-1.03239	0.556551	-0.385335	0.68 [0.19 - 2.46]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	244606_at	77	0.181818	0.0445968	0.458107	-1.22015	0.707516	-0.728881	0.48 [0.01 - 21.73]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	220948_s_at	77	0.220779	0.085749	-	-1.0646	0.492952	-0.522072	0.59 [0.13 - 2.64]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	220948_s_at	136	0.264706	0.0477331	0.47784	-0.86632	0.0930525	-0.816248	0.44 [0.17 - 1.15]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	220948_s_at	200	0.29	0.0400822	0.42824	-0.60331	0.777933	-0.129857	0.88 [0.36 - 2.17]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19823	60	0.733333	0.00398146	0.0790287	-1.84861	0.244483	-0.470521	0.62 [0.28 - 1.38]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19823	60	0.8	0.0603889	-	0.770664	0.396725	0.812899	2.25 [0.34 - 14.77]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14482	155	0.187097	0.000214343	0.00682663	-1.02696	0.0099139	-0.411083	0.66 [0.49 - 0.91]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	220948_s_at	286	0.132867	0.00222808	0.0494791	-0.705512	0.369945	-0.242671	0.78 [0.46 - 1.33]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220948_s_at	159	0.100629	0.0247057	0.310488	-0.861501	0.865417	-0.0683818	0.93 [0.42 - 2.06]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220948_s_at	159	0.100629	0.0218422	0.285057	-0.878241	0.940047	-0.0299706	0.97 [0.44 - 2.12]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220948_s_at	159	0.899371	0.0293466	0.349066	0.96222	0.820472	0.105186	1.11 [0.45 - 2.76]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	244606_at	159	0.484277	0.0246111	0.309669	0.741783	0.541351	0.172139	1.19 [0.68 - 2.06]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	244606_at	159	0.433962	0.0285984	0.343048	0.756974	0.658502	0.124867	1.13 [0.65 - 1.97]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	244606_at	159	0.433962	0.0235589	0.300464	0.947015	0.460121	0.244214	1.28 [0.67 - 2.44]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	220948_s_at	54	0.277778	0.280076	-	1.09202	0.694379	0.181036	1.20 [0.49 - 2.96]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220948_s_at	117	0.179487	0.078959	-	-0.614917	0.608997	-0.129942	0.88 [0.53 - 1.44]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220948_s_at	117	0.376068	0.00435911	0.0849268	-1.09862	0.0784677	-0.547185	0.58 [0.31 - 1.06]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220948_s_at	117	0.179487	0.078959	-	-0.614917	0.608997	-0.129942	0.88 [0.53 - 1.44]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220948_s_at	117	0.393162	0.0861997	-	-0.640229	0.444608	-0.223373	0.80 [0.45 - 1.42]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	220948_s_at	236	0.224576	0.0524371	-	-0.559358	0.621722	0.210469	1.23 [0.53 - 2.85]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	244606_at	236	0.762712	0.0280245	0.338381	0.613263	0.332043	0.25884	1.30 [0.77 - 2.19]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	220948_s_at	249	0.116466	0.0470938	0.473881	-0.570802	0.55929	-0.2028	0.82 [0.41 - 1.61]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	244606_at	249	0.807229	0.0754746	-	0.43511	0.939159	0.0159845	1.02 [0.67 - 1.53]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220948_s_at	125	0.256	0.0504938	-	1.13528	0.740096	0.124859	1.13 [0.54 - 2.37]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220948_s_at	125	0.256	0.0629819	-	0.745167	0.960131	-0.0143644	0.99 [0.56 - 1.73]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220948_s_at	54	0.148148	9.53758e-05	0.00335919	-2.14229	0.0507592	-0.853552	0.43 [0.18 - 1.00]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220948_s_at	62	0.129032	0.01034	0.165571	-1.31807	0.188076	-0.435631	0.65 [0.34 - 1.24]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220948_s_at	198	0.222222	0.0014061	0.0338694	-0.709315	0.00583052	-0.593504	0.55 [0.36 - 0.84]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220948_s_at	198	0.368687	0.0829663	-	-0.442204	0.232205	-0.298865	0.74 [0.45 - 1.21]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220948_s_at	198	0.368687	0.0567157	-	-0.504578	0.221682	-0.317379	0.73 [0.44 - 1.21]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	220948_s_at	51	0.411765	0.054671	-	-1.86743	0.750775	-0.279102	0.76 [0.14 - 4.23]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	220948_s_at	62	0.112903	0.2521	-	-0.863693	0.769487	-0.168602	0.84 [0.27 - 2.61]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	244606_at	145	0.862069	0.0190894	0.259251	-2.01956	0.167187	-1.63536	0.19 [0.02 - 1.98]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	220948_s_at	177	0.830508	0.0761621	-	-0.692467	0.445856	-0.188382	0.83 [0.51 - 1.34]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	220948_s_at	145	0.6	0.000307223	0.00932588	-1.57386	0.00890973	-0.883886	0.41 [0.21 - 0.80]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	220948_s_at	177	0.570621	0.0147191	0.215023	-0.726828	0.205388	-0.359733	0.70 [0.40 - 1.22]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	244606_at	177	0.898305	0.00964402	0.157109	-1.66004	0.0293899	-1.82252	0.16 [0.03 - 0.83]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	244606_at	177	0.372881	0.0346664	0.38987	-0.567821	0.103784	-1.56442	0.21 [0.03 - 1.38]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	220948_s_at	226	0.477876	0.0215965	0.282811	-0.665507	0.158689	-0.455734	0.63 [0.34 - 1.19]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	244606_at	226	0.553097	0.00194033	0.0441834	-0.963506	0.0322852	-0.424599	0.65 [0.44 - 0.96]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	220948_s_at	55	0.8	0.0532888	-	0.988276	0.353567	0.600906	1.82 [0.51 - 6.49]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	244606_at	55	0.690909	0.00678324	0.120066	-2.23027	0.0749027	-3.50241	0.03 [0.00 - 1.42]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	220948_s_at	49	0.163265	0.0332867	0.379605	-1.23224	0.97727	-0.0215891	0.98 [0.22 - 4.32]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	244606_at	49	0.693878	0.0450124	0.460768	-1.83065	0.305063	-2.34261	0.10 [0.00 - 8.45]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	244606_at	55	0.763636	0.060542	-	-1.30676	0.259763	-1.75055	0.17 [0.01 - 3.65]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	220948_s_at	55	0.436364	0.0997651	-	0.784622	0.691368	0.220598	1.25 [0.42 - 3.71]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1639716	34	0.676471	0.199494	-	0.581297	0.713836	0.3216	1.38 [0.25 - 7.69]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	244606_at	63	0.603175	8.60858e-06	0.000390059	-1.89119	0.00130667	-16.6164	0.00 [0.00 - 0.00]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	220948_s_at	63	0.285714	0.137504	-	-0.508101	0.911707	0.0217188	1.02 [0.70 - 1.50]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.170060.0.A1_3p_at	28	0.678571	0.215727	-	-0.79302	0.319509	-2.45042	0.09 [0.00 - 10.74]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502268_3p_a_at	28	0.142857	0.202445	-	1.25364	0.737924	0.0558299	1.06 [0.76 - 1.47]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	220948_s_at	82	0.243902	0.0964893	-	-0.599137	0.717781	-0.178325	0.84 [0.32 - 2.20]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	220948_s_at	79	0.341772	0.063943	-	-0.502977	0.181721	-0.579386	0.56 [0.24 - 1.31]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	220948_s_at	104	0.673077	0.19239	-	0.423715	0.998479	-0.000840624	1.00 [0.42 - 2.37]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P1072	117	0.504274	0.0305925	0.358927	-0.625941	0.205467	-0.229393	0.80 [0.56 - 1.13]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	220948_s_at	204	0.568627	0.0563818	-	0.697013	0.516299	0.319581	1.38 [0.52 - 3.61]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	244606_at	204	0.794118	0.0158645	0.227047	-2.0659	0.796158	0.0544182	1.06 [0.70 - 1.60]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	220948_s_at	204	0.568627	0.142211	-	0.397195	0.586076	0.19714	1.22 [0.60 - 2.48]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	244606_at	204	0.794118	0.00254897	0.0552085	-1.6125	0.461919	-0.112977	0.89 [0.66 - 1.21]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	220948_s_at	178	0.842697	0.0759165	-	-0.559569	0.201038	-0.370256	0.69 [0.39 - 1.22]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	220948_s_at	111	0.810811	0.0530763	-	0.608017	0.46413	0.235902	1.27 [0.67 - 2.38]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	244606_at	111	0.108108	0.25607	-	0.525409	0.260702	0.216473	1.24 [0.85 - 1.81]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	220948_s_at	90	0.111111	0.0173024	0.241692	-1.05536	0.179559	-0.470764	0.62 [0.31 - 1.24]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	220948_s_at	90	0.344444	0.0452705	0.462413	-0.645296	0.22664	-0.378389	0.68 [0.37 - 1.26]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	220948_s_at	138	0.246377	0.0329401	0.376993	0.690155	0.104299	0.333591	1.40 [0.93 - 2.09]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	244606_at	138	0.173913	0.0308663	0.361069	-0.585313	0.267494	-2.91886	0.05 [0.00 - 9.40]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	220948_s_at	129	0.844961	0.07485	-	0.564864	0.870505	-0.068211	0.93 [0.41 - 2.12]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29447	56	0.642857	0.00838926	0.141344	-1.07135	0.13719	-0.420278	0.66 [0.38 - 1.14]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29447	56	0.642857	0.0471753	0.474388	-0.828883	0.445298	-0.225624	0.80 [0.45 - 1.42]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35609	56	0.160714	0.0909343	-	-0.671944	0.351276	-0.29809	0.74 [0.40 - 1.39]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35609	56	0.160714	0.249651	-	-0.50061	0.605869	-0.170197	0.84 [0.44 - 1.61]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	220948_s_at	278	0.100719	0.146303	-	-0.42481	0.746949	-0.0594863	0.94 [0.66 - 1.35]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	244606_at	278	0.248201	0.0295841	0.350961	-0.44189	0.575439	-0.322885	0.72 [0.23 - 2.24]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	220948_s_at	133	0.609023	0.027765	0.336257	0.521549	0.0610116	0.341582	1.41 [0.98 - 2.01]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	220948_s_at	185	0.291892	0.0205866	0.273463	-0.455433	0.348589	-0.120964	0.89 [0.69 - 1.14]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	220948_s_at	185	0.52973	0.00697531	0.122684	-0.441822	0.293733	-0.121856	0.89 [0.71 - 1.11]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P1072	110	0.190909	0.281649	-	0.466155	0.74669	0.0931009	1.10 [0.62 - 1.93]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P1072	110	0.181818	0.355052	-	0.287465	0.809924	-0.0513973	0.95 [0.62 - 1.44]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	220948_s_at	80	0.5625	0.183497	-	0.573256	0.762491	0.12706	1.14 [0.50 - 2.59]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	220948_s_at	38	0.763158	0.00685752	0.121081	1.2636	0.0676465	0.826239	2.28 [0.94 - 5.54]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	244606_at	38	0.894737	0.00618046	0.111709	1.48601	0.865757	0.0533254	1.05 [0.57 - 1.96]
GENE	ATP1A1	ATPase, Na+/K+ transporting, alpha 1 polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	220948_s_at	140	0.614286	0.000245338	0.00767622	1.03803	0.00351929	0.663615	1.94 [1.24 - 3.03]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203295_s_at	30	0.833333	0.106287	-	0.809761	0.6827	0.145376	1.16 [0.58 - 2.32]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203296_s_at	30	0.866667	0.492249	-	0.3698	0.790067	0.0469321	1.05 [0.74 - 1.48]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1795008	165	0.266667	0.182474	-	0.3802	0.683189	-0.0424835	0.96 [0.78 - 1.18]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1795008	165	0.242424	0.0838728	-	0.896077	0.983912	0.00271829	1.00 [0.77 - 1.31]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203295_s_at	163	0.638037	0.121816	-	-0.328928	0.135711	-0.997747	0.37 [0.10 - 1.37]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203296_s_at	163	0.889571	0.0192024	0.260338	0.662363	0.863752	0.1244	1.13 [0.27 - 4.69]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203296_s_at	79	0.658228	0.0807792	-	-0.563659	0.383833	-0.708099	0.49 [0.10 - 2.42]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203295_s_at	79	0.253165	0.00765289	0.131755	-0.795	0.422338	-0.742172	0.48 [0.08 - 2.92]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203296_s_at	58	0.103448	0.382762	-	-0.387143	0.586931	-0.114526	0.89 [0.59 - 1.35]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203295_s_at	58	0.655172	0.0905547	-	0.481571	0.445788	0.109394	1.12 [0.84 - 1.48]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203296_s_at	34	0.617647	0.0853699	-	-0.710216	0.310167	-0.269302	0.76 [0.45 - 1.29]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203295_s_at	34	0.235294	0.0994785	-	-0.728168	0.621967	-0.137016	0.87 [0.51 - 1.50]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203296_s_at	158	0.297468	0.0582181	-	-0.456873	0.191762	-0.963181	0.38 [0.09 - 1.62]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203295_s_at	158	0.341772	0.239897	-	0.29419	0.820628	0.245367	1.28 [0.15 - 10.66]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203296_s_at	53	0.849057	0.00649826	0.116143	1.14622	0.389872	0.195789	1.22 [0.78 - 1.90]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203295_s_at	53	0.811321	0.16624	-	0.582029	0.700128	0.0847435	1.09 [0.71 - 1.68]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203296_s_at	53	0.849057	0.0205963	0.273553	0.965474	0.550125	0.125092	1.13 [0.75 - 1.71]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203295_s_at	53	0.584906	0.0830814	-	0.629645	0.583813	0.126804	1.14 [0.72 - 1.79]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203295_s_at	180	0.844444	0.0632057	-	0.51131	0.355169	0.102714	1.11 [0.89 - 1.38]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203296_s_at	180	0.55	0.0814395	-	0.362813	0.5549	0.0639827	1.07 [0.86 - 1.32]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203296_s_at	559	0.334526	0.123514	-	-0.31363	0.521108	-0.0739461	0.93 [0.74 - 1.16]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203295_s_at	559	0.640429	0.0086963	0.145266	-0.57781	0.311851	-0.117379	0.89 [0.71 - 1.12]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203296_s_at	77	0.545455	0.0637009	-	-0.483216	0.113945	-0.153787	0.86 [0.71 - 1.04]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203295_s_at	77	0.441558	0.0220706	0.287136	-0.578421	0.0422343	-0.167265	0.85 [0.72 - 0.99]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203296_s_at	70	0.614286	0.0116798	0.181353	0.668668	0.148775	0.126319	1.13 [0.96 - 1.35]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203295_s_at	70	0.642857	0.010981	0.173201	0.681235	0.082546	0.186916	1.21 [0.98 - 1.49]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34377_at	50	0.26	0.0939654	-	0.792966	0.502029	0.0885178	1.09 [0.84 - 1.41]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203295_s_at	74	0.378378	0.104688	-	-0.474008	0.800886	-0.0348913	0.97 [0.74 - 1.27]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203296_s_at	74	0.756757	0.0612906	-	0.577938	0.570735	0.09185	1.10 [0.80 - 1.51]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203296_s_at	67	0.238806	0.434347	-	-0.547238	0.731828	-0.0657625	0.94 [0.64 - 1.36]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203295_s_at	67	0.104478	0.293486	-	15.1864	0.869338	-0.0374412	0.96 [0.62 - 1.50]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203296_s_at	115	0.843478	0.0945956	-	-15.2924	0.552413	-0.294189	0.75 [0.28 - 1.97]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203295_s_at	115	0.347826	0.0861619	-	1.22661	0.526221	0.324242	1.38 [0.51 - 3.77]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34377_at	158	0.708861	0.149829	-	-0.47598	0.563408	-0.0893313	0.91 [0.68 - 1.24]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34377_at	76	0.776316	0.121354	-	-1.4684	0.938993	-0.0193299	0.98 [0.60 - 1.61]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203295_s_at	204	0.220588	0.0173072	0.24174	-0.404361	0.143769	-0.0968148	0.91 [0.80 - 1.03]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203296_s_at	204	0.220588	0.086123	-	-0.289497	0.367598	-0.0533092	0.95 [0.84 - 1.06]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203296_s_at	87	0.689655	0.0438283	0.453148	-1.04301	0.120666	-0.681463	0.51 [0.21 - 1.20]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203295_s_at	87	0.517241	0.0285651	0.342778	-0.887688	0.121256	-1.46525	0.23 [0.04 - 1.47]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203295_s_at	87	0.517241	0.0285651	0.342778	-0.887688	0.121256	-1.46525	0.23 [0.04 - 1.47]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203296_s_at	87	0.689655	0.0438283	0.453148	-1.04301	0.120666	-0.681463	0.51 [0.21 - 1.20]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203295_s_at	77	0.142857	0.00290834	0.0614323	-1.54719	0.0550255	-3.69066	0.02 [0.00 - 1.08]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203296_s_at	77	0.649351	0.0123811	0.18937	-15.8163	0.0613747	-1.78816	0.17 [0.03 - 1.09]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203295_s_at	77	0.142857	0.00014358	0.00481214	-2.04489	0.00375646	-8.23094	0.00 [0.00 - 0.07]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203296_s_at	77	0.649351	0.0254698	0.317053	-1.98639	0.100462	-1.1861	0.31 [0.07 - 1.26]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203295_s_at	136	0.625	0.00800492	0.136372	-1.74909	0.103716	-0.354009	0.70 [0.46 - 1.08]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203296_s_at	136	0.455882	0.0297868	0.352572	-0.99242	0.252098	-0.301827	0.74 [0.44 - 1.24]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203296_s_at	200	0.23	0.0166498	0.235105	-0.726277	0.0869335	-0.278078	0.76 [0.55 - 1.04]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203295_s_at	200	0.12	0.24397	-	-0.475628	0.830337	-0.0412935	0.96 [0.66 - 1.40]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20390	60	0.133333	0.129912	-	-0.683299	0.886545	0.0193904	1.02 [0.78 - 1.33]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20390	60	0.216667	0.020354	0.271284	-0.926515	0.976517	-0.00487215	1.00 [0.72 - 1.38]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15592	155	0.232258	0.081847	-	0.695825	0.258003	0.280171	1.32 [0.81 - 2.15]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203295_s_at	286	0.468531	0.00337177	0.0691975	-0.565496	0.251191	-0.12993	0.88 [0.70 - 1.10]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203296_s_at	286	0.447552	0.00810234	0.137639	-0.509539	0.0945268	-0.198443	0.82 [0.65 - 1.03]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203296_s_at	159	0.578616	0.00649971	0.116163	-0.990133	0.337052	-0.261342	0.77 [0.45 - 1.31]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203295_s_at	159	0.433962	0.0287144	0.343986	-0.686532	0.371281	-0.174291	0.84 [0.57 - 1.23]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203295_s_at	159	0.433962	0.0456231	0.464652	-0.737308	0.39927	-0.191779	0.83 [0.53 - 1.29]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203295_s_at	159	0.289308	0.00156891	0.0370878	-0.964695	0.0335268	-0.389388	0.68 [0.47 - 0.97]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203296_s_at	159	0.63522	0.00040708	0.0118827	-1.53635	0.0307368	-0.555283	0.57 [0.35 - 0.95]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203296_s_at	159	0.446541	0.00380815	0.0762748	-1.10514	0.0787468	-0.554658	0.57 [0.31 - 1.07]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203295_s_at	54	0.203704	0.0385974	0.418011	-1.36716	0.393791	-1.70066	0.18 [0.00 - 9.10]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203296_s_at	54	0.796296	0.0881237	-	-15.4766	0.320413	-1.02652	0.36 [0.05 - 2.71]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203296_s_at	117	0.145299	0.0044152	0.0857914	-1.00642	0.373629	-0.438998	0.64 [0.25 - 1.70]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203295_s_at	117	0.692308	0.0572558	-	-0.820373	0.247834	-0.822964	0.44 [0.11 - 1.77]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203296_s_at	117	0.145299	0.00140247	0.0337968	-1.27734	0.403253	-0.608471	0.54 [0.13 - 2.27]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203295_s_at	117	0.273504	0.0245199	0.308878	-0.853787	0.214383	-1.25875	0.28 [0.04 - 2.07]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203296_s_at	117	0.145299	0.0251581	0.314385	-0.945758	0.643884	-0.180806	0.83 [0.39 - 1.80]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203295_s_at	117	0.692308	0.0572558	-	-0.820373	0.247834	-0.822964	0.44 [0.11 - 1.77]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203295_s_at	117	0.777778	0.14384	-	-0.866325	0.44622	-0.558961	0.57 [0.14 - 2.41]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203296_s_at	117	0.145299	0.0044152	0.0857914	-1.00642	0.373629	-0.438998	0.64 [0.25 - 1.70]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203295_s_at	236	0.377119	0.00938911	0.153961	-0.688594	0.21755	-0.257197	0.77 [0.51 - 1.16]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203296_s_at	236	0.567797	0.0592881	-	-0.536061	0.506854	-0.129474	0.88 [0.60 - 1.29]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203295_s_at	249	0.208835	0.0113781	0.177854	-0.588852	0.186712	-0.216016	0.81 [0.58 - 1.11]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203296_s_at	249	0.690763	0.0159195	0.227617	-0.614194	0.495296	-0.0991004	0.91 [0.68 - 1.20]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203296_s_at	62	0.322581	0.116604	-	-0.79376	0.106516	0.48413	1.62 [0.90 - 2.92]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203295_s_at	125	0.408	0.00806402	0.137141	-0.744187	0.0873629	-1.74228	0.18 [0.02 - 1.29]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203295_s_at	125	0.544	0.0209776	0.277104	-0.933237	0.14687	-2.04312	0.13 [0.01 - 2.05]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203296_s_at	125	0.424	0.382387	-	0.369886	0.991041	-0.00344034	1.00 [0.55 - 1.82]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203296_s_at	125	0.696	0.103605	-	-0.534842	0.644481	-0.113434	0.89 [0.55 - 1.45]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203296_s_at	54	0.259259	0.130668	-	-0.977659	0.0108784	0.876301	2.40 [1.22 - 4.72]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203295_s_at	54	0.111111	0.246592	-	15.1737	0.832018	0.0908843	1.10 [0.47 - 2.54]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203295_s_at	62	0.887097	0.182525	-	-1.29449	0.959377	-0.0178501	0.98 [0.49 - 1.95]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203295_s_at	198	0.722222	0.138752	-	0.406871	0.99943	6.73344e-05	1.00 [0.83 - 1.20]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203296_s_at	198	0.727273	0.0521221	-	0.537978	0.322046	0.0998335	1.10 [0.91 - 1.35]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203296_s_at	198	0.60101	0.00435644	0.0848856	0.594961	0.191902	0.105033	1.11 [0.95 - 1.30]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203295_s_at	198	0.722222	0.131333	-	0.333971	0.667229	0.0309806	1.03 [0.90 - 1.19]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203295_s_at	198	0.722222	0.179484	-	0.355147	0.919217	0.00903951	1.01 [0.85 - 1.20]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203296_s_at	198	0.772727	0.0473178	0.475272	0.543271	0.336546	0.0914567	1.10 [0.91 - 1.32]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203295_s_at	62	0.870968	0.136671	-	-15.2756	0.57881	-0.875724	0.42 [0.02 - 9.17]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203295_s_at	51	0.215686	0.0293334	0.348961	-1.7564	0.353996	-2.3606	0.09 [0.00 - 13.89]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203296_s_at	51	0.215686	0.217208	-	15.4333	0.905099	-0.168569	0.84 [0.05 - 13.50]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203296_s_at	62	0.887097	0.150118	-	0.929723	0.837617	-0.222826	0.80 [0.10 - 6.74]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203295_s_at	177	0.531073	0.0360449	0.39992	-0.496625	0.684694	-0.193382	0.82 [0.32 - 2.10]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203296_s_at	177	0.152542	0.166306	-	0.639279	0.248463	0.216676	1.24 [0.86 - 1.79]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203295_s_at	145	0.503448	0.0182784	0.251366	-0.801902	0.351373	-0.884511	0.41 [0.06 - 2.65]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203295_s_at	177	0.531073	0.047017	0.473404	-0.545112	0.904305	0.0509995	1.05 [0.46 - 2.42]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203296_s_at	177	0.152542	0.239244	-	0.438197	0.413107	0.156683	1.17 [0.80 - 1.70]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203296_s_at	145	0.268966	0.0886404	-	-0.575302	0.331318	-0.77613	0.46 [0.10 - 2.20]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203295_s_at	226	0.469027	0.0933214	-	-0.474114	0.515452	-0.0905371	0.91 [0.70 - 1.20]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203296_s_at	226	0.128319	0.0378835	0.413017	1.38576	0.210275	0.109319	1.12 [0.94 - 1.32]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203296_s_at	55	0.872727	0.00130388	0.0318103	1.48579	0.0397227	0.729393	2.07 [1.03 - 4.16]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203296_s_at	55	0.854545	0.00158498	0.0374015	1.51585	0.0123425	0.960237	2.61 [1.23 - 5.54]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203296_s_at	49	0.877551	2.69241e-06	0.000135209	2.44326	0.00616147	1.0273	2.79 [1.34 - 5.83]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203295_s_at	55	0.509091	0.0632961	-	-0.914804	0.71662	-0.400483	0.67 [0.08 - 5.82]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203295_s_at	55	0.181818	0.0775861	-	-0.842459	0.842087	0.167102	1.18 [0.23 - 6.12]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203295_s_at	49	0.183673	0.00582324	0.106648	-1.53581	0.701167	0.427061	1.53 [0.17 - 13.58]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	156437	34	0.264706	0.133718	-	-0.667075	0.794417	-0.116387	0.89 [0.37 - 2.14]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203296_s_at	63	0.15873	0.0554917	-	1.10981	0.934114	-0.00999215	0.99 [0.78 - 1.25]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203295_s_at	63	0.126984	0.011707	0.181667	-1.03976	0.30938	-1.0342	0.36 [0.05 - 2.61]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502270_3p_a_at	28	0.857143	0.0503318	-	1.61453	0.43885	0.206942	1.23 [0.73 - 2.08]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.34114.0.S1_3p_x_at	28	0.607143	0.03983	0.426517	-1.32371	0.433422	-2.41779	0.09 [0.00 - 37.78]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	203295_3p_s_at	28	0.321429	0.0132032	0.19857	-1.39597	0.0870977	-4.38342	0.01 [0.00 - 1.89]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203295_s_at	82	0.829268	0.0387475	0.419055	-1.39139	0.527485	0.205462	1.23 [0.65 - 2.32]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203296_s_at	82	0.170732	0.0417255	0.439321	-0.766461	0.339415	-0.198688	0.82 [0.55 - 1.23]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203295_s_at	79	0.126582	0.0597912	-	-0.644422	0.713179	-0.141385	0.87 [0.41 - 1.85]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203296_s_at	79	0.253165	0.00775514	0.133102	-0.759194	0.248498	-0.212582	0.81 [0.56 - 1.16]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203295_s_at	104	0.817308	0.130456	-	0.570426	0.843319	-0.085334	0.92 [0.39 - 2.14]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203296_s_at	104	0.432692	0.0035028	0.071345	-0.952453	0.130147	-0.317858	0.73 [0.48 - 1.10]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203296_s_at	204	0.127451	6.96361e-09	5.26347e-07	-1.54705	2.65008e-07	-0.477345	0.62 [0.52 - 0.74]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203295_s_at	204	0.132353	0.00251774	0.0546584	-1.14589	0.0381617	-0.441748	0.64 [0.42 - 0.98]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203295_s_at	204	0.205882	0.00456091	0.0880243	-0.798779	0.00653295	-0.433064	0.65 [0.47 - 0.89]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203296_s_at	204	0.367647	0.00123728	0.0304514	-1.16074	0.0484209	-0.259977	0.77 [0.60 - 1.00]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203296_s_at	178	0.516854	0.278489	-	0.215152	0.850388	0.0272996	1.03 [0.77 - 1.36]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203295_s_at	111	0.882883	0.00729781	0.127032	0.906211	0.977103	0.00520065	1.01 [0.70 - 1.43]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203296_s_at	111	0.459459	0.0826822	-	-0.453765	0.295339	-0.127534	0.88 [0.69 - 1.12]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203295_s_at	90	0.122222	0.120928	-	1.07518	0.990513	-0.00796445	0.99 [0.27 - 3.69]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203295_s_at	90	0.122222	0.291953	-	0.754913	0.990216	-0.00935001	0.99 [0.22 - 4.42]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203296_s_at	90	0.111111	0.324967	-	0.584828	0.72327	-0.254723	0.78 [0.19 - 3.17]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203296_s_at	90	0.855556	0.216878	-	-0.876856	0.559843	-0.520272	0.59 [0.10 - 3.42]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5026	50	0.88	0.0442082	0.455606	1.11737	0.26195	0.448779	1.57 [0.72 - 3.43]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203295_s_at	138	0.231884	0.0332533	0.379354	-0.546452	0.290936	-0.869196	0.42 [0.08 - 2.10]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203296_s_at	138	0.369565	0.00254246	0.055094	-0.714104	0.168689	-0.442645	0.64 [0.34 - 1.21]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203295_s_at	129	0.550388	0.0543226	-	0.470986	0.114782	0.340535	1.41 [0.92 - 2.15]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203296_s_at	129	0.899225	0.00568364	0.104647	0.929291	0.187364	0.259088	1.30 [0.88 - 1.90]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22065	56	0.428571	0.0926603	-	0.584118	0.140555	0.162929	1.18 [0.95 - 1.46]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22065	56	0.339286	0.275979	-	0.406877	0.617586	0.0543653	1.06 [0.85 - 1.31]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203296_s_at	278	0.798561	0.139939	-	0.327903	0.922611	0.00666926	1.01 [0.88 - 1.15]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203295_s_at	278	0.104317	0.0402539	0.429409	-0.535601	0.741327	-0.0365162	0.96 [0.78 - 1.20]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203295_s_at	133	0.857143	0.00263246	0.0566716	0.915869	0.167688	0.239582	1.27 [0.90 - 1.79]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203296_s_at	133	0.315789	0.0366016	0.403922	0.56447	0.742966	0.0452991	1.05 [0.80 - 1.37]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9886	81	0.419753	0.0729596	-	1.03849	0.200972	0.824697	2.28 [0.64 - 8.07]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11407	81	0.54321	0.0506207	-	1.03784	0.617659	0.34623	1.41 [0.36 - 5.51]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5797	81	0.17284	0.175246	-	-0.775069	0.832716	-0.0711021	0.93 [0.48 - 1.80]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203295_s_at	185	0.897297	0.317528	-	0.274784	0.617082	0.107397	1.11 [0.73 - 1.70]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203296_s_at	185	0.140541	0.103118	-	-0.362132	0.547535	0.0790216	1.08 [0.84 - 1.40]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203295_s_at	185	0.87027	0.266163	-	-0.285601	0.801322	0.0523047	1.05 [0.70 - 1.58]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203296_s_at	185	0.816216	0.0732673	-	0.387904	0.23696	0.15182	1.16 [0.91 - 1.50]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P148879	110	0.581818	0.282301	-	0.325185	0.717532	0.0302681	1.03 [0.87 - 1.21]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P148879	110	0.581818	0.0442709	0.45601	0.464062	0.564176	0.0367496	1.04 [0.92 - 1.18]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203295_s_at	80	0.825	0.101055	-	-1.52816	0.876901	0.0223307	1.02 [0.77 - 1.36]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203296_s_at	80	0.8375	0.20256	-	-1.22924	0.712637	-0.0469171	0.95 [0.74 - 1.22]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_0740	281	0.398576	0.0120903	0.186065	-0.351619	0.0898051	-0.138072	0.87 [0.74 - 1.02]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203296_s_at	38	0.157895	5.73331e-05	0.00214122	-2.04307	0.0122016	-0.90491	0.40 [0.20 - 0.82]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203295_s_at	38	0.157895	0.0985176	-	-0.873317	0.158563	-0.440562	0.64 [0.35 - 1.19]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203295_s_at	140	0.514286	1.47338e-06	7.77517e-05	-1.60699	0.000595829	-1.0212	0.36 [0.20 - 0.65]
GENE	ATP1A2	ATPase, Na+/K+ transporting, alpha 2 polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203296_s_at	140	0.457143	6.18559e-06	0.000288895	-1.39451	0.000369179	-0.514661	0.60 [0.45 - 0.79]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214432_at	30	0.133333	0.0521037	-	-1.10361	0.901864	-0.11921	0.89 [0.13 - 5.90]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1689098	165	0.4	0.0821845	-	0.448702	0.877546	-0.0477147	0.95 [0.52 - 1.75]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1689098	165	0.4	0.275382	-	0.413731	0.927504	-0.0450662	0.96 [0.36 - 2.52]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214432_at	163	0.460123	0.0583896	-	-0.373336	0.297653	-0.592538	0.55 [0.18 - 1.69]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214432_at	79	0.151899	0.0642802	-	-0.651213	0.842499	-0.151814	0.86 [0.19 - 3.84]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214432_at	58	0.206897	0.0604762	-	0.657985	0.24519	0.222589	1.25 [0.86 - 1.82]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214432_at	34	0.823529	0.00886019	0.147342	1.3322	0.724798	0.097471	1.10 [0.64 - 1.90]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214432_at	158	0.21519	0.101311	-	0.528396	0.763295	0.165323	1.18 [0.40 - 3.46]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214432_at	53	0.716981	0.319074	-	-0.42794	0.944113	-0.0177237	0.98 [0.60 - 1.61]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214432_at	53	0.188679	0.226023	-	0.579023	0.935379	0.0192884	1.02 [0.64 - 1.63]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214432_at	180	0.716667	0.035628	0.396902	0.455459	0.616998	-0.0540919	0.95 [0.77 - 1.17]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214432_at	559	0.150268	0.0134507	0.201301	-0.598524	0.310436	-0.154382	0.86 [0.64 - 1.15]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214432_at	77	0.675325	0.0181768	0.250368	-0.681367	0.113254	-0.192981	0.82 [0.65 - 1.05]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214432_at	70	0.828571	0.0194773	0.262975	0.777822	0.332562	0.479686	1.62 [0.61 - 4.26]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35670_at	50	0.44	0.0415582	0.438204	-0.70521	0.376702	-0.101731	0.90 [0.72 - 1.13]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214432_at	74	0.202703	0.0349347	0.391843	-0.686213	0.345079	-0.133797	0.87 [0.66 - 1.15]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214432_at	67	0.656716	0.00886919	0.147456	1.70695	0.245192	2.51768	12.40 [0.18 - 866.08]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214432_at	115	0.173913	0.00520486	0.0976775	-1.39491	0.00558027	-1.01417	0.36 [0.18 - 0.74]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35670_at	158	0.721519	0.158997	-	0.419295	0.407277	0.165194	1.18 [0.80 - 1.74]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35670_at	76	0.131579	0.151607	-	-0.815991	0.511389	-0.309921	0.73 [0.29 - 1.85]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214432_at	204	0.862745	0.0760902	-	-0.361133	0.291018	-0.0764886	0.93 [0.80 - 1.07]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214432_at	87	0.298851	0.0398968	0.426974	1.06002	0.436552	0.543017	1.72 [0.44 - 6.76]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214432_at	87	0.298851	0.0398968	0.426974	1.06002	0.436552	0.543017	1.72 [0.44 - 6.76]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214432_at	77	0.142857	4.51695e-08	3.05319e-06	-2.73952	0.490327	-0.781102	0.46 [0.05 - 4.21]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214432_at	77	0.142857	1.50832e-05	0.000647807	-2.074	0.633376	-0.456547	0.63 [0.10 - 4.14]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214432_at	136	0.772059	0.0696558	-	-1.66545	0.873012	-0.0430642	0.96 [0.56 - 1.62]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214432_at	200	0.855	0.147841	-	0.511367	0.417573	0.176269	1.19 [0.78 - 1.83]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8455	60	0.3	0.201177	-	-0.507122	0.705231	0.106697	1.11 [0.64 - 1.93]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8455	60	0.883333	0.112932	-	0.767833	0.420886	0.181262	1.20 [0.77 - 1.86]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	7863	155	0.251613	2.31768e-07	1.40509e-05	-1.3453	1.70747e-05	-0.219309	0.80 [0.73 - 0.89]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214432_at	286	0.129371	0.00060688	0.016714	-0.801246	0.0371109	-0.298118	0.74 [0.56 - 0.98]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214432_at	159	0.811321	0.105591	-	-0.829097	0.646449	-0.125623	0.88 [0.52 - 1.51]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214432_at	159	0.716981	0.00444805	0.0862964	0.875898	0.115178	0.500747	1.65 [0.88 - 3.08]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214432_at	159	0.698113	0.190844	-	0.488377	0.840632	0.069257	1.07 [0.55 - 2.10]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214432_at	54	0.518519	0.106348	-	-1.22494	0.38386	-1.09489	0.33 [0.03 - 3.93]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214432_at	117	0.102564	0.0118068	0.182817	-0.965813	0.70681	-0.197303	0.82 [0.29 - 2.30]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214432_at	117	0.888889	0.125436	-	0.752861	0.718652	0.203241	1.23 [0.41 - 3.70]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214432_at	117	0.102564	0.0118068	0.182817	-0.965813	0.70681	-0.197303	0.82 [0.29 - 2.30]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214432_at	117	0.102564	0.0259467	0.321106	-0.987671	0.827615	-0.130407	0.88 [0.27 - 2.84]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214432_at	236	0.847458	0.0766891	-	0.571144	0.964136	0.0107156	1.01 [0.63 - 1.61]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214432_at	249	0.473896	0.172915	-	0.291902	0.472211	0.14039	1.15 [0.78 - 1.69]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214432_at	62	0.274194	0.0916388	-	1.57376	0.770417	-0.070443	0.93 [0.58 - 1.50]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214432_at	125	0.144	0.379652	-	-0.403156	0.839325	0.166397	1.18 [0.24 - 5.90]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214432_at	125	0.888	0.25579	-	-0.664722	0.998182	0.00144254	1.00 [0.29 - 3.46]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214432_at	54	0.296296	0.0469141	0.472763	15.4752	0.860019	-0.0518749	0.95 [0.53 - 1.69]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214432_at	198	0.484848	0.0370889	0.407399	0.575805	0.289493	0.118175	1.13 [0.90 - 1.40]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214432_at	198	0.39899	0.00581344	0.106508	0.624334	0.010321	0.229145	1.26 [1.06 - 1.50]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214432_at	198	0.484848	0.0330529	0.377844	0.557119	0.137855	0.159803	1.17 [0.95 - 1.45]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214432_at	51	0.686275	0.126295	-	1.30317	0.448276	1.03189	2.81 [0.19 - 40.41]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214432_at	62	0.887097	0.0818992	-	1.10548	0.322479	0.879245	2.41 [0.42 - 13.75]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214432_at	177	0.632768	0.0232538	0.297763	-0.708268	0.0528406	-1.25697	0.28 [0.08 - 1.02]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214432_at	177	0.451977	0.062568	-	-0.434955	0.223604	-0.661713	0.52 [0.18 - 1.50]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214432_at	145	0.717241	0.0333694	0.380227	-0.985234	0.216312	-0.968041	0.38 [0.08 - 1.76]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214432_at	226	0.884956	0.0690703	-	-1.23282	0.928631	-0.0151277	0.98 [0.71 - 1.37]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214432_at	55	0.2	0.00285446	0.0605112	-1.28613	0.00561312	-2.78083	0.06 [0.01 - 0.44]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214432_at	55	0.709091	0.0054095	0.100677	-2.302	0.026895	-2.31685	0.10 [0.01 - 0.77]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214432_at	49	0.326531	0.00345715	0.0705991	-1.62069	0.0138287	-3.32742	0.04 [0.00 - 0.51]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	970271	34	0.794118	0.0311013	0.362899	1.03523	0.124507	1.15222	3.17 [0.73 - 13.77]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214432_at	63	0.333333	0.0590595	-	-0.635362	0.521602	0.523318	1.69 [0.34 - 8.36]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	214432_3p_at	28	0.178571	0.0757846	-	-1.05061	0.213649	-10.3161	0.00 [0.00 - 381.04]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.274371.0.S1_3p_at	28	0.285714	0.215804	-	-0.700224	0.323187	-0.355275	0.70 [0.35 - 1.42]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.274371.0.S1_3p_x_at	28	0.214286	0.0038461	0.0768804	-1.56246	0.467996	-0.932535	0.39 [0.03 - 4.88]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214432_at	82	0.292683	0.0527033	-	-0.656723	0.916676	-0.0384683	0.96 [0.47 - 1.98]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214432_at	79	0.797468	0.00710276	0.124409	0.800612	0.322366	0.320004	1.38 [0.73 - 2.60]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M37457_at	86	0.604651	0.266485	-	0.450868	0.878168	0.102569	1.11 [0.30 - 4.11]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214432_at	104	0.307692	0.264858	-	-0.380041	0.741847	-0.198079	0.82 [0.25 - 2.67]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P27472	117	0.880342	0.0506164	-	-1.3154	0.39565	-0.133338	0.88 [0.64 - 1.19]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214432_at	204	0.848039	0.0824489	-	-1.59332	0.746943	-0.0791669	0.92 [0.57 - 1.49]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214432_at	204	0.818627	0.063362	-	-0.846263	0.853325	0.0361679	1.04 [0.71 - 1.52]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214432_at	178	0.898876	0.0637289	-	0.54585	0.911748	0.0337349	1.03 [0.57 - 1.88]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214432_at	111	0.882883	0.0945829	-	-0.842768	0.654304	0.0878331	1.09 [0.74 - 1.60]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214432_at	90	0.277778	0.109825	-	0.629864	0.253274	0.486037	1.63 [0.71 - 3.74]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214432_at	90	0.277778	0.0884486	-	0.817137	0.0952473	0.729752	2.07 [0.88 - 4.89]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214432_at	138	0.304348	7.51233e-06	0.000344701	-1.04645	0.160432	-5.34401	0.00 [0.00 - 8.32]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214432_at	129	0.620155	0.0626173	-	0.461475	0.798053	0.0498207	1.05 [0.72 - 1.54]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25246	56	0.803571	0.162305	-	-0.824706	0.467483	-0.252333	0.78 [0.39 - 1.53]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25246	56	0.696429	0.0682939	-	-0.756921	0.233199	-0.397005	0.67 [0.35 - 1.29]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214432_at	278	0.827338	0.00887068	0.147474	0.609204	0.305672	0.2388	1.27 [0.80 - 2.01]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214432_at	133	0.834586	0.00273391	0.0584352	0.799269	0.428966	0.23897	1.27 [0.70 - 2.30]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11937	81	0.580247	0.0569889	-	-1.06929	0.538348	-0.26073	0.77 [0.34 - 1.77]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13413	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214432_at	185	0.502703	0.0181488	0.250093	-0.38474	0.134233	-0.415211	0.66 [0.38 - 1.14]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214432_at	185	0.486486	0.0166176	0.234777	-0.422752	0.235083	-0.358037	0.70 [0.39 - 1.26]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P27472	110	0.445455	0.255693	-	-0.25913	0.827084	-0.0421449	0.96 [0.66 - 1.40]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P27472	110	0.181818	0.123869	-	-0.547451	0.868322	0.0420045	1.04 [0.63 - 1.71]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214432_at	80	0.55	0.0925391	-	0.770749	0.611312	0.118748	1.13 [0.71 - 1.78]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1969	281	0.569395	0.0448257	0.459574	-0.286096	0.520638	-0.107114	0.90 [0.65 - 1.25]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214432_at	38	0.421053	0.118549	-	-0.747718	0.422152	-0.321241	0.73 [0.33 - 1.59]
GENE	ATP1A3	ATPase, Na+/K+ transporting, alpha 3 polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214432_at	140	0.557143	0.00442599	0.0859574	-0.877448	0.0279784	-2.07333	0.13 [0.02 - 0.80]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1696132	165	0.466667	0.0913388	-	-0.405051	0.338171	-0.293168	0.75 [0.41 - 1.36]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1696132	165	0.551515	0.000714377	0.0191944	-1.41377	0.131941	-0.768244	0.46 [0.17 - 1.26]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1558612_a_at	79	0.367089	0.0532666	-	-0.565211	0.430613	-0.673518	0.51 [0.10 - 2.72]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1564241_at	79	0.113924	0.0210375	0.277659	-0.881002	0.21205	-1.09773	0.33 [0.06 - 1.87]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1565346_a_at	79	0.797468	0.187679	-	-0.534303	0.721153	-0.301094	0.74 [0.14 - 3.87]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1565346_a_at	559	0.37746	0.0191954	0.260272	0.534524	0.365867	0.134508	1.14 [0.85 - 1.53]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1558612_a_at	559	0.237925	0.00768386	0.132163	-0.593435	0.197596	-0.162227	0.85 [0.66 - 1.09]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1564241_at	559	0.309481	0.00531797	0.0993392	-0.571927	0.0187123	-0.403818	0.67 [0.48 - 0.94]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1565346_a_at	70	0.3	0.146317	-	-0.395185	0.559094	-0.519001	0.60 [0.10 - 3.39]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1558612_a_at	70	0.814286	0.141677	-	0.462383	0.989568	0.0206285	1.02 [0.05 - 22.49]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1564241_at	70	0.3	0.0746545	-	-0.505033	0.981158	-0.0215358	0.98 [0.16 - 5.85]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1565346_a_at	67	0.776119	0.0714217	-	-15.5142	0.18283	-6.04378	0.00 [0.00 - 17.27]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1558612_a_at	67	0.656716	0.312065	-	-0.793299	0.747268	-0.829252	0.44 [0.00 - 67.66]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1564241_at	67	0.865672	0.193296	-	-15.2833	0.743335	-0.99603	0.37 [0.00 - 143.46]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1565346_a_at	115	0.226087	0.00534773	0.0997747	-1.3781	0.514205	-0.422905	0.66 [0.18 - 2.33]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1558612_a_at	115	0.878261	0.14911	-	-15.2217	0.778848	-0.110644	0.90 [0.41 - 1.94]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1564241_at	115	0.434783	0.0240168	0.304492	-1.25199	0.123908	-0.44643	0.64 [0.36 - 1.13]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1565346_a_at	204	0.882353	0.0144799	0.212469	-0.529666	0.301973	-0.0726674	0.93 [0.81 - 1.07]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1558612_a_at	204	0.593137	0.000336208	0.0100801	-0.512754	0.00771656	-0.167968	0.85 [0.75 - 0.96]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1564241_at	204	0.348039	9.78663e-08	6.29245e-06	-0.8037	0.00136333	-0.209861	0.81 [0.71 - 0.92]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1565346_a_at	87	0.344828	0.0155554	0.223835	1.2293	0.977127	0.0259194	1.03 [0.17 - 6.04]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1558612_a_at	87	0.816092	0.020193	0.269768	-2.01029	0.0568066	-0.519226	0.59 [0.35 - 1.02]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1558612_a_at	87	0.816092	0.020193	0.269768	-2.01029	0.0568066	-0.519226	0.59 [0.35 - 1.02]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1564241_at	87	0.425287	0.00440285	0.0856012	-1.05626	0.0181697	-0.338533	0.71 [0.54 - 0.94]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1564241_at	87	0.425287	0.00440285	0.0856012	-1.05626	0.0181697	-0.338533	0.71 [0.54 - 0.94]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1565346_a_at	87	0.344828	0.0155554	0.223835	1.2293	0.977127	0.0259194	1.03 [0.17 - 6.04]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1565346_a_at	77	0.506494	0.0434804	0.450887	-1.46415	0.949973	0.146123	1.16 [0.01 - 111.16]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1558612_a_at	77	0.233766	0.0294022	0.34951	-1.28751	0.492001	0.24612	1.28 [0.63 - 2.58]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1564241_at	77	0.168831	0.00159794	0.0376541	-1.7623	0.803374	-0.0598555	0.94 [0.59 - 1.51]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1565346_a_at	77	0.896104	0.102147	-	1.03034	0.964571	-0.0905338	0.91 [0.02 - 49.62]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1558612_a_at	77	0.350649	0.132719	-	-0.814075	0.554651	0.195451	1.22 [0.64 - 2.33]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1564241_at	77	0.168831	0.016357	0.232118	-1.28139	0.937471	-0.0165949	0.98 [0.65 - 1.49]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1558612_a_at	177	0.491525	0.00248715	0.0541181	-0.726627	0.055744	-1.75283	0.17 [0.03 - 1.04]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1565346_a_at	177	0.384181	0.00981896	0.159254	-0.690485	0.0325667	-2.1037	0.12 [0.02 - 0.84]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1558612_a_at	177	0.559322	0.00160542	0.0377998	-0.967597	0.0503275	-2.07013	0.13 [0.02 - 1.00]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1564241_at	177	0.858757	0.00180657	0.0416644	-1.92656	0.00254462	-2.61805	0.07 [0.01 - 0.40]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1564241_at	177	0.361582	0.00377738	0.0757825	-0.771783	0.00380486	-2.89071	0.06 [0.01 - 0.39]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1565346_a_at	177	0.384181	0.0127139	0.193119	-0.580345	0.0455818	-1.65989	0.19 [0.04 - 0.97]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1558612_a_at	145	0.255172	5.5032e-05	0.00206471	-1.26311	0.0278434	-2.87234	0.06 [0.00 - 0.73]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1564241_at	145	0.855172	0.0259142	0.32083	-1.94167	0.517317	-0.745976	0.47 [0.05 - 4.54]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1565346_a_at	145	0.4	0.00506065	0.0955447	-0.918997	0.0601242	-2.22847	0.11 [0.01 - 1.10]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1558612_a_at	226	0.358407	0.324321	-	-0.282043	0.778591	0.0386984	1.04 [0.79 - 1.36]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1564241_at	226	0.123894	0.0734917	-	-0.623005	0.677881	-0.102842	0.90 [0.56 - 1.47]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1565346_a_at	226	0.323009	0.046042	0.467298	-0.561237	0.419806	-0.109347	0.90 [0.69 - 1.17]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1565346_a_at	49	0.836735	0.0113434	0.17745	1.38031	0.932201	0.14915	1.16 [0.04 - 36.06]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1558612_a_at	49	0.265306	0.0548763	-	-1.06028	0.105673	-3.43065	0.03 [0.00 - 2.07]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1564241_at	49	0.244898	0.271194	-	1.09498	0.577262	1.16103	3.19 [0.05 - 189.36]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1558612_a_at	55	0.163636	0.0188136	0.256585	-1.09909	0.299236	-1.70003	0.18 [0.01 - 4.53]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1564241_at	55	0.218182	0.117331	-	1.11226	0.326853	1.53945	4.66 [0.21 - 101.17]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1565346_a_at	55	0.8	0.00309778	0.06464	1.27094	0.976338	0.0428769	1.04 [0.06 - 17.75]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1565346_a_at	55	0.854545	0.0308497	0.360939	1.14632	0.89145	0.205997	1.23 [0.06 - 23.68]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1558612_a_at	55	0.145455	0.0281928	0.339754	-1.24154	0.0720692	-3.41983	0.03 [0.00 - 1.36]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1564241_at	55	0.2	0.0608475	-	1.71665	0.456901	1.27007	3.56 [0.13 - 101.10]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1565346_a_at	63	0.142857	5.0603e-05	0.00191631	-1.56172	0.0256716	-14.635	0.00 [0.00 - 0.17]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1558612_a_at	63	0.15873	3.45244e-05	0.00136272	-1.50237	0.064289	-28.6573	0.00 [0.00 - 5.48]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1564241_at	63	0.111111	1.44226e-05	0.000622153	-1.74305	0.252403	-7.28214	0.00 [0.00 - 179.19]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.367953.3.S1_3p_at	28	0.892857	0.160236	-	0.897196	0.931185	0.147024	1.16 [0.04 - 32.59]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.367953.4.S1_3p_a_at	28	0.214286	0.150351	-	-0.868114	0.648099	-0.227693	0.80 [0.30 - 2.12]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.367953.2.S1_3p_a_at	28	0.464286	0.216738	-	-0.673845	0.987519	0.0304265	1.03 [0.02 - 46.65]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P160177	117	0.333333	0.0154742	0.222988	-0.683707	0.095223	-0.335611	0.71 [0.48 - 1.06]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P307626	117	0.837607	0.164286	-	-0.64615	0.744821	-0.0457749	0.96 [0.73 - 1.26]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1565346_a_at	204	0.27451	0.0357932	0.3981	-0.756515	0.163758	-0.398893	0.67 [0.38 - 1.18]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1558612_a_at	204	0.240196	0.00153179	0.0363602	-1.10419	0.0471854	-0.446264	0.64 [0.41 - 0.99]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1564241_at	204	0.166667	0.0357939	0.398106	1.85709	0.278626	0.267655	1.31 [0.81 - 2.12]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1565346_a_at	204	0.196078	0.156094	-	-0.437146	0.634007	-0.117496	0.89 [0.55 - 1.44]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1558612_a_at	204	0.245098	0.0634639	-	-0.530235	0.467474	-0.123933	0.88 [0.63 - 1.23]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1564241_at	204	0.186275	0.00160209	0.0377349	1.95109	0.0174036	0.467454	1.60 [1.09 - 2.35]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1565346_a_at	111	0.720721	0.196595	-	0.359835	0.694705	0.0579302	1.06 [0.79 - 1.42]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1558612_a_at	111	0.774775	0.00745107	0.129079	0.745932	0.527245	0.12541	1.13 [0.77 - 1.67]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1564241_at	111	0.126126	0.0234875	0.299834	1.2597	0.427022	0.197822	1.22 [0.75 - 1.99]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1565346_a_at	138	0.275362	0.21742	-	-0.314149	0.97563	0.0798523	1.08 [0.01 - 181.87]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1558612_a_at	138	0.26087	0.00624062	0.112553	-0.668619	0.566212	0.978406	2.66 [0.09 - 75.29]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1564241_at	138	0.282609	0.00905169	0.149752	-0.631983	0.185497	-4.32365	0.01 [0.00 - 7.98]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13637	56	0.285714	0.242979	-	-0.425669	0.69567	-0.164296	0.85 [0.37 - 1.93]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2029	56	0.892857	0.11814	-	0.954188	0.975712	-0.011086	0.99 [0.48 - 2.02]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13637	56	0.303571	0.184185	-	-0.457604	0.477852	-0.283947	0.75 [0.34 - 1.65]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2029	56	0.892857	0.0349523	0.391972	1.32046	0.711001	-0.130968	0.88 [0.44 - 1.75]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1565346_a_at	278	0.305755	0.00841455	0.141669	-0.510268	0.442627	-0.502284	0.61 [0.17 - 2.18]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1558612_a_at	278	0.381295	0.0348485	0.39121	-0.395842	0.625928	-0.295525	0.74 [0.23 - 2.44]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1564241_at	278	0.805755	0.0150432	0.218459	-0.662604	0.168014	-0.779427	0.46 [0.15 - 1.39]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P160177	110	0.236364	0.318073	-	0.387497	0.957203	0.0177781	1.02 [0.53 - 1.95]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P333420	110	0.118182	0.0957485	-	-0.64249	0.817213	0.0535755	1.06 [0.67 - 1.66]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P307626	110	0.145455	0.151141	-	-0.420062	0.508606	-0.0861978	0.92 [0.71 - 1.18]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P160177	110	0.681818	0.207063	-	-0.318727	0.628873	-0.117672	0.89 [0.55 - 1.43]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P307626	110	0.2	0.111154	-	-0.50906	0.497703	-0.11367	0.89 [0.64 - 1.24]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P333420	110	0.454545	0.00133019	0.0323434	0.764153	0.451794	0.113785	1.12 [0.83 - 1.51]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1565346_a_at	38	0.526316	0.342402	-	-0.444576	0.930648	-0.0338316	0.97 [0.45 - 2.07]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1558612_a_at	38	0.710526	0.00246066	0.0536488	1.45419	0.0445489	1.71562	5.56 [1.04 - 29.65]
GENE	ATP1A4	ATPase, Na+/K+ transporting, alpha 4 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1564241_at	38	0.289474	0.147043	-	0.895915	0.167766	0.940421	2.56 [0.67 - 9.74]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201242_s_at	30	0.533333	0.131922	-	-0.630429	0.524229	-0.0819558	0.92 [0.72 - 1.19]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201243_s_at	30	0.733333	0.00564236	0.104052	-1.43967	0.248727	-0.220819	0.80 [0.55 - 1.17]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1736862	165	0.89697	0.170988	-	-0.692946	0.597089	-0.0546436	0.95 [0.77 - 1.16]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1736862	165	0.49697	0.00708272	0.124139	-1.01545	0.0650386	-0.281708	0.75 [0.56 - 1.02]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201243_s_at	163	0.736196	0.00106985	0.0269688	0.679595	0.0197969	0.257297	1.29 [1.04 - 1.61]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201242_s_at	163	0.766871	1.56671e-05	0.000670383	0.89602	0.0019291	0.277012	1.32 [1.11 - 1.57]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	227556_at	163	0.699386	0.000384454	0.0113132	0.718591	0.00575061	0.448803	1.57 [1.14 - 2.15]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	227556_at	79	0.544304	0.00567774	0.104562	0.798165	0.0258322	0.412647	1.51 [1.05 - 2.17]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201243_s_at	79	0.886076	0.000164061	0.00540752	1.36531	0.010712	0.39427	1.48 [1.10 - 2.01]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201242_s_at	79	0.683544	0.000383786	0.0112964	1.0203	0.0036728	0.392708	1.48 [1.14 - 1.93]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201242_s_at	58	0.534483	0.00183872	0.0422733	0.874104	0.0579869	0.255063	1.29 [0.99 - 1.68]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201243_s_at	58	0.310345	0.00726909	0.126647	0.852766	0.0695018	0.219378	1.25 [0.98 - 1.58]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201242_s_at	34	0.588235	0.120302	-	0.591762	0.587002	0.0925814	1.10 [0.79 - 1.53]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201243_s_at	34	0.382353	0.124958	-	0.616591	0.305203	0.304101	1.36 [0.76 - 2.42]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201242_s_at	158	0.443038	0.0341256	0.385872	0.509211	0.10102	0.191701	1.21 [0.96 - 1.52]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201243_s_at	158	0.28481	0.0120707	0.185842	0.748774	0.250826	0.190981	1.21 [0.87 - 1.68]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201243_s_at	53	0.150943	0.021937	0.285921	1.9906	0.102873	0.431168	1.54 [0.92 - 2.58]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201242_s_at	53	0.132075	0.0366812	0.404492	1.4096	0.170629	0.277255	1.32 [0.89 - 1.96]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201243_s_at	53	0.150943	0.0748117	-	1.03421	0.338554	0.225948	1.25 [0.79 - 1.99]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201242_s_at	53	0.132075	0.0064925	0.116063	15.3826	0.0517164	0.435218	1.55 [1.00 - 2.40]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201242_s_at	180	0.111111	0.092187	-	0.697271	0.603181	0.0552067	1.06 [0.86 - 1.30]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201243_s_at	180	0.783333	0.0903796	-	0.405585	0.377077	-0.140849	0.87 [0.64 - 1.19]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	227556_at	180	0.5	0.209162	-	-0.26474	0.71087	-0.0289666	0.97 [0.83 - 1.13]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	227556_at	559	0.556351	0.00882653	0.146917	-0.546284	0.368624	-0.075548	0.93 [0.79 - 1.09]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201243_s_at	559	0.216458	0.0506489	-	-0.42765	0.392999	-0.0954563	0.91 [0.73 - 1.13]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201242_s_at	559	0.411449	0.098374	-	-0.331576	0.358616	-0.08554	0.92 [0.76 - 1.10]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201242_s_at	77	0.142857	0.00493132	0.0936181	1.24882	0.27064	0.195208	1.22 [0.86 - 1.72]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201243_s_at	77	0.857143	0.011813	0.182888	-1.13411	0.531315	0.140627	1.15 [0.74 - 1.79]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	227556_at	77	0.896104	0.0661186	-	-0.919668	0.703375	0.0599928	1.06 [0.78 - 1.45]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	227556_at	70	0.642857	0.094167	-	0.448035	0.672988	0.0548228	1.06 [0.82 - 1.36]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201243_s_at	70	0.428571	0.173296	-	0.365253	0.393857	0.116438	1.12 [0.86 - 1.47]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201242_s_at	70	0.771429	0.100718	-	0.491306	0.33154	0.112339	1.12 [0.89 - 1.40]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37669_s_at	50	0.7	0.0747298	-	-0.747117	0.593708	-0.0727872	0.93 [0.71 - 1.21]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201242_s_at	74	0.689189	0.0269453	0.329484	0.645672	0.234081	0.219831	1.25 [0.87 - 1.79]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201243_s_at	74	0.851351	0.00375244	0.0753828	1.0181	0.0552705	0.501732	1.65 [0.99 - 2.76]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	227556_at	74	0.864865	0.0583075	-	0.688631	0.865277	0.0254038	1.03 [0.76 - 1.38]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201243_s_at	67	0.343284	0.132198	-	-0.974252	0.490981	-0.264142	0.77 [0.36 - 1.63]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	227556_at	67	0.731343	0.0588713	-	-15.5549	0.630284	-0.185998	0.83 [0.39 - 1.77]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201242_s_at	67	0.731343	0.238843	-	-1.1802	0.490396	-0.261873	0.77 [0.37 - 1.62]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201243_s_at	115	0.495652	0.020863	0.27604	-1.38967	0.268117	-0.529528	0.59 [0.23 - 1.50]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201242_s_at	115	0.773913	0.0353524	0.394897	-15.446	0.363318	-0.392063	0.68 [0.29 - 1.57]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	227556_at	115	0.869565	0.277439	-	0.696264	0.940345	-0.0225461	0.98 [0.54 - 1.76]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37669_s_at	158	0.417722	0.0566777	-	-0.534503	0.178108	-0.29548	0.74 [0.48 - 1.14]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37669_s_at	76	0.776316	0.0894056	-	0.868436	0.429415	0.3238	1.38 [0.62 - 3.09]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201243_s_at	204	0.617647	0.103077	-	0.238889	0.268985	0.125362	1.13 [0.91 - 1.42]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	227556_at	204	0.107843	0.16141	-	0.309132	0.848656	0.0164804	1.02 [0.86 - 1.20]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201242_s_at	204	0.357843	0.0234467	0.299473	-0.332847	0.999537	-5.62347e-05	1.00 [0.83 - 1.21]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201243_s_at	87	0.563218	0.0245239	0.308912	-0.946096	0.660047	-0.0989346	0.91 [0.58 - 1.41]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201242_s_at	87	0.298851	0.02423	0.306355	-0.83152	0.436572	-0.140694	0.87 [0.61 - 1.24]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201243_s_at	87	0.563218	0.0245239	0.308912	-0.946096	0.660047	-0.0989346	0.91 [0.58 - 1.41]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201242_s_at	87	0.298851	0.02423	0.306355	-0.83152	0.436572	-0.140694	0.87 [0.61 - 1.24]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	227556_at	87	0.896552	0.0618514	-	-15.1912	0.790413	-0.0431282	0.96 [0.70 - 1.32]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	227556_at	87	0.896552	0.0618514	-	-15.1912	0.790413	-0.0431282	0.96 [0.70 - 1.32]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201243_s_at	77	0.831169	0.0955824	-	-15.3121	0.985352	0.00604662	1.01 [0.53 - 1.92]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	227556_at	77	0.298701	0.0310613	0.362588	15.6291	0.384075	0.294959	1.34 [0.69 - 2.61]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201242_s_at	77	0.311688	0.0511011	-	1.78498	0.273183	0.472335	1.60 [0.69 - 3.73]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201243_s_at	77	0.194805	0.10391	-	15.3803	0.816259	0.0883729	1.09 [0.52 - 2.30]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	227556_at	77	0.298701	0.22883	-	0.895128	0.720596	0.0955466	1.10 [0.65 - 1.86]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201242_s_at	77	0.311688	0.0226936	0.292761	15.6942	0.192747	0.67448	1.96 [0.71 - 5.42]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201243_s_at	136	0.860294	0.301803	-	-1.01828	0.86101	-0.0591961	0.94 [0.49 - 1.83]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201242_s_at	136	0.139706	0.0807892	-	15.2372	0.581039	0.156485	1.17 [0.67 - 2.04]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201242_s_at	200	0.4	0.0215502	0.282387	-0.671324	0.303637	-0.222734	0.80 [0.52 - 1.22]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201243_s_at	200	0.385	0.0773883	-	-0.51674	0.454446	-0.212521	0.81 [0.46 - 1.41]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2407	60	0.866667	0.185713	-	0.600569	0.818183	0.0398192	1.04 [0.74 - 1.46]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2407	60	0.85	0.0994114	-	0.747923	0.88713	-0.0248499	0.98 [0.69 - 1.37]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	11944	155	0.845161	0.0892399	-	0.55849	0.938119	0.0118247	1.01 [0.75 - 1.36]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201242_s_at	286	0.174825	0.00364075	0.0735848	-0.638435	0.33607	-0.113507	0.89 [0.71 - 1.12]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201243_s_at	286	0.111888	0.0107924	0.170972	-0.648716	0.28468	-0.178589	0.84 [0.60 - 1.16]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201242_s_at	159	0.238994	0.000549979	0.0153703	-1.05796	0.0145602	-0.498189	0.61 [0.41 - 0.91]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201243_s_at	159	0.220126	0.0158877	0.227288	-0.78075	0.102005	-0.437991	0.65 [0.38 - 1.09]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201242_s_at	159	0.100629	0.00186878	0.0428407	-1.26589	0.0162672	-0.560484	0.57 [0.36 - 0.90]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201243_s_at	159	0.220126	0.00558319	0.103198	-0.878011	0.166579	-0.380029	0.68 [0.40 - 1.17]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201243_s_at	159	0.220126	0.00341987	0.0699882	-1.05579	0.106511	-0.497545	0.61 [0.33 - 1.11]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201242_s_at	159	0.100629	0.00720755	0.125821	-1.01966	0.0245932	-0.458903	0.63 [0.42 - 0.94]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227556_at	159	0.515723	0.0457741	0.465607	-0.650828	0.637202	-0.0931539	0.91 [0.62 - 1.34]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227556_at	159	0.440252	0.0450885	0.461253	-0.630684	0.749785	-0.0639061	0.94 [0.63 - 1.39]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	227556_at	159	0.433962	0.00994588	0.160802	-0.969226	0.36299	-0.206174	0.81 [0.52 - 1.27]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201242_s_at	54	0.111111	0.0254523	0.316904	-1.49637	0.688276	-0.135976	0.87 [0.45 - 1.70]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201243_s_at	54	0.259259	0.0172463	0.241129	-1.53539	0.962905	0.0128572	1.01 [0.59 - 1.74]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201242_s_at	117	0.82906	0.13335	-	0.565578	0.16487	0.227104	1.25 [0.91 - 1.73]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201242_s_at	117	0.880342	0.0241931	0.306033	0.997741	0.106264	0.336687	1.40 [0.93 - 2.11]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201242_s_at	117	0.82906	0.13335	-	0.565578	0.16487	0.227104	1.25 [0.91 - 1.73]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201242_s_at	117	0.880342	0.137357	-	0.719151	0.30055	0.209915	1.23 [0.83 - 1.84]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201243_s_at	117	0.897436	0.0511219	-	0.930464	0.15023	0.291017	1.34 [0.90 - 1.99]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201243_s_at	117	0.837607	0.0681803	-	0.683107	0.27304	0.172292	1.19 [0.87 - 1.62]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201243_s_at	117	0.837607	0.0681803	-	0.683107	0.27304	0.172292	1.19 [0.87 - 1.62]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201243_s_at	117	0.897436	0.24208	-	0.619583	0.45805	0.14566	1.16 [0.79 - 1.70]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201243_s_at	236	0.889831	0.0737922	-	-1.21243	0.320675	-0.294152	0.75 [0.42 - 1.33]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201242_s_at	236	0.110169	0.0793031	-	-0.604805	0.619074	-0.102029	0.90 [0.60 - 1.35]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	227556_at	236	0.131356	0.0120579	0.185695	-0.779698	0.272786	-0.177491	0.84 [0.61 - 1.15]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201242_s_at	249	0.88755	0.114168	-	-0.655041	0.405894	-0.134364	0.87 [0.64 - 1.20]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201243_s_at	249	0.803213	0.0707973	-	-0.573714	0.544523	-0.14693	0.86 [0.54 - 1.39]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	227556_at	249	0.212851	0.0720726	-	-0.42592	0.342949	-0.12397	0.88 [0.68 - 1.14]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201243_s_at	125	0.128	0.0106269	0.169005	-0.88521	0.114459	-0.303029	0.74 [0.51 - 1.08]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201243_s_at	54	0.37037	0.0134233	0.201	-1.49832	0.119502	-0.362494	0.70 [0.44 - 1.10]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201242_s_at	62	0.532258	0.0198153	0.266195	-1.17685	0.0874491	-0.333633	0.72 [0.49 - 1.05]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201242_s_at	125	0.896	0.110903	-	0.770178	0.881983	-0.0276433	0.97 [0.68 - 1.40]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201243_s_at	62	0.112903	0.0899987	-	-1.05588	0.180448	-0.247365	0.78 [0.54 - 1.12]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201242_s_at	125	0.104	0.258245	-	-0.494078	0.591163	-0.076168	0.93 [0.70 - 1.22]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201242_s_at	54	0.555556	0.00137951	0.0333369	-2.62463	0.039321	-0.502203	0.61 [0.38 - 0.98]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201243_s_at	125	0.12	0.0122126	0.187458	-1.0481	0.172721	-0.332912	0.72 [0.44 - 1.16]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201242_s_at	198	0.676768	0.0404718	0.430889	-0.616051	0.433283	-0.0988899	0.91 [0.71 - 1.16]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201243_s_at	198	0.560606	0.00490575	0.0932356	-0.613461	0.138056	-0.179532	0.84 [0.66 - 1.06]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201242_s_at	198	0.742424	0.109287	-	-0.553017	0.355421	-0.121808	0.89 [0.68 - 1.15]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201243_s_at	198	0.555556	0.0311471	0.363255	-0.572039	0.195651	-0.193103	0.82 [0.62 - 1.10]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201243_s_at	198	0.722222	0.0316737	0.367329	-0.764254	0.153184	-0.21978	0.80 [0.59 - 1.09]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201242_s_at	198	0.858586	0.0190757	0.259119	-0.893586	0.34315	-0.096142	0.91 [0.74 - 1.11]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201243_s_at	62	0.193548	0.0806101	-	15.3666	0.443694	0.617494	1.85 [0.38 - 9.00]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201242_s_at	51	0.705882	0.0109573	0.172921	2.30315	0.135307	1.12505	3.08 [0.70 - 13.48]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201242_s_at	62	0.693548	0.0278142	0.336661	1.21387	0.195313	0.539662	1.72 [0.76 - 3.88]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201243_s_at	51	0.372549	0.0859845	-	15.7713	0.400561	1.06847	2.91 [0.24 - 35.15]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201242_s_at	177	0.129944	0.131777	-	0.632478	0.47542	0.176937	1.19 [0.73 - 1.94]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201243_s_at	145	0.889655	0.0106647	0.169455	1.03432	0.18981	0.414316	1.51 [0.81 - 2.81]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201242_s_at	145	0.841379	0.154531	-	-0.835181	0.546021	-0.208572	0.81 [0.41 - 1.60]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201243_s_at	177	0.19209	0.0890757	-	0.721704	0.182379	0.3421	1.41 [0.85 - 2.33]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	227556_at	177	0.80226	0.0509345	-	-0.717053	0.280185	-0.115862	0.89 [0.72 - 1.10]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	227556_at	177	0.717514	0.0131055	0.197489	-0.967787	0.175185	-0.163009	0.85 [0.67 - 1.08]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	227556_at	145	0.289655	0.0177231	0.245886	-0.775945	0.0157641	-0.347663	0.71 [0.53 - 0.94]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201242_s_at	177	0.225989	0.211283	-	0.452954	0.981972	-0.00610235	0.99 [0.59 - 1.69]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201243_s_at	177	0.60452	0.0142986	0.210523	0.571615	0.206591	0.282568	1.33 [0.86 - 2.06]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201242_s_at	226	0.79646	0.00723631	0.126207	-1.46644	0.17081	-0.395821	0.67 [0.38 - 1.19]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	227556_at	226	0.362832	0.00339479	0.0695762	-0.809933	0.0106291	-0.304999	0.74 [0.58 - 0.93]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201243_s_at	226	0.154867	0.0686964	-	0.917276	0.423672	0.243065	1.28 [0.70 - 2.31]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201242_s_at	55	0.181818	0.00198155	0.0449519	-1.51424	0.138113	-0.644959	0.52 [0.22 - 1.23]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201242_s_at	49	0.897959	2.58074e-05	0.00105015	2.75312	0.803062	0.197329	1.22 [0.26 - 5.74]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	227556_at	55	0.472727	0.094343	-	-0.748499	0.903547	-0.0276773	0.97 [0.62 - 1.52]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201243_s_at	55	0.745455	0.0740882	-	0.796783	0.887016	0.0666225	1.07 [0.43 - 2.68]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201243_s_at	55	0.836364	0.00701571	0.123232	1.43762	0.613078	0.257764	1.29 [0.48 - 3.51]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201242_s_at	55	0.109091	0.0339266	0.384392	-1.1291	0.171818	-0.636912	0.53 [0.21 - 1.32]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	227556_at	55	0.454545	0.159936	-	-0.685992	0.696719	0.100032	1.11 [0.67 - 1.83]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201243_s_at	49	0.836735	0.0538367	-	1.12465	0.128455	0.946762	2.58 [0.76 - 8.74]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	227556_at	49	0.897959	0.0269862	0.329825	1.37195	0.619003	0.164249	1.18 [0.62 - 2.25]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	227556_at	63	0.349206	0.220415	-	0.455469	0.559923	0.0668124	1.07 [0.85 - 1.34]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201243_s_at	63	0.746032	0.0113572	0.17761	0.880221	0.201564	0.134965	1.14 [0.93 - 1.41]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201242_s_at	63	0.603175	0.0228362	0.294039	0.755624	0.272068	0.097046	1.10 [0.93 - 1.31]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12652534_3p_a_at	28	0.142857	0.138662	-	-0.941704	0.877143	-0.0177975	0.98 [0.78 - 1.23]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502276_3p_a_at	28	0.75	0.242408	-	0.697226	0.970246	0.0065659	1.01 [0.71 - 1.42]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.78629.2.A1_3p_at	28	0.785714	0.0600879	-	1.03392	0.509688	0.191408	1.21 [0.69 - 2.14]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201243_s_at	82	0.109756	0.00105578	0.0266715	-1.32441	0.0818871	-0.485786	0.62 [0.36 - 1.06]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201242_s_at	82	0.341463	0.000271928	0.00839206	-1.18231	0.000589801	-0.773837	0.46 [0.30 - 0.72]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37669_s_at	84	0.154762	0.0173913	0.242581	-0.803923	0.105853	-0.353806	0.70 [0.46 - 1.08]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201243_s_at	79	0.113924	0.266024	-	-0.422946	0.843142	-0.0715464	0.93 [0.46 - 1.89]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201242_s_at	79	0.443038	0.166048	-	0.361308	0.606534	0.107268	1.11 [0.74 - 1.67]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U16799_s_at	86	0.116279	0.00186107	0.0426952	-1.38929	0.19777	-0.503051	0.60 [0.28 - 1.30]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201242_s_at	104	0.576923	0.0452254	0.462125	-0.675884	0.533093	-0.178279	0.84 [0.48 - 1.47]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201243_s_at	104	0.442308	0.0358942	0.398832	-0.687221	0.544532	-0.202397	0.82 [0.42 - 1.57]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P146943	117	0.145299	0.204134	-	-0.465753	0.143044	-0.227607	0.80 [0.59 - 1.08]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P62932	117	0.367521	0.100251	-	-0.468309	0.18822	-0.207463	0.81 [0.60 - 1.11]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201243_s_at	204	0.333333	0.0221023	0.287424	1.16294	0.0333928	2.20587	9.08 [1.19 - 69.29]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	227556_at	204	0.210784	0.0538611	-	1.31459	0.241442	0.68917	1.99 [0.63 - 6.31]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201243_s_at	204	0.534314	0.0131683	0.198184	0.685416	0.100904	1.19402	3.30 [0.79 - 13.74]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	227556_at	204	0.142157	0.119385	-	0.788754	0.242237	0.508768	1.66 [0.71 - 3.90]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201242_s_at	204	0.897059	0.00620999	0.112124	1.12796	0.0744852	0.80881	2.25 [0.92 - 5.46]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201242_s_at	204	0.421569	0.0131456	0.197933	0.738796	0.545175	0.192302	1.21 [0.65 - 2.26]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201243_s_at	178	0.134831	0.00147813	0.0353023	-0.808736	0.014906	-0.591895	0.55 [0.34 - 0.89]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201242_s_at	178	0.106742	0.000145295	0.00486244	-1.03404	0.0519217	-0.351884	0.70 [0.49 - 1.00]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201243_s_at	111	0.414414	0.0633386	-	-0.485993	0.158989	-0.256734	0.77 [0.54 - 1.11]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201242_s_at	111	0.405405	0.018984	0.258233	-0.613239	0.149423	-0.211677	0.81 [0.61 - 1.08]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	227556_at	111	0.126126	0.00662628	0.117912	-0.919669	0.101569	-0.286317	0.75 [0.53 - 1.06]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201243_s_at	90	0.122222	0.0164383	0.232949	-0.97709	0.164768	-0.250026	0.78 [0.55 - 1.11]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201243_s_at	90	0.122222	0.0161669	0.230168	-1.06142	0.117797	-0.315929	0.73 [0.49 - 1.08]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201242_s_at	90	0.233333	0.0702683	-	-0.64257	0.113929	-0.239672	0.79 [0.58 - 1.06]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201242_s_at	90	0.233333	0.00683683	0.120799	-1.00092	0.0337845	-0.366347	0.69 [0.49 - 0.97]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5096	50	0.88	0.00826561	0.139752	1.42631	0.244463	0.555392	1.74 [0.68 - 4.44]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201243_s_at	138	0.152174	0.16969	-	0.541553	0.576977	0.0628785	1.06 [0.85 - 1.33]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201242_s_at	138	0.101449	0.0571706	-	1.07188	0.354188	0.10791	1.11 [0.89 - 1.40]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	227556_at	138	0.224638	0.151739	-	0.457224	0.604924	0.047093	1.05 [0.88 - 1.25]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201242_s_at	129	0.79845	0.00558535	0.103229	0.765279	0.984564	-0.00387351	1.00 [0.67 - 1.47]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201243_s_at	129	0.775194	0.00478438	0.0914128	0.739786	0.907334	0.030803	1.03 [0.61 - 1.73]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34025	56	0.875	0.0876134	-	0.766657	0.798791	0.0506024	1.05 [0.71 - 1.55]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43165	56	0.892857	0.0446553	0.458482	0.994767	0.853414	-0.0341999	0.97 [0.67 - 1.39]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34025	56	0.392857	0.14073	-	-0.500151	0.615763	-0.0902621	0.91 [0.64 - 1.30]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43165	56	0.892857	0.0128323	0.194445	1.21988	0.546938	0.123309	1.13 [0.76 - 1.69]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201243_s_at	278	0.284173	0.0637677	-	0.4318	0.321095	0.12143	1.13 [0.89 - 1.44]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	227556_at	278	0.428058	0.0069891	0.122871	0.533458	0.310551	0.0882231	1.09 [0.92 - 1.30]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201242_s_at	278	0.244604	0.0300015	0.354274	0.540846	0.788582	0.0273129	1.03 [0.84 - 1.25]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201242_s_at	133	0.496241	0.00457386	0.0882217	-0.675552	0.0481754	-0.159898	0.85 [0.73 - 1.00]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201243_s_at	133	0.533835	0.0750018	-	-0.428718	0.283523	-0.111006	0.89 [0.73 - 1.10]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3221	81	0.382716	0.185352	-	-0.675006	0.593173	-0.164331	0.85 [0.46 - 1.55]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16188	81	0.54321	0.163773	-	-0.743014	0.7354	-0.108535	0.90 [0.48 - 1.68]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201242_s_at	185	0.627027	0.0975938	-	0.303868	0.501804	0.0511564	1.05 [0.91 - 1.22]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201243_s_at	185	0.675676	0.0991695	-	0.282834	0.553031	0.0511145	1.05 [0.89 - 1.25]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201242_s_at	185	0.643243	0.039004	0.420833	0.351368	0.202576	0.0899483	1.09 [0.95 - 1.26]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201243_s_at	185	0.675676	0.0727605	-	0.329608	0.367861	0.0859835	1.09 [0.90 - 1.31]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P146943	110	0.881818	0.140983	-	0.639254	0.951598	0.00851228	1.01 [0.77 - 1.33]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P62932	110	0.127273	0.0562149	-	-0.60537	0.413983	-0.0997706	0.91 [0.71 - 1.15]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P146943	110	0.118182	0.131043	-	-0.486724	0.25948	-0.122594	0.88 [0.71 - 1.09]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P62932	110	0.836364	0.297651	-	0.403253	0.959901	0.00809643	1.01 [0.74 - 1.38]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201242_s_at	80	0.4875	0.0159365	0.227792	-1.1805	0.293812	-0.214623	0.81 [0.54 - 1.20]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201243_s_at	80	0.5625	0.119919	-	-0.74101	0.507511	-0.201577	0.82 [0.45 - 1.48]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_3562	281	0.850534	0.00446732	0.0865922	0.523989	0.021852	0.317543	1.37 [1.05 - 1.80]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201242_s_at	38	0.868421	0.226445	-	0.751079	0.674214	-0.127973	0.88 [0.48 - 1.60]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	227556_at	38	0.526316	0.182391	-	0.616733	0.957177	0.0153582	1.02 [0.58 - 1.78]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201243_s_at	38	0.394737	0.0876955	-	0.834138	0.265086	0.441007	1.55 [0.72 - 3.38]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201243_s_at	140	0.892857	0.00520911	0.0977401	0.960786	0.0187959	0.351915	1.42 [1.06 - 1.91]
GENE	ATP1B1	ATPase, Na+/K+ transporting, beta 1 polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201242_s_at	140	0.442857	0.016615	0.234751	0.737708	0.0157312	0.293429	1.34 [1.06 - 1.70]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204311_at	30	0.8	0.382108	-	0.406373	0.849653	0.110597	1.12 [0.36 - 3.50]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1747271	165	0.733333	0.0608152	-	0.488106	0.711366	-0.15722	0.85 [0.37 - 1.97]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1747271	165	0.872727	0.0432755	0.44955	0.841117	0.945354	0.0431296	1.04 [0.30 - 3.58]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204311_at	163	0.141104	0.0654104	-	-0.475341	0.0815574	-0.581252	0.56 [0.29 - 1.08]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204311_at	79	0.759494	0.0586339	-	-0.718189	0.202889	-0.449656	0.64 [0.32 - 1.27]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204311_at	58	0.155172	0.0270343	0.330224	-0.825799	0.0937968	-0.344784	0.71 [0.47 - 1.06]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204311_at	34	0.205882	0.00479536	0.0915782	-1.27993	0.00897106	-1.17148	0.31 [0.13 - 0.75]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204311_at	158	0.708861	0.0187159	0.255636	0.558183	0.574757	0.562562	1.76 [0.25 - 12.53]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204311_at	53	0.584906	0.00826297	0.139718	0.890603	0.117571	0.49524	1.64 [0.88 - 3.05]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204311_at	53	0.584906	0.00017573	0.00574191	1.3435	0.0063599	0.957228	2.60 [1.31 - 5.18]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204311_at	180	0.661111	0.015756	0.225922	0.513758	0.240986	0.1899	1.21 [0.88 - 1.66]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204311_at	559	0.109123	0.0217636	0.28434	-0.618898	0.418722	-0.136529	0.87 [0.63 - 1.21]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204311_at	77	0.337662	0.000512247	0.0144661	-0.924916	0.0712017	-0.306481	0.74 [0.53 - 1.03]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204311_at	70	0.714286	0.122919	-	0.445366	0.505109	0.135622	1.15 [0.77 - 1.71]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37270_at	50	0.58	0.321147	-	0.344774	0.416371	-0.104736	0.90 [0.70 - 1.16]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204311_at	74	0.878378	0.00977099	0.158667	0.98004	0.902305	0.0556346	1.06 [0.43 - 2.57]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204311_at	67	0.358209	0.160553	-	1.3878	0.683887	-0.329113	0.72 [0.15 - 3.51]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204311_at	115	0.356522	0.0738081	-	1.27518	0.526781	0.606851	1.83 [0.28 - 12.01]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37270_at	158	0.132911	0.162421	-	-0.514491	0.999389	-0.00030848	1.00 [0.45 - 2.20]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37270_at	76	0.552632	0.410911	-	-0.447072	0.865115	0.163913	1.18 [0.18 - 7.81]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204311_at	204	0.5	0.0148717	0.216645	-0.338618	0.0962374	-0.153174	0.86 [0.72 - 1.03]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204311_at	87	0.367816	0.0260062	0.321609	-0.823707	0.170785	-1.25615	0.28 [0.05 - 1.72]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204311_at	87	0.367816	0.0260062	0.321609	-0.823707	0.170785	-1.25615	0.28 [0.05 - 1.72]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204311_at	77	0.649351	0.0861707	-	-1.62451	0.175622	-2.02452	0.13 [0.01 - 2.47]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204311_at	77	0.649351	0.111411	-	-1.1582	0.308513	-1.25278	0.29 [0.03 - 3.18]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204311_at	136	0.448529	0.10372	-	0.777759	0.893248	0.0410141	1.04 [0.57 - 1.90]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204311_at	200	0.475	0.0159229	0.227651	0.771337	0.074825	0.540785	1.72 [0.95 - 3.11]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4202	60	0.383333	0.134514	-	-0.563244	0.294831	-0.443323	0.64 [0.28 - 1.47]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4202	60	0.2	0.0607123	-	-0.768378	0.858674	-0.0797191	0.92 [0.38 - 2.22]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16601	155	0.174194	0.000127345	0.00433166	-1.07036	0.0396188	-0.207219	0.81 [0.67 - 0.99]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204311_at	286	0.339161	0.0348097	0.390925	-0.413528	0.474076	-0.116049	0.89 [0.65 - 1.22]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204311_at	159	0.622642	0.113197	-	-0.554245	0.498669	-0.226065	0.80 [0.41 - 1.54]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204311_at	159	0.113208	0.0774549	-	-0.789039	0.352888	-0.359224	0.70 [0.33 - 1.49]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204311_at	159	0.566038	0.0362026	0.401057	-0.708337	0.125743	-0.491604	0.61 [0.33 - 1.15]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204311_at	54	0.314815	0.0367175	0.404751	-1.39681	0.265468	-1.03033	0.36 [0.06 - 2.19]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204311_at	117	0.213675	0.089096	-	0.792746	0.855716	-0.0622938	0.94 [0.48 - 1.84]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204311_at	117	0.213675	0.113259	-	0.932658	0.921805	0.0366236	1.04 [0.50 - 2.16]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204311_at	117	0.213675	0.089096	-	0.792746	0.855716	-0.0622938	0.94 [0.48 - 1.84]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204311_at	117	0.581197	0.0487957	0.484349	-0.885748	0.634942	-0.23465	0.79 [0.30 - 2.08]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204311_at	236	0.237288	0.0256036	0.318194	-0.624054	0.123442	-0.456281	0.63 [0.35 - 1.13]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204311_at	249	0.586345	0.00690777	0.121766	-0.619542	0.023183	-0.543678	0.58 [0.36 - 0.93]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204311_at	62	0.145161	0.107446	-	15.2614	0.729633	-0.054397	0.95 [0.70 - 1.29]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204311_at	125	0.808	0.0346541	0.38978	-1.86984	0.161296	-0.863637	0.42 [0.13 - 1.41]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204311_at	125	0.256	0.0282959	0.340594	-0.632316	0.129681	-0.728417	0.48 [0.19 - 1.24]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204311_at	54	0.259259	0.0560517	-	15.4591	0.80577	-0.0470189	0.95 [0.66 - 1.39]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204311_at	198	0.247475	0.0304483	0.357796	-0.576145	0.292489	-0.128492	0.88 [0.69 - 1.12]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204311_at	198	0.419192	0.0666394	-	-0.486002	0.577527	-0.0719261	0.93 [0.72 - 1.20]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204311_at	198	0.257576	0.000276373	0.00851068	-0.773716	0.0130413	-0.244052	0.78 [0.65 - 0.95]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204311_at	51	0.313726	0.108715	-	15.6896	0.520007	1.11288	3.04 [0.10 - 90.32]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204311_at	62	0.741935	0.360729	-	-0.694398	0.830342	-0.23542	0.79 [0.09 - 6.81]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204311_at	177	0.570621	0.111999	-	-0.447379	0.602357	-0.369004	0.69 [0.17 - 2.77]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204311_at	177	0.570621	0.0360112	0.399677	-0.516982	0.213521	-0.774703	0.46 [0.14 - 1.56]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204311_at	145	0.4	0.0501576	-	0.737675	0.34216	0.829136	2.29 [0.41 - 12.68]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204311_at	226	0.743363	0.197108	-	0.392001	0.887429	0.0243857	1.02 [0.73 - 1.44]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204311_at	55	0.745455	0.00988229	0.160027	-2.19058	0.0554542	-1.84714	0.16 [0.02 - 1.04]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204311_at	55	0.745455	0.0157051	0.225393	-2.07816	0.129507	-1.55451	0.21 [0.03 - 1.58]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204311_at	49	0.714286	0.0267531	0.327883	-15.5675	0.207678	-1.79082	0.17 [0.01 - 2.70]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	203590	34	0.264706	0.0357948	0.398112	1.2415	0.510295	0.716541	2.05 [0.24 - 17.28]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	48799	34	0.117647	0.246202	-	-0.717875	0.931251	0.0685016	1.07 [0.23 - 5.08]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204311_at	63	0.460317	0.000841858	0.0220506	1.23699	0.0691251	0.32022	1.38 [0.98 - 1.95]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502278_3p_at	28	0.357143	0.04462	0.458256	-1.1553	0.317061	-4.86536	0.01 [0.00 - 106.25]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204311_at	82	0.182927	0.0956619	-	0.963804	0.189118	0.667247	1.95 [0.72 - 5.28]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37270_at	84	0.107143	0.171122	-	-0.643483	0.766805	-0.226331	0.80 [0.18 - 3.56]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204311_at	79	0.64557	0.204492	-	0.33315	0.795917	0.14651	1.16 [0.38 - 3.51]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204311_at	104	0.384615	0.0196172	0.264311	-0.744012	0.149552	-0.932987	0.39 [0.11 - 1.40]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P31275	117	0.478632	0.0129221	0.195448	-0.714915	0.127724	-0.284202	0.75 [0.52 - 1.08]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204311_at	204	0.754902	0.00455853	0.0879879	-2.32531	0.0575204	-0.497091	0.61 [0.36 - 1.02]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204311_at	204	0.715686	0.000389618	0.0114437	-1.5163	0.000196215	-0.687385	0.50 [0.35 - 0.72]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204311_at	178	0.52809	0.325064	-	-0.196944	0.995441	-0.00206547	1.00 [0.49 - 2.03]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204311_at	111	0.522523	0.263093	-	-0.29698	0.473907	-0.154261	0.86 [0.56 - 1.31]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204311_at	90	0.822222	0.225193	-	-0.63195	0.943368	-0.0469611	0.95 [0.26 - 3.49]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204311_at	90	0.822222	0.251597	-	-0.686604	0.851666	0.139382	1.15 [0.27 - 4.95]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2632	50	0.14	0.293929	-	1.02691	0.756162	0.170473	1.19 [0.40 - 3.48]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204311_at	138	0.463768	0.0228773	0.294406	-0.551529	0.132766	-3.46746	0.03 [0.00 - 2.87]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204311_at	129	0.782946	0.0104419	0.166794	0.678057	0.983532	-0.00546328	0.99 [0.59 - 1.67]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20872	56	0.303571	0.217139	-	-0.433055	0.735602	-0.284032	0.75 [0.14 - 3.91]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34175	56	0.714286	0.0067086	0.119044	-1.37584	0.185445	-0.565426	0.57 [0.25 - 1.31]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10382	56	0.821429	0.0452961	0.462576	0.843819	0.13924	1.42589	4.16 [0.63 - 27.55]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20872	56	0.160714	0.185641	-	-0.567513	0.645745	-0.410321	0.66 [0.12 - 3.82]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39433	56	0.392857	0.0928014	-	-0.575222	0.635603	-0.318773	0.73 [0.19 - 2.72]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10382	56	0.821429	0.0984422	-	0.703711	0.471891	0.683309	1.98 [0.31 - 12.74]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34175	56	0.892857	0.0114858	0.179107	1.33884	0.554702	-0.251318	0.78 [0.34 - 1.79]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39433	56	0.392857	0.0780764	-	-0.620694	0.226548	-0.891644	0.41 [0.10 - 1.74]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204311_at	278	0.892086	0.166237	-	0.39836	0.767194	0.07451	1.08 [0.66 - 1.76]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204311_at	133	0.406015	0.00102274	0.0259703	0.833901	0.0296068	0.193808	1.21 [1.02 - 1.45]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	8969	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204311_at	185	0.648649	0.00680428	0.120354	0.485132	0.199081	0.248724	1.28 [0.88 - 1.87]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204311_at	185	0.810811	0.0262461	0.323633	0.452759	0.353385	0.165558	1.18 [0.83 - 1.67]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P31275	110	0.854545	0.0405882	0.431678	0.593066	0.158009	0.181973	1.20 [0.93 - 1.54]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P31275	110	0.854545	0.213722	-	0.447021	0.548395	0.101022	1.11 [0.80 - 1.54]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204311_at	80	0.2125	0.0229118	0.294715	1.58744	0.200834	0.419764	1.52 [0.80 - 2.89]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_0247	281	0.30605	0.000414541	0.0120694	-0.517586	0.00257151	-0.230052	0.79 [0.68 - 0.92]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204311_at	38	0.710526	0.0227131	0.292936	1.05142	0.387674	0.337684	1.40 [0.65 - 3.02]
GENE	ATP1B2	ATPase, Na+/K+ transporting, beta 2 polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204311_at	140	0.25	0.0152834	0.220989	-0.709613	0.11292	-1.04736	0.35 [0.10 - 1.28]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208836_at	30	0.266667	0.0382811	0.415805	-0.924786	0.630396	-0.235191	0.79 [0.30 - 2.06]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1759628	165	0.89697	0.349672	-	0.35162	0.243975	0.200195	1.22 [0.87 - 1.71]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1759628	165	0.315152	0.0945059	-	0.740915	0.622397	0.125251	1.13 [0.69 - 1.87]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208836_at	163	0.883436	0.13948	-	0.435747	0.20161	0.223989	1.25 [0.89 - 1.76]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	229709_at	163	0.558282	0.0146106	0.213867	0.478535	0.472295	0.525865	1.69 [0.40 - 7.10]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226570_at	163	0.165644	0.0457449	0.465423	-0.485725	0.341992	-0.841602	0.43 [0.08 - 2.45]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208836_at	79	0.278481	0.0697245	-	0.635988	0.109589	0.474588	1.61 [0.90 - 2.87]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	229709_at	79	0.443038	0.0893693	-	0.510466	0.616233	0.459036	1.58 [0.26 - 9.53]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226570_at	79	0.759494	0.0158406	0.2268	0.755933	0.2782	0.695732	2.01 [0.57 - 7.05]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208836_at	58	0.827586	0.118526	-	0.549747	0.299029	0.350047	1.42 [0.73 - 2.75]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208836_at	34	0.852941	1.15746e-05	0.000510017	2.46773	0.241322	0.491359	1.63 [0.72 - 3.72]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208836_at	158	0.797468	0.00312101	0.06503	0.735739	0.477793	0.168263	1.18 [0.74 - 1.88]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208836_at	53	0.849057	0.104817	-	0.683178	0.249997	0.601996	1.83 [0.65 - 5.09]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208836_at	53	0.584906	0.105003	-	0.587105	0.260527	0.601642	1.83 [0.64 - 5.21]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208836_at	180	0.75	0.0048381	0.0922211	0.619734	0.0182686	0.742569	2.10 [1.13 - 3.89]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	229709_at	180	0.155556	0.00515523	0.0969453	0.998999	0.830753	0.0218366	1.02 [0.84 - 1.25]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226570_at	180	0.338889	0.0102868	0.16493	0.619273	0.105502	0.158036	1.17 [0.97 - 1.42]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208836_at	559	0.660107	0.00447521	0.0867132	0.565283	0.00540743	0.563944	1.76 [1.18 - 2.62]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226570_at	559	0.13059	0.160098	-	0.512367	0.565938	0.0948295	1.10 [0.80 - 1.52]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	229709_at	559	0.525939	0.0547632	-	0.384173	0.692352	0.0478544	1.05 [0.83 - 1.33]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208836_at	77	0.168831	0.000299357	0.00911929	1.68324	0.00216922	0.979202	2.66 [1.42 - 4.98]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	229709_at	77	0.883117	0.00953071	0.155713	0.921308	0.145217	0.298073	1.35 [0.90 - 2.01]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226570_at	77	0.896104	0.0085735	0.143703	-1.30519	0.03269	-0.307169	0.74 [0.55 - 0.98]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208836_at	70	0.871429	0.0585645	-	-0.869504	0.173777	-0.446592	0.64 [0.34 - 1.22]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226570_at	70	0.585714	0.204829	-	0.334612	0.582522	0.382969	1.47 [0.37 - 5.75]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	229709_at	70	0.328571	0.225143	-	0.347588	0.658124	-0.408412	0.66 [0.11 - 4.06]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32563_at	50	0.7	0.0103625	0.165841	0.92355	0.0969965	0.705014	2.02 [0.88 - 4.65]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208836_at	74	0.391892	0.00255616	0.0553348	0.934423	0.00303347	1.29032	3.63 [1.55 - 8.53]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226570_at	74	0.716216	0.000525403	0.0147826	1.01943	0.0312931	0.414054	1.51 [1.04 - 2.21]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	229709_at	74	0.513514	0.00759862	0.131037	-0.781057	0.270306	-0.195867	0.82 [0.58 - 1.16]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208836_at	67	0.671642	0.056645	-	-15.5721	0.406867	-1.02333	0.36 [0.03 - 4.03]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	229709_at	67	0.716418	0.0510662	-	-15.5802	0.310708	-2.52948	0.08 [0.00 - 10.60]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226570_at	67	0.104478	0.0112518	0.17638	-1.61938	0.0883077	-1.98418	0.14 [0.01 - 1.35]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208836_at	115	0.669565	0.0456971	0.46512	1.031	0.524476	0.437661	1.55 [0.40 - 5.96]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226570_at	115	0.895652	0.000688482	0.0186033	1.68456	0.431571	0.744445	2.11 [0.33 - 13.46]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	229709_at	115	0.747826	0.0222295	0.288577	1.15205	0.129477	0.660741	1.94 [0.82 - 4.55]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32563_at	158	0.670886	0.00251798	0.0546627	0.864897	0.0351941	0.796488	2.22 [1.06 - 4.65]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32563_at	76	0.421053	0.3584	-	-0.471993	0.988857	-0.0087576	0.99 [0.29 - 3.39]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	229709_at	204	0.882353	0.0423827	0.443684	-0.434406	0.190823	-0.0971559	0.91 [0.78 - 1.05]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226570_at	204	0.598039	0.000882213	0.0229378	0.477046	0.0248151	0.195389	1.22 [1.03 - 1.44]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208836_at	204	0.720588	0.00303527	0.0635868	0.460135	0.073741	0.268113	1.31 [0.97 - 1.75]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208836_at	87	0.597701	0.0373815	0.409475	0.771318	0.517047	0.249485	1.28 [0.60 - 2.73]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226570_at	87	0.172414	0.128991	-	-0.625661	0.775348	-0.192217	0.83 [0.22 - 3.09]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	229709_at	87	0.344828	0.0148354	0.216259	1.14162	0.144055	1.25721	3.52 [0.65 - 18.99]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	229709_at	87	0.344828	0.0148354	0.216259	1.14162	0.144055	1.25721	3.52 [0.65 - 18.99]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226570_at	87	0.172414	0.128991	-	-0.625661	0.775348	-0.192217	0.83 [0.22 - 3.09]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208836_at	87	0.597701	0.0373815	0.409475	0.771318	0.517047	0.249485	1.28 [0.60 - 2.73]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226570_at	77	0.220779	0.0423815	0.443676	15.4528	0.674757	0.534176	1.71 [0.14 - 20.68]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	229709_at	77	0.558442	0.00340137	0.0696843	-2.4184	0.0484647	-3.35462	0.03 [0.00 - 0.98]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208836_at	77	0.818182	0.0646567	-	1.13184	0.243783	0.822015	2.28 [0.57 - 9.06]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	229709_at	77	0.558442	0.0176648	0.245307	-2.09702	0.152401	-2.72184	0.07 [0.00 - 2.73]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226570_at	77	0.220779	0.0774758	-	15.4444	0.903837	-0.183481	0.83 [0.04 - 16.33]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208836_at	77	0.818182	0.0272084	0.331669	1.18885	0.221751	0.759512	2.14 [0.63 - 7.23]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208836_at	136	0.5	0.0478529	0.478578	0.918119	0.319895	0.636558	1.89 [0.54 - 6.63]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208836_at	200	0.315	0.000338409	0.010137	1.54237	0.0080647	0.993156	2.70 [1.29 - 5.63]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2495	60	0.733333	0.0016509	0.038682	1.18413	0.140489	0.494798	1.64 [0.85 - 3.17]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2495	60	0.533333	0.0359967	0.399573	0.799059	0.239464	0.498903	1.65 [0.72 - 3.78]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12636	155	0.858065	1.41858e-05	0.000612926	1.21371	5.87542e-05	0.331688	1.39 [1.19 - 1.64]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208836_at	286	0.688811	0.0147057	0.21488	0.482337	0.278319	0.252983	1.29 [0.82 - 2.03]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208836_at	159	0.893082	0.00283243	0.0601334	1.08087	0.118512	0.566012	1.76 [0.87 - 3.58]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208836_at	159	0.893082	0.00280307	0.0596287	1.22102	0.0737899	0.723978	2.06 [0.93 - 4.56]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208836_at	159	0.893082	0.010515	0.167669	0.973596	0.337242	0.364947	1.44 [0.68 - 3.04]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226570_at	159	0.893082	0.00927705	0.152569	0.989658	0.074315	0.339317	1.40 [0.97 - 2.04]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226570_at	159	0.213836	0.0591624	-	0.957277	0.117174	0.293988	1.34 [0.93 - 1.94]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226570_at	159	0.213836	0.0112994	0.176937	2.14383	0.0533058	0.438672	1.55 [0.99 - 2.42]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229709_at	159	0.106918	0.0165856	0.234452	15.2175	0.479629	0.143455	1.15 [0.78 - 1.72]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229709_at	159	0.886792	0.127231	-	0.625357	0.354244	0.191308	1.21 [0.81 - 1.81]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229709_at	159	0.106918	0.0414803	0.437683	15.2171	0.116174	0.379021	1.46 [0.91 - 2.34]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208836_at	54	0.777778	0.0168435	0.23707	1.54796	0.166024	1.30227	3.68 [0.58 - 23.22]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208836_at	117	0.717949	0.0103475	0.16566	-1.03892	0.0770282	-0.480264	0.62 [0.36 - 1.05]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208836_at	117	0.222222	0.0063029	0.113425	-1.00186	0.0454269	-0.671488	0.51 [0.26 - 0.99]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208836_at	117	0.717949	0.0103475	0.16566	-1.03892	0.0770282	-0.480264	0.62 [0.36 - 1.05]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208836_at	117	0.222222	0.00968439	0.157605	-1.01186	0.080649	-0.60244	0.55 [0.28 - 1.08]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208836_at	236	0.478814	0.0672824	-	0.503429	0.0756243	0.750374	2.12 [0.93 - 4.85]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226570_at	236	0.372881	0.0241263	0.30545	0.700861	0.194033	0.230141	1.26 [0.89 - 1.78]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	229709_at	236	0.402542	0.0990291	-	0.476528	0.128813	0.317081	1.37 [0.91 - 2.07]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208836_at	249	0.144578	0.0350773	0.392888	0.808001	0.0211587	0.763583	2.15 [1.12 - 4.11]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	229709_at	249	0.309237	0.0151872	0.219977	0.618009	0.0331946	0.33905	1.40 [1.03 - 1.92]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226570_at	249	0.751004	0.023313	0.298288	0.50788	0.225641	0.170157	1.19 [0.90 - 1.56]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208836_at	62	0.854839	0.00293998	0.0619715	1.39762	0.401841	0.217273	1.24 [0.75 - 2.07]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208836_at	125	0.808	0.000735532	0.0196744	1.23431	0.0780897	0.568502	1.77 [0.94 - 3.32]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208836_at	125	0.808	0.000290733	0.00889181	1.07203	0.113043	0.411555	1.51 [0.91 - 2.51]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208836_at	54	0.851852	0.00143907	0.034527	1.68889	0.46168	0.236017	1.27 [0.68 - 2.37]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208836_at	198	0.833333	0.000786324	0.0208168	0.930037	0.0284117	0.429038	1.54 [1.05 - 2.25]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208836_at	198	0.833333	0.000201139	0.00645922	1.03931	0.00877991	0.534233	1.71 [1.14 - 2.54]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208836_at	198	0.833333	0.0417357	0.439388	0.521768	0.0890261	0.27446	1.32 [0.96 - 1.81]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208836_at	51	0.843137	0.110446	-	1.3531	0.864697	-0.230784	0.79 [0.06 - 11.29]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208836_at	62	0.112903	0.0577148	-	-1.19633	0.735204	-0.284737	0.75 [0.14 - 3.92]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	229709_at	177	0.327684	0.148575	-	-0.40307	0.570605	-0.430064	0.65 [0.15 - 2.88]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226570_at	177	0.169492	1.57378e-05	0.00067311	-1.18569	0.006226	-1.95697	0.14 [0.03 - 0.57]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	229709_at	177	0.350282	0.305987	-	-0.24971	0.690531	-0.261694	0.77 [0.21 - 2.79]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208836_at	177	0.740113	0.0534241	-	0.544175	0.656682	0.209419	1.23 [0.49 - 3.10]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226570_at	177	0.169492	4.11837e-05	0.00159513	-1.02572	0.00492098	-1.73339	0.18 [0.05 - 0.59]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	229709_at	145	0.241379	0.131967	-	0.711676	0.836648	0.190879	1.21 [0.20 - 7.43]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208836_at	177	0.429379	0.0389403	0.420392	0.510641	0.538322	0.250807	1.29 [0.58 - 2.86]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226570_at	145	0.675862	0.0352353	0.394043	-0.912526	0.30517	-0.854865	0.43 [0.08 - 2.18]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208836_at	145	0.296552	0.0869842	-	0.748639	0.16007	0.832149	2.30 [0.72 - 7.34]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	229709_at	226	0.893805	0.0544019	-	0.694364	0.493242	0.0749869	1.08 [0.87 - 1.34]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226570_at	226	0.106195	0.0986464	-	1.13308	0.444761	0.167093	1.18 [0.77 - 1.81]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208836_at	226	0.725664	0.207155	-	-0.442321	0.695512	0.165588	1.18 [0.51 - 2.70]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226570_at	55	0.890909	0.0484781	0.482412	1.05711	0.338332	0.518398	1.68 [0.58 - 4.85]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	229709_at	55	0.490909	0.195321	-	0.632387	0.788589	0.311443	1.37 [0.14 - 13.30]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208836_at	55	0.218182	0.16782	-	-0.662628	0.786729	0.166043	1.18 [0.35 - 3.93]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226570_at	55	0.381818	0.00977957	0.158772	1.69201	0.0422491	1.16066	3.19 [1.04 - 9.78]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	229709_at	49	0.306122	0.170666	-	-0.788506	0.627222	-0.714034	0.49 [0.03 - 8.74]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226570_at	49	0.897959	0.0765468	-	1.12397	0.197753	0.923746	2.52 [0.62 - 10.27]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208836_at	55	0.163636	0.227595	-	-0.671865	0.833216	0.140091	1.15 [0.31 - 4.24]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208836_at	49	0.204082	0.0759826	-	-1.15404	0.687473	0.375766	1.46 [0.23 - 9.08]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	229709_at	55	0.854545	0.16258	-	-1.33236	0.706551	-0.402488	0.67 [0.08 - 5.43]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208836_at	63	0.285714	0.03426	0.386869	0.918486	0.141248	0.356911	1.43 [0.89 - 2.30]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226570_at	63	0.68254	0.00805433	0.137015	-1.13231	0.236506	-7.46173	0.00 [0.00 - 133.34]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	229709_at	63	0.174603	0.000404809	0.0118258	-1.28066	0.173884	-14.474	0.00 [0.00 - 594.81]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g1522634_3p_at	28	0.678571	0.106965	-	0.886558	0.530416	0.0816684	1.09 [0.84 - 1.40]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.157112.0.A1_3p_at	28	0.25	0.0468457	0.472336	-1.13531	0.229904	-10.088	0.00 [0.00 - 590.34]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.76941.1.A1_3p_at	28	0.821429	0.107985	-	-1.52874	0.356234	-3.13309	0.04 [0.00 - 33.89]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208836_at	82	0.829268	0.0858102	-	0.680426	0.648646	-0.173138	0.84 [0.40 - 1.77]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32563_at	84	0.488095	0.0591525	-	0.55359	0.5484	0.199656	1.22 [0.64 - 2.34]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208836_at	79	0.810127	0.0133425	0.20011	0.779814	0.0437764	0.651747	1.92 [1.02 - 3.62]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U51478_at	86	0.325581	0.047692	0.477586	1.0383	0.262952	0.699894	2.01 [0.59 - 6.86]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208836_at	104	0.711538	0.0875864	-	0.568563	0.420551	0.335337	1.40 [0.62 - 3.16]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P68007	117	0.897436	0.0165845	0.23444	0.899885	0.0932023	0.335732	1.40 [0.95 - 2.07]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208836_at	204	0.406863	0.00085228	0.0222805	1.046	0.0106617	1.19785	3.31 [1.32 - 8.31]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	229709_at	204	0.102941	0.0738194	-	-0.795371	0.371055	-0.220972	0.80 [0.49 - 1.30]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226570_at	204	0.421569	0.0871081	-	0.692603	0.449149	0.21597	1.24 [0.71 - 2.17]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	229709_at	204	0.617647	0.241085	-	0.319982	0.613438	0.0857069	1.09 [0.78 - 1.52]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226570_at	204	0.686275	0.0689451	-	0.495692	0.585002	0.112514	1.12 [0.75 - 1.68]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208836_at	204	0.411765	0.000823679	0.0216484	1.618	0.0453541	1.27998	3.60 [1.03 - 12.60]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208836_at	178	0.859551	0.00118115	0.0292948	0.813877	0.202013	0.35317	1.42 [0.83 - 2.45]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208836_at	111	0.153153	0.0391212	0.421644	0.86445	0.817382	-0.0388268	0.96 [0.69 - 1.34]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	229709_at	111	0.765766	0.0114226	0.178372	-0.892615	0.0997093	-0.237887	0.79 [0.59 - 1.05]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226570_at	111	0.603604	0.0734158	-	-0.503403	0.484016	-0.130253	0.88 [0.61 - 1.26]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208836_at	90	0.211111	0.00453187	0.0875808	-0.944988	0.06021	-0.305242	0.74 [0.54 - 1.01]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208836_at	90	0.111111	0.00909613	0.150309	-1.08713	0.10401	-0.299892	0.74 [0.52 - 1.06]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1287	50	0.28	0.0772808	-	1.24106	0.692247	0.277247	1.32 [0.33 - 5.21]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226570_at	138	0.898551	0.166218	-	-0.699837	0.574136	-0.0838112	0.92 [0.69 - 1.23]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	229709_at	138	0.297101	0.0718416	-	-0.44059	0.304935	-1.15734	0.31 [0.03 - 2.87]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208836_at	138	0.108696	0.0489319	0.485177	0.98248	0.635562	0.0416628	1.04 [0.88 - 1.24]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208836_at	129	0.651163	0.211817	-	-0.321299	0.663417	-0.0864241	0.92 [0.62 - 1.35]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40116	56	0.464286	0.100099	-	0.578983	0.885173	0.0220703	1.02 [0.76 - 1.38]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7669	56	0.625	0.140292	-	0.506977	0.855163	0.0297445	1.03 [0.75 - 1.42]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40116	56	0.464286	0.0100555	0.162135	0.97135	0.262391	0.187679	1.21 [0.87 - 1.68]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7669	56	0.625	0.0173846	0.242514	0.849168	0.232508	0.215011	1.24 [0.87 - 1.76]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	229709_at	278	0.323741	0.0789831	-	-0.355852	0.165548	-0.643153	0.53 [0.21 - 1.30]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226570_at	278	0.47482	0.196825	-	0.245287	0.541571	0.241943	1.27 [0.59 - 2.77]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208836_at	278	0.23741	0.0173294	0.241962	0.617911	0.286333	0.158902	1.17 [0.88 - 1.57]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208836_at	133	0.789474	0.0671135	-	-0.592882	0.467538	-0.0991932	0.91 [0.69 - 1.18]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5834	81	0.580247	0.0460032	0.467053	1.01875	0.931268	0.0466879	1.05 [0.36 - 3.03]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6635	81	0.728395	0.204387	-	0.658904	0.833643	-0.0984101	0.91 [0.36 - 2.27]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5448	81	0.876543	0.0242601	0.306618	1.26677	0.384333	-0.439993	0.64 [0.24 - 1.74]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208836_at	185	0.891892	0.199482	-	0.330441	0.963669	-0.00477031	1.00 [0.81 - 1.22]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208836_at	185	0.891892	0.114478	-	0.420844	0.933868	0.00946973	1.01 [0.81 - 1.26]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P68007	110	0.890909	0.0108594	0.171765	0.861887	0.0652023	0.295602	1.34 [0.98 - 1.84]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P68007	110	0.872727	0.0104996	0.167484	0.943635	0.0642118	0.393372	1.48 [0.98 - 2.25]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208836_at	80	0.8625	1.78668e-05	0.000754635	1.8611	0.0387161	1.03135	2.80 [1.05 - 7.46]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3693	281	0.270463	0.00713269	0.124813	0.439256	0.0686769	0.179144	1.20 [0.99 - 1.45]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:305092	59	0.576271	0.000213048	0.00679074	1.79232	0.0016777	2.89548	18.09 [2.97 - 110.13]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208836_at	38	0.157895	0.00734932	0.127721	15.6973	0.0496642	1.36251	3.91 [1.00 - 15.23]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226570_at	38	0.815789	0.282073	-	0.611655	0.315944	0.429384	1.54 [0.66 - 3.56]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	229709_at	38	0.447368	0.00154649	0.0366487	1.62954	0.00940883	0.682275	1.98 [1.18 - 3.31]
GENE	ATP1B3	ATPase, Na+/K+ transporting, beta 3 polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208836_at	140	0.892857	0.0258389	0.320192	0.844414	0.226702	0.390158	1.48 [0.78 - 2.78]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	220556_at	30	0.133333	0.0226618	0.292475	-1.30266	0.220008	-1.27015	0.28 [0.04 - 2.14]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1653211	165	0.890909	0.0263833	0.324787	-1.11624	0.371882	-0.427994	0.65 [0.25 - 1.67]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1653211	165	0.884848	0.0886254	-	-1.56693	0.685454	-0.330318	0.72 [0.15 - 3.55]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	220556_at	163	0.484663	0.103836	-	-0.320955	0.392984	-0.506022	0.60 [0.19 - 1.93]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	220556_at	79	0.101266	0.149295	-	0.837928	0.915883	-0.0721376	0.93 [0.24 - 3.55]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	220556_at	58	0.362069	0.279129	-	0.314181	0.465725	0.0976327	1.10 [0.85 - 1.43]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	220556_at	34	0.470588	0.279923	-	0.41917	0.741757	0.0826949	1.09 [0.66 - 1.78]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	220556_at	158	0.398734	0.017533	0.243996	0.590479	0.552647	0.320896	1.38 [0.48 - 3.98]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	220556_at	53	0.886792	0.0131396	0.197866	1.19931	0.908334	-0.0231586	0.98 [0.66 - 1.45]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	220556_at	53	0.886792	0.141567	-	0.70749	0.921175	-0.018448	0.98 [0.68 - 1.41]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	220556_at	180	0.105556	0.00667258	0.118549	-0.773187	0.303757	-0.0843193	0.92 [0.78 - 1.08]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	220556_at	559	0.898032	0.00625707	0.112784	-1.4677	0.094655	-0.23324	0.79 [0.60 - 1.04]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	220556_at	77	0.220779	0.0718533	-	0.577672	0.469659	0.121115	1.13 [0.81 - 1.57]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	220556_at	70	0.7	0.0033393	0.0686623	0.818304	0.136303	1.73149	5.65 [0.58 - 55.13]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	220556_at	74	0.675676	0.012333	0.188826	0.725157	0.930375	-0.0176832	0.98 [0.66 - 1.46]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	220556_at	67	0.104478	0.0123561	0.189086	-1.60532	0.392161	-3.95044	0.02 [0.00 - 163.71]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	220556_at	115	0.191304	0.00187107	0.0428838	-1.51944	0.0518208	-0.670423	0.51 [0.26 - 1.01]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	220556_at	204	0.318627	0.0497772	0.490286	0.299313	0.726709	0.0224025	1.02 [0.90 - 1.16]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	220556_at	87	0.310345	0.308943	-	-0.400435	0.637719	0.509265	1.66 [0.20 - 13.86]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	220556_at	87	0.310345	0.308943	-	-0.400435	0.637719	0.509265	1.66 [0.20 - 13.86]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	220556_at	77	0.12987	0.0214271	0.281255	-1.29676	0.62917	-1.03083	0.36 [0.01 - 23.41]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	220556_at	77	0.12987	0.00371671	0.0748092	-1.67647	0.336663	-2.39577	0.09 [0.00 - 12.08]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	220556_at	136	0.161765	0.303558	-	-0.528906	0.57802	-0.12222	0.88 [0.58 - 1.36]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	220556_at	200	0.745	0.0999779	-	-0.630405	0.969029	-0.00569939	0.99 [0.75 - 1.33]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21877	60	0.483333	0.0333792	0.3803	-0.80465	0.159857	-1.19492	0.30 [0.06 - 1.60]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21448	60	0.7	0.0513885	-	-0.929357	0.246087	-1.53551	0.22 [0.02 - 2.88]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21448	60	0.383333	0.00640727	0.11488	-0.99812	0.0825971	-2.56641	0.08 [0.00 - 1.39]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21877	60	0.633333	0.00128506	0.0314277	-1.57594	0.00798948	-2.42726	0.09 [0.01 - 0.53]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5366	155	0.219355	0.000229378	0.0072409	-0.99576	0.0956221	-0.371799	0.69 [0.45 - 1.07]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	220556_at	286	0.335664	0.039774	0.426134	0.449122	0.320009	0.113668	1.12 [0.90 - 1.40]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220556_at	159	0.289308	0.12222	-	-0.49993	0.773867	-0.0562637	0.95 [0.64 - 1.39]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220556_at	159	0.490566	0.303767	-	-0.32578	0.969934	0.00756803	1.01 [0.68 - 1.49]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220556_at	159	0.811321	0.06477	-	-1.26718	0.460542	-0.158103	0.85 [0.56 - 1.30]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	220556_at	54	0.425926	0.0430065	0.44779	-1.4919	0.354585	-2.42403	0.09 [0.00 - 15.00]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220556_at	117	0.136752	0.10481	-	0.939969	0.96195	-0.0551581	0.95 [0.10 - 9.12]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220556_at	117	0.179487	0.108459	-	1.11909	0.451836	0.932896	2.54 [0.22 - 28.88]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220556_at	117	0.136752	0.10481	-	0.939969	0.96195	-0.0551581	0.95 [0.10 - 9.12]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220556_at	117	0.162393	0.230143	-	0.718547	0.707408	0.469837	1.60 [0.14 - 18.60]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	220556_at	236	0.152542	0.178061	-	0.621289	0.527139	0.134631	1.14 [0.75 - 1.74]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	220556_at	249	0.15261	0.0592591	-	0.684368	0.199744	0.21292	1.24 [0.89 - 1.71]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220556_at	125	0.656	0.0844544	-	0.644603	0.275133	1.51582	4.55 [0.30 - 69.28]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220556_at	125	0.648	0.0603243	-	0.5362	0.471125	0.765976	2.15 [0.27 - 17.27]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220556_at	54	0.166667	0.177147	-	15.2322	0.826055	-0.148732	0.86 [0.23 - 3.25]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220556_at	62	0.177419	0.262921	-	1.09753	0.680172	-0.229783	0.79 [0.27 - 2.37]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220556_at	198	0.161616	0.138112	-	0.47627	0.565237	0.0405846	1.04 [0.91 - 1.20]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220556_at	198	0.161616	0.0173088	0.241756	1.16832	0.120825	0.145316	1.16 [0.96 - 1.39]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220556_at	198	0.161616	0.0161117	0.2296	1.32988	0.100199	0.16529	1.18 [0.97 - 1.44]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	220556_at	51	0.156863	0.143234	-	-1.25377	0.42661	-3.09449	0.05 [0.00 - 93.19]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	220556_at	62	0.596774	0.118823	-	0.885437	0.851517	0.42202	1.53 [0.02 - 126.60]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	220556_at	177	0.757062	0.0113477	0.1775	-0.807787	0.039603	-1.6286	0.20 [0.04 - 0.93]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	220556_at	145	0.703448	0.148715	-	-0.571908	0.765934	-0.3156	0.73 [0.09 - 5.83]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	220556_at	177	0.728814	0.0172025	0.24069	-0.845382	0.0431358	-1.85687	0.16 [0.03 - 0.94]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	220556_at	226	0.455752	0.189765	-	0.38448	0.535375	0.108353	1.11 [0.79 - 1.57]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	220556_at	55	0.127273	0.000376823	0.01112	-1.68402	0.0222129	-4.96745	0.01 [0.00 - 0.49]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	220556_at	49	0.122449	0.0178117	0.246765	-1.34823	0.0968593	-4.11841	0.02 [0.00 - 2.10]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	220556_at	55	0.709091	0.00593309	0.108213	-2.29131	0.0274799	-4.37048	0.01 [0.00 - 0.62]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	220556_at	63	0.111111	0.0108285	0.1714	-1.10206	0.475067	-1.66906	0.19 [0.00 - 18.38]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12965168_3p_at	28	0.464286	0.00938886	0.153958	-1.47684	0.113027	-1.6907	0.18 [0.02 - 1.49]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	220556_at	82	0.646341	0.00941687	0.154305	0.858009	0.237943	0.524864	1.69 [0.71 - 4.04]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	220556_at	79	0.797468	0.00143992	0.034544	0.977227	0.278561	0.327966	1.39 [0.77 - 2.51]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	220556_at	104	0.826923	0.106066	-	-0.833768	0.835204	-0.075448	0.93 [0.46 - 1.89]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	220556_at	204	0.691176	0.00496838	0.0941715	0.989545	0.170106	0.259755	1.30 [0.89 - 1.88]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	220556_at	204	0.176471	0.135168	-	0.636273	0.976832	0.00406131	1.00 [0.76 - 1.32]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	220556_at	178	0.606742	0.196994	-	-0.265355	0.65083	-0.0952358	0.91 [0.60 - 1.37]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	220556_at	111	0.18018	0.00531582	0.0993076	-0.820897	0.0542337	-0.262811	0.77 [0.59 - 1.00]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	220556_at	90	0.677778	0.0631679	-	-0.885529	0.901152	0.114687	1.12 [0.18 - 6.85]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	220556_at	90	0.844444	0.0592597	-	-1.28249	0.785335	-0.236902	0.79 [0.14 - 4.34]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	220556_at	138	0.362319	0.009784	0.158826	-0.614231	0.0138484	-3.85251	0.02 [0.00 - 0.46]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	220556_at	129	0.550388	0.0944236	-	0.40841	0.254116	0.194527	1.21 [0.87 - 1.70]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35876	56	0.696429	0.135966	-	-0.618461	0.61614	-0.16343	0.85 [0.45 - 1.61]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43321	56	0.625	0.252354	-	-0.456293	0.971262	-0.0189852	0.98 [0.35 - 2.76]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35876	56	0.696429	0.0650519	-	-0.797476	0.483867	-0.232322	0.79 [0.41 - 1.52]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43321	56	0.25	0.0839118	-	-0.61616	0.973484	0.0167882	1.02 [0.38 - 2.74]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	220556_at	278	0.438849	0.107778	-	-0.307639	0.647774	0.279394	1.32 [0.40 - 4.38]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	220556_at	133	0.789474	0.00125039	0.0307201	0.810065	0.112373	0.317626	1.37 [0.93 - 2.03]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	220556_at	185	0.259459	0.0101014	0.162691	-0.506933	0.155681	-0.777364	0.46 [0.16 - 1.34]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	220556_at	185	0.259459	0.00310134	0.0646998	-0.539028	0.0357659	-1.07834	0.34 [0.12 - 0.93]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P91832	110	0.6	0.0138131	0.205268	0.719492	0.162143	0.370149	1.45 [0.86 - 2.43]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P217430	110	0.836364	0.108786	-	0.550015	0.470713	0.141681	1.15 [0.78 - 1.69]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P91832	110	0.581818	0.00254203	0.0550863	0.693505	0.100774	0.326177	1.39 [0.94 - 2.05]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P217430	110	0.863636	0.107575	-	0.490915	0.593038	0.0798113	1.08 [0.81 - 1.45]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	220556_at	80	0.575	0.0108937	0.172171	1.12473	0.495851	0.134647	1.14 [0.78 - 1.69]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	220556_at	38	0.473684	0.0114231	0.178378	-1.22573	0.105196	-0.406182	0.67 [0.41 - 1.09]
GENE	ATP1B4	ATPase, Na+/K+ transporting, beta 4 polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	220556_at	140	0.25	0.11917	-	-0.473269	0.43247	0.584761	1.79 [0.42 - 7.73]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212930_at	30	0.133333	0.0379354	0.413382	-1.17402	0.182862	-0.743131	0.48 [0.16 - 1.42]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215716_s_at	30	0.8	0.0317976	0.368283	-1.27704	0.0848253	-0.742304	0.48 [0.20 - 1.11]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209281_s_at	30	0.166667	0.104833	-	-0.821824	0.757995	0.119118	1.13 [0.53 - 2.40]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1750599	165	0.260606	0.0641298	-	-0.473351	0.815048	-0.104937	0.90 [0.37 - 2.17]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1750599	165	0.151515	0.0328098	0.376007	-0.819056	0.326464	-0.679315	0.51 [0.13 - 1.97]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215716_s_at	163	0.822086	0.129646	-	0.362016	0.637558	0.0464923	1.05 [0.86 - 1.27]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209281_s_at	163	0.269939	0.0650672	-	0.427596	0.393878	0.10722	1.11 [0.87 - 1.42]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212930_at	163	0.368098	0.248003	-	0.237793	0.92956	-0.0118322	0.99 [0.76 - 1.28]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215716_s_at	79	0.240506	0.116097	-	-0.51105	0.434487	0.12714	1.14 [0.83 - 1.56]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212930_at	79	0.835443	0.194081	-	-0.561369	0.800752	0.0417413	1.04 [0.75 - 1.44]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209281_s_at	79	0.227848	0.184317	-	-0.445206	0.747394	0.0588474	1.06 [0.74 - 1.52]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212930_at	58	0.62069	0.0641139	-	-0.537241	0.651795	-0.0526731	0.95 [0.75 - 1.19]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215716_s_at	58	0.448276	0.00985399	0.159682	-0.716646	0.310581	-0.145174	0.86 [0.65 - 1.15]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209281_s_at	58	0.862069	0.0179985	0.248612	0.915842	0.189308	0.282217	1.33 [0.87 - 2.02]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209281_s_at	34	0.176471	0.163796	-	0.744922	0.973759	-0.0073029	0.99 [0.64 - 1.53]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212930_at	34	0.852941	0.186524	-	0.679382	0.495382	0.232199	1.26 [0.65 - 2.46]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215716_s_at	34	0.470588	0.0526855	-	0.790189	0.383045	0.253983	1.29 [0.73 - 2.28]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212930_at	158	0.803797	0.228052	-	0.332186	0.934443	-0.0169022	0.98 [0.66 - 1.47]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215716_s_at	158	0.696203	0.0932306	-	-0.458646	0.624876	-0.0953392	0.91 [0.62 - 1.33]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209281_s_at	158	0.867089	0.0856262	-	0.541609	0.883279	0.0292857	1.03 [0.70 - 1.52]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209281_s_at	53	0.603774	0.127583	-	-0.600567	0.615611	-0.183905	0.83 [0.41 - 1.71]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215716_s_at	53	0.113208	0.00418706	0.0822566	-1.22599	0.384895	-0.238188	0.79 [0.46 - 1.35]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212930_at	53	0.301887	0.0167551	0.236174	-0.862945	0.433454	-0.168449	0.84 [0.55 - 1.29]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209281_s_at	53	0.603774	0.319801	-	-0.355931	0.77922	-0.0943053	0.91 [0.47 - 1.76]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215716_s_at	53	0.113208	0.00101288	0.0257603	-1.4143	0.214205	-0.356516	0.70 [0.40 - 1.23]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212930_at	53	0.301887	0.082889	-	-0.605982	0.866362	-0.0354999	0.97 [0.64 - 1.46]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212930_at	180	0.233333	0.0554069	-	-0.455106	0.770287	0.0618341	1.06 [0.70 - 1.61]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215716_s_at	180	0.872222	0.0100901	0.162554	0.70472	0.662835	-0.091101	0.91 [0.61 - 1.37]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209281_s_at	180	0.355556	0.108446	-	-0.343555	0.584195	-0.0865217	0.92 [0.67 - 1.25]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215716_s_at	559	0.381038	0.168381	-	-0.279088	0.825789	0.0455039	1.05 [0.70 - 1.57]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212930_at	559	0.847943	0.202969	-	0.311678	0.677025	0.0631895	1.07 [0.79 - 1.43]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209281_s_at	559	0.502683	0.337511	-	-0.194975	0.512787	0.131321	1.14 [0.77 - 1.69]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209281_s_at	77	0.376623	0.207185	-	0.331919	0.654927	0.106334	1.11 [0.70 - 1.77]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212930_at	77	0.246753	0.0734459	-	0.557013	0.343322	0.21548	1.24 [0.79 - 1.94]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215716_s_at	77	0.597403	0.0205827	0.273427	0.595358	0.118958	0.289735	1.34 [0.93 - 1.92]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212930_at	70	0.785714	0.0164065	0.232625	-0.849487	0.503963	-0.133732	0.87 [0.59 - 1.29]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209281_s_at	70	0.771429	0.0618206	-	-0.642346	0.904361	0.028524	1.03 [0.65 - 1.64]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215716_s_at	70	0.628571	0.1919	-	-0.359521	0.791378	-0.0493197	0.95 [0.66 - 1.37]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37661_at	50	0.84	0.00156713	0.0370529	1.28874	0.203832	0.280622	1.32 [0.86 - 2.04]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34188_at	50	0.38	0.000180761	0.00588507	-1.37054	0.843263	0.0584379	1.06 [0.59 - 1.89]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215716_s_at	74	0.22973	0.0351069	0.393105	0.80692	0.11367	0.306869	1.36 [0.93 - 1.99]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209281_s_at	74	0.418919	0.0205024	0.272675	0.703179	0.103604	0.333905	1.40 [0.93 - 2.09]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212930_at	74	0.472973	0.0119273	0.184201	0.746347	0.0559129	0.318762	1.38 [0.99 - 1.91]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215716_s_at	67	0.865672	0.212723	-	-15.2647	0.728948	-0.318447	0.73 [0.12 - 4.40]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212930_at	67	0.104478	0.0232171	0.297436	-1.75325	0.7793	0.248403	1.28 [0.23 - 7.28]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209281_s_at	67	0.119403	0.143903	-	-1.1584	0.881723	0.155777	1.17 [0.15 - 9.10]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212930_at	115	0.2	0.133364	-	-0.814643	0.20168	-0.655721	0.52 [0.19 - 1.42]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209281_s_at	115	0.843478	0.0203021	0.270796	1.21518	0.819363	0.210103	1.23 [0.20 - 7.49]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215716_s_at	115	0.330435	0.00813575	0.138073	-1.37145	0.0634983	-1.11505	0.33 [0.10 - 1.06]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34188_at	158	0.101266	0.151799	-	-0.57931	0.0280937	-0.646846	0.52 [0.29 - 0.93]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37661_at	158	0.898734	0.0113959	0.178062	0.873206	0.177818	0.329745	1.39 [0.86 - 2.25]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34188_at	76	0.736842	0.41124	-	0.447037	0.857408	0.115223	1.12 [0.32 - 3.94]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37661_at	76	0.381579	0.0417408	0.439422	-1.02907	0.506211	-0.296168	0.74 [0.31 - 1.78]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209281_s_at	204	0.166667	0.00308428	0.0644129	-0.561579	0.420684	-0.143352	0.87 [0.61 - 1.23]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215716_s_at	204	0.852941	0.0358133	0.398246	0.417372	0.435013	0.126183	1.13 [0.83 - 1.56]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212930_at	204	0.852941	0.125797	-	0.307468	0.804172	0.0362748	1.04 [0.78 - 1.38]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212930_at	87	0.62069	0.087725	-	0.637776	0.872645	0.0484881	1.05 [0.58 - 1.90]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215716_s_at	87	0.862069	0.0937971	-	-1.54809	0.802178	-0.0835645	0.92 [0.48 - 1.77]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209281_s_at	87	0.873563	0.0803306	-	0.856664	0.41449	0.213346	1.24 [0.74 - 2.07]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212930_at	87	0.62069	0.087725	-	0.637776	0.872645	0.0484881	1.05 [0.58 - 1.90]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209281_s_at	87	0.873563	0.0803306	-	0.856664	0.41449	0.213346	1.24 [0.74 - 2.07]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215716_s_at	87	0.862069	0.0937971	-	-1.54809	0.802178	-0.0835645	0.92 [0.48 - 1.77]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209281_s_at	77	0.844156	0.0454161	0.463339	1.14513	0.667393	0.147115	1.16 [0.59 - 2.27]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215716_s_at	77	0.727273	0.0493645	0.487798	1.17615	0.410945	0.36933	1.45 [0.60 - 3.49]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212930_at	77	0.701299	0.0895943	-	1.02911	0.97615	-0.0136709	0.99 [0.40 - 2.42]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215716_s_at	77	0.727273	0.237018	-	0.662647	0.697349	-0.162708	0.85 [0.37 - 1.93]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209281_s_at	77	0.844156	0.00603293	0.109629	1.6094	0.137034	0.510985	1.67 [0.85 - 3.27]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212930_at	77	0.87013	0.141945	-	-15.2467	0.262965	-0.491021	0.61 [0.26 - 1.45]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215716_s_at	136	0.102941	0.0602615	-	-1.02458	0.36378	-0.449454	0.64 [0.24 - 1.68]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209281_s_at	136	0.367647	0.17607	-	-0.61536	0.979702	0.0107882	1.01 [0.44 - 2.32]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212930_at	136	0.897059	0.0732994	-	0.967768	0.942978	-0.0240319	0.98 [0.51 - 1.89]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215716_s_at	200	0.125	0.00400332	0.0793738	-0.965211	0.277206	-0.323645	0.72 [0.40 - 1.30]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209281_s_at	200	0.135	0.120697	-	-0.572243	0.739093	-0.13406	0.87 [0.40 - 1.92]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212930_at	200	0.175	0.00828999	0.140067	-0.843643	0.282003	-0.22045	0.80 [0.54 - 1.20]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21236	60	0.333333	0.0843976	-	-0.642168	0.376648	-0.187637	0.83 [0.55 - 1.26]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15752	60	0.433333	0.258495	-	0.44789	0.855406	0.0631704	1.07 [0.54 - 2.10]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21236	60	0.616667	0.206766	-	0.476182	0.925748	0.0292666	1.03 [0.56 - 1.91]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15752	60	0.5	0.00269185	0.0577058	-1.18828	0.537751	-0.296792	0.74 [0.29 - 1.91]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	595	155	0.225806	0.166798	-	0.470294	0.934494	0.0188053	1.02 [0.65 - 1.60]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215716_s_at	286	0.877622	0.0059602	0.108599	0.670306	0.303279	0.21591	1.24 [0.82 - 1.87]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209281_s_at	286	0.395105	0.000262748	0.0081462	-0.693695	0.00409318	-0.412682	0.66 [0.50 - 0.88]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212930_at	286	0.482517	0.00202021	0.0456697	0.611104	0.0323974	0.34766	1.42 [1.03 - 1.95]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209281_s_at	159	0.578616	0.0308033	0.360576	-0.747514	0.0877723	-0.525919	0.59 [0.32 - 1.08]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212930_at	159	0.792453	0.0034983	0.0712717	-15.4224	0.136841	-0.388421	0.68 [0.41 - 1.13]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215716_s_at	159	0.396226	0.00921628	0.151811	-0.811156	0.0742069	-0.55374	0.57 [0.31 - 1.06]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215716_s_at	159	0.396226	0.0206875	0.274405	-0.847876	0.0854978	-0.622134	0.54 [0.26 - 1.09]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209281_s_at	159	0.157233	0.00981126	0.15916	-0.886725	0.0263348	-0.697578	0.50 [0.27 - 0.92]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212930_at	159	0.886792	0.0132318	0.198888	-15.2323	0.0291422	-0.462712	0.63 [0.42 - 0.95]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209281_s_at	159	0.383648	0.0366917	0.404567	-0.762265	0.0738994	-0.641857	0.53 [0.26 - 1.06]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215716_s_at	159	0.396226	0.0247797	0.311127	-0.699941	0.145426	-0.456814	0.63 [0.34 - 1.17]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212930_at	159	0.792453	0.00578598	0.106115	-1.76522	0.175434	-0.304585	0.74 [0.47 - 1.15]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209281_s_at	54	0.296296	0.337264	-	0.772991	0.824735	-0.129682	0.88 [0.28 - 2.77]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212930_at	54	0.111111	0.00142577	0.0342623	-2.03187	0.748654	-0.239965	0.79 [0.18 - 3.41]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215716_s_at	54	0.277778	0.0124444	0.190085	-1.64366	0.400714	-0.419918	0.66 [0.25 - 1.75]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209281_s_at	117	0.880342	0.241855	-	-1.13294	0.587266	-0.233672	0.79 [0.34 - 1.84]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209281_s_at	117	0.615385	0.163512	-	0.442049	0.855065	0.0605622	1.06 [0.55 - 2.03]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212930_at	117	0.726496	0.164675	-	-0.569799	0.785193	-0.0855711	0.92 [0.50 - 1.70]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212930_at	117	0.316239	0.072547	-	0.859783	0.734484	0.125042	1.13 [0.55 - 2.33]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215716_s_at	117	0.222222	0.127784	-	0.801746	0.694466	0.108203	1.11 [0.65 - 1.91]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212930_at	117	0.726496	0.164675	-	-0.569799	0.785193	-0.0855711	0.92 [0.50 - 1.70]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212930_at	117	0.65812	0.113072	-	-0.772787	0.668619	-0.170216	0.84 [0.39 - 1.84]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215716_s_at	117	0.222222	0.0926677	-	0.730086	0.833506	0.0482506	1.05 [0.67 - 1.65]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215716_s_at	117	0.222222	0.0926677	-	0.730086	0.833506	0.0482506	1.05 [0.67 - 1.65]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209281_s_at	117	0.615385	0.163512	-	0.442049	0.855065	0.0605622	1.06 [0.55 - 2.03]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215716_s_at	117	0.888889	0.187293	-	-1.25994	0.8924	-0.0389503	0.96 [0.55 - 1.69]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209281_s_at	117	0.846154	0.113337	-	0.715932	0.759581	0.123007	1.13 [0.51 - 2.49]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209281_s_at	236	0.868644	0.00402856	0.0797718	0.912421	0.0642974	0.652149	1.92 [0.96 - 3.83]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212930_at	236	0.411017	0.00384389	0.0768452	0.867911	0.00295	0.937163	2.55 [1.38 - 4.74]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215716_s_at	236	0.817797	0.000548675	0.0153392	0.974358	0.0184313	0.700677	2.02 [1.13 - 3.61]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212930_at	249	0.156627	0.0152566	0.220707	0.922701	0.00560568	0.683053	1.98 [1.22 - 3.21]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215716_s_at	249	0.714859	0.002607	0.0562265	0.648458	0.0136679	0.569507	1.77 [1.12 - 2.78]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209281_s_at	249	0.86747	0.0126143	0.192001	0.664046	0.391427	0.247439	1.28 [0.73 - 2.26]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209281_s_at	125	0.328	0.0426071	0.445165	1.05335	0.256867	0.35843	1.43 [0.77 - 2.66]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212930_at	62	0.258065	0.314478	-	0.630297	0.807386	-0.0504193	0.95 [0.63 - 1.43]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209281_s_at	125	0.328	0.084109	-	0.637773	0.350868	0.228511	1.26 [0.78 - 2.03]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209281_s_at	54	0.240741	0.354837	-	0.942613	0.984463	0.00781864	1.01 [0.46 - 2.21]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215716_s_at	62	0.209677	0.296987	-	-0.556958	0.956777	0.0154473	1.02 [0.58 - 1.78]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212930_at	125	0.424	0.185571	-	0.522397	0.392451	0.415589	1.52 [0.58 - 3.93]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212930_at	125	0.416	0.0205408	0.273034	0.71845	0.108128	0.60035	1.82 [0.88 - 3.79]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212930_at	54	0.388889	0.235447	-	-0.692622	0.575174	-0.144611	0.87 [0.52 - 1.43]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215716_s_at	125	0.352	0.0364246	0.402654	1.0839	0.300567	0.236418	1.27 [0.81 - 1.98]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215716_s_at	125	0.216	0.0342572	0.386848	1.06319	0.314024	0.181749	1.20 [0.84 - 1.71]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215716_s_at	54	0.87037	0.13059	-	-15.3002	0.762576	-0.108038	0.90 [0.45 - 1.81]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209281_s_at	62	0.483871	0.29184	-	0.526378	0.734583	0.108786	1.11 [0.59 - 2.09]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215716_s_at	198	0.671717	0.0118334	0.183123	0.527873	0.0632789	0.237515	1.27 [0.99 - 1.63]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212930_at	198	0.69697	0.0105733	0.168366	0.647201	0.331797	0.123314	1.13 [0.88 - 1.45]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212930_at	198	0.70202	0.0135223	0.202088	0.656984	0.171888	0.189644	1.21 [0.92 - 1.59]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209281_s_at	198	0.757576	0.0154501	0.222735	0.546353	0.394439	0.114655	1.12 [0.86 - 1.46]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215716_s_at	198	0.631313	0.0290646	0.346806	0.548594	0.287675	0.166733	1.18 [0.87 - 1.61]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215716_s_at	198	0.631313	0.0201852	0.269695	0.613066	0.135798	0.241991	1.27 [0.93 - 1.75]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209281_s_at	198	0.858586	0.0232006	0.297289	0.69903	0.532769	0.0999986	1.11 [0.81 - 1.51]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212930_at	198	0.69697	0.00026007	0.00807422	0.764925	0.0298747	0.23623	1.27 [1.02 - 1.57]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209281_s_at	198	0.888889	0.0229624	0.295167	0.77687	0.451513	0.12593	1.13 [0.82 - 1.57]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209281_s_at	51	0.686275	0.181641	-	1.15441	0.837774	0.138222	1.15 [0.31 - 4.31]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209281_s_at	62	0.129032	0.143673	-	15.2647	0.745003	0.152982	1.17 [0.46 - 2.93]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212930_at	51	0.862745	0.0353858	0.395141	1.71822	0.211351	1.03178	2.81 [0.56 - 14.15]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212930_at	62	0.112903	0.00259367	0.0559932	-1.70388	0.983268	0.0129702	1.01 [0.30 - 3.40]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215716_s_at	51	0.862745	0.376725	-	-15.233	0.650657	-0.278705	0.76 [0.23 - 2.53]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215716_s_at	62	0.112903	0.293848	-	-0.798747	0.99389	0.00257746	1.00 [0.52 - 1.94]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209281_s_at	145	0.386207	0.309778	-	0.357221	0.712373	0.151139	1.16 [0.52 - 2.60]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215716_s_at	177	0.20904	0.071778	-	0.714603	0.304079	0.322233	1.38 [0.75 - 2.55]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212930_at	177	0.632768	0.00493206	0.0936292	0.749479	0.031608	0.732935	2.08 [1.07 - 4.06]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215716_s_at	177	0.19774	0.0473603	0.475535	0.693158	0.124884	0.417788	1.52 [0.89 - 2.59]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215716_s_at	145	0.165517	0.193304	-	0.677366	0.561973	0.218571	1.24 [0.59 - 2.60]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209281_s_at	177	0.118644	0.14278	-	0.845704	0.336324	0.328418	1.39 [0.71 - 2.71]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212930_at	177	0.632768	0.000894617	0.0232089	0.766115	0.0287173	0.644358	1.90 [1.07 - 3.39]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209281_s_at	177	0.40113	0.0796526	-	0.439863	0.416316	0.242287	1.27 [0.71 - 2.29]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212930_at	145	0.648276	0.0368599	0.405768	0.683535	0.271766	0.443726	1.56 [0.71 - 3.44]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209281_s_at	226	0.867257	0.183962	-	0.488017	0.690846	0.137512	1.15 [0.58 - 2.26]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215716_s_at	226	0.747788	0.208269	-	0.387683	0.811066	-0.064011	0.94 [0.55 - 1.59]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212930_at	226	0.659292	0.126307	-	0.437302	0.553903	0.171109	1.19 [0.67 - 2.09]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209281_s_at	49	0.44898	0.284819	-	-0.613088	0.746138	0.268574	1.31 [0.26 - 6.65]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215716_s_at	55	0.890909	0.0710633	-	0.975386	0.177431	0.605484	1.83 [0.76 - 4.42]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212930_at	55	0.854545	0.0524301	-	0.967516	0.111655	0.738408	2.09 [0.84 - 5.20]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215716_s_at	55	0.309091	0.166849	-	-0.664323	0.92283	0.0446309	1.05 [0.42 - 2.58]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215716_s_at	49	0.204082	0.212468	-	1.22486	0.385674	0.522006	1.69 [0.52 - 5.48]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212930_at	55	0.872727	0.0972174	-	1.01989	0.373478	0.474792	1.61 [0.57 - 4.57]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209281_s_at	55	0.872727	0.0120807	0.185956	1.23013	0.151158	0.858914	2.36 [0.73 - 7.63]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212930_at	49	0.653061	0.0534394	-	1.0803	0.21192	0.747221	2.11 [0.65 - 6.82]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209281_s_at	55	0.890909	0.0508789	-	1.1112	0.966529	-0.0262737	0.97 [0.29 - 3.32]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215716_s_at	63	0.47619	0.0174359	0.243027	0.816246	0.188443	0.226567	1.25 [0.89 - 1.76]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212930_at	63	0.365079	0.00993872	0.160715	1.00006	0.285547	0.293688	1.34 [0.78 - 2.30]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209281_s_at	63	0.301587	0.0023041	0.0508523	1.29162	0.017857	0.518353	1.68 [1.09 - 2.58]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.20952.0.S1_3p_at	28	0.285714	0.143429	-	0.947122	0.534956	0.142185	1.15 [0.74 - 1.81]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.78546.2.A1_3p_a_at	28	0.535714	0.121802	-	0.821863	0.808651	0.113855	1.12 [0.45 - 2.82]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g184269_3p_a_at	28	0.571429	0.0319833	0.369709	-1.33746	0.667688	0.355734	1.43 [0.28 - 7.24]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215716_s_at	82	0.768293	0.0186349	0.254848	0.802713	0.604777	0.18339	1.20 [0.60 - 2.41]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209281_s_at	82	0.170732	0.00147723	0.0352844	-1.16135	0.35933	-0.303126	0.74 [0.39 - 1.41]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212930_at	82	0.378049	0.00384887	0.0769246	-0.961486	0.801516	-0.0728877	0.93 [0.53 - 1.64]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34188_at	84	0.607143	0.116795	-	-0.474504	0.505488	-0.215208	0.81 [0.43 - 1.52]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37661_at	84	0.880952	0.281902	-	-0.554915	0.744814	-0.0778552	0.93 [0.58 - 1.48]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209281_s_at	79	0.886076	0.00119666	0.0296154	1.1692	0.0313126	0.606026	1.83 [1.06 - 3.18]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212930_at	79	0.367089	0.0547334	-	0.524722	0.0652363	0.517472	1.68 [0.97 - 2.91]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215716_s_at	79	0.759494	0.00735097	0.127743	0.774529	0.0311232	0.63808	1.89 [1.06 - 3.38]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	J04027_at	86	0.825581	5.68657e-08	3.78791e-06	2.07851	0.17995	0.434057	1.54 [0.82 - 2.91]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212930_at	104	0.230769	0.126684	-	-0.516069	0.52084	-0.216851	0.81 [0.42 - 1.56]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215716_s_at	104	0.865385	0.112732	-	0.651049	0.918272	-0.032273	0.97 [0.52 - 1.79]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209281_s_at	104	0.115385	0.0181668	0.25027	-0.878541	0.642647	-0.16145	0.85 [0.43 - 1.68]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P128319	117	0.188034	0.14892	-	0.619324	0.374835	0.211933	1.24 [0.77 - 1.97]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215716_s_at	204	0.137255	0.000321262	0.00969256	-1.07089	0.00654579	-1.10015	0.33 [0.15 - 0.74]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212930_at	204	0.75	0.0369743	0.406583	-1.19753	0.79677	-0.1435	0.87 [0.29 - 2.58]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212930_at	204	0.897059	0.022245	0.288717	-1.97233	0.731664	-0.141247	0.87 [0.39 - 1.95]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209281_s_at	204	0.617647	0.092778	-	-0.711048	0.442351	-0.423021	0.66 [0.22 - 1.93]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209281_s_at	204	0.137255	0.207571	-	-0.438533	0.803008	-0.104228	0.90 [0.40 - 2.04]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215716_s_at	204	0.357843	0.000227352	0.00718531	-1.30486	0.0093384	-1.38822	0.25 [0.09 - 0.71]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209281_s_at	178	0.297753	0.0861181	-	0.383479	0.336418	0.221079	1.25 [0.79 - 1.96]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212930_at	178	0.117978	0.135018	-	0.516141	0.184321	0.277648	1.32 [0.88 - 1.99]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215716_s_at	178	0.898876	0.00702554	0.123365	0.788011	0.318071	0.246372	1.28 [0.79 - 2.08]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300019535	41	0.731707	0.0511804	-	0.836929	0.921895	-0.0160758	0.98 [0.71 - 1.36]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209281_s_at	111	0.756757	0.0740926	-	-0.615337	0.136597	-0.279243	0.76 [0.52 - 1.09]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215716_s_at	111	0.216216	0.0806005	-	0.625709	0.726578	-0.0573107	0.94 [0.68 - 1.30]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212930_at	111	0.711712	0.114825	-	-0.509335	0.728318	-0.0611493	0.94 [0.67 - 1.33]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215716_s_at	90	0.155556	0.0311646	0.363391	-0.806085	0.319002	-0.24555	0.78 [0.48 - 1.27]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215716_s_at	90	0.322222	0.0153745	0.221943	-0.879726	0.175396	-0.43716	0.65 [0.34 - 1.22]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209281_s_at	90	0.544444	0.00560533	0.103518	-0.957743	0.206935	-0.330186	0.72 [0.43 - 1.20]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209281_s_at	90	0.677778	0.00732511	0.127398	-1.34316	0.136736	-0.47904	0.62 [0.33 - 1.16]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212930_at	90	0.322222	0.101319	-	-0.539183	0.352609	-0.357866	0.70 [0.33 - 1.49]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212930_at	90	0.155556	0.0869895	-	-0.730068	0.220747	-0.652056	0.52 [0.18 - 1.48]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	5401	50	0.74	0.0930999	-	0.818464	0.29116	0.358781	1.43 [0.74 - 2.79]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212930_at	138	0.898551	0.057112	-	0.642805	0.409482	0.0921975	1.10 [0.88 - 1.37]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209281_s_at	138	0.318841	0.0437549	0.452672	0.559751	0.243041	0.104645	1.11 [0.93 - 1.32]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215716_s_at	138	0.644928	0.247382	-	-0.30259	0.961769	-0.00506017	0.99 [0.81 - 1.22]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212930_at	129	0.875969	0.113323	-	0.520548	0.895032	0.0221929	1.02 [0.74 - 1.42]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215716_s_at	129	0.55814	0.0848136	-	-0.430506	0.433668	-0.144152	0.87 [0.60 - 1.24]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209281_s_at	129	0.162791	0.0212234	0.279379	-0.684562	0.596596	-0.119906	0.89 [0.57 - 1.38]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31720	56	0.892857	0.0537276	-	0.929385	0.900515	0.0248578	1.03 [0.69 - 1.51]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9609	56	0.892857	0.0537276	-	0.929385	0.948559	0.0132381	1.01 [0.68 - 1.51]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31720	56	0.892857	0.0605708	-	0.909029	0.636397	0.0975686	1.10 [0.74 - 1.65]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9609	56	0.892857	0.0605708	-	0.909029	0.691828	0.0839352	1.09 [0.72 - 1.65]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215716_s_at	278	0.758993	0.224863	-	0.246456	0.877657	0.0183983	1.02 [0.81 - 1.29]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212930_at	278	0.798561	0.0207647	0.275125	0.483243	0.604293	0.0595637	1.06 [0.85 - 1.33]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209281_s_at	278	0.863309	0.0922776	-	0.39667	0.930633	0.0102581	1.01 [0.80 - 1.27]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212930_at	133	0.112782	0.041094	0.435091	1.00508	0.746202	0.0378259	1.04 [0.83 - 1.31]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215716_s_at	133	0.120301	0.0924471	-	0.761819	0.790821	0.0304335	1.03 [0.82 - 1.29]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209281_s_at	133	0.105263	0.0855685	-	0.858294	0.441546	0.0888937	1.09 [0.87 - 1.37]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7036	81	0.197531	0.330346	-	0.726288	0.681984	-0.362695	0.70 [0.12 - 3.94]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13109	81	0.234568	0.0439956	0.454232	-1.03277	0.693594	-0.357569	0.70 [0.12 - 4.14]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16299	81	0.111111	0.0157523	0.225884	-1.2694	0.299764	-0.394736	0.67 [0.32 - 1.42]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	328	81	0.111111	0.0201324	0.269197	-1.28735	0.489532	-0.210988	0.81 [0.45 - 1.47]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11697	81	0.679012	0.0967708	-	-1.19106	0.342183	-0.438233	0.65 [0.26 - 1.59]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13141	81	0.419753	0.0270884	0.330673	-1.22414	0.0640177	-2.48003	0.08 [0.01 - 1.16]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16541	81	0.864198	0.13909	-	0.839921	0.401608	0.317094	1.37 [0.65 - 2.88]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1787	81	0.82716	0.0115931	0.18035	1.32049	0.0120955	1.49878	4.48 [1.39 - 14.43]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12991	81	0.864198	0.100856	-	1.05271	0.51182	0.297509	1.35 [0.55 - 3.28]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13358	81	0.851852	0.0706314	-	1.02883	0.412804	-0.503186	0.60 [0.18 - 2.02]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215716_s_at	185	0.881081	0.12485	-	0.361377	0.492082	0.0637004	1.07 [0.89 - 1.28]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212930_at	185	0.648649	0.0727244	-	0.295554	0.169055	0.22904	1.26 [0.91 - 1.74]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215716_s_at	185	0.854054	0.0222395	0.288668	0.506472	0.264118	0.111808	1.12 [0.92 - 1.36]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209281_s_at	185	0.102703	0.06045	-	0.521585	0.436039	0.0952217	1.10 [0.87 - 1.40]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212930_at	185	0.659459	0.0273034	0.332454	0.392036	0.0891443	0.305523	1.36 [0.95 - 1.93]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209281_s_at	185	0.87027	0.0509497	-	0.483095	0.503355	0.089289	1.09 [0.84 - 1.42]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P128319	110	0.863636	0.0851671	-	0.525323	0.960056	0.00736076	1.01 [0.76 - 1.34]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P128319	110	0.645455	0.0821661	-	-0.591855	0.790106	-0.0522987	0.95 [0.65 - 1.39]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212930_at	80	0.7875	0.121081	-	-1.45782	0.711341	-0.0765563	0.93 [0.62 - 1.39]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215716_s_at	80	0.6375	0.0450378	0.46093	-1.18556	0.33313	-0.239024	0.79 [0.49 - 1.28]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209281_s_at	80	0.8	0.00917462	0.151291	-15.4677	0.196614	-0.389727	0.68 [0.37 - 1.22]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3295	281	0.604982	0.0317866	0.368198	0.304726	0.493825	0.109349	1.12 [0.82 - 1.53]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209281_s_at	38	0.289474	0.224997	-	0.638967	0.840471	-0.100266	0.90 [0.34 - 2.40]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215716_s_at	38	0.289474	0.272927	-	0.577301	0.860565	0.0654661	1.07 [0.51 - 2.22]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212930_at	38	0.552632	0.142852	-	0.699401	0.957157	0.0193287	1.02 [0.50 - 2.06]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209281_s_at	140	0.121429	0.0118825	0.183687	15.2072	0.126785	0.194231	1.21 [0.95 - 1.56]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212930_at	140	0.207143	0.0356591	0.397128	1.04886	0.0830564	0.218797	1.24 [0.97 - 1.59]
GENE	ATP2B1	ATPase, Ca++ transporting, plasma membrane 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215716_s_at	140	0.157143	0.00979148	0.158918	2.16739	0.383462	0.106004	1.11 [0.88 - 1.41]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204685_s_at	30	0.133333	0.0130197	0.196535	-1.37651	0.844393	-0.136575	0.87 [0.22 - 3.41]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211586_s_at	30	0.7	0.0223848	0.289981	0.996983	0.137552	1.23322	3.43 [0.67 - 17.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216120_s_at	30	0.133333	0.145123	-	-0.787905	0.998985	-0.000871103	1.00 [0.26 - 3.83]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1802223	165	0.127273	0.0208002	0.275456	-0.699986	0.403929	-1.39005	0.25 [0.01 - 6.52]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1802223	165	0.139394	0.00715152	0.125067	-1.01573	0.618175	-1.18033	0.31 [0.00 - 31.85]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211586_s_at	163	0.337423	0.129997	-	-0.311817	0.381674	-0.486398	0.61 [0.21 - 1.83]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216120_s_at	163	0.184049	0.0221446	0.287808	-0.534585	0.430357	-0.492196	0.61 [0.18 - 2.08]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204685_s_at	163	0.680982	0.0662664	-	-0.40565	0.456862	-0.48154	0.62 [0.17 - 2.20]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	234714_x_at	163	0.791411	0.00471153	0.0903128	-0.771758	0.0139134	-1.83999	0.16 [0.04 - 0.69]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	234741_at	163	0.595092	0.0486572	0.483505	-0.401853	0.394554	-0.502736	0.60 [0.19 - 1.92]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	234741_at	79	0.797468	0.0241222	0.305414	-1.02151	0.0777989	-1.24325	0.29 [0.07 - 1.15]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	234714_x_at	79	0.835443	0.00432761	0.0844399	-1.80889	0.0225141	-1.77877	0.17 [0.04 - 0.78]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216120_s_at	79	0.21519	0.00106696	0.0269077	1.55755	0.0684725	1.59987	4.95 [0.89 - 27.69]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211586_s_at	79	0.43038	0.461885	-	0.219164	0.863895	0.112526	1.12 [0.31 - 4.05]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204685_s_at	79	0.164557	0.114465	-	-0.566387	0.547194	-0.48681	0.61 [0.13 - 3.00]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216120_s_at	58	0.155172	0.0974678	-	0.633337	0.374445	0.126024	1.13 [0.86 - 1.50]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204685_s_at	58	0.137931	0.082689	-	0.742811	0.666175	0.0811952	1.08 [0.75 - 1.57]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211586_s_at	58	0.293103	0.0960773	-	0.508015	0.617451	0.0704352	1.07 [0.81 - 1.41]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211586_s_at	34	0.264706	0.186479	-	-0.555718	0.497115	-0.250334	0.78 [0.38 - 1.60]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216120_s_at	34	0.529412	0.0514946	-	-0.755751	0.182148	-0.282877	0.75 [0.50 - 1.14]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204685_s_at	34	0.5	0.0474249	0.475935	0.79166	0.230315	0.486739	1.63 [0.73 - 3.60]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216120_s_at	158	0.772152	0.267133	-	0.291188	0.861205	-0.121665	0.89 [0.23 - 3.46]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204685_s_at	158	0.392405	0.105403	-	0.407981	0.474167	0.573315	1.77 [0.37 - 8.53]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211586_s_at	158	0.835443	0.0134376	0.201158	0.646906	0.0156151	1.68122	5.37 [1.37 - 20.99]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211586_s_at	53	0.113208	0.0780901	-	1.61303	0.757118	-0.0852084	0.92 [0.54 - 1.58]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204685_s_at	53	0.54717	0.0692277	-	0.625584	0.279206	0.284663	1.33 [0.79 - 2.23]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216120_s_at	53	0.169811	0.106027	-	0.949478	0.190479	0.321989	1.38 [0.85 - 2.23]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211586_s_at	53	0.320755	0.0971373	-	-0.578303	0.284368	-0.30033	0.74 [0.43 - 1.28]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204685_s_at	53	0.54717	0.209891	-	0.458141	0.768709	0.0788586	1.08 [0.64 - 1.83]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216120_s_at	53	0.169811	0.0409496	0.434119	1.17097	0.102916	0.377835	1.46 [0.93 - 2.30]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216120_s_at	180	0.233333	0.178636	-	0.352304	0.868218	0.015901	1.02 [0.84 - 1.23]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204685_s_at	180	0.738889	0.0101236	0.16296	0.5667	0.620935	-0.0612534	0.94 [0.74 - 1.20]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211586_s_at	180	0.127778	0.334344	-	-0.267185	0.636119	0.113636	1.12 [0.70 - 1.79]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	234714_x_at	180	0.455556	0.0541464	-	0.40801	0.274674	0.131313	1.14 [0.90 - 1.44]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	234741_at	180	0.866667	0.097022	-	-0.575356	0.469822	-0.0766753	0.93 [0.75 - 1.14]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	234741_at	559	0.284436	0.0347592	0.390554	0.555742	0.682853	0.0556477	1.06 [0.81 - 1.38]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	234714_x_at	559	0.649374	0.0144427	0.21207	-0.557983	0.301559	-0.19748	0.82 [0.56 - 1.19]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216120_s_at	559	0.454383	0.000674122	0.0182738	-0.681153	0.0147258	-0.293968	0.75 [0.59 - 0.94]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211586_s_at	559	0.236136	0.188496	-	-0.321779	0.795398	-0.0336447	0.97 [0.75 - 1.25]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204685_s_at	559	0.300537	0.000842026	0.0220543	-0.671729	0.00662262	-0.328823	0.72 [0.57 - 0.91]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211586_s_at	77	0.779221	0.00278323	0.0592871	-1.05053	0.038778	-0.404038	0.67 [0.46 - 0.98]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216120_s_at	77	0.857143	0.00231347	0.0510208	-1.46264	0.0891653	-0.232049	0.79 [0.61 - 1.04]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204685_s_at	77	0.831169	0.00187595	0.0429756	-1.28733	0.0295278	-0.295899	0.74 [0.57 - 0.97]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	234741_at	77	0.818182	0.0771954	-	-0.629877	0.872979	-0.0262609	0.97 [0.71 - 1.34]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	234714_x_at	77	0.103896	0.0145283	0.212987	-0.918714	0.511704	-0.171435	0.84 [0.50 - 1.41]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	234741_at	70	0.628571	0.0343752	0.387722	0.561731	0.146728	1.77928	5.93 [0.54 - 65.52]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	234714_x_at	70	0.814286	0.1859	-	0.427427	0.541776	0.665321	1.95 [0.23 - 16.49]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216120_s_at	70	0.485714	0.111938	-	0.420415	0.562879	0.207978	1.23 [0.61 - 2.49]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211586_s_at	70	0.657143	0.0759778	-	0.48225	0.91748	-0.0473385	0.95 [0.39 - 2.34]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204685_s_at	70	0.171429	0.0609859	-	-0.612542	0.735499	-0.052797	0.95 [0.70 - 1.29]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41090_s_at	50	0.26	0.0195806	0.263962	-0.882748	0.598164	0.182969	1.20 [0.61 - 2.37]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37053_at	50	0.4	0.00366905	0.0740418	-1.0291	0.766518	0.0520137	1.05 [0.75 - 1.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204685_s_at	74	0.108108	0.00904585	0.149679	-1.06161	0.889982	-0.023635	0.98 [0.70 - 1.37]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211586_s_at	74	0.445946	0.148167	-	-0.423718	0.570313	-0.0779789	0.92 [0.71 - 1.21]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216120_s_at	74	0.243243	0.0477901	0.478191	-0.620636	0.297983	-0.168938	0.84 [0.61 - 1.16]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	234741_at	74	0.797297	0.0168558	0.237194	0.771953	0.293996	0.241881	1.27 [0.81 - 2.00]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	234714_x_at	74	0.216216	0.121739	-	0.624042	0.650815	0.121088	1.13 [0.67 - 1.91]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	234714_x_at	67	0.58209	0.166906	-	0.911086	0.323159	2.73519	15.41 [0.07 - 3502.85]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	234741_at	67	0.895522	0.0905458	-	1.3197	0.692501	1.13199	3.10 [0.01 - 847.57]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216120_s_at	67	0.19403	0.117611	-	15.3993	0.356871	2.0135	7.49 [0.10 - 542.88]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211586_s_at	67	0.656716	0.111259	-	1.02942	0.569402	1.77148	5.88 [0.01 - 2628.88]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204685_s_at	67	0.492537	0.140714	-	1.02201	0.455437	0.667213	1.95 [0.34 - 11.24]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216120_s_at	115	0.243478	0.327685	-	-0.542944	0.876464	0.0890525	1.09 [0.36 - 3.36]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211586_s_at	115	0.852174	0.106174	-	-15.2744	0.920559	-0.0379649	0.96 [0.46 - 2.03]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	234741_at	115	0.686957	0.000351107	0.0104638	1.8492	0.0240055	0.950797	2.59 [1.13 - 5.91]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	234714_x_at	115	0.486957	0.0706136	-	-1.0213	0.517751	-0.268422	0.76 [0.34 - 1.72]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204685_s_at	115	0.452174	0.0642983	-	1.14372	0.697131	0.186935	1.21 [0.47 - 3.09]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37053_at	158	0.411392	0.0882566	-	-0.500278	0.726681	-0.10758	0.90 [0.49 - 1.64]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41090_s_at	158	0.56962	0.0822117	-	-0.516286	0.535786	-0.0865262	0.92 [0.70 - 1.21]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37053_at	76	0.855263	0.226129	-	-1.1883	0.692057	-0.287939	0.75 [0.18 - 3.12]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41090_s_at	76	0.671053	0.12676	-	-1.10377	0.857864	-0.04539	0.96 [0.58 - 1.57]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	234714_x_at	204	0.857843	0.0505401	-	-0.389687	0.207403	-0.113484	0.89 [0.75 - 1.06]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	234741_at	204	0.455882	0.211496	-	0.175782	0.957188	0.00390118	1.00 [0.87 - 1.16]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216120_s_at	204	0.598039	0.0902336	-	0.245181	0.340373	0.0651647	1.07 [0.93 - 1.22]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211586_s_at	204	0.323529	0.040834	0.43334	0.316193	0.664489	0.0320139	1.03 [0.89 - 1.19]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204685_s_at	204	0.735294	0.214677	-	-0.198553	0.728255	0.0242235	1.02 [0.89 - 1.17]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216120_s_at	87	0.45977	0.0371759	0.408017	0.821918	0.283872	0.873317	2.39 [0.48 - 11.83]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211586_s_at	87	0.103448	0.0614644	-	-0.897184	0.480573	-0.625587	0.53 [0.09 - 3.04]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216120_s_at	87	0.45977	0.0371759	0.408017	0.821918	0.283872	0.873317	2.39 [0.48 - 11.83]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204685_s_at	87	0.827586	0.257674	-	-0.679331	0.229328	0.346283	1.41 [0.80 - 2.49]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211586_s_at	87	0.103448	0.0614644	-	-0.897184	0.480573	-0.625587	0.53 [0.09 - 3.04]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	234741_at	87	0.643678	0.00639578	0.11472	0.99607	0.353512	1.0274	2.79 [0.32 - 24.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	234741_at	87	0.643678	0.00639578	0.11472	0.99607	0.353512	1.0274	2.79 [0.32 - 24.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	234714_x_at	87	0.298851	0.00703245	0.123459	1.5049	0.172149	1.01791	2.77 [0.64 - 11.93]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	234714_x_at	87	0.298851	0.00703245	0.123459	1.5049	0.172149	1.01791	2.77 [0.64 - 11.93]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204685_s_at	87	0.827586	0.257674	-	-0.679331	0.229328	0.346283	1.41 [0.80 - 2.49]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	234741_at	77	0.324675	0.196538	-	-0.796651	0.890275	-0.227233	0.80 [0.03 - 20.11]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	234714_x_at	77	0.428571	0.0783293	-	-1.1506	0.311848	-1.6378	0.19 [0.01 - 4.65]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204685_s_at	77	0.844156	0.146697	-	0.965357	0.597472	0.324138	1.38 [0.42 - 4.61]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211586_s_at	77	0.324675	0.246504	-	-0.634281	0.845223	-0.240899	0.79 [0.07 - 8.83]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204685_s_at	77	0.493506	0.33126	-	-0.547129	0.773771	0.172654	1.19 [0.37 - 3.86]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216120_s_at	77	0.220779	0.0248522	0.311754	-1.32148	0.99512	0.00745008	1.01 [0.09 - 10.97]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	234741_at	77	0.896104	0.0477305	0.477824	1.22771	0.586968	0.683439	1.98 [0.17 - 23.32]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	234714_x_at	77	0.428571	0.141604	-	-0.815375	0.866628	-0.225475	0.80 [0.06 - 11.09]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211586_s_at	77	0.324675	0.0407623	0.432856	-1.24066	0.262679	-1.62818	0.20 [0.01 - 3.39]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216120_s_at	77	0.324675	0.0855953	-	-0.923752	0.872317	-0.185744	0.83 [0.09 - 8.00]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204685_s_at	136	0.838235	0.0635152	-	0.887733	0.545102	0.150136	1.16 [0.71 - 1.89]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211586_s_at	136	0.860294	0.0591803	-	-15.2921	0.435364	-0.263971	0.77 [0.40 - 1.49]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216120_s_at	136	0.404412	0.260484	-	0.543166	0.733337	0.0962046	1.10 [0.63 - 1.91]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204685_s_at	200	0.155	0.152327	-	-0.527217	0.548858	-0.110324	0.90 [0.62 - 1.28]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211586_s_at	200	0.875	0.000795552	0.0210229	1.12242	0.053743	0.349513	1.42 [0.99 - 2.02]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216120_s_at	200	0.495	0.294732	-	0.311005	0.990439	-0.00201799	1.00 [0.72 - 1.39]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14155	60	0.366667	0.211557	-	-0.473701	0.826214	0.0302355	1.03 [0.79 - 1.35]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14155	60	0.816667	0.0725829	-	0.747756	0.451868	0.115636	1.12 [0.83 - 1.52]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	11528	155	0.387097	8.74529e-07	4.80839e-05	-1.3529	1.96261e-05	-0.217664	0.80 [0.73 - 0.89]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204685_s_at	286	0.583916	0.00104421	0.0264265	-0.680297	0.124143	-0.188961	0.83 [0.65 - 1.05]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211586_s_at	286	0.325175	0.0373544	0.409283	-0.411255	0.249609	-0.260585	0.77 [0.49 - 1.20]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216120_s_at	286	0.5	0.00453317	0.0876006	-0.553262	0.246037	-0.131324	0.88 [0.70 - 1.09]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204685_s_at	159	0.899371	0.223652	-	0.532855	0.944846	0.0199509	1.02 [0.58 - 1.80]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211586_s_at	159	0.867925	0.00992424	0.160539	0.910304	0.396034	0.220234	1.25 [0.75 - 2.07]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204685_s_at	159	0.283019	0.0604217	-	0.972866	0.382133	0.301707	1.35 [0.69 - 2.66]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216120_s_at	159	0.27673	0.0703726	-	-0.583379	0.45918	-0.150187	0.86 [0.58 - 1.28]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211586_s_at	159	0.534591	0.154914	-	-0.46075	0.55702	-0.179111	0.84 [0.46 - 1.52]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204685_s_at	159	0.886792	0.117591	-	0.641329	0.260903	0.329791	1.39 [0.78 - 2.47]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211586_s_at	159	0.899371	0.10231	-	0.78321	0.866394	-0.0592124	0.94 [0.47 - 1.88]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216120_s_at	159	0.27673	0.29962	-	-0.34911	0.815349	-0.0496898	0.95 [0.63 - 1.44]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216120_s_at	159	0.138365	0.296003	-	0.748393	0.991202	0.00279205	1.00 [0.61 - 1.65]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234714_x_at	159	0.138365	0.176121	-	0.791992	0.839386	0.0531527	1.05 [0.63 - 1.76]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234714_x_at	159	0.144654	0.162248	-	0.816704	0.49584	0.177129	1.19 [0.72 - 1.99]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234714_x_at	159	0.45283	0.0818201	-	0.685843	0.566112	0.172849	1.19 [0.66 - 2.15]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234741_at	159	0.396226	0.0108229	0.171333	0.931167	0.0255654	0.456043	1.58 [1.06 - 2.35]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234741_at	159	0.540881	0.0194635	0.262843	0.746252	0.0912806	0.355316	1.43 [0.94 - 2.15]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234741_at	159	0.540881	0.00126218	0.030961	1.25606	0.00552173	0.653917	1.92 [1.21 - 3.05]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216120_s_at	54	0.277778	0.0556291	-	-1.30429	0.341789	-1.80674	0.16 [0.00 - 6.81]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204685_s_at	54	0.592593	0.0709306	-	-1.70461	0.313477	-1.00249	0.37 [0.05 - 2.58]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211586_s_at	54	0.777778	0.0992951	-	-15.4485	0.425504	-1.08004	0.34 [0.02 - 4.84]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211586_s_at	117	0.854701	0.0444171	0.456951	-1.35326	0.113474	-1.35811	0.26 [0.05 - 1.38]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211586_s_at	117	0.555556	0.000975416	0.0249584	-1.61183	0.0129191	-3.08369	0.05 [0.00 - 0.52]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216120_s_at	117	0.358974	0.00477563	0.091281	-0.874651	0.0197092	-2.66719	0.07 [0.01 - 0.65]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204685_s_at	117	0.316239	0.127429	-	0.550165	0.630571	-0.158301	0.85 [0.45 - 1.63]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216120_s_at	117	0.205128	0.0357829	0.398026	-0.871259	0.238321	-1.47494	0.23 [0.02 - 2.66]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204685_s_at	117	0.316239	0.0973571	-	0.746946	0.962911	-0.0171097	0.98 [0.48 - 2.02]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216120_s_at	117	0.358974	0.00477563	0.091281	-0.874651	0.0197092	-2.66719	0.07 [0.01 - 0.65]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204685_s_at	117	0.316239	0.127429	-	0.550165	0.630571	-0.158301	0.85 [0.45 - 1.63]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204685_s_at	117	0.675214	0.111202	-	-0.770319	0.400798	-0.43452	0.65 [0.24 - 1.78]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211586_s_at	117	0.273504	0.014027	0.207591	-0.900789	0.0472281	-2.20622	0.11 [0.01 - 0.97]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211586_s_at	117	0.854701	0.0444171	0.456951	-1.35326	0.113474	-1.35811	0.26 [0.05 - 1.38]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216120_s_at	117	0.777778	0.0225601	0.291561	-1.52282	0.0955946	-2.15912	0.12 [0.01 - 1.46]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211586_s_at	236	0.639831	0.105797	-	0.43684	0.748407	0.110486	1.12 [0.57 - 2.19]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216120_s_at	236	0.538136	0.190143	-	0.352402	0.231895	0.233963	1.26 [0.86 - 1.85]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204685_s_at	236	0.826271	0.0343441	0.387492	-1.05069	0.378015	-0.165486	0.85 [0.59 - 1.22]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	234741_at	236	0.427966	0.00694956	0.122334	0.797087	0.575706	0.107538	1.11 [0.76 - 1.62]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	234714_x_at	236	0.576271	0.0151726	0.219823	0.650064	0.618251	0.115136	1.12 [0.71 - 1.76]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216120_s_at	249	0.502008	0.107234	-	0.341677	0.385897	0.131122	1.14 [0.85 - 1.53]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204685_s_at	249	0.815261	0.0564062	-	-0.630672	0.782025	0.0442173	1.05 [0.76 - 1.43]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211586_s_at	249	0.630522	0.304436	-	0.221971	0.909364	-0.0305322	0.97 [0.57 - 1.64]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	234741_at	249	0.39759	0.137357	-	0.329697	0.88011	-0.0246831	0.98 [0.71 - 1.34]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	234714_x_at	249	0.578313	0.0994214	-	0.348316	0.566721	0.104212	1.11 [0.78 - 1.59]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204685_s_at	54	0.314815	0.105911	-	1.54373	0.707642	-0.0767846	0.93 [0.62 - 1.38]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216120_s_at	62	0.193548	0.046589	0.470733	15.3395	0.842422	-0.072639	0.93 [0.45 - 1.90]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211586_s_at	125	0.688	0.0511492	-	-0.929405	0.620646	-0.417725	0.66 [0.13 - 3.44]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211586_s_at	125	0.664	0.0555945	-	-0.626377	0.596209	-0.337079	0.71 [0.21 - 2.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211586_s_at	54	0.481481	0.0966591	-	1.22951	0.761602	-0.0907784	0.91 [0.51 - 1.64]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216120_s_at	125	0.544	0.0959514	-	0.63396	0.770817	0.269132	1.31 [0.21 - 8.00]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216120_s_at	125	0.104	0.127258	-	-0.661529	0.583341	-0.39661	0.67 [0.16 - 2.77]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216120_s_at	54	0.277778	0.0532561	-	15.4921	0.963437	-0.0203999	0.98 [0.41 - 2.34]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204685_s_at	62	0.725806	0.119755	-	-0.895133	0.597728	-0.0895007	0.91 [0.66 - 1.27]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204685_s_at	125	0.488	0.314653	-	-0.381666	0.727972	-0.205871	0.81 [0.26 - 2.60]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211586_s_at	62	0.887097	0.235205	-	-1.16624	0.649616	-0.112356	0.89 [0.55 - 1.45]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204685_s_at	125	0.864	0.185881	-	-0.62375	0.498812	-0.28622	0.75 [0.33 - 1.72]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204685_s_at	198	0.848485	0.0972009	-	-0.575877	0.375181	0.0787319	1.08 [0.91 - 1.29]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216120_s_at	198	0.888889	0.103373	-	-0.93086	0.84843	0.0188259	1.02 [0.84 - 1.24]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216120_s_at	198	0.843434	0.0487174	0.483872	-0.983011	0.950709	0.00635101	1.01 [0.82 - 1.23]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204685_s_at	198	0.848485	0.0875261	-	-0.778637	0.774302	0.030613	1.03 [0.84 - 1.27]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211586_s_at	198	0.464646	0.170681	-	-0.288635	0.661681	0.06436	1.07 [0.80 - 1.42]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204685_s_at	198	0.848485	0.137071	-	-0.68358	0.790222	0.0294981	1.03 [0.83 - 1.28]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216120_s_at	198	0.5	0.100541	-	-0.346452	0.498129	-0.0545968	0.95 [0.81 - 1.11]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211586_s_at	198	0.80303	0.0173247	0.241915	0.646586	0.244825	0.196062	1.22 [0.87 - 1.69]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211586_s_at	198	0.80303	0.0133846	0.200574	0.694539	0.251569	0.205546	1.23 [0.86 - 1.75]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211586_s_at	51	0.823529	0.16732	-	1.1895	0.897717	-0.178573	0.84 [0.05 - 12.73]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211586_s_at	62	0.16129	0.381791	-	0.884541	0.738226	0.290312	1.34 [0.24 - 7.34]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216120_s_at	51	0.862745	0.0654546	-	1.52921	0.497681	1.24308	3.47 [0.10 - 125.95]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216120_s_at	62	0.209677	0.211173	-	-0.749761	0.72779	-0.460871	0.63 [0.05 - 8.45]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204685_s_at	51	0.784314	0.217208	-	-15.4333	0.912519	-0.193696	0.82 [0.03 - 26.10]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204685_s_at	62	0.822581	0.0731856	-	-15.3861	0.54188	-0.702894	0.50 [0.05 - 4.74]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204685_s_at	177	0.717514	0.0470306	0.473488	-0.58359	0.231508	-0.610257	0.54 [0.20 - 1.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211586_s_at	145	0.793103	0.0356179	0.396829	-1.19464	0.412765	-0.431724	0.65 [0.23 - 1.82]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204685_s_at	145	0.131034	0.167318	-	0.96685	0.565223	0.417071	1.52 [0.37 - 6.29]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	234714_x_at	177	0.107345	0.00968294	0.157587	-0.880609	0.0743864	-1.14033	0.32 [0.09 - 1.12]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	234741_at	177	0.248588	0.207549	-	-0.345559	0.558514	-0.180112	0.84 [0.46 - 1.53]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	234741_at	177	0.175141	0.0426082	0.445172	-0.662563	0.374648	-0.302983	0.74 [0.38 - 1.44]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216120_s_at	177	0.898305	0.00443999	0.0861726	-15.2296	0.0315871	-2.16605	0.11 [0.02 - 0.83]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	234714_x_at	177	0.107345	0.0327884	0.375845	-0.68772	0.0841632	-0.965019	0.38 [0.13 - 1.14]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211586_s_at	177	0.141243	0.0348848	0.391477	-0.677972	0.161112	-0.609635	0.54 [0.23 - 1.28]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216120_s_at	177	0.898305	0.000910327	0.0235513	-15.2329	0.0106003	-2.24137	0.11 [0.02 - 0.59]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	234741_at	145	0.151724	0.127427	-	1.05993	0.984143	-0.0093411	0.99 [0.39 - 2.49]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	234714_x_at	145	0.158621	0.211948	-	0.736268	0.919128	-0.0822719	0.92 [0.19 - 4.51]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216120_s_at	145	0.896552	0.0769115	-	-1.6141	0.650072	-0.520341	0.59 [0.06 - 5.63]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204685_s_at	177	0.881356	0.0406088	0.431817	-1.36682	0.410682	-0.486306	0.61 [0.19 - 1.96]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211586_s_at	177	0.785311	0.00740472	0.128461	-1.02163	0.118408	-0.586294	0.56 [0.27 - 1.16]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211586_s_at	226	0.150442	0.183176	-	-0.468538	0.641358	-0.0712079	0.93 [0.69 - 1.26]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204685_s_at	226	0.331858	0.00359376	0.0728242	-0.807813	0.0114776	-0.323534	0.72 [0.56 - 0.93]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	234741_at	226	0.504425	0.00518816	0.0974313	0.824514	0.11721	0.153798	1.17 [0.96 - 1.41]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	234714_x_at	226	0.89823	0.0574772	-	-1.70556	0.2234	-0.248508	0.78 [0.52 - 1.16]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216120_s_at	226	0.150442	0.0260004	0.32156	-0.690749	0.311854	-0.139766	0.87 [0.66 - 1.14]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211586_s_at	49	0.469388	0.122337	-	-0.991009	0.188422	-2.15305	0.12 [0.00 - 2.87]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204685_s_at	55	0.181818	3.01459e-05	0.00120704	-1.92005	0.423197	-0.947741	0.39 [0.04 - 3.94]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	234741_at	55	0.818182	0.289027	-	-0.771274	0.872138	-0.246667	0.78 [0.04 - 15.76]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	234714_x_at	55	0.2	0.0435073	0.451062	-0.917234	0.370423	-1.05704	0.35 [0.03 - 3.51]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204685_s_at	49	0.163265	8.58175e-08	5.56582e-06	-2.65719	0.000261266	-6.1768	0.00 [0.00 - 0.06]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216120_s_at	55	0.181818	0.0137897	0.205012	-1.10637	0.18694	1.02838	2.80 [0.61 - 12.88]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211586_s_at	55	0.545455	0.0296002	0.351089	-1.07516	0.154139	-1.57256	0.21 [0.02 - 1.80]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	234741_at	55	0.618182	0.110933	-	0.744307	0.974873	-0.0515769	0.95 [0.04 - 23.52]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216120_s_at	55	0.145455	0.0373195	0.409036	-1.11122	0.269559	0.719231	2.05 [0.57 - 7.36]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	234714_x_at	55	0.363636	0.243347	-	0.65576	0.713616	-0.463491	0.63 [0.05 - 7.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	234714_x_at	49	0.714286	0.193386	-	-0.974156	0.768152	-0.442531	0.64 [0.03 - 12.18]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	234741_at	49	0.387755	0.15447	-	0.920059	0.888301	0.259828	1.30 [0.03 - 48.70]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216120_s_at	49	0.122449	0.0274688	0.33382	-1.2663	0.273648	-3.03113	0.05 [0.00 - 10.98]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211586_s_at	55	0.181818	0.0192541	0.260835	-1.04692	0.106597	-1.96705	0.14 [0.01 - 1.53]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204685_s_at	55	0.2	2.52551e-06	0.000127511	-1.90976	0.219145	-1.48969	0.23 [0.02 - 2.43]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204685_s_at	63	0.222222	0.00070302	0.0189356	-1.16782	0.929574	-0.0360229	0.96 [0.43 - 2.14]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	234741_at	63	0.190476	0.0223181	0.289379	-0.837099	0.188468	-7.49393	0.00 [0.00 - 39.44]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	234714_x_at	63	0.142857	4.59228e-05	0.00175773	-1.55629	0.11087	-8.55221	0.00 [0.00 - 7.11]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216120_s_at	63	0.142857	0.00370311	0.0745904	-1.13361	0.0430171	-13.8585	0.00 [0.00 - 0.65]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211586_s_at	63	0.301587	0.000307066	0.00932176	-1.17344	0.00422518	-24.4868	0.00 [0.00 - 0.00]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.89512.0.S2_3p_a_at	28	0.464286	0.182346	-	-0.722818	0.781464	0.200004	1.22 [0.30 - 5.02]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g190098_3p_s_at	28	0.321429	0.0691516	-	-1.03791	0.536605	-2.56588	0.08 [0.00 - 263.08]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.89512.3.A1_3p_at	28	0.642857	0.011247	0.176324	-1.82697	0.241072	-6.87967	0.00 [0.00 - 101.75]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.305923.3.S1_3p_s_at	28	0.607143	0.03983	0.426517	-1.32371	0.382578	-2.08135	0.12 [0.00 - 13.34]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.89512.3.S1_3p_at	28	0.357143	0.0097747	0.158712	-1.41265	0.58443	-3.7037	0.02 [0.00 - 14316.18]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204685_s_at	82	0.878049	2.9762e-05	0.00119327	1.59232	0.152674	0.389933	1.48 [0.87 - 2.52]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211586_s_at	82	0.792683	0.275747	-	-0.520331	0.930055	-0.0506085	0.95 [0.31 - 2.94]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216120_s_at	82	0.890244	0.00783066	0.134094	1.15037	0.215877	0.365861	1.44 [0.81 - 2.57]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37053_at	84	0.119048	0.128289	-	0.8776	0.709163	-0.151647	0.86 [0.39 - 1.91]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204685_s_at	79	0.797468	0.0883315	-	-0.619081	0.677764	-0.181395	0.83 [0.35 - 1.96]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211586_s_at	79	0.898734	0.04103	0.434661	0.774894	0.197664	0.806146	2.24 [0.66 - 7.63]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216120_s_at	79	0.860759	0.174653	-	-0.540604	0.729174	-0.131573	0.88 [0.42 - 1.85]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216120_s_at	104	0.461538	0.00822456	0.139222	-0.880841	0.18174	-0.616423	0.54 [0.22 - 1.33]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204685_s_at	104	0.5	0.235625	-	-0.388877	0.583057	-0.469675	0.63 [0.12 - 3.34]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211586_s_at	104	0.240385	0.0158683	0.227087	1.204	0.0685549	1.30628	3.69 [0.91 - 15.06]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	234741_at	204	0.117647	0.031427	0.365425	-0.898931	0.458358	-0.189405	0.83 [0.50 - 1.37]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216120_s_at	204	0.132353	0.0883633	-	-0.720779	0.327125	-0.221176	0.80 [0.52 - 1.25]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	234714_x_at	204	0.181373	0.0384671	0.417103	-0.783508	0.652373	-0.113203	0.89 [0.55 - 1.46]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	234714_x_at	204	0.779412	0.0497974	0.490407	0.567673	0.222468	0.222	1.25 [0.87 - 1.78]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	234741_at	204	0.759804	0.0389953	0.420773	0.580215	0.60134	0.0928044	1.10 [0.77 - 1.55]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216120_s_at	204	0.769608	0.128981	-	-0.573776	0.889951	0.0256444	1.03 [0.71 - 1.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211586_s_at	204	0.27451	0.0158883	0.227294	1.36118	0.246093	0.233534	1.26 [0.85 - 1.87]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211586_s_at	204	0.269608	0.0157978	0.226356	0.894945	0.121528	0.232469	1.26 [0.94 - 1.69]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204685_s_at	204	0.289216	0.0921454	-	-0.619205	0.612933	0.103748	1.11 [0.74 - 1.66]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204685_s_at	204	0.303922	0.0789304	-	-0.486145	0.864937	0.0263358	1.03 [0.76 - 1.39]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211586_s_at	178	0.685393	0.000870705	0.0226855	0.661429	0.0170689	1.06857	2.91 [1.21 - 7.01]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216120_s_at	178	0.674157	0.0274896	0.333992	0.45685	0.128516	0.267886	1.31 [0.93 - 1.85]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204685_s_at	178	0.421348	0.00571585	0.10511	0.572193	0.403328	0.236399	1.27 [0.73 - 2.21]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216120_s_at	111	0.846847	0.0499439	0.491287	0.626094	0.378193	0.1167	1.12 [0.87 - 1.46]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211586_s_at	111	0.891892	0.178048	-	0.509135	0.256	0.20597	1.23 [0.86 - 1.75]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	234741_at	111	0.891892	0.0792728	-	0.628657	0.589853	0.0846537	1.09 [0.80 - 1.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	234714_x_at	111	0.369369	0.248887	-	0.326167	0.933563	-0.0191417	0.98 [0.63 - 1.54]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204685_s_at	111	0.315315	0.14123	-	-0.400282	0.84023	-0.0317004	0.97 [0.71 - 1.32]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211586_s_at	90	0.133333	0.176253	-	0.793903	0.860718	-0.0993178	0.91 [0.30 - 2.75]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211586_s_at	90	0.133333	0.207322	-	0.894837	0.767852	0.190255	1.21 [0.34 - 4.28]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216120_s_at	90	0.811111	0.134285	-	-0.774224	0.948179	0.0520027	1.05 [0.22 - 5.05]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216120_s_at	90	0.133333	0.0273357	0.332722	-0.926784	0.888625	0.125949	1.13 [0.19 - 6.61]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204685_s_at	90	0.788889	0.217985	-	-0.58439	0.68593	-0.217769	0.80 [0.28 - 2.31]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204685_s_at	90	0.788889	0.280368	-	-0.574246	0.665404	-0.265118	0.77 [0.23 - 2.55]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216120_s_at	138	0.210145	0.0231098	0.296482	-0.588939	0.0822874	-7.51541	0.00 [0.00 - 2.62]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211586_s_at	138	0.347826	0.0162399	0.230917	-0.574357	0.0685875	-9.31525	0.00 [0.00 - 2.03]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	234741_at	138	0.369565	0.00994478	0.160789	-0.613658	0.100106	-5.12761	0.01 [0.00 - 2.68]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	234714_x_at	138	0.318841	0.0216439	0.283245	-0.554455	0.127411	-6.2184	0.00 [0.00 - 5.91]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204685_s_at	138	0.166667	0.000774459	0.0205512	-0.871554	0.341306	-3.17307	0.04 [0.00 - 28.86]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216120_s_at	129	0.108527	0.104949	-	0.814125	0.757752	0.0501129	1.05 [0.76 - 1.45]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204685_s_at	129	0.72093	0.0562113	-	-0.568243	0.375116	-0.185173	0.83 [0.55 - 1.25]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211586_s_at	129	0.426357	0.204705	-	0.321314	0.352161	0.293499	1.34 [0.72 - 2.49]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9110	56	0.428571	0.00269846	0.0578207	-1.07497	0.238141	-0.847949	0.43 [0.10 - 1.75]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26977	56	0.178571	0.024331	0.307236	1.50971	0.0528847	0.923261	2.52 [0.99 - 6.41]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9110	56	0.446429	0.0170074	0.238727	-0.820171	0.347628	-0.660946	0.52 [0.13 - 2.05]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26977	56	0.589286	0.0367857	0.405239	0.754361	0.0749998	0.855998	2.35 [0.92 - 6.04]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204685_s_at	278	0.859712	0.0572236	-	-0.649561	0.68158	-0.0368246	0.96 [0.81 - 1.15]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	234714_x_at	278	0.125899	0.076471	-	0.677051	0.498603	0.294527	1.34 [0.57 - 3.15]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	234741_at	278	0.273381	0.0559984	-	0.444732	0.719485	-0.209639	0.81 [0.26 - 2.55]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216120_s_at	278	0.269784	0.0739555	-	-0.363885	0.68177	-0.077073	0.93 [0.64 - 1.34]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211586_s_at	278	0.55036	0.0428833	0.446982	-0.393311	0.392724	-0.304654	0.74 [0.37 - 1.48]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216120_s_at	133	0.360902	0.0129562	0.195828	0.649843	0.803071	-0.0537644	0.95 [0.62 - 1.45]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204685_s_at	133	0.330827	0.0205869	0.273466	0.636059	0.667118	-0.0431703	0.96 [0.79 - 1.17]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211586_s_at	133	0.511278	0.00225411	0.0499505	0.725958	0.215647	0.353233	1.42 [0.81 - 2.49]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4704	81	0.530864	0.0610031	-	1.04739	0.329781	0.166051	1.18 [0.85 - 1.65]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14513	81	0.135802	0.0438964	0.45359	15.4266	0.670053	0.26939	1.31 [0.38 - 4.52]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204685_s_at	185	0.875676	0.124939	-	0.388425	0.968938	0.00619083	1.01 [0.74 - 1.37]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216120_s_at	185	0.475676	0.318243	-	-0.161371	0.909864	-0.0285209	0.97 [0.59 - 1.59]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211586_s_at	185	0.12973	0.210057	-	0.303173	0.969032	-0.00755962	0.99 [0.68 - 1.45]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216120_s_at	185	0.886486	0.108388	-	0.396823	0.473283	0.186946	1.21 [0.72 - 2.01]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204685_s_at	185	0.356757	0.0955718	-	-0.28156	0.875025	-0.0232428	0.98 [0.73 - 1.31]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211586_s_at	185	0.654054	0.0980755	-	0.302533	0.62925	0.102241	1.11 [0.73 - 1.68]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P18152	110	0.518182	0.103562	-	0.372517	0.995775	-0.000554375	1.00 [0.81 - 1.23]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P18152	110	0.118182	0.094985	-	0.856461	0.943716	0.00902563	1.01 [0.79 - 1.30]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204685_s_at	80	0.1125	0.144177	-	1.38815	0.446735	0.186297	1.20 [0.75 - 1.95]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211586_s_at	80	0.8125	0.000314605	0.00951902	1.4851	0.00506887	0.609095	1.84 [1.20 - 2.82]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216120_s_at	80	0.125	0.0991633	-	-0.899376	0.142435	-0.261414	0.77 [0.54 - 1.09]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1039	281	0.177936	0.0155126	0.223389	-0.422847	0.287528	-0.0907275	0.91 [0.77 - 1.08]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:71580	59	0.661017	0.000865828	0.0225785	1.51591	0.0268721	1.28951	3.63 [1.16 - 11.37]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211586_s_at	38	0.184211	0.127736	-	1.43893	0.441795	0.456693	1.58 [0.49 - 5.06]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	234741_at	38	0.5	0.0615001	-	-0.877898	0.597783	-0.13228	0.88 [0.54 - 1.43]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	234714_x_at	38	0.236842	0.0351846	0.393672	-1.09802	0.315963	-0.260898	0.77 [0.46 - 1.28]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204685_s_at	38	0.894737	0.000172129	0.00563907	2.08628	0.0119787	1.05455	2.87 [1.26 - 6.53]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216120_s_at	38	0.315789	0.00879213	0.146481	-1.21658	0.128168	-0.251778	0.78 [0.56 - 1.08]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211586_s_at	140	0.3	9.37821e-05	0.00330965	-1.08351	0.00984684	-2.26587	0.10 [0.02 - 0.58]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216120_s_at	140	0.157143	0.0226869	0.292701	-0.795977	0.219623	-1.87919	0.15 [0.01 - 3.07]
GENE	ATP2B2	ATPase, Ca++ transporting, plasma membrane 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204685_s_at	140	0.442857	0.0588302	-	-0.542255	0.344382	-0.663393	0.52 [0.13 - 2.04]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216312_at	30	0.4	0.0244009	0.307844	0.980673	0.469354	0.569763	1.77 [0.38 - 8.27]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215911_x_at	30	0.733333	0.120186	-	0.686173	0.444316	0.834732	2.30 [0.27 - 19.56]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207026_s_at	30	0.6	0.0376633	0.411466	0.853603	0.239025	0.883097	2.42 [0.56 - 10.52]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1693481	165	0.624242	0.015392	0.222127	-0.65504	0.612982	-0.753734	0.47 [0.03 - 8.73]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1693481	165	0.393939	0.216684	-	0.481692	0.114463	2.39624	10.98 [0.56 - 215.23]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207026_s_at	163	0.349693	0.168039	-	0.296153	0.916302	0.0805496	1.08 [0.24 - 4.87]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216312_at	163	0.441718	0.173567	-	0.272673	0.612107	0.339377	1.40 [0.38 - 5.21]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215911_x_at	163	0.233129	0.0485609	0.482918	-0.434089	0.436198	-0.457816	0.63 [0.20 - 2.00]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	242036_x_at	163	0.435583	0.062569	-	-0.36649	0.454612	-0.582548	0.56 [0.12 - 2.57]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	242036_x_at	79	0.544304	0.00485462	0.0924692	-0.848068	0.373283	-0.753878	0.47 [0.09 - 2.47]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216312_at	79	0.113924	0.163318	-	0.80854	0.763157	-0.309573	0.73 [0.10 - 5.50]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215911_x_at	79	0.632911	0.0203163	0.270929	-0.757805	0.0422403	-1.48376	0.23 [0.05 - 0.95]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207026_s_at	79	0.101266	0.0205136	0.27278	-1.00585	0.364331	-0.931496	0.39 [0.05 - 2.95]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215911_x_at	58	0.12069	0.182438	-	0.576971	0.512757	0.0970692	1.10 [0.82 - 1.47]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207026_s_at	58	0.137931	0.0159522	0.227955	1.01949	0.261787	0.158344	1.17 [0.89 - 1.54]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216312_at	58	0.310345	0.189453	-	0.395149	0.322395	0.12635	1.13 [0.88 - 1.46]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215911_x_at	34	0.117647	0.0601329	-	-1.0428	0.680941	-0.121975	0.89 [0.49 - 1.58]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207026_s_at	34	0.147059	0.0302533	0.356262	-1.06238	0.409233	-0.232973	0.79 [0.46 - 1.38]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216312_at	34	0.823529	0.00013404	0.0045308	1.9619	0.12187	0.391953	1.48 [0.90 - 2.43]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216312_at	158	0.765823	0.031278	0.364271	0.529484	0.312019	0.70332	2.02 [0.52 - 7.90]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215911_x_at	158	0.702532	0.0198141	0.266184	0.54413	0.719092	0.221574	1.25 [0.37 - 4.17]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207026_s_at	158	0.341772	0.0982547	-	-0.386099	0.527771	-0.557509	0.57 [0.10 - 3.23]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215911_x_at	53	0.792453	0.148744	-	0.557386	0.479887	0.141804	1.15 [0.78 - 1.71]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215911_x_at	53	0.792453	0.0504465	-	0.76741	0.204324	0.275238	1.32 [0.86 - 2.01]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207026_s_at	53	0.264151	0.0164079	0.232638	1.22066	0.276966	0.24179	1.27 [0.82 - 1.97]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207026_s_at	53	0.301887	0.0200898	0.268795	1.00939	0.397311	0.174305	1.19 [0.80 - 1.78]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216312_at	53	0.132075	0.0872261	-	-0.733029	0.526222	-0.124792	0.88 [0.60 - 1.30]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216312_at	53	0.132075	0.112477	-	-0.673278	0.604009	-0.0951214	0.91 [0.63 - 1.30]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215911_x_at	180	0.105556	0.113334	-	0.615929	0.344113	0.10545	1.11 [0.89 - 1.38]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207026_s_at	180	0.25	0.0811866	-	0.464798	0.566238	0.0697596	1.07 [0.84 - 1.36]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216312_at	180	0.644444	0.311278	-	0.21437	0.579873	0.0520259	1.05 [0.88 - 1.27]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	242036_x_at	180	0.177778	0.0134183	0.200945	-0.597321	0.624267	-0.040905	0.96 [0.81 - 1.13]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	242036_x_at	559	0.100179	0.0343745	0.387716	-0.624301	0.178521	-0.151829	0.86 [0.69 - 1.07]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216312_at	559	0.559928	0.150786	-	-0.298447	0.634476	-0.063466	0.94 [0.72 - 1.22]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215911_x_at	559	0.266547	0.124231	-	-0.32837	0.396651	-0.131849	0.88 [0.65 - 1.19]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207026_s_at	559	0.391771	0.131877	-	-0.301822	0.796402	-0.0372542	0.96 [0.73 - 1.28]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215911_x_at	77	0.311688	0.00158593	0.03742	-0.830256	0.024119	-0.3805	0.68 [0.49 - 0.95]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207026_s_at	77	0.87013	0.0227104	0.292912	-1.04319	0.0663496	-0.222562	0.80 [0.63 - 1.02]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216312_at	77	0.12987	0.0476733	0.477471	-0.710863	0.920306	-0.0177271	0.98 [0.69 - 1.39]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	242036_x_at	77	0.493506	0.00910369	0.150404	-0.667946	0.0272061	-0.251575	0.78 [0.62 - 0.97]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	242036_x_at	70	0.742857	0.0986828	-	-0.521596	0.670496	-0.0723788	0.93 [0.67 - 1.30]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216312_at	70	0.214286	0.046538	0.470414	0.668207	0.190849	1.41542	4.12 [0.49 - 34.34]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215911_x_at	70	0.342857	0.239534	-	0.328835	0.942071	-0.0903446	0.91 [0.08 - 10.45]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207026_s_at	70	0.114286	0.0492268	0.486966	-0.787719	0.434495	-0.518914	0.60 [0.16 - 2.19]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32456_s_at	50	0.16	0.000910227	0.0235491	-1.34612	0.529203	-0.319289	0.73 [0.27 - 1.96]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216312_at	74	0.202703	0.0453608	0.462987	0.764809	0.606021	0.0978824	1.10 [0.76 - 1.60]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215911_x_at	74	0.283784	0.122632	-	0.524958	0.314522	0.166928	1.18 [0.85 - 1.64]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207026_s_at	74	0.418919	0.104002	-	0.487232	0.495848	0.063333	1.07 [0.89 - 1.28]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	242036_x_at	74	0.554054	0.0446593	0.458507	0.574784	0.43937	0.0757673	1.08 [0.89 - 1.31]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216312_at	67	0.537313	0.111332	-	1.07984	0.433395	2.20449	9.07 [0.04 - 2252.89]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	242036_x_at	67	0.850746	0.117103	-	1.06168	0.346171	2.16696	8.73 [0.10 - 792.75]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215911_x_at	67	0.149254	0.135889	-	-1.0147	0.511833	-1.58225	0.21 [0.00 - 23.23]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207026_s_at	67	0.283582	0.058942	-	15.5653	0.0713399	1.82638	6.21 [0.85 - 45.22]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216312_at	115	0.869565	0.322925	-	0.635802	0.77283	-0.16557	0.85 [0.28 - 2.61]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215911_x_at	115	0.2	0.214369	-	1.2132	0.914488	0.0464057	1.05 [0.45 - 2.44]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	242036_x_at	115	0.878261	0.264181	-	0.708787	0.980774	0.00872997	1.01 [0.50 - 2.05]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207026_s_at	115	0.713043	0.0490892	0.486132	1.01125	0.36048	0.4682	1.60 [0.59 - 4.36]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32456_s_at	158	0.196203	0.0505475	-	-0.609042	0.361491	-0.204408	0.82 [0.53 - 1.26]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32456_s_at	76	0.828947	0.0985627	-	0.878521	0.810556	0.0967045	1.10 [0.50 - 2.43]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216312_at	204	0.495098	0.0209604	0.276944	0.331328	0.122971	0.126299	1.13 [0.97 - 1.33]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	242036_x_at	204	0.166667	0.00514186	0.0967477	-0.529287	0.0516998	-0.124309	0.88 [0.78 - 1.00]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215911_x_at	204	0.122549	0.0632055	-	-0.402254	0.574234	-0.040806	0.96 [0.83 - 1.11]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207026_s_at	204	0.22549	0.0793943	-	0.29335	0.331371	0.0740159	1.08 [0.93 - 1.25]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	242036_x_at	87	0.873563	0.00953529	0.155769	1.18739	0.294172	1.56081	4.76 [0.26 - 87.98]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	242036_x_at	87	0.873563	0.00953529	0.155769	1.18739	0.294172	1.56081	4.76 [0.26 - 87.98]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207026_s_at	87	0.896552	0.109535	-	-1.49013	0.46816	-0.623299	0.54 [0.10 - 2.89]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216312_at	87	0.206897	0.0113005	0.176949	2.14533	0.182698	1.38926	4.01 [0.52 - 30.96]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215911_x_at	87	0.172414	0.232438	-	-0.51704	0.598892	-0.527516	0.59 [0.08 - 4.21]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216312_at	87	0.206897	0.0113005	0.176949	2.14533	0.182698	1.38926	4.01 [0.52 - 30.96]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207026_s_at	87	0.896552	0.109535	-	-1.49013	0.46816	-0.623299	0.54 [0.10 - 2.89]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215911_x_at	87	0.172414	0.232438	-	-0.51704	0.598892	-0.527516	0.59 [0.08 - 4.21]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216312_at	77	0.896104	0.00100848	0.0256664	1.75395	0.397079	1.33039	3.78 [0.17 - 82.23]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	242036_x_at	77	0.233766	0.0516236	-	-1.16444	0.38725	-2.16247	0.12 [0.00 - 15.48]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207026_s_at	77	0.272727	0.00848912	0.142624	-1.54483	0.0352483	-2.88714	0.06 [0.00 - 0.82]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215911_x_at	77	0.285714	0.218498	-	0.915489	0.854325	-0.294446	0.74 [0.03 - 17.27]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207026_s_at	77	0.272727	0.0788497	-	-0.943564	0.242741	-1.32304	0.27 [0.03 - 2.45]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216312_at	77	0.103896	0.0139543	0.206802	-1.54489	0.719476	-0.620662	0.54 [0.02 - 15.90]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	242036_x_at	77	0.233766	0.211061	-	-0.699016	0.821019	0.43751	1.55 [0.03 - 68.57]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215911_x_at	77	0.337662	0.279713	-	0.831879	0.913329	-0.19835	0.82 [0.02 - 29.18]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207026_s_at	136	0.147059	0.0279117	0.337459	15.4009	0.867187	0.043096	1.04 [0.63 - 1.73]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216312_at	136	0.897059	0.0204658	0.272332	1.14563	0.169923	0.325093	1.38 [0.87 - 2.20]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215911_x_at	136	0.772059	0.164153	-	-0.997652	0.685582	-0.101538	0.90 [0.55 - 1.48]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216312_at	200	0.6	0.0536158	-	0.563047	0.626499	0.0916555	1.10 [0.76 - 1.59]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215911_x_at	200	0.195	0.04679	0.471989	-0.642434	0.648833	-0.0737984	0.93 [0.68 - 1.28]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207026_s_at	200	0.215	0.0873105	-	0.789806	0.344723	0.1871	1.21 [0.82 - 1.78]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12759	60	0.116667	0.146183	-	-0.784574	0.568012	-0.662852	0.52 [0.05 - 5.02]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12759	60	0.483333	0.000302737	0.00920816	-1.38964	0.00606814	-3.4486	0.03 [0.00 - 0.37]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	22605	155	0.380645	0.000195327	0.00629639	-1.01292	0.0027939	-0.177915	0.84 [0.74 - 0.94]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216312_at	286	0.426573	0.070197	-	0.362285	0.695501	0.0431005	1.04 [0.84 - 1.30]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215911_x_at	286	0.825175	0.0192872	0.261153	0.522889	0.577763	0.0741662	1.08 [0.83 - 1.40]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207026_s_at	286	0.881119	0.00214374	0.0479433	0.732411	0.0969746	0.214126	1.24 [0.96 - 1.60]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216312_at	159	0.899371	0.0912924	-	0.690207	0.83337	-0.0409055	0.96 [0.66 - 1.41]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215911_x_at	159	0.113208	0.271546	-	-0.482115	0.786172	-0.0560341	0.95 [0.63 - 1.42]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216312_at	159	0.899371	0.148286	-	0.696829	0.862261	0.0394379	1.04 [0.67 - 1.62]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207026_s_at	159	0.144654	0.0558402	-	1.29508	0.202594	0.343406	1.41 [0.83 - 2.39]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207026_s_at	159	0.119497	0.132535	-	1.04341	0.309016	0.271793	1.31 [0.78 - 2.22]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216312_at	159	0.767296	0.183553	-	-0.580757	0.756487	-0.0612103	0.94 [0.64 - 1.38]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215911_x_at	159	0.899371	0.0187781	0.25624	0.898946	0.158656	0.294367	1.34 [0.89 - 2.02]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215911_x_at	159	0.767296	0.197839	-	-0.680672	0.872895	0.0388014	1.04 [0.65 - 1.67]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207026_s_at	159	0.144654	0.174171	-	0.958852	0.821214	0.0731495	1.08 [0.57 - 2.03]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	242036_x_at	159	0.194969	0.208718	-	0.592825	0.859299	-0.0302058	0.97 [0.69 - 1.35]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	242036_x_at	159	0.886792	0.159778	-	-0.980327	0.952388	-0.0101395	0.99 [0.71 - 1.38]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	242036_x_at	159	0.36478	0.151415	-	0.61319	0.757915	0.0629276	1.06 [0.71 - 1.59]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216312_at	54	0.407407	0.0504585	-	-1.44844	0.470724	-1.52625	0.22 [0.00 - 13.75]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207026_s_at	54	0.518519	0.051589	-	-1.81142	0.335111	-0.854591	0.43 [0.07 - 2.42]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215911_x_at	54	0.407407	0.0277351	0.336011	-1.59566	0.0780615	-4.89672	0.01 [0.00 - 1.73]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207026_s_at	117	0.324786	0.132084	-	-0.478004	0.596853	-0.296229	0.74 [0.25 - 2.23]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216312_at	117	0.179487	0.106307	-	0.831841	0.982926	-0.0238381	0.98 [0.11 - 8.67]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207026_s_at	117	0.692308	0.0902681	-	-0.890278	0.889345	-0.0891541	0.91 [0.26 - 3.21]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215911_x_at	117	0.333333	0.10167	-	-0.612251	0.343547	-1.07904	0.34 [0.04 - 3.17]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215911_x_at	117	0.717949	0.047041	0.473553	-0.806414	0.146788	-1.44442	0.24 [0.03 - 1.66]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215911_x_at	117	0.717949	0.047041	0.473553	-0.806414	0.146788	-1.44442	0.24 [0.03 - 1.66]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216312_at	117	0.179487	0.0456757	0.464984	1.78891	0.751705	0.423585	1.53 [0.11 - 21.07]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215911_x_at	117	0.717949	0.207503	-	-0.611588	0.803502	-0.280816	0.76 [0.08 - 6.90]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207026_s_at	117	0.324786	0.132084	-	-0.478004	0.596853	-0.296229	0.74 [0.25 - 2.23]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207026_s_at	117	0.726496	0.0420958	0.441784	-1.17427	0.587881	-0.364034	0.69 [0.19 - 2.59]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216312_at	117	0.179487	0.106307	-	0.831841	0.982926	-0.0238381	0.98 [0.11 - 8.67]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216312_at	117	0.179487	0.0368882	0.40597	1.84993	0.806511	0.313996	1.37 [0.11 - 16.89]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207026_s_at	236	0.377119	0.183327	-	-0.358943	0.528705	-0.156906	0.85 [0.52 - 1.39]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216312_at	236	0.288136	0.0441974	0.455535	-0.547511	0.401319	-0.182502	0.83 [0.54 - 1.28]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215911_x_at	236	0.135593	0.0823668	-	0.875518	0.846776	0.0360436	1.04 [0.72 - 1.49]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	242036_x_at	236	0.182203	0.131287	-	0.64133	0.998134	0.000382783	1.00 [0.73 - 1.38]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207026_s_at	249	0.883534	0.180328	-	-0.521718	0.513253	-0.12332	0.88 [0.61 - 1.28]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216312_at	249	0.771084	0.10285	-	-0.45739	0.366437	-0.14782	0.86 [0.63 - 1.19]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215911_x_at	249	0.124498	0.227518	-	0.443045	0.726223	0.0516991	1.05 [0.79 - 1.41]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	242036_x_at	249	0.176707	0.200505	-	0.393939	0.615014	0.0649413	1.07 [0.83 - 1.37]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215911_x_at	62	0.758065	0.0804358	-	-1.23785	0.615743	-0.460143	0.63 [0.10 - 3.81]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207026_s_at	62	0.177419	0.181182	-	-0.743632	0.695323	-0.0845039	0.92 [0.60 - 1.40]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216312_at	125	0.64	0.242917	-	-0.359128	0.637987	-0.438906	0.64 [0.10 - 4.01]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207026_s_at	125	0.36	0.034474	0.388452	-0.781558	0.147134	-1.34859	0.26 [0.04 - 1.61]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215911_x_at	125	0.816	0.0129855	0.196155	0.775335	0.906624	0.0520166	1.05 [0.44 - 2.51]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207026_s_at	125	0.272	0.053759	-	-0.566496	0.146918	-0.995647	0.37 [0.10 - 1.42]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216312_at	62	0.887097	0.0769613	-	-15.2721	0.511571	-0.366323	0.69 [0.23 - 2.07]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207026_s_at	54	0.518519	0.419638	-	0.497423	0.759264	-0.0800539	0.92 [0.55 - 1.54]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216312_at	125	0.176	0.221639	-	0.871985	0.754426	0.37705	1.46 [0.14 - 15.48]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216312_at	54	0.87037	0.131423	-	-15.2907	0.62407	-0.329508	0.72 [0.19 - 2.69]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215911_x_at	125	0.824	0.00578569	0.106111	1.04243	0.30616	0.590464	1.80 [0.58 - 5.59]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215911_x_at	54	0.388889	0.0949144	-	1.58758	0.946872	-0.0757477	0.93 [0.10 - 8.60]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207026_s_at	198	0.121212	0.004084	0.0806438	2.33455	0.961651	0.00718415	1.01 [0.75 - 1.35]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216312_at	198	0.186869	0.00423032	0.0829307	1.54261	0.0731867	0.179636	1.20 [0.98 - 1.46]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216312_at	198	0.186869	0.00583403	0.106802	1.32785	0.0657934	0.17479	1.19 [0.99 - 1.43]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215911_x_at	198	0.747475	0.0746709	-	-0.589555	0.706415	-0.0365763	0.96 [0.80 - 1.17]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215911_x_at	198	0.747475	0.0237567	0.302208	-0.841273	0.695055	-0.0400698	0.96 [0.79 - 1.17]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207026_s_at	198	0.116162	0.0549971	-	0.740123	0.850488	-0.0220543	0.98 [0.78 - 1.23]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207026_s_at	198	0.121212	0.0150806	0.218854	1.34385	0.675775	0.0581708	1.06 [0.81 - 1.39]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216312_at	198	0.10101	0.0488599	0.48474	-0.583772	0.561294	-0.0484859	0.95 [0.81 - 1.12]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215911_x_at	198	0.752525	0.0191512	0.259846	-0.636647	0.402451	-0.0659302	0.94 [0.80 - 1.09]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207026_s_at	51	0.137255	0.350413	-	15.2591	0.983555	0.0381805	1.04 [0.03 - 39.21]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216312_at	51	0.823529	0.166244	-	1.19269	0.446951	1.88291	6.57 [0.05 - 841.84]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215911_x_at	62	0.193548	0.0747652	-	15.3805	0.154133	2.11788	8.31 [0.45 - 153.05]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207026_s_at	62	0.209677	0.28532	-	-0.643626	0.460474	-0.861524	0.42 [0.04 - 4.16]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215911_x_at	51	0.882353	0.0261842	0.323111	1.78663	0.5465	1.50571	4.51 [0.03 - 601.72]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216312_at	62	0.112903	0.17825	-	15.2264	0.770158	0.496054	1.64 [0.06 - 45.78]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216312_at	145	0.662069	0.0251864	0.314629	-0.912691	0.168189	-1.46293	0.23 [0.03 - 1.85]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207026_s_at	177	0.587571	0.04403	0.454454	-0.580286	0.437076	-0.510258	0.60 [0.17 - 2.17]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215911_x_at	177	0.881356	0.0508167	-	-0.966996	0.290481	-0.467437	0.63 [0.26 - 1.49]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207026_s_at	177	0.587571	0.0272757	0.332226	-0.549857	0.283298	-0.614307	0.54 [0.18 - 1.66]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215911_x_at	145	0.862069	0.300553	-	-0.615339	0.761625	-0.193669	0.82 [0.24 - 2.88]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207026_s_at	145	0.641379	0.136689	-	-0.565352	0.222985	-1.00056	0.37 [0.07 - 1.84]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216312_at	177	0.254237	0.000452786	0.0130177	-0.942569	0.00140466	-2.77411	0.06 [0.01 - 0.34]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	242036_x_at	177	0.711864	0.0264835	0.325627	0.540187	0.383874	1.14561	3.14 [0.24 - 41.44]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	242036_x_at	177	0.734463	0.00276769	0.059019	0.809878	0.215262	1.8433	6.32 [0.34 - 116.60]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216312_at	177	0.694915	0.000172208	0.00564134	-1.20657	0.00520822	-2.08352	0.12 [0.03 - 0.54]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215911_x_at	177	0.683616	0.0496822	0.489714	-0.63294	0.196999	-0.653619	0.52 [0.19 - 1.40]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	242036_x_at	145	0.717241	0.000402527	0.0117686	1.12705	0.0208525	4.18488	65.69 [1.89 - 2286.31]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215911_x_at	226	0.486726	0.345184	-	-0.269273	0.983819	-0.00277792	1.00 [0.76 - 1.30]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207026_s_at	226	0.185841	0.0414713	0.437623	-0.620552	0.310108	-0.161055	0.85 [0.62 - 1.16]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	242036_x_at	226	0.10177	0.00632549	0.113741	-0.94168	0.436997	-0.0923964	0.91 [0.72 - 1.15]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216312_at	226	0.199115	0.145577	-	0.624502	0.932507	0.0099815	1.01 [0.80 - 1.27]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	242036_x_at	49	0.102041	0.0479383	0.479103	-1.24418	0.552916	1.13441	3.11 [0.07 - 131.81]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207026_s_at	55	0.727273	0.154652	-	-0.864734	0.935244	-0.115015	0.89 [0.06 - 14.29]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215911_x_at	55	0.690909	0.0148406	0.216314	1.18422	0.546234	0.870709	2.39 [0.14 - 40.40]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215911_x_at	49	0.673469	0.00381345	0.0763594	1.58289	0.270769	1.68609	5.40 [0.27 - 108.51]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207026_s_at	55	0.163636	0.163419	-	1.29396	0.934814	0.129626	1.14 [0.05 - 25.43]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	242036_x_at	55	0.763636	0.321545	-	0.480066	0.77618	0.464943	1.59 [0.06 - 39.26]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207026_s_at	49	0.734694	0.159968	-	-1.36059	0.846988	-0.329854	0.72 [0.03 - 20.50]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216312_at	55	0.163636	0.00356387	0.0723392	-1.28934	0.0898772	-1.8414	0.16 [0.02 - 1.33]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216312_at	55	0.145455	0.00311128	0.0648666	-1.42178	0.0162322	-3.01125	0.05 [0.00 - 0.57]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215911_x_at	55	0.890909	0.0810449	-	-15.2299	0.888448	0.19705	1.22 [0.08 - 19.12]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	242036_x_at	55	0.763636	0.220001	-	0.599566	0.41109	1.23717	3.45 [0.18 - 65.84]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216312_at	49	0.510204	0.0284269	0.341658	-1.37422	0.328424	-1.26361	0.28 [0.02 - 3.56]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	51485	34	0.441176	0.136934	-	0.680453	0.4014	1.08941	2.97 [0.23 - 37.86]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	49466	34	0.852941	0.0071887	0.125567	1.32779	0.0574696	2.97784	19.65 [0.91 - 424.18]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207026_s_at	63	0.111111	0.000208166	0.0066552	-1.4849	0.00923909	-42.3685	0.00 [0.00 - 0.00]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	242036_x_at	63	0.412698	0.00275841	0.0588588	-0.994464	0.315599	-0.679454	0.51 [0.13 - 1.91]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216312_at	63	0.111111	9.46121e-06	0.000424927	-1.77603	0.0559318	-18.4281	0.00 [0.00 - 1.60]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215911_x_at	63	0.111111	0.0108285	0.1714	-1.10206	0.0975512	-4.00868	0.02 [0.00 - 2.08]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.103124.2.S1_3p_a_at	28	0.25	0.0395524	0.424614	-1.17533	0.953057	-0.0732159	0.93 [0.08 - 10.64]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11386154_3p_a_at	28	0.107143	0.0598975	-	-1.22538	0.480758	-1.57616	0.21 [0.00 - 16.53]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.103124.2.S1_3p_x_at	28	0.285714	0.0191692	0.260019	-1.31879	0.178371	-19.3382	0.00 [0.00 - 6807.80]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.103124.2.A1_3p_at	28	0.142857	0.0685508	-	-1.19105	0.258437	-2.83108	0.06 [0.00 - 8.00]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.25046.0.A1_3p_at	28	0.535714	0.261986	-	-0.63921	0.272508	-2.23466	0.11 [0.00 - 5.79]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207026_s_at	82	0.804878	0.0065387	0.116703	0.984045	0.229668	0.3854	1.47 [0.78 - 2.76]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216312_at	82	0.158537	0.142055	-	-0.57851	0.908793	-0.0301214	0.97 [0.58 - 1.62]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215911_x_at	82	0.268293	0.046229	0.468475	-0.685908	0.196883	-0.240558	0.79 [0.55 - 1.13]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215911_x_at	79	0.708861	0.0801731	-	-0.529828	0.700883	-0.0857948	0.92 [0.59 - 1.42]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207026_s_at	79	0.848101	0.0796255	-	0.605949	0.233181	0.683102	1.98 [0.64 - 6.09]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216312_at	79	0.860759	0.0376019	0.411033	-0.94003	0.140478	-0.443234	0.64 [0.36 - 1.16]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215911_x_at	104	0.826923	0.121098	-	0.575371	0.650529	0.0935567	1.10 [0.73 - 1.65]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207026_s_at	104	0.778846	0.000197887	0.00636821	-15.5252	0.009138	-1.85398	0.16 [0.04 - 0.63]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P22723	117	0.470085	0.00159856	0.0376662	-0.916773	0.123143	-0.455408	0.63 [0.36 - 1.13]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216312_at	204	0.495098	0.248155	-	0.427841	0.99457	0.00184373	1.00 [0.59 - 1.70]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	242036_x_at	204	0.27451	0.000327255	0.00984832	-1.23691	0.0245784	-0.399367	0.67 [0.47 - 0.95]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216312_at	204	0.495098	0.195697	-	0.354406	0.820995	-0.0446777	0.96 [0.65 - 1.41]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	242036_x_at	204	0.171569	0.00488215	0.0928822	-0.832413	0.0490455	-0.265335	0.77 [0.59 - 1.00]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215911_x_at	204	0.137255	0.00282908	0.0600758	-1.13168	0.153642	-0.276577	0.76 [0.52 - 1.11]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215911_x_at	204	0.171569	0.000673223	0.0182532	-0.980063	0.0571446	-0.27831	0.76 [0.57 - 1.01]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207026_s_at	204	0.602941	0.0169269	0.237914	0.863517	0.422379	0.184493	1.20 [0.77 - 1.89]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207026_s_at	204	0.122549	0.284894	-	-0.388175	0.853661	-0.0306133	0.97 [0.70 - 1.34]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207026_s_at	178	0.640449	0.114287	-	0.316145	0.601095	0.190013	1.21 [0.59 - 2.47]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216312_at	111	0.801802	0.0668328	-	-0.723717	0.751842	-0.0499132	0.95 [0.70 - 1.30]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215911_x_at	111	0.558559	0.00162632	0.0382059	0.818663	0.0900163	0.25527	1.29 [0.96 - 1.73]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	242036_x_at	111	0.135135	0.0646985	-	-0.612468	0.332967	-0.14794	0.86 [0.64 - 1.16]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207026_s_at	111	0.747748	0.174175	-	0.384338	0.362549	0.157154	1.17 [0.83 - 1.64]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207026_s_at	90	0.244444	0.0580342	-	0.823814	0.657014	0.235157	1.27 [0.45 - 3.57]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207026_s_at	90	0.177778	0.0503371	-	1.33524	0.48512	0.430248	1.54 [0.46 - 5.15]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216312_at	90	0.466667	0.0607229	-	0.623801	0.355108	0.756319	2.13 [0.43 - 10.58]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216312_at	90	0.511111	0.0078281	0.134061	1.02608	0.0705299	1.49613	4.46 [0.88 - 22.59]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215911_x_at	90	0.711111	0.276624	-	-0.429989	0.661057	0.386751	1.47 [0.26 - 8.29]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215911_x_at	90	0.488889	0.161843	-	0.530737	0.208157	1.09925	3.00 [0.54 - 16.63]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216312_at	138	0.311594	0.0425649	0.444887	-0.490433	0.128565	-6.63873	0.00 [0.00 - 6.84]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215911_x_at	138	0.818841	0.000488877	0.0139004	-1.62177	0.00210715	-4.99459	0.01 [0.00 - 0.16]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	242036_x_at	138	0.775362	0.0305698	0.358749	-0.725979	0.038022	-3.60882	0.03 [0.00 - 0.82]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207026_s_at	138	0.101449	0.000589657	0.0163097	-1.02428	0.0188958	-25.768	0.00 [0.00 - 0.01]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216312_at	129	0.875969	0.179138	-	0.444791	0.870313	0.0277973	1.03 [0.74 - 1.44]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215911_x_at	129	0.496124	0.0725339	-	-0.447378	0.162542	-0.223633	0.80 [0.58 - 1.09]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207026_s_at	129	0.899225	0.00982872	0.159373	0.831228	0.416376	0.150956	1.16 [0.81 - 1.67]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41315	56	0.232143	0.103135	-	-0.600747	0.181475	-0.84594	0.43 [0.12 - 1.48]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28252	56	0.107143	0.215052	-	-0.656947	0.350735	-0.749255	0.47 [0.10 - 2.28]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41315	56	0.232143	0.0311035	0.362916	-0.78863	0.0943401	-1.1172	0.33 [0.09 - 1.21]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28252	56	0.125	0.162272	-	-0.674747	0.311505	-0.778667	0.46 [0.10 - 2.07]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207026_s_at	278	0.899281	0.0995212	-	0.469338	0.493802	0.276531	1.32 [0.60 - 2.91]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216312_at	278	0.73741	0.0965367	-	-0.369384	0.809817	-0.123211	0.88 [0.32 - 2.41]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	242036_x_at	278	0.107914	0.0247	0.310439	-0.546272	0.526514	-0.359472	0.70 [0.23 - 2.12]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215911_x_at	278	0.863309	0.00325761	0.0673098	0.694747	0.692392	0.229807	1.26 [0.40 - 3.93]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207026_s_at	133	0.842105	0.00491995	0.0934481	0.839406	0.016539	7.61676	2031.97 [4.01 - 1030365.76]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216312_at	133	0.654135	0.00195562	0.0444688	0.731148	0.0153929	2.09209	8.10 [1.49 - 44.01]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215911_x_at	133	0.533835	0.00684744	0.120944	0.63394	0.0147555	0.86588	2.38 [1.19 - 4.77]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4869	81	0.802469	0.00135633	0.0328708	1.58849	0.0228284	1.4279	4.17 [1.22 - 14.26]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215911_x_at	185	0.389189	0.00393996	0.0783719	-0.511321	0.581891	-0.230692	0.79 [0.35 - 1.80]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207026_s_at	185	0.810811	0.0243519	0.307418	0.499641	0.596259	0.12334	1.13 [0.72 - 1.79]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216312_at	185	0.286486	0.0143241	0.210797	-0.434545	0.396762	-0.383433	0.68 [0.28 - 1.65]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215911_x_at	185	0.389189	0.00252009	0.0546999	-0.497404	0.298734	-0.409713	0.66 [0.31 - 1.44]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216312_at	185	0.286486	0.0939843	-	-0.327916	0.636633	-0.22602	0.80 [0.31 - 2.04]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207026_s_at	185	0.691892	0.00780287	0.13373	0.476998	0.139987	0.315538	1.37 [0.90 - 2.08]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P22723	110	0.827273	0.0145155	0.21285	-0.880397	0.237784	-0.191436	0.83 [0.60 - 1.13]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P337642	110	0.327273	0.0580126	-	-0.562562	0.137467	-0.421069	0.66 [0.38 - 1.14]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P22723	110	0.763636	0.0586464	-	-0.806432	0.310667	-0.209941	0.81 [0.54 - 1.22]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P337642	110	0.827273	0.00286176	0.0606362	-1.12189	0.0929774	-0.345973	0.71 [0.47 - 1.06]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216312_at	80	0.1125	0.0597937	-	-1.03477	0.706589	0.0714384	1.07 [0.74 - 1.56]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215911_x_at	80	0.425	0.0654714	-	0.855811	0.213535	0.229668	1.26 [0.88 - 1.81]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207026_s_at	80	0.325	0.162789	-	0.761055	0.490869	0.138664	1.15 [0.77 - 1.70]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5057	281	0.149466	0.0702487	-	-0.332223	0.0881372	-0.208377	0.81 [0.64 - 1.03]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215911_x_at	38	0.473684	0.00379894	0.0761276	-1.62101	0.303432	-0.388298	0.68 [0.32 - 1.42]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	242036_x_at	38	0.368421	0.00312745	0.0651381	-1.37916	0.0537456	-0.331999	0.72 [0.51 - 1.01]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207026_s_at	38	0.578947	0.00314853	0.0654911	1.52916	0.060838	0.909481	2.48 [0.96 - 6.43]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216312_at	38	0.210526	0.0137548	0.204631	15.4709	0.176239	0.800777	2.23 [0.70 - 7.11]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207026_s_at	140	0.107143	0.0181191	0.249801	-0.938712	0.142091	-0.837452	0.43 [0.14 - 1.32]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216312_at	140	0.421429	0.0978516	-	-0.47465	0.736548	-0.485461	0.62 [0.04 - 10.41]
GENE	ATP2B3	ATPase, Ca++ transporting, plasma membrane 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215911_x_at	140	0.45	0.161283	-	-0.402294	0.574978	-0.852562	0.43 [0.02 - 8.39]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205410_s_at	30	0.633333	0.334192	-	0.395092	0.848292	0.118062	1.13 [0.34 - 3.77]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212135_s_at	30	0.166667	0.255514	-	0.681731	0.702238	0.129502	1.14 [0.59 - 2.21]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212136_at	30	0.333333	0.169156	-	0.598935	0.887974	-0.0346066	0.97 [0.60 - 1.56]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1664772	165	0.884848	0.132634	-	-0.757326	0.92802	-0.0103843	0.99 [0.79 - 1.24]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1664772	165	0.70303	0.164841	-	0.495364	0.838587	-0.0350454	0.97 [0.69 - 1.35]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212135_s_at	163	0.785276	0.161692	-	-0.369123	0.897052	-0.0212586	0.98 [0.71 - 1.35]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212136_at	163	0.116564	0.157824	-	-0.390994	0.940262	-0.00942875	0.99 [0.77 - 1.27]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205410_s_at	163	0.895706	0.152188	-	-0.522294	0.720692	-0.215614	0.81 [0.25 - 2.63]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212135_s_at	79	0.683544	0.0185292	0.253819	0.69623	0.617489	0.123407	1.13 [0.70 - 1.84]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205410_s_at	79	0.189873	0.0908611	-	-0.577156	0.910041	-0.0667441	0.94 [0.29 - 2.98]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212136_at	79	0.468354	0.0271795	0.331429	0.661189	0.292736	0.231371	1.26 [0.82 - 1.94]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205410_s_at	58	0.672414	0.268599	-	-0.327676	0.886307	0.0240928	1.02 [0.74 - 1.43]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212135_s_at	58	0.862069	0.0196105	0.264246	0.909225	0.306743	0.317534	1.37 [0.75 - 2.53]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212136_at	58	0.827586	0.0120395	0.185485	0.88859	0.557864	0.241219	1.27 [0.57 - 2.85]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205410_s_at	34	0.441176	0.118969	-	-0.599509	0.698752	-0.164845	0.85 [0.37 - 1.95]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212135_s_at	34	0.117647	0.130222	-	-0.834112	0.726974	-0.0825143	0.92 [0.58 - 1.46]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212136_at	34	0.735294	0.00395454	0.078603	1.19492	0.470828	0.300563	1.35 [0.60 - 3.06]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205410_s_at	158	0.753165	0.0355416	0.396275	0.510673	0.397084	0.5821	1.79 [0.47 - 6.89]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212135_s_at	158	0.411392	0.0052144	0.0978181	0.6972	0.305443	0.35081	1.42 [0.73 - 2.78]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212136_at	158	0.436709	0.0696597	-	0.434002	0.22674	0.270058	1.31 [0.85 - 2.03]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212136_at	53	0.830189	0.0879746	-	0.725277	0.561998	0.230078	1.26 [0.58 - 2.74]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212135_s_at	53	0.245283	0.195269	-	0.577749	0.328895	0.313905	1.37 [0.73 - 2.57]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205410_s_at	53	0.811321	0.00641074	0.114928	1.05281	0.078759	0.904905	2.47 [0.90 - 6.78]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212136_at	53	0.849057	0.244911	-	0.519614	0.56794	0.208395	1.23 [0.60 - 2.52]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212135_s_at	53	0.735849	0.113278	-	0.606092	0.330544	0.345936	1.41 [0.70 - 2.84]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205410_s_at	53	0.867925	0.00501055	0.0947999	1.14458	0.110212	0.735229	2.09 [0.85 - 5.14]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205410_s_at	180	0.411111	0.0289114	0.345574	0.495893	0.203455	0.258129	1.29 [0.87 - 1.93]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212135_s_at	180	0.855556	0.0336569	0.38238	0.56586	0.524749	0.176039	1.19 [0.69 - 2.05]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212136_at	180	0.505556	0.112826	-	0.332869	0.653876	0.147545	1.16 [0.61 - 2.21]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212135_s_at	559	0.542039	0.000681367	0.0184402	0.687072	0.0114811	0.596023	1.81 [1.14 - 2.88]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205410_s_at	559	0.107335	0.0090955	0.150301	-0.668777	0.512781	-0.0674475	0.93 [0.76 - 1.14]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212136_at	559	0.470483	0.000572045	0.0158941	0.728993	0.0205244	0.386248	1.47 [1.06 - 2.04]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205410_s_at	77	0.766234	0.0049712	0.0942137	-0.926245	0.146548	-0.333283	0.72 [0.46 - 1.12]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212135_s_at	77	0.246753	0.175462	-	-0.400498	0.642244	-0.115609	0.89 [0.55 - 1.45]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212136_at	77	0.805195	0.0561792	-	0.564389	0.772678	0.0764675	1.08 [0.64 - 1.81]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205410_s_at	70	0.885714	0.0129431	0.195682	0.94488	0.867834	-0.119854	0.89 [0.22 - 3.64]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212136_at	70	0.857143	0.062389	-	0.650522	0.7073	0.0866441	1.09 [0.69 - 1.71]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212135_s_at	70	0.857143	0.0639943	-	0.646668	0.435448	0.160364	1.17 [0.78 - 1.76]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41089_at	50	0.84	0.177306	-	-0.615342	0.277493	-1.18153	0.31 [0.04 - 2.59]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40913_at	50	0.2	0.04545	0.463554	0.951861	0.178903	0.216724	1.24 [0.91 - 1.70]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40914_s_at	50	0.28	0.176156	-	-0.511087	0.964867	0.0251378	1.03 [0.34 - 3.14]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212135_s_at	74	0.310811	0.000113258	0.00390783	-1.16286	0.00664316	-1.15465	0.32 [0.14 - 0.73]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212136_at	74	0.297297	7.72041e-05	0.0027873	-1.15499	0.00746704	-1.48855	0.23 [0.08 - 0.67]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205410_s_at	74	0.662162	0.0147357	0.215199	-0.823535	0.0171922	-0.757113	0.47 [0.25 - 0.87]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212135_s_at	67	0.492537	0.179672	-	0.921206	0.367374	1.00888	2.74 [0.31 - 24.60]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205410_s_at	67	0.865672	0.000540038	0.0151331	2.23587	0.178503	1.18302	3.26 [0.58 - 18.29]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212136_at	67	0.358209	0.106484	-	1.5521	0.432014	0.915197	2.50 [0.25 - 24.49]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205410_s_at	115	0.895652	0.125235	-	0.957403	0.24453	0.982668	2.67 [0.51 - 13.98]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212136_at	115	0.591304	0.192952	-	0.687568	0.660001	0.327677	1.39 [0.32 - 5.98]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212135_s_at	115	0.130435	0.133281	-	15.2391	0.390535	0.607297	1.84 [0.46 - 7.34]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40913_at	158	0.43038	0.00202979	0.0458472	0.943568	0.481492	0.193436	1.21 [0.71 - 2.08]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40914_s_at	158	0.455696	0.163788	-	0.40872	0.670447	0.0914537	1.10 [0.72 - 1.67]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41089_at	158	0.158228	0.0958117	-	0.959076	0.479421	0.15867	1.17 [0.75 - 1.82]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40913_at	76	0.644737	0.0128616	0.194772	1.28265	0.0827295	1.09961	3.00 [0.87 - 10.40]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40914_s_at	76	0.105263	0.127441	-	-0.959901	0.523277	-0.280172	0.76 [0.32 - 1.79]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41089_at	76	0.894737	0.164246	-	0.871479	0.572387	0.318514	1.38 [0.46 - 4.16]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212136_at	204	0.666667	0.138618	-	-0.219233	0.971288	0.00512939	1.01 [0.76 - 1.33]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212135_s_at	204	0.102941	0.239427	-	-0.268463	0.736598	-0.0488858	0.95 [0.72 - 1.27]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205410_s_at	204	0.303922	0.102168	-	-0.245838	0.842656	-0.016341	0.98 [0.84 - 1.16]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205410_s_at	87	0.747126	0.0301693	0.355599	0.818453	0.0505574	1.99858	7.38 [1.00 - 54.71]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212135_s_at	87	0.264368	0.0158611	0.227012	-0.892706	0.873571	-0.054193	0.95 [0.49 - 1.85]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205410_s_at	87	0.747126	0.0301693	0.355599	0.818453	0.0505574	1.99858	7.38 [1.00 - 54.71]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212136_at	87	0.83908	0.0315654	0.366494	0.911702	0.607019	0.180713	1.20 [0.60 - 2.39]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212135_s_at	87	0.264368	0.0158611	0.227012	-0.892706	0.873571	-0.054193	0.95 [0.49 - 1.85]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212136_at	87	0.83908	0.0315654	0.366494	0.911702	0.607019	0.180713	1.20 [0.60 - 2.39]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212136_at	77	0.519481	0.00503656	0.0951869	2.36608	0.102042	0.710671	2.04 [0.87 - 4.77]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212135_s_at	77	0.545455	0.00270352	0.0579085	2.47857	0.220747	0.555982	1.74 [0.72 - 4.25]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212136_at	77	0.766234	0.0197121	0.265215	1.22209	0.173357	0.519601	1.68 [0.80 - 3.55]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205410_s_at	77	0.87013	0.00397249	0.0788869	1.66946	0.0259865	1.83276	6.25 [1.25 - 31.38]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212135_s_at	77	0.545455	0.0124888	0.190587	1.50044	0.286343	0.42724	1.53 [0.70 - 3.36]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205410_s_at	77	0.480519	0.00869556	0.145257	1.77769	0.0633679	1.37448	3.95 [0.93 - 16.87]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212135_s_at	136	0.205882	0.0457522	0.465469	-0.911861	0.0872841	-0.877438	0.42 [0.15 - 1.14]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212136_at	136	0.463235	0.100785	-	-0.752055	0.251204	-0.592044	0.55 [0.20 - 1.52]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205410_s_at	136	0.544118	0.13386	-	0.687018	0.951155	-0.0163267	0.98 [0.58 - 1.66]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212135_s_at	200	0.23	0.00124723	0.0306552	-0.954522	0.00765868	-1.09126	0.34 [0.15 - 0.75]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212136_at	200	0.52	0.00263148	0.0566546	-0.924739	0.012806	-0.881847	0.41 [0.21 - 0.83]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205410_s_at	200	0.115	0.00725649	0.126478	-0.98094	0.0950785	-0.501831	0.61 [0.34 - 1.09]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	716	60	0.65	0.0781557	-	0.660293	0.998775	-0.000263581	1.00 [0.71 - 1.40]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	716	60	0.45	0.154661	-	0.559716	0.726601	-0.0649287	0.94 [0.65 - 1.35]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12376	155	0.16129	0.00235327	0.0517352	-0.904436	0.219155	-0.393257	0.67 [0.36 - 1.26]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212135_s_at	286	0.101399	0.00222981	0.0495106	-0.772765	0.0734673	-0.445024	0.64 [0.39 - 1.04]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212136_at	286	0.874126	0.18852	-	0.354822	0.988843	-0.00444846	1.00 [0.53 - 1.86]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205410_s_at	286	0.811189	0.0248195	0.311471	-0.651874	0.0997392	-0.359763	0.70 [0.45 - 1.07]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205410_s_at	159	0.100629	0.0761478	-	-0.84679	0.168424	-0.586591	0.56 [0.24 - 1.28]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212136_at	159	0.522013	0.124622	-	-0.496718	0.307611	-0.458468	0.63 [0.26 - 1.53]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212135_s_at	159	0.207547	0.0216881	0.283649	-0.756823	0.239427	-0.537635	0.58 [0.24 - 1.43]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205410_s_at	159	0.100629	0.00733556	0.127537	-1.01639	0.283382	-0.401455	0.67 [0.32 - 1.39]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212135_s_at	159	0.113208	0.0272415	0.331942	-0.925262	0.38008	-0.44997	0.64 [0.23 - 1.74]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212136_at	159	0.396226	0.00225223	0.0499165	-0.950266	0.0390535	-0.95749	0.38 [0.15 - 0.95]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212136_at	159	0.522013	0.018027	0.248893	-0.94735	0.113203	-0.838357	0.43 [0.15 - 1.22]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205410_s_at	159	0.471698	0.0329097	0.376763	-0.675624	0.0795367	-0.671613	0.51 [0.24 - 1.08]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212135_s_at	159	0.113208	0.0774888	-	-0.684679	0.581536	-0.236235	0.79 [0.34 - 1.83]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212135_s_at	54	0.888889	0.00106399	0.026845	2.06625	0.0473391	0.914527	2.50 [1.01 - 6.16]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212136_at	54	0.888889	0.00329546	0.0679375	1.87979	0.127322	0.722897	2.06 [0.81 - 5.22]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205410_s_at	54	0.333333	0.209811	-	-0.86052	0.544441	-0.500932	0.61 [0.12 - 3.06]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205410_s_at	117	0.837607	0.206631	-	0.476832	0.817294	-0.0872331	0.92 [0.44 - 1.92]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212136_at	117	0.726496	0.140914	-	-0.782895	0.72664	-0.123606	0.88 [0.44 - 1.77]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205410_s_at	117	0.34188	0.224902	-	0.523536	0.606609	-0.249928	0.78 [0.30 - 2.02]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205410_s_at	117	0.358974	0.204136	-	0.55575	0.758282	-0.148262	0.86 [0.34 - 2.22]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205410_s_at	117	0.837607	0.206631	-	0.476832	0.817294	-0.0872331	0.92 [0.44 - 1.92]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212135_s_at	117	0.564103	0.0716797	-	0.56723	0.610319	0.159343	1.17 [0.64 - 2.16]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212135_s_at	117	0.564103	0.0715508	-	0.677281	0.527467	0.236013	1.27 [0.61 - 2.63]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212136_at	117	0.547009	0.0874865	-	0.643017	0.847357	0.0666961	1.07 [0.54 - 2.11]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212135_s_at	117	0.564103	0.0716797	-	0.56723	0.610319	0.159343	1.17 [0.64 - 2.16]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212135_s_at	117	0.74359	0.111477	-	-0.940469	0.972371	0.0130279	1.01 [0.48 - 2.12]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212136_at	117	0.547009	0.0874153	-	0.538585	0.851322	0.0550041	1.06 [0.59 - 1.88]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212136_at	117	0.547009	0.0874153	-	0.538585	0.851322	0.0550041	1.06 [0.59 - 1.88]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212136_at	236	0.122881	0.0813427	-	0.993795	0.748064	0.171019	1.19 [0.42 - 3.37]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205410_s_at	236	0.775424	0.0468874	0.472596	-0.784678	0.615595	-0.263119	0.77 [0.28 - 2.15]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212135_s_at	236	0.605932	0.183535	-	-0.380217	0.836524	-0.0899398	0.91 [0.39 - 2.15]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212136_at	249	0.86747	0.109097	-	0.45045	0.844121	0.0851458	1.09 [0.47 - 2.54]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205410_s_at	249	0.759036	0.00435152	0.0848096	-0.858906	0.256333	-0.451652	0.64 [0.29 - 1.39]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212135_s_at	249	0.859438	0.0988455	-	-0.602693	0.8984	-0.0436188	0.96 [0.49 - 1.87]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212135_s_at	125	0.264	0.160347	-	0.512586	0.744159	0.112566	1.12 [0.57 - 2.20]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212135_s_at	54	0.111111	0.296415	-	-0.800809	0.459381	-0.211064	0.81 [0.46 - 1.42]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212136_at	125	0.896	0.0239657	0.304044	1.00401	0.0635967	0.775861	2.17 [0.96 - 4.93]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212136_at	125	0.336	0.117039	-	0.504123	0.37308	0.264551	1.30 [0.73 - 2.33]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212136_at	54	0.203704	0.0774944	-	-1.08225	0.340829	-0.214258	0.81 [0.52 - 1.25]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205410_s_at	62	0.112903	0.238742	-	-0.731605	0.588884	-0.102568	0.90 [0.62 - 1.31]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205410_s_at	125	0.12	0.00531731	0.0993294	-1.15972	0.516172	-0.562407	0.57 [0.10 - 3.11]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212135_s_at	62	0.112903	0.0404049	0.430435	-1.11771	0.32291	-0.222786	0.80 [0.51 - 1.24]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205410_s_at	125	0.12	0.0165929	0.234526	-0.867391	0.534122	-0.416458	0.66 [0.18 - 2.45]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205410_s_at	54	0.796296	0.12634	-	-1.48689	0.589961	-0.124617	0.88 [0.56 - 1.39]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212136_at	62	0.209677	0.0700072	-	-0.909721	0.35692	-0.16726	0.85 [0.59 - 1.21]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212135_s_at	125	0.344	0.052908	-	0.922971	0.229655	0.561032	1.75 [0.70 - 4.38]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212136_at	198	0.89899	0.090381	-	-0.971644	0.580834	-0.116619	0.89 [0.59 - 1.35]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205410_s_at	198	0.267677	0.00438028	0.0852534	1.03368	0.0611377	0.273536	1.31 [0.99 - 1.75]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212135_s_at	198	0.853535	0.00449094	0.0869543	-1.09019	0.678514	-0.0577521	0.94 [0.72 - 1.24]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205410_s_at	198	0.207071	0.0066567	0.11833	1.31217	0.116462	0.237048	1.27 [0.94 - 1.70]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212136_at	198	0.818182	0.0587668	-	-0.569756	0.633585	-0.0796235	0.92 [0.67 - 1.28]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212135_s_at	198	0.853535	0.0840712	-	-0.740545	0.93363	-0.0144335	0.99 [0.70 - 1.38]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212135_s_at	198	0.853535	0.105681	-	-0.742635	0.733107	-0.0611893	0.94 [0.66 - 1.34]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205410_s_at	198	0.207071	0.00720579	0.125797	0.841416	0.104038	0.183793	1.20 [0.96 - 1.50]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212136_at	198	0.89899	0.0910338	-	-0.875367	0.769046	-0.0602402	0.94 [0.63 - 1.41]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212135_s_at	62	0.790323	0.0656676	-	-15.4053	0.421937	-0.632891	0.53 [0.11 - 2.49]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212136_at	51	0.72549	0.145908	-	-15.5809	0.983988	-0.0105331	0.99 [0.35 - 2.77]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212136_at	62	0.129032	0.140493	-	15.269	0.898637	0.0436879	1.04 [0.53 - 2.05]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205410_s_at	51	0.803922	0.214907	-	1.08004	0.653689	0.928221	2.53 [0.04 - 145.96]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205410_s_at	62	0.596774	0.0678527	-	-1.31778	0.445033	-0.994029	0.37 [0.03 - 4.74]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212135_s_at	51	0.686275	0.112761	-	-15.6741	0.789708	-0.273747	0.76 [0.10 - 5.69]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212136_at	177	0.689266	0.00101476	0.0258002	0.757591	0.00349817	0.47088	1.60 [1.17 - 2.20]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212135_s_at	177	0.621469	0.000161372	0.00533001	0.998537	0.00216269	0.590552	1.80 [1.24 - 2.63]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212136_at	145	0.682759	2.02191e-06	0.000103988	1.50876	0.000883096	0.997044	2.71 [1.51 - 4.88]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205410_s_at	177	0.581921	0.069438	-	0.486796	0.147081	0.411008	1.51 [0.87 - 2.63]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212135_s_at	177	0.446328	0.00882007	0.146835	0.642803	0.0267321	0.433871	1.54 [1.05 - 2.27]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205410_s_at	177	0.20904	0.0469094	0.472733	-0.510171	0.650703	0.127903	1.14 [0.65 - 1.98]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212135_s_at	145	0.641379	1.26658e-05	0.000553294	1.42808	0.00131052	1.22634	3.41 [1.61 - 7.20]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205410_s_at	145	0.551724	0.0531386	-	0.644057	0.338676	0.402577	1.50 [0.66 - 3.41]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212136_at	177	0.677966	5.42933e-05	0.00204007	1.04807	0.00018349	0.619742	1.86 [1.34 - 2.57]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212136_at	226	0.756637	0.000577122	0.0160141	0.946148	0.00503045	0.561335	1.75 [1.18 - 2.59]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212135_s_at	226	0.327434	0.0159156	0.227576	0.862477	0.13231	0.319074	1.38 [0.91 - 2.08]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205410_s_at	226	0.690265	0.10238	-	0.467765	0.352795	0.126901	1.14 [0.87 - 1.48]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212136_at	55	0.654545	0.0361213	0.400472	1.00227	0.135838	0.517391	1.68 [0.85 - 3.31]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212135_s_at	55	0.545455	0.0218333	0.284976	1.03158	0.238924	0.529409	1.70 [0.70 - 4.10]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212136_at	49	0.632653	0.0245479	0.309121	1.28782	0.180922	0.571872	1.77 [0.77 - 4.09]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205410_s_at	55	0.2	0.39686	-	-0.43458	0.675021	-0.245591	0.78 [0.25 - 2.47]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212135_s_at	55	0.272727	0.0841987	-	1.25537	0.712633	0.18557	1.20 [0.45 - 3.23]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212135_s_at	49	0.571429	0.134221	-	0.854373	0.869941	0.103502	1.11 [0.32 - 3.83]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205410_s_at	55	0.8	0.00899775	0.149075	-15.5402	0.1095	-1.21925	0.30 [0.07 - 1.32]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205410_s_at	49	0.77551	0.132685	-	-1.44483	0.189955	-1.2671	0.28 [0.04 - 1.87]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212136_at	55	0.436364	0.00770031	0.13238	1.38035	0.0229351	0.737787	2.09 [1.11 - 3.95]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	307873	34	0.352941	0.102997	-	0.816245	0.715756	0.361889	1.44 [0.20 - 10.07]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212136_at	63	0.666667	0.0936167	-	-0.641022	0.440857	-0.190649	0.83 [0.51 - 1.34]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212135_s_at	63	0.31746	0.170604	-	0.52577	0.513871	0.140014	1.15 [0.76 - 1.75]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205410_s_at	63	0.15873	0.00267113	0.0573457	-1.12005	0.220596	-14.5577	0.00 [0.00 - 6221.24]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.305923.2.A1_3p_s_at	28	0.714286	0.0744112	-	0.922207	0.279661	0.446989	1.56 [0.70 - 3.52]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502288_3p_a_at	28	0.178571	0.0289048	0.345522	-1.32686	0.226431	-2.38036	0.09 [0.00 - 4.38]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.305923.2.A1_3p_at	28	0.678571	0.157541	-	-0.918754	0.443208	-0.963253	0.38 [0.03 - 4.48]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212135_s_at	82	0.158537	0.0437539	0.452665	-0.794117	0.254136	-0.440975	0.64 [0.30 - 1.37]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212136_at	82	0.109756	0.000695418	0.018762	-1.38853	0.0454328	-0.739034	0.48 [0.23 - 0.99]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205410_s_at	82	0.52439	0.137068	-	-0.508295	0.8816	-0.0876615	0.92 [0.29 - 2.90]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212135_s_at	79	0.721519	0.0590738	-	0.521543	0.367426	0.326252	1.39 [0.68 - 2.82]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212136_at	79	0.721519	0.184935	-	0.368613	0.587405	0.167436	1.18 [0.65 - 2.16]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205410_s_at	79	0.898734	0.00867646	0.145014	0.982274	0.23487	0.480431	1.62 [0.73 - 3.57]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205410_s_at	104	0.673077	0.0292605	0.348377	-0.845748	0.232797	-0.845763	0.43 [0.11 - 1.72]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212135_s_at	104	0.105769	0.0215887	0.28274	-1.00318	0.101235	-0.827383	0.44 [0.16 - 1.18]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212136_at	104	0.894231	0.0113004	0.176948	-15.2776	0.259312	-0.384318	0.68 [0.35 - 1.33]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P405205	117	0.538462	0.0652533	-	0.52646	0.405914	0.153063	1.17 [0.81 - 1.67]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P11841	117	0.82906	0.00237159	0.0520629	0.912256	0.032435	0.306827	1.36 [1.03 - 1.80]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205410_s_at	204	0.892157	0.00300091	0.0630057	1.21155	0.00587403	1.45978	4.31 [1.52 - 12.16]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205410_s_at	204	0.877451	0.000817865	0.0215195	1.02184	0.148702	0.437884	1.55 [0.86 - 2.81]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212136_at	204	0.313726	0.0258571	0.320347	-0.794599	0.143316	-0.815169	0.44 [0.15 - 1.32]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212136_at	204	0.588235	0.00040062	0.0117207	-1.1354	0.044745	-0.827109	0.44 [0.19 - 0.98]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212135_s_at	204	0.857843	0.0899398	-	0.717054	0.586298	0.31783	1.37 [0.44 - 4.32]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212135_s_at	204	0.102941	0.190412	-	0.759535	0.379308	0.395287	1.48 [0.62 - 3.58]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212136_at	178	0.191011	0.019564	0.263804	-0.538872	0.219736	-0.250233	0.78 [0.52 - 1.16]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205410_s_at	178	0.353933	0.059624	-	-0.380374	0.187156	-0.612012	0.54 [0.22 - 1.35]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212135_s_at	178	0.640449	0.0187879	0.256335	-0.50182	0.182625	-0.317984	0.73 [0.46 - 1.16]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212136_at	111	0.540541	0.0357376	0.397698	-0.56075	0.246154	-0.41788	0.66 [0.32 - 1.33]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212135_s_at	111	0.279279	0.079438	-	-0.485726	0.289784	-0.315222	0.73 [0.41 - 1.31]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205410_s_at	111	0.738739	0.0251736	0.314519	-0.762726	0.648572	0.0747781	1.08 [0.78 - 1.49]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212135_s_at	90	0.155556	0.000824236	0.0216608	-1.1418	0.166069	-0.68454	0.50 [0.19 - 1.33]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212135_s_at	90	0.155556	0.000168433	0.00553321	-1.36947	0.126732	-0.859076	0.42 [0.14 - 1.28]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212136_at	90	0.288889	0.0331794	0.378798	-0.69866	0.153754	-0.464489	0.63 [0.33 - 1.19]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212136_at	90	0.244444	0.0231867	0.297166	-0.84641	0.158283	-0.521691	0.59 [0.29 - 1.23]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205410_s_at	90	0.733333	0.0852371	-	-0.74871	0.620021	-0.317144	0.73 [0.21 - 2.55]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205410_s_at	90	0.4	0.320348	-	-0.369267	0.913119	-0.081145	0.92 [0.21 - 3.96]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	2032	50	0.6	0.17811	-	0.645442	0.809506	-0.121477	0.89 [0.33 - 2.38]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205410_s_at	138	0.898551	0.0418182	0.439938	0.685754	0.00244049	1.03112	2.80 [1.44 - 5.46]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212136_at	138	0.115942	0.0264938	0.325714	1.23265	0.0391847	0.322789	1.38 [1.02 - 1.88]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212135_s_at	138	0.130435	0.00304566	0.0637621	1.85242	0.0133039	0.378212	1.46 [1.08 - 1.97]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205410_s_at	129	0.217054	0.0531147	-	-0.521037	0.718843	0.167415	1.18 [0.48 - 2.94]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212135_s_at	129	0.317829	0.0532657	-	-0.486542	0.394145	-0.367115	0.69 [0.30 - 1.61]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212136_at	129	0.108527	0.0288942	0.345436	-0.740251	0.36192	-0.343168	0.71 [0.34 - 1.48]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35202	56	0.446429	0.00797274	0.135953	0.961723	0.236805	0.553381	1.74 [0.70 - 4.35]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1483	56	0.178571	0.167729	-	-0.617877	0.601851	-0.20082	0.82 [0.38 - 1.74]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35202	56	0.446429	0.00959488	0.156504	1.01939	0.0975914	0.815473	2.26 [0.86 - 5.93]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1483	56	0.178571	0.209747	-	-0.614394	0.795018	-0.100795	0.90 [0.42 - 1.93]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212136_at	278	0.305755	0.0239663	0.30405	0.491536	0.124113	0.2421	1.27 [0.94 - 1.73]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212135_s_at	278	0.169065	0.0381331	0.414768	0.586551	0.0876997	0.267655	1.31 [0.96 - 1.78]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205410_s_at	278	0.28777	0.0383079	0.415992	-0.416128	0.70641	-0.0437624	0.96 [0.76 - 1.20]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212136_at	133	0.112782	0.0377983	0.412418	1.02574	0.284276	0.139312	1.15 [0.89 - 1.48]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205410_s_at	133	0.195489	0.0132387	0.198964	0.87327	0.0803083	0.221713	1.25 [0.97 - 1.60]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212135_s_at	133	0.165414	0.0224098	0.290206	0.940006	0.143104	0.183877	1.20 [0.94 - 1.54]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15198	81	0.876543	0.0250253	0.313244	1.25248	0.161425	0.623889	1.87 [0.78 - 4.47]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6727	81	0.703704	0.0778828	-	-1.63874	0.272294	-0.756761	0.47 [0.12 - 1.81]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14752	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212135_s_at	185	0.52973	0.310141	-	0.165509	0.891214	-0.0183861	0.98 [0.75 - 1.28]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212136_at	185	0.745946	0.193581	-	0.256942	0.678625	0.0460559	1.05 [0.84 - 1.30]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205410_s_at	185	0.87027	0.208215	-	0.311264	0.499024	0.140803	1.15 [0.77 - 1.73]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212135_s_at	185	0.52973	0.183029	-	0.234986	0.979527	0.00374744	1.00 [0.75 - 1.34]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205410_s_at	185	0.864865	0.231498	-	0.313262	0.596963	0.120092	1.13 [0.72 - 1.76]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212136_at	185	0.8	0.194016	-	0.255125	0.783788	0.0277604	1.03 [0.84 - 1.25]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P11841	110	0.109091	0.0979292	-	0.751165	0.512096	0.130626	1.14 [0.77 - 1.68]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P405205	110	0.754545	0.167431	-	0.349602	0.30291	0.182639	1.20 [0.85 - 1.70]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P11841	110	0.381818	0.276568	-	-0.327422	0.83927	-0.0586447	0.94 [0.54 - 1.66]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P405205	110	0.872727	0.165718	-	0.574855	0.82359	0.0544715	1.06 [0.65 - 1.70]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205410_s_at	80	0.2	0.222639	-	-0.586213	0.510038	-0.261191	0.77 [0.35 - 1.68]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212135_s_at	80	0.4375	0.022312	0.289324	-1.0202	0.231977	-0.360568	0.70 [0.39 - 1.26]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212136_at	80	0.1375	0.0141199	0.208596	-1.12989	0.343054	-0.399399	0.67 [0.29 - 1.53]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_4201	281	0.103203	0.0210135	0.277437	-0.513285	0.292696	-0.126373	0.88 [0.70 - 1.12]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212136_at	38	0.263158	0.0247689	0.311034	-1.00821	0.955676	0.0304891	1.03 [0.35 - 3.02]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212135_s_at	38	0.868421	0.00608427	0.110355	1.52965	0.330916	0.559852	1.75 [0.57 - 5.41]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205410_s_at	38	0.894737	0.00702433	0.123349	1.68194	0.0151048	1.14004	3.13 [1.25 - 7.84]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212136_at	140	0.492857	0.000201074	0.00645742	-1.14716	0.00407583	-0.642804	0.53 [0.34 - 0.82]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205410_s_at	140	0.121429	0.00586786	0.107285	-0.991119	0.110635	-0.697292	0.50 [0.21 - 1.17]
GENE	ATP2B4	ATPase, Ca++ transporting, plasma membrane 4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212135_s_at	140	0.514286	0.000208802	0.00667287	-1.17198	0.00139107	-0.881805	0.41 [0.24 - 0.71]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207139_at	30	0.166667	0.179694	-	0.813798	0.744878	0.286521	1.33 [0.24 - 7.48]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1754035	165	0.448485	0.00935268	0.153509	0.650164	0.501454	0.556865	1.75 [0.34 - 8.85]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1754035	165	0.454545	0.0062178	0.112234	1.06751	0.156195	1.45263	4.27 [0.57 - 31.83]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207139_at	163	0.760736	0.048802	0.484388	-0.480062	0.193629	-0.849961	0.43 [0.12 - 1.54]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207139_at	79	0.113924	0.0583512	-	-0.759472	0.470563	-0.60733	0.54 [0.10 - 2.84]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207139_at	58	0.534483	0.025532	0.317583	0.612582	0.316419	0.175886	1.19 [0.85 - 1.68]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207139_at	34	0.735294	0.00956671	0.156157	-1.23127	0.0277611	-0.531502	0.59 [0.37 - 0.94]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207139_at	158	0.101266	0.0303851	0.3573	1.20247	0.0801031	1.34879	3.85 [0.85 - 17.45]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207139_at	53	0.811321	0.00953526	0.155769	0.987073	0.296327	0.2709	1.31 [0.79 - 2.18]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207139_at	53	0.811321	0.00481633	0.0918938	1.08254	0.120034	0.468991	1.60 [0.88 - 2.89]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207139_at	180	0.116667	0.175635	-	-0.371511	0.929701	-0.00997573	0.99 [0.79 - 1.24]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207139_at	559	0.579606	0.194593	-	0.25893	0.868786	0.0222695	1.02 [0.79 - 1.33]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207139_at	77	0.571429	0.0115168	0.179467	-0.666261	0.195127	-0.211117	0.81 [0.59 - 1.11]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207139_at	70	0.171429	0.0588549	-	-0.611351	0.501969	-0.443612	0.64 [0.18 - 2.34]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33521_at	50	0.34	0.110159	-	0.617114	0.276314	-1.91747	0.15 [0.00 - 4.64]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207139_at	74	0.648649	0.0142974	0.21051	0.703462	0.551917	0.138305	1.15 [0.73 - 1.81]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207139_at	67	0.850746	0.102727	-	1.14848	0.520179	-1.42004	0.24 [0.00 - 18.32]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207139_at	115	0.8	0.126632	-	0.828564	0.668823	0.31405	1.37 [0.32 - 5.77]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33521_at	158	0.797468	0.00420327	0.0825094	0.83435	0.585246	0.214066	1.24 [0.57 - 2.67]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33521_at	76	0.105263	0.163877	-	15.2013	0.810822	-0.264207	0.77 [0.09 - 6.68]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207139_at	204	0.348039	0.00235762	0.051813	-0.449231	0.0133364	-0.191136	0.83 [0.71 - 0.96]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207139_at	87	0.321839	0.037286	0.408798	1.07336	0.196277	1.22738	3.41 [0.53 - 21.96]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207139_at	87	0.321839	0.037286	0.408798	1.07336	0.196277	1.22738	3.41 [0.53 - 21.96]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207139_at	77	0.714286	0.0337431	0.383024	-15.6132	0.139883	-2.31685	0.10 [0.00 - 2.14]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207139_at	77	0.454545	0.074374	-	-1.0276	0.310085	-1.38952	0.25 [0.02 - 3.65]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207139_at	136	0.801471	0.106024	-	0.778452	0.345156	0.241439	1.27 [0.77 - 2.10]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207139_at	200	0.83	0.0196442	0.264568	0.775626	0.0372947	0.62039	1.86 [1.04 - 3.33]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14890	60	0.116667	0.00487272	0.0927407	-1.37074	0.140002	1.35953	3.89 [0.64 - 23.69]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14890	60	0.466667	0.0254414	0.31681	-0.846365	0.0597029	-2.32851	0.10 [0.01 - 1.10]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14648	155	0.103226	0.000144877	0.00485019	-1.15602	0.0107838	-0.245065	0.78 [0.65 - 0.94]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207139_at	286	0.108392	0.31292	-	-0.288454	0.725413	-0.0480561	0.95 [0.73 - 1.25]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207139_at	159	0.345912	0.0035778	0.0725654	1.21456	0.0485772	0.438467	1.55 [1.00 - 2.40]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207139_at	159	0.471698	0.0669341	-	0.719816	0.315033	0.254273	1.29 [0.79 - 2.12]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207139_at	159	0.333333	0.0923943	-	0.626969	0.415466	0.172077	1.19 [0.78 - 1.80]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207139_at	54	0.87037	0.156314	-	-15.3628	0.606476	-0.666241	0.51 [0.04 - 6.48]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207139_at	117	0.136752	0.0600914	-	-0.682027	0.4373	-0.546894	0.58 [0.15 - 2.30]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207139_at	117	0.111111	0.0359438	0.39919	-0.886907	0.679302	-0.333638	0.72 [0.15 - 3.48]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207139_at	117	0.136752	0.0600914	-	-0.682027	0.4373	-0.546894	0.58 [0.15 - 2.30]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207139_at	117	0.358974	0.220876	-	-0.478535	0.862767	-0.140996	0.87 [0.18 - 4.30]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207139_at	236	0.224576	0.227201	-	0.437319	0.828551	0.0462003	1.05 [0.69 - 1.59]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207139_at	249	0.228916	0.117336	-	0.428927	0.517832	0.106801	1.11 [0.81 - 1.54]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207139_at	62	0.33871	0.110595	-	1.14009	0.697492	-0.0721855	0.93 [0.65 - 1.34]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207139_at	125	0.664	0.165019	-	-0.599056	0.883627	-0.152789	0.86 [0.11 - 6.64]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207139_at	125	0.4	0.242794	-	0.354593	0.408765	-0.65033	0.52 [0.11 - 2.44]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207139_at	54	0.314815	0.0420392	0.441408	15.5066	0.791327	-0.0596533	0.94 [0.61 - 1.47]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207139_at	198	0.792929	0.0171732	0.240395	0.660717	0.661169	0.0441028	1.05 [0.86 - 1.27]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207139_at	198	0.792929	0.121124	-	0.464829	0.879026	0.0159224	1.02 [0.83 - 1.25]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207139_at	198	0.267677	0.146053	-	-0.326559	0.531755	-0.0523258	0.95 [0.81 - 1.12]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207139_at	51	0.764706	0.0394053	0.423602	1.67765	0.464893	1.19977	3.32 [0.13 - 82.89]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207139_at	62	0.66129	0.0266446	0.326977	1.2254	0.11055	1.64434	5.18 [0.69 - 39.02]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207139_at	177	0.163842	0.00231573	0.0510616	-0.880134	0.0957529	-1.3698	0.25 [0.05 - 1.27]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207139_at	177	0.220339	0.00513016	0.0965747	-0.694439	0.115912	-1.11242	0.33 [0.08 - 1.32]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207139_at	145	0.82069	0.117425	-	-0.912685	0.141735	-1.53311	0.22 [0.03 - 1.67]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207139_at	226	0.880531	0.0466425	0.471067	0.689994	0.571869	0.0706431	1.07 [0.84 - 1.37]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207139_at	55	0.836364	0.111912	-	0.802233	0.877803	0.213318	1.24 [0.08 - 18.78]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207139_at	55	0.836364	0.0779779	-	0.941236	0.602422	0.776946	2.17 [0.12 - 40.46]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207139_at	49	0.857143	0.154263	-	0.920372	0.784203	0.517076	1.68 [0.04 - 67.89]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	174706	34	0.558824	0.0459379	0.466642	0.87938	0.172844	1.61665	5.04 [0.49 - 51.48]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207139_at	63	0.571429	0.0020316	0.0458805	-1.13854	0.0336566	-30.3964	0.00 [0.00 - 0.10]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502290_3p_at	28	0.678571	0.00343908	0.0703033	-2.46853	0.0419679	-26.8267	0.00 [0.00 - 0.38]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207139_at	82	0.780488	0.00415767	0.0817977	0.990331	0.056911	1.11587	3.05 [0.97 - 9.63]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33521_at	84	0.142857	0.00577977	0.106026	-1.00508	0.0242551	-1.48358	0.23 [0.06 - 0.82]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207139_at	79	0.556962	0.00288958	0.0611121	-0.822492	0.182978	-0.470431	0.62 [0.31 - 1.25]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M63962_rna1_at	86	0.104651	0.0836501	-	-0.850763	0.708342	-0.230583	0.79 [0.24 - 2.66]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207139_at	104	0.798077	0.0291311	0.34734	-1.23691	0.679565	-0.221819	0.80 [0.28 - 2.30]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P430728	117	0.871795	0.108896	-	0.584652	0.707279	0.0711274	1.07 [0.74 - 1.56]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207139_at	204	0.808824	0.0251732	0.314515	0.843102	0.223697	0.256117	1.29 [0.86 - 1.95]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207139_at	204	0.818627	0.00251574	0.0546232	0.859975	0.0823947	0.270987	1.31 [0.97 - 1.78]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207139_at	178	0.606742	0.0878823	-	-0.354697	0.738279	0.142817	1.15 [0.50 - 2.67]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207139_at	111	0.315315	0.0337497	0.383074	-0.571989	0.344772	-0.152196	0.86 [0.63 - 1.18]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207139_at	90	0.866667	0.175255	-	0.560856	0.269473	0.533765	1.71 [0.66 - 4.40]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207139_at	90	0.866667	0.107804	-	0.722861	0.0793411	0.813985	2.26 [0.91 - 5.60]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207139_at	138	0.15942	0.0376263	0.411206	-0.586783	0.14163	0.496705	1.64 [0.85 - 3.19]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207139_at	129	0.410853	0.033597	0.381932	-0.519316	0.614726	-0.112294	0.89 [0.58 - 1.38]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	279	56	0.821429	0.118145	-	0.608952	0.300819	0.160852	1.17 [0.87 - 1.59]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	279	56	0.821429	0.0265908	0.326526	0.871219	0.204727	0.207284	1.23 [0.89 - 1.69]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207139_at	278	0.863309	0.0393132	0.422968	0.532136	0.839088	0.0969736	1.10 [0.43 - 2.81]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207139_at	133	0.578947	0.0700559	-	0.42781	0.277832	3.10118	22.22 [0.08 - 6016.57]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9955	81	0.333333	0.0644511	-	-0.930809	0.997401	-0.00193325	1.00 [0.31 - 3.19]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5343	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207139_at	185	0.12973	0.0618744	-	0.559516	0.652522	0.114958	1.12 [0.68 - 1.85]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207139_at	185	0.486486	0.254246	-	0.185606	0.810285	0.056913	1.06 [0.67 - 1.68]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P430728	110	0.836364	0.126535	-	0.545751	0.299497	0.225049	1.25 [0.82 - 1.92]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P430728	110	0.7	0.235024	-	0.291525	0.487735	0.114615	1.12 [0.81 - 1.55]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207139_at	80	0.4125	0.290255	-	-0.457333	0.86278	-0.0358067	0.96 [0.64 - 1.45]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_2811	281	0.558719	0.121453	-	-0.219838	0.38932	-0.0654159	0.94 [0.81 - 1.09]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207139_at	38	0.263158	0.0537004	-	-1.01733	0.587573	-0.305416	0.74 [0.24 - 2.22]
GENE	ATP4A	ATPase, H+/K+ exchanging, alpha polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207139_at	140	0.107143	0.0338771	0.384024	-0.804531	0.462568	-0.71707	0.49 [0.07 - 3.31]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207546_at	30	0.266667	0.0582718	-	-0.834688	0.923982	-0.0876918	0.92 [0.15 - 5.55]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1771680	165	0.89697	0.0565608	-	-0.951039	0.137221	-2.76079	0.06 [0.00 - 2.41]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1771680	165	0.10303	0.00879726	0.146546	-1.06969	0.300281	-3.02075	0.05 [0.00 - 14.81]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207546_at	163	0.895706	0.049012	0.485664	-0.711345	0.885422	-0.0847622	0.92 [0.29 - 2.91]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1563407_x_at	79	0.708861	0.0437339	0.452536	0.599614	0.677437	0.433033	1.54 [0.20 - 11.86]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207546_at	79	0.164557	0.212418	-	-0.441801	0.974271	-0.0230911	0.98 [0.24 - 3.98]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1563405_at	79	0.886076	0.00377929	0.0758131	1.03522	0.399439	0.688102	1.99 [0.40 - 9.86]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207546_at	58	0.137931	0.0598493	-	0.801673	0.361044	0.179658	1.20 [0.81 - 1.76]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207546_at	34	0.852941	6.18171e-05	0.00228921	2.04307	0.464666	0.211343	1.24 [0.70 - 2.18]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207546_at	158	0.803797	0.00117308	0.0291276	0.819327	0.177279	0.755581	2.13 [0.71 - 6.38]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207546_at	53	0.132075	0.0430379	0.447995	-0.902508	0.248253	-0.345395	0.71 [0.39 - 1.27]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207546_at	53	0.132075	0.0606627	-	-0.831359	0.266557	-0.347904	0.71 [0.38 - 1.30]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207546_at	180	0.166667	0.0201212	0.269092	0.762789	0.107003	0.194978	1.22 [0.96 - 1.54]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1563405_at	559	0.474061	0.00106847	0.0269396	-0.662785	0.011	-0.581307	0.56 [0.36 - 0.88]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1563407_x_at	559	0.155635	0.0164121	0.232681	-0.554881	0.0703838	-0.422186	0.66 [0.41 - 1.04]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207546_at	559	0.797853	0.0164559	0.233128	-0.700186	0.0655741	-0.246065	0.78 [0.60 - 1.02]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207546_at	77	0.844156	0.0383117	0.416019	0.687063	0.408773	0.1678	1.18 [0.79 - 1.76]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1563407_x_at	70	0.542857	0.0827735	-	0.452932	0.487559	0.475265	1.61 [0.42 - 6.15]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207546_at	70	0.871429	0.00201409	0.0455563	1.0896	0.337515	0.371747	1.45 [0.68 - 3.10]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1563405_at	70	0.442857	0.145353	-	-0.393442	0.787537	0.18821	1.21 [0.31 - 4.74]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32439_at	50	0.74	0.12749	-	-0.617443	0.218433	-1.29243	0.27 [0.04 - 2.15]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207546_at	74	0.662162	0.0279474	0.337751	0.644487	0.875131	-0.03812	0.96 [0.60 - 1.55]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1563405_at	67	0.179104	0.0806995	-	-1.18743	0.96496	-0.0985611	0.91 [0.01 - 73.62]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1563407_x_at	67	0.477612	0.216538	-	-0.849742	0.911751	-0.265339	0.77 [0.01 - 83.69]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207546_at	67	0.268657	0.0255863	0.318046	-1.38916	0.0902363	-5.75074	0.00 [0.00 - 2.47]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1563405_at	115	0.521739	0.0545496	-	1.08362	0.665878	-0.195009	0.82 [0.34 - 1.99]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1563407_x_at	115	0.886957	0.0181905	0.250503	1.30025	0.433731	0.222264	1.25 [0.72 - 2.18]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207546_at	115	0.895652	0.166248	-	0.877282	0.899089	0.0953546	1.10 [0.25 - 4.80]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32439_at	158	0.721519	0.0882048	-	-0.566047	0.633054	-0.0900479	0.91 [0.63 - 1.32]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32439_at	76	0.513158	0.0313691	0.364977	1.18865	0.185598	0.475257	1.61 [0.80 - 3.25]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1563405_at	204	0.102941	0.0126234	0.192103	-0.578097	0.357581	-0.163676	0.85 [0.60 - 1.20]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1563407_x_at	204	0.181373	0.000433906	0.0125513	-0.648996	0.0905263	-0.27375	0.76 [0.55 - 1.04]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207546_at	204	0.666667	0.0925789	-	-0.24974	0.378122	-0.0649489	0.94 [0.81 - 1.08]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207546_at	87	0.103448	0.132782	-	-0.726437	0.956155	0.0710886	1.07 [0.09 - 13.54]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1563405_at	87	0.827586	0.266216	-	-0.669313	0.968826	-0.029923	0.97 [0.22 - 4.35]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1563407_x_at	87	0.850575	0.125311	-	-1.0749	0.867744	-0.136312	0.87 [0.18 - 4.34]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1563407_x_at	87	0.850575	0.125311	-	-1.0749	0.867744	-0.136312	0.87 [0.18 - 4.34]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207546_at	87	0.103448	0.132782	-	-0.726437	0.956155	0.0710886	1.07 [0.09 - 13.54]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1563405_at	87	0.827586	0.266216	-	-0.669313	0.968826	-0.029923	0.97 [0.22 - 4.35]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1563405_at	77	0.168831	0.00189999	0.0434277	-1.74005	0.0778547	-3.20416	0.04 [0.00 - 1.43]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1563407_x_at	77	0.103896	0.0169868	0.238518	-1.50601	0.613839	-0.906277	0.40 [0.01 - 13.65]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207546_at	77	0.103896	0.0152697	0.220845	-1.52497	0.0559158	-3.82413	0.02 [0.00 - 1.10]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207546_at	77	0.103896	0.0759708	-	-1.11148	0.446837	-1.20785	0.30 [0.01 - 6.71]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1563407_x_at	77	0.103896	0.0758196	-	-1.11257	0.520011	0.994253	2.70 [0.13 - 55.89]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1563405_at	77	0.168831	0.0225704	0.291654	-1.22353	0.755993	-0.488004	0.61 [0.03 - 13.33]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207546_at	136	0.573529	0.148619	-	0.647191	0.667538	0.123018	1.13 [0.65 - 1.98]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207546_at	200	0.84	7.98891e-06	0.000364498	1.27951	0.00102168	1.1055	3.02 [1.56 - 5.84]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6249	60	0.266667	0.0682308	-	-0.710716	0.43604	0.360336	1.43 [0.58 - 3.55]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6249	60	0.283333	5.86837e-06	0.000275383	-1.68713	0.892635	0.0627362	1.06 [0.43 - 2.65]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	7197	155	0.187097	0.00130993	0.0319331	-0.905926	0.0491405	-0.218759	0.80 [0.65 - 1.00]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207546_at	286	0.741259	0.013388	0.200612	0.498057	0.131837	0.255198	1.29 [0.93 - 1.80]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207546_at	159	0.496855	0.206309	-	-0.402173	0.457695	-0.195078	0.82 [0.49 - 1.38]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207546_at	159	0.660377	0.0635513	-	-0.689328	0.400514	-0.221264	0.80 [0.48 - 1.34]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207546_at	159	0.496855	0.0540283	-	-0.737216	0.248937	-0.339225	0.71 [0.40 - 1.27]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207546_at	54	0.555556	0.0933161	-	-1.60473	0.41043	-1.05762	0.35 [0.03 - 4.31]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207546_at	117	0.247863	0.36999	-	0.353111	0.584168	-0.323792	0.72 [0.23 - 2.31]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207546_at	117	0.888889	0.0535652	-	0.871362	0.555067	0.344286	1.41 [0.45 - 4.43]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207546_at	117	0.247863	0.36999	-	0.353111	0.584168	-0.323792	0.72 [0.23 - 2.31]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207546_at	117	0.247863	0.354913	-	0.452125	0.666362	-0.302858	0.74 [0.19 - 2.93]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207546_at	236	0.800847	0.0331761	0.378773	0.623304	0.384586	0.274945	1.32 [0.71 - 2.45]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207546_at	249	0.795181	0.0976187	-	0.399349	0.968235	0.00945421	1.01 [0.63 - 1.61]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207546_at	62	0.451613	0.208791	-	0.709725	0.728138	-0.122854	0.88 [0.44 - 1.77]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207546_at	125	0.792	0.0895249	-	0.6773	0.515105	0.263399	1.30 [0.59 - 2.88]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207546_at	125	0.64	0.313578	-	-0.317177	0.902338	-0.0386484	0.96 [0.52 - 1.78]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207546_at	54	0.425926	0.190243	-	0.987222	0.7611	-0.130915	0.88 [0.38 - 2.04]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207546_at	198	0.646465	0.087327	-	0.45837	0.489622	0.0864159	1.09 [0.85 - 1.39]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207546_at	198	0.550505	0.104847	-	0.339582	0.339375	0.0947143	1.10 [0.91 - 1.34]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207546_at	198	0.646465	0.161325	-	0.36116	0.714689	0.0430378	1.04 [0.83 - 1.31]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207546_at	51	0.843137	0.328811	-	-15.2815	0.975016	0.0743604	1.08 [0.01 - 113.09]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207546_at	62	0.112903	0.135592	-	-0.958513	0.47412	-1.07105	0.34 [0.02 - 6.43]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207546_at	177	0.79096	0.189686	-	0.405108	0.882652	-0.112752	0.89 [0.20 - 3.99]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1563405_at	177	0.242938	0.00083797	0.0219647	-0.907299	0.054195	-1.75901	0.17 [0.03 - 1.03]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1563407_x_at	177	0.440678	0.0124432	0.190073	-0.584978	0.039883	-1.34551	0.26 [0.07 - 0.94]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1563407_x_at	177	0.259887	0.0113387	0.177395	-0.695933	0.0859152	-1.29248	0.27 [0.06 - 1.20]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207546_at	177	0.864407	0.195783	-	-0.545205	0.772067	-0.19209	0.83 [0.22 - 3.03]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1563405_at	177	0.242938	0.000202276	0.00649101	-0.881806	0.0175005	-1.91439	0.15 [0.03 - 0.72]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1563407_x_at	145	0.22069	0.0289264	0.345695	-0.758821	0.155882	-1.31049	0.27 [0.04 - 1.65]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207546_at	145	0.22069	0.0222892	0.289117	1.2909	0.323423	0.940032	2.56 [0.40 - 16.54]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1563405_at	145	0.42069	0.0081969	0.138865	-0.86911	0.0892538	-1.89826	0.15 [0.02 - 1.34]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1563407_x_at	226	0.269911	0.0100922	0.162579	-0.720222	0.0472741	-0.47923	0.62 [0.39 - 0.99]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207546_at	226	0.110619	0.0399578	0.427391	-0.744126	0.900481	-0.0158451	0.98 [0.77 - 1.26]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1563405_at	226	0.185841	0.000394666	0.0115709	-1.03582	0.360117	-0.234709	0.79 [0.48 - 1.31]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1563407_x_at	55	0.472727	0.141272	-	0.677458	0.940305	0.107355	1.11 [0.07 - 18.49]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207546_at	55	0.436364	0.137317	-	-0.696675	0.603819	-0.963759	0.38 [0.01 - 14.53]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207546_at	55	0.436364	0.135006	-	-0.669972	0.744479	0.575267	1.78 [0.06 - 56.53]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1563405_at	55	0.490909	0.344904	-	0.428113	0.952967	0.0752527	1.08 [0.09 - 13.14]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207546_at	49	0.428571	0.106147	-	-0.954123	0.942105	0.16148	1.18 [0.02 - 91.79]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1563405_at	55	0.418182	0.082412	-	0.921565	0.421694	1.22814	3.41 [0.17 - 68.31]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1563407_x_at	55	0.472727	0.217203	-	0.628872	0.556388	0.902051	2.46 [0.12 - 49.79]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1563405_at	49	0.653061	0.0973618	-	-1.21375	0.938861	0.121301	1.13 [0.05 - 25.05]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1563407_x_at	49	0.77551	0.0327956	0.3759	-15.544	0.624963	-0.869919	0.42 [0.01 - 13.71]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1563407_x_at	63	0.111111	0.000531897	0.0149383	-1.39935	0.530267	-6.00293	0.00 [0.00 - 342598.06]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207546_at	63	0.15873	4.73875e-05	0.00180756	-1.48292	0.250606	-3.23083	0.04 [0.00 - 9.79]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1563405_at	63	0.190476	0.00708964	0.124232	-0.975691	0.373546	5.73802	310.45 [0.00 - 95696090.12]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.437173.1.S1_3p_at	28	0.535714	0.164806	-	-0.764522	0.406664	-0.519312	0.59 [0.17 - 2.03]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.437173.1.S1_3p_x_at	28	0.642857	0.102612	-	-1.04173	0.696702	-0.284946	0.75 [0.18 - 3.15]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557338_3p_at	28	0.821429	0.0502379	-	-1.81683	0.101925	-2.76118	0.06 [0.00 - 1.73]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207546_at	82	0.597561	0.12461	-	0.519433	0.83733	0.0959214	1.10 [0.44 - 2.75]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207546_at	79	0.594937	0.0423244	0.443299	0.528899	0.96387	0.0222619	1.02 [0.39 - 2.68]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207546_at	104	0.221154	0.152386	-	0.677818	0.559902	0.358231	1.43 [0.43 - 4.77]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1563405_at	204	0.897059	0.0429417	0.447365	0.896841	0.276805	0.55252	1.74 [0.64 - 4.70]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1563407_x_at	204	0.666667	0.054663	-	0.690941	0.729222	0.156636	1.17 [0.48 - 2.84]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1563405_at	204	0.769608	0.00664796	0.11821	0.750525	0.0454945	0.752122	2.12 [1.02 - 4.43]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1563407_x_at	204	0.441176	0.0565745	-	0.544261	0.0785872	0.624181	1.87 [0.93 - 3.74]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207546_at	204	0.156863	0.00349794	0.0712657	-1.07934	0.0915684	-0.371605	0.69 [0.45 - 1.06]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207546_at	204	0.156863	0.00200754	0.0454347	-0.908875	0.103699	-0.266859	0.77 [0.56 - 1.06]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207546_at	178	0.438202	0.160236	-	-0.27715	0.579023	-0.146961	0.86 [0.51 - 1.45]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1563405_at	111	0.603604	0.0119752	0.184749	-0.713256	0.80476	-0.0731014	0.93 [0.52 - 1.66]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1563407_x_at	111	0.117117	0.263334	-	0.515222	0.897281	-0.0369694	0.96 [0.55 - 1.69]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207546_at	111	0.207207	0.345135	-	-0.288519	0.650456	-0.0826501	0.92 [0.64 - 1.32]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207546_at	90	0.855556	0.199707	-	-0.753904	0.627874	0.357215	1.43 [0.34 - 6.06]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207546_at	90	0.633333	0.189203	-	0.487197	0.431201	0.638441	1.89 [0.39 - 9.28]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1563405_at	138	0.442029	0.0891023	-	-0.408575	0.0421868	3.08052	21.77 [1.11 - 425.12]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1563407_x_at	138	0.188406	0.00520165	0.0976302	-0.729122	0.935807	-0.415851	0.66 [0.00 - 16384.96]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207546_at	138	0.217391	0.0354455	0.395576	-0.545758	0.442961	-2.84429	0.06 [0.00 - 83.27]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207546_at	129	0.503876	0.22836	-	-0.297997	0.855724	0.0496729	1.05 [0.62 - 1.80]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4727	56	0.125	0.146114	-	0.76037	0.484894	0.184954	1.20 [0.72 - 2.02]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4727	56	0.857143	0.11423	-	-1.11342	0.686508	0.128984	1.14 [0.61 - 2.13]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207546_at	278	0.431655	0.195072	-	-0.242667	0.198177	-0.481992	0.62 [0.30 - 1.29]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1563405_at	278	0.28777	0.162449	-	-0.281121	0.594815	-0.237289	0.79 [0.33 - 1.89]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1563407_x_at	278	0.485611	0.0324486	0.373265	-0.405438	0.343492	-0.508857	0.60 [0.21 - 1.72]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207546_at	133	0.548872	0.00710698	0.124466	0.629554	0.437947	-0.340507	0.71 [0.30 - 1.68]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6455	81	0.160494	0.138667	-	-0.792025	0.836025	0.103817	1.11 [0.42 - 2.97]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	933	81	0.839506	0.0810642	-	-15.2995	0.836788	-0.106304	0.90 [0.33 - 2.47]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207546_at	185	0.783784	0.328606	-	0.201126	0.417151	0.238367	1.27 [0.71 - 2.26]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207546_at	185	0.313514	0.346547	-	-0.160261	0.676964	0.112979	1.12 [0.66 - 1.91]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P32308	110	0.445455	0.000986669	0.0251999	-0.978127	0.0444226	-0.299673	0.74 [0.55 - 0.99]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P32308	110	0.545455	0.00353981	0.0719481	-0.677463	0.0357945	-0.237663	0.79 [0.63 - 0.98]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207546_at	80	0.55	0.140776	-	-0.672982	0.974023	0.00740949	1.01 [0.64 - 1.57]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5508	281	0.729537	0.0361006	0.400322	-0.341628	0.332503	-0.0902195	0.91 [0.76 - 1.10]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1563405_at	38	0.684211	0.00170163	0.0396602	1.55304	0.0479803	0.554011	1.74 [1.00 - 3.01]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1563407_x_at	38	0.526316	0.005741	0.105471	-1.36534	0.160903	-0.245024	0.78 [0.56 - 1.10]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207546_at	38	0.710526	0.00636877	0.114344	-1.62696	0.382099	-0.280167	0.76 [0.40 - 1.42]
GENE	ATP4B	ATPase, H+/K+ exchanging, beta polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207546_at	140	0.871429	0.0300794	0.35489	-1.44042	0.166028	-1.7412	0.18 [0.01 - 2.06]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213738_s_at	30	0.7	0.00195088	0.0443804	-1.53059	0.0594703	-1.08373	0.34 [0.11 - 1.04]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1764494	165	0.448485	0.0217265	0.284	-0.548372	0.619506	-0.092113	0.91 [0.63 - 1.31]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1764494	165	0.393939	0.0572679	-	-0.662514	0.612123	-0.147578	0.86 [0.49 - 1.53]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213738_s_at	163	0.484663	0.0505458	-	0.389024	0.195367	0.28428	1.33 [0.86 - 2.04]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213738_s_at	79	0.329114	0.0033122	0.0682145	1.00927	0.0384174	1.05974	2.89 [1.06 - 7.87]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1569891_at	79	0.708861	0.0615106	-	-0.656394	0.239346	-1.17667	0.31 [0.04 - 2.19]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213738_s_at	58	0.87931	0.191865	-	0.531678	0.997087	-0.0014719	1.00 [0.45 - 2.20]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213738_s_at	34	0.676471	0.243264	-	0.479468	0.846002	0.14946	1.16 [0.26 - 5.25]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213738_s_at	158	0.177215	0.140352	-	0.494054	0.956945	-0.0144737	0.99 [0.58 - 1.67]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213738_s_at	53	0.886792	0.0306709	0.359541	0.951809	0.31867	0.760649	2.14 [0.48 - 9.54]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213738_s_at	53	0.886792	0.0252862	0.315483	0.99434	0.238876	0.945775	2.57 [0.53 - 12.42]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213738_s_at	180	0.816667	0.0133872	0.200603	0.593304	0.149283	0.612534	1.85 [0.80 - 4.24]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1569891_at	559	0.690519	0.0809777	-	-0.434797	0.245827	-0.147385	0.86 [0.67 - 1.11]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213738_s_at	559	0.738819	0.0373214	0.409049	0.450409	0.26303	0.397023	1.49 [0.74 - 2.98]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213738_s_at	77	0.116883	0.0598173	-	-0.673129	0.665285	-0.212027	0.81 [0.31 - 2.11]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213738_s_at	70	0.128571	0.115147	-	-0.578391	0.343374	-0.39005	0.68 [0.30 - 1.52]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1569891_at	70	0.7	0.0149502	0.217476	0.676934	0.199017	0.919591	2.51 [0.62 - 10.21]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40096_at	50	0.88	0.0843683	-	-1.18788	0.334165	-0.286061	0.75 [0.42 - 1.34]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213738_s_at	74	0.108108	0.132823	-	1.0397	0.841102	-0.157065	0.85 [0.18 - 3.97]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213738_s_at	67	0.119403	0.0520645	-	-1.30403	0.156575	-2.44014	0.09 [0.00 - 2.55]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1569891_at	67	0.835821	0.102567	-	1.11084	0.621277	0.976295	2.65 [0.06 - 127.68]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1569891_at	115	0.730435	0.0320566	0.37027	1.09409	0.246745	0.543979	1.72 [0.69 - 4.33]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213738_s_at	115	0.278261	0.0587094	-	-0.97431	0.317461	-1.09491	0.33 [0.04 - 2.86]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40096_at	158	0.588608	0.124098	-	-0.4992	0.694701	-0.0830803	0.92 [0.61 - 1.39]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40096_at	76	0.171053	0.0731889	-	15.315	0.857756	0.089547	1.09 [0.41 - 2.91]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213738_s_at	204	0.803922	0.000381054	0.0112272	0.621622	0.44151	0.274314	1.32 [0.65 - 2.65]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1569891_at	204	0.122549	0.0338319	0.383687	0.446153	0.336013	0.0745608	1.08 [0.93 - 1.25]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1569891_at	87	0.229885	0.028172	0.339585	-0.845803	0.130591	-1.29331	0.27 [0.05 - 1.47]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213738_s_at	87	0.367816	0.151544	-	0.616572	0.443127	0.584848	1.79 [0.40 - 8.00]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1569891_at	87	0.229885	0.028172	0.339585	-0.845803	0.130591	-1.29331	0.27 [0.05 - 1.47]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213738_s_at	87	0.367816	0.151544	-	0.616572	0.443127	0.584848	1.79 [0.40 - 8.00]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1569891_at	77	0.636364	0.00602735	0.10955	1.50868	0.742642	0.382211	1.47 [0.15 - 14.35]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213738_s_at	77	0.155844	0.071134	-	-1.0406	0.45409	-0.413897	0.66 [0.22 - 1.95]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1569891_at	77	0.142857	0.0692202	-	-1.18608	0.691149	-0.542721	0.58 [0.04 - 8.45]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213738_s_at	77	0.155844	0.124633	-	-1.01868	0.775184	-0.181625	0.83 [0.24 - 2.90]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213738_s_at	136	0.867647	0.132425	-	0.761046	0.75835	-0.182324	0.83 [0.26 - 2.66]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213738_s_at	200	0.55	0.0629731	-	0.547876	0.421137	0.666042	1.95 [0.38 - 9.86]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5951	155	0.767742	0.000237527	0.00746372	0.997716	0.00126798	0.139562	1.15 [1.06 - 1.25]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213738_s_at	286	0.888112	0.0263189	0.324245	-0.902242	0.269578	-0.442022	0.64 [0.29 - 1.41]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213738_s_at	159	0.584906	0.0262561	0.323717	0.693482	0.278237	0.621632	1.86 [0.61 - 5.73]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213738_s_at	159	0.584906	0.0484581	0.482291	0.72202	0.50895	0.451439	1.57 [0.41 - 6.00]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213738_s_at	159	0.584906	0.00914294	0.150895	0.812436	0.304667	0.594085	1.81 [0.58 - 5.63]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213738_s_at	54	0.388889	0.154156	-	1.39645	0.479704	0.363823	1.44 [0.52 - 3.95]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213738_s_at	117	0.401709	0.0482296	0.480892	0.690432	0.285719	0.362514	1.44 [0.74 - 2.80]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213738_s_at	117	0.42735	0.0727198	-	0.734939	0.493704	0.270218	1.31 [0.60 - 2.84]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213738_s_at	117	0.401709	0.0482296	0.480892	0.690432	0.285719	0.362514	1.44 [0.74 - 2.80]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213738_s_at	117	0.102564	0.0872431	-	-0.836086	0.760464	-0.115876	0.89 [0.42 - 1.88]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213738_s_at	236	0.855932	0.221087	-	0.425097	0.736044	0.166796	1.18 [0.45 - 3.12]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213738_s_at	249	0.586345	0.121618	-	0.326804	0.334133	0.374421	1.45 [0.68 - 3.11]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213738_s_at	62	0.145161	0.0582486	-	15.2982	0.50526	0.37049	1.45 [0.49 - 4.31]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213738_s_at	125	0.728	0.0239621	0.304012	-1.17607	0.737343	-0.144317	0.87 [0.37 - 2.01]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213738_s_at	125	0.736	0.0158632	0.227034	-0.856195	0.309519	-0.327981	0.72 [0.38 - 1.36]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213738_s_at	54	0.166667	0.10646	-	15.3231	0.648773	0.303856	1.36 [0.37 - 5.01]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213738_s_at	198	0.368687	0.00483254	0.0921376	-0.701912	0.063618	-0.602709	0.55 [0.29 - 1.03]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213738_s_at	198	0.368687	0.0048567	0.0925004	-0.738133	0.0643217	-0.630183	0.53 [0.27 - 1.04]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213738_s_at	198	0.368687	0.146162	-	-0.3093	0.711865	-0.105459	0.90 [0.51 - 1.57]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213738_s_at	51	0.215686	0.0239578	0.303975	-1.8067	0.0992203	-1.20203	0.30 [0.07 - 1.25]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213738_s_at	62	0.790323	0.0750354	-	-15.3809	0.871835	-0.0929756	0.91 [0.29 - 2.82]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213738_s_at	145	0.813793	0.100313	-	-0.954934	0.564413	-0.275989	0.76 [0.30 - 1.94]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1569891_at	145	0.172414	0.000527029	0.0148216	-1.16876	0.00749827	-2.69272	0.07 [0.01 - 0.49]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213738_s_at	177	0.694915	0.164677	-	0.389947	0.538076	0.244128	1.28 [0.59 - 2.78]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1569891_at	177	0.39548	0.000210902	0.00673121	-0.994488	0.00127696	-2.5336	0.08 [0.02 - 0.37]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213738_s_at	177	0.124294	0.131176	-	0.633886	0.2174	0.425503	1.53 [0.78 - 3.01]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1569891_at	177	0.112994	0.000124606	0.0042498	-1.08593	0.00403047	-1.93129	0.14 [0.04 - 0.54]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213738_s_at	226	0.880531	0.00718694	0.125544	-15.2195	0.154573	-0.639068	0.53 [0.22 - 1.27]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1569891_at	226	0.681416	0.000404485	0.0118177	-1.52239	0.00177028	-0.457904	0.63 [0.47 - 0.84]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213738_s_at	49	0.326531	0.125558	-	1.12908	0.74287	0.198567	1.22 [0.37 - 3.99]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1569891_at	55	0.272727	0.13593	-	-0.675085	0.492316	-0.901401	0.41 [0.03 - 5.32]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1569891_at	49	0.163265	0.0587611	-	-1.11544	0.389452	-1.18902	0.30 [0.02 - 4.57]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213738_s_at	55	0.290909	0.0712202	-	1.07987	0.343279	0.433591	1.54 [0.63 - 3.78]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1569891_at	55	0.109091	0.0135982	0.202919	-1.21046	0.21107	-1.38326	0.25 [0.03 - 2.19]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213738_s_at	55	0.690909	0.166942	-	-0.8178	0.937052	0.0358611	1.04 [0.43 - 2.52]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213738_s_at	63	0.190476	0.0576412	-	0.972737	0.223134	0.430654	1.54 [0.77 - 3.08]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1569891_at	63	0.206349	0.000218671	0.00694631	-1.32715	0.693498	1.14125	3.13 [0.01 - 913.15]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.407524.1.S1_3p_at	28	0.321429	0.0796463	-	-0.997664	0.446069	-4.22416	0.01 [0.00 - 766.12]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.155101.3.A1_3p_a_at	28	0.285714	0.0315375	0.366278	1.94342	0.454584	-0.406111	0.67 [0.23 - 1.93]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213738_s_at	82	0.865854	0.335559	-	0.403019	0.938488	0.0407549	1.04 [0.37 - 2.93]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40096_at	84	0.869048	0.0535598	-	-1.0998	0.270343	-0.332644	0.72 [0.40 - 1.30]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213738_s_at	79	0.848101	0.0785886	-	0.608498	0.700663	0.222875	1.25 [0.40 - 3.89]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D14710_at	86	0.209302	0.0167723	0.236349	-0.992489	0.139846	-0.844722	0.43 [0.14 - 1.32]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213738_s_at	104	0.375	0.00201413	0.045557	-0.975674	0.151455	-0.693097	0.50 [0.19 - 1.29]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P245358	117	0.683761	0.179433	-	0.399045	0.713087	0.0967092	1.10 [0.66 - 1.84]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213738_s_at	204	0.465686	3.48339e-05	0.00137363	1.91958	0.00287018	3.95718	52.31 [3.88 - 705.39]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213738_s_at	204	0.387255	2.07802e-06	0.000106633	1.71086	1.17466e-05	4.29619	73.42 [10.75 - 501.55]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1569891_at	204	0.710784	0.0025865	0.0558676	1.05409	0.0706992	0.412127	1.51 [0.97 - 2.36]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1569891_at	204	0.401961	0.182959	-	0.382554	0.423785	0.133773	1.14 [0.82 - 1.59]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213738_s_at	178	0.842697	0.043293	0.449664	-0.617428	0.320953	-0.442718	0.64 [0.27 - 1.54]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300009439	41	0.756098	0.0102865	0.164927	1.06978	0.0425538	0.817385	2.26 [1.03 - 4.99]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213738_s_at	111	0.801802	0.111089	-	0.4871	0.579772	0.167552	1.18 [0.65 - 2.14]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1569891_at	111	0.828829	0.0219651	0.286177	0.708585	0.100761	0.314854	1.37 [0.94 - 2.00]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213738_s_at	90	0.544444	0.333176	-	0.313495	0.463429	-0.222051	0.80 [0.44 - 1.45]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213738_s_at	90	0.111111	0.190242	-	-0.634696	0.334731	-0.325975	0.72 [0.37 - 1.40]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213738_s_at	138	0.442029	0.268432	-	0.269777	0.842426	0.0370808	1.04 [0.72 - 1.50]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1569891_at	138	0.369565	0.00699244	0.122916	-0.640783	0.215091	-2.40269	0.09 [0.00 - 4.04]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213738_s_at	129	0.75969	0.259463	-	-0.337396	0.681133	0.219906	1.25 [0.44 - 3.56]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16976	56	0.535714	0.00844066	0.142004	0.93799	0.0244817	0.695674	2.01 [1.09 - 3.68]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3722	56	0.625	0.0107299	0.17023	0.907765	0.01836	0.745363	2.11 [1.13 - 3.92]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16976	56	0.464286	0.000920732	0.0237775	1.17454	0.0125321	0.736376	2.09 [1.17 - 3.72]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3722	56	0.571429	0.00336014	0.069006	1.00684	0.00982836	0.789642	2.20 [1.21 - 4.01]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1569891_at	278	0.622302	0.00350158	0.0713252	-0.612733	0.0864605	-0.835282	0.43 [0.17 - 1.13]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213738_s_at	278	0.223022	0.00120488	0.029785	-0.651603	0.00611164	-0.682768	0.51 [0.31 - 0.82]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213738_s_at	133	0.233083	0.0255695	0.317903	-0.56225	0.461931	-0.120882	0.89 [0.64 - 1.22]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5422	81	0.111111	0.0284915	0.342182	-1.22298	0.724367	0.21214	1.24 [0.38 - 4.02]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11914	81	0.197531	0.123294	-	-0.823	0.936168	-0.0375853	0.96 [0.38 - 2.42]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213738_s_at	185	0.767568	0.0552078	-	-0.375728	0.525627	-0.0561892	0.95 [0.79 - 1.12]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213738_s_at	185	0.767568	0.114097	-	-0.336779	0.4935	-0.0661927	0.94 [0.77 - 1.13]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P245358	110	0.818182	0.190775	-	-0.563341	0.619099	-0.0993954	0.91 [0.61 - 1.34]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P245358	110	0.772727	0.0718767	-	0.469062	0.52496	0.101002	1.11 [0.81 - 1.51]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213738_s_at	80	0.55	0.157049	-	-0.648004	0.801538	-0.135122	0.87 [0.30 - 2.51]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_2966	281	0.839858	0.0645028	-	-0.385987	0.584502	0.111562	1.12 [0.75 - 1.67]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213738_s_at	38	0.684211	0.0509189	-	0.912766	0.389914	0.761033	2.14 [0.38 - 12.13]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1569891_at	38	0.105263	0.0170049	0.238701	-1.50555	0.212947	-0.430584	0.65 [0.33 - 1.28]
GENE	ATP5A1	ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213738_s_at	140	0.242857	0.000193916	0.00625676	-1.06486	0.0151952	-0.965534	0.38 [0.17 - 0.83]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201322_at	30	0.166667	0.137184	-	0.899294	0.534478	0.308171	1.36 [0.51 - 3.60]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1772132	165	0.8	0.0483733	0.481772	-0.727634	0.763489	0.0939949	1.10 [0.60 - 2.03]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1772132	165	0.333333	0.0134896	0.201729	1.14111	0.19685	0.677702	1.97 [0.70 - 5.51]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201322_at	163	0.564417	0.00610664	0.11067	0.539359	0.245144	0.239825	1.27 [0.85 - 1.90]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201322_at	79	0.556962	0.0058662	0.107261	0.797864	0.140786	0.551432	1.74 [0.83 - 3.62]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201322_at	58	0.327586	0.0781081	-	-0.545822	0.995145	-0.00213354	1.00 [0.50 - 1.98]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201322_at	34	0.352941	0.0750743	-	0.733063	0.332978	0.684407	1.98 [0.50 - 7.92]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201322_at	158	0.221519	0.000921687	0.0237982	-0.796475	0.499578	-0.186848	0.83 [0.48 - 1.43]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201322_at	53	0.830189	0.248743	-	0.524827	0.941747	0.0578497	1.06 [0.22 - 5.00]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201322_at	53	0.830189	0.122717	-	0.649308	0.725551	0.262715	1.30 [0.30 - 5.64]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201322_at	180	0.738889	0.157912	-	0.317002	0.503506	0.243488	1.28 [0.63 - 2.60]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201322_at	559	0.767442	0.00108909	0.0273741	0.699444	0.10176	0.53523	1.71 [0.90 - 3.24]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201322_at	77	0.727273	0.045326	0.462766	0.566051	0.605496	-0.150749	0.86 [0.49 - 1.52]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201322_at	70	0.642857	0.0736309	-	-0.513615	0.27298	-0.445208	0.64 [0.29 - 1.42]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41357_at	50	0.76	0.167873	-	-0.57442	0.453229	-0.503998	0.60 [0.16 - 2.25]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201322_at	74	0.824324	0.00371978	0.0748585	-1.41479	0.0378869	-1.40136	0.25 [0.07 - 0.92]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201322_at	67	0.343284	0.0154893	0.223145	15.8546	0.208092	1.42959	4.18 [0.45 - 38.69]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201322_at	115	0.330435	0.317612	-	0.641862	0.587732	-0.584915	0.56 [0.07 - 4.62]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41357_at	158	0.512658	0.222111	-	0.347226	0.565858	0.122739	1.13 [0.74 - 1.72]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41357_at	76	0.513158	0.145567	-	0.778874	0.322634	0.480581	1.62 [0.62 - 4.19]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201322_at	204	0.857843	0.0212591	0.279709	0.460791	0.103206	0.386839	1.47 [0.92 - 2.34]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201322_at	87	0.747126	0.00273448	0.0584451	1.0944	0.200112	0.549729	1.73 [0.75 - 4.02]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201322_at	87	0.747126	0.00273448	0.0584451	1.0944	0.200112	0.549729	1.73 [0.75 - 4.02]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201322_at	77	0.246753	0.139484	-	1.41697	0.678609	0.277545	1.32 [0.36 - 4.91]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201322_at	77	0.12987	0.199802	-	15.245	0.495044	0.525852	1.69 [0.37 - 7.66]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201322_at	136	0.147059	0.0205992	0.27358	-1.08217	0.852627	-0.107072	0.90 [0.29 - 2.78]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201322_at	200	0.595	0.109825	-	0.468567	0.809669	0.155272	1.17 [0.33 - 4.13]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14821	155	0.167742	0.00116189	0.0288955	-0.94494	0.373757	-0.25848	0.77 [0.44 - 1.36]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201322_at	286	0.86014	0.0762377	-	0.446831	0.661391	0.156755	1.17 [0.58 - 2.36]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201322_at	159	0.679245	0.00222206	0.0493699	0.935945	0.0125836	1.30891	3.70 [1.32 - 10.35]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201322_at	159	0.603774	6.5702e-05	0.00241633	1.24622	0.000965529	1.72614	5.62 [2.02 - 15.66]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201322_at	159	0.603774	0.000214067	0.00681898	1.37848	0.00139287	1.98596	7.29 [2.16 - 24.63]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201322_at	54	0.796296	0.0937847	-	1.16046	0.422403	0.451821	1.57 [0.52 - 4.74]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201322_at	117	0.478632	0.213103	-	0.399782	0.598285	0.155888	1.17 [0.65 - 2.09]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201322_at	117	0.632479	0.185989	-	0.512066	0.71612	0.133833	1.14 [0.56 - 2.35]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201322_at	117	0.478632	0.213103	-	0.399782	0.598285	0.155888	1.17 [0.65 - 2.09]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201322_at	117	0.606838	0.0980657	-	0.616935	0.294528	0.379609	1.46 [0.72 - 2.97]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201322_at	236	0.745763	0.0015607	0.036927	0.847184	0.0159369	1.05602	2.87 [1.22 - 6.79]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201322_at	249	0.718876	2.68692e-05	0.00108881	0.875929	0.0104359	0.870539	2.39 [1.23 - 4.65]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201322_at	62	0.887097	0.00319818	0.0663208	1.58224	0.117471	0.657815	1.93 [0.85 - 4.40]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201322_at	125	0.896	0.019329	0.261554	0.99066	0.187411	0.470673	1.60 [0.80 - 3.22]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201322_at	125	0.104	0.0530351	-	1.73372	0.478453	0.196277	1.22 [0.71 - 2.09]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201322_at	54	0.888889	0.0881915	-	1.27054	0.1696	0.72377	2.06 [0.73 - 5.79]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201322_at	198	0.116162	0.0259724	0.321323	1.46933	0.134037	0.458899	1.58 [0.87 - 2.88]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201322_at	198	0.29798	0.00179023	0.0413538	0.812558	0.0036534	0.707518	2.03 [1.26 - 3.27]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201322_at	198	0.19697	0.0249313	0.312435	0.883649	0.131697	0.43891	1.55 [0.88 - 2.74]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201322_at	51	0.411765	0.00490776	0.0932658	-16.7648	0.0311765	-1.30337	0.27 [0.08 - 0.89]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201322_at	62	0.612903	0.0232138	0.297407	-2.0143	0.635003	-0.23397	0.79 [0.30 - 2.08]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201322_at	145	0.655172	0.00867445	0.144988	-1.11706	0.0395623	-1.15422	0.32 [0.11 - 0.95]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201322_at	177	0.694915	0.0168837	0.237477	-0.814325	0.474487	-0.333272	0.72 [0.29 - 1.79]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201322_at	177	0.225989	0.145649	-	0.442892	0.831409	0.0870456	1.09 [0.49 - 2.43]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201322_at	226	0.110619	0.000957963	0.0245829	-1.04644	0.00152668	-1.63592	0.19 [0.07 - 0.54]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201322_at	55	0.145455	0.128378	-	1.43526	0.307128	0.55389	1.74 [0.60 - 5.04]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201322_at	55	0.145455	0.0483329	0.481525	15.3174	0.355406	0.540394	1.72 [0.55 - 5.40]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201322_at	49	0.163265	0.114248	-	15.3048	0.719405	0.268688	1.31 [0.30 - 5.67]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201322_at	63	0.301587	0.0209297	0.27666	0.999345	0.0673763	0.563433	1.76 [0.96 - 3.21]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502294_3p_at	28	0.535714	0.0660265	-	1.02611	0.493005	0.0950775	1.10 [0.84 - 1.44]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201322_at	82	0.780488	0.00109191	0.0274333	1.11635	0.00516219	1.72612	5.62 [1.68 - 18.84]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201322_at	79	0.341772	0.0927828	-	0.472715	0.590461	0.2553	1.29 [0.51 - 3.27]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M19483_at	86	0.825581	0.0300735	0.354844	0.913232	0.26283	0.680265	1.97 [0.60 - 6.49]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201322_at	104	0.192308	0.0471271	0.474088	1.00516	0.958872	-0.0225913	0.98 [0.41 - 2.31]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P33216	117	0.444444	0.00456738	0.0881229	0.878799	0.242717	0.334089	1.40 [0.80 - 2.45]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201322_at	204	0.818627	0.000297353	0.00906651	1.26668	0.0079276	1.90024	6.69 [1.64 - 27.19]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201322_at	204	0.857843	8.82514e-07	4.84889e-05	1.36665	2.7783e-05	2.1443	8.54 [3.13 - 23.27]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201322_at	178	0.393258	0.0160589	0.229056	0.500453	0.151046	0.551347	1.74 [0.82 - 3.68]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010071	41	0.878049	0.00234772	0.0516356	1.46087	0.099175	0.751454	2.12 [0.87 - 5.18]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201322_at	111	0.27027	0.0429548	0.447451	0.646252	0.295408	0.287682	1.33 [0.78 - 2.29]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201322_at	90	0.7	0.000321819	0.00970705	1.12082	0.0775186	0.522248	1.69 [0.94 - 3.01]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201322_at	90	0.7	5.09823e-05	0.00192908	1.40785	0.0842983	0.579143	1.78 [0.92 - 3.44]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201322_at	138	0.297101	0.158215	-	0.389324	0.670936	0.0662768	1.07 [0.79 - 1.45]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201322_at	129	0.829457	0.0550061	-	0.544799	0.26616	0.512672	1.67 [0.68 - 4.12]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24482	56	0.125	0.000502256	0.0142248	-1.9295	0.806412	-0.105288	0.90 [0.39 - 2.09]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24482	56	0.125	0.0037545	0.075416	-1.55984	0.862352	-0.0733994	0.93 [0.41 - 2.13]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201322_at	278	0.194245	0.042634	0.445342	0.526689	0.971918	-0.00770481	0.99 [0.65 - 1.52]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201322_at	133	0.451128	0.018941	0.257818	0.574002	0.18734	0.252661	1.29 [0.88 - 1.87]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5287	81	0.148148	0.00187415	0.0429417	-1.53059	0.257836	-0.587573	0.56 [0.20 - 1.54]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201322_at	185	0.221622	0.0814544	-	-0.329828	0.726614	-0.034529	0.97 [0.80 - 1.17]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201322_at	185	0.221622	0.0503639	-	-0.395064	0.463344	-0.0781619	0.92 [0.75 - 1.14]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P33216	110	0.636364	0.348838	-	0.224454	0.985287	-0.00237686	1.00 [0.77 - 1.28]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P33216	110	0.636364	0.260829	-	0.345249	0.864362	-0.0271069	0.97 [0.71 - 1.33]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201322_at	80	0.4375	0.0374604	0.410034	-0.907254	0.441447	-0.351908	0.70 [0.29 - 1.72]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_4229	281	0.558719	7.22206e-05	0.00262752	0.551331	0.00533133	0.806134	2.24 [1.27 - 3.95]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201322_at	38	0.815789	5.63732e-05	0.00210935	1.87656	0.0470592	1.60565	4.98 [1.02 - 24.30]
GENE	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201322_at	140	0.478571	0.0052491	0.0983285	-0.847431	0.0215423	-0.683518	0.50 [0.28 - 0.90]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214132_at	30	0.433333	0.231981	-	-0.475457	0.890281	-0.0847234	0.92 [0.28 - 3.06]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205711_x_at	30	0.666667	0.000790068	0.0209005	1.59139	0.0844304	1.10707	3.03 [0.86 - 10.64]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208870_x_at	30	0.7	0.000755978	0.0201359	1.58829	0.100853	1.09195	2.98 [0.81 - 10.98]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213366_x_at	30	0.733333	0.00226546	0.0501557	1.428	0.191126	0.716792	2.05 [0.70 - 6.00]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1685774	165	0.430303	0.108883	-	-0.384799	0.540111	0.112875	1.12 [0.78 - 1.61]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1685774	165	0.872727	0.0197392	0.265473	0.922525	0.568935	0.176844	1.19 [0.65 - 2.19]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208870_x_at	163	0.638037	0.00577136	0.105906	0.548285	0.0573181	0.379846	1.46 [0.99 - 2.16]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213366_x_at	163	0.447853	0.0312054	0.363708	0.431233	0.105686	0.288903	1.33 [0.94 - 1.89]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214132_at	163	0.337423	0.291827	-	0.222104	0.871841	-0.0476098	0.95 [0.53 - 1.70]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205711_x_at	163	0.680982	0.00876016	0.146076	0.528792	0.0666149	0.344506	1.41 [0.98 - 2.04]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205711_x_at	79	0.848101	0.00830967	0.14032	0.912732	0.0924825	0.652879	1.92 [0.90 - 4.11]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214132_at	79	0.177215	0.00300188	0.0630222	-0.967837	0.756292	-0.088651	0.92 [0.52 - 1.60]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213366_x_at	79	0.860759	7.27753e-07	4.05811e-05	1.60566	0.0811819	0.687891	1.99 [0.92 - 4.31]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208870_x_at	79	0.886076	5.41459e-05	0.00203514	1.42042	0.0787022	0.761939	2.14 [0.92 - 5.01]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214132_at	58	0.655172	0.0360274	0.399794	0.598281	0.870177	-0.0406798	0.96 [0.59 - 1.56]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205711_x_at	58	0.689655	0.000141241	0.00474342	1.14566	0.10086	0.628495	1.87 [0.88 - 3.97]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208870_x_at	58	0.568965	0.000117275	0.00402938	1.12685	0.101253	0.664423	1.94 [0.88 - 4.30]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213366_x_at	58	0.672414	0.000365274	0.0108262	1.06353	0.245075	0.405888	1.50 [0.76 - 2.98]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213366_x_at	34	0.323529	0.0287223	0.344049	0.911911	0.0684927	1.06432	2.90 [0.92 - 9.11]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214132_at	34	0.176471	0.00532915	0.0995029	-1.25628	0.609886	-0.171459	0.84 [0.44 - 1.63]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205711_x_at	34	0.588235	0.00738299	0.128171	1.12393	0.0287572	1.28909	3.63 [1.14 - 11.52]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208870_x_at	34	0.441176	0.00561815	0.103703	1.15979	0.0323868	1.29998	3.67 [1.12 - 12.07]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213366_x_at	158	0.297468	0.0117188	0.181804	-0.588898	0.023362	-0.598027	0.55 [0.33 - 0.92]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214132_at	158	0.575949	0.00420097	0.0824736	0.654775	0.0384703	0.814785	2.26 [1.04 - 4.89]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205711_x_at	158	0.113924	0.00712314	0.124684	-0.812408	0.0376722	-0.577783	0.56 [0.33 - 0.97]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208870_x_at	158	0.113924	0.00790342	0.135047	-0.801679	0.0150927	-0.68504	0.50 [0.29 - 0.88]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208870_x_at	53	0.320755	0.0279743	0.337971	-0.794413	0.27074	-0.719556	0.49 [0.14 - 1.75]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205711_x_at	53	0.433962	0.111996	-	-0.542405	0.455425	-0.480262	0.62 [0.18 - 2.18]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213366_x_at	53	0.169811	0.129606	-	-0.648123	0.39566	-0.571591	0.56 [0.15 - 2.11]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208870_x_at	53	0.320755	0.0404372	0.430654	-0.70429	0.373056	-0.572707	0.56 [0.16 - 1.99]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214132_at	53	0.301887	0.276192	-	-0.410561	0.707227	-0.200299	0.82 [0.29 - 2.33]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205711_x_at	53	0.433962	0.0597022	-	-0.680276	0.286794	-0.667722	0.51 [0.15 - 1.75]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213366_x_at	53	0.169811	0.0700633	-	-0.724803	0.49379	-0.467392	0.63 [0.16 - 2.39]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214132_at	53	0.830189	0.251744	-	0.483787	0.875326	0.0811462	1.08 [0.39 - 2.99]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214132_at	180	0.133333	0.0643833	-	0.672561	0.500012	0.209873	1.23 [0.67 - 2.27]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205711_x_at	180	0.55	0.0758372	-	0.3707	0.516978	0.276014	1.32 [0.57 - 3.04]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208870_x_at	180	0.816667	0.0249225	0.312359	0.545867	0.0353181	1.02034	2.77 [1.07 - 7.17]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213366_x_at	180	0.833333	0.151499	-	0.376089	0.536751	0.285245	1.33 [0.54 - 3.29]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205711_x_at	559	0.890877	0.00794336	0.135569	0.731117	0.139162	0.580148	1.79 [0.83 - 3.85]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214132_at	559	0.711986	0.0115429	0.179769	0.515378	0.317448	0.221382	1.25 [0.81 - 1.93]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213366_x_at	559	0.858676	0.000263334	0.00816193	0.878905	0.25498	0.390302	1.48 [0.75 - 2.89]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208870_x_at	559	0.898032	0.00540801	0.100655	0.725288	0.183281	0.561197	1.75 [0.77 - 4.01]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213366_x_at	77	0.298701	0.00111029	0.0278191	-0.859608	0.0406656	-0.693643	0.50 [0.26 - 0.97]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214132_at	77	0.87013	0.195869	-	-0.523373	0.982338	0.00642787	1.01 [0.57 - 1.78]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205711_x_at	77	0.298701	0.00111029	0.0278191	-0.859608	0.0558724	-0.639527	0.53 [0.27 - 1.02]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208870_x_at	77	0.38961	0.000562573	0.0156697	-0.883728	0.0364205	-0.719994	0.49 [0.25 - 0.96]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214132_at	70	0.857143	0.14226	-	-0.624776	0.586619	-0.245875	0.78 [0.32 - 1.90]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213366_x_at	70	0.6	0.00431588	0.0842585	-0.818067	0.0210307	-0.983269	0.37 [0.16 - 0.86]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208870_x_at	70	0.657143	0.0158623	0.227024	-0.702042	0.0358033	-0.936209	0.39 [0.16 - 0.94]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205711_x_at	70	0.628571	0.0406087	0.431817	-0.574623	0.0627827	-0.787546	0.45 [0.20 - 1.04]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40115_at	50	0.66	0.018649	0.254986	-1.02033	0.0372351	-0.758526	0.47 [0.23 - 0.96]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205711_x_at	74	0.297297	0.00806666	0.137176	-0.842861	0.107958	-0.858738	0.42 [0.15 - 1.21]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208870_x_at	74	0.878378	0.0375136	0.41041	-1.17584	0.0945747	-0.874926	0.42 [0.15 - 1.16]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213366_x_at	74	0.324324	0.0264616	0.325444	-0.687061	0.220069	-0.734663	0.48 [0.15 - 1.55]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214132_at	74	0.432432	5.16429e-05	0.00195129	-1.17111	0.00848785	-0.736048	0.48 [0.28 - 0.83]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205711_x_at	67	0.58209	0.254866	-	0.748535	0.392123	1.3748	3.95 [0.17 - 92.16]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214132_at	67	0.537313	0.00464269	0.0892692	2.39384	0.0911361	1.80946	6.11 [0.75 - 49.83]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213366_x_at	67	0.835821	0.0632964	-	1.24384	0.120348	2.66726	14.40 [0.50 - 416.90]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208870_x_at	67	0.761194	0.0762175	-	1.13248	0.352244	1.60656	4.99 [0.17 - 147.16]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214132_at	115	0.486957	0.0753957	-	-1.01104	0.676833	-0.319426	0.73 [0.16 - 3.26]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213366_x_at	115	0.173913	0.0602751	-	-1.01058	0.447911	-0.602191	0.55 [0.12 - 2.59]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208870_x_at	115	0.182609	0.0801822	-	-0.945922	0.545834	-0.450424	0.64 [0.15 - 2.75]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205711_x_at	115	0.886957	0.166695	-	-15.2047	0.702858	-0.250785	0.78 [0.21 - 2.82]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40115_at	158	0.873418	0.000292925	0.00894974	1.15603	0.165047	0.686315	1.99 [0.75 - 5.23]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40115_at	76	0.328947	0.190589	-	-0.665592	0.5721	-0.311525	0.73 [0.25 - 2.16]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214132_at	204	0.357843	0.0835893	-	0.254234	0.165625	0.178332	1.20 [0.93 - 1.54]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213366_x_at	204	0.323529	0.000496098	0.0140757	0.51936	0.0240126	0.500874	1.65 [1.07 - 2.55]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208870_x_at	204	0.45098	0.000420688	0.0122227	0.510524	0.0253084	0.519553	1.68 [1.07 - 2.65]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205711_x_at	204	0.382353	0.000536098	0.0150389	0.497092	0.0151815	0.521487	1.68 [1.11 - 2.57]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214132_at	87	0.103448	0.311327	-	-0.541438	0.948844	-0.0206524	0.98 [0.52 - 1.84]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205711_x_at	87	0.425287	0.00615321	0.111326	1.19228	0.024855	1.00633	2.74 [1.14 - 6.59]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213366_x_at	87	0.597701	0.00186793	0.0428246	1.14802	0.0265758	1.06452	2.90 [1.13 - 7.43]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214132_at	87	0.103448	0.311327	-	-0.541438	0.948844	-0.0206524	0.98 [0.52 - 1.84]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208870_x_at	87	0.413793	0.00280828	0.0597184	1.36769	0.0385176	1.03161	2.81 [1.06 - 7.45]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213366_x_at	87	0.597701	0.00186793	0.0428246	1.14802	0.0265758	1.06452	2.90 [1.13 - 7.43]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205711_x_at	87	0.425287	0.00615321	0.111326	1.19228	0.024855	1.00633	2.74 [1.14 - 6.59]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208870_x_at	87	0.413793	0.00280828	0.0597184	1.36769	0.0385176	1.03161	2.81 [1.06 - 7.45]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214132_at	77	0.285714	0.0148804	0.216736	15.6195	0.0372375	1.41525	4.12 [1.09 - 15.59]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208870_x_at	77	0.311688	0.155086	-	1.38556	0.972191	0.0226834	1.02 [0.29 - 3.66]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213366_x_at	77	0.415584	0.0883797	-	-0.938649	0.362877	-0.616018	0.54 [0.14 - 2.04]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205711_x_at	77	0.168831	0.158546	-	15.2924	0.951782	-0.0394716	0.96 [0.27 - 3.46]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208870_x_at	77	0.428571	0.107913	-	-0.889311	0.464925	-0.42741	0.65 [0.21 - 2.05]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214132_at	77	0.454545	0.0151343	0.219421	2.13426	0.0395256	1.60831	4.99 [1.08 - 23.09]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205711_x_at	77	0.558442	0.0695607	-	-1.13478	0.372041	-0.528743	0.59 [0.18 - 1.88]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213366_x_at	77	0.857143	0.17365	-	-15.2737	0.800365	-0.187858	0.83 [0.19 - 3.55]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208870_x_at	136	0.514706	0.0026345	0.0567072	1.53541	0.0510473	1.55039	4.71 [0.99 - 22.37]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213366_x_at	136	0.779412	0.00044168	0.0127437	1.4602	0.0094059	1.94319	6.98 [1.61 - 30.26]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214132_at	136	0.882353	0.0343656	0.387651	1.04584	0.720605	0.200337	1.22 [0.41 - 3.66]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205711_x_at	136	0.617647	0.0193428	0.261687	1.05425	0.0587751	1.29134	3.64 [0.95 - 13.88]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205711_x_at	200	0.845	0.000527423	0.0148311	1.09046	0.0147485	1.01108	2.75 [1.22 - 6.20]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208870_x_at	200	0.18	0.00284816	0.0604032	1.87431	0.0275314	0.976831	2.66 [1.11 - 6.33]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213366_x_at	200	0.615	0.000483559	0.013771	1.00831	0.0142751	1.15246	3.17 [1.26 - 7.96]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214132_at	200	0.13	0.0783193	-	1.20039	0.563957	0.181429	1.20 [0.65 - 2.22]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5763	60	0.416667	0.108611	-	0.662271	0.761299	0.34943	1.42 [0.15 - 13.52]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5763	60	0.85	0.000204033	0.00654005	1.48166	0.00101164	1.81555	6.14 [2.08 - 18.14]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	21433	155	0.832258	0.000568745	0.015816	0.980998	0.00393672	0.1868	1.21 [1.06 - 1.37]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205711_x_at	286	0.590909	0.0291251	0.347292	0.420114	0.215407	0.360919	1.43 [0.81 - 2.54]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208870_x_at	286	0.657343	0.00419021	0.0823058	0.552541	0.157655	0.416729	1.52 [0.85 - 2.70]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213366_x_at	286	0.58042	0.0119914	0.184935	0.48199	0.217875	0.367664	1.44 [0.80 - 2.59]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214132_at	286	0.559441	0.0215012	0.281937	0.441923	0.222706	0.34246	1.41 [0.81 - 2.44]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205711_x_at	159	0.566038	0.000845056	0.0221212	1.05944	0.00653645	1.04663	2.85 [1.34 - 6.06]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208870_x_at	159	0.584906	0.00128303	0.0313865	1.00972	0.00984137	1.05715	2.88 [1.29 - 6.42]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214132_at	159	0.100629	0.0637596	-	-0.826707	0.597336	-0.227442	0.80 [0.34 - 1.85]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205711_x_at	159	0.503145	0.00108897	0.0273715	1.32177	0.00561749	1.20204	3.33 [1.42 - 7.79]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213366_x_at	159	0.421384	0.00241354	0.0528115	1.09532	0.0207308	0.984143	2.68 [1.16 - 6.16]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208870_x_at	159	0.584906	8.20913e-06	0.000373604	1.42159	0.00123257	1.27982	3.60 [1.65 - 7.82]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214132_at	159	0.421384	0.0577738	-	0.643775	0.924119	0.03658	1.04 [0.49 - 2.20]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208870_x_at	159	0.584906	0.000118414	0.00406374	1.46664	0.000803409	1.4959	4.46 [1.86 - 10.70]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205711_x_at	159	0.566038	0.00360094	0.0729406	0.919638	0.0379218	0.82588	2.28 [1.05 - 4.98]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213366_x_at	159	0.421384	0.000211246	0.00674077	1.42332	0.0020211	1.25548	3.51 [1.58 - 7.79]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213366_x_at	159	0.63522	0.000365607	0.0108347	1.30068	0.0017796	1.43307	4.19 [1.71 - 10.30]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214132_at	159	0.106918	0.0350358	0.392584	-0.810744	0.232307	-0.436214	0.65 [0.32 - 1.32]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208870_x_at	54	0.481481	0.0948566	-	1.26695	0.163889	1.02681	2.79 [0.66 - 11.85]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213366_x_at	54	0.5	0.0677392	-	1.367	0.15674	1.38714	4.00 [0.59 - 27.30]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205711_x_at	54	0.333333	0.0710243	-	1.73936	0.223302	0.861079	2.37 [0.59 - 9.46]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214132_at	54	0.648148	0.186026	-	0.932013	0.702838	0.140103	1.15 [0.56 - 2.36]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213366_x_at	117	0.888889	0.0755509	-	0.695052	0.918628	-0.0363697	0.96 [0.48 - 1.94]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213366_x_at	117	0.188034	0.0645796	-	-0.731157	0.841885	-0.0838923	0.92 [0.40 - 2.10]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214132_at	117	0.863248	0.0277584	0.336203	0.929092	0.403174	0.237053	1.27 [0.73 - 2.21]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214132_at	117	0.897436	0.013332	0.199994	0.945922	0.495626	0.15977	1.17 [0.74 - 1.86]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205711_x_at	117	0.888889	0.04026	0.429451	0.83214	0.90259	0.040865	1.04 [0.54 - 2.00]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213366_x_at	117	0.794872	0.0990804	-	0.68626	0.6194	0.214866	1.24 [0.53 - 2.89]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205711_x_at	117	0.888889	0.0596712	-	0.898641	0.948409	-0.0253741	0.97 [0.45 - 2.10]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213366_x_at	117	0.888889	0.0755509	-	0.695052	0.918628	-0.0363697	0.96 [0.48 - 1.94]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214132_at	117	0.897436	0.013332	0.199994	0.945922	0.495626	0.15977	1.17 [0.74 - 1.86]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214132_at	117	0.837607	0.00378004	0.0758251	1.13705	0.0236695	0.708758	2.03 [1.10 - 3.75]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205711_x_at	117	0.888889	0.04026	0.429451	0.83214	0.90259	0.040865	1.04 [0.54 - 2.00]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205711_x_at	117	0.897436	0.0511378	-	0.939889	0.77954	0.114694	1.12 [0.50 - 2.50]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208870_x_at	117	0.888889	0.0568949	-	0.90823	0.962175	-0.0191377	0.98 [0.44 - 2.16]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208870_x_at	117	0.888889	0.00714574	0.124989	1.02359	0.88172	0.0511344	1.05 [0.54 - 2.06]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208870_x_at	117	0.888889	0.00714574	0.124989	1.02359	0.88172	0.0511344	1.05 [0.54 - 2.06]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208870_x_at	117	0.897436	0.193276	-	0.697619	0.718064	0.151961	1.16 [0.51 - 2.66]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208870_x_at	236	0.894068	0.00249975	0.0543409	0.953096	0.0122068	1.14078	3.13 [1.28 - 7.64]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213366_x_at	236	0.84322	0.00130626	0.0318586	0.923937	0.00937897	1.13833	3.12 [1.32 - 7.37]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214132_at	236	0.521186	0.0857315	-	-0.472438	0.883258	-0.0732001	0.93 [0.35 - 2.47]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205711_x_at	236	0.830508	0.00103756	0.0262854	0.925455	0.0058239	1.15107	3.16 [1.40 - 7.17]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213366_x_at	249	0.534137	0.00123475	0.0303994	0.683443	0.00588765	0.971532	2.64 [1.32 - 5.27]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214132_at	249	0.718876	0.131373	-	0.340373	0.591895	0.209559	1.23 [0.57 - 2.65]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205711_x_at	249	0.718876	0.000375865	0.0110956	0.756259	0.00437654	0.964869	2.62 [1.35 - 5.10]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208870_x_at	249	0.714859	0.000387853	0.0113991	0.75473	0.00595562	1.002	2.72 [1.33 - 5.56]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208870_x_at	125	0.896	0.223594	-	0.467409	0.499878	0.185904	1.20 [0.70 - 2.07]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208870_x_at	54	0.333333	0.0668953	-	1.7039	0.553886	0.495417	1.64 [0.32 - 8.46]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214132_at	62	0.145161	0.0157789	0.22616	-1.48166	0.458875	-0.141151	0.87 [0.60 - 1.26]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213366_x_at	125	0.272	0.0639827	-	1.08303	0.60015	0.174217	1.19 [0.62 - 2.28]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213366_x_at	125	0.24	0.0484538	0.482264	0.908441	0.436279	0.200236	1.22 [0.74 - 2.02]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205711_x_at	62	0.887097	0.0266277	0.326835	1.21757	0.128281	1.03869	2.83 [0.74 - 10.78]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214132_at	125	0.256	0.163248	-	-0.544562	0.961324	0.0222437	1.02 [0.42 - 2.51]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205711_x_at	125	0.192	0.118617	-	1.09353	0.657039	0.138874	1.15 [0.62 - 2.12]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214132_at	125	0.872	0.0645117	-	0.678921	0.178696	0.441664	1.56 [0.82 - 2.96]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213366_x_at	54	0.388889	0.0130917	0.197336	2.16109	0.171843	1.19158	3.29 [0.60 - 18.19]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214132_at	54	0.833333	0.0319672	0.369585	-15.6325	0.468398	-0.166995	0.85 [0.54 - 1.33]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208870_x_at	62	0.887097	0.0266277	0.326835	1.21757	0.298364	0.690662	2.00 [0.54 - 7.33]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205711_x_at	125	0.184	0.111035	-	0.815482	0.558256	0.142542	1.15 [0.72 - 1.86]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205711_x_at	54	0.333333	0.0578482	-	1.75297	0.338804	0.82696	2.29 [0.42 - 12.45]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213366_x_at	62	0.387097	0.0145888	0.213634	1.43065	0.0436553	1.38817	4.01 [1.04 - 15.44]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208870_x_at	125	0.208	0.091913	-	1.17245	0.722174	0.126998	1.14 [0.56 - 2.29]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213366_x_at	198	0.757576	0.215659	-	-0.408963	0.76117	0.0788204	1.08 [0.65 - 1.80]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213366_x_at	198	0.252525	0.173992	-	0.454059	0.32793	0.26492	1.30 [0.77 - 2.22]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214132_at	198	0.590909	0.108892	-	0.404993	0.634835	0.0737996	1.08 [0.79 - 1.46]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214132_at	198	0.707071	0.142932	-	0.412096	0.526369	0.104597	1.11 [0.80 - 1.53]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205711_x_at	198	0.742424	0.0758829	-	-0.609083	0.957446	-0.0140416	0.99 [0.59 - 1.65]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208870_x_at	198	0.69697	0.116777	-	-0.388388	0.991883	0.00225806	1.00 [0.65 - 1.55]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205711_x_at	198	0.757576	0.139708	-	-0.557934	0.519783	0.177381	1.19 [0.70 - 2.05]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213366_x_at	198	0.888889	0.0405479	0.431405	0.606854	0.76994	0.0633866	1.07 [0.70 - 1.63]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208870_x_at	198	0.79798	0.036905	0.40609	-0.824855	0.916617	0.0277789	1.03 [0.61 - 1.73]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214132_at	198	0.676768	0.0700019	-	0.392577	0.57284	0.0722362	1.07 [0.84 - 1.38]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208870_x_at	198	0.737374	0.100423	-	-0.590104	0.412389	0.2271	1.25 [0.73 - 2.16]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205711_x_at	198	0.484848	0.0654574	-	-0.389223	0.839039	-0.0451852	0.96 [0.62 - 1.48]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208870_x_at	62	0.112903	0.0743186	-	-1.1298	0.901665	0.0897857	1.09 [0.26 - 4.55]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213366_x_at	51	0.745098	0.0416317	0.438695	1.66737	0.959699	0.0644055	1.07 [0.09 - 12.97]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213366_x_at	62	0.467742	0.236572	-	0.712147	0.73625	0.28811	1.33 [0.25 - 7.13]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214132_at	51	0.882353	0.393162	-	-15.2189	0.821423	-0.181773	0.83 [0.17 - 4.04]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205711_x_at	51	0.137255	0.102092	-	-1.38049	0.664123	-0.418343	0.66 [0.10 - 4.35]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214132_at	62	0.822581	0.181167	-	0.798092	0.918298	-0.0499137	0.95 [0.37 - 2.47]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205711_x_at	62	0.5	0.152177	-	0.8533	0.948534	0.0435871	1.04 [0.28 - 3.92]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208870_x_at	51	0.764706	0.340915	-	0.845056	0.562818	-0.605041	0.55 [0.07 - 4.24]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214132_at	145	0.62069	0.00382772	0.0765872	0.953714	0.698715	0.142484	1.15 [0.56 - 2.37]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208870_x_at	177	0.446328	0.129845	-	-0.411696	0.786895	-0.147991	0.86 [0.29 - 2.52]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213366_x_at	177	0.898305	0.0852325	-	0.556759	0.600261	0.234513	1.26 [0.53 - 3.04]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205711_x_at	177	0.107345	0.243143	-	0.603833	0.99983	-0.000105713	1.00 [0.38 - 2.65]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208870_x_at	177	0.107345	0.156415	-	0.651078	0.538979	0.29843	1.35 [0.52 - 3.49]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213366_x_at	145	0.517241	0.0209238	0.276605	-0.815931	0.19158	-0.802456	0.45 [0.13 - 1.49]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208870_x_at	145	0.586207	0.0357044	0.397457	-0.7894	0.160718	-0.915058	0.40 [0.11 - 1.44]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205711_x_at	177	0.107345	0.148382	-	0.663443	0.382181	0.384453	1.47 [0.62 - 3.48]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214132_at	177	0.655367	0.000557482	0.0155488	0.911626	0.0271079	0.551233	1.74 [1.06 - 2.83]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205711_x_at	145	0.641379	0.03583	0.398367	-0.858995	0.227031	-0.721539	0.49 [0.15 - 1.57]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214132_at	177	0.649718	0.00208536	0.0468726	0.711528	0.0908737	0.388719	1.48 [0.94 - 2.31]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213366_x_at	177	0.762712	0.0938642	-	-0.631479	0.776213	-0.143649	0.87 [0.32 - 2.33]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213366_x_at	226	0.49115	0.00498251	0.0943823	-0.828638	0.0244063	-1.43588	0.24 [0.07 - 0.83]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208870_x_at	226	0.367257	0.0018943	0.0433209	-0.859281	0.0618177	-1.21415	0.30 [0.08 - 1.06]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205711_x_at	226	0.261062	0.000982958	0.0251203	-0.911511	0.00930176	-1.47647	0.23 [0.08 - 0.70]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214132_at	226	0.20354	0.112116	-	0.678751	0.484409	0.14359	1.15 [0.77 - 1.73]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213366_x_at	55	0.709091	0.000854392	0.022327	1.53923	0.0355366	2.1106	8.25 [1.15 - 59.05]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213366_x_at	49	0.734694	0.0205718	0.273324	1.27194	0.239025	1.26817	3.55 [0.43 - 29.35]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205711_x_at	55	0.763636	0.000114756	0.00395323	1.60284	0.0790359	1.40734	4.09 [0.85 - 19.65]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208870_x_at	55	0.781818	9.58874e-05	0.00337507	1.76948	0.0186383	2.69821	14.85 [1.57 - 140.62]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208870_x_at	49	0.816327	0.00564894	0.104147	1.47663	0.160532	1.68971	5.42 [0.51 - 57.38]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205711_x_at	55	0.763636	0.000266719	0.00825271	1.65425	0.0140291	2.43761	11.45 [1.64 - 80.04]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214132_at	55	0.109091	2.48988e-06	0.000125862	-2.12321	0.0510285	-1.19415	0.30 [0.09 - 1.01]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205711_x_at	49	0.857143	0.00129961	0.0317237	1.69954	0.116223	1.64175	5.16 [0.67 - 40.05]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214132_at	55	0.109091	0.000886052	0.0230217	-1.64293	0.831654	-0.115111	0.89 [0.31 - 2.58]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213366_x_at	55	0.690909	0.00159973	0.0376889	1.33498	0.349825	0.740604	2.10 [0.44 - 9.91]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214132_at	49	0.102041	0.000156895	0.00520047	-2.12991	0.155391	-1.15367	0.32 [0.06 - 1.55]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208870_x_at	55	0.763636	0.000114756	0.00395323	1.60284	0.120464	1.41426	4.11 [0.69 - 24.52]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	845519	34	0.5	0.000711417	0.019127	-1.62535	0.0049774	-1.21756	0.30 [0.13 - 0.69]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208870_x_at	63	0.126984	0.174924	-	0.799305	0.363605	0.155968	1.17 [0.83 - 1.64]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205711_x_at	63	0.126984	0.174924	-	0.799305	0.441577	0.127901	1.14 [0.82 - 1.57]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214132_at	63	0.666667	0.00480388	0.0917064	0.948289	0.127859	0.277466	1.32 [0.92 - 1.89]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213366_x_at	63	0.634921	0.103578	-	0.54755	0.453915	0.119889	1.13 [0.82 - 1.54]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.155433.3.A1_3p_a_at	28	0.25	0.0127821	0.193883	2.17272	0.370846	-0.48249	0.62 [0.21 - 1.78]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.155433.2.A1_3p_at	28	0.285714	0.0920245	-	-0.964862	0.864293	0.387426	1.47 [0.02 - 125.26]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208870_x_at	82	0.365854	0.0657527	-	0.699139	0.587472	0.291949	1.34 [0.47 - 3.84]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213366_x_at	82	0.170732	0.247145	-	0.605639	0.587102	0.289255	1.34 [0.47 - 3.79]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214132_at	82	0.487805	0.129244	-	-0.512231	0.62239	-0.302423	0.74 [0.22 - 2.46]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205711_x_at	82	0.280488	0.0990604	-	0.686538	0.609007	0.270232	1.31 [0.47 - 3.69]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40115_at	84	0.309524	0.232993	-	0.395952	0.551054	0.305672	1.36 [0.50 - 3.71]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208870_x_at	79	0.164557	0.0221587	0.287935	0.979364	0.604399	0.280103	1.32 [0.46 - 3.82]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213366_x_at	79	0.189873	0.0295511	0.350698	0.83636	0.408257	0.414141	1.51 [0.57 - 4.04]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214132_at	79	0.164557	0.0433269	0.449886	0.847511	0.376856	0.578713	1.78 [0.49 - 6.44]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205711_x_at	79	0.316456	0.0428364	0.446673	0.592233	0.532982	0.328137	1.39 [0.49 - 3.90]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D16562_at	86	0.895349	0.00150224	0.0357786	1.4139	0.0147702	1.77459	5.90 [1.42 - 24.56]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214132_at	104	0.115385	0.123949	-	1.06833	0.549353	0.404758	1.50 [0.40 - 5.64]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205711_x_at	104	0.826923	0.0277697	0.336295	0.773912	0.242297	0.623255	1.86 [0.66 - 5.30]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208870_x_at	104	0.884615	0.00378133	0.0758457	1.0687	0.274568	0.606635	1.83 [0.62 - 5.45]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213366_x_at	104	0.894231	0.0158713	0.227118	0.936058	0.438055	0.421466	1.52 [0.53 - 4.42]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P63655	117	0.692308	9.23206e-05	0.00326412	1.07803	0.000576118	0.884663	2.42 [1.46 - 4.01]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214132_at	204	0.343137	0.00870036	0.145318	-0.931224	0.159545	-0.612561	0.54 [0.23 - 1.27]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214132_at	204	0.372549	0.192391	-	-0.356053	0.885855	-0.049118	0.95 [0.49 - 1.86]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213366_x_at	204	0.519608	5.21967e-05	0.00196989	1.75037	0.000115925	2.84755	17.25 [4.05 - 73.37]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213366_x_at	204	0.720588	3.38727e-07	1.99886e-05	1.30101	5.93685e-06	2.42035	11.25 [3.95 - 32.07]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208870_x_at	204	0.514706	5.69346e-06	0.000267902	2.0567	0.000377666	2.7803	16.12 [3.48 - 74.67]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208870_x_at	204	0.514706	1.34888e-06	7.16864e-05	1.41806	1.21592e-05	2.45821	11.68 [3.88 - 35.15]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205711_x_at	204	0.539216	1.02334e-05	0.000456224	1.87541	0.000166718	2.80049	16.45 [3.83 - 70.70]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205711_x_at	204	0.681373	2.55714e-06	0.000128974	1.21481	1.19666e-05	2.37268	10.73 [3.71 - 31.03]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208870_x_at	178	0.837079	0.00274477	0.0586231	0.688525	0.0258453	0.930465	2.54 [1.12 - 5.75]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213366_x_at	178	0.88764	0.0124768	0.190452	0.656479	0.0609371	0.751873	2.12 [0.97 - 4.66]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214132_at	178	0.719101	0.0154777	0.223024	0.504035	0.206656	0.572518	1.77 [0.73 - 4.31]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205711_x_at	178	0.876405	0.0115	0.179272	0.646451	0.0253694	0.909013	2.48 [1.12 - 5.51]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300022420	41	0.634146	0.0153395	0.221577	0.982375	0.387873	0.337382	1.40 [0.65 - 3.01]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214132_at	111	0.297297	0.0868928	-	-0.457969	0.285898	-0.379373	0.68 [0.34 - 1.37]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213366_x_at	111	0.702703	0.208867	-	-0.391932	0.572687	-0.186952	0.83 [0.43 - 1.59]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208870_x_at	111	0.675676	0.203454	-	-0.386444	0.469312	-0.258646	0.77 [0.38 - 1.56]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205711_x_at	111	0.756757	0.195517	-	-0.444124	0.536323	-0.212014	0.81 [0.41 - 1.58]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208870_x_at	90	0.844444	0.000148229	0.00494828	1.28906	0.257464	0.396217	1.49 [0.75 - 2.95]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208870_x_at	90	0.844444	1.42538e-06	7.54188e-05	1.67949	0.272599	0.437805	1.55 [0.71 - 3.39]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213366_x_at	90	0.877778	0.0026774	0.0574547	1.14203	0.372098	0.300279	1.35 [0.70 - 2.61]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213366_x_at	90	0.877778	0.000124966	0.00426057	1.47046	0.420898	0.307456	1.36 [0.64 - 2.88]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214132_at	90	0.844444	0.0604648	-	0.703882	0.982959	-0.0116926	0.99 [0.34 - 2.89]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214132_at	90	0.844444	0.0267926	0.328212	0.893021	0.906501	0.0732147	1.08 [0.32 - 3.65]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205711_x_at	90	0.844444	8.53869e-05	0.0030468	1.33535	0.192725	0.446266	1.56 [0.80 - 3.06]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205711_x_at	90	0.844444	1.1564e-06	6.22115e-05	1.69347	0.215186	0.484089	1.62 [0.75 - 3.49]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5442	50	0.76	0.00535575	0.099892	1.29768	0.0313688	0.938284	2.56 [1.09 - 6.01]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214132_at	138	0.268116	0.134457	-	-0.38124	0.973678	0.00481665	1.00 [0.75 - 1.34]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213366_x_at	138	0.869565	0.0845037	-	0.562735	0.534026	0.145677	1.16 [0.73 - 1.83]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208870_x_at	138	0.898551	0.0626368	-	0.656992	0.52779	0.145363	1.16 [0.74 - 1.82]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205711_x_at	138	0.166667	0.0567211	-	-0.5433	0.480661	0.156286	1.17 [0.76 - 1.81]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214132_at	129	0.891473	0.0653287	-	0.651598	0.353768	0.446615	1.56 [0.61 - 4.02]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205711_x_at	129	0.682171	0.0360343	0.399844	0.536825	0.131557	0.710007	2.03 [0.81 - 5.12]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208870_x_at	129	0.79845	0.00563668	0.103971	0.742216	0.140432	0.737732	2.09 [0.78 - 5.58]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213366_x_at	129	0.635659	0.0162461	0.230981	0.593804	0.09303	0.867595	2.38 [0.87 - 6.55]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25032	56	0.107143	0.051806	-	-1.19293	0.98159	-0.00701452	0.99 [0.55 - 1.80]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41380	56	0.339286	0.193885	-	0.505806	0.979471	-0.00738579	0.99 [0.57 - 1.74]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25032	56	0.107143	0.155022	-	-0.864761	0.666135	-0.127212	0.88 [0.49 - 1.57]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41380	56	0.285714	0.0807605	-	0.845276	0.717365	0.107772	1.11 [0.62 - 2.00]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208870_x_at	278	0.669065	0.00444987	0.0863244	0.548369	0.243898	0.269209	1.31 [0.83 - 2.06]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205711_x_at	278	0.643885	0.00114278	0.0284979	0.618409	0.148849	0.329986	1.39 [0.89 - 2.18]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214132_at	278	0.446043	0.0155896	0.224191	0.483639	0.200174	0.225063	1.25 [0.89 - 1.77]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213366_x_at	278	0.478417	0.0146189	0.213955	0.466625	0.251926	0.260409	1.30 [0.83 - 2.03]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213366_x_at	133	0.571429	0.034263	0.386891	0.493742	0.40923	0.151574	1.16 [0.81 - 1.67]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214132_at	133	0.203008	0.31166	-	0.301577	0.796724	0.0275435	1.03 [0.83 - 1.27]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205711_x_at	133	0.353383	0.0399794	0.427538	0.529856	0.762606	0.0494759	1.05 [0.76 - 1.45]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208870_x_at	133	0.338346	0.0695732	-	0.473526	0.77454	0.0484742	1.05 [0.75 - 1.46]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7272	81	0.814815	0.0711668	-	0.954536	0.565029	0.357373	1.43 [0.42 - 4.83]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16289	81	0.320988	0.140403	-	-0.746704	0.92816	0.0569299	1.06 [0.31 - 3.65]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213366_x_at	185	0.848649	0.167468	-	-0.343204	0.253227	-0.116414	0.89 [0.73 - 1.09]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205711_x_at	185	0.405405	0.266921	-	-0.186357	0.32991	-0.0982499	0.91 [0.74 - 1.10]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208870_x_at	185	0.297297	0.206275	-	-0.249192	0.395698	-0.109594	0.90 [0.70 - 1.15]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214132_at	185	0.897297	0.0448855	0.459957	-0.523902	0.295983	-0.140639	0.87 [0.67 - 1.13]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205711_x_at	185	0.67027	0.256604	-	-0.214478	0.312205	-0.110046	0.90 [0.72 - 1.11]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213366_x_at	185	0.848649	0.224115	-	-0.271274	0.288748	-0.100386	0.90 [0.75 - 1.09]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214132_at	185	0.897297	0.0517899	-	-0.574557	0.143541	-0.221273	0.80 [0.60 - 1.08]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208870_x_at	185	0.297297	0.188874	-	-0.239086	0.432469	-0.0931494	0.91 [0.72 - 1.15]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P63655	110	0.672727	0.0829837	-	0.515666	0.419868	0.14609	1.16 [0.81 - 1.65]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P63655	110	0.663636	0.0144861	0.212536	0.565658	0.232541	0.185035	1.20 [0.89 - 1.63]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214132_at	80	0.1125	0.0315818	0.366621	-1.17266	0.367328	-0.361377	0.70 [0.32 - 1.53]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205711_x_at	80	0.85	0.0244842	0.308568	1.07164	0.571921	0.254991	1.29 [0.53 - 3.12]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208870_x_at	80	0.85	0.0187815	0.256273	1.11484	0.837849	0.0933624	1.10 [0.45 - 2.68]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213366_x_at	80	0.8625	0.112336	-	0.812552	0.895229	0.0563572	1.06 [0.46 - 2.45]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0230	281	0.836299	0.134157	-	0.278947	0.375923	0.129977	1.14 [0.85 - 1.52]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213366_x_at	38	0.315789	0.0318259	0.368501	1.18091	0.130214	1.06219	2.89 [0.73 - 11.45]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208870_x_at	38	0.289474	0.0180051	0.248677	1.42424	0.154202	1.09656	2.99 [0.66 - 13.53]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205711_x_at	38	0.394737	0.014385	0.211451	1.28214	0.175994	0.939783	2.56 [0.66 - 9.98]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214132_at	38	0.473684	0.00750993	0.129861	1.40141	0.175969	0.587027	1.80 [0.77 - 4.21]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208870_x_at	140	0.692857	0.0535421	-	0.574091	0.532358	-0.266307	0.77 [0.33 - 1.77]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213366_x_at	140	0.628571	0.00245809	0.0536032	0.856474	0.44655	-0.318124	0.73 [0.32 - 1.65]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214132_at	140	0.5	0.18782	-	0.384052	0.938633	0.0340316	1.03 [0.44 - 2.46]
GENE	ATP5C1	ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205711_x_at	140	0.635714	0.00927622	0.152558	0.741574	0.883122	-0.0618698	0.94 [0.41 - 2.14]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203926_x_at	30	0.4	0.0114018	0.17813	-1.04537	0.0635237	-1.46157	0.23 [0.05 - 1.09]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213041_s_at	30	0.866667	0.0973035	-	-1.17998	0.256124	-0.417305	0.66 [0.32 - 1.35]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215325_x_at	30	0.8	0.000859308	0.0224352	1.66847	0.0657408	1.38664	4.00 [0.91 - 17.52]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1679178	165	0.357576	0.00420334	0.0825104	-0.686535	0.196935	-0.173385	0.84 [0.65 - 1.09]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1679178	165	0.690909	0.00336657	0.0691119	-1.60286	0.084902	-0.32603	0.72 [0.50 - 1.05]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213041_s_at	163	0.631902	0.0182595	0.251181	0.468903	0.493391	0.120262	1.13 [0.80 - 1.59]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215325_x_at	163	0.104294	0.0493905	0.487955	-0.57678	0.249129	-0.658006	0.52 [0.17 - 1.59]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203926_x_at	163	0.723926	0.0242247	0.306309	0.475966	0.431261	0.249298	1.28 [0.69 - 2.39]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213041_s_at	79	0.21519	0.024359	0.307479	0.952344	0.177614	0.444074	1.56 [0.82 - 2.97]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203926_x_at	79	0.78481	0.0985009	-	0.53483	0.123077	0.725687	2.07 [0.82 - 5.20]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215325_x_at	79	0.240506	0.0306691	0.359528	-0.667024	0.0875771	-1.13256	0.32 [0.09 - 1.18]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203926_x_at	58	0.241379	0.0428629	0.446848	-0.633165	0.335155	-0.249918	0.78 [0.47 - 1.29]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213041_s_at	58	0.275862	0.0428702	0.446896	-0.612236	0.383365	-0.239444	0.79 [0.46 - 1.35]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215325_x_at	58	0.844828	0.0673252	-	0.68799	0.239915	0.167578	1.18 [0.89 - 1.56]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215325_x_at	34	0.147059	0.189755	-	0.797852	0.673593	0.101398	1.11 [0.69 - 1.77]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203926_x_at	34	0.764706	0.014721	0.215043	-1.27403	0.434958	-0.322255	0.72 [0.32 - 1.63]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213041_s_at	34	0.529412	0.190482	-	0.506073	0.512012	0.214031	1.24 [0.65 - 2.35]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215325_x_at	158	0.632911	0.0149975	0.217976	0.556252	0.187873	0.542319	1.72 [0.77 - 3.86]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203926_x_at	158	0.873418	0.0794582	-	-0.73113	0.726174	-0.127315	0.88 [0.43 - 1.80]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213041_s_at	158	0.898734	0.238693	-	-0.496385	0.916153	-0.02589	0.97 [0.60 - 1.58]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213041_s_at	53	0.113208	0.0343219	0.387327	-1.02586	0.939695	0.04178	1.04 [0.35 - 3.08]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203926_x_at	53	0.301887	0.189757	-	-0.462146	0.622591	-0.225204	0.80 [0.33 - 1.96]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215325_x_at	53	0.377358	0.0831698	-	-0.624618	0.901416	0.0270485	1.03 [0.67 - 1.58]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213041_s_at	53	0.113208	0.168195	-	-0.664431	0.790294	-0.136415	0.87 [0.32 - 2.38]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215325_x_at	53	0.377358	0.0272322	0.331865	-0.755393	0.876294	-0.033879	0.97 [0.63 - 1.48]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203926_x_at	53	0.754717	0.258458	-	0.449113	0.686883	0.193	1.21 [0.47 - 3.10]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203926_x_at	180	0.788889	0.175412	-	0.337382	0.577575	0.13721	1.15 [0.71 - 1.86]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213041_s_at	180	0.155556	0.10373	-	-0.424354	0.881164	-0.0467467	0.95 [0.52 - 1.76]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215325_x_at	180	0.144444	0.0385244	0.417503	0.793826	0.37717	0.106751	1.11 [0.88 - 1.41]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213041_s_at	559	0.40966	0.117098	-	-0.312976	0.510665	-0.116661	0.89 [0.63 - 1.26]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203926_x_at	559	0.801431	0.0597546	-	-0.536978	0.557165	-0.126663	0.88 [0.58 - 1.34]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215325_x_at	559	0.618962	0.0305667	0.358725	0.42966	0.428978	0.0885983	1.09 [0.88 - 1.36]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215325_x_at	77	0.116883	0.0209902	0.277221	-0.833007	0.709987	-0.0544264	0.95 [0.71 - 1.26]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203926_x_at	77	0.311688	0.0568971	-	-0.515413	0.177373	-0.456824	0.63 [0.33 - 1.23]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213041_s_at	77	0.207792	0.000239447	0.00751605	-1.09618	0.0271193	-0.535841	0.59 [0.36 - 0.94]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213041_s_at	70	0.871429	0.0850208	-	0.650535	0.498585	0.186976	1.21 [0.70 - 2.07]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203926_x_at	70	0.857143	0.0777149	-	0.606058	0.452386	0.327095	1.39 [0.59 - 3.26]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215325_x_at	70	0.514286	0.00070601	0.0190038	0.889636	0.0130152	1.41829	4.13 [1.35 - 12.65]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37992_s_at	50	0.84	0.0156902	0.225239	-2.06819	0.532016	-0.136071	0.87 [0.57 - 1.34]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37993_at	50	0.4	6.06214e-05	0.00224988	-1.38817	0.00050877	-2.53435	0.08 [0.02 - 0.33]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33695_at	50	0.12	0.13416	-	-0.720265	0.288596	-2.59344	0.07 [0.00 - 8.99]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203926_x_at	74	0.540541	0.0337945	0.383408	-0.625863	0.263043	-0.455179	0.63 [0.29 - 1.41]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213041_s_at	74	0.121622	0.0285716	0.342831	-0.835273	0.254591	-0.49828	0.61 [0.26 - 1.43]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215325_x_at	74	0.527027	0.108176	-	-0.466774	0.546695	-0.0774257	0.93 [0.72 - 1.19]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215325_x_at	67	0.104478	0.226002	-	-0.953525	0.627708	0.946097	2.58 [0.06 - 117.90]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213041_s_at	67	0.626866	0.0704356	-	1.21073	0.214104	1.47851	4.39 [0.43 - 45.20]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203926_x_at	67	0.522388	0.223864	-	0.83606	0.459421	1.13886	3.12 [0.15 - 63.82]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213041_s_at	115	0.295652	0.0135396	0.202277	-1.24967	0.11176	-1.11929	0.33 [0.08 - 1.30]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203926_x_at	115	0.191304	0.0120497	0.185601	-1.26517	0.0643547	-1.20988	0.30 [0.08 - 1.07]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215325_x_at	115	0.591304	0.0568066	-	1.01577	0.253673	0.682644	1.98 [0.61 - 6.39]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37993_at	158	0.481013	0.00134344	0.0326109	0.957512	0.179244	0.549121	1.73 [0.78 - 3.86]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33695_at	158	0.772152	0.0449833	0.460581	0.601856	0.650886	0.140749	1.15 [0.63 - 2.12]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37992_s_at	158	0.14557	0.00930153	0.152873	2.17438	0.0727499	0.8182	2.27 [0.93 - 5.54]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37993_at	76	0.184211	0.0322338	0.371626	-1.14466	0.482729	-0.568645	0.57 [0.12 - 2.77]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33695_at	76	0.618421	0.0206749	0.274288	1.20031	0.87635	0.123091	1.13 [0.24 - 5.33]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37992_s_at	76	0.736842	0.0573671	-	-1.74094	0.594095	-0.312266	0.73 [0.23 - 2.31]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203926_x_at	204	0.142157	0.258608	-	-0.229448	0.613564	-0.069338	0.93 [0.71 - 1.22]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215325_x_at	204	0.318627	0.221792	-	0.182489	0.698546	0.0285018	1.03 [0.89 - 1.19]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213041_s_at	204	0.872549	0.00255708	0.055351	-0.630533	0.0321918	-0.451388	0.64 [0.42 - 0.96]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215325_x_at	87	0.885057	0.0890737	-	-1.56883	0.190662	-0.827637	0.44 [0.13 - 1.51]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203926_x_at	87	0.678161	0.11247	-	0.593419	0.715228	0.162946	1.18 [0.49 - 2.82]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213041_s_at	87	0.827586	0.133539	-	0.645924	0.921127	-0.033045	0.97 [0.50 - 1.86]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203926_x_at	87	0.678161	0.11247	-	0.593419	0.715228	0.162946	1.18 [0.49 - 2.82]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215325_x_at	87	0.885057	0.0890737	-	-1.56883	0.190662	-0.827637	0.44 [0.13 - 1.51]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213041_s_at	87	0.827586	0.133539	-	0.645924	0.921127	-0.033045	0.97 [0.50 - 1.86]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203926_x_at	77	0.844156	0.0077443	0.13296	1.40755	0.194019	1.0125	2.75 [0.60 - 12.69]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215325_x_at	77	0.103896	0.00161351	0.037957	-1.79129	0.537598	-0.737538	0.48 [0.05 - 4.99]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213041_s_at	77	0.181818	0.0495279	0.488785	-1.20261	0.950624	-0.0386907	0.96 [0.28 - 3.27]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215325_x_at	77	0.103896	0.0103864	0.166128	-1.42348	0.747137	-0.32421	0.72 [0.10 - 5.19]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203926_x_at	77	0.844156	0.132168	-	0.998358	0.474119	0.622796	1.86 [0.34 - 10.26]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213041_s_at	77	0.818182	0.0328212	0.376094	1.15388	0.531981	0.359012	1.43 [0.46 - 4.41]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213041_s_at	136	0.639706	0.133145	-	0.660829	0.324807	-0.271696	0.76 [0.44 - 1.31]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215325_x_at	136	0.198529	0.184631	-	-0.640305	0.793832	0.065681	1.07 [0.65 - 1.75]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203926_x_at	136	0.345588	0.046222	0.468431	1.18161	0.578861	0.282772	1.33 [0.49 - 3.60]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203926_x_at	200	0.185	0.23498	-	0.514508	0.957208	0.025594	1.03 [0.40 - 2.61]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213041_s_at	200	0.46	0.126993	-	-0.451425	0.482376	-0.310232	0.73 [0.31 - 1.74]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215325_x_at	200	0.11	0.0628043	-	-0.709957	0.796245	0.0471972	1.05 [0.73 - 1.50]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19285	60	0.466667	0.151651	-	-0.542934	0.763393	0.0922488	1.10 [0.60 - 2.00]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19285	60	0.733333	0.172375	-	-0.661471	0.624868	0.125276	1.13 [0.69 - 1.87]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18094	155	0.780645	0.000126294	0.00430027	1.03769	0.131238	0.154608	1.17 [0.95 - 1.43]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203926_x_at	286	0.178322	0.00218447	0.0486866	-0.663879	0.00438866	-0.663073	0.52 [0.33 - 0.81]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213041_s_at	286	0.552448	0.13343	-	-0.296087	0.218216	-0.337853	0.71 [0.42 - 1.22]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215325_x_at	286	0.237762	0.0751132	-	-0.377773	0.706251	0.0459248	1.05 [0.82 - 1.33]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203926_x_at	159	0.138365	0.0251065	0.313942	1.94633	0.231643	0.461516	1.59 [0.74 - 3.38]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213041_s_at	159	0.893082	0.0998924	-	0.672296	0.756187	0.141141	1.15 [0.47 - 2.81]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203926_x_at	159	0.138365	0.0882855	-	1.5689	0.289557	0.483363	1.62 [0.66 - 3.97]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215325_x_at	159	0.245283	0.0811453	-	-0.571666	0.537413	-0.126078	0.88 [0.59 - 1.32]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213041_s_at	159	0.893082	0.100059	-	0.67367	0.409648	0.368246	1.45 [0.60 - 3.47]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203926_x_at	159	0.113208	0.0572551	-	1.70973	0.349348	0.353398	1.42 [0.68 - 2.98]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213041_s_at	159	0.893082	0.010096	0.162626	1.0657	0.499047	0.354527	1.43 [0.51 - 3.98]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215325_x_at	159	0.245283	0.0273157	0.332556	-0.707342	0.0903798	-0.38442	0.68 [0.44 - 1.06]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215325_x_at	159	0.245283	0.0064459	0.115417	-0.980303	0.0850381	-0.488815	0.61 [0.35 - 1.07]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203926_x_at	54	0.888889	0.057291	-	1.43172	0.570841	-0.680691	0.51 [0.05 - 5.33]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213041_s_at	54	0.592593	0.0431576	0.44878	1.37257	0.620535	0.376112	1.46 [0.33 - 6.46]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215325_x_at	117	0.393162	0.125481	-	-0.480513	0.578449	-0.323963	0.72 [0.23 - 2.27]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215325_x_at	117	0.393162	0.125481	-	-0.480513	0.578449	-0.323963	0.72 [0.23 - 2.27]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203926_x_at	117	0.547009	0.0888484	-	0.546471	0.709853	0.163778	1.18 [0.50 - 2.79]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215325_x_at	117	0.521368	0.0633308	-	-0.768604	0.585702	-0.413035	0.66 [0.15 - 2.92]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203926_x_at	117	0.452991	0.138528	-	0.591696	0.786617	0.14062	1.15 [0.42 - 3.19]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203926_x_at	117	0.666667	0.074485	-	0.683022	0.850801	0.101965	1.11 [0.38 - 3.20]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203926_x_at	117	0.547009	0.0888484	-	0.546471	0.709853	0.163778	1.18 [0.50 - 2.79]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213041_s_at	117	0.692308	0.0600256	-	0.61414	0.926815	0.0353276	1.04 [0.49 - 2.20]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213041_s_at	117	0.692308	0.0460913	0.467608	0.746686	0.754887	0.141637	1.15 [0.47 - 2.80]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215325_x_at	117	0.512821	0.184372	-	-0.517888	0.629886	-0.338101	0.71 [0.18 - 2.82]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213041_s_at	117	0.692308	0.0600256	-	0.61414	0.926815	0.0353276	1.04 [0.49 - 2.20]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213041_s_at	117	0.299145	0.121051	-	-0.615359	0.774261	-0.134595	0.87 [0.35 - 2.19]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213041_s_at	236	0.885593	0.00169031	0.0394425	0.989556	0.133689	0.600748	1.82 [0.83 - 4.00]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215325_x_at	236	0.483051	0.128602	-	0.419426	0.319061	0.204933	1.23 [0.82 - 1.84]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203926_x_at	236	0.521186	0.0575639	-	0.511101	0.607187	0.238634	1.27 [0.51 - 3.15]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215325_x_at	249	0.839357	0.0612773	-	0.480758	0.440875	0.136015	1.15 [0.81 - 1.62]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203926_x_at	249	0.53012	0.00787986	0.134739	0.562098	0.342449	0.353498	1.42 [0.69 - 2.95]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213041_s_at	249	0.891566	0.00185496	0.0425801	0.838352	0.0417778	0.646717	1.91 [1.02 - 3.56]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213041_s_at	125	0.888	0.166918	-	-0.718046	0.565375	-0.154046	0.86 [0.51 - 1.45]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213041_s_at	54	0.148148	0.0017982	0.0415054	-1.65035	0.397734	-0.300669	0.74 [0.37 - 1.49]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215325_x_at	125	0.32	0.0825635	-	0.912056	0.27087	0.630257	1.88 [0.61 - 5.77]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215325_x_at	125	0.16	0.163025	-	0.717968	0.784406	0.120453	1.13 [0.48 - 2.67]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215325_x_at	54	0.888889	6.36721e-09	4.83708e-07	3.36177	0.170411	2.05571	7.81 [0.41 - 147.65]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203926_x_at	62	0.887097	0.0880656	-	0.951958	0.805659	-0.0701339	0.93 [0.53 - 1.63]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203926_x_at	125	0.872	0.00609131	0.110454	1.10115	0.310493	0.452047	1.57 [0.66 - 3.76]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213041_s_at	62	0.129032	0.0192543	0.260837	-1.17662	0.483499	-0.207865	0.81 [0.45 - 1.45]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203926_x_at	125	0.624	0.114434	-	-0.493204	0.764927	-0.105802	0.90 [0.45 - 1.80]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203926_x_at	54	0.240741	0.0678999	-	-1.03996	0.77823	-0.0972629	0.91 [0.46 - 1.79]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215325_x_at	62	0.887097	0.00102159	0.0259458	1.61715	0.239336	1.34045	3.82 [0.41 - 35.63]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213041_s_at	125	0.848	0.0522542	-	0.799812	0.620095	0.170987	1.19 [0.60 - 2.33]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215325_x_at	198	0.186869	0.0371979	0.408173	-0.586886	0.477269	-0.065347	0.94 [0.78 - 1.12]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203926_x_at	198	0.580808	0.0509513	-	-0.533904	0.0668747	-0.406614	0.67 [0.43 - 1.03]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213041_s_at	198	0.333333	0.07902	-	0.417754	0.219718	0.209405	1.23 [0.88 - 1.72]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203926_x_at	198	0.580808	0.0373302	0.409112	-0.607228	0.0279088	-0.505371	0.60 [0.38 - 0.95]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215325_x_at	198	0.186869	0.0190495	0.258866	-0.554013	0.301352	-0.0797769	0.92 [0.79 - 1.07]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213041_s_at	198	0.191919	0.0773134	-	0.695582	0.552061	0.118984	1.13 [0.76 - 1.67]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213041_s_at	198	0.757576	0.0263526	0.324529	-0.827345	0.69408	0.0836667	1.09 [0.72 - 1.65]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203926_x_at	198	0.580808	0.0465503	0.470491	-0.437113	0.299008	-0.1952	0.82 [0.57 - 1.19]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215325_x_at	198	0.186869	0.0427076	0.445827	-0.591371	0.330187	-0.0940594	0.91 [0.75 - 1.10]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213041_s_at	62	0.129032	0.147487	-	15.2597	0.318028	0.410064	1.51 [0.67 - 3.37]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215325_x_at	51	0.117647	0.010189	0.163751	-2.01724	0.249852	-2.86801	0.06 [0.00 - 7.52]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215325_x_at	62	0.225806	0.00510326	0.0961766	-1.48509	0.827836	0.302638	1.35 [0.09 - 20.70]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203926_x_at	51	0.588235	0.0580675	-	-15.9122	0.395855	-0.789164	0.45 [0.07 - 2.81]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203926_x_at	62	0.16129	0.399332	-	0.854371	0.909164	-0.0665502	0.94 [0.30 - 2.94]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213041_s_at	51	0.72549	0.169046	-	-15.5239	0.878769	-0.0948771	0.91 [0.27 - 3.08]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203926_x_at	145	0.841379	0.26928	-	-0.57873	0.807508	-0.134835	0.87 [0.30 - 2.59]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215325_x_at	177	0.158192	0.00397267	0.0788898	-0.905686	0.0415159	-0.808693	0.45 [0.20 - 0.97]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213041_s_at	177	0.372881	0.157915	-	-0.379424	0.582333	-0.193129	0.82 [0.41 - 1.64]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215325_x_at	177	0.79096	0.0245527	0.309163	-0.781844	0.0589989	-0.657767	0.52 [0.26 - 1.03]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215325_x_at	145	0.22069	0.00827658	0.139894	-0.910376	0.134893	-0.749912	0.47 [0.18 - 1.26]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203926_x_at	177	0.169492	0.286739	-	-0.360116	0.740063	0.150647	1.16 [0.48 - 2.83]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213041_s_at	177	0.101695	0.0884619	-	-0.551618	0.876335	-0.0476559	0.95 [0.52 - 1.74]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203926_x_at	177	0.40678	0.246092	-	0.282891	0.507946	0.261211	1.30 [0.60 - 2.81]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213041_s_at	145	0.882759	0.0784509	-	-1.6077	0.295102	-0.46093	0.63 [0.27 - 1.49]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215325_x_at	226	0.216814	0.126216	-	0.656394	0.347498	0.0983643	1.10 [0.90 - 1.35]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213041_s_at	226	0.106195	0.0101316	0.163057	-0.882852	0.0580692	-0.614253	0.54 [0.29 - 1.02]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203926_x_at	226	0.548673	0.0704943	-	0.519571	0.79384	0.0455435	1.05 [0.74 - 1.47]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215325_x_at	55	0.490909	0.0155967	0.224266	-1.12269	0.154228	-1.2795	0.28 [0.05 - 1.62]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213041_s_at	55	0.109091	0.106346	-	-0.875767	0.654457	-0.146244	0.86 [0.46 - 1.64]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215325_x_at	55	0.490909	0.101522	-	-0.79118	0.430944	-0.739791	0.48 [0.08 - 3.01]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215325_x_at	49	0.265306	0.0749343	-	-1.00692	0.236792	-1.3221	0.27 [0.03 - 2.38]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203926_x_at	55	0.872727	0.27878	-	-1.06157	0.877986	-0.0706308	0.93 [0.38 - 2.30]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213041_s_at	55	0.109091	0.0404443	0.430703	-1.15828	0.469881	-0.261929	0.77 [0.38 - 1.57]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213041_s_at	49	0.693878	0.251679	-	-0.86197	0.681639	-0.16598	0.85 [0.38 - 1.87]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203926_x_at	55	0.745455	0.131479	-	-1.08384	0.63632	-0.234493	0.79 [0.30 - 2.09]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203926_x_at	49	0.897959	0.193058	-	-15.2204	0.917107	0.0594257	1.06 [0.35 - 3.25]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	307720	34	0.588235	0.208092	-	-0.575408	0.584335	-0.481998	0.62 [0.11 - 3.47]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	856650	34	0.852941	0.129796	-	-1.1368	0.91548	-0.0276564	0.97 [0.58 - 1.62]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215325_x_at	63	0.253968	0.00134649	0.0326724	-1.0681	0.00901455	-16.7492	0.00 [0.00 - 0.02]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213041_s_at	63	0.380952	0.213624	-	0.45032	0.727225	0.0539545	1.06 [0.78 - 1.43]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203926_x_at	63	0.396825	0.151115	-	0.518822	0.723587	0.0623247	1.06 [0.75 - 1.50]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.89761.1.S1_3p_a_at	28	0.214286	0.139885	-	1.09365	0.315638	0.222781	1.25 [0.81 - 1.93]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.193187.0.S1_3p_at	28	0.678571	0.0403548	0.430095	-1.47818	0.166556	-16.0937	0.00 [0.00 - 819.38]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.193187.0.S1_3p_x_at	28	0.821429	0.0454532	0.463574	-15.452	0.0875777	-21.2554	0.00 [0.00 - 22.91]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213041_s_at	82	0.536585	0.00529229	0.0989628	0.949201	0.291039	0.870811	2.39 [0.47 - 12.03]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215325_x_at	82	0.378049	0.0738706	-	-0.595505	0.573566	-0.105255	0.90 [0.62 - 1.30]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203926_x_at	82	0.792683	0.0633523	-	0.6862	0.497329	0.606248	1.83 [0.32 - 10.56]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37993_at	84	0.107143	0.0269326	0.329379	-0.946398	0.25119	-0.839786	0.43 [0.10 - 1.81]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33695_at	84	0.142857	0.0909037	-	-0.653669	0.537017	-0.373247	0.69 [0.21 - 2.25]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37992_s_at	84	0.166667	0.0125319	0.191074	1.37877	0.800819	0.0968659	1.10 [0.52 - 2.34]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213041_s_at	79	0.78481	0.00644262	0.115371	0.805298	0.0568759	0.72399	2.06 [0.98 - 4.35]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215325_x_at	79	0.202532	0.361129	-	0.315732	0.92692	0.0226787	1.02 [0.63 - 1.66]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203926_x_at	79	0.822785	0.00204518	0.0461316	0.953573	0.064559	0.694017	2.00 [0.96 - 4.18]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X63422_at	86	0.139535	0.0544171	-	-0.954927	0.564429	0.335111	1.40 [0.45 - 4.37]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203926_x_at	104	0.240385	0.138682	-	-0.509775	0.81372	0.129776	1.14 [0.39 - 3.35]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213041_s_at	104	0.538462	0.141235	-	0.483071	0.58771	0.297662	1.35 [0.46 - 3.95]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215325_x_at	104	0.548077	0.00700396	0.123073	0.882726	0.0395384	0.579431	1.79 [1.03 - 3.10]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P5089	117	0.350427	0.00704758	0.123663	-0.766203	0.188727	-0.482191	0.62 [0.30 - 1.27]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P168456	117	0.57265	0.0657685	-	-0.552054	0.21916	-0.365575	0.69 [0.39 - 1.24]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213041_s_at	204	0.852941	0.0494878	0.488543	0.633301	0.0995576	1.01764	2.77 [0.82 - 9.29]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203926_x_at	204	0.833333	0.000121114	0.00414502	1.33627	0.349644	0.485959	1.63 [0.59 - 4.50]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203926_x_at	204	0.833333	1.65358e-05	0.000703801	1.17817	0.20176	0.503801	1.65 [0.76 - 3.59]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215325_x_at	204	0.857843	0.427522	-	0.360384	0.834806	-0.0449783	0.96 [0.63 - 1.46]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215325_x_at	204	0.495098	0.0488519	0.484691	0.548514	0.963891	-0.00742097	0.99 [0.72 - 1.37]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213041_s_at	204	0.852941	0.335584	-	0.437105	0.854145	-0.154509	0.86 [0.16 - 4.45]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213041_s_at	178	0.595506	0.0971448	-	0.328104	0.883889	-0.0569687	0.94 [0.44 - 2.03]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215325_x_at	178	0.123596	0.238056	-	-0.329124	0.656931	-0.0656579	0.94 [0.70 - 1.25]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203926_x_at	178	0.101124	0.0838655	-	-0.493169	0.517572	-0.264479	0.77 [0.34 - 1.71]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010388	41	0.853659	0.0322224	0.371539	1.04484	0.813653	0.0527328	1.05 [0.68 - 1.63]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203926_x_at	111	0.315315	0.0603544	-	0.583573	0.650385	0.148322	1.16 [0.61 - 2.20]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215325_x_at	111	0.198198	0.10655	-	0.577433	0.592381	0.0718329	1.07 [0.83 - 1.40]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213041_s_at	111	0.873874	0.0109415	0.172736	0.867791	0.873568	-0.0656661	0.94 [0.42 - 2.10]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213041_s_at	90	0.655556	0.238374	-	-0.506852	0.508281	-0.276332	0.76 [0.33 - 1.72]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213041_s_at	90	0.711111	0.230937	-	-0.473124	0.553347	-0.214923	0.81 [0.40 - 1.64]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215325_x_at	90	0.133333	0.0668626	-	1.24967	0.33715	0.464695	1.59 [0.62 - 4.11]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215325_x_at	90	0.133333	0.0682076	-	1.6598	0.168366	0.643742	1.90 [0.76 - 4.76]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203926_x_at	90	0.7	0.100184	-	-0.675582	0.533359	-0.289818	0.75 [0.30 - 1.86]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203926_x_at	90	0.544444	0.166818	-	-0.534974	0.507949	-0.354739	0.70 [0.25 - 2.00]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5101	50	0.88	0.400353	-	-0.843929	0.875883	-0.0777501	0.93 [0.35 - 2.45]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203926_x_at	138	0.202899	0.0534176	-	-0.518321	0.187433	-0.283882	0.75 [0.49 - 1.15]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215325_x_at	138	0.898551	0.00153199	0.0363641	1.00939	0.0390953	1.82367	6.19 [1.10 - 35.03]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213041_s_at	138	0.724638	0.0418455	0.44012	-0.618496	0.237206	-0.223102	0.80 [0.55 - 1.16]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203926_x_at	129	0.728682	0.204695	-	0.327386	0.816678	0.109853	1.12 [0.44 - 2.83]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213041_s_at	129	0.255814	0.222781	-	0.38711	0.532567	0.24426	1.28 [0.59 - 2.75]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215325_x_at	129	0.116279	0.197275	-	0.546301	0.603149	-0.105816	0.90 [0.60 - 1.34]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43242	56	0.875	0.130531	-	-1.07344	0.520996	-0.198508	0.82 [0.45 - 1.50]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8092	56	0.732143	0.14441	-	-0.664782	0.825296	-0.0574563	0.94 [0.57 - 1.57]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43242	56	0.803571	0.0451182	0.461443	-1.35966	0.214301	-0.42369	0.65 [0.34 - 1.28]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8092	56	0.732143	0.0254617	0.316984	-1.2792	0.372617	-0.25154	0.78 [0.45 - 1.35]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215325_x_at	278	0.208633	0.0597413	-	-0.427867	0.206472	-0.384814	0.68 [0.37 - 1.24]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213041_s_at	278	0.643885	0.00454647	0.0878038	-0.595085	0.0653825	-0.284507	0.75 [0.56 - 1.02]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203926_x_at	278	0.543165	0.0736941	-	-0.34044	0.481042	-0.14875	0.86 [0.57 - 1.30]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215325_x_at	133	0.593985	0.00255711	0.0553515	0.707399	0.232446	0.522928	1.69 [0.72 - 3.98]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203926_x_at	133	0.556391	0.0560272	-	0.451764	0.220756	0.288098	1.33 [0.84 - 2.12]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213041_s_at	133	0.503759	0.113695	-	0.376686	0.549869	0.0998399	1.10 [0.80 - 1.53]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213041_s_at	185	0.491892	0.164175	-	-0.229869	0.678442	0.0394373	1.04 [0.86 - 1.25]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215325_x_at	185	0.389189	0.000261134	0.00810284	-0.64982	0.0190487	-1.04536	0.35 [0.15 - 0.84]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203926_x_at	185	0.778378	0.177462	-	0.248147	0.918928	0.0143199	1.01 [0.77 - 1.34]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213041_s_at	185	0.854054	0.0778216	-	0.391395	0.793168	0.0276192	1.03 [0.84 - 1.26]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203926_x_at	185	0.778378	0.0495223	0.48875	0.380899	0.706785	0.057662	1.06 [0.78 - 1.43]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215325_x_at	185	0.389189	0.000701442	0.0188996	-0.564116	0.0194508	-0.942126	0.39 [0.18 - 0.86]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P5089	110	0.890909	0.0795976	-	-0.793426	0.707541	-0.0769029	0.93 [0.62 - 1.38]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P168456	110	0.2	0.0691452	-	-0.630209	0.447428	-0.178724	0.84 [0.53 - 1.33]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P5089	110	0.127273	0.0196169	0.264308	-0.863536	0.234075	-0.313718	0.73 [0.44 - 1.23]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P168456	110	0.645455	0.0816175	-	-0.431856	0.975775	0.00552683	1.01 [0.70 - 1.44]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203926_x_at	80	0.7125	0.144395	-	-0.796804	0.957149	0.0184362	1.02 [0.52 - 2.00]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213041_s_at	80	0.7	0.0476222	0.477155	0.840191	0.835174	0.0702588	1.07 [0.55 - 2.08]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215325_x_at	80	0.1125	0.0515019	-	-1.07271	0.377281	-0.156749	0.85 [0.60 - 1.21]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0889	281	0.882562	0.10214	-	-0.376908	0.673356	-0.0502606	0.95 [0.75 - 1.20]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:307720	59	0.220339	0.0160137	0.228589	-1.12525	0.154331	-1.51995	0.22 [0.03 - 1.77]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215325_x_at	38	0.552632	0.0391448	0.421807	-1.0055	0.518912	-0.306058	0.74 [0.29 - 1.87]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213041_s_at	38	0.815789	0.0769115	-	0.914753	0.238606	0.604322	1.83 [0.67 - 5.00]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203926_x_at	38	0.868421	0.00201496	0.0455723	1.69783	0.238769	0.738002	2.09 [0.61 - 7.14]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213041_s_at	140	0.107143	0.017296	0.241627	-0.86071	0.210907	-0.458119	0.63 [0.31 - 1.30]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215325_x_at	140	0.114286	0.101888	-	-0.596244	0.870472	-0.181916	0.83 [0.09 - 7.42]
GENE	ATP5D	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203926_x_at	140	0.421429	0.288261	-	-0.306714	0.690927	-0.16656	0.85 [0.37 - 1.92]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217801_at	30	0.433333	0.0518681	-	-0.766344	0.24725	-0.510876	0.60 [0.25 - 1.43]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1756674	165	0.212121	0.046495	0.470144	0.646774	0.122316	0.480358	1.62 [0.88 - 2.97]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1756674	165	0.309091	0.0318609	0.368769	1.00515	0.339935	0.439599	1.55 [0.63 - 3.83]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217801_at	163	0.865031	0.0364856	0.403091	-0.683717	0.894321	-0.0326341	0.97 [0.60 - 1.57]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217801_at	79	0.670886	0.267061	-	-0.352697	0.984489	-0.00887221	0.99 [0.41 - 2.42]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217801_at	58	0.741379	0.31838	-	0.313751	0.846872	0.10614	1.11 [0.38 - 3.27]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217801_at	34	0.794118	0.12478	-	-0.816423	0.967176	-0.00812076	0.99 [0.67 - 1.46]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217801_at	158	0.367089	0.0709397	-	-0.419337	0.332776	-0.265925	0.77 [0.45 - 1.31]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217801_at	53	0.169811	0.205918	-	-0.544302	0.764883	-0.293838	0.75 [0.11 - 5.11]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217801_at	53	0.716981	0.184991	-	-0.556952	0.488395	-0.662883	0.52 [0.08 - 3.36]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217801_at	180	0.583333	0.0454807	0.463749	0.419115	0.241386	0.341026	1.41 [0.79 - 2.49]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217801_at	559	0.284436	0.0392112	0.422265	0.542923	0.208354	0.406483	1.50 [0.80 - 2.83]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217801_at	77	0.857143	0.0019236	0.0438703	1.0577	0.103018	0.712708	2.04 [0.87 - 4.80]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217801_at	70	0.585714	0.000132921	0.00449761	-1.14645	0.00640163	-1.35088	0.26 [0.10 - 0.68]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217801_at	74	0.837838	0.000456385	0.0131062	1.20039	0.011575	1.59271	4.92 [1.43 - 16.93]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217801_at	67	0.671642	0.0246502	0.310008	1.46909	0.182017	2.20243	9.05 [0.36 - 229.75]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217801_at	115	0.104348	0.0154191	0.222411	-1.33673	0.187177	-1.57662	0.21 [0.02 - 2.15]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217801_at	204	0.387255	0.000501187	0.0141989	-0.517041	0.00144007	-0.875858	0.42 [0.24 - 0.71]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217801_at	87	0.804598	0.0816954	-	0.694268	0.22856	0.746199	2.11 [0.63 - 7.11]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217801_at	87	0.804598	0.0816954	-	0.694268	0.22856	0.746199	2.11 [0.63 - 7.11]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217801_at	77	0.779221	0.0947738	-	-15.4006	0.438488	-0.876024	0.42 [0.05 - 3.82]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217801_at	77	0.779221	0.208903	-	-1.22955	0.648355	-0.428514	0.65 [0.10 - 4.11]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217801_at	136	0.816176	0.000373621	0.0110386	1.50435	0.0028548	2.02785	7.60 [2.00 - 28.80]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217801_at	200	0.725	0.00011117	0.00384441	1.08647	0.00623422	1.72855	5.63 [1.63 - 19.44]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19276	60	0.333333	0.144112	-	-0.552792	0.689948	-0.405502	0.67 [0.09 - 4.89]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19276	60	0.566667	0.00835561	0.140912	0.995495	0.0351944	1.29433	3.65 [1.09 - 12.17]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	10540	155	0.851613	0.000612776	0.0168519	0.986896	0.00652418	0.194685	1.21 [1.06 - 1.40]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217801_at	286	0.744755	0.0014949	0.0356337	0.626148	0.0343702	0.578736	1.78 [1.04 - 3.05]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217801_at	159	0.591195	0.0329035	0.376716	0.665783	0.0405197	0.907192	2.48 [1.04 - 5.90]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217801_at	159	0.779874	0.126443	-	0.521448	0.263755	0.506425	1.66 [0.68 - 4.03]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217801_at	159	0.371069	0.107109	-	0.685884	0.0883202	0.889554	2.43 [0.88 - 6.77]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217801_at	54	0.537037	0.0540931	-	1.43139	0.0981604	2.276	9.74 [0.66 - 144.51]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217801_at	117	0.384615	0.116814	-	-0.493712	0.427778	-0.398562	0.67 [0.25 - 1.80]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217801_at	117	0.384615	0.0492062	0.486841	-0.759956	0.525571	-0.38257	0.68 [0.21 - 2.22]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217801_at	117	0.384615	0.116814	-	-0.493712	0.427778	-0.398562	0.67 [0.25 - 1.80]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217801_at	117	0.384615	0.00670557	0.119002	-1.00601	0.0739895	-1.05826	0.35 [0.11 - 1.11]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217801_at	236	0.372881	5.3614e-05	0.00201736	1.42265	0.000133234	1.74068	5.70 [2.33 - 13.93]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217801_at	249	0.598394	3.03096e-05	0.00121291	0.865178	0.00159418	1.17678	3.24 [1.56 - 6.74]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217801_at	125	0.36	0.0260873	0.322294	1.05257	0.101552	0.675696	1.97 [0.88 - 4.41]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217801_at	125	0.352	0.00427319	0.0835968	1.06298	0.0986372	0.517768	1.68 [0.91 - 3.10]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217801_at	54	0.296296	0.0465855	0.470711	15.5495	0.540455	0.312618	1.37 [0.50 - 3.72]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217801_at	62	0.387097	0.123092	-	0.947328	0.717308	0.151254	1.16 [0.51 - 2.64]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217801_at	198	0.873737	0.142909	-	0.424255	0.281693	0.261657	1.30 [0.81 - 2.09]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217801_at	198	0.686869	0.272565	-	-0.324459	0.935856	-0.0240832	0.98 [0.54 - 1.75]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217801_at	198	0.328283	0.32582	-	0.289838	0.432153	0.23646	1.27 [0.70 - 2.29]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217801_at	51	0.666667	0.012545	0.191221	2.28009	0.0637437	2.67886	14.57 [0.86 - 247.38]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217801_at	62	0.66129	0.134533	-	0.839461	0.504411	0.480331	1.62 [0.39 - 6.62]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217801_at	177	0.887006	0.100337	-	-0.745428	0.834495	-0.0732829	0.93 [0.47 - 1.85]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217801_at	145	0.682759	0.00259748	0.0560599	-1.46482	0.245291	-0.578639	0.56 [0.21 - 1.49]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217801_at	177	0.858757	0.042023	0.4413	-1.14543	0.257199	-0.466572	0.63 [0.28 - 1.41]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217801_at	226	0.247788	0.0907552	-	0.642187	0.923011	-0.0335161	0.97 [0.49 - 1.91]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217801_at	55	0.690909	0.0522088	-	0.889311	0.432051	0.560783	1.75 [0.43 - 7.10]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217801_at	49	0.122449	0.0763355	-	-1.13125	0.610619	-0.474926	0.62 [0.10 - 3.87]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217801_at	55	0.2	0.00298298	0.0627019	-1.28021	0.181719	-0.965967	0.38 [0.09 - 1.57]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	2296286	34	0.647059	0.0256096	0.318245	-1.19639	0.0889487	-1.08694	0.34 [0.10 - 1.18]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217801_at	63	0.68254	0.226556	-	0.428699	0.862919	-0.0373101	0.96 [0.63 - 1.47]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5901895_3p_at	28	0.107143	0.434139	-	0.794949	0.974413	-0.00948673	0.99 [0.55 - 1.77]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217801_at	82	0.536585	0.0503643	-	0.657921	0.496188	0.537339	1.71 [0.36 - 8.04]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217801_at	79	0.620253	0.00873914	0.14581	-0.727429	0.143899	-1.14809	0.32 [0.07 - 1.48]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217801_at	104	0.557692	0.185537	-	0.433604	0.862692	0.163307	1.18 [0.18 - 7.49]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P252322	117	0.649573	0.00240928	0.0527356	0.844614	0.0184657	0.557227	1.75 [1.10 - 2.78]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P123771	117	0.102564	0.0321625	0.371081	1.87738	0.0554652	0.499229	1.65 [0.99 - 2.75]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217801_at	204	0.480392	0.000508567	0.0143773	1.54504	0.000802365	2.43572	11.42 [2.75 - 47.46]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217801_at	204	0.367647	2.02392e-05	0.000844235	1.56492	0.000176207	1.99411	7.35 [2.59 - 20.82]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217801_at	178	0.668539	0.0662524	-	0.370015	0.491592	0.464635	1.59 [0.42 - 5.98]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300008781	41	0.585366	0.330792	-	-0.424781	0.902819	-0.05249	0.95 [0.41 - 2.20]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217801_at	111	0.288288	0.110689	-	0.474033	0.468472	0.264532	1.30 [0.64 - 2.66]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217801_at	90	0.2	0.0261604	0.322911	-0.871793	0.330127	-0.343156	0.71 [0.36 - 1.42]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217801_at	90	0.111111	0.0110344	0.17383	-1.02603	0.228739	-0.374091	0.69 [0.37 - 1.27]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217801_at	138	0.391304	0.040909	0.433846	0.530135	0.216739	0.379353	1.46 [0.80 - 2.67]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217801_at	129	0.472868	0.289444	-	-0.262029	0.988125	-0.00730025	0.99 [0.38 - 2.60]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13467	56	0.875	0.160463	-	-0.82723	0.439417	-0.309015	0.73 [0.34 - 1.61]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36663	56	0.160714	0.0770129	-	-0.759262	0.249281	-0.503151	0.60 [0.26 - 1.42]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13467	56	0.875	0.113882	-	-1.10151	0.274208	-0.478072	0.62 [0.26 - 1.46]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36663	56	0.839286	0.0839912	-	-0.894923	0.409281	-0.329905	0.72 [0.33 - 1.57]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217801_at	278	0.676259	0.0141368	0.208779	0.465752	0.139654	0.373683	1.45 [0.88 - 2.39]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217801_at	133	0.285714	0.0133545	0.200242	-0.593879	0.272885	-0.320755	0.73 [0.41 - 1.29]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12931	81	0.222222	0.170259	-	1.32681	0.588532	0.364012	1.44 [0.38 - 5.38]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217801_at	185	0.789189	0.0907263	-	0.352923	0.885428	0.0162724	1.02 [0.81 - 1.27]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217801_at	185	0.572973	0.180698	-	0.218348	0.784591	0.0277464	1.03 [0.84 - 1.25]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P123771	110	0.881818	0.0327902	0.375859	0.880884	0.0554067	0.629764	1.88 [0.99 - 3.58]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P252322	110	0.209091	0.0253664	0.31617	0.716865	0.119466	0.439511	1.55 [0.89 - 2.70]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P123771	110	0.109091	0.0708997	-	0.816872	0.337063	0.229999	1.26 [0.79 - 2.01]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P252322	110	0.754545	0.0245578	0.309207	0.708301	0.0434745	0.781752	2.19 [1.02 - 4.67]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217801_at	80	0.45	0.0459922	0.466984	0.93775	0.413474	0.411837	1.51 [0.56 - 4.05]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217801_at	38	0.157895	0.0458062	0.46581	1.8138	0.107102	1.87458	6.52 [0.67 - 63.74]
GENE	ATP5E	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217801_at	140	0.892857	0.0148711	0.216638	0.875078	0.539686	-0.299176	0.74 [0.28 - 1.93]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211755_s_at	30	0.866667	0.369799	-	0.517847	0.872002	-0.0984085	0.91 [0.27 - 3.00]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1721989	165	0.884848	0.18146	-	-0.611717	0.898023	0.0168291	1.02 [0.79 - 1.32]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1721989	165	0.442424	0.146992	-	-0.511764	0.605888	-0.0982202	0.91 [0.62 - 1.32]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211755_s_at	163	0.779141	0.0797944	-	0.398509	0.257717	0.242458	1.27 [0.84 - 1.94]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211755_s_at	79	0.860759	0.0039931	0.0792125	0.99589	0.0446407	1.02321	2.78 [1.02 - 7.55]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211755_s_at	58	0.706897	0.127377	-	0.45096	0.405131	0.248576	1.28 [0.71 - 2.30]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211755_s_at	34	0.176471	0.0139619	0.206885	1.68633	0.0514723	1.65684	5.24 [0.99 - 27.78]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211755_s_at	158	0.202532	0.00940008	0.154097	-0.65236	0.101496	-0.417056	0.66 [0.40 - 1.09]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211755_s_at	53	0.320755	0.000286637	0.00878339	-1.21154	0.210606	-1.21107	0.30 [0.04 - 1.98]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211755_s_at	53	0.245283	0.00224585	0.049801	-1.13439	0.19989	-1.33646	0.26 [0.03 - 2.03]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211755_s_at	180	0.155556	0.228306	-	0.371822	0.868977	-0.0947621	0.91 [0.30 - 2.80]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211755_s_at	559	0.101968	0.00285942	0.0605962	-0.777865	0.0295134	-0.638365	0.53 [0.30 - 0.94]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211755_s_at	77	0.857143	0.0147145	0.214973	0.844375	0.213086	0.725035	2.06 [0.66 - 6.46]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211755_s_at	70	0.142857	0.0344043	0.387937	-0.741077	0.460742	-0.254658	0.78 [0.39 - 1.53]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41228_r_at	50	0.34	0.0810315	-	-0.628936	0.403739	-0.517509	0.60 [0.18 - 2.01]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211755_s_at	74	0.797297	0.00305349	0.0638942	0.942639	0.142245	1.42487	4.16 [0.62 - 27.88]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211755_s_at	67	0.686567	0.11255	-	1.02058	0.483217	1.03829	2.82 [0.16 - 51.46]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211755_s_at	115	0.704348	0.0617331	-	0.956917	0.437745	-0.734834	0.48 [0.07 - 3.07]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41228_r_at	158	0.563291	0.0226636	0.292491	0.656707	0.264014	0.294659	1.34 [0.80 - 2.25]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41228_r_at	76	0.144737	0.0728869	-	-1.01317	0.215583	-0.716437	0.49 [0.16 - 1.52]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211755_s_at	204	0.867647	0.0650612	-	0.377787	0.325566	0.275155	1.32 [0.76 - 2.28]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211755_s_at	87	0.574713	0.0102888	0.164954	0.958951	0.499527	0.461095	1.59 [0.42 - 6.05]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211755_s_at	87	0.574713	0.0102888	0.164954	0.958951	0.499527	0.461095	1.59 [0.42 - 6.05]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211755_s_at	77	0.168831	2.01189e-05	0.00083972	-2.29874	0.00325772	-2.26195	0.10 [0.02 - 0.47]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211755_s_at	77	0.168831	7.27092e-08	4.76705e-06	-2.53953	0.000149939	-2.79058	0.06 [0.01 - 0.26]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211755_s_at	136	0.875	0.01595	0.227932	1.11858	0.951363	0.027361	1.03 [0.43 - 2.48]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211755_s_at	200	0.72	0.0334517	0.380844	0.663615	0.0803774	1.30338	3.68 [0.85 - 15.87]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17439	60	0.6	0.00252048	0.0547067	-1.38375	0.0806656	-1.3479	0.26 [0.06 - 1.18]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17439	60	0.666667	0.00184228	0.0423407	-1.54239	0.337793	-1.26691	0.28 [0.02 - 3.76]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12217	155	0.741935	2.4971e-05	0.00101957	1.12584	7.28433e-05	0.470667	1.60 [1.27 - 2.02]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211755_s_at	286	0.405594	0.0672773	-	-0.352019	0.680029	0.156319	1.17 [0.56 - 2.46]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211755_s_at	159	0.893082	0.00122137	0.0301246	1.16415	0.122776	1.0205	2.77 [0.76 - 10.14]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211755_s_at	159	0.867925	0.000335716	0.0100674	1.34019	0.121339	1.23417	3.44 [0.72 - 16.37]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211755_s_at	159	0.867925	0.00310159	0.0647039	1.03554	0.0424614	1.35664	3.88 [1.05 - 14.40]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211755_s_at	54	0.833333	0.166489	-	0.961275	0.612801	0.261942	1.30 [0.47 - 3.58]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211755_s_at	117	0.273504	0.170198	-	0.538278	0.807899	0.0757589	1.08 [0.59 - 1.99]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211755_s_at	117	0.324786	0.106829	-	0.727472	0.836089	-0.0736834	0.93 [0.46 - 1.87]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211755_s_at	117	0.273504	0.170198	-	0.538278	0.807899	0.0757589	1.08 [0.59 - 1.99]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211755_s_at	117	0.504274	0.289301	-	-0.423276	0.64517	-0.181807	0.83 [0.38 - 1.81]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211755_s_at	236	0.868644	0.00665761	0.118343	0.862535	0.40313	0.483389	1.62 [0.52 - 5.04]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211755_s_at	249	0.86747	0.000808724	0.0213163	0.863161	0.14227	0.685869	1.99 [0.79 - 4.96]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211755_s_at	62	0.741935	0.0837864	-	0.821784	0.250249	0.806014	2.24 [0.57 - 8.85]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211755_s_at	125	0.4	0.071212	-	0.814952	0.591521	0.140277	1.15 [0.69 - 1.92]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211755_s_at	125	0.4	0.106738	-	0.538751	0.796028	0.0523016	1.05 [0.71 - 1.57]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211755_s_at	54	0.148148	0.356768	-	0.930232	0.706922	0.29084	1.34 [0.29 - 6.09]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211755_s_at	198	0.722222	0.0059744	0.1088	-1.00001	0.0975687	-0.54665	0.58 [0.30 - 1.11]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211755_s_at	198	0.722222	0.0236743	0.301482	-0.839202	0.277983	-0.372036	0.69 [0.35 - 1.35]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211755_s_at	198	0.257576	0.089164	-	-0.379165	0.663999	-0.12329	0.88 [0.51 - 1.54]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211755_s_at	51	0.764706	0.191154	-	-15.4806	0.657666	-0.365506	0.69 [0.14 - 3.49]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211755_s_at	62	0.419355	0.211672	-	0.810724	0.775386	0.160422	1.17 [0.39 - 3.53]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211755_s_at	177	0.446328	0.0320837	0.370478	-0.577252	0.177528	-0.693735	0.50 [0.18 - 1.37]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211755_s_at	177	0.457627	0.105726	-	-0.378988	0.73972	-0.152598	0.86 [0.35 - 2.11]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211755_s_at	145	0.634483	0.00312634	0.0651194	-1.24263	0.0182787	-1.448	0.24 [0.07 - 0.78]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211755_s_at	226	0.265487	7.46862e-05	0.00270674	-1.07226	0.000246265	-1.76379	0.17 [0.07 - 0.44]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211755_s_at	55	0.872727	0.165497	-	0.760358	0.387315	0.505771	1.66 [0.53 - 5.22]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211755_s_at	55	0.890909	0.328618	-	0.605469	0.770476	0.185015	1.20 [0.35 - 4.17]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211755_s_at	49	0.265306	0.476332	-	-0.433914	0.605601	0.384892	1.47 [0.34 - 6.33]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	34310	34	0.852941	0.256735	-	0.628039	0.840059	0.129294	1.14 [0.32 - 3.99]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211755_s_at	63	0.825397	0.185724	-	-0.692007	0.733969	0.045508	1.05 [0.80 - 1.36]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13543617_3p_s_at	28	0.892857	0.219776	-	-15.1822	0.222187	-0.266361	0.77 [0.50 - 1.18]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211755_s_at	82	0.817073	0.0257978	0.319844	-1.48157	0.264991	-0.490839	0.61 [0.26 - 1.45]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	41228_r_at	84	0.75	0.271462	-	-0.390432	0.616806	-0.217129	0.80 [0.34 - 1.88]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211755_s_at	79	0.683544	0.135178	-	0.412586	0.71416	0.198074	1.22 [0.42 - 3.52]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X60221_at	86	0.5	0.00944499	0.154653	1.23891	0.780089	0.213473	1.24 [0.28 - 5.54]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211755_s_at	104	0.673077	0.0128469	0.194609	0.793703	0.118277	1.04868	2.85 [0.77 - 10.64]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P46275	117	0.666667	0.00237797	0.0521769	0.852483	0.0116346	0.700181	2.01 [1.17 - 3.47]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211755_s_at	204	0.642157	0.00240361	0.0526345	1.08077	0.0173803	2.77913	16.11 [1.63 - 159.05]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211755_s_at	204	0.77451	0.000938527	0.0241632	0.906307	0.00580547	2.38451	10.85 [1.99 - 59.07]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211755_s_at	178	0.780899	0.11399	-	-0.408903	0.710501	0.159234	1.17 [0.51 - 2.72]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300000293	41	0.682927	0.0199326	0.267308	0.957978	0.341686	0.400125	1.49 [0.65 - 3.40]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211755_s_at	111	0.297297	0.00598886	0.109005	0.867849	0.134864	0.527501	1.69 [0.85 - 3.38]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211755_s_at	90	0.866667	0.0471183	0.474034	0.772466	0.712768	-0.0878369	0.92 [0.57 - 1.46]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211755_s_at	90	0.866667	0.0219691	0.286213	0.959646	0.433814	-0.209332	0.81 [0.48 - 1.37]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2636	50	0.66	0.0376928	0.411675	0.975238	0.211167	0.540908	1.72 [0.74 - 4.01]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211755_s_at	138	0.876812	0.0029686	0.0624578	0.896194	0.0332434	0.497718	1.64 [1.04 - 2.60]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211755_s_at	129	0.782946	0.188598	-	0.377652	0.61794	0.281249	1.32 [0.44 - 4.00]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22462	56	0.267857	0.068876	-	-0.688504	0.443004	-0.388807	0.68 [0.25 - 1.83]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22462	56	0.107143	0.103081	-	-0.861032	0.459446	-0.356055	0.70 [0.27 - 1.80]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211755_s_at	278	0.496403	0.0322417	0.371687	-0.404183	0.284403	-0.275873	0.76 [0.46 - 1.26]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211755_s_at	133	0.744361	0.0302185	0.355987	-0.676278	0.433278	-0.12962	0.88 [0.64 - 1.21]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7578	81	0.82716	0.173936	-	0.733644	0.361416	0.460138	1.58 [0.59 - 4.26]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11560	81	0.518519	0.114955	-	0.843316	0.609773	0.264421	1.30 [0.47 - 3.60]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211755_s_at	185	0.410811	0.0601226	-	-0.3124	0.323539	-0.0676857	0.93 [0.82 - 1.07]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211755_s_at	185	0.410811	0.0368928	0.406003	-0.374282	0.361511	-0.0682973	0.93 [0.81 - 1.08]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P46275	110	0.609091	0.149737	-	0.332121	0.637851	0.095333	1.10 [0.74 - 1.64]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P46275	110	0.263636	0.231555	-	0.466049	0.72797	0.0887375	1.09 [0.66 - 1.80]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211755_s_at	80	0.8875	0.0168702	0.23734	1.18227	0.0618592	0.94157	2.56 [0.95 - 6.89]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211755_s_at	38	0.815789	0.00857923	0.143776	1.43679	0.198733	0.987584	2.68 [0.60 - 12.11]
GENE	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211755_s_at	140	0.142857	0.00605434	0.109932	-0.918559	0.219606	-0.512779	0.60 [0.26 - 1.36]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208972_s_at	30	0.733333	0.00230554	0.0508783	1.4804	0.271901	0.867017	2.38 [0.51 - 11.18]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1712430	165	0.70303	0.0145204	0.212902	0.601876	0.393365	0.24572	1.28 [0.73 - 2.25]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1712430	165	0.806061	0.000293241	0.00895808	1.22808	0.0391249	0.845169	2.33 [1.04 - 5.20]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208972_s_at	163	0.871166	0.00616481	0.111489	0.721277	0.287122	0.217447	1.24 [0.83 - 1.85]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208972_s_at	79	0.240506	0.0518212	-	0.738642	0.289861	0.262856	1.30 [0.80 - 2.12]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208972_s_at	58	0.517241	0.0786374	-	0.487616	0.598917	0.157136	1.17 [0.65 - 2.10]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208972_s_at	34	0.764706	0.0388612	0.419844	-1.00936	0.290629	-0.391288	0.68 [0.33 - 1.40]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208972_s_at	158	0.765823	0.0450358	0.460917	-0.624724	0.587003	-0.144001	0.87 [0.51 - 1.46]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208972_s_at	53	0.867925	0.0524363	-	0.853351	0.448031	0.505729	1.66 [0.45 - 6.12]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208972_s_at	53	0.867925	0.169671	-	0.662709	0.631684	0.333746	1.40 [0.36 - 5.47]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208972_s_at	180	0.627778	5.23233e-05	0.00197413	0.831429	0.0102817	0.824232	2.28 [1.21 - 4.28]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208972_s_at	559	0.899821	0.023563	0.300501	0.609176	0.0968363	0.45922	1.58 [0.92 - 2.72]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208972_s_at	77	0.805195	0.0167154	0.235771	0.726002	0.581686	0.255606	1.29 [0.52 - 3.21]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208972_s_at	70	0.142857	0.00804576	0.136904	-0.929209	0.0355754	-0.975088	0.38 [0.15 - 0.94]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38076_at	50	0.86	0.0499681	0.491431	0.958111	0.924282	-0.0180981	0.98 [0.68 - 1.43]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208972_s_at	74	0.891892	0.116077	-	0.639746	0.204522	0.733032	2.08 [0.67 - 6.46]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208972_s_at	67	0.731343	0.134348	-	0.975735	0.16621	1.45359	4.28 [0.55 - 33.50]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208972_s_at	115	0.147826	0.00145369	0.0348177	-1.56627	0.435512	-0.541212	0.58 [0.15 - 2.27]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38076_at	158	0.202532	0.205661	-	-0.419782	0.797285	-0.0919648	0.91 [0.45 - 1.84]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38076_at	76	0.368421	0.0902195	-	-0.856075	0.623855	-0.403947	0.67 [0.13 - 3.36]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208972_s_at	204	0.671569	0.117706	-	-0.238312	0.885681	-0.0186694	0.98 [0.76 - 1.27]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208972_s_at	87	0.632184	0.0485195	0.482665	0.733324	0.821785	-0.0836122	0.92 [0.44 - 1.90]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208972_s_at	87	0.632184	0.0485195	0.482665	0.733324	0.821785	-0.0836122	0.92 [0.44 - 1.90]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208972_s_at	77	0.181818	0.111459	-	15.3673	0.504028	0.506965	1.66 [0.38 - 7.35]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208972_s_at	77	0.181818	0.0671342	-	15.3744	0.496383	0.449801	1.57 [0.43 - 5.73]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208972_s_at	136	0.830882	0.0182335	0.250925	1.05877	0.14894	0.984714	2.68 [0.70 - 10.20]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208972_s_at	200	0.4	0.00995471	0.16091	0.863871	0.0221055	0.978541	2.66 [1.15 - 6.15]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13942	60	0.433333	0.0621108	-	-0.699769	0.801065	-0.106667	0.90 [0.39 - 2.06]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13942	60	0.2	0.129444	-	-0.62709	0.557235	-0.380585	0.68 [0.19 - 2.44]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	8063	155	0.858065	0.00120573	0.0298027	0.959419	0.0443992	0.173177	1.19 [1.00 - 1.41]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208972_s_at	286	0.615385	0.00847735	0.142474	0.506512	0.31457	0.214702	1.24 [0.82 - 1.88]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208972_s_at	159	0.616352	0.0117672	0.182361	0.781336	0.185372	0.556707	1.74 [0.77 - 3.98]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208972_s_at	159	0.622642	0.0333563	0.380128	0.775105	0.0914883	0.813888	2.26 [0.88 - 5.81]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208972_s_at	159	0.377358	0.0278111	0.336635	0.810703	0.170267	0.575636	1.78 [0.78 - 4.05]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208972_s_at	54	0.185185	0.115529	-	15.418	0.0422909	1.20244	3.33 [1.04 - 10.62]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208972_s_at	117	0.273504	0.00732405	0.127384	-0.842797	0.0103513	-0.690563	0.50 [0.30 - 0.85]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208972_s_at	117	0.273504	0.0122442	0.187817	-0.925271	0.017115	-0.76523	0.47 [0.25 - 0.87]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208972_s_at	117	0.273504	0.00732405	0.127384	-0.842797	0.0103513	-0.690563	0.50 [0.30 - 0.85]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208972_s_at	117	0.273504	0.00553264	0.102467	-1.05379	0.126592	-0.4707	0.62 [0.34 - 1.14]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208972_s_at	236	0.851695	0.0701307	-	0.58421	0.684549	0.145056	1.16 [0.57 - 2.33]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208972_s_at	249	0.835341	0.00833351	0.140627	0.648173	0.0579016	0.528595	1.70 [0.98 - 2.93]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208972_s_at	62	0.887097	0.0042107	0.0826252	1.41984	0.672304	0.12061	1.13 [0.65 - 1.97]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208972_s_at	125	0.896	0.000305867	0.00929034	1.45385	0.314625	0.446956	1.56 [0.65 - 3.74]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208972_s_at	125	0.888	0.00060635	0.0167015	1.163	0.286927	0.364229	1.44 [0.74 - 2.81]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208972_s_at	54	0.888889	0.00296504	0.0623975	1.67657	0.581055	0.193981	1.21 [0.61 - 2.42]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208972_s_at	198	0.121212	9.97662e-05	0.00349509	-1.08203	0.0161963	-0.464147	0.63 [0.43 - 0.92]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208972_s_at	198	0.121212	0.000158096	0.00523529	-1.0882	0.0178436	-0.484178	0.62 [0.41 - 0.92]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208972_s_at	198	0.126263	0.00276283	0.0589351	-0.757327	0.320159	-0.183471	0.83 [0.58 - 1.20]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208972_s_at	51	0.176471	0.285015	-	15.3321	0.666395	0.512793	1.67 [0.16 - 17.19]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208972_s_at	62	0.612903	0.066286	-	-1.32669	0.676026	-0.281756	0.75 [0.20 - 2.83]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208972_s_at	177	0.898305	0.16908	-	-0.796336	0.413191	-0.283281	0.75 [0.38 - 1.48]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208972_s_at	177	0.129944	0.20434	-	0.535344	0.862445	-0.0523196	0.95 [0.53 - 1.72]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208972_s_at	145	0.131034	0.00298435	0.0627252	-1.0904	0.00750454	-1.08992	0.34 [0.15 - 0.75]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208972_s_at	226	0.265487	0.000846287	0.0221484	-0.92083	0.0132862	-0.741333	0.48 [0.26 - 0.86]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208972_s_at	55	0.254545	0.149491	-	0.875536	0.86241	0.073812	1.08 [0.47 - 2.48]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208972_s_at	55	0.418182	0.187944	-	-0.642324	0.940821	-0.032931	0.97 [0.41 - 2.31]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208972_s_at	49	0.265306	0.118885	-	1.48969	0.672254	0.237659	1.27 [0.42 - 3.81]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208972_s_at	63	0.31746	0.0461734	0.468125	0.825391	0.161032	0.408389	1.50 [0.85 - 2.66]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5262506_3p_a_at	28	0.607143	0.0315533	0.3664	1.2007	0.39706	0.172803	1.19 [0.80 - 1.77]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208972_s_at	82	0.560976	0.0911587	-	0.564142	0.465408	0.374933	1.45 [0.53 - 3.98]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38076_at	84	0.22619	0.0780586	-	0.704414	0.64481	0.194474	1.21 [0.53 - 2.78]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208972_s_at	79	0.670886	0.190117	-	0.36354	0.769038	0.112547	1.12 [0.53 - 2.37]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D13118_at	86	0.767442	0.302628	-	-0.628121	0.578353	-0.410911	0.66 [0.16 - 2.82]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208972_s_at	104	0.115385	0.0052673	0.0985961	-1.08941	0.54817	-0.307309	0.74 [0.27 - 2.01]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P164228	117	0.897436	0.000505853	0.0143117	1.21779	0.000546836	1.20019	3.32 [1.68 - 6.56]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208972_s_at	204	0.568627	0.00125971	0.0309106	1.21078	0.00593069	1.10084	3.01 [1.37 - 6.59]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208972_s_at	204	0.622549	2.12807e-07	1.29787e-05	1.38635	2.02985e-05	1.24576	3.48 [1.96 - 6.16]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208972_s_at	178	0.185393	0.0302443	0.356191	-0.502306	0.752526	-0.100723	0.90 [0.48 - 1.69]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300004324	41	0.609756	0.00807128	0.137236	1.06459	0.118134	0.493123	1.64 [0.88 - 3.04]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208972_s_at	111	0.792793	0.143445	-	-0.550123	0.519328	-0.159603	0.85 [0.52 - 1.39]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208972_s_at	90	0.766667	0.0319656	0.369573	0.719151	0.965811	-0.0139213	0.99 [0.52 - 1.86]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208972_s_at	90	0.777778	0.0313738	0.365013	0.819226	0.894859	-0.049275	0.95 [0.46 - 1.98]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5441	50	0.7	0.0243053	0.307012	1.04531	0.472034	0.876809	2.40 [0.22 - 26.22]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208972_s_at	138	0.144928	0.0269518	0.329539	0.987174	0.6921	0.0590381	1.06 [0.79 - 1.42]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208972_s_at	129	0.813953	0.158133	-	-0.504278	0.969153	-0.0143155	0.99 [0.48 - 2.04]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10278	56	0.25	0.0252209	0.314924	-0.85633	0.380211	-0.290258	0.75 [0.39 - 1.43]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	45020	56	0.142857	0.0669701	-	-0.891367	0.422798	-0.262716	0.77 [0.40 - 1.46]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30578	56	0.107143	0.19318	-	-0.698028	0.523247	-0.20939	0.81 [0.43 - 1.54]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	45020	56	0.142857	0.00898058	0.148859	-1.28147	0.236151	-0.416404	0.66 [0.33 - 1.31]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10278	56	0.178571	0.129509	-	-0.641276	0.6467	-0.141639	0.87 [0.47 - 1.59]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30578	56	0.196429	0.042023	0.4413	-0.833264	0.332254	-0.346661	0.71 [0.35 - 1.42]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208972_s_at	278	0.118705	0.0217618	0.284323	0.86484	0.963797	-0.00835748	0.99 [0.69 - 1.42]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208972_s_at	133	0.548872	0.0456555	0.464857	0.467471	0.385088	0.130288	1.14 [0.85 - 1.53]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5062	81	0.888889	0.0243364	0.307283	1.25967	0.472409	0.324431	1.38 [0.57 - 3.35]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16414	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17389	81	0.185185	0.0486391	0.483395	15.4576	0.212316	0.864187	2.37 [0.61 - 9.23]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208972_s_at	185	0.864865	0.117278	-	0.347524	0.630858	0.0621365	1.06 [0.83 - 1.37]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208972_s_at	185	0.864865	0.037019	0.406902	0.475875	0.259705	0.154619	1.17 [0.89 - 1.53]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P164228	110	0.681818	0.165919	-	0.425774	0.872586	0.0385396	1.04 [0.65 - 1.66]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P164228	110	0.227273	0.0993107	-	0.500268	0.442866	0.140596	1.15 [0.80 - 1.65]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208972_s_at	80	0.175	0.106497	-	-0.736297	0.422175	-0.294464	0.74 [0.36 - 1.53]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208972_s_at	38	0.631579	0.000469462	0.013427	1.63638	0.00382796	2.30942	10.07 [2.10 - 48.16]
GENE	ATP5G1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208972_s_at	140	0.871429	0.157279	-	0.575425	0.899273	-0.0569245	0.94 [0.39 - 2.28]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208764_s_at	30	0.833333	0.245639	-	-0.696106	0.938561	-0.0290069	0.97 [0.46 - 2.03]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207552_at	30	0.133333	0.0236669	0.301418	1.9954	0.139829	0.771277	2.16 [0.78 - 6.02]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1807798	165	0.218182	0.0141629	0.209061	-0.63278	0.70381	-0.0889454	0.91 [0.58 - 1.45]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1807798	165	0.139394	0.00305465	0.0639138	-1.10994	0.118915	-0.451828	0.64 [0.36 - 1.12]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207552_at	163	0.257669	0.164912	-	-0.304333	0.841636	-0.1193	0.89 [0.28 - 2.86]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208764_s_at	163	0.576687	0.0133385	0.200065	0.486841	0.122456	0.205174	1.23 [0.95 - 1.59]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207552_at	79	0.189873	0.00748912	0.129585	1.30716	0.160536	1.07056	2.92 [0.65 - 13.01]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208764_s_at	79	0.35443	0.159918	-	0.446545	0.507391	0.131968	1.14 [0.77 - 1.69]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207552_at	58	0.568965	0.00399505	0.0792433	0.857911	0.246081	0.208018	1.23 [0.87 - 1.75]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208764_s_at	58	0.827586	1.07334e-05	0.000476361	1.62236	0.0355497	0.837911	2.31 [1.06 - 5.05]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207552_at	34	0.705882	0.276961	-	-0.477472	0.993056	-0.00258919	1.00 [0.56 - 1.79]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208764_s_at	34	0.352941	0.132948	-	0.668051	0.630428	0.18685	1.21 [0.56 - 2.58]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207552_at	158	0.107595	0.0524534	-	0.87209	0.492067	0.451631	1.57 [0.43 - 5.70]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208764_s_at	158	0.386076	0.0158962	0.227375	-0.553066	0.502856	-0.149878	0.86 [0.56 - 1.33]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208764_s_at	53	0.207547	0.116976	-	0.743287	0.949876	-0.0368663	0.96 [0.31 - 3.04]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207552_at	53	0.716981	0.00526885	0.0986188	1.00128	0.0385502	0.489654	1.63 [1.03 - 2.59]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208764_s_at	53	0.207547	0.32471	-	0.479726	0.897069	0.0818191	1.09 [0.31 - 3.75]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207552_at	53	0.792453	0.00821008	0.139035	0.9572	0.0568021	0.418471	1.52 [0.99 - 2.34]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208764_s_at	180	0.394444	0.202703	-	-0.268349	0.81847	-0.0962433	0.91 [0.40 - 2.07]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207552_at	180	0.772222	0.201834	-	-0.329802	0.444471	-0.0849813	0.92 [0.74 - 1.14]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207552_at	559	0.232558	0.00518859	0.0974376	-0.610252	0.114903	-0.170591	0.84 [0.68 - 1.04]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208764_s_at	559	0.268336	0.101477	-	0.38734	0.674864	0.115829	1.12 [0.65 - 1.93]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207552_at	77	0.298701	0.129121	-	0.446928	0.68142	0.0911512	1.10 [0.71 - 1.69]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208764_s_at	77	0.155844	0.00727675	0.12675	-0.889184	0.487356	-0.2189	0.80 [0.43 - 1.49]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207552_at	70	0.614286	0.0384849	0.417227	0.55107	0.212436	0.84887	2.34 [0.62 - 8.87]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208764_s_at	70	0.357143	0.0186706	0.255196	-0.638372	0.108636	-0.644156	0.53 [0.24 - 1.15]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38776_at	50	0.74	0.035922	0.399033	-0.876946	0.16162	-1.51502	0.22 [0.03 - 1.83]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38777_at	50	0.74	0.0377027	0.411744	-0.868771	0.184922	-1.66119	0.19 [0.02 - 2.21]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208764_s_at	74	0.162162	0.0781396	-	-0.598648	0.204563	-0.741079	0.48 [0.15 - 1.50]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207552_at	74	0.472973	0.00666031	0.11838	-0.796492	0.277723	-0.252131	0.78 [0.49 - 1.23]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207552_at	67	0.80597	0.104849	-	-15.4275	0.506921	-1.14682	0.32 [0.01 - 9.40]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208764_s_at	67	0.507463	0.0440322	0.454469	1.48308	0.240105	1.66062	5.26 [0.33 - 84.04]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207552_at	115	0.721739	0.0400737	0.428182	1.05135	0.285955	0.815518	2.26 [0.51 - 10.11]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208764_s_at	115	0.686957	0.0432335	0.449276	-1.83134	0.0418276	-1.34526	0.26 [0.07 - 0.95]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38776_at	158	0.164557	0.00334308	0.0687246	-0.873162	0.250264	-0.172952	0.84 [0.63 - 1.13]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38777_at	158	0.120253	0.0248255	0.311523	-0.78072	0.436018	-0.133896	0.87 [0.62 - 1.23]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38776_at	76	0.236842	0.0236226	0.301027	15.4814	0.117988	1.00155	2.72 [0.78 - 9.56]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38777_at	76	0.776316	0.000213283	0.00679728	1.74912	0.00752286	1.15826	3.18 [1.36 - 7.45]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208764_s_at	204	0.446078	0.0019133	0.0436774	-0.444416	0.0406749	-0.407946	0.67 [0.45 - 0.98]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207552_at	204	0.27451	0.00182492	0.0420122	-0.490834	0.307146	-0.0776152	0.93 [0.80 - 1.07]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208764_s_at	87	0.724138	0.0401082	0.428417	0.766108	0.968481	0.0248961	1.03 [0.30 - 3.52]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207552_at	87	0.356322	0.00995354	0.160896	-0.950172	0.0809039	-1.6128	0.20 [0.03 - 1.22]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208764_s_at	87	0.724138	0.0401082	0.428417	0.766108	0.968481	0.0248961	1.03 [0.30 - 3.52]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207552_at	87	0.356322	0.00995354	0.160896	-0.950172	0.0809039	-1.6128	0.20 [0.03 - 1.22]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208764_s_at	77	0.584416	0.0300186	0.354409	-1.95943	0.137887	-1.36325	0.26 [0.04 - 1.55]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207552_at	77	0.857143	0.167612	-	-15.2828	0.81021	0.361353	1.44 [0.08 - 27.40]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208764_s_at	77	0.831169	0.0789458	-	-15.3486	0.407413	-0.698307	0.50 [0.10 - 2.60]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207552_at	77	0.857143	0.115269	-	-15.2828	0.542229	-0.832392	0.44 [0.03 - 6.33]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208764_s_at	136	0.852941	0.0551821	-	0.905203	0.873997	0.0776338	1.08 [0.41 - 2.82]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207552_at	136	0.102941	2.2364e-05	0.000923487	-1.77827	0.00712265	-0.636614	0.53 [0.33 - 0.84]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208764_s_at	200	0.31	0.0517768	-	-0.574435	0.290427	-0.602733	0.55 [0.18 - 1.67]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207552_at	200	0.83	0.0815115	-	-0.883634	0.419301	-0.152271	0.86 [0.59 - 1.24]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4719	60	0.433333	0.0454994	0.463867	-0.748219	0.332382	-1.1426	0.32 [0.03 - 3.21]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4719	60	0.25	0.00226925	0.0502242	-1.11315	0.62414	-0.524513	0.59 [0.07 - 4.82]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	13395	155	0.122581	6.6612e-07	3.73946e-05	-1.41238	0.00391964	-0.353384	0.70 [0.55 - 0.89]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208764_s_at	286	0.423077	0.0120506	0.185611	-0.481302	0.124108	-0.346578	0.71 [0.45 - 1.10]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207552_at	286	0.744755	0.048241	0.480962	0.404085	0.349585	0.126523	1.13 [0.87 - 1.48]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207552_at	159	0.886792	0.235941	-	0.575281	0.899889	-0.0350879	0.97 [0.56 - 1.67]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208764_s_at	159	0.113208	0.177317	-	-0.555436	0.407387	-0.406619	0.67 [0.25 - 1.74]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207552_at	159	0.886792	0.145131	-	0.597934	0.854482	0.0451294	1.05 [0.65 - 1.69]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208764_s_at	159	0.132075	0.0624706	-	-0.788545	0.332834	-0.558445	0.57 [0.18 - 1.77]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207552_at	159	0.72327	0.10849	-	-0.656268	0.20209	-0.281953	0.75 [0.49 - 1.16]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208764_s_at	159	0.113208	0.0503086	-	-0.756276	0.3324	-0.47789	0.62 [0.24 - 1.63]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208764_s_at	54	0.740741	0.257785	-	0.743202	0.696118	0.314739	1.37 [0.28 - 6.65]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207552_at	54	0.777778	0.0179141	0.247779	1.49474	0.407651	0.905072	2.47 [0.29 - 21.06]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207552_at	117	0.888889	0.0745816	-	-1.62214	0.999386	-0.000617576	1.00 [0.21 - 4.82]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207552_at	117	0.888889	0.0573819	-	-15.195	0.674156	-0.410405	0.66 [0.10 - 4.49]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207552_at	117	0.888889	0.0745816	-	-1.62214	0.999386	-0.000617576	1.00 [0.21 - 4.82]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207552_at	117	0.623932	0.0413678	0.43693	-0.975818	0.121812	-1.66894	0.19 [0.02 - 1.56]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208764_s_at	117	0.393162	0.0430582	0.448129	0.859339	0.329656	0.431068	1.54 [0.65 - 3.66]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208764_s_at	117	0.880342	0.143178	-	0.642878	0.969909	0.0134428	1.01 [0.50 - 2.04]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208764_s_at	117	0.880342	0.143178	-	0.642878	0.969909	0.0134428	1.01 [0.50 - 2.04]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208764_s_at	117	0.393162	0.0957765	-	0.720495	0.888998	0.0624722	1.06 [0.44 - 2.56]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207552_at	236	0.775424	0.131127	-	-0.569565	0.628844	-0.103872	0.90 [0.59 - 1.37]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208764_s_at	236	0.860169	0.0346377	0.389659	0.677105	0.0552777	0.940934	2.56 [0.98 - 6.71]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207552_at	249	0.220884	0.281955	-	-0.263778	0.605866	-0.0897306	0.91 [0.65 - 1.29]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208764_s_at	249	0.477912	0.00192591	0.0439135	0.677888	0.00763174	1.06432	2.90 [1.33 - 6.34]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208764_s_at	54	0.796296	0.00664269	0.118138	1.51318	0.163366	1.41667	4.12 [0.56 - 30.23]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207552_at	62	0.370968	0.0490672	0.485999	1.37252	0.833768	-0.0436391	0.96 [0.64 - 1.44]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207552_at	125	0.152	0.0885945	-	1.57029	0.45928	0.272416	1.31 [0.64 - 2.70]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208764_s_at	62	0.774194	0.000407137	0.0118842	1.58447	0.0303531	1.70112	5.48 [1.18 - 25.56]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207552_at	125	0.128	0.131235	-	1.04623	0.796846	0.0739319	1.08 [0.61 - 1.89]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207552_at	54	0.333333	0.0950664	-	1.58039	0.911516	-0.0280156	0.97 [0.59 - 1.59]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208764_s_at	125	0.352	0.0747567	-	0.860293	0.396654	0.237485	1.27 [0.73 - 2.20]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208764_s_at	125	0.176	0.14148	-	0.755234	0.897155	0.028267	1.03 [0.67 - 1.58]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207552_at	198	0.823232	0.0990976	-	-0.695491	0.307308	-0.111521	0.89 [0.72 - 1.11]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208764_s_at	198	0.292929	0.087811	-	0.429948	0.744159	0.0654492	1.07 [0.72 - 1.58]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207552_at	198	0.823232	0.108716	-	-0.735369	0.379397	-0.101565	0.90 [0.72 - 1.13]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208764_s_at	198	0.863636	0.00778664	0.133516	-1.70244	0.156556	-0.341358	0.71 [0.44 - 1.14]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208764_s_at	198	0.893939	0.00622307	0.112307	-15.2027	0.1067	-0.413314	0.66 [0.40 - 1.09]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207552_at	198	0.707071	0.027976	0.337985	0.478003	0.245835	0.102204	1.11 [0.93 - 1.32]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207552_at	51	0.823529	0.00972032	0.158046	2.00959	0.241566	2.36399	10.63 [0.20 - 555.86]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207552_at	62	0.225806	0.182704	-	1.29921	0.595214	0.718139	2.05 [0.14 - 29.00]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208764_s_at	51	0.27451	0.00545814	0.101385	-2.44946	0.0534909	-1.18448	0.31 [0.09 - 1.02]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208764_s_at	62	0.225806	0.269296	-	-0.665059	0.620558	-0.231553	0.79 [0.32 - 1.98]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208764_s_at	177	0.723164	0.016631	0.234913	-0.936459	0.817608	-0.124513	0.88 [0.31 - 2.54]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207552_at	145	0.6	0.041844	0.44011	-0.770693	0.128936	-1.14723	0.32 [0.07 - 1.40]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207552_at	177	0.310734	0.186503	-	0.418608	0.916563	0.0564393	1.06 [0.37 - 3.04]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208764_s_at	177	0.440678	0.121738	-	0.374218	0.639248	0.221807	1.25 [0.49 - 3.16]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207552_at	177	0.412429	0.329145	-	0.237221	0.924369	-0.0449384	0.96 [0.38 - 2.42]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208764_s_at	145	0.393103	0.0169033	0.237675	-0.789189	0.0895215	-1.12699	0.32 [0.09 - 1.19]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208764_s_at	226	0.429204	0.00435982	0.0849378	-0.810904	0.0456036	-1.04944	0.35 [0.13 - 0.98]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207552_at	226	0.685841	0.0921069	-	0.478401	0.389172	0.102475	1.11 [0.88 - 1.40]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208764_s_at	55	0.890909	0.0872065	-	-15.2214	0.758119	0.13494	1.14 [0.48 - 2.70]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208764_s_at	55	0.254545	0.0283302	0.340873	1.89698	0.697736	0.194063	1.21 [0.46 - 3.23]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207552_at	55	0.781818	0.0608289	-	0.860337	0.718336	0.474795	1.61 [0.12 - 21.22]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208764_s_at	49	0.326531	0.0429446	0.447384	1.84433	0.645751	0.269771	1.31 [0.41 - 4.14]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207552_at	55	0.836364	0.0779779	-	0.941236	0.459997	0.964219	2.62 [0.20 - 33.85]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207552_at	49	0.857143	0.027931	0.337617	1.281	0.879502	0.242915	1.27 [0.06 - 29.47]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	809876	34	0.147059	0.014597	0.213721	15.4312	0.247591	0.690794	2.00 [0.62 - 6.44]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208764_s_at	63	0.206349	0.102733	-	0.779112	0.527763	0.14243	1.15 [0.74 - 1.79]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207552_at	63	0.222222	9.2122e-06	0.000414779	-1.47131	0.518463	-1.77463	0.17 [0.00 - 37.04]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6671590_3p_at	28	0.178571	0.052084	-	-1.06381	0.136151	-0.197407	0.82 [0.63 - 1.06]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g285909_3p_a_at	28	0.892857	0.105524	-	-15.2876	0.233849	-0.266266	0.77 [0.49 - 1.19]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6671590_3p_a_at	28	0.25	0.0468457	0.472336	-1.13531	0.0806997	-11.5425	0.00 [0.00 - 4.10]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g285909_3p_x_at	28	0.857143	0.113805	-	-15.2931	0.874209	-0.0238233	0.98 [0.73 - 1.31]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	208764_3p_s_at	28	0.214286	0.0454224	0.463378	-1.13132	0.0785652	-4.5186	0.01 [0.00 - 1.68]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208764_s_at	82	0.756098	1.66613e-05	0.000708614	1.38741	0.000670525	2.52307	12.47 [2.91 - 53.35]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207552_at	82	0.463415	0.101443	-	0.56627	0.443798	0.478873	1.61 [0.47 - 5.50]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208764_s_at	79	0.139241	0.0144018	0.211631	-0.844167	0.107661	-0.937463	0.39 [0.12 - 1.23]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207552_at	79	0.886076	0.00639829	0.114755	0.975272	0.0886818	1.09451	2.99 [0.85 - 10.53]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X69908_rna1_at	86	0.895349	0.026711	0.327531	1.16737	0.0405029	1.39895	4.05 [1.06 - 15.45]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208764_s_at	104	0.740385	0.00938053	0.153855	-1.28482	0.0304549	-1.23018	0.29 [0.10 - 0.89]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207552_at	104	0.182692	0.046098	0.467651	1.14256	0.175532	1.19814	3.31 [0.59 - 18.76]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P87616	117	0.641026	0.0237383	0.302046	0.641083	0.254769	0.500117	1.65 [0.70 - 3.90]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207552_at	204	0.210784	0.00606001	0.110012	-0.787435	0.203085	-0.219497	0.80 [0.57 - 1.13]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208764_s_at	204	0.20098	0.050677	-	1.33026	0.25976	0.745833	2.11 [0.58 - 7.71]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208764_s_at	204	0.52451	0.00035665	0.0106059	1.00491	9.95384e-05	1.86448	6.45 [2.52 - 16.50]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207552_at	204	0.367647	0.00609797	0.110548	-0.976097	0.0426173	-0.482686	0.62 [0.39 - 0.98]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207552_at	178	0.758427	0.00497435	0.0942606	0.610153	0.131804	0.762332	2.14 [0.80 - 5.78]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208764_s_at	178	0.876405	0.0029978	0.062953	0.758458	0.602534	-0.24206	0.79 [0.32 - 1.95]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010315	41	0.390244	0.0477844	0.478156	-0.813058	0.87993	-0.0669557	0.94 [0.39 - 2.23]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208764_s_at	111	0.459459	0.24302	-	0.308887	0.985568	0.00591419	1.01 [0.53 - 1.91]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207552_at	111	0.837838	0.151652	-	0.463939	0.84705	0.0393344	1.04 [0.70 - 1.55]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207552_at	90	0.155556	0.146727	-	0.751073	0.451267	0.331613	1.39 [0.59 - 3.30]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207552_at	90	0.744444	0.025699	0.319005	0.820218	0.0990759	0.686673	1.99 [0.88 - 4.49]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208764_s_at	90	0.777778	0.0418396	0.440081	0.697148	0.914874	0.0412294	1.04 [0.49 - 2.22]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208764_s_at	90	0.777778	0.214639	-	0.510708	0.462398	-0.317068	0.73 [0.31 - 1.70]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5103	50	0.26	0.385081	-	0.544136	0.668702	0.210924	1.23 [0.47 - 3.24]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208764_s_at	138	0.130435	0.170992	-	-0.43244	0.32094	-0.300361	0.74 [0.41 - 1.34]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207552_at	138	0.101449	0.0159265	0.227689	-0.777431	0.549262	-2.15007	0.12 [0.00 - 132.53]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208764_s_at	129	0.860465	0.0124277	0.189897	0.762408	0.246766	0.505661	1.66 [0.70 - 3.90]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207552_at	129	0.883721	0.0607083	-	0.643565	0.535533	0.126019	1.13 [0.76 - 1.69]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5335	56	0.767857	0.112379	-	-0.663902	0.54441	-0.262627	0.77 [0.33 - 1.80]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5335	56	0.767857	0.0294277	0.349714	-1.02735	0.150208	-0.666372	0.51 [0.21 - 1.27]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208764_s_at	278	0.895683	0.0708051	-	-0.636311	0.534098	-0.119891	0.89 [0.61 - 1.29]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207552_at	278	0.557554	0.109541	-	0.300756	0.942037	0.0336928	1.03 [0.42 - 2.56]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207552_at	133	0.56391	0.000230836	0.00728085	0.858691	0.0147041	2.97181	19.53 [1.79 - 212.60]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208764_s_at	133	0.62406	0.00551953	0.102277	0.646052	0.0762115	0.364024	1.44 [0.96 - 2.15]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3165	81	0.160494	0.0285179	0.342396	15.5221	0.0808438	1.34553	3.84 [0.85 - 17.39]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3612	81	0.296296	0.0857059	-	1.2322	0.330146	0.670117	1.95 [0.51 - 7.53]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	698	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18023	81	0.790123	0.0279052	0.337406	1.10742	0.0421877	1.33768	3.81 [1.05 - 13.85]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207552_at	185	0.151351	0.0209563	0.276907	0.511888	0.42139	0.16683	1.18 [0.79 - 1.77]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208764_s_at	185	0.443243	0.0337131	0.382801	-0.380242	0.962283	-0.00505447	0.99 [0.81 - 1.23]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207552_at	185	0.145946	0.0351049	0.393089	0.5281	0.549821	0.135041	1.14 [0.74 - 1.78]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208764_s_at	185	0.475676	0.02209	0.287313	-0.377655	0.99429	0.000688872	1.00 [0.83 - 1.21]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87616	110	0.881818	0.201713	-	-0.503181	0.395814	-0.23324	0.79 [0.46 - 1.36]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87616	110	0.881818	0.179841	-	-0.783768	0.45838	-0.266205	0.77 [0.38 - 1.55]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208764_s_at	80	0.125	5.14834e-06	0.000244439	-1.92886	0.104016	-0.77611	0.46 [0.18 - 1.17]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207552_at	80	0.4375	0.0370681	0.407251	0.985548	0.168661	0.324378	1.38 [0.87 - 2.20]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3520	281	0.377224	0.0215811	0.28267	-0.331356	0.123506	-0.442446	0.64 [0.37 - 1.13]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208764_s_at	38	0.184211	0.0261193	0.322565	1.9845	0.285535	0.481734	1.62 [0.67 - 3.92]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207552_at	38	0.210526	0.0713593	-	-0.975855	0.307989	-0.246499	0.78 [0.49 - 1.26]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207552_at	140	0.214286	0.00274011	0.0585426	1.87718	0.0180267	1.96732	7.15 [1.40 - 36.51]
GENE	ATP5G2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208764_s_at	140	0.214286	0.0214465	0.281434	-0.704774	0.871786	-0.0396348	0.96 [0.59 - 1.56]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207507_s_at	30	0.166667	0.070898	-	1.0723	0.845905	-0.0712736	0.93 [0.45 - 1.91]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207508_at	30	0.733333	0.123333	-	-0.758896	0.585772	-0.197153	0.82 [0.40 - 1.67]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1770466	165	0.545455	0.0648446	-	-0.459897	0.579823	-0.158211	0.85 [0.49 - 1.49]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1770466	165	0.509091	0.0326682	0.374934	-0.794208	0.954572	-0.0242444	0.98 [0.42 - 2.25]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207508_at	163	0.165644	0.235785	-	0.33115	0.672007	0.0679737	1.07 [0.78 - 1.47]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207507_s_at	163	0.177914	0.0870625	-	0.488621	0.501635	0.103186	1.11 [0.82 - 1.50]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207508_at	79	0.455696	0.0117513	0.182178	0.752999	0.181287	0.398498	1.49 [0.83 - 2.67]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207507_s_at	79	0.43038	0.0286092	0.343135	0.666007	0.485588	0.162484	1.18 [0.75 - 1.86]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207507_s_at	58	0.482759	0.260796	-	0.306135	0.64132	-0.145023	0.87 [0.47 - 1.59]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207508_at	58	0.224138	0.0870567	-	0.577017	0.46982	0.252439	1.29 [0.65 - 2.55]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207507_s_at	34	0.205882	0.0282655	0.340346	1.30926	0.089486	0.733917	2.08 [0.89 - 4.86]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207508_at	34	0.5	0.0272603	0.332098	0.886647	0.0188344	1.04364	2.84 [1.19 - 6.78]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207507_s_at	158	0.151899	0.00377765	0.0757869	-0.786041	0.0106418	-0.539016	0.58 [0.39 - 0.88]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207508_at	158	0.139241	0.00410982	0.0810488	-0.816895	0.00197636	-0.651998	0.52 [0.34 - 0.79]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207508_at	53	0.188679	0.000811226	0.021372	-1.28431	0.116127	-1.01593	0.36 [0.10 - 1.29]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207507_s_at	53	0.188679	0.0146743	0.214546	-0.928459	0.298675	-0.793781	0.45 [0.10 - 2.02]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207508_at	53	0.188679	0.00397999	0.0790054	-1.0961	0.205542	-0.789447	0.45 [0.13 - 1.54]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207507_s_at	53	0.188679	0.00655231	0.116891	-1.04757	0.221597	-0.986946	0.37 [0.08 - 1.81]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207507_s_at	180	0.805556	0.0800965	-	-0.491738	0.810212	-0.0743732	0.93 [0.51 - 1.70]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207508_at	180	0.705556	0.0307799	0.360394	-0.530964	0.827098	-0.0727828	0.93 [0.48 - 1.79]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207508_at	559	0.413238	0.193246	-	0.27227	0.961236	-0.0125307	0.99 [0.60 - 1.64]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207507_s_at	559	0.871199	0.0242527	0.306553	0.546812	0.403001	0.230793	1.26 [0.73 - 2.16]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207507_s_at	77	0.662338	0.0122335	0.187696	0.673976	0.167576	0.473742	1.61 [0.82 - 3.15]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207508_at	77	0.805195	0.0057488	0.105583	0.844792	0.360678	0.348566	1.42 [0.67 - 2.99]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207508_at	70	0.428571	0.133261	-	-0.39764	0.891225	0.0347886	1.04 [0.63 - 1.70]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207507_s_at	70	0.471429	0.150902	-	-0.380536	0.911341	0.0266367	1.03 [0.64 - 1.64]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34811_at	50	0.58	0.000609922	0.0167852	1.22	0.020302	0.644165	1.90 [1.11 - 3.28]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207507_s_at	74	0.689189	0.0316289	0.366984	0.640086	0.0343888	0.99088	2.69 [1.08 - 6.75]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207508_at	74	0.702703	0.00169058	0.0394476	0.922324	0.00800986	1.3561	3.88 [1.42 - 10.57]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207508_at	67	0.179104	0.0892665	-	15.495	0.129713	1.64946	5.20 [0.62 - 43.95]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207507_s_at	67	0.895522	0.0950705	-	1.2799	0.09751	2.14169	8.51 [0.68 - 107.23]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207508_at	115	0.4	0.132893	-	0.942446	0.32163	0.954405	2.60 [0.39 - 17.15]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207507_s_at	115	0.286957	0.0603874	-	1.72336	0.280996	1.20499	3.34 [0.37 - 29.84]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34811_at	158	0.120253	0.0197087	0.265182	-0.781005	0.00896173	-1.08238	0.34 [0.15 - 0.76]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34811_at	76	0.868421	0.267227	-	0.702576	0.635685	0.320613	1.38 [0.37 - 5.19]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207508_at	204	0.686275	5.57333e-06	0.000262751	0.6924	0.00115952	0.861348	2.37 [1.41 - 3.98]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207507_s_at	204	0.764706	4.39403e-05	0.00168997	0.674995	0.00118042	0.769693	2.16 [1.36 - 3.44]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207508_at	87	0.655172	0.042255	0.442839	0.754781	0.51287	0.303244	1.35 [0.55 - 3.36]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207508_at	87	0.655172	0.042255	0.442839	0.754781	0.51287	0.303244	1.35 [0.55 - 3.36]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207507_s_at	87	0.563218	0.14169	-	0.551427	0.85784	0.0804683	1.08 [0.45 - 2.61]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207507_s_at	87	0.563218	0.14169	-	0.551427	0.85784	0.0804683	1.08 [0.45 - 2.61]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207508_at	77	0.155844	0.096636	-	15.3126	0.900588	-0.0889036	0.91 [0.23 - 3.69]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207507_s_at	77	0.662338	0.031175	0.363471	-1.92988	0.849914	-0.120652	0.89 [0.25 - 3.09]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207508_at	77	0.155844	0.148607	-	15.3068	0.948508	0.0529799	1.05 [0.21 - 5.26]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207507_s_at	77	0.662338	0.0875389	-	-1.61876	0.940685	-0.0547283	0.95 [0.22 - 4.00]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207508_at	136	0.897059	0.163828	-	-15.1727	0.77048	-0.153631	0.86 [0.31 - 2.41]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207507_s_at	136	0.102941	0.131315	-	-0.828221	0.519666	-0.204503	0.82 [0.44 - 1.52]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207507_s_at	200	0.85	0.00713122	0.124793	0.859253	0.0115551	1.70944	5.53 [1.47 - 20.82]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207508_at	200	0.79	0.000121177	0.00414692	1.10709	0.00104959	2.34464	10.43 [2.57 - 42.40]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20134	60	0.533333	0.0953214	-	-0.664109	0.257553	-0.96144	0.38 [0.07 - 2.02]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20134	60	0.866667	0.07723	-	0.799187	0.0863575	1.55624	4.74 [0.80 - 28.07]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5225	155	0.806452	0.000119479	0.00409586	1.06147	0.000747828	0.225345	1.25 [1.10 - 1.43]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207507_s_at	286	0.660839	0.0766842	-	0.350241	0.651619	0.152208	1.16 [0.60 - 2.25]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207508_at	286	0.562937	0.0447474	0.459072	0.38662	0.0927439	0.554282	1.74 [0.91 - 3.32]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207507_s_at	159	0.842767	1.19973e-05	0.000526829	1.35426	0.00457133	0.959837	2.61 [1.35 - 5.07]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207508_at	159	0.805031	3.95829e-05	0.0015397	1.24698	0.0197942	0.916353	2.50 [1.16 - 5.40]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207507_s_at	159	0.842767	3.17502e-06	0.000157231	1.58896	0.00150885	1.18204	3.26 [1.57 - 6.77]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207508_at	159	0.805031	0.000398972	0.0116793	1.10351	0.0153628	0.94778	2.58 [1.20 - 5.55]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207508_at	159	0.805031	2.00931e-06	0.000103393	1.5952	0.00457882	1.21526	3.37 [1.46 - 7.81]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207507_s_at	159	0.880503	9.72015e-05	0.0034158	1.29197	0.0105823	0.884677	2.42 [1.23 - 4.77]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207508_at	54	0.425926	0.182124	-	1.04229	0.356577	0.561386	1.75 [0.53 - 5.78]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207507_s_at	54	0.351852	0.105393	-	1.60284	0.382901	0.486481	1.63 [0.55 - 4.85]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207507_s_at	117	0.794872	0.153484	-	-0.677949	0.448362	-0.220026	0.80 [0.45 - 1.42]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207507_s_at	117	0.393162	0.0359802	0.399453	-0.790818	0.145295	-0.462621	0.63 [0.34 - 1.17]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207507_s_at	117	0.794872	0.153484	-	-0.677949	0.448362	-0.220026	0.80 [0.45 - 1.42]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207507_s_at	117	0.393162	0.00525555	0.0984234	-1.09748	0.0200968	-0.879897	0.41 [0.20 - 0.87]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207508_at	117	0.42735	0.0360203	0.399743	-0.805503	0.209848	-0.43854	0.64 [0.32 - 1.28]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207508_at	117	0.42735	0.393667	-	-0.270152	0.775657	-0.0871793	0.92 [0.50 - 1.67]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207508_at	117	0.42735	0.393667	-	-0.270152	0.775657	-0.0871793	0.92 [0.50 - 1.67]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207508_at	117	0.42735	0.00500873	0.0947728	-1.1358	0.0535739	-0.737714	0.48 [0.23 - 1.01]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207508_at	236	0.65678	0.000563137	0.0156831	0.901843	0.00322024	1.49907	4.48 [1.65 - 12.14]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207507_s_at	236	0.885593	2.27561e-05	0.000938016	1.26537	0.0105499	1.17461	3.24 [1.32 - 7.96]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207507_s_at	249	0.522088	0.00144588	0.0346625	0.67936	0.00814132	0.92373	2.52 [1.27 - 4.99]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207508_at	249	0.449799	0.00182595	0.0420316	0.691997	0.00409085	1.14133	3.13 [1.44 - 6.82]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207508_at	125	0.872	0.00108758	0.0273424	1.04137	0.188261	0.510101	1.67 [0.78 - 3.56]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207508_at	54	0.888889	0.0548467	-	1.21584	0.51552	0.353847	1.42 [0.49 - 4.14]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207507_s_at	62	0.870968	0.0105398	0.167966	1.28093	0.201396	0.453635	1.57 [0.78 - 3.16]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207507_s_at	125	0.168	0.138551	-	1.04033	0.469089	0.3281	1.39 [0.57 - 3.37]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207508_at	62	0.870968	0.0105398	0.167966	1.28093	0.361277	0.401242	1.49 [0.63 - 3.53]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207507_s_at	125	0.808	0.0799174	-	0.547948	0.34221	0.333095	1.40 [0.70 - 2.77]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207507_s_at	54	0.240741	0.0371178	0.407605	15.5259	0.395802	0.372002	1.45 [0.61 - 3.42]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207508_at	125	0.88	0.00762952	0.131446	1.10809	0.384578	0.448344	1.57 [0.57 - 4.30]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207507_s_at	198	0.656566	0.0158674	0.227077	-0.739117	0.336696	-0.227369	0.80 [0.50 - 1.27]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207508_at	198	0.878788	0.00977517	0.158718	-1.2475	0.805801	-0.0545249	0.95 [0.61 - 1.46]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207507_s_at	198	0.131313	0.0393604	0.423294	1.15765	0.641076	-0.119775	0.89 [0.54 - 1.47]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207508_at	198	0.818182	0.0109191	0.172471	-1.25523	0.398696	-0.230855	0.79 [0.46 - 1.36]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207508_at	198	0.818182	0.0521546	-	-0.969897	0.82998	-0.0618441	0.94 [0.53 - 1.65]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207507_s_at	198	0.131313	0.00480016	0.0916505	1.22699	0.813577	-0.0467021	0.95 [0.65 - 1.41]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207508_at	62	0.112903	0.199913	-	15.2054	0.95078	0.0454407	1.05 [0.25 - 4.43]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207507_s_at	51	0.411765	0.0755438	-	-1.75362	0.711685	-0.356309	0.70 [0.11 - 4.63]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207507_s_at	62	0.645161	0.244323	-	0.661183	0.576291	0.381543	1.46 [0.38 - 5.58]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207508_at	51	0.686275	0.120463	-	-15.6485	0.422946	-0.820346	0.44 [0.06 - 3.27]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207508_at	145	0.834483	0.00596506	0.108667	-15.315	0.00823035	-1.41425	0.24 [0.09 - 0.69]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207507_s_at	177	0.734463	0.0924243	-	-0.496175	0.938258	-0.0300636	0.97 [0.45 - 2.08]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207508_at	177	0.367232	0.00746914	0.129319	-0.709053	0.0794195	-0.786921	0.46 [0.19 - 1.10]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207507_s_at	145	0.675862	0.000182207	0.00592611	-2.23383	0.00973233	-1.32506	0.27 [0.10 - 0.73]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207507_s_at	177	0.751412	0.00440512	0.0856363	-1.25375	0.260169	-0.491731	0.61 [0.26 - 1.44]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207508_at	177	0.632768	0.068452	-	-0.468427	0.4827	-0.277597	0.76 [0.35 - 1.64]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207507_s_at	226	0.261062	1.51975e-05	0.000652236	-1.16113	0.0008131	-1.43742	0.24 [0.10 - 0.55]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207508_at	226	0.247788	2.2865e-06	0.000116406	-1.25721	8.83646e-05	-1.93824	0.14 [0.05 - 0.38]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207507_s_at	55	0.890909	0.0973513	-	-15.2272	0.708344	0.198046	1.22 [0.43 - 3.44]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207507_s_at	55	0.781818	0.12738	-	0.731165	0.457126	0.387919	1.47 [0.53 - 4.10]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207507_s_at	49	0.877551	0.180409	-	-15.2305	0.965986	0.02726	1.03 [0.29 - 3.60]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207508_at	55	0.672727	0.432157	-	0.357517	0.768871	0.166965	1.18 [0.39 - 3.60]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207508_at	55	0.545455	0.062716	-	-0.925971	0.837632	-0.120273	0.89 [0.28 - 2.80]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207508_at	49	0.591837	0.0889347	-	-1.08487	0.687639	-0.281718	0.75 [0.19 - 2.98]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	193106	34	0.117647	0.294802	-	-0.655559	0.622666	-0.24558	0.78 [0.29 - 2.08]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207508_at	63	0.253968	0.0407556	0.43281	0.95898	0.124022	0.644366	1.90 [0.84 - 4.33]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207507_s_at	63	0.206349	0.0168967	0.237608	1.34975	0.112099	0.583478	1.79 [0.87 - 3.68]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502300_3p_s_at	28	0.107143	0.0593188	-	-1.1806	0.106553	-0.178554	0.84 [0.67 - 1.04]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207508_at	82	0.182927	0.0173362	0.24203	1.57527	0.0139742	1.7849	5.96 [1.44 - 24.73]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207507_s_at	82	0.756098	0.010501	0.167501	0.86889	0.0643562	1.51132	4.53 [0.91 - 22.48]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34811_at	84	0.869048	0.061768	-	0.679527	0.273264	0.536126	1.71 [0.66 - 4.46]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207508_at	79	0.582278	0.0158908	0.227319	0.63462	0.199588	0.728896	2.07 [0.68 - 6.31]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207507_s_at	79	0.822785	0.0750815	-	0.57253	0.916077	-0.0769635	0.93 [0.22 - 3.88]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U09813_at	86	0.872093	0.0425796	0.444984	0.982098	0.194363	0.652747	1.92 [0.72 - 5.15]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207507_s_at	104	0.384615	0.0419366	0.440727	0.761724	0.323756	0.769736	2.16 [0.47 - 9.96]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207508_at	104	0.384615	0.0373284	0.409099	0.774553	0.198833	0.713265	2.04 [0.69 - 6.06]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P56680	117	0.495726	0.00173268	0.0402558	0.933623	0.0114082	0.722613	2.06 [1.18 - 3.61]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P174346	117	0.752137	0.00200046	0.0453035	0.881142	0.084921	0.349796	1.42 [0.95 - 2.11]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207508_at	204	0.637255	0.000109301	0.00378751	1.38741	0.0116364	1.46056	4.31 [1.39 - 13.40]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207508_at	204	0.651961	1.0966e-05	0.000485694	1.1483	0.000950212	1.38381	3.99 [1.76 - 9.07]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207507_s_at	204	0.803922	0.000130876	0.00443687	1.31561	0.00111211	1.71027	5.53 [1.98 - 15.46]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207507_s_at	204	0.514706	1.40235e-06	7.42969e-05	1.41619	4.94443e-06	1.70503	5.50 [2.65 - 11.44]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207508_at	178	0.292135	0.0418178	0.439936	0.46451	0.781069	0.108812	1.11 [0.52 - 2.40]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207507_s_at	178	0.837079	0.218469	-	-0.346085	0.842186	0.102031	1.11 [0.41 - 3.02]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200000115	41	0.536585	0.103431	-	-0.70561	0.497689	-0.203612	0.82 [0.45 - 1.47]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207508_at	111	0.765766	0.0758315	-	-0.632815	0.491569	-0.173761	0.84 [0.51 - 1.38]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207507_s_at	111	0.81982	0.15067	-	-0.609286	0.758781	-0.0649873	0.94 [0.62 - 1.42]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207508_at	90	0.422222	0.0612901	-	-0.600802	0.444305	-0.20276	0.82 [0.49 - 1.37]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207508_at	90	0.422222	0.140022	-	-0.542959	0.280955	-0.318249	0.73 [0.41 - 1.30]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207507_s_at	90	0.133333	0.0713076	-	-0.742853	0.497828	-0.179757	0.84 [0.50 - 1.40]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207507_s_at	90	0.111111	0.0215611	0.282486	-1.01826	0.313381	-0.295486	0.74 [0.42 - 1.32]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1477	50	0.72	0.00130372	0.031807	1.45544	0.0130691	0.984577	2.68 [1.23 - 5.82]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207508_at	138	0.311594	0.0178646	0.24729	0.678966	0.198003	0.191558	1.21 [0.90 - 1.62]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207507_s_at	138	0.275362	0.0465639	0.470576	0.588299	0.355543	0.124016	1.13 [0.87 - 1.47]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207507_s_at	129	0.852713	0.108334	-	-0.639605	0.895108	0.0542081	1.06 [0.47 - 2.36]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207508_at	129	0.302326	0.0340398	0.385235	0.64605	0.847645	0.0753718	1.08 [0.50 - 2.33]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20162	56	0.785714	0.0559167	-	0.78995	0.378225	0.347287	1.42 [0.65 - 3.06]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25710	56	0.142857	0.116984	-	-0.762717	0.839523	0.0721857	1.07 [0.53 - 2.16]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20162	56	0.125	0.105744	-	-0.859765	0.945374	0.0253957	1.03 [0.50 - 2.12]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25710	56	0.892857	0.0917497	-	0.906666	0.375741	0.342298	1.41 [0.66 - 3.00]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207508_at	278	0.233813	0.2786	-	-0.23516	0.776237	-0.0524029	0.95 [0.66 - 1.36]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207507_s_at	278	0.330935	0.122393	-	-0.299709	0.644105	-0.0859123	0.92 [0.64 - 1.32]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207507_s_at	133	0.864662	0.211355	-	0.39037	0.922145	0.0136029	1.01 [0.77 - 1.33]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207508_at	133	0.887218	0.0541503	-	0.624224	0.478975	0.116792	1.12 [0.81 - 1.55]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4340	81	0.469136	0.0935478	-	0.950798	0.368486	0.34205	1.41 [0.67 - 2.97]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2005	81	0.481481	0.137442	-	-0.795933	0.871896	0.0669287	1.07 [0.47 - 2.41]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207507_s_at	185	0.167568	0.113815	-	-0.371895	0.178737	-0.103779	0.90 [0.77 - 1.05]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207508_at	185	0.416216	0.0299955	0.354227	-0.359888	0.0873507	-0.138425	0.87 [0.74 - 1.02]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207507_s_at	185	0.167568	0.0829614	-	-0.375445	0.169163	-0.098461	0.91 [0.79 - 1.04]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207508_at	185	0.416216	0.0435256	0.451181	-0.363144	0.140718	-0.129513	0.88 [0.74 - 1.04]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P174346	110	0.290909	0.0432911	0.449652	-0.479535	0.353668	-0.166015	0.85 [0.60 - 1.20]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P56680	110	0.381818	0.263469	-	0.346866	0.624709	0.128286	1.14 [0.68 - 1.90]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P174346	110	0.7	0.225283	-	0.392386	0.734021	-0.0801125	0.92 [0.58 - 1.47]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P56680	110	0.545455	0.0359428	0.399183	0.477959	0.151114	0.298541	1.35 [0.90 - 2.03]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207507_s_at	80	0.8875	0.0210023	0.277333	1.14911	0.216101	0.45068	1.57 [0.77 - 3.21]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207508_at	80	0.8625	0.0287177	0.344012	1.09807	0.206407	0.558726	1.75 [0.73 - 4.16]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3470	281	0.893238	0.0133105	0.199757	0.54569	0.115178	0.26324	1.30 [0.94 - 1.81]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:193106	59	0.186441	0.000315233	0.0095354	-1.6469	0.060667	-1.43628	0.24 [0.05 - 1.07]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207507_s_at	38	0.289474	0.00191461	0.0437019	2.1878	0.00474179	2.67562	14.52 [2.27 - 93.00]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207508_at	38	0.236842	0.000168004	0.0055209	16.2281	0.00143596	3.04478	21.01 [3.23 - 136.61]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207508_at	140	0.514286	0.0014738	0.0352165	-0.973195	0.0933207	-0.38081	0.68 [0.44 - 1.07]
GENE	ATP5G3	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207507_s_at	140	0.192857	0.00010151	0.00354883	-1.14277	0.044175	-0.465534	0.63 [0.40 - 0.99]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210149_s_at	30	0.766667	0.211325	-	-0.679795	0.807051	-0.115739	0.89 [0.35 - 2.25]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1794912	165	0.878788	0.00321263	0.0665617	0.884201	0.344378	0.278149	1.32 [0.74 - 2.35]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1794912	165	0.878788	3.86174e-06	0.000188043	1.56532	0.54645	0.270205	1.31 [0.54 - 3.15]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210149_s_at	163	0.294479	0.0674971	-	0.418966	0.257597	0.144337	1.16 [0.90 - 1.48]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210149_s_at	79	0.506329	0.0588985	-	0.550238	0.338337	0.196093	1.22 [0.81 - 1.82]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1555998_at	79	0.873418	0.0028074	0.0597032	1.03683	0.117259	1.59053	4.91 [0.67 - 35.90]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210149_s_at	58	0.689655	0.171146	-	0.400657	0.930208	-0.0267376	0.97 [0.54 - 1.77]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210149_s_at	34	0.676471	0.124639	-	0.624878	0.315217	0.580537	1.79 [0.58 - 5.55]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210149_s_at	158	0.734177	0.0135561	0.202459	-0.703409	0.0210549	-0.5735	0.56 [0.35 - 0.92]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210149_s_at	53	0.509434	0.116681	-	-0.549618	0.460673	-0.556779	0.57 [0.13 - 2.52]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210149_s_at	53	0.490566	0.0884096	-	-0.62861	0.487535	-0.554514	0.57 [0.12 - 2.75]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210149_s_at	180	0.888889	5.37686e-05	0.00202253	1.15196	0.0328378	1.04419	2.84 [1.09 - 7.41]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1555998_at	559	0.538462	0.0283873	0.341336	-0.453344	0.608061	-0.119207	0.89 [0.56 - 1.40]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210149_s_at	559	0.880143	0.0613231	-	0.482967	0.438202	0.286318	1.33 [0.65 - 2.75]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210149_s_at	77	0.506494	0.0693806	-	0.475179	0.318851	0.443796	1.56 [0.65 - 3.73]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210149_s_at	70	0.2	0.107009	-	-0.511975	0.944661	0.036317	1.04 [0.37 - 2.89]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1555998_at	70	0.157143	0.0169501	0.238148	0.954739	0.170089	0.875212	2.40 [0.69 - 8.38]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35760_at	50	0.8	0.00158331	0.0373689	1.33899	0.363889	0.329148	1.39 [0.68 - 2.83]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210149_s_at	74	0.797297	6.33352e-05	0.002339	1.23409	0.00020977	2.35814	10.57 [3.04 - 36.78]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210149_s_at	67	0.865672	0.0399118	0.427076	1.35946	0.0320948	3.083	21.82 [1.30 - 365.92]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1555998_at	67	0.447761	0.0410824	0.435014	1.88197	0.316562	2.10867	8.24 [0.13 - 510.44]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1555998_at	115	0.73913	0.118837	-	0.815326	0.868612	0.207847	1.23 [0.10 - 14.45]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210149_s_at	115	0.113043	0.00234445	0.051577	-1.55224	0.958777	-0.0469453	0.95 [0.16 - 5.66]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35760_at	158	0.664557	0.0711489	-	0.513312	0.322179	0.400381	1.49 [0.68 - 3.30]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35760_at	76	0.815789	0.144708	-	0.781475	0.459649	0.556771	1.75 [0.40 - 7.63]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210149_s_at	204	0.642157	0.0338528	0.383843	-0.315758	0.437887	-0.158098	0.85 [0.57 - 1.27]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1555998_at	204	0.181373	0.108204	-	0.293406	0.298044	0.153902	1.17 [0.87 - 1.56]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1555998_at	87	0.448276	0.225456	-	0.474152	0.553431	0.308219	1.36 [0.49 - 3.77]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210149_s_at	87	0.643678	0.0394299	0.423772	0.762119	0.592997	0.253604	1.29 [0.51 - 3.27]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1555998_at	87	0.448276	0.225456	-	0.474152	0.553431	0.308219	1.36 [0.49 - 3.77]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210149_s_at	87	0.643678	0.0394299	0.423772	0.762119	0.592997	0.253604	1.29 [0.51 - 3.27]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555998_at	77	0.233766	0.0944395	-	-0.921927	0.521501	-0.923417	0.40 [0.02 - 6.69]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210149_s_at	77	0.350649	0.0289845	0.346163	-1.17729	0.214271	-0.673564	0.51 [0.18 - 1.48]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555998_at	77	0.220779	0.10138	-	-1.01456	0.460104	-1.24639	0.29 [0.01 - 7.85]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210149_s_at	77	0.337662	0.0690919	-	-1.11505	0.317652	-0.624904	0.54 [0.16 - 1.82]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210149_s_at	136	0.639706	0.107747	-	0.709715	0.614513	0.291237	1.34 [0.43 - 4.16]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210149_s_at	200	0.895	0.000281007	0.00863398	1.18865	0.0851385	0.768177	2.16 [0.90 - 5.17]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21968	60	0.266667	0.320758	-	-0.403649	0.793293	-0.0895393	0.91 [0.47 - 1.79]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21968	60	0.283333	0.00572538	0.105247	-1.04288	0.624238	-0.239945	0.79 [0.30 - 2.05]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	7034	155	0.206452	7.14332e-06	0.000329287	-1.18919	1.4382e-05	-0.490525	0.61 [0.49 - 0.76]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210149_s_at	286	0.811189	0.0217594	0.284302	0.507468	0.504079	0.180162	1.20 [0.71 - 2.03]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210149_s_at	159	0.345912	0.000166782	0.00548579	1.75341	0.0193156	0.961125	2.61 [1.17 - 5.85]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210149_s_at	159	0.345912	0.000595604	0.0164495	2.10706	0.011168	1.2186	3.38 [1.32 - 8.67]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210149_s_at	159	0.345912	0.00280168	0.0596049	1.24364	0.0113346	1.05003	2.86 [1.27 - 6.44]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210149_s_at	54	0.5	0.0201853	0.269696	1.66752	0.103078	0.853952	2.35 [0.84 - 6.56]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210149_s_at	117	0.726496	0.0363664	0.402235	-0.857388	0.280683	-0.330486	0.72 [0.39 - 1.31]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210149_s_at	117	0.726496	0.0492781	0.487276	-1.01891	0.268073	-0.392129	0.68 [0.34 - 1.35]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210149_s_at	117	0.726496	0.0363664	0.402235	-0.857388	0.280683	-0.330486	0.72 [0.39 - 1.31]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210149_s_at	117	0.74359	0.171746	-	-0.725147	0.608012	-0.192207	0.83 [0.40 - 1.72]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210149_s_at	236	0.792373	0.0121465	0.186706	0.71755	0.458533	0.268277	1.31 [0.64 - 2.66]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210149_s_at	249	0.75502	0.000117131	0.00402504	0.831318	0.0396889	0.533935	1.71 [1.03 - 2.84]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210149_s_at	62	0.112903	0.137854	-	15.2109	0.412795	0.427602	1.53 [0.55 - 4.27]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210149_s_at	125	0.832	0.00869834	0.145292	0.996935	0.162923	0.484798	1.62 [0.82 - 3.21]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210149_s_at	125	0.112	0.00720046	0.125726	-1.01661	0.828696	0.0618345	1.06 [0.61 - 1.86]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210149_s_at	54	0.777778	0.112459	-	0.910211	0.221939	0.798726	2.22 [0.62 - 8.01]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210149_s_at	198	0.712121	0.149225	-	-0.446651	0.342411	-0.257069	0.77 [0.45 - 1.31]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210149_s_at	198	0.732323	0.160993	-	-0.46756	0.321297	-0.282656	0.75 [0.43 - 1.32]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210149_s_at	198	0.868687	0.0507845	-	0.547752	0.951048	-0.0133105	0.99 [0.65 - 1.51]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210149_s_at	51	0.117647	0.031553	0.366399	-1.73776	0.422291	1.14467	3.14 [0.19 - 51.45]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210149_s_at	62	0.241935	0.122428	-	-0.876508	0.616616	0.500436	1.65 [0.23 - 11.70]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210149_s_at	145	0.365517	0.00661192	0.117714	-0.887247	0.123096	-0.916922	0.40 [0.12 - 1.28]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1555998_at	145	0.793103	0.0199052	0.267048	-1.31181	0.0704274	-2.25819	0.10 [0.01 - 1.21]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210149_s_at	177	0.367232	0.0975148	-	-0.449106	0.600697	-0.271437	0.76 [0.28 - 2.11]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1555998_at	177	0.898305	0.1411	-	-0.848985	0.829837	-0.18998	0.83 [0.15 - 4.68]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210149_s_at	177	0.740113	0.222494	-	0.307094	0.80243	0.11559	1.12 [0.45 - 2.78]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1555998_at	177	0.898305	0.0365795	0.403764	-1.1661	0.654596	-0.34649	0.71 [0.15 - 3.23]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210149_s_at	226	0.278761	0.000198456	0.00638414	-1.01324	0.0552431	-1.10629	0.33 [0.11 - 1.03]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1555998_at	226	0.610619	0.000198448	0.00638391	-1.33673	0.0230038	-0.841139	0.43 [0.21 - 0.89]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210149_s_at	49	0.204082	0.427398	-	-0.524667	0.949501	0.0537744	1.06 [0.20 - 5.57]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1555998_at	55	0.254545	0.0854633	-	-0.866926	0.263164	-1.78713	0.17 [0.01 - 3.83]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1555998_at	49	0.346939	0.0502226	-	-1.101	0.567773	-1.21154	0.30 [0.00 - 19.01]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210149_s_at	55	0.745455	0.123949	-	0.708182	0.670348	0.288507	1.33 [0.35 - 5.04]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1555998_at	55	0.4	0.0193776	0.26202	-1.02638	0.414559	-1.20899	0.30 [0.02 - 5.45]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210149_s_at	55	0.509091	0.305572	-	-0.489866	0.945981	-0.0480912	0.95 [0.24 - 3.83]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210149_s_at	63	0.444444	0.0961285	-	0.584505	0.571821	0.149534	1.16 [0.69 - 1.95]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1555998_at	63	0.52381	0.241848	-	-0.401614	0.937225	0.0418599	1.04 [0.37 - 2.96]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.376222.1.A1_3p_at	28	0.142857	0.0685508	-	-1.19105	0.557288	-2.29242	0.10 [0.00 - 213.50]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12002005_3p_s_at	28	0.464286	0.121341	-	-0.828698	0.478434	-0.133369	0.88 [0.61 - 1.27]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210149_s_at	82	0.304878	0.0256697	0.318756	-0.753968	0.155797	-1.07627	0.34 [0.08 - 1.51]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	35760_at	84	0.333333	0.00924619	0.152184	0.868705	0.402291	0.368278	1.45 [0.61 - 3.42]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210149_s_at	79	0.886076	0.122315	-	0.582282	0.479401	0.359673	1.43 [0.53 - 3.88]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210149_s_at	104	0.201923	0.0799367	-	-0.633802	0.599193	0.380365	1.46 [0.35 - 6.04]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P77818	117	0.358974	0.0011092	0.0277962	1.14867	0.00471776	1.00536	2.73 [1.36 - 5.49]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210149_s_at	204	0.553922	0.00228225	0.0504586	1.15168	0.0110529	1.39997	4.06 [1.38 - 11.94]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210149_s_at	204	0.558824	1.76703e-05	0.000747158	1.18958	0.000230009	1.50168	4.49 [2.02 - 9.98]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1555998_at	204	0.122549	0.00650454	0.11623	-1.073	0.102625	-0.989449	0.37 [0.11 - 1.22]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1555998_at	204	0.122549	0.0900889	-	-0.585938	0.28893	-0.496639	0.61 [0.24 - 1.52]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210149_s_at	178	0.685393	0.132003	-	0.305957	0.509025	0.35147	1.42 [0.50 - 4.03]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300016487	41	0.634146	0.0466108	0.470869	0.812913	0.356628	0.372775	1.45 [0.66 - 3.21]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200018769	41	0.756098	0.00781169	0.133845	1.12013	0.346359	0.400862	1.49 [0.65 - 3.44]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210149_s_at	111	0.675676	0.0467769	0.471907	-0.599985	0.58506	-0.18132	0.83 [0.44 - 1.60]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1555998_at	111	0.648649	0.0904272	-	-0.485772	0.34811	-0.329108	0.72 [0.36 - 1.43]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210149_s_at	90	0.588889	0.23519	-	-0.403756	0.54982	-0.221311	0.80 [0.39 - 1.66]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210149_s_at	90	0.8	0.189029	-	0.539622	0.610707	-0.214532	0.81 [0.35 - 1.84]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210149_s_at	138	0.884058	0.0329242	0.376873	0.689826	0.125287	0.415607	1.52 [0.89 - 2.58]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1555998_at	138	0.115942	0.026659	0.327097	-0.694391	0.496513	0.331148	1.39 [0.54 - 3.62]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210149_s_at	129	0.310078	0.00298859	0.062797	0.918054	0.0520883	0.899167	2.46 [0.99 - 6.09]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43938	56	0.446429	0.197346	-	-0.464518	0.95787	-0.0191779	0.98 [0.48 - 2.00]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19993	56	0.660714	0.333374	-	-0.372756	0.973319	0.0124287	1.01 [0.49 - 2.10]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44445	56	0.660714	0.140973	-	-0.563997	0.69414	0.120432	1.13 [0.62 - 2.06]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44445	56	0.660714	0.126953	-	-0.61603	0.922743	-0.0314102	0.97 [0.51 - 1.83]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43938	56	0.446429	0.176938	-	-0.461274	0.805064	-0.0829375	0.92 [0.48 - 1.78]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19993	56	0.660714	0.230515	-	-0.437894	0.885976	-0.0498352	0.95 [0.48 - 1.88]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1555998_at	278	0.363309	0.126615	-	-0.289903	0.625105	-0.145917	0.86 [0.48 - 1.55]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210149_s_at	278	0.81295	0.0222285	0.288568	-0.594067	0.237689	-0.242931	0.78 [0.52 - 1.17]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210149_s_at	133	0.218045	0.00596231	0.108628	-0.689453	0.255056	-0.20279	0.82 [0.58 - 1.16]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	8265	81	0.691358	0.0668041	-	0.922676	0.401255	0.421527	1.52 [0.57 - 4.08]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210149_s_at	185	0.675676	0.154541	-	-0.248361	0.311373	-0.0984605	0.91 [0.75 - 1.10]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210149_s_at	185	0.675676	0.140901	-	-0.282564	0.342178	-0.100717	0.90 [0.73 - 1.11]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P77818	110	0.309091	0.0973022	-	0.605289	0.547488	0.15883	1.17 [0.70 - 1.97]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P77818	110	0.254545	0.0302588	0.356305	0.629688	0.182002	0.270852	1.31 [0.88 - 1.95]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210149_s_at	80	0.225	0.077249	-	-0.805154	0.924297	-0.0437506	0.96 [0.39 - 2.36]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210149_s_at	38	0.763158	0.0272417	0.331944	1.12262	0.0946428	1.3008	3.67 [0.80 - 16.88]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1555998_at	38	0.421053	0.0524934	-	0.985832	0.217482	1.26941	3.56 [0.47 - 26.76]
GENE	ATP5H	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210149_s_at	140	0.364286	0.0168521	0.237157	-0.677501	0.187383	-0.568477	0.57 [0.24 - 1.32]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209492_x_at	30	0.3	0.0798734	-	-0.740562	0.297036	-0.57661	0.56 [0.19 - 1.66]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207335_x_at	30	0.566667	0.145287	-	-0.599272	0.338291	-0.472902	0.62 [0.24 - 1.64]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1703415	165	0.824242	0.0920121	-	0.477574	0.241193	0.281437	1.33 [0.83 - 2.12]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1703415	165	0.806061	0.151918	-	0.556101	0.636812	0.172962	1.19 [0.58 - 2.44]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207335_x_at	163	0.539877	0.00197847	0.0448945	0.608454	0.163101	0.326466	1.39 [0.88 - 2.19]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209492_x_at	163	0.484663	0.0397645	0.426068	0.408211	0.283449	0.23069	1.26 [0.83 - 1.92]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207335_x_at	79	0.101266	0.172545	-	0.794144	0.63839	0.171414	1.19 [0.58 - 2.43]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209492_x_at	79	0.101266	0.172545	-	0.794144	0.589188	0.195014	1.22 [0.60 - 2.47]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209492_x_at	58	0.724138	0.0560056	-	0.595596	0.315265	0.421739	1.52 [0.67 - 3.47]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207335_x_at	58	0.896552	0.131642	-	0.65932	0.966677	0.0200157	1.02 [0.40 - 2.61]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207335_x_at	34	0.323529	0.0229393	0.294961	-0.892495	0.196985	-0.52593	0.59 [0.27 - 1.31]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209492_x_at	34	0.558824	0.108041	-	-0.622919	0.438052	-0.360171	0.70 [0.28 - 1.73]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209492_x_at	158	0.151899	0.0466662	0.471216	-0.558178	0.389522	-0.22338	0.80 [0.48 - 1.33]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207335_x_at	158	0.417722	0.0454923	0.463822	-0.460658	0.561151	-0.164019	0.85 [0.49 - 1.48]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207335_x_at	53	0.811321	0.0523856	-	-1.12701	0.0856603	-1.04936	0.35 [0.11 - 1.16]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209492_x_at	53	0.113208	0.0886015	-	-0.82012	0.436667	-0.455327	0.63 [0.20 - 2.00]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207335_x_at	53	0.811321	0.023521	0.300129	-1.28565	0.0426299	-1.16911	0.31 [0.10 - 0.96]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209492_x_at	53	0.113208	0.12047	-	-0.741747	0.446301	-0.425692	0.65 [0.22 - 1.95]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209492_x_at	180	0.738889	0.146964	-	0.328374	0.521327	0.169726	1.18 [0.71 - 1.99]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207335_x_at	180	0.855556	0.0624734	-	0.485447	0.634007	0.130515	1.14 [0.67 - 1.95]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207335_x_at	559	0.815742	0.115219	-	-0.480902	0.79712	-0.0748637	0.93 [0.52 - 1.64]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209492_x_at	559	0.472272	0.0686131	-	-0.366104	0.511672	-0.164489	0.85 [0.52 - 1.39]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207335_x_at	77	0.662338	0.0536703	-	0.523755	0.206744	0.327525	1.39 [0.83 - 2.31]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209492_x_at	77	0.649351	0.0278539	0.336985	0.593445	0.250338	0.41132	1.51 [0.75 - 3.04]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209492_x_at	70	0.642857	0.00591362	0.107936	-0.81312	0.0612904	-0.898997	0.41 [0.16 - 1.04]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207335_x_at	70	0.228571	0.0136822	0.203839	-0.737853	0.0505603	-0.974729	0.38 [0.14 - 1.00]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38752_r_at	50	0.14	0.0375085	0.410373	-0.867673	0.248279	-0.382682	0.68 [0.36 - 1.31]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38751_i_at	50	0.12	0.060266	-	-0.829467	0.6057	-0.107011	0.90 [0.60 - 1.35]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207335_x_at	74	0.108108	0.16603	-	0.804876	0.823491	0.0989901	1.10 [0.46 - 2.63]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209492_x_at	74	0.891892	0.104177	-	-0.93825	0.601213	0.324909	1.38 [0.41 - 4.68]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207335_x_at	67	0.701493	0.000785397	0.0207961	2.2188	0.0180066	3.4446	31.33 [1.80 - 543.89]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209492_x_at	67	0.686567	0.00101928	0.0258966	2.18347	0.0223724	3.16731	23.74 [1.57 - 359.73]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209492_x_at	115	0.747826	0.0981898	-	0.869146	0.510318	0.762366	2.14 [0.22 - 20.74]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207335_x_at	115	0.130435	0.0709409	-	-1.01956	0.802629	-0.230934	0.79 [0.13 - 4.85]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38751_i_at	158	0.898734	0.000159716	0.00528216	1.23071	0.0182222	1.02452	2.79 [1.19 - 6.52]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38752_r_at	158	0.474684	0.01946	0.26281	-0.68744	0.448919	-0.320882	0.73 [0.32 - 1.66]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38751_i_at	76	0.605263	0.0797988	-	-1.07935	0.692652	-0.237276	0.79 [0.24 - 2.56]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38752_r_at	76	0.75	0.0698335	-	-1.67493	0.328789	-1.02993	0.36 [0.05 - 2.82]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209492_x_at	204	0.264706	0.0322046	0.371403	0.340702	0.509212	0.135194	1.14 [0.77 - 1.71]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207335_x_at	204	0.72549	0.271561	-	0.172114	0.714839	0.0555597	1.06 [0.78 - 1.42]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207335_x_at	87	0.712644	0.0107496	0.170464	0.934023	0.366984	0.487518	1.63 [0.56 - 4.70]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207335_x_at	87	0.712644	0.0107496	0.170464	0.934023	0.366984	0.487518	1.63 [0.56 - 4.70]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209492_x_at	87	0.735632	0.0596475	-	0.715752	0.255724	0.715983	2.05 [0.60 - 7.03]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209492_x_at	87	0.735632	0.0596475	-	0.715752	0.255724	0.715983	2.05 [0.60 - 7.03]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209492_x_at	77	0.12987	0.0982542	-	-1.08811	0.325619	-0.927568	0.40 [0.06 - 2.51]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207335_x_at	77	0.168831	0.0397532	0.425992	-1.24674	0.29585	-1.02323	0.36 [0.05 - 2.45]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209492_x_at	77	0.220779	0.163651	-	-0.774736	0.596612	-0.457604	0.63 [0.12 - 3.45]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207335_x_at	77	0.168831	0.0319657	0.369574	-1.15793	0.458336	-0.648378	0.52 [0.09 - 2.90]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207335_x_at	136	0.897059	0.00484976	0.0923962	1.3096	0.326118	0.392788	1.48 [0.68 - 3.24]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209492_x_at	136	0.757353	0.0383227	0.416095	0.908725	0.155794	0.791171	2.21 [0.74 - 6.58]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207335_x_at	200	0.855	0.000769471	0.0204393	1.05684	0.0522879	0.889765	2.43 [0.99 - 5.98]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209492_x_at	200	0.85	2.56693e-05	0.00104511	1.28719	0.164828	0.71351	2.04 [0.75 - 5.59]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11144	60	0.716667	0.0109872	0.173274	0.948316	0.431088	0.272178	1.31 [0.67 - 2.59]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11144	60	0.85	0.220106	-	0.558411	0.911038	-0.0362283	0.96 [0.51 - 1.82]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	11378	155	0.819355	0.000311629	0.00944125	1.00958	0.000918288	0.186182	1.20 [1.08 - 1.34]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207335_x_at	286	0.433566	0.00896471	0.14866	0.532536	0.0663429	0.388641	1.47 [0.97 - 2.23]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209492_x_at	286	0.898601	0.109902	-	0.430505	0.280339	0.257357	1.29 [0.81 - 2.06]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207335_x_at	159	0.383648	0.223178	-	-0.383454	0.784886	-0.122875	0.88 [0.37 - 2.14]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209492_x_at	159	0.72956	0.103679	-	0.613311	0.667887	0.253456	1.29 [0.40 - 4.10]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207335_x_at	159	0.119497	0.0441537	0.455254	1.78998	0.447795	0.334057	1.40 [0.59 - 3.31]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209492_x_at	159	0.72956	0.0700915	-	0.583504	0.693695	0.197912	1.22 [0.46 - 3.26]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207335_x_at	159	0.125786	0.125282	-	1.43408	0.745894	0.169598	1.18 [0.42 - 3.30]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209492_x_at	159	0.27673	0.0916341	-	0.688513	0.636451	0.232994	1.26 [0.48 - 3.32]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209492_x_at	54	0.314815	0.0188603	0.257037	15.8061	0.0668431	2.07736	7.98 [0.87 - 73.62]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207335_x_at	54	0.518519	0.0186592	0.255085	1.68808	0.08541	2.19425	8.97 [0.74 - 109.34]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207335_x_at	117	0.145299	0.027607	0.334959	15.2757	0.0453191	1.10895	3.03 [1.02 - 8.98]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207335_x_at	117	0.102564	0.0617258	-	1.68621	0.576402	0.226321	1.25 [0.57 - 2.77]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209492_x_at	117	0.136752	0.055955	-	1.29608	0.619358	0.177534	1.19 [0.59 - 2.41]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209492_x_at	117	0.145299	0.178964	-	0.950915	0.763317	0.128638	1.14 [0.49 - 2.63]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209492_x_at	117	0.136752	0.055955	-	1.29608	0.619358	0.177534	1.19 [0.59 - 2.41]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209492_x_at	117	0.837607	0.0183227	0.2518	0.974717	0.0368873	1.03247	2.81 [1.06 - 7.40]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207335_x_at	117	0.102564	0.0617258	-	1.68621	0.576402	0.226321	1.25 [0.57 - 2.77]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207335_x_at	117	0.102564	0.184326	-	1.26627	0.708231	0.180851	1.20 [0.46 - 3.09]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207335_x_at	236	0.847458	0.000535759	0.0150308	1.01101	0.00169123	1.3238	3.76 [1.64 - 8.59]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209492_x_at	236	0.381356	2.30481e-05	0.000948818	1.48169	1.62318e-05	2.19783	9.01 [3.32 - 24.46]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209492_x_at	249	0.349398	1.23199e-05	0.00053962	1.14537	4.71759e-05	1.71728	5.57 [2.44 - 12.74]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207335_x_at	249	0.566265	0.000332662	0.00998846	0.752506	0.00020914	1.2805	3.60 [1.83 - 7.08]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207335_x_at	125	0.256	0.0179293	0.247929	1.57429	0.161251	0.511177	1.67 [0.82 - 3.41]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209492_x_at	62	0.887097	0.00487998	0.0928497	1.79967	0.309838	0.440749	1.55 [0.66 - 3.64]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207335_x_at	125	0.256	0.00210742	0.0472779	1.64959	0.460034	0.206593	1.23 [0.71 - 2.13]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207335_x_at	54	0.851852	0.00131137	0.0319623	2.11746	0.0110784	2.11511	8.29 [1.62 - 42.40]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209492_x_at	125	0.328	0.00945423	0.154768	1.45905	0.0566494	0.670635	1.96 [0.98 - 3.90]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209492_x_at	125	0.304	0.00192825	0.0439573	1.36428	0.169207	0.363122	1.44 [0.86 - 2.41]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209492_x_at	54	0.703704	0.081861	-	0.980766	0.278127	0.593742	1.81 [0.62 - 5.30]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207335_x_at	62	0.854839	4.6913e-05	0.00179144	2.16426	0.0235887	1.49977	4.48 [1.22 - 16.42]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209492_x_at	198	0.727273	0.0238281	0.302837	-0.796325	0.112283	-0.363047	0.70 [0.44 - 1.09]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209492_x_at	198	0.161616	0.0288167	0.344812	-0.682283	0.192492	-0.316641	0.73 [0.45 - 1.17]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207335_x_at	198	0.318182	0.213052	-	0.293423	0.783309	-0.0416132	0.96 [0.71 - 1.29]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207335_x_at	198	0.550505	0.0471937	0.474502	-0.537832	0.169262	-0.267635	0.77 [0.52 - 1.12]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209492_x_at	198	0.732323	0.0174353	0.243021	-0.661438	0.481327	-0.128302	0.88 [0.62 - 1.26]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207335_x_at	198	0.550505	0.063013	-	-0.527214	0.298973	-0.21235	0.81 [0.54 - 1.21]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207335_x_at	51	0.784314	0.0233666	0.298763	1.81619	0.791031	0.20798	1.23 [0.26 - 5.73]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207335_x_at	62	0.887097	0.0253903	0.316374	1.38684	0.535779	0.31333	1.37 [0.51 - 3.69]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209492_x_at	51	0.843137	0.0790451	-	1.47639	0.485459	0.609614	1.84 [0.33 - 10.20]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209492_x_at	62	0.774194	0.0464743	0.470015	1.11182	0.485978	0.378805	1.46 [0.50 - 4.24]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207335_x_at	177	0.531073	0.0770962	-	-0.493775	0.355076	-0.368648	0.69 [0.32 - 1.51]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209492_x_at	177	0.497175	0.0471704	0.474357	-0.470735	0.637879	-0.166874	0.85 [0.42 - 1.70]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209492_x_at	145	0.393103	0.00225971	0.0500518	-1.00441	0.0413752	-0.986787	0.37 [0.14 - 0.96]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207335_x_at	177	0.531073	0.0797835	-	-0.420886	0.539181	-0.212601	0.81 [0.41 - 1.59]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209492_x_at	177	0.491525	0.0539574	-	-0.52839	0.434113	-0.318418	0.73 [0.33 - 1.62]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207335_x_at	145	0.372414	0.00350685	0.0714111	-0.95366	0.0205191	-1.10253	0.33 [0.13 - 0.84]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209492_x_at	226	0.889381	0.0276538	0.335343	-1.91724	0.334113	-0.239947	0.79 [0.48 - 1.28]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207335_x_at	226	0.376106	0.0117686	0.182377	-0.701137	0.187324	-0.30858	0.73 [0.46 - 1.16]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209492_x_at	55	0.490909	0.10936	-	0.786888	0.407062	0.488596	1.63 [0.51 - 5.17]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209492_x_at	49	0.489796	0.0146517	0.214305	1.69893	0.0684002	1.54286	4.68 [0.89 - 24.59]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207335_x_at	55	0.527273	0.149523	-	0.682535	0.491449	0.408685	1.50 [0.47 - 4.82]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207335_x_at	55	0.490909	0.0312985	0.36443	1.01333	0.434398	0.441939	1.56 [0.51 - 4.71]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207335_x_at	49	0.510204	0.00742234	0.128696	1.84029	0.0666827	1.50299	4.50 [0.90 - 22.41]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209492_x_at	55	0.472727	0.0104114	0.166428	1.24981	0.370551	0.495734	1.64 [0.55 - 4.86]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209492_x_at	63	0.650794	0.0403776	0.43025	0.683658	0.415143	0.262181	1.30 [0.69 - 2.44]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207335_x_at	63	0.809524	0.0112096	0.175887	0.922526	0.401789	0.304424	1.36 [0.67 - 2.76]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6005716_3p_a_at	28	0.142857	0.129595	-	-0.976949	0.366831	-0.186186	0.83 [0.55 - 1.24]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207335_x_at	82	0.402439	0.0750373	-	0.640742	0.179346	0.84898	2.34 [0.68 - 8.07]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209492_x_at	82	0.878049	0.121578	-	0.685122	0.442133	0.567929	1.76 [0.41 - 7.51]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38751_i_at	84	0.678571	0.233746	-	0.359607	0.954257	0.0177439	1.02 [0.56 - 1.87]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38752_r_at	84	0.535714	0.0719375	-	0.51887	0.475448	0.44532	1.56 [0.46 - 5.30]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207335_x_at	79	0.898734	0.169149	-	-0.701385	0.723651	-0.151021	0.86 [0.37 - 1.99]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209492_x_at	79	0.759494	0.0233828	0.298907	-0.743317	0.30304	-0.580741	0.56 [0.19 - 1.69]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209492_x_at	104	0.105769	0.0718447	-	-0.739189	0.89482	0.0808901	1.08 [0.33 - 3.60]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207335_x_at	104	0.105769	0.100471	-	-0.673495	0.934756	-0.0466684	0.95 [0.31 - 2.92]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P125420	117	0.888889	0.0199073	0.267069	0.836086	0.699823	0.148366	1.16 [0.55 - 2.47]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P302998	117	0.470085	0.0284895	0.342166	-0.626272	0.903959	-0.0545376	0.95 [0.39 - 2.30]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209492_x_at	204	0.122549	0.0903641	-	1.55998	0.213495	0.887733	2.43 [0.60 - 9.84]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209492_x_at	204	0.696078	0.0161016	0.229495	0.648064	0.112179	0.855977	2.35 [0.82 - 6.77]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207335_x_at	204	0.455882	0.150279	-	0.551481	0.97758	0.0204282	1.02 [0.25 - 4.24]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207335_x_at	204	0.54902	0.0452836	0.462496	0.545323	0.971341	0.0197563	1.02 [0.35 - 3.00]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207335_x_at	178	0.634831	0.0251671	0.314463	0.441463	0.616657	0.166315	1.18 [0.62 - 2.26]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209492_x_at	178	0.623595	0.0672177	-	0.362002	0.490023	0.294512	1.34 [0.58 - 3.10]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200007155	41	0.609756	0.0284402	0.341766	0.891465	0.0810722	0.547733	1.73 [0.93 - 3.20]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209492_x_at	111	0.54955	0.409453	-	0.215817	0.556265	0.180128	1.20 [0.66 - 2.18]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207335_x_at	111	0.531532	0.360176	-	0.239938	0.759875	0.0860471	1.09 [0.63 - 1.89]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207335_x_at	90	0.733333	0.11251	-	0.536774	0.785883	-0.0933802	0.91 [0.46 - 1.79]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207335_x_at	90	0.111111	0.0482334	0.480915	-0.878947	0.296901	-0.409382	0.66 [0.31 - 1.43]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209492_x_at	90	0.7	0.0751575	-	0.582884	0.97273	0.0112382	1.01 [0.53 - 1.93]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209492_x_at	90	0.111111	0.0482334	0.480915	-0.878947	0.566762	-0.215864	0.81 [0.39 - 1.69]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	1462	50	0.34	0.286625	-	0.591508	0.457827	0.361926	1.44 [0.55 - 3.73]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209492_x_at	138	0.101449	0.0887895	-	-0.575055	0.494386	-0.177856	0.84 [0.50 - 1.39]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207335_x_at	138	0.217391	0.131864	-	-0.397019	0.554117	-0.152442	0.86 [0.52 - 1.42]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209492_x_at	129	0.193798	0.260363	-	-0.329869	0.451324	-0.33699	0.71 [0.30 - 1.72]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207335_x_at	129	0.651163	0.105809	-	0.398011	0.944397	0.0260616	1.03 [0.49 - 2.13]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19704	56	0.196429	0.196614	-	-0.555381	0.971067	0.0114954	1.01 [0.54 - 1.88]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6355	56	0.107143	0.151978	-	-0.688252	0.959754	0.0182785	1.02 [0.50 - 2.07]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18092	56	0.732143	0.280903	-	0.413393	0.866113	0.0632121	1.07 [0.51 - 2.22]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6355	56	0.107143	0.0491954	0.486775	-0.936062	0.892258	0.0532966	1.05 [0.49 - 2.28]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19704	56	0.821429	0.224602	-	0.513013	0.677245	0.121365	1.13 [0.64 - 2.00]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18092	56	0.160714	0.156497	-	0.832819	0.759683	0.108348	1.11 [0.56 - 2.23]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209492_x_at	278	0.622302	0.00609623	0.110523	0.514041	0.040962	0.3852	1.47 [1.02 - 2.13]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207335_x_at	278	0.615108	0.00308789	0.0644736	0.5518	0.0676209	0.348827	1.42 [0.98 - 2.06]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209492_x_at	133	0.390977	0.036563	0.403646	-0.497669	0.137262	-0.274044	0.76 [0.53 - 1.09]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207335_x_at	133	0.263158	0.0111341	0.175002	-0.644221	0.255437	-0.211366	0.81 [0.56 - 1.17]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13513	81	0.246914	0.234485	-	-0.619225	0.686427	0.236469	1.27 [0.40 - 3.99]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6529	81	0.17284	0.155996	-	-0.76779	0.71415	0.208542	1.23 [0.40 - 3.76]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207335_x_at	185	0.535135	0.0354875	0.395881	-0.343756	0.324297	-0.0992479	0.91 [0.74 - 1.10]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209492_x_at	185	0.827027	0.0826426	-	-0.422588	0.360565	-0.0974003	0.91 [0.74 - 1.12]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207335_x_at	185	0.535135	0.0538188	-	-0.343328	0.226611	-0.13304	0.88 [0.71 - 1.09]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209492_x_at	185	0.621622	0.11635	-	-0.263079	0.333525	-0.0942903	0.91 [0.75 - 1.10]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P125420	110	0.190909	0.295627	-	0.31412	0.98146	-0.00366242	1.00 [0.73 - 1.36]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P302998	110	0.145455	0.120386	-	0.797112	0.874284	0.030984	1.03 [0.70 - 1.51]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P125420	110	0.118182	0.0723741	-	1.23474	0.867336	0.0322818	1.03 [0.71 - 1.51]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P302998	110	0.345455	0.193579	-	0.315266	0.980777	0.00394322	1.00 [0.73 - 1.38]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209492_x_at	80	0.65	0.109082	-	0.70209	0.36549	0.284081	1.33 [0.72 - 2.46]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207335_x_at	80	0.1375	0.130601	-	1.10352	0.571272	0.200308	1.22 [0.61 - 2.44]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0205	281	0.893238	0.0297733	0.352466	0.471011	0.063636	0.700165	2.01 [0.96 - 4.22]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209492_x_at	38	0.684211	0.105599	-	0.801032	0.463533	0.565631	1.76 [0.39 - 7.99]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207335_x_at	38	0.631579	0.0956623	-	0.816495	0.271673	0.713999	2.04 [0.57 - 7.29]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207335_x_at	140	0.421429	0.0134884	0.201716	-0.710252	0.0296175	-0.87128	0.42 [0.19 - 0.92]
GENE	ATP5I	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209492_x_at	140	0.35	0.0373782	0.409452	-0.595249	0.234496	-0.482542	0.62 [0.28 - 1.37]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202325_s_at	30	0.466667	0.127255	-	-0.608403	0.925519	0.0391853	1.04 [0.46 - 2.36]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1661574	165	0.133333	0.0551991	-	0.8001	0.497607	0.0963265	1.10 [0.83 - 1.45]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1661574	165	0.490909	0.0440181	0.454377	0.733727	0.230531	0.27523	1.32 [0.84 - 2.07]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202325_s_at	163	0.429448	0.068433	-	0.369833	0.587464	0.0893598	1.09 [0.79 - 1.51]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202325_s_at	79	0.518987	0.0496097	0.489277	0.570333	0.215669	0.352551	1.42 [0.81 - 2.49]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202325_s_at	58	0.189655	0.366268	-	0.309261	0.898435	0.0307491	1.03 [0.64 - 1.65]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202325_s_at	34	0.147059	0.00647032	0.115756	2.37283	0.398206	0.22917	1.26 [0.74 - 2.14]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202325_s_at	158	0.474684	0.0280065	0.338234	-0.511853	0.15146	-0.352354	0.70 [0.43 - 1.14]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202325_s_at	53	0.54717	0.234789	-	0.407388	0.779988	-0.189298	0.83 [0.22 - 3.12]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202325_s_at	53	0.867925	0.159888	-	-0.989837	0.581462	-0.403297	0.67 [0.16 - 2.80]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202325_s_at	180	0.277778	0.045695	0.465107	0.488164	0.421442	0.290267	1.34 [0.66 - 2.71]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202325_s_at	559	0.756708	0.00245398	0.0535305	0.607977	0.0328592	0.69417	2.00 [1.06 - 3.79]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202325_s_at	77	0.402597	0.0792615	-	0.464734	0.177941	0.55418	1.74 [0.78 - 3.90]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202325_s_at	70	0.2	0.0150987	0.219045	-0.747526	0.158463	-0.790459	0.45 [0.15 - 1.36]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36107_at	50	0.82	5.616e-05	0.00210226	1.7169	0.805669	0.0976083	1.10 [0.51 - 2.40]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202325_s_at	74	0.891892	0.0018838	0.0431235	1.19573	0.742105	0.253724	1.29 [0.28 - 5.84]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202325_s_at	67	0.41791	0.0247777	0.311111	2.05774	0.180905	1.87219	6.50 [0.42 - 100.96]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202325_s_at	115	0.843478	0.164031	-	0.802972	0.875329	0.179816	1.20 [0.13 - 11.32]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36107_at	158	0.689873	0.00133203	0.0323806	0.889421	0.878927	0.0649744	1.07 [0.46 - 2.46]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36107_at	76	0.894737	0.0147123	0.214951	1.33337	0.455544	0.59743	1.82 [0.38 - 8.73]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202325_s_at	204	0.833333	0.00297002	0.062482	0.566712	0.179137	0.376729	1.46 [0.84 - 2.53]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202325_s_at	87	0.126437	0.0390571	0.421201	-0.922322	0.631265	-0.318597	0.73 [0.20 - 2.67]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202325_s_at	87	0.126437	0.0390571	0.421201	-0.922322	0.631265	-0.318597	0.73 [0.20 - 2.67]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202325_s_at	77	0.896104	0.293724	-	0.809731	0.678371	-0.362294	0.70 [0.13 - 3.86]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202325_s_at	77	0.116883	0.126569	-	-0.971915	0.443825	-0.569115	0.57 [0.13 - 2.43]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202325_s_at	136	0.625	0.0143188	0.21074	1.09834	0.0574504	1.52816	4.61 [0.95 - 22.30]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202325_s_at	200	0.715	0.000133314	0.00450926	1.10484	0.00322333	2.07802	7.99 [2.00 - 31.84]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11801	60	0.683333	0.000132225	0.00447696	1.38037	0.103689	0.718531	2.05 [0.86 - 4.87]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11801	60	0.216667	0.0881906	-	0.997704	0.472856	0.205596	1.23 [0.70 - 2.15]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	22600	155	0.135484	0.180016	-	-0.477676	0.694371	-0.044032	0.96 [0.77 - 1.19]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202325_s_at	286	0.164336	0.126481	-	0.44792	0.580348	0.198809	1.22 [0.60 - 2.47]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202325_s_at	159	0.295597	0.00579983	0.106313	1.23935	0.0340147	0.972593	2.64 [1.08 - 6.50]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202325_s_at	159	0.754717	0.00353237	0.071827	1.0427	0.0114719	1.29973	3.67 [1.34 - 10.05]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202325_s_at	159	0.257862	0.00281292	0.0597982	1.61367	0.0189892	1.06215	2.89 [1.19 - 7.03]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202325_s_at	54	0.222222	0.102624	-	15.4349	0.0785994	1.71615	5.56 [0.82 - 37.66]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202325_s_at	117	0.837607	0.126552	-	0.574559	0.548729	0.198673	1.22 [0.64 - 2.34]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202325_s_at	117	0.837607	0.142322	-	0.629418	0.734861	0.131918	1.14 [0.53 - 2.45]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202325_s_at	117	0.837607	0.126552	-	0.574559	0.548729	0.198673	1.22 [0.64 - 2.34]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202325_s_at	117	0.606838	0.136987	-	-0.645902	0.882045	-0.0602139	0.94 [0.43 - 2.09]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202325_s_at	236	0.864407	1.83468e-05	0.000772864	1.22654	0.0119561	1.37251	3.95 [1.35 - 11.51]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202325_s_at	249	0.859438	0.000688655	0.0186073	0.874071	0.148989	0.622076	1.86 [0.80 - 4.34]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202325_s_at	62	0.596774	0.117917	-	-0.833507	0.354102	-0.384832	0.68 [0.30 - 1.54]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202325_s_at	125	0.896	0.0572585	-	0.849945	0.315041	0.450408	1.57 [0.65 - 3.78]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202325_s_at	125	0.12	0.13651	-	1.03305	0.729808	0.121329	1.13 [0.57 - 2.25]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202325_s_at	54	0.444444	0.166681	-	-0.826762	0.719289	-0.183211	0.83 [0.31 - 2.26]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202325_s_at	198	0.691919	0.0252113	0.314842	-0.731129	0.344008	-0.278089	0.76 [0.43 - 1.35]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202325_s_at	198	0.691919	0.0702016	-	-0.601248	0.608947	-0.156241	0.86 [0.47 - 1.56]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202325_s_at	198	0.888889	0.0543008	-	-0.859707	0.375277	-0.206302	0.81 [0.52 - 1.28]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202325_s_at	51	0.745098	0.415131	-	0.728463	0.868419	0.162427	1.18 [0.17 - 8.04]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202325_s_at	62	0.677419	0.0431821	0.44894	1.1254	0.380177	0.539699	1.72 [0.51 - 5.73]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202325_s_at	177	0.316384	0.0309038	0.361361	0.714056	0.852041	-0.0904697	0.91 [0.35 - 2.36]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202325_s_at	177	0.372881	0.09451	-	0.424661	0.854707	0.0773856	1.08 [0.47 - 2.47]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202325_s_at	145	0.103448	0.000637158	0.0174199	-1.24212	0.00387231	-1.63836	0.19 [0.06 - 0.59]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202325_s_at	226	0.146018	1.27345e-08	9.29656e-07	-1.51851	0.00013966	-1.86507	0.15 [0.06 - 0.40]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202325_s_at	55	0.2	0.363366	-	0.562312	0.918347	0.0664914	1.07 [0.30 - 3.81]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202325_s_at	55	0.509091	0.194852	-	0.672267	0.568557	0.426482	1.53 [0.35 - 6.64]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202325_s_at	49	0.510204	0.128408	-	0.905879	0.629119	0.422829	1.53 [0.27 - 8.49]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	292801	34	0.235294	0.0888585	-	-0.772672	0.369063	-0.750201	0.47 [0.09 - 2.43]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	825312	34	0.352941	0.314683	-	-0.440979	0.887212	-0.0584136	0.94 [0.42 - 2.11]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202325_s_at	63	0.825397	0.189366	-	0.524463	0.36726	0.2663	1.31 [0.73 - 2.33]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502292_3p_a_at	28	0.714286	0.031983	0.369707	1.18827	0.873388	-0.0673854	0.93 [0.41 - 2.14]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202325_s_at	82	0.402439	0.11503	-	-0.527963	0.80862	-0.155729	0.86 [0.24 - 3.02]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36107_at	84	0.178571	0.23496	-	0.512612	0.880437	-0.0795404	0.92 [0.33 - 2.60]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202325_s_at	79	0.139241	0.0650173	-	0.783698	0.557208	0.322634	1.38 [0.47 - 4.05]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M37104_at	86	0.883721	0.00469037	0.0899925	1.25262	0.403423	0.499178	1.65 [0.51 - 5.31]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202325_s_at	104	0.365385	0.106433	-	0.579192	0.633637	-0.264836	0.77 [0.26 - 2.28]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P154832	117	0.769231	5.59002e-06	0.000263467	1.27294	0.00169574	0.908553	2.48 [1.41 - 4.37]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202325_s_at	204	0.637255	0.0182916	0.251495	0.844518	0.159185	1.24958	3.49 [0.61 - 19.87]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202325_s_at	204	0.77451	0.0330896	0.378121	0.606257	0.502863	0.458768	1.58 [0.41 - 6.05]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202325_s_at	178	0.735955	0.180694	-	0.285758	0.865386	0.0648232	1.07 [0.50 - 2.26]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200005878	41	0.365854	0.0587369	-	-0.782957	0.991851	-0.00363226	1.00 [0.50 - 2.00]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300018015	41	0.634146	0.136357	-	-0.695187	0.69295	0.139378	1.15 [0.58 - 2.30]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202325_s_at	111	0.594595	0.154624	-	0.375057	0.736463	0.124242	1.13 [0.55 - 2.33]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202325_s_at	90	0.844444	0.0115137	0.17943	0.903373	0.518898	0.187065	1.21 [0.68 - 2.13]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202325_s_at	90	0.844444	0.0177608	0.246261	0.952239	0.64771	0.15005	1.16 [0.61 - 2.21]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5102	50	0.64	0.0151727	0.219824	1.13868	0.335324	0.83693	2.31 [0.42 - 12.67]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202325_s_at	138	0.898551	0.00376397	0.0755677	0.927469	0.0222864	0.577052	1.78 [1.09 - 2.92]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202325_s_at	129	0.674419	0.0348074	0.390908	0.523717	0.363004	0.344885	1.41 [0.67 - 2.97]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35716	56	0.482143	0.00578568	0.106111	-1.02954	0.16519	-0.67511	0.51 [0.20 - 1.32]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42506	56	0.357143	0.0461056	0.467699	-0.733942	0.443394	-0.285662	0.75 [0.36 - 1.56]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35716	56	0.196429	0.0107893	0.170935	-1.04	0.457642	-0.312697	0.73 [0.32 - 1.67]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42506	56	0.714286	0.0105403	0.167971	-1.14969	0.121078	-0.65206	0.52 [0.23 - 1.19]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202325_s_at	278	0.528777	0.060009	-	0.35692	0.529505	-0.145002	0.87 [0.55 - 1.36]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202325_s_at	133	0.43609	0.0352184	0.39392	-0.492893	0.338602	-0.193948	0.82 [0.55 - 1.23]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12838	81	0.753086	0.0975425	-	-1.55525	0.71308	-0.241846	0.79 [0.22 - 2.85]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1081	81	0.703704	0.12851	-	-1.09869	0.689323	0.263044	1.30 [0.36 - 4.72]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9913	81	0.283951	0.233073	-	-0.620533	0.455876	-0.600349	0.55 [0.11 - 2.66]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202325_s_at	185	0.172973	0.087449	-	-0.359051	0.918031	-0.00874378	0.99 [0.84 - 1.17]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202325_s_at	185	0.172973	0.0954678	-	-0.378267	0.974169	-0.00304732	1.00 [0.83 - 1.20]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P154832	110	0.836364	0.0011747	0.0291611	0.912903	0.0169886	0.541561	1.72 [1.10 - 2.68]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P310335	110	0.345455	0.111978	-	0.394484	0.526738	0.0567867	1.06 [0.89 - 1.26]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P154832	110	0.345455	0.0034272	0.0701084	1.08971	0.00641489	0.788837	2.20 [1.25 - 3.88]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P310335	110	0.590909	0.134164	-	-0.48719	0.849358	-0.0217143	0.98 [0.78 - 1.22]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202325_s_at	80	0.225	0.204766	-	0.774406	0.404213	0.385362	1.47 [0.59 - 3.64]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_3354	281	0.587189	0.000184946	0.00600374	0.526152	0.00153684	0.680287	1.97 [1.30 - 3.01]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:774166	59	0.542373	0.0424574	0.444177	-1.10471	0.147989	-0.714126	0.49 [0.19 - 1.29]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:291002	59	0.237288	0.000193843	0.00625469	-1.65358	0.0404758	-1.28737	0.28 [0.08 - 0.95]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202325_s_at	38	0.894737	2.41703e-05	0.00099019	2.29251	0.00267689	2.80335	16.50 [2.65 - 102.85]
GENE	ATP5J	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F6	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202325_s_at	140	0.221429	0.107035	-	-0.497961	0.45799	-0.216243	0.81 [0.46 - 1.43]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202961_s_at	30	0.8	0.302834	-	0.504286	0.907453	-0.0635974	0.94 [0.32 - 2.74]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1750143	165	0.109091	0.0678052	-	0.911195	0.256699	0.261716	1.30 [0.83 - 2.04]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1750143	165	0.842424	0.0298099	0.352756	0.832027	0.38034	0.360825	1.43 [0.64 - 3.21]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202961_s_at	163	0.662577	0.135192	-	0.305202	0.797533	0.0422255	1.04 [0.76 - 1.44]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1558179_at	79	0.101266	0.000158709	0.00525302	-1.40929	0.0125997	-2.73406	0.06 [0.01 - 0.56]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202961_s_at	79	0.253165	0.235255	-	0.419836	0.770105	0.0694617	1.07 [0.67 - 1.71]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202961_s_at	58	0.586207	0.00214323	0.047934	-0.894422	0.0481958	-0.650237	0.52 [0.27 - 0.99]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202961_s_at	34	0.117647	0.0651217	-	1.3254	0.960273	-0.0115505	0.99 [0.63 - 1.56]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202961_s_at	158	0.170886	0.0795887	-	-0.493089	0.429371	-0.23003	0.79 [0.45 - 1.41]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202961_s_at	53	0.207547	0.0106919	0.169778	-0.947606	0.518468	-0.475837	0.62 [0.15 - 2.63]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202961_s_at	53	0.207547	0.000892481	0.0231623	-1.24571	0.173085	-1.09785	0.33 [0.07 - 1.62]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202961_s_at	180	0.322222	0.00960179	0.156589	0.604573	0.133346	0.530624	1.70 [0.85 - 3.40]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1558179_at	559	0.415027	0.084734	-	-0.343282	0.498028	-0.137185	0.87 [0.59 - 1.30]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202961_s_at	559	0.676208	3.48951e-05	0.00137579	0.80687	0.00219873	0.957792	2.61 [1.41 - 4.81]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202961_s_at	77	0.61039	0.0151869	0.219975	0.627518	0.0659614	0.652208	1.92 [0.96 - 3.85]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1558179_at	70	0.757143	0.0326106	0.374496	0.621562	0.380937	0.753217	2.12 [0.39 - 11.45]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202961_s_at	70	0.871429	0.00727044	0.126665	-1.3096	0.797462	0.107254	1.11 [0.49 - 2.53]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40135_at	50	0.82	0.0570783	-	-0.874267	0.228799	-0.799676	0.45 [0.12 - 1.65]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40134_at	50	0.84	0.0100638	0.162235	1.07908	0.180766	0.264327	1.30 [0.88 - 1.92]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202961_s_at	74	0.797297	0.000175681	0.00574051	1.16302	0.000459415	1.7477	5.74 [2.16 - 15.26]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202961_s_at	67	0.895522	0.36073	-	-15.1506	0.984823	-0.0239519	0.98 [0.08 - 11.52]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1558179_at	67	0.298507	0.196198	-	1.28293	0.394251	1.75455	5.78 [0.10 - 327.39]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1558179_at	115	0.434783	0.0877561	-	-0.92007	0.489961	-0.252152	0.78 [0.38 - 1.59]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202961_s_at	115	0.313043	0.0227683	0.29343	-1.1621	0.22013	-1.00331	0.37 [0.07 - 1.82]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40134_at	158	0.21519	0.151369	-	-0.451345	0.81242	0.093052	1.10 [0.51 - 2.37]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40135_at	158	0.291139	0.0480795	0.479971	0.712926	0.320272	0.21104	1.23 [0.81 - 1.87]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40134_at	76	0.5	0.00782038	0.133959	-1.56277	0.249938	-0.918505	0.40 [0.08 - 1.91]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40135_at	76	0.25	0.102603	-	-0.841026	0.475125	-0.295397	0.74 [0.33 - 1.67]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1558179_at	204	0.441176	0.0243618	0.307504	0.315959	0.404096	0.0633181	1.07 [0.92 - 1.24]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202961_s_at	204	0.75	0.0126989	0.192951	0.402449	0.0666161	0.435867	1.55 [0.97 - 2.46]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1558179_at	87	0.896552	0.260638	-	0.602053	0.527818	0.47862	1.61 [0.37 - 7.13]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1558179_at	87	0.896552	0.260638	-	0.602053	0.527818	0.47862	1.61 [0.37 - 7.13]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202961_s_at	87	0.770115	0.0300435	0.354606	0.833097	0.945755	-0.0427378	0.96 [0.28 - 3.28]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202961_s_at	87	0.770115	0.0300435	0.354606	0.833097	0.945755	-0.0427378	0.96 [0.28 - 3.28]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1558179_at	77	0.727273	5.84494e-05	0.00217819	2.05034	0.00979224	2.00408	7.42 [1.62 - 33.95]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202961_s_at	77	0.844156	0.110357	-	0.926639	0.310681	0.74133	2.10 [0.50 - 8.80]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1558179_at	77	0.727273	0.000674651	0.018286	2.00106	0.0132365	2.15094	8.59 [1.57 - 47.12]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202961_s_at	77	0.844156	0.196558	-	0.864575	0.562914	0.489457	1.63 [0.31 - 8.57]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202961_s_at	136	0.830882	0.0202971	0.270749	1.04364	0.460718	0.507037	1.66 [0.43 - 6.39]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202961_s_at	200	0.895	0.00716742	0.125281	1.00957	0.168144	0.914812	2.50 [0.68 - 9.17]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7366	60	0.3	0.0161953	0.23046	1.23485	0.0570577	0.7753	2.17 [0.98 - 4.83]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3412	60	0.5	0.0361438	0.400634	0.822928	0.0661936	0.566559	1.76 [0.96 - 3.23]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7366	60	0.733333	0.0293037	0.348723	0.836632	0.283595	0.467372	1.60 [0.68 - 3.75]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3412	60	0.566667	0.297704	-	0.393414	0.746026	0.112773	1.12 [0.57 - 2.21]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	11867	155	0.729032	2.40457e-05	0.000985606	1.12426	0.000267767	0.260381	1.30 [1.13 - 1.49]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202961_s_at	286	0.891608	0.00958544	0.156388	0.674841	0.115053	0.616298	1.85 [0.86 - 3.99]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202961_s_at	159	0.704403	0.000295793	0.00902539	1.09292	0.00137983	1.48019	4.39 [1.77 - 10.88]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202961_s_at	159	0.704403	0.00069652	0.0187872	1.1948	0.00991468	1.40131	4.06 [1.40 - 11.78]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202961_s_at	159	0.874214	0.0146745	0.214547	0.894611	0.163583	0.665733	1.95 [0.76 - 4.96]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202961_s_at	54	0.851852	0.00958896	0.156431	1.69193	0.120439	1.20908	3.35 [0.73 - 15.41]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202961_s_at	117	0.34188	0.0727126	-	-0.562338	0.661982	-0.153362	0.86 [0.43 - 1.71]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202961_s_at	117	0.333333	0.0606401	-	-0.696018	0.131023	-0.604332	0.55 [0.25 - 1.20]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202961_s_at	117	0.34188	0.0727126	-	-0.562338	0.661982	-0.153362	0.86 [0.43 - 1.71]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202961_s_at	117	0.324786	0.217877	-	-0.489727	0.541416	-0.256507	0.77 [0.34 - 1.76]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202961_s_at	236	0.614407	0.00550366	0.102046	0.735381	0.0473918	0.876336	2.40 [1.01 - 5.71]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202961_s_at	249	0.779116	0.00147286	0.0351979	0.720149	0.0176185	0.817125	2.26 [1.15 - 4.45]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202961_s_at	54	0.888889	0.0382256	0.415417	1.3171	0.777332	-0.107048	0.90 [0.43 - 1.89]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202961_s_at	62	0.516129	0.110388	-	-0.796891	0.856956	-0.0560471	0.95 [0.51 - 1.74]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202961_s_at	125	0.48	0.200888	-	0.52208	0.654868	0.149277	1.16 [0.60 - 2.23]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202961_s_at	125	0.856	0.133584	-	-0.656369	0.816346	-0.0600742	0.94 [0.57 - 1.56]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202961_s_at	198	0.50505	0.039103	0.421517	-0.441303	0.549587	-0.157232	0.85 [0.51 - 1.43]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202961_s_at	198	0.823232	0.00986577	0.159826	-1.25288	0.221469	-0.39051	0.68 [0.36 - 1.27]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202961_s_at	198	0.823232	0.0273514	0.332852	-1.09126	0.280547	-0.361321	0.70 [0.36 - 1.34]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202961_s_at	51	0.254902	0.0696891	-	-1.50918	0.764834	-0.290236	0.75 [0.11 - 5.01]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202961_s_at	62	0.112903	0.169817	-	15.2364	0.672628	0.293664	1.34 [0.34 - 5.24]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1558179_at	145	0.22069	0.0576099	-	-0.679125	0.320117	-1.10936	0.33 [0.04 - 2.94]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202961_s_at	145	0.655172	0.00268693	0.0576204	-1.45953	0.0284395	-1.33302	0.26 [0.08 - 0.87]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202961_s_at	177	0.79661	0.123026	-	-0.656178	0.548594	-0.293649	0.75 [0.29 - 1.95]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1558179_at	177	0.237288	0.029626	0.351295	-0.551589	0.240352	-0.899422	0.41 [0.09 - 1.83]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1558179_at	177	0.237288	0.023788	0.302484	-0.643925	0.467883	-0.625777	0.53 [0.10 - 2.90]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202961_s_at	177	0.632768	0.0985921	-	0.393132	0.764089	0.131676	1.14 [0.48 - 2.70]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1558179_at	226	0.712389	0.0939959	-	-0.584794	0.846942	-0.0421766	0.96 [0.62 - 1.47]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202961_s_at	226	0.185841	0.0657795	-	-0.573489	0.229496	-0.487509	0.61 [0.28 - 1.36]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202961_s_at	49	0.183673	0.0910346	-	15.3482	0.575024	0.470486	1.60 [0.31 - 8.29]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1558179_at	55	0.581818	0.00157018	0.0371125	1.55358	0.155782	3.10812	22.38 [0.31 - 1636.00]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1558179_at	49	0.673469	0.0871226	-	0.954342	0.722088	-0.845304	0.43 [0.00 - 45.28]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1558179_at	55	0.618182	0.00218237	0.0486484	1.31815	0.507213	1.34013	3.82 [0.07 - 200.50]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202961_s_at	55	0.181818	0.208696	-	0.906544	0.789418	0.151087	1.16 [0.38 - 3.53]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202961_s_at	55	0.2	0.00864716	0.144641	15.5457	0.0354373	1.76802	5.86 [1.13 - 30.43]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1558179_at	63	0.396825	0.0149121	0.217072	0.887971	0.210845	0.711048	2.04 [0.67 - 6.20]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202961_s_at	63	0.507937	0.0259006	0.320716	0.776225	0.159023	0.494612	1.64 [0.82 - 3.26]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4757811_3p_s_at	28	0.892857	0.219776	-	-15.1822	0.560151	0.0987807	1.10 [0.79 - 1.54]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.376369.1.S1_3p_s_at	28	0.535714	0.166056	-	0.748762	0.245931	-0.137194	0.87 [0.69 - 1.10]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202961_s_at	82	0.707317	0.237255	-	0.43478	0.850717	0.129599	1.14 [0.30 - 4.39]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40134_at	84	0.166667	0.0657673	-	0.846513	0.156358	0.454543	1.58 [0.84 - 2.95]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202961_s_at	79	0.21519	0.0575589	-	0.630523	0.269686	0.556123	1.74 [0.65 - 4.68]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202961_s_at	104	0.826923	0.033552	0.381596	0.761759	0.129964	0.840817	2.32 [0.78 - 6.88]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P215832	117	0.512821	0.000603389	0.0166322	1.00395	0.0081624	0.898861	2.46 [1.26 - 4.78]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P343377	117	0.461538	0.00261365	0.0563429	0.919732	0.00965943	0.888777	2.43 [1.24 - 4.77]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202961_s_at	204	0.656863	7.23239e-07	4.03485e-05	1.79783	9.89583e-05	2.17241	8.78 [2.94 - 26.21]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202961_s_at	204	0.671569	2.47268e-10	2.22296e-08	1.62719	2.81287e-07	2.18551	8.90 [3.86 - 20.48]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1558179_at	204	0.426471	0.0112218	0.17603	-0.928018	0.113992	-0.406684	0.67 [0.40 - 1.10]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1558179_at	204	0.127451	0.0041275	0.0813257	-0.887204	0.0429226	-0.385354	0.68 [0.47 - 0.99]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202961_s_at	178	0.337079	0.115931	-	0.347521	0.453936	0.302458	1.35 [0.61 - 2.99]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300003797	41	0.682927	0.147361	-	0.612963	0.582772	0.228336	1.26 [0.56 - 2.84]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202961_s_at	111	0.162162	0.255585	-	0.428996	0.882127	-0.0508203	0.95 [0.49 - 1.86]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1558179_at	111	0.612613	0.137524	-	-0.412615	0.571897	-0.108807	0.90 [0.62 - 1.31]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202961_s_at	90	0.766667	0.187431	-	-0.57991	0.622845	-0.177383	0.84 [0.41 - 1.70]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202961_s_at	90	0.544444	0.363435	-	-0.346661	0.792051	-0.108057	0.90 [0.40 - 2.00]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3920	50	0.8	0.000495824	0.014069	1.58287	0.0467153	1.33841	3.81 [1.02 - 14.26]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202961_s_at	138	0.688406	0.00695656	0.122429	0.661823	0.0460559	0.462279	1.59 [1.01 - 2.50]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1558179_at	138	0.405797	0.132273	-	-0.361183	0.933681	0.12451	1.13 [0.06 - 21.27]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202961_s_at	129	0.736434	0.207155	-	0.338716	0.549358	0.325058	1.38 [0.48 - 4.01]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	475	56	0.303571	0.0998736	-	-0.582289	0.703783	-0.150234	0.86 [0.40 - 1.87]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32094	56	0.142857	8.99199e-05	0.00318913	-1.84202	0.550922	-0.272098	0.76 [0.31 - 1.86]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18270	56	0.267857	0.348418	-	0.354334	0.626048	0.216515	1.24 [0.52 - 2.97]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32094	56	0.142857	0.00397296	0.0788943	-1.27756	0.539354	-0.275348	0.76 [0.32 - 1.83]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	475	56	0.285714	0.117586	-	-0.545905	0.861959	-0.0664811	0.94 [0.44 - 1.98]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18270	56	0.785714	0.410086	-	-0.439785	0.919321	0.0495182	1.05 [0.40 - 2.74]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1558179_at	278	0.744604	0.061975	-	-0.468114	0.295064	-0.327374	0.72 [0.39 - 1.33]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202961_s_at	278	0.492806	0.10495	-	0.310053	0.58849	-0.103919	0.90 [0.62 - 1.31]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202961_s_at	133	0.691729	0.205634	-	0.306264	0.99302	0.00179892	1.00 [0.67 - 1.50]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202961_s_at	185	0.162162	0.102491	-	-0.358962	0.268316	-0.0983901	0.91 [0.76 - 1.08]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202961_s_at	185	0.162162	0.0447593	0.459148	-0.461939	0.265095	-0.106913	0.90 [0.74 - 1.08]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P343377	110	0.427273	0.0245043	0.308743	0.54606	0.079905	0.360466	1.43 [0.96 - 2.15]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P215832	110	0.436364	0.0307434	0.360109	0.712425	0.0869824	0.417927	1.52 [0.94 - 2.45]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P343377	110	0.781818	0.0140427	0.207761	0.751611	0.0902047	0.412855	1.51 [0.94 - 2.44]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P215832	110	0.4	0.0158913	0.227324	0.596123	0.122756	0.318497	1.38 [0.92 - 2.06]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202961_s_at	80	0.175	0.32707	-	0.715456	0.922036	0.0394546	1.04 [0.47 - 2.29]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3293	281	0.487544	0.0335637	0.381684	0.300024	0.177368	0.428276	1.53 [0.82 - 2.86]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202961_s_at	38	0.394737	0.000989733	0.0252655	1.88118	0.00276912	2.72343	15.23 [2.56 - 90.68]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1558179_at	38	0.526316	0.0984913	-	-0.773575	0.897206	-0.0483384	0.95 [0.46 - 1.98]
GENE	ATP5J2	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202961_s_at	140	0.821429	0.0172405	0.241071	0.785813	0.484809	0.340125	1.41 [0.54 - 3.65]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208745_at	30	0.2	0.0356954	0.397392	-1.02103	0.118453	-0.872179	0.42 [0.14 - 1.25]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208746_x_at	30	0.733333	0.199293	-	0.590902	0.712475	-0.208422	0.81 [0.27 - 2.46]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210453_x_at	30	0.533333	0.0568669	-	-0.783674	0.499671	-0.3882	0.68 [0.22 - 2.09]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207573_x_at	30	0.566667	0.0597333	-	-0.800879	0.614079	-0.292566	0.75 [0.24 - 2.33]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1812638	165	0.751515	0.062047	-	-0.631327	0.549291	-0.106963	0.90 [0.63 - 1.28]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1812638	165	0.818182	0.157116	-	-0.834206	0.441364	-0.196079	0.82 [0.50 - 1.35]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208746_x_at	163	0.276074	0.0433857	0.450269	0.468844	0.616822	0.102192	1.11 [0.74 - 1.65]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210453_x_at	163	0.392638	0.0364488	0.402827	0.43628	0.648806	0.0938544	1.10 [0.73 - 1.65]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207573_x_at	163	0.282209	0.070859	-	0.413652	0.463148	0.161065	1.17 [0.76 - 1.81]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208745_at	163	0.809816	0.00362495	0.0733294	0.674414	0.0339506	0.405192	1.50 [1.03 - 2.18]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210453_x_at	79	0.316456	0.187776	-	0.439107	0.91653	0.031955	1.03 [0.57 - 1.88]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208746_x_at	79	0.594937	0.206616	-	0.36876	0.936929	-0.0230987	0.98 [0.55 - 1.73]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208745_at	79	0.481013	0.0248803	0.311996	0.66282	0.435982	0.217847	1.24 [0.72 - 2.15]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207573_x_at	79	0.620253	0.222381	-	0.358146	0.828148	-0.0619811	0.94 [0.54 - 1.64]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207573_x_at	58	0.362069	0.141992	-	-0.42691	0.455219	-0.247433	0.78 [0.41 - 1.49]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208745_at	58	0.206897	0.35721	-	0.315879	0.789282	0.0876892	1.09 [0.57 - 2.08]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208746_x_at	58	0.431034	0.0863696	-	-0.48039	0.636704	-0.137425	0.87 [0.49 - 1.54]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210453_x_at	58	0.706897	0.0995046	-	0.483617	0.755297	-0.0949715	0.91 [0.50 - 1.65]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210453_x_at	34	0.176471	0.0192049	0.260362	1.63803	0.274159	0.350502	1.42 [0.76 - 2.66]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207573_x_at	34	0.147059	0.00647032	0.115756	2.37283	0.227681	0.381359	1.46 [0.79 - 2.72]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208745_at	34	0.294118	0.0187299	0.255772	1.18493	0.0429524	0.776224	2.17 [1.02 - 4.61]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208746_x_at	34	0.176471	0.0232209	0.29747	1.60118	0.229041	0.393626	1.48 [0.78 - 2.82]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208745_at	158	0.120253	0.164083	-	0.585301	0.442843	-0.218454	0.80 [0.46 - 1.40]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208746_x_at	158	0.139241	0.00534123	0.0996797	-0.754987	0.0092353	-0.749256	0.47 [0.27 - 0.83]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210453_x_at	158	0.164557	0.00776624	0.133248	-0.696582	0.0118904	-0.724777	0.48 [0.28 - 0.85]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207573_x_at	158	0.164557	0.00311022	0.0648489	-0.758752	0.0165106	-0.732818	0.48 [0.26 - 0.87]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208745_at	53	0.773585	0.0653152	-	0.707167	0.618493	0.226947	1.25 [0.51 - 3.07]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210453_x_at	53	0.132075	0.145412	-	1.0217	0.344109	0.683882	1.98 [0.48 - 8.17]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207573_x_at	53	0.396226	0.234218	-	-0.434784	0.568114	0.424697	1.53 [0.36 - 6.57]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208746_x_at	53	0.735849	0.181102	-	0.500639	0.386692	0.594465	1.81 [0.47 - 6.96]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210453_x_at	53	0.132075	0.196534	-	0.763077	0.263487	0.794365	2.21 [0.55 - 8.91]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208745_at	53	0.773585	0.220677	-	0.503412	0.819561	0.109304	1.12 [0.44 - 2.85]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207573_x_at	53	0.471698	0.274509	-	-0.378719	0.438966	0.558423	1.75 [0.42 - 7.19]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208746_x_at	53	0.396226	0.427229	-	-0.290766	0.459047	0.516685	1.68 [0.43 - 6.58]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208745_at	180	0.15	0.0954591	-	-0.446046	0.763113	-0.0870894	0.92 [0.52 - 1.61]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208746_x_at	180	0.894444	0.0199565	0.267535	0.689905	0.65588	0.21506	1.24 [0.48 - 3.19]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210453_x_at	180	0.488889	0.0364756	0.403019	-0.438634	0.81427	0.11727	1.12 [0.42 - 2.99]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207573_x_at	180	0.294444	0.0243167	0.307111	-0.478365	0.835685	0.0948324	1.10 [0.45 - 2.69]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210453_x_at	559	0.794275	0.0684894	-	-0.53551	0.758362	-0.0890906	0.91 [0.52 - 1.61]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208746_x_at	559	0.871199	0.142002	-	-0.534992	0.798718	-0.0729795	0.93 [0.53 - 1.63]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208745_at	559	0.828265	0.00205135	0.0462457	-1.1452	0.0191961	-0.525003	0.59 [0.38 - 0.92]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207573_x_at	559	0.898032	0.112098	-	-0.714001	0.547373	-0.149766	0.86 [0.53 - 1.40]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210453_x_at	77	0.675325	0.0447915	0.459355	0.546424	0.249334	0.433751	1.54 [0.74 - 3.23]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207573_x_at	77	0.61039	0.00776007	0.133167	0.706955	0.0652736	0.613889	1.85 [0.96 - 3.55]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208745_at	77	0.896104	0.136669	-	-0.679811	0.471211	0.189291	1.21 [0.72 - 2.02]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208746_x_at	77	0.441558	0.0423056	0.443174	0.539403	0.215573	0.45027	1.57 [0.77 - 3.20]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208746_x_at	70	0.114286	0.0587164	-	-0.722121	0.157698	-0.596793	0.55 [0.24 - 1.26]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208745_at	70	0.357143	0.132696	-	-0.403939	0.522712	-0.189895	0.83 [0.46 - 1.48]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207573_x_at	70	0.142857	0.0280286	0.338415	-0.767023	0.17216	-0.60024	0.55 [0.23 - 1.30]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210453_x_at	70	0.214286	0.00780801	0.133797	-0.802107	0.172242	-0.579687	0.56 [0.24 - 1.29]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38693_at	50	0.28	0.00115142	0.0286777	-1.14019	0.142983	-0.989519	0.37 [0.10 - 1.40]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208745_at	74	0.486486	0.124625	-	-0.44551	0.987422	-0.00668018	0.99 [0.43 - 2.28]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208746_x_at	74	0.135135	0.169572	-	-0.52698	0.879289	-0.110622	0.90 [0.21 - 3.73]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210453_x_at	74	0.716216	0.053389	-	0.577783	0.263741	0.876343	2.40 [0.52 - 11.17]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207573_x_at	74	0.162162	0.00527017	0.0986382	-0.972691	0.718133	-0.255692	0.77 [0.19 - 3.10]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210453_x_at	67	0.41791	0.0327575	0.375611	1.95449	0.131889	2.64175	14.04 [0.45 - 436.29]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208746_x_at	67	0.41791	0.0430763	0.448247	1.86588	0.225848	2.09982	8.16 [0.27 - 244.21]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208745_at	67	0.865672	0.0304098	0.357494	1.3744	0.0255175	2.77195	15.99 [1.40 - 182.09]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207573_x_at	67	0.716418	0.045304	0.462626	1.26356	0.156738	2.48902	12.05 [0.38 - 377.65]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208746_x_at	115	0.208696	0.0268992	0.329101	-1.13806	0.507631	-0.603723	0.55 [0.09 - 3.26]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208745_at	115	0.113043	0.0198823	0.266831	-1.28354	0.215552	-0.83532	0.43 [0.12 - 1.63]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207573_x_at	115	0.104348	0.152125	-	-0.905435	0.420075	-0.699001	0.50 [0.09 - 2.72]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210453_x_at	115	0.217391	0.0366923	0.404571	-1.07991	0.596696	-0.489736	0.61 [0.10 - 3.76]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38693_at	158	0.411392	0.145668	-	-0.413325	0.77926	-0.0929625	0.91 [0.48 - 1.75]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38693_at	76	0.723684	0.074978	-	0.893787	0.405588	0.479133	1.61 [0.52 - 4.99]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208745_at	204	0.112745	0.260576	-	-0.250397	0.700691	-0.0715275	0.93 [0.65 - 1.34]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207573_x_at	204	0.897059	0.00218717	0.0487359	0.703582	0.0707957	0.423769	1.53 [0.96 - 2.42]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210453_x_at	204	0.397059	0.00812201	0.137895	0.381472	0.0623709	0.438512	1.55 [0.98 - 2.46]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208746_x_at	204	0.455882	0.0137909	0.205025	0.347795	0.0615399	0.443782	1.56 [0.98 - 2.48]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208746_x_at	87	0.54023	0.00623481	0.112472	-1.09517	0.108642	-0.79371	0.45 [0.17 - 1.19]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210453_x_at	87	0.356322	0.00318667	0.0661287	-1.07718	0.104972	-0.759823	0.47 [0.19 - 1.17]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208745_at	87	0.195402	0.128614	-	1.06464	0.561332	0.256832	1.29 [0.54 - 3.08]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208746_x_at	87	0.54023	0.00623481	0.112472	-1.09517	0.108642	-0.79371	0.45 [0.17 - 1.19]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207573_x_at	87	0.413793	0.00222667	0.0494535	-1.13548	0.113488	-0.79491	0.45 [0.17 - 1.21]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208745_at	87	0.195402	0.128614	-	1.06464	0.561332	0.256832	1.29 [0.54 - 3.08]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210453_x_at	87	0.356322	0.00318667	0.0661287	-1.07718	0.104972	-0.759823	0.47 [0.19 - 1.17]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207573_x_at	87	0.413793	0.00222667	0.0494535	-1.13548	0.113488	-0.79491	0.45 [0.17 - 1.21]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208745_at	77	0.103896	1.04941e-07	6.71611e-06	-2.41819	2.73227e-05	-1.97575	0.14 [0.06 - 0.35]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210453_x_at	77	0.168831	0.00249344	0.0542293	-1.71577	0.0161685	-2.17235	0.11 [0.02 - 0.67]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207573_x_at	77	0.285714	0.00347221	0.0708455	-1.52059	0.0318472	-1.777	0.17 [0.03 - 0.86]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208746_x_at	77	0.441558	0.00985321	0.159672	-1.79566	0.019467	-2.15878	0.12 [0.02 - 0.71]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210453_x_at	77	0.246753	0.00625968	0.11282	-1.40775	0.0184565	-1.83104	0.16 [0.03 - 0.73]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208745_at	77	0.181818	1.67386e-06	8.74266e-05	-2.56853	0.000190586	-2.0482	0.13 [0.04 - 0.38]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208746_x_at	77	0.441558	0.00624435	0.112606	-1.62199	0.0238373	-1.79789	0.17 [0.03 - 0.79]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207573_x_at	77	0.285714	0.00195666	0.0444883	-1.86206	0.0222158	-2.22137	0.11 [0.02 - 0.73]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208746_x_at	136	0.808824	0.0101509	0.16329	1.11784	0.179511	0.813187	2.26 [0.69 - 7.39]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210453_x_at	136	0.75	0.00868741	0.145153	1.11572	0.121552	0.944713	2.57 [0.78 - 8.50]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207573_x_at	136	0.897059	0.0459456	0.466691	0.992084	0.346288	0.527573	1.69 [0.57 - 5.08]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208745_at	136	0.889706	0.00272805	0.0583338	1.37317	0.0465134	1.11142	3.04 [1.02 - 9.08]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208745_at	200	0.465	0.0366648	0.404374	-0.621557	0.0278466	-0.89986	0.41 [0.18 - 0.91]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208746_x_at	200	0.115	0.147134	-	-0.556923	0.497387	-0.444665	0.64 [0.18 - 2.32]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210453_x_at	200	0.895	0.124779	-	0.590151	0.767542	-0.200115	0.82 [0.22 - 3.09]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207573_x_at	200	0.375	0.0587445	-	-0.550505	0.686965	-0.265577	0.77 [0.21 - 2.79]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20332	60	0.133333	0.165436	-	0.980968	0.663078	0.117744	1.12 [0.66 - 1.91]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20332	60	0.716667	0.158336	-	-0.684716	0.742211	-0.0874426	0.92 [0.54 - 1.54]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16102	155	0.819355	0.000757882	0.0201788	0.945934	0.00258594	0.312042	1.37 [1.12 - 1.67]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208745_at	286	0.503497	0.207323	-	0.243816	0.88446	0.0372402	1.04 [0.63 - 1.72]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208746_x_at	286	0.664336	0.402062	-	0.168459	0.934692	0.0243497	1.02 [0.57 - 1.83]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210453_x_at	286	0.13986	0.250533	-	-0.296207	0.76711	-0.0929588	0.91 [0.49 - 1.69]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207573_x_at	286	0.807692	0.264069	-	-0.293904	0.95262	-0.017201	0.98 [0.56 - 1.73]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208746_x_at	159	0.144654	0.0367792	0.405192	-0.745618	0.285732	-0.440242	0.64 [0.29 - 1.44]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208745_at	159	0.421384	0.000896905	0.0232588	-1.05351	0.00373318	-1.23508	0.29 [0.13 - 0.67]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210453_x_at	159	0.132075	0.0636523	-	-0.688938	0.343981	-0.390824	0.68 [0.30 - 1.52]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208745_at	159	0.477987	0.0037668	0.0756132	-1.14193	0.0137547	-1.2305	0.29 [0.11 - 0.78]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207573_x_at	159	0.157233	0.0780542	-	-0.633159	0.526507	-0.279683	0.76 [0.32 - 1.80]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208746_x_at	159	0.358491	0.0445636	0.457893	-0.625325	0.42615	-0.328526	0.72 [0.32 - 1.62]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208746_x_at	159	0.389937	0.047314	0.475248	-0.725283	0.39689	-0.410709	0.66 [0.26 - 1.72]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210453_x_at	159	0.459119	0.102628	-	-0.516792	0.523061	-0.266956	0.77 [0.34 - 1.74]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207573_x_at	159	0.433962	0.106712	-	-0.507647	0.76071	-0.134249	0.87 [0.37 - 2.07]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208745_at	159	0.496855	0.0106102	0.168806	-0.838653	0.0883141	-0.720817	0.49 [0.21 - 1.11]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210453_x_at	159	0.459119	0.128411	-	-0.565976	0.430234	-0.381308	0.68 [0.26 - 1.76]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207573_x_at	159	0.144654	0.105933	-	-0.688333	0.718482	-0.186257	0.83 [0.30 - 2.29]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210453_x_at	54	0.574074	0.0734586	-	-1.34721	0.824165	-0.145507	0.86 [0.24 - 3.12]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208745_at	54	0.518519	0.0499316	0.491213	-1.45533	0.445246	-0.397273	0.67 [0.24 - 1.86]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208746_x_at	54	0.555556	0.0685232	-	-1.36446	0.93003	-0.0571451	0.94 [0.26 - 3.38]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207573_x_at	54	0.666667	0.23713	-	-0.93432	0.759138	-0.204024	0.82 [0.22 - 3.00]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210453_x_at	117	0.683761	0.173396	-	-0.509898	0.64442	-0.185368	0.83 [0.38 - 1.83]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210453_x_at	117	0.854701	0.140044	-	-1.39023	0.357412	-0.442214	0.64 [0.25 - 1.65]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207573_x_at	117	0.598291	0.114462	-	-0.538946	0.488839	-0.27301	0.76 [0.35 - 1.65]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207573_x_at	117	0.820513	0.0562683	-	-1.72435	0.224708	-0.59129	0.55 [0.21 - 1.44]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208745_at	117	0.119658	0.0141042	0.208426	-1.02583	0.780794	0.0989875	1.10 [0.55 - 2.22]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208745_at	117	0.119658	0.00891229	0.147999	-0.957786	0.991727	0.00310852	1.00 [0.56 - 1.81]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208745_at	117	0.119658	0.00891229	0.147999	-0.957786	0.991727	0.00310852	1.00 [0.56 - 1.81]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208745_at	117	0.102564	0.000242149	0.00758959	-1.49929	0.192344	-0.493498	0.61 [0.29 - 1.28]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208746_x_at	117	0.153846	0.216672	-	-0.485101	0.490027	-0.282556	0.75 [0.34 - 1.68]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208746_x_at	117	0.153846	0.0295815	0.35094	-0.881546	0.212496	-0.584835	0.56 [0.22 - 1.40]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210453_x_at	117	0.880342	0.0706785	-	-15.1766	0.267655	-0.508514	0.60 [0.24 - 1.48]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210453_x_at	117	0.683761	0.173396	-	-0.509898	0.64442	-0.185368	0.83 [0.38 - 1.83]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207573_x_at	117	0.598291	0.114462	-	-0.538946	0.488839	-0.27301	0.76 [0.35 - 1.65]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208746_x_at	117	0.145299	0.0384475	0.416966	-0.898646	0.319318	-0.492904	0.61 [0.23 - 1.61]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207573_x_at	117	0.854701	0.0426198	0.445249	-15.2194	0.195186	-0.589628	0.55 [0.23 - 1.35]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208746_x_at	117	0.153846	0.216672	-	-0.485101	0.490027	-0.282556	0.75 [0.34 - 1.68]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208746_x_at	236	0.898305	0.0119505	0.184466	0.854745	0.687213	0.189016	1.21 [0.48 - 3.03]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210453_x_at	236	0.894068	0.0470873	0.473841	0.710369	0.716547	0.185067	1.20 [0.44 - 3.27]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207573_x_at	236	0.889831	0.0161318	0.229806	0.819734	0.717056	0.15528	1.17 [0.50 - 2.70]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208745_at	236	0.101695	0.00147094	0.0351599	-1.03283	0.766552	-0.121693	0.89 [0.40 - 1.98]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207573_x_at	249	0.883534	0.000168477	0.00553446	1.00236	0.382629	0.302405	1.35 [0.69 - 2.67]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208745_at	249	0.13253	0.0294886	0.3502	-0.580728	0.979349	0.00837253	1.01 [0.53 - 1.90]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208746_x_at	249	0.895582	0.000209405	0.00668964	1.01218	0.552399	0.227512	1.26 [0.59 - 2.66]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210453_x_at	249	0.88755	0.000528671	0.014861	0.950747	0.458392	0.308689	1.36 [0.60 - 3.08]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207573_x_at	62	0.435484	0.131403	-	-0.710245	0.390456	-0.376845	0.69 [0.29 - 1.62]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210453_x_at	125	0.224	0.180972	-	0.799991	0.881513	0.0512832	1.05 [0.54 - 2.07]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207573_x_at	125	0.896	0.37424	-	-0.643745	0.988199	0.00549551	1.01 [0.49 - 2.08]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210453_x_at	125	0.888	0.151453	-	-0.739287	0.684597	-0.108053	0.90 [0.53 - 1.51]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208746_x_at	54	0.722222	0.0424541	0.444155	-1.86507	0.470767	-0.523773	0.59 [0.14 - 2.46]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210453_x_at	54	0.111111	0.2461	-	15.1915	0.963755	0.0333773	1.03 [0.25 - 4.36]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208745_at	62	0.693548	0.319488	-	0.484783	0.592608	0.286328	1.33 [0.47 - 3.80]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207573_x_at	125	0.896	0.196335	-	-0.668531	0.715451	-0.105361	0.90 [0.51 - 1.59]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207573_x_at	54	0.833333	0.0746024	-	-15.4245	0.493223	-0.35969	0.70 [0.25 - 1.95]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208746_x_at	62	0.741935	0.121464	-	-0.955585	0.412093	-0.496913	0.61 [0.19 - 1.99]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208745_at	125	0.352	0.074338	-	0.860017	0.581109	0.165914	1.18 [0.65 - 2.13]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208745_at	125	0.808	0.0318098	0.368377	-0.928101	0.608299	-0.121204	0.89 [0.56 - 1.41]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208745_at	54	0.240741	0.140317	-	-0.850391	0.356648	-0.592907	0.55 [0.16 - 1.95]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210453_x_at	62	0.387097	0.195474	-	-0.605344	0.889528	-0.083456	0.92 [0.28 - 2.99]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208746_x_at	125	0.264	0.389148	-	0.424867	0.759304	0.10631	1.11 [0.56 - 2.20]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208746_x_at	125	0.808	0.39486	-	-0.316532	0.767151	-0.0798304	0.92 [0.54 - 1.57]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207573_x_at	198	0.616162	0.00111437	0.0279046	-1.08395	0.0177692	-0.648844	0.52 [0.31 - 0.89]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208746_x_at	198	0.762626	0.00226704	0.0501842	-0.949413	0.0100009	-0.539183	0.58 [0.39 - 0.88]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208745_at	198	0.89899	0.0465356	0.470399	-1.33164	0.304869	-0.22834	0.80 [0.51 - 1.23]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210453_x_at	198	0.772727	0.001297	0.0316706	-1.03531	0.00559487	-0.592226	0.55 [0.36 - 0.84]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208745_at	198	0.89899	0.0690201	-	-1.23149	0.595648	-0.124615	0.88 [0.56 - 1.40]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207573_x_at	198	0.156566	0.0016404	0.0384788	-0.758901	0.0202958	-0.498056	0.61 [0.40 - 0.93]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208746_x_at	198	0.419192	0.000983555	0.0251331	-0.83733	0.00806499	-0.690443	0.50 [0.30 - 0.84]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208746_x_at	198	0.419192	0.00125453	0.0308047	-0.864487	0.0165869	-0.648941	0.52 [0.31 - 0.89]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210453_x_at	198	0.232323	0.00107603	0.0270992	-0.833975	0.00463316	-0.757639	0.47 [0.28 - 0.79]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210453_x_at	198	0.232323	0.00172545	0.0401172	-0.828181	0.00898095	-0.720905	0.49 [0.28 - 0.84]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207573_x_at	198	0.616162	0.000503318	0.0142505	-1.10244	0.00849111	-0.700236	0.50 [0.29 - 0.84]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208745_at	198	0.878788	0.0307147	0.359884	-0.889389	0.166385	-0.246977	0.78 [0.55 - 1.11]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210453_x_at	51	0.764706	0.309778	-	0.898505	0.758635	0.317359	1.37 [0.18 - 10.40]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207573_x_at	51	0.509804	0.135998	-	1.51771	0.647639	0.428397	1.53 [0.24 - 9.64]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210453_x_at	62	0.193548	0.091461	-	-1.0002	0.853713	-0.122779	0.88 [0.24 - 3.26]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207573_x_at	62	0.16129	0.270262	-	-0.72265	0.832814	-0.129613	0.88 [0.26 - 2.93]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208745_at	51	0.666667	0.106626	-	-15.6933	0.477081	-0.595731	0.55 [0.11 - 2.85]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208745_at	62	0.548387	0.0962208	-	-1.06094	0.520684	-0.328726	0.72 [0.26 - 1.96]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208746_x_at	51	0.823529	0.117484	-	1.33547	0.891248	0.133922	1.14 [0.17 - 7.80]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208746_x_at	62	0.193548	0.091461	-	-1.0002	0.575618	-0.339926	0.71 [0.22 - 2.34]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208745_at	145	0.158621	0.169169	-	0.808167	0.76109	0.190221	1.21 [0.35 - 4.12]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207573_x_at	177	0.361582	0.0173875	0.242543	0.616043	0.0959873	0.843775	2.33 [0.86 - 6.28]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210453_x_at	177	0.898305	0.14213	-	-1.01405	0.696742	0.20656	1.23 [0.44 - 3.47]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207573_x_at	145	0.751724	0.0681825	-	-0.934182	0.429239	-0.541268	0.58 [0.15 - 2.23]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210453_x_at	177	0.717514	0.0135023	0.201868	0.607021	0.110304	0.741784	2.10 [0.84 - 5.22]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208746_x_at	177	0.875706	0.262003	-	-0.575164	0.711566	0.197122	1.22 [0.43 - 3.46]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210453_x_at	145	0.813793	0.0467259	0.471589	-1.34488	0.394985	-0.528349	0.59 [0.17 - 1.99]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208745_at	177	0.898305	0.0961629	-	0.627612	0.325469	0.50505	1.66 [0.61 - 4.53]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208746_x_at	177	0.717514	0.0135023	0.201868	0.607021	0.114361	0.736426	2.09 [0.84 - 5.21]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207573_x_at	177	0.412429	0.0769072	-	0.497997	0.602036	0.301598	1.35 [0.44 - 4.20]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208745_at	177	0.898305	0.0332299	0.379178	0.68465	0.138933	0.664772	1.94 [0.81 - 4.69]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208746_x_at	145	0.703448	0.117558	-	-0.688148	0.392564	-0.534696	0.59 [0.17 - 2.00]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207573_x_at	226	0.526549	0.00786104	0.134493	-0.800635	0.163183	-0.635481	0.53 [0.22 - 1.29]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210453_x_at	226	0.504425	0.00636473	0.114288	-0.81906	0.102946	-0.848722	0.43 [0.15 - 1.19]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208746_x_at	226	0.654867	0.00222478	0.0494193	-1.17886	0.1041	-0.872728	0.42 [0.15 - 1.20]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208745_at	226	0.880531	0.180646	-	-0.778723	0.68959	0.138045	1.15 [0.58 - 2.26]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208745_at	49	0.877551	0.016851	0.237146	1.39013	0.403759	0.63799	1.89 [0.42 - 8.46]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207573_x_at	55	0.472727	0.0598764	-	0.981008	0.276032	0.971595	2.64 [0.46 - 15.18]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210453_x_at	55	0.418182	0.0377598	0.412146	1.03026	0.280276	0.748285	2.11 [0.54 - 8.22]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207573_x_at	49	0.285714	0.128414	-	1.4564	0.181058	1.67665	5.35 [0.46 - 62.40]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210453_x_at	55	0.418182	0.0548406	-	1.04	0.255753	0.886337	2.43 [0.53 - 11.19]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208746_x_at	55	0.4	0.0549942	-	0.95817	0.244652	0.834074	2.30 [0.56 - 9.39]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210453_x_at	49	0.44898	0.0823507	-	1.1065	0.165815	1.52861	4.61 [0.53 - 40.07]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208745_at	55	0.854545	0.00750958	0.129857	1.24454	0.46238	0.448813	1.57 [0.47 - 5.18]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208746_x_at	55	0.4	0.0823697	-	0.947026	0.228044	0.972958	2.65 [0.54 - 12.87]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208746_x_at	49	0.673469	0.102553	-	0.914837	0.154562	1.62172	5.06 [0.54 - 47.20]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207573_x_at	55	0.436364	0.0713708	-	0.856043	0.306965	0.814142	2.26 [0.47 - 10.76]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208745_at	55	0.854545	0.00278362	0.0592938	1.51382	0.705509	0.248082	1.28 [0.35 - 4.64]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	40148	34	0.823529	0.0538322	-	0.98068	0.918945	0.0688483	1.07 [0.28 - 4.03]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210453_x_at	63	0.365079	0.0801723	-	-0.586026	0.698084	-0.0868212	0.92 [0.59 - 1.42]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208746_x_at	63	0.428571	0.0292996	0.34869	-0.72565	0.617448	-0.111454	0.89 [0.58 - 1.39]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208745_at	63	0.730159	0.0162901	0.231433	-1.10523	0.266265	-0.197729	0.82 [0.58 - 1.16]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207573_x_at	63	0.47619	0.0188849	0.257275	-0.792	0.4612	-0.158952	0.85 [0.56 - 1.30]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5453560_3p_a_at	28	0.464286	0.272376	-	0.613133	0.566091	-0.102692	0.90 [0.64 - 1.28]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.107476.1.S2_3p_at	28	0.857143	0.00764687	0.131675	1.66716	0.998647	0.00122892	1.00 [0.24 - 4.14]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4454685_3p_x_at	28	0.107143	0.0593188	-	-1.1806	0.579973	-0.082537	0.92 [0.69 - 1.23]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208746_x_at	82	0.207317	0.023487	0.299829	-0.790801	0.956723	0.0503607	1.05 [0.17 - 6.48]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210453_x_at	82	0.768293	0.286736	-	0.39696	0.794897	0.237735	1.27 [0.21 - 7.62]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207573_x_at	82	0.134146	0.228228	-	-0.508255	0.727792	0.286767	1.33 [0.26 - 6.70]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208745_at	82	0.109756	0.0058477	0.106997	-1.13619	0.0629169	-0.608126	0.54 [0.29 - 1.03]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208746_x_at	79	0.860759	0.184185	-	-0.567559	0.551857	-0.432489	0.65 [0.16 - 2.70]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210453_x_at	79	0.101266	0.108718	-	-0.606264	0.526108	-0.454738	0.63 [0.16 - 2.59]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207573_x_at	79	0.797468	0.116436	-	-0.564214	0.546386	-0.397688	0.67 [0.18 - 2.45]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208745_at	79	0.822785	0.323963	-	0.329418	0.601884	0.206748	1.23 [0.57 - 2.67]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208745_at	104	0.105769	0.0553941	-	-0.835712	0.203948	-0.523524	0.59 [0.26 - 1.33]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208746_x_at	104	0.596154	0.0258415	0.320215	0.711394	0.589463	0.460201	1.58 [0.30 - 8.43]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210453_x_at	104	0.817308	0.121086	-	0.582987	0.773283	0.233763	1.26 [0.26 - 6.20]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207573_x_at	104	0.615385	0.0722937	-	0.577879	0.676249	0.298253	1.35 [0.33 - 5.46]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P75622	117	0.811966	0.029966	0.353993	0.691884	0.0851971	0.579173	1.78 [0.92 - 3.45]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P96527	117	0.512821	0.0166972	0.235586	-0.696539	0.167756	-0.317834	0.73 [0.46 - 1.14]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208746_x_at	204	0.509804	9.97228e-05	0.00349375	1.69664	0.00228801	2.76758	15.92 [2.69 - 94.26]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208746_x_at	204	0.509804	2.53568e-08	1.77648e-06	1.732	2.93255e-06	3.20597	24.68 [6.44 - 94.63]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208745_at	204	0.220588	0.000274508	0.00846094	-1.25127	0.0109142	-1.62458	0.20 [0.06 - 0.69]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208745_at	204	0.254902	9.33029e-06	0.000419595	-1.14882	0.000524326	-1.63026	0.20 [0.08 - 0.49]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207573_x_at	204	0.387255	1.91825e-06	9.90844e-05	15.9639	0.000973989	2.90963	18.35 [3.26 - 103.43]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207573_x_at	204	0.387255	5.64892e-10	4.87799e-08	3.0965	2.70574e-07	3.50062	33.14 [8.73 - 125.81]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210453_x_at	204	0.313726	6.11757e-05	0.00226813	15.7202	0.00148639	2.87461	17.72 [3.01 - 104.36]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210453_x_at	204	0.504902	4.08447e-08	2.7784e-06	1.71092	1.1826e-06	3.34292	28.30 [7.35 - 109.02]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208746_x_at	178	0.88764	0.14868	-	0.414983	0.52224	0.343167	1.41 [0.49 - 4.03]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210453_x_at	178	0.466292	0.118615	-	0.311307	0.651315	0.244197	1.28 [0.44 - 3.68]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207573_x_at	178	0.410112	0.134989	-	0.306454	0.538486	0.32029	1.38 [0.50 - 3.82]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208745_at	178	0.825843	0.00749039	0.129602	0.640709	0.944673	0.0243156	1.02 [0.52 - 2.04]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300008172	41	0.756098	0.0100982	0.162652	1.0884	0.346817	0.519227	1.68 [0.57 - 4.96]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208745_at	111	0.198198	0.189251	-	-0.391568	0.844953	-0.0711916	0.93 [0.46 - 1.90]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207573_x_at	111	0.477477	0.114126	-	0.419395	0.7246	0.127967	1.14 [0.56 - 2.32]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210453_x_at	111	0.486486	0.371647	-	0.236731	0.888067	0.0539437	1.06 [0.50 - 2.24]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208746_x_at	111	0.495495	0.201079	-	0.338588	0.770784	0.110083	1.12 [0.53 - 2.34]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208746_x_at	90	0.177778	0.00783889	0.134202	-0.922332	0.182979	-0.549907	0.58 [0.26 - 1.30]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208746_x_at	90	0.111111	0.0037669	0.0756147	-1.19252	0.122462	-0.713688	0.49 [0.20 - 1.21]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210453_x_at	90	0.255556	0.0208346	0.275776	-0.761632	0.207755	-0.521833	0.59 [0.26 - 1.34]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210453_x_at	90	0.122222	0.00797565	0.135991	-1.10405	0.13867	-0.687527	0.50 [0.20 - 1.25]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207573_x_at	90	0.222222	0.000641567	0.0175222	-1.10036	0.208649	-0.551596	0.58 [0.24 - 1.36]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207573_x_at	90	0.211111	0.0019732	0.0447965	-1.13181	0.142384	-0.726378	0.48 [0.18 - 1.28]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208745_at	90	0.188889	0.00172207	0.0400525	-1.05195	0.429807	-0.321927	0.72 [0.33 - 1.61]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208745_at	90	0.122222	0.0352499	0.394149	-0.934834	0.401328	-0.402626	0.67 [0.26 - 1.71]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208746_x_at	138	0.862319	0.02373	0.301973	-1.10825	0.194433	-0.356705	0.70 [0.41 - 1.20]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208745_at	138	0.137681	0.02778	0.33638	-0.668178	0.0709168	-0.343634	0.71 [0.49 - 1.03]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207573_x_at	138	0.833333	0.019582	0.263975	-0.96073	0.225856	-0.343262	0.71 [0.41 - 1.24]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210453_x_at	138	0.84058	0.0409179	0.433906	-0.848267	0.261003	-0.313918	0.73 [0.42 - 1.26]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208745_at	129	0.193798	0.0830938	-	-0.506364	0.485414	-0.244296	0.78 [0.39 - 1.56]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208746_x_at	129	0.821705	0.0444555	0.457198	0.588507	0.143402	0.58665	1.80 [0.82 - 3.95]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210453_x_at	129	0.844961	0.0505421	-	0.583638	0.168446	0.571789	1.77 [0.79 - 4.00]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207573_x_at	129	0.75969	0.0147365	0.215208	0.638791	0.161061	0.551226	1.74 [0.80 - 3.75]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37276	56	0.142857	0.00148565	0.035451	-1.51919	0.0796531	-0.470211	0.62 [0.37 - 1.06]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3031	56	0.625	0.0528257	-	-0.713717	0.353774	-0.30611	0.74 [0.39 - 1.41]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37276	56	0.142857	0.0059203	0.108032	-1.47572	0.122329	-0.43602	0.65 [0.37 - 1.12]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3031	56	0.625	0.00644469	0.1154	-1.11937	0.131545	-0.539205	0.58 [0.29 - 1.18]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210453_x_at	278	0.280576	0.00782533	0.134024	0.656088	0.251605	0.234771	1.26 [0.85 - 1.89]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208746_x_at	278	0.467626	0.0112412	0.176257	0.491838	0.215306	0.257774	1.29 [0.86 - 1.95]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208745_at	278	0.201439	0.0625646	-	0.458704	0.764529	0.0431033	1.04 [0.79 - 1.38]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207573_x_at	278	0.366906	0.0142087	0.209555	0.511318	0.322109	0.207239	1.23 [0.82 - 1.85]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207573_x_at	133	0.646617	0.0157667	0.226033	-0.627187	0.203967	-0.256877	0.77 [0.52 - 1.15]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208745_at	133	0.24812	0.00255096	0.0552434	-0.759609	0.0201492	-0.457415	0.63 [0.43 - 0.93]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208746_x_at	133	0.691729	0.00986591	0.159827	-0.717541	0.189404	-0.265636	0.77 [0.52 - 1.14]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210453_x_at	133	0.62406	0.011353	0.177562	-0.652139	0.244564	-0.223972	0.80 [0.55 - 1.17]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1157	81	0.888889	0.0362922	0.401702	1.30383	0.278874	0.913026	2.49 [0.48 - 13.01]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210453_x_at	185	0.664865	0.257002	-	0.192006	0.866747	-0.0155138	0.98 [0.82 - 1.18]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207573_x_at	185	0.2	0.111198	-	-0.349953	0.81281	-0.0259189	0.97 [0.79 - 1.21]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208746_x_at	185	0.681081	0.296163	-	0.179414	0.673668	-0.0386613	0.96 [0.80 - 1.15]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210453_x_at	185	0.664865	0.265961	-	0.204417	0.946508	-0.00677777	0.99 [0.81 - 1.21]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208745_at	185	0.124324	0.0733023	-	0.461767	0.461649	0.0836247	1.09 [0.87 - 1.36]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208746_x_at	185	0.697297	0.190706	-	0.244104	0.731394	-0.0342486	0.97 [0.79 - 1.18]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207573_x_at	185	0.810811	0.161859	-	0.291463	0.736369	-0.0339179	0.97 [0.79 - 1.18]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208745_at	185	0.124324	0.0782649	-	0.51269	0.388351	0.106488	1.11 [0.87 - 1.42]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P75622	110	0.254545	0.194276	-	0.379414	0.588148	0.128865	1.14 [0.71 - 1.81]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P96527	110	0.754545	0.0369294	0.406264	-0.590678	0.429442	-0.107503	0.90 [0.69 - 1.17]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P75622	110	0.4	0.097137	-	-0.489296	0.847396	-0.0579257	0.94 [0.52 - 1.70]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P96527	110	0.754545	0.0714543	-	-0.688785	0.298436	-0.180275	0.84 [0.59 - 1.17]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208745_at	80	0.7375	0.0740717	-	0.800698	0.544526	0.188984	1.21 [0.66 - 2.23]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208746_x_at	80	0.875	0.0516033	-	0.97492	0.0504024	0.773105	2.17 [1.00 - 4.70]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210453_x_at	80	0.8875	0.0240101	0.304433	1.11403	0.0587012	0.774066	2.17 [0.97 - 4.84]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207573_x_at	80	0.8875	0.00960118	0.156582	1.26408	0.0560849	0.709027	2.03 [0.98 - 4.21]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207573_x_at	38	0.894737	0.0714766	-	1.13023	0.61596	0.376884	1.46 [0.33 - 6.36]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210453_x_at	38	0.815789	0.0412119	0.435884	1.06358	0.450165	0.576885	1.78 [0.40 - 7.96]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208746_x_at	38	0.815789	0.0412119	0.435884	1.06358	0.35718	0.711858	2.04 [0.45 - 9.27]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208745_at	38	0.631579	0.175546	-	-0.744876	0.867555	-0.116007	0.89 [0.23 - 3.48]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208746_x_at	140	0.414286	0.00014088	0.0047328	-1.0977	0.0120982	-0.729914	0.48 [0.27 - 0.85]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210453_x_at	140	0.2	0.000231954	0.00731145	-1.06651	0.0109957	-0.748512	0.47 [0.27 - 0.84]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207573_x_at	140	0.271429	0.000202974	0.00651048	-1.0365	0.0150625	-0.728046	0.48 [0.27 - 0.87]
GENE	ATP5L	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208745_at	140	0.107143	1.18112e-05	0.000519436	-1.41377	0.000619106	-1.00845	0.36 [0.20 - 0.65]

